PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Ito, AM; Takayama, A; Oda, Y; Tamura, T; Kobayashi, R; Hattori, T; Ogata, S; Ohno, N; Kajita, S; Yajima, M; Noiri, Y; Yoshimoto, Y; Saito, S; Takamura, S; Murashima, T; Miyamoto, M; Nakamura, H				Ito, A. M.; Takayama, A.; Oda, Y.; Tamura, T.; Kobayashi, R.; Hattori, T.; Ogata, S.; Ohno, N.; Kajita, S.; Yajima, M.; Noiri, Y.; Yoshimoto, Y.; Saito, S.; Takamura, S.; Murashima, T.; Miyamoto, M.; Nakamura, H.			Molecular dynamics and Monte Carlo hybrid simulation for fuzzy tungsten nanostructure formation	NUCLEAR FUSION			English	Article						hybrid simulation; fuzzy nanostructure; tungsten; plasma-material interaction; molecular dynamics	BINARY-COLLISION-APPROXIMATION; MICROSTRUCTURE EVOLUTION; HELIUM CLUSTERS; IRRADIATION; SURFACE; HE; HYDROGEN; BEHAVIOR; PLASMA; MODEL	For the purposes of long-term use of tungsten divertor walls, the formation process of the fuzzy tungsten nanostructure induced by exposure to the helium plasma was studied. In the present paper, the fuzzy nanostructure's formation has been successfully reproduced by the new hybrid simulation method in which the deformation of the tungsten material due to pressure of the helium bubbles was simulated by the molecular dynamics and the diffusion of the helium atoms was simulated by the random walk based on the Monte Carlo method. By the simulation results, the surface height of the fuzzy nanostructure increased only when helium retention was under the steady state. It was proven that the growth of the fuzzy nanostructure was brought about by bursting of the helium bubbles. Moreover, we suggest the following key formation mechanisms of the fuzzy nanostructure: (1) lifting in which the surface lifted up by the helium bubble changes into a convexity, (2) bursting by which the region of the helium bubble changes into a concavity, and (3) the difference of the probability of helium retention by which the helium bubbles tend to appear under the concavity. Consequently, the convex-concave surface structure was enhanced and grew to create the fuzzy nanostructure.	[Ito, A. M.; Takayama, A.; Oda, Y.; Yajima, M.; Nakamura, H.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Tamura, T.; Kobayashi, R.; Hattori, T.; Ogata, S.] Nagoya Inst Technol, Showa Ku, Nagoya, Aichi 4668555, Japan; [Ohno, N.; Kajita, S.; Noiri, Y.; Nakamura, H.] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yoshimoto, Y.] Univ Tokyo, Bunkyo Ku, Tokyo 1138656, Japan; [Saito, S.] Kushiro Natl Coll Technol, Kushiro, Hokkaido 0840916, Japan; [Takamura, S.] Aichi Inst Technol, Toyota 4700392, Japan; [Murashima, T.] Tohoku Univ, Sendai, Miyagi 9808578, Japan; [Miyamoto, M.] Shimane Univ, Matsue, Shimane 6908504, Japan	Ito, AM (reprint author), Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	ito.atsushi@nifs.ac.jp	Kajita, Shin/Q-1020-2015		National Institute of Natural Science (NINS) Program for Cross-Disciplinary Study; Ministry of Education, Culture, Sports, Science, and Technology, Japan [23710135, 25249132, 15H05563]; National Institute for Fusion Science (NIFS) Collaboration Research programs [NIFS14KNTS028, NIFS13KNSS037]	We would like thank to Dr Naoaki Yoshida, Dr Yoshio Ueda, Dr Heun Tae Lee, and Dr Masayuki Tokitani for helpful discussions. Our work was supported by the National Institute of Natural Science (NINS) Program for Cross-Disciplinary Study and by Grants-in-Aid for Scientific Research (Nos. 23710135, 25249132 and 15H05563) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and the National Institute for Fusion Science (NIFS) Collaboration Research programs (NIFS14KNTS028 and NIFS13KNSS037). Numerical simulations were carried out by using the Plasma Simulator at NIFS and the HELIOS supercomputer system at the Computational Simulation Centre of International Fusion Energy Research Centre (IFERC-CSC), Aomori, Japan, under the Broader Approach collaboration between Euratom and Japan, implemented by Fusion for Energy and JAEA.	Kajita S, 2007, NUCL FUSION, V47, P1358, DOI 10.1088/0029-5515/47/9/038; Henriksson KOE, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2103390; Becquart CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.196402; Baldwin MJ, 2011, J NUCL MATER, V415, pS104, DOI 10.1016/j.jnucmat.2010.10.050; Martynenko YV, 2012, PLASMA PHYS REP+, V38, P996, DOI 10.1134/S1063780X12110074; Hu L, 2014, SURF SCI, V626, P21, DOI 10.1016/j.susc.2014.03.020; Krasheninnikov SI, 2013, J NUCL MATER, V438, pS861, DOI 10.1016/j.jnucmat.2013.01.186; Ito AM, 2015, J NUCL MATER, V463, P109, DOI 10.1016/j.jnucmat.2015.01.018; Becquart CS, 2009, J NUCL MATER, V386-88, P109, DOI 10.1016/j.jnucmat.2008.12.085; Ueda Y, 2009, J NUCL MATER, V386-88, P725, DOI 10.1016/j.jnucmat.2008.12.300; Becquart CS, 2007, NUCL INSTRUM METH B, V255, P23, DOI 10.1016/j.nimb.2006.11.006; Krasheninnikov SI, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014040; Lasa A, 2013, NUCL INSTRUM METH B, V303, P156, DOI 10.1016/j.nimb.2012.11.029; Noiri Y, 2015, J NUCL MATER, V463, P285, DOI 10.1016/j.jnucmat.2015.01.036; Kajita S, 2013, J APPL PHYS, V113, DOI 10.1063/1.4798597; Henriksson KOE, 2006, NUCL INSTRUM METH B, V244, P377, DOI 10.1016/j.nimb.2005.10.020; Baldwin MJ, 2010, J NUCL MATER, V404, P165, DOI 10.1016/j.jnucmat.2010.06.034; Smirnov RD, 2015, J NUCL MATER, V463, P359, DOI 10.1016/j.jnucmat.2014.10.033; Liu YL, 2009, NUCL INSTRUM METH B, V267, P3193, DOI 10.1016/j.nimb.2009.06.066; Iwakiri H, 2002, J NUCL MATER, V307, P135, DOI 10.1016/S0022-3115(02)01178-9; Kajita S, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/9/095005; Smirnov RD, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/8/082002; Saito S, 2013, J NUCL MATER, V438, pS895, DOI 10.1016/j.jnucmat.2013.01.194; Ferroni F, 2015, J NUCL MATER, V458, P419, DOI 10.1016/j.jnucmat.2014.12.090; Ito AM, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014062; Kajita S, 2011, J NUCL MATER, V418, P152, DOI 10.1016/j.jnucmat.2011.06.026; Wirth BD, 2015, J NUCL MATER, V463, P30, DOI 10.1016/j.jnucmat.2014.11.072; Hou M, 2010, J NUCL MATER, V403, P89, DOI 10.1016/j.jnucmat.2010.06.004; Yoshimoto Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2363987; Yajima M, 2013, PLASMA SCI TECHNOL, V15, P282, DOI 10.1088/1009-0630/15/3/18; Tamura T, 2014, MODEL SIMUL MATER SC, V22, DOI 10.1088/0965-0393/22/1/015002; Kajita S, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/3/033005; Takamura S, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/12/123001; Bond SD, 1999, J COMPUT PHYS, V151, P114, DOI 10.1006/jcph.1998.6171; Baldwin MJ, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/3/035001; Cusentino MA, 2015, J NUCL MATER, V463, P347, DOI 10.1016/j.jnucmat.2014.10.043; Henriksson K.O.E, 2006, FUSION SCI TECHNOL, V50, P18; Iwakiri H, 2000, J NUCL MATER, V283, P1134, DOI 10.1016/S0022-3115(00)00289-0; Kajita S, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/3/032002; Kobayashi R., 2015, J NUCL MAT IN PRESS; Lasa A, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/25002; Li X.-C., 2014, J NUCL MATER, V445, P544; Martynenko Y.V., 2012, FIZ PLAZMY, V38, P1082; Nose S, 2001, J PHYS SOC JPN, V70, P75, DOI 10.1143/JPSJ.70.75; Sefta F, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073015; Takamura S., 2014, PLASMA FUSION RES, V9; Takamura S., 2006, PLASMA FUSION RES, V1, P51, DOI 10.1585/pfr.1.051; Takamura S., 2014, PLASMA FUSION RES, V9; Takayama A, 2015, J NUCL MATER, V463, P355, DOI 10.1016/j.jnucmat.2014.11.001; Takayama A, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.01AL03; Yajima M, 2014, J NUCL MATER, V449, P9, DOI 10.1016/j.jnucmat.2014.02.027; Zhou Y.L., 2014, J NUCL MATER, V446, P43	52	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	JUL	2015	55	7							073013	10.1088/0029-5515/55/7/073013		11	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CL8YD	WOS:000357259600013		
J	Narushima, Y; Sakakibara, S; Ohdachi, S; Suzuki, Y; Watanabe, KY; Nishimura, S; Satake, S; Huang, B; Furukawa, M; Takemura, Y; Ida, K; Yoshinuma, M; Yamada, I				Narushima, Y.; Sakakibara, S.; Ohdachi, S.; Suzuki, Y.; Watanabe, K. Y.; Nishimura, S.; Satake, S.; Huang, B.; Furukawa, M.; Takemura, Y.; Ida, K.; Yoshinuma, M.; Yamada, I.		LHD Ext Grp	Experimental observation of response to resonant magnetic perturbation and its hysteresis in LHD	NUCLEAR FUSION			English	Article						halical plasma; magnetic island; plasma response		The magnetic island in the large helical device (LHD) shows the dynamic behaviour of the healing/ growth transition with the hysteretic behaviour. The thresholds of plasma beta and poloidal flow for island healing are larger than that for growth. The threshold of resonant magnetic perturbation (RMP) for healing is smaller than that for growth. Furthermore, thresholds of the amplitude of RMP depend on the magnetic axis position R-ax in the LHD. The RMP threshold increases as the magnetic axis position Rax increases. The poloidal viscosity may be considered as a candidate to explain the experimental observation from the viewpoint of the relationship between the electromagnetic torque and the viscous torque.	[Narushima, Y.; Sakakibara, S.; Ohdachi, S.; Suzuki, Y.; Watanabe, K. Y.; Satake, S.; Takemura, Y.; Ida, K.; Yoshinuma, M.; Yamada, I.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Narushima, Y.; Sakakibara, S.; Ohdachi, S.; Suzuki, Y.; Satake, S.; Huang, B.; Ida, K.; Yoshinuma, M.] Grad Univ Adv Studies, Sokendai, Toki, Gifu 5095292, Japan; [Nishimura, S.] Kobe City Coll Technol, Kobe, Hyogo 6512194, Japan; [Furukawa, M.] Tottori Univ, Tottori, Tottori 6808550, Japan	Narushima, Y (reprint author), Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	narusima@LHD.nifs.ac.jp			NIFS [ULPP014, IIDI001]; JSPS KAKENHI Grant [15K06649]	The authors thank the LHD operation group for their excellent technical support. One of the authors (Y.N.) wishes to thank Professor K. Ichiguchi who provided fruitful discussion. This study was supported by the budget (ULPP014 and IIDI001) of the NIFS. This work was supported by JSPS KAKENHI Grant Number 15K06649.	Nishimura S, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/1/014013; Hegna CC, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/11/113017; Narushima Y, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/8/083030; Nishimura S, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4773041; Waelbroeck FL, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/10/104025; Sakakibara S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/4/043010; Hegna CC, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694042; Satake S, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/5/054018; Itoh K, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1946731; Narushima Y, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/7/075010; Narushima Y., 2013, PLASMA FUSION RES, V8; Narushima Y., 2007, PLASMA FUSION RES, V2, pS1094, DOI 10.1585/pfr.2.S1094; Sakakibara S, 2010, FUSION SCI TECHNOL, V58, P471	13	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	JUL	2015	55	7							073004	10.1088/0029-5515/55/7/073004		7	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CL8YD	WOS:000357259600004		
J	Nishimura, Y; Huang, B; Cheng, CZ				Nishimura, Y.; Huang, B.; Cheng, C. Z.			Alpha particle transport in the presence of ballooning type electrostatic driftwaves	NUCLEAR FUSION			English	Article						driftwave turbulence; alpha particles; orbit stochasticity; tokamaks	TOROIDAL PLASMAS; INTEGRATION; EIGENMODES; STABILITY; MODES; WAVE	Employing Hamiltonian mechanics, the transport of fusion born alpha particles in the presence of driftwave turbulence is investigated. An analytical turbulence model based on the toroidal drift eigenmode is employed for guiding center orbit-following calculations. It is shown that high energy particles are less susceptible to driftwave turbulence. The passing particle transport is due to overlapping of guiding center electric islands whose widths are inversely proportional to the square root of the parallel velocity. For trapped particles, through a coordinate transformation from the poloidal angle and the parallel velocity to the action-angle variables, the resonance between the bounce motion and the toroidal precession motion, which can cause secondary island formation in the phase space, is demonstrated.	[Nishimura, Y.; Cheng, C. Z.] Natl Cheng Kung Univ, Inst Space & Plasma Sci, Tainan 70101, Taiwan; [Huang, B.] Grad Univ Adv Sci, Toki, Gifu 5095292, Japan	Nishimura, Y (reprint author), Natl Cheng Kung Univ, Inst Space & Plasma Sci, Tainan 70101, Taiwan.	nishimura@pssc.ncku.edu.tw	Cheng, Chio/K-1005-2014		National Cheng Kung University Top University Project [NSC 100-2112-M-006-021-MY3, MOST 103-2112-M-006-007]	One of the authors (Y.N.) is grateful for discussions with Dr M. Azumi. This work is supported by the National Cheng Kung University Top University Project, NSC 100-2112-M-006-021-MY3, and MOST 103-2112-M-006-007.	Estrada-Mila C, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2364149; CHENG CZ, 1980, PHYS FLUIDS, V23, P1770, DOI 10.1063/1.863202; Urano H, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/8/083003; HASTIE RJ, 1981, NUCL FUSION, V21, P187, DOI 10.1088/0029-5515/21/2/006; Qin H, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3099055; FENG K, 1986, J COMPUT MATH, V4, P279; BENETTIN G, 1976, PHYS REV A, V14, P2338, DOI 10.1103/PhysRevA.14.2338; CHEN L, 1980, PHYS FLUIDS, V23, P2242, DOI 10.1063/1.862907; Rewoldt G, 2007, COMPUT PHYS COMMUN, V177, P775, DOI 10.1016/j.cpc.2007.06.017; CHENG CZ, 1982, PHYS FLUIDS, V25, P1020, DOI 10.1063/1.863858; Zhang WL, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.095001; Kim JS, 1997, PHYS REV LETT, V79, P841, DOI 10.1103/PhysRevLett.79.841; White AE, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3318469; White AE, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3323084; CONNOR JW, 1979, P ROY SOC LOND A MAT, V365, P1, DOI 10.1098/rspa.1979.0001; MCKEE G, 1995, PHYS REV LETT, V75, P649, DOI 10.1103/PhysRevLett.75.649; CANDY J, 1991, J COMPUT PHYS, V92, P230, DOI 10.1016/0021-9991(91)90299-Z; WEYSSOW B, 1991, PLASMA PHYS CONTR F, V33, P763, DOI 10.1088/0741-3335/33/7/003; Birdsall C. K., 1986, PLASMA PHYS VIA COMP, P18; Boozer A. H., 1981, PHYS FLUIDS, V24, P859; Cheng C. Z., 2014, J PLASMA FUSION RES, V9; GILL S, 1951, P CAMB PHILOS SOC, V47, P96; Hashitsume N., 1991, STAT PHYS, V2, P10; Hauff T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.075004; Jacquinot J, 1999, NUCL FUSION, V39, P2471, DOI 10.1088/0029-5515/39/12/305; Kolmogorov A. N., 1954, DOKL AKAD NAUK SSSR, V98, P527; Kubo R., 1972, STAT PHYS; Miyamoto K., 1987, PLASMA PHYS NUCL FUS, P35; Nishimura Y, 1999, PHYS PLASMAS, V6, P4685, DOI 10.1063/1.873755; Press W. H., 1992, NUMERICAL RECIPES FO, P617; White AE, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2895408; Zakharov L. E., 1978, PLASMA PHYS CONTROLL, V1, P689	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	JUL	2015	55	7							073016	10.1088/0029-5515/55/7/073016		12	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CL8YD	WOS:000357259600016		
J	Shinya, T; Takase, Y; Wakatsuki, T; Ejiri, A; Furui, H; Hiratsuka, J; Imamura, K; Inada, T; Kakuda, H; Kasahara, H; Kumazawa, R; Moeller, C; Mutoh, T; Nagashima, Y; Nakamura, K; Nakanishi, A; Oosako, T; Saito, K; Seki, T; Sonehara, M; Togashi, H; Tsuda, S; Tsujii, N; Yamaguchi, T				Shinya, T.; Takase, Y.; Wakatsuki, T.; Ejiri, A.; Furui, H.; Hiratsuka, J.; Imamura, K.; Inada, T.; Kakuda, H.; Kasahara, H.; Kumazawa, R.; Moeller, C.; Mutoh, T.; Nagashima, Y.; Nakamura, K.; Nakanishi, A.; Oosako, T.; Saito, K.; Seki, T.; Sonehara, M.; Togashi, H.; Tsuda, S.; Tsujii, N.; Yamaguchi, T.			Non-inductive plasma start-up experiments on the TST-2 spherical tokamak using waves in the lower-hybrid frequency range	NUCLEAR FUSION			English	Article						spherical tokamak; lower hybrid wave; non-inductive plasma start-up		Non-inductive plasma current start-up and sustainment by waves in the lower-hybrid frequency range (200 MHz) have been studied on the TST-2 spherical tokamak (R-0 <= 0.38 m, a <= 0.25 m, B-t0 <= 0.3T, I-p <= 0.14 MA) using three types of antenna: the 11-element inductively-coupled combline antenna, the dielectric loaded 4-waveguide array antenna, and the 13-element capacitively-coupled combline (CCC) antenna. The maximum plasma currents of 15 kA, 10 kA and 16 kA were achieved, respectively. The highest current drive figure of merit eta(CD) = (n) over tilde eIpR/P-RF was achieved by the CCC antenna. The efficiency of current drive should improve by reducing prompt orbit losses of high energy electrons by operating at higher plasma current (to improve orbit confinement) and higher toroidal magnetic field (to improve wave accessibility to the plasma core), while keeping the density high enough (to avoid excessive acceleration of electrons), but under the 'density limit'.	[Shinya, T.; Takase, Y.; Wakatsuki, T.; Ejiri, A.; Furui, H.; Hiratsuka, J.; Imamura, K.; Inada, T.; Kakuda, H.; Nakamura, K.; Nakanishi, A.; Oosako, T.; Sonehara, M.; Togashi, H.; Tsuda, S.; Tsujii, N.; Yamaguchi, T.] Univ Tokyo, Kashiwa, Chiba 2778561, Japan; [Kasahara, H.; Kumazawa, R.; Mutoh, T.; Saito, K.; Seki, T.] Natl Inst Fusion Sci, Toki, Gifu 5095292, Japan; [Moeller, C.] Gen Atom, San Diego, CA 92186 USA; [Nagashima, Y.] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan	Shinya, T (reprint author), Univ Tokyo, Kashiwa, Chiba 2778561, Japan.	takase@k.u-tokyo.ac.jp	Kyushu, RIAM/F-4018-2015		Japan Society for the Promotion of Science (JSPS) [21226021, 21246137, 23360409]; National Institute for Fusion Science (NIFS) Collaboration Research Program [NIFS12KNWR001, NIFS14KOCR001]; Japan/US Cooperation in Fusion Research and Development; JSPS A3 Foresight Program 'Innovative Tokamak Plasma Startup and Current Drive in Spherical Torus'; US DoE [DE-AC03-97ER-54411]	This work is supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (S) (21226021), (A) (21246137) and (B) (23360409), by National Institute for Fusion Science (NIFS) Collaboration Research Program NIFS12KNWR001 and NIFS14KOCR001, by Japan/US Cooperation in Fusion Research and Development, and by JSPS A3 Foresight Program 'Innovative Tokamak Plasma Startup and Current Drive in Spherical Torus'. Collaborations with P. Bonoli and J. Wright at MIT on TORLH/GENRAY/CQL3D calculations are gratefully acknowledged. Work at General Atomics is supported by US DoE contract DE-AC03-97ER-54411.	Wakatsuki T, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/9/093014; PORKOLAB M, 1977, PHYS FLUIDS, V20, P2058, DOI 10.1063/1.861825; Baek SG, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4884355; Ejiri A, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/065010; Wallace GM, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4729734; Wright JC, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3166137; Takase Y, 2001, NUCL FUSION, V41, P1543, DOI 10.1088/0029-5515/41/11/303; Uchida M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.065001; Najmabadi F, 2003, FUSION ENG DES, V65, P143, DOI 10.1016/S0920-3796(02)00302-2; Harvey R. W., 1985, CQL3D CODE; Nishio S., 2004, P 8 INT C DAM FRACT; Peng Y.-K. M., 2014, PLASMA FUSION RES, V9; Shiraiwa S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.035001; Smirnov A. P., 1994, GENRAY CODE; Takase Y, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/6/063006; Takase Y, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063017	16	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	JUL	2015	55	7							073003	10.1088/0029-5515/55/7/073003		8	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CL8YD	WOS:000357259600003		
J	Todo, Y; Van Zeeland, MA; Bierwage, A; Heidbrink, WW; Austin, ME				Todo, Y.; Van Zeeland, M. A.; Bierwage, A.; Heidbrink, W. W.; Austin, M. E.			Validation of comprehensive magnetohydrodynamic hybrid simulations for Alfven eigenmode induced energetic particle transport in DIII-D plasmas	NUCLEAR FUSION			English	Article						energetic particle; Alfven eigenmode; hybrid simulation; magnetohydrodynamics	GYROFLUID MODEL	A multi-phase simulation, which is a combination of classical simulation and hybrid simulation for energetic particles interacting with a magnetohydrodynamic (MHD) fluid including neutral beam injection, slowing-down, and pitch angle scattering, is applied to DIII-D discharge #142111 where the fast ion spatial profile is significantly flattened due to multiple Alfven eigenmodes (AEs). The large fast ion pressure profile flattening observed experimentally is successfully reproduced by these first of a kind comprehensive simulations. Temperature fluctuations due to three of the dominant toroidal Alfven eigenmodes in the simulation results are compared in detail with electron cyclotron emission measurements in the experiment. It is demonstrated that the temperature fluctuation profile and the phase profile are in very good agreement with the measurement, and the amplitude is also in agreement within a factor of two. This level of agreement validates the multi-phase hybrid simulation for the prediction of AE activity and alpha particle transport in burning plasmas.	[Todo, Y.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Todo, Y.] SOKENDAI Grad Univ Adv Studies, Dept Fus Sci, Toki, Gifu 5095292, Japan; [Van Zeeland, M. A.] Gen Atom Co, San Diego, CA 92186 USA; [Bierwage, A.] Japan Atom Energy Agcy, Aomori 0393212, Japan; [Heidbrink, W. W.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Austin, M. E.] Univ Texas Austin, Inst Fus Studies, Austin, TX 78712 USA	Todo, Y (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	todo@nifs.ac.jp			K Computer of RIKEN Advanced Institute for Computational Science [hp120212]; JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NRF) [2012K2A2A6000443]; JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC) [11261140328]	Numerical computations were performed at the Helios of the International Fusion Energy Center, the Plasma Simulator of National Institute for Fusion Science, and the K Computer of RIKEN Advanced Institute for Computational Science (Project ID: hp120212). This work was partly supported by the JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NRF: No. 2012K2A2A6000443, NSFC: No. 11261140328).	Todo Y, 1998, PHYS PLASMAS, V5, P1321, DOI 10.1063/1.872791; Heidbrink WW, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.245002; Ghantous K, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4752011; Chen Y, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4775776; SPONG DA, 1992, PHYS FLUIDS B-PLASMA, V4, P3316, DOI 10.1063/1.860386; Todo Y, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/8/084016; LITTLEJOHN RG, 1983, J PLASMA PHYS, V29, P111; TODO Y, 1995, PHYS PLASMAS, V2, P2711, DOI 10.1063/1.871235; White RB, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3327208; ZONCA F, 1995, PHYS REV LETT, V74, P698, DOI 10.1103/PhysRevLett.74.698; Todo Y, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/9/094018; Fasoli A, 2007, NUCL FUSION, V47, pS264, DOI 10.1088/0029-5515/47/6/S05; Vlad G, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075024; Heidbrink WW, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2838239; Van Zeeland MA, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3574663; METT RR, 1992, PHYS FLUIDS B-PLASMA, V4, P2885, DOI 10.1063/1.860459; Wang X, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/11/115005; Tobias BJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.075003; Todo Y, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/3/033003; Wang ZX, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.145003; Bierwage A, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073007; BRIGUGLIO S, 1995, PHYS PLASMAS, V2, P3711, DOI 10.1063/1.871071; Todo Y, 2003, PHYS PLASMAS, V10, P2888, DOI 10.1063/1.1580122; Bass EM, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4773177; SPONG DA, 1994, PHYS PLASMAS, V1, P1503, DOI 10.1063/1.870700; Berk HL, 1995, NUCL FUSION, V35, P1713, DOI 10.1088/0029-5515/35/12/I36; Bierwage A, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/10/104001; Hazeltine R. D., 1992, PLASMA CONFINEMENT; PARK W, 1992, PHYS FLUIDS B-PLASMA, V4, P2033, DOI 10.1063/1.860011; Spong D. A., 2014, PLASMA FUSION RES, V9; Spong DA, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4747505; Todo Y, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/10/104012; Van Zeeland MA, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/065003; Van Zeeland MA, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/9/094023; White RB, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/4/045012	35	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	JUL	2015	55	7							073020	10.1088/0029-5515/55/7/073020		8	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CL8YD	WOS:000357259600020		
J	Yan, LW; Cheng, J; Dong, JQ; Itoh, K; Zhao, KJ; Huang, ZH; Ji, XQ; Yu, DL; Nie, L; Jiang, M; Liu, CH; Song, XM; Yuan, BS; Liu, Y; Yang, QW; Ding, XT; Itoh, SI; Duan, XR; Liu, Y				Yan, L. W.; Cheng, J.; Dong, J. Q.; Itoh, K.; Zhao, K. J.; Huang, Z. H.; Ji, X. Q.; Yu, D. L.; Nie, L.; Jiang, M.; Liu, C. H.; Song, X. M.; Yuan, B. S.; Liu, Yi; Yang, Q. W.; Ding, X. T.; Itoh, S. -I.; Duan, X. R.; Liu, Y.		HL-2A Team	The effect of beta-induced Alfven eigenmode on L-I-H transitions in the HL-2A tokamak	NUCLEAR FUSION			English	Article						beta-induced Alfven eigenmode; L-I-H transition; limit cycle oscillations; electrostatic fluctuation; magnetic perturbation; Langmuir probe array; bicoherence	CONFINEMENT; MODES	The characteristics of beta-induced Alfven eigenmode (BAE) at L-I-H transitions have been investigated in the HL-2A experiments for the first time. It is found that a BAE of f(BAE) similar to 13.6 kHz coexists with the limit cycle oscillations of f(LCO) similar to 2.6 kHz and both disappear after the I-H transition in the discharges with L-I-H transitions. It is also found that the ambient turbulence is modulated by the radial electric field at the BAE frequency and that the level of density fluctuation gradually drops in L-I-H transitions, but it remains invariant in L-I-L ones. These results suggest a possible correlation between the BAE and the L-I-H transitions. The sudden disappearance of the BAE in L-I and I-H transitions has the similar effect of sawtooth crashes on triggering L-I-H transitions in the HL-2A tokamak.	[Yan, L. W.; Cheng, J.; Dong, J. Q.; Zhao, K. J.; Huang, Z. H.; Ji, X. Q.; Yu, D. L.; Jiang, M.; Liu, C. H.; Song, X. M.; Yuan, B. S.; Liu, Yi; Yang, Q. W.; Ding, X. T.; Duan, X. R.; Liu, Y.] Southwestern Inst Phys, Chengdu 610041, Sichuan, Peoples R China; [Dong, J. Q.] Zhejiang Univ, Inst Fus Theory & Simulat, Hangzhou 310027, Zhejiang, Peoples R China; [Itoh, K.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Nie, L.] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China; [Itoh, S. -I.] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan	Yan, LW (reprint author), Southwestern Inst Phys, POB 432, Chengdu 610041, Sichuan, Peoples R China.	lwyan@swip.ac.cn	Kyushu, RIAM/F-4018-2015		China-Korean Joint Foundation [2012DFG02230]; National Science Foundation of China [11320101005, 11375054, 11175060, 11075046]; National Development Project on Magnetic Confinement Fusion Energy of China [2014GB107000, 2013GB112008, 2013GB107002, 2014GB108000]; KAKENHI Asada Science Foundation of Japan [21224014, 23244113]	This work is partially supported by the China-Korean Joint Foundation under the grant No. 2012DFG02230; the National Science Foundation of China under grant Nos. 11320101005, 11375054, 11175060 and 11075046; the National Development Project on Magnetic Confinement Fusion Energy of China under grant Nos 2014GB107000, 2013GB112008, 2013GB107002, 2014GB108000; and by KAKENHI (Grants No. 21224014, No 23244113) Asada Science Foundation of Japan.	Estrada T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.245004; Chen W, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.185004; Shi ZB, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4866640; Zonca F, 1996, PLASMA PHYS CONTR F, V38, P2011, DOI 10.1088/0741-3335/38/11/011; Tynan GR, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073053; Zarzoso D, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.125002; Schmitz L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.155002; Liu AD, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.095002; Yan Z, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113038; Qi LY, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4794287; Shimada M, 2007, NUCL FUSION, V47, pS1, DOI 10.1088/0029-5515/47/6/S01; Kobayashi T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.035002; Zhao KJ, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/12/123015; Zhao KJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.255004; KIM YC, 1979, IEEE T PLASMA SCI, V7, P120, DOI 10.1109/TPS.1979.4317207; HEIDBRINK WW, 1993, PHYS REV LETT, V71, P855, DOI 10.1103/PhysRevLett.71.855; TURNBULL AD, 1993, PHYS FLUIDS B-PLASMA, V5, P2546, DOI 10.1063/1.860742; Colchin RJ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.255002; Wang X, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/11/115005; Kim EJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.185006; McKee GR, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/11/115016; ITOH SI, 1988, PHYS REV LETT, V60, P2276, DOI 10.1103/PhysRevLett.60.2276; Burrell KH, 1997, PHYS PLASMAS, V4, P1499, DOI 10.1063/1.872367; Chen W, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063010; Cheng J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.265002; Cheng J., 2015, J NUCL MAT IN PRESS; Cheng J, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/11/114004; Conway G. D., 2011, PHYS REV LETT; Ding X. T., 2013, NUCL FUSION, V53; Duan XR, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/9/095011; Liu C. H., 2012, P 24 INT C FUS ENG S; Miki K, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3353037; WAGNER F, 1982, PHYS REV LETT, V49, P1408, DOI 10.1103/PhysRevLett.49.1408; Xiao WW, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/11/114027; Xu GS, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.125001; Yan LW, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/9/094016	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	JUL	2015	55	7							073026	10.1088/0029-5515/55/7/073026		7	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CL8YD	WOS:000357259600026		
J	Yoshida, M; Honda, M; Narita, E; Hayashi, N; Urano, H; Nakata, M; Miyato, N; Takenaga, H; Ide, S; Kamada, Y				Yoshida, M.; Honda, M.; Narita, E.; Hayashi, N.; Urano, H.; Nakata, M.; Miyato, N.; Takenaga, H.; Ide, S.; Kamada, Y.			Effects of toroidal rotation shear and magnetic shear on thermal and particle transport in plasmas with electron cyclotron heating on JT-60U	NUCLEAR FUSION			English	Article						rotation shear; magnetic shear; ECH; thermal transport; particle transport; plasma confinement	ADVANCED TOKAMAK PROGRAM; DIII-D; ASDEX UPGRADE; BARRIERS; MODE; DISCHARGES; BEHAVIOR	Increases in thermal and particle transport with electron cyclotron heating (ECH) that are observed in many tokamaks can be a critical issue in establishing ITER operational scenarios with electron heating. To address the issues, conditions with no increase in the thermal and particle transport with ECH have been experimentally investigated in positive magnetic shear, weak magnetic shear (WS) and reversed magnetic shear plasmas with internal transport barrier in the ion channel. The ion heat diffusivity (chi i) around the internal transport barrier in the ion temperature remains constant with ECH when a large negative toroidal rotation shear (vertical bar dV(phi)/dr vertical bar > 4 x 10(5) s(-1)) is formed before the ECH. On the other hand, chi i increases on the condition that the toroidal rotation shear is small or positive. The characteristics do not depend on magnetic shear, the electron to ion temperature ratio (T-e/T-i) and ECH power. The electron heat diffusivity stays constant with ECH when the magnetic shear is negative. Effective particle transport remains constant or reduces during ECH under the condition of negative magnetic shear. An observation indicates that there is no threshold of the negative magnetic shear or a very small one for the electron channel sustainment; the electron thermal and particle confinement is maintained during ECH with a small negative magnetic shear in the WS operation.	[Yoshida, M.; Honda, M.; Hayashi, N.; Urano, H.; Nakata, M.; Miyato, N.; Takenaga, H.; Ide, S.; Kamada, Y.] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan; [Narita, E.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Yoshida, M (reprint author), Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan.	yoshida.maiko@jaea.go.jp			Japan Society for the Promotion of Science (JSPS) [24760706]	The authors would like to thank Dr M. Yagi, Dr T. Fujita, Dr T.H. Watanabe and Dr H. Kubo for their fruitful discussions and suggestions. The authors also would like to thank the JT-60U team for their contribution to the experiments. This work was supported by a Grant-in-Aid for Young Scientists (B) (No 24760706) from the Japan Society for the Promotion of Science (JSPS) and was carried out using the HELIOS supercomputer system at International Fusion Energy Research Centre, Aomori, Japan, under the Broader Approach collaboration between Euratom and Japan, implemented by Fusion for Energy and JAEA.	Angioni C, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/2/023006; Shirai H, 2000, PLASMA PHYS CONTR F, V42, P1193, DOI 10.1088/0741-3335/42/11/306; Schmitz L, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/2/023003; WEILAND J, 1989, NUCL FUSION, V29, P1810, DOI 10.1088/0029-5515/29/10/015; Oyama N, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/10/104007; Diamond PH, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/4/045002; Tala TJJ, 2001, PLASMA PHYS CONTR F, V43, P507, DOI 10.1088/0741-3335/43/4/309; Honda M, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073018; Takenaga H, 2008, J PHYS CONF SER, V123, DOI 10.1088/1742-6596/123/1/012037; Honda M, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/8/085003; HINTON FL, 1976, REV MOD PHYS, V48, P239, DOI 10.1103/RevModPhys.48.239; Greenfield CM, 1999, NUCL FUSION, V39, P1723, DOI 10.1088/0029-5515/39/11Y/312; KOTSCHENREUTHER M, 1995, COMPUT PHYS COMMUN, V88, P128, DOI 10.1016/0010-4655(95)00035-E; Burrell KH, 2003, NUCL FUSION, V43, P1555, DOI 10.1088/0029-5515/43/12/003; Takenaga H, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075012; Ide S, 2007, NUCL FUSION, V47, P1499, DOI 10.1088/0029-5515/47/11/011; Isayama A, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/5/055006; Burrell KH, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/8/083020; Yoshida M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.065003; Crombe K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.155003; Allen SL, 2001, NUCL FUSION, V41, P1341, DOI 10.1088/0029-5515/41/10/304; Angioni C, 2004, NUCL FUSION, V44, P827, DOI 10.1088/0029-5515/44/8/003; Takenaga H, 2003, NUCL FUSION, V43, P1235, DOI 10.1088/0029-5515/43/10/026; Yoshida M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/8/083022; Yoshida M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.105002; Burrell KH, 1997, PHYS PLASMAS, V4, P1499, DOI 10.1063/1.872367; Chapman IT, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/6/063006; Fujita T, 2002, PLASMA PHYS CONTR F, V44, pA19, DOI 10.1088/0741-3335/44/5A/302; Fujita T, 2004, PLASMA PHYS CONTR F, V46, pA35, DOI 10.1088/0741-3335/46/5A/003; McKee G.R., 2014, 25 IAEA INT C FUS EN; Prater R, 2007, NUCL FUSION, V47, P371, DOI 10.1088/0029-5515/47/5/001; Stober J, 2002, PLASMA PHYS CONTR F, V44, pA159, DOI 10.1088/0741-3335/44/5A/312; Urso L, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/2/025010	33	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	JUL	2015	55	7							073014	10.1088/0029-5515/55/7/073014		9	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CL8YD	WOS:000357259600014		
J	Sato, K; Gosho, M; Yamamoto, T; Kobayashi, Y; Ishii, N; Ohashi, T; Nakade, Y; Ito, K; Fukuzawa, Y; Yoneda, M				Sato, Ken; Gosho, Masahiko; Yamamoto, Takaya; Kobayashi, Yuji; Ishii, Norimitsu; Ohashi, Tomohiko; Nakade, Yukiomi; Ito, Kiyoaki; Fukuzawa, Yoshitaka; Yoneda, Masashi			Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials	NUTRITION			English	Article						Nonalcoholic steatohepatitis; alpha-Tocopherol; Vitamin E; Meta-analysis; NASH; NAFLD	AMERICAN-GASTROENTEROLOGICAL-ASSOCIATION; LIFE-STYLE INTERVENTION; ALL-CAUSE MORTALITY; E SUPPLEMENTATION; LIPID-PEROXIDATION; PRACTICE GUIDELINE; STEATOHEPATITIS; CHILDREN; DIAGNOSIS; PIOGLITAZONE	Objectives: Vitamin E is often used in the treatment of nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH); however, the magnitude of treatment response associated with vitamin E in improving liver function and histology in NAFLD/NASH has not, to our knowledge, been quantified systematically. Thus, we conducted a meta-analysis of randomized controlled trials (RCTs) using vitamin E in the treatment of NAFLD/NASH. Methods: PubMed, Medline, and Cochrane Library Full Text Database, and Japan Medical-Literature Database (Igaku Chuo Zasshi) were searched until March 2014, and five RCTs were identified for meta-analysis. Results: According to a random effect model analysis of the five studies, vitamin E significantly reduced aspartate transaminase (AST) by -19.43 U/L, alanine aminotransferase (ALT) by -28.91 U/L, alkaline phosphatase (ALP) by -10.39 U/L, steatosis by -0.54 U/L, inflammation by -0.20 U/L, and hepatocellular ballooning by -0.34 U/L compared with the control group. Vitamin E treatment with NASH adult patients showed obvious reductions in not only AST of -13.91 U/L, ALT by -22.44 U/L, steatosis of -0.67 U/L, inflammation of -0.20 U/L, but also fibrosis of -0.30 U/L compared to the control treatment. Conclusions: Vitamin E significantly improved liver function and histologic changes in patients with NAFLD/NASH. (C) 2015 Elsevier Inc. All rights reserved.	[Sato, Ken; Yamamoto, Takaya; Kobayashi, Yuji; Ishii, Norimitsu; Ohashi, Tomohiko; Nakade, Yukiomi; Ito, Kiyoaki; Fukuzawa, Yoshitaka; Yoneda, Masashi] Aichi Med Univ, Dept Internal Med, Div Gastroenterol, Nagakute, Aichi 48011, Japan; [Gosho, Masahiko] Aichi Med Univ, Adv Med Res Ctr, Nagakute, Aichi 48011, Japan	Sato, K (reprint author), Aichi Med Univ, Dept Internal Med, Div Gastroenterol, Nagakute, Aichi 48011, Japan.	ken90041@aichi-med-u.ac.jp					Adams LA, 2007, ANN EPIDEMIOL, V17, P863, DOI 10.1016/j.annepidem.2007.05.013; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Ji HF, 2014, NUTRITION, V30, P986, DOI 10.1016/j.nut.2014.01.016; Chalasani N, 2004, AM J GASTROENTEROL, V99, P1497, DOI 10.1111/j.1572-0241.2004.30159.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hamaguchi M, 2005, ANN INTERN MED, V143, P722; BACON BR, 1994, GASTROENTEROLOGY, V107, P1103; Wang ZL, 2007, POSTGRAD MED J, V83, P192, DOI 10.1136/pgmj.2006.052258; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Boettcher E, 2012, ALIMENT PHARM THER, V35, P66, DOI 10.1111/j.1365-2036.2011.04912.x; Vajro P, 2004, J PEDIATR GASTR NUTR, V38, P48, DOI 10.1097/00005176-200401000-00012; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Wang CL, 2008, WORLD J GASTROENTERO, V14, P1598, DOI 10.3748/wjg.14.1598; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Day CP, 2002, BEST PRACT RES CL GA, V16, P663, DOI 10.1053/bega.2002.0333; Fan JG, 2007, J GASTROEN HEPATOL, V22, P663, DOI 10.1111/j.1440-1746.2007.04892.x; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2485, DOI 10.1016/j.amjgastroenterol.2003.08.005; Bugianesi E, 2005, AM J GASTROENTEROL, V100, P1082, DOI 10.1111/j.1572-0241.2005.41583.x; Egger M, 1997, BRIT MED J, V315, P629; Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128; Du J, 2014, WORLD J GASTROENTERO, V20, P569, DOI 10.3748/wjg.v20.i2.569; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Berry D, 2009, CLIN TRIALS, V6, P28, DOI 10.1177/1740774508101279; Levene AP, 2012, HISTOPATHOLOGY, V61, P141, DOI 10.1111/j.1365-2559.2011.04145.x; Dufour JF, 2006, CLIN GASTROENTEROL H, V4, P1537, DOI 10.1016/j.cgh.2006.09.025; Miller ER, 2005, ANN INTERN MED, V142, P37; Socha P, 2009, J PEDIATR GASTR NUTR, V48, P587, DOI 10.1097/MPG.0b013e31818e04d1; Nobili V, 2008, HEPATOLOGY, V48, P119, DOI 10.1002/hep.22336; Dietrich M, 2009, ATHEROSCLEROSIS, V205, P549, DOI 10.1016/j.atherosclerosis.2008.12.019; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Musso G, 2010, HEPATOLOGY, V52, P79, DOI 10.1002/hep.23623; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Gerss J, 2009, CELL MOL BIOL NOIS S; Hasegawa T, 2001, ALIMENT PHARM THERAP, V15, P1667, DOI 10.1046/j.1365-2036.2001.01083.x; Hashimoto E, 2015, HEPATOL RES, V45, P20, DOI 10.1111/hepr.12333; Lirussi F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004996.pub3; Marignani Massimo, 2002, N Engl J Med, V347, P768; PAROLA M, 1992, FEBS LETT, V308, P267, DOI 10.1016/0014-5793(92)81290-3	44	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	JUL-AUG	2015	31	7-8					923	930		10.1016/j.nut.2014.11.018		8	Nutrition & Dietetics	Nutrition & Dietetics	CL5KE	WOS:000356998000004		
J	Higuchi, K; Saito, I; Maruyama, K; Eguchi, E; Mori, H; Tanno, S; Sakurai, S; Kishida, T; Nishida, W; Osawa, H; Tanigawa, T				Higuchi, Kana; Saito, Isao; Maruyama, Koutatsu; Eguchi, Eri; Mori, Hiromi; Tanno, Sakurako; Sakurai, Susumu; Kishida, Taro; Nishida, Wataru; Osawa, Haruhiko; Tanigawa, Takeshi			Associations of serum beta-carotene and retinol concentrations with insulin resistance: The Toon Health Study	NUTRITION			English	Article						Insulin resistance; Serum beta-carotene; Serum retinol	HOMEOSTASIS MODEL ASSESSMENT; TYPE-2 DIABETES-MELLITUS; VITAMIN-C; VEGETABLE INTAKE; POPULATION; GLUCOSE; COMMUNITY; RISK; METAANALYSIS; TOCOPHEROLS	Objective: Although green and yellow vegetables have beneficial effects against type 2 diabetes, the relationship of their nutritive content with insulin resistance is poorly understood. The aim of this study was to examine the associations of serum beta-carotene and retinol concentrations with glucose and insulin concentrations. Methods: We recruited 951 Japanese men and women ages 30 to 79 y who were not undergoing treatment for diabetes and measured their serum beta-carotene and retinal concentrations. A 75-g oral glucose tolerance test was performed and the homeostasis model assessment for insulin resistance (HOMA-IR) and the Matsuda Index were calculated as measures of insulin resistance. Several confounding factors were adjusted for with multivariable logistic models. Results: Multivariable-adjusted odds ratios of the highest quartile of serum beta-carotene compared with the lowest quartile for HOMA-IR >1.6 and Matsuda Index <4.9 were 0.56 (95% confidence interval, 0.34-0.94) and 0.62 (0.37-1.02), respectively. When stratified by sex and overweight status, these associations were observed for women and non-overweight individuals. Serum retinol concentration was not associated with either index. Furthermore, according to the nutritional survey, serum beta-carotene concentration was associated with green and yellow vegetable intake (P = 0.01). Conclusion: Our findings suggest that higher serum beta-carotene levels, associated with higher intake of green and yellow vegetables, confer beneficial effects against insulin resistance. (C) 2015 Elsevier Inc. All rights reserved.	[Higuchi, Kana; Saito, Isao] Ehime Univ, Grad Sch Med, Dept Basic Nursing & Hlth Sci, Toon, Japan; [Higuchi, Kana; Nishida, Wataru; Osawa, Haruhiko] Ehime Univ, Grad Sch Med, Dept Diabet & Mol Genet, Toon, Japan; [Maruyama, Koutatsu] Ehime Univ, Grad Sch Med, Dept Basic Med Res & Educ, Toon, Japan; [Eguchi, Eri; Mori, Hiromi] Ehime Univ, Grad Sch Med, Dept Publ Hlth, Toon, Japan; [Eguchi, Eri] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Publ Hlth, Okayama 7008530, Japan; [Tanno, Sakurako] Ehime Univ Hosp, Ctr Sleep Med, Toon, Japan; [Sakurai, Susumu] Tenri Hlth Care Univ, Fac Hlth Care, Dept Clin Lab Sci, Tenri, Nara, Japan; [Kishida, Taro] Ehime Univ, Fac Agr, Matsuyama, Ehime 790, Japan; [Nishida, Wataru] Nishida Wataru Diabet Clin, Matsuyama, Ehime, Japan; [Tanigawa, Takeshi] Juntendo Univ, Grad Sch Med, Dept Publ Hlth, Bunkyo Ku, Tokyo, Japan	Saito, I (reprint author), Ehime Univ, Grad Sch Med, Dept Basic Nursing & Hlth Sci, Toon, Japan.	saitoi@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22390134, 25293142, 20590647, 20590634, 23590796, 25860443, 25860441]; Health and Labor Sciences Research Grants from the Ministry of Health, Welfare and Labor, Japan (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus) [201021038 A]	This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants-in-Aid for Research B, No. 22390134 in 2010-2012 and No. 25293142 from 2013, Grant-in-Aid for research C, No. 20590647 in 2008-2010 and No. 20590634 in 2008-2010, No. 23590796 in 2011-2013, Grand-in-Aid for Young Scientists B, No. 25860443 and No. 25860441 from 2013), Health and Labor Sciences Research Grants from the Ministry of Health, Welfare and Labor, Japan (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus, No. 201021038 A in 2010-2012). TT, IS, HO, and WN designed the study. KH, MM, EE, HM, ST, and SS collected the data. TM measured serum beta-carotene and retinal concentrations. HO and WN reviewed and edited the manuscript, contributing the valuable clinical suggestions. KY wrote the manuscript, and IS had primary responsibility for the final content of the manuscript. All authors contributed to the interpretation of the results and revising of the manuscript. There are no conflicts of interest to declare.	Alberto EC, 2014, J ATHEROSCLER THROMB, V21, P1290; Faure H, 2006, EUR J CLIN NUTR, V60, P706, DOI 10.1038/sj.ejcn.1602372; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ishikawa-Takata K, 2011, J EPIDEMIOL, V21, P114, DOI 10.2188/jea.JE20100079; Arnlov J, 2009, DIABETOLOGIA, V52, P97, DOI 10.1007/s00125-008-1189-3; Ford ES, 1999, AM J EPIDEMIOL, V149, P168; Beydoun MA, 2011, J NUTR, V141, P903, DOI 10.3945/jn.110.136580; Sugiura M, 2006, J EPIDEMIOL, V16, P71, DOI 10.2188/jea.16.71; Ohmori K, 2005, ANN EPIDEMIOL, V15, P80, DOI 10.1016/j.annepidem.2004.04.001; Coyne T, 2005, AM J CLIN NUTR, V82, P685; Larsson SC, 2007, J INTERN MED, V262, P208, DOI 10.1111/j.1365-2796.2007.01840.x; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Galan P, 2005, EUR J CLIN NUTR, V59, P1181, DOI 10.1038/sj.ejcn.1602230; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Hopping BN, 2010, J NUTR, V140, P68, DOI 10.3945/jn.109.112441; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Harding AH, 2008, ARCH INTERN MED, V168, P1493, DOI 10.1001/archinte.168.14.1493; Tabara Y, 2011, J HYPERTENS, V29, P1948, DOI 10.1097/HJH.0b013e32834abd06; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; MARTINI MC, 1995, CANCER EPIDEM BIOMAR, V4, P491; Blondin SA, 2013, ISRN NUTR, V2013; Carter P, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4229; COMSTOCK GW, 1995, CANCER EPIDEM BIOMAR, V4, P505; Eiyo Kenko, 2013, NAT HLTH NUTR SURV J; Facchini FS, 2000, AM J CLIN NUTR, V72, P776; Kenkyukai Kenko Eiyo Joho, 2011, NAT HLTH NUTR SURV J; Meisinger C, 2011, DIABETES CARE, V34, P1648, DOI 10.2337/dc11-0118; MICOZZI MS, 1992, AM J CLIN NUTR, V55, P1120; Takahashi K., 2001, Japanese Journal of Nutrition, V59, P221; Tanno S, 2014, SLEEP MED, V15, P1212, DOI 10.1016/j.sleep.2014.05.027; Venkatasamy W, 2013, J CLIN DIAGN RES, V7, P1764; Willett WC, 1997, AM J CLIN NUTR, V65, p1229S; Willett WC, 1997, AM J CLIN NUTR, V65, P1220	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	JUL-AUG	2015	31	7-8					975	980		10.1016/j.nut.2015.02.015		6	Nutrition & Dietetics	Nutrition & Dietetics	CL5KE	WOS:000356998000013		
J	Takagi, H; Kobayashi, Y; Taguchi, O; Takei, Y; Sumida, Y				Takagi, Hisayo; Kobayashi, Yoshinao; Taguchi, Osamu; Takei, Yoshiyuki; Sumida, Yasuhiro			Influence of dietary intake of fish oil, magnesium, and zinc on metabolic parameters among individuals tested for diabetes	NUTRITION			English	Article						Docosahexaenoic; Eicosapentaenoic; Polyunsaturated fatty acids; Insulin resistance; Renal function	FATTY LIVER-DISEASE; MIDDLE-AGED JAPANESE; INSULIN-RESISTANCE; TNF-ALPHA; NONALCOHOLIC STEATOHEPATITIS; INFLAMMATORY STATUS; WOMEN; RISK; GLUCOSE; ACIDS	Objective: The aim of this study was to assess the significance and degree of correlation between the intake of fish oil, magnesium (Mg), and zinc (Zn) and metabolic parameters. Methods: Correlation coefficients among nutrient intake and physical and laboratory parameters were determined using Spearman's rho (rho) test or a multiple regression model among Japanese individuals (male:female, 37:66; median age, 55 y) who completed a semiquantitative food questionnaire and underwent testing for diabetes. Individuals with diabetes were excluded. Results: Spearman's test revealed several weak but significant correlations between intake of fish oil including omega-3 polyunsaturated fatty acids (PUFAs) and various metabolic parameters. The test showed that Zn intake in women significantly correlated with reduced systolic blood pressure (SBP), alanine aminotransferase (ALT), gamma-glutamyl transpeptidase (gamma-GPT), and homeostasis model assessment-insulin resistance (HOMA-IR). Multivariate analysis revealed that intake of fish oil, eicosapentaenoic acid (EPA), and Zn was significantly associated with increased serum levels of high-density lipoprotein cholesterol (HDL-C; fish oil versus HDL-C, P = 0.0438; 95% confidence interval ICI], 0.0055-0.3724; EPA versus HDL-C, P = 0.0439; 95% CI, 0.0053-0.3724; Zn versus HDL-C, P = 0.0041; 95% Cl, 0.0890-0.4609). Multivariate analysis revealed that w-3 PUFAs were associated with decreased serum ALT levels (P = 0.0240; 95% Cl, -5.000 to -0.0367) and that Zn correlated with SBP (P = 0.0239; 95% Cl, -0.5149 to -0.0377) in women. Conclusion: Intake of fish oil, Mg, and Zn was associated with some metabolic parameters. Abundant intake of fish oil including omega-3 PUFAs and Zn can exert antiarteriosclerotic effects through increasing serum levels of HDL-C. omega-3 PUFAs can reduce liver inflammation and Zn can reduce SBP in women. (C) 2015 Elsevier Inc. All rights reserved.	[Takagi, Hisayo] Suzuka Univ Med Sci, Fac Hlth Sci, Suzuka, Japan; [Kobayashi, Yoshinao; Taguchi, Osamu; Sumida, Yasuhiro] Mie Univ, Grad Sch Med, Ctr Phys & Mental Hlth, Tsu, Mie 514, Japan; [Kobayashi, Yoshinao; Takei, Yoshiyuki] Mie Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Tsu, Mie 514, Japan; [Sumida, Yasuhiro] Japan Community Healthcare Org, Yokkaichi Hazu Med Ctr, Yokaichi, Japan	Kobayashi, Y (reprint author), Mie Univ, Grad Sch Med, Ctr Phys & Mental Hlth, Tsu, Mie 514, Japan.	Yoshinao@hac.mie-u.ac.jp					American Diabetes Association, 2013, DIABETES CARE S1, V36, pS67, DOI DOI 10.2337/DC13-S067; Hruby A, 2014, DIABETES CARE, V37, P419, DOI 10.2337/dc13-1397; Montori VM, 2000, DIABETES CARE, V23, P1407, DOI 10.2337/diacare.23.9.1407; Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Huang LP, 2014, VITAM HORM, V95, P365, DOI 10.1016/B978-0-12-800174-5.00014-4; Krauss RM, 2000, CIRCULATION, V102, P2284; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261; Daniele G, 2014, ACTA DIABETOL, V51, P123, DOI 10.1007/s00592-013-0543-1; Figueras M, 2011, OBESITY, V19, P362, DOI 10.1038/oby.2010.194; Seki N, 2013, ASIA PAC J CLIN NUTR, V22, P557, DOI 10.6133/apjcn.2013.22.4.07; Sun Q, 2009, DIABETES CARE, V32, P629, DOI 10.2337/dc08-1913; Kim DJ, 2010, DIABETES CARE, V33, P2604, DOI [10.2337/dc10-0994, 10.2337/dc10.0994]; Karlstrom BE, 2011, AM J CLIN NUTR, V94, P26, DOI 10.3945/ajcn.110.006221; Sales CH, 2011, CLIN NUTR, V30, P359, DOI 10.1016/j.clnu.2010.12.011; Nanri A, 2010, EUR J CLIN NUTR, V64, P1244, DOI 10.1038/ejcn.2010.138; Hirabara SM, 2013, J NUTR BIOCHEM, V24, P1136, DOI 10.1016/j.jnutbio.2012.08.014; [Anonymous], 2014, FOOD NUTR RES, DOI DOI 10.3402/FNR.V58.25145; Kirii K, 2010, J AM COLL NUTR, V29, P99; Kneeman JM, 2012, THER ADV GASTROENTER, V5, P199, DOI 10.1177/1756283X11430859; Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134; Kotwal S, 2012, CIRC-CARDIOVASC QUAL, V5, P808, DOI 10.1161/CIRCOUTCOMES.112.966168; Kopecky J, 2009, P NUTR SOC, V68, P361, DOI 10.1017/S0029665109990231; Swaroop JJ, 2012, INDIAN J MED RES, V135, P127; Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Hata A, 2013, DIABETIC MED, V30, P1487, DOI 10.1111/dme.12250; Friedberg CE, 1998, DIABETES CARE, V21, P494, DOI 10.2337/diacare.21.4.494; Guzman-Flores JM, 2013, J INVEST MED, V61, P265, DOI 10.231/JIM.0b013e31827b98c9; Harmon RC, 2011, EXPERT REV GASTROENT, V5, P189, DOI [10.1586/egh.11.21, 10.1586/EGH.11.21]; Hashimoto E, 2015, HEPATOL RES, V45, P20, DOI 10.1111/hepr.12333; Imaeda Nahomi, 2002, J Epidemiol, V12, P45; Kodama Y, 2009, HEPATOLOGY, V49, P6, DOI 10.1002/hep.22710; Olalla LMD, 2009, NUTR HOSP, V24, P113; Takahashi Hiroki, 2013, Nihon Rinsho, V71, P257; Tokudome S, 1998, JPN J CLIN ONCOL, V28, P679, DOI 10.1093/jjco/28.11.679; Vashum KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083944; Yu C, 2014, ENVIRON TOXICOL PHAR, V37, P729, DOI 10.1016/j.etap.2014.02.011; Zhong W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076522	40	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	JUL-AUG	2015	31	7-8					988	993		10.1016/j.nut.2015.02.019		6	Nutrition & Dietetics	Nutrition & Dietetics	CL5KE	WOS:000356998000015		
J	Prasad, B; Hino, T; Suzuki, K				Prasad, Bijoy; Hino, Takanori; Suzuki, Kazuo			Numerical simulation of free surface flows around shallowly submerged hydrofoil by OpenFOAM	OCEAN ENGINEERING			English	Article						Finite volume discretization; Volume of fluid method; Standard k-epsilon turbulence model; Free surface flows; NACA0012 hydrofoil	FLUID VOF METHOD; POTENTIAL FLOW; WAVE; VOLUME	The validation of the Computational Fluid Dynamics (CFD) methodology for numerical simulation of two-dimensional unsteady incompressible viscous flow generated by a shallowly submerged hydrofoil under the free surface is described in this study. The computations are performed using a finite volume discretization incorporated with the interface capturing volume of fluid (VOF) method to solve the fluid equations in motion. The standard k-epsilon turbulence model is used to capture turbulent flow around the hydrofoil in the free surface zone at different submergence depth ratios. The wave profiles, pressure contours, velocity contours, lift and drag coefficients are compared for the different Froude numbers based on submergence depth to demonstrate the influence of free surface on performance of the hydrofoil. A comparison of numerical and experimental results show that an accurate representation of the free surface flows can be obtained with the present numerical scheme. (C) 2015 Elsevier Ltd. All rights reserved.	[Prasad, Bijoy; Hino, Takanori; Suzuki, Kazuo] Yokohama Natl Univ, Yokohama, Kanagawa 2408501, Japan	Prasad, B (reprint author), Yokohama Natl Univ, Yokohama, Kanagawa 2408501, Japan.				MEXT Ministry of Education, Culture, Sports, Science and Technology-Japan; Yokohama National University	The first author acknowledge to MEXT Ministry of Education, Culture, Sports, Science and Technology-Japan for giving the scholarship.; All authors acknowledge Yokohama National University for the supports.	Ali M.A., 2010, P INT C MAR TECHN BU; DUNCAN JH, 1983, J FLUID MECH, V126, P507, DOI 10.1017/S0022112083000294; GIESING JP, 1967, J FLUID MECH, V28, P113, DOI 10.1017/S0022112067001934; YEUNG RW, 1979, INT J NUMER METH ENG, V14, P317, DOI 10.1002/nme.1620140303; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; WU GX, 1995, OCEAN ENG, V22, P785, DOI 10.1016/0029-8018(95)00014-C; BAI KJ, 1978, J SHIP RES, V22, P216; Bal S., 1999, INT J OCEAN ENG, V28, P243; Coleman R.M., 1986, P 16 S NAV HYDR, P51; Di Mascio A., 2007, J COMPUT FLUIDS, V36, P868; FORBES LK, 1985, J ENG MATH, V19, P329, DOI 10.1007/BF00042877; Hino T., 1988, J SOC NAVAL ARCH JPN, V164, P9; Hino T., 1993, HYDRODYNAMICS; Hough G.R., 1969, J SHIP RES, V13, P53; Karim MM, 2014, OCEAN ENG, V78, P89, DOI 10.1016/j.oceaneng.2013.12.013; KENNELL C, 1984, J SHIP RES, V28, P55; Kwag S.H., 1991, J SOC NAVAL ARCH JPN, V170, P93; OpenFOAM, 2011, OP SOURC CFD TOOLB 2; Salvesen, 1976, J SHIP RES, V20, P160	19	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0029-8018			OCEAN ENG	Ocean Eng.	JUL 1	2015	102						87	94		10.1016/j.oceaneng.2015.04.049		8	Engineering, Marine; Engineering, Civil; Engineering, Ocean; Oceanography	Engineering; Oceanography	CL8NX	WOS:000357232500009		
J	Maki, RG; Blay, JY; Demetri, GD; Fletcher, JA; Joensuu, H; Martin-Broto, J; Nishida, T; Reichardt, P; Schoffski, P; Trent, JC				Maki, Robert G.; Blay, Jean-Yves; Demetri, George D.; Fletcher, Jonathan A.; Joensuu, Heikki; Martin-Broto, Javier; Nishida, Toshirou; Reichardt, Peter; Schoffski, Patrick; Trent, Jonathan C.			Key Issues in the Clinical Management of Gastrointestinal Stromal Tumors: An Expert Discussion	ONCOLOGIST			English	Article						Gastrointestinal stromal tumor; GIST; Imatinib; Sunitinib; Regorafenib; KIT; PDGFRA; SDH; Carney-Stratakis syndrome	ADJUVANT IMATINIB MESYLATE; GIST FOLLOWING FAILURE; RANDOMIZED-TRIAL; RESIDUAL DISEASE; PDGFRA MUTATIONS; TYROSINE KINASE; PHASE-3 TRIAL; C-KIT; SUNITINIB; THERAPY	After the revelation of kinase targeting with orally available small molecules, the use of imatinib in chronic myelogenous leukemia and in gastrointestinal stromal tumor (GIST) has now become commonplace and just two of many examples of the use of kinase inhibitors in cancer. In this article, we discuss important practice points that may impact upon questions of therapy of primary and metastatic GIST, with the hope that the questions addressed in this rare solid tumor can serve as examples of what can be achieved with kinase-directed therapies in other cancers. We present cases that highlight some of the key issues in GIST management and afterward discuss both points of consensus and controversial issues in what is now recognized as one of the most common forms of sarcoma.	[Maki, Robert G.] Mt Sinai Med Ctr, Tisch Canc Inst, New York, NY 10029 USA; [Blay, Jean-Yves] Ctr Leon Berard, Dept Med Oncol, F-69373 Lyon, France; [Demetri, George D.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Joensuu, Heikki] Helsinki Univ Hosp, Helsinki, Finland; [Joensuu, Heikki] Univ Helsinki, Helsinki, Finland; [Martin-Broto, Javier] Fdn Inst Valenciano Oncol, Serv Oncol Med, Valencia, Spain; [Nishida, Toshirou] Natl Canc Ctr Hosp East, Dept Surg, Kashiwa, Chiba, Japan; [Reichardt, Peter] HELIOS Klinikum Berlin Buch, Interdisciplinary Oncol, Berlin, Germany; [Schoffski, Patrick] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Leuven Canc Inst, Gen Med Oncol, Leuven, Belgium; [Trent, Jonathan C.] Univ Miami, Sylvester Canc Ctr, Sarcoma Med Oncol Program, Miami, FL USA	Maki, RG (reprint author), Mt Sinai Med Ctr, Tisch Canc Inst, 1425 Madison Ave, New York, NY 10029 USA.	bobmakimd@gmail.com			Eisai; Tracon; Lilly; Novartis; Pfizer; Bayer; GlaxoSmithKline; Blueprint Medicines	Robert G. Maki: Bayer (C/A, H), Eisai (C/A, H, RF), Tracon (C/A, RF), Lilly (H, RF), Sarcoma Alliance for Research through Collaboration (participation/leadership); Jean-Yves Blay: Novartis, Pfizer, Bayer (C/A, RF); George D. Demetri: Blueprint Medicines Board of Directors (C/A, E, OI), Dana-Farber (IP), Novartis (C/A, IP, RF), Pfizer, Bayer, GlaxoSmithKline (C/A, RF), Ariad, AstraZeneca (C/A), Kolltan (C/A, OI); Jonathan A. Fletcher: Bayer, Ariad (C/A); Heikki Joensuu: Blueprint Medicines (RF); Javier Martin-Broto: PharmaMar, GlaxoSmithKline, Bayer, Amgen (C/A); Toshirou Nishida: Bayer, Pfizer (H); Peter Reichardt: Pfizer, Bayer (C/A, H), Ariad (C/A), Novartis (RF); Patrick Schoffski: Novartis (C/A, RF), Bayer (C/A). The other author indicated no financial relationships.	DeMatteo RP, 2009, LANCET, V373, P1097, DOI 10.1016/S0140-6736(09)60500-6; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Bauer S, 2005, INT J CANCER, V117, P316, DOI 10.1002/ijc.21164; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Trent JC, 2003, CANCER, V98, P2693, DOI 10.1002/cncr.11875; Joensuu H, 2012, LANCET ONCOL, V13, P265, DOI 10.1016/S1470-2045(11)70299-6; Patrikidou A, 2013, ANN ONCOL, V24, P1087, DOI 10.1093/annonc/mds587; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Kang YK, 2013, LANCET ONCOL, V14, P1175, DOI 10.1016/S1470-2045(13)70453-4; Corless CL, 2014, J CLIN ONCOL, V32, P1563, DOI 10.1200/JCO.2013.51.2046; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Debiec-Rychter M, 2006, EUR J CANCER, V42, P1093, DOI 10.1016/j.ejca.2006.01.030; Blay JY, 2012, ANN ONCOL, V23, P1659, DOI 10.1093/annonc/mdr622; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; DeMatteo RP, 2013, ANN SURG, V258, P422, DOI 10.1097/SLA.0b013e3182a15eb7; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Demetri GD, 2009, J CLIN ONCOL, V27, P3141, DOI 10.1200/JCO.2008.20.4818; von Mehren M, 2014, J NATL COMPR CANC NE, V12, P853; Ganjoo KN, 2014, ANN ONCOL, V25, P236, DOI 10.1093/annonc/mdt484; Rutkowski P, 2006, J SURG ONCOL, V93, P304, DOI 10.1002/jso.20466; Joensuu H, 2012, JAMA-J AM MED ASSOC, V307, P1265, DOI 10.1001/jama.2012.347; Gold JS, 2006, ANN SURG, V244, P176, DOI 10.1097/01.sla.0000218080.94145.cf; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Du CY, 2014, EUR J CANCER, V50, P1772, DOI 10.1016/j.ejca.2014.03.280; Appleman H D, 1976, Cancer, V38, P708; ESMO/European Sarcoma Network Working Group, 2014, ANN ONCOL, V25, piii21, DOI 10.1093/annonc/mdu255; Goettsch WG, 2005, EUR J CANCER, V41, P2868, DOI 10.1016/j.ejca.2005.09.009; Hohenberger P, 2010, ANN SURG ONCOL, V17, P2585, DOI 10.1245/s10434-010-1053-9; Janeway KA, 2009, PEDIATR BLOOD CANCER, V52, P767, DOI 10.1002/pbc.21909; Joensuu H, 2015, J CLIN ONCOL, V33, P634, DOI 10.1200/JCO.2014.57.4970; MARTIN J F, 1960, Ann Anat Pathol (Paris), V5, P484; MAZUR MT, 1983, AM J SURG PATHOL, V7, P507, DOI 10.1097/00000478-198309000-00001; Perry CG, 2006, AM J SURG PATHOL, V30, P42, DOI 10.1097/01.pas.0000178087.69394.9f; Rubin BP, 2010, ARCH PATHOL LAB MED, V134, P165, DOI 10.1043/1543-2165-134.2.165; STOUT AP, 1962, CANCER, V15, P400, DOI 10.1002/1097-0142(196203/04)15:2<400::AID-CNCR2820150224>3.0.CO;2-P; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; von Mehren M, 2015, SOFT TISSUE SARCOMA	39	0	0	ALPHAMED PRESS	DURHAM	318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA	1083-7159	1549-490X		ONCOLOGIST	Oncologist	JUL	2015	20	7					823	830		10.1634/theoncologist.2014-0471		8	Oncology	Oncology	CL9DK	WOS:000357275500022		
J	Hamano, J; Morita, T; Inoue, S; Ikenaga, M; Matsumoto, Y; Sekine, E; Yamaguchi, T; Hirohashi, T; Tajima, T; Tatara, R; Watanabe, H; Otani, H; Takigawa, C; Matsuda, Y; Nagaoka, H; Mori, M; Yamamoto, N; Shimizu, M; Sasara, T; Kinoshita, H				Hamano, Jun; Morita, Tatsuya; Inoue, Satoshi; Ikenaga, Masayuki; Matsumoto, Yoshihisa; Sekine, Eryuichi; Yamaguchi, Takashi; Hirohashi, Takeshi; Tajima, Tsukasa; Tatara, Ryohei; Watanabe, Hiroaki; Otani, Hiroyuki; Takigawa, Chizuko; Matsuda, Yoshinobu; Nagaoka, Hiroka; Mori, Masanori; Yamamoto, Naoki; Shimizu, Mie; Sasara, Takeshi; Kinoshita, Hiroya			Surprise Questions for Survival Prediction in Patients With Advanced Cancer: A Multicenter Prospective Cohort Study	ONCOLOGIST			English	Article						Surprise questions; Prognostic value; 7-day survival; 30-day survival; Advanced cancer	PALLIATIVE PROGNOSTIC SCORE; CARE; FAMILIES; HOSPICE; DEATH; LIFE	Background. Predicting the short-term survival in cancer patients is an important issue for patients, family, and oncologists. Although the prognostic accuracy of the surprise question has value in 1-year mortality for cancer patients, the prognostic value for short-term survival has not been formally assessed. The primary aim of the present study was to assess the prognostic value of the surprise question for 7-day and 30-day survival in patients with advanced cancer. Patients and Methods. The present multicenter prospective cohort study was conducted in Japan from September 2012 through April 2014, involving 16 palliative care units, 19 hospital-based palliative care teams, and 23 home-based palliative care services. Results. We recruited 2,425 patients and included 2,361 for analysis: 912 from hospital-based palliative care teams, 895 from hospital palliative care units, and 554 from home-based palliative care services. The sensitivity, specificity, positive predictive value, and negative predictive value of the 7-day survival surprise question were 84.7%(95% confidence interval [CI], 80.7%-88.0%), 68.0%(95% CI, 67.3%-68.5%), 30.3%(95% CI, 28.9%-31.5%), and 96.4% (95% CI, 95.5%-97.2%), respectively. The sensitivity, specificity, positive predictive value, and negative predictive value for the 30-day surprise question were 95.6% (95% CI, 94.4%-96.6%), 37.0% (95% CI, 35.9%-37.9%), 57.6% (95% CI, 56.8%-58.2%), and 90.4% (95% CI, 87.7%-92.6%), respectively. Conclusion. Surprise questions are useful for screening patients for short survival. However, the high false-positive rates do not allow clinicians to provide definitive prognosis prediction.	[Hamano, Jun] Univ Tsukuba, Fac Med, Div Clin Med, Ibaraki, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Palliat & Support Care Div, Hamamatsu, Shizuoka, Japan; [Inoue, Satoshi] Seirei Mikatahara Gen Hosp, Seirei Hospice, Hamamatsu, Shizuoka, Japan; [Ikenaga, Masayuki] Yodogawa Christians Hosp, Hospice Childrens Hospice Hosp, Osaka, Japan; [Matsumoto, Yoshihisa; Kinoshita, Hiroya] Natl Canc Ctr Hosp East, Dept Palliat Med, Kashiwa, Chiba 2778577, Japan; [Sekine, Eryuichi] Kameda Med Ctr, Dept Pain & Palliat Care, Kamogawa, Japan; [Yamaguchi, Takashi] Kobe Univ, Grad Sch Med, Dept Palliat Med, Kobe, Hyogo 657, Japan; [Hirohashi, Takeshi] Mitui Mem Hosp, Dept Palliat Care, Tokyo, Japan; [Tajima, Tsukasa] Tohoku Univ Hosp, Dept Palliat Med, Sendai, Miyagi, Japan; [Tatara, Ryohei] Osaka City Gen Hosp, Dept Palliat Med, Osaka, Japan; [Watanabe, Hiroaki] Komaki City Hosp, Komaki, Japan; [Otani, Hiroyuki] Kyushu Natl Canc Ctr, Dept Palliat Care Team & Palliat & Support Care, Fukuoka, Japan; [Takigawa, Chizuko] KKR Sapporo Med Ctr, Dept Palliat Care, Sapporo, Hokkaido, Japan; [Matsuda, Yoshinobu] Natl Hosp Organizat Kinki, Chuo Chest Med Ctr, Dept Psychosomat Med, Osaka, Japan; [Nagaoka, Hiroka] Tsukuba Univ Hosp, Ctr Palliat & Support Care, Ibaraki, Japan; [Mori, Masanori] Seirei Hamamatsu Gen Hosp, Hamamatsu, Shizuoka, Japan; [Yamamoto, Naoki] Shinsei Hosp, Dept Primary Care Serv, Nagano, Japan; [Shimizu, Mie] Saiseikai Matsusaka Gen Hosp, Matsusaka, Japan; [Sasara, Takeshi] Yuuaikai Nanbu Hosp, Itoman, Okinawa, Japan	Kinoshita, H (reprint author), Natl Canc Ctr Hosp East, Dept Palliat Med, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	hikinosh@east.ncc.go.jp			National Cancer Center Research and Development Fund [25-A-22]	This work was supported in part by the National Cancer Center Research and Development Fund (Grant 25-A-22). All researchers were independent from the funders. This study was performed in the Japan ProVal Study Group (Prognostic scores Validation Study Group). The participating study sites and site investigators were as follows: Satoshi Inoue (Seirei Hospice, Seirei Mikatahara General Hospital), Masayuki Ikenaga (Hospice Children's Hospice Hospital, Yodogawa Christian Hospital), Yoshihisa Matsumoto (Department of Palliative Medicine, National Cancer Center Hospital East), Mika Baba (Department of Palliative Care, Saito Yukoukai Hospital), Ryuichi Sekine (Department of Pain and Palliative Care, Kameda Medical Center), Takashi Yamaguchi (Department of Palliative Medicine, Kobe University Graduate School of Medicine), Takeshi Hirohashi (Department of Palliative Care, Mitui Memorial Hospital), Tsukasa Tajima (Department of Palliative Medicine, Tohoku University Hospital), Ryohei Tatara (Department of Palliative Medicine, Osaka City General Hospital), Hiroaki Watanabe (Komaki City Hospital), Hiroyuki Otani (Department of Palliative Care Team, and Palliative and Supportive Care, National Kyushu Cancer Center), Chizuko Takigawa(Department of Palliative Care, KKR Sapporo Medical Center), Yoshinobu Matsuda (Department of Psychosomatic Medicine, National Hospital), Hiroka Nagaoka (Center for Palliative and Supportive Care, Tsukuba University Hospital), Masanori Mori (Seirei Hamamatsu General Hospital), Yo Tei (Seirei Hospice, Seirei Mikatahara General Hospital), Shuji Hiramoto (Department of Oncology, Mitsubishi Kyoto Hospital), Akihiko Suga (Department of Palliative Medicine, Shizuoka Saiseikai General Hospital), Takayuki Hisanaga (Tsukuba Medical Center Foundation), Tatsuhiko Ishihara (Palliative Care Department, Okayama Saiseikai General Hospital), Tomoyuki Iwashita (Matsue City Hospital), Keisuke Kaneishi (Department of Palliative Care Unit, JCHO Tokyo Shinjuku Medical Center), Shohei Kawagoe (Aozora Clinic), Toshiyuki Kuriyama (Department of Palliative Medicine, Wakayama Medical University Hospital Oncology Center), Takashi Maeda (Department of Palliative Care, Tokyo Metropolitan Cancer, and Infectious Disease Center, Komagome Hospital), Ichiro Mori (Gratia Hospital Hospice), Nobuhisa Nakajima (Department of Palliative Medicine, Graduate School of Medicine, Tohoku University), Tomohiro Nishi (Kawasaki Comprehensive Care Center, Kawasaki Municipal Ida Hospital), Hiroki Sakurai (Department of Palliative Care, St.; Luke's International Hospital, Tokyo), Satofumi Shimoyama (Department of Palliative Care, Aichi Cancer Center Hospital), Takuya Shinjo (Shinjo Clinic, Kobe), Hiroto Shirayama (Iryouhoujinn Takumikai Osaka Kita Homecare Clinic), Takeshi Yamada (Department of Gastrointestinal and Hepato-Billiary-Pancreatic Surgery, Nippon Medical School), Shigeki Ono (Division of Palliative Medicine, Shizuoka Cancer Center Hospital), Taketoshi Ozawa (Megumi Zaitaku Clinic), Ryo Yamamoto (Department of Palliative Medicine, Saku Central Hospital Advanced Care Center), Naoki Yamamoto (Department of Primary Care Service, Shinsei Hospital), Hideki Shishido (Shishido Internal Medicine Clinic), Mie Shimizu (Saiseikai Matsusaka General Hospital), Masanori Kawahara (Soshukai Okabe Clinic), Shigeru Aoki (Sakanoue Family Clinic), Akira Demizu (Demizu Clinic), Masahiro Goshima (Homecare-Clinic Kobe), Keiji Goto (Himawari Zaitaku Clinic), Yasuaki Gyoda (Kanamecyo Home Care clinic), Jun Hamano (Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba), Kotaro Hashimoto (Fukushima Home Palliative Care Clinic), Sen Otomo (Shonan International Village Clinic), Masako Sekimoto (Sekimoto Clinic), Takemi Shibata (Kanwakeakurinikku-Eniwa), Yuka Sugimoto (Sugimoto Homecare Clinic), Mikako Matsunaga(Senri Pain Clinic), Yukihiko Takeda (Hidamari Clinic), Takeshi Sasara (Yuuaikai Nanbu Hospital), Jun Nagayama (Peace Clinic Nakai).	Maltoni M, 2005, J CLIN ONCOL, V23, P6240, DOI 10.1200/JCO.2005.06.866; Hui D, 2011, ONCOLOGIST, V16, P1642, DOI 10.1634/theoncologist.2011-0173; Moss AH, 2010, J PALLIAT MED, V13, P837, DOI 10.1089/jpm.2010.0018; Matsuyama R, 2006, J CLIN ONCOL, V24, P3490, DOI 10.1200/JCO.2005.03.6236; Morita T, 1999, SUPPORT CARE CANCER, V7, P128, DOI 10.1007/s005200050242; O'Callaghan A, 2014, PALLIATIVE MED, V28, P1046, DOI 10.1177/0269216314536089; Kutner JS, 1999, SOC SCI MED, V48, P1341, DOI 10.1016/S0277-9536(98)00453-5; Moroni M, 2014, PALLIATIVE MED, V28, P959, DOI 10.1177/0269216314526273; Kirk P, 2004, BRIT MED J, V328, P1343, DOI 10.1136/bmj.38103.423576.55; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Maltoni M, 2012, ONCOLOGIST, V17, P446, DOI 10.1634/theoncologist.2011-0397; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; Pirovano M, 1999, J PAIN SYMPTOM MANAG, V17, P231, DOI 10.1016/S0885-3924(98)00145-6; Hui D, 2014, ONCOLOGIST, V19, P681, DOI 10.1634/theoncologist.2013-0457; Finlay E, 2009, CA-CANCER J CLIN, V59, P250, DOI 10.3322/caac.20022; Baba M, 2014, J PAIN SYMPTOM MANAG; Gwilliam B, 2011, BMJ-BRIT MED J, V343, pd4920; Pattison M, 2001, J Palliat Med, V4, P249, DOI 10.1089/109662101750290335; Scarpi E, 2011, ONCOLOGIST, V16, P1793, DOI 10.1634/theoncologist.2011-0130; Steinhauser Karen E., 2000, JAMA (Journal of the American Medical Association), V284, P2476, DOI 10.1001/jama.284.19.2476; Thomas K., 2011, GSF PROGNOSTIC INDIC, V4th	21	0	0	ALPHAMED PRESS	DURHAM	318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA	1083-7159	1549-490X		ONCOLOGIST	Oncologist	JUL	2015	20	7					839	844		10.1634/theoncologist.2015-0015		6	Oncology	Oncology	CL9DK	WOS:000357275500024		
J	Takagi, Y; Hosomi, Y; Shibuya, M; Okamoto, H				Takagi, Yusuke; Hosomi, Yukio; Shibuya, Masahiko; Okamoto, Hiroaki			Total Plasma Homocysteine Level Assessment and Timing of Folate/B-12 Supplementation Prior to Initiation of Pemetrexed-Based Chemotherapy for Nonsquamous Non-Small Cell Lung Cancer Patients: An Irrelevant Investigation, an Unnecessary Delay, or Both? Reply	ONCOLOGIST			English	Letter							PHASE-III; CISPLATIN; THERAPY		[Takagi, Yusuke; Hosomi, Yukio; Shibuya, Masahiko] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; [Takagi, Yusuke] MerckSharp & Dohme Corp, Tokyo, Japan; [Okamoto, Hiroaki] Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa, Japan	Takagi, Y (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan.						Takagi Y, 2014, ONCOLOGIST, V19, P1194, DOI 10.1634/theoncologist.2014-0221; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Niyikiza C, 2002, MOL CANCER THER, V1, P545; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Singh N, 2015, ONCOLOGIST, V20, pE21, DOI 10.1634/theoncologist.2015-0040; Singh N, 2014, AM J CLIN ONCOL	6	0	0	ALPHAMED PRESS	DURHAM	318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA	1083-7159	1549-490X		ONCOLOGIST	Oncologist	JUL	2015	20	7					E22	E22		10.1634/theoncologist.2015-0070		1	Oncology	Oncology	CL9DK	WOS:000357275500002		
J	Saito, M; Maruyama, A; Fujiwara, J				Saito, Mitsunori; Maruyama, Aki; Fujiwara, Junki			Polarization-independent refractive-index change of a cholesteric liquid crystal	OPTICAL MATERIALS EXPRESS			English	Article							FABRY-PEROT ETALON; FILTER; MODULATOR; SYSTEMS	Refractive index of a cholesteric liquid crystal (chiral pitch: 5 mu m) was evaluated in the infrared region to realize a polarization-insensitive device. The liquid crystal exhibited an isotropic refractive index, since its helical microstructure was too small to recognize with a long-wavelength infrared beam (2-8 mu m). No polarization dependence appeared in interference spectra of a Fabry-Perot filter that consisted of the liquid crystal and silicon plates. The refractive index of the LC, which was evaluated from the interference peak wavelengths, changed from 1.58 to 1.49 as applied voltage increased from 0 to 18 V. This index change was close to theoretical prediction and greater than that of a polymer-stabilized blue-phase LC. (C)2015 Optical Society of America	[Saito, Mitsunori; Maruyama, Aki; Fujiwara, Junki] Ryukoku Univ, Dept Elect & Informat, Otsu, Shiga 5202194, Japan	Saito, M (reprint author), Ryukoku Univ, Dept Elect & Informat, Otsu, Shiga 5202194, Japan.	msaito@rins.ryukoku.ac.jp			Japan Society for the Promotion of Science	This research was supported by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science.	Alberucci A, 2005, OPT LETT, V30, P1381, DOI 10.1364/OL.30.001381; Kikuchi H, 2002, NAT MATER, V1, P64, DOI 10.1038/nmat712; Moore JR, 2008, IEEE PHOTONIC TECH L, V20, P60, DOI 10.1109/LPT.2007.912690; Hsiao YC, 2011, OPT EXPRESS, V19, P9744, DOI 10.1364/OE.19.009744; Kopp VI, 1998, OPT LETT, V23, P1707, DOI 10.1364/OL.23.001707; Ge SJ, 2014, OPT MATER EXPRESS, V4, P2535, DOI 10.1364/OME.4.002535; Lin YH, 2005, OPT EXPRESS, V13, P8746, DOI 10.1364/OPEX.13.008746; PATEL JS, 1991, APPL PHYS LETT, V58, P2491, DOI 10.1063/1.104853; Kim KH, 2010, OPT EXPRESS, V18, P16745, DOI 10.1364/OE.18.016745; Wu Z, 2008, OPT LETT, V33, P1653, DOI 10.1364/OL.33.001653; Provenzano C, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2355456; Lin YH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3360860; Luo D, 2013, OPT EXPRESS, V21, P31318, DOI 10.1364/OE.21.031318; Yamada I, 2011, OPT LETT, V36, P3882, DOI 10.1364/OL.36.003882; Born M., 1980, PRINCIPLES OPTICS; Crooker P. P., 2001, CHIRALITY LIQUID CRY; Dorjgotov EA, 2009, APPL OPTICS, V48, P74, DOI 10.1364/AO.48.000074; Haseba K., 2005, ADV MATER, V17, P2311; Hecht E., 1998, OPTICS; Hecht E., 1998, OPTICS; HIRABAYASHI K, 1993, J LIGHTWAVE TECHNOL, V11, P2033, DOI 10.1109/50.257967; KERLLENEVICH B, 1985, MOL CRYST LIQ CRYST, V123, P129, DOI 10.1080/00268948508074771; Lee JH, 1999, APPL PHYS LETT, V75, P859, DOI 10.1063/1.124537; MALLINSON SR, 1987, APPL OPTICS, V26, P430, DOI 10.1364/AO.26.000430; PATEL JS, 1991, IEEE PHOTONIC TECH L, V3, P739, DOI 10.1109/68.84470; PATEL JS, 1990, APPL PHYS LETT, V57, P1718, DOI 10.1063/1.104045; Saito M, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2783269; Saito M, 2013, OPT EXPRESS, V21, P11984, DOI 10.1364/OE.21.011984; Saito M, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/1/015504; Saito M, 2003, APPL OPTICS, V42, P2366, DOI 10.1364/AO.42.002366; Stegemeyer H., 2012, LIQ CRYST; Ye M, 2006, IEEE PHOTONIC TECH L, V18, P505, DOI 10.1109/LPT.2005.863623; Zhang HD, 2014, APPL OPTICS, V53, P5632, DOI 10.1364/AO.53.005632	33	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2159-3930			OPT MATER EXPRESS	Opt. Mater. Express	JUL 1	2015	5	7								10.1364/OME.5.001588		10	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CM2BO	WOS:000357484800011		
J	Yoshikawa, N; Kajihara, K				Yoshikawa, Nobukazu; Kajihara, Kazuki			Statistical generalized phase-shifting digital holography with a continuous fringe-scanning scheme	OPTICS LETTERS			English	Article							WAVE-FRONT RECONSTRUCTION; INTERFEROMETRY; EXTRACTION; ALGORITHM; STEPS	We propose a novel statistical generalized phase-shifting digital holography using a continuous fringe-scanning scheme. In this method, the continuous fringe-scanning scheme is implemented using a PC-based measurement system without any synchronous circuit between the digital camera and the phase shifter. Thus, nonuniformly phase-shifted interference fringes are captured sequentially because of the fluctuation of the image-capturing interval. To cope with the nonuniform phase shifts, we employ a statistical generalized phase-shifting approach. Since the algorithm is designed to use an arbitrary phase shift, the nonuniform phase shifts do not obstruct object wave retrieval. Simulations and experiments demonstrate that the proposed method can be used to implement a practical and accurate digital holography system. (C) 2015 Optical Society of America	[Yoshikawa, Nobukazu; Kajihara, Kazuki] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan	Yoshikawa, N (reprint author), Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	nyoshi@mail.saitama-u.ac.jp			JSPS KAKENHI [25420400]	JSPS KAKENHI (25420400).	Wang ZY, 2004, OPT LETT, V29, P1671, DOI 10.1364/OL.29.001671; Xu XF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2716069; Xu XE, 2008, OPT LETT, V33, P776, DOI 10.1364/OL.33.000776; Yoshikawa N, 2013, APPL OPTICS, V52, P1947, DOI 10.1364/AO.52.001947; Cai LZ, 2003, OPT LETT, V28, P1808, DOI 10.1364/OL.28.001808; Cai LZ, 2004, OPT LETT, V29, P183, DOI 10.1364/OL.29.000183; Kikuchi Y, 2010, OPT LETT, V35, P1548, DOI 10.1364/OL.35.001548; Gao P, 2009, OPT LETT, V34, P3553, DOI 10.1364/OL.34.003553; Yoshikawa N, 2014, OPT EXPRESS, V22, P14155, DOI 10.1364/OE.22.014155; Goodman J. W., 1996, INTRO FOURIER OPTICS; Hao Q, 2009, OPT LETT, V34, P1288; LAI G, 1991, J OPT SOC AM A, V8, P822, DOI 10.1364/JOSAA.8.000822; Meng XF, 2008, OPT COMMUN, V281, P5701, DOI 10.1016/j.optcom.2008.08.010; Schreiber H., 2007, OPTICAL SHOP TESTING, P547, DOI DOI 10.1002/9780470135976.CH14; Xu XF, 2006, OPT LETT, V31, P1966, DOI 10.1364/OL.31.001966; Yamaguchi I, 1997, OPT LETT, V22, P1268, DOI 10.1364/OL.22.001268	16	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	JUL 1	2015	40	13					3149	3152		10.1364/OL.40.003149		4	Optics	Optics	CM2CH	WOS:000357486800055		
J	Kim, Y; Hbino, K; Sugita, N; Mitsuishi, M				Kim, Yangjin; Hbino, Kenichi; Sugita, Naohiko; Mitsuishi, Mamoru			Measurement of absolute optical thickness of mask glass by wavelength-tuning Fourier analysis	OPTICS LETTERS			English	Article							PHASE-SHIFTING INTERFEROMETRY; LOW-COHERENCE INTERFEROMETRY; EXCESS FRACTION METHOD; REFRACTIVE-INDEX; TRANSPARENT PLATES; SCANNING INTERFEROMETER; INTERFERENCE; MICROSCOPE	Optical thickness is a fundamental characteristic of an optical component. A measurement method combining discrete Fourier-transform (DFT) analysis and a phase-shifting technique gives an appropriate value for the absolute optical thickness of a transparent plate. However, there is a systematic error caused by the nonlinearity of the phase-shifting technique. In this research the absolute optical-thickness distribution of mask blank glass was measured using DFT and wavelength-tuning Fizeau interferometry without using sensitive phase-shifting techniques. The error occurring during the DFT analysis was compensated for by using the unwrapping correlation. The experimental results indicated that the absolute optical thickness of mask glass was measured with an accuracy of 5 nm. (C) 2015 Optical Society of America	[Kim, Yangjin; Sugita, Naohiko; Mitsuishi, Mamoru] Univ Tokyo, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Hbino, Kenichi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058563, Japan	Kim, Y (reprint author), Univ Tokyo, Dept Mech Engn, Bunkyo Ku, 7-3-1 Congo, Tokyo 1138656, Japan.	yangjin@nml.t.u-tokyo.ac.jp					Fukano T, 1999, APPL OPTICS, V38, P4065, DOI 10.1364/AO.38.004065; Kim Y, 2014, OPT EXPRESS, V22, P21145, DOI 10.1364/OE.22.021145; Hibino K, 1997, J OPT SOC AM A, V14, P918, DOI 10.1364/JOSAA.14.000918; DEGROOT P, 1995, J MOD OPTIC, V42, P389, DOI 10.1080/09500349514550341; Haruna M, 1998, OPT LETT, V23, P966, DOI 10.1364/OL.23.000966; Hibino K, 2012, OPT REV, V19, P247, DOI 10.1007/s10043-012-0038-2; Fukano T, 1996, OPT LETT, V21, P1942, DOI 10.1364/OL.21.001942; Coppola G, 2003, APPL OPTICS, V42, P3882, DOI 10.1364/AO.42.003882; Kim S, 2008, OPT EXPRESS, V16, P5516, DOI 10.1364/OE.16.005516; LIU K, 1981, OPT LETT, V6, P117, DOI 10.1364/OL.6.000117; Deck LL, 2003, APPL OPTICS, V42, P2354, DOI 10.1364/AO.42.002354; de Groot P, 2000, APPL OPTICS, V39, P2658, DOI 10.1364/AO.39.002658; Choi HJ, 2010, OPT EXPRESS, V18, P9429, DOI 10.1364/OE.18.009429; Onodera R, 1996, J OPT SOC AM A, V13, P139, DOI 10.1364/JOSAA.13.000139; Kim Y, 2013, OPT LASER ENG, V51, P1173, DOI 10.1016/j.optlaseng.2013.04.003; Kim Y, 2015, OPT EXPRESS, V23, P4065, DOI 10.1364/OE.23.004065	16	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	JUL 1	2015	40	13					3169	3172		10.1364/OL.40.003169		4	Optics	Optics	CM2CH	WOS:000357486800060		
J	Yahiaoui, R; Hanai, K; Takano, K; Nishida, T; Miyamaru, F; Nakajima, M; Hangyo, M				Yahiaoui, Riad; Hanai, Kenichiro; Takano, Keisuke; Nishida, Tsubasa; Miyamaru, Fumiaki; Nakajima, Makoto; Hangyo, Masanori			Trapping waves with terahertz metamaterial absorber based on isotropic Mie resonators	OPTICS LETTERS			English	Article							EFFECTIVE MAGNETIC RESPONSE; FREQUENCIES; REGIME; TIO2; FABRICATION	Quasi-monodisperse dielectric particles organized in a periodic hexagonal network on an aluminum surface are exploited numerically and experimentally as a single-layered near-perfect absorber in the terahertz regime. Of particular interest are titanium dioxide (TiO2) microspheres because of their large dielectric permittivity and isotropic shape leading to Mie resonances with insensitive polarization. Absorption higher than 80% at normal incidence covering two distinct ranges of frequencies is demonstrated experimentally. Furthermore, the performance of the metamaterial absorber is kept over a wide range of incident angles. (C) 2015 Optical Society of America	[Yahiaoui, Riad] Univ Limoges, XLIM, CNRS, UMR7252, F-19100 Brive, France; [Hanai, Kenichiro; Takano, Keisuke; Nakajima, Makoto; Hangyo, Masanori] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Nishida, Tsubasa; Miyamaru, Fumiaki] Shinshu Univ, Dept Phys, Fac Sci, Nagano 3908621, Japan; [Miyamaru, Fumiaki] Shinshu Univ, Ctr Energy & Environm Sci, Nagano 3908621, Japan	Yahiaoui, R (reprint author), Univ Limoges, XLIM, CNRS, UMR7252, 7 Rue Jules Valles, F-19100 Brive, France.	riad.yahiaoui@unilim.fr	Takano, Keisuke/L-4372-2015		Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22109003]; Japan Society for the Promotion of Science (JSPS) KAKENHI [25286063]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (22109003); Japan Society for the Promotion of Science (JSPS) KAKENHI (25286063).	Chen CK, 2012, OPT EXPRESS, V20, P6952, DOI 10.1364/OE.20.006952; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Takano K, 2013, IEEE T THZ SCI TECHN, V3, P812, DOI 10.1109/TTHZ.2013.2285521; Grant J, 2011, OPT LETT, V36, P3476, DOI 10.1364/OL.36.003476; Mitrofanov O, 2014, OPT EXPRESS, V22, P23034, DOI 10.1364/OE.22.023034; Semouchkina E, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3447794; Bossard JA, 2014, ACS NANO, V8, P1517, DOI 10.1021/nn4057148; Gaillot DP, 2008, OPT EXPRESS, V16, P3986, DOI 10.1364/OE.16.003986; Ding F, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3692178; Wang BX, 2014, APPL PHYS A-MATER, V115, P1187, DOI 10.1007/s00339-013-8158-5; Landy NI, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125104; Yahiaoui R, 2012, APPL PHYS A-MATER, V109, P891, DOI 10.1007/s00339-012-7356-x; Liu XM, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813914; Wen DE, 2013, PHYS SCRIPTA, V88, DOI 10.1088/0031-8949/88/01/015402; Matsumoto N, 2008, JPN J APPL PHYS, V47, P7725, DOI 10.1143/JJAP.47.7725; Yahiaoui R, 2013, OPT LETT, V38, P4988, DOI 10.1364/OL.38.004988; Cui YX, 2012, NANO LETT, V12, P1443, DOI 10.1021/nl204118h; Shen XP, 2011, OPT EXPRESS, V19, P9401, DOI 10.1364/OE.19.009401; Li H, 2011, J APPL PHYS, V110, DOI 10.1063/1.3608246; Tao H, 2008, OPT EXPRESS, V16, P7181, DOI 10.1364/OE.16.007181; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Tao H, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/22/225102; Ye YQ, 2010, J OPT SOC AM B, V27, P498; Wang Y, 2012, NANO LETT, V12, P440, DOI 10.1021/nl203763k; Landy NI, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.207402; Iwaszczuk K, 2012, OPT EXPRESS, V20, P635, DOI 10.1364/OE.20.000635; Cong LQ, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4906109; Cramer JML, 2008, PROC SPIE, V7029, DOI 10.1117/12.797079; Haines K, 2009, J MAGN RESON, V200, P349, DOI 10.1016/j.jmr.2009.07.012; Lewin L., 1947, Journal of the Institution of Electrical Engineers. III. Radio and Communication Engineering, V94; Nemec H, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3683540; Ueda T, 2008, IEEE T MICROW THEORY, V56, P2259, DOI 10.1109/TMTT.2008.2003524; Vendik O. G., 2004, P 34 EUR MICR C AMST, V3, P1209; Yahiaoui R, 2014, APPL PHYS A-MATER, V114, P997, DOI 10.1007/s00339-013-8033-4; Yahiaoui R, 2011, APPL PHYS A-MATER, V103, P689, DOI 10.1007/s00339-011-6335-y; Yahiaoui R, 2009, OPT LETT, V34, P3541, DOI 10.1364/OL.34.003541	36	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	JUL 1	2015	40	13					3197	3200		10.1364/OL.40.003197		4	Optics	Optics	CM2CH	WOS:000357486800067		
J	Diefenbach, T				Diefenbach, Thomas			Managerialism: A Critique of an Ideology	ORGANIZATION			English	Book Review									[Diefenbach, Thomas] Ritsumeikan Asia Pacific Univ, Business Eth & Org Studies, Beppu, Oita, Japan	Diefenbach, T (reprint author), Ritsumeikan Asia Pacific Univ, Business Eth & Org Studies, Beppu, Oita, Japan.						Burnham James, 1941, MANAGERIAL REVOLUTIO; Klikauer Thomas, 2013, MANAGERIALISM CRITIQ; Mills C. W., 1956, POWER ELITE	3	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1350-5084	1461-7323		ORGANIZATION	Organization	JUL	2015	22	4			SI		613	616				4	Management	Business & Economics	CL9JN	WOS:000357294400012		
J	Mori, D; Abboud, JA; Namdari, S; Williams, GR				Mori, Daisuke; Abboud, Joseph A.; Namdari, Surena; Williams, Gerald R.			Glenoid Bone Loss in Anatomic Shoulder Arthroplasty: Literature Review and Surgical Technique	ORTHOPEDIC CLINICS OF NORTH AMERICA			English	Review						C2 glenoid; Steptech; Augmented; All-polyethylene glenoid component; Severe posterior glenoid bone loss	PRIMARY GLENOHUMERAL OSTEOARTHRITIS; POSTERIOR EROSION; HUMERAL HEAD; DEFICIENCY; MANAGEMENT; HEMIARTHROPLASTY; REPLACEMENT; MORPHOLOGY; ARTHRITIS; OUTCOMES	Despite major advances in total shoulder arthroplasty, management of severe posterior glenoid bone loss remains controversial. Several companies have provided alternative treatment options for type C glenoids associated with posterior subluxation of the humeral head. However, preoperative planning, proper selection of glenoid size, and recognition of the operative pitfalls are crucial for successful outcomes. This article presents a review of the literature and the surgical technique for management of severe posterior glenoid bone loss.	[Mori, Daisuke] Kyoto Shimogamo Hosp, Dept Orthopaed Surg, Skyo Ku, Kyoto 6060866, Japan; [Abboud, Joseph A.; Namdari, Surena; Williams, Gerald R.] Thomas Jefferson Univ, Rothman Inst, Philadelphia, PA 19107 USA	Abboud, JA (reprint author), Thomas Jefferson Univ, Rothman Inst, 925 Chestnut St, Philadelphia, PA 19107 USA.	abboudj@gmail.com					Clinton J, 2007, J SHOULDER ELB SURG, V16, P534, DOI 10.1016/j.jse.2006.11.003; Habermeyer P, 2007, CLIN ORTHOP RELAT R, P124, DOI 10.1097/BLO.0b013e31802ff03c; Denard PJ, 2013, J SHOULDER ELB SURG, V22, P1589, DOI 10.1016/j.jse.2013.06.017; Gerber C, 2009, J SHOULDER ELB SURG, V18, P505, DOI 10.1016/j.jse.2009.03.003; Walch G, 2012, J SHOULDER ELB SURG, V21, P1526, DOI 10.1016/j.jse.2011.11.030; Walch G, 2012, J BONE JOINT SURG AM, V94A, P145, DOI [10.2106/JBJS.J.00699, 10.2106/JBJSJ.00699]; NEER CS, 1988, J BONE JOINT SURG AM, V70A, P1154; Walch G, 1999, J ARTHROPLASTY, V14, P756, DOI 10.1016/S0883-5403(99)90232-2; Mizuno N, 2013, J BONE JOINT SURG AM, V95A, P1297, DOI [10.2106/JBJS.L.00820, 10.2106/JBJS.L00820]; Hsu JE, 2013, J SHOULDER ELB SURG, V22, P1298, DOI 10.1016/j.jse.2013.04.014; Steinmann SP, 2000, J SHOULDER ELB SURG, V9, P361, DOI 10.1067/mse.2000.107391; Edwards TB, 2004, J SHOULDER ELB SURG, V13, P1, DOI 10.1016/j.jse.2003.09.011; Hill JM, 2001, J BONE JOINT SURG AM, V83A, P877; Sabesan V, 2014, J SHOULDER ELB SURG, V23, P964, DOI 10.1016/j.jse.2013.09.019; Sabesan V, 2013, J BONE JOINT SURG AM, V95A, P1290, DOI [10.2106/JBJS.L.00097, 10.2106/JBJS.L00097]; Clavert P, 2007, J SHOULDER ELB SURG, V16, P843, DOI 10.1016/j.jse.2007.03.015; Matsen FA, 2014, CLIN ORTHOP RELAT R, V472, P894, DOI 10.1007/s11999-013-3327-6; Sears BW, 2012, J AM ACAD ORTHOP SUR, V20, P604, DOI 10.5435/JAAOS-20-09-604; Bonnevialle N, 2011, J SHOULDER ELB SURG, V20, P378, DOI 10.1016/j.jse.2010.07.006; Gillespie Robert, 2009, Orthopedics, V32, P21; Gilmer Brian B, 2012, J Bone Joint Surg Am, V94, pe102, DOI 10.2106/JBJS.K.00486; Gunther SB, 2012, J SHOULDER ELB SURG, V21, P675, DOI 10.1016/j.jse.2011.03.023; lannotti JP, 2012, J SHOULDER ELB SURG, V21, P48; lannotti JP, 2013, J SHOULDER ELB SURG, V22, P1530; Sperling JW, 2002, J BONE JOINT SURG AM, V84A, P541; Williams GR, 2010, OPERATIVE TECHNIQUES, P220; Youderian AR, 2012, TECH SHOULDER ELBOW, V13, P163, DOI [http://dx.doi.org/10.1097/BTE.0b013e318265354d, DOI 10.1097/BTE.0B013E318265354D]	27	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0030-5898	1558-1373		ORTHOP CLIN N AM	Orthop. Clin. North Am.	JUL	2015	46	3					389	+		10.1016/j.ocl.2015.02.007		10	Orthopedics	Orthopedics	CL5KY	WOS:000357000000010		
J	Yamazaki, H; Leigh, J; Briggs, R; Naito, Y				Yamazaki, Hiroshi; Leigh, Jaime; Briggs, Robert; Naito, Yasushi			Usefulness of MRI and EABR Testing for Predicting CI Outcomes Immediately After Cochlear Implantation in Cases With Cochlear Nerve Deficiency	OTOLOGY & NEUROTOLOGY			English	Article						ABI; Auditory brainstem implant; CI outcomes; Cochlear implant; Cochlear nerve deficiency; EABR; MRI; Vestibulocochlear nerve	BRAIN-STEM IMPLANTATION; CHILDREN; HYPOPLASIA; MALFORMATIONS; APLASIA	Objective Cochlear nerve deficiency (CND) is often associated with poor cochlear implant (CI) outcomes, and patients with CND may be candidates for auditory brainstem implantation (ABI). The purpose of this study was to identify investigations which predict CI outcomes immediately after cochlear implantation to recommend ABI within the critical period of auditory development when cochlear implantation precedes ABI. Study Design Retrospective case review. Setting Cochlear implant centers at tertiary referral hospitals. Patients Nineteen children with CND who underwent cochlear implantation and intraoperative electrically evoked auditory brainstem response (EABR) testing. Interventions Diagnostic and therapeutic. Main Outcome Measures Preoperative MRI and intraoperative EABR were used to evaluate relative diameter of the vestibulocochlear nerve (CN8) compared to the facial nerve (CN7) at the cerebellopontine angle and presence of evoked wave Vs (eVs) with typical latency, respectively. Correlation between 2-year postoperative categories of auditory performance (CAP) scores and results of MRI and EABR were evaluated. Results Each classification using MRI or EABR was significantly associated with the CI outcomes. Combination of the MRI and EABR results allowed better discrimination between poor CI users and moderate to good CI users than either examination used separately. All children in CN7 > CN8/negative eV showed 3, while all in CN7 CN8/positive eV achieved 3 in the postoperative CAP score. Conclusions Combination of MRI and EABR results allows prediction of CI outcomes immediately after cochlear implantation. This should facilitate management decision making for auditory implantation in children with CND.	[Yamazaki, Hiroshi; Naito, Yasushi] Kobe City Med Ctr Gen Hosp, Dept Otolaryngol, Kobe, Hyogo, Japan; [Yamazaki, Hiroshi; Naito, Yasushi] Inst Biomed Res & Innovat, Kobe, Hyogo, Japan; [Leigh, Jaime; Briggs, Robert] Royal Victorian Eye & Ear Hosp, Cochlear Implant Clin, East Melbourne, Australia; [Leigh, Jaime] Univ Melbourne, Dept Audiol & Speech Pathol, Parkville, Vic 3052, Australia; [Briggs, Robert] Univ Melbourne, Dept Otolaryngol, Parkville, Vic 3052, Australia; [Leigh, Jaime; Briggs, Robert] HEARing CRC, Melbourne, Vic, Australia	Naito, Y (reprint author), Kobe City Med Ctr Gen Hosp, Dept Otolaryngol, Chuo Ku, 2-1-1 Minatojima Minamimachi, Kobe, Hyogo, Japan.	naito@kcho.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [25861607, 26462574]	This study was supported by the Grant-in-Aid for Young Scientists (B): 25861607 and a Grant-in-Aid for Scientific Research (C): 26462574 from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Buchman CA, 2011, LARYNGOSCOPE, V121, P1979, DOI 10.1002/lary.22032; Kutz JW, 2011, OTOL NEUROTOL, V32, P956, DOI 10.1097/MAO.0b013e31821f473b; Eze N, 2013, OTOL NEUROTOL, V34, P1385, DOI 10.1097/MAO.0b013e3182a004b3; McClay JE, 2008, ARCH OTOLARYNGOL, V134, P945, DOI 10.1001/archotol.134.9.945; Kim AH, 2008, OTOL NEUROTOL, V29, P626, DOI 10.1097/MAO.0b013e31817781f5; Sennaroglu L, 2012, AURIS NASUS LARYNX, V39, P439, DOI 10.1016/j.anl.2011.10.013; Casselman JW, 1997, RADIOLOGY, V202, P773; Adunka OF, 2006, OTOL NEUROTOL, V27, P793, DOI 10.1097/01.mao.0000227895.34915.94; Yamazaki H, 2012, ACTA OTO-LARYNGOL, V132, P420, DOI 10.3109/00016489.2011.653442; Levi J, 2013, LARYNGOSCOPE, V123, P752, DOI 10.1002/lary.23636; Walton J, 2008, OTOL NEUROTOL, V29, P302, DOI 10.1097/MAO.0b013e318164d0f6; Colletti L, 2014, OTOLARYNG HEAD NECK, V151, P308, DOI 10.1177/0194599814531913; Giesemann AM, 2014, LARYNGOSCOPE, V124, P751, DOI 10.1002/lary.24300; Sennaroglu L, 2002, LARYNGOSCOPE, V112, P2230, DOI 10.1097/00005537-200212000-00019; Adunka OF, 2007, OTOL NEUROTOL, V28, P597, DOI 10.1097/01.mao.0000281804.36574.72; Leigh J, 2013, OTOL NEUROTOL, V34, P443, DOI 10.1097/MAO.0b013e3182814d2c; Sennaroglu L, 2011, OTOL NEUROTOL, V32, P187, DOI 10.1097/MAO.0b013e318206fc1e; NADOL JB, 1992, ANN OTO RHINOL LARYN, V101, P988; Valero J, 2012, EAR HEARING, V33, P3, DOI 10.1097/AUD.0b013e3182263460; Archbold S, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P312; Giesemann AM, 2011, EUR RADIOL, V22, P519; Naito Y, 2013, PEDIATRIC EAR DISEASES: DIAGNOSTIC IMAGING ATLAS AND CASE REPORTS, P1; Nelson EG, 2001, OTOL NEUROTOL, V22, P790, DOI 10.1097/00129492-200111000-00013; Papsin Blake C, 2005, Laryngoscope, V115, P1, DOI 10.1097/00005537-200501001-00001; Sennaroglu Levent, 2010, Cochlear Implants Int, V11, P4, DOI 10.1002/cii.416; Yamazaki H, 2014, OTOL NEUROTOL, V35, P1394, DOI 10.1097/MAO.0000000000000375; Zanetti D, 2006, OTOL NEUROTOL, V27, P815, DOI 10.1097/01.mao.0000227899.80656.1d	27	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	JUL	2015	36	6					977	984		10.1097/MAO.0000000000000721		8	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	CL3TO	WOS:000356873700006		
J	Kariya, S; Okano, M; Maeda, Y; Hirai, H; Higaki, T; Noyama, Y; Haruna, T; Nishihira, J; Nishizaki, K				Kariya, Shin; Okano, Mitsuhiro; Maeda, Yukihide; Hirai, Haruka; Higaki, Takaya; Noyama, Yasuyuki; Haruna, Takenori; Nishihira, Jun; Nishizaki, Kazunori			Macrophage Migration Inhibitory Factor Deficiency Causes Prolonged Hearing Loss After Acoustic Overstimulation	OTOLOGY & NEUROTOLOGY			English	Article						Cochlea; Ear; Hearing loss; Macrophage migration inhibitory factor; Noise-induced hearing loss	DEVELOPING INNER-EAR; NOISE-EXPOSED MICE; FACTOR-KAPPA-B; OTITIS-MEDIA; FACTOR MIF; NERVE DEGENERATION; RETINOIC ACID; UP-REGULATION; BALB/CJ MICE; NEUROTROPHIN	Hypothesis Macrophage migration inhibitory factor plays an important role in noise-induced hearing loss. Background Macrophage migration inhibitory factor is an essential factor in axis formation and neural development. Macrophage migration inhibitory factor is expressed in the inner ear, but its function remains to be elucidated. Methods Macrophage migration inhibitory factor-deficient mice (MIF-/- mice) were used in this study. Wild-type and MIF-/- mice received noise exposure composed of octave band noise. Auditory brainstem response thresholds were examined before (control) and at 0, 12, and 24 hours and 2 weeks after the intense noise exposure. Morphological findings of cochlear hair cells were investigated using scanning electron microscopy. Histopathological examination with hematoxylin and eosin staining and TUNEL assay were also performed. Results In both the wild-type and MIF-/- mice, acoustic overstimulation induced significant hearing loss compared with the control level. Two weeks after the intense noise exposure, the MIF-/- mice had an increased hearing threshold compared with the wild-type mice. Scanning electron microscopy demonstrated that the outer hair cells in the MIF-/- mice were affected 2 weeks after noise exposure compared with the wild-type mice. TUNEL-positive cells were identified in the organ of Corti of the MIF-/- mice. Conclusion The MIF-/- mice had prolonged hearing loss and significant loss of cochlear hair cells after intense noise exposure. Macrophage migration inhibitory factor may play an important role in recovery from acoustic trauma. Management of macrophage migration inhibitory factor may be a novel therapeutic option for noise-induced hearing loss.	[Kariya, Shin; Okano, Mitsuhiro; Maeda, Yukihide; Hirai, Haruka; Higaki, Takaya; Noyama, Yasuyuki; Haruna, Takenori; Nishizaki, Kazunori] Okayama Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Nishihira, Jun] Hokkaido Informat Univ, Dept Med Bioinformat, Ebetsu, Hokkaido, Japan	Kariya, S (reprint author), Okayama Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	skariya@cc.okayama-u.ac.jp			JSPS KAKENHI [25462642]	This work was supported by JSPS KAKENHI (Grants-in-Aid for Scientific Research; grant number, 25462642).	Ahn JH, 2011, OTOL NEUROTOL, V32, P926, DOI 10.1097/MAO.0b013e318225575a; Ahn JH, 2005, BIOCHEM BIOPH RES CO, V335, P485, DOI 10.1016/j.bbrc.2005.07.114; Adams JC, 2009, NEUROSCIENCE, V160, P530, DOI 10.1016/j.neuroscience.2009.02.073; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Fujioka M, 2006, J NEUROSCI RES, V83, P575, DOI 10.1002/jnr.20764; Cui Y, 2011, EUR ARCH OTO-RHINO-L, V268, P973, DOI 10.1007/s00405-011-1484-3; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Ohlemiller KK, 2000, HEARING RES, V149, P239, DOI 10.1016/S0378-5955(00)00191-X; Bank LM, 2012, DEVELOPMENT, V139, P4666, DOI 10.1242/dev.066647; Hakuba N, 2000, J NEUROSCI, V20, P8750; Wakabayashi K, 2010, NEUROSCI RES, V66, P345, DOI 10.1016/j.neures.2009.12.008; Shen YC, 2012, DEV BIOL, V363, P84, DOI 10.1016/j.ydbio.2011.12.023; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Baysal E, 2013, INT J PEDIATR OTORHI, V77, P338, DOI 10.1016/j.ijporl.2012.11.020; Chung JW, 2011, ENVIRON TOXICOL PHAR, V31, P153, DOI 10.1016/j.etap.2010.10.002; Concha-Barrientos M., 2004, WHO ENV BURDEN DIS S, V9; Fairfield DA, 2005, J NEUROSCI RES, V81, P589, DOI 10.1002/jnr.20417; Fingerle-Rowson GR, 2001, IMMUNOL CELL BIOL, V79, P368, DOI 10.1046/j.1440-1711.2001.01024.x; Gazquez I, 2013, EUR ARCH OTO-RHINO-L, V270, P1521, DOI 10.1007/s00405-012-2268-0; Honma N, 2000, IMMUNOLOGY, V100, P84, DOI 10.1046/j.1365-2567.2000.00011.x; Hori R, 2009, NEUROSCIENCE, V160, P813, DOI 10.1016/j.neuroscience.2009.03.014; Kariya S, 2003, CLIN DIAGN LAB IMMUN, V10, P417, DOI 10.1128/CDLI.10.3.417-422.2003; Kariya S, 2008, CLIN EXP IMMUNOL, V154, P134, DOI 10.1111/j.1365-2249.2008.03740.x; Kariya S, 2008, ACTA OTO-LARYNGOL, V128, P750, DOI 10.1080/00016480701714228; Kariya S, 2014, NEUROSCIENCE, V279, P132, DOI 10.1016/j.neuroscience.2014.08.042; Kim JU, 2005, LARYNGOSCOPE, V115, P1996, DOI 10.1097/01.mlg.0000180173.81034.4d; Lang HN, 2006, J NEUROSCI, V26, P3541, DOI 10.1523/JNEUROSCI.2488-05.2006; Maeda Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058775; Nishio Y, 1999, BBA-MOL BASIS DIS, V1453, P74, DOI 10.1016/S0925-4439(98)00086-6; Nishio Y, 2009, ACTA NEUROPATHOL, V117, P321, DOI 10.1007/s00401-008-0476-x; Nishio Y, 2002, MOL MED, V8, P509; Ohlemiller KK, 2011, JARO-J ASSOC RES OTO, V12, P45, DOI 10.1007/s10162-010-0238-z; Ohlemiller KK, 2002, JARO, V3, P444, DOI 10.1007/s10162-002-2041-y; Park JS, 2012, NEUROSCIENCE, V208, P123, DOI 10.1016/j.neuroscience.2012.02.010; Shim HJ, 2009, ACTA OTO-LARYNGOL, V129, P233, DOI 10.1080/00016480802226155; Suzuki M, 2004, J BIOL CHEM, V279, P21406, DOI 10.1074/jbc.M311416200; Turner JG, 2005, COMPARATIVE MED, V55, P12	38	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	JUL	2015	36	6					1103	1108		10.1097/MAO.0000000000000755		6	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	CL3TO	WOS:000356873700025		
J	Kasanuki, K; Iseki, E; Fujishiro, H; Ando, S; Sugiyama, H; Kitazawa, M; Chiba, Y; Sato, K; Arai, H				Kasanuki, Koji; Iseki, Eizo; Fujishiro, Hiroshige; Ando, Shuntaro; Sugiyama, Hideki; Kitazawa, Maiko; Chiba, Yuhei; Sato, Kiyoshi; Arai, Heii			Impaired heart rate variability in patients with dementia with Lewy bodies: Efficacy of electrocardiogram as a supporting diagnostic marker	PARKINSONISM & RELATED DISORDERS			English	Article						Dementia with Lewy bodies; Alzheimer's disease; Heart rate variability; Iodine-123 metaiodobenzylguanidine (I-123-MIBG) scintigraphy	CARDIAC SYMPATHETIC DENERVATION; PREMOTOR PARKINSONS-DISEASE; SLEEP BEHAVIOR DISORDER; ALZHEIMERS-DISEASE; MYOCARDIAL SCINTIGRAPHY; DIFFERENTIAL-DIAGNOSIS; AUTONOMIC DYSFUNCTION; ATROPHY; SYSTEM; DLB	Objective: It has been suggested that impaired heart rate variability (HRV) may be an early sign of Parkinson's disease (PD). The aim of this study was to determine whether HRV can be employed in order to differentiate between dementia with Lewy bodies (DLB) and Alzheimer's disease (AD). Methods: We examined HRV in 30 probable DLB patients (16 men and 14 women; mean age, 79.9 years; SD, 4.7 years), and 30 probable AD patients (15 men and 15 women; mean age, 79.8 years; SD, 5.6 years), compared with that in 20 age- and sex-matched controls. Subjects with other causes of impaired HRV were excluded. HRV was determined using the RR intervals of a 5-min electrocardiogram recording. Measurements of beat-to-beat RR variability, including time domains [(RR-standard deviation (SDNN), percentage of consecutive RR intervals differing by more than 50 msec (pNN50), and root mean square difference of successive RR intervals (RMSSD)), and frequency domains [very low- (VLF), low- (LF), and high-frequency (HF) components, and total spectral power (Total power)], were assessed retrospectively. The association between these HRV parameters and cardiac iodine-123 metaiodobenzylguanidine (I-123-MIBG) scintigraphy were investigated in 22 probable DLB patients. Results: DLB group showed significant decreases compared to AD group in almost all HRV parameters including SDNN, pNN50, RMSSD, VLF, LF, HF, and Total power. Among these, SDNN, VLF, and Total power were correlated with the I-123-MIBG delayed heart to mediastinum ratio. Conclusion: Impaired HRV was detected in patients with probable DLB. Non-invasive and routine electrocardiogram may have potential in differentiating DLB from AD. (C) 2015 Elsevier Ltd. All rights reserved.	[Kasanuki, Koji; Iseki, Eizo; Fujishiro, Hiroshige; Chiba, Yuhei; Sato, Kiyoshi] Juntendo Univ, Sch Med, Juntendo Tokyo Koto Geriatr Med Ctr, PET CT Dementia Res Ctr, Tokyo 113, Japan; [Kasanuki, Koji; Iseki, Eizo; Sugiyama, Hideki; Kitazawa, Maiko; Arai, Heii] Juntendo Univ, Sch Med, Dept Psychiat, Tokyo 113, Japan; [Ando, Shuntaro] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan	Kasanuki, K (reprint author), 3-3-20 Shinsuna,Koto Ku, Tokyo 1360075, Japan.	ksnk1jobim@yahoo.co.jp			Research Support Foundation of the Juntendo Institute of Mental Health; Ministry of Education, Culture, Sports, Science and Technology in Japan	The authors declare no conflicts of interest. The present study was supported, in part, by a Grant from the Research Support Foundation of the Juntendo Institute of Mental Health and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Shibata M, 2009, J NEUROL SCI, V276, P79, DOI 10.1016/j.jns.2008.09.005; Allan LM, 2007, J NEUROL NEUROSUR PS, V78, P671, DOI 10.1136/jnnp.2006.102343; Valappil RA, 2010, MOVEMENT DISORD, V25, P2296, DOI 10.1002/mds.23348; Yoshita M, 2006, NEUROLOGY, V66, P1850, DOI 10.1212/01.wnl.0000219640.59984.a7; Jellinger KA, 2003, MOVEMENT DISORD, V18, pS2, DOI 10.1002/mds.10557; Wenning GK, 1999, J NEUROL NEUROSUR PS, V67, P620, DOI 10.1136/jnnp.67.5.620; Postuma RB, 2010, MOVEMENT DISORD, V25, P2304, DOI 10.1002/mds.23347; Druschky A, 2000, J NEUROL SCI, V175, P3, DOI 10.1016/S0022-510X(00)00279-3; Treglia G, 2012, J NEUROIMAGING, V22, P111, DOI 10.1111/j.1552-6569.2010.00532.x; Scholte AJHA, 2010, EUR J NUCL MED MOL I, V37, P1698, DOI 10.1007/s00259-010-1442-0; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Yoshita M, 2001, J NEUROL NEUROSUR PS, V71, P583, DOI 10.1136/jnnp.71.5.583; Gelpi E, 2014, MOVEMENT DISORD, V29, P1010, DOI 10.1002/mds.25776; Chiba Y, 2012, DEMENT GERIATR COGN, V33, P273, DOI 10.1159/000339363; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Postuma RB, 2010, NEUROLOGY, V74, P239, DOI 10.1212/WNL.0b013e3181ca0166; Kallio M, 2000, EUR J NEUROL, V7, P667, DOI 10.1046/j.1468-1331.2000.00127.x; Orimo S, 2005, ACTA NEUROPATHOL, V109, P583, DOI 10.1007/s00401-005-0995-7; Orimo S, 2001, NEUROLOGY, V57, P1140; STEIN PK, 1995, AM HEART J, V129, P975, DOI 10.1016/0002-8703(95)90119-1; Hilton D, 2013, ACTA NEUROPATHOL, V127, P235; MCKHANN G, 1984, NEUROLOGY, V34, P939; Negami M., 2013, BMJ OPEN; Orimo S, 1999, J NEUROL NEUROSUR PS, V67, P189, DOI 10.1136/jnnp.67.2.189; Palma JA, 2013, MOVEMENT DISORD, V28, P591, DOI 10.1002/mds.25431; Camm AJ, 1996, CIRCULATION, V93, P1043; Wakabayashi K, 1997, EUR NEUROL, V38, P2, DOI 10.1159/000113469; Ziemssen T., 2010, J NEUROL SCI, P28974	28	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	JUL	2015	21	7					749	754		10.1016/j.parkreldis.2015.04.024		6	Clinical Neurology	Neurosciences & Neurology	CM0HW	WOS:000357360000013		
J	Furusawa, Y; Hanakawa, T; Mukai, Y; Aihara, Y; Taminato, T; Iawata, Y; Takei, T; Sakamoto, T; Murata, M				Furusawa, Yoshihiko; Hanakawa, Takashi; Mukai, Yohei; Aihara, Yuki; Taminato, Tomoya; Iawata, Yasuyuki; Takei, Tomohiko; Sakamoto, Takashi; Murata, Miho			Mechanism of camptocormia in Parkinson's disease analyzed by tilt table-EMG recording	PARKINSONISM & RELATED DISORDERS			English	Article						Parkinson's disease; Camptocormia; External oblique; Electromyography; Lidocaine	MUSCLE-CONTRACTION; ELECTROMYOGRAPHY; PATHOGENESIS; ONSET; SPINE	Background: We previously classified camptocormia of Parkinson's disease (PD) into upper and lower types based on the inflection point, and reported improvement of upper camptocormia after lidocaine injection into the external oblique. However, the exact pathophysiology of this phenomenon remains obscure. Methods: Surface electromyography (sEMG) was recorded in 11 PD patients with upper camptocormia, 11 PD patients with lower camptocormia, and 10 age-matched PD patients without postural deformity. Electrodes were positioned above the external oblique, hip flexors and paraspinal muscles at Th11 level bilaterally. Recording commenced with the patient in supine position on a tilt table, and continued when the table was tilted up to vertical position. Lidocaine was injected into the external oblique in patients with upper camptocormia and the psoas major in patients with lower camptocormia. Results: All patients with upper and lower camptocormia developed the corresponding camptocormic posture during tilt up. The onset of camptocormic posture was preceded by the appearance of sEMG activity in the external oblique in 10 out of 11 patients with upper camptocormia, but less frequently in patients with lower camptocormia and the controls. Hip flexors sEMG activity was recorded in almost all patients. Posture was improved in 8 out of 9 patients with upper camptocormia, and 9 out of 11 patients with lower camptocormia following injections of lidocaine. Conclusions: The results suggest the external oblique is involved, at least in part, in the development of upper camptocormia. Although EMG findings cannot differentiate pathogenicity, the psoas major is probably involved in lower camptocormia. (C) 2015 Elsevier Ltd. All rights reserved.	[Furusawa, Yoshihiko; Mukai, Yohei; Taminato, Tomoya; Sakamoto, Takashi; Murata, Miho] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Neurol, Kodaira, Tokyo 1878551, Japan; [Hanakawa, Takashi] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Kodaira, Tokyo 1878551, Japan; [Aihara, Yuki; Iawata, Yasuyuki] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Rehabil, Kodaira, Tokyo 1878551, Japan; [Takei, Tomohiko] Natl Inst Neurosci, Dept Neurophysiol, Kodaira, Tokyo 1878551, Japan; [Furusawa, Yoshihiko] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Neurol, Kofu, Yamanashi 4093898, Japan	Murata, M (reprint author), Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Neurol, 4-1-1 Ogawa Higashi Cho, Kodaira, Tokyo 1878551, Japan.	mihom@ncnp.go.jp			Research Committee of CNS Degenerative Disease; Ministry of Health, Labour and Welfare of Japan [24-5]; NCNP [21B-4]	This work was supported in part by Grants-in-Aid from the Research Committee of CNS Degenerative Disease, the Ministry of Health, Labour and Welfare of Japan (24-5), and Intramural Research Grant (21B-4) for Neurological and Psychiatric Disorders of NCNP.	Hodges PW, 1996, SPINE, V21, P2640, DOI 10.1097/00007632-199611150-00014; Azher SN, 2005, NEUROLOGY, V65, P355, DOI 10.1212/01.wnl.0000171857.09079.9f; Di Matteo A, 2011, J NEUROL, V258, P740, DOI 10.1007/s00415-010-5822-y; Doherty KM, 2011, LANCET NEUROL, V10, P538, DOI 10.1016/S1474-4422(11)70067-9; Horak FB, 1996, J NEUROPHYSIOL, V75, P2380; Furusawa Y, 2013, PARKINSONISM RELAT D, V19, P350, DOI 10.1016/j.parkreldis.2012.09.008; Tassorelli C, 2012, MOVEMENT DISORD, V27, P227, DOI 10.1002/mds.23930; Fernandes N, 2000, CLIN ORTHOP RELAT R, P193; Djaldetti R, 1999, MOVEMENT DISORD, V14, P443, DOI 10.1002/1531-8257(199905)14:3<443::AID-MDS1009>3.0.CO;2-G; Furusawa Y, 2012, MOVEMENT DISORD, V27, P802, DOI 10.1002/mds.24930; Micera S, 1998, MED ENG PHYS, V20, P211, DOI 10.1016/S1350-4533(98)00017-4; von Coelln R, 2008, MOVEMENT DISORD, V23, P889, DOI 10.1002/mds.21967; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0921-884X(96)95190-5; Escamilla RF, 2006, J ORTHOP SPORT PHYS, V36, P45; Greig AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109515; Koller H, 2012, EUR SPINE J, V21, P514, DOI 10.1007/s00586-011-2046-5; MARSDEN CD, 1984, NEUROL CLIN, V2, P435; McGill S.M., 2009, KINESIOLOGY, V2nd, P587; Ng J K, 1998, Electromyogr Clin Neurophysiol, V38, P51; Oatis C.A., 2009, KINESIOLOGY, P538; Oatis C.A., 2009, KINESIOLOGY MECH PAT, P705; YANAGISA.N, 1971, J NEUROL SCI, V13, P39, DOI 10.1016/0022-510X(71)90206-1	22	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	JUL	2015	21	7					765	770		10.1016/j.parkreldis.2015.02.027		6	Clinical Neurology	Neurosciences & Neurology	CM0HW	WOS:000357360000016		
J	Sengoku, R; Matsushima, S; Bono, K; Sakuta, K; Yamazaki, M; Miyagawa, S; Komatsu, T; Mitsumura, H; Kono, Y; Kamiyama, T; Ito, K; Mochio, S; Iguchi, Y				Sengoku, Renpei; Matsushima, Satoshi; Bono, Keiko; Sakuta, Kenichi; Yamazaki, Mikihiro; Miyagawa, Shinji; Komatsu, Teppei; Mitsumura, Hidetaka; Kono, Yu; Kamiyama, Tsutomu; Ito, Kimiteru; Mochio, Soichiro; Iguchi, Yasuyuki			Olfactory function combined with morphology distinguishes Parkinson's disease	PARKINSONISM & RELATED DISORDERS			English	Article						Olfactory bulb and tract volume; Olfactory dysfunction; MRI; Parkinsonism; meta-iodobenzylguanidine (I-123-MIBG) scintigraphy	MULTIPLE SYSTEM ATROPHY; STICK IDENTIFICATION TEST; PROGRESSIVE SUPRANUCLEAR PALSY; MYOCARDIAL SCINTIGRAPHY; SMELL IDENTIFICATION; BULB VOLUME; DIAGNOSIS; RELIABILITY; DYSFUNCTION; DISORDER	Objective: This study aimed to examine whether the volume of the olfactory bulbs and tracts (OB & T) on magnetic resonance imaging (MRI) is useful for differentiating Parkinson's disease (PD) from PD-related disorders. Methods: The study group comprised 13 patients with PD, 11 with multiple system atrophy (MSA), five with progressive supranuclear palsy, and five with corticobasal degeneration (PSP/CBD). All patients were evaluated using the odor stick identification test for Japanese (OSIT-J), I-123-meta-iodobenzylguanidine (MIBG) scintigraphy, and brain MRI. OB & T areas on 1-mm-thick coronal images were measured and summed for volumes. We examined relationships between olfactory function and volume, and cardiovascular dysautonomia. We defined the cut-off values for OSIT-J score or MIBG uptake and OB & T volume to discriminate PD from PD-related disorders and calculated the proportional rate of PD in four categorized groups. Results: OB & T volume was smaller in PD than in MSA or PSP/CBD (p < 0.05 each). The cut-off for detecting PD patients was OSIT-J score <8, heart/mediastinum ratio <1.6, and OB & T volume <270 mm(3). In the group with OSIT-J score <8 and OB & T volume <270 mm(3), the proportion of PD patients among all patients with PD-related disorders was 91%. The rate of probable PD gradually increased as OSIT-J score and OB & T volume decreased (p < 0.001). Conclusions: Although preliminary, these data obtained from a combined morphological and functional evaluation of OB or cardiovascular dysautonomia could be useful for further differential of PD and other PD-related disorders. (C) 2015 Elsevier Ltd. All rights reserved.	[Sengoku, Renpei; Bono, Keiko; Sakuta, Kenichi; Yamazaki, Mikihiro; Miyagawa, Shinji; Komatsu, Teppei; Mitsumura, Hidetaka; Kono, Yu; Kamiyama, Tsutomu; Iguchi, Yasuyuki] Jikei Univ, Sch Med, Dept Neurol, Tokyo, Japan; [Matsushima, Satoshi] Jikei Univ, Sch Med, Dept Radiol, Tokyo, Japan; [Mochio, Soichiro] Jikei Univ, Sch Nursing, Tokyo, Japan; [Sengoku, Renpei] Tokyo Metropolitan Geriatr Hosp, Dept Neurol, Tokyo 1730015, Japan; [Ito, Kimiteru] Tokyo Metropolitan Geriatr Hosp, Dept Radiol, Tokyo 1730015, Japan	Sengoku, R (reprint author), Tokyo Metropolitan Geriatr Hosp, Dept Neurol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	renpeis@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, Japan [24790897]	Dr. Sengoku was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (24790897).	Goldstein DS, 2008, PARKINSONISM RELAT D, V14, P600, DOI 10.1016/j.parkreldis.2008.01.010; HOEHN MM, 1967, NEUROLOGY, V17, P427; Hawkes CH, 1999, QJM-MON J ASSOC PHYS, V92, P473, DOI 10.1093/qjmed/92.8.473; Doty RL, 2012, NEUROBIOL DIS, V46, P527, DOI 10.1016/j.nbd.2011.10.026; Litvan I, 1996, NEUROLOGY, V47, P1; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; Brodoehl S, 2012, MOVEMENT DISORD, V27, P1019, DOI 10.1002/mds.25087; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chen S, 2014, EUR J RADIOL, V83, P564, DOI 10.1016/j.ejrad.2013.11.024; Hummel T, 2013, J NEUROL, V260, P1004, DOI 10.1007/s00415-012-6741-x; Wang J, 2011, AM J NEURORADIOL, V32, P677, DOI 10.3174/ajnr.A2350; Gudziol V, 2009, BRAIN, V132, P3096, DOI 10.1093/brain/awp243; Lichy MP, 2005, INVEST RADIOL, V40, P754, DOI 10.1097/01.rli.0000185880.92346.9e; WENNING GK, 1995, ACTA NEUROL SCAND, V91, P247; Sengoku R, 2008, J NEUROPATH EXP NEUR, V67, P1072, DOI 10.1097/NEN.0b013e31818b4126; Orimo S, 2012, PARKINSONISM RELAT D, V18, P494, DOI 10.1016/j.parkreldis.2012.01.009; Miyamoto T, 2009, MOVEMENT DISORD, V24, P268, DOI 10.1002/mds.22361; ANSARI KA, 1975, J CHRON DIS, V28, P493, DOI 10.1016/0021-9681(75)90058-2; Mueller A, 2005, J NEURAL TRANSM, V112, P1363, DOI 10.1007/s00702-005-0280-x; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; Kikuchi A, 2011, PARKINSONISM RELAT D, V17, P698, DOI 10.1016/j.parkreldis.2011.07.011; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Saito S, 2006, CHEM SENSES, V31, P379, DOI 10.1093/chemse/bjj042; Baba T, 2012, BRAIN, V135, P161, DOI 10.1093/brain/awr321; DOTY RL, 1989, ANN NY ACAD SCI, V561, P76, DOI 10.1111/j.1749-6632.1989.tb20971.x; Fahn S, 1987, UNIFIED PARKINSONS D; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hashimoto Y, 2004, CHEM SENSES, V29, P565, DOI 10.1093/chemse/bjh061; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Hummel T, 2010, J NEUROL SCI, V289, P119, DOI 10.1016/j.jns.2009.08.026; Iijima M, 2008, INTERNAL MED, V47, P1887, DOI 10.2169/internalmedicine.47.1345; Mazal P.P., 2014, EUR ARCH OTORHINOLAR; Orimo S, 1999, J NEUROL NEUROSUR PS, V67, P189, DOI 10.1136/jnnp.67.2.189; Poewe W, 2002, EUR J NEUROL, V9, P23, DOI 10.1046/j.1468-1331.9.s3.3.x; RAJPUT AH, 1976, J NEUROL NEUROSUR PS, V39, P1092, DOI 10.1136/jnnp.39.11.1092; Silveira-Moriyama L, 2010, MOVEMENT DISORD, V25, P570, DOI 10.1002/mds.22688; Suzuki M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-157; Tateno F, 2008, MOVEMENT DISORD, V23, P2097, DOI 10.1002/mds.22015; Yousem DM, 1997, ACAD RADIOL, V4, P264, DOI 10.1016/S1076-6332(97)80027-X	39	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	JUL	2015	21	7					771	777		10.1016/j.parkreldis.2015.05.001		7	Clinical Neurology	Neurosciences & Neurology	CM0HW	WOS:000357360000017		
J	Lee, D; Yun, JY; Jeong, JH; Yoshida, K; Nagasaki, S; Ahn, TB				Lee, Dokyung; Yun, Ji Young; Jeong, Jee Hyang; Yoshida, Kunihiro; Nagasaki, Sonomi; Ahn, Tae-Beom			Clinical evolution, neuroimaging, and volumetric analysis of a patient with a CSF1R mutation who presented with progressive nonfluent aphasia	PARKINSONISM & RELATED DISORDERS			English	Letter							HEREDITARY DIFFUSE LEUKOENCEPHALOPATHY; DWI CHANGES; SPHEROIDS; HDLS		[Lee, Dokyung; Ahn, Tae-Beom] Kyung Hee Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Yun, Ji Young; Jeong, Jee Hyang] Ewha Womans Univ, Sch Med, Dept Neurol, Cognit & Neurodegenerat Disorder Clin, Seoul, South Korea; [Yoshida, Kunihiro] Shinshu Univ, Sch Med, Dept Brain Dis Res, Div Neurogenet, Matsumoto, Nagano 390, Japan; [Nagasaki, Sonomi] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 390, Japan	Ahn, TB (reprint author), Kyung Hee Univ Hosp, Dept Neurol, 23 Kyungheedae Ro, Seoul 130872, South Korea.	ricash@hanmail.net					Kleinfeld K, 2013, J NEUROL, V260, P558, DOI 10.1007/s00415-012-6680-6; Konno T, 2014, NEUROLOGY, V82, P139, DOI 10.1212/WNL.0000000000000046; Mateen FJ, 2010, J NEUROL NEUROSUR PS, V81, P619, DOI 10.1136/jnnp.2008.169243; Sundal C, 2013, PARKINSONISM RELAT D, V19, P869, DOI 10.1016/j.parkreldis.2013.05.013; Terasawa Y, 2013, J NEUROL SCI, V335, P213, DOI 10.1016/j.jns.2013.08.027	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	JUL	2015	21	7					817	820		10.1016/j.parkreldis.2015.04.010		4	Clinical Neurology	Neurosciences & Neurology	CM0HW	WOS:000357360000029		
J	Sakai, Y; Kobayashi, M				Sakai, Yasuhiro; Kobayashi, Motohiro			Lymphocyte "homing' and chronic inflammation	PATHOLOGY INTERNATIONAL			English	Review						autoimmune pancreatitis; chronic inflammation; Helicobacter pylori gastritis; high endothelial venule (HEV); inflammatory bowel disease (IBD); lymphocyte homing; MALT lymphoma; mucosal addressin cell adhesion molecule 1 (MAdCAM-1); peripheral lymph node addressin (PNAd); tertiary lymphoid tissue	HIGH ENDOTHELIAL VENULES; L-SELECTIN LIGANDS; HEV-RESTRICTED SULFOTRANSFERASE; MUCOSAL VASCULAR ADDRESSIN; CHEMOKINE RECEPTOR CCR7; HELICOBACTER-PYLORI; P-SELECTIN; ULCERATIVE-COLITIS; PRIMARY ADHESION; T-CELLS	Chronic inflammation is a response to prolonged exposure to injurious stimuli that harm and destroy tissues and promote lymphocyte infiltration into inflamed sites. Following progressive accumulation of lymphocytes, the histology of inflamed tissue begins to resemble that of peripheral lymphoid organs, which can be referred to as lymphoid neogenesis or formation of tertiary lymphoid tissues. Lymphocyte recruitment to inflamed tissues is also reminiscent of lymphocyte homing to peripheral lymphoid organs. In the latter, under physiological conditions, homing receptors expressed on lymphocytes adhere to vascular addressin expressed on high endothelial venules (HEVs), initiating a lymphocyte migration process composed of sequential adhesive interactions. Intriguingly, in chronic inflammation, HEV-like vessels are induced de novo, despite the fact that the inflamed site is not originally lymphoid tissue, and these vessels contribute to lymphocyte recruitment in a manner similar to physiological lymphocyte homing. In this review, we first describe physiological lymphocyte homing mechanisms focusing on vascular addressins. We then describe HEV-like vessel-mediated pathogenesis seen in various chronic inflammatory disorders such as Helicobacter pylori gastritis, inflammatory bowel disease (IBD), autoimmune pancreatitis and sclerosing sialadenitis, as well as chronic inflammatory cell neoplasm MALT lymphoma, with reference to our work and that of others.	[Sakai, Yasuhiro; Kobayashi, Motohiro] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Tumor Pathol, Eiheiji, Japan	Kobayashi, M (reprint author), Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Tumor Pathol, 23-3 Matsuoka Shimoaizuki, Fukui 9101193, Japan.	motokoba@u-fukui.ac.jp					Connor EM, 1999, J LEUKOCYTE BIOL, V65, P349; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; PICKER LJ, 1990, AM J PATHOL, V136, P1053; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annure.immunol.21.090501.080131; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Kobayashi M, 2009, INFLAMM BOWEL DIS, V15, P697, DOI 10.1002/ibd.20827; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; SCHOLZ AT, 1976, SCIENCE, V192, P1247, DOI 10.1126/science.1273590; Gunn MD, 1998, NATURE, V391, P799; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; Liu YX, 2001, MODERN PATHOL, V14, P798, DOI 10.1038/modpathol.3880393; Fuhlbrigge RC, 1997, NATURE, V389, P978; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; MARSHALL BJ, 1984, LANCET, V1, P1311; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Brown LM, 2000, EPIDEMIOL REV, V22, P283; Hemmerich S, 2001, IMMUNITY, V15, P237, DOI 10.1016/S1074-7613(01)00188-1; Kobayashi M, 2011, J PATHOL, V224, P67, DOI 10.1002/path.2851; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P17807, DOI 10.1073/pnas.0407503101; DeGrendele HC, 1997, J IMMUNOL, V159, P2549; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; Iwaya Y, 2013, HELICOBACTER, V18, P356, DOI 10.1111/hel.12051; Jinno Y, 2006, VIRCHOWS ARCH, V448, P412, DOI 10.1007/s00428-005-0136-7; Maruyama M, 2013, PANCREAS, V42, P53, DOI 10.1097/MPA.0b013e318258ce4c; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Suzawa K, 2007, AM J GASTROENTEROL, V102, P1499, DOI 10.1111/j.1572-0241.2007.01189.x; Kobayashi M, 2012, SEMIN IMMUNOPATHOL, V34, P401, DOI 10.1007/s00281-012-0302-3; SIKORSKI EE, 1993, J IMMUNOL, V151, P5239; Pablos JL, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-6; Hoshino H, 2011, J HISTOCHEM CYTOCHEM, V59, P572, DOI 10.1369/0022155411404416; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; Estess P, 1999, J EXP MED, V190, P9, DOI 10.1084/jem.190.1.9; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; Deshpande V, 2006, AM J SURG PATHOL, V30, P1537, DOI 10.1097/01.pas.0000213331.09864.2c; BAYERDORFFER E, 1995, LANCET, V345, P1591, DOI 10.1016/S0140-6736(95)90113-2; BERG EL, 1991, J CELL BIOL, V114, P343, DOI 10.1083/jcb.114.2.343; Drillenburg P, 1997, AM J PATHOL, V150, P919; DUIJVESTIJN AM, 1988, AM J PATHOL, V130, P147; GELB AB, 1993, AM J PATHOL, V142, P1556; GOWANS JL, 1959, J PHYSIOL-LONDON, V146, P54; Hruban RH, 2014, ROBBINS COTRAN PATHO, V9th, P883; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kumar V, 2014, ROBBINS COTRAN PATHO, V9th, P69; Li FG, 1996, J BIOL CHEM, V271, P3255; Milinkovic M, 2004, BLOOD, V103, P740, DOI 10.1182/blood-2003-05-1500; MOORE KL, 1994, J BIOL CHEM, V269, P23318; PAAVONEN T, 1992, AM J PATHOL, V141, P1259; Sakai Y, 2014, ANDROLOGY-US, V2, P282, DOI 10.1111/j.2047-2927.2014.00192.x; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; STOOLMAN LM, 1987, BLOOD, V70, P1842; STOOLMAN LM, 1983, J CELL BIOL, V96, P722, DOI 10.1083/jcb.96.3.722; Turner JR, 2014, ROBBINS COTRAN PATHO, V9th, P749; Umemoto E, 2006, J EXP MED, V203, P1603, DOI 10.1084/jem.20052543; vansDinther-Janssen AC, 1990, J RHEUMATOL, V17, P11; Yoshino T, 1999, CELL IMMUNOL, V197, P39, DOI 10.1006/cimm.1999.1552	68	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JUL	2015	65	7					344	354		10.1111/pin.12294		11	Pathology	Pathology	CL9UU	WOS:000357324400002		
J	Miura, K; Egawa, Y; Moriki, T; Mineta, H; Harada, H; Baba, S; Yamamoto, S				Miura, Katsutoshi; Egawa, Yuki; Moriki, Toshiaki; Mineta, Hiroyuki; Harada, Hidekazu; Baba, Satoshi; Yamamoto, Seiji			Microscopic observation of chemical modification in sections using scanning acoustic microscopy	PATHOLOGY INTERNATIONAL			English	Article						ageing; elasticity; formalin fixation; histochemistry; histopathology; imaging analysis; pepsin; periodic acid-Schiff reaction; ultrasound	EMBEDDED TISSUE; FIBROSIS; REPAIR	A scanning acoustic microscope (SAM) calculates the speed of sound (SOS) through tissues and plots the data on the screen to form images. Hard tissues result in greater SOS; based on these differences in tissue properties regarding SOS, SAM can provide data on tissue elasticity. The present study evaluated whether tissue modifications, such as formalin fixation, periodic acid-Schiff (PAS) reactions and protein degradation, changed the acoustic properties of the tissues and whether SAM could be a useful tool for following chemical changes in sections. The fixation process was observable by the increased SOS. During the PAS reaction, the glycosylation of tissues was characterized by an increased SOS. Mucous or glycogen distribution was visualized and was found to be statistically comparable among lesions and states. Protease digestion by pepsin led to a decreased SOS. Tissue sensitivity to proteases varied due to the stage, cause and duration of inflammation or ageing. Changes in acoustic properties were more sensitive than those in optical histology. SAM facilitates the visualisation of the time course or distribution of chemical modifications in tissue sections, thus aiding their comparison among tissues. SAM may be an effective tool for studying changes such as protein cross-linkage, tissue repair and ageing.	[Miura, Katsutoshi] Hamamatsu Univ Sch Med, Dept Hlth Sci Pathol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Mineta, Hiroyuki] Hamamatsu Univ Sch Med, Dept Otorhinolaryngol, Hamamatsu, Shizuoka 4313192, Japan; [Yamamoto, Seiji] Hamamatsu Univ Sch Med, Med Photon Res Ctr, Hamamatsu, Shizuoka 4313192, Japan; [Harada, Hidekazu; Baba, Satoshi] Hamamatsu Univ Hosp, Div Pathol, Hamamatsu, Shizuoka, Japan; [Egawa, Yuki; Moriki, Toshiaki] Shizuoka City Shizuoka Hosp, Dept Diagnost Pathol, Shizuoka, Japan	Miura, K (reprint author), Hamamatsu Univ Sch Med, Dept Hlth Sci Pathol & Anat, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kmiura@hama-med.ac.jp			Japan Society for the Promotion of Science KAKENHI [24590445]	We thank K. Kobayashi (Honda Electronics Co., Ltd, Toyohashi, Japan) for his technical support and advice on scan-ning acoustic microscopy and Y. Kawabata, N. Suzuki and K. Sugaya for preparing the tissue sections. The authors would like to thank Enago (http://www.enago.jp) and Wiley Editing Services for the English language review. This work was supported by a Japan Society for the Promotion of Science KAKENHI, Grant Number Scientific Research (c) 24590445.	Bucala R, 2014, J CLIN INVEST, V124, P1887, DOI 10.1172/JCI75224; Hood BL, 2006, PROTEOMICS, V6, P4106, DOI 10.1002/pmic.200600016; Kapetanaki MG, 2013, J PATHOL, V229, P310, DOI 10.1002/path.4122; Ariel A, 2013, J PATHOL, V229, P250, DOI 10.1002/path.4108; White ES, 2013, J PATHOL, V229, P141, DOI 10.1002/path.4126; Miura K, 2012, LAB INVEST, V92, P1760, DOI 10.1038/labinvest.2012.135; Miura K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01255; Miura K, 2013, PROTOC EXCH, DOI [10.1038/protex.2013.040, DOI 10.1038/PROTEX.2013.040]; Miura K, 2014, PATHOL LAB MED INT, V6, P1; Miura K, 2014, BR J APPL SCI TECHNO, V4, P1; Saijo Y., 2009, IMAGING MED, V1, P47, DOI 10.2217/iim.09.8; Vincenti DC, 2013, CLIN BIOCHEM, V46, P546, DOI 10.1016/j.clinbiochem.2012.10.002; WELLS PNT, 1977, PHYS MED BIOL, V22, P629, DOI 10.1088/0031-9155/22/4/001	13	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JUL	2015	65	7					355	366		10.1111/pin.12288		12	Pathology	Pathology	CL9UU	WOS:000357324400003		
J	Ishida, K; Uesugi, N; Hasegawa, Y; Sugimoto, R; Takahara, T; Otsuka, K; Nitta, H; Kawasaki, T; Wakabayashi, G; Sugai, T				Ishida, Kazuyuki; Uesugi, Noriyuki; Hasegawa, Yasushi; Sugimoto, Ryo; Takahara, Takeshi; Otsuka, Koki; Nitta, Hiroyuki; Kawasaki, Tomonori; Wakabayashi, Go; Sugai, Tamotsu			Proposal for novel histological findings of colorectal liver metastases with preoperative chemotherapy	PATHOLOGY INTERNATIONAL			English	Article						chemotherapy regimen; cholesterol clefts; colorectal liver metastases; foamy macrophages; histological findings; infarct-like necrosis; preoperative chemotherapy; three-zonal changes	LONG-TERM SURVIVAL; NEOADJUVANT CHEMOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; 1ST-LINE TREATMENT; CANCER; FLUOROURACIL; LEUCOVORIN; OXALIPLATIN; RESECTION; SURGERY	This study aimed to clarify the histological characteristics related to preoperative chemotherapy for colorectal liver metastases (CRLM). Sixty-three patients with CRLM were divided into two groups: CRLM with chemotherapy (41 cases, group A) and CRLM without chemotherapy (22 cases; surgical treatment alone, group S) to identify the histological differences associated with chemotherapy. In addition, we investigated the effects of combination chemotherapy on the histology of metastatic lesions. Infarct-like necrosis (ILN), three-zonal changes, and cholesterol clefts were more frequent in group A than in group S (P < 0.05). ILN and three-zonal changes were more common in the 5-FU with leucovorin and oxaliplatin (FOLFOX), or 5-FU with leucovorin and irinotecan (FOLFIRI) with or without additional bevacizumab groups than in group S (P < 0.05). Cholesterol clefts in the FOLFOX or FOLFIRI with bevacizumab group and foamy macrophages in the FOLFOX or FOLFIRI group were more common than in group S (P < 0.05). Cases with more than three of the four histological findingsi.e. ILN, three-zonal changes, cholesterol clefts, and foamy macrophageswere more frequent in the FOLFOX or FOLFIRI with or without additional bevacizumab groups than in group S (P < 0.05). We showed histological findings for every representative chemotherapy regimen for CRLM to clarify the effects of preoperative chemotherapy.	[Ishida, Kazuyuki; Uesugi, Noriyuki; Sugimoto, Ryo; Kawasaki, Tomonori; Sugai, Tamotsu] Iwate Med Univ, Dept Mol Diagnost Pathol, Morioka, Iwate 0208505, Japan; [Hasegawa, Yasushi; Takahara, Takeshi; Otsuka, Koki; Nitta, Hiroyuki; Wakabayashi, Go] Iwate Med Univ, Dept Surg, Morioka, Iwate 0208505, Japan	Ishida, K (reprint author), Iwate Med Univ, Dept Mol Diagnost Pathol, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	ishidaka@iwate-med.ac.jp					Aloysius MM, 2007, VIRCHOWS ARCH, V451, P943, DOI 10.1007/s00428-007-0497-1; Andre T, 1999, J CLIN ONCOL, V17, P3560; Giacchetti S, 1999, ANN ONCOL, V10, P663, DOI 10.1023/A:1008347829017; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Blazer DG, 2008, J CLIN ONCOL, V26, P5344, DOI 10.1200/JCO.2008.17.5299; STANGL R, 1994, LANCET, V343, P1405, DOI 10.1016/S0140-6736(94)92529-1; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Klinger M, 2010, ANN SURG ONCOL, V17, P2059, DOI 10.1245/s10434-010-0972-9; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Allen PJ, 2003, J GASTROINTEST SURG, V7, P109, DOI 10.1016/S1091-255X(02)00121-X; Mentha G, 2009, BRIT J SURG, V96, P95, DOI 10.1002/bjs.6436; Chang HHL, 2012, AM J SURG PATHOL, V36, P570, DOI 10.1097/PAS.0b013e31824057e7; Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16; Ribba B, 2011, EUR J CANCER, V47, P479, DOI 10.1016/j.ejca.2010.10.003; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Delaunoit T, 2005, ANN ONCOL, V16, P425, DOI 10.1093/annone/mdi092; Rubbia-Brandt L, 2007, ANN ONCOL, V18, P299, DOI 10.1093/annonc/mdl386; Gruenberger B, 2008, J CLIN ONCOL, V26, P1830, DOI 10.1200/JCO.2007.13.7679; Leonard GD, 2005, J CLIN ONCOL, V23, P2038, DOI 10.1200/JCO.2005.00.0349; Andres A, 2008, ANN SURG ONCOL, V15, P134, DOI 10.1245/s10434-007-9607-1; SCHEELE J, 1995, WORLD J SURG, V19, P59; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Petrelli NJ, 2005, J CLIN ONCOL, V23, P4475, DOI 10.1200/JCO.2005.05.025; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stephane Benoist AB, 2006, J CLIN ONCOL, V24, P3939	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JUL	2015	65	7					367	373		10.1111/pin.12300		7	Pathology	Pathology	CL9UU	WOS:000357324400004		
J	Nakamura, Y; McNamara, KM; Onodera, S; Kitamoto, Y; Kisu, K; Shibahara, Y; Kurosu, A; Sasano, H; Sato, H; Joh, K				Nakamura, Yasuhiro; McNamara, Keely M.; Onodera, Shin; Kitamoto, Yasunori; Kisu, Kiyomi; Shibahara, Yukiko; Kurosu, Akira; Sasano, Hironobu; Sato, Hiroshi; Joh, Kensuke			Hypoelectrolytic isoosmotic solution for infusion prevents saline-induced ultrastuructural artifacts of renal biopsy specimens	PATHOLOGY INTERNATIONAL			English	Article						artifacts; electron micrograph; physiologic saline; renal biopsy		Artifacts in the process of specimen preparation are frequent in ultrastructural evaluation of renal biopsy. We hypothesized that the common practice of wrapping kidney biopsy specimens in saline-soaked gauze to prevent the drying of the specimens could be the major factor of artifacts. In this study, whole kidneys from two male Sprague-Dawley rats were used. Before fixation, fresh small cubes of kidney tissue were macerated in saline (Saline group) or hypoelectrolytic isoosmotic solution for infusion (HISI group) (Sorita T3 or SOLDEM 3A) for 10 or 30min. Then, the specimens were processed by 1% OsO4 in 0.1M phosphate buffer (pH7.4) and embedded by EPON 812 for ultramicroscopic analysis. In the Saline group, ultrastructural examination revealed swollen podocyte, swollen capillary protuberance of the mesangium into the glomerular capillary loop, tubular cells with swollen mitochondria and microvilli, and the smooth muscle cells in the arteriolar wall with marked vacuolar degeneration were detected after 10min maceration in saline and these findings become more pronounced after 30min maceration. However, in the HISI group, these artifacts were not identified or limited within 30min. It is postulated that HISI solution could prevent the artifacts, and be used for soaking and wrapping instead of physiologic saline solution.	[Nakamura, Yasuhiro; McNamara, Keely M.; Shibahara, Yukiko; Sasano, Hironobu; Joh, Kensuke] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808575, Japan; [Kisu, Kiyomi; Sato, Hiroshi] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 9808575, Japan; [Sato, Hiroshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Clin Pharmacol & Therapeut, Sendai, Miyagi 9808575, Japan; [Onodera, Shin] Japan Community Hlth Care Org, Sendai Hosp, Dept Pathol, Sendai, Miyagi, Japan; [Kitamoto, Yasunori] Japan Community Hlth Care Org, Sendai Hosp, Dept Lab Med, Sendai, Miyagi, Japan; [Kurosu, Akira] Dokkyo Med Univ, Dept Legal Med, Shimotsuga, Japan	Nakamura, Y (reprint author), Tohoku Univ, Sch Med, Dept Pathol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	yasu-naka@patholo2.med.tohoku.ac.jp			Japan Society for the Promotion of Science	This study was supported by the Grant in Aid for Scientific Research of Japan Society for the Promotion of Science.	Alberts B, 2002, MOL BIOL CELL, P615; Haas M, 1997, J AM SOC NEPHROL, V8, P70; MAUNSBAC.AB, 1966, J ULTRA MOL STRUCT R, V15, P283, DOI 10.1016/S0022-5320(66)80110-7; OLSEN TS, 1988, J ELECTRON MICR TECH, V9, P283, DOI 10.1002/jemt.1060090305; OSBORNE CA, 1971, AM J VET RES, V32, P1865	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JUL	2015	65	7					374	378		10.1111/pin.12302		5	Pathology	Pathology	CL9UU	WOS:000357324400005		
J	Suzuki, T; Iyoda, M; Yamaguchi, Y; Shibata, T				Suzuki, Taihei; Iyoda, Masayuki; Yamaguchi, Yutaka; Shibata, Takanori			A case of sporadic medullary cystic kidney disease type 1 (MCKD1) with kidney enlargement complicated by IgA nephropathy	PATHOLOGY INTERNATIONAL			English	Article						cystic kidney disease; IgA nephropathy; kidney enlargement; MCKD		Medullary cystic kidney disease (MCKD) is a progressive tubulointerstitial nephropathy, and it leads to end-stage kidney disease (ESKD). It is an autosomal dominant inherited disease, and is categorized into two types according to the localizing chromosome and timing of ESKD onset. Its pathogenesis has not been revealed clearly, thus accumulation of the cases is very valuable. We report here the first reported case of MCKD with kidney enlargement complicated by IgA nephropathy. A 70-year-old male was admitted to our hospital because of renal dysfunction and bilateral kidney enlargement. He was diagnosed as having MCKD complicated by IgA nephropathy (IgA-N) by renal biopsy. We speculated that he had MCKD type 1 on the basis of the late onset of renal failure and no significant evidence of mutation in the UMOD gene that is associated with MCKD type 2. Thereafter, his kidney function decreased progressively and he started to receive hemodialysis. This is an interesting case of MCKD1 in terms of its sporadic nature, kidney enlargement, and complication of IgA-N.	[Suzuki, Taihei; Iyoda, Masayuki; Shibata, Takanori] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 1428666, Japan; [Yamaguchi, Yutaka] Yamaguchis Pathol Lab, Chiba, Japan	Iyoda, M (reprint author), Showa Univ, Sch Med, Dept Med, Div Nephrol,Shinagawa ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	iyoda@med.showa-u.ac.jp					Kawamura T, 2013, J NEPHROL, V26, P350, DOI 10.5301/jn.5000151; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1053/S0272-6386(03)00829-1; Christodoulou K, 1998, HUM MOL GENET, V7, P905, DOI 10.1093/hmg/7.5.905; Kirby A, 2013, NAT GENET, V45, P299, DOI 10.1038/ng.2543; Masutani K, 2008, CLIN EXP NEPHROL, V12, P398, DOI 10.1007/s10157-008-0066-1; Bisceglia M, 2006, ADV ANAT PATHOL, V13, P26, DOI 10.1097/01.pap.0000201831.77472.d3; Bantis C, 2010, AM J KIDNEY DIS, V55, P259, DOI 10.1053/j.ajkd.2009.09.031; Chen YZ, 2010, INTERNAL MED, V49, P37, DOI 10.2169/internalmedicine.49.2722; CONTRERAS G, 1995, J AM SOC NEPHROL, V6, P1354; Fabris A, 2013, NEPHROL DIAL TRANSPL, V28, P1111, DOI 10.1093/ndt/gfs505; Hildebrandt F, 2001, PEDIATR NEPHROL, V16, P168; PANISELLO JM, 1988, AM J NEPHROL, V8, P477, DOI 10.1159/000167662; Rohatgi R, 2008, FRONT BIOSCI, V13, P4175, DOI 10.2741/2999; Scolari Francesco, 2003, Saudi J Kidney Dis Transpl, V14, P316; Storm A, 2014, AM J KIDNEY DIS, V63, pXVIII, DOI 10.1053/j.ajkd.2013.07.027; Wise SW, 1998, ABDOM IMAGING, V23, P649, DOI 10.1007/s002619900423	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JUL	2015	65	7					379	382		10.1111/pin.12292		4	Pathology	Pathology	CL9UU	WOS:000357324400006		
J	Tajima, S; Koda, K				Tajima, Shogo; Koda, Kenji			A signet-ring cell melanoma arising from a medium-sized congenital melanocytic nevus in an adult: A case report and literature review	PATHOLOGY INTERNATIONAL			English	Article						adult; congenital melanocytic nevus; p16; proliferative nodule; signet-ring cell melanoma	PROLIFERATIVE NODULES; MALIGNANT-MELANOMA; IMMUNOHISTOCHEMICAL ANALYSIS; RISK; FEATURES; LESIONS; P16	Patients with congenital nevus, especially giant congenital melanocytic nevus (CMN) measuring >20cm, are known to be at elevated risk of developing melanomas, especially during the first and second decades of life. Melanomas rarely develop in patients with small and medium-sized CMNs, but if they do, they occur during the fourth and fifth decades of life. We present a case of a rapidly enlarging signet-ring cell melanoma (over 3 months) that arose from a medium-sized CMN in a 57-year-old Japanese man. Only 11 other cases of signet-ring cell melanomas at the primary site have been reported. On the basis of morphology alone, it is difficult to diagnose a nodule appearing in a CMN as a signet-ring cell melanoma, because even a benign melanocytic nevus can appear as signet-ring cell morphology. Moreover, a rapidly growing proliferative nodule (PN) more often develops in a CMN than melanoma; PNs may at times exhibit enough atypia to be comparable to melanomas. In our case, loss of p16 expression in the melanoma distinguished it from the nevus cells and was helpful in making the correct diagnosis. Clinical information, such as the patient's age, was also useful in establishing the diagnosis.	[Tajima, Shogo] Shizuoka Saiseikai Gen Hosp, Dept Pathol, Shizuoka 4228021, Japan; [Koda, Kenji] Fujieda Municipal Gen Hosp, Dept Pathol, Shizuoka, Japan	Tajima, S (reprint author), Shizuoka Saiseikai Gen Hosp, Dept Pathol, Suruga Ku, 1-1-1 Oshika, Shizuoka 4228021, Japan.	stajima-tky@umin.ac.jp					Abbott JJ, 2004, ARCH PATHOL LAB MED, V128, P686; LIVOLSI VA, 1992, MODERN PATHOL, V5, P515; MACKIE RM, 1991, BRIT J DERMATOL, V124, P560, DOI 10.1111/j.1365-2133.1991.tb04951.x; Bastian BC, 2002, AM J PATHOL, V161, P1163, DOI 10.1016/S0002-9440(10)64393-3; Krengel S, 2006, BRIT J DERMATOL, V155, P1, DOI 10.1111/j.1365-2133.2006.07218.x; NAKHLEH RE, 1990, AM J CLIN PATHOL, V93, P731; Phadke PA, 2011, AM J SURG PATHOL, V35, P656, DOI 10.1097/PAS.0b013e31821375ea; Marghoob AA, 1996, ARCH DERMATOL, V132, P170, DOI 10.1001/archderm.132.2.170; Watt AJ, 2004, PLAST RECONSTR SURG, V113, P1968, DOI 10.1097/01.prs.0000122209.10277.2a; RUIZMALDONADO R, 1992, J PEDIATR-US, V120, P906, DOI 10.1016/S0022-3476(05)81958-4; Lade-Keller J, 2014, J CLIN PATHOL, V67, P520, DOI 10.1136/jclinpath-2013-202127; Magro CM, 2006, MODERN PATHOL, V19, pS41, DOI 10.1038/modpathol.3800516; Chen ACC, 2012, AUSTRALAS J DERMATOL, V53, P219, DOI 10.1111/j.1440-0960.2012.00897.x; Demirkan NC, 2007, CLIN EXP DERMATOL, V32, P733, DOI 10.1111/j.1365-2230.2007.02507.x; Ishida M, 2014, ONCOL LETT, V7, P65; Kocovski L, 2014, AM J DERMATOPATH, V36, P985, DOI 10.1097/DAD.0000000000000015; Leech SN, 2004, ARCH DERMATOL, V140, P83, DOI 10.1001/archderm.140.1.83; McGowan JW, 2006, J CUTAN PATHOL, V33, P253, DOI 10.1111/j.0303-6987.2006.00410.x; Yelamos O, 2015, AM J SURG PATHOL, V39, P405, DOI 10.1097/PAS.0000000000000351; Yun SJ, 2012, BRIT J DERMATOL, V166, P115, DOI 10.1111/j.1365-2133.2011.10636.x	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JUL	2015	65	7					383	387		10.1111/pin.12296		5	Pathology	Pathology	CL9UU	WOS:000357324400007		
J	Matsui, T; Hori, Y; Nagano, H; Eguchi, H; Marubashi, S; Wada, H; Wada, N; Ikeda, J; Sakamoto, M; Morii, E				Matsui, Takahiro; Hori, Yumiko; Nagano, Hiroaki; Eguchi, Hidetoshi; Marubashi, Shigeru; Wada, Hiroshi; Wada, Naoki; Ikeda, Jun-ichiro; Sakamoto, Michiie; Morii, Eiichi			Poorly differentiated hepatocellular carcinoma accompanied by anti-Hu antibody-positive paraneoplastic peripheral neuropathy	PATHOLOGY INTERNATIONAL			English	Article						anti-Hu antibody; paraneoplastic neurological syndrome; poorly differentiated hepatocellular carcinoma		The anti-Hu antibody is one of the most famous onco-neural antibodies related to paraneoplastic neurological syndrome, and is associated with small cell lung carcinoma in most cases. Here, we report a case of poorly differentiated hepatocellular carcinoma accompanied by paraneoplastic peripheral neuropathy positive for the anti-Hu antibody. Image inspection before operation revealed that no tumors were found in organs other than the liver, including lung, and that the liver tumor had no metastatic lesion. The liver tumor showed histological appearance of poorly differentiated carcinoma with cartilaginous metaplasia and partial blastoid cell appearance. Most tumor cells presented trabecular-like structure lined by sinusoidal vessels. Immunohistochemically, the tumor cells were positive for low molecular weight cytokeratin and vimentin, partially positive for cytokeratin 19 and CD56, but negative for synaptophysin, chromogranin A and alpha-fetoprotein. Based on the trabecular-like morphology and the results of immunohistochemical staining, we concluded that the tumor was diagnosed as poorly differentiated hepatocellular carcinoma. Anti-Hu antibody-positive paraneoplastic peripheral neuropathy accompanied with liver tumor is extremely rare as far as is known. The presented case indicates that poorly differentiated carcinoma has the potential to be the responsible lesion of anti-Hu antibody-positive paraneoplastic neurological syndrome and systemic work-up is important for the management of this neurological disorder.	[Matsui, Takahiro; Hori, Yumiko; Wada, Naoki; Ikeda, Jun-ichiro; Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; [Nagano, Hiroaki; Eguchi, Hidetoshi; Marubashi, Shigeru; Wada, Hiroshi] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Sakamoto, Michiie] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan	Morii, E (reprint author), Osaka Univ, Grad Sch Med, Dept Pathol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	morii@molpath.med.osaka-u.ac.jp	Sakamoto, Michiie/N-2917-2015		Ministry of Education, Culture, Sports, Science and Technology, Japan [T254604350, T264604700]	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan (#T254604350, #T264604700).	Graus F, 2001, BRAIN, V124, P1138, DOI 10.1093/brain/124.6.1138; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Yang XR, 2008, CLIN CANCER RES, V14, P3850, DOI 10.1158/1078-0432.CCR-07-4338; Iwahashi T, 1997, J NEUROL NEUROSUR PS, V63, P516, DOI 10.1136/jnnp.63.4.516; Kalanie Hossein, 2014, Case Rep Neurol, V6, P7, DOI 10.1159/000357971; Lukacs S., 2012, CASE REP UROL, V2012; Oh SJ, 2005, CLIN NEUROPHYSIOL, V116, P28, DOI 10.1016/j.clinph.2004.07.012; Rougemont AL, 2012, J HEPATOL, V56, P1392, DOI 10.1016/j.jhep.2011.10.028; Sano T, 2010, INT J UROL, V17, P99, DOI 10.1111/j.1442-2042.2009.02422.x	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JUL	2015	65	7					388	392		10.1111/pin.12304		5	Pathology	Pathology	CL9UU	WOS:000357324400008		
J	Washimi, K; Yokose, T; Noguchi, A; Ono, K; Kawachi, K; Maruyama, Y; Kawase, R; Kato, H; Kameda, Y				Washimi, Kota; Yokose, Tomoyuki; Noguchi, Akira; Ono, Kyoko; Kawachi, Kae; Maruyama, Yasuyo; Kawase, Rieko; Kato, Hisamori; Kameda, Yoichi			Diagnosis of primary pure signet-ring cell carcinoma of the cervix	PATHOLOGY INTERNATIONAL			English	Letter									[Washimi, Kota; Yokose, Tomoyuki; Noguchi, Akira; Ono, Kyoko; Kawachi, Kae; Kameda, Yoichi] Kanagawa Canc Ctr Hosp, Dept Pathol, Yokohama, Kanagawa, Japan; [Kato, Hisamori] Kanagawa Canc Ctr Hosp, Dept Gynecol, Yokohama, Kanagawa, Japan; [Maruyama, Yasuyo] Yokohama City Univ, Dept Obstet & Gynecol, Yokohama, Kanagawa 232, Japan; [Kawase, Rieko] Nippon Med Coll Hosp, Dept Obstet & Gynecol, Tokyo, Japan	Washimi, K (reprint author), Kanagawa Canc Ctr Hosp, Dept Pathol, Yokohama, Kanagawa, Japan.						Matoso A, 2010, APPL IMMUNOHISTO M M, V18, P142, DOI 10.1097/PAI.0b013e3181bdf4e7; Bhargava R, 2007, AM J CLIN PATHOL, V127, P103, DOI 10.1309/TDP92PQLDE2HLEET; Bulk S, 2006, BRIT J CANCER, V94, P171, DOI 10.1038/sj.bjc.6602915; El-Safadi Samer, 2010, Case Rep Oncol, V3, P451, DOI 10.1159/000323003; ElZimaity HMT, 1997, J CLIN PATHOL, V50, P867, DOI 10.1136/jcp.50.10.867; Giordano G, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-7; Insabato L, 2007, EUR J GYNAECOL ONCOL, V28, P411; Pudasainin S, 2011, Nepal Med Coll J, V13, P308; Yoon A., 2011, KOREAN J OBSTET GYNE, V54, P570	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JUL	2015	65	7					393	395		10.1111/pin.12275		3	Pathology	Pathology	CL9UU	WOS:000357324400009		
J	Nakagawa, T; Yamaji, M; Maki, S; Niwa, H; Hirano, T				Nakagawa, Tatsuki; Yamaji, Minoru; Maki, Shojiro; Niwa, Haruki; Hirano, Takashi			Fluorescence Properties of Diphenylthiazolo[4,5-b]pyrazines Tuned by Donor-Acceptor Substituent Effects	PHOTOCHEMISTRY AND PHOTOBIOLOGY			English	Article							CHEMILUMINESCENCE; DERIVATIVES; DENSITY; BIOLUMINESCENCE; ABSORPTION	Fluorescence properties of 2,6- and 2,5-diphenylthiazolo[4,5-b]pyrazine (TPy) derivatives having an electron-donating substituent (methoxy and dimethylamino) on the 6- and 5-phenyl groups were studied. It was found that 2,6-diphenyl derivatives fluoresce more efficiently than 2,5-diphenyl derivatives. Furthermore, a 2,6-diphenyl derivative having an additional cyano group on the 2-phenyl ring was an excellent fluorophore showing a wide solvatochromism with great fluorescence yields. Based on the obtained spectroscopic data and mechanistic explanations concerning the substituent effects on the fluorescence properties, useful information on designing new TPy fluorophores is provided.	[Nakagawa, Tatsuki; Maki, Shojiro; Niwa, Haruki; Hirano, Takashi] Univ Electrocommun, Dept Engn Sci, Grad Sch Informat & Engn, Chofu, Tokyo 182, Japan; [Yamaji, Minoru] Gunma Univ, Grad Sch Sci & Technol, Div Mol Sci, Kiryu, Gunma, Japan	Hirano, T (reprint author), Univ Electrocommun, Dept Engn Sci, Grad Sch Informat & Engn, Chofu, Tokyo 182, Japan.	thirano@uec.ac.jp			Japan Society for the Promotion of Science [22550031]; Iketani Science and Technology Foundation; Izumi Science and Technology Foundation	This work was supported by a Grant-in-Aid for Scientific Research C (No. 22550031) from the Japan Society for the Promotion of Science. Financial support was also provided by the Iketani Science and Technology Foundation and Izumi Science and Technology Foundation. We thank the Information Technology Center of the University of Electro-Communications for technical assistance in computing the quantum chemical calculations.	BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; TOYA Y, 1992, B CHEM SOC JPN, V65, P2475, DOI 10.1246/bcsj.65.2475; STRICKLER SJ, 1962, J CHEM PHYS, V37, P814, DOI 10.1063/1.1733166; Fruit C, 2002, J HETEROCYCLIC CHEM, V39, P1077; Cavalier JF, 2001, BIOORGAN MED CHEM, V9, P1037, DOI 10.1016/S0968-0896(00)00321-7; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Dennington R., 2009, GAUSSVIEW VERSION 5; Frisch M. J., 2009, GAUSSIAN 09 REVISION; GOTO T, 1969, TETRAHEDRON LETT, P4299; GOTO T, 1968, Pure and Applied Chemistry, V17, P421, DOI 10.1351/pac196817030421; Hachiya S, 2010, TETRAHEDRON LETT, V51, P1613, DOI 10.1016/j.tetlet.2010.01.072; Hirano T, 2008, PHOTOCH PHOTOBIO SCI, V7, P197, DOI 10.1039/b713374j; Hirano T, 2013, RES CHEM INTERMEDIAT, V39, P233, DOI 10.1007/s11164-012-0645-3; Hunger K., 2003, IND DYES CHEM PROPER; Nakagawa T, 2014, PHOTOCH PHOTOBIO SCI, V13, P1765, DOI 10.1039/c4pp00298a; Reichardt C., 2003, SOLVENTS SOLVENT EFF; Shimomura O., 2012, BIOLUMINESCENCE CHEM; Tsien R. Y., 1993, FLUORESCENT PHOTOCHE, P130; Valeur B., 2013, MOL FLUORESCENCE PRI; Zollinger H., 2003, COLOR CHEM SYNTHESES	21	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0031-8655	1751-1097		PHOTOCHEM PHOTOBIOL	Photochem. Photobiol.	JUL-AUG	2015	91	4					807	813		10.1111/php.12440		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CM0MZ	WOS:000357373700005		
J	Hiyama, M; Noguchi, Y; Akiyama, H; Yamada, K; Koga, N				Hiyama, Miyabi; Noguchi, Yoshifumi; Akiyama, Hidefumi; Yamada, Kenta; Koga, Nobuaki			Vibronic Structures in Absorption and Fluorescence Spectra of Firefly Oxyluciferin in Aqueous Solutions	PHOTOCHEMISTRY AND PHOTOBIOLOGY			English	Article							PK(A) VALUES; LUCIFERIN; BIOLUMINESCENCE; DENSITY; PHOTOLUMINESCENCE; DERIVATIVES	To elucidate the factors determining the spectral shapes and widths of the absorption and fluorescence spectra for keto and enol oxyluciferin and their conjugate bases in aqueous solutions, the intensities of vibronic transitions between their ground and first electronic excited states were calculated for the first time via estimation of the vibrational Franck-Condon factors. The major normal modes, overtones and combination tones in absorption and fluorescence spectra are similar for all species. The theoretical full widths at half maximum of absorption spectra are 0.4-0.7eV and those for the fluorescence spectra are 0.4-0.5eV, except for phenolate-keto that exhibits exceptionally sharp peak widths due to the dominance of the 0-0 or 0-0 band. These spectral shapes and widths explain many relevant features of the experimentally observed spectra.	[Hiyama, Miyabi; Noguchi, Yoshifumi; Akiyama, Hidefumi] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba, Japan; [Yamada, Kenta; Koga, Nobuaki] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan	Hiyama, M (reprint author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba, Japan.	miyabi@issp.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [15K05379]; Institute for Quantum Chemical Exploration; KAKENHI from JSPS [26610081]; JST-SENTAN; JST-CREST in Japan	M.H. was supported by a Grant-in-Aid for Scientific Research (C) (15K05379) from the Japan Society for the Promotion of Science (JSPS) and Institute for Quantum Chemical Exploration. This work was partly supported by KAKENHI 26610081 from JSPS, JST-SENTAN and JST-CREST in Japan. Calculations were performed at the computer centre of Nagoya University.	Hiyama M, 2014, PHOTOCHEM PHOTOBIOL, V90, P35, DOI 10.1111/php.12156; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; Ghose A, 2015, J PHYS CHEM B, V119, P2638, DOI 10.1021/jp508905m; Dierksen M, 2004, J CHEM PHYS, V120, P3544, DOI 10.1063/1.1642595; Rebarz M, 2013, CHEM SCI, V4, P3803, DOI 10.1039/c3sc50715g; da Silva LP, 2011, CHEMPHYSCHEM, V12, P951, DOI 10.1002/cphc.201000980; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Barone V, 2009, J CHEM THEORY COMPUT, V5, P540, DOI 10.1021/ct8004744; Naumov P, 2009, J AM CHEM SOC, V131, P11590, DOI 10.1021/ja904309q; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Hiyama M, 2015, PHOTOCHEM PHOTOBIOL, V91, P74, DOI 10.1111/php.12370; SELIGER HH, 1959, BIOCHEM BIOPH RES CO, V1, P21, DOI 10.1016/0006-291X(59)90082-8; Hiyama M, 2013, CHEM PHYS LETT, V577, P121, DOI 10.1016/j.cplett.2013.05.053; Hiyama M, 2013, PHOTOCHEM PHOTOBIOL, V89, P571, DOI 10.1111/php.12052; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Anselmi M, 2012, CHEM PHYS, V392, P205, DOI 10.1016/j.chemphys.2011.11.021; Barone V., 2009, VIBRATIONALLY RESOLV; Chem S. -F., 2011, INT J QUANTUM CHEM, V111, P3371; da Silva JCGE, 2001, TETRAHEDRON LETT, V42, P8173; Falklof O, 2014, J COMPUT CHEM, V35, P2184, DOI 10.1002/jcc.23735; Frisch M. J., 2009, GAUSSIAN 09 REVISION; GANDELMAN OA, 1993, J PHOTOCH PHOTOBIO B, V19, P187, DOI 10.1016/1011-1344(93)87083-Y; Hiyama M, 2014, PHOTOCHEM PHOTOBIOL, V90, P820, DOI 10.1111/php.12243; Hiyama M, 2012, PHOTOCHEM PHOTOBIOL, V88, P889, DOI 10.1111/j.1751-1097.2012.01126.x; SHIMOMURA O, 2006, BIOL CHEM PRINC METH, P1; SUZUKI N, 1972, AGR BIOL CHEM TOKYO, V36, P2213	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0031-8655	1751-1097		PHOTOCHEM PHOTOBIOL	Photochem. Photobiol.	JUL-AUG	2015	91	4					819	827		10.1111/php.12463		9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CM0MZ	WOS:000357373700007		
J	Sakayama, H; Kai, A; Nishiyama, M; Watanabe, MM; Kato, S; Ito, M; Nozaki, H; Kawai, H				Sakayama, Hidetoshi; Kai, Atsushi; Nishiyama, Mio; Watanabe, Makoto M.; Kato, Syou; Ito, Motomi; Nozaki, Hisayoshi; Kawai, Hiroshi			Taxonomy, morphology, and genetic variation of Nitella flexilis var. bifurcata (Charales, Characeae) from Japan	PHYCOLOGICAL RESEARCH			English	Article						atpB-rbcL intergenic spacer region; Charophyceae; Japanese endemic taxa; oospores; rbcL gene; scanning electron microscopy	OOSPORE WALL ORNAMENTATION; MULTIPLE SEQUENCE ALIGNMENT; POLISH CHAROPHYTES CHARALES; PHYLOGENETIC ANALYSES; CHLOROPLAST DNA; RBCL SEQUENCES; REEXAMINATION; GENERA; SEM; LYCHNOTHAMNUS	The taxonomic status of Nitella flexilis var. bifurcata (Charales, Characeae), which is endemic to Japan, has remained unclear because there have been no records since its description in 1964, and the detailed morphology of fully mature individuals as well as its molecular phylogeny have not been studied. Recently, we collected a fully mature N.flexilis var. bifurcata from two lakes near the type locality in Japan. The morphological characteristics of the thalli agreed well with that in the original description of the taxon, with distinctive fertile and sterile branchlets that divided twice and unicellular dactyls. Scanning electron microscopy showed that the fine oospore structure of N.flexilis var. bifurcata was different from that of related taxa. In addition, molecular phylogenetic and haplotype network analyses using the chloroplast rbcL DNA sequences and the intergenic spacer regions between atpB and rbcL genes demonstrated that N.flexilis var. bifurcata and N.flexilis var. flexilis were distinct.	[Sakayama, Hidetoshi; Kai, Atsushi; Kato, Syou] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan; [Kawai, Hiroshi] Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 657, Japan; [Nishiyama, Mio; Watanabe, Makoto M.] Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan; [Ito, Motomi] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, Tokyo, Japan; [Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan	Sakayama, H (reprint author), Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan.	hsak@port.kobe-u.ac.jp			Japan Society for the Promotion of Science, Japan [18770071, 22770083, 24570100, 24.1993]; Nippon Life Insurance Foundation; Ministry of the Environment, Japan [RFd-1102]	The authors thank Mr. Kenji Horiya, Dr. Fumie Kasai, Mr. Shingo Kobayashi, Ms. Aya Mizobuchi, Dr. Shuji Ohtani, Dr. Hiroshi Sato, Dr. Teruo Shimmen, Mr. Hidefumi Suga, Dr. Kazuo Uchida, Mr. Atsushi Naka, Dr. Isamu Wakana, Dr. Lothar Krienitz and Dr. Hendrik Schubert for their kind assistance with sample collection; Dr. Masanobu Kawachi for the kind use of his facilities and use of a scanning electron microscope; and Dr. Takashi Nakada for his kind suggestions on the manuscript. This work was supported in part by a Grant-in-Aid for Scientific Research (No. 18770071, 22770083 and 24570100 to H.S.) and a Grant-in-Aid for Scientific Research Fellows (No. 24.1993 to S.K.) from the Japan Society for the Promotion of Science, Japan, and Nippon Life Insurance Foundation (to H.S.), and conducted as a part of the Environment Research and Technology Development Fund of the Ministry of the Environment, Japan (No. RFd-1102 to H.S.).	Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Urbaniak J, 2011, NOVA HEDWIGIA, V93, P1, DOI 10.1127/0029-5035/2011/0093-0001; Sakayama H, 2008, PHYCOL RES, V56, P202, DOI 10.1111/j.1440-1835.2008.00502.x; Sakayama H, 2005, J PHYCOL, V41, P195, DOI 10.1111/j.1529-8817.2005.04133.x; Nakada T, 2009, J PHYCOL, V45, P482, DOI 10.1111/j.1529-8817.2009.00652.x; Urbaniak J, 2011, NOVA HEDWIGIA, V93, P537, DOI 10.1127/0029-5035/2011/0093-0537; Chen SC, 2012, J SYST EVOL, V50, P374, DOI 10.1111/j.1759-6831.2012.00210.x; TEMPLETON AR, 1992, GENETICS, V132, P619; Simmons MP, 2000, SYST BIOL, V49, P369; Watanabe K, 2006, AM J BOT, V93, P442, DOI 10.3732/ajb.93.3.442; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; JOHN DM, 1990, BRIT PHYCOL J, V25, P1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Sakayama H, 2004, PHYCOLOGIA, V43, P91, DOI 10.2216/i0031-8884-43-1-91.1; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Ray S, 2001, NORD J BOT, V21, P207, DOI 10.1111/j.1756-1051.2001.tb01359.x; Sakayama H, 2009, J PHYCOL, V45, P917, DOI 10.1111/j.1529-8817.2009.00700.x; Casanova MT, 2005, AUST SYST BOT, V18, P25, DOI 10.1071/SB04027; Casanova MT, 2009, AUST SYST BOT, V22, P193, DOI 10.1071/SB08039; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Faegri K., 1989, TXB POLLEN ANAL; FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.2307/2408542; Frame P., 1977, THESIS U TORONTO; Imahori K., 1977, ILLUSTRATIONS JAPANE, P761; JOHN DM, 1987, PHYCOLOGIA, V26, P334, DOI 10.2216/i0031-8884-26-3-334.1; Kasaki H., 1964, J HATTORI BOT LAB, V27, P215; Kato S, 2008, PHYCOLOGIA, V47, P191, DOI 10.2216/07-27.1; Leitch A. R., 1990, PROGR PHYCOLOGICAL R, V7, P213; McCourt RM, 1996, AM J BOT, V83, P125, DOI 10.2307/2445965; McCourt RM, 1999, AUST J BOT, V47, P361, DOI 10.1071/BT97100; Müller Kai, 2005, Appl Bioinformatics, V4, P65; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakayama H, 2002, PHYCOLOGIA, V41, P397, DOI 10.2216/i0031-8884-41-4-397.1; Sakayama H, 2006, PHYCOLOGIA, V45, P417, DOI 10.2216/05-31.1; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; Wessel Paul, 2013, Eos, Transactions American Geophysical Union, V94, DOI 10.1002/2013EO450001; Wood R. D., 1965, REVISION CHARACEAE, P1; WOOD R. D., 1962, TAXON, V11, P7, DOI 10.2307/1216853	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-0829	1440-1835		PHYCOL RES	Phycol. Res.	JUL	2015	63	3					159	166		10.1111/pre.12085		8	Marine & Freshwater Biology	Marine & Freshwater Biology	CL9VP	WOS:000357326500001		
J	Kogame, K; Ishikawa, S; Yamauchi, K; Uwai, S; Kurihara, A; Masuda, M				Kogame, Kazuhiro; Ishikawa, Shozo; Yamauchi, Kei; Uwai, Shinya; Kurihara, Akira; Masuda, Michio			Delimitation of cryptic species of the Scytosiphon lomentaria complex (Scytosiphonaceae, Phaeophyceae) in Japan, based on mitochondrial and nuclear molecular markers	PHYCOLOGICAL RESEARCH			English	Article						cetn-int2; cox1; cox3; gene flow; ITS2; reproductive isolation	GENETIC DIVERSITY; PHYLOGENETIC UTILITY; UNDARIA-PINNATIFIDA; COX3 GENE; SP-NOV; DNA; LAMINARIALES; SPECIATION; RHODOPHYTA; SEQUENCES	Scytosiphon lomentaria (Scytosiphonaceae, Ectocarpales) is believed to include some cryptic species, particularly in the Pacific. We attempted to delimit these species in Japan using mitochondrial cox1 and cox3 and nuclear ITS2 and the second intron of the centrin gene (cetn-int2). Fifty-three cox1+cox3 mitotypes, 26 ITS2 ribotypes and 45 cetn-int2 haplotypes were found in 107 samples collected from 33 localities in Japan. Based on phylogenetic analyses, similar sequence types were grouped into ten mitogroups, eight ribogroups and six cetn-int2 haplogroups (sequence-type groups). From the molecular trees and combinations of the mito-, ribo- and haplogroups, three cryptic species were apparent (Groups I-III). Group I, widely distributed on Pacific coasts, was highly supported by all molecular trees, whereas Groups II (North Pacific) and III (Northwestern Pacific and Australasia) were more closely related to each other. However, sequence-type-group combinations that would be characteristic of hybrids between Groups II and III were not detected, suggesting no gene flow between the two Groups. Further investigations of an additional 127 sympatrically growing plants supported the absence of gene flow between Groups II and III. Four samples did not belong to any of the Groups I-III and possibly represent additional species.	[Kogame, Kazuhiro; Ishikawa, Shozo; Yamauchi, Kei] Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 060, Japan; [Uwai, Shinya] Niigata Univ, Fac Sci, Dept Environm Sci, Niigata 95021, Japan; [Kurihara, Akira] Kyushu Univ, Fac Agr, Fukuoka 812, Japan; [Masuda, Michio] Hokkaido Univ, Hokkaido Univ Museum, Sapporo, Hokkaido, Japan	Kogame, K (reprint author), Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 060, Japan.	kogame@sci.hokudai.ac.jp			Japan Society for the Promotion of Science [17570069, 21570084]	Thanks to: Michael D. Guiry and Wilfred John E. Santianez for reading the manuscript; Kazuro Nobuta, Shigeo Kawaguchi, Ichiro Mine, Hiroshi Kawai, Terada Ryuta, Norio Kikuchi, Taizo Motomura and Norishige Yotsukura for their help with sampling. This work was partly supported by a scientific research grant provided by the Japan Society for the Promotion of Science (17570069, 21570084) to KK.	AVISE JC, 1989, EVOLUTION, V43, P1192, DOI 10.2307/2409356; Kogame K, 2005, EUR J PHYCOL, V40, P313, DOI 10.1080/09670260500193008; Lane CE, 2006, J PHYCOL, V42, P493, DOI 10.1111/j.1529-8817.2006.00204.x; McDevit DC, 2010, PHYCOLOGIA, V49, P235, DOI 10.2216/09-36.1; Uwai SY, 2006, PHYCOLOGIA, V45, P687, DOI 10.2216/05-66.1; Tellier F, 2009, MOL PHYLOGENET EVOL, V53, P679, DOI 10.1016/j.ympev.2009.07.030; Zuccarello GC, 2005, EUR J PHYCOL, V40, P337, DOI 10.1080/09670260500254743; Uwai S, 2007, PHYCOL RES, V55, P263, DOI 10.1111/j.1440-1835.2007.00469.x; DIECK IT, 1987, HELGOLANDER MEERESUN, V41, P307, DOI 10.1007/BF02366195; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Le Gac M, 2007, EVOLUTION, V61, P15, DOI 10.1111/j.1558-5646.2007.00002.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; SALISBURY JL, 1995, CURR OPIN CELL BIOL, V7, P39; Kogame K, 2001, CRYPTOGAMIE ALGOL, V22, P201, DOI 10.1016/S0181-1568(01)01064-9; Tellier F, 2011, J PHYCOL, V47, P894, DOI 10.1111/j.1529-8817.2011.01019.x; Kimura K, 2010, J PHYCOL, V46, P143, DOI 10.1111/j.1529-8817.2009.00779.x; Niwa K, 2014, J PHYCOL, V50, P897, DOI 10.1111/jpy.12220; Boo SM, 2011, BOT MAR, V54, P159, DOI 10.1515/BOT.2011.017; Camus C, 2005, J PHYCOL, V41, P931, DOI 10.1111/j.1529-8817.2005.00121.x; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Rosell JA, 2010, MOL PHYLOGENET EVOL, V57, P798, DOI 10.1016/j.ympev.2010.08.004; Nagasato C, 2004, PHYCOL RES, V52, P266, DOI 10.1111/j.1440-1835.2004.tb00336.x; Cho GY, 2007, PHYCOLOGIA, V46, P657, DOI 10.2216/06-70.1; Contreras L, 2007, J PHYCOL, V43, P1320, DOI 10.1111/j.1529-8817.2007.00413.x; McGuire JA, 2007, EVOLUTION, V61, P2879, DOI 10.1111/j.1558-5646.2007.00239.x; Katsaros C, 2006, ANN BOT-LONDON, V97, P679, DOI 10.1093/aob/mcl023; Leliaert F, 2014, EUR J PHYCOL, V49, P179, DOI 10.1080/09670262.2014.904524; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Niwa K, 2014, PHYCOL RES, V62, P36, DOI 10.1111/pre.12035; Ni-Ni-Win, 2010, PHYCOLOGIA, V49, P136, DOI 10.2216/09-54.1; Kogame K, 1999, PHYCOLOGIA, V38, P496, DOI 10.2216/i0031-8884-38-6-496.1; Lane CE, 2007, MOL PHYLOGENET EVOL, V44, P634, DOI 10.1016/j.ympev.2007.03.016; Coyer JA, 2011, MOL PHYLOGENET EVOL, V58, P283, DOI 10.1016/j.ympev.2010.11.015; Nichols R, 2001, TRENDS ECOL EVOL, V16, P358, DOI 10.1016/S0169-5347(01)02203-0; Grob GBJ, 2004, MOL PHYLOGENET EVOL, V30, P13, DOI 10.1016/S1055-7903(03)00183-0; Fujita S, 2005, EUR J PHYCOL, V40, P159, DOI 10.1080/09670260500063193; Shaw KL, 2002, P NATL ACAD SCI USA, V99, P16122, DOI 10.1073/pnas.242585899; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Gonzalez A, 2012, J PHYCOL, V48, P1153, DOI 10.1111/j.1529-8817.2012.01200.x; Kamiya M, 2011, J PHYCOL, V47, P753, DOI 10.1111/j.1529-8817.2011.01016.x; Kamiya M, 2004, J PLANT RES, V117, P421, DOI 10.1007/s10265-004-0166-2; Kato Y, 2006, PHYCOL RES, V54, P65, DOI 10.1111/j.1440-1835.2006.00409.x; Kogame Kazuhiro, 1998, Phycological Research, V46, P39, DOI 10.1111/j.1440-1835.1998.tb00095.x; DRING MJ, 1975, PLANTA, V125, P25, DOI 10.1007/BF00388870; Luning K, 1990, SEAWEEDS THEIR ENV B; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Mattio L, 2010, CRYPTOGAMIE ALGOL, V31, P467; NAKAMURA Y, 1975, Scientific Papers of the Institute of Algological Research Faculty of Science Hokkaido University, V6, P57; Peters AF, 1997, J PHYCOL, V33, P294, DOI 10.1111/j.0022-3646.1997.00294.x; Smouse PE, 2000, J CLASSIF, V17, P165, DOI 10.1007/s003570000015; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; Tatewaki M., 1966, PHYCOLOGIA, V6, P62, DOI 10.2216/i0031-8884-6-1-62.1; Templeton A.R., 1989, P3; Tronholm A, 2010, J PHYCOL, V46, P1301, DOI 10.1111/j.1529-8817.2010.00908.x; Uwai S, 2006, HYDROBIOLOGIA, V553, P345, DOI 10.1007/s10750-005-0883-0; Uwai S, 2009, MAR BIOL, V156, P901, DOI 10.1007/s00227-009-1136-y; West John A., 2001, Phycological Research, V49, P183, DOI 10.1111/j.1440-1835.2001.tb00249.x; Whittall JB, 2006, MOL PHYLOGENET EVOL, V39, P124, DOI 10.1016/j.ympev.2005.10.010; Yang EC, 2014, J PHYCOL, V50, P149, DOI 10.1111/jpy.12148; Yoshida Tadao, 2000, Phycological Research, V48, P125, DOI 10.1111/j.1440-1835.2000.tb00207.x; Zardi GI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019402	61	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-0829	1440-1835		PHYCOL RES	Phycol. Res.	JUL	2015	63	3					167	177		10.1111/pre.12091		11	Marine & Freshwater Biology	Marine & Freshwater Biology	CL9VP	WOS:000357326500002		
J	Kojima, R; Hanyuda, T; Kawai, H				Kojima, Rei; Hanyuda, Takeaki; Kawai, Hiroshi			Taxonomic re-examination of Japanese Halimeda species using genetic markers, and proposal of a new species Halimeda ryukyuensis (Bryopsidales, Chlorophyta)	PHYCOLOGICAL RESEARCH			English	Article						Bryopsidales; Halimeda ryukyuensis sp; nov; molecular phylogeny; taxonomy	NEW-CALEDONIA; MARINE-ALGAE; GENUS; PHYLOGEOGRAPHY; ULVOPHYCEAE; PHYLOGENY; EVOLUTION; LINEAGES; ECOLOGY	In order to elucidate the biodiversity of Japanese Halimeda species, we investigated molecular phylogenetic relationships using tufA and rbcL DNA sequences, and the occurrence of 9 of the 11 species previously reported in Japan was confirmed (i.e., H.borneensis, H.cuneata, H.discoidea, H.distorta, H.kanaloana, H.macroloba, H.opuntia, H.renschii and H.velasquezii). In addition, H.minima, which has not been recorded in Japan, as well as an undescribed taxon, were noticed at Okinawa Island, Okinawa, Japan. The undescribed taxon was genetically closest to H.lacunalis, but distinct from that species in having much smaller thalli, with elliptical segments and turbinate peripheral utricles. It appears to belong to the section Halimeda in the morphology of the segments, but differs from related taxa such as H.taenicola and H.tuna in its considerably smaller size and in showing fusion between the adjacent peripheral utricles. Therefore, we describe a new species Halimeda ryukyuensis sp. nov. In addition, based on morphological re-examination of the type specimen of H.lacunalis, we suggest emendation of the description of the species as having siphons completely fused in pairs or triplets at the nodes.	[Kojima, Rei] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan; [Hanyuda, Takeaki; Kawai, Hiroshi] Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 657, Japan	Kojima, R (reprint author), Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan.	xxf34404@meg.winknet.ne.jp			Strategic International Cooperative Program JST; DIISR	We are grateful to Dr. Eric C. Henry for his valuable comments on the manuscript, and Dr. Michael J. Wynne and the University of Michigan Herbarium for the kind gift and loan of the type material of H. lacunalis (MICH1306458). A part of this study was supported by the Strategic International Cooperative Program JST and DIISR to H.K.	Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Payri CE, 2009, J PHYCOL, V45, P953, DOI 10.1111/j.1529-8817.2009.00717.x; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Kawai H, 2012, PHYCOL RES, V60, P241, DOI 10.1111/j.1440-1835.2012.00651.x; DREW EA, 1988, CORAL REEFS, V6, P195, DOI 10.1007/BF00302016; Verbruggen H, 2004, EUR J PHYCOL, V39, P213, DOI 10.1080/026042000202163; Verbruggen H, 2006, EUR J PHYCOL, V41, P337, DOI 10.1080/09670260600709315; Verbruggen H, 2005, J PHYCOL, V41, P606, DOI 10.1111/j.1529-8817.2005.00083.x; Verbruggen H, 2005, CRYPTOGAMIE ALGOL, V26, P259; Verbruggen H, 2007, PHYCOLOGIA, V46, P513, DOI 10.2216/07-01.1; Kooistra WHCF, 2002, MOL PHYLOGENET EVOL, V24, P121, DOI 10.1016/S1055-7903(02)00221-X; Fama P, 2002, J PHYCOL, V38, P1040, DOI 10.1046/j.1529-8817.2002.t01-1-01237.x; Verbruggen H, 2005, MOL PHYLOGENET EVOL, V37, P789, DOI 10.1016/j.ympev.2005.06.015; Dijoux L, 2012, J PHYCOL, V48, P1465, DOI 10.1111/jpy.12002; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Verbruggen H, 2009, GLOBAL ECOL BIOGEOGR, V18, P393, DOI 10.1111/j.1466-8238.2009.00463.x; Barton E. S., 1901, MONOGRAPHS SIBOGA EX, V60; BORGESEN F., 1913, DANSK BOTANISK ARK, V1, P1; Hanyuda T, 2000, J PLANT RES, V113, P403, DOI 10.1007/PL00013948; Hillis LW, 1998, J PHYCOL, V34, P669, DOI 10.1046/j.1529-8817.1998.340669.x; Hillis-Colinvaux L, 1980, ADV MAR BIOL, V17, P1, DOI 10.1016/S0065-2881(08)60303-X; Howe M. A., 1909, B TORREY BOT CLUB, V36, P75, DOI 10.2307/2479015; ITONO H, 1973, BOT MAG TOKYO, V86, P155, DOI 10.1007/BF02489223; Lam DW, 2006, J PHYCOL, V42, P669, DOI 10.1111/j.1527-8817.2006.00230.x; Lis J T, 1980, Methods Enzymol, V65, P347; PLANK J, 1952, Zentralbl Allg Pathol, V89, P252; Rambaut A, 2007, TRACER V1 5; Taylor W.R., 1950, PLANTS BIKINI OTHER; TSUDA R T, 1991, Japanese Journal of Phycology, V39, P57; Verbruggen H, 2005, THESIS GHENT U; Yoshida T, 1998, MARINE ALGAE JAPAN; Yoshida Tadao, 2010, Japanese Journal of Phycology, V58, P69	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-0829	1440-1835		PHYCOL RES	Phycol. Res.	JUL	2015	63	3					178	188		10.1111/pre.12095		11	Marine & Freshwater Biology	Marine & Freshwater Biology	CL9VP	WOS:000357326500003		
J	Nakai, Y; Tsukada, R; Miyata, Y; Saito, T; Hata, K; Maniwa, Y				Nakai, Yusuke; Tsukada, Ryo; Miyata, Yasumitsu; Saito, Takeshi; Hata, Kenji; Maniwa, Yutaka			Observation of the intrinsic magnetic susceptibility of highly purified single-wall carbon nanotubes	PHYSICAL REVIEW B			English	Article								We report the observation of the intrinsic magnetic susceptibility of highly purified SWCNT samples prepared by a combination of acid treatment and density gradient ultracentrifugation (DGU). We observed that the diamagnetic susceptibility of SWCNTs increases linearly with increasing nanotube diameter. We found that the magnetic susceptibility divided by the diameter is a universal function of the scaled temperature. Furthermore, the estimated magnetic susceptibilities of pure semiconducting and pure metallic SWCNT samples suggest that they respond differently to changes in carrier density, which is consistent with theory. These findings provide experimental verification of the theoretically predicted diameter, temperature, and metallicity dependence of the magnetic susceptibility.	[Nakai, Yusuke; Tsukada, Ryo; Miyata, Yasumitsu; Maniwa, Yutaka] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Phys, Tokyo 1920397, Japan; [Miyata, Yasumitsu] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Saito, Takeshi; Hata, Kenji] AIST, Nanotube Res Ctr, Tsukuba, Ibaraki 3058565, Japan	Nakai, Y (reprint author), Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Phys, Tokyo 1920397, Japan.	nakai@tmu.ac.jp; maniwa@phyes.se.tmu.ac.jp			JSPS KAKENHI Grant [25800201, 25246006]	This work was supported in part by JSPS KAKENHI Grant Nos. 25800201 and 25246006.	AJIKI H, 1995, J PHYS SOC JPN, V64, P4382, DOI 10.1143/JPSJ.64.4382; AJIKI H, 1993, J PHYS SOC JPN, V62, P2470, DOI 10.1143/JPSJ.62.2470; Saito T, 2008, J NANOSCI NANOTECHNO, V8, P6153, DOI 10.1166/jnn.2008.SW23; Zaric S, 2004, NANO LETT, V4, P2219, DOI 10.1021/nl0486012; Yazyev OV, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/5/056501; Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962; Kim YH, 2007, CHEM MATER, V19, P2982, DOI 10.1021/cm063006h; Miyata Y, 2011, NANO RES, V4, P963, DOI 10.1007/s12274-011-0152-7; Liu HP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1313; RAMIREZ AP, 1994, SCIENCE, V265, P84, DOI 10.1126/science.265.5168.84; AJIKI H, 1993, J PHYS SOC JPN, V62, P1255, DOI 10.1143/JPSJ.62.1255; Nakai Y, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.025103; Yanagi K, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.034003; LU JP, 1995, PHYS REV LETT, V74, P1123, DOI 10.1103/PhysRevLett.74.1123; Alexandre SS, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.146801; Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52; Islam MF, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.201401; Likodimos V, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.045417; Lipert K, 2009, J APPL PHYS, V105, DOI 10.1063/1.3077177; Nishide D, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.015004; Okada S, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.121412; Okada S, 2003, J PHYS SOC JPN, V72, P1510, DOI 10.1143/JPSJ.72.1510; Saito R, 1998, PHYS PROPERTIES CARB; Searles TA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.017403; Tanaka T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.114001; Torrens O. N., 2006, J AM CHEM SOC, V129, P252; Wu CX, 2009, J PHYS CHEM C, V113, P3612, DOI 10.1021/jp810163u	27	2	2	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	JUL 1	2015	92	4							041402	10.1103/PhysRevB.92.041402		5	Physics, Condensed Matter	Physics	CL7OR	WOS:000357162100003		
J	Rhone, TD; Tiemann, L; Muraki, K				Rhone, T. D.; Tiemann, L.; Muraki, K.			NMR probing of spin and charge order near odd-integer filling in the second Landau level	PHYSICAL REVIEW B			English	Article							2-DIMENSIONAL ELECTRON-GAS; QUANTUM HALL FERROMAGNETS; OPTICALLY PUMPED NMR; SKYRMIONS; EXCITATIONS; WELLS; POLARIZATION; NU=1; CRYSTAL	Studies of spin degrees of freedom near odd-integer filling nu = 3 in the second Landau level have engendered conflicting accounts of the spin properties in this regime. Using resistively detected NMR as a probe of local spin density, we explore the nature of the ground state in the quantum Hall regime near nu = 3. Our Knight shift measurements reveal anomalies in NMR spectral line shapes near nu = 3, which demonstrate the presence of solid phases formed from charged quasiparticles, with maximal spin polarization (i.e., no additional spin flips) at each.. The long nuclear spin relaxation times demonstrate the absence of Skyrmions, or spin textures, in this phase nu On the basis of these observations, we attempt to reconcile conflicting reports on the quasiparticle properties and spin wave excitations at nu similar to 3, which may engender new paradigms for the understanding of spin excitations in a collinear ferromagnet with broken translational symmetry.	[Rhone, T. D.] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; Japan Sci & Technol Agcy, ERATO Nucl Spin Elect Project, Yokosuka, Kanagawa, Japan	Rhone, TD (reprint author), NTT Corp, NTT Basic Res Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	tnr2103@caa.columbia.edu					KALLIN C, 1984, PHYS REV B, V30, P5655, DOI 10.1103/PhysRevB.30.5655; Chen Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.016801; VONKLITZING K, 1980, PHYS REV LETT, V45, P494; Drozdov IK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.136804; Fukuoka D, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.126802; Green AG, 2000, PHYS REV B, V61, P16299; Aifer EH, 1996, PHYS REV LETT, V76, P680, DOI 10.1103/PhysRevLett.76.680; FERTIG HA, 1994, PHYS REV B, V50, P11018, DOI 10.1103/PhysRevB.50.11018; Friess B, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.076803; TYCKO R, 1995, SCIENCE, V268, P1460, DOI 10.1126/science.7539550; Tiemann L, 2012, SCIENCE, V335, P828, DOI 10.1126/science.1216697; Zhu H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.226801; Goerbig MO, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.115327; Wurstbauer U, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.026801; Khandelwal P, 2001, PHYS REV LETT, V86, P5353, DOI 10.1103/PhysRevLett.86.5353; Smet JH, 2002, NATURE, V415, P281, DOI 10.1038/415281a; SONDHI SL, 1993, PHYS REV B, V47, P16419, DOI 10.1103/PhysRevB.47.16419; BARRETT SE, 1995, PHYS REV LETT, V74, P5112, DOI 10.1103/PhysRevLett.74.5112; MAKI K, 1983, PHYS REV B, V28, P4349, DOI 10.1103/PhysRevB.28.4349; SCHMELLER A, 1995, PHYS REV LETT, V75, P4290, DOI 10.1103/PhysRevLett.75.4290; BREY L, 1995, PHYS REV LETT, V75, P2562, DOI 10.1103/PhysRevLett.75.2562; Hashimoto K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.176601; Rhone TD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.196805; Cooper NR, 1997, PHYS REV B, V55, pR1934; Cote R, 1997, PHYS REV LETT, V78, P4825, DOI 10.1103/PhysRevLett.78.4825; Desrat W, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.256807; Fertig HA, 1997, PHYS REV B, V55, P10671, DOI 10.1103/PhysRevB.55.10671; Gamez G, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075308; Gervais G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196803; Ito H, 2011, J PHYS CONF SER, V334, DOI 10.1088/1742-6596/334/1/012021; Kerridge GC, 1999, PHYS REV B, V60, pR5141, DOI 10.1103/PhysRevB.60.R5141; Kulik LV, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.045316; Lewis RM, 2004, PHYSICA E, V22, P104, DOI 10.1016/j.physe.2003.11.226; Mihalek I, 2000, PHYS REV B, V62, P13573, DOI 10.1103/PhysRevB.62.13573; Song YQ, 1999, PHYS REV LETT, V82, P2768, DOI 10.1103/PhysRevLett.82.2768; Stern O, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.075318; Tiemann L, 2014, NAT PHYS, V10, P648, DOI [10.1038/nphys3031, 10.1038/NPHYS3031]; TSUI DC, 1982, PHYS REV LETT, V48, P1559, DOI 10.1103/PhysRevLett.48.1559; Valeille A, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2912034; Van'kov AB, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245325; Wojs A, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.045323; Zhang D, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.076804	42	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	JUL 1	2015	92	4							041301	10.1103/PhysRevB.92.041301		5	Physics, Condensed Matter	Physics	CL7OR	WOS:000357162100001		
J	Igata, T				Igata, Takahisa			Stable bound orbits in six-dimensional Myers-Perry black holes	PHYSICAL REVIEW D			English	Article							SPACE-TIMES; GEODESICS	The existence of stable bound orbits of test particles is one of the most characteristic properties in black hole spacetimes. In higher-dimensional black holes, due to the dependence of gravity on the spacetime dimensions, there is no stable bound orbit balanced by Newtonian gravitational monopole force and centrifugal force, although this balance occurs in the four-dimensional Kerr black hole. In this paper, however, the existence of stable bound orbits of massive and massless particles is shown in six-dimensional singly spinning Myers-Perry black holes with a value of the spin parameter larger than a critical value. The innermost stable bound orbits and the outermost stable bound orbits are found on the rotational axis.	Kwansei Gakuin Univ, Grad Sch Sci & Technol, Sanda, Hyogo 6691337, Japan	Igata, T (reprint author), Kwansei Gakuin Univ, Grad Sch Sci & Technol, Sanda, Hyogo 6691337, Japan.	igata@kwansei.ac.jp			JSPS; Tokyo Institute of Technology Foundation	This work is partially supported by the JSPS Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation "Deepening and Evolution of Mathematics and Physics, Building of International Network Hub based on OCAMI," and is partially supported by a Research Grant from the Tokyo Institute of Technology Foundation.	Shibata M, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.104035; MYERS RC, 1986, ANN PHYS-NEW YORK, V172, P304, DOI 10.1016/0003-4916(86)90186-7; Frolov V, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.084004; CARTER B, 1968, PHYS REV, V174, P1559, DOI 10.1103/PhysRev.174.1559; Kagramanova V, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.084029; Diemer V, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.124026; GREGORY R, 1993, PHYS REV LETT, V70, P2837, DOI 10.1103/PhysRevLett.70.2837; Dias OJC, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.111701; WALKER M, 1970, COMMUN MATH PHYS, V18, P265, DOI 10.1007/BF01649445; Dias OJC, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.104025; Cardoso V, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.064016; Emparan R, 2003, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2003/09/025; Emparan R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.101101; Emparan R., 2008, LIVING REV RELATIVIT, V11; Frolov V, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.044002; Gooding C, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.104026; Igata T, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.104005; Igata T, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.101501; Igata T, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.047501; SHARP NA, 1979, GEN RELAT GRAVIT, V10, P659, DOI 10.1007/BF00756902; WILKINS DC, 1972, PHYS REV D, V5, P814, DOI 10.1103/PhysRevD.5.814	21	1	1	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1550-7998	1550-2368		PHYS REV D	Phys. Rev. D	JUL 1	2015	92	2							024002	10.1103/PhysRevD.92.024002		8	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CL7OW	WOS:000357162600002		
J	Nishimura, J; Shimasaki, S				Nishimura, Jun; Shimasaki, Shinji			New insights into the problem with a singular drift term in the complex Langevin method	PHYSICAL REVIEW D			English	Article							QCD	The complex Langevin method aims at performing path integral with a complex action numerically based on complexification of the original real dynamical variables. One of the poorly understood issues concerns occasional failure in the presence of logarithmic singularities in the action, which appear, for instance, from the fermion determinant in finite density QCD. We point out that the failure should be attributed to the breakdown of the relation between the complex weight that satisfies the Fokker-Planck equation and the probability distribution associated with the stochastic process. In fact, this problem can occur, in general, when the stochastic process involves a singular drift term. We show, however, in a simple example that there exists a parameter region in which the method works, although the standard reweighting method is hardly applicable.	[Nishimura, Jun; Shimasaki, Shinji] High Energy Accelerator Res Org, KEK Theory Ctr, Tsukuba, Ibaraki 3050801, Japan; [Nishimura, Jun] Grad Univ Adv Studies SOKENDAI, Sch High Energy Accelerator Sci, Dept Particle & Nucl Phys, Tsukuba, Ibaraki 3050801, Japan	Nishimura, J (reprint author), High Energy Accelerator Res Org, KEK Theory Ctr, Tsukuba, Ibaraki 3050801, Japan.	jnishi@post.kek.jp; simasaki@post.kek.jp			Japan Society for the Promotion of Science [23244057]	The authors would like to thank D. Sexty for valuable discussions. The work of J. N. was supported in part by Grant-in-Aid for Scientific Research (No. 23244057) from Japan Society for the Promotion of Science.	Aarts G, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.114505; Aarts G, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1756-5; DAMGAARD PH, 1987, PHYS REP, V152, P227, DOI 10.1016/0370-1573(87)90144-X; Splittorff K, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.034507; Seiler E, 2013, PHYS LETT B, V723, P213, DOI 10.1016/j.physletb.2013.04.062; PARISI G, 1981, SCI SINICA, V24, P483; KLAUDER JR, 1984, PHYS REV A, V29, P2036, DOI 10.1103/PhysRevA.29.2036; Sexty D, 2014, PHYS LETT B, V729, P108, DOI 10.1016/j.physletb.2014.01.019; Mollgaard A, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.116007; PARISI G, 1983, PHYS LETT B, V131, P393, DOI 10.1016/0370-2693(83)90525-7; Greensite J, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.114507; Mollgaard A, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.036007; Sexty D., ARXIV14108813	13	2	2	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1550-7998	1550-2368		PHYS REV D	Phys. Rev. D	JUL 1	2015	92	1							011501	10.1103/PhysRevD.92.011501		5	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CL7OU	WOS:000357162400001		
J	Yamazaki, T; Ishikawa, K; Kuramashi, Y; Ukawa, A				Yamazaki, Takeshi; Ishikawa, Ken-ichi; Kuramashi, Yoshinobu; Ukawa, Akira			Study of quark mass dependence of binding energy for light nuclei in 2+1 flavor lattice QCD	PHYSICAL REVIEW D			English	Article							QUANTUM-FIELD THEORIES; ALGORITHM; CLASSIFICATION; SIMULATIONS; FERMIONS	We investigate the formation of light nuclei with the nuclear mass number less than or equal to four in 2 + 1 flavor QCD using a nonperturbative improved Wilson quark and Iwasaki gauge actions. The quark mass is decreased from our previous work to the one corresponding to the pion mass of 0.30 GeV. In each multinucleon channel, the energy shift of the ground state relative to the assembly of free nucleons is calculated on two volumes, whose spatial extents are 4.3 and 5.8 fm. From the volume dependence of the energy shift, we distinguish a bound state of multinucleons from an attractive scattering state. We find that all the ground states measured in this calculation are bound states. As in the previous studies at larger m(pi), our result indicates that at m (pi)= 0.30 GeV the effective interaction between nucleons in the light nuclei is relatively stronger than the one in nature, since the results for the binding energies are larger than the experimental values and a bound state appears in the dineutron channel, which is not observed in experiment. Possible sources of systematic error in this calculation are discussed.	[Yamazaki, Takeshi; Kuramashi, Yoshinobu] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Yamazaki, Takeshi; Kuramashi, Yoshinobu] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 3058577, Japan; [Yamazaki, Takeshi; Ishikawa, Ken-ichi; Kuramashi, Yoshinobu; Ukawa, Akira] RIKEN, Adv Inst Computat Sci, Kobe, Hyogo 6500047, Japan; [Ishikawa, Ken-ichi] Hiroshima Univ, Dept Phys, Higashihiroshima, Hiroshima 7398526, Japan	Yamazaki, T (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan.				Ministry of Education, Culture, Sports, Science, and Technology [22244018, 25800138]; Japanese Ministry for Scientific Research on Innovative Areas [20105002, 21105501, 23105708]	Numerical calculations for the present work have been carried out on the FX10 cluster system at Information Technology Center of the University of Tokyo, on the T2K-Tsukuba cluster system and HA-PACS system and COMA system at University of Tsukuba, and on K computer at RIKEN Advanced Institute for Computational Science. We thank the colleagues in the PACS-CS collaboration for helpful discussions and providing us the code used in this work. This work is supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (No. 22244018 and No. 25800138) and Grants-in-Aid of the Japanese Ministry for Scientific Research on Innovative Areas (No. 20105002, No. 21105501, and No. 23105708).	Yamazaki T, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.074514; Beane SR, 2004, PHYS LETT B, V585, P106, DOI 10.1016/j.physletb.2004.02.007; LUSCHER M, 1990, NUCL PHYS B, V339, P222, DOI 10.1016/0550-3213(90)90540-T; Inoue T, 2012, NUCL PHYS A, V881, P28, DOI 10.1016/j.nuclphysa.2012.02.008; LUSCHER M, 1986, COMMUN MATH PHYS, V105, P153, DOI 10.1007/BF01211097; Yamazaki T, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.054506; Aoki S, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.074503; Beane SR, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.054511; Beane SR, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.034506; Takaishi T, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036706; Beane SR, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.012001; Yamazaki T, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.111504; FUKUGITA M, 1995, PHYS REV D, V52, P3003, DOI 10.1103/PhysRevD.52.3003; Beane SR, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.074507; Detmold W, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.114512; Aoki S, 2006, PHYS REV D, V73, DOI [10.1103/PhysRevD.73.094501, 10.1103/PhysRevD.73.034501]; Aoki S, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.034503; BEAM JE, 1967, PHYS REV, V158, P907, DOI 10.1103/PhysRev.158.907; BOLSTERLI M, 1964, PHYS REV B, V135, pB510, DOI 10.1103/PhysRev.135.B510; Detmold W, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.014511; Doi T, 2013, COMPUT PHYS COMMUN, V184, P117, DOI 10.1016/j.cpc.2012.09.004; Gunther J, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.094513; Hasenbusch M, 2001, PHYS LETT B, V519, P177, DOI 10.1016/S0370-2693(01)01102-9; Ishii N., 2013, P SCI CD, VCD12, P025; Ishikawa K.-I., 2006, POS LAT2006, V2006; Iwasaki Y., ARXIV11117054; Luscher M, 2003, J HIGH ENERGY PHYS; Luscher M, 2005, COMPUT PHYS COMMUN, V165, P199, DOI 10.1016/j.cpc.2004.10.004; Omelyan IP, 2003, COMPUT PHYS COMMUN, V151, P272, DOI 10.1016/S0010-4655(02)00754-3; Sasaki S, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.114507	30	3	3	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1550-7998	1550-2368		PHYS REV D	Phys. Rev. D	JUL 1	2015	92	1							014501	10.1103/PhysRevD.92.014501		12	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CL7OU	WOS:000357162400005		
J	Hamaue, Y; Nakano, J; Sekino, Y; Chuganji, S; Sakamoto, J; Yoshimura, T; Okita, M; Origuchi, T				Hamaue, Yohei; Nakano, Jiro; Sekino, Yuki; Chuganji, Sayaka; Sakamoto, Junya; Yoshimura, Toshiro; Okita, Minoru; Origuchi, Tomoki			Effects of Vibration Therapy on Immobilization-Induced Hypersensitivity in Rats	PHYSICAL THERAPY			English	Article							GENE-RELATED PEPTIDE; WHOLE-BODY VIBRATION; REGIONAL PAIN SYNDROME; ROOT GANGLION NEURONS; DORSAL HORN NEURONS; SYNDROME TYPE-I; CORTICAL REORGANIZATION; MECHANICAL HYPERALGESIA; PERIPHERAL VIBRATION; FINGER CIRCULATION	Background. Cast immobilization induces mechanical hypersensitivity, which disturbs rehabilitation. Although vibration therapy can reduce various types of pain, whether vibration reduces immobilization-induced hypersensitivity remains unclear. Objective. The purpose of this study was to investigate the preventive and therapeutic effects of vibration therapy on immobilization-induced hypersensitivity. Design. The experimental design of the study involved conducting behavioral, histological, and immunohistochemical studies in model rats. Methods. Thirty-five Wistar rats (8 weeks old, all male) were used. The right ankle joints of 30 rats were immobilized by plaster cast for 8 weeks, and 5 rats were used as controls. The immobilized rats were divided randomly into the following 3 groups: (1) immobilization-only group (Im, n=10); (2) vibration therapy group 1, for which vibration therapy was initiated immediately after the onset of immobilization (Im+Vib1, n=10); and (3) vibration therapy group 2, for which vibration therapy was initiated 4 weeks after the onset of immobilization (Im+Vib2, n=10). Vibration was applied to the hind paw. The mechanical hypersensitivity and epidermal thickness of the hind paw skin were measured. To investigate central sensitization, calcitonin gene-related peptide (CGRP) expression in the spinal cord and dorsal root ganglion (DRG) was analyzed. Results. Immobilization-induced hypersensiiivity was inhibited in the Im+Vib1 group but not in the Im+Vib2 group. Central sensitization, which was indicated by increases in CGRP expression in the spinal cord and the size of the area of CGRP-positive neurons in the DRG, was inhibited in only the Im+Vib1 group. Epidermal thickness was not affected by vibration stimulation. Limitations. A limitation of this study is that the results were limited to an animal model and cannot be generalized to humans. Conclusions. The data suggest that initiation of vibration therapy in the early phase of immobilization may inhibit the development of immobilization-induced hypersensitivity.	[Hamaue, Yohei; Yoshimura, Toshiro; Okita, Minoru; Origuchi, Tomoki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Locomot Rehabil Sci, Unit Rehabil Sci, Nagasaki 8528520, Japan; [Hamaue, Yohei] Juzenkai Hosp, Dept Rehabil, Nagasaki, Japan; [Sekino, Yuki; Chuganji, Sayaka; Sakamoto, Junya] Nagasaki Univ, Grad Sch Biomed Sci, Unit Phys & Occupat Therapy, Nagasaki 8528520, Japan	Nakano, J (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Unit Phys & Occupat Therapy, 1-7-1 Sakamoto, Nagasaki 8528520, Japan.	nakano-j@nagasaki-u.ac.jp			Dean's Fund Grant from the School of Health Sciences; Nagasaki University; Japan Society for the Promotion of Science [23500587]	This research was supported, in part, by a Dean's Fund Grant from the School of Health Sciences; Nagasaki University, and a grant-in-aid for scientific research (No. 23500587) from the Japan Society for the Promotion of Science.	Nakagami G, 2007, BIOSCI TRENDS, V1, P161; Psatha M, 2012, J MAGN RESON IMAGING, V35, P686, DOI 10.1002/jmri.22864; Nitzan-Luques A, 2011, PAIN, V152, P2413, DOI 10.1016/j.pain.2011.07.012; Terkelsen AJ, 2008, ANESTHESIOLOGY, V109, P297, DOI 10.1097/ALN.0b013e31817f4c9d; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Clavet H, 2008, CAN MED ASSOC J, V178, P691, DOI 10.1503/cmaj.071056; Simao AP, 2012, ARCH PHYS MED REHAB, V93, P1692, DOI 10.1016/j.apmr.2012.04.017; Imbe H, 2004, PAIN, V112, P361, DOI 10.1016/j.pain.2004.09.015; Carlton SM, 2009, PAIN, V147, P265, DOI 10.1016/j.pain.2009.09.030; van Nes IJW, 2006, STROKE, V37, P2331, DOI 10.1161/01.STR.0000236494.62957.f3; Orr R, 2008, SPORTS MED, V38, P317; Broadbent S, 2010, BRIT J SPORT MED, V44, P888, DOI 10.1136/bjsm.2008.052100; Maihofner C, 2007, BRAIN, V130, P2671, DOI 10.1093/brain/awm131; Pavel J, 2011, BRAIN RES, V1396, P1, DOI 10.1016/j.brainres.2011.04.023; Okita M, 2004, J MUSCLE RES CELL M, V25, P159, DOI 10.1023/B:JURE.0000035851.12800.39; [Anonymous], 2005, AM J PHYSIOL-REG I; Guo TZ, 2004, PAIN, V108, P95, DOI 10.1016/j.pain.2003.12.010; Gay A, 2007, JOINT BONE SPINE, V74, P461, DOI 10.1016/j.jbspin.2006.10.1010; Kosek E, 1997, PAIN, V70, P41, DOI 10.1016/S0304-3959(96)03295-2; Sun RQ, 2004, J NEUROPHYSIOL, V92, P2859, DOI 10.1152/jn.00339.2004; Sun RQ, 2003, PAIN, V104, P201, DOI 10.1016/S0304-3959(03)00008-3; SATOH M, 1992, PAIN, V49, P273, DOI 10.1016/0304-3959(92)90151-Z; Iwamoto J, 2005, AGING CLIN EXP RES, V17, P157; SKOGLUND CR, 1989, CLIN PHYSIOL, V9, P361, DOI 10.1111/j.1475-097X.1989.tb00990.x; LUNDEBERG T, 1988, SCAND J REHABIL MED, V20, P149; Fukuoka T, 1998, PAIN, V78, P13, DOI 10.1016/S0304-3959(98)00111-0; CARR PA, 1989, BRAIN RES, V497, P163, DOI 10.1016/0006-8993(89)90983-9; Maihofner C, 2003, NEUROLOGY, V61, P1707; LUNDEBERG T, 1984, PAIN, V20, P25, DOI 10.1016/0304-3959(84)90808-X; Issurin VB, 1999, J SPORT SCI, V17, P177, DOI 10.1080/026404199366073; Neumann S, 1996, NATURE, V384, P360, DOI 10.1038/384360a0; Weerakkody NS, 2003, PAIN, V105, P425, DOI 10.1016/S0304-3959(03)00257-4; Rittweger J, 2002, SPINE, V27, P1829, DOI 10.1097/01.BRS.0000025726.67278.8B; Aoki Y, 2004, LIFE SCI, V74, P2627, DOI 10.1016/j.lfs.2004.01.008; Bennett AD, 2000, PAIN, V86, P163, DOI 10.1016/S0304-3959(00)00242-6; Bovenzi M, 2001, OCCUP ENVIRON MED, V58, P185, DOI 10.1136/oem.58.3.185; DE KONINCK Y, 1992, NEUROSCIENCE, V50, P435; Elbert T, 1997, EXP BRAIN RES, V117, P161, DOI 10.1007/s002210050210; Griffin MJ, 2006, SCAND J WORK ENV HEA, V32, P383; Hamaue Y, 2013, J PHYSIOL SCI, V63, P401, DOI 10.1007/s12576-013-0277-4; Han J, 2014, J PHYS THER SCI, V26, P671, DOI 10.1589/jpts.26.671; Imbe H, 2010, BRAIN RES, V1329, P103, DOI 10.1016/j.brainres.2010.03.006; KANGRGA I, 1990, J NEUROSCI, V10, P2026; Karin R, 2004, J PHYSL, V561, P307; LUNDEBERG T, 1984, PAIN, V20, P13, DOI 10.1016/0304-3959(84)90807-8; Ma WY, 1998, EXP NEUROL, V152, P137, DOI 10.1006/exnr.1998.6827; Maikala RV, 2006, EXP PHYSIOL, V91, P853, DOI 10.1113/expphysiol.2006.033696; Murfee WL, 2005, J APPL PHYSIOL, V98, P2376, DOI 10.1152/japplphysiol.01135.2004; Nakano J, 2012, PHYSIOL RES, V61, P643; Nasu T, 2009, EUR J PAIN, V14, P236; Nishigami T, 2009, NEUROSCI LETT, V454, P97, DOI 10.1016/j.neulet.2009.02.043; Okamoto T, 1999, J BONE JOINT SURG BR, V81B, P171, DOI 10.1302/0301-620X.81B1.8566; Peleshok JC, 2010, J COMP NEUROL, V519, P49; SALTER MW, 1987, NEUROSCIENCE, V22, P631, DOI 10.1016/0306-4522(87)90359-9; Ushida T, 2001, J Orthop Sci, V6, P46, DOI 10.1007/s007760170024	55	0	0	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JUL	2015	95	7					1015	1026		10.2522/ptj.20140137		12	Orthopedics; Rehabilitation	Orthopedics; Rehabilitation	CL8PO	WOS:000357236800007		
J	Amano, S; Takebayashi, T; Hanada, K; Umeji, A; Marumoto, K; Furukawa, K; Domen, K				Amano, Satoru; Takebayashi, Takashi; Hanada, Keisuke; Umeji, Atsushi; Marumoto, Kohei; Furukawa, Keiko; Domen, Kazuhisa			Constraint-Induced Movement Therapy After Injection of Botulinum Toxin Type A for a Patient With Chronic Stroke: One-Year Follow-up Case Report	PHYSICAL THERAPY			English	Article							RESEARCH ARM TEST; MODIFIED ASHWORTH SCALE; UPPER-EXTREMITY; CONTROLLED-TRIAL; SPASTICITY; RELIABILITY; VALIDITY; ENVIRONMENT; POSTSTROKE; EXPERIENCE	Background and Purpose. Spasticity, an aspect of upper motor neuron syndrome, is a widespread problem in patients with stroke. To date, no study has reported the long-term (up to 1 year) outcomes of botulinum toxin (BTX) injection in combination with constraint-induced movement therapy in patients with chronic stroke. In this case report, the long-term (1 year) effects of the combination of BTX type A injection and constraint-induced movement therapy on spasticity and arm function in a patient with chronic stroke and arm paresis are described. Case Description. The patient was a 66-year-old man who had had an infarction in the right posterior limb of the internal capsule 4 years before the intervention. At screening, the patient was not able to voluntarily extend his interphalangeal or metacarpophalangeal joints beyond the 10 degrees required for constraint-induced movement therapy. From 12 days after BTX type A injection, the patient received 5 hours of constraint-induced movement therapy for 10 weekdays. Outcomes. All outcome measures (Modified Ashworth Scale, Fugl-Meyer Assessment, Action Research Arm Test, and amount of use scale of the Motor Activity Log) improved substantially over the 1-year period (before intervention to 1 year after intervention). Repeat BTX type A injections were not necessary because muscle tone and arm function did not worsen during the observation period. Discussion. The improved arm function may have reflected improvements in volitional movements and coordination or speed of movements in the paretic arm as a result of a reduction in spasticity, a reduction of learned nonuse behaviors, or use-dependent plasticity after the combination of BTX type A injection and constraint-induced movement therapy. In addition, the possibility of an influence of the passage of time or the Hawthorne effect cannot be ruled out. If this approach proves useful in future controlled studies, it may reduce the rising medical costs of the treatment of stroke.	[Amano, Satoru; Takebayashi, Takashi; Hanada, Keisuke; Umeji, Atsushi] Hosp Hyogo Coll Med, Dept Rehabil, Nishinomiya, Hyogo 6638501, Japan; [Marumoto, Kohei] Hyogo Prefectural Rehabil Hosp Nishi Harima, Tatsuno, Hyogo, Japan; [Furukawa, Keiko; Domen, Kazuhisa] Hyogo Coll Med, Dept Rehabil Med, Kobe, Hyogo, Japan	Takebayashi, T (reprint author), Hosp Hyogo Coll Med, Dept Rehabil, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	takshi77@hyo-med.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [26282158]	This work was partly supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (KAKENHI [26282158]).	Wolf SL, 2008, LANCET NEUROL, V7, P33, DOI 10.1016/S1474-4422(07)70294-6; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; Takebayashi T, 2013, CLIN REHABIL, V27, P418, DOI 10.1177/0269215512460779; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Evers SMAA, 2004, STROKE, V35, P1209, DOI 10.1161/01.STR.0000125860.48180.48; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Watkins CL, 2002, CLIN REHABIL, V16, P515, DOI 10.1191/0269215502cr512oa; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; van der Lee JH, 1999, STROKE, V30, P2369; Anaby D, 2014, ARCH PHYS MED REHAB, V95, P908, DOI 10.1016/j.apmr.2014.01.005; van der Lee JH, 2004, STROKE, V35, P1410, DOI 10.1161/01.STR.0000126900.24964.7e; Gregson JM, 1999, ARCH PHYS MED REHAB, V80, P1013, DOI 10.1016/S0003-9993(99)90053-9; SAHRMANN SA, 1977, ANN NEUROL, V2, P460, DOI 10.1002/ana.410020604; LANCE JW, 1980, NEUROLOGY, V30, P1303; Simpson DM, 1996, NEUROLOGY, V46, P1306; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Pandyan AD, 2003, CLIN REHABIL, V17, P290, DOI 10.1191/0269215503cr610oa; van der Lee JH, 2001, J REHABIL MED, V33, P110; Brogardh C, 2010, ARCH PHYS MED REHAB, V91, P460, DOI 10.1016/j.apmr.2009.11.009; DIFABIO RP, 1990, PHYS THER, V70, P542; Dobrossy MD, 2001, NAT REV NEUROSCI, V2, P871, DOI 10.1038/35104055; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Morris D M, 2006, Eura Medicophys, V42, P257; Sun SF, 2010, NEUROREHAB NEURAL RE, V24, P34, DOI 10.1177/1545968309341060; Turner-Stokes L, 2002, CONCISE GUIDANCE GOO; VANDENBERGH P, 1995, MUSCLE NERVE, V18, P720, DOI 10.1002/mus.880180708; Ward A B, 2004, Eura Medicophys, V40, P83; Ward AB, 2002, EUR J NEUROL, V9, P48, DOI 10.1046/j.1468-1331.2002.0090s1048.x	29	0	0	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JUL	2015	95	7					1039	1045		10.2522/ptj.20140329		7	Orthopedics; Rehabilitation	Orthopedics; Rehabilitation	CL8PO	WOS:000357236800009		
J	Samy, MN; Khalil, HE; Sugimoto, S; Matsunami, K; Otsuka, H; Kamel, MS				Samy, Mamdouh Nabil; Khalil, Hany Ezzat; Sugimoto, Sachiko; Matsunami, Katsuyoshi; Otsuka, Hideaki; Kamel, Mohamed Salah			Amphipaniculosides A-D, triterpenoid glycosides, and amphipaniculoside E, an aliphatic alcohol glycoside from the leaves of Amphilophium paniculatum	PHYTOCHEMISTRY			English	Article						Amphilophium paniculatum; Bignoniaceae; Triterpenoids; Amphipaniculosides; Aliphatic alcohol glycoside	CYCLOARTANE GLYCOSIDES; TARENNA-GRACILIPES; DERIVATIVES; GLUCOSIDES	Four new triterpenoids; One oleanane-, one ursane- and two cycloartane-type triterpenoids, named amphipaniculosides A-D, in addition to one new aliphatic alcohol glycoside, named amphipaniculoside E, were isolated from the 1-BuOH fraction of the leaves of Amphilophium paniculatum (L.) Kunth., together with five known compounds, (+)-lyoniresinol 3 alpha-O-beta-D-glucopyranoside, (-)-lyoniresinol 3 alpha-O-beta-D-glucopyranoside, acteoside (verbascoside), isoacteoside (isoverbascoside), and luteolin 7-O-beta-D-glucopyranoside. Their structures were elucidated by spectroscopic methods including 1D and 2D NMR experiments (H-1, C-13, DEPT, COSY, ROESY, HSQC, HMBC) in combination with HR-ESI-MS and by comparisons of their physical and spectroscopic data with literature values. (C) 2015 Elsevier Ltd. All rights reserved.	[Samy, Mamdouh Nabil; Sugimoto, Sachiko; Matsunami, Katsuyoshi; Otsuka, Hideaki] Hiroshima Univ, Dept Pharmacognosy, Grad Sch Biomed & Hlth Sci, Minami Ku, Hiroshima 7348553, Japan; [Samy, Mamdouh Nabil; Khalil, Hany Ezzat; Kamel, Mohamed Salah] Menia Univ, Dept Pharmacognosy, Fac Pharm, Menia 61519, Egypt; [Otsuka, Hideaki] Yasuda Womens Univ, Dept Nat Prod Chem, Fac Pharm, Asaminami Ku, Hiroshima 7310153, Japan	Matsunami, K (reprint author), Hiroshima Univ, Dept Pharmacognosy, Grad Sch Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	matunami@hiroshima-u.ac.jp; otsuka@yasuda-u.ac.jp			JSPS KAKENHI [26460122]; Ministry of Higher Education, Egypt through Scientific Mission System	This work was supported by JSPS KAKENHI Grant Number 26460122. It was also supported by the Ministry of Higher Education, Egypt through the Scientific Mission System. The authors are grateful for access to the superconducting NMR instrument, UV and ESI-MS at the Analytical Center of Molecular Medicine, the Analysis Center of Life Science and the Natural Science Center for Basic Research and Development of the Graduate School of Biomedical and Health Sciences, Hiroshima University.	Adnyana IK, 2000, J NAT PROD, V63, P496, DOI 10.1021/np990581+; Li BZ, 1998, PHYTOCHEMISTRY, V49, P2477, DOI 10.1016/S0031-9422(98)00161-7; SETO T, 1984, PHYTOCHEMISTRY, V23, P2829, DOI 10.1016/0031-9422(84)83023-X; Radwan MM, 2004, PHYTOCHEMISTRY, V65, P2909, DOI 10.1016/j.phytochem.2004.08.037; OHASHI K, 1994, CHEM PHARM BULL, V42, P1924; AGRAWAL PK, 1992, PHYTOCHEMISTRY, V31, P3307, DOI 10.1016/0031-9422(92)83678-R; Bisoli E, 2008, MOLECULES, V13, P2717, DOI 10.3390/molecules13112717; Cai WenHu, 2011, American Journal of Plant Sciences, V2, P609, DOI 10.4236/ajps.2011.24072; Facundo V. A., 2008, Revista Latinoamericana de Química, V36, P76; Gentry A., 1992, FLORA NEOTROPICA MON, V25, P1; Gentry A. H, 1980, FL NEOTROPICA MONOGR, V25, P1; Gentry A.H., 1973, BIGNONIACEAE ANN MIS, V60, P781; Kanchanapoom T, 2001, PHYTOCHEMISTRY, V58, P811, DOI 10.1016/S0031-9422(01)00306-5; Kanchanapoom T, 2002, PHYTOCHEMISTRY, V59, P557, DOI 10.1016/S0031-9422(01)00466-6; Kasai R, 1999, PHYTOCHEMISTRY, V51, P803, DOI 10.1016/S0031-9422(99)00078-3; Nasser I.N., 2013, PHARM RES, V5, P17; Nasser I.N., 2013, NAT PROD CHEM RES, V1, P1; Orhan F, 2012, FOOD CHEM, V135, P764, DOI 10.1016/j.foodchem.2012.04.137; Samy M. N., 2014, Journal of Natural Products (India), V7, P37; Verotta L, 1998, PHYTOCHEMISTRY, V49, P845, DOI 10.1016/S0031-9422(97)00869-8; Wu J, 2004, MAGN RESON CHEM, V42, P659, DOI 10.1002/mrc.1393; Yamamura S, 1998, PHYTOCHEMISTRY, V48, P131, DOI 10.1016/S0031-9422(97)01112-6; Yoshikawa K, 2000, J NAT PROD, V63, P1377, DOI 10.1021/np000182a; Zhao ZM, 2008, CHEM PHARM BULL, V56, P1153, DOI 10.1248/cpb.56.1153; Zhao ZM, 2013, J NAT MED-TOKYO, V67, P503, DOI 10.1007/s11418-012-0707-2; Zhao ZM, 2011, CHEM PHARM BULL, V59, P902, DOI 10.1248/cpb.59.902	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	JUL	2015	115						261	268		10.1016/j.phytochem.2015.02.020		8	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CL8PZ	WOS:000357237900026		
J	Kida, T; Hiejima, Y; Nitta, KH				Kida, Takumitsu; Hiejima, Yusuke; Nitta, Koh-Hei			Rheo-optical Raman study of microscopic deformation in high-density polyethylene under hot drawing	POLYMER TESTING			English	Article						High-density polyethylene; In situ Raman spectroscopy; Hot drawing	MOLECULAR-ORIENTATION DISTRIBUTIONS; CRYSTALLINE POLYMERS; MORPHOLOGICAL FACTORS; RELAXATION PROCESSES; SPECTROSCOPY; BEHAVIOR; SCATTERING; SPECTRUM; FILMS	In situ observation of the microscopic structural changes in high-density polyethylene during hot drawing was performed by incorporating a temperature-controlled tensile machine into a Raman spectroscopy apparatus. It was found that the load sharing and molecular orientation during elongation drastically changed at 50 degrees C. The microscopic stress of the crystalline chains decreased with increasing temperature and diminished around 50 degrees C. Moreover, the orientation of the crystalline chains was greatly promoted above 50 degrees C. These microscopic structural changes were caused by the thermal activation of the molecular motion within lamellar crystalline chains owing to the onset of relaxation of the crystalline phase. (C) 2015 Elsevier Ltd. All rights reserved.	[Kida, Takumitsu; Hiejima, Yusuke; Nitta, Koh-Hei] Kanazawa Univ, Dept Chem & Mat Sci, Kanazawa, Ishikawa 9201192, Japan	Hiejima, Y (reprint author), Kanazawa Univ, Dept Chem & Mat Sci, Kakuma Campus, Kanazawa, Ishikawa 9201192, Japan.	hiejima@se.kanazawa-u.ac.jp	Hiejima, Yusuke/F-3532-2014	Hiejima, Yusuke/0000-0001-9197-2021	Japanese Society for the Promotion of Science KAKENHI [26410221]	The temperature-controlled tensile machine for microscopy was kindly lent by Japan High Tech Co. Ltd. YH is thankful for financial support from the Japanese Society for the Promotion of Science KAKENHI (Grant number 26410221).	WOOL RP, 1986, J POLYM SCI POL PHYS, V24, P1039, DOI 10.1002/polb.1986.090240508; BOWER DI, 1972, J POLYM SCI POL PHYS, V10, P2135, DOI 10.1002/pol.1972.180101103; Nitta K, 2003, J MACROMOL SCI PHYS, VB42, P107, DOI 10.1081/MB-120015754; Frisk S, 2004, APPL SPECTROSC, V58, P279, DOI 10.1366/000370204322886618; Tanaka M, 2006, J MATER SCI, V41, P963, DOI 10.1007/s10853-006-6595-7; Jiang ZY, 2009, POLYMER, V50, P4101, DOI 10.1016/j.polymer.2009.06.063; Kuriyagawa M, 2011, POLYMER, V52, P3469, DOI 10.1016/j.polymer.2011.05.028; PIGEON M, 1991, MACROMOLECULES, V24, P5687, DOI 10.1021/ma00020a032; BOYD RH, 1985, POLYMER, V26, P1123, DOI 10.1016/0032-3861(85)90240-X; Men YF, 2003, MACROMOLECULES, V36, P4689, DOI 10.1021/ma0344902; STROBL GR, 1978, J POLYM SCI POL PHYS, V16, P1181, DOI 10.1002/pol.1978.180160704; BOYD RH, 1985, POLYMER, V26, P323, DOI 10.1016/0032-3861(85)90192-2; Richard-Lacroix M, 2013, MACROMOLECULES, V46, P5561, DOI 10.1021/ma400955u; BOWER DI, 1981, J POLYM SCI POL PHYS, V19, P93, DOI 10.1002/pol.1981.180190108; Brundrup J., 1999, POLYM HDB; CITRA MJ, 1995, MACROMOLECULES, V28, P4007, DOI 10.1021/ma00115a037; Everall N, 1996, APPL SPECTROSC, V50, P1229, DOI 10.1366/0003702963904971; Everall N.J., 2007, VIBRATIONAL SPECTROS; GALL MJ, 1972, SPECTROCHIM ACTA A-M, VA 28, P1485, DOI 10.1016/0584-8539(72)80118-1; GALL MJ, 1972, POLYMER, V13, P104, DOI 10.1016/S0032-3861(72)80003-X; GLENZ W, 1971, J POLYM SCI A2, V9, P1191, DOI 10.1002/pol.1971.160090703; HOFFMANN U, 1993, APPL SPECTROSC, V47, P1531, DOI 10.1366/0003702934067333; Kida T, 2015, POLYMER, V58, P88, DOI 10.1016/j.polymer.2014.12.030; LAPERSONNE P, 1992, POLYMER, V33, P1277, DOI 10.1016/0032-3861(92)90774-Q; Li HL, 2013, POLYMER, V54, P972, DOI 10.1016/j.polymer.2012.12.012; LUU DV, 1980, J RAMAN SPECTROSC, V9, P172, DOI 10.1002/jrs.1250090309; McCrum N. G., 1967, ANELASTIC DIELECTRIC; Men YF, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.095502; Nakayasu H., 1961, J RHEOL, V5, P261, DOI 10.1122/1.548899; Nitta K, 2006, POLYM J, V38, P757, DOI 10.1295/polymj.PJ2005211; Nitta KH, 2006, POLYM J, V38, P122, DOI 10.1295/polymj.38.1221; Nitta KH, 2003, J MATER SCI, V38, P4889, DOI 10.1023/B:JMSC.0000004410.56145.f1; Read B., 1968, MACROMOLECULES, V1, P116, DOI 10.1021/ma60002a004; Sharpe M., 1999, J ENVIRON MONITOR, V50, P271; TAKAYANA.M, 1974, J MACROMOL SCI PHYS, VB  9, P391, DOI 10.1080/00222347408204546; Wang YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097234; Ward I. M., 2013, MECH PROPERTIES SOLI; Zhou HY, 1997, MACROMOLECULES, V30, P2412, DOI 10.1021/ma961437n	38	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9418	1873-2348		POLYM TEST	Polym. Test	JUL	2015	44						30	36		10.1016/j.polymertesting.2015.03.018		7	Materials Science, Characterization & Testing; Polymer Science	Materials Science; Polymer Science	CL8OU	WOS:000357234800006		
J	Herzog, J; Hibi, T; Qureshi, AA				Herzog, Juergen; Hibi, Takayuki; Qureshi, Ayesha Asloob			POLARIZATION OF KOSZUL CYCLES WITH APPLICATIONS TO POWERS OF EDGE IDEALS OF WHISKER GRAPHS	PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article						Polarization; Koszul complex; whisker graphs; edge ideals		In this paper, we introduce the polarization of Koszul cycles and use it to study the depth function of powers of edge ideals of whisker graphs.	[Herzog, Juergen] Univ Duisburg Essen, Fachbereich Math, D-45117 Essen, Germany; [Hibi, Takayuki] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Pure & Appl Math, Toyonaka, Osaka 5600043, Japan; [Qureshi, Ayesha Asloob] Abdus Salam Int Ctr Theoret Phys, Trieste, Italy	Herzog, J (reprint author), Univ Duisburg Essen, Fachbereich Math, Campus Essen, D-45117 Essen, Germany.	juergen.herzog@uni-essen.de; hibi@math.sci.osaka-u.ac.jp; aqureshi@cr.math.sci.osaka-u.ac.jp					Morey S, 2010, COMMUN ALGEBRA, V38, P4042, DOI 10.1080/00927870903286900; Herzog J, 2005, J ALGEBRA, V291, P534, DOI 10.1016/j.jalgebra.2005.04.007; Bandari S, 2014, ARK MAT, V52, P11, DOI 10.1007/s11512-013-0184-1; BRODMANN M, 1979, MATH PROC CAMBRIDGE, V86, P35, DOI 10.1017/S030500410000061X; EISENBUD D, 1983, J ALGEBRA, V81, P202, DOI 10.1016/0021-8693(83)90216-8; Chen J, 2002, ROCKY MT J MATH, V32, P71, DOI 10.1216/rmjm/1030539608; Bruns Winfried, 1993, CAMBRIDGE STUDIES AD, V39; Ene Viviana, 2012, GRADUATE STUDIES MAT, V130; Guardo E, 2005, ILLINOIS J MATH, V49, P265; Herzog J., J APP PURE IN PRESS; Herzog Jurgen, 2011, GRADUATE TEXTS MATH, V260; Martinez-Bernal J, 2012, COLLECT MATH, V63, P361, DOI 10.1007/s13348-011-0045-9; SIMIS A, 1994, J ALGEBRA, V167, P389, DOI 10.1006/jabr.1994.1192; Villarreal Rafael H., 2001, MONOGRAPHS TXB PURE, V238	14	0	0	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9939	1088-6826		P AM MATH SOC	Proc. Amer. Math. Soc.	JUL	2015	143	7					2767	2778	PII S0002-9939(2015)12456-2			12	Mathematics, Applied; Mathematics	Mathematics	CL5YK	WOS:000357041300004		
J	Chida, M				Chida, Masataka			INDIVISIBILITY OF CENTRAL VALUES OF L-FUNCTIONS FOR MODULAR FORMS	PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article							HALF-INTEGRAL WEIGHT; FOURIER COEFFICIENTS; QUADRATIC TWISTS; ELLIPTIC-CURVES	In this paper, we generalize works of Kohnen and Ono (in Invent. Math., 1999) and James and Ono (in Math. Ann., 1999) on indivisibility of (the algebraic part of) central critical values of L-functions to higher weight modular forms.	Kyoto Univ, Grad Sch Math, Sakyo Ku, Kyoto 6068502, Japan	Chida, M (reprint author), Kyoto Univ, Grad Sch Math, Sakyo Ku, Kyoto 6068502, Japan.	chida@math.kyoto-u.ac.jp			Japan Society for the Promotion of Science	The author was supported in part by the Japan Society for the Promotion of Science Research Fellowships for Young Scientists.	Bruinier JH, 1999, DUKE MATH J, V98, P595, DOI 10.1215/S0012-7094-99-09819-8; SHIMURA G, 1973, ANN MATH, V97, P440, DOI 10.2307/1970831; ASH A, 1986, DUKE MATH J, V53, P849, DOI 10.1215/S0012-7094-86-05346-9; Deligne P., 1971, LECT NOTES MATH, V1968/69, P139; FRIEDBERG S, 1995, ANN MATH, V142, P385, DOI 10.2307/2118638; James K, 1999, MATH ANN, V314, P1, DOI 10.1007/s002080050283; KOHNEN W, 1985, MATH ANN, V271, P237, DOI 10.1007/BF01455989; Kohnen W, 1999, INVENT MATH, V135, P387, DOI 10.1007/s002220050290; MAZUR B, 1986, INVENT MATH, V84, P1, DOI 10.1007/BF01388731; Ono K, 1998, ANN MATH, V147, P453, DOI 10.2307/121015; Ono K, 1998, INVENT MATH, V134, P651, DOI 10.1007/s002220050275; Ribet K. A., 1977, LECT NOTES MATH, V601, P17; Ribet K.A., 1985, GLASGOW MATH J, V27, P185; Serre Jean-Pierre, 1973, LECT NOTES MATH, V317, P319; STURM J, 1987, LECT NOTES MATH, V1240, P275; Swinnerton-Dyer H. P. F., 1973, LECT NOTES MATH, V350, P1; WALDSPURGER JL, 1981, J MATH PURE APPL, V60, P375	17	0	0	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9939	1088-6826		P AM MATH SOC	Proc. Amer. Math. Soc.	JUL	2015	143	7					2829	2840	PII S0002-9939(2015)12503-8			12	Mathematics, Applied; Mathematics	Mathematics	CL5YK	WOS:000357041300010		
J	Miyachi, H				Miyachi, Hideki			A RIGIDITY THEOREM FOR HOLOMORPHIC DISKS IN TEICHMULLER SPACE	PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article						Teichmuller space; Teichmuller distance; Kobayashi distance; pseudo-convex domains	KLEINIAN-GROUPS; PSEUDOCONVEX DOMAINS; CLASSIFICATION; MANIFOLDS; GEOMETRY; MAPPINGS	In this paper, we discuss a rigidity property for holomorphic disks in Teichmuller space. In fact, we give an improvement of Tanigawa's rigidity theorem. We will also treat the rigidity property of holomorphic disks for complex manifolds. We observe the rigidity property is valid for bounded strictly pseudoconvex domains with C-2-boundaries, but the rigidity property does not hold for product manifolds.	Osaka Univ, Grad Sch Sci, Dept Math, Toyonaka, Osaka 5600043, Japan	Miyachi, H (reprint author), Osaka Univ, Grad Sch Sci, Dept Math, Machikaneyama 1-1, Toyonaka, Osaka 5600043, Japan.				Ministry of Education, Science, Sports and Culture [21540177]	The author was partially supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (C), 21540177.	ABIKOFF W, 1976, AM J MATH, V98, P109, DOI 10.2307/2373617; Brock JF, 2012, ANN MATH, V176, P1, DOI 10.4007/anna1s.2012.176.1.1; OHSHIKA K, 1990, INVENT MATH, V99, P185, DOI 10.1007/BF01234416; Balogh ZM, 2000, COMMENT MATH HELV, V75, P504, DOI 10.1007/s000140050138; Bers L., 1985, DIFFERENTIAL GEOMETR, P87; BERS L, 1970, ANN MATH, V91, P570, DOI 10.2307/1970638; Bonahon F., 2001, CONT MATH, V269, P1; BONAHON F, 1986, ANN MATH, V124, P71, DOI 10.2307/1971388; Brock JF, 2000, GEOM FUNCT ANAL, V10, P741, DOI 10.1007/PL00001637; Gardiner F., 1991, COMPLEX VARIABLES TH, V16, P209, DOI 10.1080/17476939108814480; GRAHAM I, 1975, T AM MATH SOC, V207, P219; Gromov M., 1987, MATH SCI RES I PUBL, V8, P75, DOI DOI 10.1007/978-1-4613-9586-7_3.MR919829; KERCKHOFF SP, 1980, TOPOLOGY, V19, P23, DOI 10.1016/0040-9383(80)90029-4; KOBAYASH.S, 1967, J MATH SOC JPN, V19, P460; Lusin N., 1925, ANN SCI ECOLE NORM S, V42, P143; MASKIT B, 1985, ANN ACAD SCI FENN-M, V10, P381; MASUR HA, 1995, ANN ACAD SCI FENN A1, V20, P259; Minsky YN, 1999, ANN MATH, V149, P559, DOI 10.2307/120976; Miyachi H, 2014, MATH Z, V278, P1065, DOI 10.1007/s00209-014-1346-y; Miyachi Hideki, PREPRINT; Penner R. C., 1992, ANN MATH STUD, V125; Royden H. L., 1971, ANN MATH STUD, V66, P369; SHIGA H, 1984, J MATH KYOTO U, V24, P441; SHIGA H, 1986, TOHOKU MATH J, V38, P539, DOI 10.2748/tmj/1178228406; Shiga H., 1988, MATH SCI RES I PUBL, V11, P207, DOI DOI 10.1007/978-1-4613-9611-6_15; TANIGAWA H, 1993, P AM MATH SOC, V117, P71; Thurston W., GEOMETRY TOPOLOGY 3; Tsuji M., 1959, POTENTIAL THEORY MOD	28	0	0	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9939	1088-6826		P AM MATH SOC	Proc. Amer. Math. Soc.	JUL	2015	143	7					2949	2957	PII S0002-9939(2015)12488-4			9	Mathematics, Applied; Mathematics	Mathematics	CL5YK	WOS:000357041300021		
J	Ichihara, K; Kobayashi, T; Rieck, Y				Ichihara, Kazuhiro; Kobayashi, Tsuyoshi; Rieck, YO'Av			STRONG CYLINDRICALITY AND THE MONODROMY OF BUNDLES	PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article						3-manifolds; fiber bundles; hyperbolic manifolds; translation distance	ACYLINDRICAL SURFACES; 3-MANIFOLDS; VOLUME	A surface F in a 3-manifold M is called cylindrical if M cut open along F admits an essential annulus A. If, in addition, (A, partial derivative A) is embedded in (M, F), then we say that F is strongly cylindrical. Let M be a connected 3-manifold that admits a triangulation using t tetrahedra and F a two-sided connected essential closed surface of genus g(F). We show that if g(F) is at least 38t, then F is strongly cylindrical. As a corollary, we give an alternative proof of the assertion that every closed hyperbolic 3-manifold admits only finitely many fibrations over the circle with connected fiber whose translation distance is not one, which was originally proved by Saul Schleimer.	[Ichihara, Kazuhiro] Nihon Univ, Coll Human & Sci, Dept Math, Setagaya Ku, Tokyo 1568550, Japan; [Kobayashi, Tsuyoshi] Nara Womens Univ, Dept Math, Kitauoya Nishimachi, Nara 6308506, Japan; [Rieck, YO'Av] Univ Arkansas, Dept Math Sci, Fayetteville, AR 72701 USA	Ichihara, K (reprint author), Nihon Univ, Coll Human & Sci, Dept Math, Setagaya Ku, 3-25-40 Sakurajosui, Tokyo 1568550, Japan.	ichihara@math.chs.nihon-u.ac.jp; tsuyoshi@cc.nara-wu.ac.jp; yoav@uark.edu			JSPS [23740061, 25400091]; Simons Foundation [283495]	The first author was supported by JSPS KAKENHI Grant Number 23740061.; The second author was supported by JSPS KAKENHI Grant Number 25400091.; This work was partially supported by a grant from the Simons Foundation (Grant Number 283495 to Yo'av Rieck).	Agol I, 2013, DOC MATH, V18, P1045; Sela Z, 1997, INVENT MATH, V129, P527, DOI 10.1007/s002220050172; Bachman D, 2005, COMMUN ANAL GEOM, V13, P903; Eudave-Munoz M, 2004, BOL SOC MAT MEX, V10, P147; HASS J, 1995, MICH MATH J, V42, P357; JACO W, 1984, TOPOLOGY, V23, P195, DOI 10.1016/0040-9383(84)90039-9; Kobayashi T, 2011, CONTEMP MATH, V560, P27; Kobayashi T, 2014, COMMUN ANAL GEOM, V22, P247; Schleimer Saul, 2001, P S PURE MATH, V71, P287; WISE D. T., 2012, CBMS REGIONAL C SERI, V117; Wise Daniel T., STRUCTURE GROUPS QUA	11	0	0	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9939	1088-6826		P AM MATH SOC	Proc. Amer. Math. Soc.	JUL	2015	143	7					3169	3176	PII S0002-9939(2015)12473-2			8	Mathematics, Applied; Mathematics	Mathematics	CL5YK	WOS:000357041300043		
J	Suzuki, A				Suzuki, Arata			Inverse-model-based cuffless blood pressure estimation using a single photoplethysmography sensor	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						Blood pressure estimation; cuffless; signal-to-noise ratio; Taguchi method	PULSE-WAVE VELOCITY; TIME	This paper proposes an inverse-model-based cuffless method for estimating blood pressure using a single photoplethysmography sensor. The proposed method, which is based on the relationship between blood pressure and the features of pulse waves, employs an inverse estimation and uses the blood pressure as the explanatory variable. Using this method, the blood pressure can be estimated with high accuracy even in situations where the pulse wave features are scattered, as the method uses the dynamic signal-to-noise ratio of the Taguchi method. In order to verify the effectiveness of the proposed method, we employed it to measure the systolic blood pressure. It could be confirmed that the estimation accuracy of the proposed method is higher than that of similar methods.	Wakayama Univ, Fac Syst Engn, Wakayama 6408510, Japan	Suzuki, A (reprint author), Wakayama Univ, Fac Syst Engn, Wakayama 6408510, Japan.	aratas@sys.wakayama-u.ac.jp					Amaritsakul Y, 2014, P I MECH ENG H, V228, P250, DOI 10.1177/0954411914522437; Wong MYM, 2009, CARDIOVASC ENG, V9, P32, DOI 10.1007/s10558-009-9070-7; GRIBBIN B, 1976, PSYCHOPHYSIOLOGY, V13, P86, DOI 10.1111/j.1469-8986.1976.tb03344.x; Takazawa K, 1998, HYPERTENSION, V32, P365; GLEASON WL, 1962, J CLIN INVEST, V41, P80, DOI 10.1172/JCI104469; MARCHAIS SJ, 1993, HYPERTENSION, V22, P876; Pantelopoulos A, 2010, IEEE T SYST MAN CY C, V40, P1, DOI 10.1109/TSMCC.2009.2032660; Suzuki A, 2014, IEEE T IND INFORM, V10, P1077, DOI 10.1109/TII.2013.2288498; HUGHES DJ, 1979, ULTRASONIC IMAGING, V1, P356, DOI 10.1016/0161-7346(79)90028-2; Chen W, 2000, MED BIOL ENG COMPUT, V38, P569, DOI 10.1007/BF02345755; Walker PS, 2010, P I MECH ENG H, V224, P393, DOI 10.1243/09544119JEIM655; Bortolotto LA, 2000, AM J HYPERTENS, V13, P165, DOI 10.1016/S0895-7061(99)00192-2; Cudney Elizabeth A., 2013, International Journal of Quality Engineering and Technology, V3; Elgendi Mohamed, 2012, Curr Cardiol Rev, V8, P14; Foo JYA, 2008, J ENG MED, V222, P1005; Fukushima H, 2013, IEEE ENG MED BIO, P2132, DOI 10.1109/EMBC.2013.6609955; Hsiu H, 2011, P I MECH ENG H, V225, P575, DOI 10.1177/0954411910396288; Hsiu H, 2008, P I MECH ENG H, V222, P773, DOI 10.1243/09544119JEIM349; Kernohan WG, 1991, J ENG MED, V205, P173; Padilla J., 2006, COMPUT CARDIOL, V33, P893; Sano Y., 1985, SCI LABOUR, V61, P129; Suzuki A, 2010, IEEE INTL CONF CONTR, P1374, DOI 10.1109/CCA.2010.5611231; Takada H, 1996, MED PROG TECHNOL, V21, P205, DOI 10.1023/A:1016936206694; Takada H, 2002, HEP, V29, P855; Teng XF, 2003, P ANN INT IEEE EMBS, V25, P3153; Vlachogiannis JG, 2003, P I MECH ENG H, V217, P375, DOI 10.1243/095441103770802540	26	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	JUL	2015	229	7					499	505		10.1177/0954411915587957		7	Engineering, Biomedical	Engineering	CL9LI	WOS:000357299700003		
J	Yarimitsu, S; Moro, T; Kyomoto, M; Watanabe, K; Tanaka, S; Ishihara, K; Murakami, T				Yarimitsu, Seido; Moro, Toru; Kyomoto, Masayuki; Watanabe, Kenichi; Tanaka, Sakae; Ishihara, Kazuhiko; Murakami, Teruo			Influences of dehydration and rehydration on the lubrication properties of phospholipid polymer-grafted cross-linked polyethylene	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						Artificial joint; MPC polymer; hydration lubrication; wear; friction	MOLECULAR-WEIGHT POLYETHYLENE; TOTAL HIP REPLACEMENTS; REVISION TOTAL HIP; HYDRATION LUBRICATION; UNITED-STATES; WEAR; JOINTS; ARTHROPLASTY; OSTEOLYSIS; RESISTANCE	Surface modification by grafting of biocompatible phospholipid polymer onto the surface of artificial joint material has been proposed to reduce the risk of aseptic loosening and improve the durability. Poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC)-grafted cross-linked polyethylene (CLPE) has shown promising results for reducing wear of CLPE. The main lubrication mechanism for the PMPC layer is considered to be the hydration lubrication. In this study, the lubrication properties of PMPC-grafted CLPE were evaluated in reciprocating friction test with rehydration process by unloading in various lubricants. The start-up friction of PMPC-grafted CLPE was reduced, and the damage of PMPC layer was suppressed by rehydration in water or hyaluronic acid solutions. In contrast, the start-up friction of PMPC-grafted CLPE increased in fetal bovine serum solution, and the damage for PMPC layer was quite noticeable. Interestingly, the start-up friction of PMPC-grafted CLPE was reduced in fetal bovine serum solution containing hyaluronic acid, and the damage of the PMPC layer was suppressed. These results indicate that the rehydration by unloading and hyaluronic acid are elemental in maximizing the lubrication effect of hydrated PMPC layer.	[Yarimitsu, Seido; Murakami, Teruo] Kyushu Univ, Res Ctr Adv Biomech, Fukuoka 812, Japan; [Yarimitsu, Seido] Tokyo Metropolitan Univ, Fac Syst Design, Tokyo 158, Japan; [Moro, Toru; Kyomoto, Masayuki; Watanabe, Kenichi] Univ Tokyo, Grad Sch Med, Div Sci Joint Reconstruct, Tokyo, Japan; [Moro, Toru; Tanaka, Sakae] Univ Tokyo, Fac Med, Sensory & Motor Syst Med, Tokyo 113, Japan; [Kyomoto, Masayuki; Ishihara, Kazuhiko] Univ Tokyo, Sch Engn, Dept Mat Engn, Tokyo, Japan; [Kyomoto, Masayuki; Watanabe, Kenichi] KYOCERA Med Corp, Res Dept, Osaka, Japan	Yarimitsu, S (reprint author), Tokyo Metropolitan Univ, Fac Syst Design, 6-6 Asahigaoka, Hino, Tokyo 1910065, Japan.	yarimitsu@tmu.ac.jp			Japanese Ministry of Health, Labour and Welfare [H23-007, H24-001, H26-006]	Part of this research was supported by the Health and Welfare Research Grants for Research on Publicly Essential Drugs and Medical Devices (H23-007), Research on Measures for Intractable Diseases (H24-001), and Research on Development of New Medical Devices (H26-006) from the Japanese Ministry of Health, Labour and Welfare.	Kurtz SM, 2011, CLIN ORTHOP RELAT R, V469, P2262, DOI 10.1007/s11999-011-1872-4; Takatori Y, 2015, MOD RHEUMATOL, V25, P286, DOI 10.3109/14397595.2014.941438; Takatori Y, 2013, J ARTIF ORGANS, V16, P170, DOI 10.1007/s10047-012-0681-1; Ikeuchi K, 2007, P I MECH ENG J-J ENG, V221, P301, DOI 10.1243/13506501JET214; Tomita N, 1999, J BIOMED MATER RES, V48, P474; Moro T, 2014, J ORTHOP RES, V32, P369, DOI 10.1002/jor.22526; Moro T, 2009, BIOMATERIALS, V30, P2995, DOI 10.1016/j.biomaterials.2009.02.020; Oral E, 2004, BIOMATERIALS, V25, P5515, DOI 10.1016/j.biomaterials.2003.12.048; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; Muratoglu OK, 2001, J ARTHROPLASTY, V16, P149, DOI 10.1054/arth.2001.20540; Kyomoto M, 2011, CLIN ORTHOP RELAT R, V469, P2327, DOI 10.1007/s11999-010-1718-5; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C; Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441; Oonishi H, 2001, J BIOMED MATER RES, V58, P167, DOI 10.1002/1097-4636(2001)58:2<167::AID-JBM1003>3.0.CO;2-A; ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355; Kyomoto M, 2012, BIOMATERIALS, V33, P4451, DOI 10.1016/j.biomaterials.2012.03.028; McKellop H, 1999, J ORTHOP RES, V17, P157, DOI 10.1002/jor.1100170203; Moro T, 2010, OSTEOARTHR CARTILAGE, V18, P1174, DOI 10.1016/j.joca.2010.05.019; Kyomoto M, 2007, J MATER SCI-MATER M, V18, P1809, DOI 10.1007/s10856-007-3063-0; Endo M, 2002, P I MECH ENG H, V216, P111, DOI 10.1243/0954411021536333; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Higaki H, 1998, P I MECH ENG H, V212, P337, DOI 10.1243/0954411981534114; Catelas Isabelle, 2010, Instr Course Lect, V59, P3; Ishikawa Y, 2000, P INT TRIB C NAG, V2, P1491; Sasada T., 2000, J JAPANESE SOC CLIN, V21, P17	25	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	JUL	2015	229	7					506	514		10.1177/0954411915588969		9	Engineering, Biomedical	Engineering	CL9LI	WOS:000357299700004		
J	Suzuki, S; Nozawa, Y; Tsukamoto, S; Kaneko, T; Imai, H; Minami, N				Suzuki, Shinnosuke; Nozawa, Yusuke; Tsukamoto, Satoshi; Kaneko, Takehito; Imai, Hiroshi; Minami, Naojiro			Histone methyltransferase Smyd3 regulates early embryonic lineage commitment in mice	REPRODUCTION			English	Article							EARLY MOUSE DEVELOPMENT; PRIMITIVE ENDODERM; GENE-EXPRESSION; STEM-CELLS; PREIMPLANTATION DEVELOPMENT; TRANSCRIPTIONAL REGULATION; CHROMATIN MODIFICATIONS; MAMMALIAN EMBRYO; CANCER-CELLS; METHYLATION	SET and MYND domain-containing protein 3 (Smyd3) is a histone H3 lysine 4 (H3K4) di- and tri-methyltransferase that forms a transcriptional complex with RNA polymerase II and activates the transcription of oncogenes and cell cycle genes in human cancer cells. However, the study of Smyd3 in mammalian early embryonic development has not yet been addressed. In the present study, we investigated the expression pattern of Smyd3 in mouse preimplantation embryos and the effects of RNA interference (RNAi)-mediated Smyd3 repression on the development of mouse embryos. We showed that Smyd3 mRNA levels increased after the two-cell stage, peaked at the four-cell stage, and gradually decreased thereafter. Moreover, in two-cell to eight-cell embryos, SMYD3 staining was more intense in the nuclei than it was in the cytoplasm. In Smyd3-knockdown embryos, the percentage of inner cell mass (ICM)-derived colony formation and trophectoderm (TE)-derived cell attachment were significantly decreased, which resulted in a reduction in the number of viable offspring. Furthermore, the expression of Oct4 and Cdx2 during mid-preimplantation gene activation was significantly decreased in Smyd3-knockdown embryos. In addition, the transcription levels of ICM and epiblast markers, such as Oct4, Nanog, and Sox2, the transcription levels of primitive endoderm markers, such as Gata6, and the transcription levels of TE markers, such as Cdx2 and Eomes, were significantly decreased in Smyd3-knockdown blastocysts. These findings indicate that SMYD3 plays an important role in early embryonic lineage commitment and peri-implantation development through the activation of lineage-specific genes.	[Suzuki, Shinnosuke; Nozawa, Yusuke; Imai, Hiroshi; Minami, Naojiro] Kyoto Univ, Grad Sch Agr, Reprod Biol Lab, Kyoto 6068052, Japan; [Tsukamoto, Satoshi] Natl Inst Radiol Sci, Anim Lab, Chiba 2638555, Japan; [Tsukamoto, Satoshi] Natl Inst Radiol Sci, Genome Sci Sect, Chiba 2638555, Japan; [Kaneko, Takehito] Kyoto Univ, Inst Lab Anim, Grad Sch Med, Kyoto 6068501, Japan	Minami, N (reprint author), Kyoto Univ, Grad Sch Agr, Reprod Biol Lab, Kyoto 6068052, Japan.	oog1nao@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science [23380164]	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant number 23380164 to N Minami).	Andreu-Vieyra CV, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000453; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Liu C, 2013, JNCI-J NATL CANCER I, V105, P1719, DOI 10.1093/jnci/djt304; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Lin SCJ, 2010, DEVELOPMENT, V137, P3953, DOI 10.1242/dev.054775; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Van Aller GS, 2012, EPIGENETICS-US, V7, P340, DOI 10.4161/epi.19506; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Frankenberg S, 2011, DEV CELL, V21, P1005, DOI 10.1016/j.devcel.2011.10.019; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Kang MJ, 2013, DEVELOPMENT, V140, P267, DOI 10.1242/dev.084996; Isaji Y, 2013, J REPROD DEVELOP, V59, P196, DOI 10.1262/jrd.2012-156; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Cock-Rada AM, 2012, CANCER RES, V72, P810, DOI 10.1158/0008-5472.CAN-11-1052; Sarmento OF, 2004, J CELL SCI, V117, P4449, DOI 10.1242/jcs.01328; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Chen LB, 2007, WORLD J GASTROENTERO, V13, P5718; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Medjkane S, 2012, CELL CYCLE, V11, P1865, DOI 10.4161/cc.20415; Yamada M, 2010, HUM MOL GENET, V19, P480, DOI 10.1093/hmg/ddp512; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Akiyama T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002279; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Schrode N, 2014, DEV CELL, V29, P454, DOI 10.1016/j.devcel.2014.04.011; Liu C, 2007, CANCER RES, V67, P2626, DOI 10.1158/0008-5472.CAN-06-4126; Rossant J, 2004, SEMIN CELL DEV BIOL, V15, P573, DOI 10.1016/j.semcdb.2004.04.003; Bi Y, 2011, BIOL REPROD, V84, P756, DOI 10.1095/biolreprod.110.084343; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Fujii T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023491; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Hosny NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074604; Jeong YJ, 2005, MOL REPROD DEV, V71, P284, DOI 10.1002/mrd.20269; Lepikhov Konstantin, 2004, BMC Dev Biol, V4, P12, DOI 10.1186/1471-213X-4-12; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; SCHULTZ RM, 1995, SEMIN CELL BIOL, V6, P201, DOI 10.1006/scel.1995.0028; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Suzuki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074749; Suzuki S, 2015, J REPROD DE IN PRESS, DOI [10.1262/jrd.2014-157, DOI 10.1262/JRD.2014-157]; Tsukamoto S, 2013, J REPROD DEVELOP, V59, P33; Xu Jun-Yao, 2006, Ai Zheng, V25, P526; Zou JN, 2009, CANCER LETT, V280, P78, DOI 10.1016/j.canlet.2009.02.015	55	1	1	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	1470-1626			REPRODUCTION	Reproduction	JUL	2015	150	1					21	30		10.1530/REP-15-0019		10	Developmental Biology; Reproductive Biology	Developmental Biology; Reproductive Biology	CM2FY	WOS:000357496500006		
J	Cao, Y; Zhu, KJ; Du, JZ; Liu, JS; Qiu, JH				Cao, Yang; Zhu, Kongjun; Du, Jianzhou; Liu, Jinsong; Qiu, Jinhao			Solvothermal synthesis of BaTiO3 nanoparticles from K2Ti6O13 precursors	RESEARCH ON CHEMICAL INTERMEDIATES			English	Article						K2Ti6O13 precursors; Ion exchange; Solvothermal; Barium titanate	BARIUM-TITANATE; HYDROTHERMAL SYNTHESIS; PARTICLES; NANOWIRES; NANOTUBES; SHAPE	BaTiO3 nanoparticles were prepared for the first time employing a solvothermal process from the synthetic precursors of K2Ti6O13 nano-whiskers. The obtained samples were characterized by X-ray diffraction, transmission electron microscopy, selected area electron diffraction, and high-resolution transmission electron microscopy, etc. The results indicate that well-crystallized single-phase BaTiO3 nanoparticles are synthesized using K2Ti6O13 as precursors under solvothermal conditions at as low as 0.9 M. The solvothermal method facilitates the crystallinity and formation of the BaTiO3 nanoparticles. However, the K+ ions cannot be completely replaced by Ba2+ by the hydrothermal method even at 10 M due to its unique and extremely stable "tunnel" structure. The solvothermal method provides new avenues for the ion-exchange synthesis of a variety of other perovskite-type materials such as MTiO3 (M = Pb, Sr, Ca, etc.).	[Cao, Yang; Zhu, Kongjun; Du, Jianzhou; Liu, Jinsong; Qiu, Jinhao] Nanjing Univ Aeronaut & Astronaut, State Key Lab Mech & Control Mech Struct, Coll Aerosp Engn, Nanjing 210016, Jiangsu, Peoples R China; [Cao, Yang] Tohoku Univ, Frontier Inst Interdisciplinary Sci, Sendai, Miyagi 9828578, Japan; [Liu, Jinsong] Nanjing Univ Aeronaut & Astronaut, Coll Mat Sci & Engn, Nanjing 210016, Jiangsu, Peoples R China	Zhu, KJ (reprint author), Nanjing Univ Aeronaut & Astronaut, State Key Lab Mech & Control Mech Struct, Coll Aerosp Engn, Nanjing 210016, Jiangsu, Peoples R China.	tsoyung@163.com; kjzhu@nuaa.edu.cn			National Nature Science Foundation of China (NSFC) [51372114]; NUAA Fundamental Research Funds [NP2013301]; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Nature Science Foundation of China (NSFC No. 51372114), the NUAA Fundamental Research Funds (No. NP2013301), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Gong JY, 2009, J MATER CHEM, V19, P1037, DOI 10.1039/b811523k; Li Y, 2009, J PHYS CHEM C, V113, P4386, DOI 10.1021/jp810805f; Zhu KJ, 2012, CRYSTENGCOMM, V14, P411, DOI 10.1039/c1ce06100c; Bao NZ, 2008, J PHYS CHEM C, V112, P8634, DOI 10.1021/jp802055a; Lott J, 2008, ADV MATER, V20, P3649, DOI 10.1002/adma.200800531; Frey MH, 1996, PHYS REV B, V54, P3158, DOI 10.1103/PhysRevB.54.3158; Schneller T, 2011, J MATER CHEM, V21, P7953, DOI 10.1039/c1jm10607d; Deng XY, 2006, J AM CERAM SOC, V89, P1059, DOI 10.1111/j.1551-2916.2005.00836.x; Liu PC, 2013, CRYSTENGCOMM, V15, P2753, DOI 10.1039/c3ce27085h; Maxim F, 2008, CRYST GROWTH DES, V8, P3309, DOI 10.1021/cg800215r; Ashiri R, 2011, MATER RES BULL, V46, P2291, DOI 10.1016/j.materresbull.2011.08.055; Feng Q, 2001, CHEM MATER, V13, P290, DOI 10.1021/cm000411e; Zhu KJ, 2009, CERAM INT, V35, P1947, DOI 10.1016/j.ceramint.2008.10.018; Joshi UA, 2005, SMALL, V1, P1172, DOI 10.1002/smll.200500055; Zheng HJ, 2013, J CRYST GROWTH, V363, P300, DOI 10.1016/j.jcrysgro.2012.11.019; Bao NZ, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3159817; Bao NZ, 2004, J AM CERAM SOC, V87, P326; Cao Y., ADV POWDER IN PRESS; Hu MZC, 2000, J MATER SCI, V35, P2927, DOI 10.1023/A:1004718508280	19	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	JUL	2015	41	7					4851	4859		10.1007/s11164-014-1571-3		9	Chemistry, Multidisciplinary	Chemistry	CL0DG	WOS:000356608700062		
J	Kataoka, M; Obara, Y; Kuruppu, M				Kataoka, M.; Obara, Y.; Kuruppu, M.			Estimation of Fracture Toughness of Anisotropic Rocks by Semi-Circular Bend (SCB) Tests Under Water Vapor Pressure	ROCK MECHANICS AND ROCK ENGINEERING			English	Article						Anisotropic rock; Elastic wave velocity; Mode I fracture toughness; Semi-circular bend (SCB) test; Water vapor pressure; X-ray CT method	CONFINING PRESSURE; CRACK-GROWTH; GRANITE; TEMPERATURE; ENVIRONMENTS; DEFORMATION; SPECIMENS	In order to investigate the influence of water vapor pressure in the surrounding environment on mode I fracture toughness (K-Ic) of rocks, semi-circular bend (SCB) tests under various water vapor pressures were conducted. Water vapor is one of the most effective agents which promote stress corrosion of rocks. The range of water vapor pressure used was 10(-2) to 10(3) Pa, and two anisotropic rock types, African granodiorite and Korean granite, were used in this work. The measurement of elastic wave velocity and observation of thin sections of these rocks were performed to investigate the microstructures of the rocks. It was found that the distribution of inherent microcracks and grains have a preferred orientation. Two types of specimens in different orientations, namely Type-1 and Type-3, were prepared based on the anisotropy identified by the differences in the elastic wave velocity. K-Ic of both rock types was dependent on the water vapor pressure in the surrounding environment and decreased with increasing water vapor pressure. It was found that the degree of the dependence is influenced by the orientation and density of inherent microcracks. The experimental results also showed that K-Ic depended on the material anisotropy. A fracture process was discussed on the basis of the geometry of fractures within fractured specimens visualized by the X-ray computed tomography (CT) method. It was concluded that the dominant factor causing the anisotropy of K-Ic is the distribution of grains rather than inherent microcracks in these rocks.	[Kataoka, M.; Obara, Y.] Kumamoto Univ, Chuo Ku, Kumamoto 8608555, Japan; [Kuruppu, M.] Curtin Univ, Kalgoorlie, WA 6433, Australia	Kataoka, M (reprint author), Kumamoto Univ, Chuo Ku, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	127d9401@st.kumamoto-u.ac.jp					Al-Shayea N, 2002, ROCK MECH ROCK ENG, V35, P271, DOI 10.1007/s00603-002-0027-z; Al-Shayea NA, 2000, INT J ROCK MECH MIN, V37, P629, DOI 10.1016/S1365-1609(00)00003-4; BARKER LM, 1977, ENG FRACT MECH, V9, P361, DOI 10.1016/0013-7944(77)90028-5; Funatsu T, 2004, INT J ROCK MECH MIN, V41, P927, DOI 10.1016/j.ijrmms.2004.02.008; [Anonymous], 2010, E11210 ASTM; FOWELL RJ, 1995, INT J ROCK MECH MIN, V32, P57, DOI 10.1016/0148-9062(94)00015-U; Tutluoglu L, 2011, INT J ROCK MECH MIN, V48, P1248, DOI 10.1016/j.ijrmms.2011.09.019; MEREDITH PG, 1985, PHYS EARTH PLANET IN, V39, P33, DOI 10.1016/0031-9201(85)90113-X; ATKINSON C, 1982, INT J FRACTURE, V18, P279; Atkinson BK, 1987, FRACT MECH ROCK, V2, P111; Chong K.P., 1984, INT J FRACTURE, V26, P59, DOI DOI 10.1007/BF01157555; Fowell RJ, 1990, P 31 US S ROCK MECH, P295; FREIMAN SW, 1984, J GEOPHYS RES, V89, P4072, DOI 10.1029/JB089iB06p04072; Jeong HS, 2007, INT J ROCK MECH MIN, V44, P321, DOI 10.1016/j.ijrmms.2006.07.009; Karfakis MG, 1986, P 1986 SEM SPRING C, P141; Kataoka M, 2013, J MMIJ, V129, P425; Kataoka M, 2013, P ISRM INT S EUROCK, P21; Kataoka M, 2014, P ROCKMEC 11 REG ROC, P91; Kataoka M, 2011, P ISRM 12 INT C ROCK, P667; Kataoka M, 2012, P 7 ARMS SEOUL KOR O, P458; Kudo Y, 1986, JSSMFE, V34, P47; KUDO Y, 1992, PURE APPL GEOPHYS, V138, P641, DOI 10.1007/BF00876342; Lee SE, 2001, MATER SCI RES INT, V7, P7; Mukunoki T, 2013, P 4 INT WORKSH XRAY; Nasseri MHB, 2008, INT J ROCK MECH MIN, V45, P167, DOI 10.1016/j.ijrmms.2007.04.005; Obara Y, 2007, P 11 ISRM INT C LISB, P51; Obara Y, 2006, P 4 ARMS SING NOV 20; Ouchterlony F, 1981, ASTM STP, V745, P237; Ouchterlony F, 1980, NEW CORE SPECIMEN FR; Ouchterlony F., 1988, INT J ROCK MECH MIN, V25, P71; SCHEDL A, 1986, TECTONOPHYSICS, V122, P149, DOI 10.1016/0040-1951(86)90164-2; Whittaker BN, 1992, DEV GEOTECHNICAL ENG	32	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0723-2632	1434-453X		ROCK MECH ROCK ENG	Rock Mech. Rock Eng.	JUL	2015	48	4			SI		1353	1367		10.1007/s00603-014-0665-y		15	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CL3XE	WOS:000356884500004		
J	Chen, YQ; Nagaya, Y; Ishida, T				Chen, Youqing; Nagaya, Yuya; Ishida, Tsuyoshi			Observations of Fractures Induced by Hydraulic Fracturing in Anisotropic Granite	ROCK MECHANICS AND ROCK ENGINEERING			English	Article						Anisotropy; Granite; Hydraulic fracturing; Fracture; Microscopic observation; Fluid viscosity	SANDSTONE; AQUIFER	To investigate how the viscosity of the fracturing fluid affects fracture propagation, hydraulic fracturing experiments using three fluids with different viscosities (supercritical CO2, water, and viscous oil) under the true tri-axial condition were conducted on anisotropic granite specimens, and then the induced fractures were microscopically observed via a fluorescent method. Fractures induced by hydraulic fracturing are considerably tortuous from a microscopic view. A higher viscosity creates a smoother fracture pattern. The tortuosity, which is defined as the total fracture length along a pathway divided by the direct length of the two ends of a fracture, ranges from 1.05 to 1.13, demonstrating that the viscosity of fracturing fluid influences the fracture propagation pattern due to the different pathways of fracture propagation. In addition, hydraulic fracturing can induce many derivative pathways around the main fracture. Hydraulic fracturing with a lower viscosity fluid forms a more complex fracture network in rocks; the fracture induced by supercritical CO2 has the most branches along the main fracture. From these observations, fracture propagation by hydraulic fracturing sometimes develops by the shear fracture mode. This shear fracturing is often observed for a low-viscosity supercritical CO2 injection, which agrees with our results from AE monitoring and waveform analysis.	[Chen, Youqing] Kyoto Univ, Grad Sch Energy Sci, Dept Energy Sci & Technol, Sakyo Ku, Kyoto 6068501, Japan; [Nagaya, Yuya; Ishida, Tsuyoshi] Kyoto Univ, Grad Sch Engn, Dept Civil & Earth Resources Engn, Kyoto 6068501, Japan	Chen, YQ (reprint author), Kyoto Univ, Grad Sch Energy Sci, Dept Energy Sci & Technol, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	chen@energy.kyoto-u.ac.jp			Japan Society for the Promotion of Science [21360446, 25249131]; ENEOS Hydrogen Trust	This work was financially supported by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (B) and (A), Grand Numbers 21360446 and 25249131, as well as by the ENEOS Hydrogen Trust Fund of 2012.	Chen YQ, 2011, ENG GEOL, V117, P189, DOI 10.1016/j.enggeo.2010.10.017; Ishida T, 2004, J ENERG RESOUR-ASME, V126, P190, DOI 10.1115/1.1791651; SAHIMI M, 1993, PHYS REV LETT, V70, P2186, DOI 10.1103/PhysRevLett.70.2186; HILL DP, 1977, J GEOPHYS RES, V82, P1347, DOI 10.1029/JB082i008p01347; Xue ZQ, 2006, EXPLOR GEOPHYS, V37, P19, DOI 10.1071/EG06019; Ishida T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052788; Brown D W, 2000, P 25 WORKSH GEOTH RE; [CHEN Youqing 陈友晴], 2008, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V27, P2440; Chen YQ, 2001, RESOUR GEOL, V51, P249, DOI 10.1111/j.1751-3928.2001.tb00096.x; HIRATA T, 1987, GEOPHYS J INT, V90, P369, DOI 10.1111/j.1365-246X.1987.tb00732.x; Inui S, 2014, P ARMA 2014 MINN MN; Ishida T, 2013, ROCK MECHANICS FOR RESOURCES, ENERGY AND ENVIRONMENT, P957; Kalantari-Dahaghi A, 2010, INT C CO2 CAPT STOR; Liao S, 2009, P CAN INT PETR C; Nishiyama T, 2002, ENG GEOL, V66, P257, DOI 10.1016/S0013-7952(02)00046-7; NISHIYAMA T, 1994, INT J ROCK MECH MIN, V31, P369, DOI 10.1016/0148-9062(94)90904-0; SINAL ML, 1987, J CAN PETROL TECHNOL, V26, P26; Spetzler J, 2008, GEOPHYS J INT, V172, P214, DOI 10.1111/J.1365-246X.2007.03614.x	18	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0723-2632	1434-453X		ROCK MECH ROCK ENG	Rock Mech. Rock Eng.	JUL	2015	48	4			SI		1455	1461		10.1007/s00603-015-0727-9		7	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CL3XE	WOS:000356884500010		
J	Bennour, Z; Ishida, T; Nagaya, Y; Chen, YQ; Nara, Y; Chen, Q; Sekine, K; Nagano, Y				Bennour, Ziad; Ishida, Tsuyoshi; Nagaya, Yuya; Chen, Youqing; Nara, Yoshitaka; Chen, Qu; Sekine, Kotaro; Nagano, Yu			Crack Extension in Hydraulic Fracturing of Shale Cores Using Viscous Oil, Water, and Liquid Carbon Dioxide	ROCK MECHANICS AND ROCK ENGINEERING			English	Article						Anisotropy; Acoustic emissions; Shale; Hydraulic fracturing; Carbon dioxide; Viscosity	STRESS; ROCK	We performed hydraulic fracturing experiments on cylindrical cores of anisotropic shale obtained by drilling normal to the sedimentary plane. Experiments were conducted under ambient condition and uniaxial stresses, using three types of fracturing fluid: viscous oil, water, and liquid carbon dioxide (L-CO2). In the experiments using water and oil, cracks extended along the loading direction normal to the sedimentary plane under the uniaxial loading and extended along the sedimentary plane without loading. These results suggest that the direction of crack extension is strongly affected by in situ stress conditions. Fluorescent microscopy revealed that hydraulic fracturing with viscous oil produced linear cracks with few branches, whereas that with water produced cracks with many branches inclining from the loading axis. Statistical analysis of P wave polarity of acoustic emission waveforms showed that viscous oil tended to induce Mode I fracture, whereas both water and L-CO2 tended to induce Mode II fracture. Crack extension upon injection of L-CO2 was independent of loading condition unlike extension for the other two fluids. This result seemed attributable to the low viscosity of L-CO2 and was consistent with previous observations for granite specimens that low-viscosity fluids like CO2 tend to induce widely extending cracks with many branches, with Mode II fractures being dominant. These features are more advantageous for shale gas production than those induced by injection of conventional slick water.	[Bennour, Ziad; Ishida, Tsuyoshi; Nagaya, Yuya; Nara, Yoshitaka] Kyoto Univ, Grad Sch Engn, Dept Civil & Earth Resources Engn, Nishikyo Ku, Kyoto 6158540, Japan; [Chen, Youqing] Kyoto Univ, Grad Sch Energy Sci, Dept Energy Sci & Technol, Kyoto 6158540, Japan; [Chen, Qu] 3D Geosci Inc, Tokyo, Japan; [Sekine, Kotaro; Nagano, Yu] Japan Oil Gas & Met Natl Corp, Chiba, Japan	Ishida, T (reprint author), Kyoto Univ, Grad Sch Engn, Dept Civil & Earth Resources Engn, Nishikyo Ku, Kyoto 6158540, Japan.	ishida.tsuyoshi.2a@kyoto-u.ac.jp					Amadei B, 1977, ROCK STRESS ITS MEAS; ZOBACK MD, 1977, INT J ROCK MECH MIN, V14, P49, DOI 10.1016/0148-9062(77)90196-6; Ishida T, 2004, J ENERG RESOUR-ASME, V126, P190, DOI 10.1115/1.1791651; Haimson BC, 2003, INT J ROCK MECH MIN, V40, P1011, DOI 10.1016/j.ijrmms.2003.08.002; Graham CC, 2010, INT J ROCK MECH MIN, V47, P161, DOI 10.1016/j.ijrmms.2009.05.002; Zang AR, 1998, GEOPHYS J INT, V135, P1113, DOI 10.1046/j.1365-246X.1998.00706.x; HUBBERT MK, 1957, T AM I MIN MET ENG, V210, P153; Ishida T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052788; Arthur JD, 2008, P GROUND WAT PROT CO; Cleary J, 1958, 252 DIV ILL STAT GEO, V252; Ishida T, 2013, ROCK MECHANICS FOR RESOURCES, ENERGY AND ENVIRONMENT, P957; Kalantari-Dahaghi A, 2010, P INT C CO2 CAPT STO; NISHIYAMA T, 1994, INT J ROCK MECH MIN, V31, P369, DOI 10.1016/0148-9062(94)90904-0; Nuttall BC, 2006, P 5 ANN C CARB CAPT; SCHMITT DR, 1989, INT J ROCK MECH MIN, V26, P499, DOI 10.1016/0148-9062(89)91427-7; Sun KM, 2012, PROCEDIA ENVIRON SCI, V12, P736, DOI 10.1016/j.proenv.2012.01.342; Zang A, 2010, STRESS FIELD OF THE EARTHS CRUST, P1, DOI 10.1007/978-1-4020-8444-7	17	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0723-2632	1434-453X		ROCK MECH ROCK ENG	Rock Mech. Rock Eng.	JUL	2015	48	4			SI		1463	1473		10.1007/s00603-015-0774-2		11	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CL3XE	WOS:000356884500011		
J	Kimura, H; Saitoh, M; Kobayashi, M; Ishii, H; Saraya, T; Kurai, D; Tsukagoshi, H; Shirabe, K; Nishina, A; Kozawa, K; Kuroda, M; Takeuchi, F; Sekizuka, T; Minakami, H; Ryo, A; Takeda, M				Kimura, Hirokazu; Saitoh, Mika; Kobayashi, Miho; Ishii, Haruyuki; Saraya, Takeshi; Kurai, Daisuke; Tsukagoshi, Hiroyuki; Shirabe, Komei; Nishina, Atsuyoshi; Kozawa, Kunihisa; Kuroda, Makoto; Takeuchi, Fumihiko; Sekizuka, Tsuyoshi; Minakami, Hisanori; Ryo, Akihide; Takeda, Makoto			Molecular evolution of haemagglutinin (H) gene in measles virus	SCIENTIFIC REPORTS			English	Article							GLYCOPROTEIN G GENE; B-CELL RESPONSE; PROTEIN; SELECTION; ANTIBODIES; EPITOPES; SITES; NEUTRALIZATION; ENCEPHALITIS; POPULATION	We studied the molecular evolution of the haemagglutinin (H) gene (full length) in all genotypes (24 genotypes, 297 strains) of measles virus (MeV). The gene's evolutionary timescale was estimated by the Bayesian Markov chain Monte Carlo (MCMC) method. We also analysed positive selection sites. The MCMC tree indicated that the MeV H gene diverged from the rinderpest virus (same genus) about 250 years ago and that 24 MeV genotypes formed 3 lineages dating back to a 1915 ancestor (95% highest posterior density [HPD] 1882-1941) with relatively rapid evolution (mean rate: 9.02 x 10(-4) substitutions/site/year). The 3 lineages diverged in 1915 (lineage 1, 95% HPD 1882-1941), 1954 (lineage 2, 95% HPD 1937-1969), and 1940 (lineage 3, 95% HPD 1927-1952). These 24 genotypes may have diverged and emerged between the 1940s and 1990s. Selective pressure analysis identified many negative selection sites on the H protein but only a few positive selection sites, suggesting strongly operated structural and/or functional constraint of changes on the H protein. Based on the molecular evolution of H gene, an ancestor MeV of the 24 genotypes emerged about 100 years ago and the structure of H protein has been well conserved.	[Kimura, Hirokazu] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Musashimurayama, Tokyo 2080011, Japan; [Kimura, Hirokazu; Ryo, Akihide] Yokohama City Univ, Grad Sch Med, Dept Mol Biodef Res, Yokohama, Kanagawa 2360004, Japan; [Saitoh, Mika; Kobayashi, Miho; Tsukagoshi, Hiroyuki; Kozawa, Kunihisa] Gunma Prefectural Inst Publ Hlth & Environm Sci, Maebashi, Gumma 3710052, Japan; [Ishii, Haruyuki; Saraya, Takeshi; Kurai, Daisuke] Kyorin Univ, Sch Med, Dept Resp Med, Mitaka, Tokyo 1810004, Japan; [Shirabe, Komei] Yamaguchi Prefectural Inst Publ Hlth & Environm, Yamaguchi, Yamaguchi 7530821, Japan; [Nishina, Atsuyoshi] Nihon Univ, Coll Sci & Technol, Chiyoda Ku, Tokyo 1018308, Japan; [Kuroda, Makoto; Takeuchi, Fumihiko; Sekizuka, Tsuyoshi] Natl Inst Infect Dis, Pathogen Genom Ctr, Musashimurayama, Tokyo 2080011, Japan; [Minakami, Hisanori] Hokkaido Univ, Grad Sch Med, Dept Obstet, Sapporo, Hokkaido 0608638, Japan; [Takeda, Makoto] Natl Inst Infect Dis, Dept Virol 3, Musashimurayama, Tokyo 2080011, Japan	Kimura, H (reprint author), Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Musashimurayama, Tokyo 2080011, Japan.	kimhiro@nih.go.jp; mtakeda@nih.go.jp			Japan Society for the Promotion of Science; Japanese Ministry of Health, Labour and Welfare [H25-Shinko-Ippan-010]; Japan Agency for Medical Research and Development	This work was partly supported by a Grant-in-Aid from the Japan Society for the Promotion of Science and for Research on Emerging and Re-emerging Infectious Diseases from the Japanese Ministry of Health, Labour and Welfare (H25-Shinko-Ippan-010) and Japan Agency for Medical Research and Development.	Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Hirano E, 2014, INFECT GENET EVOL, V28, P183, DOI 10.1016/j.meegid.2014.09.030; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; de Swart RL, 2005, J VIROL, V79, P11547, DOI 10.1128/JVI.79.17.11547-11551.2005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Kushibuchi I, 2013, INFECT GENET EVOL, V18, P168, DOI 10.1016/j.meegid.2013.05.010; [Anonymous], 2014, WKLY EPIDEMIOL REC, V89, P509; Woelk CH, 2001, J GEN VIROL, V82, P2463; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Munoz-Alia MA, 2015, VIRUS RES, V196, P122, DOI 10.1016/j.virusres.2014.11.015; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103; Rota PA, 2011, J INFECT DIS, V204, pS514, DOI 10.1093/infdis/jir118; Bouche FB, 2002, VIRAL IMMUNOL, V15, P451, DOI 10.1089/088282402760312331; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; Domingo E., 2007, FIELDS VIROLOGY, V1, P389; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ertl OT, 2003, ARCH VIROL, V148, P2195, DOI 10.1007/s00705-003-0159-9; Fournier P, 1997, J GEN VIROL, V78, P1295; Furuse Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-52; Griffin DE, 2007, FIELDS VIROLOGY, V1, P1551; HU AZ, 1993, VIROLOGY, V192, P351, DOI 10.1006/viro.1993.1042; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; LIEBERT UG, 1994, J VIROL, V68, P1486; Loewe L., 2008, NATURE ED, V1, P59; Masse N, 2004, J VIROL, V78, P9051, DOI 10.1128/JVI.78.17.9051-9063.2004; Rambaut A, 2013, TRACER; Rima BK, 1997, J GEN VIROL, V78, P97; ROSEN L, 1961, VIROLOGY, V13, P139, DOI 10.1016/0042-6822(61)90042-3; Saitoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050660; Suzuki Y, 2004, GENE, V328, P127, DOI 10.1016/j.gene.2003.11.020; Tahara M, 2013, J VIROL, V87, P666, DOI 10.1128/JVI.02033-12; Tahara M, 2013, J VIROL, V87, P3583, DOI 10.1128/JVI.03029-12; World Health Organization, 2014, DISTR MEASL GEN JAN; World Health Organization, 2014, IMM VACC BIOL MEASL; Xu ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073374; Yamaguchi M, 2011, J CLIN MICROBIOL, V49, P1034, DOI 10.1128/JCM.02132-10; Ziegler D, 1996, J GEN VIROL, V77, P2479, DOI 10.1099/0022-1317-77-10-2479	42	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 1	2015	5								11648	10.1038/srep11648		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CL7QJ	WOS:000357166500001		
J	Poonperm, R; Takata, H; Hamano, T; Matsuda, A; Uchiyama, S; Hiraoka, Y; Fukui, K				Poonperm, Rawin; Takata, Hideaki; Hamano, Tohru; Matsuda, Atsushi; Uchiyama, Susumu; Hiraoka, Yasushi; Fukui, Kiichi			Chromosome Scaffold is a Double-Stranded Assembly of Scaffold Proteins	SCIENTIFIC REPORTS			English	Article							TOPOISOMERASE-II-ALPHA; MITOTIC CHROMOSOME; METAPHASE CHROMOSOMES; CONDENSIN-II; MICROSCOPY; MODEL; ARCHITECTURE; SEGREGATION	Chromosome higher order structure has been an enigma for over a century. The most important structural finding has been the presence of a chromosome scaffold composed of non-histone proteins; so-called scaffold proteins. However, the organization and function of the scaffold are still controversial. Here, we use three dimensional-structured illumination microscopy (3D-SIM) and focused ion beam/scanning electron microscopy (FIB/SEM) to reveal the axial distributions of scaffold proteins in metaphase chromosomes comprising two strands. We also find that scaffold protein can adaptably recover its original localization after chromosome reversion in the presence of cations. This reversion to the original morphology underscores the role of the scaffold for intrinsic structural integrity of chromosomes. We therefore propose a new structural model of the chromosome scaffold that includes twisted double strands, consistent with the physical properties of chromosomal bending flexibility and rigidity. Our model provides new insights into chromosome higher order structure.	[Poonperm, Rawin; Takata, Hideaki; Hamano, Tohru; Uchiyama, Susumu; Fukui, Kiichi] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan; [Takata, Hideaki] Osaka Univ, Grad Sch Engn, Frontier Res Base Global Young Researchers, Suita, Osaka 5650871, Japan; [Matsuda, Atsushi; Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Matsuda, Atsushi; Hiraoka, Yasushi] Natl Inst Informat & Commun Technol, Adv ICT Res Inst Kobe, Nishi Ku, Kobe, Hyogo 6512492, Japan	Fukui, K (reprint author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kfukui@bio.eng.osaka-u.ac.jp			JSPS KAKENHI Grant [A21248040, A25252064]	This work was supported by funding from JSPS KAKENHI Grants A21248040 and A25252064 to K.F. We thank Zeiss for the use and operation of the FIB/SEM system.	Almagro S, 2004, J BIOL CHEM, V279, P5118, DOI 10.1074/jbc.M307221200; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Spence JM, 2007, J CELL SCI, V120, P3952, DOI 10.1242/jcs.013730; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Samejima K, 2012, J CELL BIOL, V199, P755, DOI 10.1083/jcb.201202155; Uchiyama S, 2005, J BIOL CHEM, V280, P16994, DOI 10.1074/jbc.M412774200; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; EARNSHAW WC, 1983, J CELL BIOL, V96, P84, DOI 10.1083/jcb.96.1.84; Hudson DF, 2003, DEV CELL, V5, P323, DOI 10.1016/S1534-5807(03)00199-0; Schroeder-Reiter E, 2009, J STRUCT BIOL, V165, P97, DOI 10.1016/j.jsb.2008.10.002; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Cano S, 2006, EUR BIOPHYS J BIOPHY, V35, P495, DOI 10.1007/s00249-006-0057-7; Cole A., 1967, THEOR BIOPHYS, V1, P305; Hart CM, 1998, CURR OPIN GENET DEV, V8, P519, DOI 10.1016/S0959-437X(98)80005-1; Hayama Ryo, 2010, Proc Natl Acad Sci U S A, V107, P18826, DOI 10.1073/pnas.1008140107; Houchmandzadeh B, 1999, J CELL BIOL, V145, P215, DOI 10.1083/jcb.145.2.215; Maeshima K, 2005, CHROMOSOMA, V114, P365, DOI 10.1007/s00412-005-0023-7; Nishikawa J, 2013, NUCLEIC ACIDS RES, V41, P1544, DOI 10.1093/nar/gks1269; Poirier MG, 2002, P NATL ACAD SCI USA, V99, P15393, DOI 10.1073/pnas.232442599; SAITOH Y, 1993, COLD SPRING HARB SYM, V58, P755; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Tang SJ, 2011, GENES-BASEL, V2, P661, DOI 10.3390/genes2040661	28	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 1	2015	5								11916	10.1038/srep11916		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CL9DT	WOS:000357276400001		
J	Shimizu, R; Dempo, Y; Nakayama, Y; Nakamura, S; Bamba, T; Fukusaki, E; Fukui, T				Shimizu, Rie; Dempo, Yudai; Nakayama, Yasumune; Nakamura, Satoshi; Bamba, Takeshi; Fukusaki, Eiichiro; Fukui, Toshiaki			New Insight into the Role of the Calvin Cycle: Reutilization of CO2 Emitted through Sugar Degradation	SCIENTIFIC REPORTS			English	Article							RALSTONIA-EUTROPHA H16; POLYHYDROXYALKANOATE PRODUCTION; ALCALIGENES-EUTROPHUS; METABOLIC TURNOVER; GENE DELETION; FIXATION; PATHWAY; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE); ASSIMILATION; RUBISCO	Ralstonia eutropha is a facultative chemolithoautotrophic bacterium that uses the Calvin-Benson-Bassham (CBB) cycle for CO2 fixation. This study showed that R. eutropha strain H16G incorporated (CO2)-C-13, emitted by the oxidative decarboxylation of [1-C-13(1)]-glucose, into key metabolites of the CBB cycle and finally into poly(3-hydroxybutyrate) [P(3HB)] with up to 5.6% C-13 abundance. The carbon yield of P(3HB) produced from glucose by the strain H16G was 1.2 times higher than that by the CBB cycle-inactivated mutants, in agreement with the possible fixation of CO2 estimated from the balance of energy and reducing equivalents through sugar degradation integrated with the CBB cycle. The results proved that the 'gratuitously' functional CBB cycle in R. eutropha under aerobic heterotrophic conditions participated in the reutilization of CO2 emitted during sugar degradation, leading to an advantage expressed as increased carbon yield of the storage compound. This is a new insight into the role of the CBB cycle, and may be applicable for more efficient utilization of biomass resources.	[Shimizu, Rie; Nakamura, Satoshi; Fukui, Toshiaki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Dempo, Yudai; Nakayama, Yasumune; Bamba, Takeshi; Fukusaki, Eiichiro] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan	Fukui, T (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Bioengn, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	tfukui@bio.titech.ac.jp	福居, 俊昭/K-5056-2012		JSPS KAKENHI [25292058, 26011292]; Solutions Research Laboratory of Tokyo Institute of Technology	We thank Asssoc. Prof. T. Tsuge and Dr. A. Hiroe (Department of Innovative and engineered Materials, Interdisciplinary Graduate School of Science and Engineering, Tokyo Institute of Technology, Japan) for GC-MS analysis. This work was supported by JSPS KAKENHI Grant Numbers 25292058 and 26011292, and Solutions Research Laboratory of Tokyo Institute of Technology.	Bowien B, 2002, ARCH MICROBIOL, V178, P85, DOI 10.1007/s00203-002-0441-3; Kusian B, 1997, FEMS MICROBIOL REV, V21, P135, DOI 10.1111/j.1574-6976.1997.tb00348.x; Matsumura H, 2011, STRUCTURE, V19, P1846, DOI 10.1016/j.str.2011.08.016; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; BOWIEN B, 1990, FEMS MICROBIOL LETT, V87, P445, DOI 10.1111/j.1574-6968.1990.tb04951.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Putri SP, 2013, J BIOSCI BIOENG, V115, P579, DOI 10.1016/j.jbiosc.2012.12.007; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Kato M, 1996, APPL MICROBIOL BIOT, V45, P363; Clasquin MF, 2011, CELL, V145, P969, DOI 10.1016/j.cell.2011.05.022; Mifune J, 2010, POLYM DEGRAD STABIL, V95, P1305, DOI 10.1016/j.polymdegradstab.2010.02.026; Chinen A, 2007, J BIOSCI BIOENG, V103, P262, DOI 10.1263/jbb.103.262; FRIEDRICH CG, 1981, J GEN MICROBIOL, V122, P69; Tamoi M, 2005, PLANT J, V42, P504, DOI 10.1111/j.1365-313X.2005.02391.x; Grzeszik C, 2000, J MOL MICROB BIOTECH, V2, P311; Budde CF, 2011, APPL ENVIRON MICROB, V77, P2847, DOI 10.1128/AEM.02429-10; Orita I, 2012, J BIOSCI BIOENG, V113, P63, DOI 10.1016/j.jbiosc.2011.09.014; Hasunuma T, 2010, J EXP BOT, V61, P1041, DOI 10.1093/jxb/erp374; Brigham CJ, 2012, APPL ENVIRON MICROB, V78, P8033, DOI 10.1128/AEM.01693-12; Kawashima Y, 2012, APPL ENVIRON MICROB, V78, P493, DOI 10.1128/AEM.06937-11; Schurmann P, 2000, ANNU REV PLANT PHYS, V51, P371, DOI 10.1146/annurev.arplant.51.1.371; Boller A. J., 2012, THESIS U S FLORIDA; Dempo Yudai, 2014, Metabolites, V4, P499, DOI 10.3390/metabo4020499; Fukui T, 2014, METABOLOMICS, V10, P190, DOI 10.1007/s11306-013-0567-0; Guadalupe-Medina V, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-125; Horken KM, 1999, ARCH BIOCHEM BIOPHYS, V361, P183, DOI 10.1006/abbi.1998.0979; Insomphun C, 2015, METAB ENG, V27, P38, DOI 10.1016/j.ymben.2014.10.006; Insomphun C, 2014, J BIOSCI BIOENG, V117, P184, DOI [10.1016/j.jbiosc.2013.07.016, 10.1016/j.biosc.2013.07.016]; Jeffke T, 1999, J BACTERIOL, V181, P4374; Nakayama Y, 2014, J BIOSCI BIOENG, V118, P350, DOI 10.1016/j.jbiosc.2014.02.014; Parry MAJ, 1997, PLANT CELL ENVIRON, V20, P528, DOI 10.1046/j.1365-3040.1997.d01-85.x; Peplinski K, 2010, MICROBIOL-SGM, V156, P2136, DOI 10.1099/mic.0.038380-0; Shimizu R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-169; WOODROW IE, 1988, ANNU REV PLANT PHYS, V39, P533, DOI 10.1146/annurev.arplant.39.1.533	34	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 1	2015	5								11617	10.1038/srep11617		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CL7PX	WOS:000357165300001		
J	Tanabe, Y; Okazaki, Y; Yoshida, M; Matsuura, H; Kai, A; Shiratori, T; Ishida, K; Nakano, S; Watanabe, MM				Tanabe, Yuuhiko; Okazaki, Yusuke; Yoshida, Masaki; Matsuura, Hiroshi; Kai, Atsushi; Shiratori, Takashi; Ishida, Ken-ichiro; Nakano, Shin-ichi; Watanabe, Makoto M.			A novel alphaproteobacterial ectosymbiont promotes the growth of the hydrocarbon-rich green alga Botryococcus braunii	SCIENTIFIC REPORTS			English	Article							BACTERIAL COMMUNITIES; PHYTOPLANKTON BLOOM; MAXIMUM-LIKELIHOOD; MARINE-BACTERIA; SP NOV.; STRAIN; GEN.; IDENTIFICATION; VITAMIN-B-12; POPULATIONS	Botryococcus braunii is a colony-forming green alga that accumulates large amounts of liquid hydrocarbons within the colony. The utilization of B. braunii for biofuel production is however hindered by its low biomass productivity. Here we describe a novel bacterial ectosymbiont (BOTRYCO-2) that confers higher biomass productivity to B. braunii. 16S rDNA analysis indicated that the sequence of BOTRYCO-2 shows low similarity (< 90%) to cultured bacterial species and located BOTRYCO-2 within a phylogenetic lineage consisting of uncultured alphaproteobacterial clones. Fluorescence in situ hybridization (FISH) studies and transmission electric microscopy indicated that BOTRYCO-2 is closely associated with B. braunii colonies. Interestingly, FISH analysis of a water bloom sample also found BOTRYCO-2 bacteria in close association with cyanobacterium Microcystis aeruginosa colonies, suggesting that BOTRYCO-2 relatives have high affinity to phytoplankton colonies. A PCR survey of algal bloom samples revealed that the BOTRYCO-2 lineage is commonly found in Microcystis associated blooms. Growth experiments indicated that B. braunii Ba10 can grow faster and has a higher biomass (1.8-fold) and hydrocarbon (1.5-fold) yield in the presence of BOTRYCO-2. Additionally, BOTRYCO-2 conferred a higher biomass yield to BOT-22, one of the fastest growing strains of B. braunii. We propose the species name 'Candidatus Phycosocius bacilliformis' for BOTRYCO-2.	[Tanabe, Yuuhiko; Yoshida, Masaki; Matsuura, Hiroshi; Kai, Atsushi; Ishida, Ken-ichiro; Watanabe, Makoto M.] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 305, Japan; [Okazaki, Yusuke; Nakano, Shin-ichi] Kyoto Univ, Ctr Ecol Res, Kyoto 6068501, Japan; [Shiratori, Takashi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan	Tanabe, Y (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 305, Japan.	tanabe.yuuhiko.fn@u.tsukuba.ac.jp	Matsuura, Hiroshi/B-3970-2013		Core Research of Evolutional Science & Technology program (CREST) from the Japan Science and Technology Agency (JST); Global Environment Research Fund of the Ministry of the Environment, Japan [D-0905]; Next-generation Energies for Tohoku Recovery (NET) Project from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	We thank Masahiro Koide for his help in taking microphotographs, Mikihide Demura and Masanobu Kawachi for providing the 18S rDNA alignment of B. braunii, Natsuki Yonezawa and Shou Kato for their help in cultivation of B. braunii, Nanda Kyaw Thu and Moat War Dai Naw for their help in collecting bloom samples in Myanmar and Shinya Fukuda for helpful advice on revising the ms. This work was financially supported by the Core Research of Evolutional Science & Technology program (CREST) from the Japan Science and Technology Agency (JST), by the Global Environment Research Fund (D-0905) of the Ministry of the Environment, Japan, and by the Next-generation Energies for Tohoku Recovery (NET) Project from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	AARONSON S, 1983, J PLANKTON RES, V5, P693, DOI 10.1093/plankt/5.5.693; Abraham WR, 2004, INT J SYST EVOL MICR, V54, P1227, DOI 10.1099/ijs.0.02943-0; Abraham WR, 2002, INT J SYST EVOL MICR, V52, P2191, DOI 10.1099/ijs.0.02248-0; Kuo RC, 2013, PROTIST, V164, P60, DOI 10.1016/j.protis.2012.08.004; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Abraham WR, 1999, INT J SYST BACTERIOL, V49, P1053; Yoshimura T, 2013, BIORESOURCE TECHNOL, V133, P232, DOI 10.1016/j.biortech.2013.01.095; Geng HF, 2010, CURR OPIN BIOTECH, V21, P332, DOI 10.1016/j.copbio.2010.03.013; KIRCHMAN DL, 1991, NATURE, V352, P612, DOI 10.1038/352612a0; Okazaki Y, 2013, FEMS MICROBIOL ECOL, V83, P82, DOI 10.1111/j.1574-6941.2012.01451.x; Behrens S, 2003, APPL ENVIRON MICROB, V69, P1748, DOI 10.1128/AEM.69.3.1748-1758.2003; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Tang YZ, 2010, P NATL ACAD SCI USA, V107, P20756, DOI 10.1073/pnas.1009566107; CHIRAC C, 1985, J PHYCOL, V21, P380; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Thu NK, 2012, PHYCOLOGIA, V51, P672, DOI 10.2216/11-130.1; Grossart HP, 1999, AQUAT MICROB ECOL, V19, P1, DOI 10.3354/ame019001; Bruhn JB, 2007, APPL ENVIRON MICROB, V73, P442, DOI 10.1128/AEM.02238-06; Amin SA, 2009, P NATL ACAD SCI USA, V106, P17071, DOI 10.1073/pnas.0905512106; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; Kodama M, 2006, ECOL STU AN, V189, P243, DOI 10.1007/978-3-540-32210-8_19; Seyedsayamdost MR, 2011, NAT CHEM, V3, P331, DOI [10.1038/nchem.1002, 10.1038/NCHEM.1002]; Vraspir JM, 2009, ANNU REV MAR SCI, V1, P43, DOI 10.1146/annurev.marine.010908.163712; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Parveen B, 2013, ENV MICROBIOL REP, V5, P716, DOI 10.1111/1758-2229.12071; GRIMME LH, 1972, BIOCHEM BIOPH RES CO, V49, P1617, DOI 10.1016/0006-291X(72)90527-X; MOUGET JL, 1995, FEMS MICROBIOL ECOL, V18, P35, DOI 10.1016/0168-6496(95)00038-C; Schattenhofer M, 2009, ENVIRON MICROBIOL, V11, P2078, DOI 10.1111/j.1462-2920.2009.01929.x; BELL W, 1972, BIOL BULL, V143, P265, DOI 10.2307/1540052; Weiss TL, 2012, EUKARYOT CELL, V11, P1424, DOI 10.1128/EC.00184-12; Morris JJ, 2008, APPL ENVIRON MICROB, V74, P4530, DOI 10.1128/AEM.02479-07; Rivas MO, 2010, MICROB ECOL, V60, P628, DOI 10.1007/s00248-010-9686-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Biegala IC, 2002, J PHYCOL, V38, P404, DOI 10.1046/j.1529-8817.2002.01045.x; Carmichael W. W., 1996, TOXIC MICROCYSTIS, P1; Chisti Y., 2007, BIOTECHNOL ADV, V25, P94; Doucette Gregory J., 1995, Natural Toxins, V3, P65, DOI 10.1002/nt.2620030202; Edgcom VP, 2011, ISME J, V5, P231, DOI 10.1038/ismej.2010.121; Falkowski P. G., 2007, AQUATIC PHOTOSYNTHES; Forni C, 1997, PHYCOLOGIA, V36, P181, DOI 10.2216/i0031-8884-36-3-181.1; Hernandez JP, 2009, EUR J SOIL BIOL, V45, P88, DOI 10.1016/j.ejsobi.2008.08.004; Ioki M, 2012, BIORESOURCE TECHNOL, V109, P300, DOI 10.1016/j.biortech.2011.07.101; Kasai F., 2004, NIES COLLECTION LIST; Kawafune K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031749; KLOAREG B, 1988, OCEANOGR MAR BIOL, V26, P259; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Murata K, 2014, ENERG FUEL, V28, P6999, DOI 10.1021/ef5018994; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Shi LM, 2009, J FRESHWATER ECOL, V24, P211, DOI 10.1080/02705060.2009.9664285; Shiho M, 2012, PROCEDIA ENVIRON SCI, V15, P90, DOI 10.1016/j.proenv.2012.05.014; Starr R. C., 1984, CELLULAR INTERACTION, P261; Tanabe Y, 2012, PROCEDIA ENVIRON SCI, V15, P22, DOI 10.1016/j.proenv.2012.05.005; Tanabe Y, 2014, J APPL PHYCOL, V26, P9, DOI 10.1007/s10811-013-0045-0; Tanoi T, 2014, J APPL PHYCOL, V26, P1, DOI 10.1007/s10811-013-0026-3; Wagner-Dobler I., 2009, ISME J, V4, P61; Watanabe MM, 2013, HDB MICROALGAL CULTU, V2nd, P369; Yoshida M., 2012, Biofuels, V3, P761, DOI 10.4155/bfs.12.63	60	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 1	2015	5								10467	10.1038/srep10467		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CL7PF	WOS:000357163500001		
J	Yaeshima, K; Negishi, D; Yamamoto, S; Ogata, T; Nakazawa, K; Kawashima, N				Yaeshima, K.; Negishi, D.; Yamamoto, S.; Ogata, T.; Nakazawa, K.; Kawashima, N.			Mechanical and neural changes in plantar-flexor muscles after spinal cord injury in humans	SPINAL CORD			English	Article							MODIFIED ASHWORTH SCALE; BONE-MINERAL DENSITY; SKELETAL-MUSCLE; GASTROCNEMIUS-MUSCLE; IN-VIVO; INTERRATER RELIABILITY; PARALYZED MUSCLE; TENDON STIFFNESS; SPASTICITY; TENSION	Study design: Cross-sectional study. Objectives: To determine the effect of injury duration on plantar-flexor elastic properties in individuals with chronic spinal cord injury (SCI) and spasticity. Setting: National Rehabilitation Center for Persons with Disabilities, Japan. Methods: A total of 16 chronic SCI patients (age, 33 +/- 9.3 years; injury localization, C6-T12; injury duration, 11-371 months) participated. Spasticity of the ankle plantar-flexors was assessed using the Modified Ashworth Scale (MAS). The calf circumference and muscle thickness of the medial gastrocnemius (MG), lateral gastrocnemius and soleus were assessed using tape measure and ultrasonography. In addition, the ankle was rotated from 10 degrees plantar-flexion to 20 degrees dorsiflexion at 5 deg s(-1) with a dynamometer, and the ankle angle and torque were recorded. After normalizing the data (the initial points of angle and torque were set to zero), we calculated the peak torque and energy. Furthermore, angle-torque data (before and after normalization) were fitted with a second- and fourth-order polynomial, and exponential (Sten-Knudsen) models, and stiffness indices (SISOP, SIFOP, SISK) and Angle(SLACK) (the angle at which plantar-flexor passive torque equals zero) were calculated. The stretch reflex gain and offset were determined from 0-10 degrees dorsiflexion at 50, 90, 120 and 150 deg s(-1). After logarithmic transformation, Pearson's correlation coefficients were calculated. Results: MAS, calf circumference, MG thickness, peak torque and SIFOP significantly decreased with injury duration (r log-log=-0.63, -0.69, -0.63, -0.53 and -0.55, respectively, P<0.05). The peak torque and SIFOP maintained significant relationships even after excluding impacts from muscle morphology. Conclusion: Plantar-flexor elasticity in chronic SCI patients decreased with increased injury duration.	[Yaeshima, K.; Nakazawa, K.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Yaeshima, K.; Ogata, T.; Kawashima, N.] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama 359855, Japan; [Negishi, D.; Yamamoto, S.] Shibaura Inst Technol, Grad Sch Syst Engn & Sci, Div Funct Control Syst, Saitama, Japan	Kawashima, N (reprint author), Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, 4-1 Namiki, Tokorozawa, Saitama 359855, Japan.	kawashima-noritaka@rehab.go.jp			KAKENHI [24700581]; Japanese Ministry of Health, Labour, and Welfare [201224026A, 201317009A]	This study was partially supported by the KAKENHI (24700581) and the Japanese Ministry of Health, Labour, and Welfare (201224026A and 201317009A).	Akman MN, 1999, SPINAL CORD, V37, P638, DOI 10.1038/sj.sc.3100892; BOHANNON RW, 1987, PHYS THER, V67, P206; Kawakami Y, 2008, J ORTHOP SPORT PHYS, V38, P269, DOI 10.2519/jospt.2008.2632; MARTIN TP, 1992, J APPL PHYSIOL, V72, P1401; Biering-Sorensen F, 2006, SPINAL CORD, V44, P708, DOI 10.1038/sj.sc.3101928; Mirbagheri MM, 2001, EXP BRAIN RES, V141, P446, DOI 10.1007/s00221-001-0901-z; Nordez A, 2006, CLIN BIOMECH, V21, P755, DOI 10.1016/j.clinbiomech.2006.03.005; Huang CY, 2006, J ELECTROMYOGR KINES, V16, P384, DOI 10.1016/j.jelekin.2005.09.001; Murillo N, 2011, CLIN NEUROPHYSIOL, V122, P1183, DOI 10.1016/j.clinph.2010.11.012; Diong J, 2012, CLIN BIOMECH, V27, P893, DOI 10.1016/j.clinbiomech.2012.07.003; ASHWORTH B, 1964, PRACTITIONER, V192, P540; CALANCIE B, 1993, ELECTROEN CLIN NEURO, V89, P177, DOI 10.1016/0168-5597(93)90131-8; Kwah LK, 2012, ARCH PHYS MED REHAB, V93, P1185, DOI 10.1016/j.apmr.2012.02.009; Foure A, 2013, J APPL PHYSIOL, V114, P523, DOI 10.1152/japplphysiol.01313.2011; Szollar SM, 1998, AM J PHYS MED REHAB, V77, P28, DOI 10.1097/00002060-199801000-00005; Rekand T, 2010, ACTA NEUROL SCAND, V122, P62; Thomas CK, 1997, MUSCLE NERVE, V20, P788, DOI 10.1002/(SICI)1097-4598(199707)20:7<788::AID-MUS2>3.0.CO;2-3; Pelletier CA, 2010, SPINAL CORD, V48, P202, DOI 10.1038/sc.2009.106; Hoang PD, 2005, J BIOMECH, V38, P1333, DOI 10.1016/j.jbiomech.2004.05.046; Foure A, 2012, EUR J APPL PHYSIOL, V112, P2849, DOI 10.1007/s00421-011-2256-x; Frey-Rindova P, 2000, SPINAL CORD, V38, P26; Ghotbi N, 2009, BRAIN INJURY, V23, P815, DOI 10.1080/02699050903200548; Nordez A, 2010, J BIOMECH, V43, P379, DOI 10.1016/j.jbiomech.2009.07.034; Boorman GI, 1996, ELECTROMYOGR MOTOR C, V101, P84, DOI 10.1016/0924-980X(95)00262-J; Cook CS, 1996, EUR J APPL PHYSIOL O, V72, P380, DOI 10.1007/BF00599700; LOTTA S, 1991, PARAPLEGIA, V29, P247; Castro MJ, 1999, EUR J APPL PHYSIOL O, V80, P373, DOI 10.1007/s004210050606; Castro MJ, 1999, J APPL PHYSIOL, V86, P350; Nakazawa K, 2006, ARCH PHYS MED REHAB, V87, P71, DOI 10.1016/j.apmr.2005.08.122; Magnusson SP, 1996, AM J SPORT MED, V24, P622, DOI 10.1177/036354659602400510; Benz EN, 2005, ARCH PHYS MED REHAB, V86, P52, DOI 10.1016/j.apmr.2004.01.033; Diong J, 2012, AM J PHYS MED REHABI, V92, P1; Diong JHL, 2012, MUSCLE NERVE, V46, P237, DOI 10.1002/mus.23356; Erni T, 2001, J PHYSIOL-LONDON, V534, P303, DOI 10.1111/j.1469-7793.2001.00303.x; Fleuren KS, 2010, J NEUROL NEUROSUR PS, V81, P46; Gorgey AS, 2008, SPINAL CORD, V46, P96, DOI 10.1038/sj.sc.3102087; GRIMBY G, 1976, SCAND J REHABIL MED, V8, P37; Grippo A, 2011, SPINAL CORD, V49, P142, DOI 10.1038/sc.2010.56; Hoang PD, 2007, J EXP BIOL, V210, P4159, DOI 10.1242/jeb.002204; Kawashima Noritaka, 2009, 2009 IEEE International Conference on Rehabilitation Robotics: Reaching Users & the Community (ICORR), DOI 10.1109/ICORR.2009.5209546; Maganaris CN, 2006, MUSCLE NERVE, V33, P85, DOI 10.1002/mus.20441; Malhotra S, 2009, CLIN REHABIL, V23, P651, DOI 10.1177/0269215508101747; Marquardt D., 1963, J SOC IND APPL, V151, P859; Nordez A, 2009, BIOCYBERN BIOMED ENG, V30, P20, DOI 10.1016/j.irbm.2009.01.004; Olsson MC, 2006, J PHYSIOL-LONDON, V577, P339, DOI 10.1113/jphysiol.2006.116749; STEIN RB, 1992, J APPL PHYSIOL, V72, P1393; Sten-Knudsen O, 1953, ACTA PHYSL SCAND, V28, P1; Winter D., 1990, BIOMECHANICS MOTOR C	48	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	JUL	2015	53	7					526	533		10.1038/sc.2015.9		8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CM3IT	WOS:000357576200006		
J	Nishikii, H; Kanazawa, Y; Umemoto, T; Goltsev, Y; Matsuzaki, Y; Matsushita, K; Yamato, M; Nolan, GP; Negrin, R; Chiba, S				Nishikii, Hidekazu; Kanazawa, Yosuke; Umemoto, Terumasa; Goltsev, Yury; Matsuzaki, Yu; Matsushita, Kenji; Yamato, Masayuki; Nolan, Garry P.; Negrin, Robert; Chiba, Shigeru			Unipotent Megakaryopoietic Pathway Bridging Hematopoietic Stem Cells and Mature Megakaryocytes	STEM CELLS			English	Article						Adult hematopoietic stem cells; Megakaryocyte; Thrombopoietin; Hematopoietic progenitors; Thrombopoiesis	SELF-RENEWAL; C-MPL; LINEAGE COMMITMENT; PROGENITOR CELLS; BONE-MARROW; THROMBOPOIETIN; QUIESCENCE; HIERARCHY; MICE	Recent identification of platelet/megakaryocyte-biased hematopoietic stem/repopulating cells requires revision of the intermediate pathway for megakaryopoiesis. Here, we show a unipotent megakaryopoietic pathway bypassing the bipotent megakaryocyte/erythroid progenitors (biEMPs). Cells purified from mouse bone marrow by CD42b (GPIb) marking were demonstrated to be unipotent megakaryocytic progenitors (MKPs) by culture and transplantation. A subpopulation of freshly isolated CD41(+) cells in the lineage Sca1(+)cKit(+) (LSK) fraction (subCD41(+)LSK) differentiated only into MKP and mature megakaryocytes in culture. Although CD41(+)LSK cells as a whole were capable of differentiating into all myeloid and lymphoid cells in vivo, they produced unipotent MKP, mature megakaryocytes, and platelets in vitro and in vivo much more efficiently than Flt3(+)CD41(-)LSK cells, especially at the early phase after transplantation. In single cell polymerase chain reaction and thrombopoietin (TPO) signaling analyses, the MKP and a fraction of CD41(+)LSK, but not the biEMP, showed the similarities in mRNA expression profile and visible TPO-mediated phosphorylation. On increased demand of platelet production after 5-FU treatment, a part of CD41(+)LSK population expressed CD42b on the surface, and 90% of them showed unipotent megakaryopoietic capacity in single cell culture and predominantly produced platelets in vivo at the early phase after transplantation. These results suggest that the CD41(+)CD42b(+)LSK are straightforward progenies of megakaryocytes/platelet-biased stem/repopulating cells, but not progenies of biEMP. Consequently, we show a unipotent/highly biased megakaryopoietic pathway interconnecting stem/repopulating cells and mature megakaryocytes, the one that may play physiologic roles especially in emergency megakaryopoiesis. Stem Cells 2015;33:2196-2207	[Nishikii, Hidekazu; Chiba, Shigeru] Univ Tsukuba, Fac Med, Dept Hematol, Tsukuba, Ibaraki 3058575, Japan; [Nishikii, Hidekazu; Kanazawa, Yosuke; Matsushita, Kenji; Chiba, Shigeru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Chiba, Shigeru] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, Tsukuba, Ibaraki 3058575, Japan; [Nishikii, Hidekazu; Negrin, Robert] Stanford Univ, Dept Med, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Umemoto, Terumasa; Matsuzaki, Yu; Yamato, Masayuki] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo, Japan; [Goltsev, Yury; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA	Chiba, S (reprint author), Univ Tsukuba, Fac Med, Dept Hematol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	schiba-t@md.tsukuba.ac.jp			(KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan [23118503, 22390191, 22790896, 24790959]; Uehara Memorial Foundation; Yasuda Medical Foundation; SENSHIN Medical Research Foundation	We thank Dr. K. Akashi of Kyushu University for critical reading of the manuscript. This work was supported by the Grants-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (23118503 and 22390191 to S.C.; 22790896 and 24790959 to H.N.) and by the Uehara Memorial Foundation, Yasuda Medical Foundation, and SENSHIN Medical Research Foundation (to H.N.).	Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Ghosn EEB, 2012, P NATL ACAD SCI USA, V109, P5394, DOI 10.1073/pnas.1121632109; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; Klimchenko O, 2009, BLOOD, V114, P1506, DOI 10.1182/blood-2008-09-178863; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kozuma Y, 2010, J THROMB HAEMOST, V8, P1088, DOI 10.1111/j.1538-7836.2010.03785.x; Nakorn TN, 2003, P NATL ACAD SCI USA, V100, P205, DOI 10.1073/pnas.262655099; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Deutsch VR, 2013, BRIT J HAEMATOL, V161, P778, DOI 10.1111/bjh.12328; Bersenev A, 2008, J CLIN INVEST, V118, P2832, DOI 10.1172/JCI35808; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Hitchcock IS, 2014, BRIT J HAEMATOL, V165, P259, DOI 10.1111/bjh.12772; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Canobbio Ilaria, 2004, Cell Signal, V16, P1329, DOI 10.1016/j.cellsig.2004.05.008; Cornejo MG, 2012, BLOOD, V118, P1264; Miyawaki K, 2014, STEM CELLS, V33, P976; Morita Y, J EXP MED, V207, P1173; Ng AP, 2012, P NATL ACAD SCI USA, V109, P2364, DOI 10.1073/pnas.1121385109; Nishikii H, 2008, J EXP MED, V205, P1917, DOI 10.1084/jem.20071482; Sanchez M, 2006, STEM CELLS, V24, P337, DOI 10.1634/stemcells.2005-0023; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Sudo T, 2012, J IMMUNOL, V189, P200, DOI 10.4049/jimmunol.1200056	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	JUL	2015	33	7					2196	2207		10.1002/stem.1985		12	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CL0YE	WOS:000356668200011		
J	Fukuda, K; Kai, H; Kamouchi, M; Hata, J; Ago, T; Nakane, H; Imaizumi, T; Kitazono, T				Fukuda, Kenji; Kai, Hisashi; Kamouchi, Masahiro; Hata, Jun; Ago, Tetsuro; Nakane, Hiroshi; Imaizumi, Tsutomu; Kitazono, Takanari		FSR Investigators	Day-by-Day Blood Pressure Variability and Functional Outcome After Acute Ischemic Stroke Fukuoka Stroke Registry	STROKE			English	Article						blood pressure; cerebral infarction; prognosis; risk factors; stroke	PROGNOSTIC-SIGNIFICANCE; CLINICAL-OUTCOMES; HEART-RATE; HOME; THROMBOLYSIS; HYPERTENSION; ASSOCIATION; HEMORRHAGE; MANAGEMENT; TRIAL	Background and Purpose The relationship between blood pressure (BP) variability and functional outcome in patients with acute ischemic stroke remains unclear. This study aimed to elucidate whether in-hospital day-by-day BP variability is associated with functional outcome after acute ischemic stroke. Methods Using the Fukuoka Stroke Registry, we included 2566 patients with a first-ever ischemic stroke who had been functionally independent before the onset and were hospitalized within 24 hours. BP was measured daily, and its variability was assessed by SD, coefficients of variance, and variations independent of mean. Poor functional outcome was assessed by modified Rankin Scale scores 3 at 3 months. Results After adjustment for multiple confounding factors including age, sex, risk factors, stroke features, baseline severity, thrombolytic therapy, antihypertensive agents, and mean BP, day-by-day BP variability during the subacute stage (4-10 days after onset) was independently associated with a poor functional outcome (multivariable-adjusted odds ratios [95% confidence interval] in the top versus bottom quartile of systolic BP variability, 1.51 [1.09-2.08] for SD; 1.63 [1.20-2.22] for coefficients of variance; 1.64 [1.21-2.24] for variations independent of mean). Similar trends were also observed for diastolic BP variability. These trends were unchanged in patients who were not treated with antihypertensive drugs. In contrast, no association was found between indices of BP variability during the acute stage and functional outcome after adjusting for potential confounders. Conclusions These data suggest that intraindividual day-by-day BP variability during the subacute stage is associated with the 3-month functional outcome after acute ischemic stroke.	[Fukuda, Kenji; Hata, Jun; Ago, Tetsuro; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan; [Kamouchi, Masahiro] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Fukuoka 8128582, Japan; [Kamouchi, Masahiro; Hata, Jun; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Ctr Cohort Studies, Fukuoka 8128582, Japan; [Fukuda, Kenji] St Marys Hosp, Dept Cerebrovasc Dis, Kurume, Fukuoka, Japan; [Fukuda, Kenji; Kai, Hisashi; Imaizumi, Tsutomu] Kurume Univ, Sch Med, Div Cardiovasc Med, Dept Internal Med, Kurume, Fukuoka 830, Japan; [Nakane, Hiroshi] Natl Hosp Org, Fukuoka Higashi Med Ctr, Cerebrovasc & Neurol Ctr, Koga, Japan; [Imaizumi, Tsutomu] Int Univ Hlth & Welf, Fukuoka Sannou Hosp, Fukuoka, Japan	Kamouchi, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kamouchi@hcam.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [22249069, 24310024, 26293158, 26460756]; Coordination, Support and Training Program for Translational Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant No. 22249069, 24310024, 26293158, 26460756, and the Coordination, Support and Training Program for Translational Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620; Johansson JK, 2012, HYPERTENSION, V59, P212, DOI 10.1161/HYPERTENSIONAHA.111.178657; Morfis L, 1997, STROKE, V28, P1401; Sykora M, 2009, STROKE, V40, P737, DOI 10.1161/STROKEAHA.108.519967; Christensen H, 2002, ACTA NEUROL SCAND, V106, P142, DOI 10.1034/j.1600-0404.2002.01356.x; Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS31, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.004; Ko Y, 2010, STROKE, V41, P2512, DOI 10.1161/STROKEAHA.110.595561; Yong M, 2008, STROKE, V39, P366, DOI 10.1161/STROKEAHA.107.492330; Kumai Y, 2012, NEUROLOGY, V78, P1909, DOI 10.1212/WNL.0b013e318259e110; Stergiou GS, 2014, HYPERTENS RES, V37, P565, DOI 10.1038/hr.2014.2; Muntner P, 2011, HYPERTENSION, V57, P160, DOI 10.1161/HYPERTENSIONAHA.110.162255; Willmot M, 2004, HYPERTENSION, V43, P18, DOI 10.1161/01.HYP.0000105052.65787.35; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Kamouchi M, 2011, STROKE, V42, P2788, DOI 10.1161/STROKEAHA.111.617415; Ishitsuka K, 2014, HYPERTENSION, V63, P54, DOI 10.1161/HYPERTENSIONAHA.113.02189; Rothwell PM, 2011, CURR HYPERTENS REP, V13, P177, DOI 10.1007/s11906-011-0201-3; Sykora M, 2009, STROKE, V40, pE678, DOI 10.1161/STROKEAHA.109.565838; Shimbo D, 2012, HYPERTENSION, V60, P625, DOI 10.1161/HYPERTENSIONAHA.112.193094; Robinson TG, 2003, STROKE, V34, P705, DOI 10.1161/01.STR.0000058493.94875.9F; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Delgado-Mederos R, 2008, NEUROLOGY, V71, P552, DOI 10.1212/01.wnl.0000318294.36223.69; Tikhonoff V, 2009, LANCET NEUROL, V8, P938, DOI 10.1016/S1474-4422(09)70184-X; BRITTON M, 1986, STROKE, V17, P861; Shinohara Y, 2008, INT J STROKE, V3, P55, DOI 10.1111/j.1747-4949.2008.00178.x; Lau KK, 2014, EUR J NEUROL, V21, P319, DOI 10.1111/ene.12310; Matsui Y, 2011, HYPERTENSION, V57, P1087, DOI 10.1161/HYPERTENSIONAHA.111.171645; Endo K, 2013, STROKE, V44, P816, DOI 10.1161/STROKEAHA.112.681007; Dolan E, 2010, HYPERTENSION, V56, P179, DOI 10.1161/HYPERTENSIONAHA.110.154708; Kang J, 2012, NEUROLOGY, V79, P2018, DOI 10.1212/WNL.0b013e3182749eb8; Manning L, 2014, LANCET NEUROL, V13, P364, DOI 10.1016/S1474-4422(14)70018-3; Mistri AK, 2011, CHHIPS COSSACS TR S2, P31; Shinohara Y, 2006, CEREBROVASC DIS, V21, P271, DOI 10.1159/000091226	32	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JUL	2015	46	7					1832	1839		10.1161/STROKEAHA.115.009076		8	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CL0ZY	WOS:000356672800013		
J	Siler, DA; Berlow, YA; Kukino, A; Davis, CM; Nelson, JW; Grafe, MR; Ono, H; Cetas, JS; Pike, M; Alkayed, NJ				Siler, Dominic A.; Berlow, Yosef A.; Kukino, Ayaka; Davis, Catherine M.; Nelson, Jonathan W.; Grafe, Marjorie R.; Ono, Hirohisa; Cetas, Justin S.; Pike, Martin; Alkayed, Nabil J.			Soluble Epoxide Hydrolase in Hydrocephalus, Cerebral Edema, and Vascular Inflammation After Subarachnoid Hemorrhage	STROKE			English	Article						communicating hydrocephalus; edema; subarachnoid hemorrhage; vascular cell adhesion molecule-1	CELL-ADHESION MOLECULE-1; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; CEREBROSPINAL-FLUID; WHITE-MATTER; MOUSE MODEL; MICE; ISCHEMIA; OPTIMIZATION; REGISTRATION	Background and Purpose Acute communicating hydrocephalus and cerebral edema are common and serious complications of subarachnoid hemorrhage (SAH), whose causes are poorly understood. Using a mouse model of SAH, we determined whether soluble epoxide hydrolase (sEH) gene deletion protects against SAH-induced hydrocephalus and edema by increasing levels of vasoprotective eicosanoids and suppressing vascular inflammation. Methods SAH was induced via endovascular puncture in wild-type and sEH knockout mice. Hydrocephalus and tissue edema were assessed by T-2-weighted magnetic resonance imaging. Endothelial activation was assessed in vivo using T2*-weighted magnetic resonance imaging after intravenous administration of iron oxide particles linked to anti-vascular cell adhesion molecule-1 antibody 24 hours after SAH. Behavioral outcome was assessed at 96 hours after SAH with the open field and accelerated rotarod tests. Results SAH induced an acute sustained communicating hydrocephalus within 6 hours of endovascular puncture in both wild-type and sEH knockout mice. This was followed by tissue edema, which peaked at 24 hours after SAH and was limited to white matter fiber tracts. sEH knockout mice had reduced edema, less vascular cell adhesion molecule-1 uptake, and improved outcome compared with wild-type mice. Conclusions Genetic deletion of sEH reduces vascular inflammation and edema and improves outcome after SAH. sEH inhibition may serve as a novel therapy for SAH.	[Siler, Dominic A.; Davis, Catherine M.; Nelson, Jonathan W.; Grafe, Marjorie R.; Alkayed, Nabil J.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Dept Anesthesiol & Perioperat Med, Portland, OR 97239 USA; [Siler, Dominic A.; Cetas, Justin S.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97239 USA; [Berlow, Yosef A.; Kukino, Ayaka; Pike, Martin] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97239 USA; [Ono, Hirohisa] Nishijima Hosp, Dept Neurosurg, Numazu, Sizuoka, Japan; [Cetas, Justin S.] Portland VA Med Ctr, Portland, OR USA	Alkayed, NJ (reprint author), Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Dept Anesthesiol & Perioperat Med, 3181 SW Sam Jackson Pk Rd,UHN 2, Portland, OR 97239 USA.	alkayedn@ohsu.edu			Oregon Brain Institute [F30 HL108624]; Veteran's Affairs Merit Award; National Institutes of Health/National Cancer Institute [1R21CA167302-0]; Nishijima Hospital; National Institute of Neurological Disease and Stroke [R01 NS070837]	This study was supported by Oregon Brain Institute (D.A. Siler: National Heart, Lung and Blood Institute F30 HL108624), Veteran's Affairs Merit Award (Dr Cetas), National Institutes of Health/National Cancer Institute grant 1R21CA167302-0, Nishijima Hospital (Dr Pike), and National Institute of Neurological Disease and Stroke R01 NS070837 (Dr Alkayed).	VANGIJN J, 1985, J NEUROSURG, V63, P355; Gauberti M, 2013, STROKE, V44, P1988, DOI 10.1161/STROKEAHA.111.000544; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Zhang WR, 2008, STROKE, V39, P2073, DOI 10.1161/STROKEAHA.107.508325; McAteer MA, 2007, NAT MED, V13, P1253, DOI 10.1038/nm1631; Deng YM, 2011, FASEB J, V25, P703, DOI 10.1096/fj.10-171488; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; Greenwood J, 2002, VASC PHARMACOL, V38, P315, DOI 10.1016/S1537-1891(02)00199-4; Kaynar MY, 2004, J NEUROSURG, V101, P1030, DOI 10.3171/jns.2004.101.6.1030; Iliff JJ, 2010, PROSTAG OTH LIPID M, V91, P68, DOI 10.1016/j.prostaglandins.2009.06.004; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Ko SB, 2012, ANN NEUROL, V72, P344, DOI 10.1002/ana.23619; Li T, 2014, BRAIN RES, V1558, P90, DOI 10.1016/j.brainres.2014.02.036; COLLINS T, 1995, FASEB J, V9, P899; Koerner IP, 2007, J NEUROSCI, V27, P4642, DOI 10.1523/JNEUROSCI.0056-07.2007; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Xiao L, 2014, AM J PHYSIOL-HEART C, V306, pH317, DOI 10.1152/ajpheart.00182.2013; Dupont S, 2013, NEUROL RES, V35, P107, DOI 10.1179/1743132812Y.0000000122; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Vale FL, 1997, J NEUROSURG, V86, P462, DOI 10.3171/jns.1997.86.3.0462; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Frijns CJM, 2006, J NEUROL NEUROSUR PS, V77, P77, DOI 10.1136/jnnp.2005.064956; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Hoyte LC, 2010, J CEREBR BLOOD F MET, V30, P1178, DOI 10.1038/jcbfm.2009.287; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Braun KPJ, 1997, BRAIN RES, V757, P295, DOI 10.1016/S0006-8993(97)00345-4; HASAN D, 1989, STROKE, V20, P747; HEIZER ML, 1991, STROKE, V22, P1389; Hoh BL, 2011, WORLD NEUROSURG, V76, P548, DOI 10.1016/j.wneu.2011.05.054; Martini RP, 2014, J NEUROSURG, V121, P1359, DOI 10.3171/2014.7.JNS131990; MILHORAT TH, 1987, NEUROSURGERY, V20, P15; Serres S, 2011, FASEB J, V25, P4415, DOI 10.1096/fj.11-183772; Siler DA, 2015, NEUROCRIT CARE, V22, P306, DOI 10.1007/s12028-014-0011-y; Siler DA, 2014, TRANSL STROKE RES, V5, P227, DOI 10.1007/s12975-014-0329-y; TADA T, 1994, J NEUROIMMUNOL, V50, P153, DOI 10.1016/0165-5728(94)90041-8; Ulu A, 2013, J CARDIOVASC PHARM, V62, P285, DOI 10.1097/FJC.0b013e318298e460; Yu Q, 2011, FRONT BIOSCI E, VE3, P10	40	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JUL	2015	46	7					1916	1922		10.1161/STROKEAHA.114.008560		7	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CL0ZY	WOS:000356672800025		
J	Sun, YY; Li, YK; Wali, B; Li, YC; Lee, J; Heinmiller, A; Abe, K; Stein, DG; Mao, H; Sayeed, I; Kuan, CY				Sun, Yu-Yo; Li, Yikun; Wali, Bushra; Li, Yuancheng; Lee, Jolly; Heinmiller, Andrew; Abe, Koji; Stein, Donald G.; Mao, Hui; Sayeed, Iqbal; Kuan, Chia-Yi			Prophylactic Edaravone Prevents Transient Hypoxic-Ischemic Brain Injury Implications for Perioperative Neuroprotection	STROKE			English	Article						antioxidants; MCI-186; stroke; thrombosis	CORONARY-ARTERY-BYPASS; FREE-RADICAL SCAVENGER; THERAPEUTIC TIME-WINDOW; CEREBRAL-ISCHEMIA; CARDIAC-SURGERY; STROKE; MCI-186; COAGULATION; INFARCTION; TRIALS	Background and Purpose Hypoperfusion-induced thrombosis is an important mechanism for postsurgery stroke and cognitive decline, but there are no perioperative neuroprotectants to date. This study investigated whether prophylactic application of Edaravone, a free radical scavenger already used in treating ischemic stroke in Japan, can prevent infarct and cognitive deficits in a murine model of transient cerebral hypoxia-ischemia. Methods Adult male C57BL/6 mice were subjected to transient hypoxic-ischemic (tHI) insult that consists of 30-minute occlusion of the unilateral common carotid artery and exposure to 7.5% oxygen. Edaravone or saline was prophylactically applied to compare their effects on cortical oxygen saturation, blood flow, coagulation, oxidative stress, metabolites, and learning-memory using methods that include photoacoustic imaging, laser speckle contrast imaging, solid-state NMR, and Morris water maze. The effects on infarct size by Edaravone application at different time points after tHI were also compared. Results Prophylactic administration of Edaravone (4.5 mg/kgx2, IP, 1 hour before and 1 hour after tHI) improved vascular reperfusion, oxygen saturation, and the maintenance of brain metabolites, reducing oxidative stress, thrombosis, white-matter injury, and learning impairment after tHI insult. Delayed Edaravone treatment after 3 h post-tHI became unable to reduce infarct size. Conclusions Acute application of Edaravone may be a useful strategy to prevent postsurgery stroke and cognitive impairment, especially in patients with severe carotid stenosis.	[Sun, Yu-Yo; Li, Yikun; Lee, Jolly; Kuan, Chia-Yi] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Sun, Yu-Yo; Li, Yikun; Lee, Jolly; Kuan, Chia-Yi] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Sun, Yu-Yo; Li, Yikun; Lee, Jolly; Kuan, Chia-Yi] Childrens Healthcare Atlanta, Atlanta, GA USA; [Wali, Bushra; Stein, Donald G.; Sayeed, Iqbal] Emory Univ, Sch Med, Brain Res Lab, Dept Emergency Med, Atlanta, GA 30322 USA; [Li, Yikun; Mao, Hui] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA; [Heinmiller, Andrew] VisualSonics Inc, Toronto, ON, Canada; [Abe, Koji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Okayama 7008530, Japan	Kuan, CY (reprint author), Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Dept Pediat Neurol, Hlth Sci Res Bldg E470 1760 Haygood Dr, Atlanta, GA 30322 USA.	alex.kuan@emory.edu			National Institute of Health [NS084744]; Children's Healthcare of Atlanta Research Center Pilot Project grant	This study was supported by the National Institute of Health grant NS084744 and a Children's Healthcare of Atlanta Research Center Pilot Project grant (to C.-Y. Kuan).	Likosky DS, 2004, HEART SURG FORUM, V7, pE271, DOI 10.1532/HSF98.20041035; Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Lapchak PA, 2010, EXPERT OPIN PHARMACO, V11, P1753, DOI 10.1517/14656566.2010.493558; Lee BJ, 2010, BRAIN RES, V1307, P22, DOI 10.1016/j.brainres.2009.10.026; GERRATY RP, 1993, STROKE, V24, P1115; Arrowsmith JE, 1998, STROKE, V29, P2357; Naylor AR, 2002, EUR J VASC ENDOVASC, V23, P283, DOI 10.1053/ejvs.2002.1609; Bilotta F, 2013, BRIT J ANAESTH, V110, P113, DOI 10.1093/bja/aet059; Needles A, 2013, IEEE T ULTRASON FERR, V60, P888, DOI 10.1109/TUFFC.2013.2646; Kaste M, 2013, CEREBROVASC DIS, V36, P196, DOI 10.1159/000353680; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Rosenberg RD, 1999, NEW ENGL J MED, V340, P1555; Wali B, 2014, BRAIN, V137, P486, DOI 10.1093/brain/awt319; Mao H, 2007, EXP BRAIN RES, V183, P477, DOI 10.1007/s00221-007-1061-6; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5; Watanabe T, 2008, CARDIOVASC THER, V26, P101, DOI 10.1111/j.1527-3466.2008.00041.x; Tang YH, 2014, EXP NEUROL, V261, P417, DOI 10.1016/j.expneurol.2014.07.004; Higashi Y, 2009, EXPERT OPIN PHARMACO, V10, P323, DOI [10.1517/14656560802636888 , 10.1517/14656560802636888]; Deguchi K, 2014, J NEUROSCI RES, V92, P1509, DOI 10.1002/jnr.23420; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Gyngell ML, 1995, NMR BIOMED, V8, P206, DOI 10.1002/nbm.1940080505; Kimura K, 2012, J NEUROL SCI, V313, P132, DOI 10.1016/j.jns.2011.09.006; Mathew JP, 2013, STROKE, V44, P3407, DOI 10.1161/STROKEAHA.113.002703; Nah HW, 2014, ANN NEUROL, V76, P347, DOI 10.1002/ana.24238; Schouten O, 2009, NEW ENGL J MED, V361, P980, DOI 10.1056/NEJMoa0808207; Selim M, 2007, NEW ENGL J MED, V356, P706, DOI 10.1056/NEJMra062668; Selnes OA, 2005, ANN NEUROL, V57, P615, DOI 10.1002/ana.20481; Sun YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098807; WATANABE T, 1988, PROSTAG LEUKOTR ESS, V33, P81, DOI 10.1016/0952-3278(88)90127-5; Zhang WR, 2004, NEUROL RES, V26, P342, DOI 10.1179/016164104225014058	32	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JUL	2015	46	7					1947	1955		10.1161/STROKEAHA.115.009162		9	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CL0ZY	WOS:000356672800029		
J	Kawada, T				Kawada, Tomoyuki			Letter by Kawada Regarding Article, "Carotid Intima-Media Thickness Is Associated With the Progression of Cognitive Impairment in Older Adults"	STROKE			English	Letter							NUMBER		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 113, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.						Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Gopal DM, 2014, CLIN CHEM, V60, P1402, DOI 10.1373/clinchem.2014.227116; Kawada T, HEART VESSELS; Kawada T, 2012, J OCCUP ENVIRON MED, V54, P273, DOI 10.1097/JOM.0b013e3182300424; Moon JH, 2015, STROKE, V46, P1024, DOI 10.1161/STROKEAHA.114.008170	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JUL	2015	46	7					e175	e175		10.1161/STROKEAHA.115.009622		1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CL0ZZ	WOS:000356672900005		
J	Blanchini, F; Colaneri, P; Fujisaki, Y; Miani, S; Pellegrino, FA				Blanchini, Franco; Colaneri, Patrizio; Fujisaki, Yasumasa; Miani, Stefano; Pellegrino, Felice Andrea			A Youla-Kucera parameterization approach to output feedback relatively optimal control	SYSTEMS & CONTROL LETTERS			English	Article						Relatively optimal control; Youla-Kucera parameterization; Output feedback; Continuous time systems	SYSTEMS	This paper presents a continuous time solution to the problem of designing a relatively optimal control, precisely, a dynamic control which is optimal with respect to a given initial condition and is stabilizing for any other initial state. This technique provides a drastic reduction of the complexity of the controller and successfully applies to systems in which (constrained) optimality is necessary for some "nominal operation" only. The technique is combined with a pole assignment procedure. It is shown that once the closed-loop poles have been fixed and an optimal trajectory originating from the nominal initial state compatible with these poles is computed, a stabilizing compensator which drives the system along this trajectory can be derived in closed form. There is no restriction on the optimality criterion and the constraints. The optimization is carried out over a finite-dimensional parameterization of the trajectories. The technique has been presented for state feedback. We propose here a technique based on the Youla-Kucera parameterization which works for output feedback. The main result is that we provide conditions for solvability in terms of a set of linear algebraic equations. (C) 2015 Elsevier B.V. All rights reserved.	[Blanchini, Franco] Univ Udine, Dipartimento Matemat & Informat, I-33100 Udine, Italy; [Colaneri, Patrizio] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy; [Colaneri, Patrizio] Politecn Milan, CNR, IEIIT, I-20133 Milan, Italy; [Fujisaki, Yasumasa] Osaka Univ, Dept Informat & Phys Sci, Suita, Osaka 5650871, Japan; [Miani, Stefano] Univ Udine, Dipartimento Ingn Elettr Gest & Meccan, I-33100 Udine, Italy; [Pellegrino, Felice Andrea] Univ Trieste, Dipartimento Ingn & Architettura, I-34127 Trieste, Italy	Blanchini, F (reprint author), Univ Udine, Dipartimento Matemat & Informat, I-33100 Udine, Italy.	blanchini@uniud.it; colaneri@elet.polimi.it; fujisaki@ist.osaka-u.ac.jp; miani.stefano@uniud.it; fapellegrino@units.it	Blanchini, Franco/A-6513-2008; 	Blanchini, Franco/0000-0002-4109-5531; Pellegrino, Felice Andrea/0000-0002-4423-1666			[Anonymous], 2008, RECENT ADV LEARNING, DOI 10.1007/978-1-84800-155-8_7; YOULA DC, 1976, IEEE T AUTOMAT CONTR, V21, P319, DOI 10.1109/TAC.1976.1101223; GARCIA CE, 1989, AUTOMATICA, V25, P335, DOI 10.1016/0005-1098(89)90002-2; WANG SH, 1972, IEEE T AUTOMAT CONTR, VAC17, P347, DOI 10.1109/TAC.1972.1099984; Bemporad A, 2002, AUTOMATICA, V38, P3, DOI 10.1016/S0005-1098(01)00174-1; Blanchini F, 2006, IEEE T AUTOMAT CONTR, V51, P183, DOI 10.1109/TAC.2005.863493; BITSORIS G, 1991, CONTR-THEOR ADV TECH, V7, P407; Blanchini F, 2008, AUTOMATICA, V44, P1, DOI 10.1016/j.automatica.2007.04.010; Blanchini F, 2003, IEEE T AUTOMAT CONTR, V48, P2151, DOI 10.1109/TAC.2003.820070; Blanchini F, 2006, IEEE DECIS CONTR P, P5645, DOI 10.1109/CDC.2006.377457; Boyd S.P., 1991, PRENTICE HALL INFORM; Grant M. C., 2014, CVX MATLAB SOFTWARE; Kucera V., 1991, PRENTICE HALL INT SE; Mayne DQ, 2001, EUR J CONTROL, V7, P87, DOI 10.3166/ejc.7.87-99; Pena R.S., 1998, ROBUST SYSTEMS THEOR; Sage AP, 1977, OPTIMUM SYSTEM CONTR; Sznaier M., 1987, Proceedings of the 26th IEEE Conference on Decision and Control (Cat. No.87CH2505-6); Zhou K., 1996, ROBUST OPTIMAL CONTR	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6911	1872-7956		SYST CONTROL LETT	Syst. Control Lett.	JUL	2015	81						14	23		10.1016/j.sysconle.2015.04.006		10	Automation & Control Systems; Operations Research & Management Science	Automation & Control Systems; Operations Research & Management Science	CL8RJ	WOS:000357241500003		
J	Sabol, ME; Finkle, J; Krucoff, M; Stockbridge, N; Parkhill, N; Shinagawa, K; Mahaffey, K; Tcheng, J; Lenihan, D; Melloni, C; Todaro, T; Michelson, E; Munley, J; Zander, J; Oh, R				Sabol, Mary Elizabeth; Finkle, John; Krucoff, Mitch; Stockbridge, Norman; Parkhill, Nancy; Shinagawa, Kaori; Mahaffey, Kenneth; Tcheng, James; Lenihan, Daniel; Melloni, Chiara; Todaro, Thomas; Michelson, Eric; Munley, Jiefen; Zander, Judith; Oh, Richard			Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report Forms	THERAPEUTIC INNOVATION & REGULATORY SCIENCE			English	Editorial Material						CSRC; cardiovascular events; case report forms; cardiovascular signals		Detection of off-target cardiovascular (CV) effects remains a significant challenge to drug development. Documentation of CV events in non-CV trials is often inadequate to interpret imbalances between treatment arms, which may lead to concerns about potential CV safety signals. The Cardiac Safety Research Consortium (CSRC) public-private partnership has developed CV case report forms (CRFs) for adverse CV events, including death. These CRFs are intended to encourage collection, as near to the occurrence of an event as possible, of the minimum information necessary to assess, or possibly adjudicate, the event. A broad range of stakeholders (representing industry, academia, and regulatory authorities) developed these forms with the goal of balancing the collection of key information with the resources likely to be available. Use of these forms is optional, and sponsors may modify them. These forms have not undergone any type of validation process. The CSRC will continue to sponsor a working group to invite public comment and feedback on these forms.	[Sabol, Mary Elizabeth; Finkle, John] GSK, Global Clin Safety & Pharmacovigilance, Upper Providence, PA USA; [Krucoff, Mitch; Tcheng, James] Duke Univ, Med Ctr, Durham, NC USA; [Stockbridge, Norman] FDA White Oak, Silver Spring, MD USA; [Parkhill, Nancy] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Shinagawa, Kaori] PMDA, Tokyo, Japan; [Mahaffey, Kenneth] Stanford Univ, Stanford, CA 94305 USA; [Lenihan, Daniel] Vanderbilt Univ, Nashville, TN 37235 USA; [Melloni, Chiara] Duke Clin Res Inst, Durham, NC USA; [Todaro, Thomas] Medpace, Cincinnati, OH USA; [Michelson, Eric; Munley, Jiefen; Zander, Judith] AstraZeneca, Wilmington, DE USA; [Oh, Richard] Takeda, Deerfield, IL USA	Sabol, ME (reprint author), GSK, Global Clin Safety & Pharmacovigilance, 1250 South Collegeville Rd, Collegeville, PA 19426 USA.	mary.e.sabol@gsk.com						0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2168-4790	2168-4804		THER INNOV REGUL SCI	Ther. Innov. Regul. Sci.	JUL	2015	49	4					511	513		10.1177/2168479014567319		3	Medical Informatics; Pharmacology & Pharmacy	Medical Informatics; Pharmacology & Pharmacy	CL9LM	WOS:000357300100007		
J	Hanada, K; Kaneko, M; Narukawa, M				Hanada, Keizo; Kaneko, Masayuki; Narukawa, Mamoru			Comparison of Approved Dosages for Pediatric and Adult Populations Based on US Labeling Information	THERAPEUTIC INNOVATION & REGULATORY SCIENCE			English	Article						pediatric drugs; pediatric dosing; labeling; pharmacokinetics; efficacy; safety	DRUG-DEVELOPMENT; CHILDREN	Background: The passing of legislation in the United States and the European Union has led to the approval of dosages for pediatric use. This study was conducted in an attempt to find potentially important factors with regard to dose selection for the pediatric population. Methods: The FDA's New Pediatric Labeling Information Database was used for this study. Drug labels for patients aged 6 months as well as those for patients aged 2, 6, and 11 years were standardized based on dosages expressed by age, normalized body weight (BW), and body surface area (BSA) in order to obtain ratios of pediatric-to-adult dosages. Labeling for 108 drugs were extracted for the analysis. Results: Ratios of pediatric-to-adult dosages based on BW were higher than 1, but those based on BSA were around 1. Relative dosages at 6 months of age showed a stronger correlation with those at 2 years compared to those at other ages. Conclusion: The approved dosages for pediatrics based on BW were higher than those of adults, but the ones based on BSA were almost the same as those of adults. The closer the age groups, the stronger the correlation of relative dosages between the groups.	[Hanada, Keizo; Kaneko, Masayuki; Narukawa, Mamoru] Kitasato Univ, Grad Sch Pharmaceut Sci, Dept Clin Med Pharmaceut Med, Tokyo 1088641, Japan	Hanada, K (reprint author), Kitasato Univ, Grad Sch Pharmaceut Sci, Dept Clin Med Pharmaceut Med, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	kzhanada@giga.ocn.ne.jp					Mahmood I, 2014, CLIN PHARMACOKINET, V53, P327, DOI 10.1007/s40262-014-0134-5; [Anonymous], 2003, PAEDIAT RES EQUITY A; Ginsberg G, 2002, TOXICOL SCI, V66, P185, DOI 10.1093/toxsci/66.2.185; [Anonymous], GUID E11 CLIN INV ME; Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; [Anonymous], 2002, BEST PHARM CHILDREN; Rodriguez W, 2008, PEDIATRICS, V121, P530, DOI 10.1542/peds.2007-1529; Johnson TN, 2008, ARCH DIS CHILD, V93, P207, DOI 10.1136/adc.2006.114835; Dunne J, 2011, PEDIATRICS, V128, pE1242, DOI 10.1542/peds.2010-3487; ATC/DDD index, 2014, ATC DDD IND 2014; Bartelink HI, 2006, CLIN PHARMACOKINET, V45, P1077; Comunication from the Commission, 2008, OFFICIAL J EUROPEAN; Fryar CD, VITAL HLTH STAT; Hawcutt DB, 2008, ARCH DIS CHILD, V93, P190, DOI 10.1136/adc.2007.127951; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098; MUNZENBERGER PJ, 1980, CONTEMP PHARM PRACT, V3, P11; Rodriguez W, 2001, CURR THER RES CLIN E, V62, P711, DOI 10.1016/S0011-393X(01)80078-3; U. S. Food and Drug Administration, NEW PED LAB INF DAT	18	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2168-4790	2168-4804		THER INNOV REGUL SCI	Ther. Innov. Regul. Sci.	JUL	2015	49	4					576	583		10.1177/2168479015570335		8	Medical Informatics; Pharmacology & Pharmacy	Medical Informatics; Pharmacology & Pharmacy	CL9LM	WOS:000357300100016		
J	Sakurai, H; Phung-Duc, T				Sakurai, Hiroyuki; Phung-Duc, Tuan			Two-way communication retrial queues with multiple types of outgoing calls	TOP			English	Article						Retrial queues; Two-way communication; Multiple classes; Embedded Markov chain; Stability condition	PERFORMANCE ANALYSIS; QUEUING MODEL; ABANDONMENT; NETWORKS; CENTERS	In this paper, we start with single server Markovian retrial queues with multiple types of outgoing calls. Incoming calls arrive at system according to a Poisson process. Service times of incoming calls follow the exponential distribution. Incoming calls that find the server busy upon arrival join an orbit and retry after some exponentially distributed time. On the other hand, the server makes an outgoing call after some exponentially distributed idle time. We assume that there are multiple types of outgoing calls whose durations follow distinct exponential distributions. For this model, we obtain explicit expressions for the joint stationary distribution of the number of calls in the orbit and the state of the server via the generating function approach. We also obtain simple asymptotic and recursive formulae for the joint stationary distribution. We show a stochastic decomposition property where we prove that the number of incoming calls in the system (server and orbit) can be decomposed into the sum of three independent random variables which have a clear physical meaning. We then consider the multiserver model for which we obtain the stability condition and derive some exact formulae by mean value analysis. Finally, we extend the single server model to the case where service time distribution of incoming calls and that of each type of outgoing calls are arbitrary. For this case, we obtain explicit expressions for the partial generating functions and recursive formulae for the joint stationary distribution of the server's state and the number of calls in the orbit.	[Sakurai, Hiroyuki; Phung-Duc, Tuan] Tokyo Inst Technol, Dept Math & Comp Sci, Meguro Ku, Tokyo 1528552, Japan	Phung-Duc, T (reprint author), Tokyo Inst Technol, Dept Math & Comp Sci, Meguro Ku, Tokyo 1528552, Japan.	tuan@is.titech.ac.jp	Phung-Duc, Tuan/N-6550-2014	Phung-Duc, Tuan/0000-0002-5002-4946			Artalejo JR, 2010, MATH COMPUT MODEL, V51, P1071, DOI 10.1016/j.mcm.2009.12.011; Krishnamoorthy A, 2014, TOP, V22, P290, DOI 10.1007/s11750-012-0256-6; Artalejo JR, 2013, APPL MATH MODEL, V37, P1811, DOI 10.1016/j.apm.2012.04.022; Artalejo JR, 2012, J IND MANAG OPTIM, V8, P781, DOI 10.3934/jimo.2012.8.781; Artalejo J. R., 1994, TOP, V2, P329, DOI 10.1007/BF02574813; Artalejo J.R., 2008, RETRIAL QUEUEING SYS; Avram F, 2011, TOP, V19, P317, DOI 10.1007/s11750-011-0195-7; Bhulai S, 2003, IEEE T AUTOMAT CONTR, V48, P1434, DOI 10.1109/TAC.2003.815038; CHOI BD, 1995, QUEUEING SYST, V19, P215, DOI 10.1007/BF01148947; Cinlar E., 1975, INTRO STOCHASTIC PRO; Deslauriers A, 2007, COMPUT OPER RES, V34, P1616, DOI 10.1016/j.cor.2005.06.019; Dimitriou I, 2014, PERFORM EVALUATION, V77, P37, DOI 10.1016/j.peva.2014.03.003; Falin G. I., 1997, RETRIAL QUEUES; FALIN GI, 1979, ENG CYBERN, V17, P53; Falin G. I., 1993, Queueing Systems Theory and Applications, V14, DOI 10.1007/BF01158878; Flajolet P, 2009, ANALYTIC COMBINATORICS, P1, DOI 10.1017/CBO9780511801655; MARTIN M, 1995, ADV APPL PROBAB, V27, P840, DOI 10.2307/1428136; Phung-Duc T, 2014, PERFORM EVALUATION, V80, P43, DOI 10.1016/j.peva.2014.03.001; Phung-Duc T., 2011, NUMBER ALGEBRA CONTR, V1, P639; Phung-Duc T, 2009, J OPER RES SOC JPN, V52, P58; Phung-Duc T, 2009, J IND MANAG OPTIM, V5, P431, DOI 10.3934/jimo.2009.5.431; Phung-Duc T, 2010, J IND MANAG OPTIM, V6, P517, DOI 10.3934/jimo.2010.6.517; Phung-Duc T, 2014, ASIA PAC J OPER RES, V31, DOI 10.1142/S0217595914400089; Phung-Duc T, 2014, ANN OPER RES, DOI [10.1007/s10479-014-1598-2, DOI 10.1007/S10479-014-1598-2]; Sakurai H, 2013, P 8 INT C QUEUEING T, P39; TWEEDIE RL, 1975, MATH PROC CAMBRIDGE, V78, P125, DOI 10.1017/S0305004100051562	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1134-5764	1863-8279		TOP	Top	JUL	2015	23	2					466	492		10.1007/s11750-014-0349-5		27	Operations Research & Management Science	Operations Research & Management Science	CL9FV	WOS:000357282800012		
J	Cheng, QM; Wei, GX				Cheng, Qing-Ming; Wei, Guoxin			A GAP THEOREM OF SELF-SHRINKERS	TRANSACTIONS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article						The second fundamental form; elliptic operator; self-shrinkers	MEAN-CURVATURE FLOW; SINGULARITIES; RIGIDITY	In this paper, we study complete self-shrinkers in Euclidean space and prove that an n-dimensional complete self-shrinker with polynomial volume growth in Euclidean space Rn+1 is isometric to either R-n, S-n(root n), or Rn-m x S-m(root m), 1 <= m <= n - 1, if the squared norm S of the second fundamental form is constant and satisfies S < 10/7.	[Cheng, Qing-Ming] Fukuoka Univ, Fac Sci, Dept Appl Math, Fukuoka 8140180, Japan; [Wei, Guoxin] S China Normal Univ, Sch Math Sci, Guangzhou 510631, Guangdong, Peoples R China	Cheng, QM (reprint author), Fukuoka Univ, Fac Sci, Dept Appl Math, Fukuoka 8140180, Japan.	cheng@fukuoka-u.ac.jp; weiguoxin@tsinghua.org.cn			JSPS [24340013, 25610016]; NSFC [11001087]; project of Pear River New Star of Guangzhou [2012J2200028]	The first author was partially supported by JSPS Grant-in-Aid for Scientific Research (B): No. 24340013 and Challenging Exploratory Research No. 25610016.; The second author was partly supported by NSFC No. 11001087 and the project of Pear River New Star of Guangzhou No. 2012J2200028.	ABRESCH U, 1986, J DIFFER GEOM, V23, P175; Angenent Sigurd B., 1992, PROGR NONLINEAR DIFF, V7, P21; Colding TH, 2012, ANN MATH, V175, P755, DOI 10.4007/annals.2012.175.2.7; Ding Q, 2013, ASIAN J MATH, V17, P443; Cao HD, 2013, CALC VAR PARTIAL DIF, V46, P879, DOI 10.1007/s00526-012-0508-1; Ding Q, 2014, T AM MATH SOC, V366, P5067; HUISKEN G, 1984, J DIFFER GEOM, V20, P237; HUISKEN G, 1990, J DIFFER GEOM, V31, P285; Huisken Gerhard, 1993, P S PURE MATH, V54, P175; Le Nam Q., 2011, COMMUN ANAL GEOM, V19, P633, DOI 10.4310/CAG.2011.v19.n4.a1; Li HZ, 2014, J MATH SOC JPN, V66, P709, DOI 10.2969/jmsj/06630709; Yang HC, 1998, MATH Z, V227, P377, DOI 10.1007/PL00004382	12	0	0	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9947	1088-6850		T AM MATH SOC	Trans. Am. Math. Soc.	JUL	2015	367	7					4895	4915	PII S0002-9947(2015)06161-3			21	Mathematics	Mathematics	CL5ZW	WOS:000357045700013		
J	Antonny, B; Vanni, S; Shindou, H; Ferreira, T				Antonny, Bruno; Vanni, Stefano; Shindou, Hideo; Ferreira, Thierry			From zero to six double bonds: phospholipid unsaturation and organelle function	TRENDS IN CELL BIOLOGY			English	Review						polyunsaturated phospholipid; membrane curvature; lipid-packing defect; mechanotransduction; lipid remodeling	POLYUNSATURATED FATTY-ACIDS; UNFOLDED-PROTEIN RESPONSE; MOLECULAR-DYNAMICS SIMULATIONS; ENDOPLASMIC-RETICULUM STRESS; SYNAPTIC VESICLE REFORMATION; LIPID-PACKING SENSOR; ROD OUTER SEGMENTS; MEMBRANE-CURVATURE; CAENORHABDITIS-ELEGANS; DOCOSAHEXAENOIC ACID	Cellular phospholipids (PLs) differ by the nature of their polar heads as well as by the length and unsaturation level of their fatty acyl chains. We discuss how the ratio between saturated, monounsaturated, and polyunsaturated PLs impacts on the functions of such organelles as the endoplasmic reticulum, synaptic vesicles, and photoreceptor discs. Recent experiments and simulations suggest that polyunsaturated PLs respond differently to mechanical stress, including membrane bending, than monounsaturated PLs owing to their unique conformational plasticity. These findings suggest a rationale for PL acyl chain remodeling by acyltransferases and a molecular explanation for the importance of a balanced fatty acid diet.	[Antonny, Bruno; Vanni, Stefano] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Antonny, Bruno; Vanni, Stefano] CNRS, F-06560 Valbonne, France; [Shindou, Hideo] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Res Inst, Shinjuku Ku, Tokyo 1628655, Japan; [Shindou, Hideo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Ferreira, Thierry] Univ Poitiers, Lab Signalisat & Transports Lon Membranaires STIM, CNRS Equipe Rech Labellisee ERL, F-86073 Poitiers 9, France	Antonny, B (reprint author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	antonny@ipmc.cnrs.fr	Vanni, Stefano/D-6414-2011	Vanni, Stefano/0000-0003-2146-1140	CNRS; European Research Council [268888]; Agence Nationale de la Recherche [ANR-11-LABX-0028-01]	Work in the laboratory of B.A. is supported by the CNRS, the European Research Council (advanced grant 268888), and the Agence Nationale de la Recherche (ANR-11-LABX-0028-01).	Aeffner S, 2012, P NATL ACAD SCI USA, V109, pE1609, DOI 10.1073/pnas.1119442109; Watanabe S, 2014, NATURE, V515, P228, DOI 10.1038/nature13846; Nath S, 2014, NAT CELL BIOL, V16, P415, DOI 10.1038/ncb2940; Kononenko NL, 2014, NEURON, V82, P981, DOI 10.1016/j.neuron.2014.05.007; Wang ZJ, 2010, J PHYS CHEM B, V114, P11207, DOI 10.1021/jp102543j; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Shindou H, 2013, J BIOCHEM, V154, P21, DOI 10.1093/jb/mvt048; Bertolotti A, 2000, NAT CELL BIOL, V2, P326; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; Rawicz W, 2000, BIOPHYS J, V79, P328; Risselada HJ, 2009, PHYS CHEM CHEM PHYS, V11, P2056, DOI 10.1039/b818782g; Surma MA, 2013, MOL CELL, V51, P519, DOI 10.1016/j.molcel.2013.06.014; Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036; Vamparys L, 2013, BIOPHYS J, V104, P585, DOI 10.1016/j.bpj.2012.11.3836; Vasquez V, 2014, CELL REP, V6, P70, DOI 10.1016/j.celrep.2013.12.012; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Hou NS, 2014, P NATL ACAD SCI USA, V111, pE2271, DOI 10.1073/pnas.1318262111; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Grossfield A, 2006, P NATL ACAD SCI USA, V103, P4888, DOI 10.1073/pnas.0508352103; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Eldho NV, 2003, J AM CHEM SOC, V125, P6409, DOI 10.1021/ja029029o; Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Puchkov D, 2013, TRENDS CELL BIOL, V23, P493, DOI 10.1016/j.tcb.2013.05.002; Wallis JG, 2002, TRENDS BIOCHEM SCI, V27, P467, DOI 10.1016/S0968-0004(02)02168-0; D'Souza K, 2014, BBA-BIOMEMBRANES, V1838, P1501, DOI 10.1016/j.bbamem.2013.10.003; Lesa GM, 2003, J CELL SCI, V116, P4965, DOI 10.1242/jcs.00918; Kitai Y, 2013, GENES CELLS, V18, P798, DOI 10.1111/gtc.12074; Ogasawara Y, 2014, J BIOL CHEM, V289, P23938, DOI 10.1074/jbc.M114.591065; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Clay L, 2014, ELIFE, V3, DOI 10.7554/eLife.01883; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340; Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Piggot TJ, 2012, J CHEM THEORY COMPUT, V8, P4593, DOI 10.1021/ct3003157; Connor WE, 1998, J LIPID RES, V39, P1404; Brugger B, 2014, ANNU REV BIOCHEM, V83, P79, DOI 10.1146/annurev-biochem-060713-035324; Vanni S, 2013, BIOPHYS J, V104, P575, DOI 10.1016/j.bpj.2012.11.3837; Nilsson IM, 2001, J BIOL CHEM, V276, P41748, DOI 10.1074/jbc.M105823200; Preston AM, 2009, DIABETOLOGIA, V52, P2369, DOI 10.1007/s00125-009-1506-5; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Rajamoorthi K, 2005, J AM CHEM SOC, V127, P1576, DOI 10.1021/ja046453b; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Hishikawa D, 2013, FASEB J, V27, P5131, DOI 10.1096/fj.13-237941; Soubias O, 2010, BIOPHYS J, V99, P817, DOI 10.1016/j.bpj.2010.04.068; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143-4160(02)00188-4; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Kincaid MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ars.2007.1817; Nilius B, 2012, TRENDS NEUROSCI, V35, P477, DOI 10.1016/j.tins.2012.04.002; Shinoda W, 2010, J PHYS CHEM B, V114, P6836, DOI 10.1021/jp9107206; Koeberle A, 2013, P NATL ACAD SCI USA, V110, P2546, DOI 10.1073/pnas.1216182110; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; Soubias O, 2006, J BIOL CHEM, V281, P33233, DOI 10.1074/jbc.M603059200; APPLEGATE KR, 1986, J LIPID RES, V27, P658; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Campelo F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003556; Choi SE, 2008, ARCH BIOCHEM BIOPHYS, V475, P109, DOI 10.1016/j.abb.2008.04.015; Deng YR, 2009, FASEB J, V23, P2866, DOI 10.1096/fj.09-130435; Entchev EV, 2008, J BIOL CHEM, V283, P17550, DOI 10.1074/jbc.M800965200; Guo S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05959; KEENAN TW, 1970, BIOCHEMISTRY-US, V9, P19, DOI 10.1021/bi00803a003; Kononenko NL, 2015, NEURON, V85, P484, DOI 10.1016/j.neuron.2014.12.016; Lyn RK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04549; Marza E, 2006, BIOCHEM SOC T, V34, P77; Mitchell DC, 2012, CHEM PHYS LIPIDS, V165, P393, DOI 10.1016/j.chemphyslip.2012.02.008; Mitchell DC, 1998, BIOPHYS J, V74, P879; Mitchell DC, 2001, J BIOL CHEM, V276, P42801; Morimoto R, 2014, J BIOL CHEM, V289, P15566, DOI 10.1074/jbc.M114.558874; Naguib A, 2015, CELL REP, V10, P8, DOI 10.1016/j.celrep.2014.12.010; PAYET LA, 2013, TRAFFIC, V14, P1228; Randall AS, 2015, J NEUROSCI, V35, P2731, DOI 10.1523/JNEUROSCI.1150-14.2015; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Seo J, 2006, FASEB J, V20, P770, DOI 10.1096/fj.05-4683fje; STONE WL, 1979, EXP EYE RES, V28, P387, DOI 10.1016/0014-4835(79)90114-3; TIXIERVIDAL A, 1986, NEUROSCIENCE, V17, P115, DOI 10.1016/0306-4522(86)90230-7; Vanni S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5916; Volmer R, 2014, CURR OPIN CELL BIO C, V33C, P67; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723; Zhendre V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023859	91	1	1	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0962-8924			TRENDS CELL BIOL	Trends Cell Biol.	JUL	2015	25	7					427	436		10.1016/j.tcb.2015.03.004		10	Cell Biology	Cell Biology	CM0GT	WOS:000357357100007		
J	Fukui, A; Kawabe, N; Hashimoto, S; Murao, M; Nakano, T; Shimazaki, H; Kan, T; Nakaoka, K; Ohki, M; Takagawa, Y; Kamei, H; Yoshioka, K				Fukui, Aiko; Kawabe, Naoto; Hashimoto, Senju; Murao, Michihito; Nakano, Takuji; Shimazaki, Hiroaki; Kan, Toshiki; Nakaoka, Kazunori; Ohki, Masashi; Takagawa, Yuka; Kamei, Hiroyuki; Yoshioka, Kentaro			Additional BCAA-enriched nutrient mixture improves the nutritional condition in cirrhotic patients with hypoalbuminemia despite treatment with regular BCAA granules: A pilot study	TURKISH JOURNAL OF GASTROENTEROLOGY			English	Article						Liver cirrhosis; amino acid; branched-chain; hypoalbuminemia	CHAIN AMINO-ACIDS; LATE EVENING SNACK; LIVER-CIRRHOSIS; ENERGY-METABOLISM; PROGNOSTIC VALUE; SUPPLEMENTATION; SURVIVAL; ALBUMIN; DISEASE; LEVEL	Background/Aims: To elucidate the effect of adding branched-chain amino acid (BCAA)-enriched nutrient mixtures in cirrhotic patients with hypoalbuminemia despite the use of BCAA granules. Materials and Methods: A BCAA-enriched nutrient mixture containing 5.6 g of BCAA and 210 kcal was additionally administered in 40 cirrhotic patients with hypoalbuminemia despite their treatment with BCAA granules containing 12 g of BCAA. Laboratory data were assessed at 6 months before beginning additional therapy, at baseline, and at 6 months after baseline. Results: Serum albumin levels significantly decreased from 6 months before baseline (3.14+/-0.47 g/dL) to baseline (2.83+/-0.46 g/dL), despite the treatment with BCAA granules (p<0.001), and tended to increase from baseline to 6 months after baseline (2.95+/-0.42 g/dL) (p=0.084). In the subset of 23 patients without hepatocellular carcinoma treatments, upper gastrointestinal tract bleeding, or albumin infusion, serum albumin levels significantly increased from baseline (2.93+/-0.38 g/dL) to 6 months after baseline (3.15+/-0.34 g/dL) (p=0.014). Conclusion: Additional therapy with BCAA-enriched nutrient mixtures increased serum albumin levels of the cirrhotic patients with hypoalbuminemia despite the treatment with BCAA granules and without hepatocellular carcinoma treatment, upper gastrointestinal tract bleeding, or albumin infusion.	[Fukui, Aiko; Kamei, Hiroyuki] Meijo Univ, Fac Pharm, Dept Clin Pharm Practice & Hlth Care Management, Nagoya, Aichi 468, Japan; [Fukui, Aiko; Kawabe, Naoto; Hashimoto, Senju; Murao, Michihito; Nakano, Takuji; Shimazaki, Hiroaki; Kan, Toshiki; Nakaoka, Kazunori; Ohki, Masashi; Takagawa, Yuka; Yoshioka, Kentaro] Fujita Hlth Univ, Fac Med, Dept Liver Biliary Tract & Pancreas Dis, Toyoake, Aichi, Japan	Yoshioka, K (reprint author), Fujita Hlth Univ, Fac Med, Dept Liver Biliary Tract & Pancreas Dis, Toyoake, Aichi, Japan.	kyoshiok@fujita-hu.ac.jp					Takeshita S, 2009, NUTR RES, V29, P89, DOI 10.1016/j.nutres.2008.12.005; Tsuchiya M, 2005, HEPATOL RES, V31, P95, DOI 10.1016/j.hepres.2004.11.009; Alberino F, 2001, NUTRITION, V17, P445, DOI 10.1016/S0899-9007(01)00521-4; Yoshizawa F, 2012, J PHARMACOL SCI, V118, P149, DOI 10.1254/jphs.11R05FM; OWEN OE, 1983, J CLIN INVEST, V72, P1821, DOI 10.1172/JCI111142; Plauth M, 1997, CLIN NUTR, V16, P43, DOI 10.1016/S0261-5614(97)80022-2; Yamanaka-Okumura H, 2006, EUR J CLIN NUTR, V60, P1067, DOI 10.1038/sj.ejcn.1602420; Aoyama K, 2007, HEPATOL RES, V37, P608, DOI 10.1111/j.1872-034X.2007.00036; Marchesini G, 2003, GASTROENTEROLOGY, V124, P1792, DOI 10.1016/S0016-5085(03)00323-8; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Moriwaki H, 2004, BIOCHEM BIOPH RES CO, V313, P405, DOI 10.1016/j.bbrc.2003.07.016; ZILLIKENS MC, 1993, J HEPATOL, V17, P377, DOI 10.1016/S0168-8278(05)80221-1; Muto Y, 2005, CLIN GASTROENTEROL H, V3, P705, DOI 10.1053/S1542-3565(05)00017-0; Guechot J, 2000, J HEPATOL, V32, P447, DOI 10.1016/S0168-8278(00)80396-7; Miwa Y, 2000, HEPATOL RES, V18, P184, DOI 10.1016/S1386-6346(99)00100-X; Charlton M, 2006, J NUTR, V136, p295S; Directors ABo, 2002, JPEN J PARENTER ENTE, V26, p1SA; Kotoh K, 2005, WORLD J GASTROENTERO, V11, P1356; Muto Y, 1992, JPN J PARENTERAL ENT, V14, P369; Nakaya Y, 2002, J GASTROENTEROL, V37, P531, DOI 10.1007/s005350200082; Nakaya Y, 2007, NUTRITION, V23, P113, DOI 10.1016/j.nut.2006.10.008; Okamoto M, 2003, HEPATOL RES, V27, P45, DOI 10.1016/S1386-6346(03)00190-6; Tajika M, 2002, NUTRITION, V18, P229, DOI 10.1016/S0899-9007(01)00754-7; YAMATO M, 1995, INT HEPATOL COMMUN, V3, P91, DOI 10.1016/0928-4346(94)00159-3	24	0	0	AVES	SISLI	BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34096, TURKEY	1300-4948			TURK J GASTROENTEROL	Turk. J. Gastroenterol.	JUL	2015	26	4					328	335		10.5152/tjg.2015.0202		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL9YD	WOS:000357334100007		
J	Lee, SY; Saito, T; Mitomi, H; Hidaka, Y; Murakami, T; Nomura, R; Watanabe, S; Yao, T				Lee, Se-Yong; Saito, Tsuyoshi; Mitomi, Hiroyuki; Hidaka, Yasuhiro; Murakami, Takashi; Nomura, Ryosuke; Watanabe, Sumio; Yao, Takashi			Mutation spectrum in the Wnt/beta-catenin signaling pathway in gastric fundic gland-associated neoplasms/polyps	VIRCHOWS ARCHIV			English	Article						Gastric adenocarcinoma of the fundic gland type; Fundic gland polyp; Fundic gland polyp with dysplasia; CTNNB1; Axin; APC; PPP2R1A; Mutation	CELL PREDOMINANT TYPE; FAMILIAL ADENOMATOUS POLYPOSIS; PROTEIN PHOSPHATASE 2A; BETA-CATENIN; TUMOR-SUPPRESSOR; COLI GENE; AXIN; ADENOCARCINOMA; CARCINOMAS; EXPRESSION	Frequent activation of the Wnt/beta-catenin signaling pathway has recently been demonstrated in gastric adenocarcinoma/neoplasia of chief cell predominant type (GA-CCP/GN-CCP) with submucosal involvement. In this study, we examined the activation status of the Wnt/beta-catenin signaling pathway in GN-CCP without submucosal involvement, which is referred to as gastric dysplasia-CCP (GD-CCP). We also examined beta-catenin expression and the mutation spectrum of PPP2R1A and Wnt pathway genes in 11 cases of GD-CCP, 25 cases of gastric polyps of fundic gland type (GPs-FG), and 21 cases of GPs-FG with dysplasia (GP-FGD). beta-catenin nuclear staining was observed in 3 cases of GD-CCP, none of GPs-FG, and 6 cases of GPs-FGD. Mutations in Wnt pathway genes, including PPP2R1A, were observed in 4 cases of GDs-CCP, 10 cases of GPs-FG, and 7 cases of GPs-FGD. Two of these seven GPs-FGD cases showed beta-catenin nuclear staining. However, none of the 4 GD-CCP cases with mutations or the 10 GPs-FG cases with mutations showed beta-catenin nuclear staining. PPP2R1A mutations were observed in 1 GD-CCP case and 1 GPs-FGD case. Although the mutation spectra of the Wnt pathway genes in GD-CCP and GP-FG differed, based on the absence of beta-catenin nuclear staining despite the genetic alterations, GD-CCP is more similar to GP-FG than to GN-CCP, which shows beta-catenin nuclear staining and submucosal involvement. Activation of the Wnt/beta-catenin signaling by the beta-catenin nuclear transition may be required during progression from GD-CCP to GN-CCP. Furthermore, this is the first report describing PPP2R1A mutations in gastric fundic gland-associated neoplasms.	[Lee, Se-Yong; Saito, Tsuyoshi; Hidaka, Yasuhiro; Murakami, Takashi; Nomura, Ryosuke; Yao, Takashi] Juntendo Univ, Sch Med, Dept Human Pathol, Bunkyo Ku, Tokyo 1138421, Japan; [Lee, Se-Yong; Hidaka, Yasuhiro; Murakami, Takashi; Nomura, Ryosuke; Watanabe, Sumio] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 1138421, Japan; [Mitomi, Hiroyuki] Dokkyo Univ, Sch Med, Dept Surg & Mol Pathol, Mibu, Tochigi 3210293, Japan	Saito, T (reprint author), Juntendo Univ, Sch Med, Dept Human Pathol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	tysaitou@juntendo.ac.jp			Ministry of Education, Science, Sports, and Culture, Tokyo, Japan [26670286, 24590429, 26460428]	This work was supported, in part, by a Grant-in-Aid for General Scientific Research from the Ministry of Education, Science, Sports, and Culture (#26670286 to Tsuyoshi Saito, #24590429 to Hiroyuki Mitomi and #26460428 to Takashi Yao), Tokyo, Japan.	Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Shih IM, 2011, AM J PATHOL, V178, P1442, DOI 10.1016/j.ajpath.2011.01.009; Ogasawara N, 2006, HISTOPATHOLOGY, V49, P612, DOI 10.1111/j.1365-2559.2006.02560.x; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Sekine S, 2002, VIRCHOWS ARCH, V440, P381, DOI 10.1007/s004280100527; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Wu TT, 1998, AM J SURG PATHOL, V22, P293, DOI 10.1097/00000478-199803000-00003; Smalley MJ, 1999, CANCER METAST REV, V18, P215, DOI 10.1023/A:1006369223282; Clements WM, 2002, CANCER RES, V62, P3503; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Abraham SC, 2000, AM J PATHOL, V157, P747, DOI 10.1016/S0002-9440(10)64588-9; Singhi AD, 2012, AM J SURG PATHOL, V36, P1030, DOI 10.1097/PAS.0b013e31825033e7; Burt RW, 2003, GASTROENTEROLOGY, V125, P1462, DOI 10.1053/S0016-5085(03)01393-3; Ratcliffe MJ, 2000, J BIOL CHEM, V275, P35680, DOI 10.1074/jbc.C000639200; Hidaka Y, 2013, HUM PATHOL, V44, P2438, DOI 10.1016/j.humpath.2013.06.002; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Itoh K, 2000, MOL CELL BIOL, V20, P2228, DOI 10.1128/MCB.20.6.2228-2238.2000; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Abraham SC, 2002, AM J PATHOL, V161, P1735, DOI 10.1016/S0002-9440(10)64450-1; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Abraham SC, 2001, AM J PATHOL, V158, P1005, DOI 10.1016/S0002-9440(10)64047-3; Bos CL, 2006, ONCOGENE, V25, P6447, DOI 10.1038/sj.onc.1209658; Ueyama H, 2010, AM J SURG PATHOL, V34, P609, DOI 10.1097/PAS.0b013e3181d94d53; Sekine S, 2004, MODERN PATHOL, V17, P1421, DOI 10.1038/modpathol.3800178; Hassan A, 2004, HUM PATHOL, V35, P328, DOI 10.1016/j.humpath.2003.10.010; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Sasaki Y, 2001, TUMOR BIOL, V22, P123, DOI 10.1159/000050606; Woo DK, 2001, INT J CANCER, V95, P108, DOI 10.1002/1097-0215(20010320)95:2<108::AID-IJC1019>3.0.CO;2-#; Chen Wei-Chung, 2012, J Gastrointest Cancer, V43 Suppl 1, P262, DOI 10.1007/s12029-012-9416-z; Cho KH, 2006, FEBS LETT, V580, P3665, DOI 10.1016/j.febslet.2006.05.053; Fukatsu H, 2011, DIGEST ENDOSC, V23, P244, DOI 10.1111/j.1443-1661.2011.01125.x; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Jalving M, 2003, SCAND J GASTROENTERO, V38, P916, DOI 10.1080/00365520310005433; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; Lagarde A, 2010, J MED GENET, V47, P721, DOI 10.1136/jmg.2010.078964; Nomura R, 2014, HUM PATHOL, V45, P2488, DOI 10.1016/j.humpath.2014.08.016; Rahman M, 2013, ANTICANCER RES, V33, P113; Turner JR, 2009, SURG PATHOLOGY GI TR, P415, DOI 10.1016/B978-141604059-0.50020-5; Ueyama H, 2014, ENDOSCOPY, V46, P153, DOI 10.1055/s-0033-1359042; Yagi OK, 1997, JPN J CANCER RES, V88, P718	42	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	JUL	2015	467	1					27	38		10.1007/s00428-015-1753-4		12	Pathology	Pathology	CM2AP	WOS:000357482200005		
J	Oiwa, M; Endo, T; Ichihara, S; Moritani, S; Hasegawa, M; Iwakoshi, A; Sato, Y; Morita, T; Hayashi, T; Kato, A				Oiwa, Mikinao; Endo, Tokiko; Ichihara, Shu; Moritani, Suzuko; Hasegawa, Masaki; Iwakoshi, Akari; Sato, Yasuyuki; Morita, Takako; Hayashi, Takako; Kato, Aya			Sclerosing adenosis as a predictor of breast cancer bilaterality and multicentricity	VIRCHOWS ARCHIV			English	Article						Cancer; Breast carcinoma; Sclerosing adenosis; Bilateral breast cancer; Multicentiric cancer	CARCINOMA IN-SITU; APOCRINE METAPLASIA; LESIONS; HYPERPLASIA; RISK	Breast cancer is occasionally complicated by sclerosing adenosis (SA). Although both lesions usually originate in the terminal duct lobular unit, their pathogenetic relationship has not yet been elucidated. The present study analyzed 63 breast cancer patients with SA (involving a total of 75 breasts) to clarify if coexisting SA increased the frequency of multicentric breast cancer or not. Using the topographical classification proposed in our previous study, breast cancers with SA were classified into the following three types: type A (n = 22), cancer area was completely surrounded by the SA; type B (n = 26), cancer area partially overlapped the SA; and type C (n = 27), cancer area was located separate from the SA. Breast cancers with SA had a significant (P < 0.001) increase in frequency of harboring bilateral and multicentric cancers [17 of 63 (27 %) and 15 of 63 (24 %), respectively] when compared to breast cancer patients without SA, regardless of topographical type. Breast cancers with SA were less invasive (P < 0.001), of lower histological grade (P = 0.034), and had similar frequency of estrogen receptor-positive (P = 0.21) and HER2-positive (P = 0.74) tumors. In conclusion, contralateral and ipsilateral multicentric breast cancers occurred at a higher frequency in those with SA. Our data suggest that SA is, in addition to lobular neoplasia, a predictor of multicentric breast cancers.	[Oiwa, Mikinao; Endo, Tokiko] Nagoya Med Ctr, Dept Radiol, Naka Ku, Nagoya, Aichi 4600001, Japan; [Ichihara, Shu; Moritani, Suzuko; Hasegawa, Masaki; Iwakoshi, Akari] Nagoya Med Ctr, Div Pathol, Dept Adv Diag, Naka Ku, Nagoya, Aichi 4600001, Japan; [Sato, Yasuyuki; Morita, Takako; Hayashi, Takako; Kato, Aya] Nagoya Med Ctr, Dept Breast Surg, Naka Ku, Nagoya, Aichi 4600001, Japan	Oiwa, M (reprint author), Nagoya Med Ctr, Dept Radiol, Naka Ku, 4-1-1 Sannnomaru, Nagoya, Aichi 4600001, Japan.	m.oiwa@nnh.hosp.go.jp					FRANQUET T, 1993, RADIOGRAPHICS, V13, P841; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; SLOANE JP, 1993, HISTOPATHOLOGY, V23, P225, DOI 10.1111/j.1365-2559.1993.tb01194.x; Yoshida A, 2012, CLIN BREAST CANCER, V12, P398, DOI 10.1016/j.clbc.2012.08.002; Van Bockstal M, 2014, VIRCHOWS ARCH, V465, P275, DOI 10.1007/s00428-014-1609-3; Hartmann LC, 2005, NEW ENGL J MED, V353, P229, DOI 10.1056/NEJMoa044383; Nichol AM, 2011, J CLIN ONCOL, V29, P4763, DOI 10.1200/JCO.2011.35.0165; Latta EK, 2002, MODERN PATHOL, V15, P1318, DOI 10.1097/01.MP.0000038462.62634.B1; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Taskin F, 2011, DIAGN INTERV RADIOL, V17, P311, DOI 10.4261/1305-3825.DIR.3785-10.2; Shoker BS, 2000, J CLIN PATHOL, V53, P778, DOI 10.1136/jcp.53.10.778; Celis JE, 2007, MOL ONCOL, V1, P97, DOI 10.1016/j.molonc.2007.02.005; Chen JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095185; Drosos Y, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-19; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; EUSEBI V, 1989, SEMIN DIAGN PATHOL, V6, P146; FAVERLY DRG, 1994, SEMIN DIAGN PATHOL, V11, P193; Gunhan-Bilgen I, 2002, EUR J RADIOL, V44, P232, DOI 10.1016/S0720-048X(02)00020-7; JENSEN RA, 1989, CANCER, V64, P1977, DOI 10.1002/1097-0142(19891115)64:10<1977::AID-CNCR2820641002>3.0.CO;2-N; Moritani S, 2011, HISTOPATHOLOGY, V58, P835, DOI 10.1111/j.1365-2559.2011.03792.x; OBERMAN HA, 1991, MODERN PATHOL, V4, P31; Ogura K, 2014, BREAST CANCER-TOKYO, V21, P732, DOI 10.1007/s12282-013-0450-x; Oiwa M, 2011, J JPN ASS BREAST CAN, V20, P196; Pojchamarnwiputh S., 2007, SMJ Singapore Medical Journal, V48, P958; PREECE PE, 1989, WORLD J SURG, V13, P721; Rosen PP, 2009, BREAST PATHOLOGY, V3rd, p[161, 690]; Sekine Ken, 2007, Breast Cancer, V14, P281, DOI 10.2325/jbcs.14.281; Selim AGA, 2002, VIRCHOWS ARCH, V441, P449, DOI 10.1007/s00428-002-0691-0; Tavassoli FA, 1999, PATHOLOGY BREAST, V2nd, p[32, 130]; The Japanese Breast Cancer Society, 2010, INV REP REG BREAST C; Visscher DW, 2014, BREAST CANCER RES TR, V144, P205, DOI 10.1007/s10549-014-2862-5	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	JUL	2015	467	1					71	78		10.1007/s00428-015-1769-9		8	Pathology	Pathology	CM2AP	WOS:000357482200010		
J	Hara, S; Goto, S; Kamiura, N; Yoshimoto, A; Naito, T; Imagawa, N; Imai, Y; Yanagita, M; Nishi, S; Itoh, T				Hara, Shigeo; Goto, Shunsuke; Kamiura, Nozomu; Yoshimoto, Akihiro; Naito, Takayuki; Imagawa, Naoko; Imai, Yukihiro; Yanagita, Motoko; Nishi, Shinichi; Itoh, Tomoo			Reappraisal of PLA2R1 in membranous nephropathy: immunostaining method influence and association with IgG4-dominant phenotype	VIRCHOWS ARCHIV			English	Article						PLA2R1; IgG subclass; Membranous nephropathy; Immunofluorescence study	PHOSPHOLIPASE-A2 RECEPTOR; IGG SUBCLASSES; DE-NOVO; AUTOANTIBODIES; ANTIBODIES; GLOMERULONEPHRITIS; GLOMERULOPATHY; COMPLEMENT; EXPRESSION; RECURRENT	The M-type phospholipase A2 receptor (PLA2R1) was identified recently as a specific target antigen in idiopathic membranous nephropathy. However, the influence of different sample preparation techniques on the immunostaining of PLA2R1 is unclear. Previous studies have identified IgG4 as the dominant subclass of PLA2R1 antibodies. However, it remains unclear whether the IgG subclass profiles of the glomerular immune complexes of PLA2R1-positive and -negative idiopathic membranous nephropathy cases are similar. To address these questions, we conducted the present study of 58 idiopathic membranous nephropathy cases. The PLA2R1 positivity rate for the paraffin-embedded sections was 61 %, whereas that for the frozen sections was 65 %. Nonspecific background staining was observed in the frozen sections. Discrepancies between different sample preparations occurred in three cases (6 %); two cases were PLA2R1-positive in paraffin sections and PLA2R1-negative in frozen sections and one case was PLA2R1-negative in paraffin sections and PLA2R1-positive in frozen sections. Regarding the IgG subclass profile, 89 % of the PLA2R1-positive cases demonstrated the IgG4-dominant/codominant phenotype versus 31 % of the PLA2R1-negative cases (p < 0.001). Clinical characteristics and pathological findings did not significantly differ between PLA2R1-positive and -negative cases. In summary, the PLA2R1 immunofluorescence results were not affected by the different sample preparation techniques, although paraffin-embedded sections were preferred for the histological detection of PLA2R1 because of the nonspecific background staining observed in frozen sections. The observed lower frequency of the non-IgG4-dominant/codominant phenotype in PLA2R1-negative idiopathic membranous nephropathy cases may suggest that there are heterogeneous subgroups of this disease.	[Hara, Shigeo; Itoh, Tomoo] Kobe Univ, Grad Sch Med, Dept Diagnost Pathol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Goto, Shunsuke; Nishi, Shinichi] Kobe Univ, Grad Sch Med, Div Nephrol, Kobe, Hyogo 6500017, Japan; [Goto, Shunsuke; Nishi, Shinichi] Kobe Univ, Grad Sch Med, Kidney Ctr, Kobe, Hyogo 6500017, Japan; [Kamiura, Nozomu; Yoshimoto, Akihiro] Kobe City Med Ctr Gen Hosp, Dept Nephrol, Kobe, Hyogo, Japan; [Naito, Takayuki] Hiroshima Prefectural Hosp, Div Nephrol & Dialysis, Hiroshima, Japan; [Imagawa, Naoko] Kobe Univ Hosp, Dept Diagnost Pathol, Kobe, Hyogo, Japan; [Imagawa, Naoko] Kobe Univ Hosp, Kobe Adv Tissue Staining Ctr, Kobe, Hyogo, Japan; [Hara, Shigeo; Imai, Yukihiro] Kobe City Med Ctr Gen Hosp, Dept Pathol, Kobe, Hyogo, Japan; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan	Hara, S (reprint author), Kobe Univ, Grad Sch Med, Dept Diagnost Pathol, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	shara@med.kobe-u.ac.jp					Akiyama S, 2014, CLIN EXP NEPHROL; Larsen C, 2013, FORTUNE, V167, P26; Hoxha E, 2012, KIDNEY INT, V82, P797, DOI 10.1038/ki.2012.209; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Ohtani H, 2004, NEPHROL DIAL TRANSPL, V19, P574, DOI 10.1093/ndt/gfg616; Debiec H, 2011, AM J TRANSPLANT, V11, P2144, DOI 10.1111/j.1600-6143.2011.03643.x; DOI T, 1984, CLIN EXP IMMUNOL, V58, P57; Dahnrich C, 2013, CLIN CHIM ACTA, V421, P213, DOI 10.1016/j.cca.2013.03.015; Huang CC, 2013, MODERN PATHOL, V26, P799, DOI 10.1038/modpathol.2012.237; Beck LH, 2010, KIDNEY INT, V77, P765, DOI 10.1038/ki.2010.34; Cossey LN, 2013, PEDIATR NEPHROL, V28, P2307, DOI 10.1007/s00467-013-2574-9; Kuroki A, 2005, KIDNEY INT, V68, P302, DOI 10.1111/j.1523-1755.2005.00415.x; Larsen CP, 2013, TRANSPLANTATION, V95, P1259, DOI 10.1097/TP.0b013e31828a947b; Qin WS, 2011, J AM SOC NEPHROL, V22, P1137, DOI 10.1681/ASN.2010090967; Coenen MJH, 2013, J AM SOC NEPHROL, V24, P677, DOI 10.1681/ASN.2012070730; Lv JC, 2013, J AM SOC NEPHROL, V24, P1323, DOI 10.1681/ASN.2012080771; Svobodova B, 2013, NEPHROL DIAL TRANSPL, V28, P1839, DOI 10.1093/ndt/gfs439; Kuroki A, 2002, INTERNAL MED, V41, P936, DOI 10.2169/internalmedicine.41.936; Hoxha E, 2014, J AM SOC NEPHROL, V25, P1357, DOI 10.1681/ASN.2013040430; Ma H, 2013, SEMIN NEPHROL, V33, P531, DOI 10.1016/j.semnephrol.2013.08.004; Daha NA, 2011, MOL IMMUNOL, V48, P1656, DOI 10.1016/j.molimm.2011.04.024; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Ifuku M, 2013, AM J NEPHROL, V38, P115, DOI 10.1159/000353102; Ma H, 2011, J AM SOC NEPHROL, V22, p62A; Oh YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062151; Seemayer CA, 2007, NEPHROL DIAL TRANSPL, V22, P568, DOI 10.1093/ndt/gfl594	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	JUL	2015	467	1					87	94		10.1007/s00428-015-1754-3		8	Pathology	Pathology	CM2AP	WOS:000357482200012		
J	Li, G; Lee, HR; Nagasawa, H; Kanezashi, M; Yoshioka, T; Tsuru, T				Li, Gang; Lee, Hye Ryeon; Nagasawa, Hiroki; Kanezashi, Masakoto; Yoshioka, Tomohisa; Tsuru, Toshinori			Pore-size evaluation and gas transport behaviors of microporous membranes: An experimental and theoretical study	AICHE JOURNAL			English	Article						membrane separation; pore-size evaluation; gas transport behavior; modified gas-translation model; normalized Knudsen-based permeance	MOLECULAR-SIEVE MEMBRANES; HYBRID SILICA MEMBRANES; PERMEATION PROPERTIES; ZEOLITE MEMBRANE; SEPARATION MEMBRANES; CERAMIC MEMBRANES; SECONDARY GROWTH; MIXTURES; PERMPOROMETRY; DISILOXANE	A modified gas-translation (GT) model based on a GT mechanism was successfully applied to the pore-size evaluation and gas transport behavior analysis of microporous membranes with different pore-size distributions. Based on the gas permeation results of three microporous membranes derived from different alkoxides, the effects of activation energy and the selection of a standard gas on the pore-size evaluation were discussed in a comparative study. The presence of nano-sized defects had an important influence on the gas permeation performance of microporous membranes, depending largely on the original pore size of the membrane in question. Moreover, the gas-separation effect of the pore-size distribution in a silica membrane was theoretically studied and revealed a significant increase in gas permeance for relatively large gas species but not for small ones. (c) 2015 American Institute of Chemical Engineers AIChE J, 61: 2268-2279, 2015	[Li, Gang] S China Univ Technol, Sch Light Ind & Food Sci, Dept Light Chem Engn, Guangzhou 510641, Guangdong, Peoples R China; [Lee, Hye Ryeon] Korea Res Inst Chem Technol, Res Ctr Green Fine Chem, Ulsan 681802, South Korea; [Nagasawa, Hiroki; Kanezashi, Masakoto; Yoshioka, Tomohisa; Tsuru, Toshinori] Hiroshima Univ, Dept Chem Engn, Higashihiroshima 7398527, Japan	Tsuru, T (reprint author), Hiroshima Univ, Dept Chem Engn, Higashihiroshima 7398527, Japan.	tsuru@hiroshima-u.ac.jp	Nagasawa, Hiroki/D-7613-2012; Kanezashi, Masakoto/G-3938-2010	Nagasawa, Hiroki/0000-0001-7972-2425; 			Nagasawa H, 2014, AICHE J, V60, P4199, DOI 10.1002/aic.14578; Lee HR, 2011, AICHE J, V57, P2755, DOI 10.1002/aic.12501; Oyama ST, 2011, J JPN PETROL INST, V54, P298; Tang Z, 2009, LANGMUIR, V25, P4848, DOI 10.1021/la900474y; Tomita T, 2004, MICROPOR MESOPOR MAT, V68, P71, DOI 10.1016/j.micromeso.2003.11.016; Kanezashi M, 2009, J AM CHEM SOC, V131, P414, DOI 10.1021/ja806762q; Venna SR, 2011, LANGMUIR, V27, P2888, DOI 10.1021/la105037n; Aoki K, 2000, IND ENG CHEM RES, V39, P2245, DOI 10.1021/ie990902c; CAO GZ, 1993, J MEMBRANE SCI, V83, P221, DOI 10.1016/0376-7388(93)85269-3; XIAO JR, 1992, CHEM ENG SCI, V47, P1123, DOI 10.1016/0009-2509(92)80236-6; SHELEKHIN AB, 1995, AICHE J, V41, P58, DOI 10.1002/aic.690410107; Weh K, 2002, MICROPOR MESOPOR MAT, V54, P27, DOI 10.1016/S1387-1811(02)00381-5; Hedlund J, 2009, J MEMBRANE SCI, V345, P276, DOI 10.1016/j.memsci.2009.09.012; Poshusta JC, 1998, IND ENG CHEM RES, V37, P3924, DOI 10.1021/ie980240b; Lovallo MC, 1998, AICHE J, V44, P1903, DOI 10.1002/aic.690440820; Hong M, 2005, IND ENG CHEM RES, V44, P4035, DOI 10.1021/ie048739v; Li G, 2011, J MEMBRANE SCI, V379, P287, DOI 10.1016/j.memsci.2011.05.071; Himeno S, 2007, IND ENG CHEM RES, V46, P6989, DOI 10.1021/ie061682n; Yoshioka T, 2001, AICHE J, V47, P2052, DOI 10.1002/aic.690470916; Kusakabe K, 1999, AICHE J, V45, P1220, DOI 10.1002/aic.690450608; Tsuru T, 2001, J MEMBRANE SCI, V186, P257, DOI 10.1016/S0376-7388(00)00692-X; Kanezashi M, 2012, J MEMBRANE SCI, V415, P478, DOI 10.1016/j.memsci.2012.05.034; Lee HR, 2011, J MEMBRANE SCI, V383, P152, DOI 10.1016/j.memsci.2011.08.046; Xu XC, 2005, J MEMBRANE SCI, V249, P51, DOI 10.1016/j.memsci.2004.09.032; Kanezashi M, 2012, IND ENG CHEM RES, V51, P944, DOI 10.1021/ie201606k; Aoki K, 1998, J MEMBRANE SCI, V141, P197, DOI 10.1016/S0376-7388(97)00300-1; Chang KS, 2010, CHEM COMMUN, V46, P9140, DOI 10.1039/c0cc02531c; Takata Y, 2002, MICROPOR MESOPOR MAT, V54, P257, DOI 10.1016/S1387-1811(02)00386-4; Yin HM, 2014, CHEM COMMUN, V50, P3699, DOI 10.1039/c4cc00068d; Yoshioka T, 2013, AICHE J, V59, P2179, DOI 10.1002/aic.13966	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-1541	1547-5905		AICHE J	AICHE J.	JUL	2015	61	7					2268	2279		10.1002/aic.14812		12	Engineering, Chemical	Engineering	CL1MP	WOS:000356707900013		
J	Aktar, MK; Kido-Nakahara, M; Furue, M; Nakahara, T				Aktar, M. K.; Kido-Nakahara, M.; Furue, M.; Nakahara, T.			Mutual upregulation of endothelin-1 and IL-25 in atopic dermatitis	ALLERGY			English	Article						atopic dermatitis; endothelin-1; IL-25; keratinocyte; MAPK	MAST-CELLS; IN-VIVO; SKIN; EXPRESSION; RESPONSES; ITCH; RECEPTOR; INDUCE; MODEL; INFLAMMATION	BackgroundEndothelin-1 (ET-1) has been reported to evoke histamine-independent pruritus in mammals. However, its association with pruritus or inflammation of atopic dermatitis (AD) has not been clarified. We sought to investigate the role of ET-1 in the skin inflammation of AD. MethodsTo examine the role of ET-1 in AD, we investigated the expression of ET-1 and IL-25 in the skin of an AD mouse model and patients with AD and examined the mutual regulatory relationship between ET-1 and IL-25, one of the important cytokines in AD, using the human HaCaT keratinocyte cell line. ResultsWe immunohistochemically confirmed the upregulation of ET-1 and IL-25 expression in the epidermis of both the AD mouse model and patients with AD. In vitro, IL-25 upregulated ET-1 mRNA and protein expression in a concentration- and time-dependent fashion in HaCaT cells. This IL-25-induced ET-1 expression was inhibited by ERK1/2 or JNK inhibitor. In a reciprocal manner, ET-1 also induced IL-25 upregulation. The enhancing effect of ET-1 on IL-25 was inhibited by an endothelin A receptor antagonist, ERK1/2 inhibitor, or p38 inhibitor, but not by an endothelin B receptor antagonist or JNK inhibitor. ConclusionThese findings suggest that mutual upregulation of ET-1 and IL-25 takes place in the epidermis of AD, which may be a future target for antipruritic agents.	[Aktar, M. K.; Kido-Nakahara, M.; Furue, M.] Kyushu Univ, Dept Dermatol, Grad Sch Med Sci, Fukuoka 812, Japan; [Furue, M.; Nakahara, T.] Kyushu Univ, Dept Dermatol, Grad Sch Med Sci, Div Skin Surface Sensing, Fukuoka 812, Japan	Kido-Nakahara, M (reprint author), Kyushu Univ, Dept Dermatol, Grad Sch Med Sci, Fukuoka 812, Japan.	macky@dermatol.med.kyushu-u.ac.jp					Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Maezawa Y, 2006, J IMMUNOL, V176, P1013; Soldano S, 2009, ANN RHEUM DIS, V68, P599, DOI 10.1136/ard.2008.097378; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; Trentin PG, 2006, EXP BIOL MED, V231, P1146; Hvid M, 2011, J INVEST DERMATOL, V131, P150, DOI 10.1038/jid.2010.277; Chiba T, 2012, ALLERGY, V67, P936, DOI 10.1111/j.1398-9995.2012.02844.x; Corrigan CJ, 2011, J ALLERGY CLIN IMMUN, V128, P116, DOI 10.1016/j.jaci.2011.03.043; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Nakanishi Kenji, 2010, Allergology International, V59, P137, DOI 10.2332/allergolint.10-RAI-0208; Stander S, 2002, EXP DERMATOL, V11, P12, DOI 10.1034/j.1600-0625.2002.110102.x; Koblenzer CS, 1999, J ALLERGY CLIN IMMUN, V104, pS109, DOI 10.1016/S0091-6749(99)70052-7; Yu HS, 2010, J KOREAN MED SCI, V25, P829, DOI 10.3346/jkms.2010.25.6.829; Hurst SD, 2002, J IMMUNOL, V169, P443; Katugampola R, 2000, EXP PHYSIOL, V85, P839, DOI 10.1111/j.1469-445X.2000.02089.x; Chen L, 2010, IMMUNOL CELL BIOL, V88, P334, DOI 10.1038/icb.2009.107; Gomes LO, 2012, LIFE SCI, V91, P628, DOI 10.1016/j.lfs.2012.03.020; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Gregory LG, 2013, ALLERGY, V68, P1579, DOI 10.1111/all.12271; Yosipovitch G, 2003, LANCET, V361, P690, DOI 10.1016/S0140-6736(03)12570-6; Goldie RG, 1999, LIFE SCI, V65, P1, DOI 10.1016/S0024-3205(98)00614-6; Greaves MW, 2004, INT ARCH ALLERGY IMM, V135, P166, DOI 10.1159/000080898; Hawro T, 2014, ALLERGY, V69, P113, DOI 10.1111/all.12316; HAY DWP, 1993, BRIT J PHARMACOL, V110, P392; MCCARRON RM, 1993, NEUROSCI LETT, V156, P31, DOI 10.1016/0304-3940(93)90432-K; Nedoszytko B, 2014, POSTEP DERM ALERGOL, V31, P84, DOI 10.5114/pdia.2014.40920; Schwarting A, 1996, SCAND J RHEUMATOL, V25, P246; Simon D, 2014, ALLERGY, V69, P46, DOI 10.1111/all.12339; Spirig R, 2009, MOL IMMUNOL, V46, P3178, DOI 10.1016/j.molimm.2009.05.179; TSUBOI R, 1995, FEBS LETT, V371, P188, DOI 10.1016/0014-5793(95)00912-S; Yamamoto Mina, 2007, Allergol Int, V56, P139, DOI 10.2332/allergolint.O-06-458; YAMAMURA H, 1995, EUR J PHARM-MOLEC PH, V288, P269; Zhan SX, 2011, EXP CELL RES, V317, P1040, DOI 10.1016/j.yexcr.2010.12.026; Zhong XH, 2014, ARCH ORAL BIOL, V59, P289, DOI 10.1016/j.archoralbio.2013.11.006	36	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-4538	1398-9995		ALLERGY	Allergy	JUL	2015	70	7					846	854		10.1111/all.12633		9	Allergy; Immunology	Allergy; Immunology	CK6VM	WOS:000356366600012		
J	Kimura, H; Suzuki, M; Konno, S; Nishimura, M				Kimura, H.; Suzuki, M.; Konno, S.; Nishimura, M.			Sputum periostin in patients with different severe asthma phenotypes	ALLERGY			English	Letter							INFLAMMATION		[Kimura, H.; Suzuki, M.; Konno, S.] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan; [Nishimura, M.] Hokkaido Univ Hosp, Dept Med 1, Sapporo, Hokkaido 060, Japan	Kimura, H (reprint author), Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan.	kimulah@med.hokudai.ac.jp					Izuhara K, 2014, ALLERGOL INT, V63, P143, DOI 10.2332/allergolint.13-RAI-0663; Jia GQ, 2012, J ALLERGY CLIN IMMUN, V130, P647, DOI 10.1016/j.jaci.2012.06.025; Arron JR, 2014, THORAX, V70, P105; Bobolea I, 2015, ALLERGY, V70, P540, DOI 10.1111/all.12580; Hoersch S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-30; Wagener A, 2014, THORAX, V70, P115	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-4538	1398-9995		ALLERGY	Allergy	JUL	2015	70	7					884	884		10.1111/all.12639		1	Allergy; Immunology	Allergy; Immunology	CK6VM	WOS:000356366600018		
J	Fuji, S; Kanda, J; Kato, S; Ikegame, K; Morishima, S; Miyamoto, T; Hidaka, M; Kubo, K; Miyamura, K; Tsudo, M; Kobayashi, H; Maesako, Y; Eto, T; Adachi, S; Ichinohe, T; Atsuta, Y; Kanda, Y				Fuji, Shigeo; Kanda, Junya; Kato, Shunichi; Ikegame, Kazuhiro; Morishima, Satoko; Miyamoto, Toshihiro; Hidaka, Michihiro; Kubo, Kohmei; Miyamura, Koichi; Tsudo, Mitsuru; Kobayashi, Hikaru; Maesako, Yoshitomo; Eto, Tetsuya; Adachi, Souichi; Ichinohe, Tatsuo; Atsuta, Yoshiko; Kanda, Yoshinobu		Japan Soc Hematopoietic Cell	A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch	AMERICAN JOURNAL OF HEMATOLOGY			English	Article							BONE-MARROW-TRANSPLANTATION; UNRELATED DONOR; ALLELE MISMATCH; BLOOD; MODEL; JAPAN	The relative importance of the resolution level of HLA typing has not been fully defined for related donor transplantation. To address this question, we retrospectively evaluated patients who underwent a first related hematopoietic stem cell transplantation (HSCT) from 2000 to 2011 from an HLA high-resolution matched (MRD, n=2,244), high-resolution 1 locus-mismatched (HR-MMRD, n=116), or low-resolution 1 locus-mismatched related donor (LR-MMRD, n=396) in the graft-versus-host direction at three loci (HLA A, B, and DRB1) using the database of the Japan Society for Hematopoietic Cell Transplantation. The median age was 40 years (0-74). The median follow-up duration of surviving patients was 950 days. Although the cumulative incidences of grade III-IV acute graft-versus-host disease (GVHD) in the HR-MMRD and LR-MMRD groups were significantly higher than those in the MRD group (HR-MMRD 19.8%, LR-MMRD 20.4%, and MRD 9.5%), there was no statistically significant difference between the HR-MMRD and LR-MMRD groups (P=0.65). Although both HR-MMRD and LR-MMRD were significantly associated with an increased risk of non-relapse mortality and a worse overall survival, there was no statistically significant difference between the HR-MMRD and LR-MMRD groups. In conclusion, LR-MM and HR-MM have a similar adverse impact on the outcome in related HSCT. Am. J. Hematol. 90:618-623, 2015. (c) 2015 Wiley Periodicals, Inc.	[Fuji, Shigeo] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Div, Tokyo, Japan; [Kanda, Junya; Kanda, Yoshinobu] Saitama Med Ctr, Div Hematol, Saitama, Japan; [Kato, Shunichi] Tokai Univ, Dept Cell Transplantat & Regenerat Med, Sch Med, Hiratsuka, Kanagawa 25912, Japan; [Ikegame, Kazuhiro] Hyogo Coll Med, Dept Internal Med, Div Hematol, Kobe, Hyogo, Japan; [Morishima, Satoko] Fujita Hlth Univ, Sch Med, Dept Hematol, Nagoya, Aichi, Japan; [Miyamoto, Toshihiro] Kyushu Univ Hosp, Med & Biosyst Sci, Fukuoka 812, Japan; [Hidaka, Michihiro] Natl Hosp Org Kumamoto Med Ctr, Dept Hematol, Kumamoto, Japan; [Kubo, Kohmei] Aomori Prefectural Cent Hosp, Dept Hematol, Aomori, Japan; [Miyamura, Koichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Tsudo, Mitsuru] Osaka Red Cross Hosp, Dept Hematol, Osaka, Japan; [Kobayashi, Hikaru] Nagano Red Cross Hosp, Dept Hematol, Nagano, Japan; [Maesako, Yoshitomo] Tenri Hosp, Dept Hematol, Nara, Japan; [Eto, Tetsuya] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan; [Adachi, Souichi] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Ichinohe, Tatsuo] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan; [Atsuta, Yoshiko] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan	Kanda, Y (reprint author), Jichi Med Univ, Saitama Med Ctr, Div Hematol, Omiya Ku, 1-847 Amanuma Cho, Saitama, Saitama, Japan.	ycanda-tky@umin.ac.jp			Ministry of Health, Labor and Welfare of Japan	Contract grant sponsor: Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan..	Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Luznik L, 2010, IMMUNOL RES, V47, P65, DOI 10.1007/s12026-009-8139-0; Atsuta Y, 2007, INT J HEMATOL, V86, P269, DOI 10.1532/IJH97.06239; Kanda Y, 2013, BRIT J HAEMATOL, V161, P566, DOI 10.1111/bjh.12279; Furst D, 2013, BLOOD, V122, P3220, DOI 10.1182/blood-2013-02-482547; Petersdorf EW, 2008, CURR OPIN IMMUNOL, V20, P588, DOI 10.1016/j.coi.2008.06.014; Valcarcel D, 2011, BIOL BLOOD MARROW TR, V17, P640, DOI 10.1016/j.bbmt.2010.07.022; Kanda J, 2012, BLOOD, V119, P2409, DOI 10.1182/blood-2011-08-372573; Bashey A, 2013, J CLIN ONCOL, V31, P1310, DOI 10.1200/JCO.2012.44.3523; Woolfrey A, 2011, BIOL BLOOD MARROW TR, V17, P885, DOI 10.1016/j.bbmt.2010.09.012; Morishima Y, 2002, BLOOD, V99, P4200, DOI 10.1182/blood.V99.11.4200; Petersdorf EW, 2013, BLOOD, V122, P1863, DOI 10.1182/blood-2013-05-355982; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Ciurea SO, 2011, BIOL BLOOD MARROW TR, V17, P923, DOI 10.1016/j.bbmt.2010.10.017; Fuji S, 2014, BONE MARROW TRANSPL, V49, P1187, DOI 10.1038/bmt.2014.141; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Park M, 2012, BONE MARROW RES, V2012; Prasad VK, 1999, TRANSPLANTATION, V68, P1044, DOI 10.1097/00007890-199910150-00024	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0361-8609	1096-8652		AM J HEMATOL	Am. J. Hematol.	JUL	2015	90	7					618	623		10.1002/ajh.24028		6	Hematology	Hematology	CL1JS	WOS:000356699300015		
J	Takahashi, K; Roh, W; Zhang, JH; Propotopov, A; Patel, K; Strickland, S; Kim, A; Vnencak-Jones, C; Pelletier, S; Parmar, S; Garcia-Manero, G; Kornblau, S; Chin, L; Kantarjian, H; Futreal, PA; Ravandi, F				Takahashi, Koichi; Roh, Whijae; Zhang, Jianhua; Propotopov, Alexei; Patel, Keyur; Strickland, Stephen; Kim, Annette; Vnencak-Jones, Cindy; Pelletier, Sarah; Parmar, Simrit; Garcia-Manero, Guillermo; Kornblau, Steven; Chin, Lynda; Kantarjian, Hagop; Futreal, P. Andrew; Ravandi, Farhad			Clonal evolution of acute myeloid leukemia relapsed after 19 years of remission	AMERICAN JOURNAL OF HEMATOLOGY			English	Letter							MUTATIONS		[Takahashi, Koichi; Pelletier, Sarah; Garcia-Manero, Guillermo; Kornblau, Steven; Kantarjian, Hagop; Ravandi, Farhad] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Takahashi, Koichi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Roh, Whijae; Chin, Lynda; Futreal, P. Andrew] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Roh, Whijae] Univ Texas Grad Sch Biomed Sci, Program Canc Biol, Houston, TX USA; [Zhang, Jianhua; Propotopov, Alexei; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Patel, Keyur] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Strickland, Stephen; Kim, Annette; Vnencak-Jones, Cindy] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Parmar, Simrit] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplant, Houston, TX 77030 USA	Futreal, PA (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	afutreal@mdanderson.org; fravandi@mdanderson.org					Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Goossens S, 2011, BLOOD, V117, P5620, DOI 10.1182/blood-2010-08-300236; Medeiros BC, 2007, LEUKEMIA LYMPHOMA, V48, P65, DOI 10.1080/10428190601043252; Menezes J, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.54; Menezes J, 2014, LEUKEMIA, V28, P823, DOI 10.1038/leu.2013.283; Verma D, 2010, LEUKEMIA LYMPHOMA, V51, P778, DOI 10.3109/10428191003661852	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0361-8609	1096-8652		AM J HEMATOL	Am. J. Hematol.	JUL	2015	90	7					E134	E135		10.1002/ajh.24009		2	Hematology	Hematology	CL1JS	WOS:000356699300003		
J	Ishibazawa, A; Nagaoka, T; Takahashi, A; Omae, T; Tani, T; Sogawa, K; Yokota, H; Yoshida, A				Ishibazawa, Akihiro; Nagaoka, Taiji; Takahashi, Atsushi; Omae, Tsuneaki; Tani, Tomofumi; Sogawa, Kenji; Yokota, Harumasa; Yoshida, Akitoshi			Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							RETINAL VASCULAR LAYERS; FLUORESCEIN ANGIOGRAPHY; MACULAR EDEMA; MICROANEURYSMS; DISEASE; NEOVASCULARIZATION; PATTERNS; RISK; AGE	PURPOSE: To evaluate how optical coherence tomography (OCT) angiography depicts clinical fundus findings in patients with diabetic retinopathy (DR). DESIGN: Prospective study evaluating imaging technology. METHODS: Forty-seven eyes of 25 patients with DR were scanned using a high-speed 840-nm-wavelength spectral-domain optical coherence tomography instrument (RTVue XR Avanti; Optovue, Inc, Fremont, California, USA). Blood flow was detected using the split-spectrum amplitude-decorrelation angiography algorithm. Fluorescein angiography (FA) images were also obtained in all eyes and the ability to visualize microaneurysms, retinal nonperfused areas, and neovascularization was compared with that of the en face OCT angiograms. RESULTS: In 42 eyes, microaneurysms detected by FA near the macula appeared as focally dilated saccular or fusiform capillaries on OCT angiograms of the superficial and/or deep capillary plexus. Retinal nonperfused area visualized by FA appeared as lesions with no or sparse capillaries on OCT angiograms. Area measurement of retinal nonperfusion near the macula in 7 eyes revealed a difference between the extent of nonperfused areas in superficial and deep plexuses. In 4 eyes, the vascular structures of neovascularization at the optic disc were clearly visualized on OCT angiograms. Decreases and re-increases of flow in new vessels were quantified in an eye treated with anti-vascular endothelial growth factor. CONCLUSIONS: OCT angiography can clearly visualize microaneurysms and retinal nonperfused areas and enables closer observation of each layer of the retinal capillaries. Quantitative information on new vessels can also be obtained. OCT angiography may be clinically useful to evaluate the microvascular status and therapeutic effect of treatments for DR. (C) 2015 by Elsevier Inc. All rights reserved.	[Ishibazawa, Akihiro; Nagaoka, Taiji; Takahashi, Atsushi; Omae, Tsuneaki; Tani, Tomofumi; Sogawa, Kenji; Yokota, Harumasa; Yoshida, Akitoshi] Asahikawa Med Univ, Dept Ophthalmol, Asahikawa, Hokkaido 0788510, Japan	Ishibazawa, A (reprint author), Asahikawa Med Univ, Dept Ophthalmol, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	bazawa14@asahikawa-med.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [25861608, 25293352]	This study was supported by a Grant-in-Aid for Young Scientists (B) 25861608 (A.I.) and Scientific Research (B) 25293352 (T.N.) from the Japan Society for the Promotion of Science, Tokyo, Japan. All authors attest that they meet the current ICMJE requirements to qualify as authors.	SNODDERLY DM, 1992, J NEUROSCI, V12, P1169; Haritoglou C, 2014, RETINA-J RET VIT DIS, V34, P157, DOI 10.1097/IAE.0b013e318295f6de; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P66, DOI 10.1001/jamaophthalmol.2014.3950; Saaddine JB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1740, DOI 10.1001/archopht.126.12.1740; Hellstedt T, 1996, BRIT J OPHTHALMOL, V80, P135, DOI 10.1136/bjo.80.2.135; Horii T, 2010, AM J OPHTHALMOL, V150, P840, DOI 10.1016/j.ajo.2010.06.015; STITT AW, 1995, BRIT J OPHTHALMOL, V79, P362, DOI 10.1136/bjo.79.4.362; Kawasaki R, 2011, OPHTHALMOLOGY, V118, P860, DOI 10.1016/j.ophtha.2010.08.040; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Miura M, 2011, INVEST OPHTH VIS SCI, V52, P2689, DOI 10.1167/iovs.10-6282; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Mariampillai A, 2008, OPT LETT, V33, P1530, DOI 10.1364/OL.33.001530; Schwartz DM, 2014, OPHTHALMOLOGY, V121, P180, DOI 10.1016/j.ophtha.2013.09.002; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Yeung L, 2009, OPHTHALMOLOGY, V116, P1158, DOI 10.1016/j.ophtha.2008.12.063; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616; Cheung N, 2007, DIABETES CARE, V30, P1742, DOI 10.2337/dc07-0264; Kohno RI, 2010, AM J OPHTHALMOL, V150, P223, DOI 10.1016/j.ajo.2010.03.016; Unoki N, 2007, AM J OPHTHALMOL, V144, P755, DOI 10.1016/j.ajo.2007.07.011; Jia YL, 2014, OPHTHALMOLOGY, V121, P1435, DOI 10.1016/j.ophtha.2014.01.034; Wessel MM, 2012, BRIT J OPHTHALMOL, V96, P694, DOI 10.1136/bjophthalmol-2011-300774; Moore J, 1999, J ANAT, V194, P89, DOI 10.1046/j.1469-7580.1999.19410089.x; Fioretto P, 1996, DIABETOLOGIA, V39, P1569, DOI 10.1007/s001250050616; GASS JDM, 1968, ARCH OPHTHALMOL-CHIC, V80, P583; Huang YP, 2014, OSLI RETINA, V45, P382, DOI 10.3928/23258160-20140909-08; Jalli PYI, 1997, RETINA-J RET VIT DIS, V17, P211, DOI 10.1097/00006982-199705000-00007; Kubota T, 2010, RETINA-J RET VIT DIS, V30, P468, DOI 10.1097/IAE.0b013e3181bd2d7b; KWITEROVICH KA, 1991, OPHTHALMOLOGY, V98, P1139; Leicht SF, 2014, OPHTHALMOLOGICA, V231, P198, DOI 10.1159/000357505; Miura M, 2015, AM J OPHTHALMOL, V159, P528, DOI 10.1016/j.ajo.2014.12.002; MURAOKA K, 1984, OPHTHALMOLOGY, V91, P1440; Suzuma Kiyoshi, 2011, Clin Ophthalmol, V5, P897, DOI 10.2147/OPTH.S22843; WEINHAUS RS, 1995, EXP EYE RES, V61, P1, DOI 10.1016/S0014-4835(95)80053-0	35	5	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	JUL	2015	160	1					35	44		10.1016/j.ajo.2015.04.021		10	Ophthalmology	Ophthalmology	CL4FS	WOS:000356908600006		
J	Hayashi, K; Ogawa, S; Manabe, SI; Hirata, A				Hayashi, Ken; Ogawa, Soichiro; Manabe, Shin-Ichi; Hirata, Akira			Influence of Patient Age at Surgery on Long-Term Corneal Astigmatic Change Subsequent to Cataract Surgery	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							SURGICALLY INDUCED ASTIGMATISM; TEMPORAL CLEAR CORNEAL; TORIC INTRAOCULAR-LENS; SCLEROCORNEAL VALVE INCISION; LIMBAL RELAXING INCISIONS; ON-AXIS INCISIONS; SHAPE CHANGES; FOLLOW-UP; PHACOEMULSIFICATION; STABILIZATION	PURPOSE: To examine whether long-term corneal astigmatic change with age after cataract surgery depends on patient age at the time of surgery, and to evaluate whether this change is different from that in eyes that did not undergo surgery. DESIGN: Retrospective cohort study. METHODS: A total of 437 eyes that underwent phacoemulsification with a 4.1-mm horizontal corneoscleral incision more than 11 years ago and 600 control eyes without surgery were divided into 4 age groups: (1) 60 years or younger, (2) 61-65 years, (3) 66-70 years, and (4) 71 years or older. The corneal astigmatic change between baseline and 5 years after baseline, between 5 and 10 years, and between baseline and 10 years, as calculated using the polar (x-y) coordinate analysis, were compared among the age groups and between eyes with and without surgery. RESULTS: Corneal astigmatic change, expressed as x- and y-coordinates, showed an against-the-rule change of 0.2-0.4 diopter during the 10 years in all age groups of the surgery and nonsurgery groups. Using multivariate analysis of variance, the mean x- and y-coordinates did not differ significantly among the age groups in either the surgery or nonsurgery groups (P >= .4112). Furthermore, the mean x- and y-coordinates did not differ significantly between the surgery and nonsurgery groups in any age group (P >= .1359). CONCLUSION: Long-term corneal astigmatic change with age after cataract surgery does not differ significantly depending on patient age at the time of surgery, and is comparable to that of eyes without surgery. (C) 2015 by Elsevier Inc. All rights reserved	[Hayashi, Ken; Ogawa, Soichiro; Manabe, Shin-Ichi; Hirata, Akira] Hayashi Eye Hosp, Fukuoka 8120011, Japan	Hayashi, K (reprint author), Hayashi Eye Hosp, Hakata Ku, 4-23-35 Hakataekimae, Fukuoka 8120011, Japan.	hayashi-ken@hayashi.or.jp		HAYASHI, KEN/0000-0002-7297-1477	Alcon Japan Ltd; Santen Pharmaceutical Inc; Abbot Medical Optics; HOYA Corp; Wakamdto Pharmaceutical Ltd.	Outside the submitted work, the Hayashi Eye Hospital (K.H., S.O., S.-I.M., A.H.) has received a research grant for clinical trials of materials sponsored by Alcon Japan Ltd; Santen Pharmaceutical Inc; Abbot Medical Optics; HOYA Corp; and Wakamdto Pharmaceutical Ltd. The authors received no government or nongovemment financial support for this study. All authors attest that they meet the current ICMJE requirements to qualify as authors.	Hayashi K, 2010, OPHTHALMOLOGY, V117, P1313, DOI 10.1016/j.ophtha.2009.11.041; Bauer NJC, 2008, J CATARACT REFR SURG, V34, P1483, DOI 10.1016/j.jcrs.2008.05.031; Rho CR, 2012, J CATARACT REFR SURG, V38, P666, DOI 10.1016/j.jcrs.2011.11.031; Masket S, 1996, J CATARACT REFR SURG, V22, P1451; Tongbai RR, 2010, J CATARACT REFR SURG, V36, P594, DOI 10.1016/j.jcrs.2009.11.002; Holland E, 2010, OPHTHALMOLOGY, V117, P2104, DOI 10.1016/j.ophtha.2010.07.033; Simsek S, 1998, J CATARACT REFR SURG, V24, P515; Khokhar S, 2006, J CATARACT REFR SURG, V32, P1432, DOI 10.1016/j.jcrs.2006.04.010; Kohnen S, 2002, J CATARACT REFR SURG, V28, P821, DOI 10.1016/S0886-3350(01)01215-9; Budak K, 1998, J CATARACT REFR SURG, V24, P503; Hayashi K, 2009, J CATARACT REFR SURG, V35, P233, DOI 10.1016/j.jcrs.2008.10.031; Ho JD, 2010, CORNEA, V29, P632, DOI 10.1097/ICO.0b013e3181c2965f; Lyhne N, 2000, J CATARACT REFR SURG, V26, P83, DOI 10.1016/S0886-3350(99)00323-5; Lever J, 2000, J CATARACT REFR SURG, V26, P803, DOI 10.1016/S0886-3350(00)00378-3; HAYASHI K, 1995, CORNEA, V14, P527; Mendicute J, 2009, J CATARACT REFR SURG, V35, P451, DOI 10.1016/j.jcrs.2008.11.043; OSHIKA T, 1995, OPHTHALMIC SURG LAS, V26, P309; Borasio E, 2006, J CATARACT REFR SURG, V32, P2030, DOI 10.1016/j.jcrs.2006.09.010; Kaufmann C, 2005, J CATARACT REFR SURG, V31, P2261, DOI 10.1016/j.jcrs.2005.08.046; Asano K, 2005, JPN J OPHTHALMOL, V49, P127, DOI 10.1007/s10384-004-0152-1; Drews RC, 2000, J CATARACT REFR SURG, V26, P250, DOI 10.1016/S0886-3350(99)00360-0; FEIL SH, 1995, J CATARACT REFR SURG, V21, P433; Gudmundsdottir E, 2000, ACTA OPHTHALMOL SCAN, V78, P642, DOI 10.1034/j.1600-0420.2000.078006642.x; Hayashi K, 2011, AM J OPHTHALMOL, V151, P858, DOI 10.1016/j.ajo.2010.11.014; Lane SS, 2009, J REFRACT SURG, V25, P899, DOI 10.3928/1081597X-20090617-05; Naeser K, 1999, OPHTHAL PHYSL OPT, V19, P50; Naeser K, 2002, J REFRACT SURG, V18, P72; Pakravan Mohammad, 2009, J Ophthalmic Vis Res, V4, P79; Pardhan S, 1999, J REFRACT SURG, V15, P469; Rainer G, 1998, J CATARACT REFR SURG, V24, P1642; Rainer G, 1997, J CATARACT REFR SURG, V23, P358; Sasaki H, 2012, JPN J OPHTHALMOL, V56, P445, DOI 10.1007/s10384-012-0168-x	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	JUL	2015	160	1					171	178		10.1016/j.ajo.2015.04.015		8	Ophthalmology	Ophthalmology	CL4FS	WOS:000356908600022		
J	Ota, K; Arai, K				Ota, Kanako; Arai, Kazuhito			Prevalence and patterns of tooth agenesis in Angle Class II Division 2 malocclusion in Japan	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							3RD MOLAR AGENESIS; DENTAL AGENESIS; DOWN-SYNDROME; MISSENSE MUTATION; PERMANENT TEETH; HYPODONTIA; METAANALYSIS; OLIGODONTIA; MORPHOLOGY; ANOMALIES	Introduction: The purpose of this study was to evaluate the prevalence and patterns of tooth agenesis in subjects with Angle Class II Division 2 malocclusion compared with general orthodontic patients in Japan. Methods: Panoramic radiographs, dental casts, and cephalograms of 76 patients with Class II Division 2 malocclusions (52 female, 24 male) and 270 orthodontic patients as the control group (168 female, 102 male) who were 14 years of age or older were selected. The prevalences of tooth agenesis in this cohort and in each tooth type were calculated and compared between the groups with the chi-square test. Odds ratios and corresponding 95% confidence intervals were also calculated. Results: The prevalence of tooth agenesis excluding the third molars was significantly higher in the Class II Division 2 group (22.4%) than in the control group (11.9%) (P < 0.05); the odds ratio was 2.14 (95% CI, 1.12-4.12). A higher prevalence of tooth agenesis excluding the third molars was observed in the Class II Division 2 group for the mandibular second premolar (P < 0.05) and the maxillary lateral incisor (P < 0.01). The prevalence of third molar agenesis was also significantly higher in the Class II Division 2 group (42.1%) compared with the control group (26.7%) (P < 0.05); the odds ratio was 2.00 (95% CI, 1.18-3.40). Conclusions: Compared with the general orthodontic patient population, permanent tooth agenesis was observed approximately 2 times more frequently, and a distinctive agenesis pattern was found in the Class II Division 2 group in Japan.	[Ota, Kanako; Arai, Kazuhito] Nippon Dent Univ Tokyo, Sch Life Dent, Dept Orthodont, Tokyo 1028159, Japan	Arai, K (reprint author), Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Orthodont, Chiyoda Ku, 1-9-20 Fujimi, Tokyo 1028159, Japan.	drarai@tky.ndu.ac.jp					Angle EH, 1899, DENT COSMOS, V41, P248; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Vieira AR, 2004, J DENT RES, V83, P723; Ruf S, 2013, J OROFAC ORTHOP, V74, P295, DOI 10.1007/s00056-013-0138-z; Shapira J, 2000, ANGLE ORTHOD, V70, P290; Peck S, 2009, ANGLE ORTHOD, V79, P1015, DOI 10.2319/0003-3219-079.005.1015; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Nieminen P, 2001, EUR J HUM GENET, V9, P743, DOI 10.1038/sj.ejhg.5200715; Uslu O, 2009, AM J ORTHOD DENTOFAC, V135, P328, DOI 10.1016/j.ajodo.2007.03.030; Tao R, 2006, J HUM GENET, V51, P498, DOI 10.1007/s10038-006-0389-2; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Harris EF, 2008, AM J ORTHOD DENTOFAC, V134, P761, DOI 10.1016/j.ajodo.2006.12.019; Endo T, 2006, AM J ORTHOD DENTOFAC, V129, P29, DOI 10.1016/j.ajodo.2004.09.024; Barka Georgia, 2012, Int J Gen Med, V5, P441, DOI 10.2147/IJGM.S31200; Bartzela TN, 2010, EUR J ORAL SCI, V118, P47, DOI 10.1111/j.1600-0722.2009.00698.x; Basdra EK, 2000, EUR J ORTHODONT, V22, P529, DOI 10.1093/ejo/22.5.529; Deguchi T, 1981, Nihon Kyosei Shika Gakkai Zasshi, V40, P300; Endo S, 2015, ODONTOLOGY, V103, P88; Garn SM, 1962, ANGLE ORTHOD, V32, P14; Hartsfield JK, 2013, J PEDIAT GENET, V2, P1; Hermus RR, 2013, EUR J ORAL SCI, V121, P328, DOI 10.1111/eos.12054; Kure K, 2012, ORTHOD WAVES JAPANES, V70, P184; Lapatki BG, 2002, J DENT RES, V81, P323; Lomholt JF, 2002, ACTA ODONTOL SCAND, V60, P151, DOI 10.1080/000163502753740160; Markovic M D, 1992, Eur J Orthod, V14, P469; Peck S, 1998, ANGLE ORTHOD, V68, P9; Pereira Pedro Mariano, 2013, J Orthod, V40, P299, DOI 10.1179/1465313313Y.0000000067; Rakhshan V, 2013, PROG ORTHOD, V14, P1; Shapira Y, 2000, ANGLE ORTHOD, V70, P16; Stavropoulos D, 2011, EUR J ORAL SCI, V119, P198, DOI 10.1111/j.1600-0722.2011.00821.x; Stavropoulos D, 2011, SWED DENT J, V35, P195; Suri S, 2006, AM J ORTHOD DENTOFAC, V130, P37, DOI 10.1016/j.ajodo.2005.09.026; Suri S, 2011, ANGLE ORTHOD, V81, P260, DOI 10.2319/070910-391.1; Vahid-Dastjerdi Elaheh, 2010, J Oral Sci, V52, P455	34	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406	1097-6752		AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	JUL	2015	148	1					123	129		10.1016/j.ajodo.2015.02.023		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CL6TK	WOS:000357100100022		
J	Kamide, D; Tomifuji, M; Maeda, M; Utsunomiya, K; Yamashita, T; Araki, K; Shiotani, A				Kamide, Daisuke; Tomifuji, Masayuki; Maeda, Mayuka; Utsunomiya, Kazuho; Yamashita, Taku; Araki, Koji; Shiotani, Akihiro			Minimally invasive surgery for pyriform sinus fistula by transoral videolaryngoscopic surgery	AMERICAN JOURNAL OF OTOLARYNGOLOGY			English	Article							TRICHLOROACETIC-ACID; CHEMOCAUTERIZATION; MANAGEMENT; DIAGNOSIS; ABSCESS	Pyriform sinus fistula is a rare branchial anomaly that manifests as recurrent cervical infection resulting from contamination of the fistula internal orifice in the pyriform sinus. Although open neck surgery to resect the fistula has been recommended as a definitive treatment, identifying the fistula within the scar is difficult and occasionally results in recurrence. Here, we describe a novel transoral surgical technique for pyriform sinus fistula using transoral videolaryngoscopic surgery (TOVS) as a definitive treatment to resect and close the fistula without skin incision. Needle cautery enables fine excision and delicate dissection of the fistula tract. TOVS is a safe, easy, and reliable treatment and is a suitable first line treatment. (C) 2015 Elsevier Inc. All rights reserved.	[Kamide, Daisuke; Tomifuji, Masayuki; Maeda, Mayuka; Utsunomiya, Kazuho; Yamashita, Taku; Araki, Koji; Shiotani, Akihiro] Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, Tokorozawa, Saitama 3598513, Japan	Tomifuji, M (reprint author), Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	tomifuji@ndmc.ac.jp			JFE (The Japanese Foundation for Research and Promotion of Endoscopy) Grant	Part of this work was supported by JFE (The Japanese Foundation for Research and Promotion of Endoscopy) Grant.	Kim KH, 2000, ANN OTO RHINOL LARYN, V109, P452; Sheng QF, 2014, J PEDIATR SURG, V49, P455, DOI 10.1016/j.jpedsurg.2013.07.008; Shiotani A, 2010, ANN OTO RHINOL LARYN, V119, P225; Nicoucar K, 2009, J PEDIATR SURG, V44, P1432, DOI [10.1016/j.jpedsurg.2008.12.001, 10.1016/j.jpedsurg.2009.12.001]; Cha W, 2013, HEAD NECK-J SCI SPEC, V35, P431, DOI 10.1002/hed.22998; DELOZIER HL, 1986, ANN OTO RHINOL LARYN, V95, P377; Edmonds JL, 1997, ARCH OTOLARYNGOL, V123, P439; GODIN MS, 1990, LARYNGOSCOPE, V100, P174; Kubota M, 1997, J PEDIATR SURG, V32, P34, DOI 10.1016/S0022-3468(97)90087-7; Park JH, 2013, LARYNGOSCOPE, V123, P410, DOI 10.1002/lary.23530; Shiotani A, 2011, OTOLARYNG HEAD NECK, V144, P288, DOI 10.1177/0194599810392148; Takai SI, 1979, LANCET, V313, P751, DOI 10.1016/S0140-6736(79)91208-X; Tomifuji M, 2013, EUR ARCH OTO-RHINO-L, V271, P589; Yamashita T, 2010, HEAD NECK-J SCI SPEC, V33, P1315; Zhang J, 2012, CLIN IMAG, V36, P826, DOI 10.1016/j.clinimag.2012.01.023	15	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0196-0709	1532-818X		AM J OTOLARYNG	Am. J. Otolaryngol.	JUL-AUG	2015	36	4					601	605		10.1016/j.amjoto.2015.02.009		5	Otorhinolaryngology	Otorhinolaryngology	CL4FG	WOS:000356907400021		
J	Kawashima, Y; Noguchi, Y; Takase, H; Takahashi, M; Horie, S				Kawashima, Yoshiyuki; Noguchi, Yoshihiro; Takase, Hiroshi; Takahashi, Masatoki; Horie, Shintaro			Bilateral hearing impairment as the initial symptom of sympathetic ophthalmia	AMERICAN JOURNAL OF OTOLARYNGOLOGY			English	Article							KOYANAGI-HARADA-DISEASE	Importance: Sympathetic ophthalmia (SO), a rare bilateral panuveitis following penetrating ocular trauma or ocular surgery to one eye, shares a strikingly similar ocular pathology to that of Vogt Koyanagi Harada disease (VKH). Audiovestibular dysfunction is a major extraocular manifestation of VKH; however, to date, only a few cases of sympathetic ophthalmia associated with hearing loss have been reported from ophthalmologists, but not otolaryngologists. Accordingly, little is known about the audiovestibular findings in patients with SO. We herein present two cases of SO with preceding bilateral hearing loss. Observations: The patient in Case 1, an 80-year-old female, experienced acute bilateral hearing loss. Five days after the onset of hearing loss, she presented with sudden bilateral blurred vision. In Case 2, a 32-year-old female noticed acute bilateral hearing loss and also experienced acute bilateral blurred vision the subsequent day. Patient 1 had a history of a penetrating injury to the right eye 25 days before the onset of hearing loss, while patient 2 had previously undergone right vitreous surgery twice for the treatment of a myopic macular hole and retinal detachment 36 and 43 days prior to the current symptom onset. Both cases were diagnosed as SO based on ocular findings of bilateral panuveitis and the history of ocular insult. Patient 1 carried HLA-DR4, HLA-DR15, HLA-A33, HLA-A24, HLA-B44 and HLA-B52, and patient 2 carried HLA-DR4. Audiograms showed bilateral mild to moderate sensorineural hearing loss in both cases, with normal auditory brainstem responses and deteriorated distortion product otoacoustic emission amplitudes. In addition, the significant recruitment phenomenon observed in case 1 suggested a cochlear origin of the hearing loss. Both patients received corticosteroid therapy, and the cochlear signs and symptoms recovered within one month. Conclusions and relevance: This is the first report to describe the comprehensive audiovestibular findings in patients with SO. In the present study, acute bilateral hearing loss developed a couple of days prior to the onset of bilateral visual loss and auditory examinations suggested a cochlear etiology in both cases. (C) 2015 Elsevier Inc. All rights reserved.	[Kawashima, Yoshiyuki; Noguchi, Yoshihiro; Takahashi, Masatoki] Tokyo Med & Dent Univ, Dept Otolaryngol, Tokyo, Japan; [Takase, Hiroshi; Horie, Shintaro] Tokyo Med & Dent Univ, Dept Ophthalmol, Tokyo, Japan	Noguchi, Y (reprint author), Yushima 1-5-45,Bunkyo Ku, Tokyo 1138519, Japan.	kawashima.oto1@mac.com; noguchi.oto@gmail.com; h.takase.oph@tmd.ac.jp; masatoki1@icloud.com; shinoph@tmd.ac.jp			JSPS KAKENHI Grant [26462551, 25462629]	This work was supported by JSPS KAKENHI Grant Numbers 26462551 (Y. K.) and 25462629 (Y.N.).	Greco A, 2013, AUTOIMMUN REV, V12, P1033, DOI 10.1016/j.autrev.2013.01.004; LUBIN JR, 1980, OPHTHALMOLOGY, V87, P109; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Savar A, 2009, AM J OPHTHALMOL, V147, P595, DOI 10.1016/j.ajo.2008.10.017; GOTO H, 1990, INT OPHTHALMOL CLIN, V30, P279, DOI 10.1097/00004397-199030040-00014; CHAN CC, 1995, ARCH OPHTHALMOL-CHIC, V113, P597; Chang GC, 2011, SEMIN OPHTHALMOL, V26, P316, DOI 10.3109/08820538.2011.588658; Comer M, 2001, BRIT J OPHTHALMOL, V85, P496, DOI 10.1136/bjo.85.4.496; Damico Francisco Max, 2005, Semin Ophthalmol, V20, P183, DOI 10.1080/08820530500232126; Damico Francisco Max, 2005, Semin Ophthalmol, V20, P191, DOI 10.1080/08820530500232100; GUSSEN R, 1978, ANN OTO RHINOL LARYN, V87, P175; Kilmartin DJ, 2000, BRIT J OPHTHALMOL, V84, P259, DOI 10.1136/bjo.84.3.259; LAFERRIE.KA, 1974, ANN OTO RHINOL LARYN, V83, P685; Morita S, 2014, AUDIOL NEURO-OTOL, V19, P49, DOI 10.1159/000356386; Nirankari M S, 1970, J All India Ophthalmol Soc, V18, P29; Noguchi Y, 2014, ACTA OTO-LARYNGOL, V134, P339, DOI 10.3109/00016489.2013.868604; Ondrey FG, 2006, LARYNGOSCOPE, V116, P1873, DOI 10.1097/01.mlg.0000234946.31603.fe; Rao NA, 1997, EYE, V11, P213; Sugita Sunao, 2007, International Ophthalmology, V27, P87, DOI 10.1007/s10792-006-9020-y; TAGAWA Y, 1976, NEW ENGL J MED, V295, P173; Venkatesh Ramesh, 2013, J Ophthalmic Inflamm Infect, V3, P65, DOI 10.1186/1869-5760-3-65; Yamaki K, 2000, J IMMUNOL, V165, P7323	22	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0196-0709	1532-818X		AM J OTOLARYNG	Am. J. Otolaryngol.	JUL-AUG	2015	36	4					606	610		10.1016/j.amjoto.2015.02.007		5	Otorhinolaryngology	Otorhinolaryngology	CL4FG	WOS:000356907400022		
J	Saiman, Y; Sugiyama, T; Simchoni, N; Spirli, C; Bansal, MB				Saiman, Yedidya; Sugiyama, Tatsuki; Simchoni, Noa; Spirli, Carlo; Bansal, Meena B.			Biliary Epithelial Cells Are Not the Predominant Source of Hepatic CXCL12	AMERICAN JOURNAL OF PATHOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; RECEPTOR CXCR4; FACTOR-I; LIVER; CHEMOKINE; NICHES; SDF-1; MAINTENANCE; EXPRESSION; MICE	Hepatic expression levels of CXCL12, a chemokine important in inflammatory and stem cell recruitment, and its receptor, C-X-C chemokine receptor 4, are increased during all forms of Liver injury. CXCL12 is expressed by both parenchymal and nonparenchymal hepatic cells, and on the basis of immunohistochemistry, biliary epithelial cells (BECs) are thought to be a predominant source of hepatic CXCL12, thereby promoting periportal recruitment of C-X-C chemokine receptor 4-expressing Lymphocytes. Our study aims to show that BECs may, in fact, not be the predominant source of hepatic CXCL12. We measured CXCL12 secretion and expression from human and murine BECs using enzyme-linked immunosorbent assay and Western blot analysis from cell culture supernatants and whole cell lysates, respectively, whereas CXCL12 expression in murine livers was analyzed in a Cxcl12-Gfp reporter mouse. Cell culture supernatants and whole cell lysates from BECs failed to demonstrate their expression of CXCL12. Furthermore, we confirmed these results with a Cxcl12-Gfp reporter mouse in which green fluorescent protein expression is notably absent from BECs. Interestingly, on the basis of green fluorescent protein expression, we demonstrate a population of CXCL12-expressing cells within the portal tract that are distinct, yet intimately associated with BECs. These findings indicate that BECs are not a predominant source of CXCL12.	[Saiman, Yedidya; Bansal, Meena B.] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, New York, NY 10029 USA; [Simchoni, Noa] Icahn Sch Med Mt Sinai, Dept Med, Div Clin Immunol, New York, NY 10029 USA; [Sugiyama, Tatsuki] Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Kyoto, Japan; [Spirli, Carlo] Yale Univ, Sch Med, Dept Internal Med, Liver Ctr & Digest Dis Sect, New Haven, CT 06510 USA	Bansal, MB (reprint author), Icahn Sch Med Mt Sinai, 1425 Madison Ave,Room 11-70,Box 1123, New York, NY 10029 USA.	meena.bansal@mssm.edu			NIH [DK-6047402, DK-071745, R56DK-092128, DK-090986]	Supported by NIH grants DK-6047402, DK-071745, and R56DK-092128 (M.B.B.) and DK-090986 (Y.S.).	Ma LX, 2012, INVEST NEW DRUG, V30, P508, DOI 10.1007/s10637-010-9578-0; Taniguchi H, 1996, NAT MED, V2, P198, DOI 10.1038/nm0296-198; Dranoff JA, 2010, HEPATOLOGY, V51, P1438, DOI 10.1002/hep.23405; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Sugiyama Tatsuki, 2012, Inflammation & Allergy Drug Targets, V11, P201; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Matsusue R, 2009, ANN SURG ONCOL, V16, P2645, DOI 10.1245/s10434-009-0599-x; Hanada S, 2003, LIVER INT, V23, P3; Guo JS, 2009, HEPATOLOGY, V49, P960, DOI 10.1002/hep.22697; Terada R, 2003, LAB INVEST, V83, P665, DOI 10.1097/01.LAB.0000067498.89585.06; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Shanmugam MK, 2011, INT J CANCER, V129, P1552, DOI 10.1002/ijc.26120; GRUBMAN SA, 1994, AM J PHYSIOL, V266, pG1060; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Omatsu Y, 2014, NATURE, V508, P536, DOI 10.1038/nature13071; Wald O, 2004, EUR J IMMUNOL, V34, P1164, DOI 10.1002/eji.200324441; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Egawa T, 2001, IMMUNITY, V15, P323, DOI 10.1016/S1074-7613(01)00185-6; Berniakovich I, 2013, INT J MOL SCI, V14, P2119, DOI 10.3390/ijms14012119; Li WL, 2013, DEV CELL, V24, P359, DOI 10.1016/j.devcel.2013.01.009; Fiorotto R, 2007, GASTROENTEROLOGY, V133, P1603, DOI 10.1053/j.gastro.2007.08.071; Kordes C, 2013, J CLIN INVEST, V123, P1874, DOI 10.1172/JCI66027; Ara T, 2003, J IMMUNOL, V170, P4649; BARBERAGUILLEM E, 1989, HEPATOLOGY, V9, P29, DOI 10.1002/hep.1840090106; Coulomb-L'Hermine A, 1999, P NATL ACAD SCI USA, V96, P8585, DOI 10.1073/pnas.96.15.8585; Maruyama M, 2004, TRANSPLANTATION, V77, P446, DOI 10.1097/01.TP.0000110292.73873.25; Mavier P, 2004, AM J PATHOL, V165, P1969, DOI 10.1016/S0002-9440(10)63248-8; Saiman Y, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00213; Santiago B, 2011, CYTOKINE, V53, P184, DOI 10.1016/j.cyto.2010.06.006; Spirli C, 2013, HEPATOLOGY, V58, P1713, DOI 10.1002/hep.26554; Takabatake Y, 2009, J AM SOC NEPHROL, V20, P1714, DOI 10.1681/ASN.2008060640	34	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JUL	2015	185	7					1859	1866		10.1016/j.ajpath.2015.03.006		8	Pathology	Pathology	CL5KA	WOS:000356997600007		
J	Okamoto, K; Honda, K; Doi, K; Ishizu, T; Katagiri, D; Wada, T; Tomita, K; Ohtake, T; Kaneko, T; Kobayashi, S; Nangaku, M; Tokunaga, K; Noiri, E				Okamoto, Koji; Honda, Kenjiro; Doi, Kent; Ishizu, Tomoko; Katagiri, Daisuke; Wada, Takehiko; Tomita, Kenji; Ohtake, Takayasu; Kaneko, Toyoji; Kobayashi, Shuzo; Nangaku, Masaomi; Tokunaga, Katsushi; Noiri, Eisei			Glypican-5 Increases Susceptibility to Nephrotic Damage in Diabetic Kidney	AMERICAN JOURNAL OF PATHOLOGY			English	Article							FIBROBLAST-GROWTH-FACTOR; GLOMERULAR MESANGIAL CELLS; EPITHELIAL-CELLS; EXTRACELLULAR-MATRIX; RAT-KIDNEY; PROLIFERATION; NEPHROPATHY; EXPRESSION; INVITRO; MICE	Type 2 diabetes mellitus is a leading health issue worldwide. Among cases of diabetes mellitus nephropathy (DN), the major complication of type 2 diabetes mellitus, the nephrotic phenotype is often intractable to clinical intervention and demonstrates the rapid decline of renal function to end-stage renal disease. We recently identified the gene for glypican-5 (GPC5), a cell-surface heparan sulfate proteoglycan, as conferring susceptibility for acquired nephrotic syndrome and additionally identified an association through a genome-wide association study between a variant in GPC5 and DN of type 2 diabetes mellitus. In vivo and in vitro data showed a progressive increase of GPC5 in type 2 DN along with severity; the excess was derived from glomerular mesangial. cells. In this study, diabetic kidney showed that accumulation of fibroblast growth factor (Fgf)2 strikingly induced progressive proteinuria that was avoided in Gpc5 knockdown mice. The efficacy of Gpc5 inhibition was exerted through expression of the Fgf receptors 3 and 4 provoked in the diabetic kidney attributively. Extraglomerular Fgf2 was pathogenic in DN, and the deterrence of Gpc5 effectively inhibited the glomerular accumulation of Fgf2, the subsequent increase of mesangial extracellular matrix, and the podocytes' small GTPase activity. These findings elucidate the pivotal role of GPC5, identified as a susceptible gene in the genome-wide association study, in hyperglycemia-induced glomerulopathy.	[Okamoto, Koji; Honda, Kenjiro; Doi, Kent; Ishizu, Tomoko; Katagiri, Daisuke; Wada, Takehiko; Nangaku, Masaomi; Noiri, Eisei] Univ Hosp, Dept Nephrol Endocrinol Hemodialysis & Apheresis, Tokyo, Japan; [Okamoto, Koji; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo 1138655, Japan; [Kaneko, Toyoji] Univ Tokyo, Adv Technol Ctr, Grad Sch Agr & Life Sci, Tokyo 1138655, Japan; [Okamoto, Koji; Tomita, Kenji] Natl Inst Diabet & Digest & Kidney Dis, Kidney Dis Sect, Kidney Dis Branch, NIH, Bethesda, MD USA; [Ohtake, Takayasu; Kobayashi, Shuzo] Shonan Kamakura Gen Hosp, Dept Nephrol Immunol & Vasc Med, Kamakura, Kanagawa, Japan	Noiri, E (reprint author), Univ Tokyo, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	noiri-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [221S0002]; Adaptable and Seamless Technology Transfer Program through Target-Driven R&D from Japan Science and Technology Agency grant [AS2617903Q]; Japan Society for the Promotion of Science [15K09245]; Japan Society for the Promotion of Science; intramural research programs of the National Institute for Diabetes, Digestive, and Kidney Diseases [ZO-1 DK043308]; Science and Technology Research Partnership for Sustainable Development, Japan Science and Technology Agency/Japan International Cooperation Agency (Tokyo, Japan) grant [10000284]	Supported by Grants-in-Aid for Scientific Research on the Priority Areas of Comprehensive Genomics 221S0002 (K.Tok.) and Tailor-made Medical Treatment Program (M.N. and E.N.) from the Ministry of Education, Culture, Sports, Science, and Technology; Adaptable and Seamless Technology Transfer Program through Target-Driven R&D from Japan Science and Technology Agency grant AS2617903Q (E.N.); and Grant-in-Aid for Scientific Research (B) 15K09245, Japan Society for the Promotion of Science (E.N.). K.O. received a 2012 Postdoctoral Fellowship for Research Abroad funded by the Japan Society for the Promotion of Science and is supported intramural research programs of the National Institute for Diabetes, Digestive, and Kidney Diseases (ZO-1 DK043308). E.N. is a leading researcher of the Science and Technology Research Partnership for Sustainable Development, Japan Science and Technology Agency/Japan International Cooperation Agency (Tokyo, Japan) grant 10000284.	Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; Strutz F, 2000, KIDNEY INT, V57, P1521, DOI 10.1046/j.1523-1755.2000.00997.x; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Li JJ, 2007, KIDNEY INT, V72, pS36, DOI 10.1038/sj.ki.5002384; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Mertens G, 1996, J CELL BIOL, V132, P487, DOI 10.1083/jcb.132.3.487; Yasuda T, 1996, J CLIN INVEST, V98, P1991, DOI 10.1172/JCI119003; MUTHUKRISHNAN L, 1991, J CELL PHYSIOL, V148, P1, DOI 10.1002/jcp.1041480102; NOIRI E, 1994, AM J PATHOL, V144, P1159; Floege J, 1995, J CLIN INVEST, V96, P2809, DOI 10.1172/JCI118351; Stephan CC, 1998, DIABETES, V47, P1771, DOI 10.2337/diabetes.47.11.1771; Okamoto K, 2011, NAT GENET, V43, P459, DOI 10.1038/ng.792; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; BALLERMANN BJ, 1989, AM J PHYSIOL, V256, pC182; Bangstad HJ, 2000, KIDNEY HYPERTENSION, P211; Cauchi J, 1996, CELL TISSUE RES, V285, P179, DOI 10.1007/s004410050635; Committee for the Update of the Guide for the Care, 2011, GUID CAR US LAB AN; DAMORE PA, 1990, CANCER METAST REV, V9, P227, DOI 10.1007/BF00046362; DAVID G, 1993, FASEB J, V7, P1023; FLOEGE J, 1992, J CLIN INVEST, V90, P2362, DOI 10.1172/JCI116126; Floege J, 1999, KIDNEY INT, V56, P883, DOI 10.1046/j.1523-1755.1999.00637.x; Hamed EA, 2011, J PHYSIOL BIOCHEM, V67, P339, DOI 10.1007/s13105-011-0080-8; Haseley LA, 1999, KIDNEY INT, V56, P964, DOI 10.1046/j.1523-1755.1999.00641.x; Issandou M, 1991, Growth Factors, V5, P255, DOI 10.3109/08977199109000289; Kimura K, 2006, INVEST OPHTH VIS SCI, V47, P4323, DOI 10.1167/iovs.05-1508; KRIZ W, 1995, KIDNEY INT, V48, P1435, DOI 10.1038/ki.1995.433; Nosaka K, 1997, FREE RADICAL BIO MED, V22, P597; NOSAKA K, 1993, KIDNEY INT, V43, P470, DOI 10.1038/ki.1993.69; Okamoto K, 2012, DIABETES, V61, P1734, DOI 10.2337/db11-1201; Okamoto K, 2010, AM J HUM GENET, V86, P54, DOI 10.1016/j.ajhg.2009.12.009; RISER BL, 1992, J CLIN INVEST, V90, P1932, DOI 10.1172/JCI116071; TAKEUCHI A, 1992, AM J PATHOL, V141, P107; Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921; Vasko R, 2009, AM J PHYSIOL-RENAL, V296, pF1452, DOI 10.1152/ajprenal.90352.2008; Zimering MB, 1996, J CLIN ENDOCR METAB, V81, P4446, DOI 10.1210/jc.81.12.4446	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JUL	2015	185	7					1889	1898		10.1016/j.ajpath.2015.03.025		10	Pathology	Pathology	CL5KA	WOS:000356997600010		
J	Morishita, K; Takemura, G; Tsujimoto, A; Kanamori, H; Okada, H; Chousa, M; Ushimaru, S; Mikami, A; Kawamura, I; Takeyama, T; Kawaguchi, T; Watanabe, T; Goto, K; Morishita, M; Ushikoshi, H; Kawasaki, M; Ogura, S; Minatoguchi, S				Morishita, Kentaro; Takemura, Genzou; Tsujimoto, Akiko; Kanamori, Hiromitsu; Okada, Hideshi; Chousa, Mitsuhiro; Ushimaru, Seiko; Mikami, Atsushi; Kawamura, Itta; Takeyama, Toshiaki; Kawaguchi, Tomonori; Watanabe, Takatomo; Goto, Kazuko; Morishita, Megumi; Ushikoshi, Hiroaki; Kawasaki, Masanori; Ogura, Shinji; Minatoguchi, Shinya			Postinfarction Cardiac Remodeling Proceeds Normally in Granulocyte Colony-Stimulating Factor Knockout Mice	AMERICAN JOURNAL OF PATHOLOGY			English	Article							ENDOTHELIAL GROWTH-FACTOR; ACUTE MYOCARDIAL-INFARCTION; OPEN ARTERY HYPOTHESIS; HEART-FAILURE; GRANULATION-TISSUE; CELLS; REPERFUSION; CARDIOMYOCYTES; APOPTOSIS; ERYTHROPOIETIN	Treatment with granulocyte colony-stimulating factor (G-CSF) reportedly mitigates postinfarction cardiac remodeling and dysfunction. We herein examined the effects of G-CSF knockout (G-CSF-KO) on the postinfarction remodeling process in the hearts of mice. Unexpectedly, the acute infarct size 24 hours after ligation was similar in the two groups. At the chronic stage (4 weeks later), there was no difference in the left ventricular dimension, left ventricular function, or histological findings, including vascular density, between the two groups. In addition, expression of vascular endothelial growth factor (VEGF) was markedly up-regulated in hearts from G-CSF-KO mice, compared with wild-type mice. Microarray failed in detecting up-regulation of VEGF mRNA, whereas G-CSF administration significantly decreased myocardial VEGF expression in mice, indicating that G-CSF post-transcriptionally down-regulates VEGF expression. When G-CSF-KO mice were treated with an anti-VEGF antibody (bevacizumab), cardiac remodeling was significantly aggravated, with thinning of the infarct wall and reduction of the cellular component, including blood vessels. In the granulation tissue of bevacizumab-treated hearts 4 days after infarction, vascular development was scarce, with reduced cell proliferation and increased apoptosis, which likely contributed to the infarct wall thinning and the resultant increase in wall stress and cardiac remodeling at the chronic stage. In conclusion, overexpression of VEGF may compensate for the G-CSF deficit through preservation of cellular components, including blood vessels, in the postinfarction heart.	[Morishita, Kentaro; Okada, Hideshi; Kawaguchi, Tomonori; Watanabe, Takatomo; Ushikoshi, Hiroaki; Ogura, Shinji] Gifu Univ, Grad Sch Med, Dept Emergency, Gifu, Japan; [Morishita, Kentaro; Okada, Hideshi; Kawaguchi, Tomonori; Watanabe, Takatomo; Ushikoshi, Hiroaki; Ogura, Shinji] Gifu Univ, Grad Sch Med, Dept Disaster Med, Gifu, Japan; [Morishita, Kentaro; Takemura, Genzou; Tsujimoto, Akiko; Kanamori, Hiromitsu; Okada, Hideshi; Mikami, Atsushi; Kawamura, Itta; Takeyama, Toshiaki; Kawaguchi, Tomonori; Watanabe, Takatomo; Goto, Kazuko; Morishita, Megumi; Ushikoshi, Hiroaki; Kawasaki, Masanori; Minatoguchi, Shinya] Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan; [Chousa, Mitsuhiro; Ushimaru, Seiko] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu, Japan; [Takemura, Genzou] Asahi Univ, Sch Dent, Dept Internal Med, Mizuho 5010296, Japan	Takemura, G (reprint author), Asahi Univ, Sch Dent, Dept Internal Med, 1851 Hozumi, Mizuho 5010296, Japan.	gt@dent.asahi-u.ac.jp			Gifu University research grants	Supported in part by Gifu University research grants (S.M.).	Al-Salam S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086994; Li YW, 2004, CIRC RES, V95, P627, DOI 10.1161/01.RES.0000141528.54850.bd; Los M, 2007, ONCOLOGIST, V12, P443, DOI 10.1634/theoncologist.12-4-443; Presta LG, 1997, CANCER RES, V57, P4593; Powell TM, 2005, ARTERIOSCL THROM VAS, V25, P296, DOI 10.1161/01.ATV.00000151690.43777.e4; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Shimoji K, 2010, CELL STEM CELL, V6, P227, DOI 10.1016/j.stem.2010.01.002; von Harsdorf R, 2004, CIRC RES, V95, P554, DOI 10.1161/01.RES.0000143717.70275.8f; Minatoguchi S, 2004, CIRCULATION, V109, P2572, DOI 10.1161/01.CIR.0000129770.93985.3E; Neufeld G, 1999, FASEB J, V13, P9; Silvestre JS, 2013, PHYSIOL REV, V93, P1743, DOI 10.1152/physrev.00006.2013; PFEFFER MA, 1995, ANNU REV MED, V46, P455; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Hayakawa K, 2003, CIRCULATION, V108, P104, DOI 10.1161/01.CIR.0000074225.62168.68; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Kawaguchi T, 2012, CARDIOVASC RES, V96, P456, DOI 10.1093/cvr/cvs282; Maekawa N, 2002, J AM COLL CARDIOL, V39, P1229, DOI 10.1016/S0735-1097(02)01738-2; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kanamori H, 2013, AM J PATHOL, V182, P701, DOI 10.1016/j.ajpath.2012.11.009; Chung JK, 1997, MOL CELL BIOL, V17, P6508; KIM CB, 1993, CIRCULATION, V88, P2426; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Boesiger J, 1998, J EXP MED, V188, P1135, DOI 10.1084/jem.188.6.1135; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje; BUSSOLINO F, 1989, NATURE, V337, P471, DOI 10.1038/337471a0; Li YW, 2006, LAB INVEST, V86, P32, DOI 10.1038/labinvest.3700367; Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, NAT RES COUNC GUID C; HALE SL, 1988, AM HEART J, V116, P1508, DOI 10.1016/0002-8703(88)90736-3; HOCHMAN JS, 1987, CIRCULATION, V75, P299; Kloner RA, 2008, CIRC RES, V103, P1, DOI 10.1161/CIRCRESAHA.108.180216; Li LH, 2009, J AM COLL CARDIOL, V53, P2378, DOI 10.1016/j.jacc.2009.02.056; Marroquin OC, 2004, PROG CARDIOVASC DIS, V42, P471; Nakagawa M, 2008, CIRC RES, V103, P98, DOI 10.1161/CIRCRESAHA.108.177568; Okada H, 2008, J CELL MOL MED, V12, P1272, DOI 10.1111/j.1582-4934.2008.00294.x; Okada H, 2009, AM J PHYSIOL-HEART C, V296, pH616, DOI 10.1152/ajpheart.01147.2008; REIMER KA, 1993, AM J CARDIOL, V72, pG13, DOI 10.1016/0002-9149(93)90102-I; Takemura G, 1998, CIRC RES, V82, P1130; Takeyama T, 2012, CIRC-HEART FAIL, V5, P274, DOI 10.1161/CIRCHEARTFAILURE.111.965061; YIN FCP, 1981, CIRC RES, V49, P829	42	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JUL	2015	185	7					1899	1911		10.1016/j.ajpath.2015.03.018		13	Pathology	Pathology	CL5KA	WOS:000356997600011		
J	Odonkor, CA; Hurst, PV; Kondo, N; Makary, MA; Pronovost, PJ				Odonkor, Charles A.; Hurst, Pia V.; Kondo, Naoki; Makary, Martin A.; Pronovost, Peter J.			Beyond the Hospital Gates Elucidating the Interactive Association of Social Support, Depressive Symptoms, and Physical Function with 30-Day Readmissions	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Hospital Readmissions; Physical Function; Depressive Symptom Severity; Neighborhood Wealth	OLDER-ADULTS; OUTPATIENT SURGERY; EXERCISE CAPACITY; CARE; RISK; MORTALITY; ANESTHESIA; MORBIDITY; ADMISSION; NOMOGRAM	Objective The aims of this study were to design patient-oriented risk models that elucidate the interactions among depressive symptoms, physical function, and sociodemographic markers and delineate the association of these indicators with 30-day readmissions. Design This prospective longitudinal study examined readmissions within 30 days of an index operation among adults (>18 yrs) undergoing outpatient surgery. The primary exposures were measures of physical function, depression, and sociodemographic factors. Multivariable logistic regression and hierarchical generalized linear mixed models with fixed and random effects tested interactions and association of these factors with 30-day readmissions. Results Adjusting for covariates and interaction terms, depressive symptoms (adjusted odds ratio, 2.50; 95% confidence interval, 1.45-4.29) and low physical function (adjusted odds ratio, 1.68; 95% confidence interval, 1.15-2.13) increased the odds of 30-day readmissions. Stratified by socioeconomic status (SES), those in the lowest SES group with depressive symptoms had a 73% increase in probability of readmissions (adjusted odds ratio, 2.67; 95% confidence interval, 1.10-4.07). Stratified by depressive symptom severity, being married or having a life partner lowered the readmission odds (adjusted odds ratio, 0.52; 95% confidence interval, 0.31-0.88). Final models had good discrimination and fitness (area under the curve,0.710; corrected Akaike Information Criterion, 541.1). Conclusions Within 30 days of index surgery, depressive symptom severity moderated the association of sociodemographic, social support and physical function indicators with 30-day readmissions.	[Odonkor, Charles A.; Makary, Martin A.; Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA; [Hurst, Pia V.] North Shore Long Isl Jewish Hlth Syst, Manhasset, NY USA; [Kondo, Naoki] Univ Tokyo, Sch Publ Hlth, Tokyo, Japan; [Odonkor, Charles A.] Yale Univ, Sch Med, New Haven, CT USA	Odonkor, CA (reprint author), Johns Hopkins Univ, Dept Phys Med & Rehabil, 600 North Wolfe St,Phipps 160, Baltimore, MD 21287 USA.						Andrews AW, 2012, TOP GERIATR REHABIL, V28, P2, DOI 10.1097/TGR.0b013e31823417a5; Marks E, 2013, JAMA INTERN MED, V173, P629, DOI 10.1001/jamainternmed.2013.4065; Uchino BN, 2012, SOC SCI MED, V74, P949, DOI 10.1016/j.socscimed.2011.11.023; Bohannon RW, 2010, J GERIATR PHYS THER, V33, P16, DOI 10.1097/JPT.0b013e3181d0735e; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Paasche-Orlow MK, 2005, J GEN INTERN MED, V20, P175, DOI 10.1111/j.1525-1497.2005.40245.x; Kassin MT, 2012, J AM COLL SURGEONS, V215, P322, DOI 10.1016/j.jamcollsurg.2012.05.024; MORRIS CK, 1993, J AM COLL CARDIOL, V22, P175; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Levasseur M, 2011, ARCH PHYS MED REHAB, V92, P1979, DOI 10.1016/j.apmr.2011.06.035; Fleisher LA, 2007, ARCH SURG-CHICAGO, V142, P263, DOI 10.1001/archsurg.142.3.263; COHEN MM, 1988, JAMA-J AM MED ASSOC, V260, P2859, DOI 10.1001/jama.260.19.2859; Furze G, 2009, INT J CARDIOL, V132, P51, DOI 10.1016/j.ijcard.2008.06.001; Gulati M, 2005, NEW ENGL J MED, V353, P468, DOI 10.1056/NEJMoa044154; WARNER MA, 1993, JAMA-J AM MED ASSOC, V270, P1437, DOI 10.1001/jama.270.12.1437; Venkat R, 2011, ARCH SURG-CHICAGO, V146, P1277, DOI 10.1001/archsurg.2011.294; Hechenbleikner EM, 2013, J AM COLL SURGEONS, V216, P1150, DOI 10.1016/j.jamcollsurg.2013.01.057; FLETCHER GF, 1995, CIRCULATION, V91, P580; Asch SM, 2004, ANN INTERN MED, V141, P938; Fielding RA, 2007, MED SCI SPORT EXER, V39, P1997, DOI 10.1249/mss.0b013e318145348d; Abellan JJ, 2008, ENVIRON HEALTH PERSP, V116, P1111, DOI 10.1289/ehp.10814; Sawatzky JAV, 2014, CLIN REHABIL, V28, P648, DOI 10.1177/0269215513516475; Cullen KA, 2006, AMBULATORY SURG US, P28; Debes C, 2014, ANN FR ANESTH, V33, P33, DOI 10.1016/j.annfar.2013.12.012; Fleisher LA, 2004, ARCH SURG-CHICAGO, V139, P67, DOI 10.1001/archsurg.139.1.67; Glass S, 2007, GB ACSMS METABOLIC C; Hoyer EH, 2013, ARCH PHYS MED REHAB, V94, P1951, DOI 10.1016/j.apmr.2013.05.028; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Kendel F, 2010, ARCH INTERN MED, V170, P1717, DOI 10.1001/archinternmed.2010.368; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Koebnick Corinna, 2012, Perm J, V16, P37; Koutlianos N, 2013, HIPPOKRATIA, V17, P136; Lavizzo-Mourey R, 2013, HUMAN FACE HOSP READ; National Medicare Readmission, 2010, FIND REC DAT TRENDS, P36; Odonkor CA, 2013, J GERONTOL A-BIOL, V68, P1532, DOI 10.1093/gerona/glt060; Odonkor CA, 2013, AM J PHYS MED REHAB, V92, P849, DOI 10.1097/PHM.0b013e3182a51ac5; Panton LB, 1996, J GERONTOL A-BIOL, V51, pM165	37	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUL	2015	94	7					555	567		10.1097/PHM.0000000000000213		13	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CK8NA	WOS:000356493700007		
J	Nozaki, T; Tasaki, A; Horiuchi, S; Osakabe, C; Ohde, S; Saida, Y; Yoshioka, H				Nozaki, Taiki; Tasaki, Atsushi; Horiuchi, Saya; Osakabe, Chiharu; Ohde, Sachiko; Saida, Yukihisa; Yoshioka, Hiroshi			Quantification of Fatty Degeneration Within the Supraspinatus Muscle by Using a 2-Point Dixon Method on 3-T MRI	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Review						fatty degeneration; MRI; muscular atrophy; quantification; rotator cuff tear	ROTATOR CUFF TEARS; SUPRASCAPULAR NEUROPATHY; ASYMPTOMATIC VOLUNTEERS; FUNCTIONAL OUTCOMES; ATROPHY; REPAIR; INFILTRATION; SPECTROSCOPY; ASSOCIATION; GOUTALLIER	OBJECTIVE. The objective of this study was to quantify fatty degeneration of the supraspinatus muscle by using a 2-point Dixon technique on 3-T MRI and to evaluate the correlation of muscular atrophy and fat fraction values among different severities of rotator cuff tears across differing ages and sexes. SUBJECTS AND METHODS. Patients with shoulder pain (n = 359) were evaluated by shoulder MRI on a 3-T unit, including a 2-point Dixon sequence for quantification of muscle atrophy and fatty degeneration within the supraspinatus muscle. Two board-certified musculoskeletal radiologists evaluated the degree of rotator cuff tears in three groups: full-thickness tear (n = 63), partial tear (n = 54), and no tear (n = 242). In quantitative analysis, we measured signal intensity values of in-phase images (S-In) and fat images (S-Fat) within the supraspinatus muscle, and the fat fraction was calculated as S-Fat / S-In. The Thomazeau occupation ratio was used as a quantitative index of muscular atrophy. Fat fraction and muscle atrophy were evaluated among these groups. RESULTS. Fat fraction values were changed with the degree of rotator cuff tears and were (mean +/- SD) 0.258 +/- 0.123 among patients with full-thickness tears, 0.166 +/- 0.067 among patients with partial tears, and 0.128 +/- 0.061 among patients with no tears, with statistically significant differences (p < 0.001). The values were higher in female than in male patients in all groups. The Pearson correlation coefficient was 0.348 between age and fat fraction value, and 0.664 between muscular atrophy rate and fat fraction value. CONCLUSION. An increase in supraspinatus fatty degeneration was statistically significantly correlated with severity of supraspinatus tears and moderately correlated with muscular atrophy. Fatty degeneration tends to progress more rapidly than muscular atrophy in female patients, with statistically significant sex differences.	[Nozaki, Taiki; Horiuchi, Saya; Osakabe, Chiharu; Saida, Yukihisa] St Lukes Int Hosp, Dept Radiol, Chuo Ku, Tokyo 1048560, Japan; [Yoshioka, Hiroshi] Univ Calif Irvine, Dept Radiol Sci, Irvine, CA 92717 USA; [Tasaki, Atsushi] St Lukes Int Hosp, Dept Orthopaed Surg, Tokyo 1048560, Japan; [Ohde, Sachiko] St Lukes Life Sci Inst, Ctr Clin Epidemiol, Tokyo, Japan	Nozaki, T (reprint author), St Lukes Int Hosp, Dept Radiol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	nojyakki@gmail.com			ZENKYOREN (National Mutual Insurance Federation of Agricultural Cooperatives)	This study was partly supported by a grant from ZENKYOREN (National Mutual Insurance Federation of Agricultural Cooperatives).	Fischer MA, 2014, EUR RADIOL, V24, P1366, DOI 10.1007/s00330-014-3121-1; Shen PH, 2008, J SHOULDER ELB SURG, V17, p1S, DOI 10.1016/j.jse.2007.04.014; Zanetti M, 1998, INVEST RADIOL, V33, P163, DOI 10.1097/00004424-199803000-00006; Fuchs B, 1999, J SHOULDER ELB SURG, V8, P599, DOI 10.1016/S1058-2746(99)90097-6; Vad VB, 2003, J SHOULDER ELB SURG, V12, P333, DOI 10.1016/S1058-2746(03)00040-5; Mallon WJ, 2006, J SHOULDER ELB SURG, V15, P395, DOI 10.1016/j.jse.2005.10.019; DIXON WT, 1984, RADIOLOGY, V153, P189; Nardo L, 2014, J MAGN RESON IMAGING, V39, P1178, DOI 10.1002/jmri.24278; Idilman IS, 2013, RADIOLOGY, V267, P767, DOI 10.1148/radiol.13121360; Visser M, 2005, J GERONTOL A-BIOL, V60, P324; COFIELD RH, 1982, SURG GYNECOL OBSTET, V154, P667; Reeder SB, 2012, J MAGN RESON IMAGING, V36, P1011, DOI 10.1002/jmri.23741; Goutallier D, 2003, J SHOULDER ELB SURG, V12, P550, DOI 10.1016/S1058-2746(03)00211-8; Gladstone JN, 2007, AM J SPORT MED, V35, P719, DOI 10.1177/0363546506297539; Mellado JM, 2005, AM J ROENTGENOL, V184, P1456; Slabaugh MA, 2012, AM J SPORT MED, V40, P1728, DOI 10.1177/0363546512452714; Barry JJ, 2013, J SHOULDER ELB SURG, V22, P18, DOI 10.1016/j.jse.2011.12.014; Burkhart SS, 2007, ARTHROSCOPY, V23, P347, DOI 10.1016/j.arthro.2006.12.012; Laron D, 2012, J SHOULDER ELB SURG, V21, P164, DOI 10.1016/j.jse.2011.09.027; Kang JR, 2012, J SHOULDER ELB SURG, V21, P175, DOI 10.1016/j.jse.2011.11.017; Warner JJP, 2001, J SHOULDER ELB SURG, V10, P37, DOI 10.1067/mse.2001.112022; Smith AC, 2014, MUSCLE NERVE, V50, P170, DOI 10.1002/mus.24255; Oh JH, 2010, CLIN ORTHOP RELAT R, V468, P1558, DOI 10.1007/s11999-009-0818-6; Lippe J, 2012, ARTHROSCOPY, V28, P154, DOI 10.1016/j.arthro.2011.07.016; Thomazeau H, 1996, ACTA ORTHOP SCAND, V67, P264; Mengiardi B, 2006, RADIOLOGY, V240, P786, DOI 10.1148/radiol.2403050820; Belangero PS, SHOULDER CONCEPTS 20, P5; Berglund J, 2011, MAGN RESON MED, V65, P994, DOI 10.1002/mrm.22679; Gokalp G, 2010, SKELETAL RADIOL, V39, P1211, DOI 10.1007/s00256-010-0927-z; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Keller K, 2014, MUSCLES LIGAMENTS TR, V3, P346; Kenn W, 2004, EUR RADIOL, V14, P2331, DOI 10.1007/s00330-004-2410-5; Kuzel BR, 2013, J AM ACAD ORTHOP SUR, V21, P613, DOI 10.5435/JAAOS-21-10-613; Lee YH, 2014, ACAD RADIOL; Ludwig UA, 2014, J MAGN RESON IMAGING, V40, P1437, DOI 10.1002/jmri.24509; Matsuki K, 2014, J SHOULDER ELB SURG, V23, P636, DOI 10.1016/j.jse.2014.01.019; Pfirrmann CWA, 2004, RADIOLOGY, V232, P709, DOI 10.1148/radiol.2323030442; Razmjou H, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-66; Schaefer O, 2002, CLIN ORTHOP RELAT R, P93, DOI 10.1097/01.blo.0000026571.55792.fe; Shi LL, 2014, J SHOULDER ELB SURG, V23, P339, DOI 10.1016/j.jse.2013.06.011; Sugihara T, 2003, J SHOULDER ELB SURG, V12, P222, DOI 10.1016/S1058-2746(02)86888-4; Yoo HJ, 2015, KNEE SURG SPORT TR A, V23, P399, DOI 10.1007/s00167-014-2992-7	42	1	1	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	JUL	2015	205	1					116	122		10.2214/AJR.14.13518		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CL2NK	WOS:000356781000036		
J	Kondo, F; Tachi, M; Gosho, M; Fukayama, M; Yoshikawa, K; Okada, S				Kondo, Fumio; Tachi, Masahiko; Gosho, Masahiko; Fukayama, Minoru; Yoshikawa, Kazuhiro; Okada, Shoshiro			Changes in hypothalamic neurotransmitter and prostanoid levels in response to NMDA, CRF, and GLP-1 stimulation	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Neurotransmitters; Prostanoids; Hypothalamic paraventricular nucleus; Microdialysis; LC-ITMSn	HIPPOCAMPAL SEROTONERGIC NEUROTRANSMISSION; SYMPATHO-ADRENOMEDULLARY OUTFLOW; IN-VIVO MICRODIALYSIS; PARAVENTRICULAR NUCLEUS; MASS-SPECTROMETRY; GLUTAMATE RELEASE; PROSTAGLANDIN E-2; THROMBOXANE A(2); RATS; ACTIVATION	Determination of neuroactive substances, such as neurotransmitters and prostanoids, in the extracellular space of the living brain is a very important technique in neuroscience. The hypothalamic paraventricular nucleus (PVN) is one of the most important autonomic control centers in the brain. Recently, we demonstrated that thromboxane (Tx) A(2) in the PVN may play an important role in adrenomedullary outflow evoked by N-methyl-d-aspartate (NMDA), corticotrophin-releasing factor (CRF), and glucagon-like peptide-1 (GLP-1) stimulation using microdialysis sampling and liquid chromatography-ion trap tandem mass spectrometry (LC-ITMSn). In the present study, we investigated whether centrally administered NMDA, CRF, and GLP-1 can release five neurotransmitters, acetylcholine (ACh), histamine, glutamate (Glu), gamma-aminobutyric acid (GABA), and serotonin (5-HT), along with six prostanoids, TxB(2), prostaglandin (PG) E-2, PGD(2), 15-deoxy-a dagger(12,14) (15d)-PGJ(2), 6-keto-PGF(1 alpha), and PGF(2 alpha) in rat PVN microdialysates after optimization of LC-ITMSn conditions . All stimulations increased the levels of 5-HT, TxB(2), PGE(2), and PGF(2 alpha) (except for 5-HT stimulated with GLP-1). Only NMDA increased the levels of ACh, Glu, and GABA. Treatment with dizocilpine maleate (MK-801), a noncompetitive NMDA receptor antagonist, attenuated the NMDA-induced increase in the levels of neuroactive substances except for Glu. This is the first study to use LC-ITMSn to analyze neurotransmitters and prostanoids in the same microdialysates from rat PVN.	[Kondo, Fumio; Tachi, Masahiko; Okada, Shoshiro] Aichi Med Univ, Sch Med, Dept Pharmacol, Nagakute, Aichi 4801195, Japan; [Gosho, Masahiko] Aichi Med Univ, Sch Med, Adv Med Res Ctr, Nagakute, Aichi 4801195, Japan; [Fukayama, Minoru; Yoshikawa, Kazuhiro] Aichi Med Univ, Sch Med, Cent Res Lab, Nagakute, Aichi 4801195, Japan	Kondo, F (reprint author), Aichi Med Univ, Sch Med, Dept Pharmacol, Nagakute, Aichi 4801195, Japan.	fumiokon@aichi-med-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24590903, S1101027]	This work was supported in part by a Grant-in-Aid for Scientific Research (No. 24590903 to S.O.) and by a Strategic Research Foundation Grant-aided Project for Private Universities grant (S1101027) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Yamaguchi N, 2009, AUTON NEUROSCI-BASIC, V148, P83, DOI 10.1016/j.autneu.2009.02.009; Anderzhanova E, 2013, CELL TISSUE RES, V354, P27, DOI 10.1007/s00441-013-1709-4; Carlsson A, 2001, SCIENCE, V294, P1021, DOI 10.1126/science.1066969; Calabresi P, 2000, PROG NEUROBIOL, V61, P231, DOI 10.1016/S0301-0082(99)00030-1; Furuyashiki T, 2011, NAT REV ENDOCRINOL, V7, P163, DOI 10.1038/nrendo.2010.194; Santos-Fandila A, 2013, TALANTA, V114, P79, DOI 10.1016/j.talanta.2013.03.082; Lopez LL, 1999, RAPID COMMUN MASS SP, V13, P663, DOI 10.1002/(SICI)1097-0231(19990430)13:8<663::AID-RCM538>3.0.CO;2-H; Milatovic D, 2011, NEUROTOXICOLOGY, V32, P312, DOI 10.1016/j.neuro.2011.02.004; Song P, 2012, ANAL CHEM, V84, P412, DOI 10.1021/ac202794q; LAZAREWICZ JW, 1995, J NEUROSCI RES, V40, P660, DOI 10.1002/jnr.490400511; Rinaman L, 1999, AM J PHYSIOL-REG I, V277, pR582; Arai J, 2000, CLIN EXP PHARM PHYSL, V35, P965; D'Aniello A, 1998, NEUROSCI LETT, V250, P131, DOI 10.1016/S0304-3940(98)00451-0; Isogawa K, 2000, NEUROPEPTIDES, V34, P234, DOI 10.1054/npep.2000.0806; KORTE SM, 1991, EUR J PHARMACOL, V197, P225, DOI 10.1016/0014-2999(91)90527-W; Li YF, 2006, AM J PHYSIOL-HEART C, V291, pH2847, DOI 10.1152/ajpheart.00625.2005; Linthorst ACE, 2002, EUR J NEUROSCI, V16, P2441, DOI 10.1046/j.1460-9568.2002.02400.x; Marti M, 2005, J NEUROCHEM, V93, P195, DOI 10.1111/j.1471-4159.2005.03015.x; Murakami Y, 2002, EUR J PHARMACOL, V452, P289, DOI 10.1016/S0014-2999(02)02308-7; Okada S, 2003, EUR J PHARMACOL, V475, P49, DOI 10.1016/S0014-2999(03)02148-4; Okada S, 2003, EUR J PHARMACOL, V467, P125, DOI 10.1016/S0014-2999(03)01629-7; Okada S, 2000, NEUROSCIENCE, V96, P585, DOI 10.1016/S0306-4522(99)00598-9; Okada S, 2010, EUR J PHARMACOL, V640, P55, DOI 10.1016/j.ejphar.2010.04.038; PATEL PM, 1994, BRAIN RES, V650, P205, DOI 10.1016/0006-8993(94)91783-3; Paxinos G., 1997, RAT BRAIN STEREOTAXI; Penalva RG, 2002, NEUROSCIENCE, V109, P253, DOI 10.1016/S0306-4522(01)00475-4; Pepicelli O, 2002, J NEUROCHEM, V81, P1028, DOI 10.1046/j.1471-4159.2002.00897.x; Sachs BD, 2013, INT J NEUROPSYCHOPH, V16, P2081, DOI 10.1017/S1461145713000321; Tachi M, 2014, AUTON NEUROSCI-BASIC, V181, P49, DOI 10.1016/j.autneu.2013.12.013; Zhang XZ, 2007, RAPID COMMUN MASS SP, V21, P3621, DOI 10.1002/rcm.3251	30	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	JUL	2015	407	18					5261	5272		10.1007/s00216-015-8496-6		12	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CL2SW	WOS:000356796000004		
J	Hossen, MA; Nagata, Y; Waki, M; Ide, Y; Takei, S; Fukano, H; Romero-Perez, GA; Tajima, S; Yao, I; Ohnishi, K; Setou, M				Hossen, Md Amir; Nagata, Yasuyuki; Waki, Michihiko; Ide, Yoshimi; Takei, Shiro; Fukano, Hana; Romero-Perez, Gustavo A.; Tajima, Shogo; Yao, Ikuko; Ohnishi, Kazunori; Setou, Mitsutoshi			Decreased level of phosphatidylcholine (16:0/20:4) in multiple myeloma cells compared to plasma cells: a single-cell MALDI-IMS approach	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Multiple myeloma; Phosphatidylcholine; Single cell; Matrix-assisted laser desorption/ionization-imaging mass spectrometry (MALDI-IMS)	IMAGING MASS-SPECTROMETRY; HUMAN METABOLOME DATABASE; COA DESATURASE 1; FATTY-ACID; PROSTATE-CANCER; CARCINOMA; ELONGASE; IONIZATION; POLYLYSINE; REGIONS	Lipid metabolic changes under diseased conditions, particularly in solid tumors, are attracting increased attention. However, in non-solid tumors, including most hematopoietic tumors, lipid analyses are scarce. Multiple myeloma (MM) is a plasma cell disorder arising from bone marrow, and the lipid status of MM cells has not been reported yet. In this study, we analyzed flow cytometry-sorted single MM cells and normal plasma cells (NPCs) using matrix-assisted laser desorption/ionization-imaging mass spectrometry (MALDI-IMS), a two-dimensional label-free mass spectrometry technique for biomolecular analysis, to obtain specific lipid information. We isolated 1.31-5.77 % of MM cells and 0.03-0.24 % of NPCs using fluorescence-activated cell sorting (FACS). Analysis of purified cells using MALDI-IMS at the single-cell level revealed that the peak intensity and ion signals of phosphatidylcholine [PC (16:0/20:4) + H](+) at m/z 782.5 were significantly decreased in MM cells compared to NPCs. By examining particular cell populations rather than cell mixtures, our method can become a suitable tool for the analysis of rare cell populations at the single-cell level and advance the understanding of MM progression.	[Hossen, Md Amir; Nagata, Yasuyuki; Waki, Michihiko; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Nagata, Yasuyuki; Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Ctr Oncol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Ide, Yoshimi] Hamamatsu Univ Sch Med, Dept Surg 1, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Takei, Shiro; Fukano, Hana; Romero-Perez, Gustavo A.; Yao, Ikuko] Hamamatsu Univ Sch Med, Dept Opt Imaging, Med Photon Res Ctr, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Takei, Shiro; Romero-Perez, Gustavo A.; Yao, Ikuko] JST, ERATO, Sato Project, Tokyo 1608582, Japan; [Tajima, Shogo] Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Setou, Mitsutoshi] Univ Hong Kong, Dept Anat, Pok Fu Lam, Hong Kong, Peoples R China	Setou, M (reprint author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	mitsutoshi.setou@gmail.com	Romero-Perez, Gustavo/O-4430-2015	Romero-Perez, Gustavo/0000-0003-2448-9704	Japan Society for the Promotion of Science [25293044]; Ministry of Education, Culture, Sports, Science and Technology [25116712]; Ministry of Health, Labor, and Welfare [H23-Iryoukiki-Ippan-001]	This work was supported by grants from the Japan Society for the Promotion of Science (Grant Number 25293044), the Ministry of Education, Culture, Sports, Science and Technology (Grant Number 25116712), and the Ministry of Health, Labor, and Welfare (Grant Number H23-Iryoukiki-Ippan-001). We appreciate the cooperation of all staff in our laboratory and in the Department of Hematology at Hamamatsu University Hospital. We proudly remember the kind support of Mr. Shibata at the Center of Facilities for Common Use in the Hamamatsu University School of Medicine.	Andre T, 2013, CANCER IMMUNOL IMMUN, V64, P213; Grove KJ, 2011, J AM SOC MASS SPECTR, V22, P192, DOI 10.1007/s13361-010-0013-8; Kurabe N, 2013, CANCER SCI, V104, P1295, DOI 10.1111/cas.12221; Bahlis NJ, 2012, BLOOD, V120, P927, DOI 10.1182/blood-2012-06-430645; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Matsumoto J, 2011, ANAL BIOANAL CHEM, V400, P1933, DOI 10.1007/s00216-011-4909-3; Muir K, 2013, CANCER RES, V73, P4722, DOI 10.1158/0008-5472.CAN-12-3797; KAWAI K, 1974, BIOCHIM BIOPHYS ACTA, V369, P222; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Vincenz L, 2013, MOL CANCER THER, V12, P831, DOI 10.1158/1535-7163.MCT-12-0782; von Roemeling CA, 2013, CLIN CANCER RES, V19, P2368, DOI 10.1158/1078-0432.CCR-12-3249; Matsuzaka T, 2002, J LIPID RES, V43, P911; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; MAZIA D, 1975, J CELL BIOL, V66, P198, DOI 10.1083/jcb.66.1.198; Schober Y, 2012, ANAL CHEM, V84, P6293, DOI 10.1021/ac301337h; Uchiyama Y, 2014, ANAL BIOANAL CHEM, V406, P1307, DOI 10.1007/s00216-013-7062-3; Rajkumar SV, 2011, NAT REV CLIN ONCOL, V8, P479, DOI 10.1038/nrclinonc.2011.63; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Rhodes DR, 2004, NEOPLASIA, V6, P1; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Doria ML, 2014, FASEB J, V28, P4247, DOI 10.1096/fj.14-249672; Fuchs B, 2007, CHEM PHYS LIPIDS, V150, P229, DOI 10.1016/j.chemphyslip.2007.08.005; Goto-Inoue N, 2011, BBA-MOL CELL BIOL L, V1811, P961, DOI 10.1016/j.bbalip.2011.03.004; Guo S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05959; Gupta R, 2009, AM J CLIN PATHOL, V132, P728, DOI 10.1309/AJCP1GYI7EHQYUYK; Hayasaka T, 2014, SURF INTERFACE ANAL, V46, P1219, DOI 10.1002/sia.5592; Ide Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061204; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Nagata Y, 2015, LEUK RES IN PRESS; Nagata Y, 2014, SURF INTERFACE ANAL, V46, P185, DOI 10.1002/sia.5522; PACHMANN K, 1976, J IMMUNOL METHODS, V12, P81, DOI 10.1016/0022-1759(76)90098-3; Rawstron AC, 1997, BRIT J HAEMATOL, V97, P46, DOI 10.1046/j.1365-2141.1997.72653.x; Roy MC, 2011, J LIPID RES, V52, P463, DOI 10.1194/jlr.M010546; Sadowski MC, 2014, ONCOTARGET, V5, P9362; Sherbenou DW, 2014, BLOOD REV IN PRESS; Tirado-Velez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046484; Wajs J, 2013, WSPOLCZESNA ONKOL, V17, P272, DOI 10.5114/wo.2013.35282; Waki M, 2014, BIOCHIMIE, V107, P73, DOI 10.1016/j.biochi.2014.10.003; Wintrobe MM, 2009, WINTROBES CLIN HEMAT, V12th, P300; Yang I, 2014, J CHROMATOGR A, V1324, P224, DOI 10.1016/j.chroma.2013.11.035	41	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	JUL	2015	407	18					5273	5280		10.1007/s00216-015-8741-z		8	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CL2SW	WOS:000356796000005		
J	Gotoh, K; Nakajima, Y; Tajima, G; Hotta, Y; Kataoka, T; Kawade, Y; Sugiyama, N; Ito, T; Kimura, K; Maeda, Y				Gotoh, Kana; Nakajima, Yoko; Tajima, Go; Hotta, Yuji; Kataoka, Tomoya; Kawade, Yoshihiro; Sugiyama, Naruji; Ito, Tetsuya; Kimura, Kazunori; Maeda, Yasuhiro			Assay for methylmalonyl coenzyme A mutase activity based on determination of succinyl coenzyme A by ultrahigh-performance liquid chromatography tandem mass spectrometry	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Methylmalonyl-CoA; Methylmalonyl-CoA mutase; Ultrahigh-performance liquid chromatography; Methylmalonic acidemia; Succinyl-CoA	ORGANIC ACIDURIAS; INBORN-ERRORS; DIAGNOSIS; JAPAN; COA; METABOLISM; ACIDEMIA; MUTATION; GENE	Methylmalonic acidemia (MMA) is an inherited metabolic disease. In this condition, metabolism from methylmalonyl coenzyme A (CoA) to succinyl-CoA is inhibited because of either low methylmalonyl-CoA mutase (MCM) activity or adenosylcobalamin deficiency owing to altered vitamin B-12 metabolism. A high-precision assay for detecting MCM activity would facilitate not only MMA diagnosis but also the ability to determine the severity of MMA. We developed an MCM assay method based on ultrahigh-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) that involves the determination of succinyl-CoA, which is formed in an enzyme reaction, using peripheral lymphocytes. Using 0.05, 0.5, and 5 mu mol/L succinyl-CoA, the intra-assay coefficient of variation (CV) was less than 5.2 % and the inter-assay CV was less than 8.7 %. The MCM activities of five healthy individuals and four patients were investigated with this assay. The MCM activities of the patients were very low in relation to those of healthy individuals. Together, these results show that the UPLC-MS/MS method is useful for a detailed MCM activity assay.	[Gotoh, Kana; Hotta, Yuji; Kawade, Yoshihiro; Kimura, Kazunori; Maeda, Yasuhiro] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Hosp Pharm, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Nakajima, Yoko; Ito, Tetsuya] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 4701192, Japan; [Tajima, Go] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Minami Ku, Hiroshima 7348551, Japan; [Kataoka, Tomoya; Kimura, Kazunori] Nagoya City Univ, Grad Sch Med Sci, Dept Clin Pharmaceut, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Sugiyama, Naruji] Aichi Gakuin Univ, Sch Pharm, Dept Pediat, Chikusa Ku, Nagoya, Aichi 4648650, Japan	Maeda, Y (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Hosp Pharm, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	maeda@phar.nagoya-cu.ac.jp			Nagoya City University	This research was supported by a Grant-in-Aid for Research in Nagoya City University.	Sakamoto O, 2007, J HUM GENET, V52, P48, DOI 10.1007/s10038-006-0077-2; Fowler B, 2008, J INHERIT METAB DIS, V31, P350, DOI 10.1007/s10545-008-0839-4; Gao L, 2007, J CHROMATOGR B, V853, P303, DOI 10.1016/j.jchromb.2007.03.029; MILLINGTON DS, 1990, J INHERIT METAB DIS, V13, P321, DOI 10.1007/BF01799385; Liu MY, 2012, JIMD REP, V6, P55, DOI 10.1007/8904_2011_117; RASHED MS, 1995, PEDIATR RES, V38, P324, DOI 10.1203/00006450-199509000-00009; Dionisi-Vici C, 2006, J INHERIT METAB DIS, V29, P383, DOI 10.1007/s10545-006-0278-z; Cornejo V, 2002, REV MED CHILE, V130, P259; Dean J. A., 1992, LANGES HDB CHEM; Fenton WA, 2001, METABOLIC MOL BASES, P2165; Fujisawa D, 2013, J HUM GENET, V58, P769, DOI 10.1038/jhg.2013.97; Ghoraba Dina A, 2015, Meta Gene, V3, P71, DOI 10.1016/j.mgene.2014.02.001; KIKUCHI M, 1989, CLIN CHIM ACTA, V184, P307, DOI 10.1016/0009-8981(89)90064-8; Manoli I, 2005, GENEREVIEWS, P1993; MORROW G, 1975, PEDIATR RES, V9, P641, DOI 10.1203/00006450-197508000-00006; Nakagawa K, 2010, J CHROMATOGR B, V878, P942, DOI 10.1016/j.jchromb.2010.02.020; Peters Heidi L, 2002, Hum Mutat, V20, P406, DOI 10.1002/humu.9074; Shigematsu Y, 2002, J CHROMATOGR B, V776, P39, DOI 10.1016/S1570-0232(02)00077-6; Tajima G, 2005, J CHROMATOGR B, V823, P122, DOI 10.1016/j.jchromb.2005.06.043; Tajima G, 2004, J INHERIT METAB DIS, V27, P633, DOI 10.1023/B:BOLI.0000042988.31581.ed	20	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	JUL	2015	407	18					5281	5286		10.1007/s00216-015-8753-8		6	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CL2SW	WOS:000356796000006		
J	Bi, K; Nishihara, K; Machleidt, T; Hermanson, S; Wang, J; Sakamuru, S; Huang, RL; Xia, MH				Bi, Kun; Nishihara, Kana; Machleidt, Thomas; Hermanson, Spencer; Wang, Jun; Sakamuru, Srilatha; Huang, Ruili; Xia, Menghang			Identification of known drugs targeting the endoplasmic reticulum stress response	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						ATF6; ER stress pathways; NPC library; qHTS; XBP1	UNFOLDED PROTEIN RESPONSE; MYELOMA CELLS; ER STRESS; MECHANISMS; INHIBITORS; DISEASE; DEATH	The endoplasmic reticulum (ER), a multifunctional organelle, plays a central role in cellular signaling, development, and stress response. Dysregulation of ER homeostasis has been associated with human diseases, such as cancer, inflammation, and diabetes. A broad spectrum of stressful stimuli including hypoxia as well as a variety of pharmacological agents can lead to the ER stress response. In this study, we have developed a stable ER stress reporter cell line that stably expresses a beta-lactamase reporter gene under the control of the ER stress response element (ESRE) present in the glucose-regulated protein, 78 kDa (GRP78) gene promoter. This assay has been optimized and miniaturized into a 1536-well plate format. In order to identify clinically used drugs that induce ER stress response, we screened approximately 2800 drugs from the NIH Chemical Genomics Center Pharmaceutical Collection (NPC library) using a quantitative high-throughput screening (qHTS) platform. From this study, we have identified several known ER stress inducers, such as 17-AAG (via HSP90 inhibition), as well as several novel ER stress inducers such as AMI-193 and spiperone. The confirmed drugs were further studied for their effects on the phosphorylation of eukaryotic initiation factor 2 alpha (eIF2 alpha), the X-box-binding protein (XBP1) splicing, and GRP78 gene expression. These results suggest that the ER stress inducers identified from the NPC library using the qHTS approach could shed new lights on the potential therapeutic targets of these drugs.	[Bi, Kun] Thermo Fisher Sci, Life Sci Solut Grp, Rockford, IL 61105 USA; [Nishihara, Kana; Sakamuru, Srilatha; Huang, Ruili; Xia, Menghang] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Nishihara, Kana] Kyoto Univ, Grad Sch Med, Radiat Genet, Sakyo Ku, Kyoto 6068501, Japan; [Machleidt, Thomas; Hermanson, Spencer; Wang, Jun] Promega Corp, Fitchburg, WI 53711 USA	Xia, MH (reprint author), NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA.	mxia@mail.nih.gov			National Center for Advancing Translational Sciences, National Institutes of Health	We thank Sam Michael and Paul Shinn for assistance with automated screening and compound management. These studies were supported by the Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health.	Miller SC, 2010, BIOCHEM PHARMACOL, V79, P1272, DOI 10.1016/j.bcp.2009.12.021; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Basso LGM, 2011, BBA-BIOMEMBRANES, V1808, P55, DOI 10.1016/j.bbamem.2010.08.009; Rahmani M, 2007, MOL CELL BIOL, V27, P5499, DOI 10.1128/MCB.01080-06; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Neutel JM, 2013, CARDIOVASC THER, V31, P251, DOI 10.1111/1755-5922.12015; Sarro E, 2012, TOXICOL APPL PHARM, V258, P275, DOI 10.1016/j.taap.2011.11.007; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84; Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Ciechomska IA, 2012, AUTOPHAGY, V8; Dufey E, 2014, AM J PHYSIOL-CELL PH, V307, pC582, DOI 10.1152/ajpcell.00258.2014; GRUNDER G, 1993, PSYCHOPHARMACOLOGY, V111, P123, DOI 10.1007/BF02257418; Hansen HC, 2000, BIOORG MED CHEM LETT, V10, P2435, DOI 10.1016/S0960-894X(00)00483-2; Huang RL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05664; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; NELSON JA, 1975, CANCER RES, V35, P2872; Robers MB, 2008, ANAL BIOCHEM, V372, P189, DOI 10.1016/j.ab.2007.09.012; Xia MH, 2009, P NATL ACAD SCI USA, V106, P2412, DOI 10.1073/pnas.0813020106	25	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	JUL	2015	407	18					5343	5351		10.1007/s00216-015-8694-2		9	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CL2SW	WOS:000356796000012		
J	Matsuda, S; Ikura, T; Matsuda, T				Matsuda, Shun; Ikura, Tsuyoshi; Matsuda, Tomonari			Absolute quantification of gamma H2AX using liquid chromatography-triple quadrupole tandem mass spectrometry	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						gamma H2AX; Multiple reaction monitoring/selected reaction monitoring (MRM/SRM); Absolute quantification; DNA damage	POLYCYCLIC AROMATIC-HYDROCARBONS; HISTONE H2AX PHOSPHORYLATION; DOUBLE-STRAND BREAKS; PROTEIN MIXTURES; HEPG2 CELLS; IN-VIVO; GENOTOXICITY; ASSAY; EXTRACTION; PROTEOMICS	Ser139-phosphorylated histone H2AX (gamma H2AX) is a useful biomarker of DNA double strand breaks. gamma H2AX has been conventionally detected by immunology-based methods using anti-gamma H2AX antibody, but quantitative analysis is difficult to perform with such methods. Here, we describe an absolute quantification method using liquid chromatography-triple quadrupole tandem mass spectrometry that is applicable to peptides derived from gamma H2AX (ATQA(pS)QEY) and unphosphorylated H2AX (ATQASQEY). Our method was successfully applied to histones extracted from human cervix adenocarcinoma HeLa S3 cells. The estimated number of molecules of gamma H2AX (ATQA(pS)QEY) per vehicle-treated HeLa S3 cell was 9.4 x 10(4) and increased to 6.2 x 10(5) molecules/cell after exposure to the DNA-damaging agent camptothecin (10 mu M) for 1 h. The estimated total amount of H2AX (ATQA(pS)QEY + ATQASQEY) was 3.3-3.6 x 10(6) molecules/cell. Due to its broad adaptability and throughput performance, we believe that our method is a powerful tool for mechanistic studies of the DNA-damage response as well as for genotoxicity testing, cancer drug screening, clinical studies, and other fields.	[Matsuda, Shun; Matsuda, Tomonari] Kyoto Univ, Res Ctr Environm Qual Management, Otsu, Shiga 5200811, Japan; [Ikura, Tsuyoshi] Kyoto Univ, Ctr Radiat Biol, Sakyo Ku, Kyoto 6068501, Japan	Matsuda, T (reprint author), Kyoto Univ, Res Ctr Environm Qual Management, 1-2 Yumihama, Otsu, Shiga 5200811, Japan.	matsuda.tomonari.8z@kyoto-u.ac.jp	Matsuda, Shun/A-4017-2011	Matsuda, Shun/0000-0002-4181-2772	KAKENHI from the Japan Society for the Promotion of Science [23221006]	This study was supported by KAKENHI (23221006) from the Japan Society for the Promotion of Science and Grants-in-Aid for Scientific Research on Innovative Areas.	Albino AP, 2009, MUTAT RES-GEN TOX EN, V678, P43, DOI 10.1016/j.mrgentox.2009.06.009; Ando M, 2014, BIOMOL SCREEN, V19, P1246, DOI [10.1177/1087057114541147, DOI 10.1177/1087057114541147]; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Kim SC, 2006, J PROTEOME RES, V5, P3446, DOI 10.1021/pr0603396; DESIDERIO DM, 1983, BIOMED MASS SPECTROM, V10, P471, DOI 10.1002/bms.1200100806; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Wu J, 2013, CLIN CANCER RES, V19, P721, DOI 10.1158/1078-0432.CCR-12-2529; Tsamou M, 2012, MUTAGENESIS, V27, P645, DOI 10.1093/mutage/ges030; Watters GP, 2009, MUTAT RES-GEN TOX EN, V679, P50, DOI 10.1016/j.mrgentox.2009.07.007; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Kao J, 2006, CURR CANCER DRUG TAR, V6, P197, DOI 10.2174/156800906776842957; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/bjc.C100569200; Sedelnikova OA, 2006, CELL CYCLE, V5, P2909, DOI 10.4161/cc.5.24.3569; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Khoury L, 2013, ENVIRON MOL MUTAGEN, V54, P737, DOI 10.1002/em.21817; Smart DJ, 2011, MUTAT RES-FUND MOL M, V715, P25, DOI 10.1016/j.mrfmmm.2011.07.001; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Audebert M, 2012, TOXICOL APPL PHARM, V260, P58, DOI 10.1016/j.taap.2012.01.022; Audebert M, 2010, TOXICOL LETT, V199, P182, DOI 10.1016/j.toxlet.2010.08.022; Matsuda S, 2014, GENES ENV, V36, P17; Podhorecka M, 2010, J NUCL ACIDS, DOI [10.4061/2010/920161, DOI 10.4061/2010/920161]; Sanchez-Flores M, 2015, TOXICOL SCI J SOC TO, DOI [10.1093/toxsci/kfv011, DOI 10.1093/T0XSCI/KFV011]; Shuford CM, 2012, MOL CELL PROTEOMICS, V11, P814, DOI 10.1074/mcp.O112.017145	35	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	JUL	2015	407	18					5521	5527		10.1007/s00216-015-8725-z		7	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CL2SW	WOS:000356796000028		
J	Kawashima, T; Thorington, RW; Bohaska, PW; Chen, YJ; Sato, F				Kawashima, Tomokazu; Thorington, Richard W., Jr.; Bohaska, Paula W.; Chen, Yen-Jean; Sato, Fumi			Anatomy of Shoulder Girdle Muscle Modifications and Walking Adaptation in the Scaly Chinese Pangolin (Manis Pentadactyla Pentadactyla: Pholidota) Compared with the Partially Osteoderm-Clad Armadillos (Dasypodidae)	ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY			English	Article						pangolin; functional anatomy; imaging analysis; shoulder girdle muscles; armadillo; locomotion; evolutionary morphology	CARDIAC NERVOUS-SYSTEM; NEW-WORLD MONKEYS; EVOLUTIONARY ANATOMY; FUNCTIONAL-ANATOMY; CHICK WINGS; MORPHOLOGY; INNERVATION; PRIMATES; FORELIMB; BRANCHES	Because pangolins are unique mammals with a body and limbs almost entirely sheathed in hard keratinous overlapping scales and with digging and climbing abilities, the shoulder girdle muscles may differ significantly from those of other mammals including the partially osteoderm-clad armadillos. Therefore, we conducted a functional anatomical study of the shoulder girdle muscles in Chinese pangolins (Manis pentadactyla pentadactyla, Pholidota) and some armadillo species (Dasypodidae). Our CT scans revealed that the pangolin's overlapping scales are hard structures completely encasing the limbs. The armadillo's limbs, however, are covered with small relatively soft non-overlapping scales embedded in the skin, and articulate completely free of the hard osteodermal carapace. The attachments of some shoulder girdle muscles in the pangolin have moved from the surrounding edges of the scapula to the spine, and they, therefore, fully cover the scapula. In addition, some pangolin shoulder girdle muscles cross the shoulder joint to insert on the distal humerus, but this does not occur in armadillos. We cannot rule out the possibility that these muscle modifications represent adaptations for digging and/or climbing in pangolins. Our results and previous literature do not establish specific links between them and locomotive modes. However, we propose that the Chinese pangolin may use its derived muscular features when walking to move its armor-restricted forelimbs more effectively by swinging its head from side to side. Anat Rec, 298:1217-1236, 2015. (c) 2015 Wiley Periodicals, Inc.	[Kawashima, Tomokazu; Sato, Fumi] Toho Univ, Dept Anat, Sch Med, Tokyo 1438540, Japan; [Thorington, Richard W., Jr.; Bohaska, Paula W.] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Div Mammals, Washington, DC 20560 USA; [Chen, Yen-Jean] Natl Museum Nat Sci, Dept Zool, Div Bird & Mammal, Taichung, Taiwan	Kawashima, T (reprint author), Toho Univ, Dept Anat, Sch Med, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan.	tomokazu.kawashima@med.toho-u.ac.jp					LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; Arnason U, 2008, GENE, V421, P37, DOI 10.1016/j.gene.2008.05.024; Thorington RW, 1997, J MORPHOL, V234, P155; Vickaryous MK, 2006, J MORPHOL, V267, P1273, DOI 10.1002/jmor.10475; MADERSON PF, 1972, AM ZOOL, V12, P159; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Rockwell H, 1938, J MORPHOL, V63, P87, DOI 10.1002/jmor.1050630105; BRYANT MD, 1945, AM MIDL NAT, V33, P257, DOI 10.2307/2421337; CARTMILL M, 1977, AM J PHYS ANTHROPOL, V47, P249, DOI 10.1002/ajpa.1330470206; Kawashima T, 2011, ANAT REC, V294, P412, DOI 10.1002/ar.21334; Sargis EJ, 2001, J ZOOL, V253, P473, DOI 10.1017/S0952836901000437; Chan LK, 1955, J MAMMAL, V76, P472; Cunningham D J, 1890, J Anat Physiol, V25, P31; D'Sauza F., 1974, PROSIMIAN BIOL, P342; Desluliis G, 2007, DISSECTION VERTEBRAT, P131; DORAN GA, 1973, J MAMMAL, V54, P887, DOI 10.2307/1379083; Endo Hideki, 1998, Mammal Study, V23, P1, DOI 10.3106/mammalstudy.23.1; Flower WH, 1885, INTRO OSTEOLOGY MAMM, P266; Furbringer M, 1888, UNTERSUCHUNGEN MORPH, V2, P894; GASC JP, 1986, J ZOOL, V208, P9; Grasse PP, 1955, TRAITE ZOOL, VXVII, P1267; Greene EC., 1959, T AM PHILOS SOC, V27; Hill J. E., 1937, University of California Publications in Zoology, V42, P81; Humphry GM, 1869, J ANAT PHYSIOL, V4, P17; JENKINS FA, 1979, J ZOOL, V188, P379; Jouffroy FK, 1962, MAMMALIA, V26, pS1; Kawashima T, 2007, J MORPHOL, V268, P771, DOI 10.1002/jmor.10549; Kawashima T, 2013, ZOOL ANZ, V252, P101, DOI 10.1016/j.jcz.2012.04.001; Kawashima T, 2012, ANAT REC, V295, P438, DOI 10.1002/ar.21530; Kawashima T, 2008, ANAT REC, V291, P939, DOI 10.1002/ar.20700; Kawashima T, 2013, ANAT REC, V296, P798, DOI 10.1002/ar.22680; Kawashima T, 2009, ANAT REC, V292, P670, DOI 10.1002/ar.20894; Kawashima T, 2007, ANAT HISTOL EMBRYOL, V36, P19, DOI 10.1111/j.1439-0264.2006.00714.x; KEYNES RJ, 1987, DEVELOPMENT, V99, P565; Kida MY, 1997, J ANAT, V190, P309, DOI 10.1046/j.1469-7580.1997.19020309.x; Kida MY, 2000, MAMMAL SCI, V40, P189; KRAUSE WJ, 1974, ACTA ANAT, V88, P1; KUBOTA K, 1962, ANAT REC, V144, P43, DOI 10.1002/ar.1091440107; LEWIS J, 1981, J EMBRYOL EXP MORPH, V64, P211; Liumsiricharoen M, 2008, KASETSART VET, V18, P12; MCKENZIE J, 1955, J ANAT, V89, P526; Miles S. S., 1941, Journal of Mammalogy, V22, P157, DOI 10.2307/1374910; NENE R V, 1978, Journal of Biological Sciences (Bombay), V21, P48; Nisa S, 2010, ANAT HISTOL EMBRYOL, V39, P432; Nowak RM, 1999, WALKERS MAMMALS WORL, VII, P1239; Parsons F. G., 1894, P ZOOL SOC LOND, V18, P251; PHELAN KA, 1990, J NEUROSCI, V10, P2699; Prapong T., 2009, Kasetsart Veterinarians, V19, P9; Romer AS, 1977, VERTEBRATE BODY; Schon MA, 1968, US NATL MUSEUM B, V273, P185; Sikes S. K., 1966, Nigerian Field, V31, P99; Stark D, 1979, VERGLEICHENDE ANATOM, V2, P654; TAYLOR BK, 1978, J MORPHOL, V157, P347, DOI 10.1002/jmor.1051570307; TOSNEY KW, 1987, DEV BIOL, V122, P540, DOI 10.1016/0012-1606(87)90318-6; Weber M, 1904, DIE SAUGETIERE; Woods C., 1972, B AM MUS NAT HIST, V147, P115; Yoshitomi S, 2012, ANAT HISTOL EMBRYOL, V41, P280, DOI 10.1111/j.1439-0264.2012.01135.x; Yoshitomi S, 2004, MAMMALIAN SCI, V44, P35; Youlatos D, 2000, ANN SCI NAT ZOOL, V21, P137, DOI 10.1016/S0003-4339(00)01022-4	59	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8486	1932-8494		ANAT REC	Anat. Rec.	JUL	2015	298	7					1217	1236		10.1002/ar.23170		20	Anatomy & Morphology	Anatomy & Morphology	CL0JS	WOS:000356629500001		
J	Naito, M; Suzuki, R; Abe, H; Rodriguez-Vazquez, JF; Murakami, G; Aizawa, S				Naito, Michiko; Suzuki, Ryoji; Abe, Hiroshi; Francisco Rodriguez-Vazquez, Jose; Murakami, Gen; Aizawa, Shin			Fetal Development of the Human Obturator Internus Muscle With Special Reference to the Tendon and Pulley	ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY			English	Article						obturator internus muscle; tendon pulley; ischium; gemellus muscles; piriformis muscle; sciatic nerve; human fetus	PROGENITORS; ADAPTATION; SCLERAXIS; GEMELLI	To examine the development of the tendon pulley of the obturator internus muscle (OI), we observed paraffin sections of 26 human embryos and fetuses (approximate to 6-15 weeks of gestation). The OI was characterized by early maturation of the proximal tendon in contrast to the delayed development of the distal tendon. At 6 weeks, the ischium corresponded to a simple round mass similar to the tuberosity in adults. At 8 weeks, before development of the definite lesser notch of the ischium, initial muscle fibers of the OI, running along the antero-posterior axis, converged onto a thick and tight but short tendon running along the left-right axis. Thus, at the beginning of development, the OI muscle belly and tendon met almost at a right angle. At 10 weeks, the OI tendon extended inferiorly along the sciatic nerve, but the distal part remained thin and loose and it was embedded in the gluteus medius tendon. At 15 weeks, in association with the gemellus muscles, the distal OI tendon was established. The mechanically strong sciatic nerve was first likely to catch the OI muscle fibers to provide a temporary insertion. Next, the ischium developing upward seemed to push the tendon to make the turn more acute along the cartilaginous ridge. Finally, the gemellus muscle appeared to provide inferior traction to the OI tendon for separation from the gluteus medius to create the final, independent insertion. Without such guidance, the piriformis tendon first attached to the OI tendon and then merged with the gluteus medius tendon. Anat Rec, 298:1282-1293, 2015. (c) 2015 Wiley Periodicals, Inc.	[Naito, Michiko; Aizawa, Shin] Nihon Univ, Sch Med, Dept Anat, Tokyo, Japan; [Suzuki, Ryoji; Abe, Hiroshi] Akita Univ, Dept Anat, Grad Sch Med, Akita 0108543, Japan; [Francisco Rodriguez-Vazquez, Jose] Univ Complutense, Dept Anat & Human Embryol 2, E-28040 Madrid, Spain; [Murakami, Gen] Iwamizawa Kojin Kai Hosp, Div Internal Med, Iwamizawa, Japan	Abe, H (reprint author), Akita Univ, Dept Anat, Grad Sch Med, Hondo 1-1-1, Akita 0108543, Japan.	abe@med.akita-u.ac.jp		Rodriguez-Vazquez, Jose Francisco/0000-0001-5423-4492			Abe S, 2010, J ANAT, V217, P167, DOI 10.1111/j.1469-7580.2010.01246.x; Hayashi S, 2011, ANAT REC, V294, P633, DOI 10.1002/ar.21351; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Aung HH, 2001, ANAT REC, V263, P41, DOI 10.1002/ar.1075; Brent AE, 2005, DEVELOPMENT, V132, P515, DOI 10.1242/dev.01605; Kjaer M, 2006, J ANAT, V208, P445, DOI 10.1111/j.1469-7580.2006.00549.x; Kjaer M, 2009, SCAND J MED SCI SPOR, V19, P500, DOI 10.1111/j.1600-0838.2009.00986.x; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Mackey AL, 2008, CONNECT TISSUE RES, V49, P165, DOI 10.1080/03008200802151672; Bardeen RC, 1907, AM J ANAT, V6, P332; Chiba S, 1994, Kaibogaku Zasshi, V69, P281; GARDNER E, 1950, AM J ANAT, V87, P163, DOI 10.1002/aja.1000870202; Grafenberg E, 1904, ANAT HEFTE, V72, P429; Heydemann A, 2009, J CLIN INVEST, V119, P448, DOI 10.1172/JCI38618; Honma Satoru, 1998, Acta Anatomica Nipponica, V73, P329; Katori Y, 2011, ANN ANAT, V193, P127, DOI 10.1016/j.aanat.2011.01.004; Katori Y, 2011, CLIN ANAT, V24, P843, DOI 10.1002/ca.21182; KIKUCHI T, 1987, Sapporo Medical Journal, V56, P319; Rodriguez-Vazquez JF, 2011, J ANAT, V219, P143, DOI 10.1111/j.1469-7580.2011.01387.x; SHINOHARA H, 1995, ANAT REC, V243, P145, DOI 10.1002/ar.1092430116	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8486	1932-8494		ANAT REC	Anat. Rec.	JUL	2015	298	7					1282	1293		10.1002/ar.23121		12	Anatomy & Morphology	Anatomy & Morphology	CL0JS	WOS:000356629500006		
J	Onodera, K; Tokuda, S				Onodera, Kensuke; Tokuda, Sawako			Do larger snags stand longer?-snag longevity in mixed conifer-hardwood forests in Hokkaido, Japan	ANNALS OF FOREST SCIENCE			English	Article						Dead wood; Forest management; Retention harvesting; Temperate zone; Wood decay	SAPROXYLIC BEETLES COLEOPTERA; COARSE WOODY DEBRIS; NORTHERN JAPAN; OLD-GROWTH; BOREAL FOREST; DEAD TREES; DYNAMICS; SPRUCE; ISLAND; ASPEN	More than half of the dead trees fell down within decade. Besides, DBH effect on snag longevity varied by tree species and was not detected for some species. Management of long-lived snags in temperate mixed forests should be reconsidered. Snags (standing dead trees) provide essential habitats for many species. Those with large diameter at breast height (DBH) are prioritized for retention; one of the reasons is that snag longevity (recruitment to falling down) increases with increasing DBH in conifer-dominated forests. Despite its importance, the DBH effect on hardwood snags is inadequately understood. The aim of this study is to investigate whether and how the DBH effect varies by tree species in mixed conifer-hardwood forests. We checked the current status (standing or falling) of dead trees that had been recorded in 37 permanent plots and applied a generalized linear mixed model. We used tree species, time since death, DBH, and interaction terms as variables. Half of the dead trees with a DBH of 25 cm were estimated to have fallen down within 1-6 years for most of the species. While snag longevity increased with increasing DBH in Abies sachalinensis and Phellodendron amurense, we detected no such effect in Picea and three hardwood species. For highly decayed or long-lived snags, retaining large snags is not always effective. Managers of species-rich mixed forests should consider the variability of the DBH effects and management of dead wood before and after tree mortality.	[Onodera, Kensuke; Tokuda, Sawako] Hokkaido Res Org, Forestry Res Inst, Bibai, Hokkaido 0790198, Japan	Onodera, K (reprint author), Hokkaido Res Org, Forestry Res Inst, Bibai, Hokkaido 0790198, Japan.	onodera-kensuke@hro.or.jp; tokuda-sawako@hro.or.jp			Hokkaido Government	This work was supported by a management expense grant from the Hokkaido Government.	Hammond HEJ, 2004, CAN J FOREST RES, V34, P1, DOI 10.1139/X03-192; LAMBERT RL, 1980, ECOLOGY, V61, P1460, DOI 10.2307/1939054; KAILA L, 1994, ANN ZOOL FENN, V31, P97; Holub SM, 2001, CAN J FOREST RES, V31, P1894, DOI 10.1139/cjfr-31-11-1894; Garber SM, 2005, CAN J FOREST RES, V35, P787, DOI 10.1139/X05-021; Ulyshen MD, 2010, AGR FOREST ENTOMOL, V12, P187, DOI 10.1111/j.1461-9563.2009.00467.x; Jonsell M, 2003, FOREST ECOL MANAG, V175, P425, DOI 10.1016/S0378-1127(02)00143-3; SCHEFFER TC, 1966, ANNU REV PHYTOPATHOL, V14, P147; Jonsell M, 1998, BIODIVERS CONSERV, V7, P749, DOI 10.1023/A:1008888319031; Parish R, 2010, FOREST ECOL MANAG, V259, P633, DOI 10.1016/j.foreco.2009.11.022; Lee P, 1998, FOREST ECOL MANAG, V105, P263, DOI 10.1016/S0378-1127(97)00286-7; Vanderwel MC, 2006, CAN J FOREST RES, V36, P2769, DOI 10.1139/X06-173; Yatskov M, 2003, CAN J FOREST RES, V33, P1211, DOI 10.1139/X03-033; Russell MB, 2012, FOREST ECOL MANAG, V284, P230, DOI 10.1016/j.foreco.2012.08.004; Bradford J, 2009, CAN J FOREST RES, V39, P802, DOI 10.1139/X09-010; Takahashi M, 2000, CAN J FOREST RES, V30, P1148, DOI 10.1139/cjfr-30-7-1148; Gibb H, 2006, BIOL CONSERV, V129, P437, DOI 10.1016/j.biocon.2005.11.010; Trotsiuk V, 2012, FOREST ECOL MANAG, V265, P181, DOI 10.1016/j.foreco.2011.10.042; Saint-Germain M, 2007, ECOGRAPHY, V30, P737, DOI 10.1111/j.2007.0906-7590.05080.x; Graves AT, 2000, CAN J FOREST RES, V30, P1214, DOI 10.1139/cjfr-30-8-1214; Ulyshen MD, 2009, FOREST ECOL MANAG, V257, P653, DOI 10.1016/j.foreco.2008.09.047; Aakala T, 2008, FOREST ECOL MANAG, V255, P410, DOI 10.1016/j.foreco.2007.09.008; Storaunet K, 2002, CAN J FOREST RES, V32, P1801, DOI 10.1139/X02-105; Drapeau P, 2009, FOREST CHRON, V85, P227; Vanderwel MC, 2006, FOREST ECOL MANAG, V234, P48, DOI 10.1016/j.foreco.2006.06.020; Bates D. M., 2014, LME4 LINEAR MIXED EF; Butler R., 2004, ECOLOGICAL B, V51, P219; Core Team R., 2013, R LANG ENV STAT COMP; Graham R.T., 1994, INTRP477 USDA FOR SE; HARMON ME, 1982, OECOLOGIA, V52, P214, DOI 10.1007/BF00363839; Hiratsuka Y, 1984, NORX262 N FOR RES CT; Imazeki R., 1965, Annals of the Phytopathological Society of Japan, V31, P248; Japan Meteorological Agency, 2002, MESH CLIM DAT JAP 20; Japan Wood Protection Association, 2012, INTR WOOD PROT SCI; KEEN F. P., 1955, JOUR FOREST, V53, P720; KEEN F. P., 1929, JOUR FOREST, V27, P735; Lyon LJ, 1977, INT219 USDA FOR SERV; Metz MR, 2011, ECOL APPL, V21, P313, DOI 10.1890/10-0419.1; MIELKE JAMES L., 1950, JOUR OF FOREST, V48, P882; Nakashizuka T, 1995, VEGETATIO, V121, P23, DOI 10.1007/BF00044669; Odajima T, 1964, 155 HOKK FOR PROD RE, V155; Onodera K, 2013, J FOREST RES-JPN, V18, P101, DOI 10.1007/s10310-011-0327-9; Sakai Y, 2008, JPN J FOR ENV, V50, P153; Stokland JN, 2012, ECOL BIODIVERS CONS, P1, DOI 10.1017/CBO9781139025843; Storaunet KO, 2004, CAN J FOREST RES, V34, P376, DOI 10.1139/X03-248; UEMURA S, 1994, VEGETATIO, V112, P113, DOI 10.1007/BF00044686; Umeki K, 2001, ECOL RES, V16, P435, DOI 10.1046/j.1440-1703.2001.00409.x; Umeki K, 2002, ECOL RES, V17, P575, DOI 10.1046/j.1440-1703.2002.00516.x; Watt WR, 1999, TN016 OMNR NE SCI TE; Witzell J, 2008, CAN J FOREST RES, V38, P2711, DOI 10.1139/X08-112; Wood Technology and Wood Utilization Division, 1982, B FOR FOR PROD RES I, V319, P85; Zuur AF, 2007, STAT BIOL HEALTH, P1	52	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1286-4560	1297-966X		ANN FOREST SCI	Ann. For. Sci.	JUL	2015	72	5					621	629		10.1007/s13595-015-0478-5		9	Forestry	Forestry	CL2SE	WOS:000356794100011		
J	Chen, ZQ; Croydon, DA; Kumagai, T				Chen, Zhen-Qing; Croydon, David A.; Kumagai, Takashi			QUENCHED INVARIANCE PRINCIPLES FOR RANDOM WALKS AND ELLIPTIC DIFFUSIONS IN RANDOM MEDIA WITH BOUNDARY	ANNALS OF PROBABILITY			English	Article						Quenched invariance principle; Dirichlet form; heat kernel; supercritical percolation; random conductance model	PARABOLIC HARNACK INEQUALITY; REFLECTING BROWNIAN MOTIONS; REVERSIBLE MARKOV-PROCESSES; ORDER LARGE DEVIATIONS; PERCOLATION CLUSTERS; RANDOM CONDUCTANCES; JUMP-PROCESSES; LIMIT-THEOREM; DOMAINS; MODELS	Via a Dirichlet form extension theorem and making full use of two-sided heat kernel estimates, we establish quenched invariance principles for random walks in random environments with a boundary. In particular, we prove that the random walk on a supercritical percolation cluster or among random conductances bounded uniformly from below in a half-space, quarter-space, etc., converges when rescaled diffusively to a reflecting Brownian motion, which has been one of the important open problems in this area. We establish a similar result for the random conductance model in a box, which allows us to improve existing asymptotic estimates for the relevant mixing time. Furthermore, in the uniformly elliptic case, we present quenched invariance principles for domains with more general boundaries.	[Chen, Zhen-Qing] Univ Washington, Dept Math, Seattle, WA 98195 USA; [Croydon, David A.] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England; [Kumagai, Takashi] Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan	Chen, ZQ (reprint author), Univ Washington, Dept Math, Seattle, WA 98195 USA.	zqchen@uw.edu; d.a.croydon@warwick.ac.uk; kumagai@kurims.kyoto-u.ac.jp			NSF [DMS-12-06276]; NNSFC [11128101];  [22340017];  [25247007]	Supported in part by NSF Grant DMS-12-06276 and NNSFC Grant 11128101.; Supported in part by Grant-in-Aid for Scientific Research (B) 22340017 and (A) 25247007.	AIZENMAN M, 1984, J STAT PHYS, V36, P107, DOI 10.1007/BF01015729; AIZENMAN M, 1987, COMMUN MATH PHYS, V108, P489, DOI 10.1007/BF01212322; OSADA H, 1983, LECT NOTES MATH, V1021, P507; Barlow MT, 2004, ANN PROBAB, V32, P3024, DOI 10.1214/009117904000000748; Antal P, 1996, ANN PROBAB, V24, P1036; BARLOW MT, 1989, ANN I H POINCARE-PR, V25, P225; Grimmett GR, 1998, ANN PROBAB, V26, P1788; Biskup M, 2007, ELECTRON J PROBAB, V12, P1323; Barlow MT, 2010, ANN PROBAB, V38, P234, DOI 10.1214/09-AOP481; Delmotte T, 1999, REV MAT IBEROAM, V15, P181; Berger N, 2007, PROBAB THEORY REL, V137, P83, DOI 10.1007/s00440-006-0498-z; Mathieu P, 2007, P R SOC A, V463, P2287, DOI 10.1098/rspa.2007.1876; KIPNIS C, 1986, COMMUN MATH PHYS, V104, P1, DOI 10.1007/BF01210789; VAISALA J, 1988, TOHOKU MATH J, V40, P101, DOI 10.2748/tmj/1178228081; Barles G, 2008, INDIANA U MATH J, V57, P2355, DOI 10.1512/iumj.2008.57.3363; Barlow MT, 2009, ELECTRON J PROBAB, V14; Andres S, 2013, PROBAB THEORY REL, V156, P535, DOI 10.1007/s00440-012-0435-2; CHEN ZQ, 1993, PROBAB THEORY REL, V94, P281, DOI 10.1007/BF01199246; Benjamini I, 2003, PROBAB THEORY REL, V125, P408, DOI 10.1007/s00440-002-0246-y; Croydon DA, 2008, POTENTIAL ANAL, V29, P351, DOI 10.1007/s11118-008-9101-9; DEMASI A, 1989, J STAT PHYS, V55, P787; Mathieu P, 2008, J STAT PHYS, V130, P1025, DOI 10.1007/s10955-007-9465-z; Burdzy K, 2008, ANN PROBAB, V36, P698, DOI 10.1214/009117907000000240; Sidoravicius V, 2004, PROBAB THEORY REL, V129, P219, DOI 10.1007/s00440-004-0336-0; Liggett TM, 1997, ANN PROBAB, V25, P71; BARSKY DJ, 1991, PROBAB THEORY REL, V90, P111, DOI 10.1007/BF01321136; Bass RF, 2010, ANN I H POINCARE-PR, V46, P59, DOI 10.1214/08-AIHP201; Benjamini I, 2004, PROBAB THEORY REL, V129, P1, DOI 10.1007/s00440-003-0318-7; Bensoussan A, 1978, ASYMPTOTIC ANAL PERI; Biskup M., 2011, PROBAB SURV, V8, P294; BUCKLEY S., INVARIANCE PRI UNPUB; Burdzy K, 2013, ANN PROBAB, V41, P2791, DOI 10.1214/12-AOP745; CHEN Z.-Q., 2012, SYMMETRIC MARKOV PRO; Chen ZQ, 1996, POTENTIAL ANAL, V5, P383; CHUNG K. L., 2005, MARKOV PROCESSES BRO; Croydon DA, 2012, ELECTRON J PROBAB, V17, P1, DOI 10.1214/EJP.v17-1705; Deuschel JD, 1996, PROBAB THEORY REL, V104, P467, DOI 10.1007/s004400050031; DURRETT R., 1996, PROBABILITY THEORY E; Ethier S. N., 1986, MARKOV PROCESSES; GRIMMETT G., 1999, FUNDAMENTAL PRINCIPL, V321; GRIMMETT GR, 1990, P ROY SOC LOND A MAT, V430, P439, DOI 10.1098/rspa.1990.0100; Gyrya Pavel, 2011, ASTERISQUE, V336; Harris T. E., 1960, MATH P CAMBRIDGE PHI, V56, P13, DOI 10.1017/S0305004100034241; JERISON DS, 1982, ADV MATH, V46, P80, DOI 10.1016/0001-8708(82)90055-X; Jikov V. V., 1994, HOMOGENIZATION DIFFE; Jonsson A., 1984, MATH REP, V2; KOMOROWSKI T, 2012, FUNDAMENTAL PRINCIPL, V345; Kozlov S. M., 1985, USP MAT NAUK, V40, P238; KUNNEMANN R, 1983, COMMUN MATH PHYS, V90, P27, DOI 10.1007/BF01209386; MOSCO U, 1994, J FUNCT ANAL, V123, P368, DOI 10.1006/jfan.1994.1093; Penrose MD, 1996, ADV APPL PROBAB, V28, P29, DOI 10.2307/1427912; Pisztora A, 1996, PROBAB THEORY REL, V104, P427; Rhodes R, 2010, ELECTRON J PROBAB, V15, P989; Tanaka H., 1984, ADV PROBAB RELATED T, V7, P411; Timar A, 2013, P AM MATH SOC, V141, P475	55	0	0	INST MATHEMATICAL STATISTICS	CLEVELAND	3163 SOMERSET DR, CLEVELAND, OH 44122 USA	0091-1798			ANN PROBAB	Ann. Probab.	JUL	2015	43	4					1594	1642		10.1214/14-AOP914		49	Statistics & Probability	Mathematics	CK9KX	WOS:000356560100002		
J	Sasada, M				Sasada, Makiko			SPECTRAL GAP FOR STOCHASTIC ENERGY EXCHANGE MODEL WITH NONUNIFORMILY POSITIVE RATE FUNCTION	ANNALS OF PROBABILITY			English	Article						Spectral gap; energy exchange; nonuniformly positive rate function; locally confined hard balls	EQUATION; SYSTEMS	We give a lower bound on the spectral gap for a class of stochastic energy exchange models. In 2011, Grigo et al. introduced the model and showed that, for a class of stochastic energy exchange models with a uniformly positive rate function, the spectral gap of an N-component system is bounded from below by a function of order N-2. In this paper, we consider the case where the rate function is not uniformly positive. For this case, the spectral gap depends not only on N but also on the averaged energy epsilon, which is the conserved quantity under the dynamics. Under some assumption, we obtain a lower bound of the spectral gap which is of order C(epsilon)N-2 where C(epsilon) is a positive constant depending on epsilon. As a corollary of the result, a lower bound of the spectral gap for the mesoscopic energy exchange process of billiard lattice studied by Gaspard and Gilbert [J. Stat. Mech. Theory Exp. 2008 (2008) p11021, J. Stat. Mech. Theory Exp. 2009 (2009) p08020] and the stick process studied by Feng et al. [Stochastic Process. Appl. 66 (1997) 147-182] are obtained.	Keio Univ, Dept Math, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Sasada, M (reprint author), Keio Univ, Dept Math, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	sasada@math.keio.ac.jp			JSPS [23840036]	Supported by JSPS Grant-in-Aid for Research Activity Start-up Grant Number 23840036.	Olla S, 2013, PROBAB THEORY REL, V157, P721, DOI 10.1007/s00440-012-0469-5; KIPNIS C, 1982, J STAT PHYS, V27, P65, DOI 10.1007/BF01011740; Grigo A, 2012, NONLINEARITY, V25, P2349, DOI 10.1088/0951-7715/25/8/2349; Morris B, 2006, ANN PROBAB, V34, P1645, DOI 10.1214/009117906000000304; Barthe F, 2009, STOCH PROC APPL, V119, P2711, DOI 10.1016/j.spa.2009.02.004; Bhatnagar N, 2007, ANN APPL PROBAB, V17, P1424, DOI 10.1214/105051607000000177; Caputo P, 2008, ALEA-LAT AM J PROBAB, V4, P205; Carlen EA, 2014, J FUNCT ANAL, V266, P1787, DOI 10.1016/j.jfa.2013.08.024; Carlen EA, 2003, ACTA MATH-DJURSHOLM, V191, P1, DOI 10.1007/BF02392695; Feng S, 1997, STOCH PROC APPL, V66, P147, DOI 10.1016/S0304-4149(96)00121-4; Gaspard P., 2008, J STAT MECH-THEORY E, V2008; Gaspard P, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/08/P08020; Giroux G, 2008, J STAT PHYS, V132, P561, DOI 10.1007/s10955-008-9571-6; Goncalves P, 2009, ANN I H POINCARE-PR, V45, P887, DOI 10.1214/09-AIHP210; KIPNIS C., 1999, SCALING LIMITS INTER, V320; Landim C, 1996, ANN PROBAB, V24, P1871; Nagahata Y, 2011, J STAT PHYS, V143, P381, DOI 10.1007/s10955-011-0176-0; SASADA M., 2013, SPRINGER P MATH STAT, V40, P543	18	0	0	INST MATHEMATICAL STATISTICS	CLEVELAND	3163 SOMERSET DR, CLEVELAND, OH 44122 USA	0091-1798			ANN PROBAB	Ann. Probab.	JUL	2015	43	4					1663	1711		10.1214/14-AOP916		49	Statistics & Probability	Mathematics	CK9KX	WOS:000356560100004		
J	Jiang, LL; Zhou, XH; Song, YC; Liu, Y; Yu, MH; Yang, MJ; Xue, ZQ; Zhao, YC; Wu, BH; Abudula, A				Jiang, Lanlan; Zhou, Xinhuan; Song, Yongchen; Liu, Yu; Yu, Minghao; Yang, Mingjun; Xue, Ziqiu; Zhao, Yuechao; Wu, Bohao; Abudula, Abuliti			Experiment Study on Temperature Distribution in Water-Saturated Porous Media	APPLIED MAGNETIC RESONANCE			English	Article							APPARENT DIFFUSION-COEFFICIENT; CHEMICAL-SHIFT; HUMAN STROKE; IN-VIVO; BRAIN; TIME; MRI; T-1; TISSUE; SEQUENCE	An attractive approach for magnetic resonance imaging (MRI) thermograph has been used to investigate temperature distribution in water-saturated porous media (silica gel). Linear relationships between several temperature-sensitive MRI parameters (longitudinal relaxation time T (1), self-diffusion coefficient D) and temperature (T) are dependent on water saturation in pore-throat structure of the porous media. Based on the linear relationships, the parameters including T (1) and D were evaluated using T (1)-weighted spin echo (SE) sequences and diffusion-weighted SE sequences, respectively, to measure temperature distribution by two-point method. In this work, we conducted calibration experiments to get the T (1)-T relationship and D-T relationship, which were then validated by cooling experiments. In the calibration experiment, the determination coefficients for the sample using T (1) and self-diffusion coefficient methods are close to 1 in the temperature range from 0 to 60 A degrees C, although T (1) method is difficult for the nonlinear relationship between signal intensity (SI) and T (1).	[Jiang, Lanlan; Zhou, Xinhuan; Song, Yongchen; Liu, Yu; Yu, Minghao; Yang, Mingjun; Zhao, Yuechao; Wu, Bohao] Dalian Univ Technol, Minist Educ, Key Lab Ocean Energy Utilizat & Energy Conservat, Dalian 116024, Liaoning, Peoples R China; [Xue, Ziqiu] Res Inst Innovat Technol Earth, Kizugawa City, Kyoto 6190292, Japan; [Abudula, Abuliti] Hirosaki Univ, North Japan New Energy Res Ctr, Aomori 0300831, Japan	Jiang, LL (reprint author), Dalian Univ Technol, Minist Educ, Key Lab Ocean Energy Utilizat & Energy Conservat, Dalian 116024, Liaoning, Peoples R China.	lanlan@dlut.edu.cn; liuyu@dlut.edu.cn			National Natural Science Foundation of China [51106019, 51376033]; National Program on Key Basic Research Project (973 Program) of China [2011CB707304]	Thanks to the National Natural Science Foundation of China (Grant No. 51106019, 51376033), the National Program on Key Basic Research Project (973 Program) of China (Grant No. 2011CB707304).	Anadon LD, 2006, AICHE J, V52, P1522, DOI 10.1002/aic.10737; Schlaug G, 1997, NEUROLOGY, V49, P113; PARKER DL, 1983, MED PHYS, V10, P321, DOI 10.1118/1.595307; Bertsch F, 1998, MAGN RESON IMAGING, V16, P393, DOI 10.1016/S0730-725X(97)00311-1; LEBIHAN D, 1989, RADIOLOGY, V171, P853; WARACH S, 1992, NEUROLOGY, V42, P1717; BLOEMBERGEN N, 1948, PHYS REV, V73, P679, DOI 10.1103/PhysRev.73.679; Deoni SCL, 2005, MAGNET RESON MED, V53, P237, DOI 10.1002/mrm.20314; Dou BL, 2010, J HAZARD MATER, V183, P759, DOI 10.1016/j.jhazmat.2010.07.091; Bock NA, 2013, NEUROIMAGE, V65, P1, DOI 10.1016/j.neuroimage.2012.09.051; DARDZINSKI BJ, 1993, MAGNET RESON MED, V30, P318, DOI 10.1002/mrm.1910300307; BLUML S, 1993, MAGNET RESON MED, V30, P289, DOI 10.1002/mrm.1910300304; CLINE HE, 1993, MAGNET RESON MED, V30, P98, DOI 10.1002/mrm.1910300115; Deoni SCL, 2006, MAGN RESON IMAGING, V24, P1241, DOI 10.1016/j.mri.2006.03.015; Graessner J., 2011, MAGNETOM FLASH, V2011, P6; HAASE A, 1990, MAGNET RESON MED, V13, P77, DOI 10.1002/mrm.1910130109; HASEGAWA Y, 1994, J CEREBR BLOOD F MET, V14, P383; Hendrick R.E., 2007, BREAST MRI FUNDAMENT, P75; Hindman J., 2004, J CHEM PHYS, V44, P4582; Imran J, 1999, MAGN RESON IMAGING, V17, P1347, DOI 10.1016/S0730-725X(99)00092-2; Kingsley PB, 2001, MAGN RESON IMAGING, V19, P279, DOI 10.1016/S0730-725X(01)00294-6; Lucas T, 2012, MAGN RESON IMAGING, V20, P431, DOI 10.1016/j.mri.2011.09.004; MOSER E, 1995, MAGN RESON IMAGING, V13, P429, DOI 10.1016/0730-725X(94)00135-P; Poorter J, 1995, MAGN RESON MED, V33, P74, DOI 10.1002/mrm.1910330111; Poorter J.D., 1995, MAGN RESON MED, V34, P359, DOI 10.1002/mrm.1910340313; Rydberg JN, 1996, JMRI-J MAGN RESON IM, V6, P356, DOI 10.1002/jmri.1880060216; Schnabel M.C., 2009, PHYS MED BIOL, V54, pN1; Schwarcz A, 2002, ACTA NEUROCHIR, V144, P811, DOI 10.1007/s00701-002-0935-4; SCHWARZMAIER HJ, 1995, MAGNET RESON MED, V33, P729, DOI 10.1002/mrm.1910330519; YOUNG IR, 1994, MAGNET RESON MED, V31, P342, DOI 10.1002/mrm.1910310317	30	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	JUL	2015	46	7					793	808		10.1007/s00723-015-0694-z		16	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CL2YF	WOS:000356813300008		
J	Moe, LL; Maekawa, S; Kawamura-Konishi, Y				Moe, Lai Lai; Maekawa, Saya; Kawamura-Konishi, Yasuko			The pro-enzyme C-terminal processing domain of Pholiota nameko tyrosinase is responsible for folding of the N-terminal catalytic domain	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Pholiota nameko; Tyrosinase; Pro-enzyme; Processing; Chaperone	MUSHROOM AGARICUS-BISPORUS; POLYPHENOL OXIDASE; STREPTOMYCES TYROSINASE; FUNGAL TYROSINASES; ASPERGILLUS-ORYZAE; ACTIVATION; PROTEIN; EXPRESSION; CRYSTAL; CLONING	Pholiota nameko (Pholiota microspore) tyrosinase is expressed as a latent 67-kDa pro-tyrosinase, comprising a 42-kDa N-terminal catalytic domain with a binuclear copper centre and a 25-kDa C-terminal domain and is activated by proteolytic digestion of the C-terminal domain. To investigate the role of the C-terminal processing domain of pro-tyrosinase, we constructed a recombinant tyrosinase lacking the C-terminal domain and four recombinant pro-tyrosinase mutants (F515G, H539N, L540G and Y543G) carrying substituted amino acid residues on the C-terminal domain. The recombinant tyrosinase lacking the C-terminal domain had no catalytic activity; whereas the mutant L540G was copper depleted, the other mutants had copper contents similar to that of the wildtype pro-tyrosinase. Proteolytic digestion activated the mutants H539N and Y543G following release of the C-terminal domain, and the resulting tyrosinases had higher K-m values for t-butyl catechol than the wild-type pro-tyrosinase. The mutants F515G and L540G were degraded by proteolytic digestion and yielded smaller proteins with no activity. These data suggest that the C-terminal processing domain of P. nameko pro-tyrosinase is essential for correct folding of the N-terminal catalytic domain and acts as an intramolecular chaperone during assembly of the active-site conformation.	[Moe, Lai Lai; Maekawa, Saya; Kawamura-Konishi, Yasuko] Ishikawa Prefectural Univ, Fac Bioresources & Environm Sci, Dept Food Sci, Nonoichi, Ishikawa 9218836, Japan	Kawamura-Konishi, Y (reprint author), Ishikawa Prefectural Univ, Fac Bioresources & Environm Sci, Dept Food Sci, 1-308 Suematsu, Nonoichi, Ishikawa 9218836, Japan.	konishi@ishikawa-pu.ac.jp					Flurkey WH, 2008, J INORG BIOCHEM, V102, P2160, DOI 10.1016/j.jinorgbio.2008.08.007; Espin JC, 1997, J AGR FOOD CHEM, V45, P1084, DOI 10.1021/jf960428a; Seo SY, 2003, J AGR FOOD CHEM, V51, P2837, DOI 10.1021/jf020826f; Mauracher SG, 2014, ACTA CRYSTALLOGR D, V70, P2301, DOI 10.1107/S1399004714013777; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; VanGelder CWG, 1997, PHYTOCHEMISTRY, V45, P1309, DOI 10.1016/S0031-9422(97)00186-6; Espin JC, 1999, J AGR FOOD CHEM, V47, P3509, DOI 10.1021/jf9813539; Chen TH, 2002, BIOPOLYMERS, V64, P292, DOI 10.1002/bip.10196; Marusek CM, 2006, J INORG BIOCHEM, V100, P108, DOI 10.1016/j.jinorgbio.2005.10.008; Halaouli S, 2006, J APPL MICROBIOL, V100, P219, DOI 10.1111/j.1365-2672.2006.02866.x; Decker H, 2007, GENE, V398, P183, DOI 10.1016/j.gene.2007.02.051; Claus H, 2006, SYST APPL MICROBIOL, V29, P3, DOI 10.1016/j.syapm.2005.07.012; Fujieda N, 2013, J BIOL CHEM, V288, P22128, DOI 10.1074/jbc.M113.477612; Li YC, 2009, P NATL ACAD SCI USA, V106, P17002, DOI 10.1073/pnas.0906095106; CHEN LY, 1993, J BIOL CHEM, V268, P18710; Faccio G, 2013, J INORG BIOCHEM, V121, P37, DOI 10.1016/j.jinorgbio.2012.12.006; Fujieda N, 2013, J BIOL INORG CHEM, V18, P19, DOI 10.1007/s00775-012-0945-5; Fujieda N, 2012, CHEMBIOCHEM, V13, P193, DOI 10.1002/cbic.201100609; Halaouli S, 2006, APPL MICROBIOL BIOT, V70, P580, DOI 10.1007/s00253-005-0109-4; HURRELL RF, 1982, BRIT J NUTR, V47, P191, DOI 10.1079/BJN19820027; Jolivet S, 1998, MYCOL RES, V102, P1459, DOI 10.1017/S0953756298006248; Kawamura-Konishi Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1752, DOI 10.1271/bbb.70171; Kawamura-Konishi Y, 2011, APPL MICROBIOL BIOT, V90, P227, DOI 10.1007/s00253-010-3039-8; KUPPER U, 1989, J BIOL CHEM, V264, P17250; Largeteau ML, 2010, APPL MICROBIOL BIOT, V85, P1499, DOI 10.1007/s00253-009-2186-2; LIAW LL, 1995, BIOCHEM BIOPH RES CO, V214, P447, DOI 10.1006/bbrc.1995.2307; Matoba M, 2006, J BIOL CHEM, V281, P8981; Mauracher SG, 2014, PHYTOCHEMISTRY, V99, P14, DOI 10.1016/j.phytochem.2013.12.016; MOORE JT, 1993, PROTEIN EXPRES PURIF, V4, P160, DOI 10.1006/prep.1993.1022; Neda H, 2008, MYCOSCIENCE, V49, P88, DOI 10.1007/s10267-007-0391-3; RODRIGUEZLOPEZ JN, 1992, ANAL BIOCHEM, V202, P356, DOI 10.1016/0003-2697(92)90118-Q; Selinheimo E, 2006, FEBS J, V273, P4322, DOI 10.1111/j.1742-4658.2006.05429.x; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Thalmann CR, 2002, EUR FOOD RES TECHNOL, V214, P276, DOI 10.1007/s00217-001-0455-0; Tsai TY, 1998, J BIOL CHEM, V273, P19243, DOI 10.1074/jbc.273.30.19243; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; WEAVER RF, 1970, P NATL ACAD SCI USA, V67, P1050, DOI 10.1073/pnas.67.2.1050; Westerhof W, 2006, PIGM CELL RES, V19, P183, DOI 10.1111/j.1600-0749.2006.00313.x; Wichers HJ, 2003, APPL MICROBIOL BIOT, V61, P336, DOI 10.1007/s00253-002-1194-2	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	JUL	2015	99	13					5499	5510		10.1007/s00253-015-6597-y		12	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CL2VV	WOS:000356805600013		
J	Kobayashi, J; Furukawa, M; Ohshiro, T; Suzuki, H				Kobayashi, Jyumpei; Furukawa, Megumi; Ohshiro, Takashi; Suzuki, Hirokazu			Thermoadaptation-directed evolution of chloramphenicol acetyltransferase in an error-prone thermophile using improved procedures	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Geobacillus kaustophilus; Chloramphenicol resistance; Chloramphenicol acetyltransferase; Thermoadaptation-directed evolution; Error-prone thermophile	GEOBACILLUS-KAUSTOPHILUS HTA426; HOST-VECTOR SYSTEM; THERMUS-THERMOPHILUS; BACILLUS-STEAROTHERMOPHILUS; ENZYME EVOLUTION; SELECTION MARKER; GENE-EXPRESSION; SHUTTLE VECTOR; PLASMID DNA; TRANSFORMATION	Enhancing the thermostability of thermolabile enzymes extends their practical utility. We previously demonstrated that an error-prone thermophile derived from Geobacillus kaustophilus HTA426 can generate mutant genes encoding enzyme variants that are more thermostable than the parent enzyme. Here, we used this approach, termed as thermoadaptation-directed enzyme evolution, to increase the thermostability of the chloramphenicol acetyltransferase (CAT) of Staphylococcus aureus and successfully generated a CAT variant with an A138T replacement (CAT(A138T)). This variant was heterologously produced, and its enzymatic properties were compared with those of the wild type. We found that CAT(A138T) had substantially higher thermostability than CAT but had comparable activities, showing that the A138T replacement enhanced protein thermostability without affecting the catalytic activity. Because variants CAT(A138S) and CAT(A138V), which were generated via in vitro site-directed mutagenesis, were more thermostable than CAT, the thermostability enhancement resulting from the A138T replacement can be attributed to both the presence of a hydroxyl group and the bulk of the threonine side chain. CAT(A138T) conferred chloramphenicol resistance to G. kaustophilus cells at high temperature more efficiently than CAT. Therefore, the gene encoding CAT(A138T) may be useful as a genetic marker in Geobacillus spp. Notably, CAT(A138T) generation was achieved only by implementing improved procedures (plasmid-based mutations on solid media); previous procedures (chromosome-based mutations in liquid media) were unsuccessful. This result suggests that this improved procedure is crucial for successful thermoadaptation-directed evolution in certain cases and increases the opportunities for generating thermostable enzymes.	[Kobayashi, Jyumpei; Ohshiro, Takashi; Suzuki, Hirokazu] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Kobayashi, Jyumpei; Furukawa, Megumi; Suzuki, Hirokazu] Kyushu Univ, Grad Sch, Fac Agr, Funct Genom Extremophiles, Fukuoka 8128581, Japan	Suzuki, H (reprint author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan.	hirokap@xpost.plala.or.jp	Kobayashi, Junjiro/J-8547-2015		Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Japan; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Japan; JSPS KAKENHI [25450105]; Institute for Fermentation, Osaka, Japan	This work was supported by the following organizations: Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, Japan, the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Japan, and in part by JSPS KAKENHI (Grant Number 25450105) and the Institute for Fermentation, Osaka, Japan.	Huang JW, 2012, APPL MICROBIOL BIOT, V94, P111, DOI 10.1007/s00253-011-3586-7; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951; Suzuki H, 2013, BIOSCI BIOTECH BIOCH, V77, P2316, DOI 10.1271/bbb.1304921; SHAW WV, 1968, J BACTERIOL, V95, P28; Taylor MP, 2008, PLASMID, V60, P45, DOI 10.1016/j.plasmid.2008.04.001; LIAO H, 1986, P NATL ACAD SCI USA, V83, P576, DOI 10.1073/pnas.83.3.576; Takami H, 2004, NUCLEIC ACIDS RES, V32, P6292, DOI 10.1093/nar/gkh970; Asako H, 2008, APPL MICROBIOL BIOT, V80, P805, DOI 10.1007/s00253-008-1594-z; MANKIN AS, 1991, J BACTERIOL, V173, P3559; IMANAKA T, 1982, J BACTERIOL, V149, P824; Drummond DA, 2005, J MOL BIOL, V350, P806, DOI 10.1016/j.jmb.2005.05.023; Brouns SJJ, 2005, J BIOL CHEM, V280, P11422, DOI 10.1074/jbc.M413623200; Labrou NE, 2010, CURR PROTEIN PEPT SC, V11, P91; Bloom JD, 2005, CURR OPIN STRUC BIOL, V15, P447, DOI 10.1016/j.sbi.2005.06.004; WU LJ, 1989, J GEN MICROBIOL, V135, P1315; Suzuki H, 2012, APPL ENVIRON MICROB, V78, P7376, DOI 10.1128/AEM.01669-12; Nakamura A, 2005, J BIOSCI BIOENG, V100, P158, DOI 10.1263/jbb.100.158; LESLIE AGW, 1990, J MOL BIOL, V213, P167, DOI 10.1016/S0022-2836(05)80129-9; Suzuki H, 2012, J MICROBIOL BIOTECHN, V22, P1279, DOI 10.4014/jmb.1203.03023; Suzuki H, 2013, APPL ENVIRON MICROB, V79, P5151, DOI 10.1128/AEM.01506-13; Stephens DE, 2014, J BIOTECHNOL, V187, P139, DOI 10.1016/j.jbiotec.2014.07.446; MCMURRY LM, 1994, ANTIMICROB AGENTS CH, V38, P542; Ben Mabrouk S, 2013, J BIOTECHNOL, V168, P601, DOI 10.1016/j.jbiotec.2013.08.026; Biswas T, 2012, PROTEIN SCI, V21, P520, DOI 10.1002/pro.2036; Fang ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102423; Fridjonsson O, 2002, J BACTERIOL, V184, P3385, DOI 10.1128/JB.484.12.3385-3391.2002; LESLIE AGW, 1988, P NATL ACAD SCI USA, V85, P4133, DOI 10.1073/pnas.85.12.4133; MATSUMURA M, 1985, J BIOL CHEM, V260, P5298; Rhee MS, 2007, PLASMID, V58, P13, DOI 10.1016/j.plasmid.2006.11.006; Suzuki H, 2015, APPL ENVIRON MICROB, V81, P149, DOI 10.1128/AEM.02577-14; Tamakoshi M, 2001, EXTREMOPHILES, V5, P17, DOI 10.1007/s007920000168	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	JUL	2015	99	13					5563	5572		10.1007/s00253-015-6522-4		10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CL2VV	WOS:000356805600018		
J	Tsuge, Y; Uematsu, K; Yamamoto, S; Suda, M; Yukawa, H; Inui, M				Tsuge, Yota; Uematsu, Kimio; Yamamoto, Shogo; Suda, Masako; Yukawa, Hideaki; Inui, Masayuki			Glucose consumption rate critically depends on redox state in Corynebacterium glutamicum under oxygen deprivation	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Corynebacterium glutamicum; Oxygen deprivation; NADH/NAD(+) ratio; NADH dehydrogenase; Glucose consumption rate	EFFICIENT ISOBUTANOL PRODUCTION; SUCCINIC ACID PRODUCTION; L-VALINE PRODUCTION; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; NADH DEHYDROGENASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; NADH/NAD(+) RATIO; FLUX ANALYSIS; METABOLISM	Rapid sugar consumption is important for the microbial production of chemicals and fuels. Here, we show that overexpression of the NADH dehydrogenase gene (ndh) increased glucose consumption rate in Corynebacterium glutamicum under oxygen-deprived conditions through investigating the relationship between the glucose consumption rate and intracellular NADH/NAD(+) ratio in various mutant strains. The NADH/NAD+ ratio was strongly repressed under oxygen deprivation when glucose consumption was accelerated by the addition of pyruvate or sodium hydrogen carbonate. Overexpression of the ndh gene in the wild-type strain under oxygen deprivation decreased the NADH/NAD(+) ratio from 0.32 to 0.13, whereas the glucose consumption rate increased by 27 %. Similarly, in phosphoenolpyruvate carboxylase gene (ppc)- or malate dehydrogenase gene (mdh)-deficient strains, overexpression of the ndh gene decreased the NADH/NAD(+) ratio from 1.66 to 0.37 and 2.20 to 0.57, respectively, whereas the glucose consumption rate increased by 57 and 330 %, respectively. However, in a lactate dehydrogenase gene (L-ldhA)-deficient strain, although the NADH/NAD(+) ratio decreased from 5.62 to 1.13, the glucose consumption rate was not markedly altered. In a tailored D-lactate-producing strain, which lacked ppc and L-ldhA genes, but expressed D-ldhA from Lactobacillus delbrueckii, overexpression of the ndh gene decreased the NADH/NAD(+) ratio from 1.77 to 0.56, and increased the glucose consumption rate by 50 %. Overall, the glucose consumption rate was found to be inversely proportional to the NADH/NAD(+) ratio in C. glutamicum cultured under oxygen deprivation. These findings could provide an option to increase the productivity of chemicals and fuels under oxygen deprivation.	[Tsuge, Yota; Uematsu, Kimio; Yamamoto, Shogo; Suda, Masako; Yukawa, Hideaki; Inui, Masayuki] Res Inst Innovat Technol Earth RITE, Kizugawa, Kyoto 6190292, Japan; [Inui, Masayuki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Inui, M (reprint author), Res Inst Innovat Technol Earth RITE, 9-2 Kizugawadai, Kizugawa, Kyoto 6190292, Japan.	mmg-lab@rite.or.jp			New Energy and Industrial Technology Development Organization (NEDO); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported by a grant from the New Energy and Industrial Technology Development Organization (NEDO). This study was also partially supported by a Grant-in-Aid for Young Scientists (B) to YT from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Garrigues C, 1997, J BACTERIOL, V179, P5282; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Hasegawa S, 2012, APPL ENVIRON MICROB, V78, P865, DOI 10.1128/AEM.07056-11; Inui M, 2007, MICROBIOL-SGM, V153, P2491, DOI 10.1099/mic.0.2006/005587-0; Yamamoto S, 2013, BIOTECHNOL BIOENG, V110, P2938, DOI 10.1002/bit.24961; de Felipe FL, 1998, J BACTERIOL, V180, P3804; Yamamoto S, 2012, APPL ENVIRON MICROB, V78, P4447, DOI 10.1128/AEM.07998-11; Bartek T, 2011, APPL ENVIRON MICROB, V77, P6644, DOI 10.1128/AEM.00575-11; Litsanov B, 2012, APPL ENVIRON MICROB, V78, P3325, DOI 10.1128/AEM.07790-11; Liang LY, 2012, ENZYME MICROB TECH, V51, P286, DOI 10.1016/j.enzmictec.2012.07.011; Okino S, 2008, APPL MICROBIOL BIOT, V81, P459, DOI 10.1007/s00253-008-1668-y; Dominguez H, 1998, EUR J BIOCHEM, V254, P96, DOI 10.1046/j.1432-1327.1998.2540096.x; Blombach B, 2011, APPL ENVIRON MICROB, V77, P3300, DOI 10.1128/AEM.02972-10; Rados D, 2014, APPL ENVIRON MICROB, V80, P3015, DOI 10.1128/AEM.04189-13; Inui M, 2004, J MOL MICROB BIOTECH, V7, P182, DOI 10.1159/000079827; Hasegawa S, 2013, APPL ENVIRON MICROB, V79, P1250, DOI 10.1128/AEM.02806-12; Heux S, 2006, METAB ENG, V8, P303, DOI 10.1016/j.ymben.2005.12.003; Molenaar D, 2000, J BACTERIOL, V182, P6884, DOI 10.1128/JB.182.24.6884-6891.2000; Tsuge Y, 2013, APPL MICROBIOL BIOT, V97, P6693, DOI 10.1007/s00253-013-4986-7; Okino S, 2005, APPL MICROBIOL BIOT, V68, P475, DOI 10.1007/s00253-005-1900-y; Palmfeldt J, 2004, APPL ENVIRON MICROB, V70, P5477, DOI 10.1128/AEM.70.9.5477-5484.2004; NAKAYAMA K, 1961, J GEN APPL MICROBIOL, V7, P145, DOI 10.2323/jgam.7.145; Danshina PV, 2001, IUBMB LIFE, V51, P309; DUGGLEBY RG, 1974, J BIOL CHEM, V249, P167; JAWOROWSKI A, 1981, BIOCHEMISTRY-US, V20, P3621, DOI 10.1021/bi00515a049; Kinoshita S, 1985, BIOL IND MICROORGANI, P115; Koebmann BJ, 2002, APPL ENVIRON MICROB, V68, P4274, DOI 10.1128/AEM.68.9.4274-4282.2002; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Matsushita K, 2001, FEMS MICROBIOL LETT, V204, P271, DOI 10.1111/j.1574-6968.2001.tb10896.x; Nantapong N, 2004, APPL MICROBIOL BIOT, V66, P187, DOI 10.1007/s00253-004-1659-6; Nantapong N, 2005, BIOSCI BIOTECH BIOCH, V69, P149, DOI 10.1271/bbb.69.149; Sambrook J., 1989, MOL CLONING LAB MANU; Tsuchida Y, 2009, APPL MICROBIOL BIOT, V87, P1855; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	34	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	JUL	2015	99	13					5573	5582		10.1007/s00253-015-6540-2		10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CL2VV	WOS:000356805600019		
J	Yano, T; Yoshida, N; Yu, FJ; Wakamatsu, M; Takagi, H				Yano, Takanori; Yoshida, Nobuyuki; Yu, Fujio; Wakamatsu, Miki; Takagi, Hiroshi			The glyoxylate shunt is essential for CO2-requiring oligotrophic growth of Rhodococcus erythropolis N9T-4	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Random mutagenesis; Carbon dioxide; Glyoxylate shunt; TCA cycle; Oligotroph; Rhodococcus erythropolis N9T-4	TRICARBOXYLIC-ACID CYCLE; ALPHA-KETOGLUTARATE DECARBOXYLASE; MYCOBACTERIUM-TUBERCULOSIS; CORYNEBACTERIUM-GLUTAMICUM; DEHYDROGENASE; BACTERIUM; ENZYME; GENE; IDENTIFICATION; CYANOBACTERIA	Rhodococcus erythropolis N9T-4 shows extremely oligotrophic growth requiring atmospheric CO2 and forms its colonies on an inorganic basal medium (BM) without any additional carbon source. Screening of a random mutation library constructed by a unique genome deletion method that we established indicated that the aceA, aceB, and pckG genes encoding isocitrate lyase, malate synthase, and phosphoenolpyruvate carboxykinase, respectively, were requisite for survival on BM plates. The aceA-and aceB deletion mutants and the pckG deletion mutant grew well on BM plates containing L-malate and D-glucose, respectively, suggesting that the glyoxylate (GO) shunt and gluconeogenesis are essential for the oligotrophic growth of N9T-4. Interestingly, most of the enzyme activities in the TCA cycle were observed in the cell-free extract of N9T-4, with perhaps the most important exception being alpha-ketoglutarate dehydrogenase (KGDH) activity. Instead of the KGDH activity, we detected a remarkable level of alpha-ketoglutarate decarboxylase (KGD) activity, which is the activity exhibited by the E1 component of the KGDH complex in Mycobacterium tuberculosis. The recombinant KGD of N9T-4 catalyzed the decarboxylation of alpha-ketoglutarate to form succinic semialdehyde (SSA) in a time-dependent manner. Since N9T-4 also showed a detectable SSA dehydrogenase activity, we concluded that N9T-4 possesses a variant TCA cycle, which uses SSA rather than succinyl-CoA. These results suggest that oligotrophic N9T-4 cells utilize the GO shunt to avoid the loss of carbons as CO2 and to conserve CoA units in the TCA cycle.	[Yano, Takanori; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Yoshida, Nobuyuki] Shizuoka Univ, Grad Sch Engn, Dept Appl Chem & Biochem Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan; [Yu, Fujio; Wakamatsu, Miki] Mitsubishi Rayon Co Ltd, Yokohama Res Labolatories, Tsurumi Ku, Yokohama, Kanagawa 2300053, Japan	Takagi, H (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	tnyoshi@ipc.shizuoka.ac.jp; hiro@bs.naist.jp			Sasakawa Scientific Research Grant from The Japan Science Society; Ministry of Education, Science, Culture, Sports and Technology of Japan	The authors greatly appreciate Maki Kaneoka for her technical assistance for construction and screening of the random mutation library. This work was partly supported by the Sasakawa Scientific Research Grant from The Japan Science Society to T.Y. and Global COE Program in NAIST from the Ministry of Education, Science, Culture, Sports and Technology of Japan.	Tian J, 2005, MOL MICROBIOL, V57, P859, DOI 10.1111/j.1365-2958.2005.04741.x; KUZNETSOV SI, 1979, ANNU REV MICROBIOL, V33, P377, DOI 10.1146/annurev.mi.33.100179.002113; Yoshida N, 2005, J BIOSCI BIOENG, V99, P143, DOI 10.1263/jbb.99.143; Pelicic V, 1996, J BACTERIOL, V178, P1197; Usuda Y, 1996, MICROBIOL-UK, V142, P3347; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10; de Carvalho LPS, 2010, CHEM BIOL, V17, P323, DOI [10.1016/j.chembiol.2010.03.009, 10.1016/j.chembiol.2010.08.009]; Hoffelder M, 2010, J BACTERIOL, V192, P5203, DOI 10.1128/JB.00597-10; Bonilla-Rosso G, 2012, ASTROBIOLOGY, V12, P659, DOI 10.1089/ast.2011.0724; Senechkin IV, 2010, MICROB ECOL, V60, P829, DOI 10.1007/s00248-010-9670-1; Konneke M, 2014, P NATL ACAD SCI USA, V111, P8239, DOI 10.1073/pnas.1402028111; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Zhang SY, 2011, SCIENCE, V334, P1551, DOI 10.1126/science.1210858; Baughn AD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000662; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Bombar D, 2014, ISME J, V8, P2530, DOI 10.1038/ismej.2014.167; BYSTRYKH LV, 1993, J GEN MICROBIOL, V139, P1979; Goryshin IY, 2000, NAT BIOTECHNOL, V18, P97; Kanao T, 2002, EUR J BIOCHEM, V269, P1926, DOI 10.1046/j.1432-1033.2002.02849.x; MUROPASTOR MI, 1994, J BACTERIOL, V176, P2718; Ohhata N, 2007, J BACTERIOL, V189, P6824, DOI 10.1128/JB.00872-07; Siering PL, 2013, GEOBIOLOGY, V11, P356, DOI 10.1111/gbi.12041; Steinhauser D, 2012, TRENDS PLANT SCI, V17, P503, DOI 10.1016/j.tplants.2012.05.005; Wagner T, 2014, BIOCHEM J, V457, P425, DOI 10.1042/BJ20131142; Yano T, 2012, J BIOSCI BIOENG, V114, P53, DOI 10.1016/j.jbiosc.2012.02.023; Yoshida N, 2011, BIOSCI BIOTECH BIOCH, V75, P123, DOI 10.1271/bbb.100700; Yoshida N, 2014, J BIOSCI BIOENG, V117, P28, DOI 10.1016/j.jbiosc.2013.06.005; Yu F, 2011, Japan patent, Patent No. [P2011-223925A, 2011223925]	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	JUL	2015	99	13					5627	5637		10.1007/s00253-015-6500-x		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CL2VV	WOS:000356805600024		
J	Zhang, X; Zhang, C; Zhou, QQ; Zhang, XF; Wang, LY; Chang, HB; Li, HP; Oda, Y; Xing, XH				Zhang, Xue; Zhang, Chong; Zhou, Qian-Qian; Zhang, Xiao-Fei; Wang, Li-Yan; Chang, Hai-Bo; Li, He-Ping; Oda, Yoshimitsu; Xing, Xin-Hui			Quantitative evaluation of DNA damage and mutation rate by atmospheric and room-temperature plasma (ARTP) and conventional mutagenesis	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						ARTP mutagenesis; Flow cytometry; Fluctuation test; umu test; SOS response	HIGH O-ACETYLTRANSFERASE; GLOW-DISCHARGE PLASMA; SALMONELLA UMU TEST; COLI SOS RESPONSE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; FLOW-CYTOMETRY; TEST SYSTEM; PRESSURE	DNA damage is the dominant source of mutation, which is the driving force of evolution. Therefore, it is important to quantitatively analyze the DNA damage caused by different mutagenesis methods, the subsequent mutation rates, and their relationship. Atmospheric and room temperature plasma (ARTP) mutagenesis has been used for the mutation breeding of more than 40 microorganisms. However, ARTP mutagenesis has not been quantitatively compared with conventional mutation methods. In this study, the umu test using a flow-cytometric analysis was developed to quantify the DNA damage in individual viable cells using Salmonella typhimurium NM2009 as the model strain and to determine the mutation rate. The newly developed method was used to evaluate four different mutagenesis systems: a new ARTP tool, ultraviolet radiation, 4-nitroquinoline-1-oxide (4-NQO), and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) mutagenesis. The mutation rate was proportional to the corresponding SOS response induced by DNA damage. ARTP caused greater DNA damage to individual living cells than the other conventional mutagenesis methods, and the mutation rate was also higher. By quantitatively comparing the DNA damage and consequent mutation rate after different types of mutagenesis, we have shown that ARTP is a potentially powerful mutagenesis tool with which to improve the characteristics of microbial cell factories.	[Zhang, Xue; Zhang, Chong; Wang, Li-Yan; Chang, Hai-Bo; Xing, Xin-Hui] Tsinghua Univ, Dept Chem Engn, Minist Educ China, Key Lab Ind Biocatalysis, Beijing 100084, Peoples R China; [Zhang, Chong; Zhou, Qian-Qian; Wang, Li-Yan; Li, He-Ping; Xing, Xin-Hui] Tsinghua Univ, Wuxi Res Inst Appl Technol, Biobreeding Res Ctr, Wuxi, Jiangsu, Peoples R China; [Zhang, Xiao-Fei; Li, He-Ping] Tsinghua Univ, Dept Engn Phys, Beijing 100084, Peoples R China; [Oda, Yoshimitsu] Osaka Shin Ai Coll, Inst Life & Environm Sci, Tsurumi Ku, Osaka, Japan	Zhang, C (reprint author), Tsinghua Univ, Dept Chem Engn, Minist Educ China, Key Lab Ind Biocatalysis, Beijing 100084, Peoples R China.	chongzhang@mail.tsinghua.edu.cn; xhxing@mail.tsinghua.edu.cn			Tsinghua University Initiative Scientific Research Program [2011THZ 01019]; JST CREST project of Japan	This work was supported by the Tsinghua University Initiative Scientific Research Program(2011THZ 01019) and the JST CREST project of Japan.	AHMAD I, 1991, ANN BOT-LONDON, V67, P521; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; Smith BT, 1998, GENETICS, V148, P1599; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Song YZ, 2009, ENVIRON SCI TECHNOL, V43, P7931, DOI 10.1021/es901349r; Zhang X, 2014, APPL MICROBIOL BIOT, V98, P5387, DOI 10.1007/s00253-014-5755-y; Wielgoss S, 2013, P NATL ACAD SCI USA, V110, P222, DOI 10.1073/pnas.1219574110; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; Kodym A, 2003, METH MOL B, V236, P189; Ptitsyn LR, 1997, APPL ENVIRON MICROB, V63, P4377; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Laroussi M, 2002, APPL PHYS LETT, V81, P772, DOI 10.1063/1.1494863; ODA Y, 1985, MUTAT RES, V147, P219, DOI 10.1016/0165-1161(85)90062-7; Liu RM, 2013, PROCESS BIOCHEM, V48, P1603, DOI 10.1016/j.procbio.2013.07.020; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; Li HP, 2012, IEEE T PLASMA SCI, V40, P2853, DOI 10.1109/TPS.2012.2213274; AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; Wang LY, 2010, J APPL MICROBIOL, V108, P851, DOI 10.1111/j.1365-2672.2009.04483.x; QUILLARDET P, 1982, P NATL ACAD SCI-BIOL, V79, P5971, DOI 10.1073/pnas.79.19.5971; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; FIERING SN, 1991, CYTOMETRY, V12, P291, DOI 10.1002/cyto.990120402; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Li HP, 2011, PLASMA PROCESS POLYM, V8, P224, DOI 10.1002/ppap.201000035; Schutze A, 1998, IEEE T PLASMA SCI, V26, P1685, DOI 10.1109/27.747887; Luria SE, 1943, GENETICS, V28, P491; Gaunt LF, 2006, IEEE T PLASMA SCI, V34, P1257, DOI 10.1109/TPS.2006.878381; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Brock RD, 1977, BASIC LIFE SCI, V8, P117; Chen HX, 2010, IEEE T PLASMA SCI, V38, P1885, DOI 10.1109/TPS.2010.2046755; ElMzibri M, 1997, BIOTECHNOL TECH, V11, P467, DOI 10.1023/A:1018445512654; Fang MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077046; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; Hua XF, 2010, BIOCH ENG J, V49, P201, DOI [10.1016/j.bej.2009.12.014, DOI 10.1016/J.BEJ.2009.12.014]; Jiang M, 2014, J IND MICROBIOL BIOT, V41, P115, DOI [10.1007/s10295-013-1346-7, DOI 10.1007/S10295-013-1346-7]; Klein-Marcuschamer D, 2008, P NATL ACAD SCI USA, V105, P2319, DOI 10.1073/pnas.0712177105; Klein-Marcuschamer D, 2010, APPL ENVIRON MICROB, V76, P5541, DOI 10.1128/AEM.00828-10; Krishna S, 2007, PLOS COMPUT BIOL, V3, P451, DOI 10.1371/journal.pcbi.0030041; Li G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2938692; LU C, 1986, P NATL ACAD SCI USA, V83, P619, DOI 10.1073/pnas.83.3.619; Miao ZH, 2006, CANCER RES, V66, P6540, DOI 10.1158/0008-5472.CAN-05-4471; ODA Y, 1993, ENVIRON MOL MUTAGEN, V21, P357, DOI 10.1002/em.2850210407; ODA Y, 1995, MUTAT RES-ENVIR MUTA, V334, P145, DOI 10.1016/0165-1161(95)90005-5; PLOVINS A, 1994, APPL ENVIRON MICROB, V60, P4638; SCHAAPER RM, 1993, GENETICS, V134, P1031; Slamenova D, 1997, MUTAT RES-DNA REPAIR, V383, P243, DOI 10.1016/S0921-8777(97)00007-4; WALKER GC, 1995, TRENDS BIOCHEM SCI, V20, P416, DOI 10.1016/S0968-0004(00)89091-X; Wang LY, 2009, STUDIES MECH APPL AT; Yasunaga K, 2004, ENVIRON MOL MUTAGEN, V44, P329, DOI 10.1002/em.20053; Yasunaga K, 2006, TOXICOL IN VITRO, V20, P712, DOI 10.1016/j.tiv.2005.10.007; Yu H, 2005, IEEE T PLASMA SCI, V33, P1405, DOI 10.1109/TPS.2005.851961; Zhang X, 2014, HUAGONG XUEBAO, V65, P2676	53	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	JUL	2015	99	13					5639	5646		10.1007/s00253-015-6678-y		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CL2VV	WOS:000356805600025		
J	Mizumoto, I; Fujimoto, Y; Ikejiri, M				Mizumoto, Ikuro; Fujimoto, Yotaro; Ikejiri, Masataka			Adaptive output predictor based adaptive predictive control with ASPR constraint	AUTOMATICA			English	Article						Adaptive control; Predictive control; Adaptive output predictor; Parallel feedforward compensator; Almost strictly positive real	LINEAR-SYSTEMS; MODEL	The predictive controls are one of the major control strategies in the process control. However, in general, an exact model of the controlled system is required in order to predict the system's outputs accurately. In this paper, we propose an adaptive predictive control using an adaptive output predictor with a simple structure for uncertain controlled systems. In the proposed method, the stability of the obtained adaptive predictive control system will be confirmed by setting a novel input constraint, "almost strictly positive real (ASPR) constraint". (C) 2015 Elsevier Ltd. All rights reserved.	[Mizumoto, Ikuro] Kumamoto Univ, Dept Intelligent Mech Syst, Kumamoto 8608555, Japan; [Fujimoto, Yotaro; Ikejiri, Masataka] Kumamoto Univ, Dept Mech Syst Engn, Kumamoto 8608555, Japan	Mizumoto, I (reprint author), Kumamoto Univ, Dept Intelligent Mech Syst, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	ikuro@gpo.kumamoto-u.ac.jp; 109d8551@st.kumamoto-u.ac.jp; 135d8504@st.kumamoto-u.ac.jp					Adetol V, 2009, SYST CONTROL LETT, V58, P320, DOI 10.1016/j.sysconle.2008.12.002; Istratov AA, 1999, REV SCI INSTRUM, V70, P1233, DOI 10.1063/1.1149581; Fukushima H, 2007, AUTOMATICA, V43, P301, DOI 10.1016/j.automatica.2006.08.026; GARCIA CE, 1989, AUTOMATICA, V25, P335, DOI 10.1016/0005-1098(89)90002-2; Wang SW, 2006, ENG APPL ARTIF INTEL, V19, P189, DOI 10.1016/j.engappai.2005.08.005; Qin CB, 2014, INT J CONTROL, V87, P1000, DOI 10.1080/00207179.2013.863432; Mizumoto I, 2010, CONTROL ENG PRACT, V18, P168, DOI 10.1016/j.conengprac.2009.09.003; Zhang HG, 2009, IEEE T NEURAL NETWOR, V20, P1490, DOI 10.1109/TNN.2009.2027233; Mayne DQ, 2000, AUTOMATICA, V36, P789, DOI 10.1016/S0005-1098(99)00214-9; Bobal V, 2013, COMPUT MATH APPL, V66, P165, DOI 10.1016/j.camwa.2013.01.035; Clarke D. W., 1996, Annual Reviews in Control, V20, DOI 10.1016/S0066-4138(97)00007-4; CLARKE DW, 1987, AUTOMATICA, V23, P137, DOI 10.1016/0005-1098(87)90087-2; Isidori A., 1995, NONLINEAR CONTROL SY; Kaufman H., 1997, DIRECT ADAPTIVE CONT, V2nd; lwai Z., 2005, T JAPAN SOC MECH E C, V71, P589; Maciejowski J. M., 2002, PREDICTIVE CONTROL C; Mizumoto I, 2011, 2011 50TH IEEE CONFERENCE ON DECISION AND CONTROL AND EUROPEAN CONTROL CONFERENCE (CDC-ECC), P8297, DOI 10.1109/CDC.2011.6160357; Mizumoto I, 2007, AUTOMATICA, V43, P2077, DOI 10.1016/j.automatica.2007.04.017; Mizumoto Ikuro, 2010, Journal of System Design and Dynamics, V4, DOI 10.1299/jsdd.4.314; Mizumoto I, 2010, AUTOMATICA, V46, P1503, DOI 10.1016/j.automatica.2010.06.007; Nicolao G. D., 1996, AUTOMATICA, V32, P597; Sanchez JMM, 1996, ADAPTIVE PREDICTIVE; Takagi Taro, 2014, Proceedings of the 2014 International Conference on Advanced Mechatronic Systems, DOI 10.1109/ICAMechS.2014.6911660; YOON TW, 1994, AUTOMATICA, V30, P621, DOI 10.1016/0005-1098(94)90150-3; Zhang H., 2013, ADAPTIVE DYNOMIS PRO	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-1098	1873-2836		AUTOMATICA	Automatica	JUL	2015	57						152	163		10.1016/j.automatica.2015.04.020		12	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	CL2AR	WOS:000356746500020		
J	Himeno, H; Nameki, N; Kurita, D; Muto, A; Abo, T				Himeno, Hyouta; Nameki, Nobukazu; Kurita, Daisuke; Muto, Akira; Abo, Tatsuhiko			Ribosome rescue systems in bacteria	BIOCHIMIE			English	Review						tmRNA; SmpB; ArfA; YaeJ; Ribosome rescue	TRANSFER-MESSENGER-RNA; PEPTIDYL-TRANSFER-RNA; ESCHERICHIA-COLI TMRNA; MEDIATED TRANS-TRANSLATION; ELONGATION-FACTOR TU; HEAT-SHOCK-PROTEIN; C-TERMINAL TAIL; STALLED RIBOSOMES; BACILLUS-SUBTILIS; 10SA RNA	Ribosomes often stall during protein synthesis in various situations in a cell, either unexpectedly or in a programmed fashion. While some of them remain stalled for gene regulation, many are rescued by some cellular systems. Ribosomes stalled at the 3' end of a truncated mRNA lacking a stop codon (non-stop mRNA) are rescued by trans-translation mediated by tmRNA (transfer-messenger RNA) and a partner protein, SmpB. Through trans-translation, a degradation tag is added to the C-termini of truncated polypeptides from a truncated mRNA to prevent them from accumulation in the cell. Trans-translation has crucial roles in a wide variety of cellular events, especially under stressful conditions. The trans-translation system is thought to be universally present in the bacterial domain, although it is not necessarily essential in all bacterial cells. It has recently been revealed that two other systems, one involving a small protein, ArfA, with RF2 and the other involving YaeJ (ArfB), a class I release factor homologue, operate to relieve ribosome stalling in Escherichia coli. Thus, many bacterial species would have multiple systems to cope with various kinds of stalled translation events. (C) 2014 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.	[Himeno, Hyouta; Kurita, Daisuke; Muto, Akira] Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori 0368561, Japan; [Nameki, Nobukazu] Gunma Univ, Grad Sch Sci & Technol, Div Mol Sci, Kiryu, Gumma 3768515, Japan; [Abo, Tatsuhiko] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biol Sci, Okayama 7008530, Japan	Himeno, H (reprint author), Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori 0368561, Japan.	himeno@cc.hirosaki-u.ac.jp; nameki@gunma-u.ac.jp; tabo@okayama-u.ac.jp			Japan Society for the Promotion of Science [23380045, 24570008, 23570205, 23780099]; Grant for Hirosaki University Institutional Research	This work was supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science to H.H. and A.M. (23380045), Grants-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science to T.A. (24570008) and to N.N. and H.H. (23570205), a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science to D.K. (23780099) and a Grant for Hirosaki University Institutional Research to H.H.	Abe T, 2008, MOL MICROBIOL, V69, P1491, DOI 10.1111/j.1365-2958.2008.06381.x; Abo T, 2000, EMBO J, V19, P3762, DOI 10.1093/emboj/19.14.3762; Abo T, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00156; Nameki N, 1999, NUCLEIC ACIDS RES, V27, P3667, DOI 10.1093/nar/27.18.3667; Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Yanofsky C, 2000, J BACTERIOL, V182, P1; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P797; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Ge ZY, 2009, MOL MICROBIOL, V74, P1083, DOI 10.1111/j.1365-2958.2009.06923.x; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Karzai AW, 2001, P NATL ACAD SCI USA, V98, P3040, DOI 10.1073/pnas.051628298; Chadani Y, 2011, GENES GENET SYST, V86, P151; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; Shimizu Y, 2012, J MOL BIOL, V423, P624, DOI 10.1016/j.jmb.2012.08.007; Kaur S, 2006, P NATL ACAD SCI USA, V103, P16484, DOI 10.1073/pnas.0607438103; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Gagnon MG, 2012, SCIENCE, V335, P1370, DOI 10.1126/science.1217443; Handa Y, 2010, J MOL BIOL, V404, P260, DOI 10.1016/j.jmb.2010.09.033; Singh NS, 2004, NUCLEIC ACIDS RES, V32, P6028, DOI 10.1093/nar/gkh924; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Yanofsky C, 2007, RNA, V13, P1141, DOI 10.1261/rna.620507; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI [10.1016/j.molcel.2008.02.026, 10.1016/j.moicel.2008.02.026]; Chiba S, 2009, EMBO J, V28, P3461, DOI 10.1038/emboj.2009.280; Petropoulos AD, 2014, J BIOL CHEM, V289, P17589, DOI 10.1074/jbc.M114.564989; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Chiba S, 2012, MOL CELL, V47, P863, DOI 10.1016/j.molcel.2012.06.034; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Handa Y, 2011, NUCLEIC ACIDS RES, V39, P1739, DOI 10.1093/nar/gkq1097; Pech M, 2011, P NATL ACAD SCI USA, V108, P3199, DOI 10.1073/pnas.1012994108; Das G, 2006, MICROBIOL-SGM, V152, P2191, DOI 10.1099/mic.0.29024-0; Feng S, 2013, NUCLEIC ACIDS RES, V41, P9549, DOI 10.1093/nar/gkt742; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Karimi R, 1998, J MOL BIOL, V281, P241, DOI 10.1006/jmbi.1998.1953; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Konno T, 2004, NUCLEIC ACIDS RES, V32, P4119, DOI 10.1093/nar/gkh750; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Asano K, 2005, NUCLEIC ACIDS RES, V33, P5544, DOI 10.1093/nar/gki871; Barends S, 2010, EMBO REP, V11, P119, DOI 10.1038/embor.2009.255; Barends S, 2000, BIOCHEMISTRY-US, V39, P2652, DOI 10.1021/bi992439d; Bessho Y, 2007, P NATL ACAD SCI USA, V104, P8293, DOI 10.1073/pnas.0700402104; Camenares D, 2013, J BIOL CHEM, V288, P30527, DOI 10.1074/jbc.M113.503896; Chadani Y, 2012, MOL MICROBIOL, V86, P37, DOI 10.1111/j.1365-2958.2012.08190.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Chen CL, 2005, J BIOL CHEM, V280, P34393, DOI 10.1074/jbc.C500333200; Cheng K, 2010, J STRUCT BIOL, V169, P342, DOI 10.1016/j.jsb.2009.10.015; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Collier J, 2002, MOL MICROBIOL, V45, P745, DOI 10.1046/j.1365-2958.2002.03045.x; de la Cruz J, 2001, RNA, V7, P1708; Dong G, 2002, EMBO J, V21, P1845, DOI 10.1093/emboj/21.7.1845; Felden B, 1996, BIOCHIMIE, V78, P979, DOI 10.1016/S0300-9084(97)86720-X; Felden B, 1997, RNA, V3, P89; Felden B, 1998, EMBO J, V17, P3188, DOI 10.1093/emboj/17.11.3188; Fu J, 2010, EMBO J, V29, P3819, DOI 10.1038/emboj.2010.255; Fujihara A., 2002, CELLS, V7, P343; Gagnon MG, 2014, SCIENCE, V345, P684, DOI 10.1126/science.1253525; Garza-Sanchez F, 2009, MOL MICROBIOL, V73, P882, DOI 10.1111/j.1365-2958.2009.06813.x; Giudice E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00113; Gong M, 2007, J BACTERIOL, V189, P3147, DOI 10.1128/JB.01868-06; GU ZP, 1994, P NATL ACAD SCI USA, V91, P5612, DOI 10.1073/pnas.91.12.5612; Gutmann S, 2003, NATURE, V424, P5503; Hanawa-Suetsugu K, 2002, NUCLEIC ACIDS RES, V30, P1620, DOI 10.1093/nar/30.7.1620; Hanawa-Suetsugu K, 2001, NUCLEIC ACIDS RES, V29, P4663, DOI 10.1093/nar/29.22.4663; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Heurgue-Hamard V, 1998, EMBO J, V17, P808, DOI 10.1093/emboj/17.3.808; Himeno H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00065; Himeno Hyouta, 2014, Frontiers in Genetics, V5, P66, DOI 10.3389/fgene.2014.00066; Himeno H, 1997, J MOL BIOL, V268, P803, DOI 10.1006/jmbi.1997.1011; Hong SJ, 2007, P NATL ACAD SCI USA, V104, P17128, DOI 10.1073/pnas.0707671104; Hong SJ, 2005, MOL MICROBIOL, V57, P565, DOI 10.1111/j.1365-2958.2005.04709.x; Huang CH, 2000, EMBO J, V19, P1098, DOI 10.1093/emboj/19.5.1098; Ito K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028413; Ivanova N, 2004, J MOL BIOL, V338, P33, DOI 10.1016/j.jmb.2004.02.043; Ivanova N, 2005, J MOL BIOL, V350, P897, DOI 10.1016/j.jmb.2005.05.033; Jiang LH, 2009, J MOL BIOL, V386, P1357, DOI 10.1016/j.jmb.2008.10.079; Keiler KC, 2003, J BACTERIOL, V185, P573, DOI 10.1128/JB.185.2.573-580.2003; Keller K.C., 2000, P NATL ACAD SCI USA, V97, P7778; Keller K.C., 2003, J BACTERIOL, V185, P1825; Keller K.C., 1996, SCIENCE, V271, P990; Kogure H, 2014, NUCLEIC ACIDS RES, V42, P3152, DOI 10.1093/nar/gkt1280; Konno T, 2007, RNA, V13, P1723, DOI 10.1261/rna.604907; Korber P, 2000, EMBO J, V19, P741, DOI 10.1093/emboj/19.4.741; Kurita D, 2007, NUCLEIC ACIDS RES, V35, P7248, DOI 10.1093/nar/gkm677; Kurita D, 2014, RNA, V20, P1706, DOI 10.1261/rna.045773.114; Kurita D, 2010, RNA, V16, P980, DOI 10.1261/rna.1916610; Kuroha K, 2009, GENES CELLS, V14, P739, DOI 10.1111/j.1365-2443.2009.01304.x; Lee S, 2001, RNA, V7, P999, DOI 10.1017/S1355838201010342; Li X, 2008, MOL MICROBIOL, V68, P462, DOI 10.1111/j.1365-2958.2008.06167.x; Liang WX, 2010, J BIOL CHEM, V285, P29054, DOI 10.1074/jbc.C110.168641; Mehta P, 2006, RNA, V12, P2187, DOI 10.1261/rna.247706; Miller MR, 2014, RNA, V20, P228, DOI 10.1261/rna.042226.113; Miller MR, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-29; Miller MR, 2011, RNA, V17, P1727, DOI 10.1261/rna.2821711; Muto A, 2000, GENES CELLS, V5, P627, DOI 10.1046/j.1365-2443.2000.00356.x; Muto A, 1996, BIOCHIMIE, V78, P985, DOI 10.1016/S0300-9084(97)86721-1; Nameki N, 1999, J MOL BIOL, V289, P1, DOI 10.1006/jmbi.1999.2754; Nameki N, 1999, J MOL BIOL, V286, P733, DOI 10.1006/jmbi.1998.2487; Nameki N, 2005, J BIOCHEM, V138, P729, DOI 10.1093/jb/mvi180; Nameki N, 2000, FEBS LETT, V470, P345, DOI 10.1016/S0014-5793(00)01349-1; Neubauer C, 2012, SCIENCE, V335, P1366, DOI 10.1126/science.1217039; Nonin-Lecomte S, 2009, EMBO REP, V10, P160, DOI 10.1038/embor.2008.243; Oh B. K., 1991, MOL GEN GENET, V25, P737; Okan NA, 2006, PLOS PATHOG, V2, P50, DOI 10.1371/journal.ppat.0020006; Ono K, 2009, GENES GENET SYST, V84, P15; Oussenko IA, 2005, J BACTERIOL, V187, P2758, DOI 10.1128/JB.187.8.2758-2767.2005; Paleckova P, 2007, FOLIA MICROBIOL, V52, P463, DOI 10.1007/BF02932105; Pech M, 2012, MOL MICROBIOL, V86, P6, DOI 10.1111/j.1365-2958.2012.08207.x; Personne Y, 2014, TUBERCULOSIS, V94, P34, DOI 10.1016/j.tube.2013.09.007; Qi H, 2007, J MOL BIOL, V368, P845, DOI 10.1016/j.jmb.2007.02.068; Ramadoss NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057537; Ramadoss NS, 2013, P NATL ACAD SCI USA, V110, P10282, DOI 10.1073/pnas.1302816110; Ramrath DJF, 2012, NATURE, V485, P526, DOI 10.1038/nature11006; Ranquet C, 2007, J BACTERIOL, V189, P4872, DOI 10.1128/JB.01838-06; Rezzonico E, 2007, FEMS MICROBIOL LETT, V271, P136, DOI 10.1111/j.1574-6968.2007.00704.x; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; ROGERS EJ, 1994, MOL MICROBIOL, V12, P181, DOI 10.1111/j.1365-2958.1994.tb01007.x; Rudinger-Thirion J, 1999, RNA, V5, P989, DOI 10.1017/S135583829999101X; Saguy M, 2007, NUCLEIC ACIDS RES, V35, P2368, DOI 10.1093/nar/gkm100; Schaub RE, 2012, J BIOL CHEM, V287, P29765, DOI 10.1074/jbc.M112.374074; Shimizu Y, 2002, FEBS LETT, V514, P74, DOI 10.1016/S0014-5793(02)02333-5; Shin JH, 2007, J BACTERIOL, V189, P3729, DOI 10.1128/JB.00062-07; Singarapu KK, 2008, PROTEINS, V71, P1027, DOI 10.1002/prot.21947; Singh NS, 2008, J MOL BIOL, V380, P451, DOI 10.1016/j.jmb.2008.05.033; Someya T, 2003, FEBS LETT, V535, P94, DOI 10.1016/S0014-5793(02)03880-2; Sunohara T, 2004, RNA, V10, P378, DOI 10.1261/rna.5169404; Tadaki T, 1996, FEBS LETT, V399, P223, DOI 10.1016/S0014-5793(96)01330-0; Takada K, 2007, RNA, V13, P503, DOI 10.1261/rna.363207; Takahashi T, 2003, J BIOL CHEM, V278, P27672, DOI 10.1074/jbc.M211724200; Thibonnier M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003810; TU GF, 1995, J BIOL CHEM, V270, P9322; Ueda K, 2002, GENES CELLS, V7, P509, DOI 10.1046/j.1365-2443.2002.00537.x; Ujiie H, 2009, J BIOCHEM, V145, P59, DOI 10.1093/jb/mvn143; USHIDA C, 1994, NUCLEIC ACIDS RES, V22, P3392, DOI 10.1093/nar/22.16.3392; Vivanco-Dominguez S, 2012, J MOL BIOL, V417, P425, DOI 10.1016/j.jmb.2012.02.008; Watts T, 2009, J MOL BIOL, V391, P275, DOI 10.1016/j.jmb.2009.06.037; Weis F, 2010, EMBO J, V29, P3810, DOI 10.1038/emboj.2010.252; Weis F, 2010, RNA, V16, P299, DOI 10.1261/rna.1757410; Williams KP, 1999, EMBO J, V18, P5423, DOI 10.1093/emboj/18.19.5423; Woolstenhulme CJ, 2013, P NATL ACAD SCI USA, V110, pE878, DOI 10.1073/pnas.1219536110; Wower IK, 2000, EMBO J, V19, P6612, DOI 10.1093/emboj/19.23.6612; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803	154	2	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0300-9084	1638-6183		BIOCHIMIE	Biochimie	JUL	2015	114						102	112		10.1016/j.biochi.2014.11.014		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CL1YX	WOS:000356741900013		
J	Sakamaki, K; Imai, K; Tomii, K; Miller, DJ				Sakamaki, Kazuhiro; Imai, Kenichiro; Tomii, Kentaro; Miller, David J.			Evolutionary analyses of caspase-8 and its paralogs: Deep origins of the apoptotic signaling pathways	BIOESSAYS			English	Review						apoptosis; bcl-2; caspase; coral; evolution; extrinsic signaling pathway; sponge	PROGRAMMED CELL-DEATH; MIXED LINEAGE KINASE; EXTRINSIC APOPTOSIS; GENE LOSS; ANIMAL DEVELOPMENT; SEA-ANEMONE; C-ELEGANS; COMPLEX; SURVIVAL; REVEALS	Although Caenorhabditis and Drosophila proved invaluable in unraveling the molecular mechanisms of apoptosis, it is now clear that these animals are of limited value for understanding the evolution of apoptotic systems. Whereas data from these invertebrates led to the assumption that the extrinsic apoptotic pathway is restricted to vertebrates, recent data from cnidarians and sponges indicate that this pathway predates bilaterian origins. Here we review the phylogenetic distribution of caspase-8, the initiator caspase of the extrinsic apoptotic pathway, its paralogs and other components of the network. The ancestral caspase-8 gave rise to four paralogs early in vertebrate evolution, and these have been maintained in many tetrapods. However, eutherians have lost caspase-18 and myo-morph rodents have lost caspase-10, these losses suggesting functional redundancy amongst caspase-8 paralogs. The apoptotic network of the eumetazoan ancestor appears to have been complex and vertebrate like, and is only now being revealed by studying simple animals.	[Sakamaki, Kazuhiro] Kyoto Univ, Dept Anim Dev & Physiol, Grad Sch Biostudies, Kyoto, Japan; [Imai, Kenichiro; Tomii, Kentaro] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tokyo, Japan; [Miller, David J.] James Cook Univ, Dept Mol & Cell Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	Sakamaki, K (reprint author), Kyoto Univ, Dept Anim Dev & Physiol, Grad Sch Biostudies, Kyoto, Japan.	sakamaki.kazuhiro.7u@kyoto-u.ac.jp; david.miller@jcu.edu.au			Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank Michael Eitel and PLoS ONE, Akihito Omori (The University of Tokyo), Noriko Funayama (Kyoto University), and Takeshi Koide (National Institute of Genetics) for use of animal photo images. We also thank Eldon Ball for critical reading and useful comments on drafts of the manuscript and Naoyuki Iwabe for valuable suggestions to understand fish genome structure, and DJM acknowledges ongoing support from the Australian Research Council. This work was supported in part by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Tchernov D, 2011, P NATL ACAD SCI USA, V108, P9905, DOI 10.1073/pnas.1106924108; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Dickens LS, 2012, MOL CELL, V47, P291, DOI 10.1016/j.molcel.2012.05.004; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj/cdd/4400989; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Sakata S, 2007, GENE, V396, P134, DOI 10.1016/j.gene.2007.03.010; Wiens M, 2003, BBA-MOL CELL RES, V1593, P179, DOI 10.1016/S0167-4889(02)00388-9; Denton D, 2013, BBA-MOL CELL RES, V1833, P3499, DOI 10.1016/j.bbamcr.2013.06.014; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Dunn SR, 2007, P R SOC B, V274, P3079, DOI 10.1098/rspb.2007.0711; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Grenet J, 1999, GENE, V226, P225, DOI 10.1016/S0378-1119(98)00565-4; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Hochman A, 1997, CRIT REV MICROBIOL, V23, P207, DOI 10.3109/10408419709115136; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Gonzalvez F, 2012, MOL CELL, V48, P888, DOI 10.1016/j.molcel.2012.09.031; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Lasi M, 2010, CELL RES, V20, P812, DOI 10.1038/cr.2010.66; KISCHKEL FC, 1995, EMBO J, V14, P5579; Schartl M, 2013, NAT GENET, V45, P567, DOI 10.1038/ng.2604; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Ozturk S, 2012, EXP CELL RES, V318, P1324, DOI 10.1016/j.yexcr.2012.01.019; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Irmler M, 1997, NATURE, V388, P190; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Matthess Y, 2014, MOL ONCOL, V8, P596, DOI 10.1016/j.molonc.2013.12.013; Quistad SD, 2014, P NATL ACAD SCI USA, V111, P9567, DOI 10.1073/pnas.1405912111; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Chai JJ, 2014, NATL SCI REV, V1, P101, DOI 10.1093/nsr/nwt025; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Bottger A, 2003, GENETICS APOPTOSIS, P145; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; David CN, 2005, INTEGR COMP BIOL, V45, P631, DOI 10.1093/icb/45.4.631; Eckhart L, 2008, MOL BIOL EVOL, V25, P831, DOI 10.1093/molbev/msn012; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; Falschlehner C, 2012, EMBO J, V31, P2750, DOI 10.1038/emboj.2012.148; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Golstein P, 2003, NAT REV MOL CELL BIO, V4, P798, DOI 10.1038/nrm1224; Hashimoto T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.52; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Kuznetsov S, 2001, ZOOL-ANAL COMPLEX SY, V104, P25, DOI 10.1078/0944-2006-00005; Lafont E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013638; Lange C, 2011, MOL BIOL EVOL, V28, P1687, DOI 10.1093/molbev/msq349; Lasi M, 2010, APOPTOSIS, V15, P269, DOI 10.1007/s10495-009-0442-7; Mandal R, 2014, MOL ONCOL, V8, P232, DOI 10.1016/j.molonc.2013.11.003; Matthess Y, 2010, MOL CELL BIOL, V30, P5726; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Mustelin T, 2002, SCI STKE, V2002, ppr3; Peng C, 2011, J BIOL CHEM, V286, P6946, DOI 10.1074/jbc.M110.172338; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Sakamaki K, 2014, MOL BIOL EVOL, V31, P3282, DOI 10.1093/molbev/msu260; Seipp S, 2001, DEVELOPMENT, V128, P4891; Sun LM, 2014, TRENDS BIOCHEM SCI, V39, P587, DOI 10.1016/j.tibs.2014.10.003; Technau U, 2003, DEV BIOL, V260, P191, DOI 10.1016/S0012-1606(03)00241-0; Van Hautegem T, 2015, TRENDS PLANT SCI, V20, P102, DOI 10.1016/j.tplants.2014.10.003; Wang Jin, 2001, Proceedings of the National Academy of Sciences of the United States of America, V98, P13884, DOI 10.1073/pnas.241358198; Wiens M, 2000, J MOL EVOL, V50, P520; Yajima N, 2005, TRANSGENIC RES, V14, P593, DOI 10.1007/s11248-005-4350-5; Zmasek CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008649; Zmasek CM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r226	97	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0265-9247	1521-1878		BIOESSAYS	Bioessays	JUL	2015	37	7					767	776		10.1002/bies.201500010		10	Biochemistry & Molecular Biology; Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	CL3CS	WOS:000356827700009		
J	Kawamura, K; Takamatsu, H; Ikeda, T; Komatsu, T; Aotsuka, N; Amano, I; Yamamoto, G; Watanabe, K; Ohno, Y; Matsue, K; Kouzai, Y; Tsukada, N; Ishiyama, K; Anzai, N; Kato, K; Suzuki, R; Sunami, K; Kanda, Y				Kawamura, Koji; Takamatsu, Hiroyuki; Ikeda, Takashi; Komatsu, Tsunehiko; Aotsuka, Nobuyuki; Amano, Itsuto; Yamamoto, Go; Watanabe, Kentaro; Ohno, Yuju; Matsue, Kosei; Kouzai, Yasuji; Tsukada, Nobuhiro; Ishiyama, Ken; Anzai, Naoyuki; Kato, Koji; Suzuki, Ritsuro; Sunami, Kazutaka; Kanda, Yoshinobu			Cord Blood Transplantation for Multiple Myeloma: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Multiple myeloma; Cord blood transplantation; Chronic graft-versus-host disease; Tandem transplantation	NEWLY-DIAGNOSED MYELOMA; TERM-FOLLOW-UP; AUTOLOGOUS TRANSPLANTATION; LENALIDOMIDE MAINTENANCE; ALLOGENEIC TRANSPLANTATION; MARROW-TRANSPLANTATION; COMPETING RISK; DONOR; AUTOGRAFT; LEUKEMIA	Cord blood has been investigated as an alternative source for hematopoietic stem cell transplantation, but information about its use for multiple myeloma is limited. The purpose of this study was to evaluate the feasibility of cord blood transplantation (CBT) for patients with multiple myeloma. Eighty-six patients with multiple myeloma who underwent a first CBT between 2001 and 2011 were included in this retrospective study. Sixty-two of them had received other types of stem cell transplantation before CBT. The cumulative incidences of neutrophil engraftment at day 50, grade II to IV acute graft-versus-host disease (GVHD), and chronic GVHD were 81.4%, 39.0%, and 19.5%, respectively. The incidence of nonrelapse mortality at 2 years was 39.0%, but it was only 6.2% in patients who underwent planned tandem autologous/reduced-intensity conditioning CBT (auto/RIC-CBT). Progression-free survival (PFS) and overall survival (OS) at 6 years were 13.0% and 15.2%, respectively. Less than a partial response before CBT and lack of prior transplantation were independent significant adverse factors for PFS, whereas the presence of prior transplantation and planned tandem transplantation were associated with better OS. OS at 6 years in patients who underwent auto/RIC-CBT was 45.9%. In addition, the development of chronic GVHD was associated with superior PFS. In conclusion, we demonstrated that cord blood is feasible as an alternative graft source for myeloma patients. Although CBT provided long-term survival for a fraction of patients, optimal use of this graft requires further clinical studies. (C) 2015 American Society for Blood and Marrow Transplantation.	[Kawamura, Koji; Kanda, Yoshinobu] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama 3308503, Japan; [Takamatsu, Hiroyuki] Kanazawa Univ, Cellular Transplantat Biol, Kanazawa, Ishikawa, Japan; [Ikeda, Takashi] Shizuoka Canc Ctr, Div Hematol & Stem Cell Transplantat, Shizuoka, Japan; [Komatsu, Tsunehiko] Tsukuba Mem Hosp, Dept Hematol, Tsukuba, Ibaraki, Japan; [Aotsuka, Nobuyuki] Japanese Red Cross Soc Narita Hosp, Div Hematol Oncol, Narita, Japan; [Amano, Itsuto] Nara Med Univ Hosp, Dept Hematol & Resp, Kashihara, Nara, Japan; [Yamamoto, Go] Federat Natl Publ Serv Personnel Mutual Aid Assoc, Dept Hematol, Tokyo, Japan; [Watanabe, Kentaro] Saiseikai Cent Hosp, Dept Hematol Oncol Infect Dis, Tokyo, Japan; [Ohno, Yuju] Kitakyushu Municipal Med Ctr, Dept Internal Med, Kitakyushu, Fukuoka, Japan; [Matsue, Kosei] Kameda Med Ctr, Dept Med, Div Hematol Oncol, Kamogawa, Japan; [Kouzai, Yasuji] Tokyo Metropolitan Tama Med Ctr, Dept Transfus Med, Tokyo, Japan; [Tsukada, Nobuhiro] Japanese Red Cross Med Ctr, Div Hematol, Tokyo, Japan; [Ishiyama, Ken] Kanazawa Univ Hosp, Dept Hematol, Kanazawa, Ishikawa, Japan; [Anzai, Naoyuki] Takatsuki Red Cross Hosp, Dept Hematol & Oncol, Takatsuki, Osaka, Japan; [Kato, Koji] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Suzuki, Ritsuro] Nagoya Univ, Sch Med, Dept Hematopoiet Stem Cell Transplantat Data Mana, Nagoya, Aichi 466, Japan; [Sunami, Kazutaka] Natl Hosp Org Okayama Med Ctr, Dept Hematol, Okayama, Japan	Kanda, Y (reprint author), Jichi Med Univ, Saitama Med Ctr, Div Hematol, Omiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan.	ycanda-tky@umin.ac.jp					Ando T, 2005, EUR J HAEMATOL, V74, P175, DOI 10.1111/j.1600-0609.2004.00364.x; Alsina M, 2014, BIOL BLOOD MARROW TR, V20, P1183, DOI 10.1016/j.bbmt.2014.04.014; Patriarca F, 2012, BIOL BLOOD MARROW TR, V18, P617, DOI 10.1016/j.bbmt.2011.07.026; Atsuta Y, 2007, INT J HEMATOL, V86, P269, DOI 10.1532/IJH97.06239; Gahrton G, 2013, BLOOD, V121, P5055, DOI 10.1182/blood-2012-11-469452; Passera R, 2013, BIOL BLOOD MARROW TR, V19, P940, DOI 10.1016/j.bbmt.2013.03.012; Eapen M, 2010, LANCET ONCOL, V11, P653, DOI 10.1016/S1470-2045(10)70127-3; Moreau P, 2008, BLOOD, V112, P3914, DOI 10.1182/blood-2008-07-168823; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Armeson KE, 2013, BONE MARROW TRANSPL, V48, P562, DOI 10.1038/bmt.2012.173; Rosinol L, 2008, BLOOD, V112, P3591, DOI 10.1182/blood-2008-02-141598; Atsuta Y, 2009, BLOOD, V113, P1631, DOI 10.1182/blood-2008-03-147041; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Attal M, 2012, NEW ENGL J MED, V366, P1782, DOI 10.1056/NEJMoa1114138; Crawley C, 2005, BLOOD, V105, P4532, DOI 10.1182/blood-2004-06-2387; Giaccone L, 2011, BLOOD, V117, P6721, DOI 10.1182/blood-2011-03-339945; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Atsuta Y, 2012, BIOL BLOOD MARROW TR, V18, P780, DOI 10.1016/j.bbmt.2011.10.008; Lokhorst HM, 2012, BLOOD, V119, P6219, DOI 10.1182/blood-2011-11-393801; McCarthy PL, 2012, NEW ENGL J MED, V366, P1770, DOI 10.1056/NEJMoa1114083; Tricot G, 1996, BLOOD, V87, P1196; Kneppers E, 2011, BLOOD, V118, P2413, DOI 10.1182/blood-2011-04-348292; SULLIVAN KM, 1991, SEMIN HEMATOL, V28, P250; Lokhorst HM, 2000, J CLIN ONCOL, V18, P3031; Krishnan A, 2011, LANCET ONCOL, V12, P1195, DOI 10.1016/S1470-2045(11)70243-1; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Lioznov M, 2010, BONE MARROW TRANSPL, V45, P349, DOI 10.1038/bmt.2009.155; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Auner HW, 2013, BONE MARROW TRANSPL, V48, P1395, DOI 10.1038/bmt.2013.73; Dune BG, 2006, LEUKEMIA, V20, P1467, DOI DOI 10.1038/SJ.LEU.2404284; Kanda J, 2013, LEUKEMIA, V27, P286, DOI 10.1038/leu.2012.203; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kasahara I, 2009, INT J HEMATOL, V90, P413, DOI 10.1007/s12185-009-0414-2; Kharfan-Dabaja MA, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-2; Kumar S, 2011, BLOOD, V118, P1979, DOI 10.1182/blood-2011-02-337329; Miura Y, 2007, INT J HEMATOL, V86, P463, DOI 10.1532/IJH97.07113; Wolschke C, 2013, EXP HEMATOL, V41, P134, DOI 10.1016/j.exphem.2012.10.004; Yamada T, 2004, INT J HEMATOL, V80, P377, DOI 10.1532/IJH97.04091	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	JUL	2015	21	7					1291	1298		10.1016/j.bbmt.2015.02.015		8	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CL2AY	WOS:000356747200020		
J	Naito, M; Hinata, N; Rodriguez-Vazquez, JF; Murakami, G; Aizawa, S; Fujisawa, M				Naito, Michiko; Hinata, Nobuyuki; Francisco Rodriguez-Vazquez, Jose; Murakami, Gen; Aizawa, Shin; Fujisawa, Masato			Absorption of the Wolffian duct and duplicated ureter by the urogenital sinus: morphological study using human fetuses and embryos	BJU INTERNATIONAL			English	Article						ureteric duplication; vesico-ureteric junction; Wolffian duct; urogenital sinus; human embryo		Objectives To describe the embryological origin of the duplicated ureter and to investigate whether the urogenital sinus absorbs not only the Wolffian duct (WD) but also the ureter. Materials and Methods During studies using sections of human fetuses (45 specimens), we incidentally found a specific type of ureteric duplication (at similar to 7 weeks) in which two unilateral ureters joined at the vesico-ureteric junction, apparently representing a morphology arising at an intermediate stage between complete and partial ureteric duplication. The existing literature lacks any photographic representation of early development of the vesico-ureteric junction, and we therefore studied horizontal sections of 10 human embryos (at similar to 5-6 weeks' gestation) in which the ureter did not join the urogenital sinus (future bladder) but instead joined the WD (future vas deferens). Results The sinus consistently showed a reversed Y-shape, the arms of which extended posteriorly to receive the WD. When absorption of the duct into the sinus wall reached the distal end of the ureter, the arm-like parts appeared to enlarge posteriorly for further involvement of the duct, with little or no incorporation of the ureter; therefore, the future trigone of the bladder might develop from these arm-like parts of the sinus posterior wall. Consequently, in the case of ureteric duplication included in the present study, it is considered that the ureters would probably have merged with the WD at closely adjacent sites. Conclusion The present study represents the first photographic illustration of the early development of the human vesico-ureteric junction.	[Naito, Michiko; Aizawa, Shin] Nihon Univ, Sch Med, Dept Anat, Tokyo, Japan; [Hinata, Nobuyuki; Fujisawa, Masato] Kobe Univ, Grad Sch Med, Dept Urol, Kobe, Hyogo 657, Japan; [Francisco Rodriguez-Vazquez, Jose] Univ Complutense Madrid, Fac Med, Inst Embryol, Madrid, Spain; [Murakami, Gen] Iwamizawa Kojin Kai Hosp, Div Internal Med, Iwamizawa, Japan	Hinata, N (reprint author), Kobe Univ, Grad Sch Med, Dept Urol, 7-5-1 Kusunoki Cho, Kobe, Hyogo 657, Japan.	hinata@med.kobe-u.ac.jp	Hinata, Nobuyuki/M-9421-2015; 	Hinata, Nobuyuki/0000-0001-7014-6812; Rodriguez-Vazquez, Jose Francisco/0000-0001-5423-4492			Mendelsohn C, 2009, ORGANOGENESIS, V5, P306; Tanaka ST, 2010, J UROLOGY, V183, P386, DOI 10.1016/j.juro.2009.08.107; GYLLENSTEN L, 1949, ACTA ANAT, V7, P305; Hamilton WJ, 1972, HAMILTON BOYD MOSSMA; Masumoto H, 2011, ANN ANAT, V193, P500, DOI 10.1016/j.aanat.2011.03.010; O'Rahilly R, 1996, HUMAN EMBRYOLOGY TER; Persaud T. V. N., 1998, DEV HUMAN CLIN ORIEN; Rodriguez-Vazquez JF, 2011, J ANAT, V219, P143, DOI 10.1111/j.1469-7580.2011.01387.x; Standring S, 2008, GRAYS ANATOMY ANATOM; Wein A. J., 2011, CAMPBELL WALSH UROLO; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]	11	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-4096	1464-410X		BJU INT	BJU Int.	JUL	2015	116	1					135	141		10.1111/bju.13006		7	Urology & Nephrology	Urology & Nephrology	CL6AT	WOS:000357048700023		
J	Mizowaki, T; Sasayama, T; Semba, S; Sasaki, R; Yasuo, K; Nakamizo, S; Tanaka, K; Mizukawa, K; Uchihashi, Y; Kohmura, E				Mizowaki, Takashi; Sasayama, Takashi; Semba, Shuho; Sasaki, Ryohei; Yasuo, Kensaku; Nakamizo, Satoshi; Tanaka, Kazuhiro; Mizukawa, Katsu; Uchihashi, Yoshito; Kohmura, Eiji			A 40-Year-Old Female with Leptomeningeal Lesions	BRAIN PATHOLOGY			English	Article							PRIMARY MENINGEAL SARCOMAS; 2 CHILDREN; MRI		[Mizowaki, Takashi; Sasayama, Takashi; Nakamizo, Satoshi; Tanaka, Kazuhiro; Mizukawa, Katsu; Uchihashi, Yoshito; Kohmura, Eiji] Kobe Univ, Dept Neurosurg, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Semba, Shuho] Kobe Univ, Dept Pathol, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Sasaki, Ryohei] Kobe Univ, Dept Radiat Oncol, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Yasuo, Kensaku] Kobe Ekisaikai Hosp, Div Neurosurg, Kobe, Hyogo, Japan	Mizowaki, T (reprint author), Kobe Univ, Dept Neurosurg, Grad Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.						BUDKA H, 1975, J NEUROL, V211, P77, DOI 10.1007/BF00312466; Buttner A, 2001, J NEURO-ONCOL, V52, P181, DOI 10.1023/A:1010662818560; Pfluger T, 1997, NEURORADIOLOGY, V39, P225; Uluc K, 2004, J NEURO-ONCOL, V66, P307, DOI 10.1023/B:NEON.0000014515.46358.5e	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	JUL	2015	25	4					509	510		10.1111/bpa.12270		2	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CL1CH	WOS:000356679600014		
J	Otsuka, H; Fujii, T; Toh, U; Iwakuma, N; Takahashi, R; Mishima, M; Takenaka, M; Kakuma, T; Tanaka, M; Shirouzu, K				Otsuka, Hiroko; Fujii, Teruhiko; Toh, Uhi; Iwakuma, Nobutaka; Takahashi, Ryuji; Mishima, Mai; Takenaka, Miki; Kakuma, Tatsuyuki; Tanaka, Maki; Shirouzu, Kazuo			Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur-gimeracil-oteracil potassium in metastatic and recurrent breast cancer	BREAST CANCER			English	Article						Breast cancer; CPT-11; TS-1; Metronomic chemotherapy	ADVANCED COLORECTAL-CANCER; ADVANCED GASTRIC-CANCER; UGT1A1-ASTERISK-6 AND-ASTERISK-28; COMBINATION THERAPY; UGT1A POLYMORPHISMS; JAPANESE PATIENTS; S-1; GENE; DOXORUBICIN; SN-38	Background We investigated the efficacy and safety of metronomic chemotherapy with combined irinotecan and tegafur-gimeracil-oteracil potassium (TS-1) in patients with metastatic and recurrent breast cancer (MRBC), and the association between irinotecan metabolizing enzyme UDP-glucuronosyltransferase 1A1 (UGT1A1) gene polymorphisms and adverse events. Methods The study group comprised 40 patients aged 35-79 years. Irinotecan (60 mg/m(2) in 5 % dextrose) was administered by 120-min infusion on days 1, 8, and 15 every 4 weeks. TS-1 (prescribed in a standard quantity) was administered at 80 mg/m(2)/day orally on days 3-7, 10-14, and 17-21 every 4 weeks. Results Tumor response data were available for 34 patients. Median follow-up was 12 months (range 1-45 months). Response rate was 47 % (one complete and 15 partial responses). Stable disease was observed in 17 patients (50 %). One patient had disease progression (3 %). Median progression-free survival was 14 months [95 % confidence interval (CI), 10-26]. Median overall survival was 26 months (95 % CI not calculable owing to sample size), and 79.3 % of patients survived for 1 year. The most common grade 3 or 4 adverse events were neutropenia (15 %), leukopenia (12.5 %), diarrhea (7.5 %), and anemia (2.5 %). All other adverse events were grade 1 or 2. Treatment-related toxicity was generally modest and manageable. No significant correlation was observed between UGT1A1 polymorphisms and hematological or non-hematological toxicities. Conclusions Metronomic chemotherapy with combined irinotecan and TS-1 was effective in MRBC patients. Adverse effects were mild and the regimen was safely administered without identifying UGT1A1 polymorphisms.	[Otsuka, Hiroko; Toh, Uhi; Iwakuma, Nobutaka; Takahashi, Ryuji; Mishima, Mai; Tanaka, Maki; Shirouzu, Kazuo] Kurume Univ, Dept Surg, Kurume, Fukuoka 8300011, Japan; [Fujii, Teruhiko] Kurume Univ, Multidisciplinary Canc Treatment Ctr, Kurume, Fukuoka 8300011, Japan; [Kakuma, Tatsuyuki] Kurume Univ, Biostat Ctr, Kurume, Fukuoka 8300011, Japan; [Tanaka, Maki] Social Insurance Kurume Daiichi Hosp, Kurume, Fukuoka 8300013, Japan	Fujii, T (reprint author), Kurume Univ, Multidisciplinary Canc Treatment Ctr, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	tfujii@med.kurume-u.ac.jp					AHERN RP, 1993, BRIT J CANCER, V67, P801, DOI 10.1038/bjc.1993.146; Han JY, 2006, J CLIN ONCOL, V24, P2237, DOI 10.1200/JCO.2005.03.0239; KAWATO Y, 1991, CANCER RES, V51, P4187; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Fukushima M, 1998, INT J ONCOL, V13, P693; Minami H, 2007, PHARMACOGENET GENOM, V17, P497, DOI 10.1097/FPC.0b013e328014341f; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Dellapasqua S, 2008, J CLIN ONCOL, V26, P4899, DOI 10.1200/JCO.2008.17.4789; Bishop JF, 1999, J CLIN ONCOL, V17, P2355; Fossati R, 1998, J CLIN ONCOL, V16, P3439; Sledge GW, 2003, J CLIN ONCOL, V21, P588, DOI 10.1200/JCO.2003.08.013; Innocenti F, 2004, J CLIN ONCOL, V22, P1382, DOI 10.1200/JCO.2004.07.173; Chan S, 1999, J CLIN ONCOL, V17, P2341; Sai K, 2004, CLIN PHARMACOL THER, V75, P501, DOI 10.1016/j.clpt.2004.01.010; Hoskins JM, 2007, J NATL CANCER I, V99, P1290, DOI 10.1093/jnci/djm115; Perez EA, 2001, J CLIN ONCOL, V19, P4216; Fedele P, 2012, EUR J CANCER, V48, P24, DOI 10.1016/j.ejca.2011.06.040; Wang ZH, 2012, CANCER CHEMOTH PHARM, V69, P515, DOI 10.1007/s00280-011-1728-3; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Hasegawa Y, 2004, CLIN CHEM, V50, P1479, DOI 10.1373/clinchem.2004.034694; Sai K, 2008, YAKUGAKU ZASSHI, V128, P575, DOI 10.1248/yakushi.128.575; VONHOFF DD, 1979, ANN INTERN MED, V91, P710; Premawardhena A, 2003, BLOOD CELL MOL DIS, V31, P98, DOI 10.1016/S1079-9796(03)00071-8; Ando Y, 2000, CANCER RES, V60, P6921; Gagne JF, 2002, MOL PHARMACOL, V62, P608, DOI 10.1124/mol.62.3.608; Shirasaka T, 1996, CANCER RES, V56, P2602; Araki K, 2006, CANCER SCI, V97, P1255, DOI 10.1111/j.1349-7006.2006.00321.x; Goto A, 2006, ANN ONCOL, V17, P968, DOI 10.1093/annonc/mdl066; Hara F, 2010, ONCOLOGY-BASEL, V79, P273, DOI 10.1159/000322371; Inokuchi M, 2006, BRIT J CANCER, V94, P1130, DOI 10.1038/sj.bjc.6603072; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Ogata Yutaka, 2009, Kurume Medical Journal, V56, P1; Paterson A H, 1981, Breast Cancer Res Treat, V1, P357, DOI 10.1007/BF01806751; Perez EA, 2004, J CLIN ONCOL, V22, P2849, DOI 10.1200/JCO.2004.10.047; Saek Toshiaki, 2004, Breast Cancer, V11, P194, DOI 10.1007/BF02968301; Sugimachi K, 1999, ONCOLOGY-BASEL, V57, P202, DOI 10.1159/000012032; Taguchi T, 1994, Gan To Kagaku Ryoho, V21, P1017; Taguchi T, 1994, Gan To Kagaku Ryoho, V21, P83; Torigoe S, 2009, ANTICANCER RES, V29, P2083; Tsunoda A, 2009, ONCOLOGY-BASEL, V77, P192, DOI 10.1159/000236017; Uedo N, 2007, ONCOLOGY-BASEL, V73, P65, DOI 10.1159/000120630	41	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JUL	2015	22	4					335	342		10.1007/s12282-013-0483-1		8	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CL4SO	WOS:000356944600002		
J	Mori, M; Tsunoda, H; Takamoto, Y; Murai, M; Kikuchi, M; Honda, S; Suzuki, K; Yamauchi, H				Mori, Miki; Tsunoda, Hiroko; Takamoto, Yayoi; Murai, Michiko; Kikuchi, Mari; Honda, Satoshi; Suzuki, Koyu; Yamauchi, Hideko			MRI and ultrasound evaluation of invasive lobular carcinoma of the breast after primary systemic therapy	BREAST CANCER			English	Article						Invasive lobular carcinoma; Primary systemic therapy; Neoadjuvant chemotherapy; Magnetic resonance imaging; Ultrasound	NEOADJUVANT CHEMOTHERAPY; METASTATIC PATTERNS; CONSERVING SURGERY; LOCAL RECURRENCE; DUCTAL CARCINOMA; CANCER; CONSERVATION; SURVIVAL; RISK	Aim To assess magnetic resonance imaging (MRI) and ultrasound (US) evaluation of invasive lobular carcinoma after primary systemic therapy compared to the primary surgery group. Methods A total of 218 breasts with invasive lobular carcinoma (ILC), which were diagnosed by core needle biopsy and underwent surgery between 2004 and 2010 in St. Luke's International Hospital, were reviewed. Of these, 44 breasts received primary systemic therapy (PST) and the residual 174 breasts underwent surgery first. Before surgery, MRI and second-look US were performed. Patients whose extent of lesion from MRI and US was over 90 degrees were recommended to receive total mastectomy. Diagnostic image evaluation was categorized from the final pathology. A negative margin of breast-conserving surgery (BCS) and mastectomy which has over 90 degrees tumor extent in pathology were regarded as "appropriate''. A positive margin of BCS was regarded as "underestimated''. "Overestimation'' was determined when the pathological extension was small enough for BCS although MRI and US diagnosis was over 90 degrees. Results Of 44 breasts which received PST, 26 breasts received BCS as initial surgery. Of these, 14 (53.8 %) breasts were "underestimated''. Of these 14, 5 breasts received additional total mastectomy. Of 174 breasts that received surgery first, 121 (69.5 %) breasts received BCS as the initial surgery. Of these, 46 (38.0 %) breasts were "underestimated'' and 6 breast of these 46 received additional total mastectomy. "Underestimated'' rate was similar in the two groups, but the additional total mastectomy rate was significantly higher in the PST group (p = 0.025). There were no "overestimations''. The "appropriate'' rate was similar between the PST (68.2 %) and surgery-first groups (73.6 %). Conclusions Although 68.2 % of ILC patients were evaluated "appropriately'' even after PST, higher additional total mastectomy rates should be considered when selecting the surgical procedure.	[Mori, Miki] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA; [Mori, Miki] Showa Univ, Dept Breast Surg Oncol, Tokyo, Japan; [Tsunoda, Hiroko; Kikuchi, Mari; Honda, Satoshi] St Lukes Int Hosp, Dept Diagnost Imaging, Tokyo, Japan; [Takamoto, Yayoi] Keio Univ, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Takamoto, Yayoi; Murai, Michiko; Yamauchi, Hideko] St Lukes Int Hosp, Dept Breast Surg Oncol, Tokyo, Japan; [Suzuki, Koyu] St Lukes Int Hosp, Dept Pathol, Tokyo, Japan	Mori, M (reprint author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, 2340 Sutter St,S441, San Francisco, CA 94115 USA.	wilsonmikity@yahoo.co.jp					McGuire KP, 2011, ANN SURG ONCOL, V18, P3149, DOI 10.1245/s10434-011-1912-z; Delpech Y, 2013, BRIT J CANCER, V108, P285, DOI 10.1038/bjc.2012.557; Wenzel C, 2007, BREAST CANCER RES TR, V104, P109, DOI 10.1007/s10549-006-9397-3; BORST MJ, 1993, SURGERY, V114, P637; Tubiana-Hulin M, 2006, ANN ONCOL, V17, P1228, DOI 10.1093/annonc/mdl114; Waljee JF, 2008, ANN SURG ONCOL, V15, P1297, DOI 10.1245/s10434-007-9777-x; Cocquyt VF, 2003, EUR J SURG ONCOL, V29, P361, DOI 10.1053/ejso.2002.1404; Colleoni M, 2004, CLIN CANCER RES, V10, P6622, DOI 10.1158/1078-0432.CCR-04-0380; SastreGarau X, 1996, CANCER, V77, P113, DOI 10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8; Chen JH, 2008, CANCER, V112, P17, DOI 10.1002/cncr.23130; van den Broek N, 2007, BREAST CANCER RES TR, V105, P63, DOI 10.1007/s10549-006-9431-5; Lips EH, 2012, BREAST CANCER RES TR, V136, P35, DOI 10.1007/s10549-012-2233-z; O'Sullivan MJ, 2007, ANN SURG ONCOL, V14, P3133, DOI 10.1245/s10434-007-9523-4; Mathieu MC, 2004, EUR J CANCER, V40, P342, DOI 10.1016/j.ejca.2003.08.015; Cristofanilli M, 2005, J CLIN ONCOL, V23, P41, DOI 10.1200/JCO.2005.03.111; Mann RM, 2010, BREAST CANCER RES TR, V119, P415, DOI 10.1007/s10549-009-0616-6; MARTINEZ V, 1979, HISTOPATHOLOGY, V3, P467, DOI 10.1111/j.1365-2559.1979.tb03029.x; Arpino G, 2004, BREAST CANCER RES, V6, P149; Boughey JC, 2009, ANN SURG ONCOL, V16, P1606, DOI 10.1245/s10434-009-0402-z; Keskek M, 2004, EJSO, V30, P1058, DOI 10.1016/j.ejso.2004.07.019; Mann RM, 2008, BREAST CANCER RES TR, V107, P1, DOI 10.1007/s10549-007-9528-5; SMITH DB, 1987, EUR J CANCER CLIN ON, V23, P979, DOI 10.1016/0277-5379(87)90344-0; Straver ME, 2010, ANN SURG, V251, P701, DOI 10.1097/SLA.0b013e3181c5dda3; Wagner J, 2009, AM J SURG, V198, P387, DOI 10.1016/j.amjsurg.2009.01.006	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JUL	2015	22	4					356	365		10.1007/s12282-013-0486-y		10	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CL4SO	WOS:000356944600005		
J	Miyake, T; Ito, T; Yanai, A; Inoue, N; Miyagawa, Y; Murase, K; Imamura, M; Ichii, S; Takatsuka, Y; Nishizaki, T; Hirota, S; Ohtsuka, M; Yamamoto, H; Noguchi, S; Miyoshi, Y				Miyake, Tomohiro; Ito, Takashi; Yanai, Ayako; Inoue, Natsuko; Miyagawa, Yoshimasa; Murase, Keiko; Imamura, Michiko; Ichii, Shigetoshi; Takatsuka, Yuichi; Nishizaki, Tomoyuki; Hirota, Seiichi; Ohtsuka, Masahisa; Yamamoto, Hirofumi; Noguchi, Shinzaburo; Miyoshi, Yasuo			C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis	BREAST CANCER			English	Article						Breast cancer; C4.4A; Immunohistochemistry; Human epidermal growth factor receptor 2 (HER2); Prognostic factor	EPITHELIAL-MESENCHYMAL TRANSITION; INTERNATIONAL EXPERT CONSENSUS; SQUAMOUS-CELL CARCINOMA; PRIMARY THERAPY; UROKINASE RECEPTOR; COLORECTAL-CANCER; POOR-PROGNOSIS; HIGHLIGHTS; PROGRESSION; HOMOLOG	Background The aim of our study was to investigate the association of C4.4A expression in breast tumors with both patients' clinicopathological characteristics and outcomes in order to clarify the significance of C4.4A in breast cancer. Methods Primary breast cancer patients (n = 125, stage I-III) who had undergone breast mastectomy or breast-conserving surgery at our hospital between 2005 and 2011 were recruited for this study. Tumor samples were obtained from surgical specimens and expression status of C4.4A, estrogen receptors, progesterone receptors, human epidermal growth factor receptor 2 (HER2) and Ki67 was analyzed immunohistochemically, while HER2 amplification was examined using fluorescence in situ hybridization. Results Multivariate analysis showed that HER2 positivity was the only independent predictive factor for C4.4A expression (odds ratio 5.31, 95 % confidence interval 2.04-15.72; P < 0.001). Univariate prognostic analysis of the relationship between C4.4A and disease-free survival showed that survival of patients with C4.4A-positive tumors was longer than that of patients with C4.4A-negative tumors in the HER2-positive subset (P = 0.004) while there was no significant difference in patient outcome according to C4.4A status for total patients (median observation period 37 months, range 1-92 months; P = 0.223). Conclusions We established a positive relationship between C4.4A and HER2 status, suggesting that C4.4A expression may be a prognostic factor for HER2-positive breast cancer patients.	[Miyake, Tomohiro; Yanai, Ayako; Inoue, Natsuko; Miyagawa, Yoshimasa; Murase, Keiko; Imamura, Michiko; Ichii, Shigetoshi; Takatsuka, Yuichi; Miyoshi, Yasuo] Hyogo Coll Med, Dept Surg, Div Breast & Endocrine Surg, Nishinomiya, Hyogo 6638501, Japan; [Miyake, Tomohiro; Noguchi, Shinzaburo] Osaka Univ, Dept Breast & Endocrine Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Ito, Takashi; Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo 6638501, Japan; [Nishizaki, Tomoyuki] Hyogo Coll Med, Dept Physiol, Div Bioinformat, Nishinomiya, Hyogo 6638501, Japan; [Ohtsuka, Masahisa; Yamamoto, Hirofumi] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan	Miyoshi, Y (reprint author), Hyogo Coll Med, Dept Surg, Div Breast & Endocrine Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	ymiyoshi@hyo-med.ac.jp					Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Criscitiello C, 2012, ANN ONCOL, V23, P13, DOI 10.1093/annonc/mds188; Albain KS, 2009, BREAST, V18, pS141, DOI 10.1016/S0960-9776(09)70290-5; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Berg D, 2012, J CELL PHYSIOL, V227, P204, DOI 10.1002/jcp.22718; Naoi Y, 2011, BREAST CANCER RES TR, V128, P633, DOI 10.1007/s10549-010-1145-z; Jo M, 2009, J BIOL CHEM, V284, P22825, DOI 10.1074/jbc.M109.023960; Liu T, 2013, J SURG ONCOL, V107, P188, DOI 10.1002/jso.23240; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Hansen LV, 2007, LUNG CANCER, V58, P260, DOI 10.1016/j.lungcan.2007.06.025; Hansen LV, 2008, INT J CANCER, V122, P734, DOI 10.1002/ijc.23082; Jeong H, 2012, HISTOPATHOLOGY, V60, pE87, DOI 10.1111/j.1365-2559.2012.04195.x; Konishi K, 2010, CANCER SCI, V101, P2269, DOI 10.1111/j.1349-7006.2010.01674.x; Murase K, 2014, BREAST CANCER-TOKYO, V21, P52, DOI 10.1007/s12282-012-0348-z; Ohtsuka M, 2013, ANN SURG ONCOL, V20, P2699, DOI 10.1245/s10434-013-2900-2; Oshiro R, 2012, CANCER SCI, V103, P1155, DOI 10.1111/j.1349-7006.2012.02263.x; Rosel M, 1998, ONCOGENE, V17, P1989, DOI 10.1038/sj.onc.1202079; Sabattini E, 1998, J CLIN PATHOL, V51, P506; Seiter S, 2001, J INVEST DERMATOL, V116, P344, DOI 10.1046/j.1523-1747.2001.01230.x; Smith BA, 2001, CANCER RES, V61, P1678; Wurfel J, 2001, GENE, V262, P35, DOI 10.1016/S0378-1119(00)00515-1	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JUL	2015	22	4					366	373		10.1007/s12282-013-0487-x		8	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CL4SO	WOS:000356944600006		
J	Miyagawa, Y; Miyake, T; Yanai, A; Murase, K; Imamura, M; Ichii, S; Takatsuka, Y; Ito, T; Hirota, S; Saito, M; Kotoura, Y; Miyauchi, K; Fujimoto, Y; Hatada, T; Sasa, M; Miyoshi, Y				Miyagawa, Yoshimasa; Miyake, Tomohiro; Yanai, Ayako; Murase, Keiko; Imamura, Michiko; Ichii, Shigetoshi; Takatsuka, Yuichi; Ito, Takashi; Hirota, Seiichi; Saito, Masaru; Kotoura, Yoshinao; Miyauchi, Keisuke; Fujimoto, Yasuhisa; Hatada, Takuya; Sasa, Mitsunori; Miyoshi, Yasuo			Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women	BREAST CANCER			English	Article						Body mass index; Breast cancer risk; Estrogen receptor; Luminal A	SEX-HORMONES; METAANALYSIS	Background The impact of body mass index (BMI) on the risk of postmenopausal estrogen receptor (ER)-positive breast cancers has been well documented. However, the mechanism for the impact of BMI on the etiology of luminal A and luminal B subtypes has not yet been identified. Methods We analyzed associations between BMI and breast cancers stratified by immunohistochemically defined intrinsic subtypes, and 1,297 Japanese women (615 breast cancer patients and 682 healthy women from a breast cancer screening program) were enrolled in a case-control study. ER-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancers were classified into luminal A and B subtypes according to Ki67 expression levels. Results Higher BMI was significantly positively associated with postmenopausal breast cancer risk for one-unit increase in BMI (adjusted odds ratio (aOR) 1.09, 95 % confidence interval (CI) 1.04-1.15; P = 0.0008). Analyses of postmenopausal women revealed that BMI was consistently and exclusively associated with luminal A incidence (aOR 1.18, 95 % CI 1.10-1.26; P < 0.0001). When BMI was divided into three categories corresponding to those of controls, among postmenopausal women, the observed positive association was confined to luminal A (high vs low, aOR 2.98, 95 % CI 1.53-5.80; P < 0.005), but not luminal B (aOR 0.95, 95 % CI 0.47-1.91) subtypes. Conclusions We observed that BMI was significantly positively associated with increased risk of postmenopausal breast cancer for Japanese women with luminal A, but not with luminal B tumor subtype.	[Miyagawa, Yoshimasa; Miyake, Tomohiro; Yanai, Ayako; Murase, Keiko; Imamura, Michiko; Ichii, Shigetoshi; Takatsuka, Yuichi; Miyoshi, Yasuo] Hyogo Coll Med, Dept Surg, Div Breast & Endocrine, Nishinomiya, Hyogo 6638501, Japan; [Ito, Takashi; Hirota, Seiichi] Hyogo Coll Med, Surg Pathol, Nishinomiya, Hyogo 6638501, Japan; [Saito, Masaru; Kotoura, Yoshinao] Maikodai Hosp, Kobe, Hyogo 6550046, Japan; [Miyauchi, Keisuke] Miyauchi Clin, Amagasaki, Hyogo 6610035, Japan; [Fujimoto, Yasuhisa] Tachibana Hosp, Amagasaki, Hyogo 6610025, Japan; [Hatada, Takuya] Uminosato Clin, Minamiawaji, Hyogo 6560501, Japan; [Sasa, Mitsunori] Tokushima Breast Care Clin, Tokushima, Tokushima 7700052, Japan	Miyoshi, Y (reprint author), Hyogo Coll Med, Dept Surg, Div Breast & Endocrine, Mukogawa Cho 1, Nishinomiya, Hyogo 6638501, Japan.	ymiyoshi@hyo-med.ac.jp					Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Cheang MCU, 2009, J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; SCHATZKIN A, 1987, J NATL CANCER I, V78, P213; Verkasalo PK, 2001, CANCER CAUSE CONTROL, V12, P47, DOI 10.1023/A:1008929714862; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Phipps AI, 2008, CANCER EPIDEM BIOMAR, V17, P2078, DOI 10.1158/1055-9965.EPI-08-0206; Furberg AS, 2004, J NATL CANCER I, V96, P1152, DOI 10.1093/jnci/djh216; Hankinson SE, 1998, J NATL CANCER I, V90, P1292, DOI 10.1093/jnci/90.17.1292; Ellis MJ, 2011, J CLIN ONCOL, V29, P2342, DOI 10.1200/JCO.2010.31.6950; Suzuki R, 2009, INT J CANCER, V124, P698, DOI 10.1002/ijc.23943; Suzuki R, 2011, INT J CANCER, V129, P1214, DOI 10.1002/ijc.25744; Yang XR, 2011, J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526; Gunter MJ, 2009, J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Nishimura R, 2008, BREAST CANCER-TOKYO, V15, P303, DOI 10.1007/s12282-008-0042-3; Creighton Chad J, 2012, Biologics, V6, P289, DOI 10.2147/BTT.S29923; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Harvie M, 2003, Obes Rev, V4, P157, DOI 10.1046/j.1467-789X.2003.00108.x; Ma HY, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1512; Murase K, 2014, BREAST CANCER-TOKYO, V21, P52, DOI 10.1007/s12282-012-0348-z; Ritte R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3186; Thomas HV, 1997, BRIT J CANCER, V75, P1075, DOI 10.1038/bjc.1997.183; Toi M, 2011, CANCER SCI, V102, P858, DOI 10.1111/j.1349-7006.2011.01867.x; TONIOLO PG, 1995, J NATL CANCER I, V87, P190, DOI 10.1093/jnci/87.3.190	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JUL	2015	22	4					399	405		10.1007/s12282-013-0493-z		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CL4SO	WOS:000356944600010		
J	Onoda, T; Yamauchi, H; Yagata, H; Tsugawa, K; Hayashi, N; Yoshida, A; Suzuki, K; Sakurai, O; Nakamura, S				Onoda, Toshinao; Yamauchi, Hideko; Yagata, Hiroshi; Tsugawa, Koichiro; Hayashi, Naoki; Yoshida, Atsushi; Suzuki, Koyu; Sakurai, Osamu; Nakamura, Seigo			The value of progesterone receptor expression in predicting the Recurrence Score for hormone-receptor positive invasive breast cancer patients	BREAST CANCER			English	Article						Breast cancer; OncotypeDX; Progesterone receptor; Nuclear grade; Ki-67	INTERNATIONAL EXPERT CONSENSUS; PRIMARY THERAPY; ESTROGEN-RECEPTOR; GENE-EXPRESSION; HIGHLIGHTS; SUBTYPES; RISK; MARKERS; WOMEN; KI67	Background OncotypeDX (R) (ODX) is a well-validated assay for breast cancer treatment planning. We explored whether the conventional pathological factors could pick up high risk patients without the help of the ODX. Methods The ODX was performed on 139 hormone receptor-positive invasive breast cancers in a single Japanese institution. The recurrence risk was compared between the ODX and the St. Gallen Consensuses. The correlations were analyzed between the Recurrence Score (RS) measured by ODX and the pathological factors. In addition, we performed a follow-up survey and examined the association of the RS with the confirmed recurrence or death. Results The ODX classified 68 (49 %) as low RS, 52 (37 %) as intermediate RS, and 19 (14 %) as high RS cases. Correlations were noted between RS and progesterone receptor (PR) (r = -0.53), Ki-67 (r = 0.42), and nuclear grade (NG) (r = 0.41). None had a high RS with PR(3+) or NG1. Only one high RS patient had a Ki-67 (<20 %). The combinations of high RS with PR(0)/Ki-67 (>= 20 %) and PR(1+)/Ki-67 (>= 20 %) were 70 and 58 %, respectively. The combinations with high RS and PR(0)/NG3, PR(0)/NG2, and PR(1+)/NG3 were 83, 75, and 75 %, respectively. The median follow-up was 39.1 months (range 24.0-67.8). There were one low RS (1 %), four intermediate RS (8 %), and three high RS patients (16 %) who developed local or distant recurrence. Conclusion Hormone receptor-positive invasive breast cancers are stratified with the combinations of PR/Ki-67 or PR/NG. Some of the high recurrence risk cases might be identified without the ODX.	[Onoda, Toshinao; Yamauchi, Hideko; Yagata, Hiroshi; Hayashi, Naoki; Yoshida, Atsushi] St Lukes Int Hosp, Breast Surg Oncol, Tokyo, Japan; [Onoda, Toshinao; Nakamura, Seigo] Showa Univ, Breast Ctr, Tokyo, Japan; [Onoda, Toshinao; Sakurai, Osamu] Yokohama Asahi Cent Gen Hosp, Breast Surg, Yokohama, Kanagawa, Japan; [Tsugawa, Koichiro] St Marianna Sch Med, Breast & Endocrine Surg, Kawasaki, Kanagawa, Japan; [Suzuki, Koyu] St Lukes Int Hosp, Pathol Diag, Tokyo, Japan	Onoda, T (reprint author), Yokohama Asahi Cent Gen Hosp, Breast Surg, Yokohama, Kanagawa, Japan.	onodato@gmail.com					Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Cheang MCU, 2009, J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Cui XJ, 2005, J CLIN ONCOL, V23, P7721, DOI 10.1200/JCO.2005.09.004; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Ingoldsby H, 2013, BREAST, V22, P879, DOI 10.1016/j.breast.2013.04.008; Cancello G, 2013, ANN ONCOL, V24, P661, DOI 10.1093/annonc/mds430; Klein ME, 2012, MODERN PATHOL, V26, P658; Kurebayashi J, 2014, BREAST CANCER-TOKYO, V21, P214, DOI 10.1007/s12282-012-0380-z; National Comprehensive Cancer Network (NCCN), 2011, BREAST CANC, VBINV1-14	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JUL	2015	22	4					406	412		10.1007/s12282-013-0495-x		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CL4SO	WOS:000356944600011		
J	Saimura, M; Anan, K; Mitsuyama, S; Ono, M; Toyoshima, S				Saimura, Michiyo; Anan, Keisei; Mitsuyama, Shoshu; Ono, Minoru; Toyoshima, Satoshi			Ductal carcinoma in situ arising in tubular adenoma of the breast	BREAST CANCER			English	Article						Tubular adenoma; Ductal carcinoma in situ; Breast carcinoma		We herein report an extremely rare case of ductal carcinoma in situ (DCIS) arising in tubular adenoma of the breast. A 33-year-old female first noticed a mass in her right breast when she was 15 years old. The tumor had not changed in size subjectively for 18 years. She finally visited the hospital one and a half years before this presentation for an examination of her breast mass. Ultrasonography (US) showed a circumscribed mass suggesting a benign tumor, and mammography (MMG) revealed the well-defined high-density mass with a focal region of microcalcification. It was suspected to be adenosis based on a core-needle biopsy (CNB). During the regular follow-up, the microcalcification in the mass increased. She was therefore referred to our hospital for further examination. US and MMG showed a well-demarcated mass with a focal microcalcified area. US-guided CNB diagnosed it as DCIS with tubular adenoma. The patient underwent tumorectomy. Histologically, the tumor was diagnosed to be DCIS in tubular adenoma with negative surgical margins.	[Saimura, Michiyo; Anan, Keisei; Mitsuyama, Shoshu] Kitakyushu Municipal Med Ctr, Dept Surg, Kokurakita Ku, Kitakyushu, Fukuoka 8020077, Japan; [Ono, Minoru] Kitakyushu Municipal Med Ctr, Dept Radiol, Kokurakita Ku, Kitakyushu, Fukuoka 8020077, Japan; [Toyoshima, Satoshi] Kitakyushu Municipal Med Ctr, Dept Pathol, Kokurakita Ku, Kitakyushu, Fukuoka 8020077, Japan	Saimura, M (reprint author), Kitakyushu Municipal Med Ctr, Dept Surg, Kokurakita Ku, 2-1-1 Bashaku, Kitakyushu, Fukuoka 8020077, Japan.	msaimura@med.kyushu-u.ac.jp					Bellocq JP, 2003, WHO CLASSIFICATION T, P84; CASE TC, 1977, NEW YORK STATE J MED, V77, P2122; Domoto H, 2002, PATHOL INT, V52, P244, DOI 10.1046/j.1440-1827.2002.01338.x; HERTEL BF, 1976, CANCER, V37, P2891, DOI 10.1002/1097-0142(197606)37:6<2891::AID-CNCR2820370647>3.0.CO;2-P; HILL RP, 1954, CANCER, V7, P318, DOI 10.1002/1097-0142(195403)7:2<318::AID-CNCR2820070216>3.0.CO;2-L; NIELSEN BB, 1987, HISTOPATHOLOGY, V11, P1259, DOI 10.1111/j.1365-2559.1987.tb01871.x; PERSAUD V, 1968, ARCH PATHOL, V86, P481; Rosen PP, 1992, ATLAS TUMOR PATHOL, V7, P67	8	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JUL	2015	22	4					428	431		10.1007/s12282-012-0375-9		4	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CL4SO	WOS:000356944600015		
J	Amano, M; Ogura, K; Ozaki, Y; Tamai, M; Kitabatake, T; Fujisawa, M; Kojima, K				Amano, Maki; Ogura, Kanako; Ozaki, Yutaka; Tamai, Mitsukuni; Kitabatake, Toshiaki; Fujisawa, Minoru; Kojima, Kuniaki			Two cases of primary small cell carcinoma of the breast showing non-mass-like pattern on diagnostic imaging and histopathology	BREAST CANCER			English	Article						Small cell carcinoma; Breast; Mammography; CT; MRI	IN-SITU	Primary small cell carcinoma of the breast is a rare breast cancer. We report two cases of this entity showing a non-mass-like pattern on multimodality images and histopathology. Both women presented with a breast mass, and one had axillary lymphadenopathy. Both cases revealed fine calcification on mammography (MMG) and an irregularly shaped, hypoechoic lesion on ultrasonography. Computed tomography (CT) and magnetic resonance imaging (MRI) showed non-mass-like enhancement in both cases. Dynamic MRI showed medium initial enhancement followed by persistent delayed enhancement in one patient, whereas rapid initial enhancement with plateau delayed enhancement was observed in the other. The breast lesions showed very high signal intensity on diffusion-weighted MRI. Positron emission tomography showed moderate accumulation of 2-fluoro-2-deoxyglucose in the breast tumor and lymph node metastasis. The non-mass-like enhancement on CT and MRI and the segmental fine calcification on MMG indicate the abundance of components of ductal carcinoma in situ and the breast origin of the small cell carcinoma.	[Amano, Maki; Ozaki, Yutaka; Tamai, Mitsukuni] Juntendo Nerima Hosp, Dept Radiol, Nerima ku, Tokyo 1770033, Japan; [Ogura, Kanako] Juntendo Nerima Hosp, Dept Pathol, Tokyo, Japan; [Kitabatake, Toshiaki; Fujisawa, Minoru; Kojima, Kuniaki] Juntendo Nerima Hosp, Dept Surg, Tokyo, Japan	Amano, M (reprint author), Juntendo Nerima Hosp, Dept Radiol, Nerima ku, 3-1-10 Takanodai, Tokyo 1770033, Japan.	ma-amano@mbj.nifty.com					An JK, 2012, J KOREAN SURG SOC, V82, P116, DOI 10.4174/jkss.2012.82.2.116; Woodhams R, 2011, RADIOGRAPHICS, V31, P1059, DOI 10.1148/rg.314105160; Rosen EL, 2007, BREAST J, V13, P545, DOI 10.1111/j.1524-4741.2007.00513.x; Christie M, 2010, INT J CLIN EXP PATHO, V3, P629; Kanat O, 2011, TUMORI, V97, P473, DOI 10.1700/950.10400; Kitakata Hidekazu, 2007, Breast Cancer, V14, P414, DOI 10.2325/jbcs.14.414; Mariscal A, 2004, AM J ROENTGENOL, V183, P1169; Tavassoli FA, 2003, WHO CLASSIFICATION T, P10; WADE PM, 1983, CANCER, V52, P121, DOI 10.1002/1097-0142(19830701)52:1<121::AID-CNCR2820520122>3.0.CO;2-F; Yamada T, 2010, RADIOGRAPHICS, V30, P1183, DOI 10.1148/rg.305095073	10	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JUL	2015	22	4					437	441		10.1007/s12282-012-0397-3		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CL4SO	WOS:000356944600017		
J	Jung, JH; Yun, M; Choo, EJ; Kim, SH; Jeong, MS; Jung, DB; Lee, H; Kim, EO; Kato, N; Kim, B; Srivastava, SK; Kaihatsu, K; Kim, SH				Jung, Ji Hoon; Yun, Miyong; Choo, Eun-Jeong; Kim, Sun-Hee; Jeong, Myoung-Seok; Jung, Deok-Beom; Lee, Hyemin; Kim, Eun-Ok; Kato, Nobuo; Kim, Bonglee; Srivastava, Sanjay K.; Kaihatsu, Kunihiro; Kim, Sung-Hoon			A derivative of epigallocatechin-3-gallate induces apoptosis via SHP-1-mediated suppression of BCR-ABL and STAT3 signalling in chronic myelogenous leukaemia	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							CHRONIC MYELOID-LEUKEMIA; PROTEIN-TYROSINE-PHOSPHATASE; PERIPHERAL-BLOOD CELLS; LUNG-CANCER CELLS; GREEN TEA; GENE-EXPRESSION; IN-VIVO; CONSTITUTIVE ACTIVATION; KINASE INHIBITORS; ARRIVE GUIDELINES	Background and PurposeEpigallocatechin-3-gallate (EGCG) is a component of green tea known to have chemo-preventative effects on several cancers. However, EGCG has limited clinical application, which necessitates the development of a more effective EGCG prodrug as an anticancer agent. Experimental ApproachDerivatives of EGCG were evaluated for their stability and anti-tumour activity in human chronic myeloid leukaemia (CML) K562 and KBM5 cells. Key ResultsEGCG-mono-palmitate (EGCG-MP) showed most prolonged stability compared with other EGCG derivatives. EGCG-MP exerted greater cytotoxicity and apoptosis in K562 and KBM5 cells than the other EGCG derivatives. EGCG-MP induced Src-homology 2 domain-containing tyrosine phosphatase 1 (SHP-1) leading decreased oncogenic protein BCR-ABL and STAT3 phosphorylation in CML cells, compared with treatment with EGCG. Furthermore, EGCG-MP reduced phosphorylation of STAT3 and survival genes in K562 cells, compared with EGCG. Conversely, depletion of SHP-1 or application of the tyrosine phosphatase inhibitor pervanadate blocked the ability of EGCG-MP to suppress phosphorylation of BCR-ABL and STAT3, and the expression of survival genes downstream of STAT3. In addition, EGCG-MP treatment more effectively suppressed tumour growth in BALB/c athymic nude mice compared with untreated controls or EGCG treatment. Immunohistochemistry revealed increased caspase 3 and SHP-1 activity and decreased phosphorylation of BCR-ABL in the EGCG-MP-treated group relative to that in the EGCG-treated group. Conclusions and ImplicationsEGCG-MP induced SHP-1-mediated inhibition of BCR-ABL and STAT3 signalling in vitro and in vivo more effectively than EGCG. This derivative may be a potent chemotherapeutic agent for CML treatment.	[Jung, Ji Hoon; Yun, Miyong; Choo, Eun-Jeong; Kim, Sun-Hee; Jeong, Myoung-Seok; Jung, Deok-Beom; Lee, Hyemin; Kim, Eun-Ok; Kim, Bonglee; Kim, Sung-Hoon] Kyung Hee Univ, Coll Korean Med, Seoul 131701, South Korea; [Kato, Nobuo; Kaihatsu, Kunihiro] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan; [Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX USA; [Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Amarillo, TX USA	Kim, SH (reprint author), Kyung Hee Univ, Coll Korean Med, Canc Prevent Mat Dev Res Ctr, 1 Hoegi Dong, Seoul 131701, South Korea.	kunihiro@sanken.osaka-u.ac.jp; sungkim7@khu.ac.kr					Ahn WS, 2003, DNA CELL BIOL, V22, P217, DOI 10.1089/104454903321655846; Amin HM, 2007, J PATHOL, V212, P402, DOI 10.1002/path.2178; Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025; Volpe G, 2009, CANCER LETT, V274, P1, DOI 10.1016/j.canlet.2008.06.003; Lee YH, 2012, INT J MOL MED, V30, P69, DOI 10.3892/ijmm.2012.966; Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Paulson RF, 1996, NAT GENET, V13, P309, DOI 10.1038/ng0796-309; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1797, DOI 10.1111/bph.12451; Peairs A, 2010, CELL MOL IMMUNOL, V7, P123, DOI 10.1038/cmi.2010.1; Davenport A, 2010, INT J MOL MED, V25, P465, DOI 10.3892/ijmm_00000366; Matsumura K, 2008, BIOCHEM BIOPH RES CO, V377, P1118, DOI 10.1016/j.bbrc.2008.10.128; Wang Y, 2013, ONCOL REP, V30, P2691, DOI 10.3892/or.2013.2743; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Coppo P, 2006, BRIT J HAEMATOL, V134, P171, DOI 10.1111/j.1365-2141.2006.06161.x; Gupta S, 2004, ONCOGENE, V23, P2507, DOI 10.1038/sj.onc.1207353; Milligan SA, 2009, CLIN CANCER RES, V15, P4885, DOI 10.1158/1078-0432.CCR-09-0109; Siddiqui IA, 2011, FASEB J, V25, P1198, DOI 10.1096/fj.10-167924; Burthem J, 2007, LEUKEMIA, V21, P1708, DOI 10.1038/sj.leu.2404762; Chai SK, 1997, J IMMUNOL, V159, P4720; Shimizu M, 2005, BIOCHEM BIOPH RES CO, V334, P947, DOI 10.1016/j.bbrc.2005.06.182; Han Y, 2006, LEUKEMIA, V20, P1602, DOI 10.1038/sj.leu.2404323; Jiao HY, 1996, MOL CELL BIOL, V16, P6985; Wang H, 2011, CARCINOGENESIS, V32, P1881, DOI 10.1093/carcin/bgr218; Masuda M, 2001, CLIN CANCER RES, V7, P4220; Agarwal A, 2012, BLOOD, V120, P2658, DOI 10.1182/blood-2011-05-355396; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Lee YK, 2004, BLOOD, V104, P788, DOI 10.1182/blood-2003-08-2763; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Mereles D, 2011, INT J MOL SCI, V12, P5592, DOI 10.3390/ijms12095592; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Han YJ, 2006, BLOOD, V108, P2796, DOI 10.1182/blood-2006-04-017434; Banetjee M. S., 2010, PLOS ONE, V5, pe8719; Bruecher-Encke B, 2001, LEUKEMIA, V15, P1424, DOI 10.1038/sj.leu.2402214; Chassot AA, 2008, CELL CYCLE, V7, P2038, DOI 10.4161/cc.7.13.6233; Chen J, 2007, BLOOD, V109, P778, DOI 10.1182/blood-2006-04-019141; Druker BJ, 2002, ONCOGENE, V21, P8541, DOI 10.1038/sj.onc.1206081; Faber E, 2006, LEUKEMIA LYMPHOMA, V47, P1082, DOI 10.1080/10428190600565057; GouilleuxGruart V, 1996, BLOOD, V87, P1692; Hai Abdul, 2014, Bioinformation, V10, P108, DOI 10.6026/97320630010108; Hu JH, 2009, J AGR FOOD CHEM, V57, P1349, DOI 10.1021/jf803143n; Jabbour E, 2010, SEMIN HEMATOL, V47, P344, DOI 10.1053/j.seminhematol.2010.06.002; Liedtke M, 1998, ONCOGENE, V17, P1889, DOI 10.1038/sj.onc.1202117; Lim YM, 2000, P NATL ACAD SCI USA, V97, P12233, DOI 10.1073/pnas.210253497; Lin YH, 2011, LIFE SCI, V89, P886, DOI 10.1016/j.lfs.2011.09.011; Liu LC, 2012, J AGR FOOD CHEM, V60, P9863, DOI 10.1021/jf303690x; Lung HL, 2002, LIFE SCI, V72, P257, DOI 10.1016/S0024-3205(02)02236-1; Ma YC, 2014, ONCOL REP, V31, P1343, DOI 10.3892/or.2013.2933; Murray-Rust P, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-44; Nair Rajesh R, 2012, Front Oncol, V2, P30, DOI 10.3389/fonc.2012.00030; Nixon C, 2005, CANCER LETT, V221, P237, DOI 10.1016/j.canlet.2004.08.039; Radujkovic A, 2006, ANTICANCER RES, V26, P2169; Rangatia J, 2006, LEUKEMIA, V20, P68, DOI 10.1038/sj.leu.2403999; Sayed D, 2014, LEUKEMIA RES, V38, P243, DOI 10.1016/j.leukres.2013.11.012; Sen T, 2011, EUR J NUTR, V50, P465, DOI 10.1007/s00394-010-0158-z; Tanaka T, 1998, BIOORG MED CHEM LETT, V8, P1801, DOI 10.1016/S0960-894X(98)00311-4; Tang SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031067; Tauchi T, 1997, INT J ONCOL, V11, P471; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; Tossidou I, 2008, CELL CYCLE, V7, P3858, DOI 10.4161/cc.7.24.7260; Viallard J F, 2001, Cancer Radiother, V5, P109, DOI 10.1016/S1278-3218(01)00087-7; Walz C, 2006, CRIT REV ONCOL HEMAT, V57, P145, DOI 10.1016/j.critrevonc.2005.06.007; Zhu Xu-zhen, 2005, Zhonghua Yi Xue Za Zhi, V85, P1903	64	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	JUL	2015	172	14			SI		3565	3578		10.1111/bph.13146		14	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CL5CB	WOS:000356976300009		
J	Kimura, T; Kohno, T; Nakajima, K; Kashimura, S; Katsumata, Y; Nishiyama, T; Nishiyama, N; Tanimoto, Y; Aizawa, Y; Fukuda, K; Takatsuki, S				Kimura, Takehiro; Kohno, Takashi; Nakajima, Kazuaki; Kashimura, Shin; Katsumata, Yoshinori; Nishiyama, Takahiko; Nishiyama, Nobuhiro; Tanimoto, Yoko; Aizawa, Yoshiyasu; Fukuda, Keiichi; Takatsuki, Seiji			Effect of Nocturnal Intermittent Hypoxia on Left Atrial Appendage Flow Velocity in Atrial Fibrillation	CANADIAN JOURNAL OF CARDIOLOGY			English	Article							OBSTRUCTIVE SLEEP-APNEA; POSITIVE AIRWAY PRESSURE; CATHETER ABLATION; THROMBOEMBOLIC RISK; PREDICTING STROKE; ISCHEMIC-STROKE; HEART HEALTH; RECURRENCE; ASSOCIATION; DISEASE	Background: The mechanism underlying the associations of sleep-disordered breathing (SDB) with stroke and atrial fibrillation (AF) is not well established. We explored the relationship between nocturnal intermittent hypoxia, a marker of SDB, and left atrial (LA)/LA appendage (LAA) function among AF patients. Methods: We evaluated 134 consecutive AF candidates for catheter ablation (age, 59.6 +/- 9.4 years; body mass index [BMI], 24.8 +/- 3.2; Congestive Heart Failure, Hypertension, Age (>= 75 years), Diabetes, Stroke/Transient Ischemic Attack, Vascular Disease, Age (65-74 years), Sex (Female) (CHA(2)DS(2)-VASc) score, 1.2 +/- 1.1, paroxysmal AF, n = 83) using nocturnal pulse oximetry, a noninvasive screening method for nocturnal intermittent hypoxia. Based on 3% oxygen desaturation index (3% ODI), patients were divided into nocturnal intermittent hypoxia (3% ODI > 15; n = 32) and control groups (3% ODI <= 15; n = 102). Results: The nocturnal intermittent hypoxia group demonstrated significantly higher weight, BMI, Congestive Heart Failure, Hypertension, Age, Diabetes, Stroke/Transient Ischemic Attack (CHADS(2)) and CHA(2)DS(2)-VASc scores, serum hemoglobin A1c and plasma brain natriuretic peptide levels, LA size, and prevalence of hypertension, vascular disease, and sick sinus syndrome. Echocardiographically, nocturnal intermittent hypoxia was associated with a higher grade of spontaneous echo contrast and low LAA flow velocity. Multiple regression analysis adjusted for type of AF, CHA(2)DS(2)-VASc score, BMI, plasma brain natriuretic peptide level, LA size, and rhythm on echocardiography revealed that 3% ODI was a factor independently associated with LAA flow velocity (beta = -0.184; 95% confidence interval, -0.818 to -0.006). Conclusions: Nocturnal intermittent hypoxia was an independent determinant for low LAA flow velocity in patients with AF, suggesting that the connection between SDB and LAA function might underlie the association of AF with stroke.	[Kimura, Takehiro; Kohno, Takashi; Nakajima, Kazuaki; Kashimura, Shin; Katsumata, Yoshinori; Nishiyama, Takahiko; Nishiyama, Nobuhiro; Tanimoto, Yoko; Aizawa, Yoshiyasu; Fukuda, Keiichi; Takatsuki, Seiji] Keio Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 1608582, Japan	Kohno, T (reprint author), Keio Univ, Sch Med, Dept Med, Div Cardiol,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	kohno.a2@keio.jp					Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Fein AS, 2013, J AM COLL CARDIOL, V62, P300, DOI 10.1016/j.jacc.2013.03.052; Naruse Y, 2013, HEART RHYTHM, V10, P331, DOI 10.1016/j.hrthm.2012.11.015; Vazquez JC, 2000, THORAX, V55, P302, DOI 10.1136/thorax.55.4.302; Kim SM, 2012, J CARDIOL, V60, P475, DOI 10.1016/j.jjcc.2012.07.007; Iwasaki Y, 2012, HEART RHYTHM, V9, P1409, DOI 10.1016/j.hrthm.2012.03.024; Linz D, 2011, HEART RHYTHM, V8, P1436, DOI 10.1016/j.hrthm.2011.03.053; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Munoz R, 2006, STROKE, V37, P2317, DOI 10.1161/01.STR.0000236560.15735.0f; Ng CY, 2011, AM J CARDIOL, V108, P47, DOI 10.1016/j.amjcard.2011.02.343; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Kanagala R, 2003, CIRCULATION, V107, P2589, DOI 10.1161/01.CIR.0000068337.25994.21; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Patel D, 2010, CIRC-ARRHYTHMIA ELEC, V3, P445, DOI 10.1161/CIRCEP.109.858381; Dimitri H, 2012, HEART RHYTHM, V9, P321, DOI 10.1016/j.hrthm.2011.10.017; GUILLEMINAULT C, 1983, AM J CARDIOL, V52, P490, DOI 10.1016/0002-9149(83)90013-9; Bassetti C, 1999, SLEEP, V22, P217; Goldman ME, 1999, J AM SOC ECHOCARDIOG, V12, P1080, DOI 10.1016/S0894-7317(99)70105-7; FATKIN D, 1994, J AM COLL CARDIOL, V23, P961; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893; Gami AS, 2004, CIRCULATION, V110, P364, DOI 10.1161/01.CIR.0000136587.68725.8E; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; Somers VK, 2008, CIRCULATION, V118, P1080, DOI 10.1161/CIRCULATIONAHA.107.189375; Muraki I, 2010, DIABETOLOGIA, V53, P481, DOI 10.1007/s00125-009-1616-0; WOLF PA, 1991, STROKE, V22, P983; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; DANIEL WG, 1988, J AM COLL CARDIOL, V11, P1204; Drager LF, 2010, INT J CARDIOL, V144, P257, DOI 10.1016/j.ijcard.2009.01.018; Iwasaki YK, 2014, J AM COLL CARDIOL, V64, P2013, DOI 10.1016/j.jacc.2014.05.077; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022; Li Li, 2014, Europace, V16, P1309, DOI 10.1093/europace/euu066; Nakamata M, 2003, J JAP SOC RESP CARE, V12, P401; Shibazaki K, 2013, EUR J NEUROL, V20, P266, DOI 10.1111/j.1468-1331.2012.03837.x; Tanigawa Takeshi, 2011, EPMA J, V2, P83, DOI 10.1007/s13167-011-0073-2; Tanigawa T, 2004, JAMA-J AM MED ASSOC, V292, P923, DOI 10.1001/jama.292.8.923-b; Valenza MC, 2014, INT J CARDIOL, V174, P73, DOI 10.1016/j.ijcard.2014.03.156	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0828-282X	1916-7075		CAN J CARDIOL	Can. J. Cardiol.	JUL	2015	31	7					846	852		10.1016/j.cjca.2014.12.032		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL2JC	WOS:000356768600005		
J	Nakae, Y; Oka, Y; Fujiki, F; Morimoto, S; Kamiya, T; Takashima, S; Nakata, J; Nishida, S; Nakajima, H; Hosen, N; Tsuboi, A; Kyo, T; Oji, Y; Mizuguchi, K; Kumanogoh, A; Sugiyama, H				Nakae, Yoshiki; Oka, Yoshihiro; Fujiki, Fumihiro; Morimoto, Soyoko; Kamiya, Toshio; Takashima, Satoshi; Nakata, Jun; Nishida, Sumiyuki; Nakajima, Hiroko; Hosen, Naoki; Tsuboi, Akihiro; Kyo, Taiichi; Oji, Yusuke; Mizuguchi, Kenji; Kumanogoh, Atsushi; Sugiyama, Haruo			Two distinct effector memory cell populations of WT1 (Wilms' tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients	CANCER IMMUNOLOGY IMMUNOTHERAPY			English	Article						WT1; CTL; Single-cell; Gene-expression profiles	PEPTIDE-BASED IMMUNOTHERAPY; MINIMAL RESIDUAL DISEASE; TUMOR SUPPRESSOR GENE; REAL-TIME PCR; WILMS-TUMOR; IMMUNOHISTOCHEMICAL DETECTION; CANCER; VACCINATION; EXPRESSION; PHASE	Wilms' tumor gene 1 (WT1) protein is a promising tumor-associated antigen for cancer immunotherapy. We have been performing WT1 peptide vaccination with good clinical responses in over 750 patients with leukemia or solid cancers. In this study, we generated single-cell gene-expression profiles of the effector memory (EM) subset of WT1-specific cytotoxic T lymphocytes (CTLs) in peripheral blood of nine acute myeloid leukemia patients treated with WT1 peptide vaccine, in order to discriminate responders (WT1 mRNA levels in peripheral blood decreased to undetectable levels, decreased but stayed at abnormal levels, were stable at undetectable levels, or remained unchanged from the initial abnormal levels more than 6 months after WT1 vaccination) from non-responders (leukemic blast cells and/or WT1 mRNA levels increased relative to the initial state within 6 months of WT1 vaccination) prior to WT1 vaccination. Cluster and principal component analyses performed using 83 genes did not discriminate between responders and non-responders prior to WT1 vaccination. However, these analyses revealed that EM subset of WT1-specific CTLs could be divided into two groups: the "activated" and "quiescent" states; in responders, EM subset of the CTLs shifted to the "quiescent" state, whereas in non-responders, those shifted to the "activated" state following WT1 vaccination. These results demonstrate for the first time the existence of two distinct EM states, each of which was characteristic of responders or non-responders, of WT1-specific CTLs in AML patients, and raises the possibility of using advanced gene-expression profile analysis to clearly discriminate between responders and non-responders prior to WT1 vaccination.	[Nakae, Yoshiki; Oka, Yoshihiro; Takashima, Satoshi; Nishida, Sumiyuki; Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med, Suita, Osaka 5650871, Japan; [Nakae, Yoshiki; Oka, Yoshihiro; Takashima, Satoshi; Nishida, Sumiyuki; Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Allergy, Suita, Osaka 5650871, Japan; [Nakae, Yoshiki; Oka, Yoshihiro; Takashima, Satoshi; Nishida, Sumiyuki; Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Rheumat Dis, Suita, Osaka 5650871, Japan; [Oka, Yoshihiro; Fujiki, Fumihiro; Morimoto, Soyoko; Nakajima, Hiroko] Osaka Univ, Grad Sch Med, Dept Canc Immunol, Suita, Osaka 5650871, Japan; [Oka, Yoshihiro; Kumanogoh, Atsushi] Osaka Univ, Immunol Frontier Res Ctr, Dept Immunopathol, Suita, Osaka 5650871, Japan; [Nakata, Jun; Tsuboi, Akihiro] Osaka Univ, Grad Sch Med, Dept Canc Immunotherapy, Suita, Osaka 5650871, Japan; [Hosen, Naoki; Oji, Yusuke] Osaka Univ, Grad Sch Med, Dept Canc Stem Cell Biol, Suita, Osaka 5650871, Japan; [Kyo, Taiichi] Hiroshima Red Cross & Atom Bomb Survivor Hosp, Dept Hematol, Naka Ku, Hiroshima, Hiroshima 7300052, Japan; [Mizuguchi, Kenji] Natl Inst Biomed Innovat, Osaka 5670085, Japan; [Kamiya, Toshio; Sugiyama, Haruo] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Suita, Osaka 5650871, Japan	Sugiyama, H (reprint author), Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	sugiyama@sahs.med.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Science, Sports, Culture and Technology; Ministry of Health, Labour and Welfare of Japan [24591164, 25830116, 25430186, 25293079]; Otsuka Pharmaceutical Co., Ltd.	The authors thank the nursing teams for their care of the patients in this study and Ms. Tomoe Umeda for coordination of clinical research. This study was partially supported by the Japan Society for the Promotion of Science (JSPS) through grants for Scientific Research, and Grants-in-Aid for Young Scientists from the Ministry of Education, Science, Sports, Culture and Technology and the Ministry of Health, Labour and Welfare of Japan (Grant Nos. 24591164, 25830116, 25430186 and 25293079). The Department of Cancer Immunology is a department in collaboration with Otsuka Pharmaceutical Co., Ltd., and is supported with a grant from the company. The company had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Takahara A, 2011, CANCER IMMUNOL IMMUN, V60, P1289, DOI 10.1007/s00262-011-1033-3; Narita M, 2010, INT J MED SCI, V7, P72; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Morita S, 2006, JPN J CLIN ONCOL, V36, P231, DOI 10.1093/jjco/hyl005; Livak KJ, 2013, METHODS, V59, P71, DOI 10.1016/j.ymeth.2012.10.004; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Nishida S, 2014, J IMMUNOTHER, V37, P105, DOI 10.1097/CJI.0000000000000020; Chiba Y, 2010, JPN J CLIN ONCOL, V40, P395, DOI 10.1093/jjco/hyp196; Sanchez-Freire V, 2012, NAT PROTOC, V7, P829, DOI 10.1038/nprot.2012.021; Nakatsuka S, 2006, MODERN PATHOL, V19, P804, DOI 10.1038/modpathol.3800588; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Ren T, 2012, J BIOL CHEM, V287, P34683, DOI 10.1074/jbc.M112.377143; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Van Tendeloo VF, 2010, P NATL ACAD SCI USA, V107, P13824, DOI 10.1073/pnas.1008051107; Van Driessche A, 2012, ONCOLOGIST, V17, P250, DOI 10.1634/theoncologist.2011-0240; Izumoto S, 2008, J NEUROSURG, V108, P963, DOI 10.3171/JNS/2008/108/5/0963; Maslak PG, 2010, BLOOD, V116, P171, DOI 10.1182/blood-2009-10-250993; Tsuboi A, 2007, INT J HEMATOL, V86, P414, DOI 10.1532/IJH97.07007; Nishioka M, 2012, EUR J DERMATOL, V22, P258, DOI 10.1684/ejd.2011.1619; Sugiyama H, 2010, JPN J CLIN ONCOL, V40, P377, DOI 10.1093/jjco/hyp194; Stahlberg A, 2010, METHODS, V50, P282, DOI 10.1016/j.ymeth.2010.01.002; Hashii Y, 2012, LEUKEMIA, V26, P530, DOI 10.1038/leu.2011.226; HEWITT SM, 1995, CANCER RES, V55, P5386; Sugiyama H, 2001, INT J HEMATOL, V73, P177, DOI 10.1007/BF02981935; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Kim J, 1999, MOL CELL BIOL, V19, P2289; Sasabe E, 2011, ORAL ONCOL, V47, P77, DOI 10.1016/j.oraloncology.2010.10.007; Oka Y, 2008, CURR OPIN IMMUNOL, V20, P211, DOI 10.1016/j.coi.2008.04.009; Buchholz VR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00031; Chen YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017844; Chiba Y, 2010, BRAIN TUMOR PATHOL, V27, P29, DOI 10.1007/s10014-010-0265-9; Citri A, 2011, NAT PROTOC, V7, P118; Dohi S, 2011, ANTICANCER RES, V31, P2441; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; Faint JM, 2001, J IMMUNOL, V167, P212; Hashii Y, 2010, PEDIATR BLOOD CANCER, V55, P352, DOI 10.1002/pbc.22522; Hashimoto Naoya, 2009, Brain and Nerve (Tokyo), V61, P805; Kawakami M, 2007, INT J HEMATOL, V85, P426, DOI 10.1532/IJH97.06194; Miyatake T, 2013, J CANCER RES CLIN, V139, P457, DOI 10.1007/s00432-012-1348-2; Ohno S, 2009, ANTICANCER RES, V29, P1691; Ohno S, 2009, ANTICANCER RES, V29, P4779; Ohta H, 2009, PEDIATR HEMAT ONCOL, V26, P74, DOI 10.1080/08880010802435500; Oji Y, 2010, EUR J HAEMATOL, V85, P358, DOI 10.1111/j.1600-0609.2010.01497.x; Oka Y, 2003, INT J HEMATOL, V78, P56, DOI 10.1007/BF02983241; Shirakata T, 2012, ANTICANCER RES, V32, P1081; Tomiyama H, 2002, J IMMUNOL, V168, P5538; Tsuboi A, 2012, LEUKEMIA, V26, P1410, DOI 10.1038/leu.2011.343; Tsuboi A, 2004, MICROBIOL IMMUNOL, V48, P175; Watanabe R, 2014, EUR J IMMUNOL, V44, P2508, DOI 10.1002/eji.201344248	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7004	1432-0851		CANCER IMMUNOL IMMUN	Cancer Immunol. Immunother.	JUL	2015	64	7					791	804		10.1007/s00262-015-1683-7		14	Oncology; Immunology	Oncology; Immunology	CL3UB	WOS:000356875000001		
J	Ikeda, H; Shiku, H				Ikeda, Hiroaki; Shiku, Hiroshi			Adoptive immunotherapy of cancer utilizing genetically engineered lymphocytes	CANCER IMMUNOLOGY IMMUNOTHERAPY			English	Review						Adoptive cell therapy; Gene engineering; T cell receptor; Chimeric antigen receptor; Integrin; CIMT 2014	CHIMERIC ANTIGEN RECEPTOR; VERSUS-HOST-DISEASE; GENE-THERAPY; T-CELLS; MELANOMA; REGRESSION; TOXICITY; BIOLOGY	It is becoming increasingly clear that adoptive immunotherapy with genetically engineered T cells has the potential to control and even cure cancer in some patients. On the other hand, severe adverse events associated with efficacy have frequently been reported in clinical trials. Current and near-future challenges for the development of adoptive immunotherapy of cancer using genetically engineered T cells include minimization and prediction of adverse events; identification of new and effective targets, including patient-specific mutations; improvement in T cell functionality, persistence, and memory formation capacity; and utilization of allogeneic or cell line-based T cells.	[Ikeda, Hiroaki; Shiku, Hiroshi] Mie Univ, Grad Sch Med, Dept Immunogene Therapy, Tsu, Mie 5148507, Japan	Ikeda, H (reprint author), Mie Univ, Grad Sch Med, Dept Immunogene Therapy, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	hikeda@clin.medic.mie-u.ac.jp			Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT); Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan; Japan Agency for Medical Research and Development	This work was supported by a Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT); a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour, and Welfare of Japan, and Japan Agency for Medical Research and Development.	Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; ROSENBERG SA, 1993, J NATL CANCER I, V85, P622, DOI 10.1093/jnci/85.8.622; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Okamoto S, 2009, CANCER RES, V69, P9003, DOI 10.1158/0008-5472.CAN-09-1450; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Jenq RR, 2010, NAT REV CANCER, V10, P213, DOI 10.1038/nrc2804; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Hosoi H, 2014, EUR J IMMUNOL, V44, P1747, DOI 10.1002/eji.201343969; Kageyama S, 2015, CLIN CANCER RES, V21, P2268, DOI 10.1158/1078-0432.CCR-14-1559; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Shirakura Y, 2012, CANCER SCI, V103, P17, DOI 10.1111/j.1349-7006.2011.02111.x	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7004	1432-0851		CANCER IMMUNOL IMMUN	Cancer Immunol. Immunother.	JUL	2015	64	7					903	909		10.1007/s00262-015-1718-0		7	Oncology; Immunology	Oncology; Immunology	CL3UB	WOS:000356875000011		
J	Takeshita, M; Shinoda, N; Takashima, H; Kurita, A; Ando, H; Harada, K; Uetani, T; Gosho, M; Murohara, T; Amano, T				Takeshita, Masahiro; Shinoda, Norihiro; Takashima, Hiroaki; Kurita, Akiyoshi; Ando, Hirohiko; Harada, Ken; Uetani, Tadayuki; Gosho, Masahiko; Murohara, Toyoaki; Amano, Tetsuya			Noninvasive mathematical analysis of spectral electrocardiographic components for coronary lesions of intermediate to obstructive stenosis severity-relationship with classic and functional SYNTAX score	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						multifunction cardiogram; functional SYNTAX score; fractional flow reserve	ARTERY-DISEASE; RISK STRATIFICATION; MEDICAL THERAPY; INTERVENTION; REVASCULARIZATION; ANGIOGRAPHY; TRIAL; FLOW; MCG	ObjectivesThe aim of this study was to evaluate the relationship between the multifunction cardiogram (MCG), and SYNTAX score (SS) and functional SYNTAX score (FSS) in detecting the presence of intermediate to obstructive coronary lesions. BackgroundPerforming coronary angiography (CAG) and measuring fractional flow reserve (FFR) to calculate the SS and FSS is inherently invasive and adds complexity. MethodsThe MCG was obtained and analyzed before performing CAG in 87 consecutive subjects with suspected coronary artery disease who were scheduled for elective CAG. The patients were divided into three groups according to risk based on high, borderline, and low MCG scores. The SS was determined, as well as FSS but only by counting lesions prone to functional ischemia (FFR0.8). The relationship between the MCG and the SS and FSS was evaluated. ResultsThe MCG was the only test significantly associated with the SS (odds ratio, 2.92 [1.60 - 5.31], P<0.001) and FSS (odds ratio, 3.66 [1.95 - 6.87], P<0.001). A high MCG score had a specificity of 92.6% (89.0-96.2%) and 92.3% (89.0-95.6%), and a predictive accuracy of 72.4% (67.6-77.2%) and 82.8% (78.7-86.8%) for the prediction of SS and FSS, respectively. ConclusionsThe MCG showed high specificity and predictive accuracy especially for the FSS, suggesting that it is useful not only in identifying functionally significant ischemia but also in reducing unnecessary CAGs. (c) 2015 Wiley Periodicals, Inc.	[Takeshita, Masahiro; Takashima, Hiroaki; Kurita, Akiyoshi; Ando, Hirohiko; Amano, Tetsuya] Aichi Med Univ, Dept Cardiol, Nagakute, Aichi 4801195, Japan; [Shinoda, Norihiro; Harada, Ken; Uetani, Tadayuki] Chubu Rosai Hosp, Dept Cardiol, Nagoya, Aichi, Japan; [Gosho, Masahiko] Aichi Med Univ, Adv Med Res Ctr, Nagakute, Aichi 4801195, Japan; [Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Amano, T (reprint author), Aichi Med Univ, Dept Cardiol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	amanot@aichimed-u.ac.jp	Murohara, Toyoaki/M-4958-2014				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H, 1985, CELEBRATION STAT, P1; Amano T, 2014, OPEN HEART, V1; Strobeck JE, 2009, INT J MED SCI, V6, P143; Serruys PW, 2009, EUROINTERVENTION, V5, P50; Strobeck JE, 2011, INT J MED SCI, V8, P717; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Garg S, 2010, CIRC-CARDIOVASC INTE, V3, P317, DOI 10.1161/CIRCINTERVENTIONS.109.914051; PIJLS NHJ, 1993, CIRCULATION, V87, P1354; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Wykrzykowska JJ, 2010, J AM COLL CARDIOL, V56, P272, DOI 10.1016/j.jacc.2010.03.044; Nam CW, 2011, J AM COLL CARDIOL, V58, P1211, DOI 10.1016/j.jacc.2011.06.020; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Chen SL, 2010, JACC-CARDIOVASC INTE, V3, P632, DOI 10.1016/j.jcin.2010.04.006; DesBruyne B, 2012, NEW ENGL J MED, V367, P991, DOI DOI 10.1056/NEJMOA1205361]; Grube Eberhard, 2007, Int J Med Sci, V4, P249; Grube Eberhard, 2008, Int J Med Sci, V5, P50; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; vansGaal WJ, 2009, INT J CARDIOL, V135, P60; Weiss Melvin B, 2002, Heart Dis, V4, P2	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	JUL	2015	86	1					21	29		10.1002/ccd.25924		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL1GJ	WOS:000356690500010		
J	Miyazaki, T; Latib, A; Panoulas, VF; Miyazaki, S; Costopoulos, C; Sato, K; Naganuma, T; Kawamoto, H; Daida, H; Colombo, A				Miyazaki, Tadashi; Latib, Azeem; Panoulas, Vasileios F.; Miyazaki, Sakiko; Costopoulos, Charis; Sato, Katsumasa; Naganuma, Toru; Kawamoto, Hiroyoshi; Daida, Hiroyuki; Colombo, Antonio			Comparison of 2-year outcomes between zotarolimus-eluting and everolimus-eluting new-generation cobalt-chromium alloy stents in real-world diabetic patients	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						diabetes mellitus; drug eluting stents (DES); percutaneous coronary intervention (PES)	PERCUTANEOUS CORONARY INTERVENTION; XIENCE V STENTS; RESOLUTE STENTS; CLINICAL-OUTCOMES; POOLED ANALYSIS; ARTERY-DISEASE; TWENTE TRIAL; VESSEL SIZE; FOLLOW-UP; REVASCULARIZATION	Background: To date, it remains unknown whether different types of new-generation drug-eluting stents have a differential impact on long-term outcomes in diabetic patients. Methods and Results: In this historical cohort study (two Italian centers), we analyzed 400 diabetic patients with 553 coronary lesions treated with new-generation CoCr zotarolimus-eluting stents (R-ZES: 136 patients, 196 lesions) or everolimus-eluting stents (EES: 264 patients, 357 lesions) between October 2006 and August 2012. Primary endpoint was the occurrence of major adverse cardiac events (MACE) over a 2-year follow-up period. MACE was defined as all-cause mortality, any myocardial infarction (MI) and/or target lesion revascularization (TLR). Multivessel revascularization, intervention for restenotic lesion and use of intravascular ultrasound were significantly higher in the R-ZES group, whereas small stent (2.5 mm) deployment was significantly higher in the EES group. At 2-year follow-up, there was no significant difference in occurrence of MACE (R-ZES vs EES: 22.8% vs 18.9%, P=0.39). Similarly, no significant differences were observed in the composite endpoint of all-cause mortality/MI (10.0% vs 10.3%, P=0.86) or TLR (12.4% vs 7.4%, P=0.11). Adjustment for confounders and baseline propensity-score matching did not alter the aforementioned associations. Conclusion: After 2 years of follow up similar outcomes (MACE, all-cause mortality/MI, TLR) were observed in real-world diabetic patients, including those with complex lesions and patient characteristics, treated with R-ZES and EES. (c) 2015 Wiley Periodicals, Inc.	[Miyazaki, Tadashi; Latib, Azeem; Panoulas, Vasileios F.; Miyazaki, Sakiko; Costopoulos, Charis; Sato, Katsumasa; Naganuma, Toru; Kawamoto, Hiroyoshi; Colombo, Antonio] Ist Sci San Raffaele, Intervent Cardiol Unit, I-20132 Milan, Italy; [Miyazaki, Tadashi; Latib, Azeem; Panoulas, Vasileios F.; Costopoulos, Charis; Sato, Katsumasa; Naganuma, Toru; Kawamoto, Hiroyoshi; Colombo, Antonio] EMO GVM Ctr Cuore Columbus, Intervent Cardiol Unit, I-20145 Milan, Italy; [Miyazaki, Tadashi; Miyazaki, Sakiko; Daida, Hiroyuki] Juntendo Univ, Dept Cardiovasc Med, Tokyo, Japan; [Panoulas, Vasileios F.] Univ London Imperial Coll Sci Technol & Med, Physiol & Dis Prevent, Natl Heart & Lung Inst, London, England	Colombo, A (reprint author), EMO GVM Ctr Cuore Columbus, 48 Via M Buonarroti, I-20145 Milan, Italy.	info@emocolumbus.it					Claessen BE, 2011, JACC-CARDIOVASC INTE, V4, P1209, DOI 10.1016/j.jcin.2011.07.016; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Park KW, 2014, JACC-CARDIOVASC INTE, V7, P471, DOI 10.1016/j.jcin.2013.12.201; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Flaherty JD, 2005, JAMA-J AM MED ASSOC, V293, P1501, DOI 10.1001/jama.293.12.1501; Elezi S, 2006, J AM COLL CARDIOL, V48, P1304, DOI 10.1016/j.jacc.2006.05.068; Park KW, 2013, J AM COLL CARDIOL, V61, P536, DOI 10.1016/j.jacc.2012.11.015; Taniwaki M, 2014, J AM COLL CARDIOL, V63, P1617, DOI 10.1016/j.jacc.2013.12.036; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Stone GW, 2011, CIRCULATION, V124, P893, DOI 10.1161/CIRCULATIONAHA.111.031070; Banning AP, 2010, J AM COLL CARDIOL, V55, P1067, DOI 10.1016/j.jacc.2009.09.057; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008; Silber S, 2013, JACC-CARDIOVASC INTE, V6, P357, DOI 10.1016/j.jcin.2012.11.006; Silber S, 2011, LANCET, V377, P1241, DOI 10.1016/S0140-6736(11)60395-4; Tandjung K, 2013, J AM COLL CARDIOL, V61, P2406, DOI 10.1016/j.jacc.2013.04.005; Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Sianos Georgios, 2005, EuroIntervention, V1, P219; Smith Sidney C Jr, 2002, Circulation, V105, pe165, DOI 10.1161/01.CIR.0000013957.30622.05	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	JUL	2015	86	1					E11	E18		10.1002/ccd.25797		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL1GJ	WOS:000356690500002		
J	Cueno, ME; Kamio, N; Seki, K; Kurita-Ochiai, T; Ochiai, K				Cueno, Marni E.; Kamio, Noriaki; Seki, Keisuke; Kurita-Ochiai, Tomoko; Ochiai, Kuniyasu			High butyric acid amounts induce oxidative stress, alter calcium homeostasis, and cause neurite retraction in nerve growth factor-treated PC12 cells	CELL STRESS & CHAPERONES			English	Article						Butyric acid; Neurite retraction; Nerve growth factor; Oxidative stress; PC12 cells	APOPTOSIS; OUTGROWTH; HEME; PHEOCHROMOCYTOMA; EXPRESSION; NEURONS; SYSTEM; PLANTS	Butyric acid (BA) is a common secondary metabolite by-product produced by oral pathogenic bacteria and is detected in high amounts in the gingival tissue of patients with periodontal disease. Previous works have demonstrated that BA can cause oxidative stress in various cell types; however, this was never explored using neuronal cells. Here, we exposed nerve growth factor (NGF)-treated PC12 cells to varying BA concentrations (0.5, 1.0, 5.0 mM). We measured total heme, H2O2, catalase, and calcium levels through biochemical assays and visualized the neurite outgrowth after BA treatment. Similarly, we determined the effects of other common periodontal short-chain fatty acids (SCFAs) on neurite outgrowth for comparison. We found that high (1.0 and 5.0 mM) BA concentrations induced oxidative stress and altered calcium homeostasis, whereas low (0.5 mM) BA concentration had no significant effect. Moreover, compared to other SCFAs, we established that only BA was able to induce neurite retraction.	[Cueno, Marni E.; Kamio, Noriaki; Seki, Keisuke; Ochiai, Kuniyasu] Nihon Univ, Sch Dent, Dept Microbiol, Chiyoda Ku, Tokyo 1018310, Japan; [Kurita-Ochiai, Tomoko] Nihon Univ, Sch Dent, Dept Microbiol & Immunol, Matsudo, Chiba 2718587, Japan	Cueno, ME (reprint author), Nihon Univ, Sch Dent, Dept Microbiol, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	marni.cueno@nihon-u.ac.jp; ochiai.kuniyasu@nihon-u.ac.jp			Dental Research Center-Nihon University School of Dentistry - Ministry of Health, Labor and Welfare; Sato Fund-Nihon University School of Dentistry, Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan through Strategic Research Base Development Program for Private Universities [S1001024]	This work was supported by the Dental Research Center-Nihon University School of Dentistry and funded by the Sato Fund-Nihon University School of Dentistry and both the Ministry of Health, Labor and Welfare and the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan through the Strategic Research Base Development Program for Private Universities 2010-2014 (S1001024).	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nm1434; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Arora A, 2002, CURR SCI INDIA, V82, P1227; Kurita-Ochiai T, 2008, J DENT RES, V87, P51; Cueno ME, 2014, CELL STRESS CHAPERON, V19, P295, DOI 10.1007/s12192-013-0462-7; Annunziato L, 2003, TOXICOL LETT, V139, P125, DOI 10.1016/S0378-4274(02)00427-7; Bogeski I, 2011, CELL CALCIUM, V50, P407, DOI 10.1016/j.ceca.2011.07.006; Hobson SA, 2006, J NEUROCHEM, V99, P1000, DOI 10.1111/j.1471-4159.2006.04143.x; Coventry J, 2000, BRIT MED J, V321, P36, DOI 10.1136/bmj.321.7252.36; Garcia-Alloza M, 2006, J NEUROPATH EXP NEUR, V65, P1082, DOI 10.1097/01.jnen.0000240468.12543.af; Cueno ME, 2013, CELL STRESS CHAPERON, V18, P661, DOI 10.1007/s12192-013-0409-z; Zhu YH, 2002, CELL GROWTH DIFFER, V13, P431; Kamata Y, 2007, NEUROSCIENCE, V146, P1073, DOI 10.1016/j.neuroscience.2007.03.001; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Balla J, 2000, BLOOD, V95, P3442; Cayo MA, 2009, AM J TRANSL RES, V1, P178; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Hu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016221; Kole AJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.220; Kurita-Ochiai T, 2010, J DENT RES, V89, P689, DOI 10.1177/0022034510365456; Liu HL, 2003, J NEUROCHEM, V86, P1553, DOI 10.1046/j.1471-4159.2003.01978.x; Marszalek JR, 2004, J BIOL CHEM, V279, P23882, DOI 10.1074/jbc.M313460200; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Scandalios John G., 2002, Trends in Biochemical Sciences, V27, P483, DOI 10.1016/S0968-0004(02)02170-9; Sheehan Jason, 2006, Neurosurg Focus, V20, pE9; Takada Y, 2002, MOL CANCER RES, V1, P137; Takatori M, 2006, ANESTH ANALG, V102, P462, DOI 10.1213/01.ane.0000194334.69103.50; Torres MA, 2006, PLANT PHYSIOL, V141, P373; Valdovinos-Flores C, 2013, FREE RADICAL RES, V47, P404, DOI 10.3109/10715762.2013.783210	32	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1355-8145	1466-1268		CELL STRESS CHAPERON	Cell Stress Chaperones	JUL	2015	20	4					709	713		10.1007/s12192-015-0584-1		5	Cell Biology	Cell Biology	CK2KV	WOS:000356040200014		
J	Lu, WJ; Saxena, N; Luk, JM; Kaul, SC; Wadhwa, R				Lu, Wen-Jing; Saxena, Nishant; Luk, John M.; Kaul, Sunil C.; Wadhwa, Renu			Circulating mortalin autoantibody-a new serological marker of liver cirrhosis	CELL STRESS & CHAPERONES			English	Article						Mortalin; Autoantibody; Liver cancer; Cirrhosis; Diagnostic marker	COLORECTAL ADENOCARCINOMAS; HUMAN CARCINOGENESIS; CANCER-CELLS; FIBROSIS; MORTALIN/MTHSP70/PBP74/GRP75; FIBROGENESIS; THERAPY; DISEASE; DEATH	Mortalin is a stress chaperone belonging to the Hsp70 family of proteins. Frequently enriched in cancers, it is a multifunctional protein and regulates cell proliferation, apoptosis, mitochondrial functions, and the activity of tumor suppressor protein p53. In the present study, we investigated circulating mortalin and its autoantibody in normal, cirrhosis, and cancerous liver. We found that although mortalin is enriched in liver cancer cells and tumors, it is not detected in the serum of either the liver cirrhosis or cancer patients. In contrast, mortalin autoantibody was detected in patients' sera and showed significant correlation with the occurrence of cirrhosis. It is suggested as a potential noninvasive marker for liver cirrhosis.	[Lu, Wen-Jing] Stanford Univ, Sch Med, Dept Surg, Asian Liver Ctr, Stanford, CA 94305 USA; [Saxena, Nishant; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, DAILAB, Drug Discovery & Assets Innovat, Tsukuba, Ibaraki, Japan; [Lu, Wen-Jing; Luk, John M.] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Pokfulam, Hong Kong, Peoples R China; [Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan	Luk, JM (reprint author), Univ Hong Kong, Queen Mary Hosp, Dept Surg, Pokfulam, Hong Kong, Peoples R China.	dr.johnluk@gmail.com; s-kaul@aist.go.jp; renu-wadhwa@aist.go.jp	Luk, John/A-4085-2008	Luk, John/0000-0002-6323-7940			Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Ando K, 2014, GASTRIC CANCER, V17, P255, DOI 10.1007/s10120-013-0279-1; Ran QT, 2000, BIOCHEM BIOPH RES CO, V275, P174, DOI 10.1006/bbrc.2000.3237; Pereira TN, 2004, J HEPATOL, V41, P576, DOI 10.1016/j.jhep.2004.06.032; Gomes-Alves P, 2010, BBA-PROTEINS PROTEOM, V1804, P856, DOI 10.1016/j.bbapap.2009.12.013; Saitou Y, 2005, WORLD J GASTROENTERO, V11, P476; Wadhwa R, 2002, CELL STRESS CHAPERON, V7, P309, DOI 10.1379/1466-1268(2002)007<0309:AHFCMM>2.0.CO;2; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Pilzer D, 2005, INT IMMUNOL, V17, P1239, DOI 10.1093/intimm/dxh300; Jarcuska P, 2010, CLIN CHIM ACTA, V411, P1009, DOI 10.1016/j.cca.2010.04.009; Kovalenko E, 2009, J VIRAL HEPATITIS, V16, P612, DOI 10.1111/j.1365-2893.2009.01110.x; Lefton HB, 2009, MED CLIN N AM, V93, P787, DOI 10.1016/j.mcna.2009.03.002; Holmberg SD, 2013, CLIN INFECT DIS, V57, P240, DOI 10.1093/cid/cit245; Kim HS, 2012, KOREAN J PHYSIOL PHA, V16, P469, DOI 10.4196/kjpp.2012.16.6.469; Lu WJ, 2011, INT J CANCER, V129, P1806, DOI 10.1002/ijc.25857; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Janicko M, 2013, ANN HEPATOL, V12, P581; Klaus C, 2014, CELL TISSUE RES, V357, P267, DOI 10.1007/s00441-014-1826-8; Poynard T, 2004, COMP HEPATOL, V3, P8, DOI DOI 10.1186/1476-5926-3-8; Rozenberg P, 2011, INT J CANCER, V133, P514; Ryu J, 2014, J BIOL CHEM, V289, P24832, DOI 10.1074/jbc.M114.565929; Sane S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.100; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1355-8145	1466-1268		CELL STRESS CHAPERON	Cell Stress Chaperones	JUL	2015	20	4					715	719		10.1007/s12192-015-0592-1		5	Cell Biology	Cell Biology	CK2KV	WOS:000356040200015		
J	Kimura, T; Jiang, SW; Yoshida, N; Sakamoto, R; Nishizawa, M				Kimura, Tominori; Jiang, Shiwen; Yoshida, Noriyuki; Sakamoto, Ryou; Nishizawa, Mikio			Interferon-alpha competing endogenous RNA network antagonizes microRNA-1270	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						Non-coding RNA; Regulatory RNA network; Competing endogenous RNA; Natural antisense RNA; Mechanisms of action	LONG NONCODING RNA; GENE-EXPRESSION; TARGET RECOGNITION; CERNA HYPOTHESIS; MESSENGER-RNAS; EMERGING ROLES; HUMAN GENOME; CANCER; CELLS; ANNOTATION	A new form of circuitry for gene regulation has been identified in which RNAs can crosstalk by competing for shared microRNAs (miRNAs). Such competing endogenous RNAs (ceRNAs) form a network via shared miRNA response elements (MREs) to antagonize miRNA function. We previously reported natural antisense RNA (AS) as an important modulator of interferon-alpha 1 (IFN-alpha 1) mRNA levels by promoting IFN-alpha 1 mRNA stability. We show that IFN-alpha 1 AS forms a ceRNA network with specific IFN-alpha AS (IFN-alpha 7/-alpha 8/-alpha 10/-alpha 14) and mRNA (IFN-alpha 8/-alpha 10/-alpha 14/-alpha 17) subtypes from the IFN-alpha gene (IFNA) family to antagonize miRNA-1270 (miR-1270), thereby modulating IFN-alpha 1 mRNA levels. Bioinformatic analysis demonstrated that IFN-alpha 1 AS harbors multiple miR-1270 MREs (MRE-1270s), whose presence was substantiated by miR-1270 overexpression and transfection of antimiR-1270. The antimiR-1270, complementary to the miR-1270 seed region, revealed that IFN-alpha 1 AS likely shares the MRE-1270 with IFN-alpha 1 mRNA and specific IFN-alpha AS and mRNA subtypes. Subsequent bioinformatic analysis for MRE-1270s showed that IFN-alpha 1 AS and other RNA subtypes shared the 6-mer MRE-1270 site. Further MRE-mapping demonstrated that the total number of MRE-1270s in IFN-alpha 1 AS accounted for approximately 30 % of the miR-1270 population. AntimiR-1270 transfection also caused specific de-repression of five cellular mRNAs, including that of CAPRIN1. These results suggest that IFN-alpha 1 AS, together with specific IFN-alpha AS and mRNA subtypes, as well as the five cellular mRNAs, participate as competing molecules in the ceRNA network against miR-1270. This coordinated regulatory architecture suggests a vital function for the innate immune system in maintaining precise physiological type I IFN levels via post-transcriptional regulatory mechanisms.	[Kimura, Tominori; Jiang, Shiwen; Yoshida, Noriyuki; Sakamoto, Ryou] Ritsumeikan Univ, Dept Pharm, Coll Pharmaceut Sci, Lab Microbiol & Cell Biol, Kusatsu, Shiga 5258577, Japan; [Nishizawa, Mikio] Ritsumeikan Univ, Dept Biomed Sci, Coll Life Sci, Med Chem Lab, Kusatsu, Shiga 5258577, Japan	Kimura, T (reprint author), Ritsumeikan Univ, Dept Pharm, Coll Pharmaceut Sci, Lab Microbiol & Cell Biol, Kusatsu, Shiga 5258577, Japan.	kimurato@ph.ritsumei.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [24510283]; Japan Science and Technology Agency (JST) [AS2511389Q]	We are grateful to J.-I. Fujisawa for providing pRL-RSV and to some of the former members of the Kimura laboratory who participated at early stages of the project. We also thank all the present members of the laboratory for our stimulating discussions. This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant No. 24510283 and the Japan Science and Technology Agency (JST) Grant No. AS2511389Q to T. K.	Karreth FA, 2013, CANCER DISCOV, V3, P1113, DOI 10.1158/2159-8290.CD-13-0202; Figliuzzi M, 2013, BIOPHYS J, V104, P1203, DOI 10.1016/j.bpj.2013.01.012; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Poliseno L, 2015, METHODS, V77-78, P41, DOI 10.1016/j.ymeth.2015.01.013; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Joshi S, 2010, CYTOKINE, V52, P123, DOI 10.1016/j.cyto.2010.03.019; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; de Giorgio A, 2013, MOL CELL BIOL, V33, P3976, DOI 10.1128/MCB.00683-13; Genin P, 2009, MOL CELL BIOL, V29, P3435, DOI 10.1128/MCB.01805-08; Ala U, 2013, P NATL ACAD SCI USA, V110, P7154, DOI 10.1073/pnas.1222509110; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1021/rna.5248604; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Matsui K, 2008, HEPATOLOGY, V47, P686, DOI 10.1002/hep.22036; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kimura T, 2013, CELL MOL LIFE SCI, V70, P1451, DOI 10.1007/s00018-012-1216-x; Kimura T, 2009, MED MOL MORPHOL, V42, P70, DOI 10.1007/s00795-009-0441-3; Kumar MS, 2014, NATURE, V505, P212, DOI 10.1038/nature12785; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mitra R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024583; Nishizawa M, 2015, FRONT BIOSCI-LANDMRK, V20, P1, DOI 10.2741/4297; Nishizawa M, 2012, FRONT BIOSCI-LANDMRK, V17, P938, DOI 10.2741/3965; Shabalina SA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-105; Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292; Wang B, 2005, J IMMUNOL, V175, P4274; Zhang Y, 2010, J INTEGR BIOINFORM, V7, P127, DOI [DOI 10.2390/BIECOLL-JIB-2010-127, 10.2390/biecoll-jib-2010-127]	51	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	JUL	2015	72	14					2749	2761		10.1007/s00018-015-1875-5		13	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CL1UT	WOS:000356731100010		
J	Mitamura, H; Iwami, T; Mitani, Y; Takeda, S; Takatsuki, S				Mitamura, Hideo; Iwami, Taku; Mitani, Yoshihide; Takeda, Satoshi; Takatsuki, Seiji			Aiming for Zero Deaths: Prevention of Sudden Cardiac Death in Schools - Statement From the AED Committee of the Japanese Circulation Society	CIRCULATION JOURNAL			English	Article							ARREST; OUTCOMES; ERA		[Mitamura, Hideo] Tachikawa Hosp, Cardiovasc Ctr, Tachikawa, Tokyo 1908531, Japan; [Iwami, Taku] Kyoto Univ, Hlth Serv, Kyoto, Japan; [Mitani, Yoshihide] Mie Univ, Grad Sch Med, Dept Pediat, Tsu, Mie, Japan; [Takeda, Satoshi] Jikei Univ, Sch Med, Dept Emergency, Tokyo, Japan; [Takatsuki, Seiji] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan	Mitamura, H (reprint author), Tachikawa Hosp, Cardiovasc Ctr, 4-2-22 Nishikicho, Tachikawa, Tokyo 1908531, Japan.	h.mitamura@tachikawa-hosp.or.jp					Mitani Y, 2014, CIRC J, V78, P701, DOI 10.1253/circj.CJ-13-1162; Nitta M, 2011, PEDIATRICS, V128, pE812, DOI 10.1542/peds.2010-3886; Nagao K, 2013, CIRC J, V77, P2742, DOI 10.1253/circj.CJ-13-0457; Nishiuchi T, 2014, RESUSCITATION, V85, P1001, DOI 10.1016/j.resuscitation.2014.04.027; Okamoto Y, 2013, CIRC J, V77, P2596, DOI 10.1253/circj.CJ-12-1604; Education Board of Saitama Prefecture, TXB EM RESP LIF THRE; The All-Japan Utstein Registry of the Fire and Disaster Management Agency, 2014, 2014 STAT REP EM MED; The Japanese Circulation Society, CALL PUSH SIMPL CPR	8	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1398	1401		10.1253/circj.CJ-15-0453		4	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800002		
J	Aoki, H				Aoki, Hiroki			Fountain of Youth in the Aorta	CIRCULATION JOURNAL			English	Editorial Material							MESENCHYMAL STROMAL CELLS; ANEURYSM FORMATION		Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka 8300011, Japan	Aoki, H (reprint author), Kurume Univ, Cardiovasc Res Inst, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	haoki@med.kurume-u.ac.jp					Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Sharma AK, 2012, CIRCULATION, V126, pS38, DOI 10.1161/CIRCULATIONAHA.111.083451; Owens AP, 2011, ARTERIOSCL THROM VAS, V31, P2813, DOI 10.1161/ATVBAHA.111.238642; Thompson RW, 1996, CURR OPIN CARDIOL, V11, P504, DOI 10.1097/00001573-199609000-00010; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Hashizume R, 2011, J VASC SURG, V54, P1743, DOI 10.1016/j.jvs.2011.06.109; Kuivaniemi H, 2008, CIRCULATION, V117, P242, DOI 10.1161/CIRCULATIONAHA.107.690982; Aoki H, 2007, J MOL MED-JMM, V85, P1077, DOI 10.1007/s00109-007-0213-2; Aoyama N, 2013, CIRC J, V77, P1565, DOI 10.1253/circj.CJ-12-1191; Blose KJ, 2014, REGEN MED, V9, P733, DOI [10.2217/rme.14.61, 10.2217/RME.14.61]; Ciavarella C, 2015, CIRC J, V79, P1460, DOI 10.1253/circj.CJ-14-0857; Fu XM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-175; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088	14	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1439	1440		10.1253/circj.CJ-15-0563		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800008		
J	Ikeda, T				Ikeda, Takanori			Use of Oral Anticoagulants According to the Degree of Renal Impairment in Japanese Patients With Atrial Fibrillation - Which Non-Vitamin K Antagonist Oral Anticoagulant to Select?	CIRCULATION JOURNAL			English	Editorial Material							WARFARIN; EFFICACY; SAFETY		[Ikeda, Takanori] Toho Univ, Fac Med, Dept Cardiovasc Med, Tokyo 1438541, Japan	Ikeda, T (reprint author), Toho Univ, Fac Med, Dept Cardiovasc Med, Ota Ku, 6-11-1 Omorinishi, Tokyo 1438541, Japan.	ikety5@gmail.com					Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; [Anonymous], 2013, PRAZ CAPS DAB ET PAC; [Anonymous], 2013, EL TABL AP PACK INS; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Hori M, 2013, CIRC J, V77, P632, DOI 10.1253/circj.CJ-12-0899; [Anonymous], 2014, RIX TABL ED PACK INS; [Anonymous], 2012, XAR TABL RIV PACK IN; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Nielsen PB, 2015, CLIN RES CARDIOL, V104, P418, DOI 10.1007/s00392-014-0797-9; De Caterina R, 2012, J AM COLL CARDIOL, V59, P1413, DOI 10.1016/j.jacc.2012.02.008; Ikeda T, 2014, CIRC J, V78, P1331, DOI 10.1253/circj.CJ-14-0409; Inoue H, 2013, GUIDELINES PHARMACOT; Koretsune Y, 2015, CIRC J, V79, P1486, DOI 10.1253/circj.CJ-14-0942; PATEL MR, 2011, ENGL J MED, V365, P883	16	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1441	1443		10.1253/circj.CJ-15-0510		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800009		
J	Sueta, D; Hokimoto, S				Sueta, Daisuke; Hokimoto, Seiji			Could Circulatory Syndecan-1 Be a Predictable Biomarker for Acute Kidney Injury in Patients With Acute Decompensated Heart Failure?	CIRCULATION JOURNAL			English	Editorial Material							HEPARAN-SULFATE PROTEOGLYCANS; CELL		[Sueta, Daisuke; Hokimoto, Seiji] Kumamoto Univ Hosp, Dept Cardiovasc Med, Kumamoto 8608556, Japan	Hokimoto, S (reprint author), Kumamoto Univ Hosp, Dept Cardiovasc Med, 1-1-1 Honjo, Kumamoto 8608556, Japan.	shokimot@kumamoto-u.ac.jp					BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365; Forman DE, 2004, J AM COLL CARDIOL, V43, P61, DOI 10.1016/j.jacc.2003.07.031; Matsuzawa Y, 2013, CIRC J, V77, P2807, DOI 10.1253/circj.CJ-13-0549; Tromp J, 2014, CIRC-HEART FAIL, V7, P457, DOI 10.1161/CIRCHEARTFAILURE.113.000846; Basile DP, 2007, KIDNEY INT, V72, P151, DOI 10.1038/sj.ki.5002312; Hokimoto S, 2015, CIRC J, V79, P1269, DOI 10.1253/circj.CJ-14-1308; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; Neves FMD, 2015, CIRC J, V79, P1511, DOI 10.1253/circj.CJ-14-1195; Kajikawa M, 2014, CIRC J, V78, P1740, DOI 10.1253/circj.CJ-14-0165; Ostrowski SR, 2013, CRIT CARE, V17, DOI 10.1186/cc12532; Szatmári Tünde, 2013, Front Oncol, V3, P310, DOI 10.3389/fonc.2013.00310	12	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1444	1445		10.1253/circj.CJ-15-0552		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800010		
J	Shiba, N				Shiba, Nobuyuki			Blood Urea Nitrogen/Creatinine Ratio in Acute Heart Failure Patients	CIRCULATION JOURNAL			English	Editorial Material							ACUTE KIDNEY INJURY; CONSENSUS CONFERENCE; CARDIORENAL SYNDROME; PROGNOSTIC IMPACT; RENAL-FUNCTION; NITROGEN		Int Univ Hlth & Welf Hosp, Cardiovasc Ctr, Nasushiobara 3292763, Japan	Shiba, N (reprint author), Int Univ Hlth & Welf Hosp, Cardiovasc Ctr, Nasushiobara 3292763, Japan.	shiba@iuhw.ac.jp					Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Cowie MR, 2006, EUR HEART J, V27, P1216, DOI 10.1093/eurheartj/ehi859; Kellum JA, 2002, KIDNEY INT, V62, P1855; Testani JM, 2010, CIRCULATION, V122, P265, DOI 10.1161/CIRCULATIONAHA.109.933275; Kazory A, 2010, AM J CARDIOL, V106, P694, DOI 10.1016/j.amjcard.2010.04.024; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Shlipak MG, 2004, CIRCULATION, V110, P1514, DOI 10.1161/01.CIR.0000143547.55093.17; Miura M, 2013, CIRC J, V77, P1221, DOI 10.1253/circj.CJ-12-1390; Shirakabe A, 2013, CIRC J, V77, P687, DOI 10.1253/circj.CJ-12-0994; Brisco MA, 2013, CIRC-HEART FAIL, V6, P233, DOI 10.1161/CIRCHEARTFAILURE.112.968230; Haase M, 2013, CONTRIB NEPHROL, V182, P99, DOI 10.1159/000349969; KDIGO, 2012, KIDNEY INT S, V2, P19, DOI DOI 10.1038/KISUP.2011.32; Lindenfeld J, 2011, J AM COLL CARDIOL, V58, P383, DOI 10.1016/j.jacc.2011.01.054; Mehta RL, 2007, CRIT CARE, V11, P1; Takaya Y, 2015, CIRC J, V79, P1520, DOI 10.1253/circj.CJ-14-1360	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1446	1447		10.1253/circj.CJ-15-0542		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800011		
J	Tsukamoto, O; Kitakaze, M				Tsukamoto, Osamu; Kitakaze, Masafumi			Different Implications of Functional Tricuspid Regurgitation Between Heart Failure (HF) With Reduced Ejection Fraction (EF) and HF With Preserved EF	CIRCULATION JOURNAL			English	Editorial Material							PULMONARY-HYPERTENSION; IMPACT; COMORBIDITIES; DYSFUNCTION; SURVIVAL		[Tsukamoto, Osamu] Osaka Univ, Grad Sch Med, Dept Med Biochem, Suita, Osaka 5650871, Japan; [Kitakaze, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Clin Med & Dev, Suita, Osaka, Japan	Tsukamoto, O (reprint author), Osaka Univ, Grad Sch Med, Dept Med Biochem, Suita, Osaka 5650871, Japan.	tsuka@medbio.med.osaka-u.ac.jp					Komajda M, 2014, EUR HEART J, V35, P1022, DOI 10.1093/eurheartj/ehu067; Guazzi M, 2012, CIRCULATION, V126, P975, DOI 10.1161/CIRCULATIONAHA.111.085761; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; Neuhold S, 2013, EUR HEART J, V34, P844, DOI 10.1093/eurheartj/ehs465; Thenappan T, 2011, CIRC-HEART FAIL, V4, P257, DOI 10.1161/CIRCHEARTFAILURE.110.958801; Nath J, 2004, J AM COLL CARDIOL, V43, P405, DOI 10.1016/j.jacc.2003.09.036; Schwartzenberg S, 2012, J AM COLL CARDIOL, V59, P442, DOI 10.1016/j.jacc.2011.09.062; Guazzi M, 2014, CIRC-HEART FAIL, V7, P367, DOI 10.1161/CIRCHEARTFAILURE.113.000823; Melenovsky V, 2014, EUR HEART J, V35, P3452, DOI 10.1093/eurheartj/ehu193; Murashita T, 2013, CIRC J, V77, P2288, DOI 10.1253/circj.CJ-13-0221; Nochioka K, 2015, CIRC J, V79, P574, DOI 10.1253/circj.CJ-14-0865; Santas E, 2015, CIRC J, V79, P1526, DOI 10.1253/circj.CJ-15-0129	13	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1448	1449		10.1253/circj.CJ-15-0560		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800012		
J	Yazaki, Y				Yazaki, Yoshikazu			How Should We Evaluate the Activity of Myocardial Inflammation and Guide Corticosteroid Treatment in Patients With Cardiac Sarcoidosis?	CIRCULATION JOURNAL			English	Editorial Material							MONOCYTES; TOMOGRAPHY; EXPRESSION; DISEASE		Saku Cent Hosp, Adv Care Ctr, Div Cardiovasc Med, Saku 3850051, Japan	Yazaki, Y (reprint author), Saku Cent Hosp, Adv Care Ctr, Div Cardiovasc Med, 3400-28 Nakagomi, Saku 3850051, Japan.	yoshiy@athena.ocn.ne.jp					Terasaki F, 2008, CIRC J, V72, P1303, DOI 10.1253/circj.72.1303; Grutters JC, 2006, EUR RESPIR J, V28, P627, DOI 10.1183/09031936.06.00105805; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; Tahara N, 2010, JACC-CARDIOVASC IMAG, V3, P1219, DOI 10.1016/j.jcmg.2010.09.015; Yazaki Y, 2001, AM J CARDIOL, V88, P1006, DOI 10.1016/S0002-9149(01)01978-6; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Miyagawa M, 2014, CIRC J, V78, P1302, DOI 10.1253/circj.CJ-14-0250; Okamoto H, 2003, J DERMATOL, V30, P503; Ishida Y, 2014, ANN NUCL MED, V28, P393, DOI 10.1007/s12149-014-0806-0; Bussinguer Michelle, 2012, Curr Treat Options Cardiovasc Med, V14, P652, DOI 10.1007/s11936-012-0208-3; Hijdra D, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-38; Isobe M, 2015, INT J CARDIOL, V182, P132, DOI 10.1016/j.ijcard.2014.12.056; Orii M, 2015, CIRC J, V79, P1585, DOI 10.1253/circj.CJ-14-1422; Ozaki Y, 2012, CIRC J, V76, P2412, DOI 10.1253/circj.CJ-12-0412	14	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1450	1452		10.1253/circj.CJ-15-0583		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800013		
J	Azuma, N				Azuma, Nobuyoshi			Impact of Demographic Changes on the Natural Course, Features and Prognosis of Critical Limb Ischemia	CIRCULATION JOURNAL			English	Editorial Material							PERIPHERAL ARTERIAL-DISEASE; CLAUDICATION; MANAGEMENT; SOCIETY		Asahikawa Med Univ, Dept Vasc Surg, Asahikawa, Hokkaido 0788510, Japan	Azuma, N (reprint author), Asahikawa Med Univ, Dept Vasc Surg, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	nazuma@asahikawa-med.ac.jp					Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Azuma N, 2014, VASCULAR, V22, P411, DOI 10.1177/1708538113518204; Conte MS, 2015, J VASC SURG, V61, p2S, DOI 10.1016/j.jvs.2014.12.009; Dormandy JA, 2000, J VASC SURG, V31, pS1; Matzke S, 2001, VASC MED, V6, P77, DOI 10.1177/1358836X0100600202; Rutherford BB, 1997, J VASC SURG, V26, P517; Shirasu T, 2015, CIRC J, V79, P1618, DOI 10.1253/circj.CJ-15-0017; Takahara M, 2015, J ATHEROSCLER THROMB, DOI [10.5551/jat.28217, DOI 10.5551/JAT.28217]; White JV, 2007, SEMIN VASC SURG, V20, P62, DOI 10.1053/j.semvascsurg.2007.02.001	10	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1453	1455		10.1253/circj.CJ-15-0581		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800014		
J	Yoshihara, F				Yoshihara, Fumiki			Why Is Proteinuria an Independent Risk Factor for Contrast-Induced Nephropathy?	CIRCULATION JOURNAL			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; ACUTE-RENAL-FAILURE; CELLS; ALBUMIN		Natl Cerebral & Cardiovasc Ctr, Div Nephrol & Hypertens, Suita, Osaka 5658565, Japan	Yoshihara, F (reprint author), Natl Cerebral & Cardiovasc Ctr, Div Nephrol & Hypertens, Suita, Osaka 5658565, Japan.	fyoshi@hsp.ncvc.go.jp					McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; Tang S, 2003, J CLIN INVEST, V111, P515, DOI [10.1172/JC1200316079, 10.1172/JCI200316079]; Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329; Donadelli R, 2000, AM J KIDNEY DIS, V36, P1226, DOI 10.1053/ajkd.2000.19838; Zoja C, 1998, KIDNEY INT, V53, P1608, DOI 10.1046/j.1523-1755.1998.00905.x; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Zoja C, 1995, AM J KIDNEY DIS, V26, P934, DOI 10.1016/0272-6386(95)90058-6; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; JSN JRS and JCS Joint Working Group, 2013, CIRC J, V77, P1883; Rudnick MR, 2014, PREVENTION CONTRAST; Saito Y, 2015, CIRC J, V79, P1624, DOI 10.1253/circj.CJ-14-1345; Ueda H, 2013, CIRC J, V77, P982, DOI 10.1253/circj.CJ-12-0761; Wang YP, 1997, J AM SOC NEPHROL, V8, P1537	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1456	1457		10.1253/circj.CJ-15-0556		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800015		
J	Min, KD				Min, Kyung-Duk			Estimating the Prognosis of Patients With Aortic Stenosis in the Current Japanese Population	CIRCULATION JOURNAL			English	Editorial Material							NATURAL-HISTORY; PREDICTORS; ADULTS		[Min, Kyung-Duk] Natl Cerebral & Cardiovasc Ctr, Dept Clin Res & Dev, Suita, Osaka 5658565, Japan; [Min, Kyung-Duk] Natl Cerebral & Cardiovasc Ctr, Cell Biol, Suita, Osaka 5658565, Japan	Min, KD (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Clin Res & Dev, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	min@ncvc.go.jp					Sato K, 2015, CIRC J, V79, P1631, DOI 10.1253/circj.CJ-15-0062; Pellikka PA, 2005, CIRCULATION, V111, P3290, DOI 10.1161/CIRCULATIONAHA.104.495903; Rosenhek R, 2010, CIRCULATION, V121, P151, DOI 10.1161/CIRCULATIONAHA.109.894170; Bouma BJ, 1999, HEART, V82, P143; CHIZNER MA, 1980, AM HEART J, V99, P419, DOI 10.1016/0002-8703(80)90375-0; Eveborn GW, 2013, HEART, V99, P396, DOI 10.1136/heartjnl-2012-302265; Barasch E, 2014, CIRC J, V78, P232, DOI 10.1253/circj.CJ-13-0821; FRANK S, 1973, BRIT HEART J, V35, P41; Martinez-Selles M, 2015, INT J CARDIOL, V189, P61, DOI 10.1016/j.ijcard.2015.04.017; Nishimura Rick A, 2014, J Am Coll Cardiol, V63, pe57, DOI 10.1016/j.jacc.2014.02.536; Otto CM, 1997, CIRCULATION, V95, P2262; Perera Suresh, 2011, N Z Med J, V124, P40; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903	13	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1458	1459		10.1253/circj.CJ-15-0578		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800016		
J	Yoshihara, T; Shimada, K; Fukao, K; Sai, E; Sato-Okabayashi, Y; Matsumori, R; Shiozawa, T; Alshahi, H; Miyazaki, T; Tada, N; Daida, H				Yoshihara, Takuma; Shimada, Kazunori; Fukao, Kosuke; Sai, Eiryu; Sato-Okabayashi, Yayoi; Matsumori, Rie; Shiozawa, Tomoyuki; Alshahi, Hamad; Miyazaki, Tetsuro; Tada, Norihiro; Daida, Hiroyuki			Omega 3 Polyunsaturated Fatty Acids Suppress the Development of Aortic Aneurysms Through the Inhibition of Macrophage-Mediated Inflammation	CIRCULATION JOURNAL			English	Article						Abdominal aortic aneurysm; Apolipoprotein E (apoE)-deficient mouse; Inflammation; Macrophages; Omega 3 polyunsaturated fatty acids (omega 3-PUFAs)	E-DEFICIENT MICE; PURIFIED EICOSAPENTAENOIC ACID; APOLIPOPROTEIN-E; FISH-OIL; ATHEROSCLEROSIS; RECEPTOR; PHENOTYPE; DISEASE; CELLS; HYPERCHOLESTEROLEMIA	Background: Dietary intake of omega 3 polyunsaturated fatty acids (omega 3-PUFAs) reduces progression of atherosclerosis and prevents future cardiovascular events. Macrophages are key players in the pathogenesis of aortic aneurysm. The effects of omega 3-PUFAs on abdominal aortic aneurysm (AAA) formation and macrophage-mediated inflammation remain unclear. Methods and Results: The AAA model was developed by angiotensin II infusion in apolipoprotein E-deficient mice. Mice were supplemented with eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA). The development of AAA lesions and macrophage infiltration in the aorta were analyzed. Gene expression of inflammatory markers in aortic tissues and peritoneal macrophages were measured by using quantitative polymerase chain reaction. AAA formation and macrophage infiltration were significantly suppressed after EPA and DHA administration. EPA administration and DHA administration significantly decreased the expression of tumor necrosis factor-a, monocyte chemoattractant protein-1, transforming growth factor-beta, matrix metalloproteinases (MMP)-2, MMP-9, and vascular cell adhesion molecule-1 in the aortas. The expression of arginase 2, which is a marker of pro-inflammatory macrophages, was significantly lower and that of Ym1, which is a marker of anti-inflammatory macrophages, and was significantly higher after EPA and DHA administration. The same trends were observed in peritoneal macrophages after EPA and DHA administration. Conclusions: Dietary intake of EPA and DHA prevented AAA development through the inhibition of aortic and macrophage-mediated inflammation.	[Yoshihara, Takuma; Shimada, Kazunori; Fukao, Kosuke; Sai, Eiryu; Sato-Okabayashi, Yayoi; Matsumori, Rie; Shiozawa, Tomoyuki; Alshahi, Hamad; Miyazaki, Tetsuro; Daida, Hiroyuki] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138421, Japan; [Tada, Norihiro] Juntendo Univ, Grad Sch Med, Atopy Res Ctr, Tokyo 1138421, Japan	Shimada, K (reprint author), Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	shimakaz@juntendo.ac.jp			MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities, Japan; Japan Society for the Promotion of Science, Japan [C-23500620]; Mochida Pharmaceutical Co Ltd, Tokyo, Japan	This work was supported by a MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities, Japan, and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, Japan (C-23500620). This study was partially funded by Mochida Pharmaceutical Co Ltd, Tokyo, Japan.	Itoh M, 2007, ARTERIOSCL THROM VAS, V27, P1918, DOI 10.1161/ATVBAHA.106.136853; Yanagisawa N, 2010, J ATHEROSCLER THROMB, V17, P285; Lopez-Garcia E, 2004, J NUTR, V134, P1806; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Sumiyoshi K, 2008, CARDIOVASC RES, V80, P463, DOI 10.1093/cvr/cvn206; Duda MK, 2009, CARDIOVASC RES, V81, P319, DOI 10.1093/cvr/cvn310; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Braga TT, 2012, MOL MED, V18, P1231, DOI 10.2119/molmed.2012.00131; Hara M, 2013, CIRC J, V77, P153, DOI 10.1253/circj.CJ-12-0875; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.000011013.72016.ea; Moran CS, 2013, ARTERIOSCL THROM VAS, V33, P814, DOI 10.1161/ATVBAHA.112.301006; Xiong WF, 2009, ATHEROSCLEROSIS, V202, P128, DOI 10.1016/j.atherosclerosis.2008.03.029; Moran CS, 2005, CIRCULATION, V111, P3119, DOI 10.1161/CIRCULATIONAHA.104.464727; Hjorth E, 2013, J ALZHEIMERS DIS, V35, P697, DOI 10.3233/JAD-130131; Fukao K, 2010, J ATHEROSCLER THROMB, V17, P1226; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Ho WZ, 1997, J IMMUNOL, V159, P5654; Shimada K, 2009, CIRC J, V73, P994; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Cheng X, 2008, J MOL CELL CARDIOL, V45, P168, DOI 10.1016/j.yjmcc.2008.04.003; Yamada H, 2008, ARTERIOSCL THROM VAS, V28, P2173, DOI 10.1161/ATVBAHA.108.171736; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323; Iso H, 2006, CIRCULATION, V113, P195, DOI 10.1161/CIRCULATIONAHA.105.581355; COHN ZA, 1965, J EXP MED, V121, P153, DOI 10.1084/jem.121.1.153; Asset G, 2001, ARTERIOSCL THROM VAS, V21, P401; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Dyerberg J, 1982, Scand J Clin Lab Invest Suppl, V161, P7; Hirose K, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-1; Kajimoto K, 2009, ATHEROSCLEROSIS, V206, P505, DOI 10.1016/j.atherosclerosis.2009.03.028; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Ming XF, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000992; Mozaffarian D, 2012, J NUTR, V142, P614; Nakajima K, 2011, ARTERIOSCL THROM VAS, V31, P1963, DOI 10.1161/ATVBAHA.111.229443; Sakata Ryuzo, 2010, Gen Thorac Cardiovasc Surg, V58, P356, DOI 10.1007/s11748-010-0604-0; Tani S, 2013, CIRC J, V77, P2349, DOI 10.1253/circj.CJ-12-1401; Xue BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045990	47	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1470	U292		10.1253/circj.CJ-14-0471		15	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800018		
J	Ihara, K; Sasaki, T; Shirai, Y; Tao, S; Maeda, S; Kawabata, M; Sasano, T; Yokoyama, Y; Isobe, M; Hirao, K				Ihara, Kensuke; Sasaki, Takeshi; Shirai, Yasuhiro; Tao, Susumu; Maeda, Shingo; Kawabata, Mihoko; Sasano, Tetsuo; Yokoyama, Yasuhiro; Isobe, Mitsuaki; Hirao, Kenzo			High Atrial Defibrillation Threshold With Internal Cardioversion Indicates Arrhythmogenicity of Superior Vena Cava in Non-Long-Standing Persistent Atrial Fibrillation	CIRCULATION JOURNAL			English	Article						Atrial fibrillation; Catheter ablation; Defibrillation threshold; Internal cardioversion; Superior vena cava	CATHETER ABLATION REGISTRY; ELECTRICAL ISOLATION; PULMONARY VEINS; J-CARAF; BREAKTHROUGHS; ORGANIZATION; RECURRENCE; STRATEGY	Background: The purpose of this study was to clarify the relation between atrial defibrillation threshold (ADFT) for internal cardioversion (IC) and arrhythmogenicity of the superior vena cava (SVC). Methods and Results: A total of 159 consecutive patients (139 male, age 59.9 +/- 10.3 years) who underwent radio-frequency catheter ablation of atrial fibrillation (AF) were assessed. IC was performed in 50 patients with non-longstanding persistent AF (non-LSAF) with a purpose-built cardioversion catheter in which direct current is delivered between the right atrium and the coronary sinus. SVC arrhythmogenicity was defined as SVC firing initiating AF, SVC associated with maintenance of AF, or frequent ectopy in the SVC. In all 50 non-LSAF patients, AF termination was obtained on IC during the procedure except in 1 patient with SVC AF. In the patients with ADFT >10 J (n=10), SVC arrhythmogenicity was observed more often than in those with ADFT <= 10 J (n=40; 60% vs. 13%; P=0.004). There were no significant differences between the 2 groups in left atrial diameter (40.8 +/- 7.6 vs. 40.6 +/- 6.3 mm; P=0.92), persistent AF (33% vs. 50%; P=0.46), or other clinical parameters. The patients who underwent SVC isolation, however, had higher ADFT before SVC isolation than those who did not (15.5 +/- 8.8 vs. 9.2 +/- 4.4 J; P=0.01). Conclusions: High IC ADFT is associated with SVC arrhythmogenicity in non-LSAF patients.	[Ihara, Kensuke; Sasaki, Takeshi; Shirai, Yasuhiro; Tao, Susumu; Kawabata, Mihoko; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo 1138510, Japan; [Sasano, Tetsuo] Tokyo Med & Dent Univ, Dept Biofunct Informat, Tokyo 1138510, Japan; [Hirao, Kenzo] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo 1138510, Japan; [Yokoyama, Yasuhiro] St Lukes Int Hosp, Cardiovasc Ctr, Dept Cardiol, Tokyo, Japan; [Maeda, Shingo] Hosp Univ Penn, Cardiovasc Div, Electrophysiol Sect, Philadelphia, PA 19104 USA	Ihara, K (reprint author), Tokyo Med & Dent Univ, Dept Cardiovasc Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	ihara-tmd@umin.ac.jp					Tsai CF, 2000, CIRCULATION, V102, P67; LEVY S, 1992, CIRCULATION, V86, P1415; Inoue K, 2014, CIRC J, V78, P1112, DOI 10.1253/circj.CJ-13-1179; Haissaguerre M, 2000, CIRCULATION, V102, P2463; Miyazaki S, 2014, J CARDIOVASC ELECTR, V25, P380, DOI 10.1111/jce.12342; Plank G, 2005, J CARDIOVASC ELECTR, V16, P205, DOI 10.1046/j.1540-8167.2005.40140.x; Corrado A, 2010, J CARDIOVASC ELECTR, V21, P1, DOI 10.1111/j.1540-8167.2009.01577.x; VANGELDER IC, 1991, AM J CARDIOL, V68, P41, DOI 10.1016/0002-9149(91)90707-R; Arruda M, 2007, J CARDIOVASC ELECTR, V18, P1261, DOI 10.1111/j.1540-8167.2007.00953.x; Miyazaki S, 2013, CIRC J, V77, P352, DOI 10.1253/circj.CJ-12-0951; Ouyang FF, 2004, CIRCULATION, V110, P2090, DOI 10.1161/01.CIR.0000144459.37455.EE; Lin WS, 2003, CIRCULATION, V107, P3176, DOI 10.1161/01.CIR.0000074206.52056.2D; Zhang JL, 2014, J CARDIOVASC ELECTR, V25, P364, DOI 10.1111/jce.12362; Bollmann A, 2002, PACE, V25, P1179, DOI 10.1046/j.1460-9592.2002.01179.x; Everett TH, 2001, CIRCULATION, V103, P2857; Everett TH, 2007, HEART RHYTHM, V4, P1048, DOI 10.1016/j.hrthm.2007.03.032; Goya M, 2002, CIRCULATION, V106, P1317, DOI 10.1161/01.CIR.0000033115.92612.F4; Higuchi K, 2013, CURR OPIN CARDIOL, V28, P2, DOI 10.1097/HCO.0b013e32835b099b; Higuchi K, 2010, HEART RHYTHM, V7, P1186, DOI 10.1016/j.hrthm.2010.05.017; JCS Joint Working Group, 2013, CIRC J, V77, P249; Komatsu Y, 2011, EUROPACE, V13, P213, DOI 10.1093/europace/euq357; Lau CP, 1997, PACE, V20, P2442, DOI 10.1111/j.1540-8159.1997.tb06084.x; Levy S, 1997, CIRCULATION, V96, P253; Mairesse GH, 2003, J INTERV CARD ELECTR, V9, P371, DOI 10.1023/A:1027403729049; Murakawa Y, 2014, CIRC J, V78, P1091, DOI 10.1253/circj.CJ-14-0099; Okumura Y, 2005, CIRC J, V69, P1514, DOI 10.1253/circj.69.1514; Saliba W, 1999, J AM COLL CARDIOL, V34, P2031, DOI 10.1016/S0735-1097(99)00463-5; Santini M, 1997, J AM COLL CARDIOL, V29, P576; Tao S, 2014, J INTERV CARD ELECTR, V39, P103, DOI 10.1007/s10840-013-9862-y	29	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1479	1485		10.1253/circj.CJ-14-1300		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800019		
J	Koretsune, Y; Yamashita, T; Kimura, T; Fukuzawa, M; Abe, K; Yasaka, M				Koretsune, Yukihiro; Yamashita, Takeshi; Kimura, Tetsuya; Fukuzawa, Masayuki; Abe, Kenji; Yasaka, Masahiro			Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment	CIRCULATION JOURNAL			English	Article						Anticoagulants; Atrial fibrillation; Edoxaban; Renal impairment	FACTOR XA INHIBITOR; PHARMACOKINETICS; WARFARIN; STROKE; THROMBOEMBOLISM; MULTICENTER; POPULATION; PREVENTION; IMPACT	Background: The short-term safety and plasma concentrations of edoxaban 15 mg once daily in Japanese patients with non-valvular atrial fibrillation (NVAF) and severe renal impairment (SRI; creatinine clearance [CLCR] >= 15 to <30 ml/min) were compared with those in NVAF patients with normal renal function or mild renal impairment (normal/MiRI; CLCR >= 50 ml/min) treated with edoxaban 30 or 60 mg. Methods and Results: In this Phase 3 multicenter open-label 3 parallel-group study, SRI patients received once-daily edoxaban 15 mg (n=50), whereas normal/MiRI patients were randomized to receive either once-daily edoxaban 30 or 60 mg (n=22 and 21, respectively) for 12 weeks. Plasma edoxaban concentrations and biomarkers of blood coagulation and fibrinolysis were measured. Adverse events and thromboembolic events were recorded throughout the study. Rates of any bleeding were comparable between SRI patients receiving edoxaban 15 mg (20.0%) and normal/MiRI patients receiving edoxaban 30 or 60 mg (22.7% and 23.8%, respectively). No major bleeding or thromboembolic events occurred in any treatment group. Similar plasma concentrations and biomarker profiles were observed in SRI patients receiving edoxaban 15 mg and normal/MiRI patients receiving edoxaban 30 or 60 mg. Conclusions: In this 12-week short-term study in Japanese NVAF patients with SRI, edoxaban 15 mg once daily exhibited similar safety, plasma concentration, and biomarker profiles as did the 30-mg and 60-mg doses in patients with normal/MiRI.	[Koretsune, Yukihiro] Natl Hosp Org, Osaka Natl Hosp, Inst Clin Res, Osaka 5400006, Japan; [Yamashita, Takeshi] Cardiovasc Inst, Tokyo, Japan; [Kimura, Tetsuya] Daiichi Sankyo Co Ltd, Clin Planning Dept, Tokyo, Japan; [Fukuzawa, Masayuki] Daiichi Sankyo Co Ltd, Clin Execut Dept, Tokyo, Japan; [Abe, Kenji] Daiichi Sankyo Co Ltd, Clin Data & Biostat Dept, Tokyo, Japan; [Yasaka, Masahiro] Natl Hosp Org, Kyushu Med Ctr, Dept Cerebrovasc Med & Neurol, Fukuoka, Japan	Koretsune, Y (reprint author), Natl Hosp Org, Osaka Natl Hosp, Inst Clin Res, Chuo Ku, 2-1-14 Hoenzaka, Osaka 5400006, Japan.	koretune@onh.go.jp			Daiichi-Sankyo Company, Ltd; Daiichi Sankyo, Inc (Parsippany, NJ, USA)	Daiichi-Sankyo Company, Ltd sponsored this study and was involved in the design of the study and the analysis of the data. Writing and statistical support was provided by Takehiro Hagiwara, Kenichi Sakakura, and Atsushi Takita (Daiichi Sankyo Co Ltd); writing and editorial support was provided by Terri Schochet, PhD, and Meryl Gersh, PhD (AlphaBioCom, King of Prussia, PA, USA), and funded by Daiichi Sankyo, Inc (Parsippany, NJ, USA).	[Anonymous], 2013, PRAZ CAPS DAB ET PAC; [Anonymous], 2013, EL TABL AP PACK INS; Hart RG, 2007, ANN INTERN MED, V146, P857; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; [Anonymous], 2012, XAR TABL RIV PACK IN; Shlipak MG, 2003, CIRCULATION, V107, P87, DOI 10.1161/01.CIR.0000042700.48769.59; Salazar DE, 2012, THROMB HAEMOSTASIS, V107, P925, DOI 10.1160/TH11-08-0566; Ridout G, 2009, J CLIN PHARMACOL, V49, P1124; Ogata K, 2010, J CLIN PHARMACOL, V50, P743, DOI 10.1177/0091270009351883; Fuji T, 2010, J THROMB HAEMOST, V8, P2458, DOI 10.1111/j.1538-7836.2010.04021.x; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Go AS, 2009, CIRCULATION, V119, P1363, DOI 10.1161/CIRCULATIONAHA.108.816082; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Yamashita T, 2012, CIRC J, V76, P1840, DOI 10.1253/circj.CJ-11-1140; Watanabe H, 2009, AM HEART J, V158, P629, DOI 10.1016/j.ahj.2009.06.031; Inoue H, 2009, INT J CARDIOL, V137, P102, DOI 10.1016/j.ijcard.2008.06.029; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Bathala MS, 2012, DRUG METAB DISPOS, V40, P2250, DOI 10.1124/dmd.112.046888; Weitz JI, 2010, THROMB HAEMOSTASIS, V104, P633, DOI 10.1160/TH10-01-0066; Furugohri T, 2008, J THROMB HAEMOST, V6, P1542, DOI 10.1111/j.1538-7836.2008.03064.x; JCS Joint Working Group, 2013, GUID PHARM ATR FIBR; Lip GYH, 2008, J INTERN MED, V264, P50, DOI 10.1111/j.1365-2796.2007.01909.x; Tanaka H, 2009, CIRC J, V73, P846	23	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1486	U313		10.1253/circj.CJ-14-0942		14	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800020		
J	Arai, T; Lefevre, T; Hayashida, K; Watanabe, Y; O'Connor, SA; Hovasse, T; Romano, M; Garot, P; Bouvier, E; Chevalier, B; Morice, MC				Arai, Takahide; Lefevre, Thierry; Hayashida, Kentaro; Watanabe, Yusuke; O'Connor, Stephen A.; Hovasse, Thomas; Romano, Mauro; Garot, Philippe; Bouvier, Erik; Chevalier, Bernard; Morice, Marie-Claude			Usefulness of a Simple Clinical Risk Prediction Method, Modified ACEF Score, for Transcatheter Aortic Valve Implantation	CIRCULATION JOURNAL			English	Article						Acute kidney injury; Modified age; creatinine clearance; ejection fraction score; Severe symptomatic aortic stenosis; Transcatheter aortic valve implantation	PERCUTANEOUS CORONARY INTERVENTION; VENTRICULAR SYSTOLIC FUNCTION; REDUCED EJECTION FRACTION; CREATININE CLEARANCE; SYNTAX SCORE; EUROSCORE II; OUTCOMES; REPLACEMENT; REGISTRY; MORTALITY	Background: We assessed the predictive accuracy of a simple risk score, modified age, creatinine clearance, ejection fraction (ACEFmodif) score, for outcome of transcatheter aortic valve implantation (TAVI). Methods and Results: We prospectively included 703 consecutive patients undergoing TAVI. Patients were divided into low, middle and high ACEFmodif tertiles. Increased ACEFmodif score was associated with a significantly higher 1-year mortality rate (22%, 28% and 36%, P<0.01) and higher risk of acute kidney injury (AKI; 10%, 10% and 22%, P<0.01). On multivariate logistic regression analysis, ACEFmodif score was the only independent predictor of AKI. On multivariate Cox regression, ACEFmodif score was an independent predictor of 1-year cumulative mortality. Although the area under curve (AUC) showed that all risk scores poorly predicted the incidence of AKI and 1-year cumulative mortality, ACEFmodif score was more efficient in predicting the incidence of AKI compared with STS, LES and ES II (AUC, 0.61, 0.55, 0.54, 0.57, respectively). Furthermore, ACEFmodif score had similar accuracy in predicting 1-year mortality compared with other risk scores (AUC, 0.61, 0.61, 0.61, 0.61, respectively). Conclusions: ACEFmodif score may provide useful information for predicting AKI, 30-day and 1-year mortality in patients undergoing TAVI, but these results need further confirmation.	[Arai, Takahide; Lefevre, Thierry; Hayashida, Kentaro; Watanabe, Yusuke; O'Connor, Stephen A.; Hovasse, Thomas; Garot, Philippe; Bouvier, Erik; Chevalier, Bernard; Morice, Marie-Claude] Inst Cardiovasc Paris Sud, Dept Intervent Cardiol, Massy, France; [Romano, Mauro] Inst Cardiovasc Paris Sud, Dept Cardiovasc Surg, Massy, France; [Hayashida, Kentaro] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Watanabe, Yusuke] Teikyo Univ, Sch Med, Dept Cardiol, Tokyo 173, Japan	Lefevre, T (reprint author), Hop Pr Jacques Cartier, Dept Intervent Cardiol, Gen Sante, 6 Ave Noyer Lambert, FR-91300 Massy, France.	t.lefevre@angio-icps.com			Japanese Circulation Society	The authors thank Mrs Catherine Dupic for her assistance with the manuscript. This study was supported, in part, by research grants from the Japanese Circulation Society (to T.A.).	Zahn R, 2011, EUR HEART J, V32, P198, DOI 10.1093/eurheartj/ehq339; O'Sullivan CJ, 2013, EUR HEART J, V34, P3437, DOI 10.1093/eurheartj/eht408; Yamamoto M, 2013, J AM COLL CARDIOL, V62, P869, DOI 10.1016/j.jacc.2013.04.057; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Garg S, 2010, CIRC-CARDIOVASC INTE, V3, P317, DOI 10.1161/CIRCINTERVENTIONS.109.914051; Ranucci M, 2009, CIRCULATION, V119, P3053, DOI 10.1161/CIRCULATIONAHA.108.842393; Ando G, 2013, INT J CARDIOL, V168, P4386, DOI 10.1016/j.ijcard.2013.05.049; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Werner N, 2014, CIRC J, V78, P811, DOI 10.1253/circj.CJ-14-0113; Keelan PC, 2003, AM J CARDIOL, V91, P1168, DOI 10.1016/S0002-9149(03)00261-3; Noyez L, 2006, EUR J CARDIO-THORAC, V29, P461, DOI 10.1016/j.ejcts.2006.01.024; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Durand E, 2013, AM J CARDIOL, V111, P891, DOI 10.1016/j.amjcard.2012.11.056; Hayashida K, 2011, JACC-CARDIOVASC INTE, V4, P851, DOI 10.1016/j.jcin.2011.03.019; Yamamoto M, 2014, ANN THORAC SURG, V97, P29, DOI 10.1016/j.athoracsur.2013.07.100; Capodanno D, 2013, CIRC J, V77, P1131, DOI 10.1253/circj.CJ-12-1613; Webb J, 2011, EUR HEART J, V32, P140, DOI 10.1093/eurheartj/ehq453; Feldman DN, 2006, AM J CARDIOL, V98, P1334, DOI 10.1016/j.amjcard.2006.06.026; Hayashida K, 2013, EUR J CARDIO-THORAC, V44, P692, DOI 10.1093/ejcts/ezt037; Kobayashi J, 2013, CIRC J, V77, P309, DOI 10.1253/circj.CJ-12-1546; Hayashida K, 2012, JACC-CARDIOVASC INTE, V5, P1247, DOI 10.1016/j.jcin.2012.09.003; D'Ascenzo F, 2013, J CARDIOVASC MED, V14, P894, DOI 10.2459/JCM.0b013e3283638e26; Yamamoto M, 2012, AM J CARDIOL, V110, P1156, DOI 10.1016/j.amjcard.2012.05.058; Lefevre T, 2011, EUR HEART J, V32, P148, DOI 10.1093/eurheartj/ehq427; van der Boon RM, 2012, CATHETER CARDIO INTE, V79, P702, DOI 10.1002/ccd.23423; CONCATO J, 1993, ANN INTERN MED, V118, P201; Watanabe Y, 2013, CATHETER CARDIO INTE, V81, P1053, DOI 10.1002/ccd.24702; Bauer F, 2013, ECHOCARDIOGR-J CARD, V30, P865, DOI 10.1111/echo.12171; Biondi-Zoccai G, 2012, EUROINTERVENTION, V8, P359, DOI 10.4244/EIJV8I3A55; Capodanno D, 2013, INT J CARDIOL, V168, P396, DOI 10.1016/j.ijcard.2012.09.026; Shaw James A, 2008, Cardiovasc Revasc Med, V9, P218, DOI 10.1016/j.carrev.2008.05.002; Walter Jörg, 2003, BMC Surg, V3, P4, DOI 10.1186/1471-2482-3-4; Wykrzykowska JJ, 2011, CIRC-CARDIOVASC INTE, V4, P47, DOI 10.1161/CIRCINTERVENTIONS.110.958389	33	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1496	1503		10.1253/circj.CJ-14-1242		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800021		
J	Ozaki, S; Kawase, I; Yamashita, H; Uchida, S; Takatoh, M; Hagiwara, S; Kiyohara, N				Ozaki, Shigeyuki; Kawase, Isamu; Yamashita, Hiromasa; Uchida, Shin; Takatoh, Mikio; Hagiwara, So; Kiyohara, Nagaki			Aortic Valve Reconstruction Using Autologous Pericardium for Aortic Stenosis	CIRCULATION JOURNAL			English	Article						Aortic root; Aortic stenosis; Aortic valve (repair); Heart valve (autograft); Pericardium	NATURAL-HISTORY; RISK PATIENTS; REPLACEMENT; TRANSCATHETER; IMPLANTATION; SURGERY; TRICUSPIDIZATION; INSUFFICIENCY; PROSTHESIS; DYNAMICS	Background: To determine the feasibility of original aortic valve reconstruction (AVRec) for patients with aortic stenosis (AS), 416 consecutive cases were reviewed. Methods and Results: AVRecs for AS were performed for 416 patients from April 2007 through April 2013. All 416 patients were retrospectively reviewed. One hundred and fourteen patients had bicuspid valves and 16 had unicuspid valves. There were 182 men and 234 women. Mean age was 71.2 +/- 12.0 years old. On preoperative echocardiography, peak pressure gradient averaged 79.0 +/- 33.6 mmHg. Surgical annular diameter was 20.1 +/- 2.8 mm. The procedure is based on independent tricuspid replacement by autologous pericardium using original sizing apparatus and template. There was no conversion to prosthetic valve replacement. There were 8 in-hospital mortalities due to non-cardiac cause. On postoperative echocardiography, peak pressure gradient averaged 21.2 +/- 10.7 mmHg 1 week after surgery and 14.3 +/- 5.0 mmHg 5.5 years after surgery. Four reoperations were done for infective endocarditis. The other 412 patients had less than mild regurgitation. No thrombo-embolic events were recorded. The mean follow-up period was 25.2 +/- 17.5 months. Freedom from reoperation was 96.7% with 73-month follow-up. Conclusions: Medium-term results were excellent. Original AVRec was feasible for the patients with AS. Long-term data will be presented in the future.	[Ozaki, Shigeyuki; Kawase, Isamu; Yamashita, Hiromasa; Uchida, Shin; Takatoh, Mikio; Hagiwara, So; Kiyohara, Nagaki] Toho Univ, Ohashi Med Ctr, Dept Cardiovasc Surg, Tokyo 1538515, Japan	Ozaki, S (reprint author), Toho Univ, Ohashi Med Ctr, Dept Cardiovasc Surg, Meguro Ku, 2-17-6 Ohashi, Tokyo 1538515, Japan.	ozakis@oha.toho-u.ac.jp					Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Aicher D, 2010, EUR J CARDIO-THORAC, V37, P127, DOI 10.1016/j.ejcts.2009.06.021; Bach DS, 2009, CIRC-CARDIOVASC QUAL, V2, P533, DOI 10.1161/CIRCOUTCOMES.109.848259; Lansac E, 2002, EUR J CARDIO-THORAC, V22, P497, DOI 10.1016/S1010-7940(02)00405-0; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630; HARKEN DE, 1960, J THORAC CARDIOV SUR, V40, P744; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; OTTO CM, 1994, CIRCULATION, V89, P642; Osnabrugge RLJ, 2012, ANN THORAC SURG, V94, P1954, DOI 10.1016/j.athoracsur.2012.07.002; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Hamdan A, 2012, J AM COLL CARDIOL, V59, P119, DOI 10.1016/j.jacc.2011.09.045; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Ozaki S, 2014, J THORAC CARDIOV SUR, V147, P301, DOI 10.1016/j.jtcvs.2012.11.012; Varadarajan P, 2006, ANN THORAC SURG, V82, P2111, DOI 10.1016/j.athoracsur.2006.07.048; Bonet T., 1679, SEPULCHRETUM SIVE AN; Braunwald E, 2000, EUR HEART J, V21, P1032, DOI 10.1053/euhj.1999.2052; BRAUNWALD NS, 1960, J THORAC CARDIOV SUR, V40, P1; Conradi L, 2012, J THORAC CARDIOV SUR, V143, P64, DOI 10.1016/j.jtcvs.2011.08.047; Doss M, 2008, EUR J CARDIO-THORAC, V33, P881, DOI 10.1016/j.ejcts.2008.01.052; Durán C M, 1988, Eur J Cardiothorac Surg, V2, P217, DOI 10.1016/1010-7940(88)90075-9; Faggiano Pompilio, 2006, Cardiovasc Ultrasound, V4, P27, DOI 10.1186/1476-7120-4-27; Fokin AA, 2013, ADV CONTROVERSIES AD, P15; FRANK S, 1973, BRIT HEART J, V35, P41; Grude E, 2007, J AM COLL CARDIOL, V50, P69; HILL DG, 1973, J THORAC CARDIOV SUR, V65, P708; Kawase I, 2012, ANN THORAC SURG, V94, P1180, DOI 10.1016/j.athoracsur.2012.05.016; Kawase I, 2011, ANN THORAC SURG, V91, P1598, DOI 10.1016/j.athoracsur.2010.10.068; Lansac E, 2008, EUR J CARDIO-THORAC, V33, P872, DOI 10.1016/j.ejcts.2007.12.033; LILLEHEI CW, 1958, J THORAC SURG, V35, P154; Manning WJ, 2013, JAMA-J AM MED ASSOC, V310, P1490, DOI 10.1001/jama.2013.279194; Otto CM, 2011, BRAUNWALDS HEART DIS, P1468; Ozaki S., 2001, ACTA BIOMEDICA LOVAN, V2001; Ozaki S, 2014, CIRC J, V78, P1144, DOI 10.1253/circj.CJ-13-1335; Ozaki S, 2011, INTERACT CARDIOV TH, V12, P550, DOI 10.1510/icvts.2010.253682; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tagliari AP, 2012, REV BRAS CIR CARDIOV, V27, P267, DOI 10.5935/1678-9741.20120043; Urbanski PP, 2013, ADV CONTROVERSIES AD, P48; Yaku H, 2014, CIRC J, V78, P1063, DOI 10.1253/circj.CJ-14-0299	39	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1504	1510		10.1253/circj.CJ-14-1092		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800022		
J	Takaya, Y; Yoshihara, F; Yokoyama, H; Kanzaki, H; Kitakaze, M; Goto, Y; Anzai, T; Yasuda, S; Ogawa, H; Kawano, Y				Takaya, Yoichi; Yoshihara, Fumiki; Yokoyama, Hiroyuki; Kanzaki, Hideaki; Kitakaze, Masafumi; Goto, Yoichi; Anzai, Toshihisa; Yasuda, Satoshi; Ogawa, Hisao; Kawano, Yuhei			Risk Stratification of Acute Kidney Injury Using the Blood Urea Nitrogen/Creatinine Ratio in Patients With Acute Decompensated Heart Failure	CIRCULATION JOURNAL			English	Article						Acute decompensated heart failure; Acute kidney injury; Blood urea nitrogen/creatinine ratio; Prognosis	WORSENING RENAL-FUNCTION; PROGNOSTIC IMPACT; NITROGEN; DYSFUNCTION; MORTALITY; METAANALYSIS; ROLOFYLLINE; DIURETICS; PREDICTOR	Background: Risk stratification of acute kidney injury (AKI) is important for acute decompensated heart failure (ADHF). The aim of this study was to determine whether clinical markers, such as the blood urea nitrogen/creatinine ratio (BUN/Cr) or BUN or creatinine values alone, stratify the risk of AKI for mortality. Methods and Results: In all, 371 consecutive ADHF patients were enrolled in the study. AKI was defined as serum creatinine >= 0.3 mg/dl or a 1.5-fold increase in serum creatinine levels within 48 h. During ADHF therapy, AKI occurred in 99 patients; 55 patients died during the 12-month follow-up period. Grouping patients according to AKI and a median BUN/Cr at admission of 22.1 (non-AKI+low BUN/Cr, non-AKI+high BUN/Cr, AKI+low BUN/Cr, and AKI+high BUN/Cr groups) revealed higher mortality in the AKI+high BUN/Cr group (log-rank test, P<0.001). Cox's proportional hazard analysis revealed an association between AKI+high BUN/Cr and mortality, whereas the association with AKI+low BUN/Cr did not reach statistical significance. When patients were grouped according to AKI and median BUN or creatinine values at admission, AKI was associated with mortality, regardless of BUN or creatinine. Conclusions: The combination of AKI and elevated BUN/Cr, but not BUN or creatinine individually, is linked with an increased risk of mortality in ADHF patients, suggesting that the BUN/Cr is useful for risk stratification of AKI.	[Takaya, Yoichi; Yokoyama, Hiroyuki; Kanzaki, Hideaki; Kitakaze, Masafumi; Goto, Yoichi; Anzai, Toshihisa; Yasuda, Satoshi; Ogawa, Hisao] Natl Cerebral & Cardiovasc Ctr, Dept Cardiol, Suita, Osaka 5658565, Japan; [Yoshihara, Fumiki; Kawano, Yuhei] Natl Cerebral & Cardiovasc Ctr, Dept Hypertens & Nephrol, Suita, Osaka 5658565, Japan	Yoshihara, F (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Hypertens & Nephrol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	fyoshi@hsp.ncvc.go.jp	Anzai, Toshihisa/J-2179-2015	Anzai, Toshihisa/0000-0003-3319-4967	Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency in Japan	This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency in Japan.	Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Smith GL, 2006, J AM COLL CARDIOL, V47, P1987, DOI 10.1016/j.jacc.2005.11.084; Damman K, 2007, J CARD FAIL, V13, P599, DOI 10.1016/j.cardfai1.2007.04.008; Breidthardt T, 2011, AM J CARDIOL, V107, P730, DOI 10.1016/j.amjcard.2010.10.056; Hillege HL, 2006, CIRCULATION, V113, P671, DOI 10.1161/CIRCULATIONAHA.105.580506; Forman DE, 2004, J AM COLL CARDIOL, V43, P61, DOI 10.1016/j.jacc.2003.07.031; Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7; Testani JM, 2010, CIRCULATION, V122, P265, DOI 10.1161/CIRCULATIONAHA.109.933275; Kazory A, 2010, AM J CARDIOL, V106, P694, DOI 10.1016/j.amjcard.2010.04.024; Nieminen MS, 2005, EUR HEART J, V26, P384; Schrier RW, 2008, CIRC-HEART FAIL, V1, P2, DOI 10.1161/CIRCHEARTFAILURE.108.770834; Aronson D, 2004, AM J MED, V116, P466, DOI 10.1016/j.amjmed.2003.11.014; Lin HJ, 2009, CLIN RES CARDIOL, V98, P487, DOI 10.1007/s00392-009-0025-1; Metra M, 2011, EUR HEART J, V32, P1519, DOI 10.1093/eurheartj/ehr042; Weinfeld MS, 1999, AM HEART J, V138, P285, DOI 10.1016/S0002-8703(99)70113-4; Miura M, 2013, CIRC J, V77, P1221, DOI 10.1253/circj.CJ-12-1390; Metra M, 2008, EUR J HEART FAIL, V10, P188, DOI 10.1016/j.ejheart.2008.01.011; Shirakabe A, 2013, CIRC J, V77, P687, DOI 10.1253/circj.CJ-12-0994; Testani JM, 2011, EUR J HEART FAIL, V13, P1224, DOI 10.1093/eurjhf/hfr123; Brisco MA, 2013, CIRC-HEART FAIL, V6, P233, DOI 10.1161/CIRCHEARTFAILURE.112.968230; Costanzo MR, 2007, J AM COLL CARDIOL, V49, P675, DOI 10.1016/j.jacc.2006.07.073; Metra M, 2012, CIRC-HEART FAIL, V5, P54, DOI 10.1161/CIRCHEARTFAILURE.111.963413; Chittineni H, 2007, AM J NEPHROL, V27, P55, DOI 10.1159/000099012; Lindenfeld J, 2011, J AM COLL CARDIOL, V58, P383, DOI 10.1016/j.jacc.2011.01.054; Massie BM, 2010, NEW ENGL J MED, V363, P1419, DOI 10.1056/NEJMoa0912613; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Schrier RW, 1999, NEW ENGL J MED, V341, P577; Takaya Y, 2014, HEART VESSELS, DOI [10.1007/s00380-014-0572-x, DOI 10.1007/S00380-014-0572-X]	28	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1520	1525		10.1253/circj.CJ-14-1360		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800024		
J	Kobayashi, M; Hoshina, K; Yamamoto, S; Nemoto, Y; Akai, T; Shigematsu, K; Watanabe, T; Ohshima, M				Kobayashi, Masaharu; Hoshina, Katsuyuki; Yamamoto, Sota; Nemoto, Youkou; Akai, Takafumi; Shigematsu, Kunihiro; Watanabe, Toshiaki; Ohshima, Marie			Development of an Image-Based Modeling System to Investigate Evolutional Geometric Changes of a Stent Graft in an Abdominal Aortic Aneurysm	CIRCULATION JOURNAL			English	Article						Aortic aneurysm; Modeling system; Stent graft	DEVICE-SPECIFIC ANALYSIS; ENDOVASCULAR REPAIR; NECK ANGULATION; ENDOLEAK; OUTCOMES; MIGRATION; NETWORK; TRIAL; JAPAN; EVAR	Background: Quantification of geometric changes of the stent graft (SG) in abdominal aortic aneurysm has been required for follow up of endovascular aneurysm repair (EVAR). The aim was to develop an image-based modeling system (V-Modeler) to investigate these changes over time. Methods and Results: V-Modeler was applied to investigate the migration of the SG. Three sets of computed tomography images were taken at 3 different times: (1) 5 days after the implantation; (2) 7 months later when the unilateral leg migrated upward; and (3) 10 months later when the limb had migrated into the common iliac aneurysm resulting in a type 1b endoleak. A spline function was used to represent the center lines of the SG to track its evolutional geometric changes in a three-dimensional manner. The characteristics of vascular geometry, as well as the SG geometry using geometric parameters such as length, curvature, torsion, angle of tangent vector (ATV), and migrated length, was evaluated. It was observed that the strong peak of the curvature in the distal area appeared, and a conversion of the torsion disappeared chronologically. Conclusions: The V-Modeler was developed, which not only can extract vascular geometry but also can identify geometric parameter, such as curvature, torsion, and ATV, to predict adverse events following EVAR.	[Kobayashi, Masaharu; Ohshima, Marie] Univ Tokyo, Inst Ind Sci, Interfac Initiat Informat Studies, Tokyo 1138655, Japan; [Hoshina, Katsuyuki; Nemoto, Youkou; Akai, Takafumi; Shigematsu, Kunihiro; Watanabe, Toshiaki] Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg, Tokyo 1138655, Japan; [Yamamoto, Sota] Shibaura Inst Technol, Grad Sch, Dept Mech Engn, Tokyo 108, Japan	Hoshina, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	traruba@gmail.com					Albertini JN, 2000, EUR J VASC ENDOVASC, V19, P308, DOI 10.1053/ejvs.1999.1045; O'Flynn PM, 2007, ANN BIOMED ENG, V35, P1368, DOI 10.1007/s10439-007-9307-9; Abbruzzese TA, 2008, J VASC SURG, V48, P19, DOI 10.1016/j.jvs.2008.02.003; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; van Keulen JW, 2010, J VASC SURG, V51, P821, DOI 10.1016/j.jvs.2009.10.114; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Sternbergh WC, 2002, J VASC SURG, V35, P482, DOI 10.1067/mva.2002.119506; AbuRahma AF, 2009, J VASC SURG, V50, P738, DOI 10.1016/j.jvs.2009.04.061; Hoshina K, 2011, INT ANGIOL, V30, P467; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Hobo R, 2007, J ENDOVASC THER, V14, P1, DOI 10.1583/06-1914.1; Ohrlander T, 2008, J ENDOVASC THER, V15, P427, DOI 10.1583/07-2315.1; Arun K S, 1987, IEEE Trans Pattern Anal Mach Intell, V9, P698; Ghouri M, 2010, TEX HEART I J, V37, P19; Handa N, 2014, CIRC J, V78, P1104, DOI 10.1253/circj.CJ-14-0131; Higashiura W, 2009, CARDIOVASC INTER RAD, V32, P441, DOI 10.1007/s00270-009-9531-9; Hoshina K, 2012, EUR J VASC ENDOVASC, V43, P257, DOI 10.1016/j.ejvs.2011.11.023; Hoshina K, 2013, CIRC J, V77, P1996, DOI 10.1253/circj.CJ-13-0204; O'Flynn PM, 2010, ANN BIOMED ENG, V38, P824, DOI 10.1007/s10439-010-9925-5; Rogers DF, 2001, INTRO NURBS HIST PER; SAITO T, 1994, IEICE T INF SYST, VE77D, P1005; Torii R, 2012, COMPUT METHOD BIOMEC, V15, P615, DOI 10.1080/10255842.2011.554407; van Keulen JW, 2010, J ENDOVASC THER, V17, P594, DOI 10.1583/10-3131MR.1; Velazquez OC, 2004, J VASC SURG, V40, P222, DOI 10.1016/j.jvs.2004.04.004; Whittaker DR, 2005, J VASC SURG, V41, P575, DOI 10.1016/j.jvs.2005.01.033	25	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1534	1541		10.1253/circj.CJ-15-0037		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800026		
J	Tsuda, T; Ishii, H; Ichimiya, S; Kanashiro, M; Watanabe, J; Takefuji, M; Aoyama, T; Suzuki, S; Tanaka, A; Matsubara, T; Murohara, T				Tsuda, Takuma; Ishii, Hideki; Ichimiya, Satoshi; Kanashiro, Masaaki; Watanabe, Jyunji; Takefuji, Mikito; Aoyama, Toru; Suzuki, Susumu; Tanaka, Akihito; Matsubara, Tatsuaki; Murohara, Toyoaki			Assessment of In-Stent Restenosis Using High-Definition Computed Tomography With a New Gemstone Detector	CIRCULATION JOURNAL			English	Article						Computed tomography; Diagnosis; Restenosis; Stent	SIROLIMUS-ELUTING STENT; CORONARY-ARTERY-DISEASE; CATCH-UP PHENOMENON; INTRAVASCULAR ULTRASOUND; DIAGNOSTIC-ACCURACY; BALLOON ANGIOPLASTY; INITIAL-EXPERIENCE; RANDOMIZED-TRIAL; IMPLANTATION; ANGIOGRAPHY	Background: Until now, there have been few reports on the accuracy of in-stent restenosis (ISR) detection using high-definition computed tomography (HDCT). The purpose of this study was to assess ISR using HDCT with a new gemstone detector and to examine the diagnostic accuracy compared with invasive coronary angiography. Methods and Results: We evaluated 162 consecutive patients with 316 stents and the image quality (IQ) scores used to assess ISR, and analyzed whether stent strut thickness and diameter affected IQ score and assessability. In the 316 stents, 278 were diagnosed as assessable with HDCT (88.0%). IQ score for stent diameter >= 3 mm was significantly higher than that for stent diameter <3 mm, for stents with both thick struts >= 140 mu m in thickness (mean IQ: 2.04 +/- 0.97 vs. 2.83 +/- 1.06, P<0.001) and thin struts <140 mu m (mean IQ: 1.92 +/- 0.87 vs. 2.64 +/- 0.96, P=0.01). Assessability for stent diameter <3 mm was significantly higher than that for stent diameter <3 mm only for stents with thick struts (92.8% vs. 76.1%, P<0.001). Stent strut thickness, however, was not statistically significantly associated with either IQ score or assessability. Conclusions: In-stent lumens have high HDCT assessability, and HDCT is useful to evaluate thick-strut stents with diameter <3 mm.	[Tsuda, Takuma; Ishii, Hideki; Takefuji, Mikito; Suzuki, Susumu; Tanaka, Akihito; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Tsuda, Takuma; Ichimiya, Satoshi; Kanashiro, Masaaki; Watanabe, Jyunji; Aoyama, Toru] Yokkaichi Municipal Hosp, Dept Cardiol, Yokaichi, Japan; [Matsubara, Tatsuaki] Aichi Gakuin Univ, Sch Dent, Dept Internal Med, Nagoya, Aichi 464, Japan	Ishii, H (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	hkishii@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014		Department of Cardiology of Yokkaichi Municipal Hospital; University of Nagoya, Japan	The study was supported in part by the Department of Cardiology of Yokkaichi Municipal Hospital and University of Nagoya, Japan.	Leschka S, 2005, EUR HEART J, V26, P1482, DOI 10.1093/eurheartj/ehi261; Gilard M, 2006, HEART, V92, P58, DOI 10.1136/hrt.2004.056010; Mahnken AH, 2006, ACTA RADIOL, V47, P36, DOI 10.1080/02841850500406779; Rixe J, 2006, EUR HEART J, V27, P2567, DOI 10.1093/eurheartj/ehl303; de Graaf FR, 2010, INVEST RADIOL, V45, P331, DOI 10.1097/RLI.0b013e3181dfa312; Ehara M, 2007, J AM COLL CARDIOL, V49, P951, DOI 10.1016/j.jacc.2006.10.065; Yang TH, 2012, INT J CARDIOL, V160, P48, DOI 10.1016/j.ijcard.2011.03.024; Gaspar T, 2005, J AM COLL CARDIOL, V46, P1573, DOI 10.1016/j.jacc.2005.07.049; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; Imai M, 2011, CIRCULATION, V123, P2382, DOI 10.1161/CIRCULATIONAHA.110.003459; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Mark DB, 2010, CIRCULATION, V121, P2509, DOI 10.1161/CIR.0b013e3181d4b618; Kitagawa T, 2006, INT J CARDIOL, V109, P188, DOI 10.1016/j.ijcard.2005.06.012; Iijima R, 2013, INT J CARDIOL, V168, P2588, DOI 10.1016/j.ijcard.2013.03.046; Sheth T, 2007, CATHETER CARDIO INTE, V69, P933, DOI 10.1002/ccd.21130; Oncel D, 2007, RADIOLOGY, V242, P403, DOI 10.1148/radiol.2422060065; Ehara M, 2006, CIRC J, V70, P564, DOI 10.1253/circj.70.564; KHALTAEV NG, 1994, WHO TECH REP SER, V844, P1; Siddiqi OK, 2012, CURR OPIN CARDIOL, V27, P634, DOI 10.1097/HCO.0b013e3283587c7e; Morice MC, 2006, JAMA-J AM MED ASSOC, V295, P895, DOI 10.1001/jama.295.8.895; Schuijf JD, 2004, AM J CARDIOL, V94, P427, DOI 10.1016/j.amjcard.2004.04.057; Lv PJ, 2011, RADIOLOGY, V259, P720, DOI 10.1148/radiol.11101425; Mehanna E, 2013, CIRC J, V77, P2334, DOI 10.1253/circj.CJ-12-1458; Araki T, 2014, J CARDIOL, V64, P423, DOI 10.1016/j.jjcc.2014.03.001; Beohar N, 2006, CATHETER CARDIO INTE, V68, P8, DOI 10.1002/ccd.20786; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Imai Masao, 2014, Cardiovasc Interv Ther, V29, P226, DOI 10.1007/s12928-014-0248-6; Jung I., 2007, KOREAN CIRC J, V37, P521; Kong Ling-yan, 2009, Chinese Medical Sciences Journal, V24, P156; Mahnken AH, 2007, EUR RADIOL, V17, P994, DOI 10.1007/s00330-006-0433-9; Park KW, 2013, CIRC J, V77, P2912, DOI 10.1253/circj.CJ-13-0645; Rist C, 2006, EUR RADIOL, V16, P1564, DOI 10.1007/s00330-006-0186-5; Suga T, 2014, J CARDIOL, V63, P218, DOI 10.1016/j.jjcc.2013.08.006; Yamanaga K, 2014, J CARDIOL, V64, P279, DOI 10.1016/j.jjcc.2014.02.008; Youn YJ, 2014, AM HEART J, V167, P241, DOI 10.1016/j.ahj.2013.08.028; Zhang JY, 2012, INT J CARDIOVAS IMAG, V28, P651, DOI 10.1007/s10554-011-9842-1	37	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1542	1548		10.1253/circj.CJ-14-1344		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800027		
J	Nakajima, K; Matsuo, S; Wakabayashi, H; Yokoyama, K; Bunko, H; Okuda, K; Kinuya, S; Nystrom, K; Edenbrandt, L				Nakajima, Kenichi; Matsuo, Shinro; Wakabayashi, Hiroshi; Yokoyama, Kunihiko; Bunko, Hisashi; Okuda, Koichi; Kinuya, Seigo; Nystrom, Karin; Edenbrandt, Lars			Diagnostic Performance of Artificial Neural Network for Detecting Ischemia in Myocardial Perfusion Imaging	CIRCULATION JOURNAL			English	Article						Artificial neural network; Coronary artery disease; Myocardial ischemia; Myocardial perfusion imaging; Quantitative analysis	CORONARY-ARTERY-DISEASE; EMISSION COMPUTED-TOMOGRAPHY; DIFFERENT SOFTWARE PACKAGES; OPTIMAL MEDICAL THERAPY; GATED-SPECT; RISK STRATIFICATION; NUCLEAR CARDIOLOGY; HEART-ASSOCIATION; CARDIAC EVENTS; CLINICAL-USE	Background: The purpose of this study was to apply an artificial neural network (ANN) in patients with coronary artery disease (CAD) and to characterize its diagnostic ability compared with conventional visual and quantitative methods in myocardial perfusion imaging (MPI). Methods and Results: A total of 106 patients with CAD were studied with MPI, including multiple vessel disease (49%), history of myocardial infarction (27%) and coronary intervention (30%). The ANN detected abnormal areas with a probability of stress defect and ischemia. The consensus diagnosis based on expert interpretation and coronary stenosis was used as the gold standard. The left ventricular ANN value was higher in the stress-defect group than in the no-defect group (0.92 +/- 0.11 vs. 0.25 +/- 0.32, P<0.0001) and higher in the ischemia group than in the noischemia group (0.70 +/- 0.40 vs. 0.004 +/- 0.032, P<0.0001). Receiver-operating characteristics curve analysis showed comparable diagnostic accuracy between ANN and the scoring methods (0.971 vs. 0.980 for stress defect, and 0.882 vs. 0.937 for ischemia, both P=NS). The relationship between the ANN and defect scores was non-linear, with the ANN rapidly increased in ranges of summed stress score of 2-7 and summed defect score of 2-4. Conclusions: Although the diagnostic ability of ANN was similar to that of conventional scoring methods, the ANN could provide a different viewpoint for judging abnormality, and thus is a promising method for evaluating abnormality in MPI.	[Nakajima, Kenichi; Matsuo, Shinro; Wakabayashi, Hiroshi; Kinuya, Seigo] Kanazawa Univ Hosp, Dept Nucl Med, Kanazawa, Ishikawa 9208641, Japan; [Yokoyama, Kunihiko] Matto Ishikawa Cent Hosp, Positron Emiss Tomog Ctr, Haku San, Japan; [Bunko, Hisashi] Kanazawa Cardiovasc Hosp, Dept Radiol, Kanazawa, Ishikawa, Japan; [Okuda, Koichi] Kanazawa Med Univ, Dept Phys, Uchinada, Ishikawa 92002, Japan; [Nystrom, Karin] EXINI Diagnost, Lund, Sweden; [Edenbrandt, Lars] Univ Gothenburg, Dept Clin Physiol & Nucl Med, Gothenburg, Sweden	Nakajima, K (reprint author), Kanazawa Univ Hosp, Dept Nucl Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	nakajima@med.kanazawa-u.ac.jp					Sharir T, 2001, J NUCL MED, V42, P831; Nishimura T, 2008, EUR J NUCL MED MOL I, V35, P319, DOI 10.1007/s00259-007-0608-x; Ficaro EP, 2007, J NUCL CARDIOL, V14, P455, DOI 10.1016/j.nuclcard.2007.06.006; Wolak A, 2008, J NUCL CARDIOL, V15, P27, DOI 10.1016/j.nuclcard.2007.09.020; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Germano G, 2007, J NUCL CARDIOL, V14, P433, DOI 10.1016/j.nuclcard.2007.06.008; Slomka PJ, 2005, J NUCL CARDIOL, V12, P66, DOI 10.1016/j.nuclcard.2004.10.006; Garcia EV, 2007, J NUCL CARDIOL, V14, P420, DOI 10.1016/j.nuclcard.2007.06.009; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Guner LA, 2010, EUR J NUCL MED MOL I, V37, P2070, DOI 10.1007/s00259-010-1522-1; Svensson A, 2004, EUR J NUCL MED MOL I, V31, P229, DOI 10.1007/s00259-003-1361-4; Wijns W, 2010, EUR HEART J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Berman DS, 2004, J NUCL CARDIOL, V11, P414, DOI 10.1016/j.nuclcard.2004.03.033; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Edenbrandt L, 2014, BMC MED IMAGING, V14, DOI 10.1186/1471-2342-14-5; Furuhashi T, 2014, CIRC J, V78, P1676, DOI 10.1253/circj.CJ-14-0018; Garcia EV, 2014, J NUCL CARDIOL, V21, P427, DOI 10.1007/s12350-014-9857-9; Garcia EV, 2014, J NUCL CARDIOL, V21, P440; Gimelli A, 2009, J NUCL MED, V50, P546, DOI 10.2967/jnumed.108.055954; GORRY GA, 1973, METHOD INFORM MED, V12, P45; Johansson L, 2014, J NUCL CARDIOL, V21, P416, DOI 10.1007/s12350-013-9815-y; Klocke FJ, 2003, CIRCULATION, V108, P1404, DOI 10.1161/01.CIR.0000080946.42225.4D; Lomsky M, 2008, EUR J NUCL MED MOL I, V35, P1523, DOI 10.1007/s00259-008-0746-9; Lomsky M, 2006, CLIN PHYSIOL FUNCT I, V26, P139, DOI 10.1111/j.1475-097X.2006.00667.x; Matsumoto N, 2007, CIRC J, V71, P1580, DOI 10.1253/circj.71.1580; Nakajima K, 2013, EUR J NUCL MED MOL I, V40, P1163, DOI 10.1007/s00259-013-2431-x; Nakajima K, 2012, CIRC J, V76, P168, DOI 10.1253/circj.CJ-11-0857; Nakajima K, 2010, ANN NUCL MED, V24, P125, DOI 10.1007/s12149-009-0337-2; Nakajima K, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-83; Okuda K, 2011, ANN NUCL MED, V25, P571, DOI 10.1007/s12149-011-0504-0; Tamaki N, 2012, CIRC J, V76, P761, DOI 10.1253/circj.CJ-88-0019	32	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1549	1556		10.1253/circj.CJ-15-0079		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800028		
J	Oba, T; Yasukawa, H; Nagata, T; Kyogoku, S; Minami, T; Nishihara, M; Ohshima, H; Mawatari, K; Nohara, S; Takahashi, J; Sugi, Y; Igata, S; Iwamoto, Y; Kai, H; Matsuoka, H; Takano, M; Aoki, H; Fukumoto, Y; Imaizumi, T				Oba, Toyoharu; Yasukawa, Hideo; Nagata, Takanobu; Kyogoku, Sachiko; Minami, Tomoko; Nishihara, Michihide; Ohshima, Hideki; Mawatari, Kazutoshi; Nohara, Shoichiro; Takahashi, Jinya; Sugi, Yusuke; Igata, Sachiyo; Iwamoto, Yoshiko; Kai, Hisashi; Matsuoka, Hidehiro; Takano, Makoto; Aoki, Hiroki; Fukumoto, Yoshihiro; Imaizumi, Tsutomu			Renal Nerve-Mediated Erythropoietin Release Confers Cardioprotection During Remote Ischemic Preconditioning	CIRCULATION JOURNAL			English	Article						Cardioprotection; Erythropoietin; JAK-STAT; Remote ischemic preconditioning; Renal nerve	ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; JAK-STAT PATHWAY; HEART-FAILURE; CLINICAL-APPLICATION; REPERFUSION INJURY; LATE PROTECTION; BYPASS SURGERY; RATS; DENERVATION	Background: Remote ischemic preconditioning (RIPC) induced by transient limb ischemia is a powerful innate mechanism of cardioprotection against ischemia. Several described mechanisms explain how RIPC may act through neural pathways or humoral factors; however, the mechanistic pathway linking the remote organ to the heart has not yet been fully elucidated. This study aimed to investigate the mechanisms underlying the RIPC-induced production of Janus kinase (JAK)-signal transducer and activator of the transcription (STAT)-activating cytokines and cardioprotection by using mouse and human models of RIPC. Methods and Results: Screened circulating cardioprotective JAK-STAT-activating cytokines in mice unexpectedly revealed increased serum erythropoietin (EPO) levels after RIP induced by transient ischemia. In mice, RIPC rapidly upregulated EPO mRNA and its main transcriptional factor, hypoxia-inducible factor-1 alpha (HIF1 alpha), in the kidney. Laser Doppler blood flowmetry revealed a prompt reduction of renal blood flow (RBF) after RIPC. RIPC activated cardioprotective signaling pathways and the anti-apoptotic Bcl-xL pathway in the heart, and reduced infarct size. In mice, these effects were abolished by administration of an EPO-neutralizing antibody. Renal nerve denervation also abolished RIPC-induced RBF reduction, EPO production, and cardioprotection. In humans, transient limb ischemia of the upper arm reduced RBF and increased serum EPO levels. Conclusions: Based on the present data, we propose a novel RIPC mechanism in which inhibition of infarct size by RIPC is produced through the renal nerve-mediated reduction of RBF associated with activation of the HIF1 alpha-EPO pathway.	[Oba, Toyoharu; Yasukawa, Hideo; Nagata, Takanobu; Kyogoku, Sachiko; Minami, Tomoko; Nishihara, Michihide; Ohshima, Hideki; Mawatari, Kazutoshi; Nohara, Shoichiro; Takahashi, Jinya; Sugi, Yusuke; Iwamoto, Yoshiko; Kai, Hisashi; Matsuoka, Hidehiro; Fukumoto, Yoshihiro] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka 8300011, Japan; [Yasukawa, Hideo; Aoki, Hiroki; Fukumoto, Yoshihiro] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka 8300011, Japan; [Igata, Sachiyo; Takano, Makoto] Kurume Univ, Sch Med, Dept Physiol, Div Integrated Auton Funct, Kurume, Fukuoka 8300011, Japan; [Imaizumi, Tsutomu] Fukuoka Sanno Hosp, Fukuoka, Japan; [Imaizumi, Tsutomu] Int Univ Hlth & Welf, Fukuoka, Japan	Yasukawa, H (reprint author), Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	yahideo@med.kurume-u.ac.jp			grant for the Science Frontier Research Promotion Centers (Cardiovascular Research Institute); Ministry of Education, Science, Sports, and Culture, Japan; Kimura Memorial Heart Foundation; Japanese Ministry of Health, Labour and Welfare Research Grant	We thank Kimiko Kimura, Miyuki Nishigata, Makiko Kiyohiro, Katsue Shiramizu, and Miho Nakao for their excellent technical assistance. This study was supported, in part, by a grant for the Science Frontier Research Promotion Centers (Cardiovascular Research Institute); by Grants-in-Aid for Scientific Research (T.O., H.Y., T.I.) from the Ministry of Education, Science, Sports, and Culture, Japan; by a Research Grant for Cardiovascular Diseases from the Kimura Memorial Heart Foundation (H.Y.); and by a Japanese Ministry of Health, Labour and Welfare Research Grant (T.I.).	Hausenloy DJ, 2011, NAT REV CARDIOL, V8, P619, DOI 10.1038/nrcardio.2011.85; Chen J, 2013, CIRCULATION, V128, P2577, DOI 10.1161/CIRCULATIONAHA.113.003668; Liem DA, 2002, AM J PHYSIOL-HEART C, V283, pH29, DOI 10.1152/ajpheart.01031.2001; Wei M, 2011, CIRC RES, V108, P1220, DOI 10.1161/CIRCRESAHA.110.236190; Thielmann M, 2013, LANCET, V382, P597, DOI 10.1016/S0140-6736(13)61450-6; Loukogeorgakis SP, 2005, J AM COLL CARDIOL, V46, P450, DOI 10.1016/j.jacc.2005.04.044; MURRY CE, 1986, CIRCULATION, V74, P1124; Nakamura R, 2009, CIRC J, V73, P1920; Lim SY, 2010, BASIC RES CARDIOL, V105, P651, DOI 10.1007/s00395-010-0099-y; Slagsvold KH, 2014, CIRC RES, V114, P851, DOI 10.1161/CIRCRESAHA.114.302751; PRZYKLENK K, 1993, CIRCULATION, V87, P893; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Ferrario M, 2007, EUR HEART J, V28, P1805, DOI 10.1093/eurheartj/ehm065; Barry SP, 2007, TRENDS MOL MED, V13, P82, DOI 10.1016/j.molmed.2006.12.002; Davies WR, 2013, CIRC-CARDIOVASC INTE, V6, P246, DOI 10.1161/CIRCINTERVENTIONS.112.000184; Nozawa T, 2002, HEART VESSELS, V16, P51, DOI 10.1007/s380-002-8317-8; Dickson EW, 1999, AM J PHYSIOL-HEART C, V277, pH2451; Birnbaum Y, 1997, CIRCULATION, V96, P1641; Schoemaker RG, 2000, AM J PHYSIOL-HEART C, V278, pH1571; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Johns EJ, 2011, COMPR PHYSIOL, V1, P731, DOI 10.1002/cphy.c100043; Heusch G, 2012, CIRC RES, V110, P111, DOI 10.1161/CIRCRESAHA.111.259556; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Igarashi G, 2013, CIRC J, V77, P3037, DOI 10.1253/circj.CJ-13-0171; Shimizu M, 2009, CLIN SCI, V117, P191, DOI 10.1042/CS20080523; Hu JL, 2014, INT J CARDIOL, V172, pE414, DOI 10.1016/j.ijcard.2013.12.254; Cai ZQP, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0277-1; CHAREONTHAITAWEE P, 1995, J AM COLL CARDIOL, V25, P567, DOI 10.1016/0735-1097(94)00431-O; Ditting T, 2007, AM J PHYSIOL-RENAL, V293, pF1099, DOI 10.1152/ajprenal.00267.2007; ECKARDT KU, 1992, AM J PHYSIOL, V263, pF925; FINK GD, 1976, AM J PHYSIOL, V230, P508; Gebhard C, 2006, J PHARMACOL EXP THER, V319, P111, DOI 10.1124/jpet.106.105973; Hirata A, 2006, J AM COLL CARDIOL, V48, P176, DOI 10.1016/j.jacc.2006.04.008; Hu JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045986; Kloner RA, 2009, CIRCULATION, V119, P776, DOI 10.1161/CIRCULATIONAHA.108.832832; MATSUOKA H, 1994, HYPERTENSION, V23, P971; Namiuchi S, 2005, J AM COLL CARDIOL, V45, P1406, DOI 10.1016/j.jacc.2005.01.043; Oba T, 2012, J AM COLL CARDIOL, V59, P838, DOI 10.1016/j.jacc.2011.10.887; Redington KL, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0241-5; Riksen NP, 2008, TRENDS PHARMACOL SCI, V29, P258, DOI 10.1016/j.tips.2008.02.002; Seino Y, 2013, CIRC J, V77, P2883, DOI 10.1253/circj.CJ-13-1297; Zhang WD, 2006, J NEUROIMMUNOL, V174, P63, DOI 10.1016/j.jneuroim.2006.01.014	46	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1557	U392		10.1253/circj.CJ-14-1171		14	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800029		
J	Orii, M; Imanishi, T; Teraguchi, I; Nishiguchi, T; Shiono, Y; Yamano, T; Ino, Y; Hirata, K; Kubo, T; Tanaka, A; Akasaka, T				Orii, Makoto; Imanishi, Toshio; Teraguchi, Ikuko; Nishiguchi, Tsuyoshi; Shiono, Yasutsugu; Yamano, Takashi; Ino, Yasushi; Hirata, Kumiko; Kubo, Takashi; Tanaka, Atsushi; Akasaka, Takashi			Circulating CD14(++)CD16(+) Monocyte Subsets as a Surrogate Marker of the Therapeutic Effect of Corticosteroid Therapy in Patients With Cardiac Sarcoidosis	CIRCULATION JOURNAL			English	Article						Cardiac sarcoidosis; CD14(++)16(+) monocytes; F-18-fluoro-2-deoxyglucose; Positron emission tomography	POSITRON-EMISSION-TOMOGRAPHY; ACUTE MYOCARDIAL-INFARCTION; PERIPHERAL-BLOOD; CONVERTING-ENZYME; KAWASAKI-DISEASE; F-18-FDG PET; EXPRESSION; CELLS; BRONCHOALVEOLAR; IDENTIFICATION	Background: We aimed to evaluate whether specific monocyte subsets could serve as surrogate markers of disease activity in cardiac sarcoidosis (CS) evaluated by F-18-fluoro-2-deoxyglucose positron emission tomography (F-18-FDG PET). Methods and Results: We studied 28 patients with CS (8 men; mean age: 61 +/- 9 years) diagnosed according to consensus criteria. We divided the patients into 2 groups: known CS receiving corticosteroid therapy (Rx(+); n=13) and new-onset CS (Rx(-); n=15), and analyzed 3 distinct monocyte subsets (CD14(+)CD16(-), CD14(++) CD16(+), and CD14(+)-CD16(+)). Monocyte subsets were also analyzed in 10 Rx(-) patients before and 12 weeks after starting corticosteroid therapy. Inflammatory activity was quantified by F-18-FDG PET using the coefficient of variation (COV) of the standardized uptake value (SUV). The proportion of CD14(++)CD16(+) monocytes in Rx(+) patients (10.8 [0.2-23.5] %) was significantly lower than in Rx(-) patients (23.0 [11.5-38.4] %, P=0.001). After corticosteroid therapy, the COV of the SUV was significantly improved from 0.32 [0.14-0.62] to 0.17 [0.04-0.43] (P=0.017). The proportion of CD14(++)16(+) monocytes showed a significant decrease from 22.2 [8.8-38.4] % to 8.4 [1.8-16.8] % (P=0.001). The decrease in the proportion of CD14(++)16(+) monocytes significantly correlated with the decrease in the COV of the SUV (r=0.495, P=0.027). Conclusions: CD14(++)16(+) monocytes are a possible surrogate marker of the therapeutic effect of corticosteroid therapy in CS.	[Orii, Makoto; Imanishi, Toshio; Teraguchi, Ikuko; Nishiguchi, Tsuyoshi; Shiono, Yasutsugu; Yamano, Takashi; Ino, Yasushi; Hirata, Kumiko; Kubo, Takashi; Tanaka, Atsushi; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418510, Japan	Imanishi, T (reprint author), Wakayama Med Univ, Dept Cardiovasc Med, 811-1 Kimiidera, Wakayama 6418510, Japan.	t-imani@wakayama-med.ac.jp					ROBERTS WC, 1977, AM J MED, V63, P86, DOI 10.1016/0002-9343(77)90121-8; LIEBERMAN J, 1975, AM J MED, V59, P365, DOI 10.1016/0002-9343(75)90395-2; Ziegenhagen MW, 2003, EUR RESPIR J, V21, P407, DOI 10.1183/09031936.03.00010403; Escher F, 2011, HEART, V97, P733, DOI 10.1136/hrt.2010.205716; Tadamura E, 2006, CIRCULATION, V113, pE771, DOI 10.1161/CIRCULATIONAHA.105.594200; Tahara N, 2010, JACC-CARDIOVASC IMAG, V3, P1219, DOI 10.1016/j.jcmg.2010.09.015; Katayama K, 2000, CLIN EXP IMMUNOL, V121, P566, DOI 10.1046/j.1365-2249.2000.01321.x; Rothkrantz-Kos S, 2003, CLIN CHEM, V49, P1510, DOI 10.1373/49.9.1510; Ishimaru S, 2005, EUR HEART J, V26, P1538, DOI 10.1093/eurheartj/ehi180; Langah R, 2009, J NUCL CARDIOL, V16, P801, DOI 10.1007/s12350-009-9110-0; Vanham G, 1996, CLIN EXP IMMUNOL, V103, P30, DOI 10.1046/j.1365-2249.1996.907600.x; Blankstein R, 2014, J AM COLL CARDIOL, V63, P329, DOI 10.1016/j.jacc.2013.09.022; Wahlstrom J, 1999, THORAX, V54, P339; NOCKHER WA, 1994, CLIN EXP IMMUNOL, V98, P369; Takeda N, 2002, CIRCULATION, V105, P1144, DOI 10.1161/hc0902.103432; Youssef G, 2012, J NUCL MED, V53, P241, DOI 10.2967/jnumed.111.090662; Uemura A, 1999, AM HEART J, V138, P299, DOI 10.1016/S0002-8703(99)70115-8; Okumura W, 2004, J NUCL MED, V45, P1989; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Miyagawa M, 2014, CIRC J, V78, P1302, DOI 10.1253/circj.CJ-14-0250; Mc Ardle BA, 2013, J NUCL CARDIOL, V20, P297, DOI 10.1007/s12350-012-9668-9; Okamoto H, 2003, J DERMATOL, V30, P503; FINGERLE G, 1993, BLOOD, V82, P3170; Blankstein R, 1994, EUR J NUCL MED, V21, P297; Heron M, 2008, CHEST, V134, P1001, DOI 10.1378/chest.08-0443; Hiraga H, 1993, GUIDELINE DIAGNOSIS, P23; Kuroi A, 2010, CIRC J, V74, P2720, DOI 10.1253/circj.CJ-10-0317; LEWIS PJ, 1994, J NUCL MED, V35, P1647; Moller DR, 1999, VASC DIFFUSE LUNG DI, V16, P24; Ohira Hiroshi, 2011, Eur J Nucl Med Mol Imaging, V38, P1773, DOI 10.1007/s00259-011-1832-y; Ohira H, 2013, CIRC J, V77, P836, DOI 10.1253/circj.CJ-13-0213; Ozaki Y, 2012, CIRC J, V76, P2412, DOI 10.1253/circj.CJ-12-0412; SELROOS O, 1979, SCAND J RESPIR DIS, V60, P328; Tamaki N, 2012, CIRC J, V76, P761, DOI 10.1253/circj.CJ-88-0019; Tsujioka H, 2010, CIRC J, V74, P1175, DOI 10.1253/circj.CJ-09-1045; Yoshida T, 2005, CARDIOVASC RES, V68, P278, DOI 10.1016/j.cardiores.2005.06.006; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	38	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1585	1592		10.1253/circj.CJ-14-1422		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800032		
J	Nagai, T; Nagano, N; Sugano, Y; Asaumi, Y; Aiba, T; Kanzaki, H; Kusano, K; Noguchi, T; Yasuda, S; Ogawa, H; Anzai, T				Nagai, Toshiyuki; Nagano, Nobutaka; Sugano, Yasuo; Asaumi, Yasuhide; Aiba, Takeshi; Kanzaki, Hideaki; Kusano, Kengo; Noguchi, Teruo; Yasuda, Satoshi; Ogawa, Hisao; Anzai, Toshihisa			Effect of Corticosteroid Therapy on Long-Term Clinical Outcome and Left Ventricular Function in Patients With Cardiac Sarcoidosis	CIRCULATION JOURNAL			English	Article						Cardiac sarcoidosis; Corticosteroid; Left ventricular function; Long-term prognosis	POSITRON-EMISSION-TOMOGRAPHY; STEROID-THERAPY; ATRIOVENTRICULAR-BLOCK; MYOCARDIAL INVOLVEMENT; TL-201 SCINTIGRAPHY; GA-67; IDENTIFICATION; DIAGNOSIS; DISEASE; BIOPSY	Background: Cardiac involvement is the worst prognostic determinant in patients with sarcoidosis, but the long-term prognostic significance of corticosteroid therapy for cardiac sarcoidosis (CS) remains unclear. Methods and Results: We examined 83 consecutive patients diagnosed with CS. Patients were divided into 2 groups based on the presence or absence of corticosteroid therapy at diagnosis. Patients with corticosteroid therapy had lower age and higher rate of positive findings in the myocardium on gallium scintigraphy (Ga) at diagnosis than those without. LVEF, biomarkers, and use of cardiovascular medication were similar between the 2 groups. During the follow-up (7.6 +/- 4.4 years), corticosteroid therapy was associated with fewer long-term adverse events (overall, P=0.005; cardiac death, P=0.92; symptomatic arrhythmias, P=0.89; heart failure admission, P<0.0001) and a greater % increase in LVEF than those without (7.9 +/- 36.3% vs. -16.7 +/- 34.8%, P=0.03). On Cox proportional hazards modeling, corticosteroid therapy (HR, 0.41; 95% CI: 0.20-0.89) was an independent determinant of long-term adverse event-free survival, but age, sex, LVEF, and Ga findings were not. Conclusions: Corticosteroid therapy might have a beneficial effect on long-term clinical outcome in CS patients, particularly by reduction of heart failure admission and retarding the progression of LV systolic dysfunction.	[Nagai, Toshiyuki; Nagano, Nobutaka; Sugano, Yasuo; Asaumi, Yasuhide; Aiba, Takeshi; Kanzaki, Hideaki; Kusano, Kengo; Noguchi, Teruo; Yasuda, Satoshi; Ogawa, Hisao; Anzai, Toshihisa] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan; [Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan	Anzai, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	anzai@ncvc.go.jp	Anzai, Toshihisa/J-2179-2015	Anzai, Toshihisa/0000-0003-3319-4967	Japan Cardiovascular Research Foundation; Japan Society for the Promotion of Science [25860630]	This work was supported by a Grant from the Japan Cardiovascular Research Foundation (T. Anzai), and a Grant-in-Aid for Young Scientists (T. Nagai, 25860630) from the Japan Society for the Promotion of Science.	PALEVSKY HI, 1992, J NUCL MED, V33, P751; ROBERTS WC, 1977, AM J MED, V63, P86, DOI 10.1016/0002-9343(77)90121-8; Vignaux O, 2002, J COMPUT ASSIST TOMO, V26, P762, DOI 10.1097/00004728-200209000-00017; Ohira H, 2008, EUR J NUCL MED MOL I, V35, P933, DOI 10.1007/s00259-007-0650-8; Grutters JC, 2006, EUR RESPIR J, V28, P627, DOI 10.1183/09031936.06.00105805; Tadamura E, 2006, CIRCULATION, V113, pE771, DOI 10.1161/CIRCULATIONAHA.105.594200; SILVERMAN KJ, 1978, CIRCULATION, V58, P1204; Sekiguchi M, 1996, CARDIOVASC DRUG THER, V10, P495, DOI 10.1007/BF00050989; Kaminaga T, 2004, INT J CARDIOL, V94, P99, DOI 10.1016/j.ijcard.2003.05.012; Vignaux O, 2005, AM J ROENTGENOL, V184, P249; Ishimaru S, 2005, EUR HEART J, V26, P1538, DOI 10.1093/eurheartj/ehi180; Futamatsu H, 2006, INT J CARDIOVAS IMAG, V22, P443, DOI 10.1007/s10554-005-9043-x; Langah R, 2009, J NUCL CARDIOL, V16, P801, DOI 10.1007/s12350-009-9110-0; Yazaki Y, 2001, AM J CARDIOL, V88, P1006, DOI 10.1016/S0002-9149(01)01978-6; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Chiu CZ, 2005, AM J CARDIOL, V95, P143, DOI 10.1016/j.amjcard.2004.08.083; Tadamura E, 2005, AM J ROENTGENOL, V185, P110; Vignaux O, 2002, CHEST, V122, P1895, DOI 10.1378/chest.122.6.1895; OKAYAMA K, 1995, CHEST, V107, P330, DOI 10.1378/chest.107.2.330; Hiramitsu S, 2005, SARCOIDOSIS VASC DIF, V22, P210; KHALIL N, 1993, J CLIN INVEST, V92, P1812, DOI 10.1172/JCI116771; Kato Y, 2003, SARCOIDOSIS VASC DIF, V20, P133; Okumura W, 2004, J NUCL MED, V45, P1989; Miyagawa M, 2014, CIRC J, V78, P1302, DOI 10.1253/circj.CJ-14-0250; Chapelon-Abric C, 2004, MEDICINE, V83, P315, DOI 10.1097/01.md.0000145367.17934.75; Bussinguer Michelle, 2012, Curr Treat Options Cardiovasc Med, V14, P652, DOI 10.1007/s11936-012-0208-3; DUBOIS RM, 1994, EUR RESPIR J, V7, P1203, DOI 10.1183/09031936.94.07071203; FIELDS CL, 1990, SOUTHERN MED J, V83, P339, DOI 10.1097/00007611-199003000-00022; FLEMING HA, 1974, BRIT HEART J, V36, P54; Fujita N, 1990, Heart Vessels Suppl, V5, P16; Hiraga H, 1993, GUIDELINE DIAGNOSIS, P23; ISHIKAWA T, 1984, CHEST, V85, P445, DOI 10.1378/chest.85.3.445; LORELL B, 1978, AM J CARDIOL, V42, P143, DOI 10.1016/0002-9149(78)90999-2; Namboodiri Narayanan, 2012, Indian Pacing Electrophysiol J, V12, P284; Nemeth MA, 2004, TEX HEART I J, V31, P99; OCONNELL JB, 1984, CIRCULATION, V70, P58; Ohira H, 2013, CIRC J, V77, P836, DOI 10.1253/circj.CJ-13-0213; Radulescu B, 2009, EUR HEART J, V31, P400; Tsuda T, 2006, JPN J SARCOIDOSIS OT, V27, P89; Umetani K, 2000, INTERNAL MED, V39, P245, DOI 10.2169/internalmedicine.39.245; VALANTINE H A, 1987, Journal of Heart Transplantation, V6, P244	41	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1593	1600		10.1253/circj.CJ-14-1275		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800033		
J	Nagano, N; Nagai, T; Sugano, Y; Morita, Y; Asaumi, Y; Aiba, T; Kanzaki, H; Kusano, K; Noguchi, T; Yasuda, S; Ogawa, H; Anzai, T				Nagano, Nobutaka; Nagai, Toshiyuki; Sugano, Yasuo; Morita, Yoshiaki; Asaumi, Yasuhide; Aiba, Takeshi; Kanzaki, Hideaki; Kusano, Kengo; Noguchi, Teruo; Yasuda, Satoshi; Ogawa, Hisao; Anzai, Toshihisa			Association Between Basal Thinning of Interventricular Septum and Adverse Long-Term Clinical Outcomes in Patients With Cardiac Sarcoidosis	CIRCULATION JOURNAL			English	Article						Cardiomyopathy; Echocardiography; Heart failure; Sarcoidosis	POSITRON-EMISSION-TOMOGRAPHY; CARDIOVASCULAR MAGNETIC-RESONANCE; ATRIOVENTRICULAR-BLOCK; HYPERTROPHIC CARDIOMYOPATHY; ENDOMYOCARDIAL BIOPSY; PROGNOSTIC VALUE; INVOLVEMENT; DIAGNOSIS; HEART; MANIFESTATION	Background: Basal thinning of the interventricular septum (IVS) is an important diagnostic feature of cardiac sarcoidosis (CS), but its long-term prognostic significance remains unclear. Methods and Results: We examined 74 consecutive patients who were diagnosed with CS. Basal IVS thickness at a point located 10 mm from the aortic annulus was measured. IVS thickness at the left ventricular minor axis level (IVS) was also measured according to the recommended procedure of the American Society of Echocardiography. Patients were divided into 2 groups based on the presence or absence of basal IVS thinning, which was defined as basal IVS <= 4 mm and/or basal IVS/IVS ratio <= 0.6. Basal IVS thinning was observed in 21 patients and was associated with greater long-term adverse events during follow-up (5.1 +/- 2.5 years), although the baseline characteristics were comparable between groups (overall, P<0.01; all-cause death, P=0.53; symptomatic arrhythmias, P<0.01; heart failure admission, P=0.027). Multivariate analysis showed basal IVS thinning was an independent determinant of long-term adverse events (hazard ratio 2.86, 95% confidence interval 1.31-6.14) even after adjustment for existing prognostic variables. Conclusions: The presence of basal IVS thinning at the time of CS diagnosis was associated with poor long-term clinical outcomes, suggesting its prognostic significance in patients with CS.	[Nagano, Nobutaka; Nagai, Toshiyuki; Sugano, Yasuo; Asaumi, Yasuhide; Aiba, Takeshi; Kanzaki, Hideaki; Kusano, Kengo; Noguchi, Teruo; Yasuda, Satoshi; Ogawa, Hisao; Anzai, Toshihisa] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan; [Morita, Yoshiaki] Natl Cerebral & Cardiovasc Ctr, Dept Radiol, Suita, Osaka 5658565, Japan; [Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan	Anzai, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	anzai@ncvc.go.jp	Anzai, Toshihisa/J-2179-2015	Anzai, Toshihisa/0000-0003-3319-4967	Japan Cardiovascular Research Foundation [24-6-2]; Japan Society for the Promotion of Science [25860630]	This work was supported by a Grant from the Japan Cardiovascular Research Foundation (T. Anzai, 24-6-2) and a Grant-in-Aid for Young Scientists (T. Nagai, 25860630) from the Japan Society for the Promotion of Science.	Greulich S, 2013, JACC-CARDIOVASC IMAG, V6, P501, DOI 10.1016/j.jcmg.2012.10.021; Manabe O, 2013, EUR J NUCL MED MOL I, V40, P1558, DOI 10.1007/s00259-013-2460-5; ROBERTS WC, 1977, AM J MED, V63, P86, DOI 10.1016/0002-9343(77)90121-8; Mehta D, 2008, CHEST, V133, P1426, DOI 10.1378/chest.07-2784; Kim JS, 2009, AM HEART J, V157, P9, DOI 10.1016/j.ahj.2008.09.009; Kandolin R, 2011, J INTERN MED, V270, P461, DOI 10.1111/j.1365-2796.2011.02396.x; KINNEY E, 1979, CHEST, V76, P476, DOI 10.1378/chest.76.4.476; SILVERMAN KJ, 1978, CIRCULATION, V58, P1204; Mc Ardle BA, 2013, CIRC-CARDIOVASC IMAG, V6, P617, DOI 10.1161/CIRCIMAGING.112.000289; Schuller JL, 2011, ANN NONINVAS ELECTRO, V16, P70, DOI 10.1111/j.1542-474X.2010.00411.x; Vignaux O, 2005, AM J ROENTGENOL, V184, P249; Fahy GJ, 1996, CHEST, V109, P62, DOI 10.1378/chest.109.1.62; Ishimaru S, 2005, EUR HEART J, V26, P1538, DOI 10.1093/eurheartj/ehi180; Nureki S, 2014, INT HEART J, V55, P181; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Manabe O, 2014, ANN NUCL MED, V28, P656, DOI 10.1007/s12149-014-0860-7; Yazaki Y, 2001, AM J CARDIOL, V88, P1006, DOI 10.1016/S0002-9149(01)01978-6; SEKIGUCHI M, 1980, JPN CIRC J, V44, P249; Smedema JP, 2005, J AM COLL CARDIOL, V45, P1683, DOI 10.1016/j.jacc.2005.01.047; Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352; Blankstein R, 2014, J AM COLL CARDIOL, V63, P329, DOI 10.1016/j.jacc.2013.09.022; Miyazaki S, 2011, INT J CARDIOL, V150, pE4, DOI 10.1016/j.ijcard.2009.05.047; OKAYAMA K, 1995, CHEST, V107, P330, DOI 10.1378/chest.107.2.330; Moller DR, 1999, SARCOIDOSIS VASC DIF, V16, P24; Ise T, 2014, HEART, V100, P1165, DOI 10.1136/heartjnl-2013-305187; Uemura A, 2005, SARCOIDOSIS VASC DIF, V22, P63; Miyagawa M, 2014, CIRC J, V78, P1302, DOI 10.1253/circj.CJ-14-0250; FLEMING HA, 1974, BRIT HEART J, V36, P54; GARRETT J, 1984, AM HEART J, V107, P394, DOI 10.1016/0002-8703(84)90394-6; Hiraga H, 1993, GUIDELINE DIAGNOSIS, P23; Kandolin R, 2015, CIRCULATION, V131, P624, DOI 10.1161/CIRCULATIONAHA.114.011522; LORELL B, 1978, AM J CARDIOL, V42, P143, DOI 10.1016/0002-9149(78)90999-2; Matsumori A, 2000, JPN CIRC J, V64, P679, DOI 10.1253/jcj.64.679; Morimoto S, 2006, CIRC J S, V70, P215; Ohira H, 2013, CIRC J, V77, P836, DOI 10.1253/circj.CJ-13-0213; Tsuda T, 2006, JPN J SARCOIDOSIS OT, V27, P89; VALANTINE H, 1987, BRIT HEART J, V57, P256; Yazaki Y, 1998, JPN CIRC J, V62, P465, DOI 10.1253/jcj.62.465	38	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1601	1608		10.1253/circj.CJ-14-1217		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800034		
J	Shirasu, T; Hoshina, K; Yamamoto, S; Shigematsu, K; Miyata, T; Watanabe, T				Shirasu, Takuro; Hoshina, Katsuyuki; Yamamoto, Satoshi; Shigematsu, Kunihiro; Miyata, Tetsuro; Watanabe, Toshiaki			Poor Prognosis in Critical Limb Ischemia Without Pre-Onset Intermittent Claudication	CIRCULATION JOURNAL			English	Article						Asymptomatic; Chronic subclinical ischemia; Critical limb ischemia; Intermittent claudication; Peripheral artery disease	PERIPHERAL ARTERIAL-DISEASE; SKIN PERFUSION-PRESSURE; ENDOVASCULAR TREATMENT; RISK STRATIFICATION; MULTICENTER; MANAGEMENT; SOCIETY; BYPASS; FOOT	Background: Some patients with critical limb ischemia (CLI) lack symptoms of intermittent claudication (IC) before the onset of CLI. We studied the outcome of such patients, because this is currently unknown. Methods and Results: For retrospective exploratory analysis, we divided 225 patients (265 limbs) with CLI into 2 groups: 142 patients (172 limbs) without a history of IC (non-IC group) and 83 patients (93 limbs) with IC (IC group). We examined comorbid factors and found that a higher proportion of patients in the non-IC group failed to undergo arterial revascularization (49% vs. 20%, P<0.0001) due to progressed limb ischemia and infection. We then analyzed 140 patients (161 limbs) with revascularization. Patients in the non-IC group were more likely to have diabetes mellitus (P=0.03), hypoalbuminemia (P=0.02), advanced Rutherford's classification (P=0.0007), worse ambulatory function (P=0.009), and longer postoperative stay (P=0.04). Amputation-free survival was lower in the non-IC group (P=0.005). On Cox regression anlaysis, hemodialysis (P=0.002), coronary artery disease (P=0.04), cerebrovascular disease (P=0.02), non-ambulatory status (P=0.02), and non-IC (P=0.01) were independent risk factors for lower amputation-free survival. Conclusions: Patients without IC before CLI onset have several unique features, and non-IC is an independent risk factor for poor outcome.	[Shirasu, Takuro; Hoshina, Katsuyuki; Shigematsu, Kunihiro; Watanabe, Toshiaki] Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg, Tokyo 1138655, Japan; [Yamamoto, Satoshi] Ome Municipal Gen Hosp, Dept Surg, Tokyo, Japan; [Miyata, Tetsuro] Sanno Hosp, Vasc Ctr, Tokyo, Japan; [Miyata, Tetsuro] Sanno Med Ctr, Tokyo, Japan	Hoshina, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	traruba@gmail.com					Taylor SM, 2007, J AM COLL SURGEONS, V204, P831, DOI 10.1016/j.jamcollsurg.2007.01.037; McDermott MM, 2008, CIRCULATION, V117, P2484, DOI 10.1161/CIRCULATIONAHA.107.736108; Egorova N, 2010, J VASC SURG, V51, P372, DOI 10.1016/j.jvs.2009.09.006; Tsai FW, 2000, J VASC SURG, V32, P32, DOI 10.1067/mva.2000.107310; Iida O, 2013, CIRC-CARDIOVASC INTE, V6, P68, DOI 10.1161/CIRCINTERVENTIONS.112.975318; Soga Y, 2013, CIRC J, V77, P2102, DOI 10.1253/circj.CJ-13-0020; Belch JJF, 2003, ARCH INTERN MED, V163, P884, DOI 10.1001/archinte.163.8.884; Mills JL, 2014, J VASC SURG, V59, P220, DOI 10.1016/j.jvs.2013.08.003; Schanzer A, 2008, J VASC SURG, V48, P1464, DOI 10.1016/j.jvs.2008.07.062; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Castronuovo JJ, 1997, J VASC SURG, V26, P629, DOI 10.1016/S0741-5214(97)70062-4; Ortmann J, 2012, J VASC SURG, V55, P98, DOI 10.1016/j.jvs.2011.07.074; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Diehm C, 2009, CIRCULATION, V120, P2053, DOI 10.1161/CIRCULATIONAHA.109.865600; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; De Caridi G, 2014, INT WOUND J, DOI [10.1111/iwj.12301, DOI 10.1111/IWJ.12301]; Flu HC, 2010, J VASC SURG, V51, P360, DOI 10.1016/j.jvs.2009.08.051; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Kobayashi N, 2014, CIRC J, V78, P1746, DOI 10.1253/circj.CJ-14-0171; Kumakura H, 2011, ATHEROSCLEROSIS, V219, P846, DOI 10.1016/j.atherosclerosis.2011.08.037; Soga Y, 2014, JACC-CARDIOVASC INTE, V7, P1444, DOI 10.1016/j.jcin.2014.06.018; Urabe Go, 2009, Ann Vasc Dis, V2, P21, DOI 10.3400/avd.AVDoa08029; van Kuijk JP, 2010, EUR HEART J, V31, P992, DOI 10.1093/eurheartj/ehp553	23	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1618	1623		10.1253/circj.CJ-15-0017		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800036		
J	Saito, Y; Watanabe, M; Aonuma, K; Hirayama, A; Tamaki, N; Tsutsui, H; Murohara, T; Ogawa, H; Akasaka, T; Yoshimura, M; Sato, A; Takayama, T; Sakakibara, M; Suzuki, S; Ishigami, K; Onoue, K				Saito, Yoshihiko; Watanabe, Makoto; Aonuma, Kazutaka; Hirayama, Atsushi; Tamaki, Nagara; Tsutsui, Hiroyuki; Murohara, Toyoaki; Ogawa, Hisao; Akasaka, Takashi; Yoshimura, Michihiro; Sato, Akira; Takayama, Tadateru; Sakakibara, Mamoru; Suzuki, Susumu; Ishigami, Kenichi; Onoue, Kenji		CINC-J Study Investigators	Proteinuria and Reduced Estimated Glomerular Filtration Rate Are Independent Risk Factors for Contrast-Induced Nephropathy After Cardiac Catheterization	CIRCULATION JOURNAL			English	Article						Contrast-induced nephropathy; Estimated glomerular filtration rate; Proteinuria	PERCUTANEOUS CORONARY INTERVENTION; ACUTE KIDNEY INJURY; RELATIVE RENAL SAFETY; MORTALITY; DISEASE; METAANALYSIS; HYDRATION; FAILURE; MEDIA; INSUFFICIENCY	Background: The aim of this study was to investigate the incidence of contrast-induced nephropathy (CIN) according to renal function in patients with or without proteinuria after cardiac catheterization in Japan. Methods and Results: We conducted a multicenter prospective observational study involving 27 hospitals from all over Japan, which enrolled 906 patients with cardiac catheterization. CIN was defined as increase in serum creatinine >= 0.5 mg/dl or >= 25% from baseline between 48 and 72 h after exposure to contrast. The incidence of CIN in patients with estimated glomerular filtration rate (eGFR) <30 ml/min/1.73 m(2) was significantly higher than that in patients with eGFR >= 60 ml/min/1.73 m(2). In patients without proteinuria, the incidence of CIN did not increase as eGFR decreased, but such a trend was observed in patients with proteinuria. Proteinuria was highly significantly associated with CIN in patients with eGFR 30-44 ml/min/1.73 m(2) (OR, 12.1; 95% CI: 2.81-82.8; P=0.0006) and eGFR < 30 ml/min/1.73 m(2) (OR, 17.4; 95% CI: 3.32-321; P=0.0001). On multivariate logistic regression analysis, proteinuria (OR, 4.09; 95% CI: 1.66-10.0), eGFR (OR, 1.02; 95% CI: 1.00-1.04), contrast volume/eGFR (OR, 1.31; 95% CI: 1.04-1.65), and Ca antagonist use (OR, 3.79; 95% CI: 1.52-10.8) were significant predictors of CIN. Conclusions: Proteinuria and reduced eGFR are independent risk factors for CIN after cardiac catheterization.	[Saito, Yoshihiko; Watanabe, Makoto; Onoue, Kenji] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 6348522, Japan; [Aonuma, Kazutaka; Sato, Akira] Univ Tsukuba, Fac Med, Div Cardiovasc, Tsukuba, Ibaraki, Japan; [Hirayama, Atsushi; Takayama, Tadateru] Nihon Univ, Sch Med, Dept Med, Div Cardiol, Tokyo, Japan; [Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido, Japan; [Tsutsui, Hiroyuki; Sakakibara, Mamoru] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Murohara, Toyoaki; Suzuki, Susumu] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan; [Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama, Japan; [Yoshimura, Michihiro] Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan; [Ishigami, Kenichi] Saiseikai Suita Hosp, Dept Cardiol, Suita, Osaka, Japan	Saito, Y (reprint author), Nara Med Univ, Dept Internal Med 1, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	saitonaramed@gmail.com	Murohara, Toyoaki/M-4958-2014		Japanese Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation	This study was supported by a fund from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and Takeda Science Foundation.	Gruberg L, 2000, J AM COLL CARDIOL, V36, P1542, DOI 10.1016/S0735-1097(00)00917-7; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Gleeson TG, 2004, AM J ROENTGENOL, V183, P1673; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; [Anonymous], JROAD ANN REP 2012; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Lacquaniti A, 2013, ACTA DIABETOL, V50, P935, DOI 10.1007/s00592-013-0485-7; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; Abe D, 2014, CIRC J, V78, P85, DOI 10.1253/circj.CJ-13-0574; Tepel M, 2006, CIRCULATION, V113, P1799, DOI 10.1161/CIRCULATIONAHA.105.595090; EISENBERG RL, 1981, AM J ROENTGENOL, V136, P859; Meier P, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-23; Gurm HS, 2011, J AM COLL CARDIOL, V58, P907, DOI 10.1016/j.jacc.2011.05.023; Trivedi HS, 2003, NEPHRON CLIN PRACT, V93, pC29, DOI 10.1159/000066641; Reed M, 2009, JACC-CARDIOVASC INTE, V2, P645, DOI 10.1016/j.jcin.2009.05.002; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Gupta R, 2005, CATHETER CARDIO INTE, V64, P442, DOI 10.1002/ccd.20316; Zoja C, 1995, AM J KIDNEY DIS, V26, P934, DOI 10.1016/0272-6386(95)90058-6; Goldenberg I, 2009, AM J NEPHROL, V29, P136, DOI 10.1159/000151772; CIGARROA RG, 1989, AM J MED, V86, P649, DOI 10.1016/0002-9343(89)90437-3; Fu WJ, 2012, ENDOCRINE, V41, P82, DOI 10.1007/s12020-011-9509-7; McCullough PA, 2005, CRIT CARE CLIN, V21, P261, DOI 10.1016/j.ccc.2004.12.003; Igarashi G, 2013, CIRC J, V77, P3037, DOI 10.1253/circj.CJ-13-0171; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Maioli M, 2012, CIRCULATION, V125, P3099, DOI 10.1161/CIRCULATIONAHA.111.085290; Cirillo M, 2008, ARCH INTERN MED, V168, P617, DOI 10.1001/archinte.168.6.617; Clark JJ, 2011, AM SURGEON, V77, P1194; Foster MC, 2007, ARCH INTERN MED, V167, P1386, DOI 10.1001/archinte.167.13.1386; JSN JRS and JCS Joint Working Group, 2013, CIRC J, V77, P1883; Reed MC, 2010, J INVASIVE CARDIOL, V22, P467; Ren L, 2011, J INT MED RES, V39, P647; Singh N, 2014, OPEN HEART, V1, DOI [DOI 10.1136/OPENHRT-2014-000127, 10.1136/openhrt-2014-000127]; Zhang T, 2011, AM J NEPHROL, V33, P344, DOI 10.1159/000326269	35	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1624	1630		10.1253/circj.CJ-14-1345		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800037		
J	Sato, K; Sakata, Y; Miura, M; Tadaki, S; Ushigome, R; Yamauchi, T; Onose, T; Tsuji, K; Abe, R; Nochioka, K; Takahashi, J; Miyata, S; Shimokawa, H				Sato, Kenjiro; Sakata, Yasuhiko; Miura, Masanobu; Tadaki, Soichiro; Ushigome, Ryoichi; Yamauchi, Takeshi; Onose, Takeo; Tsuji, Kanako; Abe, Ruri; Nochioka, Kotaro; Takahashi, Jun; Miyata, Satoshi; Shimokawa, Hiroaki		CHART-2 Investigators	Comprehensive Risk Stratification of Japanese Patients With Aortic Stenosis - A Proposal of a New Risk Score From the CHART-2 Study	CIRCULATION JOURNAL			English	Article						Aortic stenosis; Heart failure; Risk score	HEART-FAILURE; NATURAL-HISTORY; ASYMPTOMATIC PATIENTS; VALVE STENOSIS; SEVERITY; ADULTS; PREDICTION; BIOMARKERS; SURVIVAL; IMPACT	Background: The risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities. Methods and Results: We aimed to develop a risk score for mortality in 412 patients with AS (pressure gradient >= 30 mmHg, mean age 74.9 years, male 52.4%) in the CHART-2 Study (n=10,219). During a 3-year follow-up, 73 (17.7%) patients died. Crude 3-year mortality of patients in New York Heart Association (NYHA) classes I, II, and III/IV was 9.5%, 16.5%, and 49.7%, respectively (P<0.001). Stepwise Cox regression analysis showed that the combination of 7 factors was the best model to predict the mortality of AS patients, who were scored according to their hazard ratios, including NYHA class III-IV (score 6), male sex (3), serum albumin level <= 4 g/dl (2), aortic peak flow >= 4.5 m/s (2), age >= 75 years (2), chronic kidney disease (2), and anemia (1). Receiver-operating characteristic analysis showed excellent association between the sum of the scores and 3-year mortality (area under the curve, 0.78). The multivariate Cox proportional hazard model demonstrated that the present risk score also well stratified the mortality risk. Conclusions: The present study demonstrates that, in addition to the classical prognostic factors related to symptoms and AS severity, various comorbidities are associated with mortality. Thus, the present comprehensive risk score may be useful for risk stratification of AS patients.	[Sato, Kenjiro; Sakata, Yasuhiko; Miura, Masanobu; Tadaki, Soichiro; Ushigome, Ryoichi; Yamauchi, Takeshi; Onose, Takeo; Tsuji, Kanako; Abe, Ruri; Nochioka, Kotaro; Takahashi, Jun; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan; [Miyata, Satoshi] Tohoku Univ, Grad Sch Med, Dept Evidence Based Cardiovasc Med, Sendai, Miyagi 9808574, Japan	Sakata, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	sakatayk@cardio.med.tohoku.ac.jp			Ministry of Health, Labor and Welfare	This study was supported by Grants-in-Aid from the Research Grant from the Ministry of Health, Labor and Welfare (H.S.).	Blackshear JL, 2013, AM J CARDIOL, V111, P374, DOI 10.1016/j.amjcard.2012.10.015; Garcia D, 2000, CIRCULATION, V101, P765; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Kang DH, 2010, CIRCULATION, V121, P1502, DOI 10.1161/CIRCULATIONAHA.109.909903; Nochioka K, 2013, CIRC J, V77, P2318, DOI 10.1253/circj.CJ-13-0127; Monin JL, 2009, CIRCULATION, V120, P69, DOI 10.1161/CIRCULATIONAHA.108.808857; PELLIKKA PA, 1990, J AM COLL CARDIOL, V15, P1012; Shiba N, 2011, CIRC J, V75, P823, DOI 10.1253/circj.CJ-11-0135; Shibayama K, 2012, CIRC J, V76, P1761, DOI 10.1253/circj.CJ-12-0025; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Bahlmann E, 2010, JACC-CARDIOVASC IMAG, V3, P555, DOI 10.1016/j.jcmg.2009.11.019; Pellikka PA, 2005, CIRCULATION, V111, P3290, DOI 10.1161/CIRCULATIONAHA.104.495903; Miura M, 2014, CIRC J, V78, P2276, DOI 10.1253/circj.CJ-14-0387; Bouma BJ, 1999, HEART, V82, P143; Pocock SJ, 2013, EUR HEART J, V34, P1404, DOI 10.1093/eurheartj/ehs337; CHIZNER MA, 1980, AM HEART J, V99, P419, DOI 10.1016/0002-8703(80)90375-0; Henkel DM, 2012, J AM COLL CARDIOL, V60, P2325, DOI 10.1016/j.jacc.2012.08.988; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Ky B, 2012, CIRC-HEART FAIL, V5, P183, DOI 10.1161/CIRCHEARTFAILURE.111.965020; Sawa Y, 2014, CIRC J, V78, P1083, DOI 10.1253/circj.CJ-14-0162; Hachicha Z, 2009, J AM COLL CARDIOL, V54, P1003, DOI 10.1016/j.jacc.2009.04.079; Brown ML, 2008, J THORAC CARDIOV SUR, V135, P308, DOI 10.1016/j.jtcvs.2007.08.058; Varadarajan P, 2006, ANN THORAC SURG, V82, P2111, DOI 10.1016/j.athoracsur.2006.07.048; Bonow R, 2006, CIRCULATION, V114, P450; Japanese Circulation Society, GUID SURG INT TREATM; Kume T, 2008, CIRC J, V72, P1265, DOI 10.1253/circj.72.1265; Ohno M, 2011, CIRC J, V75, P2474, DOI 10.1253/circj.CJ-11-0012; Perera Suresh, 2011, N Z Med J, V124, P40; Qi W, 2001, AM HEART J, V142, P725, DOI 10.1067/mhj.2001.117131; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; Ross Jr J, 1968, CIRCULATION S5, V38, P61; Weber M, 2004, AM J CARDIOL, V94, P740, DOI 10.1016/j.amjcard.2004.05.055; World Health Organization, 1968, WHO TECH REP SER, V405, P3	34	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1631	U270		10.1253/circj.CJ-15-0062		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800038		
J	Yamashita, Y; Horii, T				Yamashita, Yoichi; Horii, Taiko			Biatrial Myxomas With Various Manifestations - Carney Complex	CIRCULATION JOURNAL			English	Editorial Material							RECURRENT		[Yamashita, Yoichi; Horii, Taiko] Kagawa Univ, Dept Cardiovasc Surg, Fac Med, Kita, Kagawa 7610793, Japan	Horii, T (reprint author), Kagawa Univ, Dept Cardiovasc Surg, 1750-1 Miki, Kita, Kagawa 7610793, Japan.	thorii@med.kagawa-u.ac.jp					Amano Jun, 2013, Gen Thorac Cardiovasc Surg, V61, P435, DOI 10.1007/s11748-013-0214-8; Stratakis CA, 2001, J CLIN ENDOCR METAB, V86, P4041, DOI 10.1210/jc.86.9.4041; MCCARTHY PM, 1986, J THORAC CARDIOV SUR, V91, P389; CARNEY JA, 1985, MEDICINE, V64, P270; Miyagawa M, 2014, CIRC J, V78, P1302, DOI 10.1253/circj.CJ-14-0250; Pursnani AK, 2010, J AM COLL CARDIOL, V55, P1395, DOI 10.1016/j.jacc.2009.07.077; Wilbring M, 2013, J THORAC CARDIOV SUR, V146, pE22, DOI 10.1016/j.jtcvs.2013.05.016	7	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JUL	2015	79	7					1639	1640		10.1253/circj.CJ-15-0163		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL3RJ	WOS:000356867800039		
J	Naito, M; Yu, HC; Kim, JH; Rodriguez-Vazquez, JF; Murakami, G; Cho, BH				Naito, Michiko; Yu, Hee Chul; Kim, Ji Hyun; Francisco Rodriguez-Vazquez, Jose; Murakami, Gen; Cho, Baik Hwan			Topographic anatomy of the fetal inferior vena cava, coronary sinus, and pulmonary veins: Variations in Chiari's network	CLINICAL ANATOMY			English	Article						Chiari's network; inferior vena cava; coronary sinus; sinus septum; right sinus valve; atrium; human embryo	ATRIAL-FIBRILLATION; HEART	To understand anomalies in Chiari's network better, we assessed the topographical anatomy of the fetal inferior vena cava (IVC), coronary sinus, and atria. We examined sagittal serial paraffin sections of 15 human fetuses of crown-rump length 24-36 mm, corresponding to a gestational age of 8 weeks. Although their outflow tract morphologies were similar, these 15 specimens could be classified into two groups. In eight specimens, the left common cardinal vein reached the body wall, whereas in the other seven the vein was obliterated near the left pulmonary vein. Irrespective of the group in which the specimen was included, the anteroposterior arrangement of the coronary sinus, the sinus septum (septum), and the right sinus valve (right valve) could be classified into three types: the right valve-septum-coronary sinus arrangement in seven specimens; the right valve-coronary sinus-septum arrangement in five; and the coronary sinus-right valve-septum arrangement in three. Depending on differences in topographical anatomy, the sinus septum separated the coronary sinus opening from either the right or the left atrium. Likewise, the coronary sinus opening was either adjacent to or distant from the IVC terminal. Rather than the counter-side position of the right valve being at the IVC terminal, the left sinus valve protruded leftward, forming an incomplete interatrial septum. Fetal variations seemed to be closely connected with individual variations and a high frequency of Chiari's network anomalies in adults. Clin. Anat. 28:627-637, 2015. (c) 2014 Wiley Periodicals, Inc.	[Naito, Michiko] Nihon Univ, Sch Med, Dept Anat, Tokyo, Japan; [Yu, Hee Chul; Cho, Baik Hwan] Chonbuk Natl Univ Hosp, Dept Surg, Jeonju, South Korea; [Yu, Hee Chul; Cho, Baik Hwan] Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju, South Korea; [Kim, Ji Hyun] Chonbuk Natl Univ, Sch Med, Dept Anat, Jeonju 561712, South Korea; [Francisco Rodriguez-Vazquez, Jose] Univ Complutense, Inst Embryol, E-28040 Madrid, Spain; [Murakami, Gen] Iwamizawa Asuka Hosp, Div Internal Med, Iwamizawa, Japan	Kim, JH (reprint author), Chonbuk Natl Univ, Sch Med, Dept Anat, San 2-20, Jeonju 561712, South Korea.	407kk@hanmail.net			National R & D Program (Cancer Control, Ministry of Health & Welfare, Republic of Korea) [0620220-1]	Contract grant sponsor: National R & D Program (Cancer Control, Ministry of Health & Welfare, Republic of Korea); Contract grant number: 0620220-1.	Hayashi S, 2011, ANAT REC, V294, P633, DOI 10.1002/ar.21351; Perez-Lugones A, 2003, J CARDIOVASC ELECTR, V14, P803, DOI 10.1046/j.1540-8167.2003.03075.x; Anderson RH, 2003, HEART, V89, P949, DOI 10.1136/heart.89.8.949; Bhatnagar Kunwar P, 2006, Clin Anat, V19, P510, DOI 10.1002/ca.20195; Ghosh SK, 2014, ANAT SCI INT, V89, P85, DOI 10.1007/s12565-013-0203-0; Hamilton WJ, 1978, HUMAN EMBRYOLOGY, V4th, P247; Han S, 2010, HEART RHYTHM, V7, P786, DOI 10.1016/j.hrthm.2010.02.028; His W, 1990, ANATOMIE MENSCHLIC 3; Loukas M, 2010, SURG RADIOL ANAT, V32, P895, DOI 10.1007/s00276-010-0639-z; Rodriguez-Vazquez JF, 2011, J ANAT, V219, P143, DOI 10.1111/j.1469-7580.2011.01387.x; Ruchat P, 2007, EUR J CARDIO-THORAC, V31, P65, DOI 10.1016/j.ejcts.2006.10.015; Sizarov A, 2010, CIRCULATION, V122, P798, DOI 10.1161/CIRCULATIONAHA.110.953844; STEDING G, 1990, ANAT EMBRYOL, V181, P469, DOI 10.1007/BF02433794	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0897-3806	1098-2353		CLIN ANAT	Clin. Anat.	JUL	2015	28	5					627	637		10.1002/ca.22489		11	Anatomy & Morphology	Anatomy & Morphology	CL2WB	WOS:000356806400014		
J	Imataki, O; Uchida, S; Shiroshita, K; Kida, J; Uemura, M				Imataki, Osamu; Uchida, Shumpei; Shiroshita, Kohei; Kida, Jun-ichiro; Uemura, Makiko			Marked Hematopoiesis Masquerading Multiple Bone Metastasis in a Lung Cancer Patient With Myelodysplastic Syndrome	CLINICAL NUCLEAR MEDICINE			English	Editorial Material							STANDARDIZED UPTAKE VALUE; MARROW UPTAKE; FDG PET; TOMOGRAPHY	We diagnosed a 62-year-old man with lung cancer, well-differentiated squamous cell carcinoma, on the right upper lobe and left lower lobe. He had a history of myelodysplastic syndrome and refractory anemia with ringed sideroblasts diagnosed 5 years earlier. The patient's F-18-FDG PET/CT for the clinical staging of lung cancer revealed accumulations of FDG in multiple bones including the rib bones, which strongly suggested multiple bone metastases. He underwent lobectomies and excision of the right fourth and fifth rib bones. The pathological findings of resected rib bones exhibited hypercellular bone marrow without excess of blasts.	[Imataki, Osamu; Kida, Jun-ichiro; Uemura, Makiko] Kagawa Univ, Fac Med, Dept Internal Med, Div Hematol & Stem Cell Transplantat, Miki, Kagawa 7610793, Japan; [Uchida, Shumpei; Shiroshita, Kohei] Kagawa Univ, Fac Med, Postgrad Med Training Ctr, Miki, Kagawa 7610793, Japan	Imataki, O (reprint author), Kagawa Univ, Fac Med, Dept Internal Med, Div Hematol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	oima@med.kagawa-u.ac.jp					Hashimoto Y, 2006, J NUCL MED, V47, P426; Chiang SB, 2003, CLIN NUCL MED, V28, P674, DOI 10.1097/01.rlu.0000079394.76990.08; Inoue K, 2006, CLIN NUCL MED, V31, P721, DOI 10.1097/01.rlu.0000242685.55001.67; Shin DS, 2008, ANN NUCL MED, V22, P603, DOI 10.1007/s12149-008-0151-2; Blodgett TM, 2004, CLIN NUCL MED, V29, P161, DOI 10.1097/01.rlu.0000115654.90324.02; CASTELLO A, 1992, HAEMATOLOGICA, V77, P392; Degirmenci B, 2008, NUCL MED COMMUN, V29, P614, DOI 10.1097/MNM.0b013e3282f9b5a0; Teo BK, 2008, NUCL MED COMMUN, V29, P359, DOI 10.1097/MNM.0b013e3282f44f99	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	JUL	2015	40	7					574	575		10.1097/RLU.0000000000000698		2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK6YL	WOS:000356375000009		
J	Yoneyama, H				Yoneyama, Hiroto			Improved Detection of Sentinel Lymph Nodes in SPECT/CT Images Acquired Using a Low- to Medium-Energy General-Purpose Collimator	CLINICAL NUCLEAR MEDICINE			English	Letter							BREAST-CANCER; DISSECTION; BIOPSY		Kanazawa Univ Hosp, Dept Radiol Technol, Kanazawa, Ishikawa, Japan	Yoneyama, H (reprint author), Kanazawa Univ Hosp, Dept Radiol Technol, Kanazawa, Ishikawa, Japan.	kizu@cf6.so-net.ne.jp					Alazraki NP, 2000, SEMIN NUCL MED, V30, P56, DOI 10.1016/S0001-2998(00)80062-8; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Schrenk P, 2000, CANCER, V88, P608, DOI 10.1002/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K; Kizu Hiroto, 2005, J Nucl Med Technol, V33, P78; Moncayo VM, 2013, SEMIN NUCL MED, V43, P281, DOI 10.1053/j.semnuclmed.2013.02.004; Okuda K, 2014, ANN NUCL MED, V28, P60, DOI 10.1007/s12149-013-0785-6; Ramin S, 2013, CLIN NUCL MED, V38, P811, DOI 10.1097/RLU.0b013e31829f8cc0; Takahashi Yasuyuki, 2007, J Nucl Med Technol, V35, P34; Tsushima Hiroyuki, 2006, J Nucl Med Technol, V34, P153; Yokoi T, 2002, ANN NUCL MED, V16, P11; Yoneyama H, 2014, CLIN NUCL MED, V39, pE1, DOI 10.1097/RLU.0b013e31828da362	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	JUL	2015	40	7					612	613		10.1097/RLU.0000000000000725		2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CK6YL	WOS:000356375000022		
J	Yoshino, K; Ito, K; Kuroda, M; Sugihara, N				Yoshino, Koichi; Ito, Koji; Kuroda, Masahiko; Sugihara, Naoki			Prevalence of vertical root fracture as the reason for tooth extraction in dental clinics	CLINICAL ORAL INVESTIGATIONS			English	Article						Vertical root fracture; Reasons for tooth extraction; Permanent teeth; Prevalence	ENDODONTICALLY TREATED TEETH; SUPPORTIVE THERAPY; MAINTENANCE; JAPAN	Objectives The aim of this study was to investigate the prevalence, by gender, of vertical root fracture (VRF) as the main reason for the extraction of permanent teeth in dental clinics in Tokyo. Materials and methods Participating dentists were requested to provide information about extractions of permanent teeth they had performed from 1 January 2013 to 30 June 2013. The main reasons for extraction were categorized as follows: VRF, caries (horizontal root fracture included), periodontal disease and others. Results At a total of 24 clinics, 736 teeth were extracted from 626 patients during the 6-month period. A total of 233 teeth were extracted by VRF (31.7%), and 93.6% of these were endodontically treated teeth. Among non-vital extracted teeth, 82.1% (179/218) had cast posts or screw posts. The percentage of extraction due to VRF was 29.4% in males and 34.7% in females. In females, the percentage of extractions due to VRF (34.7%) was higher than for periodontal disease (28.1%). In males, the percentage of extractions due to VRF increased with age (p<0.05). The tooth types with the highest percentage of extractions due to VRF were the upper canine (46.7%), lower second premolar (48.0%) and lower first molar (50.0%) in males and the upper first premolar (43.3%), upper second premolar (44.4%), lower second premolar (53.8%) and lower first molar (54.5%) in females. Conclusions These results indicate that we need to pay more attention to maintaining vital teeth while being aware of the particular tooth types in which VRF most frequently occurs.	[Yoshino, Koichi; Sugihara, Naoki] Tokyo Dent Coll, Dept Epidemiol & Publ Hlth, Chiyoda Ku, Tokyo 1010061, Japan; [Yoshino, Koichi; Ito, Koji; Kuroda, Masahiko] Kyushikai, Kuroda Dent Clin, Chiyoda Ku, Tokyo 1010047, Japan	Yoshino, K (reprint author), Kyushikai, Kuroda Dent Clin, Chiyoda Ku, 3-5-5-7F Uchikanda, Tokyo 1010047, Japan.	ko-yoshi@d8.dion.ne.jp; kurototo@t3.rim.or.jp					TESTORI T, 1993, J ENDODONT, V19, P87, DOI 10.1016/S0099-2399(06)81202-1; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; MEISTER F, 1980, ORAL SURG ORAL MED O, V49, P243, DOI 10.1016/0030-4220(80)90056-0; Aida J, 2006, J EPIDEMIOL, V16, P214, DOI 10.2188/jea.16.214; Shibuya K, 2011, LANCET, V378, P1265, DOI 10.1016/S0140-6736(11)61098-2; Fuss Z, 1999, INT ENDOD J, V32, P283, DOI 10.1046/j.1365-2591.1999.00208.x; VIRE DE, 1991, J ENDODONT, V17, P338; [Anonymous], REP DENT HLTH TOK 20; Carnevale G, 2007, J CLIN PERIODONTOL, V34, P342, DOI 10.1111/j.1600-051X.2007.01052.x; Chambrone LA, 2006, J CLIN PERIODONTOL, V33, P759, DOI 10.1111/j.1600-051X.2006.00972.x; Chan CP, 1999, ORAL SURG ORAL MED O, V87, P504, DOI 10.1016/S1079-2104(99)70252-0; Chrysanthakopoulos NA, 2011, INT DENT J, V61, P19, DOI 10.1111/j.1875-595X.2011.00004.x; Llena-Puy MC, 2001, ORAL SURG ORAL MED O, V92, P553, DOI 10.1067/moe.2001.117262; Malhotra Neeraj, 2011, Dent Update, V38, P615; MORFIS AS, 1990, ORAL SURG ORAL MED O, V69, P631, DOI 10.1016/0030-4220(90)90248-Q; Rivera ER, 2009, ENDOD TOPICS, V16, P82; Takeuchi N, 2009, DENT TRAUMATOL, V25, P332, DOI 10.1111/j.1600-9657.2009.00768.x; The Statistical Analysis Committee on the Survey of Dental Diseases, 2013, COMPR GUID SURV DENT; Tsuneishi M, 2005, ORAL SURG ORAL MED O, V100, P631, DOI 10.1016/j.tripleo.2005.07.029	19	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1432-6981	1436-3771		CLIN ORAL INVEST	Clin. Oral Investig.	JUL	2015	19	6					1405	1409		10.1007/s00784-014-1357-4		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CL2LA	WOS:000356774100026		
J	Inada, E; Saitoh, I; Yu, Y; Tomiyama, D; Murakami, D; Takemoto, Y; Morizono, K; Iwasaki, T; Iwase, Y; Yamasaki, Y				Inada, Emi; Saitoh, Issei; Yu, Yong; Tomiyama, Daisuke; Murakami, Daisuke; Takemoto, Yoshihiko; Morizono, Ken; Iwasaki, Tomonori; Iwase, Yoko; Yamasaki, Youichi			Quantitative evaluation of toothbrush and arm-joint motion during tooth brushing	CLINICAL ORAL INVESTIGATIONS			English	Article						Tooth brushing; Toothbrush motion; Arm-joint motion; Quantitative motion acquisition; Distinctive rhythm	ORAL-HEALTH; HEAD; MOVEMENTS; STABILITY; WALKING; YOUNG	Objectives It is very difficult for dental professionals to objectively assess tooth brushing skill of patients, because an obvious index to assess the brushing motion of patients has not been established. The purpose of this study was to quantitatively evaluate toothbrush and arm-joint motion during tooth brushing. Materials and methods Tooth brushing motion, performed by dental hygienists for 15 s, was captured using a motion-capture system that continuously calculates the three-dimensional coordinates of object's motion relative to the floor. The dental hygienists performed the tooth brushing on the buccal and palatal sides of their right and left upper molars. The frequencies and power spectra of toothbrush motion and joint angles of the shoulder, elbow, and wrist were calculated and analyzed statistically. Results The frequency of toothbrush motion was higher on the left side (both buccal and palatal areas) than on the right side. There were no significant differences among joint angle frequencies within each brushing area. The inter-and intraindividual variations of the power spectrum of the elbow flexion angle when brushing were smaller than for any of the other angles. Conclusions This study quantitatively confirmed that dental hygienists have individual distinctive rhythms during tooth brushing. All arm joints moved synchronously during brushing, and tooth brushing motion was controlled by coordinated movement of the joints. The elbow generated an individual's frequency through a stabilizing movement. Clinical relevance The shoulder and wrist control the hand motion, and the elbow generates the cyclic rhythm during tooth brushing.	[Inada, Emi; Murakami, Daisuke; Takemoto, Yoshihiko; Morizono, Ken; Iwasaki, Tomonori; Yamasaki, Youichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat Dent, Kagoshima 8908544, Japan; [Saitoh, Issei; Iwase, Yoko] Niigata Univ, Grad Sch Med & Dent Sci, Div Pediat Dent, Chuo Ku, Niigata 9518514, Japan; [Yu, Yong; Tomiyama, Daisuke] Kagoshima Univ, Grad Sch Sci & Engn, Dept Mech Engn, Kagoshima 8900065, Japan	Saitoh, I (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Pediat Dent, Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	isaito@dent.niigata-u.ac.jp			KAKENHI from Japan society for the Promotion of Science [24792298, 25862025]	This work was supported by KAKENHI from Japan society for the Promotion of Science (No. 24792298, 25862025).	Schlueter N, 2010, CLIN ORAL INVEST, V14, P99, DOI 10.1007/s00784-009-0269-1; POCHE C, 1982, J APPL BEHAV ANAL, V15, P315, DOI 10.1901/jaba.1982.15-315; Mulavara AP, 2002, GAIT POSTURE, V16, P271, DOI 10.1016/S0966-6362(02)00016-4; Dounskaia N, 2002, EXP BRAIN RES, V146, P11, DOI 10.1007/s00221-002-1144-3; Kim KS, 2009, COMPUT METH PROG BIO, V96, P125, DOI 10.1016/j.cmpb.2009.04.006; Jahn CA, 2004, DIABETES EDUCATOR, V30, P754, DOI 10.1177/014572170403000510; Hwang S, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-15; Baur B, 2006, HUM MOVEMENT SCI, V25, P464, DOI 10.1016/j.humov.2006.05.007; Galloway JC, 2002, EXP BRAIN RES, V142, P163, DOI 10.1007/s002210100882; BOWDEN J, 1989, BRIT MED J, V298, P186; Latt MD, 2008, EXP BRAIN RES, V184, P201, DOI 10.1007/s00221-007-1094-x; Armand M, 2001, J COMPUT NEUROSCI, V11, P217, DOI 10.1023/A:1013771014232; Dai BY, 2013, J SPORT SCI, V31, P219, DOI 10.1080/02640414.2012.729078; Udo H, 2000, IND HEALTH, V38, P47, DOI 10.2486/indhealth.38.47; Hingtgen B, 2006, J BIOMECH, V39, P681, DOI 10.1016/j.jbiomech.2005.01.008; Laudani L, 2006, J ELECTROMYOGR KINES, V16, P603, DOI 10.1016/j.jelekin.2006.08.001; Mourey F, 1998, AGE AGEING, V27, P137, DOI 10.1093/ageing/27.2.137; Graetz C, 2013, J PERIODONTOL, V84, P186, DOI 10.1902/jop.2012.110675; Green JR, 2006, DEV PSYCHOBIOL, V48, P16, DOI 10.1002/dev.20112; Matsuo K, 2005, J DENT RES, V84, P39; Bardal EM, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-186; Das U M, 2009, J Indian Soc Pedod Prev Dent, V27, P104, DOI 10.4103/0970-4388.55335; Henmi S, 2006, MOD RHEUMATOL, V16, P289; Lee WCSM, 1986, J JAPAN SOC PERIODON, V28, P252; Luker KR, 2014, CLIN ORTHOP RELAT R, V472, P1123, DOI 10.1007/s11999-013-2964-0; Poyato-Ferrera M, 2003, Int J Dent Hyg, V1, P110, DOI 10.1034/j.1601-5037.2003.00018.x; [Anonymous], 1989, PROG BRAIN RES; Tosaka Y, 2014, CLIN ORAL INVEST, V18, P2045, DOI 10.1007/s00784-013-1172-3	28	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1432-6981	1436-3771		CLIN ORAL INVEST	Clin. Oral Investig.	JUL	2015	19	6					1451	1462		10.1007/s00784-014-1367-2		12	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CL2LA	WOS:000356774100032		
J	Mita, S; Meyers, D; Pal, P; Lin, T; Majumdar, T; Rebello, S; Sunkara, G; Chen, J				Mita, Sachiko; Meyers, Dan; Pal, Parasar; Lin, TsuHan; Majumdar, Tapan; Rebello, Sam; Sunkara, Gangadhar; Chen, Jin			Effect of Renal Impairment on the Pharmacokinetics of Pradigastat, a Novel Diacylglycerol Acyltransferase1 (DGAT1) Inhibitor	CLINICAL PHARMACOKINETICS			English	Article							DRUG-METABOLISM; FAILURE; TRANSPORT	Background and Objective Pradigastat, a diacylglycerol acyltransferase1 inhibitor, is being developed for the treatment of familial chylomicronemia syndrome. The primary objective of this clinical study was to evaluate the effect of renal impairment on the pharmacokinetics of pradigastat. Methods In an open-label, parallel-group study, the single-dose (40 mg) pharmacokinetics of pradigastat were evaluated in patients with mild (n = 9), moderate (n = 10) and severe renal impairment (n = 9) compared with matched healthy subjects (n = 28). The protein binding and urinary excretion of pradigastat were also assessed in this study. Results In patients with mild and moderate renal impairment the geometric means of the maximum plasma concentration (C-max) and the area under the plasma concentration-time curve from time zero to infinity (AUC(inf)) of pradigastat were similar as compared with healthy subjects. In patients with severe renal impairment, the geometric means of the C-max and AUC(inf) increased by 40 % [geometric mean ratio 1.41; 90 % confidence interval (CI) 0.92-2.14] and 18 % (geometric mean ratio 1.18; 90 % CI 0.68-2.05), respectively. There was no significant correlation between renal function (measured by creatinine clearance) and C-max or AUC(inf). Protein binding values were > 99 % and the urinary excretion of pradigastat was minimal in all subjects. There were no severe adverse events in the study and mild transient diarrhoea was the most common adverse event. The safety profile was similar between patients with renal impairment and healthy subjects. Conclusion There was no change in the pharmacokinetics of pradigastat in patients with mild and moderate renal impairment. In patients with severe renal impairment, the mean exposure C-max and AUC(inf) of pradigastat were increased by 40 and 18 %, respectively.	[Mita, Sachiko] Novartis Pharma KK, Tokyo, Japan; [Meyers, Dan] Novartis Inst BioMed Res, Cambridge, MA USA; [Pal, Parasar] Novartis Healthcare Private Ltd, Hyderabad, Andhra Pradesh, India; [Lin, TsuHan; Rebello, Sam; Sunkara, Gangadhar; Chen, Jin] Novartis Inst BioMed Res, E Hanover, NJ 07936 USA; [Majumdar, Tapan] Alcon Labs Inc, Ft Worth, TX 76101 USA	Chen, J (reprint author), Novartis Inst BioMed Res, One Hlth Plaza, E Hanover, NJ 07936 USA.	jin.chen@novartis.com					[Anonymous], 1998, GUID IND PHARM PAT I; Sun H, 2006, PHARMACOL THERAPEUT, V109, P1, DOI 10.1016/j.pharmthera.2005.05.010; Nolin TD, 2008, CLIN PHARMACOL THER, V83, P898, DOI 10.1038/clpt.2008.59; Pichette V, 2003, CURR DRUG METAB, V4, P91, DOI 10.2174/1389200033489532; Committee for Medicinal Products for Human Use, 2004, NOT GUID EV PHARM ME; Kulmatycki K, PHARM EV ESC SINGL I; Meyerss CD, 2013, J CLIN LIPIDOL, V7, P285; Sugandhan S, 2007, PEDIATR DERMATOL, V24, P323, DOI 10.1111/j.1525-1470.2007.00415.x; TOUCHETTE MA, 1991, DICP ANN PHARMAC, V25, P1214; UPTHAGROVE A, 2013, DRUG METAB REV, V45, P33; US Food and Drug Administration, 2010, GUID IND PHARM PAT I; Yan JH, 2014, J CLIN PHARMACOL, V54, P800, DOI 10.1002/jcph.285; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200	13	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0312-5963	1179-1926		CLIN PHARMACOKINET	Clin. Pharmacokinet.	JUL	2015	54	7					751	760		10.1007/s40262-015-0234-x		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CL6DM	WOS:000357057800006		
J	Hirano, M; Meyers, D; Golla, G; Pal, P; Pinot, P; Lin, T; Majumdar, T; Rebello, S; Sunkara, G; Chen, J				Hirano, Masaru; Meyers, Dan; Golla, GangaRaju; Pal, Parasar; Pinot, Pascale; Lin, TsuHan; Majumdar, Tapan; Rebello, Sam; Sunkara, Gangadhar; Chen, Jin			Effect of Hepatic Impairment on the Pharmacokinetics of Pradigastat, a Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor	CLINICAL PHARMACOKINETICS			English	Article							CIRRHOSIS; ENZYMES	Background and Objective Pradigastat, a novel diacylglycerol acyltransferase 1 inhibitor, is under development to treat familial chylomicronemia syndrome. The potential impact of hepatic impairment on the pharmacokinetics of pradigastat was evaluated in this study. Methods In this study, a single oral dose of 20 mg pradigastat was administered first to patients with mild and moderate hepatic impairment (n = 10/group) and subsequently to patients with severe hepatic impairment (n = 6). The pharmacokinetics of pradigastat were compared between each patient group and the respective matched healthy subjects. Results As compared with the respective matched healthy groups, the geometric mean ratios of the area under the plasma concentration-time curve from time zero to infinity (AUC(inf)) (h.ng/mL) were 1.49, 1.06 and 1.99 in mild, moderate and severe hepatic impairment patients, respectively; the observed maximum plasma concentration (C-max) (ng/mL) values were 0.97, 1.28 and 2.74, respectively; and the total body clearance of the drug from plasma (CL/F) (L/h) values were 0.67, 0.95 and 0.50, respectively. The elimination half-life and plasma protein binding of pradigastat were comparable among all the patients. There were no apparent relationships between AUC(inf) or C-max and albumin or bilirubin levels (R-2 < 0.3; p > 0.05). Overall, 19 adverse events (AEs) were reported in 13 patients. The incidence of AEs appeared to increase with increasing severity of hepatic impairment. Conclusion No clinically significant differences in the pharmacokinetics of pradigastat were observed in mild and moderate hepatic impairment patients compared with healthy subjects. However, the systemic exposure of pradigastat doubled while the clearance decreased by half in patients with severe hepatic impairment compared with healthy subjects. All treatments were well tolerated in the study.	[Hirano, Masaru] Novartis Pharma KK, Tokyo, Japan; [Meyers, Dan] Novartis Inst BioMed Res, Cambridge, MA USA; [Golla, GangaRaju; Pal, Parasar] Novartis Healthcare Private Ltd, Hyderabad, Andhra Pradesh, India; [Pinot, Pascale] Novartis Pharma AG, Basel, Switzerland; [Lin, TsuHan; Rebello, Sam; Sunkara, Gangadhar; Chen, Jin] Novartis Inst BioMed Res, E Hanover, NJ 07936 USA; [Majumdar, Tapan] Alcon Labs Inc, Ft Worth, TX 76101 USA	Chen, J (reprint author), Novartis Inst BioMed Res, One Hlth Plaza, E Hanover, NJ 07936 USA.	jin.chen@novartis.com			Novartis Pharma AG, Basel, Switzerland	This study was supported by Novartis Pharma AG, Basel, Switzerland.	Verbeeck RK, 2008, EUR J CLIN PHARMACOL, V64, P1147, DOI 10.1007/s00228-008-0553-z; Elbekai RH, 2004, CURR DRUG METAB, V5, P157, DOI 10.2174/1389200043489054; Smith SJ, 2000, NAT GENET, V25, P87; Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004; FDA draft guidance, 2013, BIOAN METH VAL; FDA guidance, 2003, CLIN PHARM; HOYUMPA AM, 1991, HEPATOLOGY, V13, P786, DOI 10.1016/0270-9139(91)92580-2; Kulmatycki K, 2013, COMMUNICATIONS; Meyerss CD, 2013, J CLIN LIPIDOL, V7, P285; Meyerss CD, 2012, J CLIN LIPIDOL, V6, P266, DOI DOI 10.1016/J.JACL.2012.04.034; Roberts JA, 2013, CLIN PHARMACOKINET, V52, P1, DOI 10.1007/s40262-012-0018-5; Sugandhan S, 2007, PEDIATR DERMATOL, V24, P323, DOI 10.1111/j.1525-1470.2007.00415.x; Sulsa GM, 2007, PRINCIPLES CLIN PHAR, V2nd, P73; Upthagrove A, 2013, 10 INT ISSX M TOR; Yan JH, 2014, J CLIN PHARMACOL, V54, P800, DOI 10.1002/jcph.285; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200	16	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0312-5963	1179-1926		CLIN PHARMACOKINET	Clin. Pharmacokinet.	JUL	2015	54	7					761	770		10.1007/s40262-015-0235-9		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CL6DM	WOS:000357057800007		
J	Fujimaki, M; Kawajiri, S; Ichikawa, K; Tomizawa, Y; Nakazato, T; Noda, K; Hattori, N; Koike, M; Okuma, Y				Fujimaki, Motoki; Kawajiri, Sumihiro; Ichikawa, Kunimoto; Tomizawa, Yuji; Nakazato, Tomoko; Noda, Kazuyuki; Hattori, Nobutaka; Koike, Michiaki; Okuma, Yasuyuki			Lymphomatoid Granulomatosis with Central Nervous System Involvement Successfully Treated with Cyclophosphamide, High-dose Cytarabine, Dexamethasone, Etoposide, and Rituximab (CHASER therapy) Followed by Brain Irradiation: A Case Study	CNS NEUROSCIENCE & THERAPEUTICS			English	Letter							REMISSION		[Fujimaki, Motoki; Kawajiri, Sumihiro; Tomizawa, Yuji; Nakazato, Tomoko; Noda, Kazuyuki; Okuma, Yasuyuki] Juntendo Univ, Shizuoka Hosp, Dept Neurol, Izunokuni, Shizuoka 4102295, Japan; [Fujimaki, Motoki; Nakazato, Tomoko; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan; [Ichikawa, Kunimoto; Koike, Michiaki] Juntendo Univ, Shizuoka Hosp, Dept Hematol, Izunokuni, Shizuoka 4102295, Japan	Kawajiri, S (reprint author), Juntendo Univ, Shizuoka Hosp, Dept Neurol, 1129 Nagaoka, Izunokuni, Shizuoka 4102295, Japan.	skawaji@juntendo.ac.jp					Lucantoni C, 2009, J NEURO-ONCOL, V94, P235, DOI 10.1007/s11060-009-9834-3; Imashuku S, 2001, J CLIN ONCOL, V19, P2665; De Graaff HJ, 2013, JAMA NEUROL, V70, P915, DOI 10.1001/jamaneurol.2013.2016; Katzenstein ALA, 2010, AM J SURG PATHOL, V34, pE35, DOI 10.1097/PAS.0b013e3181fd8781; Ishiura H, 2008, ARCH NEUROL-CHICAGO, V65, P662, DOI 10.1001/archneur.65.5.662; Aoki T, 2013, J CLIN ONCOL, V31, pE390, DOI 10.1200/JCO.2012.47.4999; Mizuno T, 2003, J NEUROL SCI, V213, P67, DOI 10.1016/S0022-510X(03)00127-8; SIMARD H, 1993, CHEST, V103, P650, DOI 10.1378/chest.103.2.650; Tateishi U, 2001, AM J NEURORADIOL, V22, P1283; Zhang YX, 2013, CNS NEUROSCI THER, V19, P536, DOI 10.1111/cns.12109	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JUL	2015	21	7					610	612		10.1111/cns.12414		3	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CL1LF	WOS:000356704000011		
J	Fujii, S; Kobayashi, K; Nakamura, Y; Okubo, T				Fujii, Syuji; Kobayashi, Koji; Nakamura, Yoshinobu; Okubo, Tsuneo			Drying structures of micrometer-sized cationic gel spheres of lightly cross-linked poly(2-vinyl pyridine) in the deionized aqueous suspension	COLLOID AND POLYMER SCIENCE			English	Article						Cationic gel spheres; Poly(2-vinyl pyridine); Drying pattern; Dissipative structure; Dissipative crystallization; Array of single crystals	DISSIPATIVE STRUCTURES; COLLOIDAL CRYSTALLIZATION; 170-SIMILAR-TO-180 NM; COVER GLASS; DIAMETER; POLY(N-ISOPROPYLACRYLAMIDE); MICROGELS; LINKING	Drying dissipative patterns of cationic gel crystals of lightly cross-linked poly(2-vinyl pyridine) spheres stabilized with poly(ethylene glycol) (mu PEGMA-P2VP (0.1), mu PEGMA-P2VP (0.5), and mu PEGMA-P2VP (1) (1.12 similar to 1.20 mu m in diameter and 0.1, 0.5, and 1 in degrees of cross-linking) were studied on a cover glass, a watch glass and a Petri glass dish. Iridescent colors and hexagonal spots were observed with the naked eyes in the dried film. Two kinds of the broad rings were observed at the outside edge and inner region in the macroscopic drying patterns. The size of the inner rings increased with gel concentration. Formation of the similar sized aggregates (or agglomerates) and their ordered arrays ((a) ordered ring, (b) spoke-lines, (c) net, and (d) lattice structures) have been observed in common for cationic and anionic gel sphere suspensions examined hitherto. However, the ordering of the agglomerates was not observed for mu PEGMA-P2VP spheres. Coexistence of the similar-sized face-centered cubic (fcc) and body-centered cubic (bcc) single crystals was observed instead. Interestingly, fcc crystals looked like white clouds and distributed roughly broad ring-like. This morphological effect on the drying patterns of mu PEGMA-P2VP cationic gel spheres is considered to be one of the dissipative crystallization phenomena of colloidal gel spheres during drying processes accompanied with the release of the strain during the course of solidification. Importance of the dissipative convectional flow, formation of the electrical double layers around the spheres, and the interaction of the large gel spheres with the substrates was clear during dryness on the drying pattern formation.	[Fujii, Syuji; Kobayashi, Koji; Nakamura, Yoshinobu] Osaka Inst Technol, Dept Appl Chem, Fac Engn, Asahi Ku, Osaka 5358585, Japan; [Okubo, Tsuneo] Inst Colloidal Org, Uji, Kyoto 6110012, Japan	Okubo, T (reprint author), Inst Colloidal Org, Hatoyama 3-1-112, Uji, Kyoto 6110012, Japan.	okubotsu@ybb.ne.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [24655212]	S.F. acknowledges Grant-in-Aid for Challenging Exploratory Research (Project No. 24655212) for Japan Society for Promotion of Science and Grant-in-Aid for Scientific Research on Innovative Areas "Engineering Neo-Biomimetics," "New Polymeric Materials Based on Element-Blocks", and "Molecular Soft Interface Science" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Loxley A, 1997, COLLOID POLYM SCI, V275, P1108, DOI 10.1007/s003960050190; Suzuki D, 2012, COLLOID POLYM SCI, V290, P107, DOI 10.1007/s00396-011-2534-5; Suzuki D, 2011, COLLOID POLYM SCI, V289, P1799, DOI 10.1007/s00396-011-2499-4; Okubo T, 2012, COLLOID POLYM SCI, V290, P1901, DOI 10.1007/s00396-012-2727-6; Dupin D, 2006, LANGMUIR, V22, P3381, DOI 10.1021/la053258h; Okubo T, 2011, COLLOID POLYM SCI, V289, P1273, DOI 10.1007/s00396-011-2459-z; Fujii S, 2014, COLLOID POLYM SCI, V292, P1627, DOI 10.1007/s00396-014-3228-6; Fujii S, 2014, COLLOID POLYM SCI, V292, P2621, DOI 10.1007/s00396-014-3315-8; Greer RG, 1971, 4 ANN SCANN EL MICR, P153; Okubo T, 2006, MOL COLLOIDAL ELECTR, P573; Okubo T, 2013, COLLOID POLYM SCI, V291, P2569, DOI 10.1007/s00396-013-3000-3; Okubo T, 2012, COLLOID POLYM SCI, V290, P1019; Okubo T, 2008, NANOPARTICLES SYNTHE, P256; Okubo T, 1984, J CHEM SOC FARADAY T, V1, P2087; Okubo T, 2012, COLLOID POLYM SCI, V290, P867, DOI 10.1007/s00396-012-2602-5; Okubo T, 2004, COLLOID POLYM SCI, V282, P230, DOI 10.1007/s00396-003-0899-9; Okubo T, 2011, COLLOID POLYM SCI, V289, P807, DOI 10.1007/s00396-011-2402-3; Okubo T, 2009, COLLOID POLYM SCI, V287, P1155, DOI 10.1007/s00396-009-2075-3; Okubo T, 2012, COLLOID POLYM SCI, V290, P411, DOI 10.1007/s00396-011-2561-2; Okubo T, 2006, COLLOID POLYM SCI, V285, P339, DOI 10.1007/S00396-006-1577-5; Okubo T, 2013, COLLOID POLYM SCI, V291, P1201, DOI 10.1007/s00396-012-2850-4; Okubo T, 2013, COLLOID POLYM SCI, V291, P2805, DOI 10.1007/s00396-013-3030-x; Okubo T, 2011, COLLOID POLYM SCI, V289, P291, DOI 10.1007/s00396-010-2358-8; Okubo T, 2010, COLLOID POLYM SCI, V288, P1435, DOI 10.1007/s00396-010-2281-z; OKUBO T, 1987, BER BUNSEN PHYS CHEM, V91, P516; Okubo T, 2010, MACROMOL SYMP, V288, P67, DOI 10.1002/masy.201050209; Okubo T, 2009, COLLOID POLYM SCI, V287, P933, DOI 10.1007/s00396-009-2049-5; Stoeber W., 1968, J COLLOID INTERF SCI, V26, P62; TOMITA M, 1983, J COLLOID INTERF SCI, V92, P367, DOI 10.1016/0021-9797(83)90159-5	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JUL	2015	293	7					1855	1864		10.1007/s00396-015-3575-y		10	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CL4RZ	WOS:000356942800001		
J	Pham, TD; Kobayashi, M; Adachi, Y				Tien Duc Pham; Kobayashi, Motoyoshi; Adachi, Yasuhisa			Adsorption characteristics of anionic azo dye onto large alpha-alumina beads	COLLOID AND POLYMER SCIENCE			English	Article						Anionic dye adsorption; alpha-Alumina; Surface charge effect; FTIR-ATR; Two-step adsorption model	TEXTILE WASTE-WATER; PHOTO-FENTON OXIDATION; SMALL SURFACE-AREA; ELECTROCHEMICAL OXIDATION; AQUEOUS-SOLUTIONS; OXIDE SURFACES; CRYSTAL VIOLET; REMOVAL; ISOTHERMS; DECOLORIZATION	Adsorption of anionic azo dye, new coccine (NC), onto large alpha-alumina beads in aqueous media was systematically investigated as functions of pH and NaCl concentration. Adsorption amounts of NC decrease with increasing pH of solutions due to less positive charges of alpha-Al2O3 surface at high pH. At a fixed pH, the NC adsorption increases with decreasing NaCl concentration, indicating that NC molecules mainly adsorb onto alpha-Al2O3 by electrostatic attraction. Experimental results of NC adsorption isotherms onto alpha-Al2O3 at different pH, and ionic strength can be represented well by two-step adsorption model. The effects of NC on surface charge and surface modification of alpha-Al2O3 at the plateau adsorption are evaluated by streaming potential and Fourier transform infrared spectroscopy with attenuated total reflection technique (FTIR-ATR), respectively. On the basis of adsorption isotherms, surface charge effect, and surface modification, we suggested that the formation of a bridged bidentate complex between aluminum ions of alpha-Al2O3 and two oxygen atoms of a sulfonic group induced the adsorption of NC onto alpha-Al2O3.	[Tien Duc Pham] Vietnam Natl Univ, Hanoi Univ Sci, Fac Chem, Hanoi 10000, Vietnam; [Tien Duc Pham; Kobayashi, Motoyoshi; Adachi, Yasuhisa] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Pham, TD (reprint author), Vietnam Natl Univ, Hanoi Univ Sci, Fac Chem, 19 Le Thanh Tong, Hanoi 10000, Vietnam.	tienduchphn@gmail.com			JSPS KAKENHI [22248025, 23688027]	We would like to thank the financial support from JSPS KAKENHI (22248025, 23688027).	Al-Momani F, 2002, J PHOTOCH PHOTOBIO A, V153, P191, DOI 10.1016/S1010-6030(02)00298-8; Bandara J, 1999, LANGMUIR, V15, P7670, DOI 10.1021/la9900270; Harris RG, 2001, COLLOID SURFACE A, V180, P131, DOI 10.1016/S0927-7757(00)00747-0; Wong YC, 2003, LANGMUIR, V19, P7888, DOI 10.1021/la030064y; Delgado AV, 2007, J COLLOID INTERF SCI, V309, P194, DOI 10.1016/j.jcis.2006.12.075; Wang JM, 1998, J COLLOID INTERF SCI, V208, P518, DOI 10.1006/jcis.1998.5875; KOOPAL LK, 1995, J COLLOID INTERF SCI, V170, P85, DOI 10.1006/jcis.1995.1075; Mohan N, 2007, J HAZARD MATER, V147, P644, DOI 10.1016/j.jhazmat.2007.01.063; Hameed BH, 2008, J HAZARD MATER, V154, P237, DOI 10.1016/j.jhazmat.2007.10.017; BITTING D, 1987, LANGMUIR, V3, P500, DOI 10.1021/la00076a011; Adak A, 2005, SEP PURIF TECHNOL, V44, P139, DOI 10.1016/j.seppur.2005.01.002; Ramos-Tejada MM, 2006, J COLLOID INTERF SCI, V297, P317, DOI 10.1016/j.jcis.2005.09.065; Piccin JS, 2012, CHEM ENG J, V183, P30, DOI 10.1016/j.cej.2011.12.013; Ledakowicz S, 2001, J BIOTECHNOL, V89, P175, DOI 10.1016/S0168-1656(01)00296-6; Perez M, 2002, WATER RES, V36, P2703, DOI 10.1016/S0043-1354(01)00506-1; Goloub TP, 1996, LANGMUIR, V12, P3188, DOI 10.1021/la9505475; Forgacs E, 2004, ENVIRON INT, V30, P953, DOI 10.1016/j.envint.2004.02.001; Kobayashi M, 2009, COLLOID SURFACE A, V347, P2, DOI 10.1016/j.colsurfa.2008.09.054; Bauer C, 1999, CHEM PHYS LETT, V307, P397, DOI 10.1016/S0009-2614(99)00518-7; Dogan M, 2004, J HAZARD MATER, V109, P141, DOI 10.1016/j.jhazmat.2004.03.003; Hind AR, 2001, ADV COLLOID INTERFAC, V93, P91, DOI 10.1016/S0001-8686(00)00079-8; Papic S, 2004, DYES PIGMENTS, V62, P291, DOI 10.1016/S0143-7208(03)00148-7; Kang SF, 2000, CHEMOSPHERE, V41, P1287, DOI 10.1016/S0045-6535(99)00524-X; Bourikas K, 2005, LANGMUIR, V21, P9222, DOI 10.1021/la051434g; Gupta VK, 2009, J ENVIRON MANAGE, V90, P2313, DOI 10.1016/j.jenvman.2008.11.017; Almeida CAP, 2009, J COLLOID INTERF SCI, V332, P46, DOI 10.1016/j.jcis.2008.12.012; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; Bohmer MR, 1992, LANGMUIR, V8, P2649; Buergisser C. S., 1993, ENVIRON SCI TECHNOL, V27, P943, DOI DOI 10.1021/ES00042A018; Ardejani FD, 2008, J HAZARD MATER, V151, P730, DOI 10.1016/j.jhazmat.2007.06.048; Hameed BH, 2008, J HAZARD MATER, V155, P601, DOI 10.1016/j.jhazmat.2007.11.102; Hoffmann I, 2012, LANGMUIR, V28, P7695, DOI 10.1021/la300192q; Hunter R. J., 1981, ZETA POTENTIAL COLLO; Jada A, 2012, J COLLOID SCI BIOTEC, V1, P26; JAIN VK, 1988, COLLOID SURFACE, V29, P373, DOI 10.1016/0166-6622(88)80148-3; Kamari A, 2009, DESALINATION, V249, P1180, DOI 10.1016/j.desal.2009.04.010; Kumar AR, 2007, COLLOID SURFACE A, V301, P462, DOI 10.1016/j.colsurfa.2007.01.021; Ndong RS, 2012, RHEOL ACTA, V51, P771, DOI 10.1007/s00397-012-0633-y; Park IY, 1990, J CHEM SOC DA, V10, P3071; Pham TD, 2014, ADV PHYS CHEM, V2014, P9; Pham TD, 2013, COLLOID SURFACE A, V436, P148, DOI 10.1016/j.colsurfa.2013.06.026; Pham TD, 2015, COLLOID POLYM SCI, V293, P217, DOI 10.1007/s00396-014-3409-3; Schoonen MA, 2014, J COLLOID INTERF SCI, V422, P1, DOI 10.1016/j.jcis.2014.02.008; Vlyssides AG, 1999, J HAZARD MATER, V70, P41, DOI 10.1016/S0304-3894(99)00130-2; Yahyaei B, 2012, CHEM ENG J, V209, P589, DOI 10.1016/j.cej.2012.08.055; ZHU BY, 1991, ADV COLLOID INTERFAC, V37, P1, DOI 10.1016/0001-8686(91)80037-K	46	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JUL	2015	293	7					1877	1886		10.1007/s00396-015-3576-x		10	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CL4RZ	WOS:000356942800003		
J	Hasegawa, U; Moriyama, M; Uyama, H; van der Vlies, AJ				Hasegawa, Urara; Moriyama, Masaki; Uyama, Hiroshi; van der Vlies, Andr J.			Antioxidant micelles for bortezomib delivery	COLLOID AND POLYMER SCIENCE			English	Article						Polymeric micelles; Drug delivery; Antioxidant; Bortezomib	CANCER-CELLS; INHIBITOR BORTEZOMIB; PROTEASOME; THERAPEUTICS; ANGIOGENESIS; DOXORUBICIN; STRESS	Reactive oxygen species (ROS) serve important regulatory roles in cellular processes. However, elevated ROS levels have been linked with several diseases such as cancer. ROS has been known to stimulate cancer cell proliferation and enhance angiogenesis, a process crucial for tumor development and metastasis. Previously, we reported on catechol-bearing micelles capable of scavenging ROS and blocking angiogenesis. Here, we investigate whether the micelles could be loaded with a chemotherapeutic while maintaining its ROS-scavenging activity. Since bortezomib (BTZ), a boronic acid-containing drug, can interact with catechol groups in a pH-dependent manner, we investigated its loading into the micelles. The BTZ-loaded micelles were prepared by mixing of the catechol-bearing micelles and BTZ in phosphate buffer at pH 7.4. We used dynamic light scattering, atomic force microscopy, and surface tension measurements to investigate the effect of BTZ on micelle size and structural stability. The BTZ-loaded micelles maintained their ROS-scavenging activity and released BTZ in a pH-dependent manner. Furthermore, the BTZ-loaded micelles showed cytotoxicity in MCF7 human breast cancer cells. The micelles may show promise as a platform in cancer treatment by delivering the chemotherapeutic BTZ and blocking angiogenesis at the same time.	[Hasegawa, Urara] Osaka Univ, Grad Sch Engn, Frontier Res Base Young Researchers, Suita, Osaka 5650871, Japan; [Hasegawa, Urara; Moriyama, Masaki; Uyama, Hiroshi; van der Vlies, Andr J.] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Osaka, Japan; [van der Vlies, Andr J.] Osaka Univ, Grad Sch Engn, Frontier Res Ctr, Osaka, Japan	Hasegawa, U (reprint author), Osaka Univ, Grad Sch Engn, Frontier Res Base Young Researchers, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	urara.hasegawa@chem.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science [26560241]	This work was supported by Grant-in-Aid for Challenging Exploratory Research, No. 26560241, from the Japan Society for the Promotion of Science.	Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Moriyama M, 2015, ADV HEALTHC MATER, V4, P569, DOI 10.1002/adhm.201400249; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Su J, 2011, J AM CHEM SOC, V133, P11850, DOI 10.1021/ja203077x; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Garvin S, 2006, CANCER LETT, V231, P113, DOI 10.1016/j.canlet.2005.01.031; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/nchembio.607, 10.1038/NCHEMBIO.607]; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Iversen TG, 2011, NANO TODAY, V6, P176, DOI 10.1016/j.nantod.2011.02.003; Chegaev K, 2013, BIOORG MED CHEM LETT, V23, P5307, DOI 10.1016/j.bmcl.2013.07.070; Conklin K.A., 2004, J NUTR, V134, P3201; Geisow MJ, 1984, EXP CELL RES, V150, P36, DOI [10.1016/0014-4827(84)90699-2, DOI 10.1016/0014-4827(84)90699-2]; Labutti J, 2006, CHEM RES TOXICOL, V19, P539, DOI 10.1021/tx050313d; Yoshitomi T, 2013, J CONTROL RELEASE, V172, P137, DOI 10.1016/j.jconrel.2013.08.011	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JUL	2015	293	7					1887	1892		10.1007/s00396-015-3582-z		6	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CL4RZ	WOS:000356942800004		
J	Yang, Y; Ohno, T; Yoshinaga, K				Yang, Yin; Ohno, Teruhisa; Yoshinaga, Kohji			Colloidal crystallization of C-60/polymer-grafted silica particles in organic solvent	COLLOID AND POLYMER SCIENCE			English	Article						Fullerene-tethered polymer; Polymer grafting; Colloidal silica; Colloidal crystallization	POLYMER-GRAFTED SILICA; PHOTONIC CRYSTAL; IMMOBILIZATION; ARRAYS; FILMS; MONODISPERSE; CHEMISTRY; SPHERES; SIZE; GEL	Synthesis of fullerene (C-60)-tethered polymer-grafted silica and colloidal crystallization of the particles was investigated. The particles were prepared by the reaction of C-60 with 4-azidobenzoyl groups introduced in poly(methyl methacrylate-co-2-hydroxyethyl methacrylate), followed by esterification of 2-hydroxyethyl metharylate moieties with 4-azidobenzoyl chloride and grafting onto colloidal silica. The reaction afforded bindings of C-60 in the range from 0.44 x 10(4) to 1.71 x 10(4) molecules/particle. The C-60 amounts did not monotonously increase with 4-azidobenzoyl group on the particles, but decreased with mole fraction of methyl methacrylate in the copolymer. Colloidal crystallizations of the C-60-tethered silica particles were observed in acetonitrile with critical volume fractions in the range from 0.018 to 0.024. Inter-sphere distances in the colloidal crystals were consistent with calculated values on assumption of face-centered cubic-closed packing, and then it was suggested that the crystallization took place due to electrostatic repulsion between the particles.	[Yang, Yin; Ohno, Teruhisa] Kyushu Inst Technol, Grad Sch Engn, Dept Appl Chem, Kitakyushu, Fukuoka 8048555, Japan; [Yoshinaga, Kohji] Kyushu Inst Technol, Senior Acad, Kitakyushu, Fukuoka 8048555, Japan	Yoshinaga, K (reprint author), Kyushu Inst Technol, Senior Acad, 1-1 Sensui, Kitakyushu, Fukuoka 8048555, Japan.	yoshinaga.koji334@mail.kyutech.jp					Camargo PHC, 2007, LANGMUIR, V23, P2985, DOI 10.1021/la0632070; Xia YN, 2000, ADV MATER, V12, P693, DOI 10.1002/(SICI)1521-4095(200005)12:10<693::AID-ADMA693>3.0.CO;2-J; Weekes SM, 2007, LANGMUIR, V23, P1057, DOI 10.1021/la061396g; Reese CE, 2004, J AM CHEM SOC, V126, P1493, DOI 10.1021/ja037118a; Holtz JH, 1997, NATURE, V389, P829; Lee JK, 2008, J AM CHEM SOC, V130, P3619, DOI 10.1021/ja710079w; Yoshinaga K, 2005, LANGMUIR, V21, P4471, DOI 10.1021/la0467786; Lawrence JR, 2006, ADV MATER, V18, P300, DOI 10.1002/adma.200501833; Hosein ID, 2007, LANGMUIR, V23, P2892, DOI 10.1021/la062592q; Zhou ZC, 2007, LANGMUIR, V23, P1473, DOI 10.1021/la062601v; Bonifazi D, 2007, CHEM SOC REV, V36, P390, DOI 10.1039/b604308a; Dresselhaus M. S., 1996, SCI FULLERENES CARBO; Evanoff DD, 2007, ADV MATER, V19, P3507, DOI 10.1002/adma.200602901; Fernandez G, 2008, J ORG CHEM, V73, P9; Kumada M, 2006, LANGMUIR, V22, P4403; Li YZ, 2007, LANGMUIR, V23, P9109, DOI 10.1021/la700610p; Ma ZG, 2011, COLLOID POLYM SCI, V289, P85, DOI 10.1007/s00396-010-2326-3; Ma ZG, 2010, COLLOID POLYM SCI, V288, P519, DOI 10.1007/s00396-009-2143-8; Muscatello MMW, 2009, MACROMOLECULES, V42, P4403, DOI 10.1021/ma900919y; Nakamura H, 2006, J APPL POLYM SCI, V102, P2308, DOI 10.1002/app.24446; Nakamura H, 2005, LANGMUIR, V21, P11578, DOI 10.1021/la052050t; Okubo T, 1998, J COLLOID INTERF SCI, V204, P198, DOI 10.1006/jcis.1998.5598; Okubo T, 1996, COLLOID SURFACE A, V109, P77, DOI 10.1016/0927-7757(96)03475-9; Park JH, 2005, ADV MATER, V17, P879, DOI 10.1002/adma.200400632; Sakai T, 2007, LANGMUIR, V23, P8651, DOI 10.1021/la700448t; Toyotama A, 2009, LANGMUIR, V25, P589, DOI 10.1021/la8013706; Yan HH, 2014, MATER HORIZONS, V1, P247, DOI 10.1039/c3mh00105a; Yoshinaga K, 2004, COLLOID POLYM SCI, V283, P340, DOI 10.1007/s00396-004-1202-4; Yoshinaga K, 2006, COLLOID POLYM SCI, V284, P694, DOI 10.1007/s00396-005-1455-6; Yoshinaga K, 2002, COLLOID SURFACE A, V204, P285, DOI 10.1016/S0927-7757(02)00013-4; Yoshinaga K, 2003, CHEM LETT, V32, P1082, DOI 10.1246/cl.2003.1082; Yoshinaga K, 2007, COLLOID SURFACE B, V54, P108, DOI 10.1016/j.colsurfb.2006.10.010; Yoshinaga K, 1999, COLLOID POLYM SCI, V277, P479, DOI 10.1007/s003960050412; Zhou J, 2006, LANGMUIR, V22, P863, DOI 10.1021/la0515773	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JUL	2015	293	7					2075	2081		10.1007/s00396-015-3601-0		7	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CL4RZ	WOS:000356942800023		
J	Tohsan, A; Kishi, R; Ikeda, Y				Tohsan, Atitaya; Kishi, Ryota; Ikeda, Yuko			A model filler network in nanocomposites prepared by in situ silica filling and peroxide cross-linking in natural rubber latex	COLLOID AND POLYMER SCIENCE			English	Article						Natural rubber latex; In situ silica; Filler network; Peroxide cross-linking; Dynamic mechanical properties	SOL-GEL PROCESS; MECHANICAL-PROPERTIES; DYNAMIC PROPERTIES; COMPOSITES; REINFORCEMENT; FILMS	Preparation and characteristics of model filler networks in nanocomposites are reported for development of rubber science. The nanocomposites were prepared via a sol-gel reaction in natural rubber (NR) latex using tetraethoxysilane followed by a peroxide cross-linking reaction in the liquid state employing a casting method. The filler network structure was formed in the NR matrix, even though the silica content was only 10 and 17 parts per one hundred rubber by weight. One of the important factors for the formation of the filler network was utilization of rubber particles in the latex as a template. Dynamic mechanical analysis revealed the significant characteristics of the filler network of silica particles in the rubber matrix: Higher and longer plateau regions of storage modulus and dissipation loss modulus in the low frequency region were observed in the in situ silica-filled nanocomposites compared with conventionally prepared nanocomposites. This was mainly ascribed to a strong filler-filler interaction.	[Tohsan, Atitaya] Kyoto Inst Technol, Venture Lab, Sakyo Ku, Kyoto 6068585, Japan; [Kishi, Ryota; Ikeda, Yuko] Kyoto Inst Technol, Grad Sch Sci & Technol, Sakyo Ku, Kyoto 6068585, Japan	Ikeda, Y (reprint author), Kyoto Inst Technol, Grad Sch Sci & Technol, Sakyo Ku, Kyoto 6068585, Japan.	atitaya@kit.ac.jp; yuko@kit.ac.jp			Kansai Research Foundation for technology promotion [2012R212]	This work was partially supported by Kansai Research Foundation for technology promotion (project no. 2012R212).	Saphiannikova M, 2014, MACROMOLECULES, V47, P4813, DOI 10.1021/ma501159u; Wang MJ, 1998, RUBBER CHEM TECHNOL, V71, P520, DOI 10.5254/1.3538492; Mujtaba A, 2012, MACROMOLECULES, V45, P6504, DOI 10.1021/ma300925p; Ikeda Y, 2008, J SOL-GEL SCI TECHN, V45, P299, DOI 10.1007/s10971-008-1682-7; Ikeda Y, 2009, MACROMOLECULES, V42, P2741, DOI 10.1021/ma802730z; Tirumkudulu MS, 2005, LANGMUIR, V21, P4938, DOI 10.1021/la048298k; MEDALIA AI, 1978, RUBBER CHEM TECHNOL, V51, P437, DOI 10.5254/1.3535748; WILLIAMS ML, 1955, J AM CHEM SOC, V77, P3701, DOI 10.1021/ja01619a008; Chaichua B, 2009, J SOL-GEL SCI TECHN, V52, P219, DOI 10.1007/s10971-009-2019-x; Meera AP, 2009, J PHYS CHEM C, V113, P17997, DOI 10.1021/jp9020118; Dufresne ER, 2006, LANGMUIR, V22, P7144, DOI 10.1021/la061251+; Scotti R, 2012, SOFT MATTER, V8, P2131, DOI 10.1039/c1sm06716h; Ashizawa T, 1963, GOMU, V10, P29; Bateman L., 1963, CHEM PHYS RUBBER LIK; Class JB, 2002, ACS RUBB DIV M GEORG; Ferry JD, 1980, VISCOELASTIC PROPERT; FERRY JD, 1964, J PHYS CHEM-US, V68, P3414, DOI 10.1021/j100793a052; Ferry JD, 1968, MACROMOLECULES, V1, P353; Ikeda Y, 2014, COLLOID POLYM SCI, V292, P567, DOI 10.1007/s00396-013-3084-9; JONES KP, 1992, DEV CROP SCI, V23, P1; Kato A, 2008, J OPT SOC AM B, V25, P1602, DOI 10.1364/JOSAB.25.001602; Kato A, 2014, WOODHEAD PUBL MATER, P193, DOI 10.1533/9780857096913.1.193; Kramer O, 1994, SCI TECHNOLOGY RUBBE, V2nd; MARK JE, 1982, MAKROMOL CHEM-RAPID, V3, P681; Miloskovska E, 2014, MACROMOLECULES, V47, P5174, DOI 10.1021/ma500594a; Poompradub S, 2008, KGK-KAUT GUMMI KUNST, V61, P152; Poompradub S, 2014, MATER CHEM PHYS, V144, P122, DOI 10.1016/j.matchemphys.2013.12.030; Poompradub S, 2005, CHEM LETT, V34, P672, DOI 10.1246/cl.2005.672; Roberts A. D., 1988, NATURAL RUBBER SCI T, P1136; Rodgers B, 2005, SCI TECHNOLOGY RUBBE, V3rd; Satraphan P, 2009, POLYM ADVAN TECHNOL, V20, P473, DOI 10.1002/pat.1297; Shaw MT, 2005, INTRODUCTION TO POLYMER VISCOELASTICITY, 3RD EDITION, P1, DOI 10.1002/0471741833; Sirisamont J., 2009, POLYM ENG SCI, V49, P1099; Tangpasuthadol V, 2008, J APPL POLYM SCI, V109, P424, DOI 10.1002/app.28120; Tohsan A, 2012, POLYM ADVAN TECHNOL, V23, P1335, DOI 10.1002/pat.2051; Tohsan A, 2014, WOODHEAD PUBL MATER, P168, DOI 10.1533/9780857096913.1.168; Toutorski IA, 2003, J SOL-GEL SCI TECHN, V26, P505, DOI 10.1023/A:1020747315536; Toutorski IA, 1998, J SOL-GEL SCI TECHN, V13, P1057, DOI 10.1023/A:1008628919412; Treloar L. R. G., 1975, PHYS RUBBER ELASTICI; Wanger MP, 1976, RUBBER CHEM TECHNOL, V76, P703; Watcharakul N, 2011, J SOL-GEL SCI TECHN, V58, P407, DOI 10.1007/s10971-011-2407-x; Yasuda Y, 2014, MACROMOL CHEM PHYS, V215, P971, DOI 10.1002/macp.201400066; Yoshikai K., 1996, NIPPON GOMU KYOKAISH, V69, P485; Yoshikai K, 2002, J APPL POLYM SCI, V85, P2053, DOI 10.1002/app.10679	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JUL	2015	293	7					2083	2093		10.1007/s00396-015-3586-8		11	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CL4RZ	WOS:000356942800024		
J	Suwabe, C; Nagao, D; Ishii, H; Konno, M				Suwabe, Chika; Nagao, Daisuke; Ishii, Haruyuki; Konno, Mikio			Chemical bonding heterocoagulation of nanoparticles onto polymeric spheres by two-step addition of polymerizable coupling agent	COLLOID AND POLYMER SCIENCE			English	Article						Desorption; Heterocoagulation; Nanoparticle; Silane coupling agent; Sonication	PARTICLES; COMPOSITE; SILICA; HYBRID	Raspberry-shaped particles of a polymethylmethacrylate (PMMA) core chemically binding silica nanoparticles (NPs) could be synthesized with heterocoagulation in combination with two-step addition of a polymerizable silane coupling agent of 3-methacryloxypropylmethoxysilane (MPTMS) before and after the heterocoagulation, respectively. Submicron-sized PMMA particles were prepared in soap-free emulsion polymerization in the presence of MPTMS that was introduced into the PMMA particles as a scaffold for the chemical bonding. The PMMA particles were mixed with silica NPs under an acidic condition of pH = 2 to cause electrostatic heterocoagulation of the PMMA cores and the silica NPs. Then, MPTMS was added to the acidic suspension, and the suspension pH of heterocoagulated particles was raised to 8 to generate strong chemical bonding between the PMMA and silica NPs in stable particle dispersion. The strong interaction between the PMMA cores and silica NPs was demonstrated in sonication experiments where desorption of silica NPs from the PMMA cores was drastically suppressed by the two-step MPTMS addition.	[Suwabe, Chika; Nagao, Daisuke; Ishii, Haruyuki; Konno, Mikio] Tohoku Univ, Dept Chem Engn, Aramaki Aza Aoba Ku, Sendai, Miyagi 9808579, Japan	Nagao, D (reprint author), Tohoku Univ, Dept Chem Engn, Aramaki Aza Aoba Ku, 6-6-07 Aoba, Sendai, Miyagi 9808579, Japan.	nagao@mickey.che.tohoku.ac.jp; konno@mickey.che.tohoku.ac.jp			Samsung R&D Institute Japan; Ministry of Education, Culture, Sports, Science and Technology [MEXT 25600001, 26286019]	This research was supported by Samsung R&D Institute Japan and also partially supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT 25600001 and 26286019).	Pan YF, 2014, MACROMOL RAPID COMM, V35, P635, DOI 10.1002/marc.201300794; Qian Z, 2009, J MATER CHEM, V19, P1297, DOI 10.1039/b810808k; Sakurai Y, 2014, COLLOID POLYM SCI, V292, P449, DOI 10.1007/s00396-013-3090-y; Chenal M, 2014, POLYMER, V55, P3516, DOI 10.1016/j.polymer.2014.05.057; FURUSAWA K, 1987, COLLOID POLYM SCI, V265, P882, DOI 10.1007/BF01421816; FURUSAWA K, 1992, COLLOID SURFACE, V63, P103, DOI 10.1016/0166-6622(92)80076-E; Faucon A, 2013, J MATER CHEM C, V1, P3879, DOI 10.1039/c3tc30508b; Han SJ, 2013, J APPL POLYM SCI, V127, P3601, DOI 10.1002/app.37798; Ishii M, 2010, US Patent, Patent No. 7803508; Li R, 2006, LANGMUIR, V22, P8127, DOI 10.1021/la053519n; Matsumoto H, 2010, LANGMUIR, V26, P4207, DOI 10.1021/la903266e; Nagao D, 2006, J COLLOID INTERF SCI, V298, P232, DOI 10.1016/j.jcis.2005.10.052; Nagao D, 2011, LANGMUIR, V27, P13302, DOI 10.1021/la202968f; Taniguchi T, 2012, J COLLOID INTERF SCI, V368, P107, DOI 10.1016/j.jcis.2011.11.077; Wang JY, 2008, COLLOID POLYM SCI, V286, P283, DOI 10.1007/s00396-007-1767-9; Yanagida N, 2000, KOBUNSHI RONBUNSHU, V57, P336	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JUL	2015	293	7					2095	2100		10.1007/s00396-015-3603-y		6	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CL4RZ	WOS:000356942800025		
J	Tei, M; Wakasugi, M; Akamatsu, H				Tei, M.; Wakasugi, M.; Akamatsu, H.			Comparison of perioperative and short-term oncological outcomes after single- or multiport surgery for colorectal cancer	COLORECTAL DISEASE			English	Article						Single-incision laparoscopic surgery; single-port surgery; colorectal cancer; oncological outcomes	CONVENTIONAL LAPAROSCOPIC COLECTOMY; RANDOMIZED-TRIAL; COLON-CANCER; INCISION; RESECTION; MULTICENTER	AimThe aim of this retrospective study was to compare the short-term surgical results of single-port surgery (SPS) with those of multiport surgery (MPS) for colorectal cancer. MethodWe studied 673 consecutive patients who underwent SPS or MPS for colorectal cancer in our department from January 2008 to December 2013. The operative parameters and oncological outcome were analysed and compared between the SPS and the MPS groups retrospectively. ResultsThe SPS and MPS groups did not differ significantly in terms of preoperative evaluation. The median operative time was significantly shorter with SPS than with MPS (176min vs 193min; P<0.001). The two groups did not differ significantly in terms of postoperative complications. Length of hospital stay was significantly shorter with SPS than with MPS (8days vs 10days; P<0.001). Oncological resection was similar in the two groups. The disease-free survival rates at 2years according to the TNM stage did not differ significantly between the two groups (Stage I, 98.5% vs 94.7%; Stage II, 93.4% vs 90.7%; and Stage III, 70.8% vs 68.4%). ConclusionOur experience demonstrates that SPS is safe and can provide oncological outcomes equal to those of MPS in patients with colorectal cancer.	[Tei, M.; Wakasugi, M.; Akamatsu, H.] Osaka Police Hosp, Dept Surg, Tennoji Ku, Osaka, Osaka 5430035, Japan	Tei, M (reprint author), Osaka Police Hosp, Dept Surg, Tennoji Ku, 10-31 Kitayama Cho, Osaka, Osaka 5430035, Japan.	mtei@live.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Yun JA, 2013, SURG ENDOSC, V27, P2122, DOI 10.1007/s00464-012-2722-5; Champagne BJ, 2012, ANN SURG, V255, P66, DOI 10.1097/SLA.0b013e3182378442; Huscher CG, 2012, AM J SURG, V204, P115, DOI 10.1016/j.amjsurg.2011.09.005; Lowry PS, 2003, J ENDOUROL, V17, P493, DOI 10.1089/089277903769013649; Poon JTC, 2012, SURG ENDOSC, V26, P2729, DOI 10.1007/s00464-012-2262-z; Remzi FH, 2008, COLORECTAL DIS, V10, P823, DOI 10.1111/j.1463-1318.2008.01660.x; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Kim SJ, 2011, ANN SURG, V254, P933, DOI 10.1097/SLA.0b013e318237826b; Chen WTL, 2011, SURG ENDOSC, V25, P1887, DOI 10.1007/s00464-010-1481-4; Leung KL, 2004, LANCET, V363, P1187, DOI 10.1016/S0140-6736(04)15947-3; Merchant AM, 2009, DIS COLON RECTUM, V52, P1021, DOI 10.1007/DCR.0b013e3181a4fabe; Kwag SJ, 2013, AM J SURG, V206, P320, DOI 10.1016/j.amjsurg.2012.11.007; Bucher P, 2009, DIS COLON RECTUM, V52, P1797, DOI 10.1007/DCR.0b013e3181b551ce; Gaujoux S, 2012, J GASTROINTEST SURG, V16, P629, DOI 10.1007/s11605-011-1780-7; Marcovici I, 2001, JSLS, V5, P293; Milsom JW, 1998, J AM COLL SURGEONS, V187, P46, DOI 10.1016/S1072-7515(98)00132-X; Milsom JW, 1998, J AM COLL SURGEONS, V187, P54; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Papaconstantinou HT, 2011, SURGERY, V150, P820, DOI 10.1016/j.surg.2011.07.060; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Wolthuis AM, 2012, COLORECTAL DIS, V14, P634, DOI 10.1111/j.1463-1318.2011.02721.x	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8910	1463-1318		COLORECTAL DIS	Colorectal Dis.	JUL	2015	17	7					O141	O147		10.1111/codi.12986		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CL1IF	WOS:000356695300001		
J	Miyaji, A; Omote, K				Miyaji, Atsuko; Omote, Kazumasa			Self-healing wireless sensor networks	CONCURRENCY AND COMPUTATION-PRACTICE & EXPERIENCE			English	Article						wireless sensor networks; security; self-healing; resiliency		Availability is very important for long-term use of wireless sensor networks (WSNs), assuming the presence of an attacker. It is thus important to achieve secure communication among WSNs even if some sensor nodes are compromised. Self-healing WSNs possess the feature that a network automatically self-heals after node-capture attacks in order to achieve availability. The self-healing means that the ratio of compromised links decreases with time, even if the attacker corrupts sensor nodes of the network. In this paper, three kinds of self-healing schemes for WSNs are described, a polynomial-based self-healing scheme, a simple random key pre-distribution scheme with self-healing, and a proactive co-operative link self-healing scheme. Our contributions are the self-healing schemes with security evaluation, in which we conduct analytical evaluation and a simulation experiment of our schemes, and results obtained from both analysis and simulations indicate that our schemes are effective in self-healing. Furthermore, comparing three schemes, we clarify each difference and discuss optimal scheme under each different environments. (c) 2015 The Authors. Concurrency and Computation: Practice and Experience Published by John Wiley & Sons Ltd.	[Miyaji, Atsuko; Omote, Kazumasa] JAIST, Sch Informat Sci, Nomi, Japan	Omote, K (reprint author), JAIST, Sch Informat Sci, Nomi, Japan.	omote@jaist.ac.jp			CREST, JST;  [i21240001];  [25730083]	This study is partly supported by Grant-in-Aid for Scientific Research (A)(i21240001), Grant-in-Aid for Young Scientists (B) (25730083) and CREST, JST.	Du WL, 2004, IEEE INFOCOM SER, P586; Chan HW, 2003, P IEEE S SECUR PRIV, P197; Ma D, 2008, LECT NOTES COMPUT SC, V5340, P47; Castelluccia C, 2007, 2007 THIRD INTERNATIONAL CONFERENCE ON SECURITY AND PRIVACY IN COMMUNICATION NETWORKS AND WORKSHOPS, P351, DOI 10.1109/SECCOM.2007.4550354; Blundo C, 1993, LNCS, V740, P471; Da AK, 2012, INT J INF SECUR, V11, P189; Ergun M, 2011, COMPUT J, V54, P602, DOI 10.1093/comjnl/bxq043; Eschenauer L., 2002, CCS 2002 SCOTTSD AR, V17, P41; Iida T, 2011, LECT NOTES COMPUT SC, V6976, P253, DOI 10.1007/978-3-642-24550-3_20; Ito H, 2010, GLOBECOM, P1; Kalkan K, 2009, Q2SWINET09: PROCEEDING OF THE FIFTH ACM INTERNATIONAL SYMPOSIUM ON QOS AND SECURITY FOR WIRELESS AND MOBILE NETWORKS, P29; Liu D., 2005, ACM T INFORM SYSTEM, V8, P41, DOI DOI 10.1145/1053283; Miyaji A, 2013, INT CON ADV INFO NET, P205, DOI 10.1109/AINA.2013.68; Pietro RD, 2008, SRDS 2008, P185; Pietro RD, 2010, INFOCOM, P2303; Tian W, EUC 2010 HONG KONG C, P617; Yilmaz OZ, 2008, SECRYPT 2008: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SECURITY AND CRYPTOGRAPHY, P136	17	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1532-0626	1532-0634		CONCURR COMP-PRACT E	Concurr. Comput.-Pract. Exp.	JUL	2015	27	10			SI		2547	2568		10.1002/cpe.3434		22	Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	CL2YW	WOS:000356815400004		
J	Shida, H; Mende, M; Takano-Yamamoto, T; Osumi, N; Streit, A; Wakamatsu, Y				Shida, Hiroko; Mende, Michael; Takano-Yamamoto, Teruko; Osumi, Noriko; Streit, Andrea; Wakamatsu, Yoshio			Otic placode cell specification and proliferation are regulated by Notch signaling in avian development	DEVELOPMENTAL DYNAMICS			English	Article						otic placode; Notch; Delta; Hes; Pax2; Sox9	CHICK INNER-EAR; LATERAL INHIBITION; NEURONAL DIFFERENTIATION; PROSENSORY PATCHES; FATE DETERMINATION; CRANIAL PLACODES; XENOPUS-LAEVIS; EXPRESSION; INDUCTION; WNT	Background: The entire inner ear including the cochlear-vestibular ganglion arises from a simple epithelium, the otic placode. Precursors for the placode originate from a pool of progenitors located in ectoderm next to the future hindbrain, the pre-otic field, where they are intermingled with future epibranchial and epidermal cells. While the importance of secreted proteins, such as FGFs and Wnts, in imparting otic identity has been well studied, how precursors for these different fates segregate locally is less well understood. Results: (1) The Notch ligand Delta1 and the Notch target Hes5-2 are expressed in a part of pre-otic field before otic commitment, indicative of active Notch signaling, and this is confirmed using a Notch reporter. (2) Loss and gain-of-function approaches reveal that Notch signaling regulates both proliferation and specification of pre-otic progenitors. Conclusions: Our results identify a novel function of Notch signaling in cell fate determination in the pre-otic field of avian embryos. Developmental Dynamics 244: 839-851, 2015. (C) 2015 Wiley Periodicals, Inc.	[Shida, Hiroko; Osumi, Noriko; Wakamatsu, Yoshio] Tohoku Univ, Dept Dev Neurosci, Grad Sch Med, Ctr Translat & Adv Anim Res, Sendai, Miyagi 9808575, Japan; [Shida, Hiroko; Takano-Yamamoto, Teruko] Tohoku Univ, Div Orthodont & Dentofacial Orthoped, Grad Sch Dent, Sendai, Miyagi 9808575, Japan; [Mende, Michael; Streit, Andrea] Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England	Wakamatsu, Y (reprint author), Tohoku Univ, Dept Dev Neurosci, Grad Sch Med, Aoba Ku, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan.	wakasama@med.tohoku.ac.jp			JSPS [25111701]; BBSRC [G20323]	Grant sponsor: JSPS; Grant number: 25111701; Grant sponsor: BBSRC project grant; Grant number: G20323.	Abello G, 2007, MECH DEVELOP, V124, P631, DOI 10.1016/j.mod.2007.04.002; Endo Y, 2002, DEVELOPMENT, V129, P863; Jayasena CS, 2008, DEVELOPMENT, V135, P2251, DOI 10.1242/dev.017905; Liu D, 2003, DEVELOPMENT, V130, P2213, DOI 10.1242/dev.00445; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Morrison A, 1999, MECH DEVELOP, V84, P169, DOI 10.1016/S0925-4773(99)00066-0; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Urness LD, 2010, DEV BIOL, V340, P595, DOI 10.1016/j.ydbio.2010.02.016; Wakamatsu Y, 1997, DEVELOPMENT, V124, P3449; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; Streit A, 2007, INT J DEV BIOL, V51, P447, DOI 10.1387/ijdb.072327as; Dutta S, 2005, DEVELOPMENT, V132, P1579, DOI 10.1242/dev.01723; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Brugmann SA, 2004, DEVELOPMENT, V131, P5871, DOI 10.1242/dev01516; Bailey AP, 2006, DEV CELL, V11, P505, DOI 10.1016/j.devcel.2006.08.009; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Christophorou NAD, 2010, DEV BIOL, V345, P180, DOI 10.1016/j.ydbio.2010.07.007; Haddon C, 1998, DEVELOPMENT, V125, P4637; Takeuchi H, 2014, BIOCHEM BIOPH RES CO, V453, P235, DOI 10.1016/j.bbrc.2014.05.115; Lanford PJ, 1999, NAT GENET, V21, P289; Brugmann SA, 2005, BIOL CELL, V97, P303, DOI 10.1042/BC20040515; Riley BB, 1999, DEVELOPMENT, V126, P5669; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Wakamatsu Y, 1997, DEVELOPMENT, V124, P1953; Schlosser G, 2004, DEV BIOL, V271, P439, DOI 10.1016/j.ydbio.2004.04.013; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev/00555; Adam J, 1998, DEVELOPMENT, V125, P4645; Bhattacharyya S, 2004, DEV BIOL, V271, P403, DOI 10.1016/j.ydbio.2004.04.010; Wakamatsu Y, 2011, DEV GROWTH DIFFER, V53, P994, DOI 10.1111/j.1440-169X.2011.01311.x; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Streit A, 2002, DEV BIOL, V249, P237, DOI 10.1006/dbio.2002.0739; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Kiernan AE, 2013, SEMIN CELL DEV BIOL, V24, P470, DOI 10.1016/j.semcdb.2013.04.002; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Bagheri-Fam S, 2001, GENOMICS, V78, P73, DOI 10.1006/geno.2001.6648; Barrionuevo F, 2008, DEV BIOL, V317, P213, DOI 10.1016/j.ydbio.2008.02.011; CONNOLLY D, 1995, TRENDS GENET, V11, P259, DOI 10.1016/S0168-9525(00)89070-8; Fior H, 2005, DEV BIOL, V281, P318; Formosa-Jordan P, 2013, INT J DEV BIOL, V57, P341, DOI 10.1387/ijdb.120259jf; Freter S, 2012, DEV DYNAM, V241, P1716, DOI 10.1002/dvdy.23856; Groves AK, 2000, DEVELOPMENT, V127, P3489; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Kohyama J, 2005, DEV BIOL, V286, P311, DOI 10.1016/j.ydbio.2005.08.003; Kozlowski DJ, 1997, BIOCHEM CELL BIOL, V75, P551, DOI 10.1139/bcb-75-5-551; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Listou A, 2005, DEVELOPMENT, V132, P4051; Marin F, 2000, DEVELOPMENT, V127, P4925; Matsuda Y, 2005, DEVELOPMENT, V132, P2783, DOI 10.1242/dev.01853; Maynard TM, 2000, DEVELOPMENT, V127, P4561; Pieper M, 2011, DEV BIOL, V360, P257, DOI 10.1016/j.ydbio.2011.09.024; Saint-Germain N, 2004, DEVELOPMENT, V131, P1755, DOI 10.1242/dev.01066; Streit A, 2001, METHODS, V23, P339, DOI 10.1006/meth.2000.1146; Wakamatsu Y, 2009, DEV GROWTH DIFFER, V51, P707, DOI 10.1111/j.1440-169X.2009.01130.x; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Xu H, 2008, DEV BIOL, V317, P174, DOI 10.1016/j.ydbio.2008.02.012	65	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	JUL	2015	244	7					839	851		10.1002/dvdy.24291		13	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CL5AV	WOS:000356972600002		
J	Okubo, T; Takada, S				Okubo, Tadashi; Takada, Shinji			Pharyngeal arch deficiencies affect taste bud development in the circumvallate papilla with aberrant glossopharyngeal nerve formation	DEVELOPMENTAL DYNAMICS			English	Article						pharyngeal arch; glossopharyngeal nerve; taste bud development circumvallate papilla; epibranchial placode	CRANIAL SENSORY NEURONS; 22Q11 DELETION SYNDROME; MUTANT MICE; NEURAL CREST; CARDIOVASCULAR DEFECTS; NEUROTROPHIC FACTOR; GUSTATORY PAPILLAE; LINGUAL DEFICITS; SONIC-HEDGEHOG; TBX1	Background: The pharyngeal arches (PAs) generate cranial organs including the tongue. The taste placodes, formed in particular locations on the embryonic tongue surface, differentiate into taste buds harbored in distinct gustatory papillae. The developing tongue also has a complex supply of cranial nerves through each PA. However, the relationship between the PAs and taste bud development is not fully understood. Results: Ripply3 homozygous mutant mice, which have impaired third/ fourth PAs, display a hypoplastic circumvallate papilla and lack taste buds, although the taste placode is normally formed. Formation of the glossopharyngeal ganglia is defective and innervation toward the posterior tongue is completely missing in Ripply3 mutant embryos at E12.5. Moreover, the distribution of neuroblasts derived from the epibranchial placode is severely, but not completely, atenuated, and the neural crest cells are diminished in the third PA region of Ripply3 mutant embryos at E9.5-E10.5. In Tbx1 homozygous mutant embryos, which exhibit another type of deficiency in PA development, the hypoplastic circumvallate papilla is observed along with abnormal formation of the glossopharyngeal ganglia and severely impaired innervation. Conclusions: PA deficiencies affect multiple aspects of taste bud development, including formation of the cranial ganglia and innervation to the posterior tongue. Developmental Dynamics 244: 874-887, 2015. (C) 2015 Wiley Periodicals, Inc.	[Okubo, Tadashi] Kitasato Univ, Sch Med, Dept Lab Anim Sci, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Takada, Shinji] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi, Japan	Okubo, T (reprint author), Kitasato Univ, Sch Med, Dept Lab Anim Sci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	okubo@med.kitasato-u.ac.jp					Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Karpinski BA, 2014, DIS MODEL MECH, V7, P245, DOI 10.1242/dmm.012484; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; Ito A, 2009, CELL TISSUE RES, V337, P349, DOI 10.1007/s00441-009-0833-7; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Scambler PJ, 2010, PEDIATR CARDIOL, V31, P378, DOI 10.1007/s00246-009-9613-0; El-Sharaby A, 2001, ARCH HISTOL CYTOL, V64, P401, DOI 10.1679/aohc.64.401; Liao J, 2004, HUM MOL GENET, V13, P1577, DOI 10.1093/hmg/ddh176; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Pattyn A, 1999, NATURE, V399, P366; Hall JMH, 2003, DEV BIOL, V255, P263, DOI 10.1016/S0012-1606(02)00048-9; Oakley B, 2004, J NEUROCYTOL, V33, P631, DOI 10.1007/s11068-005-3332-0; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Nosrat CA, 1997, DEVELOPMENT, V124, P1333; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Mistretta CM, 2003, DEV BIOL, V254, P1, DOI 10.1016/S0012-1606(02)00014-3; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Thirumangalathu S, 2009, DEVELOPMENT, V136, P1519, DOI 10.1242/dev.029090; Hall JM, 1999, J COMP NEUROL, V406, P143, DOI 10.1002/(SICI)1096-9861(19990405)406:2<143::AID-CNE1>3.0.CO;2-X; Artinger KB, 1998, J NEUROBIOL, V36, P572, DOI 10.1002/(SICI)1097-4695(19980915)36:4<572::AID-NEU10>3.0.CO;2-A; Calmont A, 2011, NEUROGASTROENT MOTIL, V23, P125, DOI 10.1111/j.1365-2982.2010.01615.x; Freter S, 2013, DEVELOPMENT, V140, P3595, DOI 10.1242/dev.091033; Freyer L, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-33; Graham A, 2001, BIOESSAYS, V23, P54, DOI 10.1002/1521-1878(200101)23:1<54::AID-BIES1007>3.0.CO;2-5; Harlow DE, 2007, DEV BIOL, V310, P317, DOI 10.1016/j.ydbio.2007.07.042; Harlow DE, 2011, DEV DYNAM, V240, P309, DOI 10.1002/dvdy.22527; Ito A, 2010, NEUROSCI LETT, V471, P189, DOI 10.1016/j.neulet.2010.01.039; Ivins S, 2005, DEV BIOL, V285, P554, DOI 10.1016/j.ydbio.2005.06.026; Kist R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004709; Kriebitz NN, 2009, DEV BIOL, V336, P280, DOI 10.1016/j.ydbio.2009.10.013; Krimm RF, 2001, DEV BIOL, V232, P508, DOI 10.1006/dbio.2001.0190; Krimm RF, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-S3-S4; Lassiter RNT, 2014, DEV BIOL, V389, P39, DOI 10.1016/j.ydbio.2013.11.025; Liebl DJ, 1999, DEV BIOL, V213, P378, DOI 10.1006/dbio.1999.9385; Ma LQ, 2009, J NEUROSCI, V29, P3354, DOI 10.1523/JNEUROSCI.3970-08.2009; Mistretta CM, 1999, J COMP NEUROL, V409, P13; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Nosrat IV, 2004, J NEUROCYTOL, V33, P607, DOI 10.1007/s11068-005-3330-2; Okubo T, 2011, DEVELOPMENT, V138, P339, DOI 10.1242/dev.054056; Patel AV, 2010, J COMP NEUROL, V518, P3290, DOI 10.1002/cne.22400; Ringstedt T, 1999, J NEUROSCI, V19, P3507; Trokovic N, 2005, INT J DEV BIOL, V49, P797, DOI 10.1387/ijdb.051976nt; Zhang GH, 2008, ARCH ORAL BIOL, V53, P583, DOI 10.1016/j.archoralbio.2008.01.005	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	JUL	2015	244	7					874	887		10.1002/dvdy.24289		14	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CL5AV	WOS:000356972600005		
J	Yorifuji, T; Matsubara, K; Sakakibara, A; Hashimoto, Y; Kawakita, R; Hosokawa, Y; Fujimaru, R; Murakami, A; Tamagawa, N; Hatake, K; Nagasaka, H; Suzuki, J; Urakami, T; Izawa, M; Kagami, M				Yorifuji, T.; Matsubara, K.; Sakakibara, A.; Hashimoto, Y.; Kawakita, R.; Hosokawa, Y.; Fujimaru, R.; Murakami, A.; Tamagawa, N.; Hatake, K.; Nagasaka, H.; Suzuki, J.; Urakami, T.; Izawa, M.; Kagami, M.			Abnormalities in chromosome 6q24 as a cause of early-onset, non-obese, non-autoimmune diabetes mellitus without history of neonatal diabetes	DIABETIC MEDICINE			English	Article							FOLLOW-UP; PHENOTYPE; REGION; TNDM	Aims Abnormalities in the imprinted locus on chromosome 6q24 are the most common causes of transient neonatal diabetes mellitus (6q24-related transient neonatal diabetes). 6q24-Related transient neonatal diabetes is characterized by the patient being small-for-gestational age, diabetes mellitus at birth, spontaneous remission within the first few months and frequent recurrence of diabetes after childhood. However, it is not clear whether individuals with 6q24 abnormalities invariably develop transient neonatal diabetes. This study explored the possibility that 6q24 abnormalities might cause early-onset, non-autoimmune diabetes without transient neonatal diabetes. Methods The 6q24 imprinted locus was screened for abnormalities in 113 Japanese patients with early-onset, non-obese, non-autoimmune diabetes mellitus who tested negative for mutations in the common maturation-onset diabetes of the young (MODY) genes and without a history of transient neonatal diabetes. Positive patients were further analysed by combined loss of heterozygosity / comparative genomic hybridization analysis and by microsatellite analysis. Detailed clinical data were collected through the medical records of the treating hospitals. Results Three patients with paternal uniparental isodisomy of chromosome 6q24 were identified. None presented with hyperglycaemia in the neonatal period. Characteristically, these patients were born small-for-gestational age, representing 27.2% of the 11 patients whose birth weight standard deviation score (SDS) for gestational age was below -2.0. Conclusions Abnormalities in the imprinted locus on chromosome 6q24 do not necessarily cause transient neonatal diabetes. Non-penetrant 6q24-related diabetes could be an underestimated cause of early-onset, non-autoimmune diabetes in patients who are not obese and born small-for-gestational age.	[Yorifuji, T.; Sakakibara, A.; Hashimoto, Y.; Kawakita, R.; Hosokawa, Y.; Fujimaru, R.] Osaka City Gen Hosp, Childrens Med Ctr, Dept Pediat Endocrinol & Metab, Osaka, Japan; [Yorifuji, T.; Murakami, A.; Tamagawa, N.] Osaka City Gen Hosp, Dept Med Genet, Osaka, Japan; [Yorifuji, T.; Hatake, K.] Osaka City Gen Hosp, Clin Res Ctr, Osaka, Japan; [Matsubara, K.; Kagami, M.] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan; [Nagasaka, H.] Takarazuka City Hosp, Dept Pediat, Takarazuka, Hyogo, Japan; [Suzuki, J.; Urakami, T.] Nihon Univ, Sch Med, Dept Pediat, Tokyo 102, Japan; [Izawa, M.] Aichi Childrens Hlth & Med Ctr, Dept Endocrinol & Metab, Nagoya, Aichi, Japan	Yorifuji, T (reprint author), Osaka City Gen Hosp, Childrens Med Ctr, Dept Pediat Endocrinol & Metab, Osaka, Japan.	t-yorifuji@med.osakacity-hp.or.jp			National Center for Child Health and Development from Ministry of Health, Labour and Welfare of Japan	This work was supported in part by a Grant for National Center for Child Health and Development (25-10) from the Ministry of Health, Labour and Welfare of Japan.	Sovik O, 2012, PEDIATR DIABETES, V13, P155, DOI 10.1111/j.1399-5448.2011.00776.x; Flanagan SE, 2013, DIABETOLOGIA, V56, P218, DOI 10.1007/s00125-012-2766-z; Hoffmann A, 2012, MOL CELL BIOL, V32, P2549, DOI 10.1128/MCB.06637-11; Mackay DJG, 2005, HUM GENET, V116, P255, DOI 10.1007/s00439-004-1236-1; Fowden AL, 2009, HORM RES, V72, P257, DOI 10.1159/000245927; Boonen SE, 2013, DIABETES CARE, V36, P505, DOI 10.2337/dc12-0700; Yorifuji T, 2012, PEDIATR DIABETES, V13, P26, DOI 10.1111/j.1399-5448.2011.00827.x; Mackay DJG, 2010, AM J MED GENET C, V154C, P335, DOI 10.1002/ajmg.c.30272; Bittencourt MC, 1997, J MED GENET, V34, P77, DOI 10.1136/jmg.34.1.77; Docherty LE, 2010, DIABETOLOGIA, V53, P2347, DOI 10.1007/s00125-010-1853-2; Docherty LE, 2013, DIABETOLOGIA, V56, P758, DOI 10.1007/s00125-013-2832-1; Gloyn AL, 2006, DIABETES, V55, P2272, DOI 10.2337/db06-0216; Mackay D, 2014, EUR J HUM GENET, V22, pE1, DOI 10.1038/ejhg.2014.27; Valerio G, 2004, DIABETES CARE, V27, P2405, DOI 10.2337/diacare.27.10.2405; Yorifuji T, 2014, PEDIATR DIABETES, V15, P606, DOI 10.1111/pedi.12123	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3071	1464-5491		DIABETIC MED	Diabetic Med.	JUL	2015	32	7					963	967		10.1111/dme.12758		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CK7YK	WOS:000356452900017		
J	Endo, C; Nakashima, R; Taguchi, A; Yahata, K; Kawahara, E; Shimagaki, N; Kamio, J; Saito, Y; Ikeda, N; Sato, M				Endo, Chiaki; Nakashima, Ryutaro; Taguchi, Akemi; Yahata, Kazunobu; Kawahara, Ei; Shimagaki, Nikako; Kamio, Junko; Saito, Yasuki; Ikeda, Norihiko; Sato, Masami			Inter-rater agreement of sputum cytology for lung cancer screening in Japan	DIAGNOSTIC CYTOPATHOLOGY			English	Article						sputum cytology; lung cancer screening; quality assurance; interrater agreement; kappa statistics; Fleiss'; kappa	OBSERVER VARIATION; INTEROBSERVER; CYTODIAGNOSIS; PREFECTURE; PROGRAM	BackgroundTo compare lung cancer detection rate by sputum cytology, we need some assurance that the estimates do not vary widely if different observers evaluate the same specimens. The aim of this study was to determine inter-rater agreement of sputum cytology diagnoses. MethodsSlides of sputum cytology from 150 subjects were selected from a pool of slides held by six of the laboratories that had participated in a population-based lung cancer screening program over the last ten years in Japan. The cytotechnologists in these laboratories had considerable experience with sputum cytology. Each case was re-evaluated six times. Cases that were diagnosed as the same category by all six laboratories were selected as consensus cases to serve as standardized sputum cytology cases. Thirty-seven cytotechnologists with various levels of experience in sputum cytology then re-evaluated these consensus cases. Inter-rater agreement was calculated by kappa statistics including Fleiss' kappa. ResultsAll pairs of interlaboratory agreement for the 150 cases showed statistically significant kappa values, most pairs showing substantial agreement. Fleiss' kappa value across the six laboratories was 0.5. Fourteen cases were identified as the consensus cases, and the agreement among observers with less experience of sputum cytology showed significantly lower than the agreement among those with considerable experience (Fleiss' kappa value 0.27 vs. 0.45, P<0.05). Moreover, cytotechnologists with less experience under-diagnosed the slides significantly more often than those with considerable experience. ConclusionWhen the observers have considerable experience with sputum cytology, inter-observer agreement is good. Diagn. Cytopathol. 2015;43:545-550. (c) 2015 Wiley Periodicals, Inc.	[Endo, Chiaki] Tohoku Univ Hosp, Dept Thorac Surg, Sendai, Miyagi 9808575, Japan; [Nakashima, Ryutaro] Miyagi Canc Soc, Dept Cytol, Sendai, Miyagi, Japan; [Taguchi, Akemi] Chiba Fdn Hlth Promot & Dis Prevent, Dept Pathol & Cytol, Chiba, Japan; [Yahata, Kazunobu] Osaka Med Assoc, Dept Cytol, Osaka, Japan; [Kawahara, Ei] Kanazawa Univ, Dept Clin Lab Sci, Kanazawa, Ishikawa, Japan; [Shimagaki, Nikako] Niigata Hlth Serv Ctr, Dept Cytol, Niigata, Japan; [Kamio, Junko] Fukushima Preservat Serv Assoc Hlth, Dept Cytol, Fukushima, Japan; [Saito, Yasuki] Sendai Med Ctr, Dept Thorac Surg, Sendai, Miyagi, Japan; [Ikeda, Norihiko] Tokyo Med Univ, Dept Surg, Tokyo 1608402, Japan; [Sato, Masami] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Gen Thorac Surg, Kagoshima 890, Japan	Endo, C (reprint author), Tohoku Univ Hosp, Dept Thorac Surg, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	endo@idac.tohoku.ac.jp	Kawahara, Ei/C-3233-2015				Turner JK, 2013, HISTOPATHOLOGY, V62, P916, DOI 10.1111/his.12110; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; BROWMAN GP, 1990, CANCER RES, V50, P1216; Darragh TM, 2013, CANCER CYTOPATHOL, V121, P72, DOI 10.1002/cncy.21218; EVANS DMD, 1982, THORAX, V37, P259, DOI 10.1136/thx.37.4.259; Gupta DK, 2001, ACTA CYTOL, V45, P697; HOLIDAY DB, 1995, ACTA CYTOL, V39, P195; Mandrekar JN, 2011, J THORAC ONCOL, V6, P6, DOI 10.1097/JTO.0b013e318200f983; NAKADA T, 1987, TOHOKU J EXP MED, V152, P173, DOI 10.1620/tjem.152.173; Papanicolaou GN, 1954, ATLAS EXFOLIATIVE CY; Sagawa M, 2001, CANCER, V92, P588, DOI 10.1002/1097-0142(20010801)92:3<588::AID-CNCR1358>3.0.CO;2-8; Sato M, 1997, J JPN SOC CLIN CYTOL, V36, P490; Tsukada H, 2001, BRIT J CANCER, V85, P1326, DOI 10.1054/bjoc.2001.2060	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-1039	1097-0339		DIAGN CYTOPATHOL	Diagn. Cytopathol.	JUL	2015	43	7					545	550		10.1002/dc.23253		6	Medical Laboratory Technology; Pathology	Medical Laboratory Technology; Pathology	CL2XM	WOS:000356811100005		
J	Hjerpe, A; Ascoli, V; Bedrossian, CWM; Boon, ME; Creaney, J; Davidson, B; Dejmek, A; Dobra, K; Fassina, A; Field, A; Firat, P; Kamei, T; Kobayashi, T; Michael, CW; Onder, S; Segal, A; Vielh, P				Hjerpe, Anders; Ascoli, Valeria; Bedrossian, Carlos W. M.; Boon, Mathilde E.; Creaney, Jenette; Davidson, Ben; Dejmek, Annika; Dobra, Katalin; Fassina, Ambrogio; Field, Andrew; Firat, Pinar; Kamei, Toshiaki; Kobayashi, Tadao; Michael, Claire W.; Onder, Sevgen; Segal, Amanda; Vielh, Philippe			Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology	DIAGNOSTIC CYTOPATHOLOGY			English	Article						Malignant mesothelioma; Guidelines; International Mesothelioma Interest Group; Cytology; Ancillary testing	DIFFERENTIATED PAPILLARY MESOTHELIOMA; IN-SITU HYBRIDIZATION; PLEURAL MESOTHELIOMA; EFFUSION CYTOLOGY; PATHOLOGICAL DIAGNOSIS; CONSENSUS STATEMENT; TELOMERASE ACTIVITY; SOLUBLE MESOTHELIN; CELLS; IMMUNOHISTOCHEMISTRY	ObjectiveTo provide practical guidelines for the cytopathologic diagnosis of malignant mesothelioma. Data SourcesCytopathologists with an interest in the field involved in the International Mesothelioma Interest Group (IMIG) and the International Academy of Cytology (IAC) contributed to this update. Reference material includes peer-reviewed publications and textbooks. RationaleThis article is the result of discussions during and after the IMIG 2012 conference in Boston, followed by thorough discussions during the 2013 IAC meeting in Paris. Additional contributions have been obtained from cytopathologists and scientists who could not attend these meetings, with final discussions and input during the IMIG 2014 conference in Cape Town. Diagn. Cytopathol. 2015;43:563-576. (c) 2015 Wiley Periodicals, Inc.	[Hjerpe, Anders; Dobra, Katalin] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Clin Pathol Cytol, SE-14186 Huddinge, Sweden; [Ascoli, Valeria] Univ Roma La Sapienza, Dept Radiol Oncol & Pathol Sci, I-00185 Rome, Italy; [Bedrossian, Carlos W. M.] Rush Univ, Coll Med, Chicago, IL 60612 USA; [Boon, Mathilde E.] Leiden Cytol & Pathol Lab, Lieveren, Netherlands; [Creaney, Jenette] Univ Western Australia, QEII Med Ctr, Sch Med & Pharmacol, Natl Ctr Asbestos Related Dis, Perth, WA 6009, Australia; [Davidson, Ben] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Dejmek, Annika] Lund Univ, Malmo Univ Hosp, Dept Lab Med Malmo, Malmo, Sweden; [Fassina, Ambrogio] Univ Padua, Dept Med, Padua, Italy; [Field, Andrew] St Vincents Hosp, Dept Pathol Anat, Sydney, NSW 2010, Australia; [Firat, Pinar] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey; [Kamei, Toshiaki] Yamaguchi Grand Med Ctr, Div Pathol, Hofu, Japan; [Kobayashi, Tadao] Osaka Univ, Grad Sch Med, Canc Educ & Res Ctr, Osaka, Japan; [Michael, Claire W.] Case Western Reserve Univ, Dept Pathol, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Onder, Sevgen] Hacettepe Univ, Fac Med, Dept Pathol, TR-06100 Ankara, Turkey; [Segal, Amanda] QE2 Med Ctr, PathWest Lab Med WA, Dept Tissue Pathol, Perth, WA, Australia; [Vielh, Philippe] Gustave Roussy Comprehens Canc Ctr, Dept Biopathol, Villejuif, France	Hjerpe, A (reprint author), Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Clin Pathol Cytol, SE-14186 Huddinge, Sweden.	anders.hjerpe@karolinska.se					Adell E, 2014, DIAGN CYTOPATHOL, V42, P1051, DOI 10.1002/dc.23165; Creaney J, 2013, LUNG CANCER, V82, P491, DOI 10.1016/j.lungcan.2013.09.016; Washimi K, 2013, PATHOL INT, V63, P220, DOI 10.1111/pin.12053; Paintal A, 2013, CANCER CYTOPATHOL, V121, P703, DOI 10.1002/cncy.21342; Creaney J, 2007, THORAX, V62, P569, DOI 10.1136/thx.2006.068114; Henderson DW, 2013, J CLIN PATHOL, V66, P847, DOI 10.1136/jclinpath-2012-201303; Husain AN, 2009, ARCH PATHOL LAB MED, V133, P1317, DOI 10.1043/1543-2165-133.8.1317; NURMINEN M, 1994, CLIN CHEM, V40, P777; Flores-Staino C, 2010, LUNG CANCER, V68, P39, DOI 10.1016/j.lungcan.2009.05.004; Pass HI, 2008, ANN THORAC SURG, V85, P265, DOI 10.1016/j.athoracsur.2007.07.042; Benjamin H, 2010, J MOL DIAGN, V12, P771, DOI 10.2353/jmoldx.2010.090169; Husain AN, 2014, LUNG CANCER, V83, P324, DOI 10.1016/j.lungcan.2013.12.009; Churg A, 2014, AM J SURG PATHOL, V38, P990, DOI 10.1097/PAS.0000000000000200; Davidson B, 2011, CYTOPATHOLOGY, V22, P5, DOI 10.1111/j.1365-2303.2010.00829.x; Pass HI, 2012, NEW ENGL J MED, V367, P1417, DOI 10.1056/NEJMoa1115050; Zellos LS, 2002, SEMIN ONCOL, V29, P41, DOI 10.1053/sonc.2002.30230; Robinson BWS, 2003, LANCET, V362, P1612, DOI 10.1016/S0140-6736(03)14794-0; Segal A, 2013, PATHOLOGY, V45, P44, DOI 10.1097/PAT.0b013e32835bc848; Matsumoto S, 2013, CANCER CYTOPATHOL, V121, P415, DOI 10.1002/cncy.21269; Hasteh F, 2010, CANCER CYTOPATHOL, V118, P90, DOI 10.1002/cncy.20071; Sato A, 2010, MODERN PATHOL, V23, P1458, DOI 10.1038/modpathol.2010.134; Minato H, 2014, AM J CLIN PATHOL, V141, P85, DOI 10.1309/AJCP5KNL7QTELLYI; Husain AN, 2013, ARCH PATHOL LAB MED, V137, P647, DOI 10.5858/arpa.2012-0214-OA; Dejmek A, 2000, CYTOPATHOLOGY, V11, P8, DOI 10.1046/j.1365-2303.2000.00211.x; Ordonez NG, 2014, HUM PATHOL, V45, P1529, DOI 10.1016/j.humpath.2014.03.006; Baker PM, 2005, AM J CLIN PATHOL, V123, P724, DOI 10.1309/2HONVRERPP2LJDUA; Bedrossian CWM, 1994, MALIGNANT EFFUSIONS; BOON ME, 1984, ACTA CYTOL, V28, P443; BOON ME, 1984, ANAL QUANT CYTOL, V6, P221; Bovin N, 2012, BBA-GEN SUBJECTS, V1820, P1373, DOI 10.1016/j.bbagen.2012.02.005; Davidson B, 2012, SEROUS EFFUSIONS ETI; DEJMEK A, 1994, CANCER, V73, P464, DOI 10.1002/1097-0142(19940115)73:2<464::AID-CNCR2820730235>3.0.CO;2-#; Fujimoto Nobukazu, 2013, Respir Investig, V51, P92, DOI 10.1016/j.resinv.2013.02.002; Ismail-Khan Roohi, 2006, Cancer Control, V13, P255; Kho-Duffin J, 1999, DIAGN CYTOPATHOL, V20, P57, DOI 10.1002/(SICI)1097-0339(199902)20:2<57::AID-DC2>3.0.CO;2-M; KWEE WS, 1982, ACTA CYTOL, V26, P401; LEONG ASY, 1990, DIAGN CYTOPATHOL, V6, P9, DOI 10.1002/dc.2840060104; Michael CW, 2015, CYTOHISTOLOGY SEROUS; Michael Claire W, 2014, Acta Cytol, V58, P563, DOI 10.1159/000369198; Mundt F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072030; Pinelli V, 2012, J THORAC ONCOL, V7, P595, DOI 10.1097/JTO.0b013e31823e0667; Rakha EA, 2010, DIAGN CYTOPATHOL, V38, P874, DOI 10.1002/dc.21303; Saad RS, 2005, DIAGN CYTOPATHOL, V32, P156, DOI 10.1002/dc.20208; Sheaff M, 2011, CYTOPATHOLOGY, V22, P3, DOI 10.1111/j.1365-2303.2010.00840.x; Tao L, 1996, CYTOPATHOLOGY MALIGN; Wan C, 2012, ASIAN PAC J CANCER P, V13, P4745, DOI 10.7314/APJCP.2012.13.9.4745; Whitaker D, 2000, CYTOPATHOLOGY, V11, P139, DOI 10.1046/j.1365-2303.2000.00247.x; WIDEHN S, 1988, ULTRASTRUCT PATHOL, V12, P131; Zendehrokh N, 2005, MODERN PATHOL, V18, P189, DOI 10.1038/modpathol.3800278	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-1039	1097-0339		DIAGN CYTOPATHOL	Diagn. Cytopathol.	JUL	2015	43	7					563	576		10.1002/dc.23271		14	Medical Laboratory Technology; Pathology	Medical Laboratory Technology; Pathology	CL2XM	WOS:000356811100008		
J	Tonooka, A; Oda, KI; Hayashi, M; Sakazume, KI; Tanaka, H; Kaburaki, KH; Uekusa, T				Tonooka, Akiko; Oda, Ken-Ichi; Hayashi, Mamoru; Sakazume, Ko-Ichi; Tanaka, Hiroki; Kaburaki, Kyo-Hei; Uekusa, Toshimasa			Cytological findings of appendiceal mixed adenoneuroendocrine carcinoma in pleural effusion: Morphological changes evident after metastasis	DIAGNOSTIC CYTOPATHOLOGY			English	Article						goblet cell carcinoid; mixed adenoneuroendocrine carcinoma; pleural fluid; p53; ki67	GOBLET-CELL; FLUID	Goblet cell carcinoid (GCC) of the appendix is now regarded as a malignant tumor, and mixed adenoneuroendocrine carcinoma (MANEC) is a carcinoma progressing from GCC. We describe a man initially diagnosed with GCC of the appendix who died 4 years after diagnosis. Pleural fluid due to metastasis was noted in the terminal phase. Histological findings of the initial tumor indicated that cells with signet-ring morphology were predominant, but the cytological morphology of the fluid was more atypical, making it difficult to diagnose as metastatic GCC by cellular morphology alone. The cells in the pleural fluid were immunopositive for synaptophysin, which was compatible with GCC, but p53 and ki67 staining indicated that the metastatic tumor was more aggressive. These findings suggested a final diagnosis of poorly differentiated adenocarcinoma-type MANEC, which we define as a tumor with typical GCC characteristics and foci that cannot be distinguished from a poorly differentiated adenocarcinoma. This case, which we believe is reported here for the first time, indicates the cytological features of GCC cells may change at metastatic sites to be more atypical and aggressive as the tumor progresses, and these changes should be considered in diagnosis. Diagn. Cytopathol. 2015;43:577-580. (c) 2014 Wiley Periodicals, Inc.	[Tonooka, Akiko; Oda, Ken-Ichi; Hayashi, Mamoru; Sakazume, Ko-Ichi; Tanaka, Hiroki; Kaburaki, Kyo-Hei; Uekusa, Toshimasa] Kanto Rosai Hosp, Dept Diagnost Pathol, Kawasaki, Kanagawa 2118510, Japan	Tonooka, A (reprint author), Kanto Rosai Hosp, Dept Diagnost Pathol, 1-1 Kizukisumiyoshi Cho, Kawasaki, Kanagawa 2118510, Japan.	akitono@kantoh.rofuku.go.jp					Alsaad KO, 2007, ENDOCR PATHOL, V18, P16, DOI 10.1007/s12022-007-0004-x; Tang LH, 2008, AM J SURG PATHOL, V32, P1429, DOI 10.1097/PAS.0b013e31817f1816; Carr NJ, 2010, WHO CLASSIFICATION T, P122; Eeden SV, 2007, HISTOPATHOLOGY, V51, P763; Gupta A, 2013, J CYTOL, V30, P136, DOI 10.4103/0970-9371.112659; Kobayashi TK, 1997, DIAGN CYTOPATHOL, V16, P522; Komminoth P, 2010, WHO CLASSIFICATION T, P126; Li X, 2012, DIAGN CYTOPATHOL, V41, P922; Paromita R, 2010, WORLD J GASTROINTEST, V2, P251; Stefano LR, 2012, CANCERS, V4, P11; WOJCIK EM, 1991, DIAGN CYTOPATHOL, V7, P155, DOI 10.1002/dc.2840070211; Zafar S, 2008, DIAGN CYTOPATHOL, V36, P894, DOI 10.1002/dc.20950	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-1039	1097-0339		DIAGN CYTOPATHOL	Diagn. Cytopathol.	JUL	2015	43	7					577	580		10.1002/dc.23236		4	Medical Laboratory Technology; Pathology	Medical Laboratory Technology; Pathology	CL2XM	WOS:000356811100009		
J	Omori, M; Kondo, T; Yuminamochi, T; Nakazawa, K; Ishii, Y; Fukasawa, H; Hashi, A; Hirata, S				Omori, Makiko; Kondo, Tetsuo; Yuminamochi, Tsutomu; Nakazawa, Kumiko; Ishii, Yoshio; Fukasawa, Hiroko; Hashi, Akihiko; Hirata, Shuji			Cytologic features of ovarian granulosa cell tumors in pleural and ascitic fluids	DIAGNOSTIC CYTOPATHOLOGY			English	Article						ovarian neoplasm; pleural effusion; ascites; cytology; granulosa cell tumor; Call-Exner body; nuclear groove	OF-THE-LITERATURE; TERM-FOLLOW-UP	Adult granulosa cell tumor (AGCT) is an uncommon neoplasm of the ovary with potential for aggressive behavior and late recurrence. The most important prognostic factor for AGCT is tumor stage. Thus, cytological assessment of pleural or ascitic fluids is crucial for initial staging and subsequent patient management. We report herein two cases of ovarian AGCT presenting with exfoliated tumor cells in pleural and ascitic fluid. The first case involved a 61-year-old woman who presented with stage Ic (a) AGCT. Seven years after initial diagnosis, pleural effusion and pleural dissemination were identified. The second case involved a 50-year-old woman who presented with stage IV AGCT with massive ascites and right pleural effusion. Fluid cytology from both cases showed cohesive or loose clusters of small uniform neoplastic cells with round-to-oval nuclei, coffee-bean-shaped nuclear grooves, small nucleoli, and scant cytoplasm. Call-Exner bodies were also observed in these cytologic specimens. In the differential diagnosis of small monomorphic tumor cells in pleural effusion or ascites, coffee-bean-shaped nuclear grooves and cell clusters forming Call-Exner bodies are diagnostic clues of AGCT. Diagn. Cytopathol. 2015;43:581-584. (c) 2015 Wiley Periodicals, Inc.	[Omori, Makiko; Fukasawa, Hiroko; Hashi, Akihiko; Hirata, Shuji] Univ Yamanashi, Dept Obstet & Gynecol, Chuo, Yamanashi 4093898, Japan; [Kondo, Tetsuo; Yuminamochi, Tsutomu; Nakazawa, Kumiko; Ishii, Yoshio] Univ Yamanashi, Dept Pathol, Chuo, Yamanashi 4093898, Japan	Omori, M (reprint author), Univ Yamanashi, Dept Obstet & Gynecol, 1110 Simokato, Chuo, Yamanashi 4093898, Japan.	msasaki@yamanashi.ac.jp					Ali S, 2008, DIAGN CYTOPATHOL, V36, P297, DOI [10.1002/dc.20798, 10.1002/de.20798]; Crew KD, 2005, GYNECOL ONCOL, V96, P235, DOI 10.1016/j.ygyno.2004.09.023; Atilgan AO, 2013, J CYTOL, V30, P74, DOI 10.4103/0970-9371.107528; Auranen A, 2007, INT J GYNECOL CANCER, V17, P1011, DOI 10.1111/j.1525-1438.2007.00914.x; Azad K, 2010, INDIAN J PATHOL MICR, V53, P119, DOI 10.4103/0377-4929.59200; EHYA H, 1986, AM J CLIN PATHOL, V85, P402; Ertas IE, 2014, INT J CLIN ONCOL, V19, P912, DOI 10.1007/s10147-013-0630-x; Gupta N, 2012, DIAGN CYTOPATHOL, V40, P912, DOI 10.1002/dc.21675; Kavuri S, 2010, ACTA CYTOL, V54, P551; Lal A, 2004, ACTA CYTOL, V48, P315, DOI 10.1159/000326379; Ng WK, 1997, DIAGN CYTOPATHOL, V16, P57, DOI 10.1002/(SICI)1097-0339(199701)16:1<57::AID-DC14>3.0.CO;2-A; Sun HD, 2012, GYNECOL ONCOL, V124, P244, DOI 10.1016/j.ygyno.2011.10.015; Tavassoli FA, 2003, WHO CLASSIFICATION T, P146	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-1039	1097-0339		DIAGN CYTOPATHOL	Diagn. Cytopathol.	JUL	2015	43	7					581	584		10.1002/dc.23248		4	Medical Laboratory Technology; Pathology	Medical Laboratory Technology; Pathology	CL2XM	WOS:000356811100010		
J	Suzuki, H; Komuta, M; Bolog, A; Yokobori, T; Wada, S; Araki, K; Kubo, N; Watanabe, A; Tsukagoshi, M; Kuwano, H				Suzuki, Hideki; Komuta, Mina; Bolog, Altan; Yokobori, Takehiko; Wada, Satoshi; Araki, Kenichiro; Kubo, Norio; Watanabe, Akira; Tsukagoshi, Mariko; Kuwano, Hiroyuki			Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma	DIGESTIVE AND LIVER DISEASE			English	Article						18F-2-Fluoro-2-deoxy-D-glucose-positron emission tomography; Glucose transporter 1; Glycolytic metabolism; Intrahepatic cholangiocarcinoma; Pyruvate kinase type M2	POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; F-18-FDG UPTAKE; POOR-PROGNOSIS; HEXOKINASE-II; TUMOR-GROWTH; METABOLISM; RECURRENCE	Background: Cholangiocellular carcinoma is characterized by elevated glucose consumption, resulting in an increased uptake of 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG). This study investigates the relationship between 18F-FDG uptake and tumour glucose metabolism. Methods: This was a retrospective analysis of 19 patients with cholangiocellular carcinoma. Immunohistochemistry for glucose transporter 1 and pyruvate kinase type M2 were performed. Overall tumour glucose metabolism was evaluated by measuring 18F-FDG uptake and the protein expression levels of glucose transporter 1 and pyruvate kinase type M2. Results: 18F-FDG uptake had a strong positive correlation with histological differentiation. Both tumour status (p = 0.044) and tumour size (p = 0.011) were correlated with primary tumour 18F-FDG uptake. Glucose transporter 1 expression correlated with histological differentiation (p = 0.017), while pyruvate kinase type M2 expression tended to correlate with lymph node metastasis (p = 0.051). Glucose transporter 1 expression was strongly related to the standard uptake value (p = 0.001), but that of pyruvate kinase type M2 was not (p = 0.461). Conclusions: Glucose transporter 1 expression exhibits a strong correlation with 18F-FDG uptake in cholangiocellular carcinoma tissue, while pyruvate kinase type M2 expression was not associated with fluoro-2-deoxy-D-glucose uptake. In addition to its glycolytic function, pyruvate kinase type M2 has a variety of roles and its expression may enhance tumour cell invasion and promote the lymph node metastasis of intrahepatic cholangiocarcinoma. (C) 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.	[Suzuki, Hideki; Bolog, Altan; Yokobori, Takehiko; Wada, Satoshi; Araki, Kenichiro; Kubo, Norio; Watanabe, Akira; Tsukagoshi, Mariko; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci Surg 1, Maebashi, Gumma 3718511, Japan; [Komuta, Mina] St Luc Univ, Pathol Serv, Brussels, Belgium	Suzuki, H (reprint author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci Surg 1, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	hidesuzuki044@gmail.com					ADLER LP, 1993, RADIOLOGY, V187, P743; Kim Y, 2009, CURR MOL MED, V9, P425; Yen TC, 2004, J NUCL MED, V45, P22; Kluge R, 2001, HEPATOLOGY, V33, P1029, DOI 10.1053/jhep.2001.23912; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Lee JD, 2005, J NUCL MED, V46, P1753; Lang H, 2009, J AM COLL SURGEONS, V208, P218, DOI 10.1016/j.jamcollsurg.2008.10.017; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Tamada M, 2012, CLIN CANCER RES, V18, P5554, DOI 10.1158/1078-0432.CCR-12-0859; Kunkel M, 2003, CANCER, V97, P1015, DOI 10.1002/cncr.11159; Shirabe K, 1999, SURGERY, V126, P842, DOI 10.1016/S0039-6060(99)70024-3; Kaira K, 2010, J CLIN ONCOL, V28, P3746, DOI 10.1200/JCO.2009.27.4662; Hyder O, 2013, SURGERY, V153, P811, DOI 10.1016/j.surg.2012.12.005; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; [Anonymous], 1997, JAPAN LCSGO CLASSIFI, P6; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Aloj L, 1999, CANCER RES, V59, P4709; Park BK, 2006, AM J CLIN ONCOL-CANC, V29, P138, DOI 10.1097/01.coc.0000204402.29830.08; Endo I, 2008, ANN SURG, V248, P84, DOI 10.1097/SLA.0b013e318176c4d3; Amann T, 2009, AM J PATHOL, V174, P1544, DOI 10.2353/ajpath.2009.080596; Kimura S, 2004, EUR J CANCER, V40, P1904, DOI 10.1016/j.ejca.2004.04.035; Higashi T, 2002, J NUCL MED, V43, P173; Gu J, 2006, DIGEST DIS SCI, V51, P2198, DOI 10.1007/s10620-006-9428-2; Tanaka T, 2002, AM J SURG, V184, P433, DOI 10.1016/S0002-9610(02)01004-8; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; de Jong MC, 2011, J CLIN ONCOL, V29, P3140, DOI 10.1200/JCO.2011.35.6519; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Lang H, 2005, ANN SURG, V241, P134, DOI 10.1097/01.sla.0000149426.08580.a1; Guglielmi A, 2009, WORLD J SURG, V33, P1247, DOI 10.1007/s00268-009-9970-0; Haber RS, 1998, CANCER, V83, P34, DOI 10.1002/(SICI)1097-0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E; Gil-Rendo A, 2009, BRIT J SURG, V96, P166, DOI 10.1002/bjs.6459; Gomez-Casero E, 2001, MOL CARCINOGEN, V32, P100, DOI 10.1002/mc.1069; Komuta M, 2012, HEPATOLOGY, V55, P1876, DOI 10.1002/hep.25595; Muros MA, 2000, AM J SURG, V179, P457, DOI 10.1016/S0002-9610(00)00381-0; Paudyal B, 2008, CANCER SCI, V99, P260, DOI 10.1111/j.1349-7006.2007.00683.x; Saxena A, 2010, J GASTROINTEST SURG, V14, P1128, DOI 10.1007/s11605-010-1203-1; Seo S, 2008, SURGERY, V143, P769, DOI 10.1016/j.surg.2008.01.010; Sobin LH, TNM CLASSIFICATION M, V6th; Yedibela S, 2009, ANN SURG ONCOL, V16, P404, DOI 10.1245/s10434-008-0227-1; Zhou XD, 2009, J CANCER RES CLIN, V135, P1073, DOI 10.1007/s00432-009-0547-y	42	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	JUL	2015	47	7					590	596		10.1016/j.dld.2015.03.017		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL0IK	WOS:000356625100012		
J	Moscariello, M; Wieloch, R; Kurosawa, A; Li, FH; Adachi, N; Mladenov, E; Iliakis, G				Moscariello, Mario; Wieloch, Radi; Kurosawa, Aya; Li, Fanghua; Adachi, Noritaka; Mladenov, Emil; Iliakis, George			Role for Artemis nuclease in the repair of radiation-induced DNA double strand breaks by alternative end joining	DNA REPAIR			English	Article						Non-homologous end-joining (NHEJ); Alternative end joining (A-EJ); DNA double-strand breaks (DSBs); Artemis nuclease; Ionizing radiation (IR)	CHROMOSOMAL TRANSLOCATION FORMATION; B-CELL LINE; BACKUP PATHWAYS; LIGASE-III; HOMOLOGOUS RECOMBINATION; IONIZING-RADIATION; ENDONUCLEASE ACTIVITY; GEL-ELECTROPHORESIS; V(D)J RECOMBINATION; MAMMALIAN-CELLS	Exposure of cells to ionizing radiation or radiomimetic drugs generates DNA double-strand breaks that are processed either by homologous recombination repair (HRR), or by canonical, DNA-PKcs-dependent non-homologous end-joining (C-NHEJ). Chemical or genetic inactivation of factors involved in C-NHEJ or HRR, but also their local failure in repair proficient cells, promotes an alternative, error-prone end-joining pathway that serves as backup (A-EJ). There is evidence for the involvement of Artemis endonuclease, a protein deficient in a human radiosensitivity syndrome associated with severe immunodeficiency (RS-SCID), in the processing of subsets of DSBs by HRR or C-NHEJ. It is thought that within HRR or C-NHEJ Artemis processes DNA termini at complex DSBs. Whether Artemis has a role in A-EJ remains unknown. Here, we analyze using pulsed-field gel electrophoresis (PFGE) and specialized reporter assays, DSB repair in wild-type pre-B NALM-6 lymphocytes, as well as in their Artemis(-/-), DNA ligase 4(-/-) (LIG4(-/-)), and LIG4(-/-)Artemis(-/-) double mutant counterparts, under conditions allowing evaluation of A-EJ. Our results substantiate the suggested roles of Artemis in C-NHEJ and HRR, but also demonstrate a role for the protein in A-EJ that is confirmed in Artemis deficient normal human fibroblasts. We conclude that Artemis is a nuclease participating in DSB repair by all major repair pathways. (C) 2015 Elsevier B.V. All rights reserved.	[Moscariello, Mario; Wieloch, Radi; Li, Fanghua; Mladenov, Emil; Iliakis, George] Univ Duisburg Essen, Inst Med Radiat Biol, Sch Med, D-45122 Essen, Germany; [Kurosawa, Aya; Adachi, Noritaka] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 232, Japan; [Kurosawa, Aya; Adachi, Noritaka] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 232, Japan	Mladenov, E (reprint author), Univ Duisburg Essen, Inst Med Radiat Biol, Sch Med, Hufelandstr 55, D-45122 Essen, Germany.	Emil.Mladenov@uk-essen.de; Georg.Iliakis@uk-essen.de			BMBF; European Union	Supported by grants from the BMBF and European Union. The authors gratefully acknowledge M. Mesbah and T. Mussfeldt for expert technical support. The authors are indebted to Prof. M. Lobrich for providing the CJ179-hTert and the 82-6 hTert cell lines. The authors are indebted to Prof. J. Stark for providing U2OS cells, harboring different DSB repair reporter substrates.	Adachi Noritaka, 2008, V435, P17, DOI 10.1007/978-1-59745-232-8_2; Adachi N, 2001, P NATL ACAD SCI USA, V98, P12109, DOI 10.1073/pnas.201271098; Adachi N, 2008, BIOSCI TRENDS, V2, P169; Oh S, 2014, DNA REPAIR, V21, P97, DOI 10.1016/j.dnarep.2014.04.015; Schipler A, 2013, NUCLEIC ACIDS RES, V41, P7589, DOI 10.1093/nar/gkt556; Li SC, 2014, J BIOL CHEM, V289, P7825, DOI 10.1074/jbc.M113.544874; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Tsai AG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S1; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Wang HC, 2001, ONCOGENE, V20, P2212, DOI 10.1038/sj.onc.1204350; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Abe T, 2008, CELL SIGNAL, V20, P1978, DOI 10.1016/j.cellsig.2008.07.006; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; HURWITZ R, 1979, INT J CANCER, V23, P174, DOI 10.1002/ijc.2910230206; Kocher S, 2012, NUCLEIC ACIDS RES, V40, P8336, DOI 10.1093/nar/gks604; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Perrault R, 2004, J CELL BIOCHEM, V92, P781, DOI 10.1002/jcb.20104; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Wu W, 2008, DNA REPAIR, V7, P329, DOI 10.1016/j.dnarep.2007.11.008; Andres SN, 2012, NUCLEIC ACIDS RES, V40, P1868, DOI 10.1093/nar/gks022; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Lee-Theilen M, 2011, NAT STRUCT MOL BIOL, V18, P75, DOI 10.1038/nsmb.1942; Liang L, 2008, NUCLEIC ACIDS RES, V36, P3297, DOI 10.1093/nar/gkn184; Darroudi F, 2007, MUTAT RES-FUND MOL M, V615, P111, DOI 10.1016/j.mrfmmm.2006.11.029; Wang HY, 2009, J BIOL CHEM, V284, P18236, DOI 10.1074/jbc.M109.002584; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Lieber MR, 2010, NAT STRUCT MOL BIOL, V17, P393, DOI 10.1038/nsmb0410-393; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Povirk LR, 2006, DNA REPAIR, V5, P1199, DOI 10.1016/j.dnarep.2006.05.016; Dibiase SJ, 2000, CANCER RES, V60, P1245; Chappell C, 2002, EMBO J, V21, P2827, DOI 10.1093/emboj/21.11.2827; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Wu WQ, 2008, RADIAT RES, V170, P512, DOI 10.1667/RR1456.1; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Zhang Y, 2011, NAT STRUCT MOL BIOL, V18, P80, DOI 10.1038/nsmb.1940; Frit P, 2014, DNA REPAIR, V17, P81, DOI 10.1016/j.dnarep.2014.02.007; Pannunzio NR, 2014, DNA REPAIR, V17, P74, DOI 10.1016/j.dnarep.2014.02.006; Singh SK, 2009, RADIAT RES, V172, P152, DOI 10.1667/RR1745.1; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Rosidi B, 2008, NUCLEIC ACIDS RES, V36, P1610, DOI 10.1093/nar/gkn013; Soni A, 2014, NUCLEIC ACIDS RES, V42, P6380, DOI 10.1093/nar/gku298; Gu JF, 2010, DNA REPAIR, V9, P429, DOI 10.1016/j.dnarep.2010.01.001; Yan H, 2011, J CELL BIOL, V192, P251, DOI 10.1083/jcb.201005110; Kurosawa A, 2008, DNA CELL BIOL, V27, P55, DOI 10.1089/dna.2007.0649; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Windhofer F, 2007, J CELL PHYSIOL, V213, P475, DOI 10.1002/jcp.21120; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Wang HC, 2001, CANCER RES, V61, P270; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; Mansour WY, 2010, NUCLEIC ACIDS RES, V38, P6065, DOI 10.1093/nar/gkq387; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Windhofer F, 2007, INT J RADIAT ONCOL, V68, P1462, DOI 10.1016/j.ijrobp.2007.04.038; Bennardo N., 2008, PLOS GENET, V4; Calsou P, 1999, J BIOL CHEM, V274, P7848, DOI 10.1074/jbc.274.12.7848; Chen S, 2001, J BIOL CHEM, V276, P24323, DOI 10.1074/jbc.M010544200; Cottarel J, 2013, J CELL BIOL, V200, P173, DOI 10.1083/jcb.201203128; DENKO N, 1989, ANAL BIOCHEM, V178, P172, DOI 10.1016/0003-2697(89)90375-8; Deriano L., 2013, ANNU REV GENET, V47, P451; D'Mello SR, 1998, J NEUROCHEM, V70, P1809; Filippini G, 1998, CYTOMETRY, V31, P180, DOI 10.1002/(SICI)1097-0320(19980301)31:3<180::AID-CYTO5>3.0.CO;2-P; Geng LY, 2007, MOL CELL BIOL, V27, P2625, DOI 10.1128/MCB.02072-06; Haber JE, 2008, P NATL ACAD SCI USA, V105, P405, DOI 10.1073/pnas.0711334105; Hashimoto M, 2003, J RADIAT RES, V44, P151, DOI 10.1269/jrr.44.151; ILIAKIS GE, 1991, INT J RADIAT BIOL, V59, P343, DOI 10.1080/09553009114550321; Jeggo P. A., 2005, CELL CYCLE, V4; Kurosawa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072253; Lieber M. R., 2010, ANNU REV BIOCHEM, V79, P11; Malu S, 2012, J EXP MED, V209, P955, DOI 10.1084/jem.20111437; Mladenov E, 2006, GENES CELLS, V11, P513, DOI 10.1111/j.1365-2443.2006.00958.x; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Mladenov Emil, 2013, Front Oncol, V3, P113, DOI 10.3389/fonc.2013.00113; Nick McElhinny Stephanie A, 2005, Mol Cell, V19, P357, DOI 10.1016/j.molcel.2005.06.012; Paul K., 2013, PLOS ONE, V8; Pawelczak KS, 2010, DNA REPAIR, V9, P670, DOI 10.1016/j.dnarep.2010.03.002; Povirk LF, 2007, J BIOL CHEM, V282, P3547, DOI 10.1074/jbc.M607745200; Povirk LF, 2012, ISRN MOL BIOL, V2012, P2012, DOI DOI 10.5402/2012/345805; Roy S, 2012, NUCLEIC ACIDS RES, V40, P1684, DOI 10.1093/nar/gkr1315; Singh SK, 2011, INT J RADIAT ONCOL, V79, P540, DOI 10.1016/j.ijrobp.2010.08.018; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061189; Van C. T., 2007, NATURE, V449, P478; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Waters CA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5286; Wlodarska I, 1997, BLOOD, V89, P1716	92	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	JUL	2015	31						29	40		10.1016/j.dnarep.2015.04.004		12	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CL7FT	WOS:000357138600004		
J	Takeuchi, Y; Kajiyama, K; Ishiguro, C; Uyama, Y				Takeuchi, Yoshinori; Kajiyama, Kazuhiro; Ishiguro, Chieko; Uyama, Yoshiaki			Atypical Antipsychotics and the Risk of Hyperlipidemia: A Sequence Symmetry Analysis	DRUG SAFETY			English	Article							OLANZAPINE-TREATED PATIENTS; TRIGLYCERIDE LEVELS; SCHIZOPHRENIA; PRESCRIPTION; WEIGHT; MEDICATION; EXPRESSION; INSULIN; LEPTIN; LIPIDS	Introduction Although hyperlipidemia is a well known adverse event of atypical antipsychotic (AAP) medication, there are few studies that have quantitatively compared the risks of various AAPs. Objective Our aim was to comparatively evaluate the risk of hyperlipidemia associated with the use of AAPs approved in Japan through a consecutive epidemiological study. Methods We conducted a sequence symmetry analysis (SSA) using health insurance claims data to analyze the following nine AAPs approved for use in Japan: risperidone, paliperidone, perospirone hydrochloride hydrate, blonanserin, clozapine, olanzapine, quetiapine fumarate, aripiprazole, and zotepine. Exposed cases were identified from drug dispensing records as those who had been administered both AAPs and antihyperlipidemic drugs. The adjusted sequence ratio (ASR) and 95 % confidence interval (CI) for each individual AAP and for all AAPs were calculated while controlling for time trends in dispensing patterns. Results Olanzapine was significantly associated with increased hyperlipidemia occurrence (ASR 1.56; 95 % CI 1.25-1.95). The ASRs obtained for risperidone (1.01; 95 % CI 0.80-1.27), perospirone hydrochloride hydrate (0.93; 95 % CI 0.63-1.39), blonanserin (0.83; 95 % CI 0.52-1.33), quetiapine fumarate (0.93; 95 % CI 0.73-1.18), and aripiprazole (1.02; 95 % CI 0.82-1.26) were approximately 1.0. Unstable estimates (wide CIs) were obtained for paliperidone and zotepine due to the small sample sizes. Conclusions Among the AAPs used in Japan, only olanzapine was found to have an elevated risk of hyperlipidemia. In contrast, risperidone, perospirone hydrochloride hydrate, blonanserin, quetiapine fumarate, and aripiprazole had relatively low risks.	[Takeuchi, Yoshinori; Kajiyama, Kazuhiro; Ishiguro, Chieko; Uyama, Yoshiaki] Pharmaceut & Med Devices Agcy, Off Med Informat & Epidemiol, Chiyoda Ku, Tokyo 1000013, Japan	Takeuchi, Y (reprint author), Pharmaceut & Med Devices Agcy, Off Med Informat & Epidemiol, Chiyoda Ku, Shin Kasumigaseki Bldg,3-3-2 Kasumigaseki, Tokyo 1000013, Japan.	takeuchi-yoshinori@pmda.go.jp					Almqvist C, 2012, CLIN EXP ALLERGY, V42, P104, DOI 10.1111/j.1365-2222.2011.03850.x; Skrede S, 2012, INT J NEUROPSYCHOPH, V15, P163, DOI 10.1017/S1461145711001271; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; Atmaca M, 2003, J CLIN PSYCHIAT, V64, P598; Yan H, 2013, PSYCHOPHARMACOLOGY, V229, P1, DOI 10.1007/s00213-013-3193-7; Lauressergues E, 2010, N-S ARCH PHARMACOL, V381, P427, DOI 10.1007/s00210-010-0499-4; Meyer JM, 2002, J CLIN PSYCHIAT, V63, P425; Tsiropoulos I, 2009, PHARMACOEPIDEM DR S, V18, P483, DOI 10.1002/pds.1736; Olfson M, 2006, AM J PSYCHIAT, V163, P1821, DOI 10.1176/appi.ajp.163.10.1821; Meyer JM, 2004, SCHIZOPHR RES, V70, P1, DOI 10.1016/j.schres.2004.01.014; Hallas J, 1996, EPIDEMIOLOGY, V7, P478, DOI 10.1097/00001648-199609000-00004; Victoriano M, 2010, BRAIN RES, V1350, P167, DOI 10.1016/j.brainres.2010.05.060; Bersot T, 2011, GOODMAN GILMANS PHAR, P877; Cher DJ, 2000, EPIDEMIOLOGY, V11, P446, DOI 10.1097/00001648-200007000-00014; Corrao G, 2005, PHARMACOEPIDEM DR S, V14, P31, DOI 10.1002/pds.1019; Eder U, 2001, AM J PSYCHIAT, V158, P1719, DOI 10.1176/appi.ajp.158.10.1719; Katagiri H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-138; Kimura S, 2010, J EPIDEMIOL, V20, P413, DOI 10.2188/jea.JE20090066; Kishi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088049; Koro CE, 2002, ARCH GEN PSYCHIAT, V59, P1021, DOI 10.1001/archpsyc.59.11.1021; Koro Carol E, 2005, Essent Psychopharmacol, V6, P148; Lund BC, 2001, ARCH GEN PSYCHIAT, V58, P1172, DOI 10.1001/archpsyc.58.12.1172; Melkersson KI, 2000, J CLIN PSYCHIAT, V61, P742; Ministry of Education Culture Sports Science and Technology (MEXT) Ministry of Health Labour and Welfare (MHLW), 2002, ETH GUID EP RES; Nagamine T, 2008, INTERNAL MED, V47, P181, DOI 10.2169/internalmedicine.47.0557; Novartis Pharma K.K., 2014, CLOZARIL CLOZ TABL R; Paramsothy P, 2009, METABOLISM, V58, P212, DOI 10.1016/j.metabol.2008.09.016; Pouwels KB, 2013, DRUG SAFETY, V36, P1079, DOI 10.1007/s40264-013-0085-z; Vik-Mo AO, 2008, INT J NEUROPSYCHOPH, V11, P679, DOI 10.1017/S1461145708008468; Weiden PJ, 2003, J CLIN PSYCHOPHARM, V23, P595, DOI 10.1097/01.jcp.0000095347.32154.08	31	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0114-5916	1179-1942		DRUG SAFETY	Drug Saf.	JUL	2015	38	7					641	650		10.1007/s40264-015-0298-4		10	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Toxicology	CL6UH	WOS:000357102400005		
J	Matsuzaki, SS; Kadoya, T				Matsuzaki, Shin-ichiro S.; Kadoya, Taku			Trends and stability of inland fishery resources in Japanese lakes: introduction of exotic piscivores as a driver	ECOLOGICAL APPLICATIONS			English	Article						capture fisheries; commercially important species; ecosystem goods; fishing efficiency; human stressors; invasions; lake size; macroecology; piscivorous fish; sustainability; top-down drivers	FOOD-CHAIN LENGTH; ECOSYSTEM SERVICES; UNIT EFFORT; FUNCTIONAL DIVERSITY; SPECIES INVASIONS; LARGEMOUTH BASS; COMMUNITIES; LONG; WEB; BIODIVERSITY	Although many studies have focused on marine resources, few studies have considered the resources of inland fisheries. Inland fishery resources are typically either monitored on the basis of catch data alone or are not assessed quantitatively at all, despite their social, economic, and ecological importance. Because freshwater ecosystems have been severely degraded by human activities, evaluating the trends and current status of fishery resources and assessing their drivers are urgent tasks. We compiled long-term data on the annual catch, fishing effort, and fishing power of 23 Japanese lakes, using two sets of government statistics that date back to the 1950s, which were previously neglected because of the large number of missing values. Using Bayesian state-space models, we examined the trajectories of the catch per unit effort (CPUE) of entire communities, considering changes in fishing effort and fishing power, and quantified both changes in the CPUE over the 10-, 20-, and 30-year periods preceding 2008 and the temporal detrended stability of the CPUE over the three periods. We also investigated the relationships among the CPUE changes and stability, anthropogenic drivers, and lake morphometric characteristics. The CPUE declined in 17, 19, and 15 of the 23 lakes over the past 10-, 20-, and 30-year periods, respectively. Our macroecological analyses demonstrate that the functional group richness of exotic piscivores was the most important predictor of changes in the CPUE among the drivers we considered. The stability of the CPUE was positively related to lake area; larger lakes have more stable CPUE. The functional group richness of exotic piscivores also negatively affected the stability of the CPUE. The effect of overfishing was considered to be small because both fishing effort and power declined in almost all of the lakes. Thus, our findings suggest that increasing exotic piscivore species may diminish the resources and their stability, particularly in Japanese lakes where native piscivores are rare. This might lead to a substantial decline in ecosystem services. Our study highlights the importance of assessing inland fishery resources in a comprehensive manner and the need for restoration strategies to mitigate the effects of exotic piscivores.	[Matsuzaki, Shin-ichiro S.; Kadoya, Taku] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki 3058506, Japan; [Kadoya, Taku] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Matsuzaki, SS (reprint author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	matsuzakiss@nies.go.jp			Ministry of the Environment [S9]; Joint Research with Regional Environmental Research Organizations [1214AH002]; Japan Society for the Promotion of Science [H25-330, 26870832]	We wish to note that both authors contributed equally to this paper. We are grateful to Yohei Higo, Munemitsu Akasaka, and Yasuko Oikawa for compiling the fishery data and collecting the data on the lakes' morphometric characteristics. We are also grateful to Noriko Takamura, Jun Nishihiro, Keita Fukasawa, Naoki Kumagai, Takehiro Sasaki, Boris Worm, Ruth Thurstan, and Hiroyuki Matsuda for their helpful comments and suggestions for this study. Finally, we thank Kevin S. McCann, Olaf Jensen, and anonymous reviewers for their comments, which greatly improved early drafts of the manuscript. This study was supported by the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment and Joint Research with Regional Environmental Research Organizations (1214AH002). T. Kadoya was supported by funding from the Japan Society for the Promotion of Science (H25-330 and No. 26870832).	Lotze HK, 2004, ECOL APPL, V14, P1428, DOI 10.1890/03-5027; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; Amano T, 2010, BIOL CONSERV, V143, P2238, DOI 10.1016/j.biocon.2010.06.010; Azuma M, 1998, ENVIRON BIOL FISH, V52, P379, DOI 10.1023/A:1007476104352; Mehner T, 2005, FRESHWATER BIOL, V50, P70, DOI 10.1111/j.1365-2427.2004.01294.x; Fay G, 2013, ECOL APPL, V23, P1455, DOI 10.1890/12-1645.1; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icejms.2006.05.008; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Welcomme RL, 2010, PHILOS T R SOC B, V365, P2881, DOI 10.1098/rstb.2010.0168; Findlay CS, 2000, CAN J FISH AQUAT SCI, V57, P570, DOI 10.1139/cjfas-57-3-570; McClanahan TR, 2010, CONSERV BIOL, V24, P1519, DOI 10.1111/j.1523-1739.2010.01530.x; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; Eby LA, 2006, TRENDS ECOL EVOL, V21, P576, DOI 10.1016/j.tree.2006.06.016; Beard TD, 2011, BIOL LETTERS, V7, P481, DOI 10.1098/rsbl.2011.0046; Moyle PB, 1996, BIOL CONSERV, V78, P149, DOI 10.1016/0006-3207(96)00024-9; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Long ZT, 2011, J ANIM ECOL, V80, P586, DOI 10.1111/j.1365-2656.2010.01800.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Tsunoda H, 2012, AQUAT LIVING RESOUR, V25, P163, DOI 10.1051/alr/2012013; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Clark JS, 2004, ECOLOGY, V85, P3140, DOI 10.1890/03-0520; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; Humbert JY, 2009, OIKOS, V118, P1940, DOI 10.1111/j.1600-0706.2009.17839.x; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Jennings S, 2005, FISH FISH, V6, P212, DOI 10.1111/j.1467-2979.2005.00189.x; Lotze HK, 2011, ECOSYSTEMS, V14, P198, DOI 10.1007/s10021-010-9404-8; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Latimer AM, 2006, ECOL APPL, V16, P33, DOI 10.1890/04-0609; Narwani A, 2010, ECOLOGY, V91, P3441, DOI 10.1890/10-0850.1; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Hoeinghaus DJ, 2009, CONSERV BIOL, V23, P1222, DOI 10.1111/j.1523-1739.2009.01248.x; Maezono Y, 2005, ECOL APPL, V15, P638, DOI 10.1890/02-5386; GOLDSCHMIDT T, 1993, CONSERV BIOL, V7, P686, DOI 10.1046/j.1523-1739.1993.07030686.x; MILLS EL, 1994, BIOSCIENCE, V44, P666, DOI 10.2307/1312510; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Yuma M, 1998, ENVIRON BIOL FISH, V52, P97, DOI 10.1023/A:1007451417556; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Lorenzen K, 2006, CAN J FISH AQUAT SCI, V63, P1334, DOI 10.1139/F06-038; Strayer DL, 2012, ECOL LETT, V15, P1199, DOI 10.1111/j.1461-0248.2012.01817.x; Nadon MO, 2012, CONSERV BIOL, V26, P493, DOI 10.1111/j.1523-1739.2012.01835.x; Petchey OL, 2000, J ANIM ECOL, V69, P874, DOI 10.1046/j.1365-2656.2000.00446.x; Swain DP, 2009, ECOL APPL, V19, P1347, DOI 10.1890/08-1699.1; Worm B, 2003, TRENDS ECOL EVOL, V18, P628, DOI 10.1016/j.tree.2003.09.003; Buchheister A, 2013, MAR ECOL PROG SER, V481, P161, DOI 10.3354/meps10253; Bates D., 2009, LME4 LINEAR MIXED EF; BROWNE RA, 1981, J BIOGEOGR, V8, P75, DOI 10.2307/2844594; Burnham K. P., 2002, MODEL SELECTION MULT; FAO, 2009, STAT WORLD FISH AQ 2; Fisheries Office of Kasumigaura and Kitaura in Ibaraki Prefecture, 2013, ANN REP FISH KAS KIT; Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136; Geweke J, 1992, BAYESIAN STATISTICS, V4, P169, DOI DOI 10.1371/J0URNAL.P0NE.0059328; Hoffmann MD, 2005, ECOLOGY, V86, P255, DOI 10.1890/03-0833; Hughes RM, 2012, FISHERIES, V37, P201, DOI 10.1080/03632415.2012.676833; Katano O., 2012, BIODIVERSITY OBSERVA, P431; Kitano Satoshi, 2004, Global Environmental Research, V8, P41; Lowe S, 2000, 100 WORLDS WORST INV; Matsuda H, 2009, BIOL CONSERV, V142, P1937, DOI 10.1016/j.biocon.2009.03.017; Matsuzaki SS, 2013, GLOBAL ECOL BIOGEOGR, V22, P1071, DOI 10.1111/geb.12067; Matsuzaki SS, 2011, AQUAT CONSERV, V21, P348, DOI 10.1002/aqc.1198; Methratta ET, 2006, ECOL INDIC, V6, P575, DOI 10.1016/j.ecolind.2005.08.022; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING OU; Ministry of the Environment, 2002, RES FY 2000 WAT QUAL; Miyake M, 2011, AQUAT CONSERV, V21, P292, DOI 10.1002/aqc.1178; Nakai Katsuki, 1999, P227; Ntzoufras I., 2009, BAYESIAN MODELING US; Plummer M., 2007, CODA OUTPUT ANAL DIA; R Development Core Team, 2014, R LANG ENV STAT COMP; Rist J, 2010, CONSERV BIOL, V24, P489, DOI 10.1111/j.1523-1739.2010.01470.x; Shiga Statistics Association of Agricultural and Forestry, 1962, STAT YB AGR FOR FISH; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Tanaka M., 1992, THE LAKES IN JAPAN; Thurstan RH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1013; Tunney TD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2098	75	0	0	ECOLOGICAL SOC AMER	WASHINGTON	1990 M STREET NW, STE 700, WASHINGTON, DC 20036 USA	1051-0761	1939-5582		ECOL APPL	Ecol. Appl.	JUL	2015	25	5					1420	1432		10.1890/13-2182.1		13	Ecology; Environmental Sciences	Environmental Sciences & Ecology	CL4BU	WOS:000356898400020		
J	Ishihara, MI; Utsugi, H; Tanouchi, H; Aiba, M; Kurokawa, H; Onoda, Y; Nagano, M; Umehara, T; Ando, M; Miyata, R; Hiura, T				Ishihara, Masae I.; Utsugi, Hajime; Tanouchi, Hiroyuki; Aiba, Masahiro; Kurokawa, Hiroko; Onoda, Yusuke; Nagano, Masahiro; Umehara, Toru; Ando, Makoto; Miyata, Rie; Hiura, Tsutom			Efficacy of generic allometric equations for estimating biomass: a test in Japanese natural forests	ECOLOGICAL APPLICATIONS			English	Article						aboveground biomass; allometry; carbon stocks; database; functional traits; functional types; leaf mass per area; model selection; natural forests in Japan; root biomass; wood density	CARBON STOCKS; ABOVEGROUND BIOMASS; SECONDARY FORESTS; FUNCTIONAL TRAIT; TROPICAL TREES; WOOD DENSITY; ALLOCATION; HEIGHT; MODELS; GROWTH	Accurate estimation of tree and forest biomass is key to evaluating forest ecosystem functions and the global carbon cycle. Allometric equations that estimate tree biomass from a set of predictors, such as stem diameter and tree height, are commonly used. Most allometric equations are site specific, usually developed from a small number of trees harvested in a small area, and are either species specific or ignore interspecific differences in allometry. Due to lack of site-specific allometries, local equations are often applied to sites for which they were not originally developed (foreign sites), sometimes leading to large errors in biomass estimates. In this study, we developed generic allometric equations for aboveground biomass and component (stem, branch, leaf, and root) biomass using large, compiled data sets of 1203 harvested trees belonging to 102 species (60 deciduous angiosperm, 32 evergreen angiosperm, and 10 evergreen gymnosperm species) from 70 boreal, temperate, and subtropical natural forests in Japan. The best generic equations provided better biomass estimates than did local equations that were applied to foreign sites. The best generic equations included explanatory variables that represent interspecific differences in allometry in addition to stem diameter, reducing error by 4-12% compared to the generic equations that did not include the interspecific difference. Different explanatory variables were selected for different components. For aboveground and stem biomass, the best generic equations had species-specific wood specific gravity as an explanatory variable. For branch, leaf, and root biomass, the best equations had functional types (deciduous angiosperm, evergreen angiosperm, and evergreen gymnosperm) instead of functional traits (wood specific gravity or leaf mass per area), suggesting importance of other traits in addition to these traits, such as canopy and root architecture. Inclusion of tree height in addition to stem diameter improved the performance of the generic equation only for stem biomass and had no apparent effect on aboveground, branch, leaf, and root biomass at the site level. The development of a generic allometric equation taking account of interspecific differences is an effective approach for accurately estimating aboveground and component biomass in boreal, temperate, and subtropical natural forests.	[Ishihara, Masae I.] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Kita Ku, Sapporo, Hokkaido 0600809, Japan; [Utsugi, Hajime; Tanouchi, Hiroyuki] Hokkaido Res Ctr, Forestry & Forest Prod Res Inst, Sapporo, Hokkaido 0628516, Japan; [Aiba, Masahiro; Kurokawa, Hiroko] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Onoda, Yusuke] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; [Nagano, Masahiro] Osaka City Univ, Sumiyoshi Ku, Osaka 5588585, Japan; [Umehara, Toru] Univ Hyogo, Grad Sch Landscape Design & Management, Awaji City 6561726, Japan; [Ando, Makoto] Kyoto Univ, Field Sci Educ & Res Ctr, Sakyo Ku, Kyoto 6068502, Japan; [Miyata, Rie] Hokkaido Univ, Fac Environm Earth Sci, Kita Ku, Sapporo, Hokkaido 0600809, Japan; [Hiura, Tsutom] Hokkaido Univ, Tomakomai Res Stn, Field Sci Ctr Northern Biosphere, Takaoka, Tomakomai 0530035, Japan	Ishihara, MI (reprint author), Hiroshima Univ, Grad Sch Int Dev & Cooperat, 1-5-1 Kagamiyama, Higashihiroshima 7398529, Japan.	masaish.n@gmail.com	Onoda, Yusuke/L-7179-2015	Onoda, Yusuke/0000-0001-6245-2342	Ministry of the Environment, Japan [S-9-3]	We thank all the people who participated in collecting the biomass data; Kaichiro Sasa and Kentarou Takagi for biomass data of the Teshio2 and Teshio3 sites; the late Masahito Nishioka for biomass data of the Minoh site; the site managers of core and subcore forest sites of the Monitoring Sites 1000 Project (Ministry of the Environment, Japan) for help in collecting trait data; Takahiro Inoue, Hayato Aoyama, Tetsuro Yoshikawa, and Emiko Ishii for compiling data; Shin-ichiro Aiba for valuable information; subject matter editor, anonymous reviewers, and Jerome Chave for valuable comments. The study was supported by the Environmental Research and Technology Development Fund (S-9-3) of the Ministry of the Environment, Japan.	Ando T., 1962, B FOR FOR PROD RES I, V144, P1; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Rutishauser E, 2013, FOREST ECOL MANAG, V307, P219, DOI 10.1016/j.foreco.2013.07.013; Parresol BR, 1999, FOREST SCI, V45, P573; Basuki TM, 2009, FOREST ECOL MANAG, V257, P1684, DOI 10.1016/j.foreco.2009.01.027; MADGWICK HAI, 1975, ECOLOGY, V56, P1446, DOI 10.2307/1934713; King DA, 2006, J ECOL, V94, P670, DOI 10.1111/j.1365-2745.2006.01112.x; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Alvarez E, 2012, FOREST ECOL MANAG, V267, P297, DOI 10.1016/j.foreco.2011.12.013; Xiang WH, 2011, ECOL RES, V26, P697, DOI 10.1007/s11284-011-0829-0; Fisher JB, 2014, ANNU REV ENV RESOUR, V39, P91, DOI 10.1146/annurev-environ-012913-093456; Wang CK, 2006, FOREST ECOL MANAG, V222, P9, DOI 10.1016/j.foreco.2005.10.074; Fayolle A, 2013, FOREST ECOL MANAG, V305, P29, DOI 10.1016/j.foreco.2013.05.036; NIKLAS KJ, 1995, ANN BOT-LONDON, V75, P217, DOI 10.1006/anbo.1995.1015; Fang JY, 2006, CLIMATIC CHANGE, V74, P355, DOI 10.1007/s10584-005-9028-8; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Chojnacky DC, 2014, FORESTRY, V87, P129, DOI 10.1093/forestry/cpt053; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Fortunel C, 2012, FUNCT ECOL, V26, P1153, DOI 10.1111/j.1365-2435.2012.02020.x; SPRUGEL DG, 1983, ECOLOGY, V64, P209, DOI 10.2307/1937343; Niklas KJ, 2002, AM J BOT, V89, P812, DOI 10.3732/ajb.89.5.812; Clark DA, 2001, ECOL APPL, V11, P356; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Vieilledent G, 2012, ECOL APPL, V22, P572, DOI 10.1890/11-0039.1; Navar J, 2009, FOREST ECOL MANAG, V257, P427, DOI 10.1016/j.foreco.2008.09.028; Chave J, 2004, PHILOS T ROY SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Enquist BJ, 2007, NATURE, V449, P218, DOI 10.1038/nature06061; Jenkins JC, 2003, FOREST SCI, V49, P12; Ishihara MI, 2011, AGR FOREST METEOROL, V151, P1016, DOI 10.1016/j.agrformet.2011.02.007; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Reich PB, 2012, P ROY SOC B-BIOL SCI, V279, P2128, DOI 10.1098/rspb.2011.2270; Peichl M, 2007, FOREST ECOL MANAG, V253, P68, DOI 10.1016/j.foreco.2007.07.003; van Breugel M, 2011, FOREST ECOL MANAG, V262, P1648, DOI 10.1016/j.foreco.2011.07.018; Chave J., 2005, OECOLOGIA; Dannoura M., 2006, Journal of the Japanese Forest Society, V88, P120, DOI 10.4005/jjfs.88.120; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; Falster D. S., 2015, Ecology, V96, P1445, DOI 10.1890/14-1889.1; Forestry Laboratories of Kyoto University Tokyo University Niigata University and Shinshu University, 1965, FOR PROD DAT PERSP M, P2; Forestry Laboratories of Kyoto University Tokyo University Niigata University and Shinshu University, 1963, FOR PROD DAT PERSP M, P1; Fujiwara T, 2007, B FFPRI, V6, P215; Furuno T., 1967, B KYOTO U FORESTS, V39, P9; Garcia-Morote F. A., 2012, FOR ECOL MANAG, V270, P85; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Goto Y, 2003, B FFPRI, V387, P115; Haruki M., 1979, Research Bulletins, College Experiment Forests, Hokkaido University, V36, P147; Hashizume H., 1980, KOUYOJYU KENKYU, V1, P73; Hashizume H., 1985, B FACULTY AGR, V38, P60; Henry M., 2013, iForest, V6, P326; Hosoda K, 2010, J FOREST RES-JPN, V15, P299, DOI 10.1007/s10310-010-0192-y; Ishihara M, 2011, ECOL RES, V26, P1007, DOI 10.1007/s11284-011-0847-y; Ishihara M. I., 2014, ASIA PACIFIC BIODIVE, P351; Ishii H., 2000, NAGOYA U FOREST SCI, V19, P197; Kabaya H., 1981, B TOKYO U FORESTS, V70, P11; KATAGIRI S, 1984, B FACULTY AGR, V18, P53; Katakura M, 2007, B NAGANO PREF FOR RE, V22, P33; Kawanabe S., 1977, JIBP SYNTHESIS, V16, P268; Kawanabe S., 1988, B KYOTO U FORESTS, V60, P67; KIRA TATUO, 1967, JAP J ECOL, V17, P70; Kitazawa Y., 1959, MISCELLANEOUS REPORT, V49, P19; Komiyama A., 2011, Journal of the Japanese Forest Society, V93, P220, DOI 10.4005/jjfs.93.220; Komiyama A., 2003, Journal of the Japanese Forestry Society, V85, P152; Komiyama A., 2002, Journal of the Japanese Forestry Society, V84, P130; Mittermeier RA, 2004, HOTSPOTS REVISITED E; Mori M., 1979, REPORT RES ENV APPRA, V5; Motohoka T., 2011, P GEOSC REM SENS S I, P3518; Nagano M., 1978, JIBP SYNTHESIS, V18, P69; Nishioka M., 1982, REPORTS JAPANESE MAC, P117; PASTOR J, 1984, FOREST ECOL MANAG, V7, P265, DOI 10.1016/0378-1127(84)90003-3; R Development Core Team, 2013, R LANG ENV STAT COMP; Rasband WS, 1997, IMAGEJ; Saito M., 1981, B NIIGATA U FOREST, V14, P107; Satake Y., 1989, WILD FLOWERS JAPAN W, V1; Satake Y., 1989, WILD FLOWERS JAPAN W, V2; Sato A., 1971, B JAPAN FOREST SOC, V82, P180; SATOO T, 1974, Bulletin of the Tokyo University Forests, V66, P109; SATOO T, 1974, Bulletin of the Tokyo University Forests, V66, P127; Segawa K., 1969, ANN REPORT TOUHOKU R, V11, P188; Sueda T., 2003, REPORT GRANT IN AID, P120; Suzuki H., 2012, THESIS HOKKAIDO U SA; Tadaki Y., 1995, B NAGOYA U FOR, V14, P1; Tadaki Y., 1979, B FORESTRY FOREST PR, V305, P125; Tadaki Y, 1966, B GOV FOR EXP STN TO, V184, P135; Takagi K., 2010, Eurasian Journal of Forest Research, V13-1, P1; Takahashi K., 1999, Research Bulletin of the Hokkaido University Forests, V56, P70; TANOUCHI H, 1995, VEGETATIO, V117, P51, DOI 10.1007/BF00033258; Terashi K., 1982, B KYUSHU BRANCH JAPA, V35, P91; TerMikaelian MT, 1997, FOREST ECOL MANAG, V97, P1, DOI 10.1016/S0378-1127(97)00019-4; Utsugi H., 2004, B HOKKAIDO BRANCH JA, V52, P99; Wahlgren H. E., 1959, 2146 USDA FOR SERV F; Wood Technology and Wood Utilization Division, 1982, B FOR FOR PROD RES I, V319, P85; Yamaba A., 2007, B HIROSHIMA PREFECTU, V39, P23; Zanne A.E., 2009, GLOBAL WOOD DENSITY; Zianis D, 2004, FOREST ECOL MANAG, V187, P311, DOI 10.1016/j.foreco.2003.07.007	96	0	0	ECOLOGICAL SOC AMER	WASHINGTON	1990 M STREET NW, STE 700, WASHINGTON, DC 20036 USA	1051-0761	1939-5582		ECOL APPL	Ecol. Appl.	JUL	2015	25	5					1433	1446		10.1890/14-0175.1		14	Ecology; Environmental Sciences	Environmental Sciences & Ecology	CL4BU	WOS:000356898400021		
J	Ono, S; Fujishiro, M; Yoshida, N; Doyama, H; Kamoshida, T; Hirai, S; Kishihara, T; Yamamoto, Y; Sakae, H; Imagawa, A; Hirano, M; Koike, K				Ono, Satoshi; Fujishiro, Mitsuhiro; Yoshida, Naohiro; Doyama, Hisashi; Kamoshida, Toshiro; Hirai, Shinji; Kishihara, Teruhito; Yamamoto, Yorimasa; Sakae, Hiroyuki; Imagawa, Atsushi; Hirano, Masaaki; Koike, Kazuhiko			Thienopyridine derivatives as risk factors for bleeding following high risk endoscopic treatments: Safe Treatment on Antiplatelets (STRAP) study	ENDOSCOPY			English	Article							DRUG-ELUTING STENT; EARLY GASTRIC-CANCER; BARE-METAL STENTS; LOW-DOSE ASPIRIN; SUBMUCOSAL DISSECTION; CLINICAL-OUTCOMES; RANDOMIZED-TRIAL; CORONARY STENTS; DOUBLE-BLIND; THERAPY	Background and study aims: The optimal method of perioperative management of antiplatelet agents during endoscopic procedures that carry a high risk of bleeding is still controversial. The aim of this study was to evaluate the safety of continuing aspirin treatment during these procedures in an Asian population. Patients and methods: Amulticenter, prospective, observational cohort study was conducted at six high volume endoscopy centers in Japan. The study included patients at high risk of thromboembolism whowere regularly taking antiplatelet agents (e.g. thienopyridine derivatives and aspirin). Enrolled patients continued their aspirin therapy, and underwent endoscopic procedures that had a high risk of bleeding for treatment of lesions in the upper and lower gastrointestinal tracts. The primary end point was the rate of major bleeding complications after endoscopic procedures. Results: The study was terminated in accordance with predetermined safety criteria because 7 of 28 consecutive patients experienced major bleeding complications (25.0 %; 95% confidence inter-val 10.7%-44.9 %). All major bleeding complications occurred following endoscopic submucosal dissection (ESD; 6 stomach, 1 colon). Univariate analysis showed that postoperative administration of thienopyridine derivatives was the only significant factor associated with postoperative bleeding (P = 0.01). Subanalysis of gastric ESD (23 lesions in 19 patients) confirmed that the administration of thienopyridine derivatives (P = 0.01) and that of multiple agents (P = 0.02) were the significant factors. All bleeding complications (postoperative day 11.2 +/- 3.5) occurred after resuming thienopyridine derivative therapy postoperatively (postoperative day 2.3 +/- 2.4). Conclusion: In Asian patients taking thienopyridine derivatives with aspirin, cautious postoperative care is necessary for those undergoing endoscopic procedures that are associated with a high risk of bleeding, especially gastric ESD. Continuation of aspirin alone during these endoscopic procedures may be acceptable.	[Ono, Satoshi; Fujishiro, Mitsuhiro; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Fujishiro, Mitsuhiro] Univ Tokyo, Grad Sch Med, Dept Endoscopy & Endoscop Surg, Tokyo, Japan; [Yoshida, Naohiro; Doyama, Hisashi] Ishikawa Prefectural Cent Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Kamoshida, Toshiro; Hirai, Shinji] Hitachi Gen Hosp, Dept Internal Med, Hitachi, Ibaraki, Japan; [Kishihara, Teruhito; Yamamoto, Yorimasa; Sakae, Hiroyuki] JFCR, Canc Inst Hosp, Gastroenterol Ctr, Tokyo, Japan; [Imagawa, Atsushi] Mitoyo Gen Hosp, Dept Gastroenterol, Kanonji, Japan; [Hirano, Masaaki] Niigata Prefectural Cent Hosp, Dept Gastroenterol, Niigata, Japan	Ono, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	satoshi-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported in part by Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Mauri L, 2010, AM HEART J, V160, P1035, DOI 10.1016/j.ahj.2010.07.038; Byrne RA, 2009, AM HEART J, V157, P620, DOI 10.1016/j.ahj.2008.12.019; Hallas J, 2006, BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; Boustiere C, 2011, ENDOSCOPY, V43, P445, DOI 10.1055/s-0030-1256317; Sanomura Y, 2014, GASTRIC CANCER, V17, P489, DOI 10.1007/s10120-013-0305-3; Tsuji Y, 2014, GASTROINTEST ENDOSC, V79, P151, DOI 10.1016/j.gie.2013.08.041; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Palmerini T, 2014, J AM COLL CARDIOL, V63, P299, DOI 10.1016/j.jacc.2013.09.061; Nishio S, 2012, CIRCULATION, V125, P2343, DOI 10.1161/CIRCULATIONAHA.110.000901; Sung JJY, 2010, ANN INTERN MED, V152, P1, DOI 10.7326/0003-4819-152-1-201001050-00179; Singh M, 2010, GASTROINTEST ENDOSC, V71, P998, DOI 10.1016/j.gie.2009.11.022; Tsuji Y, 2010, WORLD J GASTROENTERO, V16, P2913, DOI 10.3748/wjg.v16.i23.2913; Goto O, 2010, GASTROINTEST ENDOSC, V71, P241, DOI 10.1016/j.gie.2009.08.030; Oda I, 2013, DIGEST ENDOSC, V25, P71, DOI 10.1111/j.1443-1661.2012.01376.x; Anderson MA, 2009, GASTROINTEST ENDOSC, V70, P1060, DOI 10.1016/j.gie.2009.09.040; Veitch AM, 2008, GUT, V57, P1322, DOI 10.1136/gut.2007.142497; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Lim JH, 2012, GASTROINTEST ENDOSC, V75, P719, DOI 10.1016/j.gie.2011.11.034; Fujimoto K, 2014, DIGEST ENDOSC, V26, P1, DOI 10.1111/den.12183; Mauri L, 2010, JACC-CARDIOVASC INTE, V3, P1240, DOI 10.1016/j.jcin.2010.08.021; Bangalore S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6625; Cho SJ, 2012, ENDOSCOPY, V44, P114, DOI 10.1055/s-0031-1291459; Fujishiro M, 2009, J GASTROEN HEPATOL, V24, P214, DOI 10.1111/j.1440-1746.2008.05604.x; Hayashis T, 2013, GASTROENTEROL ENDOSC, V55, P1806; Jeong HK, 2007, J KOREAN MED SCI, V22, P1055, DOI 10.3346/jkms.2007.22.6.1055; Kotani J, 2013, INTERNAL MED, V52, P703, DOI 10.2169/internalmedicine.52.8205; Nakamura M, 2014, CATHETER CARDIO INTE, V84, P368, DOI 10.1002/ccd.25282; Oda Ichiro, 2006, Gastric Cancer, V9, P262, DOI 10.1007/s10120-006-0389-0; Ono S, 2011, J GASTROEN HEPATOL, V26, P1434, DOI 10.1111/j.1440-1746.2011.06761.x; Takimoto K, 2012, Endoscopy, V44 Suppl 2 UCTN, pE414, DOI 10.1055/s-0032-1325739; Tounous S, 2011, GASTROENTEROL ENDOSC, V53, P3326; Uedo N, 2007, AM J GASTROENTEROL, V102, P1610, DOI 10.1111/j.1572-0241.2007.01197.x	33	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	JUL	2015	47	7					633	638		10.1055/s-0034-1391354		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CL5XR	WOS:000357038600011		
J	Ning, ZG; Liang, MC; Wang, ZH; Li, YK; Liu, YZ; Wang, TZ				Ning, Zigong; Liang, Mingchao; Wang, Zhenhua; Li, Yunkai; Liu, Yaoze; Wang, Tianzhi			Nitrogen and phosphate adsorption on biofilms in reclaimed water	ENVIRONMENTAL EARTH SCIENCES			English	Article						Reclaimed water; Biofilm; Ammonia nitrogen; Phosphate; Adsorption	WASTE-WATER; DESORPTION CHARACTERISTICS; RIVER BIOFILM; SEDIMENTS; AMMONIUM; BIOREACTOR; SORPTION; SOILS	Biofilms, abundantly attached on the surfaces of multiple media ( such as pebbles and aquatic plants) in rivers or lakes reusing reclaimed water ( RW), are of great significance to contaminants' self-purification of water bodies. In this paper, the nitrogen and phosphate adsorption characteristics of such biofilms were studied by the batch method, using biofilms cultivated under an outdoor simulative process. Two types of RW treated by anaerobicanoxic-oxic process (A(2)/O) and cyclic activated sludge technology ( CASS), and surface water ( NW) were chosen as the experimental water bodies. And the glasses of surface roughness of 0.1, 1.0, and 10 mu m, respectively, were used as the substrates, where the biofilms adhere to them. The results indicated that the isothermal adsorption of biofilms for ammonia nitrogen and phosphates was proved to conform to the Langmuir and the Freundlich equation, whereas the adsorption capacity was significantly lower than that of soils and sediments limited by the pore structure and surface area. There were also significant differences between the adsorption behaviors. The distribution coefficients were ranked as K-dCASS > K-dNW > K-dA/O(2), and the maximum adsorption capacities (S-m), under these conditions were ranked as S-mA/O(2) > S-mNW > S-mCASS, while other parameters did not change regularly. Extracellular polymers (R-N(2) = 0.95**, R-p(2) = 0.84**), iron oxides (R-N(2) = 0.86**, R-p(2) = 0.68*), and aluminum oxides (R-N(2) = 0.95**, R-p(2) = 0.81**) in the biofilms had a significant impact on the S-m for ammonia and phosphates. The roughness of media surfaces also had a considerable influence on the S-m, which was in the order of S-m10 mu m > S-m0.1 mu m > S-m1.0 mu m, whereas other parameters did not change regularly. The research aimed to provide theory reference for in situ decontamination of RW in rivers or lakes.	[Ning, Zigong; Liang, Mingchao; Wang, Zhenhua; Li, Yunkai; Wang, Tianzhi] China Agr Univ, Coll Water Resources & Civil Engn, Beijing 100083, Peoples R China; [Ning, Zigong] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0600809, Japan; [Wang, Zhenhua] Shihezi Univ, Coll Water & Architectural Engn, Shihezi City 832000, Xinjiang, Peoples R China; [Liu, Yaoze] Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA	Li, YK (reprint author), China Agr Univ, Coll Water Resources & Civil Engn, Beijing 100083, Peoples R China.	liyunkai@126.com			National Natural Science Fund of China [51321001]; Key Project of the Beijing Eleventh-Five Year Research Program [D090409004009004]; Special Fund for Water Conservancy scientific Research in the Public Interest [201001067]	We are grateful for financial support from the National Natural Science Fund of China (No. 51321001), Key Project of the Beijing Eleventh-Five Year Research Program (No. D090409004009004), Special Fund for Water Conservancy scientific Research in the Public Interest (No. 201001067).	Lawrence JR, 2001, CAN J MICROBIOL, V47, P634, DOI 10.1139/cjm-47-7-634; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; RAUNKJAER K, 1994, WATER RES, V28, P251, DOI 10.1016/0043-1354(94)90261-5; Wang WJ, 2002, WATER RES, V36, P551, DOI 10.1016/S0043-1354(01)00267-6; Liang MC, 2013, ENVIRON EARTH SCI, V70, P2319, DOI 10.1007/s12665-013-2285-3; Headley JV, 1998, ENVIRON SCI TECHNOL, V32, P3968, DOI 10.1021/es980499l; OPUWARIBO E, 1978, SOIL SCI, V125, P137, DOI 10.1097/00010694-197803000-00003; Behra R, 2002, AQUAT SCI, V64, P300, DOI 10.1007/s00027-002-8074-9; Cao Z, 1988, CHIN ACTA PEDOLOGICA, V25, P218; Chen S, 2006, CHARACTERISTICS EFFI; Farag AM, 1998, ARCH ENVIRON CON TOX, V34, P119, DOI 10.1007/s002449900295; Jeong YS, 2006, PROCESS BIOCHEM, V41, P141, DOI [10.1016/j.procbio.12.010, DOI 10.1016/J.PROCBIO.12.010]; Jiang GH, 2004, CHIN J CHANGAN U, V21, P32; Jiang M, 2012, CHIN ENV SCI TECHNOL, V35, P18, DOI [10.3969/j.issn.1003-6504.2012.05.005, DOI 10.3969/J.ISSN.1003-6504.2012.05.005]; Koeadagistan B, 2004, PROCESS BIOCHEM, V40, P177, DOI [10.1016/j.procbio.2003.11.055, DOI 10.1016/J.PROCBIO.2003.11.055]; Kurniawan A, 2012, MICROBES ENVIRON, V27, P399, DOI 10.1264/jsme2.ME11339; Lenardos N, 2000, AQUACULUTRE, V182, P301, DOI [10.1016/S0044-8486(99)00269-0, DOI 10.1016/S0044-8486(99)00269-0]; Li Y, 2002, CHIN SCI GEOGRAPHICA, V22, P445; Li YK, 2012, CHINA WATER RES, V5, P30; Liang MC, 2015, ENVIRON EARTH SCI, V73, P4325, DOI 10.1007/s12665-014-3717-4; Mowla D, 2007, BIOCHEM ENG J, V36, P147, DOI 10.1016/j.bej.2007.02.031; Rao TS, 1997, BIOFOULING, V11, P265; Rusten B, 1999, WATER SCI TECHNOL, V39, P257, DOI 10.1016/S0273-1223(99)00286-3; Suvilampi J, 2003, BIORESOURCE TECHNOL, V88, P207, DOI 10.1016/S0960-8524(03)00006-3; Tatlor GT, 1997, BIOFOULING, V11, P31, DOI [10.1080/08927019709378319, DOI 10.1080/08927019709378319]; Wimpenny J, 1996, BIOFOULING, V10, P43, DOI 10.1080/08927019609386270; Zhai Li-hua, 2007, Huanjing Kexue, V28, P1770; Zhang JL, 2008, STUDIES CHARACTERIST; Zhang Rui, 2011, Shengtaixue Zazhi, V30, P2628; Zhao W, 2013, ENVIRON EARTH SCI, V69, P41, DOI 10.1007/s12665-012-1932-4; Zhou CF, 2013, APPL MECH MATER, V395-396, P678, DOI 10.4028/www.scientific.net/AMM.395-396.678	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	JUL	2015	74	1					451	461		10.1007/s12665-015-4053-z		11	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CK6OQ	WOS:000356347800034		
J	Hashem, MA; Toda, K; Ohira, SI				Hashem, Md. Abul; Toda, Kei; Ohira, Shin-Ichi			Leaching behavior of arsenite and arsenate from the contaminated sediment by the effect of phosphate ion under anaerobic conditions	ENVIRONMENTAL EARTH SCIENCES			English	Article						Leaching; Arsenite; Arsenate; Phosphate; Sequential hydride generation flow injection analyzer (SHGFIA)	IN-GROUND WATER; FLOW-INJECTION ANALYSIS; MINE TAILINGS; SEQUENTIAL EXTRACTION; COMPETITIVE SORPTION; SOILS; RELEASE; SAMPLES; IRON; FRACTIONATION	This article presents the effect of phosphate ion on the potential leaching of arsenic from the contaminated sediment under anaerobic conditions near neutral pH for 120 h. Arsenic content in the selected sediments was 450 mg/kg. In the leaching experiment, 50 g of sediment sample was added into 400 mL of five different concentrated 0 (no phosphate), 3, 10, 15, and 20 mg/L phosphate solutions, and leachates were analyzed by distinguishing As(III) and As(V) with the sequential hydride generation flow injection analyzer (SHGFIA). The results indicate that arsenic concentration in the leachates was increased for As(V) up to 72 h, and subsequently As(V) concentration was decreased in the suspension. The leached amount of As(V) concentration in the aqueous phase was increased with increasing the phosphate concentration in the suspensions, and statistically significant correlation (R-2 = 0.9959) was found. Conversely, As(III) concentration in the leachates was almost constant up to 24 h then As(III) concentration was decreased in the suspension. The phosphate ion was potentially leached arsenic, especially As(V) as phosphate (PO43-) ion has more charge density than arsenate (AsO43-) resulting more As(V) was leached from the contaminated sediment with increasing the phosphate concentration in the suspensions.	[Hashem, Md. Abul; Toda, Kei; Ohira, Shin-Ichi] Kumamoto Univ, Dept Chem, Kumamoto 8608555, Japan; [Hashem, Md. Abul] KUET, Dept Leather Engn, Khulna 9203, Bangladesh	Hashem, MA (reprint author), KUET, Dept Leather Engn, Khulna 9203, Bangladesh.	mahashem@mail.kuet.ac.bd					Smith E, 2002, J ENVIRON QUAL, V31, P557; Acharyya SK, 1999, NATURE, V401, P545, DOI 10.1038/44052; Kumaresan M, 2001, CURR SCI INDIA, V80, P837; Roussel C, 2000, SCI TOTAL ENVIRON, V263, P209, DOI 10.1016/S0048-9697(00)00707-5; Dixit S, 2003, ENVIRON SCI TECHNOL, V37, P4182, DOI 10.1021/es030309t; Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0; Anawar HM, 2003, J GEOCHEM EXPLOR, V77, P109, DOI 10.1016/S0375-6742(02)00273-X; Chakraborti D, 2002, TALANTA, V58, P3, DOI 10.1016/S0039-9140(02)00270-9; Berg M, 2001, ENVIRON SCI TECHNOL, V35, P2621, DOI 10.1021/es010027y; Yang JK, 2002, ENVIRON SCI TECHNOL, V36, P4562, DOI 10.1021/es011507s; Wei CJ, 2007, TALANTA, V73, P540, DOI 10.1016/j.talanta.2007.04.026; Bagla P, 1996, SCIENCE, V274, P174, DOI 10.1126/science.274.5285.174; Zhang H, 2008, SOIL SCI, V173, P3, DOI 10.1097/ss.06013e31815ce750; Ettler V, 2004, CHEMOSPHERE, V57, P567, DOI 10.1016/j.chemosphere.2004.07.022; Noubactep C, 2012, WATER SA, V38, P511, DOI 10.4314/wsa.v38i4.5; Kinniburgh DG, 2002, TALANTA, V58, P165, DOI 10.1016/S0039-9140(02)00265-5; Sengupta MK, 2009, ANAL CHEM, V81, P9737, DOI 10.1021/ac9020243; Masue Y, 2007, ENVIRON SCI TECHNOL, V41, P837, DOI 10.1021/es061160z; Wenzel WW, 2001, ANAL CHIM ACTA, V436, P309, DOI 10.1016/S0003-2670(01)00924-2; Violante A, 2002, SOIL SCI SOC AM J, V66, P1788; Noubactep C, 2008, ENG LIFE SCI, V8, P622, DOI 10.1002/elsc.200800016; Jain A, 2000, J ENVIRON QUAL, V29, P1422; Acharyya SK, 2000, ENVIRON GEOL, V39, P1127, DOI 10.1007/s002540000107; Akter KF, 2005, TALANTA, V68, P406, DOI 10.1016/j.talanta.2005.09.011; Miro M, 2005, TRAC-TREND ANAL CHEM, V24, P759, DOI 10.1016/j.trac.2005.01.016; Minakata K, 2009, ANAL CHIM ACTA, V631, P87, DOI 10.1016/j.aca.2008.10.016; Hashem MA, 2011, TALANTA, V84, P1336, DOI 10.1016/j.talanta.2011.02.042; Meng XG, 2001, ENVIRON SCI TECHNOL, V35, P3476, DOI 10.1021/es010645e; Rigol A, 2009, ANAL CHIM ACTA, V632, P69, DOI 10.1016/j.aca.2008.10.066; Nickson RT, 2000, APPL GEOCHEM, V15, P403, DOI 10.1016/S0883-2927(99)00086-4; Carbonell-Barrachina AA, 1999, WATER RES, V34, P216, DOI DOI 10.1016/S0043-1354(99)00127-X; Fazal MA, 2001, WATER INT, V26, P370; Fedotov PS, 2005, ANAL CHIM ACTA, V538, P93, DOI 10.1016/j.aca.2005.02.034; Igarashi T, 2008, MINER ENG, V21, P191, DOI 10.1016/j.mineng.2007.07.014; Jacob DL, 2004, SCI TOTAL ENVIRON, V333, P9, DOI 10.1016/j.scitotenv.2004.05.005; Kenkyukai Kagaku Jikken Tekisuto, 1997, KANKYO KAGAKU, P66; Krysiak A, 2007, SCI TOTAL ENVIRON, V379, P190, DOI 10.1016/j.scitotenv.2006.09.031; Lombi E, 2000, WATER AIR SOIL POLL, V124, P319, DOI 10.1023/A:1005230628958; Muller J, 1999, FRESEN J ANAL CHEM, V363, P572, DOI 10.1007/s002160051250; National Research Council, 1999, ARS DRINK WAT; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Stoltz E, 2006, PLANT SOIL, V289, P199, DOI 10.1007/s11104-006-9129-9; Tabelin CB, 2009, J HAZARD MATER, V169, P980, DOI 10.1016/j.jhazmat.2009.04.049; Toda K, 2008, CHEMOSPHERE, V72, P1517, DOI 10.1016/j.chemosphere.2008.04.073; Toda K, 2005, ANAL CHEM, V77, P4765, DOI 10.1021/ac050193e	45	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	JUL	2015	74	1					737	743		10.1007/s12665-015-4078-3		7	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CK6OQ	WOS:000356347800057		
J	Hashem, MA; Toda, K; Ohira, SI				Hashem, Md. Abul; Toda, Kei; Ohira, Shin-Ichi			Leaching behavior of arsenite and arsenate from the contaminated sediment by the effect of phosphate ion under anaerobic conditions (vol 74, pg 737, 2015)	ENVIRONMENTAL EARTH SCIENCES			English	Correction									[Hashem, Md. Abul; Toda, Kei; Ohira, Shin-Ichi] Kumamoto Univ, Dept Chem, Kumamoto 8608555, Japan; [Hashem, Md. Abul] KUET, Dept Leather Engn, Khulna 9203, Bangladesh	Hashem, MA (reprint author), KUET, Dept Leather Engn, Khulna 9203, Bangladesh.	mahashem@mail.kuet.ac.bd					HASHEM A, 2015, ENVIRON EARTH SCI, V74, P737, DOI DOI 10.1007/S12665-015-4078-3	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	JUL	2015	74	1					745	745		10.1007/s12665-015-4205-1		1	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CK6OQ	WOS:000356347800058		
J	Bortey-Sam, N; Ikenaka, Y; Akoto, O; Nakayama, SMM; Yohannes, YB; Baidoo, E; Mizukawa, H; Ishizuka, M				Bortey-Sam, Nesta; Ikenaka, Yoshinori; Akoto, Osei; Nakayama, Shouta M. M.; Yohannes, Yared Beyene; Baidoo, Elvis; Mizukawa, Hazuki; Ishizuka, Mayumi			Levels, potential sources and human health risk of polycyclic aromatic hydrocarbons (PAHs) in particulate matter (PM10) in Kumasi, Ghana	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Airborne particulate; PAHs; Kumasi; BaP toxic equivalent; Incremental lifetime cancer risk; Chemical mass balance	VOLATILE ORGANIC-COMPOUNDS; AMBIENT AIR; ATMOSPHERIC-ENVIRONMENT; SOURCE IDENTIFICATION; SOURCE APPORTIONMENT; CARBONYL-COMPOUNDS; METROPOLITAN-AREA; MEXICO-CITY; CHIANG-MAI; URBAN	Airborne particulate samples were collected on quartz filters to determine the concentrations, sources and health risks of polycyclic aromatic hydrocarbons (PAHs) in air in Kumasi, Ghana. A total of 32 air samples were collected in Kwame Nkrumah University of Science and Technology (KNUST) campus (pristine site) and city centre (CC). Samples were extracted with 1:2v/v acetone/hexane mixture prior to GC-MS analyses. The sum of concentrations of 17 PAHs in air ranged from 0.51 to 16 (KNUST) and 19-38 ng/m(3) (CC). The concentration of benzo[a]pyrene, BaP, ranged from below detection limit to 0.08 ng/m(3) (KNUST) and 1.6 to 5.6 ng/m(3) (CC). Chemical mass balance model showed that PAHs in air in Kumasi were mainly from fuel combustion. The total BaP equivalent concentration (BaPeq) in CC was 18 times higher compared to KNUST; based on the European Legislation and Swedish and UK Standards for BaP in air, CC could be classified as highly polluted. Estimated carcinogenicity of PAHs in terms of BaPeq indicated that BaP was the principal PAH contributor in CC (70 %). Health risk to adults and children associated with PAH inhalation was assessed by taking into account the lifetime average daily dose and corresponding incremental lifetime cancer risk (ILCR). The ILCR was within the acceptable range (10(-6) to 10(-4)), indicating low health risk to residents.	[Bortey-Sam, Nesta; Ikenaka, Yoshinori; Nakayama, Shouta M. M.; Yohannes, Yared Beyene; Mizukawa, Hazuki; Ishizuka, Mayumi] Hokkaido Univ, Toxicol Lab, Dept Environm Vet Sci, Grad Sch Vet Med,Kita Ku, Sapporo, Hokkaido 0600818, Japan; [Akoto, Osei; Baidoo, Elvis] Kwame Nkrumah Univ Sci & Technol, Dept Chem, Kumasi, Ghana	Ishizuka, M (reprint author), Hokkaido Univ, Toxicol Lab, Dept Environm Vet Sci, Grad Sch Vet Med,Kita Ku, Kita 18,Nishi 9, Sapporo, Hokkaido 0600818, Japan.	ishizum@vetmed.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; foundation of JSPS Core to Core Program (AA Science Platforms)	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan awarded to M. Ishizuka and Y. Ikenaka as well as the Research Fellowship from the Japan Society for the Promotion of Science grant-in-aid awarded to S. Nakayama and the foundation of JSPS Core to Core Program (AA Science Platforms).	Akyuz M, 2009, J HAZARD MATER, V170, P13, DOI 10.1016/j.jhazmat.2009.05.029; Caricchia AM, 1999, ATMOS ENVIRON, V33, P3731, DOI 10.1016/S1352-2310(99)00199-5; Park SS, 2002, ATMOS ENVIRON, V36, P2917, DOI 10.1016/S1352-2310(02)00206-6; Lodovici M, 2003, CHEMOSPHERE, V50, P377, DOI 10.1016/S0045-6535(02)00404-6; Manoli E, 2000, CHEMOSPHERE, V41, P1845, DOI 10.1016/S0045-6535(00)00134-X; Liu YN, 2007, CHEMOSPHERE, V66, P1922, DOI 10.1016/j.chemosphere.2006.07.076; Tobiszewski M, 2012, ENVIRON POLLUT, V162, P110, DOI 10.1016/j.envpol.2011.10.025; Ho KF, 2002, SCI TOTAL ENVIRON, V289, P145, DOI 10.1016/S0048-9697(01)01031-2; Vasconcellos PC, 2003, ATMOS ENVIRON, V37, P3009, DOI 10.1016/S1352-2310(03)00181-X; Pietrogrande MC, 2014, TALANTA, V120, P283, DOI 10.1016/j.talanta.2013.12.010; Nadal M, 2004, ENVIRON POLLUT, V132, P1, DOI 10.1016/j.envpol.2004.04.003; Magi E, 2002, ENVIRON POLLUT, V119, P91, DOI 10.1016/S0269-7491(01)00321-9; Harrison RM, 1996, ENVIRON SCI TECHNOL, V30, P825, DOI 10.1021/es950252d; Kaur S, 2013, ARCH ENVIRON CON TOX, V65, P382, DOI 10.1007/s00244-013-9912-6; Pengchai P, 2009, ENVIRON MONIT ASSESS, V154, P197, DOI 10.1007/s10661-008-0389-0; Callen MS, 2008, WATER AIR SOIL POLL, V190, P271, DOI 10.1007/s11270-007-9599-2; Schubert P, 2003, ANAL CHEM, V75, P234, DOI 10.1021/ac0259111; Marr LC, 2004, ENVIRON SCI TECHNOL, V38, P2584, DOI 10.1021/es034962s; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451; Shen GF, 2012, ENVIRON SCI TECHNOL, V46, P4666, DOI 10.1021/es300144m; [Anonymous], 2000, AIR QUAL GUID EUR; Ho KF, 2002, ATMOS ENVIRON, V36, P57, DOI 10.1016/S1352-2310(01)00475-7; Mastral AM, 2000, ENVIRON SCI TECHNOL, V34, P3051, DOI 10.1021/es001028d; Li A, 2003, ENVIRON SCI TECHNOL, V37, P2958, DOI 10.1021/es026309v; Wang WT, 2010, ENVIRON POLLUT, V158, P1245, DOI 10.1016/j.envpol.2010.01.021; Bortey-Sam N, 2014, SCI TOTAL ENVIRON, V496, P471, DOI 10.1016/j.scitotenv.2014.07.071; LAFLAMME RE, 1978, GEOCHIM COSMOCHIM AC, V42, P289, DOI 10.1016/0016-7037(78)90182-5; Jamhari AA, 2014, ATMOS ENVIRON, V86, P16, DOI 10.1016/j.atmosenv.2013.12.019; Mostert MMR, 2010, TRAC-TREND ANAL CHEM, V29, P430, DOI 10.1016/j.trac.2010.02.009; Wiriya W, 2013, ATMOS RES, V124, P109, DOI 10.1016/j.atmosres.2012.12.014; Tsai PJ, 2004, ATMOS ENVIRON, V38, P333, DOI 10.1016/j.atmosenv.2003.08.038; Barranco A, 2004, J FOOD PROTECT, V67, P2786; Bozek F, 2009, ENERGY ENVIRON ENG S, P104; Brown LE, 2005, SCI TOTAL ENVIRON, V349, P161, DOI 10.1016/j.scitotenv.2005.01.008; Callen M, 2013, ENVIRON SCI POLLUT R, V21, P2064; Chang KF, 2006, ENVIRON POLLUT, V142, P388, DOI 10.1016/j.envpol.2005.09.025; Chetwittayachan T, 2002, ATMOS ENVIRON, V36, P2027, DOI 10.1016/S1352-2310(02)00099-7; Christensen ER, 1999, J ENVIRON ENG-ASCE, V125, P1022, DOI 10.1061/(ASCE)0733-9372(1999)125:11(1022); Dimashki M, 2001, ENVIRON SCI TECHNOL, V35, P2264, DOI 10.1021/es000232y; Dissanayake A, 2004, MAR ENVIRON RES, V58, P281, DOI 10.1016/j.marenvres.2004.03.072; Halek F, 2008, ENVIRON MONIT ASSESS, V143, P303, DOI 10.1007/s10661-007-9983-9; IARC, 2006, MON EV CANC RISKS HU, V92; Kuo CY, 2003, ARCH ENVIRON CON TOX, V44, P454, DOI 10.1007/s00244-002-1177-4; LAKE JL, 1979, GEOCHIM COSMOCHIM AC, V43, P1847, DOI 10.1016/0016-7037(79)90033-4; Li K, 2001, ENVIRON SCI TECHNOL, V35, P2896, DOI 10.1021/es001790f; McSweeney C, UNDP CLIMATE CHANGE; Oanh NTK, 2000, ATMOS ENVIRON, V34, P4557; Pereira PAD, 2002, J ENVIRON MONITOR, V4, P558, DOI 10.1039/b201990f; Ruchirawat M, 2002, SCI TOTAL ENVIRON, V287, P121, DOI 10.1016/S0048-9697(01)01008-7; Salam MA, 2011, INT J ENVIRON SCI TE, V8, P255, DOI 10.1007/BF03326214; Szolar OHJ, 2002, ANAL CHEM, V74, P2379, DOI 10.1021/ac0157391; United States Environmental Protection Agency (USEPA), 2005, GUID CARC RISK ASS; USEPA, 1992, HLTH EFF ASS SUMM TA; Velasco E, 2004, ATMOS ENVIRON, V38, P4957, DOI 10.1016/j.atmosenv.2004.05.020; Wisconsin Department of Natural Resources (WDNR), 1997, SOIL CLEAN LEV POL A	55	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	JUL	2015	22	13					9658	9667		10.1007/s11356-014-4022-1		10	Environmental Sciences	Environmental Sciences & Ecology	CL4QI	WOS:000356937900009		
J	Kitajima, K; Suenaga, Y; Ueno, Y; Maeda, T; Ebina, Y; Yamada, H; Okunaga, T; Kubo, K; Sofue, K; Kanda, T; Tamaki, Y; Sugimura, K				Kitajima, Kazuhiro; Suenaga, Yuko; Ueno, Yoshiko; Maeda, Tetsuo; Ebina, Yasuhiko; Yamada, Hideto; Okunaga, Takashi; Kubo, Kazuhiro; Sofue, Keitarou; Kanda, Tomonori; Tamaki, Yukihisa; Sugimura, Kazuro			Preoperative risk stratification using metabolic parameters of F-18-FDG PET/CT in patients with endometrial cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						FDG; PET/CT; Endometrial cancer; SUVmax; MTV; TLG	TOTAL LESION GLYCOLYSIS; TUMOR VOLUME; PROGNOSTIC VALUE; SUVMAX; CARCINOMA; LYMPHADENECTOMY; INFILTRATION; METAANALYSIS; MANAGEMENT; TRIAL	Purpose To evaluate the usefulness of metabolic parameters obtained by F-18-FDG PET/CT for preoperative stratification of high-risk and low-risk endometrial carcinomas. Methods Preoperative F-18-FDG PET/CT was performed in 56 women with endometrial cancer. Maximum standardized uptake values (SUVmax), metabolic tumour volume (MTV) and total lesion glycolysis (TLG) of primary tumours were compared with clinicopathological features of surgical specimens. Diagnostic performance in terms of differentiation of low-risk disease (endometrioid histology, histological grade 1 or 2, invasion of less than half of the myometrium, and FIGO stage I) from high-risk disease was assessed. Results MTV and TLG were significantly higher in patients with higher histological grade (p = 0.0026 and p = 0.034), larger tumour size (p = 0.002 and p = 0.0017), lymphovascular space involvement (LVSI; p = 0.012 and p = 0.0051), myometrial invasion (p = 0.027 and p = 0.031), cervical stromal invasion (p = 0.023 and p = 0.014), ovarian metastasis (p = 0.00022 and p = 0.00034), lymph node metastasis (p < 0.0001 and p < 0.0001), and higher FIGO stage (p = 0.0011 and p = 0.00048). SUVmax was significantly higher in patients with larger tumour size (p = 0.0025), LVSI (p = 0.00023) and myometrial invasion (p < 0.0001). The areas under the ROC curves (AUCs) for distinguishing high-risk from low-risk carcinoma were 0.625, 0.829 and 0.797 for SUVmax, MTV and TLG, respectively. AUCs for both MTV and TLG were significantly larger than that for SUVmax (p = 0.0049 and p = 0.021). The optimal TLG cut-off value of 70.2, determined by ROC analysis, was found to have 72.0 % sensitivity and 74.2 % specificity for risk stratification. Conclusion MTV and TLG of primary endometrial cancer show better correlations with clinicopathological features and are more useful for differentiating high-risk from low-risk carcinoma than SUVmax.	[Kitajima, Kazuhiro; Suenaga, Yuko; Ueno, Yoshiko; Maeda, Tetsuo; Sofue, Keitarou; Sugimura, Kazuro] Kobe Univ, Sch Med, Dept Radiol, Kobe, Hyogo 650, Japan; [Ebina, Yasuhiko; Yamada, Hideto] Kobe Univ, Sch Med, Dept Obstet & Gynecol, Kobe, Hyogo 6500017, Japan; [Okunaga, Takashi; Kubo, Kazuhiro] Kobe Univ Hosp, Dept Radiol Div, Kobe, Hyogo, Japan; [Kanda, Tomonori] Teikyo Univ, Sch Med, Dept Radiol, Itabashi Ku, Tokyo 173, Japan; [Tamaki, Yukihisa] Shimane Univ, Sch Med, Dept Radiat Oncol, Izumo, Shimane, Japan; [Kitajima, Kazuhiro] Kobe Univ, Grad Sch Med, Dept Radiol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Kitajima, K (reprint author), Kobe Univ, Sch Med, Dept Radiol, Kobe, Hyogo 650, Japan.	kitajima@med.kobe-u.ac.jp; kazu10041976@yahoo.co.jp					Crivellaro C, 2013, GYNECOL ONCOL, V130, P306, DOI 10.1016/j.ygyno.2013.05.011; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Bakkum-Gamez JN, 2008, MAYO CLIN PROC, V83, P97, DOI 10.4065/83.1.97; Liu FY, 2012, GYNECOL ONCOL, V125, P566, DOI 10.1016/j.ygyno.2012.03.021; Pak K, 2014, J NUCL MED, V55, P884, DOI 10.2967/jnumed.113.133801; Maffione AM, 2013, EUR J NUCL MED MOL I, V40, P853, DOI 10.1007/s00259-013-2357-3; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Chen SW, 2013, EUR J RADIOL, V82, pE405, DOI 10.1016/j.ejrad.2013.04.022; Nakamura K, 2011, GYNECOL ONCOL, V123, P82, DOI 10.1016/j.ygyno.2011.06.026; Tsujikawa T, 2009, J NUCL MED, V50, P1598, DOI 10.2967/jnumed.108.060145; Lee JA, 2010, RADIOTHER ONCOL, V96, P302, DOI 10.1016/j.radonc.2010.07.003; Wright JD, 2012, LANCET, V379, P1352, DOI 10.1016/S0140-6736(12)60442-5; Antonsen SL, 2013, GYNECOL ONCOL, V129, P298, DOI 10.1016/j.ygyno.2013.01.019; Panici PB, 2008, J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Chung HH, 2013, GYNECOL ONCOL, V130, P446, DOI 10.1016/j.ygyno.2013.06.021; Ghooshkhanei H, 2014, GYNECOL ONCOL, V132, P669, DOI 10.1016/j.ygyno.2014.01.039; Kitajima K, 2012, EUR J NUCL MED MOL I, V39, P840, DOI 10.1007/s00259-011-2057-9; Lee HJ, 2011, NUKLEARMED-NUCL MED, V50, P204, DOI 10.3413/nukmed-0375-10-12; Nakamura K, 2010, INT J GYNECOL CANCER, V20, P110, DOI 10.1111/IGC.0b013e3181c3a288; Shim SH, 2014, BJOG-INT J OBSTET GY, V121, P1097, DOI 10.1111/1471-0528.12543; Sudo S, 2015, EUR J NUCL MED MOL I, V42, P676, DOI 10.1007/s00259-014-2964-7; Torizuka T, 2006, NUCL MED COMMUN, V27, P481, DOI 10.1097/00006231-200606000-00002; Walentowicz-Sadlecka M, 2014, BIOMED RES INT, V2014	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	JUL	2015	42	8					1268	1275		10.1007/s00259-015-3037-2		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CL2WV	WOS:000356809100012		
J	Aslam, NA; Babu, SA; Rani, S; Mahajan, S; Solanki, J; Yasuda, M; Baba, A				Aslam, Nayyar Ahmad; Babu, Srinivasarao Arulananda; Rani, Soniya; Mahajan, Shivam; Solanki, Jagmohan; Yasuda, Makoto; Baba, Akio			Diastereoselective Construction of 3-Aminooxindoles with Adjacent Stereocenters: Stereocontrolled Addition of -Substituted Allylindiums to Isatin Ketimines	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Synthetic methods; Allylation; Indium; Nitrogen heterocycles; Diastereoselectivity	INDIUM-MEDIATED ALLYLATION; BARBIER-TYPE ALLYLATION; ALPHA-AMINO-ACIDS; TERT-BUTANESULFINYL IMINES; CATALYTIC ASYMMETRIC-SYNTHESIS; N-HETEROCYCLIC CARBENE; HIGHLY ENANTIOSELECTIVE SYNTHESIS; BRYOZOAN CHARTELLA-PAPYRACEA; REFORMATSKY-TYPE REACTIONS; QUATERNARY CARBON CENTERS	The diastereoselective construction of 3-allyl-3-aminooxindoles that have two adjacent stereocenters has been achieved by the In-promoted Barbier-type addition of -substituted allylic halides to the C=N bond of isatin ketimines. The reactions of cinnamyl-, crotyl-, and geranylindium compounds with isatin ketimines proceeded in either aqueous or alcohol solution. The addition of a cyclohexenylindium species to an isatin ketimine was carried out in N,N-dimethylformamide (DMF), and the addition of ethyl 4-bromocrotonate to an isatin ketimine in EtOH gave oxindole-based -amino acid scaffolds. In all of these processes, the reaction conditions were screened to obtain the respective 3-allyl-3-aminooxindoles with very high stereoselectivity. In addition, plausible TS models are proposed, and representative synthetic transformations were carried out by using the oxindole-based -amino acid scaffolds. Furthermore, the stereochemistry of representative compounds were unequivocally established by single-crystal X-ray structure analysis.	[Aslam, Nayyar Ahmad; Babu, Srinivasarao Arulananda; Rani, Soniya; Mahajan, Shivam; Solanki, Jagmohan] Indian Inst Sci Educ & Res IISER Mohali, Dept Chem Sci, Mohali 140306, Punjab, India; [Yasuda, Makoto; Baba, Akio] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan	Babu, SA (reprint author), Indian Inst Sci Educ & Res IISER Mohali, Dept Chem Sci, Sect 81,Manauli PO, Mohali 140306, Punjab, India.	sababu@iisermohali.ac.in			Department of Science and Technology (DST), New Delhi; Indian Institute of Science Education and Research (IISER), Mohali; University Grants Commission (UGC), New Delhi; DST; IAS	This work was funded by the Department of Science and Technology (DST), New Delhi (Fast Track Young Scientist Scheme) and the Indian Institute of Science Education and Research (IISER), Mohali. The authors thank IISER Mohali for the use of their NMR, X-ray, and HRMS facilities. The authors also thank the Department of Chemical Sciences, IISER Mohali for the use of their single-crystal X-ray facility. N. A. A. thanks the University Grants Commission (UGC), New Delhi for a SRF fellowship. S. R. and J. S. thank the DST for the INSPIRE fellowship, and S. M. thanks the IAS for the summer research fellowship.	Alcaide B, 2010, EUR J ORG CHEM, P2845, DOI 10.1002/ejoc.201000141; Andrews PC, 2004, TETRAHEDRON LETT, V45, P243, DOI 10.1016/j.tetlet.2003.10.188; Andrews PC, 2004, GREEN CHEM, V6, P119, DOI 10.1039/b311944k; Bui T, 2010, ORG LETT, V12, P5696, DOI 10.1021/ol102493q; Tietze LF, 2009, ACCOUNTS CHEM RES, V42, P367, DOI 10.1021/ar800170y; Lesma G, 2009, J ORG CHEM, V74, P4537, DOI 10.1021/jo900623c; Crosignani S, 2011, ACS MED CHEM LETT, V2, P644, DOI 10.1021/ml2001196; Kobayashi S, 2011, CHEM REV, V111, P2626, DOI 10.1021/cr100204f; Jensen BS, 2002, CNS DRUG REV, V8, P353; Hara N, 2012, CHEM-EUR J, V18, P9276, DOI 10.1002/chem.201200367; Paquette LA, 1997, J ORG CHEM, V62, P4293, DOI 10.1021/jo970274d; Guo QX, 2012, J ORG CHEM, V77, P3589, DOI 10.1021/jo202585w; Cheng L, 2009, ORG LETT, V11, P3874, DOI 10.1021/ol901405r; Shen ZL, 2013, CHEM REV, V113, P271, DOI 10.1021/cr300051y; Li CJ, 2005, CHEM REV, V105, P3095, DOI 10.1021/cr030009u; Azizian J, 2012, MED CHEM RES, V21, P3730, DOI 10.1007/s00044-011-9896-6; Roy UK, 2010, CHEM REV, V110, P2472, DOI 10.1021/cr800336a; Wolan A, 2011, TETRAHEDRON LETT, V52, P1195, DOI 10.1016/j.tetlet.2011.01.032; Tokunaga T, 2001, J MED CHEM, V44, P4641, DOI 10.1021/jm0103763; Hewawasam P, 2002, J MED CHEM, V45, P1487, DOI 10.1021/jm0101850; Kargbo R, 2007, J AM CHEM SOC, V129, P3846, DOI 10.1021/ja070742t; Sun XW, 2006, ORG LETT, V8, P4979, DOI 10.1021/ol062216x; Gordon CM, 2002, GREEN CHEM, V4, P124, DOI 10.1039/b110224a; Friestad GK, 2007, TETRAHEDRON, V63, P2541, DOI 10.1016/j.tet.2006.11.076; Gonzalez A, 2009, BIOORG MED CHEM LETT, V19, P5270, DOI 10.1016/j.bmcl.2009.03.004; Luppi G, 2006, TETRAHEDRON, V62, P12017, DOI 10.1016/j.tet.2006.09.077; Abadi AH, 2006, EUR J MED CHEM, V41, P296, DOI 10.1016/j.ejmech.2005.12.004; Slaton R, 2011, TETRAHEDRON LETT, V52, P5073, DOI 10.1016/j.tetlet.2011.07.095; Kargbo RB, 2007, CURR ORG CHEM, V11, P1287, DOI 10.2174/138527207782023139; Foubelo F, 2014, EUR J ORG CHEM, V2014, P485, DOI 10.1002/ejoc.201301068; Hu FL, 2013, ORG BIOMOL CHEM, V11, P1921, DOI 10.1039/c3ob27495k; Sridhar SK, 2001, BIOL PHARM BULL, V24, P1149, DOI 10.1248/bpb.24.1149; Suchy M, 2001, J ORG CHEM, V66, P3940, DOI 10.1021/jo0155052; Gorokhovik I, 2011, ORG LETT, V13, P5536, DOI 10.1021/ol202263a; Wang ZY, 2002, TETRAHEDRON LETT, V43, P5097, DOI 10.1016/S0040-4039(02)00995-4; Galliford CV, 2007, ANGEW CHEM INT EDIT, V46, P8748, DOI 10.1002/anie.200701342; Bernardi L, 2003, J ORG CHEM, V68, P3348, DOI 10.1021/jo026823j; Jia LN, 2012, ORG BIOMOL CHEM, V10, P236, DOI 10.1039/c1ob06413d; Bui T, 2009, J ORG CHEM, V74, P8935, DOI 10.1021/jo902039a; Yan WJ, 2012, J ORG CHEM, V77, P3311, DOI 10.1021/jo300110a; Dalpozzo R, 2012, CHEM SOC REV, V41, P7247, DOI 10.1039/c2cs35100e; Denmark SE, 2003, CHEM REV, V103, P2763, DOI 10.1021/cr020050h; Yasuda M, 2009, ORGANOMETALLICS, V28, P1998, DOI 10.1021/om900096r; Ren L, 2013, CHEM-EUR J, V19, P3315, DOI 10.1002/chem.201203993; Chan TH, 1999, J AM CHEM SOC, V121, P3228, DOI 10.1021/ja984359n; Bernard K, 2005, BRIT J PHARMACOL, V144, P1037, DOI 10.1038/sj.bjp.0706103; Lesma G, 2014, BEILSTEIN J ORG CHEM, V10, P1383, DOI 10.3762/bjoc.10.141; Paquette LA, 1996, J AM CHEM SOC, V118, P1931, DOI 10.1021/ja953682c; ANTHONI U, 1987, J ORG CHEM, V52, P4709, DOI 10.1021/jo00230a010; Zhou F, 2010, ADV SYNTH CATAL, V352, P1381, DOI 10.1002/adsc.201000161; BASILE T, 1994, J ORG CHEM, V59, P7766, DOI 10.1021/jo00104a037; Sun XW, 2008, ORG LETT, V10, P1259, DOI 10.1021/ol8001514; Yan WJ, 2012, ORG LETT, V14, P2512, DOI 10.1021/ol3007953; Ochi M, 2001, BIOCHEM BIOPH RES CO, V283, P1118, DOI 10.1006/bbrc.2001.4911; Merino P, 2005, CURR ORG SYNTH, V2, P479, DOI 10.2174/157017905774322659; Reddy C, 2014, RSC ADV, V4, P40199, DOI 10.1039/c4ra04293j; Sato S, 2009, J ORG CHEM, V74, P7522, DOI 10.1021/jo901352u; Kanai M, 2008, PURE APPL CHEM, V80, P1055, DOI 10.1351/pac200880051055; Vilaivan T, 2005, CURR ORG CHEM, V9, P1315, DOI 10.2174/1385272054880214; Foubelo F, 2004, TETRAHEDRON-ASYMMETR, V15, P3823, DOI 10.1016/j.tetasy.2004.10.031; Zha ZG, 2005, TETRAHEDRON, V61, P2521, DOI 10.1016/j.tet.2004.12.063; Liu YY, 2013, ASIAN J ORG CHEM, V2, P374, DOI 10.1002/ajoc.201200180; Sridhar SK, 2001, EUR J MED CHEM, V36, P615, DOI 10.1016/S0223-5234(01)01255-7; Yang ZG, 2010, CHEM-EUR J, V16, P6632, DOI 10.1002/chem.201000126; Cao ZY, 2014, TETRAHEDRON LETT, V55, P2571, DOI 10.1016/j.tetlet.2014.01.084; Sugiura M, 2004, J AM CHEM SOC, V126, P7182, DOI 10.1021/ja049689o; Barros OSD, 2014, CHEM COMMUN, V50, P6898, DOI 10.1039/c4cc02317j; Gao YZ, 2012, ORG BIOMOL CHEM, V10, P3991, DOI 10.1039/c2ob25397f; Riant O, 2007, ORG BIOMOL CHEM, V5, P873, DOI 10.1039/b617746h; Yus M, 2013, CHEM REV, V113, P5595, DOI 10.1021/cr400008h; Aslam NA, 2014, TETRAHEDRON, V70, P6402, DOI 10.1016/j.tet.2014.07.039; Marshall JA, 2007, J ORG CHEM, V72, P8153, DOI 10.1021/jo070787c; Schneider U, 2012, ACCOUNTS CHEM RES, V45, P1331, DOI 10.1021/ar3000081; Paquette LA, 1998, J ORG CHEM, V63, P5604, DOI 10.1021/jo980974y; Hilt G, 2002, TETRAHEDRON LETT, V43, P1437, DOI 10.1016/S0040-4039(02)00044-8; Chen D, 2013, CHEM COMMUN, V49, P1327, DOI 10.1039/c2cc38600c; Law MC, 2007, J ORG CHEM, V72, P923, DOI 10.1021/jo062198x; Takao K, 2012, HETEROCYCLES, V86, P147, DOI 10.3987/COM-12-S(N)31; Liu YL, 2010, ORG BIOMOL CHEM, V8, P3847, DOI 10.1039/c0ob00174k; Varano F, 2005, BIOORGAN MED CHEM, V13, P5536, DOI 10.1016/j.bmc.2005.07.010; MORICONI EJ, 1964, J ORG CHEM, V29, P3577, DOI 10.1021/jo01035a033; Singh GS, 2012, CHEM REV, V112, P6104, DOI 10.1021/cr300135y; Cheng DJ, 2014, ACS CATAL, V4, P743, DOI 10.1021/cs401172r; Vilaivan T, 2005, J ORG CHEM, V70, P3464, DOI 10.1021/jo0477244; Munoz-Bascon J, 2012, CHEM-EUR J, V18, P14479, DOI 10.1002/chem.201201720; Mouri S, 2010, J AM CHEM SOC, V132, P1255, DOI 10.1021/ja908906n; Tolstoy P, 2012, ORG LETT, V14, P4810, DOI 10.1021/ol302119j; Haddad TD, 2010, J ORG CHEM, V75, P642, DOI 10.1021/jo902173j; Li SX, 2011, TETRAHEDRON, V67, P849, DOI 10.1016/j.tet.2010.12.035; CHEVOLOT L, 1985, J AM CHEM SOC, V107, P4542, DOI 10.1021/ja00301a027; ARAKI S, 1988, J ORG CHEM, V53, P1831, DOI 10.1021/jo00243a052; Yeung BKS, 2010, J MED CHEM, V53, P5155, DOI 10.1021/jm100410f; Liu XL, 2011, J ORG CHEM, V76, P4008, DOI 10.1021/jo2004378; Jain R, 2012, TETRAHEDRON LETT, V53, P6236, DOI 10.1016/j.tetlet.2012.09.013; YAMAMOTO Y, 1993, CHEM REV, V93, P2207, DOI 10.1021/cr00022a010; Koszinowski K, 2010, J AM CHEM SOC, V132, P6032, DOI 10.1021/ja908101j; Ding K, 2005, J AM CHEM SOC, V127, P10130, DOI 10.1021/ja051147z; Hong L, 2013, ADV SYNTH CATAL, V355, P1023, DOI 10.1002/adsc.201200808; Antonchick AP, 2010, NAT CHEM, V2, P735, DOI 10.1038/nchem.730; Arena G, 2011, ORG LETT, V13, P2294, DOI 10.1021/ol200557r; Cao ZY, 2011, ORG LETT, V13, P6398, DOI 10.1021/ol202705g; Xu JF, 2014, ORG LETT, V16, P3272, DOI 10.1021/ol501286e; Chen D, 2014, J ORG CHEM, V79, P7746, DOI 10.1021/jo501360g; Yamamoto H, 2007, CHEM-ASIAN J, V2, P692, DOI 10.1002/asia.200600413; Shen K, 2011, ANGEW CHEM INT EDIT, V50, P4684, DOI 10.1002/anie.201100758; Yus M, 2011, CHEM REV, V111, P7774, DOI 10.1021/cr1004474; Decaux G, 2008, LANCET, V371, P1624, DOI 10.1016/S0140-6736(08)60695-9; Ball-Jones NR, 2012, ORG BIOMOL CHEM, V10, P5165, DOI 10.1039/c2ob25184a; Koep S, 2003, J AM CHEM SOC, V125, P13243, DOI 10.1021/ja030324y; Badillo JJ, 2010, CURR OPIN DRUG DISC, V13, P758; Das A, 2014, ORG LETT, V16, P3808, DOI 10.1021/ol501699x; Tan KL, 2007, ANGEW CHEM INT EDIT, V46, P1315, DOI 10.1002/anie.200603354; Fang XM, 1999, J ORG CHEM, V64, P4844, DOI 10.1021/jo990238+; Aslam NA, 2012, EUR J ORG CHEM, P4395, DOI 10.1002/ejoc.201200254; Aslam NA, 2013, TETRAHEDRON, V69, P6598, DOI 10.1016/j.tet.2013.05.130; Babu S. A., 2015, STUD NAT PROD CHEM, V46, P227; Babu SA, 2002, SYNLETT, P531; Babu SA, 2006, ORG LETT, V8, P3029, DOI 10.1021/ol060943m; Babu SA, 2005, J ORG CHEM, V70, P10408, DOI 10.1021/jo051659w; Babu SA, 2007, J ORG CHEM, V72, P10264, DOI 10.1021/jo701899j; Babu SA, 2004, ORG LETT, V6, P4475, DOI 10.1021/ol0482846; Barbier P., 1899, CR HEBD ACAD SCI, V128, P110; Borad MA, 2014, SYNTHETIC COMMUN, V44, P1043, DOI 10.1080/00397911.2013.858361; Bowyer WJ, 2011, TETRAHEDRON, V67, P7449, DOI 10.1016/j.tet.2011.06.041; Cere V, 1999, SYNLETT, P1585; Cook GR, 2005, ORG LETT, V7, P2767, DOI 10.1021/ol051160o; Debnath K, 2013, TETRAHEDRON LETT, V54, P4110, DOI 10.1016/j.tetlet.2013.05.105; Dickstein JS, 2008, CHEM SOC REV, V37, P1166, DOI 10.1039/b709139g; Ding H, 2005, SYNTHESIS-STUTTGART, P2815, DOI 10.1055/s-2005-875218; Galliford C. V., 2007, ANGEW CHEM, V119, P8902, DOI 10.1002/ange.200701342; Ghosh AK, 2006, BIOORG MED CHEM LETT, V16, P1869, DOI 10.1016/j.bmcl.2006.01.011; Claudine SLG, 2003, STRESS, V6, P199, DOI 10.1080/1025389032000114524; Goswami D, 2012, J ORG CHEM, V77, P11064, DOI 10.1021/jo3020775; Grignard V, 1900, CR HEBD ACAD SCI, V130, P1322; Guimaraes RL, 2007, MOLECULES, V12, P2089, DOI 10.3390/12092089; Gung B. W., 2004, ORG REACTIONS, V64, P1, DOI DOI 10.1002/0471264180.OR064.01; Hall DG, 2007, SYNLETT, P1644, DOI 10.1055/s-2007-980384; Hanessian S, 1996, TETRAHEDRON LETT, V37, P5273, DOI 10.1016/0040-4039(96)01118-5; Hietanen A, 2010, EUR J ORG CHEM, P909, DOI 10.1002/ejoc.200901216; Hirashita T, 2003, J ORG CHEM, V68, P1309, DOI 10.1021/jo026609v; Horoszok L., 2009, U. S. Patent Appl. Publ., Patent No. [US 20090076049A1, 20090076049]; Huang X, 2013, TETRAHEDRON LETT, V54, P5857, DOI 10.1016/j.tetlet.2013.08.076; Ikotun Adebomi A, 2012, Acta Crystallogr Sect E Struct Rep Online, V68, po2098, DOI 10.1107/S1600536812024506; Jia YX, 2008, CHEM COMMUN, P4040, DOI 10.1039/b810858g; Jin SS, 2010, ADV SYNTH CATAL, V352, P3136, DOI 10.1002/adsc.201000688; Justicia J, 2009, ADV SYNTH CATAL, V351, P2295, DOI 10.1002/adsc.200900479; Kallstrom S, 2007, TETRAHEDRON LETT, V48, P6958, DOI 10.1016/j.tetlet.2007.07.167; Kang HY, 2004, B KOR CHEM SOC, V25, P1627; Kim SH, 2010, TETRAHEDRON, V66, P7065, DOI 10.1016/j.tet.2010.05.103; Kim SJ, 2010, J AM CHEM SOC, V132, P12168, DOI 10.1021/ja1035336; Klein JEMN, 2011, EUR J ORG CHEM, P6821, DOI 10.1002/ejoc.201100836; Kobayashi S, 2008, CHEM COMMUN, P2313, DOI 10.1039/b802153h; Kouznetsov VV, 2008, TETRAHEDRON LETT, V49, P5855, DOI 10.1016/j.tetlet.2008.07.096; Kumar S, 2004, TETRAHEDRON LETT, V45, P3413, DOI 10.1016/j.tetlet.2004.03.022; Kuznetsov NY, 2014, TETRAHEDRON-ASYMMETR, V25, P667, DOI 10.1016/j.tetasy.2014.03.003; Lachance H., 2008, ORG REACTIONS, V73, P1; Lee JG, 2002, J CHEM SOC PERK T 1, P1314, DOI 10.1039/b110505c; Lee PH, 2007, B KOR CHEM SOC, V28, P17; Legros J, 2003, J ORG CHEM, V68, P6444, DOI 10.1021/jo034205c; Lemonnier G, 2014, J ORG CHEM, V79, P2916, DOI 10.1021/jo402810s; Lesma G, 2010, TETRAHEDRON, V66, P4474, DOI 10.1016/j.tet.2010.04.077; Leugn C., 2007, U. S. Patent Appl. Publ., Patent No. [US 2007185179 A1, 2007185179]; Li CJ, 1998, GREEN CHEMISTRY, P234; Lobben PC, 1998, J ORG CHEM, V63, P6990, DOI 10.1021/jo980825f; Loh TP, 1997, TETRAHEDRON LETT, V38, P865, DOI 10.1016/S0040-4039(96)02427-6; Loh T.-P., 2004, SCI SYNTH, V7, P413; Lu WS, 2001, J ORG CHEM, V66, P3467, DOI 10.1021/jo0018038; Lu WS, 2000, J ORG CHEM, V65, P8589, DOI 10.1021/jo0009898; Marti C, 2003, EUR J ORG CHEM, P2209, DOI 10.1002/ejoc.200300050; Millemaggi A, 2010, EUR J ORG CHEM, P4527, DOI 10.1002/ejoc.201000643; Min Q.-Q., 2010, CHEM COMMUN, P8029; Miyabe H, 2005, SYNLETT, P1641, DOI 10.1055/s-2005-869871; Miyabe H, 2002, CHEM COMMUN, P1454, DOI 10.1039/b203493j; MOLLE G, 1982, J AM CHEM SOC, V104, P3481, DOI 10.1021/ja00376a039; Moyano A., 2013, STUDIES IN NATURAL P, V40, P71; Nair V, 2004, TETRAHEDRON, V60, P1959, DOI 10.1016/j.tet.2003.12.037; Narayan R, 2014, ACCOUNTS CHEM RES, V47, P1296, DOI 10.1021/ar400286b; Nicolaou C., 2003, ANGEW CHEM, V115, P1795; Nicolaou KC, 2003, ANGEW CHEM INT EDIT, V42, P1753, DOI 10.1002/anie.200351112; Ogawa C., 2004, ANGEW CHEM, V116, P6653, DOI 10.1002/ange.200461312; Paquette LA, 2003, SYNTHESIS-STUTTGART, P765, DOI 10.1055/s-2003-38061; Paquette LA, 1999, J ORG CHEM, V64, P217, DOI 10.1021/jo981717w; Paquette LA, 1996, J ORG CHEM, V61, P8799, DOI 10.1021/jo9613489; Paquette LA, 1996, J AM CHEM SOC, V118, P1917, DOI 10.1021/ja9536835; Paquette LA, 1998, J ORG CHEM, V63, P1836, DOI 10.1021/jo9715534; Podlech J, 2003, SYNTHESIS-STUTTGART, P633, DOI 10.1055/s-2003-38064; Qian ZQ, 2009, CHEM COMMUN, P6753, DOI 10.1039/b915257a; Rajkumar V, 2012, SYNLETT, P549, DOI 10.1055/s-0031-1290342; Ramadhar TR, 2011, SYNTHESIS-STUTTGART, P1321, DOI 10.1055/s-0030-1258434; Ranu BC, 2000, EUR J ORG CHEM, P2347; REETZ MT, 1984, ANGEW CHEM INT EDIT, V23, P556, DOI 10.1002/anie.198405561; Reetz M. T., 1984, ANGEW CHEM, V96, P542, DOI 10.1002/ange.19840960805; Ritson DJ, 2004, ORG BIOMOL CHEM, V2, P1921, DOI 10.1039/b402764g; Rottmann M., 2012, SCIENCE, V329, P1175; Samanta D, 2009, J ORG CHEM, V74, P7183, DOI 10.1021/jo901195g; Sasmal D., 2004, J TEACH RES CHEM, V11, P83; Schleusner M, 2002, J AM CHEM SOC, V124, P7789, DOI 10.1021/ja0201799; Schneider U, 2008, ORG LETT, V10, P737, DOI 10.1021/ol702756k; Serradeil-Le Gal C., 2005, CNS DRUG REV, V11, P53; Shen K, 2012, CHEM SCI, V3, P327, DOI 10.1039/c1sc00544h; Shi YH, 2012, TETRAHEDRON, V68, P3649, DOI 10.1016/j.tet.2012.02.046; Sirvent JA, 2012, CHEM COMMUN, V48, P2543, DOI 10.1039/c2cc17493f; Smith K, 2004, ORG BIOMOL CHEM, V2, P935, DOI 10.1039/b400179f; Somogyi L, 2001, B CHEM SOC JPN, V74, P873, DOI 10.1246/bcsj.74.873; Steurer S, 1999, EUR J ORG CHEM, P1551; Su L, 2014, ORG LETT, V16, P4118, DOI 10.1021/ol501815e; Subari A. A., 2010, ACTA CRYSTALLOGR E, V66, po453; Ogawa C, 2004, ANGEW CHEM INT EDIT, V43, P6491, DOI 10.1002/anie.200461312; Suzuki H., 2001, ORGANOBISMUTH CHEM; Tan K. L., 2007, ANGEW CHEM, V119, P1337, DOI 10.1002/ange.200603354; Tang BQ, 2014, J NAT PROD, V77, P1839, DOI 10.1021/np500240b; Trost BM, 2009, SYNTHESIS-STUTTGART, P3003, DOI 10.1055/s-0029-1216975; Trost B. M., 1991, COMPREHENSIVE ORGANI, V2; Trost B.M., 1991, COMPREHENSIVE ORGANI, V1-2; Venkataiah M, 2009, TETRAHEDRON, V65, P6950, DOI 10.1016/j.tet.2009.06.060; Vilaivan T, 2001, TETRAHEDRON LETT, V42, P9073, DOI 10.1016/S0040-4039(01)01977-3; Vintonyak V. V., 2012, ANGEW CHEM INT EDIT, V49, P5902; WHITE NJ, 1992, J ANTIMICROB CHEMOTH, V30, P571, DOI 10.1093/jac/30.5.571; Yadav JS, 2010, EUR J ORG CHEM, P591, DOI 10.1002/ejoc.200900895; Yanada R, 2001, J ORG CHEM, V66, P7516, DOI 10.1021/jo015719j; Yasuda M, 2009, EUR J ORG CHEM, P5513, DOI 10.1002/ejoc.200900955; Yasuda M, 2010, EUR J ORG CHEM, P5359, DOI 10.1002/ejoe.201000956; Zhao X, 2014, ORG BIOMOL CHEM, V12, P8072, DOI 10.1039/c4ob01358a; Zhou W., 2008, SYNLETT, P131	224	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	JUL	2015		19					4168	4189		10.1002/ejoc.201500340		22	Chemistry, Organic	Chemistry	CL3SK	WOS:000356870600016		
J	Yamane, K; Tanaka, M; Sugimoto, Y; Misawa, H; Ozaki, T				Yamane, Kentaro; Tanaka, Masato; Sugimoto, Yoshihisa; Misawa, Haruo; Ozaki, Toshifumi			Scoliosis correction surgery for patients with McCune-Albright syndrome using pedicle screws: a report of two cases with different characteristics and a review of the literature	EUROPEAN SPINE JOURNAL			English	Article						McCune-Albright syndrome; Polyostotic fibrous dysplasia of bone; Spinal fibrous dysplasia; Scoliosis correction surgery; Pedicle screw fixation	FIBROUS DYSPLASIA; SPINE	Scoliosis can occur secondary to McCune-Albright syndrome (MAS); it can be progressive and sometimes requires surgical treatment. It is still unclear if pedicle screw (PS) fixation in these patients with poor bone quality can be considered an effective treatment for scoliosis. The purpose of this study is to report two MAS patients with spinal fibrous dysplasia (FD) who underwent scoliosis surgeries with the PS system. Case 1: a 12-year-old girl. Standing posteroanterior radiographs revealed a 58A degrees right curve from T7 to L2. Computed tomography (CT) showed small areas of FD throughout the spine. A posterior spinal arthrodesis from T4 to L3 using PS fixation was performed with a CT-based navigation system. Case 2: a 26-year-old woman. Radiographs in the standing position revealed a right 87A degrees curve from T8 to L2 and a 55A degrees kyphosis from T8 to T12. CT images showed multiple areas of severe spinal FD causing angular deformity and collapse of vertebral bodies. The patient underwent posterior spinal arthrodesis from T8 to her pelvis using a CT-based navigation system for PS fixation. Superior scoliosis corrections were obtained using PS instrumentation, attaining complete bony union in both cases without major complications. However, Case 2 had some technical difficulties in treating due to the multiple large FD lesions. PS fixation can be considered an effective treatment for correcting scoliosis and maintaining the correction at follow-up in MAS patients with poor bone quality. However, great care must be taken when performing correction and follow-up.	[Yamane, Kentaro; Tanaka, Masato; Sugimoto, Yoshihisa; Ozaki, Toshifumi] Okayama Univ Grad Sch Med, Dept Orthopaed Surg, Kita Ku, Okayama 7008558, Japan; [Misawa, Haruo] Okayama Med Ctr, Dept Orthopaed Surg, Okayama, Japan	Yamane, K (reprint author), Okayama Univ Grad Sch Med, Dept Orthopaed Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	kentaro0311@do7.enjoy.ne.jp					Mancini F, 2009, EUR SPINE J, V18, P196, DOI 10.1007/s00586-008-0860-1; Albright F, 1937, NEW ENGL J MED, V216, P727, DOI 10.1056/NEJM193704292161701; Asghar J, 2009, SPINE, V34, P804, DOI 10.1097/BRS.0b013e3181996c1b; Dumitrescu CE, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-12; GUILLE JT, 1995, SPINE, V20, P248, DOI 10.1097/00007632-199501150-00024; Janus G J, 1998, Eur Spine J, V7, P260, DOI 10.1007/s005860050070; Leet AI, 2004, J BONE JOINT SURG AM, V86A, P531; McCune DJ, 1936, AM J DIS CHILD, V52, P743; PFEIFER BA, 1994, SPINE, V19, P350, DOI 10.1097/00007632-199402000-00017; SHIKATA J, 1992, SPINE, V17, P1534; Sunnassee Y, 2013, SCI RES, V2, P562; Wu XH, 2010, J SPINAL DISORD TECH, V23, P467, DOI 10.1097/BSD.0b013e3181bf6797	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	JUL	2015	24	7					1362	1367		10.1007/s00586-015-3813-5		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CL3UG	WOS:000356875500003		
J	Sugawara, R; Tsuji, T; Saito, T; Nohara, A; Kawakami, K; Kawakami, N				Sugawara, Ryo; Tsuji, Taichi; Saito, Toshiki; Nohara, Ayato; Kawakami, Kazuki; Kawakami, Norikaki			Medially misplaced pedicle screws in patients without neurological deficits following scoliosis surgery: to observe or to remove?	EUROPEAN SPINE JOURNAL			English	Article						Pedicle screw; Medial perforation; Scoliosis surgery; CSF leakage	THORACIC SCOLIOSIS; PLACEMENT; SPINE; INSTRUMENTATION; MANAGEMENT; AORTA; SAFE	This study investigated whether pedicle screws medially misplaced into the spinal canal without neurological complications should be removed or not. A total of 86 patients with scoliosis that underwent spinal fusion using 988 pedicle screws were retrospectively reviewed after a minimum follow-up of 2 years. The inclusion criteria were: (1) patients without outstanding problems during the insertion of pedicle screws, (2) patients without neurological deficits either intraoperatively or postoperatively, and (3) patients that had all implants removed after bone union upon the request of the patient. Medial perforations were evaluated using immediate postoperative helical CT images and classified into three grades: grade 1 (0-2 mm), grade 2 (2-4 mm), and grade 3 (over 4 mm). All unexpected events were recorded at the time of removal. CT images obtained 2 years postoperatively exhibited neither loosening of screws nor pseudoarthrosis in all patients. CSF leakage from screw holes were recognized in 3 of 87 medially misplaced screws (3.4 %). There was no CSF leakage in grade 1 (35 screws), one CSF leakage (2.5 %) in grade 2 (40 screws), and two (16.7 %) in grade 3 (12 screws). No neurological abnormalities occurred either intraoperatively or postoperatively. This study indicated that screws medially misplaced at a distance greater than 2 mm, especially 4 mm, may be a cause of negative effects on the neural structure and should be removed during the early phase of the postoperative period, even among patients without postoperative neurological abnormalities.	[Sugawara, Ryo] Jichi Childrens Med Ctr, Dept Pediat Orthoped, Shimotsuke, Tochigi 3290498, Japan; [Tsuji, Taichi; Saito, Toshiki; Nohara, Ayato; Kawakami, Kazuki; Kawakami, Norikaki] Meijo Hosp, Dept Orthoped & Spine Surg, Naka Ku, Nagoya, Aichi 4600001, Japan	Kawakami, N (reprint author), Meijo Hosp, Dept Orthoped & Spine Surg, Naka Ku, 1-3-1 Sannomaru, Nagoya, Aichi 4600001, Japan.	sugaryo@jichi.ac.jp; nupriver@gmail.com					Albayram S, 2008, EUR SPINE J, V17, pS347, DOI 10.1007/s00586-008-0681-2; Wang JC, 1998, J BONE JOINT SURG AM, V80A, P1728; GERTZBEIN SD, 1990, SPINE, V15, P11, DOI 10.1097/00007632-199001000-00004; Reidy DP, 2001, J BONE JOINT SURG BR, V83B, P1009, DOI 10.1302/0301-620X.83B7.12017; Liljenqvist U, 2002, EUR SPINE J, V11, P336, DOI 10.1007/s00586-002-0415-9; Mac-Thiong JM, 2013, SPINE, V38, P229, DOI 10.1097/BRS.0b013e31826980a9; Di Silvestre M, 2007, SPINE, V32, P1655, DOI 10.1097/BRS.0b013e318074d604; Papin P, 1999, EUR SPINE J, V8, P156, DOI 10.1007/s005860050147; Suk SI, 2001, SPINE, V26, P2049, DOI 10.1097/00007632-200109150-00022; Liljenqvist UR, 2002, J BONE JOINT SURG AM, V84A, P359; Choi JB, 2001, J TRAUMA, V50, P140, DOI 10.1097/00005373-200101000-00029; Kim YJ, 2004, SPINE, V29, P333, DOI 10.1097/01.BRS.0000109983.12113.9B; VACCARO AR, 1995, J BONE JOINT SURG AM, V77A, P1193; Wegener B, 2008, EUR SPINE J, V17, pS351, DOI 10.1007/s00586-008-0715-9	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	JUL	2015	24	7					1450	1456		10.1007/s00586-015-3860-y		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CL3UG	WOS:000356875500015		
J	Matsumoto, Y; Matsumoto, K; Harimaya, K; Okada, S; Doi, T; Iwamoto, Y				Matsumoto, Yoshihiro; Matsumoto, Kazu; Harimaya, Katsumi; Okada, Seiji; Doi, Toshio; Iwamoto, Yukihide			Scoliosis in patients with multiple hereditary exostoses	EUROPEAN SPINE JOURNAL			English	Article						Multiple hereditary exostoses; Scoliosis; Spinal deformity; Classification	GROWTH-FACTOR RECEPTOR-3; HEPARAN-SULFATE; IDIOPATHIC SCOLIOSIS; NATURAL-HISTORY; OSTEOCHONDROMAS; EXT1; DEFECTS	To investigate the prevalence of and to identify independent predictors associated with scoliosis in patients with multiple hereditary exostoses (MHE). Fifty patients with MHE were clinically examined, and the diagnosis of scoliosis was made based on radiographs. To classify disease severity, three classes based on the presence of deformities and functional limitations were defined. Significant independent predictors of scoliosis in MHE were statistically analyzed. Scoliosis was present in 36 patients (MHE-scoliosis) (72 %). In the MHE-scoliosis group, the mean primary curve was 15.3A degrees A A +/- A 5.7A degrees (range 10A degrees-34A degrees) and the mean minor curve was 10.6A degrees A A +/- A 7A degrees (range 6A degrees-32A degrees). Left curve was predominant (72 %), and the apex was located in the thoracolumbar or lumbar spine in 64 % of patients. Univariable and multivariable analyses confirmed that MHE severity was a significant predictor of moderate scoliosis (a parts per thousand yen20A degrees). Our study confirmed that scoliosis is a common feature of MHE and disease severity is a predictor of moderate scoliosis (a parts per thousand yen20A degrees).	[Matsumoto, Yoshihiro; Harimaya, Katsumi; Okada, Seiji; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan; [Matsumoto, Kazu] Gifu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Gifu 5011194, Japan; [Doi, Toshio] Kyushu Univ Beppu Hosp, Dept Orthopaed Surg, Beppu, Oita, Japan	Matsumoto, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ymatsu@ortho.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science [23592192]	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (#23592192).	SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986; Shu C, 2013, EUR SPINE J, V22, P1774, DOI 10.1007/s00586-013-2680-1; MORRISSY RT, 1990, J BONE JOINT SURG AM, V72A, P320; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; FOGEL GR, 1984, J BONE JOINT SURG AM, V66A, P670; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; NASH CL, 1969, J BONE JOINT SURG AM, VA 51, P223; KING HA, 1983, J BONE JOINT SURG AM, V65, P1302; Anower-E-Khuda MF, 2013, GLYCOBIOLOGY, V23, P865, DOI 10.1093/glycob/cwt024; Benoist-Lasselin C, 2006, BONE, V39, P17, DOI 10.1016/j.bone.2005.12.003; CATES HE, 1991, J HAND SURG-AM, V16A, P127; Chen S, 2014, SPINE J, V14, P2968, DOI 10.1016/j.spinee.2014.05.019; Felix NA, 2000, J BONE JOINT SURG BR, V82B, P555, DOI 10.1302/0301-620X.82B4.9894; Francannet C, 2001, J MED GENET, V38, P430, DOI 10.1136/jmg.38.7.430; Jäger Marcus, 2007, J Orthop Res, V25, P1541, DOI 10.1002/jor.20479; Matsumoto K, 2010, P NATL ACAD SCI USA, V107, P10932, DOI 10.1073/pnas.0914642107; Matsumoto Y, 2010, J BIOL CHEM, V285, P19227, DOI 10.1074/jbc.M110.105338; Matsuo I, 2013, CURR OPIN GENET DEV, V23, P399, DOI 10.1016/j.gde.2013.02.004; Mordenti M, 2013, AM J MED GENET A, V161A, P556, DOI 10.1002/ajmg.a.35819; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	JUL	2015	24	7					1568	1573		10.1007/s00586-015-3883-4		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CL3UG	WOS:000356875500029		
J	Heinonen, I; Koga, S; Kalliokoski, KK; Musch, TI; Poole, DC				Heinonen, Ilkka; Koga, Shunsaku; Kalliokoski, Kari K.; Musch, Timothy I.; Poole, David C.			Heterogeneity of Muscle Blood Flow and Metabolism: Influence of Exercise, Aging, and Disease States	EXERCISE AND SPORT SCIENCES REVIEWS			English	Review							NITRIC-OXIDE SYNTHASE; RAT SKELETAL-MUSCLE; OXYGEN-UPTAKE KINETICS; CHRONIC HEART-FAILURE; DIFFERENT FIBER TYPES; MICROVASCULAR OXYGENATION; DYNAMIC HETEROGENEITY; ONSET; INHIBITION; MEN	The systematic increase in VO2 uptake and O-2 extraction with increasing work rates conceals a substantial heterogeneity of O-2 delivery (QO(2))-to- VO2 matching across and within muscles and other organs. We hypothesize that whether increased/decreased QO(2)/VO2 heterogeneity can be judged as "good" or "bad," for example, after exercise training or in aged individuals or with disease (heart failure, diabetes) depends on the resultant effects on O-2 transport and contractile performance.	[Heinonen, Ilkka; Kalliokoski, Kari K.] Univ Turku, Turku PET Ctr, Turku, Finland; [Heinonen, Ilkka] Erasmus MC, Univ Med Ctr Rotterdam, Thoraxctr, Div Expt Cardiol, Rotterdam, Netherlands; [Heinonen, Ilkka] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Crawley, WA, Australia; [Koga, Shunsaku] Kobe Design Univ, Appl Physiol Lab, Kobe, Hyogo, Japan; [Musch, Timothy I.; Poole, David C.] Kansas State Univ, Dept Kinesiol, Manhattan, KS 66506 USA; [Musch, Timothy I.; Poole, David C.] Kansas State Univ, Dept Anat, Manhattan, KS 66506 USA; [Musch, Timothy I.; Poole, David C.] Kansas State Univ, Dept Physiol, Manhattan, KS 66506 USA	Heinonen, I (reprint author), Turku PET Ctr, POB 52, FIN-20521 Turku, Finland.	ilkka.heinonen@utu.fi			Academy of Finland; Finnish Foundation for Cardiovascular Research; Finnish Diabetes Research Foundation; Ministry of Education and Culture, State of Finland; Japan Society for the Promotion of Science [KAKENHI-18207019, 20650103, 21370111, 22370091, 22650151, 24650401, 24247046, 26560362]; National Institutes of Health [HL-50306, HL-108328]; American Heart Association, Heartland Affiliate	The research of the authors I.H. and K.K. has been supported by The Academy of Finland, The Finnish Foundation for Cardiovascular Research, Finnish Diabetes Research Foundation, and Ministry of Education and Culture, State of Finland. S.K. was supported by grants from Japan Society for the Promotion of Science (KAKENHI-18207019, 20650103, 21370111, 22370091, 22650151, 24650401, 24247046, 26560362). D.C.P. and T.I.M. were funded by grants from the National Institutes of Health (HL-50306 and HL-108328) and the American Heart Association, Heartland Affiliate.	Kalliokoski KK, 2001, AM J PHYSIOL-ENDOC M, V280, pE1015; Koga S, 2011, AM J PHYSIOL-REG I, V301, pR534, DOI 10.1152/ajpregu.00101.2011; Poole DC, 2012, AM J PHYSIOL-HEART C, V302, pH1050, DOI 10.1152/ajpheart.00943.2011; Heinonen I, 2007, J APPL PHYSIOL, V103, P2042, DOI 10.1152/japplphysiol.00567.2007; Heinonen IH, 2010, AM J PHYSIOL-REG I, V299, pR72, DOI 10.1152/ajpregu.00056.2010; Poole DC, 2013, EXP PHYSIOL, V98, P1645, DOI 10.1113/expphysiol.2013.073874; HIRAI T, 1994, J APPL PHYSIOL, V77, P1288; Rudroff T, 2014, J PHYSIOL-LONDON, V592, P337, DOI 10.1113/jphysiol.2013.264614; McAllister RM, 2003, J APPL PHYSIOL, V94, P1777, DOI 10.1152/japplphysiol.00901.2002; Behnke BJ, 2011, AM J PHYSIOL-REG I, V301, pR783, DOI 10.1152/ajpregu.00205.2011; McDonough P, 2005, J PHYSIOL-LONDON, V563, P903, DOI 10.1113/jphysiol.2004.079533; Kano Y, 2014, J APPL PHYSIOL, V117, P163, DOI 10.1152/japplphysiol.00080.2014; Koga S, 2014, MED SCI SPORT EXER, V46, P860, DOI 10.1249/MSS.0000000000000178; Behnke BJ, 2001, RESP PHYSIOL, V126, P53, DOI 10.1016/S0034-5687(01)00195-5; Sperandio PA, 2012, AM J PHYSIOL-HEART C, V303, pH1474, DOI 10.1152/ajpheart.00435.2012; Hirai DM, 2012, J APPL PHYSIOL, V113, P557, DOI 10.1152/japplphysiol.00151.2012; Behnke BJ, 2005, RESP PHYSIOL NEUROBI, V146, P259, DOI 10.1016/j.resp.2004.12.009; Behnke BJ, 2002, RESP PHYSIOL NEUROBI, V133, P229, DOI 10.1016/S1569-9048(02)00183-0; Poole DC, 2012, COMPR PHYSIOL, V2, P933, DOI 10.1002/cphy.c100072; Kalliokoski KK, 2005, J APPL PHYSIOL, V98, P380, DOI 10.1152/japplphysiol.01306.2003; Murias JM, 2014, EXERC SPORT SCI REV, V42, P4, DOI 10.1249/JES.0000000000000005; Shoemaker JK, 1996, CARDIOVASC RES, V31, P278, DOI 10.1016/S0008-6363(95)00199-9; LAUGHLIN MH, 1982, AM J PHYSIOL, V243, pH296; Behnke BJ, 2003, J PHYSIOL-LONDON, V549, P597, DOI 10.1113/jphysiol.2002.035915; Richardson RS, 2001, J APPL PHYSIOL, V91, P1845; Phillips SM, 1995, J APPL PHYSIOL, V79, P1914; Bowen TS, 2013, EXP PHYSIOL, V98, P1585, DOI 10.1113/expphysiol.2013.073270; Beere PA, 1999, CIRCULATION, V100, P1085; Heinonen I, 2012, J APPL PHYSIOL, V112, P1059, DOI 10.1152/japplphysiol.00732.2011; Ferreira LF, 2006, ACTA PHYSIOL, V186, P223, DOI 10.1111/j.1748-1716.2006.01523.x; Laughlin MH, 2012, COMPR PHYSIOL, V2, P321, DOI 10.1002/cphy.c100048; ARMSTRONG RB, 1984, AM J PHYSIOL, V246, pH59; Heinonen I, 2014, PHYSIOLOGY, V29, P421, DOI 10.1152/physiol.00067.2013; Ferreira LF, 2006, ACTA PHYSIOL, V188, P3, DOI 10.1111/j.1748-1716.2006.01598.x; Padilla DJ, 2006, AM J PHYSIOL-HEART C, V291, pH2439, DOI 10.1152/ajpheart.00290.2006; Copp SW, 2013, J PHYSIOL-LONDON, V591, P2885, DOI 10.1113/jphysiol.2013.251082; Copp SW, 2010, J PHYSIOL-LONDON, V588, P1321, DOI 10.1113/jphysiol.2009.183723; Copp SW, 2011, MICROCIRCULATION, V18, P501, DOI 10.1111/j.1549-8719.2011.00111.x; Heinonen Ilkka, 2011, Am J Physiol Heart Circ Physiol, V300, pH1510, DOI 10.1152/ajpheart.00996.2010; Heinonen I, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0413-1; Heinonen I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052191; Heinonen I, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-43; Heinonen I, 2013, AM J PHYSIOL-HEART C, V305, pH163, DOI 10.1152/ajpheart.00925.2012; Kaijser L, 2000, EXERCISE CIRCULATION; Laaksonen MS, 2013, EUR J APPL PHYSIOL, V113, P1775, DOI 10.1007/s00421-013-2609-8; Poole DC, 2000, J APPL PHYSIOL, V88, P186; von Restorff W, 1977, Pflugers Arch, V372, P181; YOSHIDA T, 1992, EUR J APPL PHYSIOL O, V64, P78, DOI 10.1007/BF00376445	48	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0091-6331	1538-3008		EXERC SPORT SCI REV	Exerc. Sport Sci. Rev.	JUL	2015	43	3					117	124		10.1249/JES.0000000000000044		8	Physiology; Sport Sciences	Physiology; Sport Sciences	CK8MP	WOS:000356492600004		
J	Ohgo, S; Hasegawa, S; Hasebe, Y; Mizutani, H; Nakata, S; Akamatsu, H				Ohgo, Shiro; Hasegawa, Seiji; Hasebe, Yuichi; Mizutani, Hiroshi; Nakata, Satoru; Akamatsu, Hirohiko			Senescent dermal fibroblasts enhance stem cell migration through CCL2/CCR2 axis	EXPERIMENTAL DERMATOLOGY			English	Article						chemokine; dermal fibroblasts; mesenchymal stem cells; senescence; skin homeostasis	SKIN	During aging, increases in the number of senescent cells are seen in various tissues. On the other hand, stem cells play crucial roles in tissue repair and homeostasis. Therefore, it is likely that stem cells give rise to new cells that replace senescent cells. However, how stem cells contribute to homeostasis in the dermis has not been elucidated. Here, we investigated the effects of factors secreted from senescent fibroblasts on stem cells. We found that senescent human dermal fibroblast (HDF) conditioned medium (CM) significantly enhanced stem cell migration compared with young HDF CM. The senescent HDF CM strongly secreted chemokine ligand 2 (CCL2). Furthermore, CCL2 was found to enhance stem cell migration, and the inhibition of CCR2, a receptor for CCL2, reduced stem cell migration. These results suggest that senescent fibroblasts recruit stem cells by secreting various factors and that the CCL2/CCR2 axis is one of the mechanisms underlying this phenomenon.	[Ohgo, Shiro; Hasegawa, Seiji; Hasebe, Yuichi; Mizutani, Hiroshi; Nakata, Satoru] Nippon Menard Cosmet Co Ltd, Res Labs, Nagoya, Aichi 4510071, Japan; [Hasegawa, Seiji] Fujita Hlth Univ, Sch Med, Dept Dermatol, Toyoake, Aichi 47011, Japan; [Akamatsu, Hirohiko] Fujita Hlth Univ, Sch Med, Dept Appl Cell & Regenerat Med, Toyoake, Aichi 47011, Japan	Ohgo, S (reprint author), Nippon Menard Cosmet Co Ltd, Res Labs, Nishi Ku, 2-7 Torimicho, Nagoya, Aichi 4510071, Japan.	oogo.shirou@menard.co.jp					Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Fuchs E, 2013, EMBO REP, V14, P39, DOI 10.1038/embor.2012.197; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Lorenz K, 2008, EXP DERMATOL, V17, P925, DOI 10.1111/j.1600-0625.2008.00724.x; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Xu F, 2010, ONCOL REP, V23, P1561, DOI 10.3892/or_00000796; Yamada T, 2010, J DERMATOL SCI, V58, P36, DOI 10.1016/j.jdermsci.2010.02.003	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	JUL	2015	24	7					552	554		10.1111/exd.12701		3	Dermatology	Dermatology	CL1HI	WOS:000356693000017		
J	Sugita, K; Hanakawa, S; Honda, T; Kondoh, G; Miyachi, Y; Kabashima, K; Nomura, T				Sugita, Kazunari; Hanakawa, Sho; Honda, Tetsuya; Kondoh, Gen; Miyachi, Yoshiki; Kabashima, Kenji; Nomura, Takashi			Generation of Helios reporter mice and an evaluation of the suppressive capacity of Helios(+) regulatory T cells in vitro	EXPERIMENTAL DERMATOLOGY			English	Article						contact hypersensitivity; Foxp3; Helios; lymph node; Treg	ALLERGIC CONTACT-DERMATITIS; HYPERSENSITIVITY; MODEL	Helios is a member of the Ikaros transcription factor family and has been reported to be a marker of thymus-derived regulatory T cells (Treg). Helios is an intracellular protein, however, and hence cannot be used as a marker to separate living Tregs. To solve this problem, we generated Helios reporter mice in which Helios+ cells selectively express Venus, a variant of green fluorescent protein. Most of the Tregs in the thymus expressed Helios, whereas its expression was varied in peripheral lymphoid organs. The Helios+ Treg-population was superior in ability to suppress both antigen-specific and TCR-stimulated T cell responses. We also showed that Helios+ Tregs inhibited the cytokine production by T cells more efficiently than Helios- Tregs. We conclude that Helios reporter mouse strain is a useful tool to study function of Helios and that Helios+ Tregs represent the highly suppressive population.	[Sugita, Kazunari; Hanakawa, Sho; Honda, Tetsuya; Miyachi, Yoshiki; Kabashima, Kenji; Nomura, Takashi] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; [Sugita, Kazunari] Univ Occupat & Environm Hlth, Dept Dermatol, Kitakyushu, Fukuoka 807, Japan; [Kondoh, Gen] Kyoto Univ, Lab Anim Expt Regenerat, Inst Frontier Med Sci, Kyoto 6068507, Japan	Nomura, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	tnomura@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	We are grateful to Dr. Atsushi Miyawaki, laboratory head of cell function dynamics at RIKEN Brain Science Institute, Saitama, for providing Venus cDNA. We thank members of our departments for helpful discussions. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Honda T, 2011, J DERMATOL SCI, V63, P75, DOI 10.1016/j.jdermsci.2011.06.004; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Peiser M, 2012, CELL MOL LIFE SCI, V69, P763, DOI 10.1007/s00018-011-0846-8; Park JM, 2012, EXP DERMATOL, V21, P969, DOI 10.1111/exd.12044	9	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	JUL	2015	24	7					554	556		10.1111/exd.12711		3	Dermatology	Dermatology	CL1HI	WOS:000356693000018		
J	Kawashima, I; Mitsumori, T; Nozaki, Y; Yamamoto, T; Shobu-Sueki, Y; Nakajima, K; Kirito, K				Kawashima, Ichiro; Mitsumori, Toni; Nozaki, Yumi; Yamamoto, Takeo; Shobu-Sueki, Yuki; Nakajima, Kei; Kirito, Keita			Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells	EXPERIMENTAL HEMATOLOGY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; SIGNAL-TRANSDUCTION; TUMOR-SUPPRESSOR; ENERGY SENSOR; GROWTH; AMPK; METFORMIN; ACTIVATION; THERAPY; CANCER	Adenosine monophosphate activated protein kinase (AMPK) is a sensor for cellular energy status. When the cellular energy level is decreased, AMPK is activated and functions to suppress energy-consuming processes, including protein synthesis. Recently, AMPK has received attention as an attractive molecular target for cancer therapy. Several studies have revealed that the activation of AMPK by chemical stimulators, such as metformin, induces apoptosis in a variety of hematologic malignant cells. From another perspective, these results suggest that the function of AMPK is impaired in hematologic tumor cells. However, the precise mechanisms by which this impairment occurs are not well understood. In melanoma cells, oncogenic BRAF constitutively activates the extracellular signal-regulated kinase (ERK) pathway and phosphorylates liver kinase B1, an upstream activator of 5' adenosine monophosphate activated protein kinase (AMPK), resulting in the inactivation of liver kinase B1 and AMPK. In this study, we analyzed whether ERK is involved in the suppression of AMPK activity using established and primary human leukemia cells. We found an inverse correlation between the intensity of ERK activity and the degree of AMPK activation after stimulation with either glucose deprivation or metformin. We also found that the inhibition of ERK activity by U0126 restored AMPK activation after metformin treatment. Furthermore, a combined treatment with metformin and U0126 enhanced the antileukemic activity of metformin. Importantly, metformin induced ERK activation by suppressing the protein levels of dual specificity phosphatase 6, a negative regulator of ERK. This crosstalk between AMPK and ERK could diminish the antileukemic activity of metformin. Taken together, our present observations suggest a novel therapeutic strategy for improving the efficacy of metformin in treating leukemia. Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.	[Kawashima, Ichiro; Mitsumori, Toni; Nozaki, Yumi; Yamamoto, Takeo; Shobu-Sueki, Yuki; Nakajima, Kei; Kirito, Keita] Univ Yamanashi, Dept Hematol & Oncol, Yamanashi 4093898, Japan	Kirito, K (reprint author), Univ Yamanashi, Dept Hematol & Oncol, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	kirito@yamanashi.ac.jp			Ministry of Education, Science, Sports and Technology of Japan [24591386]	We thank Mirai Iwaya, Mariko Ozawa, and Hidemi Yamazoe for their technical assistance. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Technology of Japan (grant no. 24591386).	Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Steelman LS, 2011, LEUKEMIA, V25, P1080, DOI 10.1038/leu.2011.66; Kuznetsov JN, 2011, MOL CANCER THER, V10, P437, DOI 10.1158/1535-7163.MCT-10-0777; Green AS, 2010, BLOOD, V116, P4262, DOI 10.1182/blood-2010-02-269837; Choudhary C, 2005, BLOOD, V106, P265, DOI 10.1182/blood-2004-07-2942; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Vakana E, 2011, BLOOD, V118, P6399, DOI 10.1182/blood-2011-01-332783; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Martin MJ, 2012, CANCER DISCOV, V2, P344, DOI 10.1158/2159-8290.CD-11-0280; Morgillo F, 2013, CLIN CANCER RES, V19, P3508, DOI 10.1158/1078-0432.CCR-12-2777; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Baumann P, 2007, EXP CELL RES, V313, P3592, DOI 10.1016/j.yexcr.2007.06.020; Du JH, 2008, BIOCHEM BIOPH RES CO, V368, P402, DOI 10.1016/j.bbrc.2008.01.099; Esteve-Puig R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004771; Grimaldi C, 2012, LEUKEMIA, V26, P91, DOI 10.1038/leu.2011.269; Huai L, 2012, BIOCHEM BIOPH RES CO, V422, P398, DOI 10.1016/j.bbrc.2012.05.001; Kirito K, 1997, J BIOL CHEM, V272, P16507, DOI 10.1074/jbc.272.26.16507; Kothe S, 2013, J CELL SCI, V126, P4746, DOI 10.1242/jcs.131789; Lalic H, 2013, LEUKEMIA LYMPHOMA, V55, P2375; Leclerc GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074420; Mitsumori T, 2014, EXP HEMATOL, V42, P783, DOI 10.1016/j.exphem.2014.05.007; Rosilio C, 2013, CANCER LETT, V336, P114, DOI [10.1016/j.canlet.2013.04.015, 10.1016/j.canlet2013.04.015]; Sengupta TK, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-46; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	JUL	2015	43	7					524	533		10.1016/j.exphem.2015.03.005		10	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CL4ET	WOS:000356906100003		
J	Kuroda, J; Kobayashi, T; Taniwaki, M				Kuroda, Junya; Kobayashi, Tsutomu; Taniwaki, Masafumi			Prognostic indicators of lenalidomide for multiple myeloma: consensus and controversy	EXPERT REVIEW OF ANTICANCER THERAPY			English	Review						cereblon; cytogenetics; immunomodulatory drug; lenalidomide; mode of action; multiple myeloma; prognostic indicators; treatment history	STEM-CELL TRANSPLANTATION; LOW-DOSE DEXAMETHASONE; NATURAL-KILLER-CELL; INTERNATIONAL STAGING SYSTEM; BONE-MARROW MICROENVIRONMENT; RECEIVING INITIAL THERAPY; HIGH-RISK CYTOGENETICS; PLUS DEXAMETHASONE; T-CELLS; IMMUNOMODULATORY DRUGS	The long-term outcome of multiple myeloma (MM) has been greatly improved through new agents, one being lenalidomide (LEN). Based upon the findings of in vitro experiments, its mode of action against MM occurs through a combination of direct tumoricidal effects on myeloma cells, modulatory effects on tumor immunity and tumor microenvironment-regulatory effects. However, it has not been clearly defined whether the clinical response and long-term outcome of MM with LEN treatment truly reflect the mechanisms of action of LEN proposed by in vitro studies. To ascertain what is known and what remains to be elucidated with LEN, we review the current literature on the mode of action of LEN in association with myeloma pathophysiology, and discuss the prognostic indicators in the treatment of MM with LEN.	[Kuroda, Junya; Kobayashi, Tsutomu; Taniwaki, Masafumi] Kyoto Prefectural Univ Med, Div Hematol & Oncol, Dept Med, Kamigyo Ku, Kyoto 6028566, Japan	Kuroda, J (reprint author), Kyoto Prefectural Univ Med, Div Hematol & Oncol, Dept Med, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	junkuro@koto.kpu-m.ac.jp			National Cancer Center Research and Development Fund of Japan [23-A-17]; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by Grants-in-Aid for Scientific Research from the National Cancer Center Research and Development Fund of Japan (23-A-17), and the Ministry of Education, Culture, Sports, Science and Technology of Japan (J Kuroda, M Taniwaki). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Alejandre ME, 2010, CLIN CHEM LAB MED, V48, P727, DOI 10.1515/CCLM.2010.050; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Alegre A, 2011, INT J HEMATOL, V93, P351, DOI 10.1007/s12185-011-0785-z; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; Lopez-Girona A, 2011, BRIT J HAEMATOL, V154, P325, DOI 10.1111/j.1365-2141.2011.08689.x; Walker BA, 2014, LEUKEMIA, V28, P384, DOI 10.1038/leu.2013.199; Moreau P, 2014, J CLIN ONCOL, V32, P2173, DOI 10.1200/JCO.2013.53.0329; Gorgun G, 2010, BLOOD, V116, P3227, DOI 10.1182/blood-2010-04-279893; Decaux O, 2008, J CLIN ONCOL, V26, P4798, DOI 10.1200/JCO.2007.13.8545; Stadtmauer EA, 2009, EUR J HAEMATOL, V82, P426, DOI 10.1111/j.1600-0609.2009.01257.x; Abe M, 2011, INT J HEMATOL, V94, P334, DOI 10.1007/s12185-011-0949-x; Kapoor P, 2009, BLOOD, V114, P518, DOI 10.1182/blood-2009-01-202010; Gorgun GT, 2013, BLOOD, V121, P2975, DOI 10.1182/blood-2012-08-448548; Richardson PG, 2002, BLOOD, V100, P3063, DOI 10.1182/blood-2002-03-0996; Ronchetti D, 2001, ONCOGENE, V20, P3553, DOI 10.1038/sj.onc.1204465; Wu L, 2008, CLIN CANCER RES, V14, P4650, DOI 10.1158/1078-0432.CCR-07-4405; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063; Chesi M, 2013, INT J HEMATOL, V97, P313, DOI 10.1007/s12185-013-1291-2; Mateos MV, 2010, J CLIN ONCOL, V28, P2259, DOI 10.1200/JCO.2009.26.0638; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Avet-Loiseau H, 2013, J CLIN ONCOL, V31, P2806, DOI 10.1200/JCO.2012.46.2598; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; De Luisi A, 2011, CLIN CANCER RES, V17, P1935, DOI 10.1158/1078-0432.CCR-10-2381; Mahindra A, 2010, BLOOD REV, V24, pS5, DOI 10.1016/S0268-960X(10)70003-5; Harada T, 2013, INT J HEMATOL, V97, P743, DOI 10.1007/s12185-013-1321-0; Lode L, 2010, HAEMATOL-HEMATOL J, V95, P1973, DOI 10.3324/haematol.2010.023697; Escoubet-Lozach L, 2009, CANCER RES, V69, P7347, DOI 10.1158/0008-5472.CAN-08-4898; Mateos MV, 2013, NEW ENGL J MED, V369, P438, DOI 10.1056/NEJMoa1300439; Shimura Y, 2012, MOL CANCER THER, V11, P2600, DOI 10.1158/1535-7163.MCT-12-0605; Kleber M, 2013, CL LYMPH MYELOM LEUK, V13, P541, DOI 10.1016/j.clml.2013.03.013; Huang SY, 2014, ANN HEMATOL, V93, P1371, DOI 10.1007/s00277-014-2063-7; Hideshima T, 2001, ONCOGENE, V20, P4519, DOI 10.1038/sj.onc.1204623; Benson DM, 2010, BLOOD, V116, P2286, DOI 10.1182/blood-2010-02-271874; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Attal M, 2012, NEW ENGL J MED, V366, P1782, DOI 10.1056/NEJMoa1114138; Chang H, 2010, LEUKEMIA LYMPHOMA, V51, P2084, DOI 10.3109/10428194.2010.524325; Avet-Loiseau H, 2010, LEUKEMIA, V24, P623, DOI 10.1038/leu.2009.273; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Klein B, 2003, INT J HEMATOL, V78, P106, DOI 10.1007/BF02983377; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Christiansen A, 2013, CANCER LETT, V331, P18, DOI 10.1016/j.canlet.2012.12.013; Tan D, 2013, LEUKEMIA RES, V37, P1070, DOI 10.1016/j.leukres.2013.06.008; Marriott JB, 2002, CLIN EXP IMMUNOL, V130, P75, DOI 10.1046/j.1365-2249.2002.01954.x; Mitsiades N, 2002, BLOOD, V99, P4525, DOI 10.1182/blood.V99.12.4525; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Chan AC, 2014, CLIN EXP IMMUNOL, V175, P49, DOI 10.1111/cei.12196; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Klein U, 2011, CANCER-AM CANCER SOC, V117, P2136, DOI 10.1002/cncr.25775; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Srivastava G, 2013, LEUKEMIA, V27, P2062, DOI 10.1038/leu.2013.143; Breitkreutz I, 2008, LEUKEMIA, V22, P1925, DOI 10.1038/leu.2008.174; Heintel D, 2013, BRIT J HAEMATOL, V161, P695, DOI 10.1111/bjh.12338; Li SR, 2011, BLOOD, V117, P5157, DOI 10.1182/blood-2010-10-314278; Reddy N, 2008, BRIT J HAEMATOL, V140, P36, DOI 10.1111/j.1365-2141.2007.06841.x; Zhu YX, 2013, LEUKEMIA LYMPHOMA, V54, P683, DOI 10.3109/10428194.2012.728597; McCarthy PL, 2012, NEW ENGL J MED, V366, P1770, DOI 10.1056/NEJMoa1114083; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Walker BA, 2012, BLOOD, V120, P1077, DOI 10.1182/blood-2012-03-412981; Munshi NC, 2011, BLOOD, V117, P4696, DOI 10.1182/blood-2010-10-300970; Abdi J, 2013, ONCOTARGET, V4, P2186; Jacobus SJ, 2011, BRIT J HAEMATOL, V155, P340, DOI 10.1111/j.1365-2141.2011.08849.x; Burington B, 2008, CLIN CANCER RES, V14, P4821, DOI 10.1158/1078-0432.CCR-07-4568; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P233, DOI 10.1111/bjh.12622; Boyd KD, 2011, GENE CHROMOSOME CANC, V50, P765, DOI 10.1002/gcc.20899; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Schafer PH, 2003, J PHARMACOL EXP THER, V305, P1222, DOI 10.1124/jpet.102.048496; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Galustian C, 2009, CANCER IMMUNOL IMMUN, V58, P1033, DOI 10.1007/s00262-008-0620-4; Gandhi AK, 2010, CURR CANCER DRUG TAR, V10, P155; Tai YT, 2005, CANCER RES, V65, P11712, DOI 10.1158/0008-5472.CAN-05-1657; Reece D, 2009, BLOOD, V114, P522, DOI 10.1182/blood-2008-12-193458; Chang DH, 2006, BLOOD, V108, P618, DOI 10.1182/blood-2005-10-4184; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Chang XB, 2014, ACTA BIOCH BIOPH SIN, V46, P240, DOI 10.1093/abbs/gmt142; Henry JY, 2013, IMMUNOLOGY, V139, P377, DOI 10.1111/imm.12087; Busch A, 2014, CLIN EXP IMMUNOL, V177, P439, DOI 10.1111/cei.12343; Wang M, 2008, BLOOD, V112, P4445, DOI 10.1182/blood-2008-02-141614; Paiva B, 2012, BLOOD, V119, P687, DOI 10.1182/blood-2011-07-370460; Lonial S, 2012, J CLIN ONCOL, V30, P1953, DOI 10.1200/JCO.2011.37.2649; Egan JB, 2012, BLOOD, V120, P1060, DOI 10.1182/blood-2012-01-405977; Dewald GW, 2005, BLOOD, V106, P3553, DOI 10.1182/blood-2005-05-1981; Manier S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/157496; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Katodritou E, 2014, ANN HEMATOL, V93, P129, DOI 10.1007/s00277-013-1841-y; Kumar SK, 2011, BLOOD, V118, P4359, DOI 10.1182/blood-2011-03-342089; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Richardson PG, 2014, BLOOD, V123, P1826, DOI 10.1182/blood-2013-11-538835; LeBlanc R, 2004, BLOOD, V103, P1787, DOI 10.1182/blood-2003-02-0361; Khagi Y, 2014, ONCOTARGETS THER, V7, P1095, DOI 10.2147/OTT.S49480; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Boyle EM, 2014, HAEMATOLOGICA, V99, P605, DOI 10.3324/haematol.2013.097907; Buckle CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041127; Chang H, 2007, BRIT J HAEMATOL, V138, P324, DOI 10.1111/j.1365-2141.2007.06649.x; Chen MH, 2012, AM J CLIN PATHOL, V137, P208, DOI 10.1309/AJCPHC85DGAXZDBE; Cibeira MT, 2008, CYTOKINE, V41, P244, DOI 10.1016/j.cyto.2007.11.017; Davies F, 2010, BLOOD REV, V24, pS13, DOI 10.1016/S0268-960X(10)70004-7; Dimopoulos MA, 2010, LEUKEMIA, V24, P1769, DOI 10.1038/leu.2010.175; Dredge K, 2002, BRIT J CANCER, V87, P1166, DOI 10.1038/sj.bjc.6600607; Dredge K, 2002, J IMMUNOL, V168, P4914; Fonseca R, 2001, BLOOD, V98, P1271, DOI 10.1182/blood.V98.4.1271; Guglielmelli T, 2011, EUR J CANCER, V47, P814, DOI 10.1016/j.ejca.2010.12.026; Gupta R, 2011, LEUKEMIA RES, V35, P874, DOI 10.1016/j.leukres.2010.11.010; Karadag A, 2000, BRIT J HAEMATOL, V108, P383; Kim K, 2014, ANN HEMATOL, V93, P113, DOI 10.1007/s00277-013-1893-z; Kiyota M, 2012, INT J HEMATOL, V95, P516, DOI 10.1007/s12185-012-1035-8; Kleber M, 2012, CL LYMPH MYELOM LEUK, V12, P38, DOI 10.1016/j.clml.2011.09.216; Kobayashi T, 2015, INT J HEMATOL, V101, P37, DOI 10.1007/s12185-014-1696-6; Kuroda J, 2013, EXPERT REV ANTICANC, V13, P1081, DOI 10.1586/14737140.2013.829641; Lendvai N, 2014, BLOOD, V124, P899, DOI 10.1182/blood-2014-02-556308; Maltezas D, 2013, HEMATOL ONCOL, V31, P356, DOI 10.1002/hon.2026; Mark T, 2008, BRIT J HAEMATOL, V143, P654, DOI 10.1111/j.1365-2141.2008.07374.x; Mateos MV, 2014, BLOOD, V124, P178; Raja KRM, 2012, LEUKEMIA LYMPHOMA, V53, P1406, DOI 10.3109/10428194.2011.652106; Muthu Raja KR, 2011, KLIN ONKOL S, V24, pS30; Richardson PG, 2014, BLOOD, V124, P1038, DOI 10.1182/blood-2014-01-548826; Terpos E, 2009, EXPERT OPIN BIOL TH, V9, P465, DOI [10.1517/14712590902845610 , 10.1517/14712590902845610]; Thomas X, 1998, LEUKEMIA LYMPHOMA, V32, P107; Wang JH, 2014, BLOOD, V124, P555, DOI [10.1182/blood-2014-03-562439, 10.1182/blood-2014-03562439]; Zamarin D, 2013, LEUKEMIA, V27, P2422, DOI 10.1038/leu.2013.126; Zhu YX, 2014, BLOOD, V124, P536, DOI 10.1182/blood-2014-02-557819; Zhu YX, 2015, BLOOD, V125, P483, DOI 10.1182/blood-2014-05-577130	123	0	0	EXPERT REVIEWS	LONDON	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND	1473-7140	1744-8328		EXPERT REV ANTICANC	Expert Rev. Anticancer Ther	JUL	2015	15	7					787	804		10.1586/14737140.2015.1044249		18	Oncology	Oncology	CL3UF	WOS:000356875400007		
J	Toh-e, A; Ohkusu, M; Li, HM; Shimizu, K; Takahashi-Nakaguchi, A; Gonoi, T; Kawamoto, S; Kanesaki, Y; Yoshikawa, H; Nishizawa, M				Toh-e, Akio; Ohkusu, Misako; Li, Hao-Man; Shimizu, Kiminori; Takahashi-Nakaguchi, Azusa; Gonoi, Toru; Kawamoto, Susumu; Kanesaki, Yu; Yoshikawa, Hirofumi; Nishizawa, Masafumi			Identification of genes involved in the phosphate metabolism in Cryptococcus neoformans	FUNGAL GENETICS AND BIOLOGY			English	Article						CnPHO system; Cryptococcus neoformans; ChIP-seq; PHO-regulatory genes; RNA-seq	CYCLIN-DEPENDENT KINASE; USTILAGO-MAYDIS DEPENDS; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS; FUNCTIONAL-CHARACTERIZATION; INSERTIONAL MUTAGENESIS; VIRULENCE; TRANSFORMATION; PROTEIN; PHO85	Cryptococcus neoformans is a pathogenic basidiomycetous yeast that can cause life-threatening meningoencephalitis in immuno-compromized patients. To propagate in the human body, this organism has to acquire phosphate that functions in cellular signaling pathways and is also an essential component of nucleic acids and phospholipids. Thus it is reasonable to assume that C. neoformans (Cn) possesses a phosphate regulatory system (PHO system) analogous to that of other fungi. By BLAST searches using the amino acid sequences of the components of the PHO system of Saccharomyces cerevisiae (Sc), we found potential counterparts to ScPHO genes in C. neoformans, namely, acid phosphatase (CnPHO2), the cyclin-dependent protein kinase (CDK) inhibitor (CnPHO81), Pho85-cyclin (CnPHO80), and CDK (CnPHO85). Disruption of each candidate gene, except CnPHO85, followed by phenotypic analysis, identified most of the basic components of the CnPHO system. We found that CnPHO85 was essential for the growth of C neoformans, having regulatory function in the CnPHO system. Genetic screening and ChIP analysis, showed that CnPHO4 encodes a transcription factor that binds to the CnPHO genes in a Pi-dependent manner. By RNA-seq analysis of the wild-type and the regulatory mutants of the CnPHO system, we found C neoformans genes whose expression is controlled by the regulators of the CnPHO system. Thus the CnPHO system shares many properties with the ScPHO system, but expression of those CnPHO genes that encode regulators is controlled by phosphate starvation, which is not the case in the ScPHO system (except ScPHO81). We also could identify some genes involved in the stress response of the pathogenic yeast, but CnPho4 appeared to be responsible only for phosphate starvation. (C) 2015 Elsevier Inc. All rights reserved.	[Toh-e, Akio; Ohkusu, Misako; Li, Hao-Man; Shimizu, Kiminori; Takahashi-Nakaguchi, Azusa; Gonoi, Toru; Kawamoto, Susumu] Chiba Univ, Med Mycol Res Ctr, Chiba, Chiba 2608673, Japan; [Kanesaki, Yu; Yoshikawa, Hirofumi] Tokyo Univ Agr, NODAI Genome Res Ctr, Setagaya Ku, Tokyo 1568502, Japan; [Yoshikawa, Hirofumi] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan; [Nishizawa, Masafumi] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan	Toh-e, A (reprint author), Chiba Univ, Med Mycol Res Ctr, Chiba, Chiba 2608673, Japan.	toh-e@faculty.chiba-u.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Genome Research for BioResource; NODAI Genome Research Center; Tokyo University of Agriculture	We thank J. Tkacz for reading of the manuscript. A part of this work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan to AT. ChIP-seq analysis was carried out by Cooperative Research Grant of the Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture.	Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; Castillo-Lluva S, 2007, J CELL SCI, V120, P1584, DOI 10.1242/jcs.005314; Goins CL, 2006, FUNGAL GENET BIOL, V43, P531, DOI 10.1016/j.fgb.2006.02.007; Shimizu K, 2014, FUNGAL GENET BIOL, V69, P13, DOI 10.1016/j.fgb.2014.05.007; Kronstad JW, 2011, NAT REV MICROBIOL, V9, P193, DOI 10.1038/nrmicro2522; Mohapatra NP, 2010, J IMMUNOL, V184, P5141, DOI 10.4049/jimmunol.0903413; OCHMAN H, 1988, GENETICS, V120, P621; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Kretschmer M, 2014, INFECT IMMUN, V82, P2697, DOI 10.1128/IAI.01607-14; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Idnurm A, 2004, EUKARYOT CELL, V3, P420, DOI 10.1128/EC.3.2.420-429.2004; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; McClelland CA, 2005, FUNGAL GENET BIOL, V42, P904, DOI 10.1016/j.fgb.2005.07.003; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; BACA OG, 1993, INFECT IMMUN, V61, P4232; Bussink HJ, 1998, EMBO J, V17, P3990, DOI 10.1093/emboj/17.14.3990; Chen LC, 1997, INFECT IMMUN, V65, P2599; Collopy I, 2006, FEMS YEAST RES, V6, P1010, DOI 10.1111/j.1567-1364.2006.00105.x; de Gouvea PF, 2008, FUNGAL GENET BIOL, V45, P1135, DOI 10.1016/j.fgb.2008.04.001; Dou XW, 2003, GENETICS, V165, P1105; Flor-Parra I, 2007, PLANT CELL, V19, P3280, DOI 10.1105/tpc.107.052738; Fu J, 2006, FUNGAL GENET BIOL, V43, P200, DOI 10.1016/j.fgb.2005.09.007; KANG S, 1993, GENETICS, V133, P193; Lenburg ME, 2001, GENETICS, V157, P39; Lev S, 2014, MBIO, V5, DOI 10.1128/mBio.01649-14; Meimoun A, 2000, MOL BIOL CELL, V11, P915; Nishizawa M, 1998, MOL BIOL CELL, V9, P2393; Nishizawa M, 2008, EUKARYOT CELL, V7, P949, DOI 10.1128/EC.00366-07; Nishizawa M., 2015, YEAST, V32; TANAKA K, 1990, MOL CELL BIOL, V10, P4303; TOHE A, 1973, J BACTERIOL, V113, P727; VANDERWALT JP, 1976, A VAN LEEUW J MICROB, V42, P157; Virtudazo EV, 2010, FEMS YEAST RES, V10, P605, DOI 10.1111/j.1567-1364.2010.00633.x; WHITE CW, 1985, J BACTERIOL, V161, P1231; Wu DL, 2004, J BIOL CHEM, V279, P37693, DOI 10.1074/jbc.M403853200	36	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1087-1845	1096-0937		FUNGAL GENET BIOL	Fungal Genet. Biol.	JUL	2015	80						19	30		10.1016/j.fgb.2015.04.019		12	Genetics & Heredity; Mycology	Genetics & Heredity; Mycology	CL4EU	WOS:000356906200003		
J	Iwamuro, M; Tsuzuki, T; Otsuka, F				Iwamuro, Masaya; Tsuzuki, Takao; Otsuka, Fumio			A Rare Cause of Esophageal Ulcers	GASTROENTEROLOGY			English	Editorial Material									[Iwamuro, Masaya; Tsuzuki, Takao; Otsuka, Fumio] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Okayama 7008530, Japan; [Iwamuro, Masaya; Tsuzuki, Takao] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008530, Japan	Iwamuro, M (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Okayama 7008530, Japan.						Rosolowski M, 2013, PRZ GASTROENTEROL, V8, P333, DOI 10.5114/pg.2013.39914; Kim SJ, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-86; Yen Hsu-Heng, 2010, Clin Gastroenterol Hepatol, V8, pe35, DOI 10.1016/j.cgh.2009.10.004	3	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	JUL	2015	149	1					31	32		10.1053/j.gastro.2015.02.016		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL0DW	WOS:000356610400016		
J	Hart, PA; Zen, Y; Chari, ST				Hart, Phil A.; Zen, Yoh; Chari, Suresh T.			Recent Advances in Autoimmune Pancreatitis	GASTROENTEROLOGY			English	Review						Lymphoplasmacytic Sclerosing Pancreatitis; Idiopathic Duct-Centric Chronic Pancreatitis; IgG4-Related Disease; Rituximab	IMMUNOGLOBULIN G4-ASSOCIATED CHOLANGITIS; PRIMARY SCLEROSING CHOLANGITIS; IDIOPATHIC CHRONIC-PANCREATITIS; REGULATORY T-CELLS; DUAL-PHASE CT; IGG4-RELATED DISEASE; DIAGNOSTIC-CRITERIA; SERUM IGG4; CORTICOSTEROID TREATMENT; CARBONIC-ANHYDRASE	Autoimmune pancreatitis (AIP) is a form of chronic pancreatitis that is characterized clinically by frequent presentation with obstructive jaundice, histologically by a dense lymphoplasmacytic infiltrate with fibrosis, and therapeutically by a dramatic response to corticosteroid therapy. Two distinct diseases, type 1 and type 2 AIP, share these features. However, these 2 diseases have unique pancreatic histopathologic patterns and differ significantly in their demographic profiles, clinical presentation, and natural history. Recognizing the popular and long-standing association of the term "AIP" with what is now called "type 1 AIP," we suggest using "AIP" solely for type 1 AIP and to acknowledge its own distinct disease status by using "idiopathic duct-centric chronic pancreatitis" (IDCP) for type 2 AIP. AIP is the pancreatic manifestation of immunoglobulin G4-related disease (IgG4-RD). The etiopathogenesis of AIP and IgG4-RD is largely unknown. However, the remarkable effectiveness of B-cell depletion therapy with rituximab in patients with AIP and IgG4-RD highlights the crucial role of B cells in its pathogenesis. IDCP is less commonly recognized, and little is known about its pathogenesis. IDCP has no biomarker but is associated with inflammatory bowel disease in similar to 25% of patients. Recently, the international consensus diagnostic criteria for AIP identified combinations of features that are diagnostic of both diseases. Both AIP and IDCP are corticosteroid responsive; however, relapses are common in AIP and rare in IDCP. Therefore, maintenance therapy with either an immunomodulator (eg, azathioprine, 6-mercaptopurine, or mycophenolate mofetil) or rituximab is often necessary for patients with AIP. Long-term survival is excellent for both patients with AIP and patients with IDCP.	[Hart, Phil A.] Ohio State Univ, Wexner Med Ctr, Div Gastroenterol Hepatol & Nutr, Columbus, OH 43210 USA; [Zen, Yoh] Kobe Univ, Dept Diagnost Pathol, Kobe, Hyogo 657, Japan; [Chari, Suresh T.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Chari, ST (reprint author), Mayo Clin, Div Gastroenterol & Hepatol, 200 First St Southwest, Rochester, MN 55905 USA.	chari.suresh@mayo.edu					Algul H, 2012, GASTROENTEROLOGY, V143, P1147, DOI 10.1053/j.gastro.2012.09.018; Kamisawa T, 2009, GUT, V58, P1504, DOI 10.1136/gut.2008.172908; Zen Y, 2013, J HEPATOL, V59, P1059, DOI 10.1016/j.jhep.2013.06.016; Okazaki K, 2006, J GASTROENTEROL, V41, P626, DOI 10.1007/s00535-006-1868-0; Miyoshi H, 2008, PANCREAS, V36, P133, DOI 10.1097/MPA.0b013e3181577553; Soler D, 2006, J IMMUNOL, V177, P6940; Carruthers MN, 2015, ANN RHEUM DIS, V74, P1171, DOI 10.1136/annrheumdis-2014-206605; Watanabe T, 2013, J GASTROENTEROL, V48, P247, DOI 10.1007/s00535-012-0626-8; Bjornsson E, 2011, AM J THER, V18, P198, DOI 10.1097/MJT.0b013e3181c9dac6; Raina A, 2009, AM J GASTROENTEROL, V104, P2295, DOI 10.1038/ajg.2009.325; Guarneri F, 2005, J CELL MOL MED, V9, P741, DOI 10.1111/j.1582-4934.2005.tb00506.x; Watanabe T, 2012, ARTHRITIS RHEUM-US, V64, P914, DOI 10.1002/art.33386; Mattoo H, 2014, J ALLERGY CLIN IMMUN, V134, P679, DOI 10.1016/j.jaci.2014.03.034; Zamboni G, 2004, VIRCHOWS ARCH, V445, P552, DOI 10.1007/s00428-004-1140-z; KAWAGUCHI K, 1991, HUM PATHOL, V22, P387, DOI 10.1016/0046-8177(91)90087-6; Yamamoto M, 2005, RHEUMATOLOGY, V44, P227, DOI 10.1093/rheumatology/keh447; Takahashi N, 2009, AM J ROENTGENOL, V193, P479, DOI 10.2214/AJR.08.1883; Ettinger R, 2008, ANN RHEUM DIS, V67, P83, DOI 10.1136/ard.2008.098400; Khosroshahi A, 2012, MEDICINE, V91, P57, DOI 10.1097/MD.0b013e3182431ef6; Okazaki K, 2008, J GASTROENTEROL, V43, P409, DOI 10.1007/s00535-008-2190-9; Bodily KD, 2009, AM J ROENTGENOL, V192, P431, DOI 10.2214/AJR.07.2956; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Mendes FD, 2006, AM J GASTROENTEROL, V101, P2070, DOI 10.1111/j.1572-0241.2006.00772.x; Otsuki M, 2008, J GASTROENTEROL, V43, P403, DOI 10.1007/s00535-008-2205-6; ITOH Y, 1992, ARTHRITIS RHEUM, V35, P73, DOI 10.1002/art.1780350112; Kamisawa T, 2011, PANCREAS, V40, P809, DOI 10.1097/MPA.0b013e3182258a15; Ko SBH, 2010, GASTROENTEROLOGY, V138, P1988, DOI 10.1053/j.gastro.2010.01.001; Akitake R, 2010, GUT, V59, P542, DOI 10.1136/gut.2009.200972; Kamisawa T, 2010, J GASTROENTEROL, V45, P471, DOI 10.1007/s00535-010-0221-9; Ghazale A, 2007, AM J GASTROENTEROL, V102, P1646, DOI 10.1111/j.1572-0241.2007.01264.x; Umemura T, 2006, GUT, V55, P1367, DOI 10.1136/gut.2006.095059; Moon SH, 2008, GUT, V57, P1704, DOI 10.1136/gut.2008.150979; Topazian M, 2008, CLIN GASTROENTEROL H, V6, P364, DOI 10.1016/j.cgh.2007.12.020; Chang MC, 2014, J GASTROEN HEPATOL, V29, P2038, DOI 10.1111/jgh.12649; Sandanayake NS, 2009, CLIN GASTROENTEROL H, V7, P1089, DOI 10.1016/j.cgh.2009.03.021; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Chari ST, 2010, PANCREAS, V39, P549, DOI 10.1097/MPA.0b013e3181e4d9e5; Ghazale A, 2007, GUT, V56, P1650, DOI 10.1136/gut.2007.129833; Muller T, 2013, GASTROENTEROLOGY, V144, P1116, DOI 10.1053/j.gastro.2013.01.055; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Chari ST, 2009, CLIN GASTROENTEROL H, V7, P1097, DOI 10.1016/j.cgh.2009.04.020; Park DH, 2008, GASTROENTEROLOGY, V134, P440, DOI 10.1053/j.gastro.2007.11.023; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Kusuda T, 2011, PANCREAS, V40, P1120, DOI 10.1097/MPA.0b013e31821fc796; Zen Y, 2010, AM J SURG PATHOL, V34, P1812, DOI 10.1097/PAS.0b013e3181f7266b; Chari ST, 2006, CLIN GASTROENTEROL H, V4, P1010, DOI 10.1016/j.cgh.2006.05.017; Chang MC, 2007, CLIN CHEM, V53, P1700, DOI 10.1373/clinchem.2007.085951; Shiokawa M, 2013, AM J GASTROENTEROL, V108, P610, DOI 10.1038/ajg.2012.465; Jeannin P, 1998, J IMMUNOL, V160, P3555; Nirula A, 2011, CURR OPIN RHEUMATOL, V23, P119, DOI 10.1097/BOR.0b013e3283412fd4; Schwaiger T, 2014, GUT, V63, P494, DOI 10.1136/gutjnl-2012-303635; Kamisawa T, 2009, EUR J GASTROEN HEPAT, V21, P1136, DOI 10.1097/MEG.0b013e3283297417; Oseini AM, 2011, HEPATOLOGY, V54, P940, DOI 10.1002/hep.24487; Cornell LD, 2012, CURR OPIN NEPHROL HY, V21, P279, DOI 10.1097/MNH.0b013e32835265ac; Raina A, 2008, ARCH PATHOL LAB MED, V132, P48, DOI 10.1043/1543-2165(2008)132[48:SIGFLI]2.0.CO;2; Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Wenniger LJMD, 2013, HEPATOLOGY, V57, P2390, DOI 10.1002/hep.26232; Umemura T, 2008, AM J GASTROENTEROL, V103, P588, DOI 10.1111/j.1572-0241.2007.01750.x; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Lohr JM, 2010, AM J GASTROENTEROL, V105, P2060, DOI 10.1038/ajg.2010.141; Notohara K, 2003, AM J SURG PATHOL, V27, P1119, DOI 10.1097/00000478-200308000-00009; Ectors N, 1997, GUT, V41, P263; Sah RP, 2010, GASTROENTEROLOGY, V139, P140, DOI 10.1053/j.gastro.2010.03.054; Hart PA, 2014, PANCREAS, V43, P417, DOI 10.1097/MPA.0000000000000053; Zhang LZ, 2011, PANCREAS, V40, P1172, DOI 10.1097/MPA.0b013e318233bec5; Detlefsen S, 2012, PANCREATOLOGY, V12, P276, DOI 10.1016/j.pan.2012.03.055; Kawa S, 2002, GASTROENTEROLOGY, V122, P1264, DOI 10.1053/gast.2002.33022; AALBERSE RC, 1983, J IMMUNOL, V130, P722; Huggett MT, 2014, AM J GASTROENTEROL, V109, P1675, DOI 10.1038/ajg.2014.223; Yamamoto M, 2012, MOD RHEUMATOL, V22, P414, DOI 10.1007/s10165-011-0520-x; Ghazale A, 2008, GASTROENTEROLOGY, V134, P706, DOI 10.1053/j.gastro.2007.12.009; Takahashi N, 2008, AM J ROENTGENOL, V190, P280, DOI 10.2214/AJR.07.2309; Hart PA, 2013, GUT, V62, P1607, DOI 10.1136/gutjnl-2012-302886; Boonstra K, 2014, HEPATOLOGY, V59, P1954, DOI 10.1002/hep.26977; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; Pearson RK, 2003, PANCREAS, V27, P1, DOI 10.1097/00006676-200307000-00001; Sugumar A, 2011, GUT, V60, P666, DOI 10.1136/gut.2010.207951; Mahajan VS, 2014, ANNU REV PATHOL-MECH, V9, P315, DOI 10.1146/annurev-pathol-012513-104708; Buijs J, 2014, PANCREAS, V43, P261, DOI 10.1097/MPA.0000000000000044; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Maehara T, 2012, ANN RHEUM DIS, V71, P2011, DOI 10.1136/annrheumdis-2012-201477; Hirano K, 2007, GUT, V56, P1719, DOI 10.1136/gut.2006.115246; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Aparisi L, 2005, GUT, V54, P703, DOI 10.1136/gut.2004.047142; Deshpande V, 2006, AM J SURG PATHOL, V30, P1537, DOI 10.1097/01.pas.0000213331.09864.2c; Kwon S, 2007, PANCREAS, V34, P279, DOI 10.1097/MPA.0b013e31802eff5f; Chandan VS, 2008, AM J SURG PATHOL, V32, P1762, DOI 10.1097/PAS.0b013e318181f9ca; Wenniger LJMD, 2014, HEPATOLOGY, V60, P1453, DOI 10.1002/hep.26999; Detlefsen S, 2010, HISTOPATHOLOGY, V57, P825, DOI 10.1111/j.1365-2559.2010.03717.x; Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society, 2002, J JPN PANCREAS SOC, V17, P585; Hart PA, 2015, MODERN PATHOL, V28, P238, DOI 10.1038/modpathol.2014.91; Hirano K, 2014, INTERNAL MED, V53, P171, DOI 10.2169/internalmedicine.53.1342; Hirano K, 2013, PANCREAS, V42, P502, DOI 10.1097/MPA.0b013e31826b3984; Kloppel G, 2010, J GASTROENTEROL, V45, P787, DOI 10.1007/s00535-010-0265-x; Maire F, 2014, PANCREATOLOGY, V14, P284, DOI 10.1016/j.pan.2014.05.793; Masuda A, 2014, PANCREATOLOGY, V14, P361, DOI 10.1016/j.pan.2014.07.005; Muraki T, 2006, PANCREAS, V32, P16, DOI 10.1097/01.mpa.0000188308.75043.e4; Ngwa TN, 2014, PANCREAS, V43, P704, DOI 10.1097/MPA.0000000000000118; ROCK B, 1989, NEW ENGL J MED, V320, P1463, DOI 10.1056/NEJM198906013202206; Ryu JK, 2008, PANCREAS, V37, P377, DOI 10.1097/MPA.0b013e31817a0914; Sah RP, 2010, AM J GASTROENTEROL, V105, P2485, DOI 10.1038/ajg.2010.236; Schneider A, 2009, INTERNIST, V50, P318, DOI 10.1007/s00108-008-2262-1; Seleznik GM, 2014, CYTOKINE GROWTH F R, V25, P125, DOI 10.1016/j.cytogfr.2014.01.003; Seleznik GM, 2012, GASTROENTEROLOGY, V143, P1361, DOI 10.1053/j.gastro.2012.07.112; Sumimoto K, 2014, PANCREATOLOGY, V14, P193, DOI 10.1016/j.pan.2014.02.004; Suzuki K, 2010, CLIN RADIOL, V65, P735, DOI 10.1016/j.crad.2010.06.002; Tabeya T, 2014, MOD RHEUMATOL, V24, P953, DOI 10.3109/14397595.2014.882045; Uchida K, 2012, INT J RHEUMATOL, V2012; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Wallace ZS, 2015, ANN RHEUM DIS, V74, P190, DOI 10.1136/annrheumdis-2014-205233; Witzig TE, 2007, MAYO CLIN PROC, V82, P692; Wood N, 2004, CELL IMMUNOL, V231, P133, DOI 10.1016/j.cellimm.2005.01.001; Yamamoto M, 2014, MOD RHEUMATOL, P1; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209; Yun James, 2014, Asia Pac Allergy, V4, P172, DOI 10.5415/apallergy.2014.4.3.172	118	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	JUL	2015	149	1					39	51		10.1053/j.gastro.2015.03.010		13	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL0DW	WOS:000356610400020		
J	Nakanishi, H; Akagi, T; Hangai, M; Kimura, Y; Suda, K; Kumagai, KK; Morooka, S; Ikeda, HO; Yoshimura, N				Nakanishi, Hideo; Akagi, Tadamichi; Hangai, Masanori; Kimura, Yugo; Suda, Kenji; Kumagai, Kyoko Kawashima; Morooka, Satoshi; Ikeda, Hanako Ohashi; Yoshimura, Nagahisa			Sensitivity and specificity for detecting early glaucoma in eyes with high myopia from normative database of macular ganglion cell complex thickness obtained from normal non-myopic or highly myopic Asian eyes	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Glaucoma; High myopia; Ganglion cell complex; Normative database; Sensitivity; Specificity	OPTICAL COHERENCE TOMOGRAPHY; OPEN-ANGLE GLAUCOMA; FIBER LAYER DEFECTS; QUALITY-OF-LIFE; AXIAL LENGTH; DIAGNOSTIC PERFORMANCE; PREPERIMETRIC GLAUCOMA; ASYMMETRY-ANALYSIS; RETINAL-THICKNESS; PARAMETERS	We aimed to determine the sensitivity and specificity of the normative database of non-myopic and highly myopic eyes of the macular ganglion cell complex (mGCC) thickness embedded in the NIDEK RS-3000 spectral-domain optical coherence tomography (SD-OCT) for detecting early glaucoma in highly myopic eyes. Forty-seven highly myopic eyes (axial length a parts per thousand yen26.0 mm) of 47 subjects were studied. The SD-OCT images were used to determine the mGCC thickness within a 9-mm diameter circle centered on the fovea. The sensitivity and specificity of the non-myopic database were compared to that of the highly myopic database for distinguishing the early glaucomatous eyes from the non-glaucomatous eyes. The mGCC scans were classified as abnormal if at least one of the eight sectors of the significance map was < 1 % of the normative thickness. Twenty-one eyes were diagnosed to be non-glaucomatous and 26 eyes to have early glaucoma. . The average mGCC thickness was significantly thinner (80.9 +/- 8.5 mu m) in the early glaucoma group than in the non-glaucomatous group (91.2 +/- 7.5 mu m; p < 1 x 10(-4)). The sensitivity was 96.2 % and specificity was 47.6 % when the non-myopic database was used, and the sensitivity was 92.3 % and the specificity was 90.5 % when the highly myopic database was used. The difference in the specificity was significant (p < 0.01). The significantly higher specificity of the myopic normative database for detecting early glaucoma in highly myopic eyes will lead to fewer false positive diagnoses. The database obtained from highly myopic eyes should be used when evaluating the mGCC thickness of highly myopic eyes.	[Nakanishi, Hideo; Akagi, Tadamichi; Hangai, Masanori; Kimura, Yugo; Suda, Kenji; Kumagai, Kyoko Kawashima; Morooka, Satoshi; Ikeda, Hanako Ohashi; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan; [Hangai, Masanori] Saitama Med Univ, Dept Ophthalmol, Saitama, Japan	Nakanishi, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Shogoin Kawahara Cho 54, Kyoto 6068507, Japan.	hideon@kuhp.kyoto-u.ac.jp			Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This study was partly supported by the Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Anderson DR, 1999, AUTOMATED STATIC PER, P121; Goldberg I, 2009, J GLAUCOMA, V18, P6, DOI 10.1097/IJG.0b013e3181752c83; Kim YJ, 2014, JPN J OPHTHALMOL, V58, P244, DOI 10.1007/s10384-014-0315-7; Kim MJ, 2014, INVEST OPHTH VIS SCI, V55, P2079, DOI 10.1167/iovs.13-13506; Mwanza JC, 2014, OPHTHALMOLOGY, V121, P849, DOI 10.1016/j.ophtha.2013.10.044; Morooka S, 2012, INVEST OPHTH VIS SCI, V53, P4805, DOI 10.1167/iovs.12-9870; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Chong GT, 2012, CURR OPIN OPHTHALMOL, V23, P79, DOI 10.1097/ICU.0b013e32834ff431; Kanamori A, 2013, INVEST OPHTH VIS SCI, V54, P6401, DOI 10.1167/iovs.13-12805; Yamada H, 2014, AM J OPHTHALMOL, V158, P1318, DOI 10.1016/j.ajo.2014.08.040; Knight OJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P312, DOI 10.1001/archopthalmol.2011.1576; Tan Ou, 2009, Ophthalmology, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Shaikh Y, 2014, AM J OPHTHALMOL, V158, P1121, DOI [10.1016/j.ajo.2014.08.023, 10.1016/j.ajo.2014.081023]; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453; Kimura Y, 2012, INVEST OPHTH VIS SCI, V53, P6472, DOI 10.1167/iovs.12-10319; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Kim NR, 2011, BRIT J OPHTHALMOL, V95, P1115, DOI 10.1136/bjo.2010.182493; Mori S, 2010, J GLAUCOMA, V19, P528, DOI 10.1097/IJG.0b013e3181ca7acf; Weinreb RN, 2004, AM J OPHTHALMOL, V138, P458, DOI 10.1016/j.ajo.2004.04.054; Asrani S, 2011, ARCH OPHTHALMOL-CHIC, V129, P1205, DOI 10.1001/archophthalmol.2011.242; Jonas JB, 1997, GRAEF ARCH CLIN EXP, V235, P627, DOI 10.1007/BF00946938; [Anonymous], 2014, 060914 NDB; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Kimura Y, 2013, AM J OPHTHALMOL, V156, P907, DOI 10.1016/j.ajo.2013.06.029; Varma R, 2011, AM J OPHTHALMOL, V152, P515, DOI 10.1016/j.ajo.2011.06.004; Wakitani Y, 2003, RETINA-J RET VIT DIS, V23, P177, DOI 10.1097/00006982-200304000-00007; ARAIE M, 1995, JPN J OPHTHALMOL, V39, P60; Bagga H, 2005, J GLAUCOMA, V14, P358, DOI 10.1097/01.ijg.0000176930.21853.04; CHIHARA E, 1994, GRAEF ARCH CLIN EXP, V232, P265, DOI 10.1007/BF00194475; GROSSNIKLAUS HE, 1992, RETINA-J RET VIT DIS, V12, P127; Hirasawa K, 2013, JPN J OPHTHALMOL, V57, P429, DOI 10.1007/s10384-013-0241-0; Iester M, 2002, EYE, V16, P44, DOI 10.1038/sj/EYE/6700036; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Klein R., 2013, INVEST OPHTH VIS SCI, V54, P5; Mayama C, 2002, OPHTHALMOLOGY, V109, P2072, DOI 10.1016/S0161-6420(02)01175-2; Nakano N, 2013, AM J OPHTHALMOL, V156, P511, DOI 10.1016/j.ajo.2013.04.028; Realini T, 2014, J GLAUCOMA; Rolle Teresa, 2011, Clin Ophthalmol, V5, P961, DOI 10.2147/OPTH.S20249; Shoji T, 2012, GRAEF ARCH CLIN EXP, V250, P1843, DOI 10.1007/s00417-012-1994-8; Takeyama A, 2014, JPN J OPHTHALMOL, V58, P86, DOI 10.1007/s10384-013-0292-2; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Topcon Medical Systems I, 2011, TOPCON 3D OCT SER NO	42	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	JUL	2015	253	7					1143	1152		10.1007/s00417-015-3026-y		10	Ophthalmology	Ophthalmology	CL4TS	WOS:000356948400019		
J	Tanaka, R; Takamoto, M; Komae, K; Ohtomo, K; Fujino, Y; Kaburaki, T				Tanaka, Rie; Takamoto, Mitsuko; Komae, Keiko; Ohtomo, Kazuyoshi; Fujino, Yujiro; Kaburaki, Toshikatsu			Clinical features of psoriatic uveitis in Japanese patients	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Psoriasis; Psoriatic uveitis; Biological therapy; HLA-A2	ARTHRITIS; IRIDOCYCLITIS; ASSOCIATION; EYE	To investigate the clinical features of psoriatic uveitis in Japanese patients. Clinical features of 13 consecutive patients with psoriatic uveitis treated at our facility were retrospectively examined using medical records. In this study, we collected data about psoriasis type, uveitis laterality, onset type, HLA types, visual acuity, ocular inflammation localization, anterior segment findings, funduscopy findings, complications, recurrence, and medical treatments for uveitis and skin diseases. The cohort comprised ten males and three females (43.6 +/- 7.1 years old), and types of psoriasis included psoriasis vulgaris (seven cases), psoriatic arthritis (four cases), pustular psoriasis (three cases) and psoriatic erythroderma (one case). Two cases represented complicated cases of pustular psoriasis and psoriatic arthritis. Seven cases were unilateral, and six cases were bilateral. All cases had acute non-granulomatous anterior uveitis, whereas panuveitis occurred in one case. Furthermore, macular edema and vascular leakage on fluorescein angiography occurred in four cases, and hyperemic disc occurred in two cases. Recurrence occurred in nine cases. In addition to topical corticosteroid treatment, eight cases underwent oral immunosuppressive treatment or biologics. All six cases undergoing HLA typing were HLA-A2 positive. Cases of psoriatic uveitis in Japan appear to present with acute non-granulomatous uveitis; other symptoms may include macular edema, retinal vasculitis, or hyperemic disc.	[Tanaka, Rie; Ohtomo, Kazuyoshi; Kaburaki, Toshikatsu] Tokyo Univ Hosp, Dept Ophthalmol, Bunkyo Ku, Tokyo 1130033, Japan; [Takamoto, Mitsuko] Tokyo Metropolitan Police Hosp, Dept Ophthalmol, Nakano Ku, Tokyo 1648541, Japan; [Komae, Keiko] Kawakita Gen Hosp, Dept Ophthalmol, Suginami Ku, Tokyo 1668588, Japan; [Fujino, Yujiro] Japan Community Hlth Care Org, Tokyo Shinjuku Med Ctr, Dept Ophthalmol, Shinjyuku Ku, Tokyo 1628543, Japan	Tanaka, R (reprint author), Tokyo Univ Hosp, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	rtanaka-ymn@umin.ac.jp					LAMBERT JR, 1976, ANN RHEUM DIS, V35, P354, DOI 10.1136/ard.35.4.354; Paiva ES, 2000, ANN RHEUM DIS, V59, P67, DOI 10.1136/ard.59.1.67; Niccoli L, 2012, INT J RHEUM DIS, V15, P414, DOI 10.1111/j.1756-185X.2012.01736.x; Chandran NS, 2007, J DERMATOL, V34, P805, DOI 10.1111/j.1346-8138.2007.00390.x; Aso K, 1984, HIFU RINSHO, V26, P585; CATSAROUCATSARI A, 1984, ACTA DERM-VENEREOL, V64, P557; GREAVES MW, 1995, NEW ENGL J MED, V332, P581; Iijima S, 1996, DERMATOLOGY, V193, P295; Keino H, 2003, GRAEF ARCH CLIN EXP, V241, P777, DOI 10.1007/s00417-003-0706-9; Nestle FO, 1976, NEW ENGL J MED, V361, P496; Okunuki Y, 2008, JPN J CLIN OPHTHAL, V62, P897; Watanabe Y, 2012, JPN J DERMATOL, V122, P2321	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	JUL	2015	253	7					1175	1180		10.1007/s00417-015-2968-4		6	Ophthalmology	Ophthalmology	CL4TS	WOS:000356948400023		
J	Yokouchi, H; Oshitari, T; Baba, T; Yamamoto, S				Yokouchi, Hirotaka; Oshitari, Toshiyuki; Baba, Takayuki; Yamamoto, Shuichi			Thalidomide reduces choroidal thickness and optic disc edema in a patient with POEMS syndrome	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Letter							ENDOTHELIAL GROWTH-FACTOR; CYSTOID MACULAR EDEMA; VEGF		[Yokouchi, Hirotaka; Oshitari, Toshiyuki; Baba, Takayuki; Yamamoto, Shuichi] Chiba Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Chuo Ku, Chiba 2600856, Japan	Yokouchi, H (reprint author), Chiba Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2600856, Japan.	yokouchi123@peace.ocn.ne.jp					Kaushik M, 2011, OPHTHALMOLOGY, V118, P778, DOI 10.1016/j.ophtha.2010.08.013; Kuwabara S, 2008, J NEUROL NEUROSUR PS, V79, P1255, DOI 10.1136/jnnp.2008.150177; Watanabe O, 1996, LANCET, V347, P702, DOI 10.1016/S0140-6736(96)91261-1; Dispenzieri A, 2007, BLOOD REV, V21, P285, DOI 10.1016/j.blre.2007.07.004; Chong DY, 2007, J NEURO-OPHTHALMOL, V27, P180; Ecsedy M, 2014, OCUL IMMUNOL INFLAMM, V22, P454, DOI 10.3109/09273948.2014.883548; Imai H, 2005, AM J OPHTHALMOL, V139, P563, DOI 10.1016/j.ajo.2004.09.016; Okada K, 2007, JPN J OPHTHALMOL, V51, P237, DOI 10.1007/s10384-006-0428-8	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	JUL	2015	253	7					1195	1198		10.1007/s00417-014-2892-z		4	Ophthalmology	Ophthalmology	CL4TS	WOS:000356948400026		
J	Akbari, S; Ghanbari, M; Ozeki, K				Akbari, S.; Ghanbari, M.; Ozeki, K.			The Chromatic Index of a Claw-Free Graph Whose Core has Maximum Degree	GRAPHS AND COMBINATORICS			English	Article						Edge coloring; Claw-free; Core; Class 1	SUFFICIENT CONDITION; CLASS-1	Let be a graph. The core of , denoted by , is the subgraph of induced by the vertices of degree , where denotes the maximum degree of . A -edge coloring of is a function such that and , for any two adjacent edges and of . The chromatic index of , denoted by , is the minimum number for which has a -edge coloring. A graph is said to be Class if and Class if . Hilton and Zhao conjectured that if is a connected graph, , and is not the Petersen graph with one vertex removed, then is Class if and only if is overfull. In this paper, we prove this conjecture for claw-free graphs of even order.	[Akbari, S.] Sharif Univ Technol, Dept Math Sci, Tehran, Iran; [Akbari, S.; Ghanbari, M.] Inst Res Fundamental Sci, Sch Math, Tehran, Iran; [Ozeki, K.] Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Ozeki, K.] JST, ERATO, Kawarabayashi Large Graph Project, Tokyo, Japan	Akbari, S (reprint author), Sharif Univ Technol, Dept Math Sci, Tehran, Iran.	s_akbari@sharif.edu; marghanbari@gmail.com; ozeki@nii.ac.jp			School of Mathematics, Institute for Research in Fundamental Sciences (IPM); IPM [92050212, 92050014]	The authors are grateful to the referee for useful comments. The first and the second authors are indebted to the School of Mathematics, Institute for Research in Fundamental Sciences (IPM) for support. The research of the first and the second authors were in part supported by a grant from IPM (No. 92050212) and (No. 92050014), respectively.	Akbari S., 2012, ELECTRON J COMB, V19, pP58; Akbari S, 2012, DISCRETE MATH, V312, P2593, DOI 10.1016/j.disc.2011.09.035; CHETWYND AG, 1989, DISCRETE MATH, V75, P103, DOI 10.1016/0012-365X(89)90082-4; Cariolaro D, 2003, ELECTRON J COMB, V10; CHETWYND AG, 1989, J COMB THEORY B, V46, P37, DOI 10.1016/0095-8956(89)90005-1; Dugdale JK, 2000, COMB PROBAB COMPUT, V9, P97, DOI 10.1017/S0963548300004211; Fiorini S., 1977, RES NOTES MATH; FOURNIER J., 1973, CAHIERS CTR ETUDES R, V15, P311; HILTON AJW, 1993, J GRAPH THEOR, V17, P701, DOI 10.1002/jgt.3190170607; HILTON AJW, 1992, DISCRETE MATH, V101, P135, DOI 10.1016/0012-365X(92)90598-A; HILTON AJW, 1989, DISCRETE MATH, V74, P61, DOI 10.1016/0012-365X(89)90198-2; Hilton A.J.W., 1996, JCMCC, V21, P97; HOFFMAN DG, 1995, J GRAPH THEOR, V20, P397, DOI 10.1002/jgt.3190200314; HOLYER I, 1981, SIAM J COMPUT, V10, P718, DOI 10.1137/0210055; Song ZX, 2005, GRAPH COMBINATOR, V21, P239, DOI 10.1007/s00373-005-0610-7; SUMNER DP, 1974, P AM MATH SOC, V42, P8, DOI 10.2307/2039666; Vizing V.G., 1965, DISKRET ANAL, V5, P6; Vizing V.G., 1964, DISKRET ANAL, V3, P25	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	JUL	2015	31	4					805	811		10.1007/s00373-014-1417-1		7	Mathematics	Mathematics	CK8BG	WOS:000356462000001		
J	Zhang, MC; Luo, S; Shigeno, M				Zhang, Mingchao; Luo, Song; Shigeno, Maiko			On the Number of Edges in a Minimum -Saturated Graph	GRAPHS AND COMBINATORICS			English	Article						C-6-saturated graph; Extremal graph; Forbidden graph; Cycle-free	MAXIMALLY NONHAMILTONIAN GRAPHS; C-5-SATURATED GRAPHS; SIZE	A graph is said to be -saturated if it contains no cycles of length but does contain such a cycle after the addition of any edge from the complement of the graph. Determining the minimum size of -saturated graphs is one of the interesting problems on extremal graphs. The exact minimum sizes are known for and , but only general bounds are shown for . This paper deals with bounds of the minimum size when . It is shown that the minimum size of a -saturated graph on vertices is at least and at most . This lower bound improves the best previously known result.	[Zhang, Mingchao; Luo, Song; Shigeno, Maiko] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan	Zhang, MC (reprint author), Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan.	mzhang@sk.tsukuba.ac.jp			MEXT [22510135]	The authors are grateful to Prof. Katsuhiro Ota for his helpful suggestions on this research, and thank Prof. John R. Schmitt for his comments and information about [15]. We are also indebted to the anonymous referees for their detailed and constructive comments. This research is supported in part by the MEXT Grand in Aid for Scientific Research (C) No. 22510135.	Chen YC, 2009, J GRAPH THEOR, V61, P111, DOI 10.1002/jgt.20372; CLARK LH, 1992, GRAPH COMBINATOR, V8, P225, DOI 10.1007/BF02349959; Barefoot CA, 1996, DISCRETE MATH, V150, P31, DOI 10.1016/0012-365X(95)00173-T; Lin XH, 1997, ARS COMBINATORIA, V45, P263; KASZONYI L, 1986, J GRAPH THEOR, V10, P203, DOI 10.1002/jgt.3190100209; Chen YC, 2011, J GRAPH THEOR, V67, P9, DOI 10.1002/jgt.20508; ERDOS P, 1964, AM MATH MON, V71, P1107, DOI 10.2307/2311408; BONDY JA, 1972, CAN MATH BULLETIN, V15, P57, DOI 10.4153/CMB-1972-012-3; Chen Y., 2010, ARXIV10124152; Clark L. H., 1986, C NUMER, V53, P215; Clark L. H., 1983, PERIOD MATH HUNG, V15, P57; Dudek A., 2003, ELECT NOTES DISCRET, V13, P41, DOI 10.1016/S1571-0653(04)00434-2; Dudek A., 2004, Discussiones Mathematicae Graph Theory, V24; Faudree J. R., 2011, ELECTRON J COMB, V18, pDS19; Frick M, 2005, ELECTRON J COMB, V12; Furedi Z., 2011, ELECT NOTES DISCRET, V38, P505; Gould R, 2006, ELECTRON J COMB, V13; Ollmann L.T., 1972, P 3 SE C COMB GRAPH, P367; Tuza Z., 1989, ACTA U CAROLIN MATH, V30, P161	19	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	JUL	2015	31	4					1085	1106		10.1007/s00373-014-1422-4		22	Mathematics	Mathematics	CK8BG	WOS:000356462000021		
J	Miyasaka, A; Oda, K; Ikeda, Y; Sone, K; Fukuda, T; Inaba, K; Makii, C; Enomoto, A; Hosoya, N; Tanikawa, M; Uehara, Y; Arimoto, T; Kuramoto, H; Wada-Hiraike, O; Miyagawa, K; Yano, T; Kawana, K; Osuga, Y; Fujii, T				Miyasaka, Aki; Oda, Katsutoshi; Ikeda, Yuji; Sone, Kenbun; Fukuda, Tomohiko; Inaba, Kanako; Makii, Chinami; Enomoto, Atsushi; Hosoya, Noriko; Tanikawa, Michihiro; Uehara, Yuriko; Arimoto, Takahide; Kuramoto, Hiroyuki; Wada-Hiraike, Osamu; Miyagawa, Kiyoshi; Yano, Tetsu; Kawana, Kei; Osuga, Yutaka; Fujii, Tomoyuki			PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-alpha/VEGF pathway in endometrial cancer	GYNECOLOGIC ONCOLOGY			English	Article						TP53; Phosphatidylinositol 3-kinase; Hypoxia-inducible factor-1 alpha; Radiosensitivity; Endometrial carcinoma	IONIZING-RADIATION; RAPAMYCIN INHIBITOR; ANTITUMOR-ACTIVITY; CARCINOMA-CELLS; RADIOTHERAPY; P53; RADIOSENSITIVITY; SENSITIVITY; GROWTH; ACTIVATION	Radiation therapy is a key therapeutic strategy for endometrial carcinomas. However, biomarkers that predict radiosensitivity and drugs to enhance this sensitivity have not yet been established. We aimed to investigate the roles of TP53 and MAPK/PI3K pathways in endometrial carcinomas and to identify appropriate radiosensitizing therapeutics. D-10 values (the irradiating dose required to reduce a cell population by 90%) were determined in eight endometrial cancer cell lines with known mutational statuses for TP53, PIK3CA, and KRAS. Cells were exposed to ionizing radiation (2-6 Gy) and either a dual PI3K/mTOR inhibitor (NVP-BEZ235) or a MEK inhibitor (UO126), and their radiosensitizing effects were evaluated using clonogenic assays. The effects of silencing hypoxia-inducible factor-1 alpha (HIF-1 alpha) expression with small interfering RNAs (siRNAs) were evaluated following exposure to ionizing radiation (2-3 Gy). D-10 values ranged from 2.0 to 3.1 Gy in three cell lines expressing wild-type TP53 or from 3.3 to more than 6.0 Gy in five cell lines expressing mutant TP53. NVP-BEZ235, but not UO126, significantly improved radiosensitivity through the suppression of HIF-1 alpha/vascular endothelial growth factor-A expression. HIF-1 alpha silencing significantly increased the induction of the sub-G(1) population by ionizing radiation. Our study data suggest that TP53 mutation and PI3K pathway activation enhances radioresistance in endometrial carcinomas and that targeting the PI3K/mTOR or HIF-1 alpha pathways could improve radiosensitivity. (C) 2015 Elsevier Inc. All rights reserved.	[Miyasaka, Aki; Oda, Katsutoshi; Ikeda, Yuji; Sone, Kenbun; Fukuda, Tomohiko; Inaba, Kanako; Makii, Chinami; Tanikawa, Michihiro; Uehara, Yuriko; Arimoto, Takahide; Wada-Hiraike, Osamu; Kawana, Kei; Osuga, Yutaka; Fujii, Tomoyuki] Univ Tokyo, Fac Med, Dept Obstet & Gynaecol, Bunkyo Ku, Tokyo 1138655, Japan; [Enomoto, Atsushi; Hosoya, Noriko; Miyagawa, Kiyoshi] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Lab Mol Radiol, Tokyo 1138655, Japan; [Kuramoto, Hiroyuki] Kanagawa Hlth Serv Assoc, Yokohama, Kanagawa, Japan; [Yano, Tetsu] Natl Ctr Global Hlth & Med, Dept Obstet & Gynaecol, Tokyo, Japan	Oda, K (reprint author), Univ Tokyo, Fac Med, Dept Obstet & Gynaecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	katsutoshi-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23592437, 25861473, 25861471, 25893229, 11114014]	We thank Yoko Matsumoto, Kazunori Nagasaka, Katsuyuki Adachi, Tetsushi Tsuruga, Tomoko Kashiyama, Ayumi Taguchi, Mana Hirano, Kayo Asada, and Reiko Kurikawa for their support and assistance. We also thank Masato Nishida for generously providing the Ishikawa cells. We thank Editage for assistance with English language editing (http://englishediting.editage.com/). This work was financially supported by a Grants-in-Aid for Scientific Research (C), Grant Number 23592437 (to K. Oda), Grants-in-Aid for Young Scientific Research (B), Grant Numbers 25861473 (to Y. Uehara) and 25861471 (to T. Arimoto), and Grant-in-Aid for Research Activity Start-up, grant number 25893229 (to Y. Ikeda) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This study was also supported as a research program by the Project for Development of Innovative Research on Cancer Therapeutics (11114014) (P-Direct), Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T Yano).	Shimura T, 2011, INT J RADIAT ONCOL, V80, P540, DOI 10.1016/j.ijrobp.2010.12.065; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; del Alcazar CRG, 2014, CLIN CANCER RES, V20, P1235, DOI 10.1158/1078-0432.CCR-13-1607; Manegold PC, 2008, CLIN CANCER RES, V14, P892, DOI 10.1158/1078-0432.CCR-07-0955; Chung EJ, 2009, CLIN CANCER RES, V15, P3050, DOI 10.1158/1078-0432.CCR-08-2954; Zhu WJ, 2013, CANCER BIOTHER RADIO, V28, P665, DOI 10.1089/cbr.2012.1443; Ikeda Y, 2013, ONCOL REP, V30, P584, DOI 10.3892/or.2013.2515; Moeller B, 2006, BRIT J CANCER, V95, P1, DOI 10.1038/sj.bjc.6603201; Burke WM, 2014, GYNECOL ONCOL, V134, P393, DOI 10.1016/j.ygyno.2014.06.003; Dent P, 2003, RADIAT RES, V159, P283, DOI 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO;2; Gottschalk AR, 2005, INT J RADIAT ONCOL, V63, P1221, DOI 10.1016/j.ijrobp.2005.08.014; Lin LL, 2005, INT J RADIAT ONCOL, V63, P500, DOI 10.1016/j.ijrobp.2005.02.004; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Fang J, 2007, CELL SIGNAL, V19, P2487, DOI 10.1016/j.cellsig.2007.07.025; Lee CG, 2000, CANCER RES, V60, P5565; McKenna WG, 2003, ONCOGENE, V22, P5866, DOI 10.1038/sj.onc.1206699; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Gorski DH, 1999, CANCER RES, V59, P3374; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Meijer TWH, 2012, CLIN CANCER RES, V18, P5585, DOI 10.1158/1078-0432.CCR-12-0858; Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/008-5472.CAN-05-2620; Qiao L, 2002, CANCER BIOL THER, V1, P168; Criswell T, 2005, J BIOL CHEM, V280, P14212, DOI 10.1074/jbc.M412569200; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Herzog A, 2013, CLIN CANCER RES, V19, P3808, DOI 10.1158/1078-0432.CCR-12-2716; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Lee CM, 2006, CLIN CANCER RES, V12, P250, DOI 10.1158/1078-0432.CCR-05-1084; Ryan AJ, 2005, CELL TISSUE RES, V322, P53, DOI 10.1007/s00441-005-1109-5; Chow JPH, 2013, MOL CANCER THER, V12, P2517, DOI 10.1158/1535-7163.MCT-13-0010; Arvanitis DA, 2002, INT J MOL MED, V10, P55; Bendifallah S, 2015, BRIT J CANCER, V112, P793, DOI 10.1038/bjc.2015.35; BERCHUCK A, 1995, CANCER, V76, P2034, DOI 10.1002/1097-0142(19951115)76:10+<2034::AID-CNCR2820761321>3.0.CO;2-U; Bilbao C, 2010, INT J RADIAT ONCOL, V76, P9, DOI 10.1016/j.ijrobp.2009.09.035; Fujisawa T, 2003, Hum Cell, V16, P47, DOI 10.1111/j.1749-0774.2003.tb00128.x; Gupta AK, 2001, CANCER RES, V61, P4278; Hess C, 2001, BRIT J CANCER, V85, P2010, DOI 10.1054/bjoc.2001.2166; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Karar J, 2009, CANCER BIOL THER, V8, P1994, DOI 10.4161/cbt.8.21.9988; Kashiyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087220; Kim DW, 2006, INT J RADIAT ONCOL, V64, P38, DOI 10.1016/j.ijrobp.2005.02.008; Kuger Sebastian, 2014, Breast Cancer (Auckl), V8, P39, DOI 10.4137/BCBCR.S13693; KURAMOTO H, 1991, ANN NY ACAD SCI, V622, P402, DOI 10.1111/j.1749-6632.1991.tb37884.x; Miyasaka A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-179; Murayama-Hosokawa S, 2010, ONCOGENE, V29, P1897, DOI 10.1038/onc.2009.474; RANTANEN V, 1992, GYNECOL ONCOL, V44, P217, DOI 10.1016/0090-8258(92)90045-K; Rodriguez-Viciana P, 2005, COLD SH Q B, V70, P461, DOI 10.1101/sqb.2005.70.044; Shoji K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037431; SOLBERG TD, 1992, PHYS MED BIOL, V37, P439, DOI 10.1088/0031-9155/37/2/010; Wik E, 2014, GYNECOL ONCOL, V134, P599, DOI 10.1016/j.ygyno.2014.06.026; YAGINUMA Y, 1991, CANCER RES, V51, P6506; Yoshimura M, 2013, BIOMED RES INT, DOI 10.1155/2013/685308	54	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	JUL	2015	138	1					174	180		10.1016/j.ygyno.2015.04.015		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CL3HN	WOS:000356841100028		
J	Matsumoto, F; Fujimaki, M; Ohba, S; Kojima, M; Yokoyama, J; Ikeda, K				Matsumoto, Fumihiko; Fujimaki, Mitsuhisa; Ohba, Shinichi; Kojima, Masataka; Yokoyama, Junkichi; Ikeda, Katsuhisa			Relationship between insulin-like growth factor-1 receptor and human papillomavirus in patients with oropharyngeal cancer	HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK			English	Article						human papillomavirus; oropharyngeal squamous cell carcinoma; insulin-like growth factor-1 receptor; prognosis; head and neck cancer	SQUAMOUS-CELL CARCINOMA; IGF-1R EXPRESSION; PROGNOSTIC-SIGNIFICANCE; THERAPEUTIC TARGET; ANTITUMOR-ACTIVITY; NECK-CANCER; HEAD; SURVIVAL; RADIATION; RADIOTHERAPY	BackgroundHuman papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (SCC) is associated with better prognosis than HPV-negative oropharyngeal SCC. The purpose of this study was to assess the expression of insulin-like growth factor-1 receptor (IGF-1R) in patients with oropharyngeal SCC, its relationship to HPV status and various clinical parameters, and its relationship with clinical outcome. MethodsThe study subjects were 59 patients with oropharyngeal SCC. IGF-1R expression was examined by immunohistochemistry in paraffin-embedded tumor tissues. HPV status was evaluated by in situ hybridization (ISH) in the same tissues. ResultsIGF-1R did not correlate with clinical parameters, but IGF-1R expression was more common in HPV-negative tumors than in HPV-positive tumors. The prognosis was poorer in patients of the IGF-1R-positive group than in the IGF-1R-negative group. ConclusionThe results suggested that IGF-1R expression in oropharyngeal SCC correlated with poor prognosis in HPV-negative patients. Treatment targeting IGF-1R could potentially improve the survival of patients with HPV-negative oropharyngeal SCC. (c) 2014 Wiley Periodicals, Inc. Head Neck 37: 977-981, 2015	[Matsumoto, Fumihiko; Fujimaki, Mitsuhisa; Ohba, Shinichi; Kojima, Masataka; Yokoyama, Junkichi; Ikeda, Katsuhisa] Juntendo Univ, Fac Med, Dept Otorhinolaryngol, Tokyo 1138421, Japan	Matsumoto, F (reprint author), Juntendo Univ, Fac Med, Dept Otorhinolaryngol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	fmatsu@juntendo.ac.jp					Lassen P, 2009, J CLIN ONCOL, V27, P1992, DOI 10.1200/JCO.2008.20.2853; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Fakhry C, 2008, J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Lu D, 2005, J BIOL CHEM, V280, P19665, DOI 10.1074/jbc.M500815200; Barnes CJ, 2007, CLIN CANCER RES, V13, P4291, DOI 10.1158/1078-0432.CCR-06-2040; Williams KJ, 2002, BRIT J CANCER, V86, P1157, DOI 10.1038/sj/bjc/6600182; Turner BC, 1997, CANCER RES, V57, P3079; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Lindel K, 2001, CANCER-AM CANCER SOC, V92, P805, DOI 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Sedaghat AR, 2009, LARYNGOSCOPE, V119, P1542, DOI 10.1002/lary.20533; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Benini S, 2001, CLIN CANCER RES, V7, P1790; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Hirano S, 2004, EUR J GYNAECOL ONCOL, V25, P187; Kalinina T, 2010, INT J CANCER, V127, P1931, DOI 10.1002/ijc.25196; Ang KK, 2012, SEMIN RADIAT ONCOL, V22, P128, DOI 10.1016/j.semradonc.2011.12.004; Ramqvist T, 2011, ANTICANCER RES, V31, P1515; Belinsky MG, 2008, CELL CYCLE, V7, P2949, DOI 10.4161/cc.7.19.6760; Chinnaiyan P, 2006, SEMIN RADIAT ONCOL, V16, P59, DOI 10.1016/j.semradonc.2005.08.008; Kurihara S, 2000, ENDOCR J, V47, P739, DOI 10.1507/endocrj.47.739; Lara PC, 2011, ORAL ONCOL, V47, P615, DOI 10.1016/j.oraloncology.2011.05.005; Lee Chang Youl, 2008, Korean Journal of Internal Medicine, V23, P116, DOI 10.3904/kjim.2008.23.3.116; Lloret M, 2007, GYNECOL ONCOL, V106, P8, DOI 10.1016/j.ygyno.2007.04.004; Park YW, 2005, CLIN CANCER RES, V11, P1963, DOI 10.1158/1078-0432.CCR-04-1665; Reszeć J, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P58; Slomiany MG, 2007, CANCER LETT, V248, P269, DOI 10.1016/j.canlet.2006.08.004; Steinbach JP, 2004, BIOCHEM BIOPH RES CO, V321, P524, DOI 10.1016/j.bbrc.2004.06.175; Sun JM, 2011, ORAL ONCOL, V47, P714, DOI 10.1016/j.oraloncology.2011.06.007; Tanno B, 2006, CLIN CANCER RES, V12, P6772, DOI 10.1158/1078-0432.CCR-06-1479; Taunk NK, 2010, RADIOTHER ONCOL, V96, P204, DOI 10.1016/j.radonc.2010.03.009; Toner M, 2009, Head Neck Pathol, V3, P246, DOI 10.1007/s12105-009-0135-0	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1043-3074	1097-0347		HEAD NECK-J SCI SPEC	Head Neck-J. Sci. Spec. Head Neck	JUL	2015	37	7					977	981		10.1002/hed.23702		5	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	CL2WH	WOS:000356807300010		
J	Takenaka, Y; Cho, H; Nakahara, S; Yamamoto, Y; Yasui, T; Inohara, H				Takenaka, Yukinori; Cho, Hironori; Nakahara, Susumu; Yamamoto, Yoshifumi; Yasui, Toshimichi; Inohara, Hidenori			Chemoradiation therapy for squamous cell carcinoma of the external auditory canal: A meta-analysis	HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK			English	Review						external auditory canal; squamous cell carcinoma; chemoradiation therapy; surgery; complication	TEMPORAL BONE RESECTION; MIDDLE-EAR; INTRAARTERIAL CHEMOTHERAPY; MALIGNANT-TUMORS; ADVANCED HEAD; NECK-CANCER; RADIOTHERAPY; MANAGEMENT; OUTCOMES; CHEMORADIOTHERAPY	BackgroundThe standard treatment for advanced external auditory canal squamous cell carcinoma (SCC) is subtotal temporal bone resection and postoperative radiation therapy (RT), whereas chemoradiation therapy (CRT) is used in some institutions to improve patient prognosis. The purpose of this study was to evaluate the efficacy of CRT in external auditory canal SCC treatment. MethodsMeta-analyses of external auditory canal SCC studies were performed. We extracted 5-year overall survival rates and number of patients for aggregate patient data, and types of treatment and outcomes for individual patient data. ResultsThe 5-year overall survival rate of 752 patients was 57%. In the individual patient data meta-analysis, the 5-year overall survival rates of patients who received surgery RT, preoperative CRT, definitive CRT, and postoperative CRT were 53.5%, 85.7%, 43.6%, and 0%, respectively. ConclusionOur data suggest that preoperative CRT may improve the survival of surgically treated patients with external auditory canal SCC and that definitive CRT may be equivalent to surgical resection. (c) 2014 Wiley Periodicals, Inc. Head Neck 37: 1073-1080, 2015	[Takenaka, Yukinori; Cho, Hironori; Nakahara, Susumu; Yamamoto, Yoshifumi; Yasui, Toshimichi; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka, Japan	Takenaka, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, 2-2 Yamadaoka, Suita, Osaka, Japan.	ytakenaka@ent.med.osaka-u.ac.jp					Silver CE, 2009, EUR ARCH OTO-RHINO-L, V266, P1333, DOI 10.1007/s00405-009-1028-2; Ogawa K, 2007, INT J RADIAT ONCOL, V68, P1326, DOI 10.1016/j.ijrobp.2007.01.052; Gidley PW, 2010, LARYNGOSCOPE, V120, P1144, DOI 10.1002/lary.20937; Moody SA, 2000, AM J OTOL, V21, P582; Kunst H, 2008, OTOL NEUROTOL, V29, P549, DOI 10.1097/MAO.0b013e31816c7c71; Nakagawa T, 2006, OTOL NEUROTOL, V27, P242, DOI 10.1097/01.mao.0000190463.88873.3d; Kuhel WI, 1996, OTOLARYNG CLIN N AM, V29, P827; Shiga K, 2011, SKULL BASE-INTERD AP, V21, P153, DOI 10.1055/s-0031-1275244; Rasch CRN, 2010, CANCER-AM CANCER SOC, V116, P2159, DOI 10.1002/cncr.24916; Lassig AAD, 2013, OTOL NEUROTOL, V34, P141, DOI 10.1097/MAO.0b013e318278bf38; Yin M, 2006, AURIS NASUS LARYNX, V33, P251, DOI 10.1016/j.anl.2005.11.012; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Bacciu A, 2013, OTOL NEUROTOL, V34, P898, DOI 10.1097/MAO.0b013e318281e0a9; Ito M, 2009, ACTA OTO-LARYNGOL, V129, P1313, DOI 10.3109/00016480802642096; Madsen AR, 2008, HEAD NECK-J SCI SPEC, V30, P1332, DOI 10.1002/hed.20877; Pemberton LS, 2006, CLIN ONCOL-UK, V18, P390, DOI 10.1016/j.clon.2006.03.001; Morris LGT, 2012, HEAD NECK-J SCI SPEC, V34, P1231, DOI 10.1002/hed.21883; Higgins TS, 2010, OTOL NEUROTOL, V31, P1473, DOI 10.1097/MAO.0b013e3181f7ab85; Leong SC, 2013, LARYNGOSCOPE, V123, P2442, DOI 10.1002/lary.24063; Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Chang CH, 2009, AM J OTOLARYNG, V30, P44, DOI 10.1016/j.amjoto.2008.02.007; Cristalli G, 2009, J CRANIOFAC SURG, V20, P816, DOI 10.1097/SCS.0b013e3181a14b99; Fleiner F, 2009, INDIAN J OTOLARYNGOL, V61, P270, DOI 10.1007/s12070-009-0081-x; Hirsch BE, 2008, OPERATIVE OTOLARYNGO, P1271; Hosokawa S, 2008, PRACT OTORHINOLARYNG, V101, P845; Ikezaki S, 2012, PRACT OTORHINOLARYNG, V105, P119; Kamimae H, 2007, OTOL JPN, V17, P653; Kinebuchi Y, 2006, J JPN SOC THER RADIO, V18, P147; Kumano T, 2009, J JPN SOC THER RADIO, V21, P77; Kuze B, 2010, OTOL JPN, V20, P79; Lobo D, 2008, SKULL BASE-INTERD AP, V18, P167, DOI 10.1055/s-2007-994290; Martinez-Devesa P, 2008, SKULL BASE-INTERD AP, V18, P1, DOI 10.1055/s-2007-992766; Matsuda Y, 2010, PRACT OTORHINOLARYNG, V103, P615; Ouaz K, 2013, EUR ANN OTORHINOLARY; PRASAD S, 1994, OTOLARYNG HEAD NECK, V110, P270, DOI 10.1016/S0194-5998(94)70769-3; Rasch CRN, 2011, CANCER-AM CANCER SOC, V117, P874, DOI 10.1002/cncr.25577; Robbins KT, 1996, SKULL BASE SURG, V6, P69, DOI 10.1055/s-2008-1058647; Sato K, 2008, JPN J HEAD NECK CANC, V34, P582; Sterne JAC, 2001, COCHRANE HDB SYSTEMA; Sugimoto H, 2011, ANN OTO RHINOL LARYN, V120, P372; Uchida M, 2012, J JPN SOC HEAD NECK, V22, P41; Ueda Y, 2009, J LARYNGOL OTOL, V123, P75, DOI 10.1017/S0022215109005143	42	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1043-3074	1097-0347		HEAD NECK-J SCI SPEC	Head Neck-J. Sci. Spec. Head Neck	JUL	2015	37	7					1073	1080		10.1002/hed.23698		8	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	CL2WH	WOS:000356807300021		
J	Sasaki, T; Calkins, H; Miller, CF; Zviman, MM; Zipunnikov, V; Arai, T; Sawabe, M; Terashima, M; Marine, JE; Berger, RD; Nazarian, S; Zimmerman, SL				Sasaki, Takeshi; Calkins, Hugh; Miller, Christopher F.; Zviman, Menekhem M.; Zipunnikov, Vadim; Arai, Tomio; Sawabe, Motoji; Terashima, Masashiro; Marine, Joseph E.; Berger, Ronald D.; Nazarian, Saman; Zimmerman, Stefan L.			New insight into scar-related ventricular tachycardia circuits in ischemic cardiomyopathy: Fat deposition after myocardial infarction on computed tomography-A pilot study	HEART RHYTHM			English	Article						Ventricular tachycardia; Ischemic cardiomyopathy; Fat; Computed tomography; Magnetic resonance imaging	LIPOMATOUS-METAPLASIA; NONISCHEMIC CARDIOMYOPATHY; ADIPOSE-TISSUE; ELECTROGRAMS; PREVALENCE; SUBSTRATE	BACKGROUND Myocardial fat deposition (FAT-DEP) has been frequently observed in regions of chronic myocardial infarction in patients with ischemic cardiomyopathy. The role of FAT-DEP within scar-related ventricular tachycardia (VT) circuits has not been investigated. OBJECTIVE This pilot study aimed to assess the impact of myocardial FAT-DEP on local electrograms and VT circuits in patients with ischemic cardiomyopathy. METHODS Contrast-enhanced computed tomography was performed in 22 patients with ischemic VT. Electroanatomic map points were registered to the corresponding contrast-enhanced computed tomography images. Myocardial FAT-DEP was identified and characterized using a postprocessing image overlay that highlighted areas below 0 Hounsfield units (HU). The mean attenuation of local myocardial regions corresponding to sampled electrograms was measured on short-axis images. The associations of mean attenuation with bipolar and unipolar amplitudes, left ventricular wall thickness, and VT circuit sites were investigated. RESULTS Of 1801 electroanatomic map points, 519 (28.8%) were located in regions with FAT-DEP. Significant differences were observed in mean intensity (23.2 +/- 35.6 HU vs 81.7 +/- 21.9 HU; P < .001), bipolar (0.75 +/- 0.83 mV vs 2.9 +/- 2.4 mV; P < .001) and unipolar (3.1 +/- 1.7 mV vs 7.4 +/- 4.3 mV; P < .001) amplitudes, and left ventricular wall thickness (5.2 +/- 1.7 mm vs 8.2 +/- 2.5 mm; P < .001) between regions with and without FAT-DEP. Lower HU was strongly associated with lower bipolar and unipolar amplitudes (P < .0001, respectively). Importantly, FAT-DEP was associated with critical VT circuit sites with fractionated or isolated potentials. CONCLUSION FAT-DEP was associated with electrogram characteristics and VT circuit sites. Further work will be needed to determine whether FAT-DEP plays a causal role in the generation of ischemic scar-related VT circuits.	[Sasaki, Takeshi; Calkins, Hugh; Miller, Christopher F.; Zviman, Menekhem M.; Marine, Joseph E.; Berger, Ronald D.; Nazarian, Saman] Johns Hopkins Univ, Dept Cardiol, Baltimore, MD 21287 USA; [Zipunnikov, Vadim] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21287 USA; [Arai, Tomio] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo, Japan; [Sawabe, Motoji] Tokyo Med & Dent Univ, Dept Mol Pathol, Tokyo, Japan; [Terashima, Masashiro] Cardiovasc Imaging Clin Iidabashi, Tokyo, Japan; [Zimmerman, Stefan L.] Johns Hopkins Univ, Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA	Sasaki, T (reprint author), Johns Hopkins Univ, Div Cardiol, Carnegie 592A,600 N Wolfe St, Baltimore, MD 21287 USA.	tsasaki.cvm@tmd.ac.jp			US National Institutes of Health [K23HL089333, R01HL116280]	The study was supported by the US National Institutes of Health (grant nos. K23HL089333 and R01HL116280, to Dr Nazarian). Dr Nazarian is a scientific advisor to and principal investigator for research support to Johns Hopkins from Biosense Webster. The Johns Hopkins University Conflict of Interest Committee manages all commercial arrangements.	STEVENSON WG, 1995, J AM COLL CARDIOL, V26, P481, DOI 10.1016/0735-1097(95)80026-D; Ichikawa Y, 2009, JACC-CARDIOVASC IMAG, V2, P548, DOI 10.1016/j.jcmg.2009.01.010; Sasaki T, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1081, DOI 10.1161/CIRCEP.112.970699; ALMENDRAL JM, 1988, CIRCULATION, V77, P569; Polin GM, 2011, HEART RHYTHM, V8, P76, DOI 10.1016/j.hrthm.2010.09.088; Nikolaou K, 2004, J COMPUT ASSIST TOMO, V28, P286, DOI 10.1097/00004728-200403000-00021; Nazarian S, 2011, ANN INTERN MED, V155, P415, DOI 10.7326/0003-4819-155-7-201110040-00004; Estner HL, 2011, HEART RHYTHM, V8, P1942, DOI 10.1016/j.hrthm.2011.07.027; Karamitsos TD, 2009, J AM COLL CARDIOL, V54, P1407, DOI 10.1016/j.jacc.2009.04.094; Philips B, 2013, CIRC-ARRHYTHMIA ELEC, V6, P160, DOI 10.1161/CIRCEP.112.975441; Su L, 2004, CARDIOVASC PATHOL, V13, P98, DOI 10.1016/s1054-8807(03)00134-0; Goldfarb JW, 2009, RADIOLOGY, V253, P65, DOI 10.1148/radiol.2532082290; Sasaki T, 2011, CIRC-CARDIOVASC IMAG, V4, P662, DOI 10.1161/CIRCIMAGING.111.965764; Desjardins B, 2009, HEART RHYTHM, V6, P644, DOI 10.1016/j.hrthm.2009.02.018; Baroldi G, 1997, CAN J CARDIOL, V13, P65; Nazarian S, 2005, CIRCULATION, V112, P2821, DOI 10.1161/CIRCULATIONAHA.105.549659; Pouliopoulos J, 2013, CIRCULATION, V128, P2296, DOI 10.1161/CIRCULATIONAHA.113.002238; Schmitt M, 2007, CIRCULATION, V116, pE5, DOI 10.1161/CIRCULATIONAHA.107.690800; Basso C, 2004, CIRCULATION, V109, P1180, DOI 10.1161/01.CIR.0000118494.07530.65; Buzug TM, 2008, INTRO COMPUTED TOMOG, P475; Gupta M, 2011, J NUCL CARDIOL, V18, P96, DOI 10.1007/s12350-010-9314-3; Komatsu Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000935; Lucke C, 2010, EUR RADIOL, V20, P2074, DOI 10.1007/s00330-010-1791-x; Psaltis PJ, 2011, INT J CARDIOVAS IMAG, V27, P25, DOI 10.1007/s10554-010-9657-5; Vassallo JA, 1984, CIRCULATION, V70, P37; Winer-Muram HT, 2004, J COMPUT ASSIST TOMO, V28, P455, DOI 10.1097/00004728-200407000-00004	26	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	JUL	2015	12	7					1508	1518		10.1016/j.hrthm.2015.03.041		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CL2II	WOS:000356766500023		
J	Reddy, KR; Bourliere, M; Sulkowski, M; Omata, M; Zeuzem, S; Feld, JJ; Lawitz, E; Marcellin, P; Welzel, TM; Hyland, R; Ding, X; Yang, J; Knox, S; Pang, P; Dvory-Sobol, H; Subramanian, GM; Symonds, W; McHutchison, JG; Mangia, A; Gane, E; Mizokami, M; Pol, S; Afdhal, N				Reddy, K. Rajender; Bourliere, Marc; Sulkowski, Mark; Omata, Masao; Zeuzem, Stefan; Feld, Jordan J.; Lawitz, Eric; Marcellin, Patrick; Welzel, Tania M.; Hyland, Robert; Ding, Xiao; Yang, Jenny; Knox, Steven; Pang, Phillip; Dvory-Sobol, Hadas; Subramanian, G. Mani; Symonds, William; McHutchison, John G.; Mangia, Alessandra; Gane, Edward; Mizokami, Masashi; Pol, Stanislas; Afdhal, Nezam			Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis	HEPATOLOGY			English	Article							TREATMENT-EXPERIENCED PATIENTS; FIXED-DOSE COMBINATION; TREATMENT-NAIVE; PHASE-2 TRIAL; OPEN-LABEL; HCV; RIBAVIRIN; THERAPY; INTERFERON; BOCEPREVIR	Patients with hepatitis C virus (HCV) infection and cirrhosis are underrepresented in clinical trials of interferon-free regimens of direct-acting antiviral agents, making it difficult to optimize therapy. We performed a post-hoc analysis of data from seven clinical trials to evaluate the efficacy and safety of the fixed-dose combination of ledipasvir (LDV) and sofosbuvir (SOF), with and without ribavirin (RBV), in 513 treatment-naive and previously treated patients with genotype 1 HCV and compensated cirrhosis. All patients received LDV-SOF for 12 or 24 weeks with or without RBV. We determined the rates of sustained virological response (SVR) 12 weeks after treatment (SVR12) overall and for subgroups. Of the 513 patients analyzed, 69% were previously treated and 47% had failed previous treatment with a protease-inhibitor regimen. Overall, 493 patients (96%; 95% confidence interval [CI]: 94%-98%) achieved SVR12, 98% of treatment-naive and 95% of previously treated patients. SVR12 rates did not vary greatly by treatment duration (95% of patients receiving 12 weeks and 98% of patients receiving 24 weeks of treatment), nor by addition of RBV (95% of patients receiving LDV-SOF alone and 97% of those who received LDV-SOF plus RBV), although previously treated patients receiving 12 weeks of LDV-SOF without RBV had an SVR12 rate of 90%. One patient discontinued LDV-SOF because of an adverse event (AE). The most common AEs were headache (23%), fatigue (16%-19%), and asthenia (14%-16%). One patient (<1%) of those receiving LDV-SOF alone, and 4 (2%) of those receiving LDV-SOF plus RBV had treatment-related serious AEs. Conclusions: This analysis suggests that 12 weeks of LDV-SOF is safe and effective for treatment-naive patients with HCV genotype 1 and compensated cirrhosis. The relatively lower SVR in treatment-experienced patients treated with 12 weeks of LDV-SOF raises the question of whether these patients would benefit from adding RBV or extending treatment duration to 24 weeks. (Hepatology 2015;62:79-86)	[Reddy, K. Rajender] Univ Penn, Philadelphia, PA 19104 USA; [Bourliere, Marc] Hop St Joseph, Marseilles, France; [Sulkowski, Mark] Johns Hopkins Univ, Baltimore, MD USA; [Omata, Masao] Yamanashi Prefectural Hosp Org, Kofu, Yamanashi, Japan; [Zeuzem, Stefan; Welzel, Tania M.] Goethe Univ Hosp, Frankfurt, Germany; [Feld, Jordan J.] Univ Toronto, Sandra Rotman Ctr Global Hlth, Toronto, ON, Canada; [Lawitz, Eric] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78229 USA; [Marcellin, Patrick] Univ Paris, Hop Beaujon, Paris, France; [Hyland, Robert; Ding, Xiao; Yang, Jenny; Knox, Steven; Pang, Phillip; Dvory-Sobol, Hadas; Subramanian, G. Mani; Symonds, William; McHutchison, John G.] Gilead Sci Inc, Foster City, CA 94404 USA; [Mangia, Alessandra] Casa Sollievo Sofferenza Hosp, Liver Unit, San Giovanni Rotondo, Italy; [Gane, Edward] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand; [Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan; [Pol, Stanislas] Univ Paris 05, Dept Hepatol, Paris, France; [Afdhal, Nezam] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Reddy, KR (reprint author), Hosp Univ Penn, 3400 Spruce St,16, Philadelphia, PA 19104 USA.	rajender.reddy@uphs.upenn.edu; mbourliere@hopital-saint-joseph.fr			Gilead Sciences, Inc. (Foster City, CA)	This analysis was supported by Gilead Sciences, Inc. (Foster City, CA).	Alqahtani S, 2014, 65 ANN M AM ASS STUD; American Association for the Study of Liver Diseases, 2014, REC TEST MAN TREAT H; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; [Anonymous], 2015, HARV LED SOF TABL US; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Gordon SC, 2015, J HEPATOL, V62, P286, DOI 10.1016/j.jhep.2014.08.052; Bourliere M, 2015, LANCET INFECT DIS, V15, P397, DOI [10.1016/S1473-3099(15)70050-2, 10.1016/51473-3099(15)70050-2]; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Bourliere M, 2013, LIVER INT, V33, P46, DOI 10.1111/liv.12067; European Association for Study of Liver, 2014, J HEPATOL, V60, P392, DOI DOI 10.1016/J.JHEP.2013.11.003; Gane E, 2012, ANTIVIR THER, V17, P1201, DOI 10.3851/IMP2431; Gane EJ, 2013, HEPATOLOGY, V58, p243A; Gane EJ, 2014, GASTROENTEROLOGY, V146, DOI [10. 1053/j.gastro.2013.11.007, DOI 10.1053/J.GASTRO.2013.11.007]; Lawitz E, 2012, 47 ANN M EUR ASS STU; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Omata M, 2014, J VIRAL HEPATITIS, V21, P762, DOI 10.1111/jvh.12312; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869	21	12	12	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	JUL	2015	62	1					79	86		10.1002/hep.27826		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL3QH	WOS:000356864800014		
J	Fujita, T				Fujita, Tetsuji			Assessing a microrNA panel in diagnosing early cholangiocarcinoma	HEPATOLOGY			English	Letter									Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan	Fujita, T (reprint author), Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan.						Li L, 2014, HEPATOLOGY, V60, P896, DOI 10.1002/hep.27050; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; Huang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037188; Jonas S, 2009, ANN SURG, V249, P303, DOI 10.1097/SLA.0b013e318195e164; Tan CH, 2011, INT J HEPATOL, V2011	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	JUL	2015	62	1					322	322		10.1002/hep.27561		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL3QH	WOS:000356864800044		
J	Tanaka, N; Izawa, T; Takenaka, S; Yamate, J; Kuwamura, M				Tanaka, Natsuki; Izawa, Takeshi; Takenaka, Shigeo; Yamate, Jyoji; Kuwamura, Mitsuru			Ccdc85C, a causative protein for hydrocephalus and subcortical heterotopia, is expressed in the systemic epithelia with proliferative activity in rats	HISTOLOGY AND HISTOPATHOLOGY			English	Article						Apical junction; Ccdc85C; Cell proliferation; Hydrocephalus; Rat	HIPPO PATHWAY; YAP ONCOPROTEIN; DOMAIN; EPIDERMIS; CELLS; HHY	Coiled-coil domain containing 85c (Ccdc85c) is a causative gene for spontaneous mutant mouse with non-obstructive hydrocephalus and subcortical heterotopia. Detailed functions of Ccdc85C protein have not been clarified. To reveal roles of Ccdc85C, we examined the distribution and expression pattern of Ccdc85C in the systemic developing organs in rats. Ccdc85C was expressed in various simple epithelia but not stratified epithelia. In the various epithelia, Ccdc85C was localized at cell-cell junctions and its expression was strong at apical junctions. Furthermore, intense expression was seen at developing period and gradually decreased with advancing development. Distribution of Ccdc85C coincides with that of proliferating epithelial cells. These results suggest that Ccdc85C plays an important role in the proliferative property of simple epithelia.	[Tanaka, Natsuki; Izawa, Takeshi; Takenaka, Shigeo; Yamate, Jyoji; Kuwamura, Mitsuru] Osaka Prefecture Univ, Lab Vet Pathol, Izumisano, Osaka 5988531, Japan	Kuwamura, M (reprint author), Osaka Prefecture Univ, Lab Vet Pathol, Izumisano, Osaka 5988531, Japan.	kuwamura@vet.osakafu-u.ac.jp			Japan Society for Promotion of Science (JSPS) [25660230]; Kenyuukai (The Veterinary Practitioners Association of Osaka Prefecture University)	This work was supported by Grant-in-Aid for Scientific Research from Japan Society for Promotion of Science (JSPS; no. 25660230) and Kenyuukai (The Veterinary Practitioners Association of Osaka Prefecture University).	Wang WQ, 2014, MOL CELL PROTEOMICS, V13, P119, DOI 10.1074/mcp.M113.030049; KORENBROT CC, 1977, BIOL REPROD, V17, P298, DOI 10.1095/biolreprod17.2.298; Oka T, 2010, BIOCHEM J, V432, P461, DOI 10.1042/BJ20100870; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Markham NO, 2014, MOL BIOL CELL, V25, P2592, DOI 10.1091/mbc.E13-08-0492; Moya IM, 2014, CELL RES, V24, P137, DOI 10.1038/cr.2014.6; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Combs HL, 1998, KIDNEY INT, V53, P892, DOI 10.1046/j.1523-1755.1998.00842.x; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Kuwamura M, 2004, DEV BRAIN RES, V152, P69, DOI 10.1016/j.devbrainres.2004.05.006; Mori N, 2012, AM J PATHOL, V180, P314, DOI 10.1016/j.ajpath.2011.09.014; Muroyama A, 2012, SEMIN CELL DEV BIOL, V23, P890, DOI 10.1016/j.semcdb.2012.08.008; NAGATA M, 1993, ANAT EMBRYOL, V187, P275; Xiao L., 2011, J BIOL CHEM, V286, P7798	20	0	0	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	JUL	2015	30	7					823	832		10.14670/HH-11-589		10	Cell Biology; Pathology	Cell Biology; Pathology	CL2XN	WOS:000356811200007		
J	Iwamoto, M; Nakatani, Y; Fugo, K; Kishimoto, T; Kiyokawa, T				Iwamoto, Masami; Nakatani, Yukio; Fugo, Kazunori; Kishimoto, Takashi; Kiyokawa, Takako			Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium	HUMAN PATHOLOGY			English	Article						Clear cell carcinoma; Endometrial carcinoma; Napsin A; Ovarian carcinoma; PAX8	TRANSCRIPTION FACTOR-I; METASTATIC LUNG ADENOCARCINOMA; TISSUE MICROARRAY; CANCER ANTIGEN; MARKER; TTF-1; DIAGNOSIS; ORIGIN; IMMUNOHISTOCHEMISTRY; DISTINGUISH	Napsin A is a reliable marker for pulmonary adenocarcinoma and is expressed in a subset of ovarian clear cell carcinomas (O-CCCs), endometrial (EM) CCCs, and endometrioid carcinomas (EC). We investigated napsin A levels in O-CCC and EM-CCC and compared these with levels in other nonmucinous ovarian carcinomas and EM-EC, respectively. Napsin A, thyroid transcription factor (TTF)-1, paired box (PAX) 8, and cancer antigen (CA) 125 expression was evaluated in Ill ovarian and uterine carcinoma cases (22 O-CCC, 15 EM-CCC, 13 ovarian EC (O-EC), 39 high-grade serous carcinoma [HGSC], and 22 EM-EC) using immunohistochemistry. Napsin A immunoreactivity was observed in 21(95.5%) of 22 O-CCC and 10(66.7%) of 15 EM-CCC cases but was rare in O-EC and EM-EC (7.7% and 4.5%) and undetectable in HGSC cases. Thyroid transcription factor 1 was not expressed in O-CCC but was detected in 1 (6.7%) of 15 EM-CCC, 3 (23.1%) of 13 O-EC, 2(5.1%) of 39 HGSC, and 1(4.5%) of 22 EM-EC cases. All 111 cases examined were positive for PAX8, whereas 3 (20.0%) of 15 of EM-CCC and 1 (4.5%) of 22 EM-EC cases were negative for CA125. There were no napsin A/TTF-1 double-positive cases, except for 1 EM-CCC, in which cells had a focal expression pattern. All napsin A- and/or TTF-1-positive cases expressed PAX8 and CA 125. In conclusion, napsin A is frequently expressed in O-CCC and EM-CCC, rarely in O-EC and EM-EC, and never in HGSC cases. These findings confirm the importance of using a panel of antibodies that includes napsin A, TTF-1, and PAX8 when evaluating metastatic carcinomas of unknown origin, particularly when gynecologic and pulmonary adenocarcinomas are included in the differential diagnosis. (C) 2015 Elsevier Inc. All rights reserved.	[Iwamoto, Masami; Nakatani, Yukio] Chiba Univ, Grad Sch Med, Dept Diagnost Pathol, Chuo Ku, Chiba 2608670, Japan; [Fugo, Kazunori; Kishimoto, Takashi] Chiba Univ, Grad Sch Med, Dept Mol Pathol, Chuo Ku, Chiba 2608670, Japan; [Kiyokawa, Takako] Jikei Univ, Sch Med, Dept Pathol, Minato Ku, Tokyo 1058461, Japan	Iwamoto, M (reprint author), Chiba Univ, Grad Sch Med, Dept Diagnost Pathol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	m-iwamoto@chiba-u.jp; nakatani@faculty.chiba-u.jp; fugo@faculty.chiba-u.jp; tkishi@faculty.chiba-u.jp; kiyokawa@jikei.ac.jp					Tan A, 2011, ANN DIAGN PATHOL, V15, P108, DOI 10.1016/j.anndiagpath.2010.11.005; Ordonez NG, 2012, ADV ANAT PATHOL, V19, P140, DOI 10.1097/PAP.0b013e318253465d; Kobel M, 2009, AM J SURG PATHOL, V33, P14, DOI 10.1097/PAS.0b013e3181788546; Rosen DG, 2005, GYNECOL ONCOL, V99, P267, DOI 10.1016/j.ygyno.2005.06.040; Hirano T, 2003, LUNG CANCER-J IASLC, V41, P155, DOI 10.1016/S0169-5002(03)00194-6; Bishop JA, 2010, HUM PATHOL, V41, P20, DOI 10.1016/j.humpath.2009.06.014; Fadare O, 2014, AM J SURG PATHOL, V38, P189, DOI 10.1097/PAS.0000000000000085; Ye JQ, 2011, APPL IMMUNOHISTO M M, V19, P313, DOI 10.1097/PAI.0b013e318205b059; Ozcan A, 2011, AM J SURG PATHOL, V35, P1837, DOI 10.1097/PAS.0b013e31822d787c; Larsen JE, 2011, CANCER J, V17, P512, DOI 10.1097/PPO.0b013e31823e701a; Kim MY, 2014, HISTOPATHOLOGY, V65, P195, DOI 10.1111/his.12383; Turner BM, 2012, ARCH PATHOL LAB MED, V136, P163, DOI 10.5858/arpa.2011-0320-OA; Stoll LM, 2010, CANCER CYTOPATHOL, V118, P441, DOI 10.1002/cncy.20108; Streppel MM, 2012, HUM PATHOL, V43, P1755, DOI 10.1016/j.humpath.2012.01.005; Fadare O, 2013, AM J CANCER RES, V3, P70; Jagirdar J, 2008, ARCH PATHOL LAB MED, V132, P384, DOI 10.1043/1543-2165(2008)132[384:AOITTD]2.0.CO;2; Kim MJ, 2013, ANN DIAGN PATHOL, V17, P85, DOI 10.1016/j.anndiagpath.2012.07.006; Bae HS, 2014, INT J GYNECOL PATHOL, V34, P74; Comperat E, 2005, MODERN PATHOL, V18, P1371, DOI 10.1038/modpathol.3800422; Hirano T, 2000, JPN J CANCER RES, V91, P1015; Hoang LN, 2015, HISTOPATHOLOGY, V66, P664, DOI 10.1111/his.12581; Holmes BJ, 2014, USCAP; Kadivar M, 2013, APPL IMMUNOHISTO M M, V21, P191, DOI 10.1097/PAI.0b013e3182612643; Kandalaft PL, 2014, AM J CLIN PATHOL, V142, P830, DOI 10.1309/AJCP8WO2EOIAHSOF; Kubba LA, 2008, MODERN PATHOL, V21, P485, DOI 10.1038/modpathol.2008.4; Kurman RJ, 2014, WHO CLASSIFICATION T; Lau SK, 2002, APPL IMMUNOHISTO M M, V10, P97, DOI 10.1097/00022744-200206000-00001; Lim D, 2014, USCAP; LOY TS, 1992, AM J CLIN PATHOL, V98, P175; Mukhopadhyay S, 2012, AM J CLIN PATHOL, V138, P703, DOI 10.1309/AJCPKVBXTI9O3TEM; Nur S, 2006, INT J GYNECOL CANCER, V16, P1903, DOI 10.1111/j.1525-1438.2006.00706.x; Siami K, 2007, AM J SURG PATHOL, V31, P1759; Skimisdottir I, 2013, BMC CANCER, V13, P524; Yamashita Y, 2015, MODERN PATHOL, V28, P111, DOI 10.1038/modpathol.2014.61; Zhang PJ, 2009, INT J GYNECOL PATHOL, V28, P10, DOI 10.1097/PGP.0b013e3181804bc6	35	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	JUL	2015	46	7					957	962		10.1016/j.humpath.2015.03.008		6	Pathology	Pathology	CL4GJ	WOS:000356910300004		
J	Al-Eryani, K; Cheng, J; Abe, T; Maruyama, S; Yamazaki, M; Babkair, H; Essa, A; Saku, T				Al-Eryani, Kamal; Cheng, Jun; Abe, Tatsuya; Maruyama, Satoshi; Yamazaki, Manabu; Babkair, Hamzah; Essa, Ahmed; Saku, Takashi			Protease-activated receptor 2 modulates proliferation and invasion of oral squamous cell carcinoma cells	HUMAN PATHOLOGY			English	Article						PAR-2; Oral mucosa; Squamous cell carcinoma; Carcinoma in situ; Cell proliferation; Cell invasion	IN-SITU; EPITHELIAL DYSPLASIA; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; GASTRIC-CANCER; PAR AGONISTS; EXPRESSION; TRYPSIN; PERLECAN; PROTEASE-ACTIVATED-RECEPTOR-2	Based on our previous finding that protease-activated receptor 2 (PAR-2) regulates hemophagocytosis of oral squamous cell carcinoma (SCC) cells, which induces their heme oxygenase 1- dependent keratinization, we have formulated a hypothesis that PAR-2 functions in wider activities of SCC cells. To confirm this hypothesis, we investigated immunohistochemical profiles of PAR-2 in oral SCC tissues and its functional roles in cell proliferation and invasion in SCC cells in culture. The PAR-2 expression modes were determined in 48 surgical tissue specimens of oral SCC. Using oral SCC derived cell systems, we determined both gene and protein expression levels of PAR-2. SCC cell proliferation and invasive properties were also examined in conditions in which PAR-2 was activated by the synthetic peptide SLIGRL. PAR-2 was immunolocalized in oral SCC and carcinoma in situ cells, especially in those on the periphery of carcinoma cell foci (100% of cases), but not in normal oral epithelia. Its expression at both gene and protein levels was confirmed in 3 oral SCC cell lines including ZK-1. Activation of PAR-2 induced ZK-1 cell proliferation in a dose-dependent manner. PAR-2 activated ZK-1 cells invaded faster than nonactivated ones. The expression of PAR-2 is specific to oral malignancies, and PAR-2 regulates the growth and invasion of oral SCC cells. (C) 2015 Elsevier Inc. All rights reserved.	[Al-Eryani, Kamal; Cheng, Jun; Abe, Tatsuya; Yamazaki, Manabu; Babkair, Hamzah; Essa, Ahmed; Saku, Takashi] Niigata Univ, Div Oral Pathol, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Niigata 9518514, Japan; [Al-Eryani, Kamal] Sanaa Univ, Dept Oral Med & Pathol, Fac Dent, Sanaa, Yemen; [Abe, Tatsuya; Maruyama, Satoshi; Saku, Takashi] Niigata Univ Hosp, Oral Pathol Sect, Dept Surg Pathol, Niigata 9518520, Japan	Saku, T (reprint author), Niigata Univ, Div Oral Pathol, Grad Sch Med & Dent Sci, Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	tsaku@dent.niigata-u.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [25305035, 25462849, 26305032, 23406038]; Japan Student Services Organization	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI grant nos. 25305035 and 25462849 to J. C. and 26305032 and 23406038 to T. S.) and by a Follow-up Research Fellowship from the Japan Student Services Organization (K. A.).	Al-Eryani K, 2013, J CELL PHYSIOL, V228, P1977, DOI 10.1002/jcp.24364; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; Darmoul D, 2001, BRIT J CANCER, V85, P772, DOI 10.1054/bjoc.2001.1976; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; D'Andrea MR, 1998, J HISTOCHEM CYTOCHEM, V46, P157; Sharlow ER, 2000, J CELL SCI, V113, P3093; Koshikawa N, 1997, FEBS LETT, V409, P442, DOI 10.1016/S0014-5793(97)00565-6; Wilson SR, 2004, PROSTATE, V60, P168, DOI 10.1002/pros.20047; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; ALANI B, 1995, CAN J PHYSIOL PHARM, V73, P1203; Funayama A, 2011, PATHOBIOLOGY, V78, P171, DOI 10.1159/000324926; Metwaly H, 2012, HUM PATHOL, V43, P1973, DOI 10.1016/j.humpath.2012.02.006; Tsuneki M, 2013, LAB INVEST, V93, P921, DOI 10.1038/labinvest.2013.86; Alvarado CG, 2011, HISTOPATHOLOGY, V59, P283, DOI 10.1111/j.1365-2559.2011.03929.x; Bernardes VF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002077; Compton SJ, 2000, J BIOL CHEM, V275, P39207, DOI 10.1074/jbc.M007215200; Cottrell GS, 2003, BIOCHEM SOC T, V31, P1191; Fujimoto D, 2006, J SURG ONCOL, V93, P139, DOI 10.1002/jso.20420; Funayama A, 2012, VIRCHOWS ARCH, V460, P473, DOI 10.1007/s00428-012-1224-0; Ichikawa Y, 2000, CLIN CANCER RES, V6, P1385; Ida-Yonemochi H, 2012, MODERN PATHOL, V25, P784, DOI 10.1038/modpathol.2011.218; Ikarashi T, 2004, J ORAL PATHOL MED, V33, P87, DOI 10.1111/j.1600-0714.2004.00026.x; Ikeda O, 2003, INT J ONCOL, V22, P295; Jahan I, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-301; Jahan I, 2007, ANN ONCOL, V18, P1506, DOI 10.1093/annonc/mdm190; Kobayashi T, 2012, HISTOPATHOLOGY, V61, P910, DOI 10.1111/j.1365-2559.2012.04283.x; Kobayashi T, 2010, PATHOL INT, V60, P156, DOI 10.1111/j.1440-1827.2009.02499.x; Maruyama S, 2010, CANCER GENET CYTOGEN, V196, P14, DOI 10.1016/j.cancergencyto.2009.08.002; Maruyama S, 2014, HISTOCHEM CELL BIOL, V142, P297, DOI 10.1007/s00418-014-1198-x; Mikami T, 2011, ORAL ONCOL, V47, P497, DOI 10.1016/j.oraloncology.2011.03.015; Milia AF, 2002, CIRC RES, V91, P346, DOI 10.1161/01.RES.0000031958.92781.9E; Miyata S, 1999, J BIOCHEM-TOKYO, V125, P1067; Miyota S, 2014, BIOMED RES INT, DOI 10.1155/2014/823968; Sanchez-Hernandez PE, 2008, GYNECOL ONCOL, V108, P19, DOI 10.1016/j.ygyno.2007.08.083; Sciubba J J, 2001, Am J Clin Dermatol, V2, P239, DOI 10.2165/00128071-200102040-00005; Tilakaratne WM, 2009, J ORAL PATHOL MED, V38, P348, DOI 10.1111/j.1600-0714.2009.00750.x; Vouret-Craviari V, 2003, J THROMB HAEMOST, V1, P1103, DOI 10.1046/j.1538-7836.2003.00238.x	37	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	JUL	2015	46	7					991	999		10.1016/j.humpath.2015.03.003		9	Pathology	Pathology	CL4GJ	WOS:000356910300008		
J	Kashio, N; Hoshi, T; Kurishima, K; Ida, M; Matsuzaki, H				Kashio, Norihide; Hoshi, Takuya; Kurishima, Kenji; Ida, Minoru; Matsuzaki, Hideaki			Improvement of High-Frequency Characteristics of InGaAsSb-Base Double Heterojunction Bipolar Transistors by Inserting a Highly Doped GaAsSb Base Contact Layer	IEEE ELECTRON DEVICE LETTERS			English	Article						GaAsSb; double heterojunction bipolar transistors (DHBTs); InP/InGaAsSb; highly doped base contact	SIMULTANEOUS F(T); GHZ; DHBTS; F(MAX)	This letter presents InP/GaAsSb/InGaAsSb/InP double heterojunction bipolar transistors (DHBTs) with a highly doped base contact layer. In order to reduce the base contact resistivity, a 3-nm-thick highly doped GaAsSb contact layer is inserted between the InP emitter and 17-nm-thick composition-and doping-graded InGaAsSb base. Fabricated DHBTs with a 0.25-mu m emitter show a current gain of 32 and a high open-base breakdown voltage BVCEO of 5.2 V. The DHBTs also exhibit f(T)/f(max) = 513/637 GHz at a collector current density of 9.5 mA/mu m(2) and V-CE = 1 V. The f(max) is higher by 124 GHz than that for InP/InGaAsSb DHBTs without the GaAsSb contact layer. These results indicate that the use of the GaAsSb/InGaAsSb base structure is very effective in improving f(max).	[Kashio, Norihide] NTT Corp, Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan; [Hoshi, Takuya; Kurishima, Kenji; Ida, Minoru; Matsuzaki, Hideaki] NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan	Kashio, N (reprint author), NTT Corp, Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan.	kashio.norihide@lab.ntt.co.jp					Alexandrova M, 2014, IEEE ELECTR DEVICE L, V35, P1218, DOI 10.1109/LED.2014.2364622; Dvorak MW, 2001, IEEE ELECTR DEVICE L, V22, P361, DOI 10.1109/55.936343; Fluckiger R, 2014, IEEE ELECTR DEVICE L, V35, P166, DOI 10.1109/LED.2013.2295424; Hoshi T, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.114102; Hoshi T, 2013, J CRYST GROWTH, V380, P197, DOI 10.1016/j.jcrysgro.2013.06.014; Hoshi T, 2014, J CRYST GROWTH, V404, P172, DOI 10.1016/j.jcrysgro.2014.07.025; Kashio N, 2014, ELECTRON LETT, V50, P1631, DOI 10.1049/el.2014.2774; Kashio N, 2014, IEEE ELECTR DEVICE L, V35, P1209, DOI 10.1109/LED.2014.2365216; Lovblom R., 2014, P IPRM MAY, P1; Snodgrass W, 2007, INT EL DEVICES MEET, P663, DOI 10.1109/IEDM.2007.4419031; Urteaga M., 2011, P 69 ANN DEV RES C J, P281; Xu HuanWen, 2013, Journal of Southwest Forestry University, V33, P34	12	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	JUL	2015	36	7					657	659		10.1109/LED.2015.2429142		3	Engineering, Electrical & Electronic	Engineering	CL4AV	WOS:000356895500008		
J	Nagari, A; Okada, K; Verhelst, M				Nagari, Angelo; Okada, Kenichi; Verhelst, Marian			Introduction to the Special Issue on the 40th European Solid-State Circuits Conference (ESSCIRC)	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Editorial Material									[Nagari, Angelo] ST Microelect, Grenoble, France; [Okada, Kenichi] Tokyo Inst Technol, Tokyo 1528552, Japan; [Verhelst, Marian] KU Leuven ESAT MICAS, B-3001 Leuven, Belgium	Nagari, A (reprint author), ST Microelect, Grenoble, France.	angelo.nagari@st.com; okada@ssc.pe.titech.ac.jp; marian.verhelst@kuleuven.be	Verhelst, Marian/E-5739-2011	Verhelst, Marian/0000-0003-3495-9263				0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	JUL	2015	50	7			SI		1512	1515		10.1109/JSSC.2015.2442451		4	Engineering, Electrical & Electronic	Engineering	CL4PG	WOS:000356934800001		
J	Kawano, Y; Kotta, U				Kawano, Yu; Kotta, Uelle			On Integrability of Observable Space for Discrete-Time Polynomial Control Systems	IEEE TRANSACTIONS ON AUTOMATIC CONTROL			English	Article						Discrete-time systems; integrability; observable spaces; polynomial systems	SQUARES; SUM	The goal of the technical note is to extend the results on the observability decomposition of continuous-time nonlinear systems into the discrete-time polynomial systems. In general, the observable space related to the concept of single-experiment observability of the discrete-time nonlinear systems cannot always be locally spanned by exact one-forms whose integrals would define the observable state coordinates. In this technical note, we show that for the special subclass of reversible polynomial systems, the observable space is integrable like in the continuous-time case.	[Kawano, Yu] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto 6068501, Japan; [Kotta, Uelle] Tallinn Univ Technol, Inst Cybernet, EE-12618 Tallinn, Estonia	Kawano, Y (reprint author), Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto 6068501, Japan.	ykawano@i.kyoto-u.ac.jp; kotta@cc.ioc.ee			JST CREST; EU through the European Regional Development Fund; Estonian Research Council [PUT481]	This work was supported in part by JST CREST, by the EU through the European Regional Development Fund, and by the Estonian Research Council under Grant PUT481. Recommended by Associate Editor C. Moog.	Albertini F., 1996, SYSTEM MODELING OPTI, P155; WANG Y, 1995, SIAM J CONTROL OPTIM, V33, P1102, DOI 10.1137/S0363012993246828; Ben Sassi MA, 2012, AUTOMATICA, V48, P3114, DOI 10.1016/j.automatica.2012.08.014; Conte G., 2007, NONLINEAR CONTROL SY, V2nd; Ebenbauer C, 2006, COMPUT CHEM ENG, V30, P1590, DOI 10.1016/j.compchemeng.2006.05.014; Franze G, 2012, SYST CONTROL LETT, V61, P839, DOI 10.1016/j.sysconle.2012.05.001; Isidori A., 1995, NONLINEAR CONTROL SY; Kaparin V, 2011, P EST ACAD SCI, V60, P174, DOI 10.3176/proc.2011.3.05; Khalil H.K., 2002, NONLINEAR SYSTEMS; Kotta U., 2005, Proceedings of the Estonian Academy of Sciences. Physics, Mathematics, V54; Kotta U, 2008, P 17 IFAC WORLD C, P9852; Mohler R. R., 1973, BILINEAR CONTROL PRO, V106; Nesic D, 1998, SYST CONTROL LETT, V35, P219, DOI 10.1016/S0167-6911(98)00055-3; NIJMEIJER H, 1982, INT J CONTROL, V36, P867, DOI 10.1080/00207178208932936; Nijmeijer H., 1990, NONLINEAR DYNAMICAL; SONTAG ED, 1979, SIAM J CONTROL OPTIM, V17, P139, DOI 10.1137/0317011	16	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9286	1558-2523		IEEE T AUTOMAT CONTR	IEEE Trans. Autom. Control	JUL	2015	60	7					1987	1991		10.1109/TAC.2014.2365685		5	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	CL3SR	WOS:000356871400028		
J	Umemura, Y; Sakamoto, N				Umemura, Yoshio; Sakamoto, Noboru			Optimal Servo Design for Lock-Up Slip Control for Torque Converter-Nonlinear Output Regulation Approach	IEEE TRANSACTIONS ON CONTROL SYSTEMS TECHNOLOGY			English	Article						Automotive applications; non-linear control systems; observers; servosystems	SERVOMECHANISM PROBLEM	It is well known that slip control of lock-up clutch in automatic transmission systems is a crucial technology for improving fuel economy and driving comfort. However, plant parameters rapidly vary according to turbine speed, making the slip control challenging. For this problem, we apply non-linear output regulation theory for the system represented as a linear parameter-varying system with the turbine speed as the parameter. In this framework, it is possible to design a servo controller that is optimally scheduled according to the turbine speed. The effectiveness of the proposed method is confirmed by experiments compared with an H-infinity controller, which is one of the most advanced methods employed in the field of lock-up clutch slip control.	[Umemura, Yoshio] Aisin AW Co Ltd, Anjo City, Aichi 4441192, Japan; [Sakamoto, Noboru] Nagoya Univ, Dept Aerosp Engn, Nagoya, Aichi 4648601, Japan	Umemura, Y (reprint author), Aisin AW Co Ltd, Anjo City, Aichi 4441192, Japan.	umemura.yoshio@g.mbox.nagoya-u.ac.jp; sakamoto@nuae.nagoya-u.ac.jp					FRANCIS BA, 1977, SIAM J CONTROL OPTIM, V15, P486, DOI 10.1137/0315033; FRANCIS BA, 1976, AUTOMATICA, V12, P457, DOI 10.1016/0005-1098(76)90006-6; ISIDORI A, 1990, IEEE T AUTOMAT CONTR, V35, P131, DOI 10.1109/9.45168; DAVISON EJ, 1976, IEEE T AUTOMAT CONTR, V21, P35, DOI 10.1109/TAC.1976.1101126; Doyle J. C., 1992, FEEDBACK CONTROL THE; DOYLE JC, 1989, IEEE T AUTOMAT CONTR, V34, P831, DOI 10.1109/9.29425; Hibino R., 2009, J DYN SYST MEAS CONT, V131; Hirata M., 2010, IEEJ T IND APPL, V130, P1139; Huang J., 2004, NONLINEAR OUTPUT REG; HUANG J, 1990, AUTOMATICA, V26, P963, DOI 10.1016/0005-1098(90)90081-R; HUANG J, 1992, IEEE T AUTOMAT CONTR, V37, P1009, DOI 10.1109/9.148359; Ieko T., 1998, Transactions of the Society of Instrument and Control Engineers, V34; Kono K., 1995, 950672 SAE, P49; Marconi L, 2002, AUTOMATICA, V38, P21, DOI 10.1016/S0005-1098(01)00184-4; Sakamoto N, 2011, 2011 50TH IEEE CONFERENCE ON DECISION AND CONTROL AND EUROPEAN CONTROL CONFERENCE (CDC-ECC), P4640, DOI 10.1109/CDC.2011.6161089	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-6536	1558-0865		IEEE T CONTR SYST T	IEEE Trans. Control Syst. Technol.	JUL	2015	23	4					1587	1593		10.1109/TCST.2014.2366077		7	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	CK8XO	WOS:000356523600028		
J	Werth, A; Kitamura, N; Tanaka, K				Werth, Annette; Kitamura, Nobuyuki; Tanaka, Kenji			Conceptual Study for Open Energy Systems: Distributed Energy Network Using Interconnected DC Nanogrids	IEEE TRANSACTIONS ON SMART GRID			English	Article						DC-DC converter; dc power distribution; dc power transmission; interconnected power system; microgrid; power system control; smart grid	MULTIAGENT SYSTEM; OPERATION; GRIDS	We describe the general concept and practical feasibility of a dc-based open energy system (OES) that proposes an alternative way of exchanging intermittent energy between houses in a local community. Each house is equipped with a dc nanogrid, including photovoltaic panels and batteries. We extend these nanogrids with a bidirectional dc-dc converter and a network controller so that power can be exchanged between houses over an external dc power bus. In this way, demand-response fluctuations are absorbed not only by the local battery, but can be spread over all batteries in the system. By using a combination of voltage and current controlled units, we implemented a higher-level control software independent from the physical process. A further software layer for autonomous control handles power exchange based on a distributed multiagent system, using a peer-to-peer like architecture. In parallel to the software, we made a physical model of a four-node OES on which different power exchange strategies can be simulated and compared. First results show an improved solar replacement ratio, and thus a reduction of ac grid consumption thanks to power interchange. The concept's feasibility has been demonstrated on the first three houses of a full-scale OES platform in Okinawa.	[Werth, Annette; Kitamura, Nobuyuki; Tanaka, Kenji] Univ Tokyo, Grad Sch Engn, Tokyo 1138656, Japan; [Werth, Annette] Sony Comp Sci Labs Inc, Tokyo 1410022, Japan	Werth, A (reprint author), Univ Tokyo, Grad Sch Engn, Tokyo 1138656, Japan.	annette@csl.sony.co.jp			Subtropical and Island Energy Infrastructure Technology Research	This work was supported in part by the Subtropical and Island Energy Infrastructure Technology Research Subsidy Program of the Okinawa Prefectural Government.	Abe R, 2011, IEEE T SMART GRID, V2, P399, DOI 10.1109/TSG.2011.2132744; Alford R., 2012, POWER SYSTEMS FUTURE; [Anonymous], 2012, BID DC DC CONV, P1; Khayyer P, 2014, IEEE T SMART GRID, V5, P1300, DOI 10.1109/TSG.2014.2311093; Kok JK, 2010, INTEL SYST CONTR AUT, V42, P179, DOI 10.1007/978-90-481-3598-1_8; Farhangi H, 2010, IEEE POWER ENERGY M, V8, P18, DOI 10.1109/MPE.2009.934876; Logenthiran T, 2012, IEEE T SMART GRID, V3, P925, DOI 10.1109/TSG.2012.2189028; Justo JJ, 2013, RENEW SUST ENERG REV, V24, P387, DOI 10.1016/j.rser.2013.03.067; Dimeas AL, 2005, IEEE T POWER SYST, V20, P1447, DOI 10.1109/TPWRS.2005.852060; Asmus P., 2014, MICROGRIDS; Asmus P., 2013, MICROGRIDS; Barnes M., 2007, P IEEE INT C SYST SY, P1; Basso G., 2013, SMART GRID RENEW ENE, V4, P333; Brenna M., 2012, P IEEE PES INN SMART, P1; Dimeas A., 2004, P IEEE POW ENG SOC G, V2, P55; Donoho A., 2008, UPNP DEVICE ARCHITEC; Falvo M. C., 2011, P 10 INT C ENV EL EN, P1; Gross R. UKERC (Organization), 2006, COSTS IMPACTS INTERM; Jin C., 2010, P IEEE INT C SUST EN, P1, DOI 10.1145/1900008.1900073; Kakigano H., 2009, P TRANSM DISTR C EXP, P1; Kitamura N., 2014, P JSAE ANN C, P1; Lawrence M., 2013, DIRECT CURRENT DISTR; Lawrence M., 2014, VIRTUAL POWER PLANTS; Mariam Lubna, 2013, Journal of Engineering, DOI 10.1155/2013/937614; MIYAWAKI S, 2012, P 27 ANN IEEE APPL P, P547; Nikonowicz, 2012, J POWER TECHNOLOGIES, V92, P135; Pipattanasomporn M., 2009, POW SYST C EXP 2009, P1; Sonnenberg B. J., 2013, 380 VDC ARCHITECTURE; Tannenbaum A. S., 2007, DISTRIBUTED SYSTEMS, V17; The SGMM Team, 2011, CMUSEI2011TR025; Tokoro M., 2010, OPEN SYSTEMS SCI; Tokoro M., 2014, P 1 INT S OP EN SYST, P64; Yu XH, 2011, IEEE IND ELECTRON M, V5, P49, DOI 10.1109/MIE.2011.942176	33	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1949-3053	1949-3061		IEEE T SMART GRID	IEEE Trans. Smart Grid	JUL	2015	6	4					1621	1630		10.1109/TSG.2015.2408603		10	Engineering, Electrical & Electronic	Engineering	CL2XL	WOS:000356810900005		
J	Abu Jami'in, M; Sutrisno, I; Hu, JL				Abu Jami'in, Mohammad; Sutrisno, Imam; Hu, Jinglu			Maximum power tracking control for a wind energy conversion system based on a quasi-ARX neural network model	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						wind energy conversion system (WECS); quasi-ARX neural network; nonlinear parameter estimation; switching controller	MULTIPLE MODELS; PREDICTIVE CONTROL; NONLINEAR-SYSTEMS; GENERATOR	By itself, a wind turbine is already a fairly complex system with highly nonlinear dynamics. Changes in wind speed can affect the dynamic parameters of wind turbines, thus rendering the parameters uncertain. However, we can identify the dynamics of the wind energy conversion system (WECS) online by a quasi-ARX neural network (QARXNN) model. A QARXNN presents a problem in searching for the coefficients of the regression vector (input vector). A multilayer perceptron neural network (MLPNN) is an embedded system that provides the unknown parameters used to parameterize the input vector. Fascinatingly, the coefficients of the input vector from prediction model can be set as controller parameters directly. The stability of the closed-loop controller is guaranteed by the switching of the linear and nonlinear parts of the parameters. The dynamic of WECS is derived with given parameters, and then a wind speed signal created by a random model is fed to the system causing uncertainty parameters and reducing the power that can be absorbed from wind. By using a minimum variance controller, the maximum power is tracked from WECS. From the simulation results, it is observed that the proposed controller is effective in tracking the maximum power of WECS. (c) 2015 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Abu Jami'in, Mohammad; Sutrisno, Imam; Hu, Jinglu] Waseda Univ, Grad Sch Informat Prod & Syst, Wakamatsu Ku, Kitakyushu, Fukuoka 8080135, Japan; [Abu Jami'in, Mohammad; Sutrisno, Imam] Politekn Perkapalan Negeri Surabaya, Surabaya 60111, Jawa Timur, Indonesia	Hu, JL (reprint author), Waseda Univ, Grad Sch Informat Prod & Syst, Wakamatsu Ku, Hibikino 2-7, Kitakyushu, Fukuoka 8080135, Japan.	jinglu@waseda.jp			Indonesian Government Scholarship; Directorate General of Higher Education, Ministry of National Education; Shipbuilding Institute of Polytechnic Surabaya	This research was partly supported by the Indonesian Government Scholarship with Directorate General of Higher Education, Ministry of National Education, (Beasiswa Luar Negeri DIKTI Kementrian Pendidikan dan Kebudayaan Republik Indonesia) and the Shipbuilding Institute of Polytechnic Surabaya (Politeknik Perkapalan Negeri Surabaya PPNS).	Bose BK, 2010, IEEE IND ELECTRON M, V4, P6, DOI 10.1109/MIE.2010.935860; She Y, 2011, IEEE T ENERGY CONVER, V26, P766, DOI 10.1109/TEC.2011.2159607; Muhando EB, 2007, IET CONTROL THEORY A, V1, P1431, DOI 10.1049/iet-cta:20060448; Chai TY, 2011, IEEE T NEURAL NETWOR, V22, P2154, DOI 10.1109/TNN.2011.2167685; Mesemanolis A, 2012, IEEE T ENERGY CONVER, V27, P958, DOI 10.1109/TEC.2012.2213602; Kamal E, 2012, IEEE T SUSTAIN ENERG, V3, P231, DOI 10.1109/TSTE.2011.2178105; Billinton R, 2012, IEEE T POWER SYST, V27, P2297, DOI 10.1109/TPWRS.2012.2205022; Chen LJ, 2001, AUTOMATICA, V37, P1245, DOI 10.1016/S0005-1098(01)00072-3; Kamal E, 2013, INT J ELEC POWER, V44, P202, DOI 10.1016/j.ijepes.2012.07.009; Cheng Y., 2011, NONLINEAR THEORY ITS, V2, P165; Cheng Y, 2012, IEICE T FUND ELECTR, VE95A, P876, DOI 10.1587/transfun.E95.A.876; Fu Y, 2007, AUTOMATICA, V43, P1101, DOI 10.1016/j.automatica.2006.12.010; Hu JL, 2001, INT J CONTROL, V74, P1754, DOI 10.1080/00207170110089770; Jami'in MA, 2013, P IEEE INT JOINT C N, P2759; Jami'in MA, 2012, P IEEE INT C SYST MA, P3141; RAHMAN S, 1995, IEEE T ENERGY CONVER, V10, P307, DOI 10.1109/60.391897; Soliman M, 2011, IET RENEW POWER GEN, V5, P124, DOI 10.1049/iet-rpg.2009.0137; Wang L, 2010, SICE J CONTROL MEASU, V3, P246; Zhang YJ, 2010, IEEE T FUZZY SYST, V18, P1070, DOI 10.1109/TFUZZ.2010.2062524	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	JUL	2015	10	4					368	375		10.1002/tee.22095		8	Engineering, Electrical & Electronic	Engineering	CL2SV	WOS:000356795900003		
J	Zeng, AD; Xu, QS; Ding, MS; Yukita, K; Ichiyanagi, K				Zeng, Aidong; Xu, Qingshan; Ding, Maosheng; Yukita, Kazuto; Ichiyanagi, Katsuhiro			A classification control strategy for energy storage system in microgrid	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						storage classification control; wind-storage hybrid microgrid; Monte Carlo methods; energy storage system; distribution network reliability	POWER DISTRIBUTION NETWORKS; RELIABILITY TEST SYSTEM; DIESEL HYBRID SYSTEM; WIND POWER; TECHNOLOGIES; GENERATION	Storage devices are indispensable elements in a microgrid to compensate for the power imbalance between loads and the distributed generator (DG) output. Different storage strategies give diverse performances in adjustment speed and capacity. Based on the performance of different storage devices and the features of power imbalance curve in different periods, a classification control strategy is proposed in this paper. First, storage devices are given priorities according to the adjusting speed, and the power imbalance curve is divided into two periods according to the changing speed. During an emergency, all the storages are employed to compensate the rapidly increasing power imbalance; during the steady period, storage device with higher priority is employed to track the instantaneous component of power imbalance, while storage device with lower priority is used to replace the kWh output of higher priority storage. The proposed strategy is tested in a microgrid within the subdistribution network of IEEE RBTS Bus6 system using Monte Carlo methods. Simulation results indicate that the classification control strategy could endow the system with fast adjusting ability through coordination between storages. Reliability indices of the testing system are utilized to demonstrate that the classification control strategy could improve the stability of the microgrid and reliability of the distribution network. (c) 2015 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Zeng, Aidong; Xu, Qingshan] Southeast Univ, Sch Elect Engn, Nanjing 210096, Jiangsu, Peoples R China; [Ding, Maosheng] State Grid Ningxia Elect Power Co, Yinchuan 750001, Peoples R China; [Yukita, Kazuto; Ichiyanagi, Katsuhiro] Aichi Inst Technol, Dept Elect & Elect Engn, Toyota, Aichi 4700392, Japan	Xu, QS (reprint author), Southeast Univ, Sch Elect Engn, Sipailou 2, Nanjing 210096, Jiangsu, Peoples R China.	xuqingshan@seu.edu.cn			National Key Technology Research and Development Program of China [2013BAA01B00]; National Natural Science Foundation of China [51377021]; Natural Science Foundation of Jiangsu Province [BK2012753]; Science and Technology Project of State Grid Corporation of China [SGTJ0000KXJS1400087]; Qing Lan Project	This research was funded by National Key Technology Research and Development Program of China (No. 2013BAA01B00), National Natural Science Foundation of China (No. 51377021), Natural Science Foundation of Jiangsu Province (No. BK2012753), Science and Technology Project of State Grid Corporation of China(No. SGTJ0000KXJS1400087), and Qing Lan Project.	ALLAN RN, 1991, IEEE T POWER SYST, V6, P813, DOI 10.1109/59.76730; Grigg C, 1999, IEEE T POWER SYST, V14, P1010, DOI 10.1109/59.780914; Bae IS, 2007, IEEE T POWER SYST, V22, P785, DOI 10.1109/TPWRS.2007.894842; Diaz-Gonzalez F, 2012, RENEW SUST ENERG REV, V16, P2154, DOI 10.1016/j.rser.2012.01.029; Seguro JV, 2000, J WIND ENG IND AEROD, V85, P75, DOI 10.1016/S0167-6105(99)00122-1; Hadjipaschalis I, 2009, RENEW SUST ENERG REV, V13, P1513, DOI 10.1016/j.rser.2008.09.028; Yamegueu D, 2013, INT J ELEC POWER, V44, P267, DOI 10.1016/j.ijepes.2012.07.027; Heide D, 2011, RENEW ENERG, V36, P2515, DOI 10.1016/j.renene.2011.02.009; Billinton R, 1999, IEEE T POWER SYST, V14, P397, DOI 10.1109/59.761856; Di Fazio AR, 2013, J AMB INTEL HUM COMP, V4, P663, DOI 10.1007/s12652-013-0182-y; Hu P, 2009, IET GENER TRANSM DIS, V3, P783, DOI 10.1049/iet-gtd.2008.0639; Zhou ZB, 2013, RENEW SUST ENERG REV, V18, P390, DOI 10.1016/j.rser.2012.10.006; Bandara K, 2012, RENEW ENERG, V37, P82, DOI 10.1016/j.renene.2011.05.036; Balijepalli N, 2004, IEEE T POWER DELIVER, V19, P1950, DOI 10.1109/TPWRD.2004.829144; Bian HH, 2013, ELEKTRON ELEKTROTECH, V19, P47, DOI 10.5755/j01.eee.19.7.5161; Chen H, PROGR NATURAL SCI, V19, P291; Datta M, 2010, IEEJ T ELECTR ELECTR, V5, P677, DOI 10.1002/tee.20592; Datta M, 2011, ELECTR POW COMPO SYS, V39, P621, DOI 10.1080/15325008.2010.536809; Gkavanoudis SI, 2014, ELECTR POW SYST RES, V106, P62, DOI 10.1016/j.epsr.2013.08.007; Kumar D, 2014, INT J ELEC POWER, V57, P11, DOI 10.1016/j.ijepes.2013.11.039; Wang X, 2010, AUTOMATION ELECT POW, V4, P38; Yujun L, 2013, ELEKTRON ELEKTROTECH, V19, P13	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	JUL	2015	10	4					396	403		10.1002/tee.22099		8	Engineering, Electrical & Electronic	Engineering	CL2SV	WOS:000356795900007		
J	Ren, FJ; Wang, Y; Quan, CQ				Ren, Fuji; Wang, Yu; Quan, Changqin			TFSM-based dialogue management model framework for affective dialogue systems	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						dialogue management model; affective dialogue system; finite state machine; affective computing	POMDPS	A new dialogue management model for affective dialogue system, which aims to provide a service of information inquiry and affective interaction, is proposed in this paper. First, we construct two finite state machines (TFSM) to model the user and the system, respectively, and simulate the dialogue process as an information exchange between the two state machines. All possible state transitions in dialogue and its probabilities of the user are summarized as a user model, which is helpful for the system to inference and predict the user's internal states. Second, we further discuss the implementation methods of information inquiry and emotional response modules. Finally, we employ the return function of partially observable Markov decision processes (POMDP) model to analyze and evaluate the TFSM-based dialogue management model. The experimental results not only show the relationships between the average returns, recognition error rates, and state transition probabilities but also confirm that our TFSM-based dialogue management model outperforms the conventional FSM model. (c) 2015 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Ren, Fuji] Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan; [Ren, Fuji; Wang, Yu; Quan, Changqin] Hefei Univ Technol, Sch Comp & Informat, Hefei 230009, Peoples R China	Ren, FJ (reprint author), Univ Tokushima, Inst Sci & Technol, 2-1 Minamijyosanjima Cho, Tokushima 7708506, Japan.	ren@is.tokushima-u.ac.jp			Ministry of Education, Science, Sports and Culture [22240021]; National High-Tech Research & Development Program of China (863 Program) [2012AA011103]; National Natural Science Foundation of China [61432004]; ANHUI Province Key Laboratory of Affective Computing & Advanced Intelligent Machine [ACAIM150107]	This work was partially supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (A), 22240021, the National High-Tech Research & Development Program of China (863 Program, Grant No. 2012AA011103), and the National Natural Science Foundation of China (Grant No. 61432004). ANHUI Province Key Laboratory of Affective Computing & Advanced Intelligent Machine (Grant No. ACAIM150107).	Abe K, 2000, P 6 INT C SPOK LANG, P118; Andre E, 2004, LECT NOTES ARTIFICIA; Kim D, 2011, IEEE T AUDIO SPEECH, V19, P1029, DOI 10.1109/TASL.2010.2076394; Williams JD, 2007, IEEE T AUDIO SPEECH, V15, P2116, DOI 10.1109/TASL.2007.902050; Calvo RA, 2010, IEEE T AFFECT COMPUT, V1, P18, DOI 10.1109/T-AFFC.2010.1; Lee C, 2009, SPEECH COMMUN, V51, P466, DOI 10.1016/j.specom.2009.01.008; Levin E, 2000, IEEE T SPEECH AUDI P, V8, P11, DOI 10.1109/89.817450; Han MJ, 2013, IEEE T CYBERNETICS, V43, P1290, DOI 10.1109/TSMCB.2012.2228851; Lopatovska I, 2011, INFORM PROCESS MANAG, V47, P575, DOI 10.1016/j.ipm.2010.09.001; Williams JD, 2007, COMPUT SPEECH LANG, V21, P393, DOI 10.1016/j.csl.2006.06.008; Spaan MTJ, 2005, J ARTIF INTELL RES, V24, P195; Young S, 2013, P IEEE, V101, P1160, DOI 10.1109/JPROC.2012.2225812; Young Steve, 2010, Computer Speech and Language, V24, DOI 10.1016/j.csl.2009.04.001; Bui TH, 2007, NAT LANG ENG, V15, P273; Bui TH, 2010, INTERACTIVE COLLABOR, V281, P207, DOI 10.1007/978-3-642-11688-9_8; Callejas Z, 2011, EURASIP J ADV SIG PR, V6, P1; Lee C, 2008, INT C CONTR AUT SYST, P2038; Lee C., 2010, J COMPUT SCI ENG, V4, P1; Li J, 2013, IEEJ T ELECTR ELECTR, V8, P616, DOI 10.1002/tee.21905; Lopez-Cozar R, 2011, SPEECH COMMUN, V53, P1210, DOI 10.1016/j.specom.2011.01.006; Mariani J, 1998, P 1998 BROADC NEWS T, P247; Oh HJ, 2007, IEEE T CONSUM ELECTR, V53, P1602, DOI 10.1109/TCE.2007.4429258; Picard R. W., 1997, AFFECTIVE COMPUTING; Pittermann A, 2010, INT J SPEECH TECHNOL, V13, P49; Ren FJ, 2013, IEEE T AFFECT COMPUT, V4, P412, DOI 10.1109/T-AFFC.2013.22; Ren FJ, 2013, COMPUT SPEECH LANG, V27, P943, DOI 10.1016/j.csl.2012.07.012; Ren Fuji, 2009, J ELECT NOTES THEORE, V225, P39; Roy N., 2000, P 38 ANN M ASS COMP, P93, DOI DOI 10.3115/1075218.1075231; Skowron M, 2013, IEEE T AFFECT COMPUT, V4, P267, DOI 10.1109/T-AFFC.2013.16; Walker MA, 2002, DARPA COMMUNICATOR E, P273; Wang Y, 2012, P INT C NAT LANG PRO, P407; Williams J., 2005, P 4 WORKSH KNOWL REA, P76	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	JUL	2015	10	4					404	410		10.1002/tee.22100		7	Engineering, Electrical & Electronic	Engineering	CL2SV	WOS:000356795900008		
J	Cortez, R; Vazhenin, A				Cortez, Ruth; Vazhenin, Alexander			Virtual model-view-controller design pattern: Extended MVC for service-oriented architecture	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						service-oriented architecture; service-oriented engineering; Web services; design patterns; integration; interoperability		In the framework of service-oriented architecture (SOA), the initial stage of application development is a complex task due to the upfront costs, software redesign, and specialized skills. The focus of this study is on the formalization of a virtual model-view-controller (Virtual-MVC) design pattern to simplify the development of service-oriented applications for medium and small-sized enterprises. The Virtual-MVC pattern facilitates the implementation of service-oriented applications by abstracting the complex integration logic and service interface design from the developer's tasks. The main changes introduced by the Virtual-MVC pattern are the total decoupling of the View from the Model, whose links are reorganized within an enhanced Controller based on the enterprise service bus. The Controller is reinforced with dependency injection for service virtualization. In this paper, the description of a Virtual-MVC-based programming framework is formalized, and a standard functional classification of MVC-related patterns is proposed for comparison. The Virtual-MVC pattern is implemented into a software development framework, along with its corresponding programming strategy. The evaluation is performed through a study in a software engineering course at the University of Aizu, where services were designed following the Virtual-MVC programming approach. The results indicate a reduction of development complexity, while enforcing service design principles. (c) 2015 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Cortez, Ruth; Vazhenin, Alexander] Univ Aizu, Dept Comp Sci, Fukushima 9658580, Japan	Cortez, R (reprint author), Univ Aizu, Dept Comp Sci, Ikki Machi, Fukushima 9658580, Japan.	d8132103@u-aizu.ac.jp					Balani N, WEB SERVICES ARCHITE; Chapman M, 2009, SERVICE COMPONENT AR; Chappell DA., 2004, THEORY PRACTICE ENTE; Cohen F, 2006, BARTEL SERVICE GOVER; Crimson Consulting Group, 2011, OR SOA VS IBM SOA CU; Doshi K., 2009, ENTERPRISE SERVICE B; Dreibelbis A., 2008, ENTERPRISE MASTER DA; Erl T., 2009, SOA DESIGN PATTERNS; Fowler M, 2004, INVERSION CONTROL CO; Fowler M, 2006, GUI ARCHITECTURES; Gens F, 2011, TOP 10 IDC PREDICTIO; Krasner GE, 1988, DESCRIPTION MODEL VI; Microsoft MSDN, 2012, IMPL MVVM PATT; Microsoft MSDN, MOD VIEW PRES PATT; Ming-xia G, 2010, 2010 INT C ENV SCI I, V2, P391; MuleSoft, EV SOAH ORG DEV AG S; MuleSoft, 2014, TECHN SPECS CAP; Papazoglou MP, 2008, INT J COOP INF SYST, V17, P223, DOI 10.1142/S0218843008001816; Papazoglou MP, 2007, VLDB J, V16, P398; Rajam S, 2011, FRONT ARTIF INTEL AP, V231, P108, DOI 10.3233/978-1-60750-831-1-108; Ramsdale C, BUILDING MVP APPL; Shepherd P., 2009, ORACLE SCA POWER COM; Thorsten H, 2008, P 41 ANN HAW INT C S, P314; Zdun U, 2007, ACM T WEB, V1, DOI 10.1145/1281480.1281484	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	JUL	2015	10	4					411	422		10.1002/tee.22101		12	Engineering, Electrical & Electronic	Engineering	CL2SV	WOS:000356795900009		
J	Tamura, K; Makise, K; Yasuda, K				Tamura, Kenichi; Makise, Kengo; Yasuda, Keiichiro			Concept of feedback-controlled differential evolution and its realization	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						differential evolution; metaheuristics; multipoint search method; evolutionary computation; feedback control	OPTIMIZATION	This paper first proposes a novel concept of differential evolution (DE) with an automatic parameter adjustment that controls its search situation to be a promising situation by the error feedback. It is called feedback-controlled differential evolution (FCDE), whose adjustment mechanism consists of three parts: Evaluator, Referencer, and Controller. Evaluator calculates an evaluation index which measures the search situation. Referencer generates a reference index being a target of the evaluation index which corresponds to a promising situation. Controller operates the parameters to make the evaluation index follow the reference index using its error feedback. Further, this paper realizes a method in FCDE for a typical DE called DE/best/1/bin" by designing the three parts. The effectiveness of the proposed method is confirmed through various computational experiments from the viewpoints of controllability and performance. (c) 2015 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Tamura, Kenichi; Yasuda, Keiichiro] Tokyo Metropolitan Univ, Hachioji, Tokyo 1920397, Japan; [Makise, Kengo] Fuji Xerox Co Ltd, Minato Ku, Tokyo 1070052, Japan	Tamura, K (reprint author), Tokyo Metropolitan Univ, 1-1 Minamiosawa, Hachioji, Tokyo 1920397, Japan.	tamu@tmu.ac.jp					Das S, 2011, IEEE T EVOLUT COMPUT, V15, P4, DOI 10.1109/TEVC.2010.2059031; Zhang JQ, 2009, IEEE T EVOLUT COMPUT, V13, P945, DOI 10.1109/TEVC.2009.2014613; Qin AK, 2009, IEEE T EVOLUT COMPUT, V13, P398, DOI 10.1109/TEVC.2008.927706; Das S, 2005, GECCO 2005: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOLS 1 AND 2, P991; Yasuda K, 2008, IEEJ T ELECTR ELECTR, V3, P642, DOI 10.1002/tee.20326; Brest J, 2006, IEEE T EVOLUT COMPUT, V10, P646, DOI 10.1109/TEVC.2006.872133; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Liu J, 2005, SOFT COMPUT, V9, P448, DOI 10.1007/s00500-004-0363-x; Mori N., 2012, J I ELECT ENG JPN, V132, P767; Omran MGH, 2005, LECT NOTES ARTIF INT, V3801, P192; Price K., 2005, DIFFERENTIAL EVOLUTI; Storn RM, TR95012; Zaharie D., 2003, P 9 INT C SOFT COMP, P41; Zhang J, 2009, ADAPT LEARN OPTIM, V1, P1, DOI 10.1007/978-3-642-01527-4	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	JUL	2015	10	4					423	437		10.1002/tee.22102		15	Engineering, Electrical & Electronic	Engineering	CL2SV	WOS:000356795900010		
J	Han, HG; Higaki, Y				Han, Hugang; Higaki, Yuta			Polynomial fuzzy controller design with disturbance observer using the SOS-based approach	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						Polynomial fuzzy model; disturbance observer; sum of squares (SOS); asymptotical stability	DYNAMICAL-SYSTEMS; TRACKING CONTROL; ROBUST-CONTROL	The polynomial fuzzy model is an effective model to design a fuzzy controller for nonlinear systems. In order to improve the control performance, a so-called lumped disturbance is considered in the model. For countering the influence of the lumped disturbance, a new fuzzy disturbance observer (FDO) is proposed. Compared to the existing FDO, which is designed on the basis of an individual rule and whose estimate may not match the disturbance properly, the proposed method is able to follow the disturbance, in principle. As a result, the estimate of the new FDO is used directly to synthesize a part of controller along with the regular control input where such a disturbance is not considered. Finally, a set of conditions in the form of the sum of squares for the asymptotic stability of the closed-loop system is provided. (c) 2015 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Han, Hugang; Higaki, Yuta] Prefectural Univ Hiroshima, Dept Management & Informat Syst, Minami Ku, Hiroshima 7348558, Japan	Han, HG (reprint author), Prefectural Univ Hiroshima, Dept Management & Informat Syst, Minami Ku, 1-1-71 Ujina Higashi, Hiroshima 7348558, Japan.	hhan@pu-hiroshima.ac.jp					Yao B, 1997, IEEE-ASME T MECH, V2, P63; Kim E, 2002, IEEE T FUZZY SYST, V10, P77; Chen WH, 2004, IEEE-ASME T MECH, V9, P706, DOI 10.1109/TMECH.2004.839034; Kim E, 2005, IEEE T FUZZY SYST, V13, P725; Yang J, 2013, IEEE T IND ELECTRON, V60, P160, DOI 10.1109/TIE.2012.2183841; Tseng CS, 2001, IEEE T FUZZY SYST, V9, P381; Tanaka K, 2009, IEEE T FUZZY SYST, V17, P911, DOI 10.1109/TFUZZ.2008.924341; Yang J, 2011, IET CONTROL THEORY A, V5, P2053, DOI 10.1049/iet-cta.2010.0616; WANG LX, 1992, IEEE T NEURAL NETWOR, V3, P807, DOI 10.1109/72.159070; SOFFKER D, 1995, INT J SYST SCI, V26, P1571, DOI 10.1080/00207729508929120; Cao YY, 2000, IEEE T FUZZY SYST, V8, P406; Han H, 2009, J JAPAN SOC FUZZY TH, V21, P577; Han H, 2010, P 2010 IEEE WORLD C; Han H, 2014, P 2014 IEEE INT C FU; Prajna S., 2002, P 41 IEEE C DEC CONT; Soffker D., 1993, ASME J DYNAMIC SYSTE, V3, P518; TAKAGI T, 1985, IEEE T SYST MAN CYB, V15, P116; Tanaka K., 2001, FUZZY CONTROL SYSTEM	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	JUL	2015	10	4					458	464		10.1002/tee.22106		7	Engineering, Electrical & Electronic	Engineering	CL2SV	WOS:000356795900014		
J	Fukazawa, T; Kiyota, A; Ninagawa, C				Fukazawa, Taro; Kiyota, Akihisa; Ninagawa, Chuzo			Aggregated transfer function for smart grid FastADR feedback control of wide area distributed building facilities	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Letter						automated demand response; building air-conditioner; feedback control; transfer function		Feedback control of fast automated demand response (FastADR) is gaining much attention for load frequency control (LFC) of the future smart grids. We propose a single aggregated transfer function for feedback control of power consumption of a cluster of wide-area-distributed building air-conditioner facilities. An example of aggregated transfer function is derived from the measured step responses of the loads, and the effectiveness of the approximation for control properties is confirmed by simulations. (c) 2015 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Fukazawa, Taro; Kiyota, Akihisa; Ninagawa, Chuzo] Gifu Univ, Dept Elect & Elect Engn, Gifu 5011193, Japan	Ninagawa, C (reprint author), Gifu Univ, Dept Elect & Elect Engn, 1-1 Yanagido, Gifu 5011193, Japan.	ninagawa@gifu-u.ac.jp					Zhang W, 2013, IEEE T POWER SYST, V28, P4655, DOI 10.1109/TPWRS.2013.2266121; Braslavsky J, 2013, IEEE CDC2013, P6274; Hermans P, 2010, INT C EUR EN MARK; Kikuchi H, 2014, IEEJ POW EN SOC C, p[8, 19, 6]; Kiyota A, 2014, IEEJ IND APPL SOC C, pV267; Suzuki K, 2013, IEEE INT C INN SMART, P1	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	JUL	2015	10	4					487	489		10.1002/tee.22110		3	Engineering, Electrical & Electronic	Engineering	CL2SV	WOS:000356795900018		
J	Hiejima, E; Kawai, T; Nakase, H; Tsuruyama, T; Morimoto, T; Yasumi, T; Taga, T; Kanegane, H; Hori, M; Ohmori, K; Higuchi, T; Matsuura, M; Yoshino, T; Ikeuchi, H; Kawada, K; Sakai, Y; Kitazume, MT; Hisamatsu, T; Chiba, T; Nishikomori, R; Heike, T				Hiejima, Eitaro; Kawai, Tomoki; Nakase, Hiroshi; Tsuruyama, Tatsuaki; Morimoto, Takeshi; Yasumi, Takahiro; Taga, Takashi; Kanegane, Hirokazu; Hori, Masayuki; Ohmori, Katsuyuki; Higuchi, Takeshi; Matsuura, Minoru; Yoshino, Takuya; Ikeuchi, Hiroki; Kawada, Kenji; Sakai, Yoshiharu; Kitazume, Mina T.; Hisamatsu, Tadakazu; Chiba, Tsutomu; Nishikomori, Ryuta; Heike, Toshio			Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease	INFLAMMATORY BOWEL DISEASES			English	Article						inflammatory bowel disease; human; mucosal-associated invariant T cells	ULCERATIVE-COLITIS; MAIT CELLS; MULTIPLE-SCLEROSIS; CROHNS-DISEASE; HIV-INFECTION; PATHOGENESIS; ALPHA(4)BETA(7); EXPRESSION; INHIBITOR; DYSBIOSIS	Background:Mucosal-associated invariant T (MAIT) cells are innate-like T cells involved in the homeostasis of mucosal immunity; however, their role in inflammatory bowel disease (IBD) is unclear.Methods:Flow cytometry was used to enumerate peripheral blood MAIT cells in 88 patients with ulcerative colitis (UC), 68 with Crohn's disease (CD), and in 57 healthy controls. Immunohistochemistry identified MAIT cells in intestinal tissue samples from patients with UC (n = 5) and CD (n = 10), and in control colon (n = 5) and small intestine (n = 9) samples. In addition, expression of activated caspases by MAIT cells in the peripheral blood of 14 patients with UC and 15 patients with CD, and 16 healthy controls was examined.Results:Peripheral blood analysis revealed that patients with IBD had significantly fewer MAIT cells than healthy controls (P < 0.0001). The number of MAIT cells in the inflamed intestinal mucosae of patients with UC and CD was also lower than that in control mucosae (P = 0.0079 and 0.041, respectively). The number of activated caspase-expressing MAIT cells in the peripheral blood of patients with UC and CD was higher than that in healthy controls (P = 0.0061 and 0.0075, respectively), suggesting that the reduced MAIT cell numbers in IBD are associated with an increased level of apoptosis among these cells.Conclusions:The number of MAIT cells in the peripheral blood and inflamed mucosae of patients with UC and CD was lower than that in non-IBD controls. Also, MAIT cells from patients with IBD exhibited proapoptotic features. These data suggest the pathological involvement and the potential for therapeutic manipulation of these cells in patients with IBD.	[Hiejima, Eitaro; Kawai, Tomoki; Yasumi, Takahiro; Hori, Masayuki; Nishikomori, Ryuta; Heike, Toshio] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto 6068507, Japan; [Nakase, Hiroshi; Matsuura, Minoru; Yoshino, Takuya; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto 6068507, Japan; [Tsuruyama, Tatsuaki] Kyoto Univ, Grad Sch Med, Dept Anat Forens Med & Pathol Studies, Kyoto 6068507, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Div Gen Med, Dept Internal Med, Nishinomiya, Hyogo, Japan; [Taga, Takashi] Toyama Univ, Dept Pediat, Toyama 930, Japan; [Kanegane, Hirokazu] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga, Japan; [Kanegane, Hirokazu] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan; [Ohmori, Katsuyuki; Higuchi, Takeshi] Kyoto Univ Hosp, Dept Clin Lab, Kyoto 606, Japan; [Ikeuchi, Hiroki] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan; [Kawada, Kenji; Sakai, Yoshiharu] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto 6068507, Japan; [Kitazume, Mina T.; Hisamatsu, Tadakazu] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol, Kyoto, Japan	Kawai, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	tom0818@kuhp.kyoto-u.ac.jp			 [839120600005];  [264461582]	Grant Support: This work was supported by Grant-in-Aid for Research Activity start-up (ID 839120600005) and Grant-in-Aid for Scientific Research (C) (ID 264461582). The authors have no conflicts of interest to disclose.	Abrahamsson SV, 2013, BRAIN, V136, P2888, DOI 10.1093/brain/awt182; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Yang X, 2012, J CLIN IMMUNOL, V32, P411, DOI 10.1007/s10875-011-9638-z; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Schmid JP, 2011, BLOOD, V117, P1522, DOI 10.1182/blood-2010-07-298372; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Filipovich AH, 2010, BLOOD, V116, P3398, DOI 10.1182/blood-2010-03-275909; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Miyazaki Y, 2011, INT IMMUNOL, V23, P529, DOI 10.1093/intimm/dxr047; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Chinen H, 2007, GASTROENTEROLOGY, V133, P559, DOI 10.1053/j.gastro.2007.05.017; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Serriari NE, 2014, CLIN EXP IMMUNOL, V176, P266, DOI 10.1111/cei.12277; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Souza HS, 1999, GUT, V45, P856; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Meenan J, 1997, GUT, V40, P241; Deveraux QL, 1997, NATURE, V388, P300; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Sakuraba A, 2009, GASTROENTEROLOGY, V137, P1736, DOI 10.1053/j.gastro.2009.07.049; Gerart S, 2013, BLOOD, V121, P614, DOI 10.1182/blood-2012-09-456095; HARVEY RF, 1980, LANCET, V1, P514; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Broadhurst MJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001500; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; GARDINER KR, 1995, GUT, V36, P897, DOI 10.1136/gut.36.6.897; Godfrey DI, 2010, NAT IMMUNOL, V11, P693, DOI 10.1038/ni0810-693; Jager S, 2013, LANGENBECK ARCH SURG, V398, P1, DOI 10.1007/s00423-012-1030-9; Kempster SL, 2014, GUT, V63, P1377, DOI 10.1136/gutjnl-2013-305967; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Mora JR, 2006, CURR TOP MICROBIOL, V308, P83; RACHMILEWITZ D, 1989, BRIT MED J, V298, P82; Tamboli CP, 2004, GUT, V53, P1057	40	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-0998	1536-4844		INFLAMM BOWEL DIS	Inflamm. Bowel Dis.	JUL	2015	21	7					1529	1540		10.1097/MIB.0000000000000397		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL0BA	WOS:000356602200006		
J	Ando, K; Fujiya, M; Konishi, H; Ueno, N; Inaba, Y; Moriichi, K; Ikuta, K; Tanabe, H; Ohtake, T; Kohgo, Y				Ando, Katsuyoshi; Fujiya, Mikihiro; Konishi, Hiroaki; Ueno, Nobuhiro; Inaba, Yuhei; Moriichi, Kentaro; Ikuta, Katsuya; Tanabe, Hiroki; Ohtake, Takaaki; Kohgo, Yutaka			Heterogeneous Nuclear Ribonucleoprotein A1 Improves the Intestinal Injury by Regulating Apoptosis Through Trefoil Factor 2 in Mice with Anti-CD3-induced Enteritis	INFLAMMATORY BOWEL DISEASES			English	Article						heterogeneous nuclear ribonucleoprotein A1; trefoil factor 2; apoptosis; anti-CD3 antibody; inflammatory bowel diseases	SYSTEMIC LUPUS-ERYTHEMATOSUS; EPIDERMAL-GROWTH-FACTOR; INDUCED MUCOSAL DAMAGE; NECROSIS-FACTOR-ALPHA; VERSUS-HOST-DISEASE; ULCERATIVE-COLITIS; EPITHELIAL-CELLS; MESSENGER-RNA; HNRNP A1; CROHNS-DISEASE	Background:The role of hnRNP A1 in the onset of intestinal inflammation remains unclear. This study investigated the function of hnRNP A1 in mice enteritis models.Methods:C57Bl6/J mice were intraperitoneally injected with anti-CD3 antibodies to develop enteritis. In the DSS-induced colitis group, the mice were allowed free access to 3% DSS solution in their drinking water for 5 days. H-3-mannitol flux and complementary DNA array tests were used to assess the intestinal barrier function and messenger RNA (mRNA) expression, respectively. Real-time PCR was performed after immunoprecipitation with anti-hnRNP antibodies to determine the specific mRNA binding of hnRNP A1.Results:The hnRNP A1 expression was increased in the intestine of the mouse at 24 hours after treatment with anti-CD3 antibodies and 5 days after starting DSS administration. Small interfering RNA (siRNA) against hnRNP A1 exacerbated the intestinal injuries in both models. According to the microarray analysis, trefoil factor 2 (TFF2) was identified as a candidate molecule targeted by hnRNP A1 in the anti-CD3 antibody-induced enteritis group. Moreover, the binding between hnRNP A1 and TFF2 mRNA significantly increased in the enteritis mice, and the administration of siRNA against either hnRNP A1 or TFF2 exacerbated the degree of intestinal injury. In the DSS-induced colitis group, treatment with the siRNA of hnRNP A1 worsened the intestinal injury, while the expression of TFF3 did not change.Conclusions:hnRNP A1 improves intestinal injury in anti-CD3 antibody-induced enteritis mice through the upregulation of TFF2, which regulates apoptosis and enhances epithelial restoration, whereas this molecule ameliorates DSS-induced colitis through a different pathway.	[Ando, Katsuyoshi; Fujiya, Mikihiro; Konishi, Hiroaki; Ueno, Nobuhiro; Inaba, Yuhei; Moriichi, Kentaro; Ikuta, Katsuya; Ohtake, Takaaki; Kohgo, Yutaka] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido 0788510, Japan; [Ando, Katsuyoshi; Tanabe, Hiroki] Int Hlth & Sci Univ Hosp, Dept Gastroenterol, Nasushiobara, Japan	Fujiya, M (reprint author), Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	fjym@asahikawa-med.ac.jp					ALISON MR, 1995, J PATHOL, V175, P405, DOI 10.1002/path.1711750408; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; HALL PA, 1994, J CELL SCI, V107, P3569; Iwamoto M, 1996, J PATHOL, V180, P152; MACDONALD TT, 1988, J EXP MED, V167, P1341, DOI 10.1084/jem.167.4.1341; SUEMORI S, 1991, P NATL ACAD SCI USA, V88, P11017, DOI 10.1073/pnas.88.24.11017; Dubeykovskaya Z, 2009, J BIOL CHEM, V284, P3650, DOI 10.1074/jbc.M804935200; Madsen J, 2007, J HISTOCHEM CYTOCHEM, V55, P505, DOI 10.1369/jhc.6A7100.2007; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Lichtenberger GS, 2004, INFLAMM BOWEL DIS, V10, pS58, DOI 10.1097/00054725-200402001-00012; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Longman RJ, 2000, GUT, V47, P792, DOI 10.1136/gut.47.6.792; STEINER G, 1992, J CLIN INVEST, V90, P1061, DOI 10.1172/JCI115921; Ueyama H, 1998, GUT, V43, P48; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Kyburz A, 2006, MOL CELL, V23, P195, DOI 10.1016/j.molcel.2006.05.037; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; BURD CG, 1994, EMBO J, V13, P1197; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632; Irmler M, 1997, NATURE, V388, P190; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Fan HK, 2012, INFLAMMATION, V35, P130, DOI 10.1007/s10753-011-9297-5; Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331; HASSFELD W, 1995, ARTHRITIS RHEUM, V38, P777, DOI 10.1002/art.1780380610; Di Sabatino A, 2003, DIS COLON RECTUM, V46, P1498, DOI 10.1097/01.DCR.0000089118.20964.12; Guy-Grand D, 1998, EUR J IMMUNOL, V28, P730, DOI 10.1002/(SICI)1521-4141(199802)28:02<730::AID-IMMU730>3.0.CO;2-U; WRIGHT NA, 1990, J PATHOL, V162, P279, DOI 10.1002/path.1711620402; Merger M, 2002, GUT, V51, P155, DOI 10.1136/gut.51.2.155; Strater J, 1997, GASTROENTEROLOGY, V113, P160, DOI 10.1016/S0016-5085(97)70091-X; Hagiwara C, 2002, J GASTROEN HEPATOL, V17, P758, DOI 10.1046/j.1440-1746.2002.02791.x; Brown GR, 1999, GASTROENTEROLOGY, V116, P593, DOI 10.1016/S0016-5085(99)70181-2; Caprioli F, 2008, GUT, V57, P1674, DOI 10.1136/gut.2008.149286; Croitoru K, 2004, CURR OPIN GASTROEN, V20, P581, DOI 10.1097/00001574-200411000-00013; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Fiset S, 2001, NUCLEIC ACIDS RES, V29, P2268, DOI 10.1093/nar/29.11.2268; Fujiya M, 2014, ONCOGENE, V33, P4847, DOI 10.1038/onc.2013.429; HANBY AM, 1993, J PATHOL, V171, P3, DOI 10.1002/path.1711710103; LEFEBVRE O, 1993, J CELL BIOL, V122, P191, DOI 10.1083/jcb.122.1.191; Miura N, 2005, INT IMMUNOL, V17, P513, DOI 10.1093/intimm/dxh231; ONEILL TW, 1993, CLIN EXP RHEUMATOL, V11, P409; PODOLSKY DK, 1993, J BIOL CHEM, V268, P6694; Sakai T, 1997, GASTROENTEROLOGY, V113, P168, DOI 10.1016/S0016-5085(97)70092-1; SMOLEN JS, 1990, CLIN EXP RHEUMATOL, V8, P41; WRIGHT NA, 1993, GASTROENTEROLOGY, V104, P12; Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806	49	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-0998	1536-4844		INFLAMM BOWEL DIS	Inflamm. Bowel Dis.	JUL	2015	21	7					1541	1552		10.1097/MIB.0000000000000401		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CL0BA	WOS:000356602200007		
J	Skellett, S; Nitta, M; Berg, RA				Skellett, Sophie; Nitta, Masahiko; Berg, Robert A.			Neuropsychologic outcomes from paediatric cardiac arrest: an important step forward	INTENSIVE CARE MEDICINE			English	Editorial Material							AMERICAN-HEART-ASSOCIATION; PERFORMANCE CATEGORY; FOLLOW-UP; RESUSCITATION; CHILDREN; CARE; GUIDELINES		[Skellett, Sophie] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Nitta, Masahiko] Osaka Med Coll, Dept Emergency Med, Takatsuki, Osaka 5698686, Japan; [Berg, Robert A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Berg, Robert A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Berg, RA (reprint author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	bergra@email.chop.edu					Moler FW, 2009, CRIT CARE MED, V37, P2259, DOI 10.1097/CCM.0b013e3181a00a6a; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Nitta M, 2011, PEDIATRICS, V128, pE812, DOI 10.1542/peds.2010-3886; Fiser DH, 2000, CRIT CARE MED, V28, P2616; Atkins DL, 2009, CIRCULATION, V119, P1484, DOI 10.1161/CIRCULATIONAHA.108.802678; Berg MD, 2010, CIRCULATION, V122, pS862, DOI 10.1161/CIRCULATIONAHA.110.971085; Girotra S, 2013, CIRC-CARDIOVASC QUAL, V6, P42, DOI 10.1161/CIRCOUTCOMES.112.967968; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Maryniak A, 2008, RESUSCITATION, V77, P46, DOI 10.1016/j.resuscitation.2007.10.024; MORRIS RD, 1993, J LEARN DISABIL, V26, P46; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Suominen PK, 2014, RESUSCITATION, V85, P1059, DOI 10.1016/j.resuscitation.2014.03.307; van Zellem L, 2015, INTENS CARE MED, DOI [10.1007/s00134-015-3789-y, DOI 10.1007/S00134-015-3789-Y]	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	JUL	2015	41	7					1307	1309		10.1007/s00134-015-3910-2		3	Critical Care Medicine	General & Internal Medicine	CL4UY	WOS:000356952200013		
J	Bennett, JA; Sanada, S; Selig, MK; Hariri, LP; Nielsen, GP; Oliva, E				Bennett, Jennifer A.; Sanada, Sakiko; Selig, Martin K.; Hariri, Lida P.; Nielsen, Gunnlaugur P.; Oliva, Esther			Giant Cell Tumor of the Uterus: A Report of 3 Cases With a Spectrum of Morphologic Features	INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY			English	Article						Giant cell tumor; Osteoclast-like giant cells; Uterine carcinoma and; or sarcoma	UNDIFFERENTIATED PLEOMORPHIC SARCOMA; INFLAMMATORY MYOFIBROBLASTIC TUMOR; MALIGNANT FIBROUS HISTIOCYTOMA; OF-THE-LITERATURE; SOFT-TISSUE; UTERINE LEIOMYOSARCOMA; SMOOTH-MUSCLE; BONE-TUMORS; H-CALDESMON; CYCLIN D1	Giant cell tumors, a well-recognized neoplasm of bone, can rarely be found in the uterus. Such tumors are characterized by a dual population of mononuclear and osteoclast-like giant cells that lack epithelial and specific mesenchymal differentiation. In this study, the clinicopathologic features of 3 giant cell tumors of the uterus were reviewed. Immunohistochemistry for CD68, CD163, h-caldesmon, desmin, SMA, AE1/AE3, CD10, ER, PR, cyclin D1, CD1a, CD34, CD30, S100, myogenin/myoglobin, and Ki-67 was performed in all tumors, along with ultrastructural analysis in one. The patients were 47, 57, and 59 yr and the tumors measured 2.5, 7.5, and 16.0 cm. One neoplasm was confined to the endometrium, whereas the other 2 were myometrial. All 3 tumors showed a nodular growth comprised of mononuclear and osteoclast-like giant cells. The endometrial-confined tumor consisted of histologically benign mononuclear cells, whereas the others exhibited marked atypia. Mitotic activity was up to 5/10 HPF in the benign tumor and up to 22/10 HPF in the malignant. No cytologic atypia or mitoses were observed in the giant cells. CD68 and CD10 were strongly and diffusely expressed in both components of 3 and 2 neoplasms, respectively. Cyclin D1 was focal in the mononuclear cells and focal to diffuse in the giant cells. CD163 was diffuse in the mononuclear cells, but absent to focal in the giant cells. Ultrastructural analysis lacked diagnostic features of epithelial or specific mesenchymal differentiation. Both malignant tumors demonstrated an aggressive behavior. In summary, although rare, giant cell tumor of the uterus should be included in the differential diagnosis of benign or malignant tumors containing osteoclast-like giant cells.	[Bennett, Jennifer A.; Selig, Martin K.; Hariri, Lida P.; Nielsen, Gunnlaugur P.; Oliva, Esther] Massachusetts Gen Hosp, James Homer Wright Pathol Labs, Boston, MA 02114 USA; [Bennett, Jennifer A.; Selig, Martin K.; Hariri, Lida P.; Nielsen, Gunnlaugur P.; Oliva, Esther] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Sanada, Sakiko] Kurume Univ, Sch Med, Dept Pathol, Fukuoka, Japan	Bennett, JA (reprint author), Lahey Hosp & Med Ctr, Dept Pathol, 41 Mall Rd, Burlington, MA 01805 USA.	Jennifer.A.Bennett@lahey.org					Albores-Saavedra J, 2006, AM J SURG PATHOL, V30, P495, DOI 10.1097/00000478-200604000-00010; Hemingway F, 2012, VIRCHOWS ARCH, V460, P525, DOI 10.1007/s00428-012-1235-x; Aru A, 2001, ACTA OBSTET GYN SCAN, V80, P371, DOI 10.1034/j.1600-0412.2001.080004371.x; Alberghini M, 2010, VIRCHOWS ARCH, V456, P97, DOI 10.1007/s00428-009-0863-2; Imura J, 2005, APMIS, V113, P140, DOI 10.1111/j.1600-0463.2005.apm1130208.x; PILON VA, 1986, GYNECOL ONCOL, V23, P381, DOI 10.1016/0090-8258(86)90142-3; Rabban JT, 2005, AM J SURG PATHOL, V29, P1348, DOI 10.1097/01.pas.0000172189.02424.91; Chiang S, 2013, HISTOPATHOLOGY, V62, P124, DOI 10.1111/his.12048; CHEN KK, 1995, AM J SURG PATHOL, V19, P487, DOI 10.1097/00000478-199504000-00017; Olivera P, 2002, HUM PATHOL, V33, P165, DOI 10.1053/hupa.2002.31476; Lee CH, 2012, AM J SURG PATHOL, V36, P1562, DOI 10.1097/PAS.0b013e31825fa931; Manglik N, 2012, INT J SURG PATHOL, V20, P618, DOI 10.1177/1066896912436554; Sukpan Kornkanok, 2010, Journal of the Medical Association of Thailand, V93, P510; Patai K, 2006, GYNECOL ONCOL, V102, P403, DOI 10.1016/j.ygyno.2006.02.030; DARBY AJ, 1975, CANCER, V36, P495, DOI 10.1002/1097-0142(197508)36:2<495::AID-CNCR2820360228>3.0.CO;2-I; MARSHALL RJ, 1986, INT J GYNECOL PATHOL, V5, P260, DOI 10.1097/00004347-198609000-00008; Lee CH, 2012, AM J SURG PATHOL, V36, P641, DOI 10.1097/PAS.0b013e31824a7b1a; Watanabe K, 1996, PATHOL INT, V46, P656, DOI 10.1111/j.1440-1827.1996.tb03668.x; Ceballos KM, 2000, AM J CLIN PATHOL, V114, P746; Maruno M, 2006, BRAIN TUMOR PATHOL, V23, P65, DOI 10.1007/s10014-006-0200-2; FUJII S, 1987, GYNECOL ONCOL, V26, P319, DOI 10.1016/0090-8258(87)90024-2; Luo XP, 2010, J MINIM INVAS GYN, V17, P30, DOI 10.1016/j.jmig.2009.09.012; Amant F, 2006, EUR J GYNAECOL ONCOL, V27, P92; Folpe AL, 2005, AM J SURG PATHOL, V29, P1558, DOI 10.1097/01.pas.0000173232.22117.37; Downes KA, 1997, AM J SURG PATHOL, V21, P1261, DOI 10.1097/00000478-199711000-00001; Azuno Y, 2003, AM J OBSTET GYNECOL, V189, P890, DOI 10.1067/S0002-9378(03)00208-4; van Meurs HS, 2012, ANN DIAGN PATHOL, V16, P67, DOI 10.1016/j.anndiagpath.2010.11.010; SIEINSKI W, 1990, CANCER, V65, P1838, DOI 10.1002/1097-0142(19900415)65:8<1838::AID-CNCR2820650829>3.0.CO;2-1; Balbi G, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-21; Bardarov S, 2011, PATHOLOG RES INT, V2011; Behzatoglu K, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-48; Chan JKC, 1999, HISTOPATHOLOGY, V34, P266; Ciavarella P, 1997, CURR EYE RES, V16, P111, DOI 10.1076/ceyr.16.2.111.5094; CLEMENT PB, 1988, ARCH PATHOL LAB MED, V112, P566; DOUSSIS IA, 1992, J CLIN PATHOL, V45, P398, DOI 10.1136/jcp.45.5.398; EGOROV VP, 1983, ARK PATOL, V45, P78; Fadare O, 2003, AM J SURG PATHOL, V27, P854, DOI 10.1097/00000478-200306000-00021; Fadare Oluwole, 2005, Ann Diagn Pathol, V9, P160, DOI 10.1016/j.anndiagpath.2005.03.002; Fadare O, 2010, INT J GYNECOL PATHOL, V29, P122, DOI 10.1097/PGP.0b013e3181bc98c0; Fletcher CDM, 2013, PATHOLOGY GENETICS T; Folpe AL, 1999, MODERN PATHOL, V12, P894; Fu Kai, 2002, Ann Diagn Pathol, V6, P100, DOI 10.1053/adpa.2002.32376; GILKS CB, 1987, INT J GYNECOL PATHOL, V6, P275, DOI 10.1097/00004347-198709000-00008; GUCCION JG, 1972, CANCER, V29, P1518, DOI 10.1002/1097-0142(197206)29:6<1518::AID-CNCR2820290616>3.0.CO;2-#; Haque Anwar Ul, 2008, Int J Clin Exp Pathol, V1, P489; Hirano Atsuyuki, 2011, Nihon Shokakibyo Gakkai Zasshi, V108, P1705; KAWAI K, 1989, Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie, V135, P743; Kim HS, 2009, HEPATOB PANCREAT DIS, V8, P541; KINDBLOM LG, 1981, ACTA PATH MICRO IM A, V89, P179; Li Yuan, 2011, Zhonghua Bing Li Xue Za Zhi, V40, P363; LORENTZEN M, 1980, VIRCHOWS ARCH A, V388, P113, DOI 10.1007/BF00430681; Maggiani F, 2011, J CLIN PATHOL, V64, P701, DOI 10.1136/jcp.2011.090852; Magni E, 1991, APMIS Suppl, V23, P113; Masui F, 1998, PATHOL INT, V48, P355; Mendenhall WM, 2006, AM J CLIN ONCOL-CANC, V29, P96, DOI 10.1097/01.coc.0000195089.11620.b7; O'Connell JX, 2000, AM J SURG PATHOL, V24, P386, DOI 10.1097/00000478-200003000-00007; Oliveira AM, 2000, AM J SURG PATHOL, V24, P248, DOI 10.1097/00000478-200002000-00011; Orosz Z, 1996, PATHOL ONCOL RES, V2, P84; Roux S, 2002, AM J CLIN PATHOL, V117, P210; SALM R, 1972, J PATHOL, V107, P27, DOI 10.1002/path.1711070106; Shintaku M, 2006, PATHOL INT, V56, P625, DOI 10.1111/j.1440-1827.2006.02018.x; Shiozawa Manabu, 2002, Int J Clin Oncol, V7, P376, DOI 10.1007/s101470200059; Skubitz KM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-46; Vered M, 2008, HISTOL HISTOPATHOL, V23, P1151; Watanabe K, 2000, AM J CLIN PATHOL, V113, P663; Wieneke JA, 2001, MODERN PATHOL, V14, P1209, DOI 10.1038/modpathol.3880462	66	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-1691	1538-7151		INT J GYNECOL PATHOL	Int. J. Gynecol. Pathol.	JUL	2015	34	4					340	350		10.1097/PGP.0000000000000164		11	Obstetrics & Gynecology; Pathology	Obstetrics & Gynecology; Pathology	CK9VU	WOS:000356588400005		
J	Asaka, S; Yoshizawa, A; Sano, K; Uhara, H; Honda, T; Ota, H				Asaka, Shiho; Yoshizawa, Akihiko; Sano, Kenji; Uhara, Hisashi; Honda, Takayuki; Ota, Hiroyoshi			A Case of Vulval Extramammary Paget Disease With Dermal Invasion Showing Mucinous Carcinoma	INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY			English	Article						Extramammary Paget disease; Mucinous carcinoma; Invasion; Differential diagnosis	MAMMARY-LIKE GLANDS; ADENOCARCINOMA; EXPRESSION	We report a case of vulval extramammary Paget disease (EMPD) with dermal invasion showing mucinous carcinoma (MC). An 80-year-old woman presented with vulvar itching and pain. A physical examination showed a pigmented vulvar, perianal erythematous plague, and a subcutaneous nodule in the left major labia. No internal malignancy, such as colorectal or genitourinary carcinoma, was identified in any of the clinical examinations. A histological examination of the resected specimen revealed Pagetoid tumor cells that had spread widely through the epidermis and invaded the dermis forming a solid nest with mucous lake-like MC. Immunohistochemical examination revealed that the tumor cells in the epidermis and dermis were positive for CK7, CEA, GCDFP-15, MUC5AC, and MUC2, but negative for CK20, MUC6, and CDX2. Only the invasive component showed overexpression of p53. A diagnosis of primary EMPD with dermal invasion showing MC of the vulva was made. This is an extremely rare diagnosis, and we suggest that immunohistochemical evaluations in addition to systemic work-ups are helpful in distinguishing between these cases and those involving vulvar or perianal skin invasion of underlying colorectal or genitourinary carcinomas, which are referred to as secondary EMPD.	[Asaka, Shiho; Yoshizawa, Akihiko; Sano, Kenji; Honda, Takayuki] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; [Uhara, Hisashi] Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano 390, Japan; [Ota, Hiroyoshi] Shinshu Univ, Sch Med, Sch Hlth Sci, Dept Biomed Sci, Matsumoto, Nagano 390, Japan	Yoshizawa, A (reprint author), Shinshu Univ Hosp, Dept Lab Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	akyoshi@shinshu-u.ac.jp					Abbott JJ, 2006, AM J DERMATOPATH, V28, P127, DOI 10.1097/01.dad.0000171601.25315.2b; VANDERPUTTE SCJ, 1994, INT J GYNECOL PATHOL, V13, P150, DOI 10.1097/00004347-199404000-00009; Matin RN, 2011, AM J DERMATOPATH, V33, P705, DOI 10.1097/DAD.0b013e3181f9c83d; Belousova IE, 2006, AM J DERMATOPATH, V28, P84, DOI 10.1097/01.dad.0000194052.65695.f1; Shiomi T, 2013, J EUR ACAD DERMATOL, V27, P589, DOI 10.1111/j.1468-3083.2012.04489.x; Fanning J, 1999, AM J OBSTET GYNECOL, V180, P24, DOI 10.1016/S0002-9378(99)70143-2; Karam A, 2012, GYNECOL ONCOL, V125, P346, DOI 10.1016/j.ygyno.2012.01.032; Goldblum JR, 1998, AM J SURG PATHOL, V22, P170, DOI 10.1097/00000478-199802000-00004; Kondo Y, 2002, AM J SURG PATHOL, V26, P617, DOI 10.1097/00000478-200205000-00007; Kuan SF, 2001, AM J SURG PATHOL, V25, P1469, DOI 10.1097/00000478-200112000-00001; LeBoit PE, 2006, PATHOLOGY GENETICS S; Pascual JC, 2008, CLIN EXP DERMATOL, V33, P595, DOI 10.1111/j.1365-2230.2008.02731.x; Patterson JW, 2006, NONMELANOCYTIC TUMOR; Taniyama K, 1988, Gan No Rinsho, V34, P379; Zhang CX, 2003, HUM PATHOL, V34, P880, DOI 10.1016/S0046-8177(03)00289-2	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-1691	1538-7151		INT J GYNECOL PATHOL	Int. J. Gynecol. Pathol.	JUL	2015	34	4					396	400		10.1097/PGP.0000000000000169		5	Obstetrics & Gynecology; Pathology	Obstetrics & Gynecology; Pathology	CK9VU	WOS:000356588400014		
J	Imoto, A; Matsuyama, A; Ambauen-Berger, B; Honda, S				Imoto, Atsuko; Matsuyama, Aldko; Ambauen-Berger, Beatrice; Honda, Sumihisa			Health-related quality of life among women in rural Bangladesh after surgical repair of obstetric fistula	INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS			English	Article						Bangladesh; Obstetric fistula; Quality of life; Repair surgery	MENTAL-HEALTH; FOLLOW-UP; SF-36; ETHIOPIA; SURGERY	Objective: To identify factors influencing health-related quality of life (QOL) among women in Bangladesh after successful surgical repair of obstetric fistula. Methods: In 2012, a cross-sectional study was conducted of women who had undergone a successful surgical repair of an obstetric fistula at a hospital in northwest Bangladesh between June 2005 and May 2012. Sociodemographic, obstetric, and fistula-related information was collected by interview. Health-related QOL was assessed using the 36-item Short Form Health Survey (SF-36). Results: A total of 113 women were included. Linear regression analysis showed that discrimination experiences negatively affected four of the eight scales of SF-36, as well as both the physical and mental component summaries (P < 0.05 for all). Married status had a positive effect on four scales and the mental component summary (P < 0.05 for all). Age inversely affected two scales and the physical component summary (P < 0.01 for all). Internalized stigma negatively influenced two scales (P < 0.05 for both). Not having living children and experiencing two or more previous stillbirths negatively influenced one scale (P < 0.05 for both). Conclusion: Several factors influence health-related QOL after obstetric fistula repair; a comprehensive approach is needed to address these issues. (C) 2015 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.	[Imoto, Atsuko; Honda, Sumihisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Community Based Rehabil Sci, Nagasaki 8528523, Japan; [Matsuyama, Aldko] Nagasaki Univ, Grad Sch Int Hlth Dev, Dept Int Hlth Dev, Nagasaki 8528523, Japan; [Ambauen-Berger, Beatrice] LAMB Hosp, Integrated Rural Hlth & Dev Project, Dept Obstet & Gynaecol, Dinajpur, Bangladesh	Imoto, A (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Community Based Rehabil Sci, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	imotoatsuko@hotmail.co.jp					Erbaydar NP, 2011, TURK J MED SCI, V41, P307, DOI 10.3906/sag-1002-10; Browning A, 2007, BJOG-INT J OBSTET GY, V114, P1439, DOI 10.1111/j.1471-0528.2007.01419.x; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Goh JTW, 2005, BJOG-INT J OBSTET GY, V112, P1328, DOI 10.1111/j.1471-0528.2005.00712.x; Browning A, 2008, BJOG-INT J OBSTET GY, V115, P1564, DOI 10.1111/j.1471-0528.2008.01900.x; Ahmed SM, 2002, J HEALTH POPUL NUTR, V20, P334; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Nielsen HS, 2009, BJOG-INT J OBSTET GY, V116, P1258, DOI 10.1111/j.1471-0528.2009.02200.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Jacobi F, 2004, PSYCHOL MED, V34, P597, DOI 10.1017/S0033291703001399; Miller S, 2005, J MIDWIFERY WOM HEAL, V50, P286, DOI 10.1016/j.jmwh.2005.03.009; Arrowsmith S, 1996, Obstet Gynecol Surv, V51, P568, DOI 10.1097/00006254-199609000-00024; Bhuiya A, 2005, J HEALTH POPUL NUTR, V23, P82; ELKINS TE, 1994, AM J OBSTET GYNECOL, V170, P1108; EngenderHealth Bangladesh Country Office, 2003, SIT AN OBST FIST BAN; Hasan MT, 2012, J HEALTH POPUL NUTR, V30, P22, DOI 10.3329/jhpn.v30i1.11272; International Planned Parenthood Federation, 2008, PEOPL LIV HIV STIGM; Khisa AM, 2012, REPROD HEALTH MATTER, V20, P59, DOI 10.1016/S0968-8080(12)40661-9; Mishra G, 1998, QUAL LIFE RES, V7, P215, DOI 10.1023/A:1008821913429; Mohammad RH, 2007, INT J GYNECOL OBSTET, V99, pS137, DOI 10.1016/j.ijgo.2007.06.035; Mselle LT, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-49; Muleta Mulu, 2008, J Obstet Gynaecol Can, V30, P44; Organization WH, 2006, OBST FIST GUID PRINC; UNFPA, 2002, 2 M WORK GROUP PREV; Women's Dignity Project, RISK RES OBST FIST T	25	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0020-7292	1879-3479		INT J GYNECOL OBSTET	Int. J. Gynecol. Obstet.	JUL	2015	130	1					79	83		10.1016/j.ijgo.2015.01.018		5	Obstetrics & Gynecology	Obstetrics & Gynecology	CL5DH	WOS:000356979500018		
J	Wakabayashi, H				Wakabayashi, Hidetaka			Commentary on Lee et al. (2015) "Need-based nutritional intervention is effective in improving handgrip strength and Barthel Index scores of older people living in a nursing home: A randomized controlled trial"	INTERNATIONAL JOURNAL OF NURSING STUDIES			English	Editorial Material									Yokohama City Univ, Med Ctr, Dept Rehabil Med, Yokohama, Kanagawa, Japan	Wakabayashi, H (reprint author), Yokohama City Univ, Med Ctr, Dept Rehabil Med, Yokohama, Kanagawa, Japan.			Wakabayashi, HIdetaka/0000-0002-0364-0818			Lee L.C., 2015, INT J NURS STUD, V52; Schulz KF, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c332	2	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7489	1873-491X		INT J NURS STUD	Int. J. Nurs. Stud.	JUL	2015	52	7					1281	1282		10.1016/j.ijnurstu.2015.03.016		2	Nursing	Nursing	CL0LN	WOS:000356634300017		
J	Albougha, S; Darwich, K; Darwich, MA; Albogha, MH				Albougha, S.; Darwich, K.; Darwich, M. A.; Albogha, M. H.			Assessment of sagittal split ramus osteotomy rigid internal fixation techniques using a finite element method	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						finite element method; sagittal split ramus osteotomy; rigid internal fixation; bicortical screws; miniplates	ORTHOGNATHIC SURGERY; IN-VITRO; BIOMECHANICAL EVALUATION; ADVANCEMENT OSTEOTOMIES; PROSPECTIVE MULTICENTER; MANDIBULAR PROGNATHISM; SURGICAL-CORRECTION; SETBACK SURGERY; MINIPLATE; STABILIZATION	In this study, finite element analysis (FEA) was used to evaluate nine rigid internal fixation techniques for sagittal split ramus osteotomy. To achieve this, a computed tomography (CT) scan of a healthy patient was obtained and used to generate the geometry of a half-mandible. The geometries of bicortical screws, miniplates, and monocortical screws were designed and combined with the mandible in nine models simulating various techniques. Four models used bicortical screws in various arrangements and four used miniplates of various designs. One model represented a hybrid technique. A load of 500 N was applied to the posterior teeth and FEA was applied. The most stable techniques were the hybrid technique and a single straight miniplate, presenting the least displacement among all models. Bicortical screws, while presenting reasonable stability, showed high strain areas near the anterior ramus ridge, superoposterior to the screws, implying a risk of bone fracture in this area. On the other hand, the T-shaped and double Y-shaped miniplates were associated with high von Mises stresses that would impair their rigidity, especially where angles appeared in their designs. We recommend the use of a single straight miniplate because it provides sufficient stable fixation with minimal risks or disadvantages.	[Albougha, S.; Darwich, K.] Damascus Univ, Fac Dent, Dept Oral & Maxillofacial Surg, Damascus, Syria; [Darwich, M. A.] Tartous Univ, Fac Tech Engn, Damascus, Syria; [Darwich, M. A.] Al Andalus Univ Med Sci, Fac Biomed Engn, Al Qadmus, Syria; [Albogha, M. H.] Kyushu Univ, Dent Grad Sch, Sect Orthodont & Dentofacial Orthoped, Fukuoka 812, Japan; [Albogha, M. H.] Damascus Univ, Fac Med Dent, Dept Orthodont, Damascus, Syria	Albogha, MH (reprint author), Maidashi 3-1-1,Higashiku, Fukuoka 8128582, Japan.	hassanbuga@hotmail.com	Albogha, Mhd Hassan/B-1840-2015	Albogha, Mhd Hassan/0000-0001-9063-520X			Joss CU, 2009, J ORAL MAXIL SURG, V67, P301, DOI 10.1016/j.joms.2008.06.060; Throckmorton GS, 1996, J ORAL MAXIL SURG, V54, P1080, DOI 10.1016/S0278-2391(96)90165-2; Borstlap WA, 2004, INT J ORAL MAX SURG, V33, P535, DOI 10.1016/j.ijom.2004.01.015; Sato FRL, 2010, J ORAL MAXIL SURG, V68, P160, DOI 10.1016/j.joms.2009.09.004; Brasileiro BF, 2012, J ORAL MAXIL SURG, V70, P941, DOI 10.1016/j.joms.2011.02.106; Schileo E, 2007, J BIOMECH, V40, P2982, DOI 10.1016/j.jbiomech.2007.02.01; Ochs MW, 2003, J ORAL MAXIL SURG, V61, P1477, DOI 10.1016/j.joms.2003.07.003; Frost HM, 2004, ANGLE ORTHOD, V74, P3; Iwase M, 2006, INT J ORAL MAX SURG, V35, P1102, DOI 10.1016/j.ijom.2006.08.014; Borstlap WA, 2004, INT J ORAL MAX SURG, V33, P649, DOI 10.1016/j.ijom.2004.01.018; Schileo E, 2008, J BIOMECH, V41, P356, DOI 10.1016/j.jbiomech.2007.09.009; Aymach Z, 2011, ORAL SURG ORAL MED O, V111, P58, DOI 10.1016/j.tripleo.2010.03.028; Erkmen E, 2005, INT J ORAL MAX SURG, V34, P551, DOI 10.1016/j.ijom.2004.10.009; Tharanon W, 1998, J ORAL MAXIL SURG, V56, P1055, DOI 10.1016/S0278-2391(98)90255-5; Ellis E, 1996, J ORAL MAXIL SURG, V54, P176, DOI 10.1016/S0278-2391(96)90443-7; Erkmen E, 2005, BRIT J ORAL MAX SURG, V43, P97, DOI 10.1016/j.bjoms.2004.10.007; Hoffmannová J, 2008, Prague Med Rep, V109, P286; Kabasawa Y, 2013, OR SURG OR MED OR PA, V116, pE333, DOI 10.1016/j.oooo.2012.02.025; Keaveny T. M., 1998, HDB BIOMATERIAL PROP, P15; Keyak JH, 1998, J BIOMECH, V31, P125; Keyak JH, 2005, CLIN ORTHOP RELAT R, P219, DOI 10.1097/01.blo.0000164400.37905.22; Natali A., 2003, DENT BIOMECHANICS, P69; Nieblerova J, 2012, INT J ORAL MAX SURG, V41, P482, DOI 10.1016/j.ijom.2011.11.005; Pereira VA, 2013, INT J ORAL MAX SURG, V42, P316, DOI 10.1016/j.ijom.2012.07.008; Proffit William R, 2007, Head Face Med, V3, P21, DOI 10.1186/1746-160X-3-21; Sato FRL, 2012, OR SURG OR MED OR PA, V114, pS60, DOI 10.1016/j.tripleo.2011.08.027; Sato FRL, 2012, INT J ORAL MAX SURG, V41, P934, DOI 10.1016/j.ijom.2012.03.018; Stoelinga PJW, 2003, J ORAL MAXIL SURG, V61, P1471, DOI 10.1016/j.joms.2003.07.002; VanSickels JE, 1996, BRIT J ORAL MAX SURG, V34, P279, DOI 10.1016/S0266-4356(96)90002-9; Yun Kyoung-In, 2012, [Journal of the Korean Association of Oral and Maxillofacial Surgeons, 대한구강악안면외과학회지], V38, P271	30	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	JUL	2015	44	7					823	829		10.1016/j.ijom.2015.02.006		7	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CL5FC	WOS:000356984200003		
J	Shintani, T; Hayashido, Y; Mukasa, H; Akagi, E; Hoshino, M; Ishida, Y; Hamana, T; Okamoto, K; Kanda, T; Koizumi, K; Yoshioka, Y; Tani, R; Toratani, S; Okamoto, T				Shintani, T.; Hayashido, Y.; Mukasa, H.; Akagi, E.; Hoshino, M.; Ishida, Y.; Hamana, T.; Okamoto, K.; Kanda, T.; Koizumi, K.; Yoshioka, Y.; Tani, R.; Toratani, S.; Okamoto, T.			Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						BRONJ; sequestrectomy; osteonecrosis; oral bisphosphonate; intravenous bisphosphonate; osteoporosis	OSTEOPOROSIS; PAMIDRONATE; ALENDRONATE	Bisphosphonates (BPs) have been used in medical practice for the treatment of osteoporosis, bone metastasis, and multiple myeloma. Although many studies have been published, the treatment and prognosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ) remain unclear. This study included 59 patients with BRONJ: 29 had taken oral BPs and 30 had taken intravenous (IV) BPs. All received conservative treatments. When separated sequestra were seen, a sequestrectomy was performed. Segmental mandibular resection was performed when pathological fractures were diagnosed. The outcomes of treatments were compared between groups. For patients treated with oral rinses or mandibular resection, the number in whom clinical healing was observed did not differ between the oral BP and IV BP groups. With regard to sequestrectomy, 94% of patients in the oral BP group showed improvement with this treatment compared to 50% in the IV BP group. The number of patients in whom clinical healing of BRONJ was achieved was statistically better in the oral BP group than in the IV BP group after 6 months of treatment (P < 0.001). The results showed that >90% of patients treated with oral BPs could be cured. However, 50% of patients treated with IV BPs did not show an improvement. Additional research is needed to further increase the therapeutic efficacy for the resolution of BRONJ.	[Shintani, T.] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima 7348553, Japan; [Hayashido, Y.; Mukasa, H.; Okamoto, K.; Kanda, T.; Tani, R.] Hiroshima Univ Hosp, Oral Maxillofacial Surg, Hiroshima 7348553, Japan; [Akagi, E.; Hoshino, M.; Ishida, Y.; Hamana, T.; Koizumi, K.; Yoshioka, Y.; Toratani, S.; Okamoto, T.] Hiroshima Univ, Dept Mol Oral Med & Maxillofacial Surg, Div Appl Life Sci, Inst Biomed & Hlth Sci, Hiroshima, Japan	Shintani, T (reprint author), Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	tshintan@hiroshima-u.ac.jp					Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws. American Association of Oral and Maxillofacial Surgeons, 2007, J ORAL MAXILLOFAC SU, V65, P369, DOI DOI 10.1016/J.JOMS.2006.11.003; Anavi-Lev K, 2013, OR SURG OR MED OR PA, V115, P660, DOI 10.1016/j.oooo.2013.03.001; Taylor KH, 2010, BRIT J ORAL MAX SURG, V48, P221, DOI 10.1016/j.bjoms.2009.08.030; Yoneda T, 2010, J BONE MINER METAB, V28, P365, DOI 10.1007/s00774-010-0162-7; Heymann D, 2004, TRENDS MOL MED, V10, P337, DOI 10.1016/j.molmed.2004.05.007; Wehrhan F, 2011, ORAL SURG ORAL MED O, V112, P216, DOI 10.1016/j.tripleo.2011.02.028; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Licata AA, 2005, ANN PHARMACOTHER, V39, P668, DOI 10.1345/aph.1E357; Hortobagyi GN, 1998, J CLIN ONCOL, V16, P2038; Carlson ER, 2009, J ORAL MAXIL SURG, V67, P85, DOI 10.1016/j.joms.2009.01.006; Marx RE, 2009, J ORAL MAXIL SURG, V67, P107, DOI 10.1016/j.joms.2008.12.007; Ersan N, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20130144; Hagino H, 2013, J BONE MINER METAB, V31, P544, DOI 10.1007/s00774-013-0439-8; Kim KM, 2014, OSTEOPOROSIS INT, V23, P2721; Nagai T, 2007, INVEST OPHTH VIS SCI, V48, P5716, DOI 10.1167/iovs.07-1023; Paiva-Fonseca F, 2014, MED ORAL PATOL ORAL, V19, pE106, DOI 10.4317/medoral.19094; Paparella ML, 2012, HISTOPATHOLOGY, V60, P514, DOI 10.1111/j.1365-2559.2011.04061.x; Sharma Dileep, 2013, Vasc Cell, V5, P1, DOI 10.1186/2045-824X-5-1; Shintani T, 2015, J ORAL MAXILLOFAC SU, V27, P283; Shiraki M, 2012, CURR MED RES OPIN, V28, P1357, DOI 10.1185/03007995.2012.709838; Watts NB, 2003, CLIN GERIATR MED, V19, P395, DOI 10.1016/S0749-0690(02)00069-1	21	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	JUL	2015	44	7					840	844		10.1016/j.ijom.2015.03.013		5	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CL5FC	WOS:000356984200006		
J	Huang, W; Hasegawa, T; Imai, Y; Takeda, D; Akashi, M; Komori, T				Huang, W.; Hasegawa, T.; Imai, Y.; Takeda, D.; Akashi, M.; Komori, T.			Low-intensity pulsed ultrasound enhances bone morphogenetic protein expression of human mandibular fracture haematoma-derived cells	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						low-intensity pulsed ultrasound (LIPUS); bone morphogenetic protein (BMP); mandibular fracture; haematoma; osteogenesis; real-time PCR; immunofluorescence	OSTEOGENIC DIFFERENTIATION; GENE-EXPRESSION; IN-VITRO; BMPS; LIPUS	We previously demonstrated that human mandibular fracture haematoma-derived cells (MHCs) play an important role in mandibular fracture healing and that low-intensity pulsed ultrasound (LIPUS) accelerates this effect by stimulating various osteogenic cytokines. In the present study, we investigated how LIPUS affects the expression of bone morphogenetic proteins (BMPs), which are also known to have the ability to induce bone formation. MHCs were isolated from human mandibular fracture haematomas and the cells were divided into two groups: a LIPUS (+) group and a LIPUS (-) group, both of which were cultured in osteogenic medium. LIPUS was applied to the LIPUS (+) group 20 min a day for 4, 8, 14, and 20 days (1.5 MHz, 30 mW/cm(2)). Real-time PCR and immunofluorescence studies were carried out to determine the expression of BMP-2, 4, and 7. Compared to the LIPUS (+) group, gene expression levels were significantly increased in the LIPUS (+) group for BMP-2 on day 20 (67.38 +/- 26.59 vs. 11.52 +/- 3.42, P<0.001), for BMP-4 on days 14 (45.12 +/- 11.06 vs. 9.20 +/- 2.88, P=0.045) and 20 (40.96 +/- 24.81 vs. 3.22 +/- 1.53, P=0.035), and for BMP-7 on day 8 (48.11 +/- 35.36 vs. 7.03 +/- 3.96, P=0.034). These findings suggest that BMP-2, 4, and 7 may be mediated by LIPUS therapy during the bone repair process.	[Huang, W.; Hasegawa, T.; Imai, Y.; Takeda, D.; Akashi, M.; Komori, T.] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 6500017, Japan	Hasegawa, T (reprint author), Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hasetaku@med.kobe-u.ac.jp					Kloen P, 2012, BONE, V51, P59, DOI 10.1016/j.bone.2012.03.032; Yang Z, 2014, J ULTRAS MED, V33, P865, DOI 10.7863/ultra.33.5.865; Sena K, 2005, ULTRASOUND MED BIOL, V31, P703, DOI 10.1016/j.ultrasmedbio.2005.01.013; Sant'Anna EF, 2005, J ORTHOP RES, V23, P646, DOI 10.1016/j.orthres.2004.09.007; Warden SJ, 2001, BIOCHEM BIOPH RES CO, V286, P443, DOI 10.1006/bbrc.2001.5412; Kumagai K, 2012, J ORTHOP RES, V30, P1516, DOI 10.1002/jor.22103; Rubin C, 2001, J BONE JOINT SURG AM, V83A, P259; Takayama T, 2007, LIFE SCI, V80, P965, DOI 10.1016/j.lfs.2006.11.037; Bandow K, 2007, J CELL PHYSIOL, V211, P392, DOI 10.1002/jcp.20944; Shiozaki Y, 2013, INT J NANOMED, V8, P1349, DOI 10.2147/IJN.S44124; Kloen P, 2003, BONE, V33, P362, DOI 10.1016/S8756-3282(03)00191-1; Abe E, 2006, ANN NY ACAD SCI, V1068, P41, DOI 10.1196/annals.1346.007; Fajardo M, 2009, CLIN ORTHOP RELAT R, V467, P3071, DOI 10.1007/s11999-009-0981-9; Favaro-Pipi E, 2010, ULTRASOUND MED BIOL, V36, P2057, DOI 10.1016/j.ultrasmedbio.2010.07.012; Hasegawa T, 2009, J BONE JOINT SURG BR, V91B, P264, DOI 10.1302/0301-620X.91B2.20827; Imai Y, 2014, INT J ORAL MAX SURG, V43, P367, DOI 10.1016/j.ijom.2013.07.746; Ishihara Y, 2014, J CRANIO MAXILL SURG, V42, P185, DOI 10.1016/j.jcms.2013.05.002; Kim M, 2011, BMB REP, V44, P619, DOI 10.5483/BMBRep.2011.44.10.619; Lavery K, 2009, BONE, V45, P27, DOI 10.1016/j.bone.2009.03.656; Niikura T, 2006, J ORTHOP RES, V24, P1463, DOI 10.1002/jor.20182; Reddi AH, 2001, J BONE JOINT SURG AM, V83A, pS1; Suzuki Akito, 2009, J Oral Sci, V51, P29; Xue H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068926	23	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	JUL	2015	44	7					929	935		10.1016/j.ijom.2015.03.001		7	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CL5FC	WOS:000356984200020		
J	Nakayama, H; Ozaki, K				Nakayama, Hiroyuki; Ozaki, Kimihiro			Effect of mechanical milling of elemental powders on interface formation in TiN-Ni cermets prepared by pulsed current sintering	INTERNATIONAL JOURNAL OF REFRACTORY METALS & HARD MATERIALS			English	Article						Transmission electron microscope (TEM); High resolution electron microscope (HREM); Coherent interface; Dislocation	PHASE RELATIONSHIP; TITANIUM NITRIDE; COMPACTS	Interfaces of TiN-Ni cermets prepared by mechanical milling (MM) of TiN and Ni powders and the pulsed current sintering (PCS) method were investigated using TEM and high resolution TEM. The MM is an effective method for the formation of the TiN/Ni interface. Coherent TiN/Ni interfaces were observed in the sintered sample. The orientation relationship of the coherent interface was (111)(TiN)/(111)(Ni) This coherent interface was formed by the Ni lattice expansion due to the introduction of the dislocations. Therefore, the Ni energy state in the cermet was metastable. The MM can excite the Ni energy state to a higher state rather than the metastable state in the cermet, and subsequent PCS leads to the Ni metastable state by relaxation of the exited energy; presuming that this process requires the lower activation energy compared with the amount that the Ni energy is excited to the metastable state from the stable (non-milled) state. (C) 2015 Published by Elsevier Ltd.	[Nakayama, Hiroyuki; Ozaki, Kimihiro] Natl Inst Adv Ind Sci & Technol, Green Innovat Magnet Mat Res Ctr, Nagoya, Aichi 4638560, Japan	Nakayama, H (reprint author), Natl Inst Adv Ind Sci & Technol, Green Innovat Magnet Mat Res Ctr, Moriyama Ku, Nagoya, Aichi 4638560, Japan.	hiro-nakayama@aist.go.jp					Xiao P, 1996, ACTA MATER, V44, P307, DOI 10.1016/1359-6454(95)00165-0; Delogu F, 2012, J MATER SCI, V47, P4757, DOI 10.1007/s10853-012-6358-6; Fukuhara M., 1979, J JPN SOC POWDER POW, V26, P143; FUKUHARA M, 1980, T JPN I MET, V21, P211; FUKUHARA M, 1979, J JPN I MET, V43, P169; Garroni S, 2012, J PHYS CHEM SOLIDS, V73, P770, DOI 10.1016/j.jpcs.2012.01.024; KAIDASH ON, 1991, SOV POWDER METALL+, V30, P69, DOI 10.1007/BF00793405; Kim W, 2013, J ALLOY COMPD, V574, P260, DOI 10.1016/j.jallcom.2013.05.060; Louidi S, 2010, J ALLOY COMPD, V493, P110, DOI 10.1016/j.jallcom.2009.12.077; MERKLE KL, 1992, ACTA METALL MATER, V40, pS249, DOI 10.1016/0956-7151(92)90283-K; Nakayama H, 2012, MATER TRANS, V53, P1029, DOI 10.2320/matertrans.MBW201109; Nakayama H., 2011, P MATER PROCE ENER S, V1, P505; Park JK, 1999, INT J REFRACT MET H, V17, P295, DOI 10.1016/S0263-4368(99)00016-5; Pierson H. O., 1996, HDB REFRACTORY CARBI; Tse YY, 2004, SURF COAT TECH, V180, P470, DOI 10.1016/j.surfcoat.2003.10.139; Tu R, 2014, J EUR CERAM SOC, V34, P1955, DOI 10.1016/j.jeurceramsoc.2013.12.050; Villars P., 2015, ASM ALLOY PHASE DIAG; Zeng K, 1998, J PHASE EQUILIB, V19, P124, DOI 10.1361/105497198770342580	18	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-4368			INT J REFRACT MET H	Int. J. Refract. Met. Hard Mat.	JUL	2015	51						309	314		10.1016/j.ijrmhm.2015.05.007		6	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CL1ZV	WOS:000356744300043		
J	Wintermark, M; Luby, M; Bornstein, NM; Demchuk, A; Fiehler, J; Kudo, K; Lees, KR; Liebeskind, DS; Michel, P; Nogueira, RG; Parsons, MW; Sasaki, M; Wardlaw, JM; Wu, O; Zhang, WW; Zhu, GM; Warach, SJ				Wintermark, Max; Luby, Marie; Bornstein, Natan M.; Demchuk, Andrew; Fiehler, Jens; Kudo, Kohsuke; Lees, Kennedy R.; Liebeskind, David S.; Michel, Patrik; Nogueira, Raul G.; Parsons, Mark W.; Sasaki, Makoto; Wardlaw, Joanna M.; Wu, Ona; Zhang, Weiwei; Zhu, Guangming; Warach, Steven J.			International survey of acute Stroke imaging used to make revascularization treatment decisions	INTERNATIONAL JOURNAL OF STROKE			English	Article						CT; MRI; penumbra; perfusion imaging; stroke; vascular imaging	ACUTE ISCHEMIC-STROKE; ENDOVASCULAR TREATMENT; TRIAL	BackgroundTo assess the differences across continental regions in terms of stroke imaging obtained for making acute revascularization therapy decisions, and to identify obstacles to participating in randomized trials involving multimodal imaging. MethodsSTroke Imaging Repository (STIR) and Virtual International Stroke Trials Archive (VISTA)-Imaging circulated an online survey through its website, through the websites of national professional societies from multiple countries as well as through email distribution lists from STIR and the above mentioned societies. ResultsWe received responses from 223 centers (2 from Africa, 38 from Asia, 10 from Australia, 101 from Europe, 4 from Middle East, 55 from North America, 13 from South America). In combination, the sites surveyed administered acute revascularization therapy to a total of 25326 acute stroke patients in 2012. Seventy-three percent of these patients received intravenous (IV) tissue plasminogen activator (tPA), and 27%, endovascular therapy. Vascular imaging was routinely obtained in 79% (152/193) of sites for endovascular therapy decisions, and also as part of standard IV tPA treatment decisions at 46% (92/198) of sites. Modality, availability and use of acute vascular and perfusion imaging before revascularization varied substantially between geographical areas. The main obstacles to participate in randomized trials involving multimodal imaging included: mainly insufficient research support and staff (50%, 79/158) and infrequent use of multimodal imaging (27%, 43/158) . ConclusionThere were significant variations among sites and geographical areas in terms of stroke imaging work-up used tomake decisions both for intravenous and endovascular revascularization. Clinical trials using advanced imaging as a selection tool for acute revascularization therapy should address the need for additional resources and technical support, and take into consideration the lack of routine use of such techniques in trial planning.	[Wintermark, Max] Stanford Univ, Dept Radiol, Neuroradiol, Palo Alto, CA 94304 USA; [Luby, Marie] NINDS, NIH, Bethesda, MD 20892 USA; [Luby, Marie; Warach, Steven J.] UT Southwestern Med Ctr, Dept Neurol & Neurotherapeut, Seton UT Southwestern Clin Res Inst Austin, Austin, TX USA; [Bornstein, Natan M.] Tel Aviv Univ, Sackler Fac Med, Dept Neurol, Elias Sourasky Med Ctr, IL-69978 Tel Aviv, Israel; [Demchuk, Andrew] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada; [Demchuk, Andrew] Univ Calgary, Hotchkiss Brain Inst, Dept Radiol, Calgary, AB, Canada; [Fiehler, Jens] Univ Med Ctr Hamburg Eppendorf, Dept Neuroradiol, Hamburg, Germany; [Kudo, Kohsuke] Hokkaido Univ Hosp, Dept Diagnost Radiol, Sapporo, Hokkaido 060, Japan; [Lees, Kennedy R.] Univ Glasgow, Western Infirm, Univ Dept Med & Therapeut, Glasgow G11 6NT, Lanark, Scotland; [Liebeskind, David S.] Univ Calif Los Angeles, Dept Neurol, Stroke Ctr, Los Angeles, CA 90024 USA; [Michel, Patrik] Univ Lausanne, CHU Vaudois, Lausanne, Switzerland; [Nogueira, Raul G.] Emory Univ, Sch Med, Marcus Stroke & Neurosci Ctr, Atlanta, GA USA; [Parsons, Mark W.] Univ Newcastle, Dept Neurol, John Hunter Hosp, Med Res Inst, Newcastle, NSW 2300, Australia; [Sasaki, Makoto] Iwate Med Univ, Inst Biomed Sci, Yahaba, Iwate, Japan; [Wardlaw, Joanna M.] Univ Edinburgh, Ctr Clin Brain Sci, Brain Res Imaging Ctr, Div Neuroimaging Sci, Edinburgh, Midlothian, Scotland; [Wu, Ona] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Wu, Ona] Harvard Univ, Sch Med, Boston, MA USA; [Zhang, Weiwei; Zhu, Guangming] Beijing PLA, Mil Gen Hosp, Dept Neurol, Beijing, Peoples R China	Wintermark, M (reprint author), UVA Dept Radiol, Neuroradiol Div, Radiol Neurol Neurosurg & Biomed Engn, Box 800170, Charlottesville, VA 22908 USA.	Max.Wintermark@gmail.com		Wintermark, Max/0000-0002-6726-3951			Wintermark M, 2013, AM J NEURORADIOL, V34, pE117, DOI 10.3174/ajnr.A3690; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Hacke W, 2009, LANCET NEUROL, V8, P141, DOI 10.1016/S1474-4422(08)70267-9; Wintermark M, 2013, STROKE, V44, P2628, DOI 10.1161/STROKEAHA.113.002015; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Fransen PSS, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-343; Qureshi AI, 2012, J STROKE CEREBROVASC, V21, P131, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.014	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	JUL	2015	10	5					759	762		10.1111/ijs.12491		4	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CL1QD	WOS:000356718000030		
J	Suzuki, R; Uehara, T; Ohara, T; Hama, Y; Shimomura, R; Matsushima, H; Tanaka, K; Miyagi, T; Toyoda, K; Minematsu, K				Suzuki, Rieko; Uehara, Toshiyuki; Ohara, Tomoyuki; Hama, Yuka; Shimomura, Ryo; Matsushima, Hayato; Tanaka, Koji; Miyagi, Tetsuya; Toyoda, Kazunori; Minematsu, Kazuo			Transient ischemic attack clinic in an urban area of Japan	INTERNATIONAL JOURNAL OF STROKE			English	Letter									[Suzuki, Rieko; Uehara, Toshiyuki; Ohara, Tomoyuki; Hama, Yuka; Shimomura, Ryo; Matsushima, Hayato; Tanaka, Koji; Miyagi, Tetsuya; Toyoda, Kazunori; Minematsu, Kazuo] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan	Suzuki, R (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	rsuzuki@ncvc.go.jp	Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845			Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	JUL	2015	10	5					E43	E43		10.1111/ijs.12503		1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CL1QD	WOS:000356718000001		
J	Nakamura, N; Inaba, Y; Machida, J; Saito, T				Nakamura, Naoyuki; Inaba, Yutaka; Machida, Jiro; Saito, Tomoyuki			Rotational open-wedge osteotomy improves treatment outcomes for patients older than eight years with Legg-Calve-Perthes disease in the modified lateral pillar B/C border or C group	INTERNATIONAL ORTHOPAEDICS			English	Article						Legg-Calve-Perthesdisease; Femoralosteotomy; Conservative treatment; Operative treatment; Non-weight bearing	FEMORAL VARUS OSTEOTOMY; PROSPECTIVE MULTICENTER; FOLLOW-UP; HEAD; CLASSIFICATIONS	Purpose Since 2003, we have been performing rotational open-wedge osteotomy (ROWO) for older children with severe Legg-Calve-Perthes disease (LCPD). We compared the treatment outcomes before and after the introduction of ROWO for patients aged >= eight years, classified in the modified lateral pillar B/C border or C group. Methods Before the introduction of ROWO, conservative treatment (non-weight bearing [NWB]) was performed for all cases between 1986 and 2002, whereby there were 34 hips (NWB group). The median patient age, at the first visit, was 9.1 years. According to the lateral pillar classification, 21 hips were categorized into the B/C border group and the others into the C group. Meanwhile, 14 consecutive hips underwent ROWO combined with NWB between 2003 and 2008 (ROWO+NWB group). The median patient age, at the first visit, was 9.1 years. Six hips were in the lateral pillar B/C border group and the others were classified into the C group. There were no significant differences in pre-treatment patients' demographic data. Results At the latest follow-up, according to the Stulberg classification, there were 19 class II hips, 13 class III hips, and two class IV hips in the NWB group. In the ROWO+NWB group, there were 12 class II hips, two class III hips, and no class IV hips. Conclusions The application of ROWO combined with NWB in the treatment of older children with severe LCPD improved their outcomes, compared to those obtained by NWB treatment alone.	[Nakamura, Naoyuki; Machida, Jiro] Kanagawa Childrens Med Ctr, Pediat Orthopaed Surg, Yokohama, Kanagawa, Japan; [Inaba, Yutaka; Saito, Tomoyuki] Yokohama City Univ, Orthopaed Surg, Yokohama, Kanagawa 232, Japan	Nakamura, N (reprint author), Kanagawa Childrens Med Ctr, Pediat Orthopaed Surg, Yokohama, Kanagawa, Japan.	nnakamura@kcmc.jp					Aksoy MC, 2005, J PEDIATR ORTHOP B, V14, P88; Park MS, 2012, CLIN ORTHOP RELAT R, V470, P2376, DOI 10.1007/s11999-012-2314-7; Larson AN, 2012, J BONE JOINT SURG AM, V94A, P584, DOI 10.2106/JBJS.J.01073; Herring JA, 2004, J BONE JOINT SURG AM, V86A, P2121; Guille JT, 1998, J BONE JOINT SURG AM, V80A, P1256; STULBERG SD, 1981, J BONE JOINT SURG AM, V63, P1095; Herring JA, 2004, J BONE JOINT SURG AM, V86A, P2103; Terjesen T, 2012, CLIN ORTHOP RELAT R, V470, P2394, DOI 10.1007/s11999-011-2181-7; HERRING JA, 1992, J PEDIATR ORTHOPED, V12, P143; Atsumi T, 2002, ARCH ORTHOP TRAUM SU, V122, P346, DOI 10.1007/s00402-002-0408-5; BOBECHKO WP, 1974, CLIN ORTHOP RELAT R, P115; CATTERALL A, 1971, Journal of Bone and Joint Surgery British Volume, V53, P37; COOPERMAN DR, 1986, CLIN ORTHOP RELAT R, P289; Copeliovitch Leonel, 2011, J Pediatr Orthop, V31, pS189, DOI 10.1097/BPO.0b013e318223b55c; Friedlander JK, 2000, J PEDIATR ORTHOPED, V20, P566; Hefti Fritz, 2007, J Child Orthop, V1, P19, DOI 10.1007/s11832-007-0010-z; HERRING JA, 1993, J PEDIATR ORTHOPED, V13, P41; Herring JA, 1996, J PEDIATR ORTHOPED, V16, P1; Kim HKW, 2012, J BONE JOINT SURG AM, V94A, P2228, DOI 10.2106/JBJS.L.00300; MEEHAN PL, 1992, J BONE JOINT SURG AM, V74A, P2; Nakamura N, 2012, J JPN PEDIAT ORTHOP, V21, P358; Nakamura N, 2007, SEIKEIGEKA, V58, P135; Nakamura N, 2007, J JPN PEDIAT ORTHOP, V16, P6; OHARA JP, 1977, CLIN ORTHOP RELAT R, P49; PETRIE J G, 1971, Journal of Bone and Joint Surgery British Volume, V53, P54; Tachdjian MO, 1968, J BONE JOINT SURG AM, V50-A, P1271; Thompson George H, 2011, J Pediatr Orthop, V31, pS192, DOI 10.1097/BPO.0b013e318223b59d; THOMPSON GH, 1987, ORTHOP CLIN N AM, V18, P617; Wenger Dennis R, 2011, J Pediatr Orthop, V31, pS198, DOI 10.1097/BPO.0b013e31822602b0; Wenger DR, 2010, J PEDIATR ORTHOPED, V30, P749, DOI 10.1097/BPO.0b013e3181f5a0de; Wiig Ola, 2007, J Child Orthop, V1, P101, DOI 10.1007/s11832-007-0020-x; Yoon Pil Whan, 2012, Clin Orthop Surg, V4, P66, DOI 10.4055/cios.2012.4.1.66	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	JUL	2015	39	7					1359	1364		10.1007/s00264-015-2729-3		6	Orthopedics	Orthopedics	CL2XB	WOS:000356809900016		
J	Kanayama, M; Oha, F; Hashimoto, T				Kanayama, Masahiro; Oha, Fumihiro; Hashimoto, Tomoyuki			What types of degenerative lumbar pathologies respond to nerve root injection? A retrospective review of six hundred and forty one cases	INTERNATIONAL ORTHOPAEDICS			English	Article						Nerveroot; Periradicular injection; Nonoperative treatment; Herniated disc; Spinal stenosis; Spondylolisthesis	DISC HERNIATION; RADICULAR PAIN; NATURAL-HISTORY; FOLLOW-UP; RADICULOPATHY; INFILTRATION; SCIATICA	Purpose Peri-radicular injection is a widely used procedure for treating lumbar radicular pain, but it remains unclear what types of lumbar pathologies respond well to this treatment. We aimed to investigate the efficacy of peri-radicular injection for degenerative lumbar disorders and to determine what types of pathologies respond well to this treatment. Methods We reviewed the records of 641 consecutive patients who underwent peri-radicular injection for degenerative lumbar pathologies with mean follow-up of 23.4 months. The pathologies included herniated disc in 286 patients, spinal stenosis in 141, degenerative spondylolisthesis in 136, failed back surgery in 24, isthmic spondylolisthesis in 22, degenerative scoliosis in 18, and foraminal stenosis in 14. Outcome measure was whether or not surgery is avoided by using peri-radicular injection. The rate of obviating surgery was determined in each pathology. Results Peri-radicular injection obviated surgeries in 331 patients (51.7 %). There were no complications related to the procedure, including neurological deterioration, infection, and haematoma. The rate of obviating surgery was 42.0 % in disc herniation, 52.9 % in degenerative spondylolisthesis, 67.4 % in spinal stenosis, 54.5 % in isthmic spondylolisthesis, 57.1 % in foraminal stenosis, 61.1 % in degenerative scoliosis and 54.1 % in failed back surgery. Poor outcomes were observed in herniated disc with spinal stenosis (17.9 % success), foraminal disc herniation (33.3 %), recurrent disc herniation (18.2 %) and failed back surgery with instability (33.3 %). Conclusions This study demonstrated that 51.7 % of patients with degenerative lumbar pathologies were successfully treated by peri-radicular injection. Efficacy was limited in cases of herniated disc with spinal stenosis, foraminal disc herniation, recurrent disc herniation and failed back surgery with instability.	[Kanayama, Masahiro; Oha, Fumihiro; Hashimoto, Tomoyuki] Hakodate Cent Gen Hosp, Spine Ctr, Hakodate, Hokkaido 0408585, Japan; [Kanayama, Masahiro; Hashimoto, Tomoyuki] Hokkaido Univ, Grad Sch Med, Clin Collaborat Dept, Sapporo, Hokkaido, Japan	Kanayama, M (reprint author), Hakodate Cent Gen Hosp, Spine Ctr, Hon Cho 33-2, Hakodate, Hokkaido 0408585, Japan.	mkanayama@aol.com					DePalma MJ, 2005, ARCH PHYS MED REHAB, V86, P1477, DOI 10.1016/j.apmr.2005.01.006; Karppinen J, 2001, SPINE, V26, P1059, DOI 10.1097/00007632-200105010-00015; Riew KD, 2006, J BONE JOINT SURG AM, V88A, P1722, DOI 10.2106/JBJS.E.00278; Benoist M, 2002, JOINT BONE SPINE, V69, P155, DOI 10.1016/S1297-319X(02)00385-8; Cherkin DC, 1998, SPINE, V23, P607, DOI 10.1097/00007632-199803010-00015; Riew KD, 2000, J BONE JOINT SURG AM, V82A, P1589; BELL GR, 1984, SPINE, V9, P54, DOI 10.1097/00007632-198401000-00012; Cyteval C, 2006, AM J NEURORADIOL, V27, P978; DOOLEY JF, 1988, SPINE, V13, P79, DOI 10.1097/00007632-198801000-00019; Herron L D, 1989, J Spinal Disord, V2, P75; Jonsson B, 1988, J SPINAL DISORD, V1, P232; KIKUCHI S, 1984, SPINE, V9, P23, DOI 10.1097/00007632-198401000-00007; KREMPEN JF, 1974, J BONE JOINT SURG AM, VA 56, P1435; Ng LCL, 2004, EUR SPINE J, V13, P325, DOI 10.1007/s00586-003-0649-1; van Akkerveeken P F, 1993, Acta Orthop Scand Suppl, V251, P61; WEBER H, 1994, SPINE, V19, P2234, DOI 10.1097/00007632-199410000-00022; Weber H, 1994, SPINE, V19, P2233; Yukawa Y, 1996, J SPINAL DISORD, V9, P251	18	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	JUL	2015	39	7					1379	1382		10.1007/s00264-015-2761-3		4	Orthopedics	Orthopedics	CL2XB	WOS:000356809900019		
J	Takigami, J; Hashimoto, Y; Yamasaki, S; Terai, S; Nakamura, H				Takigami, Junsei; Hashimoto, Yusuke; Yamasaki, Shinya; Terai, Shozaburo; Nakamura, Hiroaki			Direct bone-to-bone integration between recombinant human bone morphogenetic protein-2-injected tendon graft and tunnel wall in an anterior cruciate ligament reconstruction model	INTERNATIONAL ORTHOPAEDICS			English	Article						Recombinant human bone morphogenetic protein 2 (rhBMP-2); Anterior cruciate ligament (ACL) reconstruction; Semitendinosus tendon; Enthesis	PATELLAR TENDON; RABBIT MODEL; BMP-2; SEMITENDINOSUS; ENHANCEMENT; REPLACEMENT; FIXATION; SHEEP; TIBIA	Purpose This study was performed to evaluate one-stage anterior cruciate ligament (ACL) reconstruction using a semitendinosus tendon graft injected with bone morphogenetic protein 2 (BMP-2) in a rabbit model. Methods We injected recombinant human BMP-2 (rhBMP-2) in the experimental group and phosphate-buffered saline in the control group at two sites of the semitendinosus tendon (15 mu g in each site) to replace tendon with bone in the bone tunnel. Twenty minutes later, the injected tendon graft was transplanted for ACL reconstruction by passing the graft through the bone tunnel. The animals were harvested at four, eight, or 12 weeks postoperatively and examined by histological and biomechanical methods. Results Histological analysis revealed that the tendon graft was replaced with new bone in the tunnel of the experimental group. Characteristic features identical to the regenerated direct insertion morphology at the bone-tendon junction were acquired at eight or 12 weeks in the experimental group. Biomechanical pull-out testing revealed greater stiffness in the experimental than control group at 12 weeks, although the maximum load to failure showed no significant difference between the two groups at four, eight, or 12 weeks. Conclusion These results indicate the potential for ACL reconstruction with regenerated direct insertion morphology.	[Takigami, Junsei; Hashimoto, Yusuke; Terai, Shozaburo; Nakamura, Hiroaki] Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka 558, Japan; [Yamasaki, Shinya] Osaka City Gen Hosp, Dept Orthopaed Surg, Osaka, Japan	Hashimoto, Y (reprint author), Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka 558, Japan.	hussy@med.osaka-cu.ac.jp			JSPS KAKENHI [23791654]	We thank Osteopharma Inc. for kindly providing rhBMP. This work was supported by JSPS KAKENHI Grant Number 23791654.	Hashimoto Y, 2007, J ORTHOP RES, V25, P1415, DOI 10.1002/jor.20447; Rodeo SA, 1999, AM J SPORT MED, V27, P476; Tomita F, 2001, ARTHROSCOPY, V17, P461, DOI 10.1053/jars.2001.24059; Ishibashi Y, 1997, ARTHROSCOPY, V13, P177, DOI 10.1016/S0749-8063(97)90152-3; Fu FH, 2000, AM J SPORT MED, V28, P124; Shino K, 2005, ARTHROSCOPY, V21, P1402, DOI 10.1016/j.arthro.2005.08.017; Kaito T, 2013, J BONE JOINT SURG AM, V95A, P1612, DOI 10.2106/JBJS.L.01396; Ju YJ, 2008, CELL TISSUE RES, V332, P469, DOI 10.1007/s00441-008-0610-z; Martinek V, 2002, J BONE JOINT SURG AM, V84A, P1123; Yamazaki S, 2005, ARTHROSCOPY, V21, P1034, DOI 10.1016/j.arthro.2005.05.011; Feller JA, 2003, AM J SPORT MED, V31, P564; Clatworthy MG, 1999, KNEE SURG SPORT TR A, V7, P138, DOI 10.1007/s001670050138; Shaieb MD, 2002, AM J SPORT MED, V30, P214; Beynnon BD, 2002, J BONE JOINT SURG AM, V84A, P1503; Brucker PU, 2006, ARTHROSCOPY, V22; Demirag B, 2005, J BONE JOINT SURG AM, V87A, P2401, DOI 10.2106/JBJS.D.01952; Doi Y, 2011, BONE, V49, P777, DOI 10.1016/j.bone.2011.07.005; Hashimoto Y, 2011, J ORTHOP RES, V29, P1923, DOI 10.1002/jor.21455; Kartus J, 1999, KNEE SURG SPORT TR A, V7, P2, DOI 10.1007/s001670050112; L'Insalata J C, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P234, DOI 10.1007/s001670050056; Leonardi ABD, 2014, ACTA ORTOP BRAS, V22, P240, DOI 10.1590/1413-78522014220500338; Lui PPY, 2010, J ORTHOP SURG RES, V5, P1; Ma CB, 2007, AM J SPORT MED, V35, P597, DOI 10.1177/0363546506296312; Mihelic R, 2004, AM J SPORT MED, V32, P1619, DOI 10.1177/0363546504263703; Pecina M, 2007, INT ORTHOP, V31, P719, DOI 10.1007/s00264-007-0425-7; STEINER ME, 1994, AM J SPORT MED, V22, P240, DOI 10.1177/036354659402200215; Walsh WR, 2007, ARTHROSCOPY, V23, P197, DOI 10.1016/j.arthro.2006.09.003; WOO SLY, 1991, AM J SPORT MED, V19, P217, DOI 10.1177/036354659101900303	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	JUL	2015	39	7					1441	1447		10.1007/s00264-015-2774-y		7	Orthopedics	Orthopedics	CL2XB	WOS:000356809900029		
J	Ahn, JY; Boettiger, D; Law, M; Kumarasamy, N; Yunihastuti, E; Chaiwarith, R; Lee, MP; Sim, BLH; Oka, S; Wong, WW; Kamarulzaman, A; Kantipong, P; Phanuphak, P; Ng, OT; Kiertiburanakul, S; Zhang, FJ; Pujari, S; Ditangco, R; Ratanasuwan, W; Merati, TP; Saphonn, V; Sohn, AH; Choi, JY				Ahn, Jin Young; Boettiger, David; Law, Matthew; Kumarasamy, Nagalingeswaran; Yunihastuti, Evy; Chaiwarith, Romanee; Lee, Man Po; Sim, Benedict L. H.; Oka, Shinichi; Wong, Wingwai; Kamarulzaman, Adeeba; Kantipong, Pacharee; Phanuphak, Praphan; Oon Tek Ng; Kiertiburanakul, Sasisopin; Zhang, Fujie; Pujari, Sanjay; Ditangco, Rossana; Ratanasuwan, Winai; Merati, Tuti Parwati; Saphonn, Vonthanak; Sohn, Annette H.; Choi, Jun Yong		TREAT Asia HIV Observational Datab	Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression	JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES			English	Article						HIV infection; HIV suppression; CD4 count; CD4 monitoring	ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS-INFECTION; T-CELL COUNT; IMMUNOLOGICAL CRITERIA; BASE-LINE; RECOVERY; INDIVIDUALS; LYMPHOCYTES; COHORT	Background:Current treatment guidelines for HIV infection recommend routine CD4(+) lymphocyte (CD4) count monitoring in patients with viral suppression. This may have a limited impact on influencing care as clinically meaningful CD4 decline rarely occurs during viral suppression.Methods:In a regional HIV observational cohort in the Asia-Pacific region, patients with viral suppression (2 consecutive viral loads <400 copies/mL) and a CD4 count 200 cells per microliter who had CD4 testing 6 monthly were analyzed. Main study end points were occurrence of 1 CD4 count <200 cells per microliter (single CD4 <200) and 2 CD4 counts <200 cells per microliter within a 6-month period (confirmed CD4 <200). A comparison of time with single and confirmed CD4 <200 with biannual or annual CD4 assessment was performed by generating a hypothetical group comprising the same patients with annual CD4 testing by removing every second CD4 count.Results:Among 1538 patients, the rate of single CD4 <200 was 3.45/100 patient-years and of confirmed CD4 <200 was 0.77/100 patient-years. During 5 years of viral suppression, patients with baseline CD4 200-249 cells per microliter were significantly more likely to experience confirmed CD4 <200 compared with patients with higher baseline CD4 [hazard ratio, 55.47 (95% confidence interval: 7.36 to 418.20), P < 0.001 versus baseline CD4 500 cells/L]. Cumulative probabilities of confirmed CD4 <200 was also higher in patients with baseline CD4 200-249 cells per microliter compared with patients with higher baseline CD4. There was no significant difference in time to confirmed CD4 <200 between biannual and annual CD4 measurement (P = 0.336).Conclusions:Annual CD4 monitoring in virally suppressed HIV patients with a baseline CD4 250 cells per microliter may be sufficient for clinical management.	[Ahn, Jin Young; Choi, Jun Yong] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120752, South Korea; [Ahn, Jin Young; Choi, Jun Yong] Yonsei Univ, Coll Med, AIDS Res Inst, Seoul 120752, South Korea; [Boettiger, David; Law, Matthew] UNSW Australia, Kirby Inst, Sydney, NSW, Australia; [Kumarasamy, Nagalingeswaran] VHS, YRGCARE Med Ctr, CART CRS, Madras, Tamil Nadu, India; [Yunihastuti, Evy] Univ Indonesia, Cipto Mangunkusumo Hosp, Working Grp AIDS Fac Med, Jakarta, Indonesia; [Chaiwarith, Romanee] Res Inst Hlth Sci, Chiang Mai, Thailand; [Lee, Man Po] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China; [Sim, Benedict L. H.] Hosp Sungai Buloh, Sungai Buloh, Malaysia; [Oka, Shinichi] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Wong, Wingwai] Taipei Vet Gen Hosp, Taipei, Taiwan; [Kamarulzaman, Adeeba] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Kantipong, Pacharee] Chiangrai Prachanukroh Hosp, Chiang Rai, Thailand; [Phanuphak, Praphan] HIV NAT Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Oon Tek Ng] Tan Tock Seng Hosp, Singapore, Singapore; [Kiertiburanakul, Sasisopin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok 10400, Thailand; [Zhang, Fujie] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China; [Pujari, Sanjay] Inst Infect Dis, Pune, Maharashtra, India; [Ditangco, Rossana] Res Inst Trop Med, Manila, Philippines; [Ratanasuwan, Winai] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok 10700, Thailand; [Merati, Tuti Parwati] Udayana Univ, Fac Med, Bali, Indonesia; [Merati, Tuti Parwati] Sanglah Hosp, Bali, Indonesia; [Saphonn, Vonthanak] Dermatol & STDs, Natl Ctr HIV AIDS, Phnom Penh, Cambodia; [Saphonn, Vonthanak] Univ Hlth Sci, Phnom Penh, Cambodia; [Sohn, Annette H.] AmfAR Fdn AIDS Res, TREAT Asia, Bangkok, Thailand	Choi, JY (reprint author), Yonsei Univ, Coll Med, AIDS Res Inst, Dept Internal Med, 50 Yonsei Ro, Seoul 120752, South Korea.	seran@yuhs.ac			NIH grants IeDEA [U01AI069907]; Dutch Ministry of Foreign Affairs through a partnership with Stichting Aids Fonds, Australian Government Department of Health and Ageing; Australian Government Department of Health and Ageing; Faculty of Medicine, UNSW Australia (The University of New South Wales); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A2005412]; BioNano Health-Guard Research Center - Ministry of Science, ICT, and Future Planning of Korea as a Global Frontier Project [H-GUARD_2013M3A6B2078953]	Supported by NIH grants IeDEA; U01AI069907; Dutch Ministry of Foreign Affairs through a partnership with Stichting Aids Fonds, Australian Government Department of Health and Ageing. The Kirby Institute is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, UNSW Australia (The University of New South Wales). J.Y.C. involvement was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2005412) and BioNano Health-Guard Research Center funded by the Ministry of Science, ICT, and Future Planning of Korea as a Global Frontier Project (Grant H-GUARD_2013M3A6B2078953).	Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Zoufaly A, 2011, J INFECT DIS, V203, P364, DOI [10.1093/jinfdis/jiq055, 10.1093/infdis/jiq055]; Garcia F, 2004, JAIDS-J ACQ IMM DEF, V36, P702, DOI 10.1097/00126334-200406010-00007; Gale HB, 2013, CLIN INFECT DIS, V56, P1340, DOI 10.1093/cid/cit004; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5; Girard PM, 2013, AIDS, V27, P2759, DOI 10.1097/01.aids.0000432458.98851.c1; Whitlock GG, 2013, CLIN INFECT DIS, V57, P327, DOI 10.1093/cid/cit203; [Anonymous], 1992, MMWR RECOMM REP, V41, P1; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Khanna N, 2008, CLIN INFECT DIS, V47, P1093, DOI 10.1086/592113; Mellors JW, 1997, ANN INTERN MED, V126, P946; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV I; Duncan CJA, 2014, AIDS, V28, P2638, DOI 10.1097/QAD.0000000000000469; FEENEY C, 1995, CRIT CARE MED, V23, P1680, DOI 10.1097/00003246-199510000-00012; Ford N, 2014, AIDS, V28, P2003, DOI 10.1097/QAD.0000000000000406; Goetz MB, 2001, AIDS, V15, P1576, DOI 10.1097/00002030-200108170-00017; Hyle EP, 2013, JAMA INTERN MED, V173, P1746, DOI 10.1001/jamainternmed.2013.9329; Maggiolo F, 2010, CLIN INFECT DIS, V51, P465, DOI 10.1086/655152; Phillips AN, 2002, AIDS, V16, P1073, DOI 10.1097/00002030-200205030-00016; Raboud JM, 1996, J INFECT DIS, V174, P191; Sax PE, 2013, CLIN INFECT DIS, V56, P1344, DOI 10.1093/cid/cit008; Staszewski S, 1999, AIDS, V13, P951, DOI 10.1097/00002030-199905280-00011; Stephan C, 2012, JAIDS-J ACQ IMM DEF, V61, pE73, DOI 10.1097/QAI.0b013e3182737254	27	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1525-4135	1077-9450		JAIDS-J ACQ IMM DEF	JAIDS	JUL 1	2015	69	3					e85	e92		10.1097/QAI.0000000000000634		8	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CL1PH	WOS:000356715500001		
J	Gawaz, A; Metzler, G; Hertl, M; Hashimoto, T; Schaller, M				Gawaz, Andrea; Metzler, Gisela; Hertl, Michael; Hashimoto, Takashi; Schaller, Martin			Treatment of anti-laminin 1 pemphigoid with mycophenolate mofetil	JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT			German	Letter							ANTI-P200; DIAGNOSIS		[Gawaz, Andrea; Metzler, Gisela; Schaller, Martin] Univ Hautklinik Tubingen, D-72076 Tubingen, Germany; [Hertl, Michael] Klin Dermatol & Allergol Univ, Marburg, Germany; [Hashimoto, Takashi] Kurume Univ, Dept Dermatol, Kurume, Fukuoka 830, Japan	Schaller, M (reprint author), Univ Hautklinik Tubingen, Liebermeisterstr 25, D-72076 Tubingen, Germany.	martin.schaller@med.uni-tuebingen.de					Dainichi T, 2009, P NATL ACAD SCI USA, V106, P2800, DOI 10.1073/pnas.0809230106; Schmidt E, 2009, J DTSCH DERMATOL GES, V7, P296, DOI 10.1111/j.1610-0387.2008.06974.x; Kneisel A, 2011, J DTSCH DERMATOL GES, V9, P927, DOI [10.1111/j.1610-0387.2011.07809.x, 10.1111/j.1610-0387.2011.07749.x]; Goletz S, 2014, J AM ACAD DERMATOL, V71, P185, DOI 10.1016/j.jaad.2014.02.036; Dainichi T, 2010, J DERMATOL, V37, P231, DOI 10.1111/j.1346-8138.2009.00793.x; Ishii N, 2004, BRIT J DERMATOL, V150, P843, DOI 10.1111/j.1365-2133.2004.05933.x; Shimanovich Iakov, 2004, J Dtsch Dermatol Ges, V2, P7, DOI 10.1046/j.1439-0353.2004.03047.x; Shimizu A, 2013, BRIT J DERMATOL, V168, P647, DOI 10.1111/bjd.12033; Vafia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041769; Yasuda H, 2004, DERMATOLOGY, V209, P149, DOI 10.1159/000079602	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1610-0379	1610-0387		J DTSCH DERMATOL GES	J. Dtsch. Dermatol. Ges.	JUL	2015	13	7					696	697		10.1111/ddg.12564		2	Dermatology	Dermatology	CL3WJ	WOS:000356882100012		
J	Katagiri, J; Matsushima, T; Yamada, Y; Tsuchiyama, A; Nakano, T; Uesugi, K; Ohtake, M; Saiki, K				Katagiri, Jun; Matsushima, Takashi; Yamada, Yasuo; Tsuchiyama, Akira; Nakano, Tsukasa; Uesugi, Kentaro; Ohtake, Makiko; Saiki, Kazuto			Investigation of 3D Grain Shape Characteristics of Lunar Soil Retrieved in Apollo 16 Using Image-Based Discrete-Element Modeling	JOURNAL OF AEROSPACE ENGINEERING			English	Article						Lunar soil; X-ray computed tomography (CT); Image-based discrete-element method (DEM); Grain classification; Agglutinate content	X-RAY TOMOGRAPHY; PARTICLE-SHAPE; NONSPHERICAL PARTICLES; CONTACT DETECTION; DEM SIMULATION; REAL PARTICLES; REPRESENTATION; MICROTOMOGRAPHY; STRENGTH; BEHAVIOR	This paper describes three-dimensional (3D) grain shape characteristics of returned lunar soil (No. 60501) and its numerical simulation by using the image-based discrete-element method (DEM). First, the lunar soil sample was investigated by X-ray computed tomography (CT) at the SPring-8 facility. Next, the obtained grain shapes were modeled by an original technique based on a clumped sphere method. The CT images were processed by an originally developed image analysis, and 74 grains were identified. Based on their 3D shapes and intraparticle voids and cracks, the grains were classified into four categories: (1) agglutinate (ag), (2) breccia type A (brA), (3) breccia type B (brB), and (4) plagioclase (pl). The content ratio of each grain category favorably agreed with those reported in previous studies. The 3D shape indices, namely, the aspect, flatness, and elongation ratios; the Krumbein's sphericity; and the newly proposed volume ratio to ellipsoid were computed for 74 grains. Evaluating the differences in grain shape among the four categories, it was found that ag grains were considerably more angular (irregular) than grains belonging to the other categories. The volumes of the internal voids and cracks in the four categories were also quantitatively evaluated. There is no production of ag grains on Earth because the atmosphere prevents micrometeorite impacts. Although the effect of ag grains on the bulk properties of lunar soil should be evaluated, mechanical experiments may damage the lunar soil grains. Thus, the authors used computer simulations via image-based DEM. The grain shapes were modeled by clumping 10 spheres in the image-based DEM simulations. The effect of ag content on the dynamic (angle of repose) and quasistatic (simple shear) behaviors of the grain assembly were evaluated in a series of image-based DEM simulations. In simulations of ag = 0%, ag = 27%, and ag = 100%, the ag = 100% specimens developed the largest angle of repose. In addition, it was found that the ag content primarily affects the bulk density compared with the shear strength. This work is important for understanding the mechanical properties of lunar soils because simulation methods offer a suitable alternative to mechanical experiments, which may damage the specimens. (C) 2014 American Society of Civil Engineers.	[Katagiri, Jun] Natl Inst Adv Ind Sci & Technol, Methane Hydrate Res Ctr, Tsukuba, Ibaraki 3058569, Japan; [Matsushima, Takashi; Yamada, Yasuo] Univ Tsukuba, Dept Engn Mech & Energy, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan; [Tsuchiyama, Akira] Kyoto Univ, Dept Geol & Mineral, Fac Sci, Sakyo Ku, Kyoto 6068502, Japan; [Nakano, Tsukasa] AIST, Inst Geol & Geoinformat, Tsukuba, Ibaraki 3058567, Japan; [Uesugi, Kentaro] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Ohtake, Makiko] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Saiki, Kazuto] Osaka Univ, Dept Earth & Space Sci, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan	Katagiri, J (reprint author), Natl Inst Adv Ind Sci & Technol, Methane Hydrate Res Ctr, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	j-katagiri@aist.go.jp					Abedi S, 2011, PARTICUOLOGY, V9, P387, DOI 10.1016/j.partic.2010.11.005; Andrade JE, 2012, COMPUT METHOD APPL M, V241, P262, DOI 10.1016/j.cma.2012.06.012; Wang LB, 2007, CONSTR BUILD MATER, V21, P338, DOI 10.1016/j.conbuildmat.2005.08.013; Lin CL, 2005, POWDER TECHNOL, V154, P61, DOI 10.1016/j.powtec.2005.04.031; Duttine A, 2008, SOILS FOUND, V48, P297, DOI 10.3208/sandf.48.297; Latham JP, 2008, MINER ENG, V21, P797, DOI 10.1016/j.mineng.2008.05.015; Nakata Y, 2001, SOILS FOUND, V41, P39; Garboczi EJ, 2002, CEMENT CONCRETE RES, V32, P1621, DOI 10.1016/S0008-8846(02)00836-0; Garcia X, 2009, GEOTECHNIQUE, V59, P779, DOI 10.1680/geot.8.T.037; Lu M, 2007, GRANUL MATTER, V9, P69, DOI 10.1007/s10035-006-0021-3; LEES G, 1964, SEDIMENTOLOGY, V3, P2, DOI 10.1111/j.1365-3091.1964.tb00271.x; [Anonymous], 2014, PFC3D; Nezami EG, 2006, INT J NUMER ANAL MET, V30, P783, DOI 10.1002/nag.500; [Anonymous], 2014, LIGGGHTS; Katagiri J, 2010, GRANUL MATTER, V12, P491, DOI 10.1007/s10035-010-0207-6; Hogue C, 1998, ENG COMPUTATION, V15, P374, DOI 10.1108/02644409810208525; Favier JF, 1999, ENG COMPUTATION, V16, P467, DOI 10.1108/02644409910271894; Tsuchiyama A, 2011, SCIENCE, V333, P1125, DOI 10.1126/science.1207807; ROWE PW, 1962, PROC R SOC LON SER-A, V269, P500, DOI 10.1098/rspa.1962.0193; Matsushima T, 2009, J AEROSPACE ENG, V22, P15, DOI 10.1061/(ASCE)0893-1321(2009)22:1(15); Basu A., 1981, P LUN PLAN SCI C 12, P433; CUNDALL PA, 1988, INT J ROCK MECH MIN, V25, P107, DOI 10.1016/0148-9062(88)92293-0; Dobrohotoff PB, 2012, GRANUL MATTER, V14, P651, DOI 10.1007/s10035-012-0357-9; EDEM, 2014, EDEM SOFTW PLATF; Favier JF, 2001, J ENG MECH-ASCE, V127, P971, DOI 10.1061/(ASCE)0733-9399(2001)127:10(971); MiDi GDR, 2004, EUR PHYS J E, V14, P341, DOI 10.1140/epje/i2003-10153-0; Gorz H., 1971, P 2 LUN SCI C, V3, P2021; Gorz H., 1972, P 3 LUN SCI C, V3, P3195; HEIKEN G, 1975, REV GEOPHYS, V13, P567, DOI 10.1029/RG013i004p00567; Heiken G. H., 1991, LUNAR SOURCE BOOK; Heywood H., 1971, P 2 LUN SCI C CAMBR, V3; HOUCK KJ, 1982, J GEOPHYS RES, V87, pA197, DOI 10.1029/JB087iS01p0A197; Ikeda S, 2000, MINERAL MAG, V64, P945, DOI 10.1180/002646100549760; Jaffe L. D., 1972, EARTH MOON PLANETS, V8, P58; Kanamori H, 1998, P SPAC 98, V98, P462; Katagiri J., 2012, THESIS U TSUKUBA JAP; Katagiri J., 2012, J JSCE, V68, P67; Katagiri J., 2014, J JSCE C IN PRESS; Katagiri J., 2010, P EARTH SPAC 2010, P254; Kordesh K., 1983, LUNAR PLANET SCI, P387; Krumbein W.C., 1941, J SEDIMENT PETROL, V11, P64, DOI DOI 10.1306/D42690F3-2B26-11D7-8648000102C1865D; Lee X., 1993, REV PROGR QUANTITATI, P1675; Lim KW, 2014, INT J NUMER ANAL MET, V38, P167, DOI 10.1002/nag.2203; Matsuo T., 2008, P IEEE 30 INT TEL EN, P1; Matsushima T., 2004, P 2 INT PFC S NUM MO, P421; Matsushima T., 2003, EL P 16 ENG MECH C; Matsushima T., 2008, J APPL MECH JSCE, V11, P507; McDowell G, 2011, GEOTECH LETT, V1, P59, DOI 10.1680/geolett.11.00025; MechSys, 2014, MECH SYST COMP LIB S; Mitchell J.K., 1972, P LUNAR PLANET SCI C, V3, P3235; Miura K., 1998, SOILS FOUND, V38, P159; Munjiza A., 2004, COMBINED FINITE DISC; OSullivan C, 2011, APPL GEOTECH, V4, P1; Pentland A., 1989, P 1 US C DISCR EL ME; Perko HA, 2001, J GEOTECH GEOENVIRON, V127, P371, DOI 10.1061/(ASCE)1090-0241(2001)127:4(371); Saomoto H., 2002, P NUMGE2002 NUM METH, P239; Schofield A. N., 1968, CRITICAL STATE SOIL; SCOTT RF, 1987, GEOTECHNIQUE, V37, P423; SPANNE P, 1994, PHYS REV LETT, V73, P2001, DOI 10.1103/PhysRevLett.73.2001; Terzaghi K, 1948, SOIL MECH ENG PRACTI; Wadell H, 1935, J GEOL, V43, P250; WILLMAN BM, 1995, J AEROSPACE ENG, V8, P77, DOI 10.1061/(ASCE)0893-1321(1995)8:2(77); YERAZUNI.S, 1965, NATURE, V207, P835, DOI 10.1038/207835a0; Zingg T., 1935, MINERALOGISCHE PETRO, V15, P39	64	2	2	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0893-1321	1943-5525		J AEROSPACE ENG	J. Aerosp. Eng.	JUL	2015	28	4							04014092	10.1061/(ASCE)AS.1943-5525.0000421		13	Engineering, Aerospace; Engineering, Civil	Engineering	CK7NT	WOS:000356420000004		
J	Yoshida, S; Koitabashi, M; Nakamura, J; Fukuoka, T; Sakai, H; Abe, M; Kitamoto, D; Kitamoto, H				Yoshida, S.; Koitabashi, M.; Nakamura, J.; Fukuoka, T.; Sakai, H.; Abe, M.; Kitamoto, D.; Kitamoto, H.			Effects of biosurfactants, mannosylerythritol lipids, on the hydrophobicity of solid surfaces and infection behaviours of plant pathogenic fungi	JOURNAL OF APPLIED MICROBIOLOGY			English	Article						anthracnose; Blumeria graminis f; sp; tritici; Colletotrichum dematium; Glomerella cingulata; Magnaporthe grisea; mannosylerythritol lipids; powdery mildew; rice blast	APPRESSORIUM FORMATION; MAGNAPORTHE-GRISEA; CANDIDA-ANTARCTICA; GLYCOLIPID BIOSURFACTANTS; CHEMICAL SIGNALS; PSEUDOZYMA; YEAST; GERMINATION; GRAMINIS; LEAF	AimsTo investigate the effects of mannosylerythritol lipids (MELs) on the hydrophobicity of solid surfaces, their suppressive activity against the early infection behaviours of several phytopathogenic fungal conidia, and their suppressive activity against disease occurrences on fungal host plant leaves. Methods and ResultsThe changes in the hydrophobicity of plastic film surfaces resulting from treatments with MEL solutions (MEL-A, MEL-B, MEL-C and isoMEL-B) and synthetic surfactant solutions were evaluated based on the changes in contact angles of water droplets placed on the surfaces. The droplet angles on surfaces treated with MELs were verified to decrease within 100s after placement, with contact angles similar to those observed on Tween 20-treated surfaces, indicating decreases in surface hydrophobicity after MEL treatments. Next, conidial germination, germ tube elongation and the formation of appressorium of Blumeria graminis f. sp. tritici, Colletotrichum dematium, Glomerella cingulata and Magnaporthe grisea were evaluated on plastic surfaces that were pretreated with surfactant solutions. On the surfaces of MEL-treated plastic film, inhibition of conidial germination, germ tube elongation, and suppression of appressoria formation tended to be observed, although the level of effect was dependent on the combination of fungal species and type of MEL. Inoculation tests revealed that the powdery mildew symptom caused by B.graminis f. sp. tritici was significantly suppressed on wheat leaf segments treated with MELs. ConclusionsMELs exhibited superior abilities in reducing the hydrophobicity of solid surfaces, and have the potential to suppress powdery mildew in wheat plants, presumably due to the inhibition of conidial germination. Significance and Impact of the StudyThis study provides significant evidence of the potential for MELs to be used as novel agricultural chemical pesticides.	[Yoshida, S.; Koitabashi, M.; Kitamoto, H.] Natl Inst Agroenvironm Sci, Biofunct Div, Tsukuba, Ibaraki 3058604, Japan; [Nakamura, J.; Sakai, H.; Abe, M.] Tokyo Univ Sci, Fac Sci & Technol, Noda, Chiba 278, Japan; [Fukuoka, T.; Kitamoto, D.] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki, Japan	Kitamoto, H (reprint author), Natl Inst Agroenvironm Sci, Biofunct Div, 3-1-3 Kan Nondai, Tsukuba, Ibaraki 3058604, Japan.	kitamoto@affrc.go.jp			Science and Technology Research Promotion Program for Agriculture, Forestry and Food Industry, MAFF, Japan [25017A]	This work was partly financially supported by the Science and Technology Research Promotion Program 25017A for Agriculture, Forestry and Food Industry, MAFF, Japan.	Adamson A. W., 1997, PHYS CHEM SURFACES; Fukuoka T, 2008, CARBOHYD RES, V343, P555, DOI 10.1016/j.carres.2007.11.023; Morita T, 2007, APPL MICROBIOL BIOT, V74, P307, DOI 10.1007/s00253-006-0672-3; [Anonymous], 1980, ADV APPL MICROBIOL, DOI 10.1016/S0065-2164(08)70335-6; [Anonymous], 2002, J BIOSCI BIOENG; Yamamoto S, 2012, J OLEO SCI, V61, P407, DOI 10.5650/jos.61.407; Clement-Mathieu G, 2008, FUNGAL ECOL, V1, P69, DOI 10.1016/j.funeco.2008.09.003; Arutchelvi JI, 2008, J IND MICROBIOL BIOT, V35, P1559, DOI 10.1007/s10295-008-0460-4; LEE YH, 1994, FEMS MICROBIOL LETT, V115, P71, DOI 10.1111/j.1574-6968.1994.tb06616.x; KITAMOTO D, 1993, J BIOTECHNOL, V29, P91, DOI 10.1016/0168-1656(93)90042-L; Banat IM, 2010, APPL MICROBIOL BIOT, V87, P427, DOI 10.1007/s00253-010-2589-0; Chaky J, 2001, PHYTOPATHOLOGY, V91, P558, DOI 10.1094/PHYTO.2001.91.6.558; Emmit R. W., 1975, ANNU REV PHYTOPATHOL, V13, P147; FORSYTH F. R., 1964, CAN J BOT, V42, P1335; Fukuoka T, 2015, J OLEO SCI, V64, P689, DOI 10.5650/jos.ess15017; Gilbert RD, 1996, PHYSIOL MOL PLANT P, V48, P335, DOI 10.1006/pmpp.1996.0027; HAJLAOUI MR, 1993, BIOCONTROL SCI TECHN, V3, P427, DOI 10.1080/09583159309355297; Hammami W, 2011, APPL ENVIRON MICROB, V77, P926, DOI 10.1128/AEM.01255-10; Hasselbring H, 1906, BOT GAZ, V42, P0135, DOI 10.1086/328937; Hegde Y, 1997, PHYSIOL MOL PLANT P, V51, P75, DOI 10.1006/pmpp.1997.0105; Ishii H., 2011, P ANN M PEST SCI SOC, V36, P114; KITAMOTO D, 1990, AGR BIOL CHEM TOKYO, V54, P31; KITAMOTO D, 1990, AGR BIOL CHEM TOKYO, V54, P37; Kitamoto D, 2009, CURR OPIN COLLOID IN, V14, P315, DOI 10.1016/j.cocis.2009.05.009; Kitamoto D, 2001, BIOTECHNOL PROGR, V17, P362, DOI 10.1021/bp000159f; Konishi M, 2007, APPL MICROBIOL BIOT, V75, P521, DOI 10.1007/s00253-007-0853-8; Morita T, 2013, APPL MICROBIOL BIOT, V97, P4691, DOI 10.1007/s00253-013-4858-1; MOSEMAN JG, 1965, BR MYCOL SOC TRANS, V48, P479; PODILA GK, 1993, PLANT PHYSIOL, V103, P267; Preece T. F., 1971, ECOLOGY LEAF SURFACE; Rodoriguez S. B., 1994, APPL ENVIRON MICROB, V60, P106; Shaw BD, 2006, MYCOLOGIA, V98, P186, DOI 10.3852/mycologia.98.2.186; Tsuba M, 2002, PHYSIOL MOL PLANT P, V60, P51, DOI 10.1006/pmpp.2002.0376; WATANABE T, 1991, J PESTIC SCI, V16, P651; Yoshida S, 2000, PHYTOPATHOLOGY, V90, P285, DOI 10.1094/PHYTO.2000.90.3.285; Zabka V, 2008, NEW PHYTOL, V177, P251, DOI 10.1111/j.1469-8137.2007.02233.x	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-5072	1365-2672		J APPL MICROBIOL	J. Appl. Microbiol.	JUL	2015	119	1					215	224		10.1111/jam.12832		10	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CL1NB	WOS:000356709500020		
J	Mehta, SK; Fujiwara, M; Tsuda, T; Vernier, JP				Mehta, Sanjay Kumar; Fujiwara, Masatomo; Tsuda, Toshitaka; Vernier, Jean-Paul			Effect of recent minor volcanic eruptions on temperatures in the upper troposphere and lower stratosphere	JOURNAL OF ATMOSPHERIC AND SOLAR-TERRESTRIAL PHYSICS			English	Article							QUASI-BIENNIAL OSCILLATION; GPS RADIO OCCULTATION; CLIMATE-CHANGE; MODEL; AEROSOL; PINATUBO; CONFIGURATION; UNCERTAINTY; ATMOSPHERE; ACCOUNT	The impact of the recent minor volcanic eruptions during 2001-2010 in the temperature of the upper troposphere and lower stratosphere (UTLS) is investigated using data from the Global Positioning System Radio Occultation (GPS RO), three radiosonde compilations and two reanalyses (ERA-Interim and MERRA). The volcanic signals are identified in the residual temperature time series after removal of the linear trend, the quasi-biennial oscillation and El Nino Southern Oscillation components. Eight minor volcanic eruptions (six from the tropics and two from midlatitude) over the last decade (2001-2010) are analyzed in this study. We found significant volcanic signals in the UTLS temperature only in association with the tropical Soufriere Hills and Tavurvur eruptions (in May 2006 and in October 2006, respectively). Other four tropical eruptions had very small aerosol perturbations and did not show any significant UTLS temperature change. Out of the two midlatitude eruptions, Sarychev peak had similar stratospheric aerosol perturbations as Soufriere Hills and Tavurvur eruptions, but did not show any significant UTLS temperature change. The volcanic signals in the UTLS temperature from the tropical Soufriere Hills and Tavurvur eruptions were observed for the period of 7 months after August 2006. A warming of 0.5-0.8 K in the tropical 16-18.5 km (100-70 hPa) layer was observed in association with these two tropical eruptions. (c) 2015 Elsevier Ltd. All rights reserved.	[Mehta, Sanjay Kumar; Tsuda, Toshitaka] Kyoto Univ, RISH, Kyoto 6068501, Japan; [Fujiwara, Masatomo] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 060, Japan; [Vernier, Jean-Paul] Sci Syst & Applicat Inc, Hampton, VA 23666 USA; [Vernier, Jean-Paul] NASA, Langley Res Ctr, Hampton, VA 23666 USA	Mehta, SK (reprint author), SRM Univ, Res Inst, Madras, Tamil Nadu, India.	sanjaymehta@rish.kyoto-u.ac.jp			Kyoto University [11380599]; Japan Society for the Promotion of Science (JSPS) Foundation [P12025];  [21340138]	The first author (SKM) thanks Kyoto University for providing a grant for this study under the Mission Oriented Research Program (ID No. 11380599). This work is supported in part by the Japan Society for the Promotion of Science (JSPS) Foundation (ID No. P12025). This study was also supported in part by Grants-in-Aid for Scientific Research (No. 21340138). SKM thanks to Susan Solomon and Karen Rosenlof of NOAA, William Randel of National Center for Atmospheric Research and Masato Shiotani of Kyoto University for their valuable suggestions.	Angell JK, 2000, J GEOPHYS RES-ATMOS, V105, P11841, DOI 10.1029/2000JD900044; Angell JK, 1997, J GEOPHYS RES-ATMOS, V102, P9479, DOI 10.1029/96JD03588; Kuo YH, 2004, J METEOROL SOC JPN, V82, P507, DOI 10.2151/jmsj.2004.507; Free M, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001128; Meehl GA, 2011, NAT CLIM CHANGE, V1, P360, DOI 10.1038/NCLIMATE1229; Baldwin MP, 2001, REV GEOPHYS, V39, P179, DOI 10.1029/1999RG000073; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Haywood JM, 2014, ATMOS SCI LETT, V15, P92, DOI 10.1002/asl2.471; Solomon S, 2011, SCIENCE, V333, P866, DOI 10.1126/science.1206027; TREPTE CR, 1992, NATURE, V355, P626, DOI 10.1038/355626a0; Fyfe JC, 2013, GEOPHYS RES LETT, V40, P584, DOI 10.1002/grl.50156; Randel WJ, 1994, J GEOPHYS RES-ATMOS, V99, P5433, DOI 10.1029/93JD03454; Santer BD, 1996, NATURE, V382, P39, DOI 10.1038/382039a0; Anthes RA, 2008, B AM METEOROL SOC, V89, P313, DOI 10.1175/BAMS-89-3-313; Kaufmann RK, 2011, P NATL ACAD SCI USA, V108, P11790, DOI 10.1073/pnas.1102467108; PLUMB RA, 1982, Q J ROY METEOR SOC, V108, P335, DOI 10.1002/qj.49710845604; Lohmann MS, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007764; ZWIERS FW, 1995, J CLIMATE, V8, P336, DOI 10.1175/1520-0442(1995)008<0336:TSCIAI>2.0.CO;2; HITCHMAN MH, 1994, J GEOPHYS RES-ATMOS, V99, P20689, DOI 10.1029/94JD01525; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; LABITZKE K, 1992, GEOPHYS RES LETT, V19, P207, DOI 10.1029/91GL02940; Randel WJ, 1999, J ATMOS SCI, V56, P457, DOI 10.1175/1520-0469(1999)056<0457:GQCDFU>2.0.CO;2; Hajj GA, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003909; Frame THA, 2010, J CLIMATE, V23, P2213, DOI 10.1175/2009JCLI3150.1; Free M, 2009, J CLIMATE, V22, P2925, DOI 10.1175/2008JCLI2562.1; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Vernier JP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047563; Ramaswamy V, 2001, REV GEOPHYS, V39, P71, DOI 10.1029/1999RG000065; Solomon S, 2010, SCIENCE, V327, P1219, DOI 10.1126/science.1182488; Haywood JM, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014447; Randel WJ, 2010, GEOPHYS MONOGR SER, V190, P123, DOI 10.1029/2009GM000870; Haimberger L, 2012, J CLIMATE, V25, P8108, DOI 10.1175/JCLI-D-11-00668.1; Bourassa AE, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013274; Foelsche U, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009231; Free Seidel D.J., 2005, J GEOPHYS RES, V110; Haimberger L., 2008, J CLIMATOL, V21, P817; HARSHVARDHAN, 1976, TELLUS, V28, P1; Hofmann D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039008; Kravitz B, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013525; Kursinski E.R., 2000, TERR ATMOS OCEANIC S, V11, P235; Kursinski E.R., 1997, J GEOPHYS RES, V102; MCCORMICK MP, 1995, NATURE, V373, P399, DOI 10.1038/373399a0; Neely III R.R., 2013, GEOPHYS RES LETT, V40; Scherllin-Pirscher B, 2011, ATMOS MEAS TECH, V4, P2019, DOI 10.5194/amt-4-2019-2011; Seidel DJ, 2004, J CLIMATE, V17, P2225, DOI 10.1175/1520-0442(2004)017<2225:UISOLC>2.0.CO;2; Thorne PW, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005753; WALLACE JM, 1993, J ATMOS SCI, V50, P1751, DOI 10.1175/1520-0469(1993)050<1751:ROTESQ>2.0.CO;2; Wickert J, 2005, ANN GEOPHYS-GERMANY, V23, P653	48	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-6826	1879-1824		J ATMOS SOL-TERR PHY	J. Atmos. Sol.-Terr. Phys.	JUL	2015	129						99	110		10.1016/j.jastp.2015.04.009		12	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	CK9JZ	WOS:000356557700013		
J	Hori, E; Yoshida, S; Haratake, M; Ura, S; Fuchigami, T; Nakayama, M				Hori, Eriko; Yoshida, Sakura; Haratake, Mamoru; Ura, Sakiko; Fuchigami, Takeshi; Nakayama, Morio			An effective method for profiling the selenium-binding proteins using its reactive metabolic intermediate	JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY			English	Article						Liver fatty acid-binding protein; Mass spectrometry; Selenium; Selenotrisulfide; Thiol exchange	GLUTATHIONE; LIVER; ACID; SELENOTRISULFIDE; RAT; SELENOPHOSPHATE; SELENOPROTEINS; HEMOGLOBIN; MECHANISM; TARGET	Currently, the intracellular reduction and/or transport of selenium still remain unknown. Certain reduced forms of selenium species are thought to be reactive with various endogenous molecules, particularly thiol-containing proteins. In this study, a profiling method for identifying the selenium-binding proteins using l-penicillamine selenotrisulfide (PenSSeSPen) as a model of the selenium metabolic intermediate was applied to the cell lysate generated from the rat liver. Several proteins with cysteine thiol were found to be reactive with PenSSeSPen through the thiol-exchange reaction by MALDI TOF-MS analysis. The most distinctive cysteine-containing protein at m/z 14,313 in the liver cell lysate was identified as the liver fatty acid-binding protein based on a rat protein database search and a tryptic fragmentation experiment. This methodology could be used for determining the selenium-binding proteins and/or selenium-interactive species and provide a better understanding of the selenium metabolism and utilization in biological systems.	[Hori, Eriko; Yoshida, Sakura; Ura, Sakiko; Fuchigami, Takeshi; Nakayama, Morio] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Haratake, Mamoru] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600082, Japan	Haratake, M (reprint author), Sojo Univ, Fac Pharmaceut Sci, 4-22-1 Ikeda, Kumamoto 8600082, Japan.	haratake@ph.sojo-u.ac.jp; morio@nagasaki-u.ac.jp					Wang PF, 2001, BIOCHEMISTRY-US, V40, P11698, DOI 10.1021/bi011208f; Copley SD, 2004, BIOCHEMISTRY-US, V43, P13981, DOI 10.1021/bi048947r; Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005; Margis R, 2008, FEBS J, V275, P3959, DOI 10.1111/j.1742-4658.2008.06542.x; Navarro-Alarcon M, 2008, SCI TOTAL ENVIRON, V400, P115, DOI 10.1016/j.scitotenv.2008.06.024; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Weekley CM, 2013, CHEM SOC REV, V42, P8870, DOI 10.1039/c3cs60272a; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Thompson J, 1997, J BIOL CHEM, V272, P7140; SCHWARZ K, 1957, J AM CHEM SOC, V79, P3292, DOI 10.1021/ja01569a087; Haratake M, 2008, INORG CHEM, V47, P6273, DOI 10.1021/ic800310j; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; SHAKED Z, 1980, BIOCHEMISTRY-US, V19, P4156, DOI 10.1021/bi00559a004; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Chalker JM, 2009, CHEM-ASIAN J, V4, P630, DOI 10.1002/asia.200800427; Lacourciere GM, 2000, J BIOL CHEM, V275, P23769, DOI 10.1074/jbc.M000926200; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; BANSAL MP, 1989, J BIOL CHEM, V264, P13780; BASSUK JA, 1987, P NATL ACAD SCI USA, V84, P7547, DOI 10.1073/pnas.84.21.7547; BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; DANIELSON KG, 1986, CANCER RES, V46, P4582; GANTHER HE, 1969, BIOCHEMISTRY-US, V8, P2557, DOI 10.1021/bi00834a044; Haratake M, 2004, J HEALTH SCI, V50, P366, DOI 10.1248/jhs.50.366; Haratake M, 2009, INORG CHEM, V48, P7805, DOI 10.1021/ic900988j; Haratake M, 2005, BBA-GEN SUBJECTS, V1723, P215, DOI 10.1016/j.bbagen.2005.02.002; Haratake M, 2008, J BIOL INORG CHEM, V13, P471, DOI 10.1007/s00775-007-0335-6; HAWKES WC, 1985, J INORG BIOCHEM, V23, P77, DOI 10.1016/0162-0134(85)83011-7; Hongoh M, 2012, DALTON T, V41, P7340, DOI 10.1039/c2dt30707c; Kryukov VG, 2003, SCIENCE, V300, P1439; Lindemann T, 2002, ANAL CHEM, V74, P4602, DOI 10.1021/ac020196g; MEDINA D, 1988, PATHOL IMMUNOPATH R, V7, P187, DOI 10.1159/000157115; Moghadaszadeh Behzad, 2006, Physiology (Bethesda), V21, P307, DOI 10.1152/physiol.00021.2006; Ogasawara Y, 2001, P NATL ACAD SCI USA, V98, P9494, DOI 10.1073/pnas.171320998; Self WT, 2000, P NATL ACAD SCI USA, V97, P12481, DOI 10.1073/pnas.220426897; Tang SS, 1996, J BIOCHEM-TOKYO, V119, P1182; VERES Z, 1994, J BIOL CHEM, V269, P10597; WATKINSO.JH, 1966, ANAL CHEM, V38, P92; YANG JG, 1987, J BIOL CHEM, V262, P13372	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-8257	1432-1327		J BIOL INORG CHEM	J. Biol. Inorg. Chem.	JUL	2015	20	5					781	789		10.1007/s00775-015-1265-3		9	Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear	Biochemistry & Molecular Biology; Chemistry	CL3WL	WOS:000356882300003		
J	Kawai, T; Takemoto, M; Fujibayashi, S; Tanaka, M; Akiyama, H; Nakamura, T; Matsuda, S				Kawai, Toshiyuki; Takemoto, Mitsuru; Fujibayashi, Shunsuke; Tanaka, Masashi; Akiyama, Haruhiko; Nakamura, Takashi; Matsuda, Shuichi			Comparison between alkali heat treatment and sprayed hydroxyapatite coating on thermally-sprayed rough Ti surface in rabbit model: Effects on bone-bonding ability and osteoconductivity	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						titanium (alloys); hydroxy(1)lapatite; bone ingrowth; orthopaedic; animal model	TOTAL HIP-ARTHROPLASTY; POROUS BIOACTIVE TITANIUM; COATED FEMORAL STEMS; TREATED TITANIUM; RANDOMIZED-TRIAL; ALLOY IMPLANTS; REMOVAL TORQUE; APATITE LAYER; IN-VIVO; METAL	In this study, we investigated the effect of different surface treatments (hydroxyapatite (HA) coating, alkali heat treatment, and no treatment) on the ability of bone to bond to a rough arc-sprayed Ti metal surface, using rabbit models. The bone-to-implant contacts for untreated, HA-coated, and alkali heat-treated implants were 21.2%, 72.1%, and 33.8% at 4 weeks, 21.8%, 70.9%, and 30.0% at 8 weeks, and 16.3%, 70.2%, and 29.9% at 16 weeks, respectively (n = 8). HA -coated implants showed significantly higher bone-to-implant contacts than the untreated and alkali heat-treated implants at all the time point, whereas alkali heat-treated implants showed significantly higher bone-to-implant contacts than untreated implants at 4 and 16 weeks. The failure loads in a mechanical test for untreated, HA coated, alkali heat-treated plates were 65.4 N, 70.7 N, and 90.8 N at 4 weeks, 76.1 N, 64.7 N, and 104.8 N at 8 weeks and 88.7 N, 92.6 N, and 118.5 N at 16 weeks, respectively (n = 8). The alkali heat-treated plates showed significantly higher failure loads than HA-coated plates at 8 and 16 weeks. The difference between HA-coated plates and untreated plates were not statistically significant at any time point. Thus HA coating, although it enables high bone-to-implant contact, may not enhance the bone-bonding properties of thermally-sprayed rough Ti metal surfaces. In contrast, alkali heat treatment can be successfully applied to thermally-sprayed Ti metal to enhance both bone-to-implant contact and bone-bonding strength. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 1069-1081, 2015.	[Kawai, Toshiyuki; Takemoto, Mitsuru; Fujibayashi, Shunsuke; Tanaka, Masashi; Akiyama, Haruhiko; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Nakamura, Takashi] Natl Hosp Org, Kyoto Med Ctr, Kyoto, Japan	Kawai, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan.	kawait@kuhp.kyoto-u.ac.jp			KYOCERA Medical Corporation, Osaka, Japan	Contract grant sponsor: KYOCERA Medical Corporation, Osaka, Japan	Lazarinis S, 2010, ACTA ORTHOP, V81, P53, DOI 10.3109/17453670903413178; Gandhi R, 2009, J ARTHROPLASTY, V24, P38, DOI 10.1016/j.arth.2008.01.299; Moroni A, 1998, J BONE JOINT SURG AM, V80A, P547; Nishiguchi S, 1999, J BIOMED MATER RES, V48, P689, DOI 10.1002/(SICI)1097-4636(1999)48:5<689::AID-JBM13>3.0.CO;2-C; Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283; Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409; GEESINK RGT, 1995, J BONE JOINT SURG BR, V77B, P534; Fujibayashi S, 2001, J BIOMED MATER RES, V56, P562, DOI 10.1002/1097-4636(20010915)56:4<562::AID-JBM1128>3.0.CO;2-M; Nishiguchi S, 2003, J BIOMED MATER RES A, V67A, P26, DOI 10.1002/jbm.a.10540; Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x; Yee AJM, 1999, CLIN ORTHOP RELAT R, P120; Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9; Khanuja HS, 2011, J BONE JOINT SURG AM, V93A, P500, DOI 10.2106/JBJS.J.00774; Lazarinis S, 2011, ACTA ORTHOP, V82, P399, DOI 10.3109/17453674.2011.597699; NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608; Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Meirelles L, 2008, J BIOMED MATER RES A, V87A, P299, DOI 10.1002/jbm.a.31744; Grandfield K, 2011, J MATER SCI-MATER M, V22, P899, DOI 10.1007/s10856-011-4253-3; Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4; [Anonymous], 2002, CLIN ORFHOP REL RES, DOI DOI 10.1097/00003086-200202000-00009; Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.0.CO;2-F; Nishiguchi S, 2001, BIOMATERIALS, V22, P2525, DOI 10.1016/S0142-9612(00)00443-9; Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R; WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213; Yan WQ, 1997, J BIOMED MATER RES, V37, P267, DOI 10.1002/(SICI)1097-4636(199711)37:2<267::AID-JBM17>3.0.CO;2-B; Camazzola D, 2009, J ARTHROPLASTY, V24, P33, DOI 10.1016/j.arth.2008.01.129; FUJISAWA A, 1995, MAT SCI ENG C-BIOMIM, V2, P151, DOI 10.1016/0928-4931(95)00053-4; Yamada M, 2012, INT J NANOMED, V7, P859, DOI 10.2147/IJN.S28082; Faeda RS, 2012, MICROSC RES TECHNIQ, V75, P940, DOI 10.1002/jemt.22018; Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019; Morscher EW, 1998, J BONE JOINT SURG BR, V80B, P267, DOI 10.1302/0301-620X.80B2.8316; Eom TG, 2012, OR SURG OR MED OR PA, V114, P411, DOI 10.1016/j.oooo.2011.10.036; Fontana F, 2011, CLIN ORAL IMPLAN RES, V22, P760, DOI 10.1111/j.1600-0501.2010.02056.x; Suh JY, 2007, CLIN ORAL IMPLAN RES, V18, P362, DOI 10.1111/j.1600-0501.2006.01323.x; BLOEBAUM RD, 1994, CLIN ORTHOP RELAT R, P19; BOURNE RB, 1994, CLIN ORTHOP RELAT R, P37; desGroot K, 1987, J BIOMED MATER RES, V21, P1375; FEIGHAN JE, 1995, J BONE JOINT SURG AM, V77, P1380; Fuming H, 2008, J ORAL REHABIL, V35, P754, DOI 10.1111/j.1365-2842.2008.01859.x; Hacking SA, 2003, J BONE JOINT SURG BR, V85B, P1182, DOI 10.1302/0301-620X.85B8.14233; Hacking SA, 1999, CLIN ORTHOP RELAT R, P240; Hacking SA, 2002, CLIN ORTHOP RELAT R, P24, DOI 10.1097/01.blo.0000038469.05771.3d; HEAD WC, 1995, CLIN ORTHOP RELAT R, P85; Kawai T, 2012, J MATER SCI-MATER M, V23, P2981, DOI 10.1007/s10856-012-4758-4; Kawai T, 2013, J MATER SCI-MATER M, V24, P1707, DOI 10.1007/s10856-013-4919-0; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; LesGuehennec L, 2007, DENT MATER, V23, P844; Lester DK, 1997, CLIN ORTHOP RELAT R, P143; McNally SA, 2000, J BONE JOINT SURG BR, V82B, P378, DOI 10.1302/0301-620X.82B3.10114; Onishi E, 2008, BIOMATERIALS, V29, P877, DOI 10.1016/j.biomaterials.2007.10.028; Peraire C, 2006, J BIOMED MATER RES A, V77A, P370, DOI 10.1002/jbm.a.30556; PILLIAR RM, 1983, CLIN ORTHOP RELAT R, P42; Porter AE, 2002, BIOMATERIALS, V23, P725, DOI 10.1016/S0142-9612(01)00177-6; Stilling M, 2009, CLIN ORTHOP RELAT R, V467, P2872, DOI 10.1007/s11999-009-0796-8; Takemoto M, 2006, J BIOMED MATER RES A, V78A, P693, DOI 10.1002/jbm.a.30748; Tinsley D, 2001, CLIN ORAL IMPLAN RES, V12, P159, DOI 10.1034/j.1600-0501.2001.012002159.x; Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P340; Yan WQ, 1997, BIOMATERIALS, V18, P1185, DOI 10.1016/S0142-9612(97)00057-4; Yin KF, 2012, CLIN ORAL IMPLAN RES, V23, P846, DOI 10.1111/j.1600-0501.2011.02209.x; ZWEYMULLER KA, 1988, CLIN ORTHOP RELAT R, P195	61	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	JUL	2015	103	5					1069	1081		10.1002/jbm.b.33281		13	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CL0ZO	WOS:000356671800014		
J	Suzuki, A; Takai-Igarashi, T; Nakaya, J; Tanaka, H				Suzuki, Asami; Takai-Igarashi, Takako; Nakaya, Jun; Tanaka, Hiroshi			Development of an Ontology for Periodontitis	JOURNAL OF BIOMEDICAL SEMANTICS			English	Article						ontology; periodontitis; biomedical process; bone remodeling; Gene Ontology; osteoimmunology	GENE-ONTOLOGY; DATA INTEGRATION; CELL-TYPES; DISEASE; REPRESENTATION; PATHOGENESIS; INFLAMMATION; DATABASE; GENOME	Background: In the clinical dentists and periodontal researchers' community, there is an obvious demand for a systems model capable of linking the clinical presentation of periodontitis to underlying molecular knowledge. A computer-readable representation of processes on disease development will give periodontal researchers opportunities to elucidate pathways and mechanisms of periodontitis. An ontology for periodontitis can be a model for integration of large variety of factors relating to a complex disease such as chronic inflammation in different organs accompanied by bone remodeling and immune system disorders, which has recently been referred to as osteoimmunology. Methods: Terms characteristic of descriptions related to the onset and progression of periodontitis were manually extracted from 194 review articles and PubMed abstracts by experts in periodontology. We specified all the relations between the extracted terms and constructed them into an ontology for periodontitis. We also investigated matching between classes of our ontology and that of Gene Ontology Biological Process. Results: We developed an ontology for periodontitis called Periodontitis-Ontology (PeriO). The pathological progression of periodontitis is caused by complex, multi-factor interrelationships. PeriO consists of all the required concepts to represent the pathological progression and clinical treatment of periodontitis. The pathological processes were formalized with reference to Basic Formal Ontology and Relation Ontology, which accounts for participants in the processes realized by biological objects such as molecules and cells. We investigated the peculiarity of biological processes observed in pathological progression and medical treatments for the disease in comparison with Gene Ontology Biological Process (GO-BP) annotations. The results indicated that peculiarities of Perio existed in 1) granularity and context dependency of both the conceptualizations, and 2) causality intrinsic to the pathological processes. PeriO defines more specific concepts than GO-BP, and thus can be added as descendants of GO-BP leaf nodes. PeriO defines causal relationships between the process concepts, which are not shown in GO-BP. The difference can be explained by the goal of conceptualization: PeriO focuses on mechanisms of the pathogenic progress, while GO-BP focuses on cataloguing all of the biological processes observed in experiments. The goal of conceptualization in PeriO may reflect the domain knowledge where a consequence in the causal relationships is a primary interest. We believe the peculiarities can be shared among other diseases when comparing processes in disease against GO-BP. Conclusions: This is the first open biomedical ontology of periodontitis capable of providing a foundation for an ontology-based model of aspects of molecular biology and pathological processes related to periodontitis, as well as its relations with systemic diseases. PeriO is available at http://bio-omix.tmd.ac.jp/periodontitis/.	[Suzuki, Asami; Takai-Igarashi, Takako; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Dept Computat Biol, Bunkyo Ku, Tokyo, Japan; [Suzuki, Asami] Nippon Dent Univ Hosp Tokyo, Gen Dent, Tokyo, Japan; [Takai-Igarashi, Takako; Nakaya, Jun; Tanaka, Hiroshi] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Nakaya, Jun] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan	Takai-Igarashi, T (reprint author), Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan.	takai@megabank.tohoku.ac.jp			JSPS KAKENHI [15K00295]; MEXT Tohoku Medical Megabank Project	This work was partially supported by JSPS KAKENHI, Grant-in-Aid for Scientific Research (C), Grant Number 15K00295 and TTI, JN, and HT were supported by MEXT Tohoku Medical Megabank Project.	Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Matarese G, 2012, INT J MOL MED, V30, P502, DOI 10.3892/ijmm.2012.1024; Kornman KS, 2008, J PERIODONTOL, V79, P1560, DOI 10.1902/jop.2008.080213; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Offenbacher S, 2008, J PERIODONTOL, V79, P1577, DOI 10.1902/jop.2008.080220; Grant MM, 2012, J PERIODONTAL RES, V47, P2, DOI 10.1111/j.1600-0765.2011.01387.x; Ashburner M, 2000, NAT GENET, V25, P25; Schulz S, 2014, J PERIODONTOL, V85, P1424, DOI 10.1902/jop.2014.130644; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Malone J, 2010, BIOINFORMATICS, V26, P1112, DOI 10.1093/bioinformatics/btq099; Bard J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r21; Ceusters W, 2010, J BIOMED SEMANT, V1, DOI 10.1186/2041-1480-1-10; de Matos P, 2012, METHODS MOL BIOL, V803, P273, DOI 10.1007/978-1-61779-364-6_19; Duan L, 2013, EUR J ORTHODONT, V35, P175, DOI 10.1093/ejo/cjs002; Feltrin E, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-6; Ficenec David, 2003, Briefings in Bioinformatics, V4, P260, DOI 10.1093/bib/4.3.260; Freitas F, 2009, RECIIS ELECT J COMMU, V3, P7; Gomes IS, 2014, J PERIODONTOL, V85, pE179, DOI 10.1902/jop.2013.130509; Gruber Reinhard, 2010, Wien Med Wochenschr, V160, P438, DOI 10.1007/s10354-010-0809-y; Jung SM, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/263625; Kozaki K, 2012, POST DEM NOT 11 INT; Lindeberg M, 2009, TRENDS MICROBIOL, V17, P304, DOI 10.1016/j.tim.2009.04.001; Lindeberg M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S4; Martande SS, 2014, AM J ALZHEIMERS DIS, V29, P498, DOI 10.1177/1533317514549650; Masci AM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-70; Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6; Mizoguchi R, 2011, INT CON BIOMED ONTOL; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; Rosse C, 2007, ANATOMY ONTOLOGIES B, V6, P59; Rubin DL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S2-S3; Schmidt A, 2014, BMC SYST BIOL S2, pS3; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith B, 2012, RATIO, V25, P463, DOI 10.1111/j.1467-9329.2012.00557.x; Suzuki Asami, 2009, In Silico Biology, V9, P233, DOI 10.3233/ISB-2009-0400; U.S. National Library of Medicine, UN MED LANG SYST UML; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; World Health Organization, INT CLASS DIS ICD	41	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2041-1480			J BIOMED SEMANT	J. Biomed. Semant.	JUL 1	2015	6								30	10.1186/s13326-015-0028-y		13	Mathematical & Computational Biology	Mathematical & Computational Biology	CL6KL	WOS:000357075900001		
J	Morohoshi, T; Tominaga, Y; Someya, N; Ikeda, T				Morohoshi, Tomohiro; Tominaga, Yoshiaki; Someya, Nobutaka; Ikeda, Tsukasa			Characterization of a novel thermostable N-acylhomoserine lactonase from the thermophilic bacterium Thermaerobacter marianensis	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Quorum sensing; Acylhomoserine lactone; Lactonase; Thermaerobacter; Thermostable enzyme	ACYL HOMOSERINE LACTONASE; COMPLETE GENOME SEQUENCE; MARINE BACTERIUM; SP-NOV.; COMMUNICATION; INFECTION; ALIGNMENT; ENZYME; SIGNAL	Thermaerobacter marianensis is an extremely thermophilic bacterium, which was isolated from the Mariana Trench, with an optimal growth temperature of approximately 75 degrees C. N-Acylhomoserine lactone (AHL) is a quorum-sensing signal molecule used by many gram-negative bacteria. Here, we report the identification of an AHL-degrading gene homolog (designated aiiT) in the genome of T. marianensis JCM 10246. AiiT has 59.7%, 21.2%, and 11.2% identity to AhIS from Solibacillus silvestris, AiiA from Bacillus cereus, and AidC from Chryseobacterium sp., respectively. Homologs of aiiT were also found in Thermaerobacter nagasakiensis, T. composti, and T. subterraneus. A purified AiiT-maltose binding fusion showed high AHL-degrading activity against N-hexanoyl-L-homoserine lactone, N-octanoyl-L-homoserine lactone, and N-decanoyl-L-homoserine lactone at temperatures ranging from 40 to 80 degrees C. HPLC analysis revealed that AliT functions as an AHL-lactonase that catalyzes AHL ring opening by hydrolyzing lactones. AiiT displayed maximal activity at high temperatures (60-80 degrees C) and showed higher thermostability than other AHL lactonases. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Morohoshi, Tomohiro; Tominaga, Yoshiaki; Ikeda, Tsukasa] Utsunomiya Univ, Grad Sch Engn, Dept Mat & Environm Chem, Utsunomiya, Tochigi 3218585, Japan; [Someya, Nobutaka] Natl Agr & Food Res Org NARO, HARC, Memuro, Hokkaido 0820081, Japan	Morohoshi, T (reprint author), Utsunomiya Univ, Grad Sch Engn, Dept Mat & Environm Chem, 7-1-2 Yoto, Utsunomiya, Tochigi 3218585, Japan.	morohosi@cc.utsunomiya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24760643]; UU-COE Research Project at Utsunomiya University	We thank Y. Kokuba and K. Takimoto for technical assistance. This work was supported by a Grant-in-Aid for Young Scientists (B) (No. 24760643) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the UU-COE Research Project at Utsunomiya University.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; Cao YA, 2012, APPL ENVIRON MICROB, V78, P1899, DOI 10.1128/AEM.06139-11; Chhabra SR, 2003, J MED CHEM, V46, P97, DOI 10.1021/jm020909n; Wang WZ, 2012, APPL ENVIRON MICROB, V78, P7985, DOI 10.1128/AEM.02188-12; Krell T, 2001, PROTEIN SCI, V10, P1137, DOI 10.1110/ps.52501; Yabe S, 2009, J GEN APPL MICROBIOL, V55, P323; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang WZ, 2010, APPL ENVIRON MICROB, V76, P2524, DOI 10.1128/AEM.02738-09; Vieille C, 1996, Biotechnol Annu Rev, V2, P1, DOI 10.1016/S1387-2656(08)70006-1; Dong YH, 2002, APPL ENVIRON MICROB, V68, P1754, DOI 10.1128/AEM.68.4.1754-1759.2002; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Morohoshi T, 2012, J BIOSCI BIOENG, V113, P20, DOI 10.1016/j.jbiosc.2011.09.006; Uroz S, 2009, CHEMBIOCHEM, V10, P205, DOI 10.1002/cbic.200800521; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002; Cambillau C, 2000, J BIOL CHEM, V275, P32383, DOI 10.1074/jbc.C000497200; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Morohoshi T, 2008, FEMS MICROBIOL LETT, V279, P124, DOI 10.1111/j.1574-6968.2007.01016.x; Han C, 2010, STAND GENOMIC SCI, V3, P337, DOI 10.4056/sigs.1373474; Nunoura T, 2002, ARCH MICROBIOL, V177, P339, DOI 10.1007/s00203-002-0398-2; Sambrook J, 2001, MOL CLONING LAB MANU; Seo MJ, 2011, BIOSCI BIOTECH BIOCH, V75, P1789, DOI 10.1271/bbb.110322; Suzuki T, 2001, PROTEIN ENG, V14, P85, DOI 10.1093/protein/14.2.85; Takai K, 1999, INT J SYST BACTERIOL, V49, P619	27	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	JUL	2015	120	1					1	5		10.1016/j.jbiosc.2014.11.014		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CL2ES	WOS:000356757000001		
J	Hirabayashi, S; Wang, JQ; Kawagishi, H; Hirai, H				Hirabayashi, Sho; Wang, Jianqiao; Kawagishi, Hirokazu; Hirai, Hirofumi			Improving xylitol production through recombinant expression of xylose reductase in the white-rot fungus Phanerochaete sordida YK-624	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						white-rot fungi; Phanerochaete sordida YK-624; Xylose reductase; Recombinant expression; Xylitol	FERMENTATION	We generated an expression construct consisting of the xylose reductase (XR) gene (xr) from Phanerochaete chrysosporium. Transformant X7 exhibited increased xylitol production and markedly higher XR activities than the wild-type strain. RT-PCR analysis demonstrated that the increased XR activity was associated with constant expression of the recombinant xr gene. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Hirabayashi, Sho; Wang, Jianqiao; Kawagishi, Hirokazu; Hirai, Hirofumi] Shizuoka Univ, Grad Sch Agr, Suruga Ku, Shizuoka 4228529, Japan; [Kawagishi, Hirokazu; Hirai, Hirofumi] Shizuoka Univ, Res Inst Green Sci & Technol, Suruga Ku, Shizuoka 4228529, Japan; [Kawagishi, Hirokazu] Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka 4228529, Japan	Hirai, H (reprint author), Shizuoka Univ, Dept Appl Biol Chem, Grad Sch Agr, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	ahhirai@ipc.shizuoka.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21248023, 24248030]	This work was partially supported by Grants-in-Aid for Scientific Research (A) (Nos. 21248023 and 24248030) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	HIRAI H, 1994, MOKUZAI GAKKAISHI, V40, P980; Sasaki M, 2010, APPL MICROBIOL BIOT, V86, P1057, DOI 10.1007/s00253-009-2372-2; Lin Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI 10.1007/s00253-005-0229-x; Kamei I, 2012, BIORESOURCE TECHNOL, V126, P137, DOI 10.1016/j.biortech.2012.09.007; [Anonymous], 1988, METHOD ENZYMOL; Sugiura T, 2009, BIOSCI BIOTECH BIOCH, V73, P1793, DOI 10.1271/bbb.90152; Eliasson A, 2000, APPL ENVIRON MICROB, V66, P3381, DOI 10.1128/AEM.66.8.3381-3386.2000; FitzPatrick M, 2010, BIORESOURCE TECHNOL, V101, P8915, DOI 10.1016/j.biortech.2010.06.125; Vallet C, 1996, BIOORG CHEM, V24, P319, DOI 10.1006/bioo.1996.0028; Harcus D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080733; Leticia P., 1997, BIOTECHNOL LETT, V19, P45; Sugiura T, 2012, FEMS MICROBIOL LETT, V331, P81, DOI 10.1111/j.1574-6968.2012.02556.x; Suzuki T, 2014, J MICROBIOL METH, V100, P70, DOI 10.1016/j.mimet.2014.02.016; Witter P., 1993, APPL MICROBIOL BIOT, V38, P776; Yamagishi K., 2007, APPL MICROBIOL BIOT, V76, P1079; Yokoyama I., 1995, J FERMENT BIOENG, V79, P217	16	0	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	JUL	2015	120	1					6	8		10.1016/j.jbiosc.2014.11.024		3	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CL2ES	WOS:000356757000002		
J	Doukyu, N; Nihei, S				Doukyu, Noriyuki; Nihei, Shyou			Cholesterol oxidase with high catalytic activity from Pseudomonas aeruginosa: Screening, molecular genetic analysis, expression and characterization	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Cholesterol; Cholesterol oxidase; Pseudomonas aeruginosa; Cholest-4-en-3-one; 6 beta-Hydroperoxycholest-4-en-3-one; Vanillyl-alcohol oxidase family	CHROMOBACTERIUM SP DS-1; COVALENTLY BOUND FAD; BOLL-WEEVIL LARVAE; ORGANIC-SOLVENT; BREVIBACTERIUM-STEROLICUM; STRAIN ST-200; RHODOCOCCUS-ERYTHROPOLIS; SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; OXYGEN ACCESS	An extracellular cholesterol oxidase producer, Pseudomonas aeruginosa strain PA157, was isolated by a screening method to detect 613-hydroperoxycholest-4-en-3-one-forming cholesterol oxidase. On the basis of a putative cholesterol oxidase gene sequence in the genome sequence data of P. aeruginosa strain PAO1, the cholesterol oxidase gene from strain PA157 was cloned. The mature form of the enzyme was overexpressed in Escherichia con cells. The overexpressed enzyme formed inclusion bodies in recombinant E. coli cells grown at 20 degrees C and 30 degrees C. A soluble and active PA157 enzyme was obtained when the recombinant cells were grown at 10 degrees C. The purified enzyme was stable at pH 5.5 to 10 and was most active at pH 7.5-8.0, showing optimal activity at pH 7.0 and 70 degrees C. The enzyme retained about 90% of its activity after incubation for 30 min at 70 degrees C. The enzyme oxidized 3 beta-hydroxysteroids such as cholesterol, beta-cholestanol, and beta-sitosterol at high rates. The K-m value and V-max value for the cholesterol were 92.6 mu M and 15.9 mu mol/min/mg of protein, respectively. The V-max value of the enzyme was higher than those of commercially available cholesterol oxidases. This is the first report to characterize a cholesterol wddase from P. aeruginosa. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Doukyu, Noriyuki] Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama 3508585, Japan; [Doukyu, Noriyuki; Nihei, Shyou] Toyo Univ, Grad Sch Life Sci, Itakura Machi, Gunma 3740193, Japan; [Doukyu, Noriyuki] Toyo Univ, Dept Life Sci, Itakura Machi, Gunma 3740193, Japan	Doukyu, N (reprint author), Toyo Univ, Dept Life Sci, 1-1-1 Izumino, Itakura Machi, Gunma 3740193, Japan.	dokyu@toyo.jp			Japan Society for the Promotion of Science (JSPS) [24580127]; Grant for the Programme for the Strategic Research Foundation at Private Universities [S1101017]	This work was supported in part by a Grant-in-Aid for Scientific Research (C) 24580127 from the Japan Society for the Promotion of Science (JSPS) and by a Grant for the Programme for the Strategic Research Foundation at Private Universities S1101017, organized by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, since April 2011.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Doukyu N, 2008, APPL MICROBIOL BIOT, V80, P59, DOI 10.1007/s00253-008-1526-y; AONO R, 1994, APPL ENVIRON MICROB, V60, P2518; Doukyu N, 1998, APPL ENVIRON MICROB, V64, P1929; Brzostek A, 2007, FEMS MICROBIOL LETT, V275, P106, DOI 10.1111/j.1574-6968.2007.00865.x; Sorensen HP, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-1; MacLachlan J, 2000, J STEROID BIOCHEM, V72, P169, DOI 10.1016/S0960-0760(00)00044-3; Mendes MV, 2007, CHEM BIOL, V14, P279, DOI 10.1016/j.chembiol.2007.01.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Aono R, 1996, BIOSCI BIOTECH BIOCH, V60, P1146; Aparicio JF, 2008, MOL BIOSYST, V4, P804, DOI 10.1039/b717500k; ARIMA K, 1969, AGR BIOL CHEM TOKYO, V33, P1636; Barrow G. I., 1993, COWAN STEELS MANUAL; Biellmann JF, 2001, CHIRALITY, V13, P34, DOI 10.1002/1520-636X(2001)13:1<34::AID-CHIR7>3.0.CO;2-O; Brenner D., 2005, BERGEYS MANUAL SYSTE, V2, P323; Cho HJ, 1995, APPL MICROBIOL BIOT, V44, P133; Coulombe R, 2001, J BIOL CHEM, V276, P30435, DOI 10.1074/jbc.M104103200; Croteau N, 1996, J STRUCT BIOL, V116, P317, DOI 10.1006/jsbi.1996.0047; DIETH S, 1995, TETRAHEDRON LETT, V36, P2243, DOI 10.1016/0040-4039(95)00235-5; Doukyu N., 2009, APPL MICROBIOL BIOT, V85, P825; Doukyu N, 1999, BIOCHEM J, V341, P621, DOI 10.1042/0264-6021:3410621; Doukyu N, 2001, APPL MICROBIOL BIOT, V57, P146, DOI 10.1007/s002530100753; Doukyu N, 2009, APPL MICROBIOL BIOT, V82, P479, DOI 10.1007/s00253-008-1775-9; Ernst ND, 2002, CURR OPIN LIPIDOL, V13, P69, DOI 10.1097/00041433-200202000-00010; KAZANDJIAN RZ, 1986, BIOTECHNOL BIOENG, V28, P417, DOI 10.1002/bit.260280315; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Mathieu JM, 2012, BIOTECHNOL BIOENG, V109, P2409, DOI 10.1002/bit.24506; Navas J, 2001, J BACTERIOL, V183, P4796, DOI 10.1128/JB.183.16.4796-4805.2001; Piubelli L, 2008, J BIOL CHEM, V283, P24738, DOI 10.1074/jbc.M802321200; Pollegioni L, 2009, FEBS J, V276, P6857, DOI 10.1111/j.1742-4658.2009.07379.x; Volonte F, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-33; PURCELL JP, 1993, BIOCHEM BIOPH RES CO, V196, P1406, DOI 10.1006/bbrc.1993.2409; Sagermann M, 2010, J STRUCT BIOL, V170, P32, DOI 10.1016/j.jsb.2010.01.012; Sampson NS, 2003, ACCOUNTS CHEM RES, V36, P713, DOI 10.1021/ar9800587; SMITH AG, 1974, J CHROMATOGR, V101, P373, DOI 10.1016/S0021-9673(00)82854-X; Snyder A, 2006, J BACTERIOL, V188, P1762, DOI 10.1128/JB.188.5.1762-1774.2006; UWAJIMA T, 1974, AGR BIOL CHEM TOKYO, V38, P1149	38	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	JUL	2015	120	1					24	30		10.1016/j.jbiosc.2014.12.003		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CL2ES	WOS:000356757000005		
J	Mitsui, R; Katayama, H; Tanaka, M				Mitsui, Ryoji; Katayama, Hiroko; Tanaka, Mitsuo			Requirement of carbon dioxide for initial growth of facultative methylotroph, Acidomonas methanolica MB58	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Ribulose monophosphate pathway; Calvin cycle; Methylotroph bacteria; Carbon dioxide; Acidomonas methanolica MB58	RIBULOSE MONOPHOSPHATE PATHWAY; BRADYRHIZOBIUM-JAPONICUM; FORMALDEHYDE FIXATION; AUTOTROPHIC GROWTH; GENES; BACTERIUM; DENITRIFICANS; ASSIMILATION; CARBOXYLASE; BINDING	The facultative methylotrophic bacterium Acidomonas methanolica MB58 can utilize C-1 compounds via the ribulose monophosphate pathway. A large gene cluster comprising three components related to C-1 metabolism was found in the genome. From upstream, the first was an mxa cluster encoding proteins for oxidation of methanol to formaldehyde; the second was the rmp cluster encoding enzymes for formaldehyde fixation; and the third was the cbb gene cluster encoding proteins for carbon dioxide (CO2) fixation. Examination of CO2 requirements for growth of A. methanolica MB58 cells demonstrated that it did not grow on any carbon source under CO2-free conditions. Measurement of ribulose-1,5-bisphosphate carboxylase activity and RT-PCR analysis demonstrated enzymatic activity was detected in A. methanolica MB58 at growth phase, regardless of carbon sources. However, methanol dehydrogenase and 3-hexlose-6-phosphate synthase expression was regulated by methanol or formaldehyde; it were detected during growth and apparently differed from ribulose-1,5-bisphosphate carboxylase expression. These results suggested that A. methanolica MB58 may be initially dependent on autotrophic growth and that carbon assimilation was subsequently coupled with the ribulose monophosphate pathway at early- to mid-log phases during methylotrophic growth. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Mitsui, Ryoji; Katayama, Hiroko; Tanaka, Mitsuo] Okayama Univ Sci, Dept Biochem, Fac Sci, Kita Ku, Okayama 7000005, Japan	Mitsui, R (reprint author), Okayama Univ Sci, Dept Biochem, Fac Sci, Kita Ku, 1-1 Ridai Cho, Okayama 7000005, Japan.	rmitsui@dbc.ous.ac.jp; k.hiroko@me.com; mtanaka@dbc.ous.ac.jp			JSPS KAKENHI [23580122, 26660074]	This work was financially supported by JSPS KAKENHI (grant no.: 23580122 and 26660074). The authors thank Dr. Hiroki Ashida of the NARA Institute of Science and Technology for the technical advice for RubisCO activity measurements.	Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Hayashi NR, 2002, BIOCHEM BIOPH RES CO, V290, P1434, DOI 10.1006/bbrc.2002.6366; MARMUR J, 1961, J MOL BIOL, V3, P208; Kusian B, 1997, FEMS MICROBIOL REV, V21, P135, DOI 10.1111/j.1574-6976.1997.tb00348.x; Mitsui R, 2003, APPL ENVIRON MICROB, V69, P6128, DOI 10.1128/AEM.69.10.6128-6132.2003; Marx CJ, 2001, MICROBIOL-SGM, V147, P2065; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Chen LM, 2010, BIOSCI BIOTECH BIOCH, V74, P627, DOI 10.1271/bbb.90847; COX RB, 1975, BIOCHEM J, V150, P569; Du YC, 1996, JPN J CROP SCI, V65, P714; Esparza M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-229; Gourion B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021900; Masuda S, 2010, APPL ENVIRON MICROB, V76, P2402, DOI 10.1128/AEM.02783-09; Masuda S, 2010, MICROBES ENVIRON, V25, P220, DOI 10.1264/jsme2.ME10124; Mitsui R, 2000, J BACTERIOL, V182, P944, DOI 10.1128/JB.182.4.944-948.2000; Mitsui R, 2005, J BIOSCI BIOENG, V99, P18, DOI 10.1263/jbb.99.018; MULLER RH, 1990, METHOD ENZYMOL, V188, P401; SHIVELY JM, 1978, J BACTERIOL, V134, P1123; UHLIG H, 1986, INT J SYST BACTERIOL, V36, P317; Yamakawa T, 2004, SOIL SCI PLANT NUTR, V50, P713; Yamashita S, 2004, INT J SYST EVOL MICR, V54, P865, DOI 10.1099/ijs.0.02946-0	21	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	JUL	2015	120	1					31	35		10.1016/j.jbiosc.2014.11.016		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CL2ES	WOS:000356757000006		
J	Nakagawa, T; Wakayama, K; Hayakawa, T				Nakagawa, Tomoyuki; Wakayama, Keishi; Hayakawa, Takashi			Selection of suitably non-repressing carbon sources for expression of alcohol oxidase isozyme promoters in the methylotrophic yeast Pichia methanolica	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Pichia methaolica; Alcohol oxidase isozymes; Gene expression; Non-repressing carbon source; MOD promoters	INDUCIBLE GENE-EXPRESSION; CANDIDA-BOIDINII; PASTORIS	In this work, we aimed to select suitable non-repressing carbon sources for the expression of promoters derived from the alcohol oxidase (AOD) isozyme genes, P-MOD1 and P-MOD2, during the growth of Pichia methanolica. Our results revealed that xylose is the best non-repressing carbon source for heterologous gene expression using both P-MOD1 and P-MOD2, and that glycerol is also a suitable carbon source with by which the on/off of P-MOD2 expression can be controlled. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Nakagawa, Tomoyuki; Wakayama, Keishi; Hayakawa, Takashi] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan	Nakagawa, T (reprint author), Gifu Univ, Fac Appl Biol Sci, 1-1 Yanagido, Gifu 5011193, Japan.	t_nakaga@gifu-u.ac.jp			Kiyomi Yoshizaki foundation	This research was supported in part by the 2014 Kiyomi Yoshizaki foundation (T.N.).	Inan M, 2001, J BIOSCI BIOENG, V92, P585, DOI 10.1263/jbb.92.585; Raymond CK, 1998, YEAST, V14, P11, DOI 10.1002/(SICI)1097-0061(19980115)14:1<11::AID-YEA196>3.0.CO;2-S; Stratton J, 1998, METH MOL B, V103, P107; LEE JD, 1980, J GEN APPL MICROBIOL, V26, P133, DOI 10.2323/jgam.26.133; Ozimek P, 2005, FEMS YEAST RES, V5, P975, DOI 10.1016/j.femsyr.2005.06.005; Gellissen G, 2005, FEMS YEAST RES, V5, P1079, DOI 10.1016/j.femsyr.2005.06.004; Hartner FS, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-39; Ito T, 2007, YEAST, V24, P523, DOI 10.1002/yea.1490; Nakagawa T, 2006, YEAST, V23, P15, DOI 10.1002/yea.1334; Nakagawa T, 1999, YEAST, V15, P1223, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1223::AID-YEA450>3.3.CO;2-O; Nakagawa T, 1996, J FERMENT BIOENG, V81, P498, DOI 10.1016/0922-338X(96)81469-3; Nakagawa T, 2001, J BIOSCI BIOENG, V91, P225, DOI 10.1263/jbb.91.225; Nakagawa T, 2002, YEAST, V19, P1067, DOI 10.1002/yea.896; TANI Y, 1985, AGR BIOL CHEM TOKYO, V49, P2699; TOHE A, 1973, J BACTERIOL, V113, P727; van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1453, DOI 10.1016/j.bbamcr.2006.07.016; Yurimoto H, 2009, BIOTECHNOL APPL BIOC, V53, P85, DOI 10.1042/BA20090030; Yurimoto H, 2009, BIOSCI BIOTECH BIOCH, V73, P793, DOI 10.1271/bbb.80825	18	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	JUL	2015	120	1					41	44		10.1016/j.jbiosc.2014.12.007		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CL2ES	WOS:000356757000008		
J	Ogara, T; Takahashi, T; Yasui, H; Uwai, K; Tokuraku, K				Ogara, Toshiki; Takahashi, Tomohito; Yasui, Hajime; Uwai, Koji; Tokuraku, Kiyotaka			Evaluation of the effects of amyloid beta aggregation from seaweed extracts by a microliter-scale high-throughput screening system with a quantum dot nanoprobe	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Alzheimer's disease; Amyloid; Quantum dots; Seaweed; High-throughput screening	ALZHEIMERS-DISEASE; IN-VITRO; PROTEIN; THERAPEUTICS; MEMORY	Inhibitors of amyloid beta (A beta) aggregation have the potential to serve as lead compounds for anti-Alzheimer's disease (AD) agents because A beta aggregation is a key step in AD pathogenesis. Recently, we developed a novel microliter-scale high-throughput screening (MSHTS) system for A beta aggregation inhibitors that applied fluorescence microscopic analysis with quantum dot nanoprobes, and attempted to comprehensively screen the inhibitors from spices using this system (Ishigaki et al., PLoS One, 8, e72992, 2013). In this study, we tried to evaluate the inhibitory activities of 11 seaweed extracts on A beta aggregation using the MSHTS system. The half-maximal effective concentration (EC50) of the ethanolic extracts from all seaweeds exceeded 4.9 mg/ml, indicating that the extracts inhibit A beta aggregation although this activity was significantly lower than that displayed by members of the Lamiaceae, a family of herbal spices that showed highest activity among 52 spices tested in our 2013 study. On the other hand, the EC50 of boiling water extracts was 0.013-0.42 mg/ml which was comparable with the EC50 of the extracts from the Lamiaceae family. These results suggest that the extraction efficiency of the inhibitors by boiling water extraction was higher than that by ethanolic extraction. Moreover, analysis of fluorescence micrographs, which were obtained from the MSHTS system, revealed that the morphology of the A beta aggregates coincubated with boiling water extracts differed from control aggregates, suggesting that the MSHTS system is also useful for screening substances that affect the morphology of aggregates. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Ogara, Toshiki; Takahashi, Tomohito; Uwai, Koji; Tokuraku, Kiyotaka] Muroran Inst Technol, Dept Appl Sci, Muroran, Hokkaido 0508585, Japan; [Yasui, Hajime] Hokkaido Univ, Fac Fisheries Sci, Lab Marine Ind Sci & Technol, Hakodate, Hokkaido 0418611, Japan	Tokuraku, K (reprint author), Muroran Inst Technol, Dept Appl Sci, 27-1 Mizumoto Cho, Muroran, Hokkaido 0508585, Japan.	tokuraku@mmm.muroran-it.ac.jp			MuIT Grant for Selective Research; JSPS [25350974]	We thank Dr. Hiroyuki Yoshino and Dr. Masaru Kusaka (Hakodate Regional Industry Promotion Organization) for providing information about seaweeds. This work is supported by the MuIT Grant for Selective Research (K.T.) and JSPS KAKENHI Grant Numbers 25350974 (K.T.).	Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1993, PROTEIN SCI, V2, P404; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; Kahkonen MP, 1999, J AGR FOOD CHEM, V47, P3954, DOI 10.1021/jf990146l; Wang PP, 2014, CARBOHYD POLYM, V110, P142, DOI 10.1016/j.carbpol.2014.03.060; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Holdt SL, 2011, J APPL PHYCOL, V23, P543, DOI 10.1007/s10811-010-9632-5; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Ishigaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072992; Tokuraku K., 2013, BIONANOIMAGING PROTE, P121; Tokuraku K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008492	16	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	JUL	2015	120	1					45	50		10.1016/j.jbiosc.2014.11.018		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CL2ES	WOS:000356757000009		
J	Kimura, T; Fukuda, W; Sanada, T; Imanaka, T				Kimura, Tomomi; Fukuda, Wakao; Sanada, Tomoe; Imanaka, Tadayuki			Characterization of water-soluble dark-brown pigment from Antarctic bacterium, Lysobacter oligotrophicus	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Antarctic; Melanin; Microbial product; Macromolecular structure; UV-protection	PERFORMANCE LIQUID-CHROMATOGRAPHY; SP NOV.; MELANIN PIGMENT; FUNGAL MELANINS; GEN. NOV.; LAKE; BIOSYNTHESIS; MICROORGANISMS; MELANOGENESIS; PURIFICATION	Lysobacter oligotrophicus strain 107-E2(T) isolated from Antarctica produces dark-brown colored water-soluble pigment, in addition to hydrolases and lytic enzymes. The production of pigment is a common characteristic among members of the genus Lysobacter, but the identity of the pigments has been unknown. In this study, we identified the pigment from L oligotrophicus as melanin pigment (Lo-melanin) by chemical and spectroscopic analyses. Although melanin is generally insoluble in both aqueous and organic solvents, the results in this study revealed that Lo-melanin shows water-solubility by means of the added polysaccharide chain. Lo-melanin production of L. oligotrophicus was increased by ultraviolet (UV) exposure, and survival rate of Escherichia coli under UV-irradiated condition was increased by the addition of Lo-melanin to the medium. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Kimura, Tomomi; Fukuda, Wakao; Imanaka, Tadayuki] Ritsumeikan Univ, Dept Biotechnol, Coll Life Sci, Kusatsu, Shiga 5258577, Japan; [Sanada, Tomoe] Ritsumeikan Univ, Dept Appl Chem, Coll Life Sci, Kusatsu, Shiga 5258577, Japan	Imanaka, T (reprint author), Ritsumeikan Univ, Dept Biotechnol, Coll Life Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	imanaka@sk.ritsumei.ac.jp			JSPS [19205022, 23657068]	The authors would like to express their sincere thanks to all members concerned to the 46th Japanese Antarctic Research Expedition. This study was supported by JSPS KAKENHI (19205022 and 23657068).	Agar N, 2005, MUTAT RES-FUND MOL M, V571, P121, DOI 10.1016/j.mrfmmm.2004.11.016; Aghajanyan AA, 2011, APPL BIOCHEM MICRO+, V47, P500, DOI 10.1134/S0003683811050024; Yasuno S, 1997, BIOSCI BIOTECH BIOCH, V61, P1944; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; PIATELLI M, 1965, TETRAHEDRON, V21, P3229, DOI 10.1016/S0040-4020(01)96941-8; Plonka PM, 2006, ACTA BIOCHIM POL, V53, P429; Tindall BJ, 2004, MICROBIAL ECOL, V47, P271, DOI 10.1007/s00248-003-1050-7; Aghajanyan AE, 2005, PIGM CELL RES, V18, P130, DOI 10.1111/j.1600-0749.2005.00211.x; Cary SC, 2010, NAT REV MICROBIOL, V8, P129, DOI 10.1038/nrmicro2281; CUBO MT, 1988, APPL ENVIRON MICROB, V54, P1812; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Priscu JC, 1998, SCIENCE, V280, P2095, DOI 10.1126/science.280.5372.2095; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; Araujo M, 2012, STRUCT CHEM, V23, P115, DOI 10.1007/s11224-011-9843-7; BLOIS MS, 1964, BIOPHYS J, V4, P471; Fukuda W, 2013, INT J SYST EVOL MICR, V63, P3313, DOI 10.1099/ijs.0.051805-0; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; Yuan WL, 2007, PHYSIOL PLANTARUM, V131, P180, DOI 10.1111/j.1399-3054.2007.00948.x; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Casadevall A., 2000, CURR OPIN MICROBIOL, V3, P354; Christensen P., 2005, BERGEYS MANUAL SYSTE, V2, P95; Cowan DA, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P119; FAVA F, 1993, CHEMOSPHERE, V27, P825, DOI 10.1016/0045-6535(93)90014-V; Fukuda W, 2012, INT J SYST EVOL MICR, V62, P1945, DOI 10.1099/ijs.0.032953-0; HEARING VJ, 1987, METHOD ENZYMOL, V142, P154, DOI 10.1016/S0076-6879(87)42024-7; Hodge J. E., 1962, METHODS CARBOHYDRATE, V1, P380; Karr EA, 2006, APPL ENVIRON MICROB, V72, P1663, DOI 10.1128/AEM.72.2.1663-1666.2006; Kumar CG, 2013, LETT APPL MICROBIOL, V57, P295, DOI 10.1111/lam.12111; Martinez-Levasseur LM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02386; Prisco G, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P145; Reddy GSN, 2007, INT J SYST EVOL MICR, V57, P2014, DOI 10.1099/ijs.0.64932-0; Rothschild L. J., 2001, NATURE, V409, P1092; Sajjan S, 2010, J MICROBIOL BIOTECHN, V20, P1513, DOI 10.4014/jmb.1002.02006; Sandmann G, 1998, APPL ENVIRON MICROB, V64, P1972; Selvakumar P, 2008, WORLD J MICROB BIOT, V24, P2125, DOI 10.1007/s11274-008-9718-2; SENESI N, 1987, BIOL FERT SOILS, V5, P120; Yamada K, 2011, INT J SYST EVOL MICR, V61, P1973, DOI 10.1099/ijs.0.026625-0; Yasuno S, 1999, BIOSCI BIOTECH BIOCH, V63, P1353, DOI 10.1271/bbb.63.1353	41	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	JUL	2015	120	1					58	61		10.1016/j.jbiosc.2014.11.020		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CL2ES	WOS:000356757000011		
J	Zhou, X; Zhang, CF; Zhang, DD; Awata, T; Xiao, ZX; Yang, Q; Katayama, A				Zhou, Xue; Zhang, Chunfang; Zhang, Dongdong; Awata, Takanori; Xiao, Zhixing; Yang, Qi; Katayama, Arata			Polyphasic characterization of an anaerobic hexachlorobenzene-dechlorinating microbial consortium with a wide dechlorination spectrum for chlorobenzenes	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Hexachlorobenzene; Chlorobenzenes; Full reductive dechlorination; Dehalococcoides sp.; Geobacter sp.	SP STRAIN CBDB1; CHLORINATED BENZENES; REDUCTIVE DECHLORINATION; ELECTRON-DONOR; SP-NOV; DEHALOGENATION; DEHALOBACTER; ENRICHMENT; REDOX; TETRACHLOROETHENE	An anaerobic consortium that was capable of reductively dechlorinating hexachlorobenzene (HCB) to benzene was enriched from contaminated sediment. The consortium was capable of dechlorinating all chlorobenzene isomers except 1,4-dichlorobenzene. Singly and doubly flanked chlorines, as well as unflanked meta-substituted chlorines, were dechlorinated, although doubly flanked chlorines were preferred. Formate, acetate and lactate (but not ethanol) could be utilized as optimum electron donors for reductive dechlorination. Alternative electron acceptors, including nitrate and sulfate, completely inhibited HCB degradation, whereas amorphous iron oxide (FeOOH) did not suppress dechlorination activity. No degradation was found in chloramphenicol-treated consortium; however, vancomycin, molybdate, and 2-bromoethanesulfonate did not inhibit HCB dechlorination. The results of inhibitory treatments suggested that the dechlorinators were non-sulfate-reducing gram-negative or vancomycin resistant gram-positive bacteria. In addition to physiological characterization, analyses of 16S rRNA gene library of the consortium and quantitative PCR of 16S rRNA genes suggested that Dehalococcoides sp. was involved in the reductive dechlorination of HCB, and Geobacter sp. may serve as a dechlorinating candidate. (C) 2015, The Society for Biotechnology, Japan. All rights reserved.	[Zhou, Xue; Yang, Qi] China Univ Geosci, Sch Water Resources & Environm, Beijing 100083, Peoples R China; [Zhou, Xue; Katayama, Arata] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648603, Japan; [Zhang, Chunfang] Zhejiang Univ, Inst Marine Biol, Ocean Coll, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Chunfang; Awata, Takanori; Katayama, Arata] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan; [Zhang, Dongdong; Awata, Takanori; Xiao, Zhixing; Katayama, Arata] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan	Katayama, A (reprint author), Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	a-katayama@esi.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology in Japan [20310041, 23310055, 26281040]; China Scholarship Council	This study was supported in part by Grants-in-Aid for Scientific Research (B2: 20310041, B2: 23310055 and B2: 26281040) and a university grant for "Design of cascade utilization system for unused biological resources in the Tokai area" from the Ministry of Education, Culture, Sports, Science, and Technology in Japan. Xue Zhou was supported by the China Scholarship Council.	Adrian L, 2000, NATURE, V408, P580, DOI 10.1038/35046063; Agency for Toxic Substances Disease Registry (ATSDR), 2002, TOX PROF HEX; Smidt H, 2004, ANNU REV MICROBIOL, V58, P43, DOI 10.1146/annurev.micro.58.030603.123600; Sung Y, 2006, APPL ENVIRON MICROB, V72, P2775, DOI 10.1128/AEM.72.4.2775-2782.2006; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; Wagner A, 2009, APPL ENVIRON MICROB, V75, P1876, DOI 10.1128/AEM.01042-08; Adrian L, 2007, APPL ENVIRON MICROB, V73, P7717, DOI 10.1128/AEM.01649-07; Nelson JL, 2011, ENVIRON SCI TECHNOL, V45, P6806, DOI 10.1021/es200480k; Li ZL, 2013, J BIOSCI BIOENG, V116, P602, DOI 10.1016/j.jbiosc.2013.05.009; FATHEPURE BZ, 1988, APPL ENVIRON MICROB, V54, P327; DOLFING J, 1993, FEMS MICROBIOL ECOL, V13, P23; Barber JL, 2005, SCI TOTAL ENVIRON, V349, P1, DOI 10.1016/j.sciotenv.2005.03.014; Bailey RE, 2001, CHEMOSPHERE, V43, P167, DOI 10.1016/S0045-6535(00)00186-7; Tas DO, 2008, ENVIRON SCI TECHNOL, V42, P3234, DOI 10.1021/es702261w; Adrian L, 2002, RES MICROBIOL, V153, P131, DOI 10.1016/S0923-2508(02)01298-6; Men YJ, 2012, ISME J, V6, P410, DOI 10.1038/ismej.2011.111; Hirano T, 2007, CHEMOSPHERE, V67, P428, DOI 10.1016/j.chemosphere.2006.09.087; BEURSKENS JEM, 1994, ENVIRON SCI TECHNOL, V28, P701, DOI 10.1021/es00053a026; Holliger C, 1998, ARCH MICROBIOL, V169, P313, DOI 10.1007/s002030050577; GUNSALUS RP, 1978, BIOCHEMISTRY-US, V17, P2374, DOI 10.1021/bi00605a019; Fennell DE, 2004, ENVIRON SCI TECHNOL, V38, P2075, DOI 10.1021/es034989b; WIDDEL F, 1983, ARCH MICROBIOL, V134, P286, DOI 10.1007/BF00407804; PICARDAL F, 1995, APPL ENVIRON MICROB, V61, P8; Jayachandran G, 2004, ARCH MICROBIOL, V182, P498, DOI 10.1007/s00203-004-0734-9; NIETO M, 1971, BIOCHEM J, V123, P773; Adrian L, 1998, APPL ENVIRON MICROB, V64, P496; Bunge M, 2008, ENVIRON MICROBIOL, V10, P2670, DOI 10.1111/j.1462-2920.2008.01688.x; Chang BV, 1997, WATER AIR SOIL POLL, V100, P25, DOI 10.1023/A:1018392125200; Chen IM, 2000, WATER ENVIRON RES, V72, P675, DOI 10.2175/106143000X138283; Chen IM, 2010, J HAZARD MATER, V177, P244, DOI 10.1016/j.jhazmat.2009.12.024; Duan TH, 2013, BIODEGRADATION, V24, P513, DOI 10.1007/s10532-012-9607-0; GALE EF, 1963, PHARMACOL REV, V15, P481; Jayachandran G, 2003, ARCH MICROBIOL, V180, P411, DOI 10.1007/s00203-003-0607-7; Middeldorp PJM, 1997, APPL ENVIRON MICROB, V63, P1225; Milligan PW, 1999, ENVIRON SCI TECHNOL, V33, P1224, DOI 10.1021/es981117e; MOHN WW, 1992, MICROBIOL REV, V56, P482; Nelson JL, 2014, ENVIRON SCI TECHNOL, V48, P3776, DOI 10.1021/es4044769; Richardson RE, 2002, ENVIRON SCI TECHNOL, V36, P2652, DOI 10.1021/es0157797; TAYLOR BF, 1979, CURR MICROBIOL, V3, P101, DOI 10.1007/BF02602440; Tiedje J. M., 1987, J IND MICROBIOL S, P117; Zhang CF, 2012, J BIOSCI BIOENG, V114, P512, DOI 10.1016/j.jbiosc.2012.05.025; Zhang DD, 2015, J BIOSCI BIOENG, V119, P188, DOI 10.1016/j.jbiosc.2014.07.010; Zhang DD, 2014, BIORESOURCE TECHNOL, V164, P232, DOI 10.1016/j.biortech.2014.04.071	43	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	JUL	2015	120	1					62	68		10.1016/j.jbiosc.2014.11.023		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CL2ES	WOS:000356757000012		
J	Yohda, M; Yagi, O; Takechi, A; Kitajima, M; Matsuda, H; Miyamura, N; Aizawa, T; Nakajima, M; Sunairi, M; Daiba, A; Miyajima, T; Teruya, M; Teruya, K; Shiroma, A; Shimoji, M; Tamotsu, H; Juan, A; Nakano, K; Aoyama, M; Terabayashi, Y; Satou, K; Hirano, T				Yohda, Masafumi; Yagi, Osami; Takechi, Ayane; Kitajima, Mizuki; Matsuda, Hisashi; Miyamura, Naoaki; Aizawa, Tomoko; Nakajima, Mutsuyasu; Sunairi, Michio; Daiba, Akito; Miyajima, Takashi; Teruya, Morimi; Teruya, Kuniko; Shiroma, Akino; Shimoji, Makiko; Tamotsu, Hinako; Juan, Ayaka; Nakano, Kazuma; Aoyama, Misako; Terabayashi, Yasunobu; Satou, Kazuhito; Hirano, Takashi			Genome sequence determination and metagenomic characterization of a Dehalococcoides mixed culture grown on cis-1,2-dichloroethene	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Dehalococcoides; Bioremediation; Metagenome; Chloroethene; Reductive dehalogenase	VINYL-CHLORIDE REDUCTASE; SP STRAIN; ANAEROBIC BACTERIUM; ENRICHMENT CULTURE; TETRACHLOROETHENE; TRICHLOROETHENE; ETHENE; DECHLORINATION; IDENTIFICATION; DEHALOGENASE	A Dehalococcoides-containing bacterial consortium that performed dechlorination of 0.20 mM cis-1,2-dichloroethene to ethene in 14 days was obtained from the sediment mud of the lotus field. To obtain detailed information of the consortium, the metagenome was analyzed using the short-read next-generation sequencer SOLiD 3. Matching the obtained sequence tags with the reference genome sequences indicated that the Dehalococcoides sp. in the consortium was highly homologous to Dehalococcoides mccartyi CBDB1 and BAV1. Sequence comparison with the reference sequence constructed from 16S rRNA gene sequences in a public database showed the presence of Sedimentibacter, Sulfurospirillum, Clostridium, Desulfovibrio, Parabacteroides, Alistipes, Eubacterium, Peptostreptococcus and Proteocatella in addition to Dehalococco ides sp. After further enrichment, the members of the consortium were narrowed down to almost three species. Finally, the full-length circular genome sequence of the Dehalococcoides sp. in the consortium, D. mccartyi IBARAKI, was determined by analyzing the metagenome with the single-molecule DNA sequencer PacBio RS. The accuracy of the sequence was confirmed by matching it to the tag sequences obtained by SOLiD 3. The genome is 1,451,062 nt and the number of CDS is 1566, which includes 3 rRNA genes and 47 tRNA genes. There exist twenty-eight RDase genes that are accompanied by the genes for anchor proteins. The genome exhibits significant sequence identity with other Dehalococcoides spp. throughout the genome, but there exists significant difference in the distribution RDase genes. The combination of a short-read next-generation DNA sequencer and a long-read single-molecule DNA sequencer gives detailed information of a bacterial consortium. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Yohda, Masafumi; Takechi, Ayane; Kitajima, Mizuki] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Yagi, Osami] Nihon Univ, Coll Ind Technol, Dept Appl Mol Chem, Narashino, Chiba 2758575, Japan; [Matsuda, Hisashi; Miyamura, Naoaki; Aizawa, Tomoko; Nakajima, Mutsuyasu; Sunairi, Michio] Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Fujisawa, Kanagawa 2520880, Japan; [Daiba, Akito] Accelrys, Chiyoda Ku, Tokyo 1000013, Japan; [Miyajima, Takashi] TM Software, Arcadia, CA 91007 USA; [Teruya, Morimi] Okinawa Ind Technol Ctr, Uruma, Okinawa 9042234, Japan; [Teruya, Kuniko; Shiroma, Akino; Shimoji, Makiko; Tamotsu, Hinako; Juan, Ayaka; Nakano, Kazuma; Aoyama, Misako; Terabayashi, Yasunobu; Satou, Kazuhito; Hirano, Takashi] Okinawa Inst Adv Sci, Uruma, Okinawa 9042234, Japan	Yohda, M (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	yohda@cc.tuat.ac.jp	Yohda, Masafumi/A-5149-2013; 	Yohda, Masafumi/0000-0001-8307-9671; Nakano, Kazuma/0000-0001-9908-6526	Okinawa Intellectual Cluster Program	This research was supported by Okinawa Intellectual Cluster Program.	Cupples AM, 2003, APPL ENVIRON MICROB, V69, P953, DOI 10.1128/AEM.69.2.953-959.2003; He JZ, 2003, NATURE, V424, P62, DOI 10.1038/nature01717; Holscher T, 2004, APPL ENVIRON MICROB, V70, P5290, DOI 10.1128/AEM.70.9.5290-5297.2004; Kube M, 2005, NAT BIOTECHNOL, V23, P1269, DOI 10.1038/nbt1131; Miller E, 1997, ARCH MICROBIOL, V168, P513, DOI 10.1007/s002030050529; Muller JA, 2004, APPL ENVIRON MICROB, V70, P4880, DOI 10.1128/AEM.70.8.4880-4888.2004; Magnuson JK, 2000, APPL ENVIRON MICROB, V66, P5141, DOI 10.1128/AEM.66.12.5141-5147.2000; Ferguson JF, 2000, ENVIRON POLLUT, V107, P209, DOI 10.1016/S0269-7491(99)00139-6; Krajmalnik-Brown R, 2004, APPL ENVIRON MICROB, V70, P6347, DOI 10.1128/AEM.70.10.6347-6351.2004; Magnuson JK, 1998, APPL ENVIRON MICROB, V64, P1270; He JZ, 2003, APPL ENVIRON MICROB, V69, P996, DOI 10.1128/AEM.69.2.996-1003.2003; Sung Y, 2006, APPL ENVIRON MICROB, V72, P1980, DOI 10.1128/AEM.72.3.1980-1987.2006; Hendrickson ER, 2002, APPL ENVIRON MICROB, V68, P485, DOI 10.1128/AEM.68.2.485-495.2002; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Holliger C, 1998, ARCH MICROBIOL, V169, P313, DOI 10.1007/s002030050577; He J, 2005, ENVIRON MICROBIOL, V7, P1442, DOI 10.1111/j.1462-2920.2005.00830.x; Maymo-Gatell X, 1999, APPL ENVIRON MICROB, V65, P3108; Seshadri R, 2005, SCIENCE, V307, P105, DOI 10.1126/science.1102226; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Futamata H, 2009, MICROBES ENVIRON, V24, P330, DOI 10.1264/jsme2.ME09133; Koenigsberg Stephen, 2006, Bioremediation Journal, V10, P45, DOI 10.1080/10889860600842837; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Pöritz Marlén, 2013, FEMS Microbiol Lett, V343, P101	26	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	JUL	2015	120	1					69	77		10.1016/j.jbiosc.2014.12.001		9	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CL2ES	WOS:000356757000013		
J	Kishishita, S; Katayama, S; Kodaira, K; Takagi, Y; Matsuda, H; Okamoto, H; Takuma, S; Hirashima, C; Aoyagi, H				Kishishita, Shohei; Katayama, Satoshi; Kodaira, Kunihiko; Takagi, Yoshinori; Matsuda, Hiroki; Okamoto, Hiroshi; Takuma, Shinya; Hirashima, Chikashi; Aoyagi, Hideki			Optimization of chemically defined feed media for monoclonal antibody production in Chinese hamster ovary cells	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Amino acid; Chemically defined medium; Chinese hamster ovary cells; Monoclonal antibody; Tripeptide	RECOMBINANT PROTEIN THERAPEUTICS; LACTIC-ACID FORMATION; FED-BATCH CULTURE; CHO-CELLS; PYRUVATE-CARBOXYLASE; MAMMALIAN-CELLS; AMINO-ACID; LACTATE CONSUMPTION; GROWTH-INHIBITION; FUSION PROTEIN	Chinese hamster ovary (CHO) cells are the most commonly used mammalian host for large-scale commercial production of therapeutic monoclonal antibodies (mAbs). Chemically defined media are currently used for CHO cell based mAb production. An adequate supply of nutrients, especially specific amino acids, is required for cell growth and mAb production, and chemically defined fed-batch processes that support rapid cell growth, high cell density, and high levels of mAb production is still challenging. Many studies have highlighted the benefits of various media designs, supplements, and feed addition strategies in cell cultures. In the present study, we used a strategy involving optimization of a chemically defined feed medium to improve mAb production. Amino acids that were consumed in substantial amounts during a control culture were added to the feed medium as supplements. Supplementation was controlled to minimize accumulation of waste products such as lactate and ammonia. In addition, we evaluated supplementation with tyrosine, which has poor solubility, in the form of a dipeptide or tripeptide to improve its solubility. Supplementation with serine, cysteine, and tyrosine enhanced mAb production, cell viability, and metabolic profiles. A cysteine tyrosine serine tripeptide showed high solubility and produced beneficial effects similar to those observed with the free amino acids and with a dipeptide in improving mAb titers and metabolic profiles. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Kishishita, Shohei] Chugai Pharmaceut Co Ltd, Project Planning & Coordinat Dept, Project & Lifecycle Management Unit, Chuo Ku, Tokyo 1038324, Japan; [Katayama, Satoshi] Chugai Pharmaceut Co Ltd, Human Resource Management Dept, Chuo Ku, Tokyo 1038324, Japan; [Kodaira, Kunihiko; Takagi, Yoshinori; Matsuda, Hiroki; Okamoto, Hiroshi; Takuma, Shinya] Chugai Pharmaceut Co Ltd, Pharmaceut Technol Div, API Proc Dev Dept, Kita Ku, Tokyo 1158543, Japan; [Hirashima, Chikashi] Chugai Pharmaceut Mfg Co Ltd, Utsunomiya Plant Mfg, Utsunomiya, Tochigi 3213231, Japan; [Kishishita, Shohei; Aoyagi, Hideki] Univ Tsukuba, Grad Sch Life & Environm Sci, Life Sci & Bioengn, Tsukuba, Ibaraki 3058572, Japan	Kishishita, S (reprint author), Chugai Pharmaceut Co Ltd, Project Planning & Coordinat Dept, Project & Lifecycle Management Unit, Chuo Ku, 1-1 Nihonbashi Muromachi 2 Chome, Tokyo 1038324, Japan.	kishishitasuh@chugai-pharm.co.jp			New Energy and Industrial Technology Development Organization, Japan [P04014]	This work was supported by the New Energy and Industrial Technology Development Organization, Japan (P04014).	Altamirano C, 2000, BIOTECHNOL PROGR, V16, P69, DOI 10.1021/bp990124j; Irani N, 1999, BIOTECHNOL BIOENG, V66, P238, DOI 10.1002/(SICI)1097-0290(1999)66:4<238::AID-BIT5>3.0.CO;2-6; Crowell CK, 2007, BIOTECHNOL BIOENG, V96, P538, DOI 10.1002/bit.21141; Yu M, 2011, BIOTECHNOL BIOENG, V108, P1078, DOI 10.1002/bit.23031; Zhou MX, 2011, J BIOTECHNOL, V153, P27, DOI 10.1016/j.jbiotec.2011.03.003; Gagnon M, 2011, BIOTECHNOL BIOENG, V108, P1328, DOI 10.1002/bit.23072; Gawlitzek M, 1999, GLYCOBIOLOGY, V9, P125, DOI 10.1093/glycob/9.2.125; Zhang XW, 2010, BIOTECHNOL LETT, V32, P1587, DOI 10.1007/s10529-010-0331-8; PALLAVICINI MG, 1990, MOL CELL BIOL, V10, P401; Luo Y, 2007, BIOTECHNOL BIOENG, V97, P1654, DOI 10.1002/bit.21365; Franek F, 2005, BIOTECHNOL PROGR, V21, P96, DOI 10.1021/bp0400184; Franek F, 2002, BIOTECHNOL PROGR, V18, P155, DOI 10.1021/bp0101278; Yang M, 2000, BIOTECHNOL PROGR, V16, P751, DOI 10.1021/bp000090b; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Huang EP, 2007, J CHEM TECHNOL BIOT, V82, P431, DOI 10.1002/jctb.1670; Xing ZZ, 2011, PROCESS BIOCHEM, V46, P1423, DOI 10.1016/j.procbio.2011.03.014; Pascoe DE, 2007, BIOTECHNOL BIOENG, V98, P391, DOI 10.1002/bit.21460; Seth G, 2006, ADV BIOCHEM ENG BIOT, V101, P119, DOI 10.1007/10_017; Franek F, 2003, BIOTECHNOL PROGR, V19, P169, DOI 10.1021/bp020077m; Wlaschin KF, 2007, J BIOTECHNOL, V131, P168, DOI 10.1016/j.jbiotec.2007.06.006; Kim SH, 2007, APPL MICROBIOL BIOT, V76, P659, DOI 10.1007/s00253-007-1041-6; Burteau CC, 2003, IN VITRO CELL DEV-AN, V39, P291; Jayapal KR, 2007, CHEM ENG PROG, V103, P40; Altamirano C, 2006, J BIOTECHNOL, V125, P547, DOI 10.1016/j.jbiotec.2006.03.023; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Khoo SHG, 2009, METAB ENG, V11, P199, DOI 10.1016/j.ymben.2009.02.001; Dinnis DM, 2005, BIOTECHNOL BIOENG, V91, P180, DOI 10.1002/bit.20499; Zhang JY, 2005, CYTOTECHNOLOGY, V48, P59, DOI 10.1007/s10616-005-3563-z; Kim SH, 2007, APPL MICROBIOL BIOT, V74, P152, DOI 10.1007/s00253-006-0654-5; Heidemann R, 2000, CYTOTECHNOLOGY, V32, P157, DOI 10.1023/A:1008196521213; Chen PF, 2005, J BIOTECHNOL, V117, P277, DOI 10.1016/j.biotec.2005.02.003; Tabuchi H, 2010, BIOTECHNOL BIOENG, V107, P998, DOI 10.1002/bit.22880; Chong WPK, 2010, J BIOTECHNOL, V147, P116, DOI 10.1016/j.jbiotec.2010.03.018; Fogolin MB, 2004, J BIOTECHNOL, V109, P179, DOI 10.1016/j.jbiotec.2003.10.035; REUVENY S, 1986, J IMMUNOL METHODS, V86, P53, DOI 10.1016/0022-1759(86)90264-4; Chen KQ, 2001, BIOTECHNOL BIOENG, V72, P55, DOI 10.1002/1097-0290(20010105)72:1<55::AID-BIT8>3.0.CO;2-4; Ma NN, 2009, BIOTECHNOL PROGR, V25, P1353, DOI 10.1002/btpr.238; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Kang S, 2012, BIOTECHNOL BIOENG, V109, P2286, DOI 10.1002/bit.24507; Dean J, 2013, BIOTECHNOL BIOENG, V110, P1735, DOI 10.1002/bit.24826; Gorfien S, 2000, BIOTECHNOL PROGR, V16, P682, DOI 10.1021/bp000109a; Sung YH, 2004, APPL MICROBIOL BIOT, V63, P527, DOI 10.1007/s00253-003-1389-1; Arunakumari A., 2009, BIOPHARM INT S; MCQUEEN A, 1991, BIOPROCESS ENG, V6, P49; Candor C., 1995, FEBS LETT, V377, P290; CANNING WM, 1983, SCIENCE, V219, P987, DOI 10.1126/science.6297010; Chen ZL, 2000, BIOTECHNOL LETT, V22, P837, DOI 10.1023/A:1005665530028; Committee for Medicinal Products for Human Use (CHMP), 2013, CPMPBWP179302 CHMP E; Costa AR, 2014, METHODS MOL BIOL, V1104, P105, DOI 10.1007/978-1-62703-733-4_8; Ha TK, 2014, J BIOTECHNOL, V180, P23, DOI 10.1016/j.jbiotec.2014.04.002; HASSELL T, 1991, APPL BIOCHEM BIOTECH, V30, P29, DOI 10.1007/BF02922022; HATA J, 1992, CYTOTECHNOLOGY, V10, P9, DOI 10.1007/BF00376095; ITO M, 1981, CELL BIOL INT REP, V5, P661, DOI 10.1016/0309-1651(81)90185-5; Le H, 2012, J BIOTECHNOL, V162, P210, DOI 10.1016/j.jbiotec.2012.08.021; Lee MS, 2001, CYTOTECHNOLOGY, V36, P61, DOI 10.1023/A:1014032701800; Mulukutla B. C., 2011, METAB ENG, V14, P138; Schneider M, 1997, ENZYME MICROB TECH, V20, P268, DOI 10.1016/S0141-0229(96)00122-6; SINGH RP, 1994, BIOTECHNOL BIOENG, V44, P720, DOI 10.1002/bit.260440608; Xie LZ, 1997, BIOTECHNOL BIOENG, V56, P577, DOI 10.1002/(SICI)1097-0290(19971205)56:5&lt;577::AID-BIT11&gt;3.0.CO;2-9; Zhang JY, 2003, BIOTECHNOL BIOENG, V82, P640, DOI 10.1002/bit.10608; Zhou WC, 1997, BIOTECHNOL BIOENG, V55, P783, DOI 10.1002/(SICI)1097-0290(19970905)55:5&lt;783::AID-BIT8&gt;3.0.CO;2-7; Zhu Marie M., 2005, Biotechnology Progress, V21, P70, DOI 10.1021/bp049815s	62	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	JUL	2015	120	1					78	84		10.1016/j.jbiosc.2014.11.022		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CL2ES	WOS:000356757000014		
J	Inao, T; Kawabe, Y; Yamashiro, T; Kameyama, Y; Wang, X; Ito, A; Kamihira, M				Inao, Takanori; Kawabe, Yoshinori; Yamashiro, Takuro; Kameyama, Yujiro; Wang, Xue; Ito, Akira; Kamihira, Masamichi			Improved transgene integration into the Chinese hamster ovary cell genome using the Cre-loxP system	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Accumulative site-specific gene integration; Chinese hamster ovary cells; Cre/loxP; Recombinase-mediated cassette exchange; Mutated loxP	SITE-SPECIFIC RECOMBINATION; MEDIATED CASSETTE EXCHANGE; SPACER REGION; GENE INTEGRATION; EXPRESSION; MICE	Genetic engineering of cellular genomes has provided useful tools for biomedical and pharmaceutical studies such as the generation of transgenic animals and producer cells of biopharmaceutical proteins. Gene integration using site-specific recombinases enables precise transgene insertion into predetermined genomic sites if the target site sequence is introduced into a specific chromosomal locus. We previously developed an accumulative site-specific gene integration system (AGIS) using Cre and mutated loxPs. The system enabled the repeated integration of multiple transgenes into a predetermined locus of a genome. In this study, we explored applicable mutated loxP pairs for AGIS to improve the integration efficiency. The integration efficiencies of 52 mutated loxP sequences, including novel sequences, were measured using an in vitro evaluation system. Among mutated loxP pairs that exhibited a high integration efficiency, the applicability of the selected pairs to AGIS was confirmed for transgene integration into the Chinese hamster ovary cell genome. The newly found mutated loxP pairs should be useful for Cre-mediated integration of transgenes and AGIS. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Inao, Takanori; Kamihira, Masamichi] Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, Fukuoka 8190395, Japan; [Kawabe, Yoshinori; Yamashiro, Takuro; Kameyama, Yujiro; Wang, Xue; Ito, Akira; Kamihira, Masamichi] Kyushu Univ, Fac Engn, Dept Chem Engn, Nishi Ku, Fukuoka 8190395, Japan	Kamihira, M (reprint author), Kyushu Univ, Fac Engn, Dept Chem Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	kamihira@chem-eng.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [26119714]; Ministry of Economy, Trade and Industry (METI), Japan	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 26119714) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and by a grant for the project to build infrastructure for creating next-generation drugs for personalized medicine from the Ministry of Economy, Trade and Industry (METI), Japan.	Kameyama Y, 2010, BIOTECHNOL BIOENG, V105, P1106, DOI 10.1002/bit.22619; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; WILLIAMS SR, 1994, P NATL ACAD SCI USA, V91, P11943, DOI 10.1073/pnas.91.25.11943; Obayashi H, 2012, J BIOSCI BIOENG, V113, P381, DOI 10.1016/j.jbiosc.2011.10.027; Kawabe Y, 2012, CYTOTECHNOLOGY, V64, P267, DOI 10.1007/s10616-011-9397-y; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cb.06.110190.003335; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287; Hacker DL, 2009, BIOTECHNOL ADV, V27, P1023, DOI 10.1016/j.biotechadv.2009.05.008; Missirlis PI, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-73; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Turan S, 2011, J MOL BIOL, V407, P193, DOI 10.1016/j.jmb.2011.01.004; Thomson JG, 2003, GENESIS, V36, P162, DOI 10.1002/gene.10211; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Araki K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf102; Gonzalez-Prieto C, 2013, TRENDS BIOTECHNOL, V31, P41, DOI 10.1016/j.tibtech.2013.02.002; Kwaks THJ, 2006, TRENDS BIOTECHNOL, V24, P137, DOI 10.1016/j.tibtech.2006.01.007; Langer SJ, 2002, NUCLEIC ACIDS RES, V30, P3067, DOI 10.1093/nar/gkf421; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87; Wirth Dagmar, 2007, Curr Opin Biotechnol, V18, P411, DOI 10.1016/j.copbio.2007.07.013	20	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	JUL	2015	120	1					99	106		10.1016/j.jbiosc.2014.11.019		8	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CL2ES	WOS:000356757000017		
J	Onitsuka, M; Omasa, T				Onitsuka, Masayoshi; Omasa, Takeshi			Rapid evaluation of N-glycosylation status of antibodies with chemiluminescent lectin-binding assay	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Glycosylation; Antibody; Chinese hamster ovary cells; Lectin; Chemiluminescent assay	HAMSTER OVARY CELLS; FRONTAL AFFINITY-CHROMATOGRAPHY; OLIGOSACCHARIDE SPECIFICITY; CHO-CELLS; CULTURE	We constructed an assay system for the rapid detection of the glycosylation status of antibodies with a chemiluminescence-based lectin-binding assay, and investigated the glycosylation dynamics during the culture of recombinant Chinese hamster ovary cells. This rapid detection system is applicable to the high-throughput evaluation of therapeutic glycoproteins. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Onitsuka, Masayoshi; Omasa, Takeshi] Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan	Onitsuka, M (reprint author), Univ Tokushima, Inst Sci & Technol, Minamijosanjima Cho 2-1, Tokushima 7708506, Japan.	onitsuka@tokushima-u.ac.jp			Manufacturing Technology Association of Biologics (MAB) under the program Project Focused on Developing Key Technology for Discovering and Manufacturing Drugs for Next-generation Treatment and Diagnosis (Ministry of Economy, Trade and Industry of Japan); Japan Society for the Promotion of Science [26249125, 2663043]	We are grateful to Dr. Nami Kamura, Mr. Hiroyuki Minami, and Perkin Elmer Japan Co., Ltd. for their technical assistance. This study was partly supported by the Manufacturing Technology Association of Biologics (MAB) under the program Project Focused on Developing Key Technology for Discovering and Manufacturing Drugs for Next-generation Treatment and Diagnosis (Ministry of Economy, Trade and Industry of Japan), and a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (Grant Number 26249125 and 2663043).	Kochanowski N, 2008, BIOTECHNOL BIOENG, V100, P721, DOI 10.1002/bit.21816; Kaneko Y, 2010, J BIOSCI BIOENG, V109, P274, DOI 10.1016/j.jbiosc.2009.09.044; Butler M, 2006, CYTOTECHNOLOGY, V50, P57, DOI 10.1007/s10616-005-4537-x; Tateno H, 2009, GLYCOBIOLOGY, V19, P527, DOI 10.1093/glycob/cwp016; Omasa T, 2010, CURR PHARM BIOTECHNO, V11, P233; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Kou TC, 2011, J BIOSCI BIOENG, V111, P365, DOI 10.1016/j.jbiosc.2010.11.016; Onitsuka M, 2014, J BIOSCI BIOENG, V117, P639, DOI 10.1016/j.jbiosc.2013.11.001; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Omasa T, 2008, J BIOSCI BIOENG, V106, P168, DOI 10.1263/jbb.106.168; Ishii Y, 2014, J BIOSCI BIOENG, V118, P223, DOI 10.1016/j.jbiosc.2014.01.013; Gramer MJ, 2011, BIOTECHNOL BIOENG, V108, P1591, DOI 10.1002/bit.23075; Grainger RK, 2013, BIOTECHNOL BIOENG, V110, P2970, DOI 10.1002/bit.24959; Kayser V, 2011, BIOTECHNOL J, V6, P38, DOI 10.1002/biot.201000091; Itakura Y, 2007, J BIOCHEM, V142, P459, DOI 10.1093/jb/mvm153; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Eglen Richard M, 2008, Curr Chem Genomics, V1, P2, DOI 10.2174/1875397300801010002; Liu CH, 2007, J BIOSCI BIOENG, V103, P45, DOI 10.1263/jbb.103.45; Nakamura-Tsuruta S, 2006, J BIOCHEM, V140, P285, DOI 10.1093/jb/mvj148; Umekawa M, 2010, BBA-GEN SUBJECTS, V1800, P1203, DOI 10.1016/j.bbagen.2010.07.003	20	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	JUL	2015	120	1					107	110		10.1016/j.jbiosc.2014.11.015		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CL2ES	WOS:000356757000018		
J	Nakata, R; Osumi, Y; Miyagawa, S; Tachibana, A; Tanabe, T				Nakata, Ryo; Osumi, Yu; Miyagawa, Shoko; Tachibana, Akira; Tanabe, Toshizumi			Preparation of keratin and chemically modified keratin hydrogels and their evaluation as cell substrate with drug releasing ability	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Keratin; Hydrogel; Chemical modification; Cell substrate; Sustained drug release	CARBOXYMETHYLATED FEATHER KERATINS; HUMAN-HAIR; EPITHELIAL CYTOKERATINS; MAMMALIAN-TISSUES; SPONGE SCAFFOLDS; DIFFERENTIATION; BIOMATERIALS; EXPRESSION; MOUSE; NAIL	Keratin was extracted as a reduced form from wool, which was then subjected to acetamidation, carboxymethylation or aminoethylation at abundant free cysteine residues to give acetamidated keratin (AAK), carboxymethylated keratin (CMK) and aminoethylated keratin (AEK). Hydrogels were prepared from intact and three chemically modified keratins simply by concentrating their aqueous solution and subsequent cooling. The lowest concentration to form a hydrogel without fluidity was 110 mg/ml for AAK, 120 mg/ml for AEK, 130 mg/ml for keratin and 180 mg/ml for CMK. Comparing with a hydrogel just prepared (swelling ratio: 600-700), each hydrogel slightly shrank in an acidic solution. While AAK hydrogel little swelled in neutral and basic solutions, other hydrogels became swollen and CMK hydrogel reached to dissolution. Hydrogels of keratin, AAK and AEK were found to support cell proliferation, although cell elongation on AAK and AEK hydrogel was a little suppressed. On the other hand, CMK hydrogel did not seem to be suitable for a cell substrate because of its high swelling in culture medium. Evaluation of the hydrogels as a drug carrier showed that keratin and AAK hydrogels were good sustained drug release carriers, which showed the drug release for more than three days, while the release from AEK and CMK hydrogels completed within one day. Thus, keratin and chemically modified keratin hydrogels, especially keratin and AAK hydrogels, were promising biomaterials as a cell substrate and a sustained drug release carrier. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Nakata, Ryo; Osumi, Yu; Miyagawa, Shoko; Tachibana, Akira; Tanabe, Toshizumi] Osaka City Univ, Grad Sch Engn, Dept Bioengn, Sumiyoshi Ku, Osaka 5588585, Japan	Tanabe, T (reprint author), Osaka City Univ, Grad Sch Engn, Dept Bioengn, Sumiyoshi Ku, Sugimoto 3-3-138, Osaka 5588585, Japan.	tanabe@bioa.eng.osaka-cu.ac.jp					ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Kurimoto A, 2003, J BIOSCI BIOENG, V96, P307, DOI 10.1016/S1389-1723(03)80199-8; Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023; Katoh K, 2004, BIOMATERIALS, V25, P4255, DOI 10.1016/j.biomaterials.2003.11.018; Apel PJ, 2008, J HAND SURG-AM, V33A, P1541, DOI 10.1016/j.jhsa.2008.05.034; Schrooyen PMM, 2000, J AGR FOOD CHEM, V48, P4326, DOI 10.1021/jf9913155; Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9; Schrooyen PMM, 2001, J AGR FOOD CHEM, V49, P221, DOI 10.1021/jf0004154; Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251; BOWDEN PE, 1984, EUR J BIOCHEM, V142, P29, DOI 10.1111/j.1432-1033.1984.tb08246.x; Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9; Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M; Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425; BERTOLINO AP, 1988, J INVEST DERMATOL, V91, P541, DOI 10.1111/1523-1747.ep12476901; de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054; HEID HW, 1986, DIFFERENTIATION, V32, P101, DOI 10.1111/j.1432-0436.1986.tb00562.x; HEID HW, 1988, DIFFERENTIATION, V37, P137, DOI 10.1111/j.1432-0436.1988.tb00805.x; HEID HW, 1988, DIFFERENTIATION, V37, P215, DOI 10.1111/j.1432-0436.1988.tb00724.x; JEFFREY PD, 1970, AUST J BIOL SCI, V23, P809; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; MARSHALL RC, 1983, J INVEST DERMATOL, V80, P519, DOI 10.1111/1523-1747.ep12535117; POWELL BC, 1986, P NATL ACAD SCI USA, V83, P5048, DOI 10.1073/pnas.83.14.5048; Richter JR, 2012, ACTA BIOMATER, V8, P274, DOI 10.1016/j.actbio.2011.08.020; TOBIASCH E, 1992, DIFFERENTIATION, V50, P163, DOI 10.1111/j.1432-0436.1992.tb00671.x	24	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	JUL	2015	120	1					111	116		10.1016/j.jbiosc.2014.12.005		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CL2ES	WOS:000356757000019		
J	Ota, H; Mushiga, M; Yoshimura, T; Yoshimune, K				Ota, Hiroki; Mushiga, Masuwo; Yoshimura, Tohru; Yoshimune, Kazuaki			Enzyme assay for pyridoxal 5 '-phosphate by apo-D-amino acid aminotransferase	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						D-Amino acid aminotransferase; Pyridoxal 5 '-phosphate; Ultraviolet irradiation; Apoenzyme; Enzyme assay	THERMOPHILIC BACILLUS; VITAMIN-B-6; 5-PHOSPHATE; DEFICIENCY; PLASMA	D-Amino acid aminotransferase (D-AAT) is a pyridoxal 5'-phosphate (PLP)-dependent enzyme. n-AAT from thermophilic. Bacillus sp. YM-1 was inactivated by ultraviolet irradiation. The activity was restored by the addition of PLP and showed a linear correlation with respect to PLP concentrations in the range of 10-40 nM. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Ota, Hiroki; Mushiga, Masuwo; Yoshimune, Kazuaki] Nihon Univ, Coll Ind Technol, Dept Appl Mol Chem, Narashino, Chiba 2758575, Japan; [Yoshimura, Tohru] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Yoshimune, K (reprint author), Nihon Univ, Coll Ind Technol, Dept Appl Mol Chem, 1-2-1 Izumichou, Narashino, Chiba 2758575, Japan.	yoshimune.kazuaki@nihon-u.ac.jp					Ahmad I, 2013, PAK J PHARM SCI, V26, P1057; SUGIO S, 1995, BIOCHEMISTRY-US, V34, P9661, DOI 10.1021/bi00030a002; NEWTON WA, 1965, J BIOL CHEM, V240, P1211; BOHNEY JP, 1992, FEBS LETT, V298, P266, DOI 10.1016/0014-5793(92)80073-P; Hamase K, 2002, J CHROMATOGR B, V781, P73, DOI 10.1016/S1570-0232(02)00690-6; EDWARDS P, 1989, ANN CLIN BIOCHEM, V26, P158; Fuchikami Y, 1998, J BIOCHEM, V124, P905; Hill MJ, 1997, EUR CANC PREV, V6, P43; HIROSE N, 1990, J NUTR SCI VITAMINOL, V36, P521; Kasama R, 1996, AM J KIDNEY DIS, V27, P680, DOI 10.1016/S0272-6386(96)90103-1; delPozo AM, 1996, BIOCHEMISTRY-US, V35, P2112; Mintzer S, 2012, EPILEPSY BEHAV, V24, P341, DOI 10.1016/j.yebeh.2012.04.132; STODDARD B, 1987, J MOL BIOL, V196, P441, DOI 10.1016/0022-2836(87)90705-4; TANIZAWA K, 1989, J BIOL CHEM, V264, P2450; Tsuda H, 2012, J NUTR SCI VITAMINOL, V58, P149, DOI 10.3177/jnsv.58.149; Tsuge H, 1997, METHOD ENZYMOL, V280, P3; YONAHA K, 1975, J BIOL CHEM, V250, P6983	17	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	JUL	2015	120	1					117	119		10.1016/j.jbiosc.2014.12.006		3	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CL2ES	WOS:000356757000020		
J	Hunter, DJ; Bardet, C; Mouraret, S; Liu, B; Singh, G; Sadoine, J; Dhamdhere, G; Smith, A; Tran, XV; Joy, A; Rooker, S; Suzuki, S; Vuorinen, A; Miettinen, S; Chaussain, C; Helms, JA				Hunter, Daniel J.; Bardet, Claire; Mouraret, Sylvain; Liu, Bo; Singh, Gurpreet; Sadoine, Jeremy; Dhamdhere, Girija; Smith, Andrew; Tran, Xuan Vinh; Joy, Adrienne; Rooker, Scott; Suzuki, Shigeki; Vuorinen, Annukka; Miettinen, Susanna; Chaussain, Catherine; Helms, Jill A.			Wnt Acts as a Prosurvival Signal to Enhance Dentin Regeneration	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						REPARATIVE DENTIN; RODENT MODEL; TOOTH INJURY; WNT; BETA CATENIN; LRP; DENTAL BIOLOGY	STEM-CELLS; NESTIN EXPRESSION; TOOTH DEVELOPMENT; BONE-MARROW; PULP; REPAIR; SIALOPROTEIN; DENTINOGENESIS; TISSUE; AXIN2	Wnt proteins are lipid-modified, short-range signals that control stem cell self-renewal and tissue regeneration. We identified a population of Wnt responsive cells in the pulp cavity, characterized their function, and then created a pulp injury. The repair response was evaluated over time using molecular, cellular, and quantitative assays. We tested how healing was impacted by wound environments in which Wnt signaling was amplified. We found that a Wnt-amplified environment was associated with superior pulp healing. Although cell death was still rampant, the number of cells undergoing apoptosis was significantly reduced. This resulted in significantly better survival of injured pulp cells, and resulted in the formation of more tertiary dentin. We engineered a liposome-reconstituted form of WNT3A then tested whether this biomimetic compound could activate cells in the injured tooth pulp and stimulate dentin regeneration. Pulp cells responded to the elevated Wnt stimulus by differentiating into secretory odontoblasts. Thus, transiently amplifying the body's natural Wnt response resulted in improved pulp vitality. These data have direct clinical implications for treating dental caries, the most prevalent disease affecting mankind. (c) 2015 American Society for Bone and Mineral Research.	[Hunter, Daniel J.; Bardet, Claire; Mouraret, Sylvain; Liu, Bo; Singh, Gurpreet; Dhamdhere, Girija; Smith, Andrew; Joy, Adrienne; Rooker, Scott; Suzuki, Shigeki; Helms, Jill A.] Stanford Sch Med, Div Plast & Reconstruct Surg, Dept Surg, Stanford, CA USA; [Bardet, Claire; Sadoine, Jeremy; Tran, Xuan Vinh; Chaussain, Catherine] Univ Paris 05, Sch Dent, EA 2496, Sorbonne Paris Cite, Montrouge, France; [Mouraret, Sylvain] Univ Paris 07, Rothschild Hosp, AP HP, Dept Periodontol,Serv Odontol,UFR, Paris, France; [Smith, Andrew] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Suzuki, Shigeki] Univ Grad Sch Biomed Sci, Div Cervicognathostomatol Hiroshima, Dept Dent Sci Hlth Promot, Hiroshima, Japan; [Vuorinen, Annukka; Miettinen, Susanna] Univ Tampere, Adult Stem Cell Res, BioMediTech, FIN-33101 Tampere, Finland; [Vuorinen, Annukka] Finnish Student Hlth Serv, Tampere, Finland; [Miettinen, Susanna] Univ Tampere, Sci Ctr, FIN-33101 Tampere, Finland	Helms, JA (reprint author), Stanford Univ, Dept Surg, 257 Campus Dr, Stanford, CA 94305 USA.	jhelms@stanford.edu			California Institute of Regenerative Medicine (CIRM) [TR1-01249]; University Paris Descartes, Fondation des Gueules cassees et Fondation de la Recherche Medicale [DBS2013128438]	This work was supported by grants from the California Institute of Regenerative Medicine (CIRM) (TR1-01249 to JAH); DJH was a CIRM Bridge Scholar (TB1-01190) and GS was a CIRM Bridge Scholar (TB1-01181). In addition, grants from University Paris Descartes, Fondation des Gueules cassees et Fondation de la Recherche Medicale (DBS2013128438) to EA-2496 contributed to this work.	Love RM, 2002, CRIT REV ORAL BIOL M, V13, P171; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Lohi M, 2010, DEV DYNAM, V239, P160, DOI 10.1002/dvdy.22047; Tziafas D, 2004, CARIES RES, V38, P314, DOI 10.1159/000077771; DSOUZA RN, 1992, J HISTOCHEM CYTOCHEM, V40, P359; Bataille C, 2012, BONE, V50, P1162, DOI 10.1016/j.bone.2012.01.023; Cohen GM, 1997, BIOCHEM J, V326, P1; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; SMITH AJ, 1995, INT J DEV BIOL, V39, P273; Leucht P, 2013, J BONE JOINT SURG AM, V95A, P1278, DOI [10.2106/JBJS.L.01502, 10.2106/JBJS.L01502]; Smith AJ, 2001, CRIT REV ORAL BIOL M, V12, P425; Koizumi Y, 2013, CONGENIT ANOM, V53, P101, DOI 10.1111/cga.12011; Liu B, 2013, INVEST OPHTH VIS SCI, V54, P444, DOI 10.1167/iovs.12-10774; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Begue-Kirn C, 1998, EUR J ORAL SCI, V106, P963, DOI 10.1046/j.0909-8836.1998.eos106510.x; Minear S, 2010, J BONE MINER RES, V25, P1196, DOI 10.1002/jbmr.29; Fujita S, 2006, J CLIN PATHOL, V59, P240, DOI 10.1136/jcp.2004.025403; Lin LM, 2014, INT ENDOD J, V47, P713, DOI 10.1111/iej.12210; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Beers MF, 2011, J CLIN INVEST, V121, P2065, DOI 10.1172/JCI45961; Brugmann SA, 2007, DEVELOPMENT, V134, P3283, DOI 10.1242/dev.005132; Chen S, 2009, J DENT RES, V88, P904, DOI 10.1177/0022034509342873; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Hao JJ, 2009, J HISTOCHEM CYTOCHEM, V57, P227, DOI 10.1369/jhc.2008.952119; Goldberg M, 2008, PHARMACOL RES, V58, P137, DOI 10.1016/j.phrs.2008.05.013; Shi S, 2001, BONE, V29, P532, DOI 10.1016/S8756-3282(01)00612-3; Zhao L, 2009, METHOD ENZYMOL, V465, P331, DOI 10.1016/S0076-6879(09)65017-5; About I, 2000, AM J PATHOL, V157, P287, DOI 10.1016/S0002-9440(10)64539-7; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Arany P R, 2014, SCI TRANSL MED, V6, P238; Baume LJ., 1980, MONOGRAPHS ORAL SCI, V8, P67; Dhamdhere GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083650; Farahani RM, 2011, J COMP NEUROL, V519, P3306, DOI 10.1002/cne.22701; Goldberg M, 2009, J DENT RES, V88, P396, DOI 10.1177/0022034509337101; Goldberg M, 2011, FRONT BIOSCI, V1, P711; Goldberg M, 2011, Adv Dent Res, V23, P270, DOI 10.1177/0022034511405385; Herman B., 1928, ZAHNARZTL RUNDSCH, V37, P1327; Huang George T-J, 2011, Front Biosci (Elite Ed), V3, P788, DOI 10.2741/e286; Khanna-Jain R., 2012, J TISSUE ENG, V3, P1; Lim WH, 2014, J BONE MINER RES, V29, P892, DOI 10.1002/jbmr.2088; Minear S., 2010, SCI TRANSL MED, V2; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; Murray PE, 2003, J DENT, V31, P75, DOI 10.1016/S0300-5712(02)00089-1; Quispe-Salcedo A, 2012, BIOMED RES-TOKYO, V33, P119; Salmon B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056749; SOGNNAES RF, 1959, SCIENCE, V130, P1681, DOI 10.1126/science.130.3390.1681; Stanley H R, 1978, J Endod, V4, P325, DOI 10.1016/S0099-2399(78)80229-5; Thesleff I., 2008, TOOTH ORGANOGENESIS; Whyte JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076883; Yamashiro T, 2007, DIFFERENTIATION, V75, P452, DOI 10.1111/j.1432-0436.2006.00150.x	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	JUL	2015	30	7					1150	1159		10.1002/jbmr.2444		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CL1PL	WOS:000356715900004		
J	Azuma, K; Shiba, S; Hasegawa, T; Ikeda, K; Urano, T; Horie-Inoue, K; Ouchi, Y; Amizuka, N; Inoue, S				Azuma, Kotaro; Shiba, Sachiko; Hasegawa, Tomoka; Ikeda, Kazuhiro; Urano, Tomohiko; Horie-Inoue, Kuniko; Ouchi, Yasuyoshi; Amizuka, Norio; Inoue, Satoshi			Osteoblast-Specific gamma-Glutamyl Carboxylase-Deficient Mice Display Enhanced Bone Formation With Aberrant Mineralization	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						VITAMIN K; GGCX; BONE FORMATION; OSTEOBLASTS	MATRIX GLA PROTEIN; ESTROGEN-RECEPTOR-ALPHA; VITAMIN-K; HYDROXYAPATITE FORMATION; CONDITIONAL EXPRESSION; CARBOXYGLUTAMIC ACID; XENOBIOTIC RECEPTOR; WARFARIN; OSTEOCALCIN; RATS	Vitamin K is a fat-soluble vitamin that is necessary for blood coagulation. In addition, it has bone-protective effects. Vitamin K functions as a cofactor of -glutamyl carboxylase (GGCX), which activates its substrates by carboxylation. These substrates are found throughout the body and examples include hepatic blood coagulation factors. Furthermore, vitamin K functions as a ligand of the nuclear receptor known as steroid and xenobiotic receptor (SXR) and its murine ortholog, pregnane X receptor (PXR). We have previously reported on the bone-protective role of SXR/PXR signaling by demonstrating that systemic Pxr-knockout mice displayed osteopenia. Because systemic Ggcx-knockout mice die shortly after birth from severe hemorrhage, the GGCX-mediated effect of vitamin K on bone metabolism has been difficult to evaluate. In this work, we utilized Ggcx-floxed mice to generate osteoblast-specific GGCX-deficient (Ggcx(obl/obl)) mice by crossing them with Col1-Cre mice. The bone mineral density (BMD) of Ggcx(obl/obl) mice was significantly higher than that of control Col1-Cre (Ggcx(+/+)) mice. Histomorphometrical analysis of trabecular bones in the proximal tibia showed increased osteoid volume and a higher rate of bone formation in Ggcx(obl/obl) mice. Histomorphometrical analysis of cortical bones revealed a thicker cortical width and a higher rate of bone formation in Ggcx(obl/obl) mice. Electron microscopic examination revealed disassembly of mineralized nodules and aberrant calcification of collagen fibers in Ggcx(obl/obl) mice. The mechanical properties of bones from Ggcx(obl/obl) mice tended to be stronger than those from control Ggcx(+/+) mice. These results suggest that GGCX in osteoblasts functions to prevent abnormal mineralization in bone formation, although this function may not be a prerequisite for the bone-protective effect of vitamin K. (c) 2015 American Society for Bone and Mineral Research. (c) 2015 American Society for Bone and Mineral Research.	[Azuma, Kotaro; Urano, Tomohiko; Ouchi, Yasuyoshi; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo 1138655, Japan; [Shiba, Sachiko; Ikeda, Kazuhiro; Horie-Inoue, Kuniko; Inoue, Satoshi] Saitama Med Univ, Div Gene Regulat & Signal Transduct, Res Ctr Genom Med, Saitama, Japan; [Hasegawa, Tomoka; Amizuka, Norio] Hokkaido Univ, Grad Sch Dent Med, Dept Dev Biol Hard Tissue, Sapporo, Hokkaido, Japan; [Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Tokyo 1138655, Japan; [Ouchi, Yasuyoshi] Toranomon Gen Hosp, Tokyo, Japan	Inoue, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	INOUE-GER@h.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science; Ministry of Health, Labor, and Welfare; Novartis Foundation for Gerontological Research	This work was supported by grants from the Cell Innovation Program from the Ministry of Education, Culture, Sports, Science, and Technology; grants from the Japan Society for the Promotion of Science; grants-in-aid from the Ministry of Health, Labor, and Welfare; and a grant from the Novartis Foundation for Gerontological Research. We are grateful to Mr T Tanaka for his technical assistance.	Amizuka N, 2009, J ELECTRON MICROSC, V58, P55, DOI 10.1093/jmicro/dfp008; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Furie B, 1999, BLOOD, V93, P1798; Julien M, 2009, J BONE MINER RES, V24, P1856, DOI [10.1359/jbmr.090508, 10.1359/JBMR.090508]; Cockayne S, 2006, ARCH INTERN MED, V166, P1256, DOI 10.1001/archinte.166.12.1256; Nishihara E, 2000, ENDOCRINOLOGY, V141, P615, DOI 10.1210/en.141.2.615; Ishida M, 2004, J BONE MINER METAB, V22, P415, DOI 10.1007/s00774-004-0503-5; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Hunter GK, 1996, BIOCHEM J, V317, P59; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; PRICE PA, 1983, BIOCHEM BIOPH RES CO, V117, P765, DOI 10.1016/0006-291X(83)91663-7; Gage BF, 2006, ARCH INTERN MED, V166, P241, DOI 10.1001/archinte.166.2.241; Coutu DL, 2008, J BIOL CHEM, V283, P17991, DOI 10.1074/jbc.M708029200; Yaegashi Y, 2008, EUR J EPIDEMIOL, V23, P219, DOI 10.1007/s10654-008-9225-7; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Asawa Y, 2004, BONE, V35, P870, DOI 10.1016/j.bone.2004.06.007; Azuma K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088643; Azuma K, 2014, GERIATR GERONTOL INT, V14, P1, DOI 10.1111/ggi.12060; Azuma K, 2010, J ENDOCRINOL, V207, P257, DOI 10.1677/JOE-10-0208; BOSKEY AL, 1985, CALCIFIED TISSUE INT, V37, P57, DOI 10.1007/BF02557680; Casey SC, 2011, MOL ENDOCRINOL, V25, P933, DOI 10.1210/me.2010-0486; Haffa A, 2000, J BONE MINER RES, V15, P872, DOI 10.1359/jbmr.2000.15.5.872; Hasegawa T, 2011, BIOMED RES-TOKYO, V32, P259, DOI 10.2220/biomedres.32.259; HAUSCHKA PV, 1975, P NATL ACAD SCI USA, V72, P3925, DOI 10.1073/pnas.72.10.3925; Ikeda K, 2011, FEBS LETT, V585, P1303, DOI 10.1016/j.febslet.2011.03.038; Ikeda K, 2012, BIOCHEM BIOPH RES CO, V424, P164, DOI 10.1016/j.bbrc.2012.06.098; Jamal SA, 1998, ANN INTERN MED, V128, P829; LUO GB, 1995, J BONE MINER RES, V10, P325; Nakamura YS, 1998, STEM CELLS, V16, P229; Shiba S, 2014, BIOCHEM BIOPH RES CO, V453, P350, DOI 10.1016/j.bbrc.2014.09.091; Simon RR, 2002, THROMB RES, V105, P353, DOI 10.1016/S0049-3848(02)00035-X; Suttie J W, 1987, Adv Exp Med Biol, V214, P3; VILLANUEVA AR, 1989, STAIN TECHNOL, V64, P129; Wada Y, 1998, BONE, V22, P479, DOI 10.1016/S8756-3282(98)00039-8; Zhu AH, 2007, BLOOD, V109, P5270, DOI 10.1182/blood-2006-12-064188	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	JUL	2015	30	7					1245	1254		10.1002/jbmr.2463		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CL1PL	WOS:000356715900012		
J	Karasawa, K; Arakawa, H				Karasawa, Koji; Arakawa, Hidetoshi			Detection of telomerase activity using microchip electrophoresis	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						Microchip electrophoresis; Telomerase; Tumor marker; Hydroxypropyl methylcellulose; Polyethylene oxide; Diagnostic assay	REPEAT AMPLIFICATION PROTOCOL; CAPILLARY-ELECTROPHORESIS; GEL-ELECTROPHORESIS; ASSAY; CANCER; RNA; CELLS	Telomerase participates in malignant transformation or immortalization of cells and thus has attracted attention as an anticancer drug target and diagnostic tumor marker. The telomeric repeat amplification protocol (TRAP) and improved TRAP methods (TRAP-fluorescence, TRAP-hybridization, etc.) are widely used forms of this telomerase assay. However, these approaches generally employ acrylamide gel electrophoresis after amplification of telomeric repeats by polymerase chain reaction (PCR); making these TRAP methods time consuming and technically demanding. In this study we developed a novel telomerase assay using microchip electrophoresis for rapid and highly sensitive detection of telomerase activity in cancer cells. The mixed gel of 0.8% hydroxypropyl methylcellulose (HPMC) and 0.3% polyethylene oxide (PEO) with SYBR Gold (fluorescent reagent) was used for microchip electrophoresis. As a result, the product amplified by a telomerase-positive cell could be measured in one cell per assay and detected with high reproducibility (CV= 0.67%) in the short time of 100 s. (C) 2015 Elsevier B.V. All rights reserved.	[Karasawa, Koji; Arakawa, Hidetoshi] Showa Univ, Sch Pharm, Dept Analyt Biochem, Shinagawa Ku, Tokyo 1428555, Japan	Arakawa, H (reprint author), Showa Univ, Sch Pharm, Dept Analyt Biochem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	arakawa@pharm.showa-u.ac.jp					Aldous WK, 1997, DIAGN MOL PATHOL, V6, P102, DOI 10.1097/00019606-199704000-00006; ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Hou M, 2001, CLIN CHEM, V47, P519; WRIGHT WE, 1995, NUCLEIC ACIDS RES, V23, P3794, DOI 10.1093/nar/23.18.3794; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Wu L, 2012, ADV MATER, V24, P2447, DOI 10.1002/adma.201200412; Sato S, 2005, ANAL CHEM, V77, P7304, DOI 10.1021/ac0510235; Hirose M, 1997, J CANCER RES CLIN, V123, P337, DOI 10.1007/BF01438310; Kasicka V, 2014, ELECTROPHORESIS, V35, P69, DOI 10.1002/elps.201300331; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Atha DH, 2003, ELECTROPHORESIS, V24, P109, DOI 10.1002/elps.200390001; Autexier C, 1996, TRENDS BIOCHEM SCI, V21, P387, DOI 10.1016/S0968-0004(96)10042-6; Donald H., 2003, ELECTROPHORESIS, V24, P109; Hess JL, 2004, ELECTROPHORESIS, V25, P1852, DOI 10.1002/elps.200305811; Jin Y, 2001, ELECTROPHORESIS, V22, P2150, DOI 10.1002/1522-2683(20017)22:11<2150::AID-ELPS2150>3.0.CO;2-U; Karasawa K, 2004, J CHROMATOGR B, V810, P41, DOI 10.1016/j.jchromb.2004.07.011; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kolioliou M, 2001, CLIN BIOCHEM, V34, P277, DOI 10.1016/S0009-9120(01)00225-9; Lian DS, 2014, ANALYST, V139, P3492, DOI 10.1039/c4an00400k; Ludlow AT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku439; Morinaga S., 2009, BIOTHERAPY, V23, P107; Ogura M, 1998, CLIN CHEM, V44, P2249; Pontillo C, 2015, PROTEOM CLIN APPL, V9, P322, DOI 10.1002/prca.201400115; Shimayama T., 2003, ITE LETT BATTER NEW, V4, P661; Skeidsvoll J, 1996, ELECTROPHORESIS, V17, P1512, DOI 10.1002/elps.1150170917; Yamaguchi T, 2000, BIOCHEM BIOPH RES CO, V279, P475, DOI 10.1006/bbrc.2000.3982; Zhelev Z, 2005, ELECTROPHORESIS, V26, P3021, DOI 10.1002/elps.200410435	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	JUL 1	2015	993						14	19		10.1016/j.jchromb.2015.04.032		6	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CK9HP	WOS:000356551500003		
J	Nishizawa, T; Maekawa, T; Watanabe, N; Harada, N; Hosoda, Y; Yoshinaga, M; Yoshio, T; Ohta, H; Inoue, S; Toyokawa, T; Yamashita, H; Saito, H; Kuwai, T; Katayama, S; Masuda, E; Miyabayashi, H; Kimura, T; Nishizawa, Y; Takahashi, M; Suzuki, H				Nishizawa, Toshihiro; Maekawa, Takama; Watanabe, Noriko; Harada, Naohiko; Hosoda, Yasuo; Yoshinaga, Masahiro; Yoshio, Toshiyuki; Ohta, Hajime; Inoue, Syuuji; Toyokawa, Tatsuya; Yamashita, Haruhiro; Saito, Hiroki; Kuwai, Toshio; Katayama, Shunsuke; Masuda, Eiji; Miyabayashi, Hideharu; Kimura, Toshio; Nishizawa, Yuko; Takahashi, Masahiko; Suzuki, Hidekazu			Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication A Multicenter, Prospective, Randomized Controlled Study in Japan	JOURNAL OF CLINICAL GASTROENTEROLOGY			English	Article						metronidazole; clarithromycin; eradication; Helicobacter pylori	PROTON PUMP INHIBITOR; 3RD-LINE REGIMEN; TRIPLE THERAPY; RESISTANCE; AMOXICILLIN; INFECTION; GUIDELINES; MANAGEMENT	Background:Helicobacter pylori eradication rates achieved with a first-line regimen of clarithromycin (CLR) combined with amoxicillin (AMX) and a proton pump inhibitor have recently fallen to 80% because of the increasing incidence of CLR resistance in Japan. This randomized multicenter trial aimed to compare the eradication success of 2 first-line triple therapy regimens: rabeprazole, amoxicillin, and clarithromycin (RAC) versus rabeprazole, amoxicillin, and metronidazole (RAM).Methods:A total of 124 consecutive patients infected with H. pylori were randomized into one of two 7-day therapeutic regimens: RAC (n=60) or RAM (n=64). Eradication was confirmed by the C-13-urea breath test. Adverse effects were also assessed.Results:Intention-to-treat and per protocol H. pylori eradication rates were 73.3%/77.2% in the RAC group and 90.6%/93.5% in the RAM group. The eradication rate of RAM therapy was significantly higher than that of RAC therapy. CLR, metronidazole, and AMX resistance was found in 36.2%, 2.1%, and 0% of patients, respectively. In addition, no relevant differences in adverse effects were observed.Conclusions:Metronidazole-based therapy (RAM) was superior to standard CLR-based therapy (RAC) for first-line H. pylori eradication. This reflects the progressive increase in CLR resistance observed in Japan.	[Nishizawa, Toshihiro; Takahashi, Masahiko] Tokyo Med Ctr, Natl Hosp Org, Div Gastroenterol, Tokyo, Japan; [Nishizawa, Toshihiro; Suzuki, Hidekazu] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 108, Japan; [Nishizawa, Yuko] Natl Ctr Global Hlth & Med, Dept Pharm, Tokyo, Japan; [Maekawa, Takama] Kyoto Med Ctr, Natl Hosp Org, Div Gastroenterol, Kyoto, Japan; [Watanabe, Noriko] Mie Cent Med Ctr, Natl Hosp Org, Div Gastroenterol, Tsu, Mie, Japan; [Harada, Naohiko] Natl Kyushu Med Ctr, Div Gastroenterol, Fukuoka, Japan; [Hosoda, Yasuo] Saitama Natl Hosp, Natl Hosp Org, Div Gastroenterol, Wako, Saitama, Japan; [Yoshinaga, Masahiro] Beppu Med Ctr, Natl Hosp Org, Div Gastroenterol, Beppu, Oita, Japan; [Yoshio, Toshiyuki] Osaka Med Ctr, Natl Hosp Org, Div Gastroenterol, Osaka, Japan; [Masuda, Eiji] Osaka Minami Med Ctr, Natl Hosp Org, Div Gastroenterol, Osaka, Japan; [Ohta, Hajime] Kanazawa Med Ctr, Natl Hosp Org, Div Gastroenterol, Kanazawa, Ishikawa, Japan; [Toyokawa, Tatsuya] Fukuyama Med Ctr, Natl Hosp Org, Div Gastroenterol, Fukuyama, Hiroshima, Japan; [Kuwai, Toshio] Kure Med Ctr, Natl Hosp Org, Div Gastroenterol, Hiroshima, Japan; [Yamashita, Haruhiro] Okayama Med Ctr, Natl Hosp Org, Div Gastroenterol, Okayama, Japan; [Saito, Hiroki] Asahikawa Med Ctr, Natl Hosp Org, Div Gastroenterol, Asahikawa, Hokkaido, Japan; [Kimura, Toshio] Hokkaido Med Ctr, Natl Hosp Org, Div Gastroenterol, Sapporo, Hokkaido, Japan; [Katayama, Shunsuke] Yonago Med Ctr, Natl Hosp Org, Div Gastroenterol, Yonago, Tottori, Japan; [Inoue, Syuuji] Kochi Natl Hosp, Div Gastroenterol, Kochi, Japan; [Miyabayashi, Hideharu] Matsumoto Med Ctr, Div Gastroenterol, Natl Hosp Org, Matsumoto, Nagano, Japan	Suzuki, H (reprint author), Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hsuzuki@a6.keio.jp	Suzuki, Hidekazu/J-4396-2013				Hirata K, 2010, J GASTROEN HEPATOL, V25, pS75, DOI 10.1111/j.1440-1746.2009.06220.x; Suzuki H, 2010, FUTURE MICROBIOL, V5, P639, DOI [10.2217/fmb.10.25, 10.2217/FMB.10.25]; Sasaki M, 2010, J CLIN BIOCHEM NUTR, V47, P53, DOI 10.3164/jcbn.10-10; Nishizawa T, 2008, J GASTROEN HEPATOL, V23, pS167, DOI 10.1111/j.1440-1746.2008.05407.x; Asaka M, 2010, HELICOBACTER, V15, P1, DOI 10.1111/j.1523-5378.2009.00738.x; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Nishizawa T, 2012, WORLD J GASTROENTERO, V18, P2735, DOI [10.3748/wjg.v18.i21.2735, 10.3748/wjg.v18.i212735]; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Nishizawa T, 2011, ANTIMICROB AGENTS CH, V55, P3012, DOI 10.1128/AAC.00188-11; Asaoka D, 2013, HELICOBACTER, V18, P468, DOI 10.1111/hel.12063; Murakami K, 2013, J GASTROENTEROL, V48, P1128, DOI 10.1007/s00535-012-0731-8; Nishizawa T, 2009, DIGESTION, V79, P99, DOI 10.1159/000209219; Nishizawa T, 2007, DIGESTION, V76, P215, DOI 10.1159/000112649; Nishizawa T, 2012, J CLIN BIOCHEM NUTR, V51, P114, DOI 10.3164/jcbn.D-11-00029R1; Nishizawa T, 2013, INT J MOL SCI, V14, P9487, DOI 10.3390/ijms14059487; Nishizawa T, 2011, ANTIMICROB AGENTS CH, V55, P5374, DOI 10.1128/AAC.05437-11; Nishizawa T, 2013, J GASTROEN HEPATOL, V28, P1608, DOI 10.1111/jgh.12281; Suzuki Hidekazu, 2012, Keio Journal of Medicine, V61, P109, DOI 10.2302/kjm.2012-0001-RE	18	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0192-0790	1539-2031		J CLIN GASTROENTEROL	J. Clin. Gastroenterol.	JUL	2015	49	6					468	471		10.1097/MCG.0000000000000165		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK9VI	WOS:000356587200003		
J	Nunoue, T; Keisuke, HM; Hori, K; Okazaki, N; Hamada, K; Baba, Y; Yamasaki, Y; Kono, Y; Seki, H; Inokuchi, T; Takemoto, K; Taira, A; Tsugeno, H; Fujiki, S; Kawahara, Y; Okada, H				Nunoue, Tomokazu; Takenaka, Ryuta; Hori, Keisuke; Okazaki, Noriko; Hamada, Kenta; Baba, Yuki; Yamasaki, Yasushi; Kono, Yoshiyasu; Seki, Hiroyuki; Inokuchi, Toshihiro; Takemoto, Koji; Taira, Akihiko; Tsugeno, Hirofumi; Fujiki, Shigeatsu; Kawahara, Yoshiro; Okada, Hiroyuki			A Randomized Trial of Monopolar Soft-mode Coagulation Versus Heater Probe Thermocoagulation for Peptic Ulcer Bleeding	JOURNAL OF CLINICAL GASTROENTEROLOGY			English	Article						duodenal ulcer bleeding; gastric ulcer bleeding; heater probe thermocoagulation; peptic ulcer bleeding; soft coagulation	UPPER GASTROINTESTINAL HEMORRHAGE; EPINEPHRINE INJECTION; ENDOSCOPIC HEMOSTASIS; THERAPY; METAANALYSIS; COMBINATION; MANAGEMENT; HEMOCLIP; FORCEPS	Background and Aim:Endoscopic therapy has been demonstrated to be effective in achieving hemostasis for bleeding peptic ulcers. Thermal coagulation is one of the most commonly used methods, with a high success rate. Recently, endoscopic submucosal dissection for early gastric carcinoma was developed and hemostasis with soft coagulation using hemostatic forceps was introduced. The aim of this study was to compare the hemostatic efficacy of soft coagulation with heater probe thermocoagulation for peptic ulcer bleeding.Methods:Patients who visited our hospital with hematemesis or melena underwent emergency endoscopy. Inclusion criteria were presentation with an actively bleeding ulcer, a nonbleeding visible vessel, or an adherent clot. Patients were excluded if they were unwilling to give written informed consent or had a bleeding gastric malignancy. Patients were randomized to receive endoscopic hemostasis with soft coagulation (Group S) or heater probe thermocoagulation (Group H). The primary endpoint was the primary hemostasis rate and secondary endpoints were rebleeding rate, complications, and the procedure time.Results:Between May 2010 and February 2012, a total of 111 patients (89 gastric ulcers and 22 duodenal ulcers) were enrolled. Primary hemostasis was achieved in 54 patients (96%) in Group S and 37 (67%) in Group H (P<0.0001). Rebleeding occurred in 7 patients in Group H and none in Group S. Of these 7 patients, urgent surgery was performed in 1. Perforation occurred in 2 patients in Group H, which was managed conservatively.Conclusions:For patients with gastroduodenal ulcer bleeding, soft coagulation using monopolar hemostatic forceps is more effective than heater probe thermocoagulation for achieving hemostasis.	[Nunoue, Tomokazu; Takenaka, Ryuta; Okazaki, Noriko; Hamada, Kenta; Baba, Yuki; Yamasaki, Yasushi; Kono, Yoshiyasu; Seki, Hiroyuki; Inokuchi, Toshihiro; Takemoto, Koji; Taira, Akihiko; Tsugeno, Hirofumi; Fujiki, Shigeatsu] Tsuyama chuo Hosp, Dept Gastroenterol, Tsuyama, Okayama 7080841, Japan; [Hori, Keisuke; Kawahara, Yoshiro; Okada, Hiroyuki] Okayama Univ Hosp, Div Endoscopy, Okayama, Japan	Keisuke, HM (reprint author), Tsuyama chuo Hosp, Dept Gastroenterol, 1756 Kawasaki, Tsuyama, Okayama 7080841, Japan.	rtakenak@tch.or.jp					Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; LAINE L, 1994, NEW ENGL J MED, V331, P717, DOI 10.1056/NEJM199409153311107; van Leerdam ME, 2003, AM J GASTROENTEROL, V98, P1494, DOI 10.1016/S0002-9270(03)00299-5; Laine L, 2012, AM J GASTROENTEROL, V107, P345, DOI 10.1038/ajg.2011.480; ROCKALL TA, 1995, BRIT MED J, V311, P222; Arima S, 2010, J GASTROENTEROL, V45, P501, DOI 10.1007/s00535-009-0186-8; COOK DJ, 1992, GASTROENTEROLOGY, V102, P139; Marmo R, 2007, AM J GASTROENTEROL, V102, P279, DOI 10.1111/j.1572-0241.2006.01023.x; Sung JJY, 2007, GUT, V56, P1364, DOI 10.1136/gut.2006.123976; Gralnek IM, 1998, AM J GASTROENTEROL, V93, P2047; Calvet X, 2004, GASTROENTEROLOGY, V126, P441, DOI 10.1053/j.gastro.2003.11.006; Takizawa K, 2008, ENDOSCOPY, V40, P179, DOI 10.1055/s-2007-995530; Chung IK, 1999, GASTROINTEST ENDOSC, V49, P13, DOI 10.1016/S0016-5107(99)70439-6; Chung SSC, 1997, BRIT MED J, V314, P1307; Church NI, 2003, GASTROENTEROLOGY, V125, P396, DOI 10.1016/S0016-5085(03)00889-8; Cipolletta L, 2001, GASTROINTEST ENDOSC, V53, P147, DOI 10.1067/mge.2001.111386; Fujishiro M, 2010, DIGEST ENDOSC, V22, pS15, DOI 10.1111/j.1443-1661.2010.00962.x; LAINE L, 1990, GASTROENTEROLOGY, V99, P1303; Lin HJ, 2002, AM J GASTROENTEROL, V97, P2250; Nagata S, 2010, DIGEST ENDOSC, V22, pS22, DOI 10.1111/j.1443-1661.2010.00973.x; Ohmann C, 2005, SCAND J GASTROENTERO, V40, P914, DOI 10.1080/00365520510015809; Reidenbach HD, 1994, OPERATIVE MANUAL END, P46; SACKS HS, 1990, JAMA-J AM MED ASSOC, V264, P494, DOI 10.1001/jama.264.4.494; Sakuragi Tohru, 2008, Interact Cardiovasc Thorac Surg, V7, P764, DOI 10.1510/icvts.2008.177923; Saltzman JR, 2005, AM J GASTROENTEROL, V100, P1503, DOI 10.1111/j.1572-0241.2005.41561.x; Sugiyama T, 2006, GASTROENTEROL ENDOSC, V48, P204; Thomopoulos KC, 1997, SCAND J GASTROENTERO, V32, P212, DOI 10.3109/00365529709000196	27	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0192-0790	1539-2031		J CLIN GASTROENTEROL	J. Clin. Gastroenterol.	JUL	2015	49	6					472	476		10.1097/MCG.0000000000000190		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK9VI	WOS:000356587200004		
J	Uchida, D; Kato, H; Muro, S; Noma, Y; Yamamoto, N; Horiguchi, S; Harada, R; Tsutsumi, K; Kawamoto, H; Okada, H; Yamamoto, K				Uchida, Daisuke; Kato, Hironari; Muro, Shinichiro; Noma, Yasuhiro; Yamamoto, Naoki; Horiguchi, Shigeru; Harada, Ryo; Tsutsumi, Koichiro; Kawamoto, Hirofumi; Okada, Hiroyuki; Yamamoto, Kazuhide			Efficacy of Endoscopic Over 3-branched Partial Stent-in-Stent Drainage Using Self-expandable Metallic Stents in Patients With Unresectable Hilar Biliary Carcinoma	JOURNAL OF CLINICAL GASTROENTEROLOGY			English	Article						biliary drainage; metallic stent; multistenting; hilar biliary stricture	PALLIATIVE TREATMENT; OBSTRUCTION; CHOLANGIOCARCINOMA; MANAGEMENT; PLACEMENT; WALLSTENTS; DEPLOYMENT	Background:The treatment of biliary stricture is crucially important for continuing stable chemotherapy for unresectable biliary carcinoma; however, there is no consensus regarding the use of hilar biliary drainage. In this study, we examined the efficacy of endoscopic over 3-branched biliary drainage using self-expandable metallic stents (SEMSs) in patients with unresectable malignant hilar biliary stricture (HBS).Methods:A total of 77 patients with unresectable HBS treated with a SEMS and chemotherapy were retrospectively reviewed. There were 59 patients with cholangiocarcinoma and 18 patients with gallbladder carcinoma. The patients were divided into 2 groups (4- or 3-branched group and 2- or 1-branched group) and compared with respect to the duration of stent patency and overall survival.Results:A comparison of the patients' baseline characteristics showed no significant differences between the 4- or 3-branched group and the 2- or 1-branched group. Neither the duration of patency nor survival time exhibited significant differences between the 2 groups, although, among the patients achieving disease control , the duration of patency period and survival time of the 4- or 3-branched group were significantly higher than those observed in the 2- or 1-branched group (P=0.0231 and 0.0466).Conclusions:The use of endoscopic over 3-branched biliary drainage with a SEMS may improve the duration of patency in patients with HBS.	[Uchida, Daisuke; Kato, Hironari; Muro, Shinichiro; Noma, Yasuhiro; Yamamoto, Naoki; Horiguchi, Shigeru; Harada, Ryo; Tsutsumi, Koichiro; Yamamoto, Kazuhide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008558, Japan; [Kawamoto, Hirofumi] Kawasaki Hosp, Kawasaki Med Sch, Dept Gen Internal Med 2, Okayama, Japan; [Okada, Hiroyuki] Okayama Univ Hosp, Dept Endoscopy, Okayama, Japan	Kato, H (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	drkatocha@yahoo.co.jp					De Palma GD, 2001, GASTROINTEST ENDOSC, V53, P547, DOI 10.1067/mge.2001.113381; Stern N, 2008, EJSO-EUR J SURG ONC, V34, P313, DOI 10.1016/j.ejso.2007.07.210; Singhal D, 2005, SURG ONCOL, V14, P59, DOI 10.1016/j.suronc.2005.05.004; Simmons DT, 2006, AM J GASTROENTEROL, V101, P1792, DOI 10.1111/j.1572-0241.2006.00700.x; Inal M, 2003, J VASC INTERV RADIOL, V14, P1409, DOI 10.1097/01.RVI.0000096762.74047.A6; WAGNER HJ, 1993, ENDOSCOPY, V25, P213, DOI 10.1055/s-2007-1010295; Paik WH, 2009, GASTROINTEST ENDOSC, V69, P55, DOI 10.1016/j.gie.2008.04.005; Ohkubo M, 2004, ANN SURG, V239, P82, DOI 10.1097/01.sla.0000102934.93029.89; Chahal P, 2010, GASTROINTEST ENDOSC, V71, P195, DOI 10.1016/j.gie.2009.08.006; Cheng JLS, 2002, GASTROINTEST ENDOSC, V56, P33, DOI 10.1067/mge.2002.125364; Cipolletta L, 2007, DIGEST LIVER DIS, V39, P375, DOI 10.1016/j.dld.2006.12.016; Hwang JC, 2011, SCAND J GASTROENTERO, V46, P326, DOI 10.3109/00365521.2010.536253; Iwano H, 2011, DIGEST ENDOSC, V23, P43, DOI 10.1111/j.1443-1661.2010.01036.x; Kawamoto H, 2008, CLIN GASTROENTEROL H, V6, P401, DOI 10.1016/j.cgh.2007.12.036; Kawamoto H, 2007, GASTROINTEST ENDOSC, V66, P1030, DOI 10.1016/j.gie.2007.06.055; Lammer J, 1996, RADIOLOGY, V201, P167; Liberato MJA, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-103; Schmassmann A, 1996, AM J GASTROENTEROL, V91, P654	18	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0192-0790	1539-2031		J CLIN GASTROENTEROL	J. Clin. Gastroenterol.	JUL	2015	49	6					529	536		10.1097/MCG.0000000000000213		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK9VI	WOS:000356587200012		
J	Hiraga, A; Nakagawa, Y; Kamitsukasa, I; Suzuki, T; Kuwabara, S				Hiraga, Akiyuki; Nakagawa, Yoko; Kamitsukasa, Ikuo; Suzuki, Takeshi; Kuwabara, Satoshi			Muscle haematoma due to antithrombotic treatment for ischaemic stroke	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Cerebrovascular disorders; Ischaemic stroke; Muscular haematoma	RECTUS SHEATH HEMATOMA; HEPARIN-THERAPY; CASE SERIES; MANAGEMENT	The purpose of this study was to evaluate the incidence and clinical features of muscle haematoma in ischaemic stroke patients. Muscle haematomas are rare complications that occur during antithrombotic treatment for acute ischaemic stroke. Clinical and laboratory records of ischaemic stroke patients with muscle haematomas in the last 3.5 years were retrospectively reviewed. Muscular haematoma developed in three of 694 (0.4%) consecutive patients with acute ischaemic stroke who were admitted to our institution. In addition, one outpatient presenting with muscle haematoma was found during the same period. The types of haematomas were rectus sheath haematoma in two patients and iliopsoas haematoma in the remaining two. All three acute patients received both antiplatelet and anticoagulant therapies. The outpatient was treated with warfarin. Initial symptoms of haematoma included pain (n = 3) and syncope (n = 1). No patient was correctly diagnosed at the onset of muscle haematoma. At initial examination of muscle haematoma, no patients showed skin lesions. An ecchymosis developed in the abdominal area at an average of 3 days after the initial symptoms. Mean decrease in haemoglobin was 6.8 g/dL from baseline. None required surgery whereas two patients required blood transfusion. Muscle haematomas in stroke patients receiving antithrombotic therapy are rare complications that are difficult to diagnose at onset. The possibility of muscle haematoma should be considered in patients with ischaemic stroke undergoing antithrombotic therapy and presenting with acute pain and syncope, even if skin manifestations or a palpable mass are lacking. (C) 2015 Elsevier Ltd. All rights reserved.	[Hiraga, Akiyuki; Nakagawa, Yoko; Kamitsukasa, Ikuo] Chiba Rosai Hosp, Dept Neurol, Ichihara, Chiba 2900003, Japan; [Suzuki, Takeshi] Chiba Rosai Hosp, Dept Surg, Chiba, Japan; [Kuwabara, Satoshi] Chiba Univ, Dept Neurol, Grad Sch Med, Chiba, Japan	Hiraga, A (reprint author), Chiba Rosai Hosp, Dept Neurol, 2-16 Tatsumidai Higashi, Ichihara, Chiba 2900003, Japan.	hiragaa@yahoo.co.jp					Alla Venkata M, 2010, West J Emerg Med, V11, P76; Kern R, 2013, CEREBROVASC DIS, V35, P402, DOI 10.1159/000351753; Cherry WB, 2006, MEDICINE, V85, P105, DOI 10.1097/01.md.0000216818.13067.5a; Salemis NS, 2010, INT J SURG, V8, P290, DOI 10.1016/j.ijsu.2010.02.011; Smithson A, 2013, EUR J INTERN MED, V24, P579, DOI 10.1016/j.ejim.2013.02.016; Berna JD, 2000, ABDOM IMAGING, V25, P230, DOI 10.1007/s002610000007; Ozucelik DN, 2005, ANN SAUDI MED, V25, P250; ZAINEA GG, 1988, AM SURGEON, V54, P630; Klingler PJ, 1999, SURG ENDOSC-ULTRAS, V13, P1129, DOI 10.1007/s004649901188; Dag A, 2011, ULUS TRAVMA ACIL CER, V17, P210, DOI 10.5505/tjtes.2011.84669; Fitzgerald JEF, 2009, INT J SURG, V7, P150, DOI 10.1016/j.ijsu.2009.01.007; Bene J, 1998, AGE AGEING, V27, P512; Berge E, 2002, COCHRANE DB SYST REV, V4; Carkman S, 2010, ULUS TRAVMA ACIL CER, V16, P532; Costello J, 2005, EMERG MED J, V22, P523, DOI 10.1136/emj.2004.015834; Denard PJ, 2007, INT J LAB HEMATOL, V29, P190, DOI 10.1111/j.1365-2257.2006.00833.x; DUCATMAN BS, 1983, JAMA-J AM MED ASSOC, V249, P924, DOI 10.1001/jama.249.7.924; Fujikawa T, 2011, BMJ-BRIT MED J, V28, P2011; Gabel A, 1999, NEW ENGL J MED, V340, P61, DOI 10.1056/NEJM199901073400115; Kaya MG, 2008, CLIN APPL THROMB-HEM, V14, P116, DOI 10.1177/1076029607304414; Kayrak M, 2008, CAN FAM PHYSICIAN, V54, P1246; Khan MI, 2005, ANZ J SURG, V75, P502, DOI 10.1111/j.1445-2197.2005.03406.x; Kizilkanat Kansav Tunc, 2009, Cases J, V2, P6353, DOI 10.4076/1757-1626-2-6353; Linhares MM, 1999, INT SURG, V84, P251; Luhmann A, 2006, WORLD J SURG, V30, P2050, DOI 10.1007/s00268-005-0702-9; Sasson Z, 1996, CAN J CARDIOL, V12, P490; Schulman S, 2008, CHEST, V133, P257, DOI DOI 10.1378/CHEST.08-0674; TESKE JM, 1946, AM J SURG, V71, P689, DOI 10.1016/0002-9610(46)90453-9; Turkoglu E, 2009, BMJ CASE REP, P2009	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2015	22	7					1160	1163		10.1016/j.jocn.2015.01.023		4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CK9KE	WOS:000356558200017		
J	Miki, S; Ishikawa, E; Yamamoto, T; Akutsu, H; Matsuda, M; Sakamoto, N; Matsumura, A				Miki, Shunichiro; Ishikawa, Eiichi; Yamamoto, Tetsuya; Akutsu, Hiroyoshi; Matsuda, Masahide; Sakamoto, Noriaki; Matsumura, Akira			Extreme volume expansion of a vestibular schwannoma due to intratumoral hemorrhage after gamma knife radiosurgery	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Complication; Gamma knife surgery; Intratumoral bleeding; Regrowth; Vestibular schwannoma		A 48-year-old man with right hemi-facial palsy and cerebellar ataxia was referred to our hospital. Three years and 10 months earlier he had undergone gamma knife radiosurgery (GKRS) at the referring hospital for an 18 mm right vestibular schwannoma. Slight tumor enlargement had been observed on MRI performed at the referring hospital 3 years after the GKRS. On close follow-up after another 6 months an MRI showed an obvious enlargement of the tumor. An MRI on admission revealed an iso-intense mass lesion measuring 36 mm in maximum diameter at the right cerebellopontine angle. A two stage surgery was conducted using a retrosigmoid approach because bleeding from the tumor wall was difficult to control intraoperatively during the first operation. At the second operation, the majority of the tumor capsule had converted to necrotic tissue. A large hematoma cavity was present inside the tumor capsule which explained the rapid increase in size over a short period of time. Near total removal was achieved. Histopathological examination revealed massive intratumoral hemorrhage within a typical vestibular schwannoma with no malignancy. The complication of intratumoral hemorrhage is very rare and the utility of stereotactic radiation surgery/therapy, including GKRS, for vestibular schwannoma is well known. However, we must emphasize that careful follow-up is still required, even after several years. (C) 2015 Elsevier Ltd. All rights reserved.	[Miki, Shunichiro; Ishikawa, Eiichi; Yamamoto, Tetsuya; Akutsu, Hiroyoshi; Matsuda, Masahide; Sakamoto, Noriaki; Matsumura, Akira] Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki 3058576, Japan	Ishikawa, E (reprint author), Univ Tsukuba, Fac Med, Dept Neurosurg, 2-1-1 Tennodai, Tsukuba, Ibaraki 3058576, Japan.	e-ishikawa@md.tsukuba.ac.jp					Cassis A, 2013, OTOLARYNG HEAD NECK, V148, P1056, DOI 10.1177/0194599813478574; Gerganov VM, 2012, J NEUROSURG, V116, P713, DOI 10.3171/2011.12.JNS111682; Hasegawa T, 2006, NEUROSURGERY, V58, P1119, DOI 10.1227/01.NEU.0000215947.35646.DD; Iwai Y, 2003, NEUROSURGERY, V53, P282, DOI 10.1227/01.NEU.0000073416.22608.B3; Iwai Y, 2003, NEUROSURGERY, V53, P287; Karampelas I, 2007, ACTA NEUROCHIR, V149, P313, DOI 10.1007/s00701-006-1107-8; Karampelas I, 2007, ACTA NEUROCHIR WIEN, V149, P316; Maimone Giuseppe, 2013, Surg Neurol Int, V4, P67, DOI 10.4103/2152-7806.112605; Mandl ES, 2009, ACTA NEUROCHIR, V151, P1325, DOI 10.1007/s00701-009-0213-9	9	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2015	22	7					1196	1199		10.1016/j.jocn.2014.12.019		4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CK9KE	WOS:000356558200027		
J	Buaban, S; Duangjinda, M; Suzuki, M; Masuda, Y; Sanpote, J; Kuchida, K				Buaban, S.; Duangjinda, M.; Suzuki, M.; Masuda, Y.; Sanpote, J.; Kuchida, K.			Short communication: Genetic analysis for fertility traits of heifers and cows from smallholder dairy farms in a tropical environment	JOURNAL OF DAIRY SCIENCE			English	Article						Holstein upgraded; genetic parameters; reproduction; tropics	BROWN SWISS CATTLE; REPRODUCTIVE TRAITS; VARIANCE-COMPONENTS; DIFFERENT PARITIES; FEMALE FERTILITY; FRIESIAN CATTLE; MILK-PRODUCTION; BULL FERTILITY; FIELD DATA; PARAMETERS	The objective of this study was to estimate genetic parameters for various fertility traits on Holstein upgraded dairy heifers and cows in a smallholder system under tropical conditions using data sets from the Thailand national recording scheme. The investigated traits were age at first service (AFS), age at first calving (AFC), days from calving to first service (DTFS), days between first and last service (DFLS), days open (DO), calving interval (CI), number of services per conception (NSPC), and conception at first service (FSC). The data consisted of 68,555, 34,401, and 54,004 records on heifers, primiparous, and multiparous cows, respectively, calving between 1996 and 2011. Gibbs sampling was employed to obtain (co)variance components using both univariate and bivariate analyses with linear and threshold animal models. Virgin heifers had better fertility performance than primiparous and multiparous cows. The reproductive performance in primiparous cows was inferior compared with multiparous cows. "Cows with higher Holstein-Friesian blood showed lower reproductive efficiency. Estimated heritabilities for most of the fertility traits were 0.04 or less except for AFS (0.26) and AFC (0.25). The estimated genetic correlations among fertility traits within parity indicated that selection for cows with high conception rate could lead to shortened DO and CI, as well as DTFS. The FSC and NSPC could be used as the best indicators for heifer and cow fertility and could be complemented by other traits, which were genetically considered as different traits such as DTFS and DFLS in terms of a fertility index. This would enable efficient selection for better fertility. Genetic correlations for fertility traits in primiparous and multiparous cows were very high (>0.90), but those between heifers and cows were lower (0.03 to 0.83). The latter results indicated that fertility traits of heifers and cows should be considered as different traits.	[Buaban, S.; Sanpote, J.] Bur Biotechnol Livestock Prod, Dept Livestock Dev, Pratumtani 12000, Thailand; [Duangjinda, M.] Khon Kaen Univ, Dept Anim Sci, Khon Kaen 40002, Thailand; [Kuchida, K.] Obihiro Univ Agr & Vet Med, Dept Anim & Food Hyg, Obihiro, Hokkaido 0808555, Japan; [Suzuki, M.; Masuda, Y.] Obihiro Univ Agr & Vet Med, Dept Life Sci & Agr, Obihiro, Hokkaido 0808555, Japan	Buaban, S (reprint author), Bur Biotechnol Livestock Prod, Dept Livestock Dev, Pratumtani 12000, Thailand.	buaban_ai@hotmail.com			Agricultural Research Development Agency (Bangkok, Thailand)	The authors thank the Bureau of Biotechnology for Livestock Production, Department of Livestock Development, for providing the dataset and pedigree file. Special thanks go to Ignacy Misztal and Shogo Tsuruta (Department of Animal and Dairy Science, University of Georgia, Athens) for software technical support and the Agricultural Research Development Agency (Bangkok, Thailand) for financial support.	Zambrano JC, 2014, REV BRAS ZOOTECN, V43, P132, DOI 10.1590/S1516-35982014000300005; Kuhn MT, 2008, J DAIRY SCI, V91, P2481, DOI 10.3168/jds.2007-0743; Haile-Mariam M, 2003, LIVEST PROD SCI, V80, P189, DOI 10.1016/S0301-6226(02)00188-4; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514; Demeke S, 2004, J ANIM BREED GENET, V121, P57, DOI 10.1046/j.0931-2668.2003.00438.x; Tiezzi F, 2012, J DAIRY SCI, V95, P7355, DOI 10.3168/jds.2012-5775; Roxstrom A, 2001, ACTA AGR SCAND A-AN, V51, P7, DOI 10.1080/090647001300004745; Jamrozik J, 2005, J DAIRY SCI, V88, P2199; Lovendahl P, 2010, J DAIRY SCI, V93, P1998, DOI 10.3168/jds.2009-2739; Tiezzi F, 2013, J DAIRY SCI, V96, P7325, DOI 10.3168/jds.2013-6885; Abe H, 2009, J DAIRY SCI, V92, P4055, DOI 10.3168/jds.2008-1896; McDermott JJ, 2010, LIVEST SCI, V130, P95, DOI 10.1016/j.livsci.2010.02.014; Banos G, 2006, J DAIRY SCI, V89, P2222; Buxadera AM, 1997, GENET SEL EVOL, V29, P469; de Haer L. C. M., 2013, INTERBULL B, V47, P143; Department of Livestock Development, 2014, ANN INF DAIR FARM 20; Eghbalsaied S, 2011, TROP ANIM HEALTH PRO, V43, P811, DOI 10.1007/s11250-010-9767-z; Estrada-Leon RJ, 2008, J ANIM VET ADV, V7, P124; Gredler B., 2007, INTERBULL B, V37, P152; Guo G, 2014, CAN J ANIM SCI, V94, P281, DOI 10.4141/CJAS2013-113; Guyomard H., 2013, Animal Frontiers, V3, P14; Herath P. S. M. H., 2009, SELECTION BREEDING C, P3; HODEL F, 1995, LIVEST PROD SCI, V41, P95, DOI 10.1016/0301-6226(94)00051-8; Konig S, 2005, ARCH TIERZUCHT, V48, P233; Leelasiri C., 2006, J BIOTEC LIVEST PROD, V1, P48; Liu Z, 2008, J DAIRY SCI, V91, P4333, DOI 10.3168/jds.2008-1029; Lobo R. N. B., 2000, ANIM BREED ABSTR, V68, P433; Meteorological Department, 2013, ANN WEATH SUMM THAIL; Office of Agricultural Economics, 2014, NUMB DAIR CATTL AV F; Ojango JMK, 2001, J ANIM SCI, V79, P1742; Philipsson J., 2000, DEV BREED STRAT LOW, P551; Pongpiachan P, 2003, ASIAN AUSTRAL J ANIM, V16, P1093; Pryce J.E., 2001, BRIT SOC ANIMAL SCI, V26, P223; Tsuruta S, 2006, J ANIM SCI, V84, P15; Utrera AR, 2010, VET MEXICO, V41, P117; VACCARO R, 1985, ANIM PROD, V40, P279	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-0302	1525-3198		J DAIRY SCI	J. Dairy Sci.	JUL	2015	98	7					4990	4998		10.3168/jds.2014-8866		9	Agriculture, Dairy & Animal Science; Food Science & Technology	Agriculture; Food Science & Technology	CL0PV	WOS:000356645600068		
J	Takao, T; Kimura, K; Suka, M; Yanagisawa, H; Kikuchi, M; Kawazu, S; Matsuyama, Y				Takao, Toshiko; Kimura, Kumiko; Suka, Machi; Yanagisawa, Hiroyuki; Kikuchi, Masatoshi; Kawazu, Shoji; Matsuyama, Yutaka			Relationships between the risk of cardiovascular disease in type 2 diabetes patients and both visit-to-visit variability and time-to-effect differences in blood pressure	JOURNAL OF DIABETES AND ITS COMPLICATIONS			English	Article						Blood pressure; Cardiovascular disease; Type 2 diabetes; Visit-to-visit variability; Time-to-effect differences	NON-HDL CHOLESTEROL; LONG-TERM; ANTIHYPERTENSIVE THERAPY; EPISODIC HYPERTENSION; ADVANCE TRIAL; FOLLOW-UP; REPRODUCIBILITY; COMPLICATIONS; INFARCTION; PREDICTOR	Aims: To determine whether visit-to-visit blood pressure (BP) variability can predict cardiovascular disease (CVD) incidence in type 2 diabetes patients independently of mean BP, and to analyze the time-to-effect relationship between BP and CVD risk. Methods: We retrospectively enrolled 629 type 2 diabetes patients with no history of CVD who first visited our hospital between 1995 and 1996, made at least one hospital visit per year, were followed-up for at least 1 year, and had undergone four or more BP measurements. The patients were followed until June 2012 at the latest. Results: CVD occurred in 66 patients. Variability in systolic or diastolic BP (SBP and DBP, respectively) was a significant predictor of CVD incidence, independent of mean SBP or DBP. CVD incidence was significantly associated with SBP during the preceding 3-5 years, with the highest risk occurring during the preceding 3 years. Conclusions: Visit-to-visit BP variability independently predicts CVD incidence in type 2 diabetes patients. Increased SBP over the preceding 3-5 years indicated a significant CVD risk. To prevent CVD, BP management should focus on stable and well-timed control. In particular, BP stabilization at an early phase and BP control during late phases are important. (C) 2015 Elsevier Inc. All rights reserved.	[Takao, Toshiko; Kimura, Kumiko; Kikuchi, Masatoshi; Kawazu, Shoji] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Tokyo 1030002, Japan; [Suka, Machi; Yanagisawa, Hiroyuki] Jikei Univ, Sch Med, Dept Publ Hlth & Environm Med, Tokyo, Japan; [Matsuyama, Yutaka] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan	Takao, T (reprint author), Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Chuo Ku, 2-2-6 Nihonbashi Bakurocho, Tokyo 1030002, Japan.	t-takao@asahi-life.or.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Jiang R, 2004, DIABETES CARE, V27, P1991, DOI 10.2337/diacare.27.8.1991; Stewart R, 2009, HYPERTENSION, V54, P233, DOI 10.1161/HYPERTENSIONAHA.109.128744; Tatti P, 1998, DIABETES CARE, V21, P597, DOI 10.2337/diacare.21.4.597; Hata J, 2013, CIRCULATION, V128, P1325, DOI 10.1161/CIRCULATIONAHA.113.002717; Howard SC, 2009, CEREBROVASC DIS, V28, P331, DOI 10.1159/000229551; Mancia G, 2012, HYPERTENSION, V60, P512, DOI 10.1161/HYPERTENSIONAHA.112.194340; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Hata Y, 2000, HYPERTENS RES, V23, P553, DOI 10.1291/hypres.23.553; Shan ZZ, 2001, J CARDIOVASC PHARM, V38, P427, DOI 10.1097/00005344-200109000-00011; Nagai M, 2013, AM J HYPERTENS, V26, P1369, DOI 10.1093/ajh/hpt167; Parati G, 2012, CURR HYPERTENS REP, V14, P421, DOI 10.1007/s11906-012-0290-7; Muntner P, 2011, J HYPERTENS, V29, P2332, DOI 10.1097/HJH.0b013e32834cf213; Holman RR, 2005, DIABETES CARE, V28, P1796, DOI 10.2337/diacare.28.7.1796; Hsieh YT, 2012, EUR J CLIN INVEST, V42, P245, DOI 10.1111/j.1365-2362.2011.02574.x; Muntner P, 2011, HYPERTENSION, V57, P160, DOI 10.1161/HYPERTENSIONAHA.110.162255; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Qiu CX, 2004, STROKE, V35, P1810, DOI 10.1161/01.STR.0000133128.42462.ef; Hata Y, 2002, J HUM HYPERTENS, V16, P141, DOI 10.1038/sj/jhh/1001301; Staessen JA, 2004, J HYPERTENS, V22, P847, DOI 10.1097/01.hjh.000098286.36684.27; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Pahor M, 2000, DIABETES CARE, V23, P888, DOI 10.2337/diacare.23.7.888; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Bloch Michael J, 2009, J Clin Hypertens (Greenwich), V11, P46, DOI 10.1111/j.1751-7176.2008.00064.x; FLORAS JS, 1988, J HYPERTENS, V6, P525, DOI 10.1097/00004872-198807000-00003; Hastie CE, 2013, HYPERTENSION, V62, P698, DOI 10.1161/HYPERTENSIONAHA.113.01343; Heart Outcomes Prevention Evaluation Study Investigators, 2000, LANCET, V355, P253; Katayama S, 2011, DIABETOLOGIA, V54, P1025, DOI 10.1007/s00125-010-2025-0; Levitan EB, 2012, J CLIN HYPERTENS, V14, P744, DOI 10.1111/jch.12005; Parati G, 2011, DIABETES CARE, V34, pS297, DOI 10.2337/dc11-s243; Parati G, 2013, HYPERTENSION, V62, P682, DOI 10.1161/HYPERTENSIONAHA.113.01801; Skirton H, 2011, J CLIN NURS, V20, P602, DOI 10.1111/j.1365-2702.2010.03528.x; Sone H, 2012, DIABETES CARE, V35, P1150, DOI 10.2337/dc11-1412; UK Prospective Diabetes Study Group, 1998, BMJ-BRIT MED J, V317, P703, DOI DOI 10.1136/BMJ.317.7160.703	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1056-8727	1873-460X		J DIABETES COMPLICAT	J. Diabetes Complications	JUL	2015	29	5					699	706		10.1016/j.jdiacomp.2015.03.010		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CL4EW	WOS:000356906400016		
J	Shefferson, RP; Salguero-Gomez, R				Shefferson, Richard P.; Salguero-Gomez, Roberto			Eco-evolutionary dynamics in plants: interactive processes at overlapping time-scales and their implications	JOURNAL OF ECOLOGY			English	Editorial Material						density dependence; eco-evolutionary cascades; eco-evolutionary feedback; ecological time; evolutionary time; interaction; plant population and community dynamics; rapid evolution	LIFE-HISTORY EVOLUTION; GUPPY POECILIA-RETICULATA; PREDATOR-PREY SYSTEM; RAPID EVOLUTION; POPULATION-DYNAMICS; NATURAL-SELECTION; INDIVIDUAL HETEROGENEITY; FLUCTUATING ENVIRONMENTS; ECOLOGICAL DYNAMICS; DENSITY	Evolution can happen rapidly and frequently. This realization has motivated a rethinking of ecological and evolutionary time-scales and their overlap, and stimulated research on processes at their interface. This premise lays at the heart of eco-evolutionary dynamics, a relatively recent field redeveloping how we conceive of ecological and evolutionary processes. Classical evolutionary theory and empirical evidence has generally supported a gradualist view of evolution as occurring on much longer time-scales than ecological processes. The systematic documentation of rapid evolution beginning in the 1970s served as a catalyst to question this basic assumption. The commonness of rapid evolution suggests that ecological and evolutionary processes often occur at the same time-scale, which may allow them to interact. As a new field, eco-evolutionary dynamics faces some important challenges. First, the field is primarily driven by theoretical research and empirical work on organisms with simple, short life cycles, typically animals, and mostly performed under controlled conditions. Secondly, it is unclear whether interactions between ecology and evolution are driven through a few common mechanisms, or whether all interactions are context dependent. Thirdly, there is a lack of eco-evolutionary research at higher organizational levels (e.g. ecosystem and landscape), although it is at those levels that the impact of evolution on our greatest conservation challenges may be most acute. Finally, it remains unclear how genetic diversity impacts eco-evolutionary dynamics, although the strong relationships between additive genetic variance, fitness and the speed of evolution suggest that it is important.Summary. This Special Feature includes five research manuscripts expanding our knowledge of eco-evolutionary dynamics in plants and the organisms they interact with. Its contributors address the aforementioned challenges outlined above, ranging from demonstrating the impacts of genetic variation on plant and herbivore populations, to exploring the role of density in the evolution of plant life-history traits and to documenting genetic covariation among co-occurring communities. This Special Feature highlights the cutting-edge exploration of the dynamic effects of interacting ecological and evolutionary processes, including the potential for complex life histories to influence eco-evolutionary interactions, for common mechanisms to underlie most eco-evolutionary dynamics, for evolution to impact higher organizational levels and for genetic changes to cascade through communities.	[Shefferson, Richard P.] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo 1538902, Japan; [Salguero-Gomez, Roberto] Univ Queensland, Ctr Biodivers & Conservat Sci, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Salguero-Gomez, Roberto] Max Planck Inst Demog Res, Evolutionary Demog Lab, D-18057 Rostock, Germany	Shefferson, RP (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, 3-8-1 Komaba, Tokyo 1538902, Japan.	dormancy@gmail.com					Whitham TG, 2008, SCIENCE, V320, P492, DOI 10.1126/science.1153918; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; [Anonymous], 2007, TRENDS ECOL EVOL, DOI DOI 10.1016/J.TREE.2006.12.001; Loeuille N, 2005, P NATL ACAD SCI USA, V102, P5761, DOI 10.1073/pnas.0408424102; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Ozgul A, 2009, SCIENCE, V325, P464, DOI 10.1126/science.1173668; Yoshida T, 2007, PLOS BIOL, V5, P1868, DOI 10.1371/journal.pbio.0050235; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Gremer JR, 2014, ECOL LETT, V17, P380, DOI 10.1111/ele.12241; Hutchings MJ, 2010, J ECOL, V98, P867, DOI 10.1111/j.1365-2745.2010.01661.x; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Orr HA, 2009, NAT REV GENET, V10, P531, DOI 10.1038/nrg2603; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.2307/2408316; Thompson JN, 2009, AM NAT, V173, P125, DOI 10.1086/595752; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Bassar RD, 2012, AM NAT, V180, P167, DOI 10.1086/666611; PIMENTEL D, 1961, AM NAT, V95, P65, DOI 10.1086/282160; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Svanback R, 2009, AM NAT, V173, P507, DOI 10.1086/597223; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Coulson T, 2011, SCIENCE, V334, P1275, DOI 10.1126/science.1209441; Crone EE, 2013, CONSERV BIOL, V27, P968, DOI 10.1111/cobi.12049; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Shefferson RP, 2012, ECOLOGY, V93, P793, DOI 10.1890/11-0742.1; Law R, 1997, EVOL ECOL, V11, P485, DOI 10.1023/A:1018441108982; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Turcotte MM, 2011, ECOL LETT, V14, P1084, DOI 10.1111/j.1461-0248.2011.01676.x; Reznick D, 2002, ECOLOGY, V83, P1509, DOI 10.2307/3071970; Agrawal AA, 2013, AM NAT, V181, pS35, DOI 10.1086/666727; Childs DZ, 2003, P ROY SOC B-BIOL SCI, V270, P1829, DOI 10.1098/rspb.2003.2399; Salguero-Gomez R, 2015, J ECOL, V103, P202, DOI 10.1111/1365-2745.12334; Matthews B, 2011, ECOL LETT, V14, P690, DOI 10.1111/j.1461-0248.2011.01627.x; Gerhold P, 2015, FUNCT ECOL, V29, P600, DOI 10.1111/1365-2435.12425; Bailey JK, 2009, NEW PHYTOL, V184, P746, DOI 10.1111/j.1469-8137.2009.03081.x; Saether BE, 2013, AM NAT, V182, P743, DOI 10.1086/673497; Reznick DN, 2008, MOL ECOL, V17, P97, DOI 10.1111/j.1365-294X.2007.03474.x; Childs DZ, 2011, ECOL LETT, V14, P985, DOI 10.1111/j.1461-0248.2011.01657.x; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; Kokko H, 2007, ECOL LETT, V10, P773, DOI 10.1111/j.1461-0248.2007.01086.x; Cameron TC, 2013, ECOL LETT, V16, P754, DOI 10.1111/ele.12107; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Saether BE, 2015, TRENDS ECOL EVOL, V30, P273, DOI 10.1016/j.tree.2015.03.007; Roach DA, 2004, AM NAT, V164, P60, DOI 10.1086/421301; Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; Turcotte MM, 2013, AM NAT, V181, pS46, DOI 10.1086/668078; Palkovacs EP, 2008, EVOL ECOL RES, V10, P699; Uyeda JC, 2011, P NATL ACAD SCI USA, V108, P15908, DOI 10.1073/pnas.1014503108; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Salguero-Gomez R, 2013, J ECOL, V101, P545, DOI 10.1111/1365-2745.12089; Post DM, 2009, PHILOS T R SOC B, V364, P1629, DOI 10.1098/rstb.2009.0012; Crone EE, 2011, ECOL LETT, V14, P1, DOI 10.1111/j.1461-0248.2010.01540.x; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Silvertown J, 1996, CONSERV BIOL, V10, P591, DOI 10.1046/j.1523-1739.1996.10020591.x; VERMEIJ GJ, 1994, ANNU REV ECOL SYST, V25, P219, DOI 10.1146/annurev.es.25.110194.001251; Pelletier F, 2009, PHILOS T R SOC B, V364, P1483, DOI 10.1098/rstb.2009.0027; KAYS S, 1974, J ECOL, V62, P97, DOI 10.2307/2258882; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Metcalf CJE, 2008, P NATL ACAD SCI USA, V105, P10466, DOI 10.1073/pnas.0800777105; Antonovics J., 1976, Systematic Botany, V1, P233, DOI 10.2307/2418718; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; Bronikowski AM, 2002, ECOLOGY, V83, P2194, DOI 10.2307/3072051; Brooks Daniel R., 1991, PHYLOGENY ECOLOGY BE; CLARKE B, 1972, AM NAT, V106, P1, DOI 10.1086/282747; Darwin Charles, 1859, ORIGIN SPECIES MEANS; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; Doebeli M, 2005, J EVOLUTION BIOL, V18, P1194, DOI 10.1111/j.1420-9101.2005.00912.x; Endler JA, 1986, NATURAL SELECTION WI; Finkenstadt B, 1998, P ROY SOC B-BIOL SCI, V265, P753; Fisher R.A., 1930, GENETICAL THEORY NAT; Haag JJ, 2004, J ECOL, V92, P156, DOI 10.1111/j.1365-2745.2004.00847.x; Hahn MA, 2012, ECOL LETT, V15, P947, DOI 10.1111/j.1461-0248.2012.01813.x; HALDANE J. B. S., 1957, JOUR GENETICS, V55, P511, DOI 10.1007/BF02984069; HALDANE JBS, 1956, PROC R SOC SER B-BIO, V145, P306, DOI 10.1098/rspb.1956.0039; HARPER JL, 1967, J ECOL, V55, P247, DOI 10.2307/2257876; HICKEY DA, 1975, EVOLUTION, V29, P458, DOI 10.2307/2407258; HODGSON GL, 1957, J EXP BOT, V8, P195, DOI 10.1093/jxb/8.2.195; Holling CS, 1965, MEMOIRS ENTOMOLOGICA, V97, P5, DOI [10.4039/entm9745fv, DOI 10.4039/ENTM9745FV]; Hutchinson G. E., 1965, ECOLOGICAL THEATER E; Huxley J, 1942, EVOLUTION; Kasada M, 2014, P NATL ACAD SCI USA, V111, P16035, DOI 10.1073/pnas.1406357111; Lamit LJ, 2015, J ECOL, V103, P840, DOI 10.1111/1365-2745.12416; Lewontin Richard, 2002, TRIPLE HELIX GENE OR; Malthus T., 1798, ESSAY PRINCIPLE POPU; MCINTYRE GA, 1953, J ECOL, V41, P319, DOI 10.2307/2257044; MCNEILLY T, 1968, EVOLUTION, V22, P108, DOI 10.2307/2406655; MCNEILLY T, 1968, HEREDITY, V23, P99, DOI 10.1038/hdy.1968.8; Metcalf CJE, 2015, J ECOL, V103, P819, DOI 10.1111/1365-2745.12391; Miner BE, 2012, P ROY SOC B-BIOL SCI, V279, P1873, DOI 10.1098/rspb.2011.2404; PIMENTEL D, 1968, SCIENCE, V159, P1432, DOI 10.1126/science.159.3822.1432; Reznick DN, 2013, AM NAT, V181, pS1, DOI 10.1086/670030; Shaw RG, 2015, J ECOL, V103, P809, DOI 10.1111/1365-2745.12422; Shefferson RP, 2014, J ECOL, V102, P1318, DOI 10.1111/1365-2745.12281; SLOBODKIN LAWRENCE B., 1961; Smallegange IM, 2014, AM NAT, V183, P188, DOI 10.1086/674377; Solbrig O. T., 1980, Demography and evolution in plant populations., P1; SPITZE K, 1991, EVOLUTION, V45, P1081, DOI 10.2307/2409717; Sussman R., 2014, OLDEST LIVING THINGS; Turchin P., 2003, COMPLEX POPULATION D; Utsumi S, 2015, J ECOL, V103, P829, DOI 10.1111/1365-2745.12419; Vindenes Y, 2008, AM NAT, V171, P455, DOI 10.1086/528965; Vindenes Y, 2015, ECOL LETT, V18, P417, DOI 10.1111/ele.12421; Williams JL, 2015, J ECOL, V103, P798, DOI 10.1111/1365-2745.12369	107	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-0477	1365-2745		J ECOL	J. Ecol.	JUL	2015	103	4					789	797		10.1111/1365-2745.12432		9	Plant Sciences; Ecology	Plant Sciences; Environmental Sciences & Ecology	CL0KC	WOS:000356630600001		
J	Utsumi, S				Utsumi, Shunsuke			Feeding evolution of a herbivore influences an arthropod community through plants: implications for plant-mediated eco-evolutionary feedback loop	JOURNAL OF ECOLOGY			English	Article						contemporary evolution; feeding preference; herbivore-induced plant response; indirect effect; insect community; phenotypic plasticity; plant-herbivore interactions	HOST-PLANT; LEAF BEETLE; ECOLOGICAL DYNAMICS; INSECT HERBIVORES; RAPID EVOLUTION; TRADE-OFFS; RESPONSES; DEFENSE; SPECIFICITY; CONSEQUENCES	Genetic variation in individual species can have important ecological consequences, and sometimes, these interactions are mediated through another species. For example, genetic variation in an herbivore could alter plant responses that then influence other plant-associated arthropods. However, few systems have experimentally tested the ecological consequences of genetic variation as mediated through other species, especially within the same trophic community context. I studied how evolution of feeding preference in the willow leaf beetle (Plagiodera versicolora), which occurs under selection in a herbivore community context, feeds back to an arthropod community through plant-mediated indirect interactions. Previous studies show beetle populations locally adapt distinct preferences ranging from the gourmet-type, which feeds exclusively on new leaves of willows, to the no-preference (no-pref) type, which displays non-preferential feeding on leaves of different ages. I conducted field experiments at two sites that mimicked evolutionary changes in the feeding preference of the leaf beetle. I manipulated the composition of leaf beetle feeding types for 6days in spring and then investigated subsequent development of arthropod communities. I found that initial herbivory by a higher proportion of gourmet-type beetles led to lower subsequent abundance of conspecific beetle larvae. In contrast, a higher proportion of gourmet-type beetles resulted in higher abundance of aphids. Aphid-tending ants also increased with the increasing abundance of aphids. As a result, species diversity of arthropod communities decreased with the proportion of gourmet-type beetles in the initial beetle treatment. Community assembly dynamics were significantly influenced by interactive effects between the initial beetle treatment and subsequent colonizer species identities. Thus, beetle genetic variation had long-lasting effects through a temporal chain of indirect interactions likely mediated through induced plant responses and the abundance of aphids.Synthesis. Evolutionary changes in feeding traits within an herbivore species had profound but predictable impact on local arthropod communities. Because the feeding evolution of herbivores nearly always occurs in a community context, plant-mediated feedback loops between the evolution and ecological community of arthropods may be widespread in nature.	Hokkaido Univ, Field Sci Ctr Northern Biosphere, Uryu Expt Forest, Horokanai Moshiri 0740741, Japan	Utsumi, S (reprint author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Uryu Expt Forest, Horokanai Moshiri 0740741, Japan.	utsumi@fsc.hokudai.ac.jp			MEXT [19J09260, 26840135]	I thank N. E. Turley, E. Nakajima, T. Nakazawa, M. Yamamich, R. Shefferson and anonymous referees for their valuable comments on early drafts and thank Y. Ando for assistance with field experimental work. I also thank the Center for Ecological Research, Kyoto University, and T. Ohgushi for their help during the common garden experiment. This research was supported by Grants-in-Aid for JSPS Fellows and Young Scientists from MEXT to S.U. (19J09260 and 26840135).	Agrawal AA, 2005, ENTOMOL EXP APPL, V115, P97, DOI 10.1111/j.1570-7458.2005.00294.x; Ando Y, 2008, POPUL ECOL, V50, P181, DOI 10.1007/s10144-007-0072-2; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Agrawal AA, 2014, J CHEM ECOL, V40, P717, DOI 10.1007/s10886-014-0449-6; Poelman EH, 2008, MOL ECOL, V17, P3352, DOI 10.1111/j.1365-294X.2008.03838.x; Farkas TE, 2013, CURR BIOL, V23, P1835, DOI 10.1016/j.cub.2013.07.067; McCall AC, 2010, J ECOL, V98, P985, DOI 10.1111/j.1365-2745.2010.01693.x; Bingham RA, 2010, J ECOL, V98, P1014, DOI 10.1111/j.1365-2745.2010.01681.x; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Bassar RD, 2012, AM NAT, V180, P167, DOI 10.1086/666611; van den Berg AK, 2004, FOREST ECOL MANAG, V200, P113, DOI 10.1016/j.foreco.2004.06.005; Viswanathan DV, 2007, OIKOS, V116, P1389, DOI 10.1111/j.2007.0030-1299.15882.x; Voelckel C, 2004, PLANT J, V38, P650, DOI 10.1111/j.1365-313X.2004.02077.x; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Stam JM, 2014, ANNU REV PLANT BIOL, V65, P689, DOI 10.1146/annurev-arplant-050213-035937; Kessler A, 2007, CURR OPIN PLANT BIOL, V10, P409, DOI 10.1016/j.pbi.2007.06.001; Weih M, 2007, TREE PHYSIOL, V27, P1551; Thaler JS, 2002, OECOLOGIA, V131, P227, DOI 10.1007/s00442-002-0885-9; Turcotte MM, 2011, ECOL LETT, V14, P1084, DOI 10.1111/j.1461-0248.2011.01676.x; EDMUNDS GF, 1978, SCIENCE, V199, P941, DOI 10.1126/science.199.4332.941; Wimp GM, 2001, ECOLOGY, V82, P440, DOI 10.1890/0012-9658(2001)082[0440:BCOPAH]2.0.CO;2; Stadler B, 2005, ANNU REV ECOL EVOL S, V36, P345, DOI 10.1146/annurev.ecolsys.36.091704.175531; Utsumi S, 2010, POPUL ECOL, V52, P485, DOI 10.1007/s10144-010-0237-2; Jones LE, 2009, PHILOS T R SOC B, V364, P1579, DOI 10.1098/rstb.2009.0004; Poelman EH, 2010, ECOL ENTOMOL, V35, P240, DOI 10.1111/j.1365-2311.2010.01179.x; Quintero C, 2011, J CHEM ECOL, V37, P992, DOI 10.1007/s10886-011-0007-4; Inouye B, 2001, OIKOS, V95, P353, DOI 10.1034/j.1600-0706.2001.950218.x; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Arimura G, 2004, PLANT J, V37, P603, DOI 10.1111/j.1365-313X.2003.01987.x; DRAKE JA, 1991, AM NAT, V137, P1, DOI 10.1086/285143; Poelman EH, 2008, TRENDS PLANT SCI, V13, P534, DOI 10.1016/j.tplants.2008.08.003; Felton GW, 2000, CURR OPIN PLANT BIOL, V3, P309, DOI 10.1016/S1369-5266(00)00086-8; Ali JG, 2014, FUNCT ECOL, V28, P1404, DOI 10.1111/1365-2435.12271; Palkovacs EP, 2008, EVOL ECOL RES, V10, P699; Utsumi S, 2009, OIKOS, V118, P1805, DOI 10.1111/j.1600-0706.2009.17580.x; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; FAETH SH, 1986, ECOLOGY, V67, P479, DOI 10.2307/1938591; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Strauss SY, 2005, NEW PHYTOL, V165, P81, DOI 10.1111/j.1469-8137.2004.01228.x; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Erb M, 2011, J ECOL, V99, P7, DOI 10.1111/j.1365-2745.2010.01757.x; Bates D., 2014, J STAT SOFTWAR UNPUB, DOI DOI 10.1016/J.JSPS.2012.11.002; Boecklen William J., 1998, P64; Davies F. T., 2004, J AM SOC HORTIC SCI, V129, P244; Fields MJ, 2006, J CHEM ECOL, V32, P2647, DOI 10.1007/s10886-006-9188-7; Gianoli E, 1997, ENVIRON ENTOMOL, V26, P638; GOTELLI N. J., 2004, ECOSIM NULL MODELS S; HARRISON S, 1986, OECOLOGIA, V69, P354, DOI 10.1007/BF00377056; JANZ N, 1994, OECOLOGIA, V99, P132, DOI 10.1007/BF00317093; Kant MR, 2008, P R SOC B, V275, P443, DOI 10.1098/rspb.2007.1277; Karban R., 1997, INDUCED RESPONSES HE; Messina FJ, 2004, ECOL ENTOMOL, V29, P318, DOI 10.1111/j.1365-2311.2004.0599.x; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; R Core Team, 2014, R LANG ENV STAT COMP; Rhoades D. F., 1979, HERBIVORES THEIR INT, P3; Rundle HD, 2003, P NATL ACAD SCI USA, V100, P14943, DOI 10.1073/pnas.2036360100; Ruuhola TM, 2001, ANN BOT-LONDON, V88, P483, DOI 10.1006/anbo.2001.1491; Schuepp C, 2014, BIOL CONTROL, V71, P56, DOI 10.1016/j.biocontrol.2014.01.007; Simon M, 2003, AGR FOREST ENTOMOL, V5, P275, DOI 10.1046/j.1461-9563.2003.00189.x; Singer M. C., 1991, AM NAT, V139, P9; Turcotte M. M., 2013, AM NAT, V181, P546; Utsumi S, 2011, POPUL ECOL, V53, P23, DOI 10.1007/s10144-010-0253-2; Utsumi S, 2008, ECOL ENTOMOL, V33, P250, DOI 10.1111/j.1365-2311.2007.00959.x; Utsumi S, 2009, ECOL LETT, V12, P920, DOI 10.1111/j.1461-0248.2009.01349.x; Utsumi S, 2013, ECOL LETT, V16, P362, DOI 10.1111/ele.12051; Utsumi S., 2015, J ECOL, DOI [10.5061/dryad.s2nr5, DOI 10.5061/DRYAD.S2NR5]; VansZandt P. A., 2004, ECOLOGY, V85, P2626; VansZandt P. A., 1998, AM NAT, V152, P595; Wood S. N, 2006, GEN ADDITIVE MODELS	72	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-0477	1365-2745		J ECOL	J. Ecol.	JUL	2015	103	4					829	839		10.1111/1365-2745.12419		11	Plant Sciences; Ecology	Plant Sciences; Environmental Sciences & Ecology	CL0KC	WOS:000356630600005		
J	Paine, CET; Amissah, L; Auge, H; Baraloto, C; Baruffol, M; Bourland, N; Bruelheide, H; Dainou, K; de Gouvenain, RC; Doucet, JL; Doust, S; Fine, PVA; Fortunel, C; Haase, J; Holl, KD; Jactel, H; Li, XF; Kitajima, K; Koricheva, J; Martinez-Garza, C; Messier, C; Paquette, A; Philipson, C; Piotto, D; Poorter, L; Posada, JM; Potvin, C; Rainio, K; Russo, SE; Ruiz-Jaen, M; Scherer-Lorenzen, M; Webb, CO; Wright, SJ; Zahawi, RA; Hector, A				Paine, C. E. Timothy; Amissah, Lucy; Auge, Harald; Baraloto, Christopher; Baruffol, Martin; Bourland, Nils; Bruelheide, Helge; Dainou, Kasso; de Gouvenain, Roland C.; Doucet, Jean-Louis; Doust, Susan; Fine, Paul V. A.; Fortunel, Claire; Haase, Josephine; Holl, Karen D.; Jactel, Herve; Li, Xuefei; Kitajima, Kaoru; Koricheva, Julia; Martinez-Garza, Cristina; Messier, Christian; Paquette, Alain; Philipson, Christopher; Piotto, Daniel; Poorter, Lourens; Posada, Juan M.; Potvin, Catherine; Rainio, Kalle; Russo, Sabrina E.; Ruiz-Jaen, Mariacarmen; Scherer-Lorenzen, Michael; Webb, Campbell O.; Wright, S. Joseph; Zahawi, Rakan A.; Hector, Andy			Globally, functional traits are weak predictors of juvenile tree growth, and we do not know why	JOURNAL OF ECOLOGY			English	Article						functional ecology; FunDivEurope; growth; hierarchical models; plant population and community dynamics; relative growth rate; size-standardized growth rate; TreeDivNet	COMMUNITY ECOLOGY; PLANT TRAITS; DEMOGRAPHIC RATES; MODELS; FOREST; BIODIVERSITY; SIZE; LEAF; TEMPERATE; MORTALITY	Plant functional traits, in particular specific leaf area (SLA), wood density and seed mass, are often good predictors of individual tree growth rates within communities. Individuals and species with high SLA, low wood density and small seeds tend to have faster growth rates. If community-level relationships between traits and growth have general predictive value, then similar relationships should also be observed in analyses that integrate across taxa, biogeographic regions and environments. Such global consistency would imply that traits could serve as valuable proxies for the complex suite of factors that determine growth rate, and, therefore, could underpin a new generation of robust dynamic vegetation models. Alternatively, growth rates may depend more strongly on the local environment or growth-trait relationships may vary along environmental gradients. We tested these alternative hypotheses using data on 27352 juvenile trees, representing 278 species from 27 sites on all forested continents, and extensive functional trait data, 38% of which were obtained at the same sites at which growth was assessed. Data on potential evapotranspiration (PET), which summarizes the joint ecological effects of temperature and precipitation, were obtained from a global data base. We estimated size-standardized relative height growth rates (SGR) for all species, then related them to functional traits and PET using mixed-effect models for the fastest growing species and for all species together. Both the mean and 95th percentile SGR were more strongly associated with functional traits than with PET. PET was unrelated to SGR at the global scale. SGR increased with increasing SLA and decreased with increasing wood density and seed mass, but these traits explained only 3.1% of the variation in SGR. SGR-trait relationships were consistently weak across families and biogeographic zones, and over a range of tree statures. Thus, the most widely studied functional traits in plant ecology were poor predictors of tree growth over large scales.Synthesis. We conclude that these functional traits alone may be unsuitable for predicting growth of trees over broad scales. Determining the functional traits that predict vital rates under specific environmental conditions may generate more insight than a monolithic global relationship can offer.	[Paine, C. E. Timothy] Univ Stirling, Biol & Environm Sci, Stirling FK9 4LA, Scotland; [Amissah, Lucy; Poorter, Lourens] Wageningen Univ, Forest Ecol & Forest Management Grp, NL-6700 AA Wageningen, Netherlands; [Amissah, Lucy] KNUST, Council Sci & Ind Res, Forestry Res Inst Ghana, Kumasi, Ghana; [Auge, Harald] Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, D-06120 Halle, Germany; [Auge, Harald; Bruelheide, Helge] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany; [Baraloto, Christopher; Fortunel, Claire] INRA, UMR Ecol Forets Guyane, Kourou 97387, French Guiana; [Baraloto, Christopher; Kitajima, Kaoru] Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA; [Baruffol, Martin] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Bourland, Nils; Dainou, Kasso; Doucet, Jean-Louis] Univ Liege, Unit Forest & Nat Management, Lab Trop & Subtrop Forest Reg, Liege, Belgium; [Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, D-06108 Halle, Germany; [de Gouvenain, Roland C.] Rhode Isl Coll, Dept Biol, Providence, RI 02908 USA; [Doust, Susan] Australian Antarctic Div, Kingston, Tas 7050, Australia; [Fine, Paul V. A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Fortunel, Claire] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Haase, Josephine; Scherer-Lorenzen, Michael] Univ Freiburg, Geobot, Fac Biol, D-79104 Freiburg, Germany; [Haase, Josephine; Philipson, Christopher] ETH, Inst Terr Ecosyst, Ecosyst Management, CH-8092 Zurich, Switzerland; [Holl, Karen D.] Univ Calif Santa Cruz, Environm Studies Dept, Santa Cruz, CA 95064 USA; [Jactel, Herve] INRA, BIOGECO, UMR1202, F-33510 Cestas, France; [Jactel, Herve] Univ Bordeaux, UMR1202, BIOGECO, F-33400 Talence, France; [Kitajima, Kaoru; Potvin, Catherine; Wright, S. Joseph] Smithsonian Trop Res Inst, Balboa 084303092, Panama; [Kitajima, Kaoru] Kyoto Univ, Forest Biomat Sci, Sakyo Ku, Kyoto, Japan; [Koricheva, Julia] Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Martinez-Garza, Cristina] Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac, Cuernavaca 62209, Morelos, Mexico; [Messier, Christian; Paquette, Alain] Univ Quebec, Ctr Forest Res, Montreal, PQ H3C 3P8, Canada; [Messier, Christian] Univ Quebec, ISFORT, Montreal, PQ H3C 3P8, Canada; [Messier, Christian] Univ Quebec Outaouais, Montreal, PQ H3C 3P8, Canada; [Piotto, Daniel] Univ Fed Sul Bahia, BR-45613204 Ferradas Itabuna, BA, Brazil; [Posada, Juan M.] Univ Rosario, Fac Nat Sci & Math, Biol Program, Bogota 111221, Colombia; [Potvin, Catherine; Ruiz-Jaen, Mariacarmen] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Rainio, Kalle] Univ Turku, Dept Biol, Sect Ecol, FI-20014 Turku, Finland; [Russo, Sabrina E.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Webb, Campbell O.] Arnold Arboretum Harvard Univ, Boston, MA 02131 USA; [Zahawi, Rakan A.] Org Trop Studies, Las Cruces Biol Stn, Apartado San Vito De Cot, Costa Rica; [Hector, Andy] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	Paine, CET (reprint author), Univ Stirling, Biol & Environm Sci, Stirling FK9 4LA, Scotland.	c.e.t.paine@stir.ac.uk	Auge, Harald/D-4802-2015; Piotto, Daniel/F-9956-2012	Auge, Harald/0000-0001-7432-8453; Piotto, Daniel/0000-0002-6505-0098	Swiss National Science [121967]; European Union [265171, 226299]	We thank the multitudes involved in planting, measuring and maintenance of the study sites, and collecting growth and trait data. Jens Kattge, manager of the TRY global trait data base, and Kyle Dexter contributed additional trait data. Statistical advice from Marco Geraci, Sophia Ratcliffe, Nadja Ruger and Christian Wirth strengthened the analysis. This research was funded by Swiss National Science grant number 121967 to A.H. and by the European Union Seventh Framework Program (FP7/2007-2013) under grant agreements no 265171 (project FunDivEUROPE) and no 226299 (project BACCARA).	Adler PB, 2014, P NATL ACAD SCI USA, V111, P740, DOI 10.1073/pnas.1315179111; Allen R., 1998, 56 FAO, P1; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Bruelheide H, 2014, METHODS ECOL EVOL, V5, P74, DOI 10.1111/2041-210X.12126; Ruger N, 2012, ECOLOGY, V93, P2626, DOI 10.1890/12-0622.1; GRIME JP, 1975, J ECOL, V63, P393, DOI 10.2307/2258728; Turnbull LA, 2012, ECOLOGY, V93, P1283, DOI 10.1890/11-0261.1; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Marks CO, 2006, AM NAT, V167, P55, DOI 10.1086/498276; Poorter L, 2007, AM NAT, V169, P433, DOI 10.1086/512045; Boulangeat I, 2012, GLOBAL CHANGE BIOL, V18, P3464, DOI 10.1111/j.1365-2486.2012.02783.x; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; POORTER H, 1990, OECOLOGIA, V83, P553, DOI 10.1007/BF00317209; Martinez-Garza C, 2005, FOREST ECOL MANAG, V217, P365, DOI 10.1016/j.foreco.2005.07.001; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Rees M, 2010, AM NAT, V176, pE152, DOI 10.1086/657037; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Gelman A, 2005, ANN STAT, V33, P1, DOI 10.1214/009053604000001048; Wright SJ, 2010, ECOLOGY, V91, P3664, DOI 10.1890/09-2335.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Enquist BJ, 2007, NATURE, V449, P218, DOI 10.1038/nature06061; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Loik ME, 2001, OECOLOGIA, V127, P40, DOI 10.1007/s004420000566; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Martinez-Garza C, 2013, FOREST ECOL MANAG, V303, P35, DOI 10.1016/j.foreco.2013.03.046; Scheiter S, 2013, NEW PHYTOL, V198, P957, DOI 10.1111/nph.12210; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Kunstler G, 2012, ECOL LETT, V15, P831, DOI 10.1111/j.1461-0248.2012.01803.x; Paine CET, 2011, OIKOS, V120, P720, DOI 10.1111/j.1600-0706.2010.19110.x; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Sakschewski B, 2015, GLOBAL CHANGE BIOL, V21, P2711, DOI 10.1111/gcb.12870; Baeten L, 2013, PERSPECT PLANT ECOL, V15, P281, DOI 10.1016/j.ppees.2013.07.002; Atkin OK, 2005, FUNCT PLANT BIOL, V32, P87, DOI 10.1071/FP03176; Paine CET, 2012, METHODS ECOL EVOL, V3, P245, DOI 10.1111/j.2041-210X.2011.00155.x; Bates D. M., 2014, LME4 LINEAR MIXED EF; Cornwell WK, 2010, J ECOL, V98, P814, DOI 10.1111/j.1365-2745.2010.01662.x; Craine JM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00246; Gallagher RV, 2012, OIKOS, V121, P2026, DOI 10.1111/j.1600-0706.2012.20025.x; Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136; Geraci M, 2014, LQMM QUANTILE MIXED; Martinez-Vilalta J, 2010, J ECOL, V98, P1462, DOI 10.1111/j.1365-2745.2010.01718.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Poorter H., 1998, PHYSL MECH ECOLOGICA, P309; R Core Development Team, 2014, R LANG ENV STAT COMP; Russo SE, 2010, FUNCT ECOL, V24, P253, DOI 10.1111/j.1365-2435.2009.01670.x; Stan Development Team, 2014, STAN MOD LANG US GUI; ter Steege H., 2003, LONG TERM CHANGES TR; Tobner C.M., 2013, OECOLOGIA, V174, P609	51	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-0477	1365-2745		J ECOL	J. Ecol.	JUL	2015	103	4					978	989		10.1111/1365-2745.12401		12	Plant Sciences; Ecology	Plant Sciences; Environmental Sciences & Ecology	CL0KC	WOS:000356630600020		
J	Kondo, N				Kondo, Naoki			Epidemiologic Study on Social Determinants of Health: What's Next?	JOURNAL OF EPIDEMIOLOGY			English	Editorial Material						health inequality; child; social determinants of health; policy			[Kondo, Naoki] Univ Tokyo, Dept Hlth & Social Behav, Dept Hlth Educ & Hlth Sociol, Sch Publ Hlth, Tokyo 1130033, Japan	Kondo, N (reprint author), Univ Tokyo, Dept Hlth & Social Behav, Dept Hlth Educ & Hlth Sociol, Sch Publ Hlth,Bunkyo Ku, Med Sch Bldg 3 S310,7-3-1 Hongo, Tokyo 1130033, Japan.	naoki-kondo@umin.ac.jp					Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777; Leventhal T, 2011, SOC SCI MED, V73, P737, DOI 10.1016/j.socscimed.2011.06.042; Kachi Y, 2015, J EPIDEMIOL, V25, P463, DOI 10.2188/jea.JE20140108; Kondo N, 2014, J EPIDEMIOL COMMUNIT, V68, P1145; Kristensen AH, 2014, AM J PREV MED, V47, P604, DOI 10.1016/j.amepre.2014.07.011; Okuhara Tsuyoshi, 2014, BMC Res Notes, V7, P896, DOI 10.1186/1756-0500-7-896; Roberto CA, 2014, AM J PREV MED, V47, P832, DOI 10.1016/j.amepre.2014.08.002; Stuckler D, 2013, BODY EC WHY AUSTERIT; Wada K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1191; WHO Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ	10	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	JUL	2015	25	7					461	462		10.2188/jea.JE20150082		2	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CL4ZL	WOS:000356967400001		
J	Kachi, Y; Otsuka, T; Kawada, T				Kachi, Yuko; Otsuka, Toshiaki; Kawada, Tomoyuki			Socioeconomic Status and Overweight: A Population-Based Cross-Sectional Study of Japanese Children and Adolescents	JOURNAL OF EPIDEMIOLOGY			English	Article						socioeconomic status; overweight; children; adolescent; Japan	CHILDHOOD OBESITY; ADULTS; HEALTH; PREVALENCE; INEQUALITIES; ASSOCIATION; INDICATOR; TRENDS; RISK	Background: Socioeconomic status (SES) as a determinant of obesity has received scant attention in Japan. This study examined the association between SES and overweight among Japanese children and adolescents. Methods: Cross-sectional analyses of a representative sample of Japanese children (6-11 years: n = 397) and adolescents (12-18 years: n = 397) were performed, with measured heights and weights from the 2010 National Health and Nutrition Examination Survey and the 2010 Comprehensive Survey of Living Conditions. Overweight, including obesity, was defined by International Obesity Task Force cut-offs. SES indicators included household income, equivalent household expenditure, parental educational attainment, and parental occupational class. Results: Overweight prevalence was 12.3% in children and 9.1% in adolescents. Adolescents living in middle-income households were more likely to be overweight than those living in high-income households (OR 2.26, 95% CI, 1.01-5.67) after adjustment for age, sex, and parental weight status. Similarly, adolescents living in households with low expenditure levels were more likely to be overweight than those living in households with high expenditure levels (OR 3.40, 95% CI, 1.20-9.60). In contrast, no significant association was observed among children. Conclusions: Our results indicated that low household economic status was associated with being overweight, independent of parental weight status, among Japanese adolescents.	[Kachi, Yuko; Otsuka, Toshiaki; Kawada, Tomoyuki] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 1138602, Japan	Kachi, Y (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kachi@nms.ac.jp			Japan Society for the Promotion of Science [24790516]	This study was supported by a Grant-in-Aid for Young Scientists (B) No. 24790516 from the Japan Society for the Promotion of Science.	Kanazawa M, 2002, ASIA PAC J CLIN NUTR, V11, pS732, DOI 10.1046/j.1440-6047.11.s8.19.x; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; The NS, 2010, JAMA-J AM MED ASSOC, V304, P2042, DOI 10.1001/jama.2010.1635; Kondo N, 2008, SOC SCI MED, V67, P982, DOI 10.1016/j.socscimed.2008.06.002; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.2012.40; Reilly J J, 2011, Int J Obes (Lond), V35, P891, DOI 10.1038/ijo.2010.222; Cole TJ, 2000, BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Puder JJ, 2010, INT J OBESITY, V34, pS37, DOI 10.1038/ijo.2010.238; El-Sayed AM, 2012, OBESITY FACTS, V5, P671, DOI 10.1159/000343611; MARMOT MG, 1989, BRIT MED J, V299, P1547; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Semmler C, 2009, OBESITY, V17, P814, DOI 10.1038/oby.2008.621; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Lakshman R, 2012, CIRCULATION, V126, P1770, DOI 10.1161/CIRCULATIONAHA.111.047738; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Fukuda Y, 2013, J EPIDEMIOL, V23, P21, DOI 10.2188/jea.JE20120021; Fukuda Y, 2007, J EPIDEMIOL, V17, P93, DOI 10.2188/jea.17.93; Haga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051896; Hashimoto H., 2012, IRYO SHAKAI, V22, P5; Kachi Y, 2013, SOC SCI MED, V81, P94, DOI 10.1016/j.socscimed.2012.11.042; Kawada T, 2012, OCCUP ENVIRON MED, V69, P606, DOI 10.1136/oemed-2011-100565; Kikkawa T, 2000, INT J SOCIOLOGY, V30, P34; Ministry of Education, 2010, REP SCH HLTH STAT; Ministry of Education Culture Sports Science and Technology, 2012, SURV SCH LUNCH; Ministry of Health Labour and Welfare, NAT HLTH NUTR SURV; Ministry of Health Labour and Welfare, SUMM REP COMPR SURV; Mitsuhashi T, 2012, J OCCUP HEALTH, V54, P25, DOI 10.1539/joh.11-0100-OA; Nishi N, 2012, J HLTH WELFARE STAT, V59, P10; OECD, 2008, GROW UN INC DISTR PO; Sakai R, 2013, ASIA-PAC J PUBLIC HE, V25, P159, DOI 10.1177/1010539511416347; Sobal J, 1991, Med Anthropol, V13, P231	35	1	1	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	JUL	2015	25	7					463	469		10.2188/jea.JE20140108		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CL4ZL	WOS:000356967400002		
J	Oikawa, J; Ukawa, S; Ohira, H; Kawamura, T; Wakai, K; Ando, M; Hata, A; Tamakoshi, A				Oikawa, Junko; Ukawa, Shigekazu; Ohira, Hideki; Kawamura, Takashi; Wakai, Kenji; Ando, Masahiko; Hata, Akira; Tamakoshi, Akiko			Diabetes Mellitus is Associated With Low Secretion Rates of Immunoglobulin A in Saliva	JOURNAL OF EPIDEMIOLOGY			English	Article						diabetes mellitus; secretory immunoglobulin A; saliva	POSTMENOPAUSAL WOMEN; TRACT-INFECTION; IGA; EXERCISE; RISK; AGE; POPULATION; IMMUNITY; SEX	Background: The association between diabetes mellitus (DM) and low secretory immunoglobulin A (s-IgA) secretion rates is one mechanism suspected of influencing susceptibility to infections among DM patients. However, several studies have shown contradictory results. We examined these two factors to seek evidence of an association among older people. Methods: We analyzed a prospective cohort of 2306 subjects (1209 men and 1097 women) around 64 years old from the New Integrated Suburban Seniority Investigation (NISSIN) Project in Nisshin, Japan. DM statuses were ascertained from levels of fasting plasma glucose and HbA1c, and s-IgA secretion rates were obtained from 5-min saliva samples. We used an analysis of covariance adjusted for possible confounders to compare s-IgA secretion rates according to DM status. Results: s-IgA secretion rates in DM participants were lower than in those classified as normal (18.6 mu g/min vs 15.0 mu g/min, P = 0.03), even after elimination of the effects of possible confounders. Conclusions: DM was associated with lower s-IgA secretion rates. This suggests that lower s-IgA levels may be a mechanism of susceptibility to infection in individuals with DM.	[Oikawa, Junko; Ukawa, Shigekazu; Tamakoshi, Akiko] Hokkaido Univ, Dept Publ Hlth, Grad Sch Med, Sapporo, Hokkaido 0600812, Japan; [Oikawa, Junko; Hata, Akira] Chiba Univ, Dept Publ Hlth, Grad Sch Med, Chiba, Japan; [Ohira, Hideki] Nagoya Univ, Dept Psychol, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Kawamura, Takashi] Kyoto Univ, Hlth Serv, Kyoto, Japan; [Wakai, Kenji] Nagoya Univ, Grad Sch Med, Dept Prevent Med, Nagoya, Aichi 4648601, Japan; [Ando, Masahiko] Nagoya Univ, Ctr Adv Med & Clin Res, Nagoya, Aichi 4648601, Japan	Tamakoshi, A (reprint author), Hokkaido Univ, Dept Publ Hlth, Grad Sch Med, Kita Ku, N15 W7, Sapporo, Hokkaido 0600812, Japan.	tamaa@med.hokudai.ac.jp		HATA, AKIRA/0000-0003-0867-3704	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [15390197]	The authors express their sincere appreciation to the Health Center and Hygiene Department of Nisshin City for their generous cooperation. We also gratefully acknowledge the special efforts of the Nisshin Medical and Dental Associations. We thank Dr. Mariko Naito for her advice on our analysis. This study was supported by a Grant-in-Aid for Scientific Research (B) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT; no. 15390197). The authors report no potential conflicts of interest relevant to this article.	Aghamohammadi A, 2009, J CLIN IMMUNOL, V29, P130, DOI 10.1007/s10875-008-9229-9; American DA, 2013, DIABETES CARE S1, V36, pS67, DOI DOI 10.2337/DC13-S067; Boyko EJ, 2005, AM J EPIDEMIOL, V161, P557, DOI 10.1093/aje/kwi078; Akimoto T, 2003, BRIT J SPORT MED, V37, P76, DOI 10.1136/bjsm.37.1.76; Kitamura T, 2009, J EPIDEMIOL, V19, P237, DOI 10.2188/jea.JE20081026; Kimura K, 2007, BIOL PSYCHOL, V74, P39, DOI 10.1016/j.biopsycho.2006.06.006; Benfield T, 2007, DIABETOLOGIA, V50, P549, DOI 10.1007/s00125-006-0570-3; Yavuzyilmaz E, 1996, AUST DENT J, V41, P193; Evans P, 2000, BRAIN BEHAV IMMUN, V14, P41, DOI 10.1006/brbi.1999.0571; Sloan CA, 2013, INT J SPORTS MED, V34, P81, DOI 10.1055/s-0032-1314817; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.1016/j.jclinepi.2007.11.008; Woof JM, 2005, IMMUNOL REV, V206, P64, DOI 10.1111/j.0105-2896.2005.00290.x; Gleeson M, 2012, SCAND J MED SCI SPOR, V22, P410, DOI 10.1111/j.1600-0838.2010.01272.x; Leegaard A, 2011, DIABETES CARE, V34, P2530, DOI 10.2337/dc11-0902; Nederfors T, 1997, COMMUNITY DENT ORAL, V25, P211, DOI 10.1111/j.1600-0528.1997.tb00928.x; Gallagher S, 2008, BRAIN BEHAV IMMUN, V22, P565, DOI 10.1016/j.bbi.2007.11.007; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Nieman DC, 2006, J SPORT MED PHYS FIT, V46, P158; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Branco-de-Almeida LS, 2011, BRAZ ORAL RES, V25, P550, DOI 10.1590/S1806-83242011000600013; Eliasson L, 2006, EUR J ORAL SCI, V114, P494, DOI 10.1111/j.1600-0722.2006.00413.x; Japan Ministry of Health Labour and Welfare, 2011, TOK NAT HLTH NUTR SU; Japan Ministry of Health Labour and Welfare, 2013, TOK VIT STAT JAP; Japan Ministry of Health Labour and Welfare, 2010, TOK VIT STAT JAP; Jennbacken K, 2013, CLIN EXP IMMUNOL, V174, P129, DOI 10.1111/cei.12148; Klentrou P, 2002, EUR J APPL PHYSIOL, V87, P153, DOI 10.1007/s00421-002-0609-1; Ngo BT, 2005, AM J CLIN DERMATOL, V6, P225, DOI 10.2165/00128071-200506040-00003; Phillips AC, 2006, BRAIN BEHAV IMMUN, V20, P191, DOI 10.1016/j.bbi.2005.06.006; SATO N, 1992, DIABETES CARE, V15, P1050, DOI 10.2337/diacare.15.8.1050; Sreebny L M, 1997, Gerodontology, V14, P33, DOI 10.1111/j.1741-2358.1997.00033.x; Waszkiewicz N, 2012, FOLIA HISTOCHEM CYTO, V50, P605, DOI [10.5603/19709, 10.5603/FHC.2012.0085]	31	1	1	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	JUL	2015	25	7					470	474		10.2188/jea.JE20140088		5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CL4ZL	WOS:000356967400003		
J	Shirasawa, T; Ochiai, H; Nanri, H; Nishimura, R; Ohtsu, T; Hoshino, H; Tajima, N; Kokaze, A				Shirasawa, Takako; Ochiai, Hirotaka; Nanri, Hinako; Nishimura, Rimei; Ohtsu, Tadahiro; Hoshino, Hiromi; Tajima, Naoko; Kokaze, Akatsuki			Trends of Underweight and Overweight/Obesity Among Japanese Schoolchildren From 2003 to 2012, Defined by Body Mass Index and Percentage Overweight Cutoffs	JOURNAL OF EPIDEMIOLOGY			English	Article						body mass index; percentage overweight; schoolchildren; secular trends; Japanese	INTERNATIONAL SURVEY; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; BLOOD-PRESSURE; CHILDREN; ADOLESCENTS; POPULATION; THINNESS; WEIGHT; DEFINITION	Background: We investigated the prevalence and trends of underweight and overweight/obesity in a population-based sample of Japanese schoolchildren from 2003 to 2012, defined by body mass index (BMI) and percentage overweight (POW). Methods: Subjects comprised fourth and seventh graders from the town of Ina, Japan, from 2003 to 2012. The height and weight of each subject were measured. Children were classified as underweight, normal weight, or overweight/obese using two criteria: BMI cutoff points proposed by the International Obesity Task Force and cutoffs based on POW in Japan. Results: Data from 4367 fourth graders and 3724 seventh graders were analyzed. The prevalence of underweight and overweight as defined by POW criteria were lower than those based on BMI criteria. There was a decrease in the prevalence of overweight among fourth-grade boys and girls and seventh-grade girls according to BMI; this decrease was also observed when POW criteria were used for the definition of overweight. Conclusions: The prevalence and trends of both underweight and overweight as defined by POW were underestimated among Japanese schoolchildren compared to those determined using BMI. The results of this study also suggest that trends in underweight and overweight/obesity using POW criteria are similar to those based on BMI criteria among schoolchildren in Japan.	[Shirasawa, Takako; Ochiai, Hirotaka; Nanri, Hinako; Ohtsu, Tadahiro; Hoshino, Hiromi; Kokaze, Akatsuki] Showa Univ, Sch Med, Dept Publ Hlth, Tokyo 1428555, Japan; [Nishimura, Rimei] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan; [Tajima, Naoko] Jikei Univ, Sch Med, Tokyo, Japan	Shirasawa, T (reprint author), Showa Univ, Sch Med, Dept Publ Hlth, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	shirasawa@med.showa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [14207020, 17209024, 25350854]	The authors would like to thank all of the study participants, their parents and guardians, all members of the Board of Education in Ina, Saitama Prefecture, and the Ina Conference for Promotion and Implementation of the Childhood Lifestyle-related Disease Prevention Examination (Chairmen: Dr. Michio Sato and Dr. Yoshihito Toriyama). This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (2002-2004, No. 14207020; 2005-2008, No. 17209024; and 2013-2015, No. 25350854).	Elinder LS, 2011, J ADOLESCENT HEALTH, V48, P481, DOI 10.1016/j.jadohealth.2010.08.005; Kouda K, 2010, J EPIDEMIOL, V20, P212, DOI 10.2188/jea.JE20090079; Cole TJ, 2000, BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Guinhouya BC, 2012, PAEDIATR PERINAT EP, V26, P438, DOI 10.1111/j.1365-3016.2012.01269.x; Asayama K, 2003, PEDIATR INT, V45, P642, DOI 10.1046/j.1442-200X.2003.01795.x; Wang YF, 2002, AM J CLIN NUTR, V75, P971; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI [10.1111/j.2047-6310.2012.00064.x, 10.1111/j.2047-6310.2012.000064.x]; Flores LS, 2013, J PEDIAT-BRAZIL, V89, P456, DOI 10.1016/j.jped.2013.02.021; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Cole TJ, 2007, BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Patton GC, 1999, BRIT MED J, V318, P765; Tuan NT, 2009, EUR J CLIN NUTR, V63, P1305, DOI 10.1038/ejcn.2009.90; Turner JM, 2001, INT J EAT DISORDER, V30, P245, DOI 10.1002/eat.1081; Power C, 1997, INT J OBESITY, V21, P507, DOI 10.1038/sj.ijo.0800454; Lakshman R, 2012, CIRCULATION, V126, P1770, DOI 10.1161/CIRCULATIONAHA.111.047738; Kaneko K, 1999, PSYCHIAT CLIN NEUROS, V53, P365, DOI 10.1046/j.1440-1819.1999.00559.x; Shirasawa T, 2012, J EPIDEMIOL, V22, P448, DOI 10.2188/jea.JE20110137; Inokuchi M, 2009, ANN HUM BIOL, V36, P139, DOI 10.1080/03014460802635213; Kurokawa N, 2011, OBES RES CLIN PRACT, V5, pE1, DOI 10.1016/j.orcp.2010.11.002; Lazzeri G, 2008, J Prev Med Hyg, V49, P13; Martinez-Vizcaino V, 2012, PUBLIC HEALTH NUTR, V15, P2170, DOI 10.1017/S1368980012003473; Nishizawa Y, 2003, PSYCHIAT CLIN NEUROS, V57, P189, DOI 10.1046/j.1440-1819.2003.01100.x; Okuda M, 2010, J EPIDEMIOL, V20, P46, DOI 10.2188/jea.JE20090036; Sakamaki R, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-31; Selzer R, 1996, J ADOLESCENT HEALTH, V19, P56, DOI 10.1016/1054-139X(95)00229-L; Shirasawa T., 2012, Health, V4, P506, DOI 10.4236/health.2012.48081; Takimoto H, 2004, AM J PUBLIC HEALTH, V94, P1592, DOI 10.2105/AJPH.94.9.1592; The Ministry of Education Culture Sports Science and Technology, 1991, NAT STAT PHYS DEV JA	28	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	JUL	2015	25	7					482	488		10.2188/jea.JE20140144		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CL4ZL	WOS:000356967400005		
J	Tatsumi, Y; Watanabe, M; Nakai, M; Kokubo, Y; Higashiyama, A; Nishimura, K; Kobayashi, T; Takegami, M; Nakao, YM; Watanabe, T; Okayama, A; Okamura, T; Miyamoto, Y				Tatsumi, Yukako; Watanabe, Makoto; Nakai, Michikazu; Kokubo, Yoshihiro; Higashiyama, Aya; Nishimura, Kunihiro; Kobayashi, Takashi; Takegami, Misa; Nakao, Yoko M.; Watanabe, Takuya; Okayama, Akira; Okamura, Tomonori; Miyamoto, Yoshihiro			Changes in Waist Circumference and the Incidence of Type 2 Diabetes in Community-Dwelling Men and Women: The Suita Study	JOURNAL OF EPIDEMIOLOGY			English	Article						waist circumference; type 2 diabetes mellitus; prospective cohort study	WEIGHT CHANGE; CARDIOVASCULAR-DISEASE; FAT DISTRIBUTION; RISK-FACTORS; BLOOD-PRESSURE; JAPANESE; OVERWEIGHT; OBESITY; COHORT; ADULTS	Backgrounds: The association between weight gain and the incidence of type 2 diabetes is well known. The aim of our study was to investigate the relationship between change in waist circumference (WC) and type 2 diabetes incidence. Methods: The participants in the Suita Study, a population-based cohort study in an urban area of Japan, underwent a baseline survey between 1989 and 1994 (Exam 1) and were examined at follow-up every 2 years. We performed a 9.3-year cohort study of 946 men and 1327 women with no history of diabetes who underwent Exam 1 and Exam 2 (between 1997 and 1999). Participants were stratified by sex and median WC at Exam 1, and, in each stratum, participants were further classified into three categories by tertile of WC change per year between Exam 1 and Exam 2. Hazard ratios (HRs) and 95% confidence intervals (CIs) for type 2 diabetes incidence were calculated by Cox proportional hazard models. The endpoints were first diagnosis of type 2 diabetes or March 2011. Results: During follow-up, 287 participants developed type 2 diabetes. In both sexes with median WC or higher, participants in the highest tertile of WC change had a significantly higher risk of developing type 2 diabetes. Multivariable adjusted HRs were 1.84 (95% CI, 1.10-3.08) in men and 2.30 (95% CI, 1.31-4.04) in women. No significant association was observed among participants with WC below median. Conclusions: Preventing WC gain is important in preventing type 2 diabetes in the Japanese population, especially among individuals with a relatively high WC.	[Tatsumi, Yukako; Nakai, Michikazu; Higashiyama, Aya; Nishimura, Kunihiro; Takegami, Misa; Nakao, Yoko M.; Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Suita, Osaka 5658565, Japan; [Tatsumi, Yukako] Osaka Univ, Grad Sch Med, Dept Math Hlth Sci, Suita, Osaka, Japan; [Watanabe, Makoto; Kokubo, Yoshihiro; Kobayashi, Takashi; Nakao, Yoko M.; Watanabe, Takuya; Okayama, Akira; Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka 5658565, Japan; [Okamura, Tomonori] Keio Univ, Dept Prevent Med & Publ Hlth, Tokyo, Japan	Watanabe, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	watanabe.makoto.hp@ncvc.go.jp	Okamura, Tomonori/L-1693-2013		Intramural Research Fund of the National Cerebral and Cardiovascular Center [22-4-5]; Ministry of Health, Labour and Welfare [H26-Junkankitou [Seisaku]-Ippan-001, H25-Junkankitou [Seisyu]-Ippan-005]; Japan Society for the Promotion of Science [24590837]	The present study was supported by the Intramural Research Fund of the National Cerebral and Cardiovascular Center (22-4-5), a grant-in-aid from the Ministry of Health, Labour and Welfare (H26-Junkankitou [Seisaku]-Ippan-001 and H25-Junkankitou [Seisyu]-Ippan-005), and a grant-in-aid for scientific research (C) from the Japan Society for the Promotion of Science (Grant number: 24590837). We sincerely appreciate the members of the Suita Medical Foundation and the Suita City Health Center. We thank all researchers and co-medical staff in the Department of Preventive Cardiology, the National Cerebral and Cardiovascular Center, for their excellent medical examinations and follow-up surveys. We also thank the Satsuki-Junyukai, the society members of the Suita study.	Wannamethee SG, 1999, DIABETES CARE, V22, P1266, DOI 10.2337/diacare.22.8.1266; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; Sugihara M, 2011, INTERNAL MED, V50, P679, DOI 10.2169/internalmedicine.50.4292; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Kokubo Y, 2008, HYPERTENSION, V52, P652, DOI 10.1161/HYPERTENSIONAHA.108.118273; Okamura T, 2009, ATHEROSCLEROSIS, V203, P587, DOI 10.1016/j.atherosclerosis.2008.07.020; Ford ES, 1997, AM J EPIDEMIOL, V146, P214; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Mishra GD, 2007, DIABETES CARE, V30, P1418, DOI 10.2337/dc06-2187; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Watanabe M, 2011, ATHEROSCLEROSIS, V216, P477, DOI 10.1016/j.atherosclerosis.2011.02.033; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Wannamethee SG, 2005, J EPIDEMIOL COMMUN H, V59, P134, DOI 10.1136/jech.2003.015651; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Hadaegh F, 2012, PREV MED, V55, P608, DOI 10.1016/j.ypmed.2012.09.025; HAN TS, 1995, BRIT MED J, V311, P1401; International Diabetes Federation, IDF DIABETES ATLAS; Jacobs-van der Bruggen MAM, 2010, AM J EPIDEMIOL, V172, P263, DOI 10.1093/aje/kwq134; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Ruan Y, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003408; Tanaka S, 2003, ACTA DIABETOL, V40, pS302, DOI 10.1007/s00592-003-0093-z; The Commitee of Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus, 2010, DIABETOL INT, V1, P2	24	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	JUL	2015	25	7					489	495		10.2188/jea.JE20140160		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CL4ZL	WOS:000356967400006		
J	Yamada, K; Mori, N; Kashiwabara, M; Yasuda, S; Horie, R; Yamato, H; Garcon, L; Armada, F				Yamada, Keiko; Mori, Nagisa; Kashiwabara, Mina; Yasuda, Sakiko; Horie, Rumi; Yamato, Hiroshi; Garcon, Loic; Armada, Francisco			Industry Speed Bumps on Local Tobacco Control in Japan? The Case of Hyogo	JOURNAL OF EPIDEMIOLOGY			English	Article						smoking; tobacco smoke pollution; legislation; local government; Japan	STRATEGIES; SMOKING	Background: Despite being a signatory since 2004, Japan has not yet fully implemented Article 8 of the World Health Organization's Framework Convention on Tobacco Control regarding 100% protection against exposure to second-hand smoke (SHS). The Japanese government still recognizes designated smoking rooms (DSRs) in public space as a valid control measure. Furthermore, subnational initiatives for tobacco control in Japan are of limited effectiveness. Through an analysis of the Hyogo initiative in 2012, we identified key barriers to the achievement of a smoke-free environment. Methods: Using a descriptive case-study approach, we analyzed the smoke-free policy development process. The information was obtained from meeting minutes and other gray literature, such as public records, well as key informant interviews. Results: Hyogo Prefecture established a committee to propose measures against SHS, and most committee members agreed with establishing completely smoke-free environments. However, the hospitality sector representatives opposed regulation, and tobacco companies were allowed to make a presentation to the committee. Further, political power shifted against completely smoke-free environments in the context of upcoming local elections, which was an obvious barrier to effective regulation. Throughout the approving process, advocacy by civil society for stronger regulation was weak. Eventually, the ordinance approved by the Prefectural Assembly was even weaker than the committee proposal and included wide exemptions. Conclusions: The analysis of Hyogo's SHS control initiative shed light on three factors that present challenges to implementing tobacco control regulations in Japan, from which other countries can also draw lessons: incomplete national legislation, the weakness of advocacy by the civil society, and the interference of the tobacco industry.	[Yamada, Keiko; Mori, Nagisa; Garcon, Loic; Armada, Francisco] WHO, Ctr Hlth Dev, Kobe, Hyogo, Japan; [Yamada, Keiko] Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Suita, Osaka 5650871, Japan; [Yamada, Keiko] Hyogo Prefectural Govt, Hlth & Welf Dept, Kobe, Hyogo, Japan; [Mori, Nagisa] Univ Tokyo, Grad Sch Med, Dept Social & Prevent Epidemiol, Tokyo, Japan; [Kashiwabara, Mina] WHO, Western Pacific Reg Off, Manila, Philippines; [Yasuda, Sakiko] Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Horie, Rumi] World Bank, Tokyo Dev Learning Ctr, Tokyo, Japan; [Yamato, Hiroshi] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Hlth Dev, Kitakyushu, Fukuoka 807, Japan	Yamada, K (reprint author), Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	keiko-yamada@umin.org					Almaty Sadykova J., 2012, KAZAKHSTAN SMOK FREE; Flyvbjerg B, 2006, QUAL INQ, V12, P219, DOI 10.1177/1077800405284363; Kashiwabara M, 2011, ASIAN PAC J CANCER P, V12, P1909; [Anonymous], 2012, EV ED NIKK NEWSP, P13; Dearlove JV, 2002, TOB CONTROL, V11, P94, DOI 10.1136/tc.11.2.94; Katanoda K, 2014, TOB CONTROL, V23, P359, DOI 10.1136/tobaccocontrol-2012-050852; [Anonymous], 2011, SEC SMOK CANC; Center for Cancer Control and Information Services National Cancer Center Japan, 2014, SMOK RAT PREF COMPR; Feldman EA, 2006, MICHIGAN J INT LAW; Government of Japan, 2011, IND SAF HLTH; Hamel J., 1993, CASE STUDY METHODS Q, V32; Hyogo Medical Association, 2011, COMM OUTL HYOG ORD S; Hyogo Prefecture, 2008, HYOG SURV SEC HAND S; Hyogo Prefecture, 2012, HYOG PREF ASS; Hyogo Prefecture, 2012, STAND COMM HYOG HLTH; Hyogo Prefecture, 2012, 18 HYOG PREFECTURE O; Hyogo Prefecture, 2010, MEMB HYOG PREF CONSU; Hyogo Prefecture, 2012, REC M HYOG PREF CONU; Hyogo Prefecture, 2012, HYOG PREF CONS COMM; Iida K, 2004, LANCET, V363, P1820, DOI 10.1016/S0140-6736(04)16310-1; Kashiwabara Mina, 2011, Indian J Public Health, V55, P234, DOI 10.4103/0019-557X.89937; Levin MA, 1997, STANFORD LAW POL REV, V18, P99; Liberal Democratic Part of Hyogo Prefectural Assembly, 2011, REQ LDP HYOG PREF AS; Ministry of Health Labour and Welfare, 2000, HLTH JAP 21; Schneider NK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-907; The Minister of Health Labour and Welfare, 2011, FUNDS AV INT SMOK SE; Ueda H, 2011, HEALTH POLICY, V102, P49, DOI 10.1016/j.healthpol.2011.05.013; Word Health Organization, 2012, WHO FRAM CONV TOB CO; World Health Organization, 2012, MAK CIT SMOK FREE; World Health Organization, 2007, PROT EXP SEC TOB SMO; World Health Organization, WHO REP GLOB TOB EP; Yin R.K., 2009, CASE STUDY RES DESIG	32	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	JUL	2015	25	7					496	504		10.2188/jea.JE20150001		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CL4ZL	WOS:000356967400007		
J	Nakao, R; Kitagawa, T				Nakao, Ryohei; Kitagawa, Tadao			Differences in the behavior and ecology of wild type medaka (Oryzias latipes complex) and an orange commercial variety (himedaka)	JOURNAL OF EXPERIMENTAL ZOOLOGY PART A-ECOLOGICAL GENETICS AND PHYSIOLOGY			English	Article							GENOME EVOLUTION; NARA PREFECTURE; MALE COLORATION; YAMATO RIVER; MATE CHOICE; POPULATIONS; FISH; GENE; PREFERENCES; SYSTEM	Genetic disturbance in wild populations of medaka (Oryzias latipes complex) has been mainly caused by the introduction of the orange-red commercial variety medaka (himedaka) in Japan. To examine whether survival, reproduction, and species recognition would be influenced by this difference in body coloration, we conducted three laboratory experiments (predatory pressure, mate choice, schooling behavior) using wild type medaka and himedaka. In the predation experiment using dark chub (Candidia temminckii) as a predator, himedaka were predated upon more often than wild type medaka. However, individuals did not choose mates or select schooling groups based on himedaka or wild type medaka phenotypes. The results indicate that himedaka receive higher predation pressure but are able to easily mate with wild type medaka in a natural environment. To conserve the genetic diversity of wild medaka populations, we need to control the risk of genetic disturbance caused by himedaka. J. Exp. Zool. 323A: 349-358, 2015. (c) 2015 Wiley Periodicals, Inc.	[Nakao, Ryohei; Kitagawa, Tadao] Kinki Univ, Grad Sch Agr, Program Environm Management, Nara, Nara 6318505, Japan	Nakao, R (reprint author), Kinki Univ, Grad Sch Agr, Program Environm Management, 3327-204 Nakamachi, Nara, Nara 6318505, Japan.	1344680001h@nara.kindai.ac.jp			Kinki University [SR14]	Grant sponsor: Research Grant of Kinki University; grant number: SR14.	Aki M., 2004, KAGAWA SEIBUTSU, V31, P13; McRobert SP, 1998, ANIM BEHAV, V56, P611, DOI 10.1006/anbe.1998.0846; Ishikawa Y, 2000, BIOESSAYS, V22, P487, DOI 10.1002/(SICI)1521-1878(200005)22:5<487::AID-BIES11>3.3.CO;2-#; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; Aida T, 1921, GENETICS, V6, P554; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.2307/2408316; Oshima Y, 2003, CHEMOSPHERE, V50, P429, DOI 10.1016/S0045-6535(02)00494-0; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Asai T, 2011, ICHTHYOL EXPLOR FRES, V22, P289; Takehana Y, 2003, ZOOL SCI, V20, P1279, DOI 10.2108/zsj.20.1279; Couldridge CKV, 2002, BEHAV ECOL, V13, P59; Egami N., 1989, BIOL OF MEDAKA; Fukamachi S, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-64; Hayakawa Youichi, 2012, Japanese Journal of Ichthyology, V59, P111; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Iwamatsu T, 1994, B AICHI U ED ED SCI, V18, P199; Kawasaki A, 2009, MEM FAC ED KUMAMOTO, V58, P21; Kitagawa T., 2013, GENETIC DISTURBANCE; Kobayashi M, 2012, NIPPON SUISAN GAKK, V78, P922, DOI 10.2331/suisan.78.922; Koya Y, 2002, SCI REP FAC ED GIFU, V26, P19; Koyama Naoto, 2009, Japanese Journal of Ichthyology, V56, P153; Ministry of Environment Japan, 2013, REV RED LIST FRESHW; Nakai Koji, 2011, Japanese Journal of Ichthyology, V58, P189; Naruse K, 2000, GENETICS, V154, P1773; Nature conservation committee of Ichthyological society of Japan, 2013, DOM AL FISH HIDD THR; Partridge B.L., 1982, Scientific American, V246, P90; SAKAIZUMI M, 1983, COPEIA, P311, DOI 10.2307/1444373; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Takehana Yusuke, 2010, Japanese Journal of Ichthyology, V57, P76; Uono T, 2011, J JAPAN SOC WATER EN, V34, P109; Yamamoto T., 1975, MED KILLF BIOL STRAI	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-5223	1932-5231		J EXP ZOOL PART A	J. Exp. Zool. Part A	JUL	2015	323	6					349	358		10.1002/jez.1916		10	Zoology	Zoology	CL3QT	WOS:000356866100003		
J	Horie, Y; Kobayashi, T				Horie, Yoshifumi; Kobayashi, Tohru			Gonadotrophic cells and gonadal sex differentiation in medaka: Characterization of several northern and southern strains	JOURNAL OF EXPERIMENTAL ZOOLOGY PART A-ECOLOGICAL GENETICS AND PHYSIOLOGY			English	Article							GENETICALLY FEMALE MEDAKA; ORYZIAS-LATIPES; HIGH-TEMPERATURE; CAUSES MASCULINIZATION; WILD POPULATIONS; LH CELLS; PITUITARY; EXPRESSION; SUBUNITS; REVERSAL	Gonadotropins play an important role in gametogenesis and reproduction in vertebrates. Their localization in the pituitary during gonadal sex differentiation has been studied mainly in southern (Oryzias latipes) strains of medaka fish, with that in northern medaka (O. sakaizumii) remaining poorly understood. Hence, in this study, we characterized gonadal differentiation and gonadotrophic cells during sex differentiation in two northern strains (HNI and Kaga) and two southern strains (Hd-rR and d-rR/Tokyo). All strains exhibited similar sex differentiation at hatching, such as (1) sex difference in germ cell number (XX>XY), and (2) the transition of XX germ cells into meiosis, and (3) presence of glycoprotein- (Gpa)- positive cells. However, follicle-stimulating hormone- (Fshb)-positive cells were first detected in the pituitary 1 day post-hatching in HNI. Exposure to high-temperature conditions and to cortisol in a dose dependent manner resulted in the localization of Fshb cells in the pituitary at hatching. This study demonstrates differences in gonadotropin subunit expression between northern and southern strains of medaka, and suggests that Fsh is not involved in early gonadal sex differentiation, such as the sex difference in germ cell number, and that high-temperature induce Fshb expression via cortisol production in medaka. J. Exp. Zool. 323A: 392-397, 2015. (c) 2015 Wiley Periodicals, Inc.	[Horie, Yoshifumi] Univ Shizuoka, Grad Sch Integrated Pharmaceut & Nutr Sci, Lab Mol Reprod Biol, Shizuoka 4228526, Japan; [Kobayashi, Tohru] Univ Shizuoka, Inst Environm Sci, Lab Mol Reprod Biol, Shizuoka 4228526, Japan; [Kobayashi, Tohru] Univ Shizuoka, Grad Div Nutr & Environm Sci, Lab Mol Reprod Biol, Shizuoka 4228526, Japan	Kobayashi, T (reprint author), Univ Shizuoka, Inst Environm Sci, Lab Mol Reprod Biol, Shizuoka 4228526, Japan.	tohruk@u-shizuoka-ken.ac.jp			Ministry of Education, Science, Sports and Culture of Japan	Grant sponsor: Grant-in-Aid for Research for Priority Area from the Ministry of Education, Science, Sports and Culture of Japan (T.K).	An KW, 2010, COMP BIOCHEM PHYS A, V156, P407, DOI 10.1016/j.cbpa.2010.03.015; VANDERKRAAK G, 1992, GEN COMP ENDOCR, V85, P217, DOI 10.1016/0016-6480(92)90005-5; STEGER DJ, 1994, MOL CELL BIOL, V14, P5592; Kobayashi H, 2005, ZOOL SCI, V22, P1163, DOI 10.2108/zsj.22.1163; Pandolfi M, 2006, ANAT EMBRYOL, V211, P355, DOI 10.1007/s00429-006-0086-0; Sato T, 2005, ZOOL SCI, V22, P985, DOI 10.2108/zsj.22.985; Shimizu A, 2008, GEN COMP ENDOCR, V156, P312, DOI 10.1016/j.ygcen.2008.01.022; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Asai T, 2011, ICHTHYOL EXPLOR FRES, V22, P289; SAGA T, 1993, GEN COMP ENDOCR, V92, P233, DOI 10.1006/gcen.1993.1159; Selim KM, 2009, AQUACULTURE, V289, P340, DOI 10.1016/j.aquaculture.2008.12.019; SUZUKI K, 1988, GEN COMP ENDOCR, V71, P452, DOI 10.1016/0016-6480(88)90274-2; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Hayashi Y, 2010, MOL REPROD DEV, V77, P679, DOI 10.1002/mrd.21203; Nasonkin IO, 2004, HUM MOL GENET, V13, P2727, DOI 10.1093/hmg/ddh311; Kobayashi T, 2004, DEV DYNAM, V231, P518, DOI 10.1002/dvdy.20158; Zhao LP, 2001, DEVELOPMENT, V128, P147; Chen W., 2012, BIOL REPROD, V86, P1; Horie Y, 2014, GEN COMP ENDOCR, V204, P173, DOI 10.1016/j.ygcen.2014.04.036; Horie Y, 2014, J EXP ZOOL PART A, V321, P472, DOI 10.1002/jez.1879; Kitano T, 2012, MOL REPROD DEV, V79, P19; Kobayashi Y, 2010, BIOL REPROD, V82, P1030, DOI 10.1095/biolreprod.109.080986; Matsuda M, 2015, ZOOLOG SCI IN PRESS; Murozumi N, 2014, ENDOCRINOLOGY, V155, P3136, DOI 10.1210/en.2013-2060; Nica G, 2006, DEV BIOL, V292, P189, DOI 10.1016/j.ydbio.2005.12.036; SAKAIZUMI M, 1983, COPEIA, P311, DOI 10.2307/1444373; SAKAIZUMI M, 1986, GENETICA, V69, P119, DOI 10.1007/BF00115131; Sato T, 2004, TOD INT S MED GEN VE, P72; Yan H, 2012, BIOL REPROD, V87, P1	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-5223	1932-5231		J EXP ZOOL PART A	J. Exp. Zool. Part A	JUL	2015	323	6					392	398		10.1002/jez.1932		7	Zoology	Zoology	CL3QT	WOS:000356866100008		
J	Akiyama, K; Noh, B; Fukano, M; Miyakawa, S; Hirose, N; Fukubayashi, T				Akiyama, Kei; Noh, Byungjoo; Fukano, Mako; Miyakawa, Shumpei; Hirose, Norikazu; Fukubayashi, Toru			Analysis of the talocrural and subtalar joint motions in patients with medial tibial stress syndrome	JOURNAL OF FOOT AND ANKLE RESEARCH			English	Article						Medial tibial stress syndrome; Subtalar joint; Talocrural joint; 3D to 2D registration technique	SHIN SPLINTS; RISK-FACTORS; PES PLANUS; LEG PAIN; RUNNERS; FRACTURE; ANKLE; FOOT; KINEMATICS; KNEE	Background: The rearfoot motion during sports activities in patients with the medial tibial stress syndrome (MTSS) is unknown. This study aimed to investigate the difference in kinematics of the rearfoot in MTSS patients (eight male soccer players) and control participants (eight male soccer players) during a forward step. Methods: Sixteen male soccer players, including eight players with MTSS, participated. Forward step trials were recorded with cineradiographic images obtained at a sampling rate of 60 Hz. Geometric bone models of the tibia and talus/calcaneus were created from computed tomography scans of the distal part of one lower limb. Following a combination of approaches, anatomical coordinate systems were embedded in each bone model. The talocrural joint motion (relative motion of the talus with respect to the tibia) and subtalar joint motion (relative motion of the calcaneus with respect to the talus) were examined. Results: A significantly larger range of internal/external rotation and inversion/eversion motion was observed in the subtalar joint of MTSS patients compared to healthy controls (P < 0.05) from heel contact to heel off. There were no significant differences between the MTSS patients and healthy participants in the ranges of all talocrural joint angles during the forward step. Conclusion: Our results indicate that the range of subtalar joint motion is greater in patients with MTSS during the stance phase of the forward step. The kinematic results obtained of this study may have important clinical implications and add quantitative data to an in vivo database of MTSS patients.	[Akiyama, Kei] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama 3591192, Japan; [Akiyama, Kei] Japan Inst Sports Sci, Sports Sci, Kita Ku, Nishigaoka 1150056, Japan; [Noh, Byungjoo; Miyakawa, Shumpei] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Sports Med, Tsukuba, Ibaraki 3058577, Japan; [Fukano, Mako; Hirose, Norikazu; Fukubayashi, Toru] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama 3591192, Japan	Akiyama, K (reprint author), Waseda Univ, Grad Sch Sport Sci, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan.	k-akisan@suou.waseda.jp					Anderson MW, 1997, RADIOLOGY, V204, P177; VIITASALO JT, 1983, AM J SPORT MED, V11, P125; Milner CE, 2007, CLIN BIOMECH, V22, P697, DOI 10.1016/j.clinbiomech.2007.03.003; Banks SA, 2004, J ARTHROPLASTY, V19, P809, DOI 10.1016/j.arth.2004.04.011; Milner CE, 2006, MED SCI SPORT EXER, V38, P323, DOI 10.1249/01.mss.0000183477.75808.92; Stacoff A, 2000, CLIN BIOMECH, V15, P54, DOI 10.1016/S0268-0033(99)00028-5; Arndt A, 2004, FOOT ANKLE INT, V25, P357; Milner CE, 2006, J BIOMECH, V39, P2819, DOI 10.1016/j.jbiomech.2005.09.022; Korpelainen R, 2001, AM J SPORT MED, V29, P304; BECK BR, 1994, J BONE JOINT SURG AM, V76A, P1057; Pohl MB, 2008, J BIOMECH, V41, P1160, DOI 10.1016/j.jbiomech.2008.02.001; Moen MH, 2009, SPORTS MED, V39, P523, DOI 10.2165/00007256-200939070-00002; Tong JWK, 2013, J ORTHOP SPORT PHYS, V43, P700, DOI 10.2519/jospt.2013.4225; Yamaguchi S, 2009, FOOT ANKLE INT, V30, P361, DOI 10.3113/FAI.2009.0361; Reinschmidt C, 1997, J BIOMECH, V30, P729, DOI 10.1016/S0021-9290(97)00001-8; Newman P, 2012, BRIT J SPORT MED, V46, P861, DOI 10.1136/bjsports-2011-090409; BRODY DM, 1982, ORTHOP CLIN N AM, V13, P541; Yates B, 2004, AM J SPORT MED, V32, P772, DOI 10.1177/0095399703258776; Yagi S, 2013, KNEE SURG SPORT TR A, V21, P556, DOI 10.1007/s00167-012-2160-x; SOMMER HM, 1995, MED SCI SPORT EXER, V27, P800; Batt ME, 1998, MED SCI SPORT EXER, V30, P1564, DOI 10.1097/00005768-199811000-00002; Bennett JE, 2001, J ORTHOP SPORT PHYS, V31, P504; Burne SG, 2004, BRIT J SPORT MED, V38, P441, DOI 10.1136/bjsm.2002.004499; Campbell KJ, 2014, KNEE SURG SPORTS TRA; CLANTON TO, 1994, CLIN SPORT MED, V13, P743; Clement D B, 1974, J Sports Med, V2, P81; Craig DI, 2008, J ATHL TRAINING, V43, P316, DOI 10.4085/1062-6050-43.3.316; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136; Hubbard TJ, 2009, MED SCI SPORT EXER, V41, P490, DOI 10.1249/MSS.0b013e31818b98e6; Komistek RD, 2000, FOOT ANKLE INT, V21, P343; Moen Maarten Hendrik, 2012, Sports Med Arthrosc Rehabil Ther Technol, V4, P12, DOI 10.1186/1758-2555-4-12; MUBARAK SJ, 1982, AM J SPORT MED, V10, P201, DOI 10.1177/036354658201000402; Noh B, 2015, EUR J SPORT SCI, V15, P173, DOI 10.1080/17461391.2014.932848; PICCIANO AM, 1993, J ORTHOP SPORT PHYS, V18, P553; PRICHASUK S, 1994, CLIN ORTHOP RELAT R, P192; PRICHASUK S, 1995, FOOT ANKLE INT, V16, P500; Raissi Golam Reza D, 2009, Sports Med Arthrosc Rehabil Ther Technol, V1, P11, DOI 10.1186/1758-2555-1-11; Reinking MF, 2006, AM J SPORT MED, V34, P1500, DOI 10.1177/0363546506287298; Wearing SC, 1999, J AM PODIAT MED ASSN, V89, P188	39	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-1146			J FOOT ANKLE RES	J. Foot Ankle Res.	JUL 1	2015	8								25	10.1186/s13047-015-0084-7		8	Orthopedics	Orthopedics	CL9OL	WOS:000357307900001		
J	Kim, PJ; Steinberg, JS; Kikuchi, M; Attinger, CE				Kim, Paul J.; Steinberg, John S.; Kikuchi, Mamoru; Attinger, Christopher E.			Tibialis Anterior Tendon Lengthening: Adjunctive Treatment of Plantar Lateral Column Diabetic Foot Ulcers	JOURNAL OF FOOT & ANKLE SURGERY			English	Article						anterior tibial tendon; biomechanics; chronic ulcer; diabetes; pressure; tibialis anterior tendon lengthening	ACHILLES-TENDON; ULCERATION	Tendon lengthening and rebalancing are adjunctive procedures for the treatment of chronic ulcerations in the diabetic foot. For example, the equinus deformity has been implicated as a major deforming force and is surgically treated by lengthening the Achilles tendon. A contracted tibialis anterior tendon can also play a role by potentiating a varus rotational force, increasing the pressures along the lateral column of the forefoot, and resulting in the development or chronicity of an ulceration. We present a novel application of tibialis anterior tendon lengthening for the adjunctive treatment of chronic ulcerations in the diabetic foot. (C) 2015 by the American College of Foot and Ankle Surgeons. All rights reserved.	[Kim, Paul J.; Steinberg, John S.; Attinger, Christopher E.] Georgetown Univ Hosp, Dept Plast Surg, Washington, DC 20007 USA; [Kikuchi, Mamoru] Saga Univ Hosp, Dept Plast Surg, Saga, Japan	Kim, PJ (reprint author), Georgetown Univ Hosp, Dept Plast Surg, 3800 Reservoir Rd Northwest, Washington, DC 20007 USA.	paul.j.kim@gunet.georgetown.edu					Mueller MJ, 2003, J BONE JOINT SURG AM, V85A, P1436; Lavery LA, 1998, ARCH INTERN MED, V158, P157, DOI 10.1001/archinte.158.2.157; Laborde JM, 2007, FOOT ANKLE INT, V28, P1160, DOI 10.3113/FAI.2007.1160; Kearney TP, 2010, DIABETES RES CLIN PR, V89, P224, DOI 10.1016/j.diabres.2010.05.025; Orendurff MS, 2006, J BONE JOINT SURG BR, V88B, P65, DOI 10.1302/0301-620X.88B1.16807; Grant WP, 2005, J AM PODIAT MED ASSN, V95, P242; ARKKILA PET, 1994, J INTERN MED, V236, P215; Reddy GK, 2004, EXP DIABESITY RES, V5, P143, DOI 10.1080/15438600490277860; Laborde JM, 2008, FOOT ANKLE INT, V29, P378, DOI 10.3113/FAI.2008.0378; Armstrong D G, 1996, J Foot Ankle Surg, V35, P585; Boulton AJ, 1983, DIABETES CARE, V16, P26; Hamilton Graham A, 2005, J Foot Ankle Surg, V44, P37, DOI 10.1053/j.jfas.2004.11.001; Holstein P, 2004, DIABETES-METAB RES, V20, pS37, DOI 10.1002/dmrr.452; Kim JY, 2010, FOOT ANKLE INT, V31, P480, DOI 10.3113/FAI.2010.0480; Wicart PR, 2002, J PEDIATR ORTHOPED, V22, P526, DOI 10.1097/01.BPO.0000018997.02445.E0	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1067-2516	1542-2224		J FOOT ANKLE SURG	J. Foot Ankle Surg.	JUL-AUG	2015	54	4					686	691		10.1053/j.jfas.2015.04.006		6	Orthopedics; Surgery	Orthopedics; Surgery	CL3FU	WOS:000356836600031		
J	Kobayashi, H; Kageyama, Y; Shido, Y				Kobayashi, Hayato; Kageyama, Yasunori; Shido, Yoji			Isolated Fifth Metatarsocuboid Coalition: A Case Report	JOURNAL OF FOOT & ANKLE SURGERY			English	Article						arthrodesis; opening wedge distal tibial osteotomy; osteoarthritis; tarsometatarsal coalition; varus ankle	NONOSSEOUS TARSAL COALITION; LOW TIBIAL OSTEOTOMY; METATARSAL JOINT; ARTHRODESIS; OSTEOARTHRITIS; ANKLE	Isolated tarsometatarsal coalitions are extremely rare, and the previous 5 documented cases involved the first and third metatarsocuneiform joints. We report the case of a 69-year-old female with symptomatic fifth metatarsocuboid coalition associated with ipsilateral varus-type ankle osteoarthritis and instability. The patient was successfully treated by arthrodesis of the fifth metatarsocuboid joint, resection of the hypertrophied tuberosity of the fifth metatarsal, advancement of the peroneus brevis tendon, opening wedge distal tibial osteotomy, and calcaneal displacement osteotomy. After 1 year, 6 months, she was able to walk well, although she complained of minor discomfort under the fifth metatarsal base, which resolved with the use of protective padding. Radiographs at this stage confirmed consolidation of both the arthrodesis and the osteotomy sites. Although isolated fifth metatarsocuboid coalition is less likely to be encountered than other tarsal coalitions, it can sometimes be painful enough to necessitate surgery. (C) 2015 by the American College of Foot and Ankle Surgeons. All rights reserved.	[Kobayashi, Hayato] Fujieda Heisei Mem Hosp, Dept Orthopaed Surg, Shizuoka, Japan; [Kageyama, Yasunori] Hamamatsu Minami Hosp, Dept Orthopaed Surg, Shizuoka, Japan; [Shido, Yoji] Hamamatsu Univ Sch Med, Dept Orthopaed Surg, Shizuoka, Japan	Kobayashi, H (reprint author), Fujieda Heisei Mem Hosp, Dept Orthopaed Surg, 123-1 Mizukami, Fujieda, Shizuoka 4268662, Japan.	heisei.kobayasi@ny.tokai.or.jp					Berlet GC, 2002, FOOT ANKLE INT, V23, P440; TAKAKURA Y, 1995, J BONE JOINT SURG BR, V77B, P50; OUZOUNIAN TJ, 1989, FOOT ANKLE, V10, P140; Tanaka Y, 2006, J BONE JOINT SURG BR, V88B, P909, DOI 10.1302/0301-620X.88B7.17325; Kumai T, 1998, FOOT ANKLE INT, V19, P525; DAY FN, 1994, J AM PODIAT MED ASSN, V84, P197; Fujishiro T, 2003, FOOT ANKLE INT, V24, P793; Jacobs A M, 1981, J Foot Surg, V20, P214; Kobayashi H, 2013, ORTHOP SURG, V64, P1001; Komenda GA, 1996, J BONE JOINT SURG AM, V78A, P1665; Steven M, 1996, FOOT ANKLE INT, V17, P286; Kumai T, 1996, FOOT ANKLE INT, V17, P635; Mann RA, 1996, J BONE JOINT SURG AM, V78A, P1376; MIKI T, 1985, CLIN ORTHOP RELAT R, P256; Mirmiran Roya, 2002, J Foot Ankle Surg, V41, P173; MOELLER RR, 1988, J AM PODIAT MED ASSN, V78, P313; PAGE JC, 1987, J AM PODIAT MED ASSN, V77, P29; Park D S, 2000, J Foot Ankle Surg, V39, P239; Sakellariou A, 1999, ORTHOPEDICS, V22, P1066; Stevens BW, 2008, FOOT ANKLE INT, V29, P867, DOI 10.3113/FAI.2008.0867; STORMONT DM, 1983, CLIN ORTHOP RELAT R, P28; Takakura Y, 1999, FOOT ANKLE INT, V20, P815; Tanaka Y, 2000, FOOT ANKLE INT, V21, P1043	23	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1067-2516	1542-2224		J FOOT ANKLE SURG	J. Foot Ankle Surg.	JUL-AUG	2015	54	4					734	738		10.1053/j.jfas.2014.06.030		5	Orthopedics; Surgery	Orthopedics; Surgery	CL3FU	WOS:000356836600041		
J	Fujimoto, J				Fujimoto, Jiro			Highlights of topic "Recent advances in hepato-biliary-pancreatic science"	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Editorial Material									Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan	Fujimoto, J (reprint author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	sfujimo@hyo-med.ac.jp					Seki E, 2015, J HEPATO-BIL-PAN SCI, V22, P512, DOI 10.1002/jhbp.245; Fujimoto J, 2015, J HEPATO-BIL-PAN SCI, V22, P538, DOI 10.1002/jhbp.249; Fukuda A, 2015, J HEPATO-BIL-PAN SCI, V22, P519, DOI 10.1002/jhbp.246; Inagaki NF, 2015, J HEPATO-BIL-PAN SCI, V22, P524, DOI 10.1002/jhbp.247; Kok CYY, 2015, J HEPATO-BIL-PAN SCI, V22, P546, DOI 10.1002/jhbp.250; Tanaka S, 2015, J HEPATO-BIL-PAN SCI, V22, P531, DOI 10.1002/jhbp.248	6	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JUL	2015	22	7					511	511		10.1002/jhbp.251		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CL2XP	WOS:000356811400002		
J	Fukuda, A				Fukuda, Akihisa			Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Cellular origin; Chromatin remodeling; Intraductal papillary mucinous neoplasia; Mouse model; Pancreatic cancer	ONCOGENIC KRAS; CANCER; MUTATIONS; PROGRESSION; EXPRESSION; CARCINOMA; INITIATION; GENES; MOUSE; CELLS	Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal human malignancies. Dissecting the mechanisms underlying PDA development is important for developing early detection methods and effective prevention and therapies for the disease. PDA is considered to arise from distinct precursor lesions, including pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasia (IPMN). However, little is known about molecular mechanisms of development of IPMN and IPMN-derived PDA. We have recently reported that loss of Brg1, a core subunit of SWI/SNF chromatin remodeling complexes, cooperates with oncogenic Kras to form cystic neoplastic lesions that resemble human IPMN and progress to PDA. Brg1 null IPMN-PDA is less lethal compared to PanIN-derived PDA (PanIN-PDA) driven by mutant Kras and hemizygous p53 deletion, mirroring prognostic trends in PDA patients. Brg1 null IPMN-PDA possesses a distinct molecular signature that supports less malignant potential compared to PanIN-PDA. Furthermore, Brg1 deletion inhibits Kras-dependent PanIN development from adult acinar cells, but promotes Kras-driven preneoplastic transformation in adult duct cells. Therefore, Brg1 is a determinant of context-dependent Kras-driven pancreatic tumorigenesis and chromatin remodeling may underlie the development of distinct PDA subsets. Understanding molecular mechanism of IPMN and IPMN-derived PDA could provide critical clues for novel diagnostic and therapeutic strategies of the disease.	Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan	Fukuda, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, 54 Syougoin Kawahara Cho, Kyoto 6068507, Japan.	fukuda26@kuhp.kyoto-u.ac.jp					Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Matthaei H, 2011, NAT REV GASTRO HEPAT, V8, P141, DOI 10.1038/nrgastro.2011.2; Takehara A, 2007, CANCER RES, V67, P9704, DOI 10.1158/0008-5472.CAN-07-2099; Piscuoglio S, 2012, HISTOPATHOLOGY, V60, P397, DOI 10.1111/j.1365-2559.2011.04121.x; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Shi CJ, 2012, HUM PATHOL, V43, P1, DOI 10.1016/j.humpath.2011.04.003; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Masui T, 2001, CLIN CANCER RES, V7, P3437; von Figura G, 2014, NAT CELL BIOL, V16, P255, DOI 10.1038/ncb2916; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Matthaei H, 2012, ANN SURG, V255, P326, DOI 10.1097/SLA.0b013e3182378a18; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Mino-Kenudson M, 2011, GUT, V60, P1712, DOI 10.1136/gut.2010.232272; Poultsides GA, 2010, ANN SURG, V251, P470, DOI 10.1097/SLA.0b013e3181cf8a19; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Dal Molin M, 2012, HUM PATHOL, V43, P585, DOI 10.1016/j.humpath.2011.06.009; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; McKenna ES, 2009, CELL CYCLE, V8, P23, DOI 10.4161/cc.8.1.7290; von Figura G, 2014, GUT, V63, P656, DOI 10.1136/gutjnl-2012-304287; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543	34	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JUL	2015	22	7					519	523		10.1002/jhbp.246		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CL2XP	WOS:000356811400004		
J	Inagaki, NF; Inagaki, FF; Kokudo, N; Miyajima, A				Inagaki, Natsuko F.; Inagaki, Fuyuki F.; Kokudo, Norihiro; Miyajima, Atsushi			Cell-based therapy for preventing postoperative adhesion and promoting regeneration after hepatectomy	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Liver regeneration; Mesothelial cells; Postoperative adhesion	RANDOMIZED CLINICAL-TRIAL; HEPATIC STELLATE CELLS; GROWTH-FACTOR-BETA; CARBOXYMETHYLCELLULOSE MEMBRANE; INTRAABDOMINAL ADHESIONS; ABDOMINAL ADHESIONS; REPEAT HEPATECTOMY; INTERFERON-GAMMA; MESOTHELIAL CELL; RAT MODEL	Postoperative adhesion is a critical clinical issue after almost all abdominal or pelvic surgeries including liver surgery. Postoperative adhesion causes several complications, such as small bowel obstruction and chronic abdominal pain. Furthermore, it makes reoperation much more difficult, leading to increased mortality and morbidity rate. Postoperative adhesion is particularly problematic for repeated hepatectomy, since hepatic malignant neoplasm recurs frequently and repeated hepatectomy is widely used as one of the most curative treatments. Several treatments to reduce postoperative adhesion have been developed, which include laparoscopic surgery, administration of pharmacological agents and use of prophylactic barrier materials. However, none of them are optimal. We have proposed a novel treatment using a cell sheet of fetal liver mesothelial cells (FL-MCs) to prevent postoperative adhesion in a novel mouse model. Besides adhesion, repeated hepatectomy has another serious problem; although the liver has a remarkable ability to regenerate, the recovery of liver mass and function of the remnant liver after multiple repeated hepatectomy is limited. The FL-MC cell sheet enhances proliferation of hepatocytes after hepatectomy by providing growth factors for hepatocytes. Thus the FL-MC sheet could simultaneously solve the two problems associated with repeated hepatectomy.	[Inagaki, Natsuko F.; Miyajima, Atsushi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Inagaki, Fuyuki F.; Kokudo, Norihiro] Univ Tokyo, Hepatobiliary Pancreat Surg Div, Artificial Organ & Transplantat Div, Dept Surg,Grad Sch Med, Tokyo 1130032, Japan	Miyajima, A (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	miyajima@iam.u-tokyo.ac.jp			Rohto	AM is a recipient of a research grant from Rohto.	Ahmad G., 2008, COCHRANE DB SYST REV, V2; Ohashi K, 2014, BRIT J SURG, V101, P398, DOI 10.1002/bjs.9405; Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Lim R, 2009, J GASTROINTEST SURG, V13, P35, DOI 10.1007/s11605-008-0724-3; Shimizu A, 2014, SURG TODAY, V44, P314, DOI 10.1007/s00595-013-0530-8; WILLIAMS RS, 1992, J SURG RES, V52, P65; DEKAN G, 1991, P NATL ACAD SCI USA, V88, P5398, DOI 10.1073/pnas.88.12.5398; Vrijland WW, 2002, ANN SURG, V235, P193, DOI 10.1097/00000658-200202000-00006; Higgins GM, 1931, ARCH PATHOL, V12, P186; Boland GM, 2006, J SURG RES, V132, P3, DOI 10.1016/j.jss.2005.12.002; Wiseman DM, 1999, J REPROD MED, V44, P325; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Kosaka H, 2008, NAT MED, V14, P437, DOI 10.1038/nm1733; Mutsaers SE, 2004, INT J BIOCHEM CELL B, V36, P9, DOI 10.1016/S1357-2725(03)00242-5; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; SPRENGERS ED, 1987, BLOOD, V69, P381; Kaptanoglu L, 2008, EUR SURG RES, V41, P203, DOI 10.1159/000134919; ELIAS D, 1993, BRIT J SURG, V80, P1557, DOI 10.1002/bjs.1800801223; Lim R, 2010, SURGERY, V148, P991, DOI 10.1016/j.surg.2010.01.024; Polymeneas G, 2001, SURG ENDOSC-ULTRAS, V15, P41, DOI 10.1007/s004640000269; Aoki T, 2011, J GASTROINTEST SURG, V15, P1594, DOI 10.1007/s11605-011-1590-y; HARRIS ES, 1995, SURGERY, V117, P663, DOI 10.1016/S0039-6060(95)80010-7; Onitsuka I, 2010, GASTROENTEROLOGY, V138, P1525, DOI 10.1053/j.gastro.2009.12.059; Lower AM, 2004, HUM REPROD, V19, P1877, DOI 10.1093/humrep/deh321; Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4; Li YC, 2013, P NATL ACAD SCI USA, V110, P2324, DOI 10.1073/pnas.1214136110; Holmdahl L, 2001, SURGERY, V129, P626, DOI 10.1067/msy.2001.113039; Sadamori H, 2013, BRIT J SURG, V100, P122, DOI 10.1002/bjs.8957; Dowson HM, 2008, BRIT J SURG, V95, P909, DOI 10.1002/bjs.6211; Irkorucu O, 2009, CLINICS, V64, P143, DOI 10.1590/S1807-59322009000200012; Asahina K, 2009, HEPATOLOGY, V49, P998, DOI 10.1002/hep.22721; Takeda T, 2000, MOL BIOL CELL, V11, P3219; Ray NF, 1998, J AM COLL SURGEONS, V186, P1, DOI 10.1016/S1072-7515(97)00127-0; Cheong YC, 2001, HUM REPROD UPDATE, V7, P556, DOI 10.1093/humupd/7.6.556; Lesurtel M, 2005, ANN SURG, V242, P814, DOI 10.1097/01.sla.0000189121.35617.d7; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Hellebrekers BWJ, 2011, BRIT J SURG, V98, P1503, DOI 10.1002/bjs.7657; Aoki T, 2001, HEPATOL RES, V21, P228, DOI 10.1016/S1386-6346(01)00124-3; Aramaki M, 2000, HEPATO-GASTROENTEROL, V47, P478; Baysal B., 2001, Clinical and Experimental Obstetrics and Gynecology, V28, P126; Binda MM, 2009, SURG ENDOSC, V23, P1018, DOI 10.1007/s00464-008-0111-x; Butte JM, 2015, ANN SURG ONCOL, DOI [10.1245/s10434-015-4370-1, DOI 10.1245/S10434-015-4370-1.]; Chapman GB, 2007, TISSUE CELL, V39, P343, DOI 10.1016/j.tice.2007.06.005; Falk K, 2001, BRIT J SURG, V88, P286, DOI 10.1046/j.1365-2168.2001.01647.x; Falk P, 2000, SCAND J CLIN LAB INV, V60, P439, DOI 10.1080/003655100448419; Hellebrekers BWJ, 2000, FERTIL STERIL, V74, P203, DOI 10.1016/S0015-0282(00)00656-7; Holmdahl Lena, 1999, European Journal of Surgery, V165, P1012; Holmdahl L, 1998, SURGERY, V123, P539, DOI 10.1067/msy.1998.86984; Holmdahl L, 1996, SURGERY, V119, P701, DOI 10.1016/S0039-6060(96)80196-6; Inagaki NF, 2015, J HEPATOL, V62, P1141, DOI 10.1016/j.jhep.2014.12.010; KLING J, 1996, NAT BIOTECHNOL, V14, P572; Kumar S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005080.pub2; Kusunoki M, 2005, SURG TODAY, V35, P940, DOI 10.1007/s00595-005-3061-0; Lucas PA, 1996, J SURG RES, V65, P135, DOI 10.1006/jsre.1996.0355; MENZIES D, 1990, ANN ROY COLL SURG, V72, P60; Mise Y, 2014, ANN SURG, DOI [10.1097/SLA.0000000000000882, DOI 10.1097/SLA.0000000000000882]; Robertson Deborah, 2010, J Obstet Gynaecol Can, V32, P598; RPG tensBroek, 2014, LANCET, V383, P48; Saito S, 2006, J SURG RES, V134, P322, DOI 10.1016/j.jss.2006.01.008; SCOTTCOOMBES DM, 1995, EUR J SURG, V161, P395; Sikirica V, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-13; Tang CL, 2003, DIS COLON RECTUM, V46, P1200, DOI 10.1097/01.DCR.0000080171.54770.86; tensBroek RP, 2013, BMJ-BRIT MED J, V347, pf5588; tensBroek RP, 2013, ANN SURG, V258, P98; van der Krabben AA, 2000, BRIT J SURG, V87, P467, DOI 10.1046/j.1365-2168.2000.01394.x; Zeng QQ, 2007, WORLD J SURG, V31, P2125, DOI 10.1007/s00268-007-9242-9	67	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JUL	2015	22	7					524	530		10.1002/jhbp.247		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CL2XP	WOS:000356811400005		
J	Tanaka, S				Tanaka, Shinji			Cancer stem cells as therapeutic targets of hepato-biliary-pancreatic cancers	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Asymmetric cell division; Epigenetic reprograming; Hedgehog; PI3K; Akt; Wnt	TUMOR-INITIATING CELLS; HEPATOCELLULAR-CARCINOMA CELLS; HUMAN LIVER-CANCER; SELF-RENEWAL; IDENTIFICATION; EXPRESSION; PATHWAY; QUERCETIN; FEATURES; CHOLANGIOCARCINOMA	Heterogeneity is one of the essential hallmarks of malignancies. Within bulk cancer cells, a striking variability differs in biological characteristics including the proliferation rate, cell-cell interaction, metastatic tendency and even sensitivity to anticancer therapies. Such diversity makes the investigation and treatment of the cancers complicated. Increasing evidence suggests this plasticity of cancers is a result of self-renewing and differentiation of a small subpopulation of cancer cells with stem-like properties, called cancer stem cells (CSCs). More importantly, CSCs are believed to be responsible for the resistance to conventional therapies and metastatic abilities in clinical practice. This review summarizes the molecular pathogenesis of hepato-biliary-pancreatic CSCs on the basis of the recent studies, and promising strategy of novel therapy targeting the signal transduction pathways or potentially epigenetic addictions of CSCs.	Tokyo Med & Dent Univ, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138519, Japan	Tanaka, S (reprint author), Tokyo Med & Dent Univ, Dept Mol Oncol, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138519, Japan.	tanaka.monc@tmd.ac.jp			Ministry of Education, Culture, Sports, Science & Technology of Japan; Ministry of Health Labour & Welfare of Japan	I sincerely appreciate the opportunity to write this review article by recommendation of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. I thank all of my colleagues and collaborators at Tokyo Medical and Dental University, Osaka University, Kyushu University, Tokushima University, and Brown Medical School. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Scientific Research (A), Project of Development of Innovative Research on Cancer Therapeutics from Ministry of Education, Culture, Sports, Science & Technology of Japan, and Health & Labour Sciences Research Grant from Ministry of Health Labour & Welfare of Japan.	Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Shukla S, 2014, BBA-GEN SUBJECTS, V1840, P3494, DOI 10.1016/j.bbagen.2014.09.017; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Bailey JM, 2014, GASTROENTEROLOGY, V146, P245, DOI 10.1053/j.gastro.2013.09.050; Tamai K, 2014, CANCER SCI, V105, P667, DOI 10.1111/cas.12406; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Muramatsu S, 2013, HEPATOLOGY, V58, P218, DOI 10.1002/hep.26345; Murakata A, 2011, ANN SURG, V253, P94, DOI 10.1097/SLA.0b013e3181f9bc00; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Adikrisna R, 2012, GASTROENTEROLOGY, V143, P234, DOI 10.1053/j.gastro.2012.03.054; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Gupta PB, 2009, NAT MED, V15, P1010, DOI [10.1038/nm0909-1010, 10.1038/nm.2032]; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Rasheed ZA, 2010, J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Ogawa K, 2014, ANN SURG ONCOL, V21, P1314, DOI 10.1245/s10434-013-3430-7; Shi CJ, 2011, WORLD J GASTROENTERO, V17, P2965, DOI 10.3748/wjg.v17.i24.2965; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Sartelet H, 2012, HISTOPATHOLOGY, V60, P1144, DOI 10.1111/j.1365-2559.2012.04191.x; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Tan SN, 2009, CHEMOTHERAPY, V55, P6, DOI 10.1159/000166383; Min TH, 2011, DEV BIOL, V358, P262, DOI 10.1016/j.ydbio.2011.07.035; Tanaka S, 2012, SEMIN ONCOL, V39, P486, DOI 10.1053/j.seminoncol.2012.05.005; Yin AH, 1997, BLOOD, V90, P5002; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Inaba M, 2012, CELL STEM CELL, V11, P461, DOI 10.1016/j.stem.2012.09.003; Zhao W, 2013, CANCER CELL, V23, P541, DOI 10.1016/j.ccr.2013.02.025; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Lee WJ, 2011, ONCOL REP, V25, P583, DOI 10.3892/or.2010.1097; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Shi CJ, 2010, CANCER BIOL THER, V10, P1183, DOI 10.4161/cbt.10.11.13664; Tanaka S, 1998, P NATL ACAD SCI USA, V95, P10164, DOI 10.1073/pnas.95.17.10164; Tanaka S., 2015, ANN SURG ONCOL, DOI [10.1245/s10434-015-4463-x, DOI 10.1245/S10434-015-4463-X]; Waddington CH, 1957, STRATEGY GENES, P26; Wang M, 2011, INT J CANCER, V128, P72, DOI 10.1002/ijc.25317; Wang YK, 2010, CARCINOGENESIS, V31, P1376, DOI 10.1093/carcin/bgq120; Weimer JM, 2006, NEURON, V49, P3, DOI 10.1016/j.neuron.2005.12.016; YOSHIDA T, 1952, J NATL CANCER I, V12, P947	50	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JUL	2015	22	7					531	537		10.1002/jhbp.248		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CL2XP	WOS:000356811400006		
J	Fujimoto, J; Hai, SK; Hirano, T; Iimuro, Y; Yamanaka, J				Fujimoto, Jiro; Hai, Seikan; Hirano, Tadamichi; Iimuro, Yuji; Yamanaka, Junichi			Anatomic liver resection of right paramedian sector: ventral and dorsal resection	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Anatomic liver resection; Dorsal area; Right paramedian sector; Ventral area	HEPATOCELLULAR-CARCINOMA; HEPATECTOMY SIMULATION; HEPATIC HILUS; TRANSPLANTATION; TRANSECTION; IMPACT	The purpose of anatomic resection of the liver is to systemically eliminate malignant tumors that spread via the portal vein. Moreover, it results in reducing bleeding and bile leakage from the cut surface of the liver because Glisson's pedicle resection leads to parenchyma transection. Anatomical resection includes hemi-hepatectomy, sectionectomy, and segmentectomy. Recently, it has been noticed that this concept is not always appropriate for the liver resection including the right paramedian sector. It can be divided vertically into the ventral and the dorsal area according to the ramification of the third order of the portal veins. In the present study, we focused on the right paramedian sector and described techniques of surgical procedures of hepatectomy including resection of the ventral or dorsal areas.	[Fujimoto, Jiro; Hai, Seikan; Hirano, Tadamichi; Iimuro, Yuji; Yamanaka, Junichi] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan	Fujimoto, J (reprint author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawacho, Nishinomiya, Hyogo 6638501, Japan.	sfujimo@hyo-med.ac.jp					Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; NAKASHIMA T, 1986, SEMIN LIVER DIS, V6, P259, DOI 10.1055/s-2008-1040608; Yamamoto M, 2012, J HEPATO-BIL-PAN SCI, V19, P3, DOI 10.1007/s00534-011-0443-0; Saito S, 2005, HEPATOLOGY, V41, P1297, DOI 10.1002/hep.20684; Yamanaka J, 2006, J HEPATO-BILIARY-PAN, V13, P363, DOI 10.1007/s00534-005-1075-z; Cho A, 2005, AM J SURG, V189, P195, DOI 10.1016/j.amjsurg.2004.04.014; Couinaud C, 1989, SURG ANATOMY LIVER R; HJORTSJO CH, 1951, ACTA ANAT, V11, P599; Kogure K, 2002, ARCH SURG-CHICAGO, V137, P1118, DOI 10.1001/archsurg.137.10.1118; Ryu M, 2009, NEW LIVER ANATOMY: PORTAL SEGMENTATION AND THE DRAINAGE VEIN, P1, DOI 10.1007/978-4-431-95993-9; TAKASAKI K, 1990, INT SURG, V75, P73; Yamamoto M, 2001, SURGERY, V130, P443, DOI 10.1067/msy.2001.116406; Yamanaka J, 2012, J HEPATO-BIL-PAN SCI, V19, P54, DOI 10.1007/s00534-011-0447-9; Yoshida H, 2012, J HEPATO-BIL-PAN SCI, V19, P67, DOI 10.1007/s00534-011-0448-8	14	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JUL	2015	22	7					538	545		10.1002/jhbp.249		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CL2XP	WOS:000356811400007		
J	Kok, CYY; Miyajima, A; Itoh, T				Kok, Cindy Yuet-Yin; Miyajima, Atsushi; Itoh, Tohru			Adaptive remodeling of the biliary tree: the essence of liver progenitor cell expansion	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Ductular reaction; Regeneration; Three-dimensional visualization	INTRAHEPATIC BILE-DUCTS; INJURED MOUSE-LIVER; DUCTULAR REACTIONS; OVAL CELLS; HEPATOCYTES; REGENERATION; MICE; RAT; HETEROGENEITY; FIBROSIS	The liver progenitor cell population has long been thought to exist within the liver. However, there are no standardized criteria for defining the liver progenitor cells, and there has been intense debate about the origin of these cells in the adult liver. The characteristics of such cells vary depending on the disease model used and also on the method of analysis. Visualization of three-dimensional biliary structures has revealed that the emergence of liver progenitor cells essentially reflects the adaptive remodeling of the hepatic biliary network in response to liver injury. We propose that the progenitor cell exists as a subpopulation in the biliary tree and show that the appearance of liver progenitor cells in injured parenchyma is reflective of extensive remodeling of the biliary structure.	[Kok, Cindy Yuet-Yin; Miyajima, Atsushi; Itoh, Tohru] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Bunkyo Ku, Tokyo 1130032, Japan	Itoh, T (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	itohru@iam.u-tokyo.ac.jp			JSPS Kakenhi [2503750]	We thank Dr Kota Kaneko for help in preparing the figures. Cindy Kok is an International Research Fellow of the Japan Society for the Promotion of Science and was supported by JSPS Kakenhi (grant #2503750).	Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Kanno N, 2000, HEPATOLOGY, V31, P555, DOI 10.1002/hep.510310302; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; FARBER E, 1956, CANCER RES, V16, P142; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Itoh T, 2014, HEPATOLOGY, V59, P1617, DOI 10.1002/hep.26753; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Yeh CN, 2004, CARCINOGENESIS, V25, P631, DOI 10.1093/carcin/bgh037; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Pritchard MT, 2010, AM J PATHOL, V176, P2743, DOI 10.2353/ajpath.2010.091186; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Sekiya S, 2014, AM J PATHOL, V184, P1468, DOI 10.1016/j.ajpath.2014.01.005; Dumble ML, 2002, CARCINOGENESIS, V23, P435, DOI 10.1093/carcin/23.3.435; Jelnes P, 2007, HEPATOLOGY, V45, P1462, DOI 10.1002/hep.21569; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Sparks EE, 2010, HEPATOLOGY, V51, P1391, DOI 10.1002/hep.23431; Kaneko K, 2015, HEPATOLOGY, V61, P2056, DOI 10.1002/hep.27685; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Alpini G, 1997, AM J PHYSIOL-GASTR L, V272, pG1064; Choi TY, 2014, GASTROENTEROLOGY, V146, P776, DOI 10.1053/j.gastro.2013.10.019; Clouston AD, 2009, HEPATOLOGY, V49, P1424, DOI 10.1002/hep.22893; Craig CEH, 2004, SEMIN LIVER DIS, V24, P49; Masyuk TV, 2003, AM J PATHOL, V162, P1175, DOI 10.1016/S0002-9440(10)63913-2; Nagahama Y, 2014, AM J PATHOL, V184, P3001, DOI 10.1016/j.ajpath.2014.07.005; POPPER HANS, 1957, JOUR MT SINAI HOSP, V24, P551; Rodrigo-Torres D, 2014, HEPATOLOGY, V60, P1367, DOI 10.1002/hep.27078; Sell S, 2003, INT J BIOCHEM CELL B, V35, P267, DOI 10.1016/S1357-2725(02)00182-6; Takashima Y, 2015, HEPATOLOGY, V61, P1003, DOI 10.1002/hep.27436; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008	32	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JUL	2015	22	7					546	550		10.1002/jhbp.250		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CL2XP	WOS:000356811400008		
J	Kurata, M; Honda, G; Okuda, Y; Kobayashi, S; Sakamoto, K; Iwasaki, S; Chiba, K; Tabata, T; Kuruma, S; Kamisawa, T				Kurata, Masanao; Honda, Goro; Okuda, Yukihiro; Kobayashi, Shin; Sakamoto, Katsunori; Iwasaki, Susumu; Chiba, Kazuro; Tabata, Taku; Kuruma, Sawako; Kamisawa, Terumi			Preoperative detection and handling of aberrant right posterior sectoral hepatic duct during laparoscopic cholecystectomy	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Aberrant hepatic duct; Bile duct injury; Infraportal right posterior sectoral hepatic duct; Laparoscopic cholecystectomy	INTRAOPERATIVE CHOLANGIOGRAPHY; BILE-DUCTS; INJURY; COMPLICATIONS; RISK	BackgroundAn aberrant right posterior sectoral hepatic duct (PHD) draining into extrahepatic bile duct, gallbladder or cystic duct directly is a common and critical anomaly during cholecystectomy. This study aimed to investigate the frequency of aberrant PHD and describe why PHD is critical. MethodsIn 753 consecutive patients who underwent laparoscopic cholecystectomy (LC) using our standardized procedure over 9years, we reinvestigated whether an aberrant PHD was present using preoperative images. A PHD joining the common bile duct through the cranial side of the hilar plate was defined as the supraportal type, and one passing through the caudal side of the right portal vein was defined as the infraportal type. ResultsFifty-one (6.8%) patients had aberrant PHD. All of them had the infraportal type, and the cystic duct drained into aberrant PHD in 10 (1.3%) and aberrant PHD drained into the cystic duct in six (0.8%). These 16 most dangerous anomalies were diagnosed before surgery. In all patients with aberrant PHD, LC was completed without any complications. ConclusionsIt seems possible to identify most aberrant PHD by attention to the infraportal-type PHD, and injury to them can be avoided by exposing a critical view using an appropriate procedure.	[Kurata, Masanao; Honda, Goro; Okuda, Yukihiro; Kobayashi, Shin; Sakamoto, Katsunori] Komagome Hosp, Dept Surg, Tokyo Metropolitan Canc & Infect Dis Ctr, Bunkyo Ku, Tokyo 1138677, Japan; [Iwasaki, Susumu; Chiba, Kazuro; Tabata, Taku; Kuruma, Sawako; Kamisawa, Terumi] Komagome Hosp, Dept Internal Med, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo 1138677, Japan	Honda, G (reprint author), Komagome Hosp, Dept Surg, Tokyo Metropolitan Canc & Infect Dis Ctr, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	ghon@cick.jp					Kitami M, 2006, RADIOLOGY, V238, P156, DOI 10.1148/radiol.2381041783; Hugh TB, 2002, SURGERY, V132, P826, DOI 10.1067/msy.2002.127681; Adamsen S, 1997, J AM COLL SURGEONS, V184, P571; Way LW, 2003, ANN SURG, V237, P460, DOI 10.1097/00000658-200304000-00004; Giger UF, 2006, J AM COLL SURGEONS, V203, P723, DOI 10.1016/j.jamcollsurg.2006.07.018; Suhocki PV, 1999, AM J ROENTGENOL, V172, P955; Fletcher DR, 1999, ANN SURG, V229, P449, DOI 10.1097/00000658-199904000-00001; Ludwig K, 2002, SURG ENDOSC, V16, P1098, DOI 10.1007/s00464-001-9183-6; Grbas H, 2013, HEPATO-GASTROENTEROL, V60, P1873, DOI 10.5754/hge.121136; Ohkubo M, 2004, ANN SURG, V239, P82, DOI 10.1097/01.sla.0000102934.93029.89; Flum DR, 2003, JAMA-J AM MED ASSOC, V289, P1639, DOI 10.1001/jama.289.13.1639; Hisatsugu T, 1974, RINSHOU SEIJINBYOU, V4, P581; HJORTSJO CH, 1951, ACTA ANAT, V11, P599; Honda G, 2010, ASIAN J ENDOSC SURG, V3, P192; Honda G, 2009, J HEPATO-BILIARY-PAN, V16, P445, DOI 10.1007/s00534-009-0060-3; Honda G, 2008, J HEPATO-BILIARY-PAN, V15, P293, DOI 10.1007/s00534-007-1260-3; Kullman E, 1996, BRIT J SURG, V83, P171, DOI 10.1046/j.1365-2168.1996.02190.x; Kurata M, 2011, NIPPON SHOUKAKIGEKA, V44, P1411; Lau WY, 2010, ANZ J SURG, V80, P75, DOI 10.1111/j.1445-2197.2009.05205.x; Seibert D, 1996, SURG LAPAROSC ENDOSC, V6, P61, DOI 10.1097/00019509-199602000-00014	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JUL	2015	22	7					558	562		10.1002/jhbp.252		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CL2XP	WOS:000356811400010		
J	Sho, M; Akahori, T; Tanaka, T; Kinoshita, S; Nagai, M; Tamamoto, T; Ohbayashi, C; Hasegawa, M; Kichikawa, K; Nakajima, Y				Sho, Masayuki; Akahori, Takahiro; Tanaka, Toshihiro; Kinoshita, Shoichi; Nagai, Minako; Tamamoto, Tetsuro; Ohbayashi, Chiho; Hasegawa, Masatoshi; Kichikawa, Kimihiko; Nakajima, Yoshiyuki			Importance of resectability status in neoadjuvant treatment for pancreatic cancer	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Adjuvant treatment; Borderline resectable; Neoadjuvant treatment; Pancreatic cancer; Surgery	RANDOMIZED PHASE-III; PREOPERATIVE CHEMORADIATION; ADJUVANT CHEMOTHERAPY; DUCTAL ADENOCARCINOMA; PLUS GEMCITABINE; SURVIVAL; THERAPY; TRIAL; SURGERY; S-1	BackgroundMuch attention has been paid to neoadjuvant treatment (NAT) as a new strategy especially for borderline resectable pancreatic cancer (BRPC). However, the optimal indication of NAT remains undetermined. MethodsWe analyzed 248 patients with pancreatic cancer (PC). One hundred resectable tumors were classified as R group. Sixty-nine tumors with venous involvement were classified as BR-P group, while 31 tumors with arterial involvement were classified as BR-A group. Ninety-nine patients received NAT. Furthermore, 48 unresectable locally advanced PC served as controls (LAPC group). Among them, 11 patients received adjuvant surgery afterwards (Ad-surg group). ResultsThe overall median survival time in the R, BR-P and BR-A groups was 45.3, 24.8 and 16.8months. In the R and BR-P groups, patients treated with NAT had a better prognosis than those without. In contrast, NAT had no impact on prognosis in the BR-A group. Patients treated with NAT in the BR-P, but not BR-A group, had a better prognosis than patients in the LAPC group. Furthermore, patients in the Ad-surg group had a significantly better prognosis than patients in the BR-A group. ConclusionsBorderline resectable pancreatic cancer with venous involvement, but without arterial involvement, may be a good indication for NAT. Our data highlight the importance of preoperative resectability assessment to evaluate the indication and efficacy of NAT.	[Sho, Masayuki; Akahori, Takahiro; Kinoshita, Shoichi; Nagai, Minako; Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 6348522, Japan; [Tanaka, Toshihiro; Kichikawa, Kimihiko] Nara Med Univ, Dept Radiol, Kashihara, Nara 6348522, Japan; [Tamamoto, Tetsuro; Hasegawa, Masatoshi] Nara Med Univ, Dept Radiat Oncol, Kashihara, Nara 6348522, Japan; [Ohbayashi, Chiho] Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara 6348522, Japan	Sho, M (reprint author), Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	m-sho@naramed-u.ac.jp			Nara Medical University	This study was partly supported by Nara Medical University Grant-in-Aid for Collaborative Research Projects.	Katz MHG, 2013, ANN SURG ONCOL, V20, P2787, DOI 10.1245/s10434-013-2886-9; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Schnelldorfer T, 2008, ANN SURG, V247, P456, DOI 10.1097/SLA.0b013e3181613142; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Ueno H, 2009, BRIT J CANCER, V101, P908, DOI 10.1038/sj.bjc.6605256; Laurence JM, 2011, J GASTROINTEST SURG, V15, P2059, DOI 10.1007/s11605-011-1659-7; Takahashi H, 2011, SURGERY, V150, P547, DOI 10.1016/j.surg.2011.03.001; Truty MJ, 2012, J AM COLL SURGEONS, V215, P41, DOI 10.1016/j.jamcollsurg.2012.03.024; Ma JM, 2013, JNCI-J NATL CANCER I, V105, P1694, DOI 10.1093/jnci/djt292; Ferrone CR, 2008, J GASTROINTEST SURG, V12, P701, DOI 10.1007/s11605-007-0384-8; Landry J, 2010, J SURG ONCOL, V101, P587, DOI 10.1002/jso.21527; Cheng TY, 2006, ANN SURG ONCOL, V13, P66, DOI 10.1245/ASO.2006.02.003; Tempero MA, 2014, J NATL COMPR CANC NE, V12, P1083; Motoi F, 2013, ANN SURG ONCOL, V20, P3794, DOI 10.1245/s10434-013-3129-9; Heinemann V, 2013, ANN ONCOL, V24, P2484, DOI 10.1093/annonc/mdt239; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Sho M, 2011, J HEPATO-BIL-PAN SCI, V18, P235, DOI 10.1007/s00534-010-0336-7; Bockhorn M, 2014, SURGERY, V155, P977, DOI 10.1016/j.surg.2014.02.001; Rose JB, 2014, ANN SURG ONCOL, V21, P1530, DOI 10.1245/s10434-014-3486-z; Valle JW, 2014, J CLIN ONCOL, V32, P504, DOI 10.1200/JCO.2013.50.7657; Egawa S, 2012, PANCREAS, V41, P985, DOI 10.1097/MPA.0b013e318258055c; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Takahashi H, 2013, ANN SURG, V258, P1040, DOI 10.1097/SLA.0b013e31829b3ce4; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Patel M, 2011, J SURG ONCOL, V104, P155, DOI 10.1002/jso.21954; Paulson AS, 2013, GASTROENTEROLOGY, V144, P1316, DOI 10.1053/j.gastro.2013.01.078; Araujo RLC, 2013, HPB, V15, P574, DOI 10.1111/hpb.12033; Blazer M, 2015, ANN SURG ONCOL, V22, P1153, DOI 10.1245/s10434-014-4225-1; Festa Virginia, 2013, JOP, V14, P618, DOI 10.6092/1590-8577/1724; Heinrich S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-346; Kato K, 2009, PANCREAS, V38, P605, DOI 10.1097/MPA.0b013e3181a4891d; Katz MHG, 2014, SEMIN RADIAT ONCOL, V24, P105, DOI 10.1016/j.semradonc.2013.11.006; McClaine RJ, 2009, HPB OXFORD, V12, P73; Polistina F, 2014, WORLD J GASTROENTERO, V20, P9374, DOI 10.3748/wjg.v20.i28.9374; Sahora K, 2011, WORLD J SURG, V35, P1580, DOI 10.1007/s00268-011-1113-8; Satoi S, 2013, J HEPATO-BIL-PAN SCI, V20, P590, DOI 10.1007/s00534-013-0616-0; Sherman WH, 2015, CANCER-AM CANCER SOC, V121, P673, DOI 10.1002/cncr.29112; Sho M, 2011, HPB OXFORD, V18, P9; Sho M, 2013, J HEPATO-BIL-PAN SCI, V20, P197, DOI 10.1007/s00534-012-0532-8; Sutton JM, 2014, WORLD J GASTROENTERO, V20, P15564, DOI 10.3748/wjg.v20.i42.15564; Yanagimoto H, 2014, J HEPATO-BIL-PAN SCI, V21, P761, DOI 10.1002/jhbp.130	41	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JUL	2015	22	7					563	570		10.1002/jhbp.258		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CL2XP	WOS:000356811400011		
J	Kawakami, H; Kuwatani, M; Kawahata, S				Kawakami, Hiroshi; Kuwatani, Masaki; Kawahata, Shuhei			Peroral ultra-slim endoscopy-guided biliary drainage and stone extraction for postoperative upper gastrointestinal stenosis with a naive papilla (with videos)	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Acute cholangitis; Bile duct stone; Surgically altered anatomy; Ultra-slim endoscopy; Ultrathin endoscopy	ACUTE CHOLANGITIS		[Kawakami, Hiroshi; Kawahata, Shuhei] Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Kuwatani, Masaki] Hokkaido Univ Hosp, Div Endoscopy, Sapporo, Hokkaido 0608648, Japan	Kawakami, H (reprint author), Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Kita Ku, Kita 14,Nishi 5, Sapporo, Hokkaido 0608648, Japan.	hiropon@med.hokudai.ac.jp					Itoi T, 2008, GASTROINTEST ENDOSC, V68, P84, DOI 10.1016/j.gie.2007.11.050; Kawakami H, 2015, ENDOSCOPY, V47, pE43, DOI 10.1055/s-0034-1391258; Lee YN, 2013, J GASTROEN HEPATOL, V28, P739, DOI 10.1111/jgh.12105; Mori A, 2006, J GASTROENTEROL, V41, P1237, DOI 10.1007/s00535-006-1911-1	4	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	JUL	2015	22	7					571	572		10.1002/jhbp.253		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CL2XP	WOS:000356811400012		
J	Takai, M; Thaung-Htike; Zin-Maung-Maung-Thein; Soe, AN; Maung, M; Tsubamoto, T; Egi, N; Nishimura, TD; Nishioka, Y				Takai, Masanaru; Thaung-Htike; Zin-Maung-Maung-Thein; Soe, Aung Naing; Maung, Maung; Tsubamoto, Takehisa; Egi, Naoko; Nishimura, Takeshi D.; Nishioka, Yuichiro			First discovery of colobine fossils from the Late Miocene/Early Pliocene in central Myanmar	JOURNAL OF HUMAN EVOLUTION			English	Article						Colobinae; Cercopithecidae; Irrawaddy sediments; Myanmarcolobus; Late Neogene; Southeast Asia	OLD-WORLD MONKEYS; MIDDLE PLEISTOCENE; CERCOPITHECIDAE; PRIMATES; MAMMALIA; KENYA; HISTORY; EURASIA; RUSSIA; JAPAN	Here we report two kinds of colobine fossils discovered from the latest Miocene/Early Pliocene Irrawaddy sediments of the Chaingzauk area, central Myanmar. A left mandibular corpus fragment preserving M1-3 is named as a new genus and species, Myanmarcolobus yawensis. Isolated upper (M-1?) and lower (M-2) molars are tentatively identified as Colobinae gen. et sp. indet. Although both forms are medium-sized colobines, they are quite different from each other in M-2 morphology. The isolated teeth of the latter show typical colobine-type features, so it is difficult to identify their taxonomic position, whereas lower molars of Myanmarcolobus have unique features, such as a trapezoid-shaped long median lingual notch, a deeply concave median buccal cleft, a strongly developed mesiobuccal notch, and rather obliquely running transverse lophids. Compared with fossil and living Eurasian colobine genera, Myanmarcolobus is most similar in lower molar morphology to the Pliocene Dolichopithecus of Europe rather than to any Asian forms. In Dolichopithecus, however, the tooth size is much larger and the median lingual notch is mesiodistally much shorter than that of Myanmarcolobus. The discovery of Myanmarcolobus in central Myanmar is the oldest fossil record in Southeast Asia not only of colobine but also of cercopithecid monkeys and raises many questions regarding the evolutionary history of Asian colobine monkeys. (C) 2015 Elsevier Ltd. All rights reserved.	[Takai, Masanaru; Egi, Naoko; Nishimura, Takeshi D.; Nishioka, Yuichiro] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan; [Thaung-Htike] Shwebo Univ, Shwebo, Myanmar; [Zin-Maung-Maung-Thein] Mandalay Univ, Mandalay, Myanmar; [Soe, Aung Naing] Def Serv Acad, Pyin Oo Lwin, Myanmar; [Maung, Maung] Magway Univ, Magway, Myanmar; [Tsubamoto, Takehisa] Hayashibara Museum Nat Sci, Setouchi 7014212, Japan	Takai, M (reprint author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan.	takai.masanaru.2s@kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Tokyo (MEXT) [16405018, 20405015, 26304019]	We are grateful to Aung-Aung-Kyaw, Hla-Shwe, Myat-Swe, Kyaw Myo Win, Kyaw Soe Win, Zin-Oo, Kyaw Khaing and many other staff of the Department of Archaeology, Ministry of Culture, Myanmar for their help in our paleontological studies in Myanmar, and also all research members who participated in the field works in Myanmar. We thank E. Delson (AMNH); M. Pickford, B. Senut, P. Tassy, and C. Sagne (MNHN); Changzhu Jin and Yingqi Zhang (IVPP); Baoguo Li and Xiaoguang Qi (Northwest University, Xi'an, China); D. Shimizu and Y. Shintaku (JMC); J. de Vos and R. van Zelst (National Natuurhistorisch Museum, Leiden, Netherlands); R. Kruszynski and P. Jenkins (BMNH); E.V. Maschenko (PIN); Lim Kok Peng Kelvin (National University of Singapore, Singapore); and C. Nahallage (University of Sri Jayewardenepura, Sri Lanka) for graciously providing access to the specimens examined at their respective institutions. We thank the reviewers (E. Delson and an anonymous reviewer), Associate Editor, and JHE Editor for helpful comments and suggestions on a previous version of this paper. E. Delson kindly provided us with the casts of European colobine fossils and measurements data of PRIMO (Primate Morphometrics Online, the NYCEP Primate Morphometric database). Financial supports were provided by the Ministry of Education, Culture, Sports, Science and Technology, Tokyo (MEXT): Grants-in-Aid for Scientific Research to M.T. (Nos. 16405018, 20405015 and 26304019).	Andrews P., 1996, P168; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; [Anonymous], 2007, AM J PHYS ANTHRO S44; Jin CZ, 2009, CHINESE SCI BULL, V54, P788, DOI 10.1007/s11434-008-0531-y; Jablonski NG, 2011, AM J PHYS ANTHROPOL, V144, P174; DELSON E, 1975, CONTRIB PRIMATOL, V5, P167; Ji XP, 2013, CHINESE SCI BULL, V58, P3771, DOI 10.1007/s11434-013-6021-x; Roos C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-77; Sterner KN, 2006, MOL PHYLOGENET EVOL, V40, P1, DOI 10.1016/j.ympev.2006.01.017; COLBERT EH, 1953, B AM MUS NAT HIST, V102, P1; Takai M, 2014, QUATERN INT, V354, P75, DOI 10.1016/j.quaint.2014.02.021; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; Jablonski NG, 2002, CAM S BIO EVOL ANTHR, V33, P255; Gu Yumin, 1996, Vertebrata Palasiatica, V34, P235; Tsubamoto T, 2012, J VERTEBR PALEONTOL, V32, P956, DOI 10.1080/02724634.2012.670176; Badgley C, 2008, P NATL ACAD SCI USA, V105, P12145, DOI 10.1073/pnas.0805592105; Tougard C, 2001, PALAEOGEOGR PALAEOCL, V168, P337, DOI 10.1016/S0031-0182(00)00243-1; Delson E, 2005, GEODIVERSITAS, V27, P159; Barry J. C., 1987, HUMAN EVOLUTION, V2, P47, DOI 10.1007/BF02436530; BENDER F., 1983, GEOLOGY OF BURMA; BENEFIT BR, 1986, AM J PHYS ANTHROPOL, V69, P441, DOI 10.1002/ajpa.1330690404; Borissoglebskaya M.B, 1981, T SOVMESTNOI SOVETSK, P97; Chang CH, 2012, J HUM EVOL, V63, P439, DOI 10.1016/j.jhevol.2012.03.005; Chhibber H.L, 1934, GEOLOGY OF BURMA; Colbert E.H., 1935, T AM PHILOS SOC, V26, P1, DOI DOI 10.2307/1005467; Colbert EH, 1938, B AM MUS NAT HIST, V74, P259; Colbert Edwin H., 1943, TRANS AMER PHIL SOC, V32, P395; Cotter G.D.P, 1938, MEMOIRS GEOLOGICAL S, V72, P1; Delson Eric, 1994, P11; Delson E., 1980, P10; Delson E., 1996, INT S EV AS PRIM, P40; Egi N, 2007, ANTHROPOL SCI, V115, P107, DOI 10.1537/ase.061008; Falconer H., 1837, J ASIATIC SOC BENGAL, V6, P354; Fleagle JG, 2013, PRIMATE ADAPTATION AND EVOLUTION, 3RD EDITION, P1; Heintz E., 1981, International Journal of Primatology, V2, P273, DOI 10.1007/BF02739335; Iwamoto M, 2005, ANTHROPOL SCI, V113, P123, DOI 10.1537/ase.04S017; Jablonski NG, 1999, INT J PRIMATOL, V20, P319, DOI 10.1023/A:1020544519463; Kalmykov N.P., 1992, PALEONTOL J, V26, P178; KOUFOS GD, 1991, J HUM EVOL, V21, P283, DOI 10.1016/0047-2484(91)90109-9; Lydekker R., 1878, RECORDS GEOLOGICAL S, V11, P64; Maschenko EN, 2005, ANTHROPOL SCI, V113, P103, DOI 10.1537/ase.04S015; Maschenko E.N., 1991, B MOSK OB VA ISPYT P, V66, P61; MATTHEW W. D., 1929, BULL AMER MUS NAT HIST, V56, P437; Meijaard E, 2006, DEV PRIMATOL, P305, DOI 10.1007/0-387-31710-4_11; Nakatsukasa M, 2010, AM J PHYS ANTHROPOL, V143, P365, DOI 10.1002/ajpa.21327; Nishimura TD, 2007, J HUM EVOL, V52, P637, DOI 10.1016/j.jhevol.2006.12.004; Nishimura TD, 2012, J HUM EVOL, V62, P548, DOI 10.1016/j.jhevol.2012.02.006; Nishioka Y, 2011, J VERTEBR PALEONTOL, V31, P919, DOI 10.1080/02724634.2011.580809; Nishioka Y, 2015, J SYST PALAEONTOL, V13, P287, DOI 10.1080/14772019.2014.909537; Nishioka Y., 2013, THESIS KYOTO U; Ogino S, 2011, J ASIAN EARTH SCI, V42, P408, DOI 10.1016/j.jseaes.2011.05.017; Osterholz M., 2008, BMC EVOL BIOL, V8, P1; Pickford M., 1988, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V12, P1; Pilgrim G. E., 1939, PALAEONTOLOGIA INDIC, V26, P1; Pilgrim G. E., 1915, Records of the Geological Survey of India Calcutta, V45; Pilgrim Guy E., 1910, Records of the Geological Survey of India Calcutta, V40; Rossie JB, 2013, P NATL ACAD SCI USA, V110, P5818, DOI 10.1073/pnas.1213691110; Simons E.L., 1970, OLD WORLD MONKEYS EV, P99; Spassov N, 2007, J HUM EVOL, V52, P434, DOI 10.1016/j.jhevol.2006.11.002; Springer M.S., 2012, PLOS ONE, V7; Stamp LD, 1922, GEOL MAG, V59, P481, DOI 10.1017/S001675680010915X; Szalay F., 1979, EVOLUTIONARY HIST PR; Takai M, 2008, QUATERN INT, V179, P108, DOI 10.1016/j.quaint.2007.10.012; Takai M., 2006, ASIAN PALEOPRIMATOLO, V4, P143; Zin-Maung-Maung-Thein, 2011, PALAEOGEOGR PALAEOCL, V300, P11, DOI 10.1016/j.palaeo.2010.11.016; Takai M., 2012, ANTHROPOL SCI, V120, P274; Takai M., 2009, ASIAN PALEOPRIMATOL, V5, P1; Zin-Maung-Maung-Thein, 2010, J ASIAN EARTH SCI, V37, P154, DOI 10.1016/j.jseaes.2009.08.009; Takai M., 2015, HIST BIOL IN PRESS; Thaung-Htike, 2008, U RES J, V1, P65; Thaung-Htike, 2007, Paleontological Research, V11, P307, DOI 10.2517/1342-8144(2007)11[307:NSOLTM]2.0.CO;2; Thaung-Htike, 2008, THESIS KYOTO U; Trofimov B.A., 1977, J PALEONTOLOGICAL SO, V20, P26; Thaung-Htike, 2005, Paleontological Research, V9, P243, DOI 10.2517/prpsj.9.243; van der Made J, 1999, T ROY SOC EDIN-EARTH, V89, P199; Wandrey C.J., 2006, US GEOLOGICAL SURVEY, P1; Williams FJ, 2011, STAND, V10, P26; Zin-Maung-Maung-Thein, 2010, THESIS KYOTO U	78	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0047-2484			J HUM EVOL	J. Hum. Evol.	JUL	2015	84						1	15		10.1016/j.jhevol.2015.04.003		15	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CL5EG	WOS:000356982000001		
J	Shimizu, T; Azuma, T				Shimizu, Takeyuki; Azuma, Takachika			Detection and isolation of anti-hapten antibody-secreting cells by cellular affinity matrix technology	JOURNAL OF IMMUNOLOGICAL METHODS			English	Article						Antibody; Plasma cells; Affinity matrix; Hapten; Flow cytometry	MEMORY B-CELLS; PLASMA-CELLS; CYTOKINE SECRETION; SECONDARY RESPONSE; NP ANTIBODIES; C57BL/6 MICE; ANTIGEN; MATURATION; GENERATION; ENRICHMENT	We developed a method to detect and isolate plasma cells that produce antigen-specific antibodies. An affinity matrix of hapten was constructed on a cell surface, and subsequent incubation allowed cells to secrete antibodies. Anti-hapten antibodies preferentially bound to the affinity matrix on the cells from which they were secreted. We showed that the combination of surface biotinylation and streptavidin which was conjugated with a high valence of hapten was suitable for sensitive detection of antibody binding. Using this protocol, anti-hapten plasma cells from immunized mouse spleen were detected and enriched by flow cytometry. This method allows for isolation of intact plasma cells according to the antibody specificity and may be useful for highly efficient and precise analysis of an antibody repertoire. (C) 2015 Elsevier B.V. All rights reserved.	[Shimizu, Takeyuki] Kochi Univ, Kochi Med Sch, Dept Immunol, Nankoku, Kochi 7838505, Japan; [Azuma, Takachika] Tokyo Univ Sci, RIBS, Lab Struct Immunol, Div Bioinformat, Noda, Chiba 2780022, Japan	Shimizu, T (reprint author), Kochi Univ, Kochi Med Sch, Dept Immunol, Nankoku, Kochi 7838505, Japan.	tshimizu@kochi-u.ac.jp; tazuma@rs.nodatus.ac.jp			Japan Society for the Promotion of Science [23570169]	We thank Dr. K. Udaka for helpful discussion and support. We also thank Dr. W. Campbell for English editing. This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI Grant Number 23570169 to T.S.) from the Japan Society for the Promotion of Science.	CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Takemori T, 2014, EUR J IMMUNOL, V44, P1258, DOI 10.1002/eji.201343716; Nishimura M, 2011, INT IMMUNOL, V23, P271, DOI 10.1093/intimm/dxr002; Tuaillon E, 2006, J IMMUNOL METHODS, V315, P144, DOI 10.1016/j.jim.2006.07.016; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Brosterhus H, 1999, EUR J IMMUNOL, V29, P4053, DOI 10.1002/(SICI)1521-4141(199912)29:12<4053::AID-IMMU4053>3.0.CO;2-C; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; MANZ R, 1995, P NATL ACAD SCI USA, V92, P1921, DOI 10.1073/pnas.92.6.1921; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; Eisen HN, 2014, CANCER IMMUNOL RES, V2, P381, DOI 10.1158/2326-6066.CIR-14-0029; Clargo AM, 2014, MABS-AUSTIN, V6, P143, DOI 10.4161/mabs.27044; Erkes DA, 2014, J IMMUNOL RES, DOI 10.1155/2014/175265; Campbell JDM, 2003, METHODS, V31, P150, DOI 10.1016/S1046-2023(03)00125-7; Carroll S, 2005, J IMMUNOL METHODS, V296, P171, DOI 10.1016/j.jim.2004.11.007; GORER PA, 1950, BRIT J CANCER, V4, P372, DOI 10.1038/bjc.1950.36; Kaji T, 2013, INT IMMUNOL, V25, P683, DOI 10.1093/intimm/dxt030; Murakami A, 2014, INT IMMUNOL, V26, P195, DOI 10.1093/intimm/dxt057; Taddeo A, 2015, EUR J IMMUNOL, V45, P317, DOI 10.1002/eji.201444993; Weill JC, 2013, CURR OPIN IMMUNOL, V25, P334, DOI 10.1016/j.coi.2013.05.004	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1759	1872-7905		J IMMUNOL METHODS	J. Immunol. Methods	JUL	2015	422						80	86		10.1016/j.jim.2015.04.006		7	Biochemical Research Methods; Immunology	Biochemistry & Molecular Biology; Immunology	CL5FL	WOS:000356985100009		
J	Murakami, M; Sato, H; Miki, Y; Yamamoto, K; Taketomi, Y				Murakami, Makoto; Sato, Hiroyasu; Miki, Yoshimi; Yamamoto, Kei; Taketomi, Yoshitaka			Thematic Review Series: Phospholipases: Central Role in Lipid Signaling and Disease A new era of secreted phospholipase A(2)	JOURNAL OF LIPID RESEARCH			English	Review						arachidonic acid; eicosanoids; fatty acid; immunology; inflammation; lipidomics; lysophospholipid; membranes; obesity; phospholipids/metabolism	LOW-MOLECULAR-WEIGHT; DIET-INDUCED OBESITY; HUMAN GROUP-IIA; RECEPTOR-DEFICIENT MICE; IDIOPATHIC MEMBRANOUS NEPHROPATHY; ALLERGIC PULMONARY INFLAMMATION; ABDOMINAL AORTIC-ANEURYSMS; SHOWS STRONG ASSOCIATION; SNP HAPLOTYPE ANALYSIS; FOAM CELL-FORMATION	Among more than 30 members of the phospholipase A(2) (PLA(2)) superfamily, secreted PLA(2) (sPLA(2)) enzymes represent the largest family, being Ca2+ -dependent low-molecular-weight enzymes with a His-Asp catalytic dyad. Individual sPLA(2)s exhibit unique tissue and cellular distributions and enzymatic properties, suggesting their distinct biological roles. Recent studies using transgenic and knockout mice for nearly a full set of sPLA(2) subtypes, in combination with sophisticated lipidomics as well as biochemical and cell biological studies, have revealed distinct contributions of individual sPLA(2)s to various pathophysiological events, including production of pro-and anti-inflammatory lipid mediators, regulation of membrane remodeling, degradation of foreign phospholipids in microbes or food, or modification of extracellular noncellular lipid components. In this review, we highlight the current understanding of the in vivo functions of sPLA(2)s and the underlying lipid pathways as revealed by a series of studies over the last decade.	[Murakami, Makoto; Sato, Hiroyasu; Miki, Yoshimi; Yamamoto, Kei; Taketomi, Yoshitaka] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Tokyo 1568506, Japan; [Murakami, Makoto] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Murakami, M (reprint author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Tokyo 1568506, Japan.	murakami-mk@igakuken.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; CREST from the Japan Science and Technology Agency	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and CREST from the Japan Science and Technology Agency. The authors have no conflicting financial interests.	Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Wilson SG, 2006, EUR J HUM GENET, V14, P340, DOI 10.1038/sj.ejhg.5201.551; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Augert A, 2013, FREE RADICAL BIO MED, V65, P969, DOI 10.1016/j.freeradbiomed.2013.08.177; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Sato H, 2009, BIOCHEM J, V421, P17, DOI 10.1042/BJ20082429; Movert E, 2011, J IMMUNOL, V187, P6437, DOI 10.4049/jimmunol.1100499; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Mounier CM, 2008, BRIT J CANCER, V98, P587, DOI 10.1038/sj.bjc.6604184; Munoz NM, 2007, J IMMUNOL, V179, P4800; Zvaritch E, 1996, J BIOL CHEM, V271, P250; Huhtinen HT, 2006, APMIS, V114, P127, DOI 10.1111/j.1600-0463.2006.apm_330.x; Wootton PTE, 2006, HUM MOL GENET, V15, P355, DOI 10.1093/hmg/ddi453; Zeissig S, 2012, NAT MED, V18, P1060, DOI 10.1038/nm.2811; Lapointe S, 2010, J CELL PHYSIOL, V224, P127, DOI 10.1002/jcp.22106; Yang SK, 2013, INFLAMM BOWEL DIS, V19, P954, DOI 10.1097/MIB.0b013e3182802ab6; Henderson WR, 2011, J BIOL CHEM, V286, P28049, DOI 10.1074/jbc.M111.235812; Martinez-Garcia A, 2010, J ALZHEIMERS DIS, V22, P1181, DOI 10.3233/JAD-2010-101348; Kugiyama K, 1999, CIRCULATION, V100, P1280; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Tamaru S, 2013, J IMMUNOL, V191, P1021, DOI 10.4049/jimmunol.1300738; Yamamoto K, 2011, J BIOL CHEM, V286, P11616, DOI 10.1074/jbc.M110.206714; Labonte ED, 2006, DIABETES, V55, P935, DOI 10.2337/diabetes.55.04.06.db05-1286; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Gora S, 2009, J MOL MED-JMM, V87, P723, DOI 10.1007/s00109-009-0483-y; Bostrom MA, 2007, ARTERIOSCL THROM VAS, V27, P600, DOI 10.1161/01.ATV.0000257133.60884.44; Giannattasio G, 2010, J IMMUNOL, V185, P4430, DOI 10.4049/jimmunol.1001384; Ait-Oufella H, 2013, ARTERIOSCL THROM VAS, V33, P466, DOI 10.1161/ATVBAHA.112.300309; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Gelb MH, 2000, J BIOL CHEM, V275, P39823, DOI 10.1074/jbc.C000671200; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Brglez V, 2014, BIOCHIMIE, V107, P114, DOI 10.1016/j.biochi.2014.09.023; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Huggins KW, 2002, AM J PHYSIOL-ENDOC M, V283, pE994, DOI 10.1152/ajpendo.00110.2002; Cormier RT, 1997, NAT GENET, V17, P88, DOI 10.1038/ng0997-88; Nicholls SJ, 2014, JAMA-J AM MED ASSOC, V311, P252, DOI 10.1001/jama.2013.282836; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Masuda S, 2005, J BIOL CHEM, V280, P23203, DOI 10.1074/jbc.M500985200; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; PRUZANSKI W, 1991, IMMUNOL TODAY, V12, P143, DOI 10.1016/0167-5699(91)90077-7; Leung SY, 2002, P NATL ACAD SCI USA, V99, P16203, DOI 10.1073/pnas.212646299; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; Sato H, 2011, J BIOL CHEM, V286, P11632, DOI 10.1074/jbc.M110.206755; WEISS J, 1994, J BIOL CHEM, V269, P26331; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Beck S, 2003, J BIOL CHEM, V278, P29799, DOI 10.1074/jbc.M211763200; Mishina H, 2014, CIRC RES, V114, P493, DOI 10.1161/CIRCRESAHA.114.302319; Ilic D, 2014, BBA-MOL CELL BIOL L, V1841, P416, DOI 10.1016/j.bbalip.2013.11.002; Guan M, 2011, HEPATOLOGY, V53, P458, DOI 10.1002/hep.24066; Rouault M, 2003, BIOCHEMISTRY-US, V42, P11494, DOI 10.1021/bi0349930; Koprivnjak T, 2002, J BIOL CHEM, V277, P47636, DOI 10.1074/jbc.M205104200; Valentin E, 2000, J BIOL CHEM, V275, P7492, DOI 10.1074/jbc.275.11.7492; ANCIAN P, 1995, J BIOL CHEM, V270, P8963; Scott KF, 2010, BIOCHIMIE, V92, P601, DOI 10.1016/j.biochi.2010.03.019; Balsinde J, 1996, J BIOL CHEM, V271, P6758; Shridas P, 2010, J BIOL CHEM, V285, P20031, DOI 10.1074/jbc.M109.090423; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Graff JR, 2001, CLIN CANCER RES, V7, P3857; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; Man MQ, 2014, J INVEST DERMATOL, V134, P2399, DOI 10.1038/jid.2014.187; Augert A, 2009, EMBO REP, V10, P271, DOI 10.1038/embor.2008.255; Weinrauch Y, 1998, J CLIN INVEST, V102, P633, DOI 10.1172/JCI3121; Wang VM, 2012, MOL VIS, V18, P2578; Zack M, 2011, ATHEROSCLEROSIS, V214, P58, DOI 10.1016/j.atherosclerosis.2010.08.054; von Allmen CE, 2009, P NATL ACAD SCI USA, V106, P11673, DOI 10.1073/pnas.0812569106; Mulherkar R, 2003, ONCOGENE, V22, P1936, DOI 10.1038/sj.onc.1206229; Piris-Gimenez A, 2005, J IMMUNOL, V175, P6786; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378; Sato H, 2010, J CLIN INVEST, V120, P1400, DOI 10.1172/JCI40493; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Uozumi N, 1997, NATURE, V390, P618; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; CHEN J, 1994, J BIOL CHEM, V269, P2365; Vindrieux D, 2013, CANCER RES, V73, P6334, DOI 10.1158/0008-5472.CAN-13-0318; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Boyanovsky B, 2009, ARTERIOSCL THROM VAS, V29, P532, DOI 10.1161/ATVBAHA.108.183038; Boyanoysky BB, 2012, AM J PATHOL, V181, P1088, DOI 10.1016/j.ajpath.2012.05.037; Cash JG, 2011, INT J OBESITY, V35, P877, DOI 10.1038/ijo.2010.215; Chen J, 1997, J CELL BIOCHEM, V64, P369, DOI 10.1002/(SICI)1097-4644(19970301)64:3<369::AID-JCB3>3.0.CO;2-T; CHEN J, 1994, J BIOL CHEM, V269, P23018; Chen YJ, 1998, BBA-LIPID LIPID MET, V1394, P57, DOI 10.1016/S0005-2760(98)00098-8; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Curfs DMJ, 2008, J BIOL CHEM, V283, P21640, DOI 10.1074/jbc.M710584200; Degousee N, 2011, J BIOL CHEM, V286, P35650, DOI 10.1074/jbc.M111.262733; Diaz BL, 2006, BBA-MOL CELL BIOL L, V1761, P1489, DOI 10.1016/j.bbalip.2006.09.009; Ee SM, 2014, MOL NEUROBIOL, V50, P60, DOI 10.1007/s12035-014-8635-7; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Guardiola M., 2015, CIRC-CARDIOVASC GENE, DOI [10.1161/CIRCGENETICS.114.000633, DOI 10.1161/CIRCGENETICS.114.000633]; Hallstrand TS, 2013, AM J RESP CRIT CARE, V188, P42, DOI 10.1164/rccm.201301-0084OC; Hallstrand TS, 2011, CLIN EXP ALLERGY, V41, P801, DOI 10.1111/j.1365-2222.2010.03676.x; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Hanasaki K, 1997, J BIOL CHEM, V272, P32792, DOI 10.1074/jbc.272.52.32792; Henderson WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056172; HILLE JDR, 1983, BIOCHEMISTRY-US, V22, P5347, DOI 10.1021/bi00292a014; Hoeft B, 2010, CARCINOGENESIS, V31, P466, DOI 10.1093/carcin/bgp325; Hollie NI, 2011, J LIPID RES, V52, P2005, DOI 10.1194/jlr.M019463; Hollie NI, 2014, ATHEROSCLEROSIS, V234, P377, DOI 10.1016/j.atherosclerosis.2014.03.027; Hui DY, 2009, BRIT J PHARMACOL, V157, P1263, DOI 10.1111/j.1476-5381.2009.00308.x; ISHIZAKI J, 1994, J BIOL CHEM, V269, P5897; Jemel I, 2011, J BIOL CHEM, V286, P36509, DOI 10.1074/jbc.M111.268540; Kelvin AA, 2014, VIROLOGY, V454, P78, DOI 10.1016/j.virol.2014.01.030; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; Labonte ED, 2010, FASEB J, V24, P2516, DOI 10.1096/fj.09-144436; Lai Y, 2010, J BIOL CHEM, V285, P41491, DOI 10.1074/jbc.M110.153338; Laine VJO, 2000, INFECT IMMUN, V68, P87; Laine VJO, 1999, J IMMUNOL, V162, P7402; Li X, 2010, FASEB J, V24, P4313, DOI 10.1096/fj.10-154716; Limou S, 2008, BIOMED PHARMACOTHER, V62, P31, DOI 10.1016/j.biopha.2007.11.001; Meliton AY, 2013, AM J PHYSIOL-LUNG C, V304, pL689, DOI 10.1152/ajplung.00047.2013; Mitsuishi M, 2007, BBA-MOL CELL BIOL L, V1771, P1389, DOI 10.1016/j.bbalip.2007.09.006; Munoz NM, 2009, AM J PHYSIOL-LUNG C, V296, pL879, DOI 10.1152/ajplung.90580.2008; Munoz-Sanjuan I, 2005, MOL CELL BIOL, V25, P3608, DOI 10.1128/MCB.25.9.3608-3619.2005; Murakami M, 2005, J BIOL CHEM, V280, P24987, DOI 10.1074/jbc.M502088200; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Murakami M, 2014, BIOCHIMIE, V107, P105, DOI 10.1016/j.biochi.2014.09.003; Murakami M, 2003, J BIOL CHEM, V278, P10657, DOI 10.1074/jbc.M211325200; Nevalainen TJ, 2012, COMP BIOCHEM PHYS D, V7, P340, DOI 10.1016/j.cbd.2012.07.002; Ohta S, 2013, J IMMUNOL, V190, P5927, DOI 10.4049/jimmunol.1203202; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Pan YH, 2002, J BIOL CHEM, V277, P29086, DOI 10.1074/jbc.M202531200; Pernet E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6105; Pettersson C, 2008, J INTERN MED, V264, P155, DOI 10.1111/j.1365-2796.2008.01932.x; Pruzanski W, 2005, BBA-MOL CELL BIOL L, V1736, P38, DOI 10.1016/j.bbalip.2005.07.005; Raymond B, 2007, PLOS PATHOG, V3, P1907, DOI 10.1371/journal.ppat.0030187; ROUAULT M, 2007, J BIOL CHEM, V46, P1647, DOI DOI 10.1021/BI062119B; Rubio JM, 2015, J IMMUNOL, V194, P3327, DOI 10.4049/jimmunol.1401026; Ruiperez V, 2009, J IMMUNOL, V182, P3877, DOI 10.4049/jimmunol.0804003; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Sawada H, 1999, EUR J BIOCHEM, V263, P826, DOI 10.1046/j.1432-1327.1999.00565.x; SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070; SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335; SEILHAMER JJ, 1986, DNA-J MOLEC CELL BIO, V5, P519, DOI 10.1089/dna.1.1986.5.519; Sergouniotis PI, 2011, AM J HUM GENET, V89, P782, DOI 10.1016/j.ajhg.2011.11.004; Shridas P, 2011, J IMMUNOL, V187, P482, DOI 10.4049/jimmunol.1003552; Shridas P, 2014, J BIOL CHEM, V289, P27410, DOI 10.1074/jbc.M114.591735; Takabatake N, 2005, AM J RESP CRIT CARE, V172, P1097, DOI 10.1164/rccm.200503-319OC; Tischfield JA, 1996, GENOMICS, V32, P328, DOI 10.1006/geno.1996.0126; Tomlinson IPM, 1996, ANN HUM GENET, V60, P369, DOI 10.1111/j.1469-1809.1996.tb00434.x; Valentin E, 1999, J BIOL CHEM, V274, P19152, DOI 10.1074/jbc.274.27.19152; VERHEIJ HM, 1983, BIOCHIM BIOPHYS ACTA, V747, P93, DOI 10.1016/0167-4838(83)90126-7; Wang YX, 1998, P NATL ACAD SCI USA, V95, P15345, DOI 10.1073/pnas.95.26.15345; Watanabe K, 2012, AM J PHYSIOL-HEART C, V302, pH95, DOI 10.1152/ajpheart.00695.2011; Webb NR, 2003, ARTERIOSCL THROM VAS, V23, P263, DOI 10.1161/01.ATV.0000051701.90972.E5; Wooton-Kee CR, 2004, ARTERIOSCL THROM VAS, V24, P762, DOI 10.1161/01.ATV.0000122363.02961.c1; Wootton PTE, 2007, HUM MOL GENET, V16, P1437, DOI 10.1093/hmg/ddm094; Yano T, 2011, CARDIOVASC RES, V90, P335, DOI 10.1093/cvr/cvq399; Zhao X, 2007, DEV BIOL, V304, P508, DOI 10.1016/j.ydbio.2007.01.013	165	6	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	JUL	2015	56	7					1248	1261		10.1194/jlr.R058123		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CL3FB	WOS:000356834700003		
J	Hirata, A; Kishino, S; Park, SB; Takeuchi, M; Kitamura, N; Ogawa, J				Hirata, Akiko; Kishino, Shigenobu; Park, Si-Bum; Takeuchi, Michiki; Kitamura, Nahoko; Ogawa, Jun			A novel unsaturated fatty acid hydratase toward C16 to C22 fatty acids from Lactobacillus acidophilus	JOURNAL OF LIPID RESEARCH			English	Article						arachidonic acid; docosahexaenoic acid; enzymology; fatty acid/metabolism; lipids; lipids/chemistry; lactic acid bacteria; hydroxy fatty acid; hydration; dehydration	GUT MICROBIAL METABOLITE; DOUBLE-BOND HYDRATASE; PLANTARUM AKU 1009A; LINOLEIC-ACID; OLEATE HYDRATASE; 10-HYDROXY-CIS-12-OCTADECENOIC ACID; BACTERIA; HYDROXYLATION; SATURATION; GROWTH	Hydroxy FAs, one of the gut microbial metabolites of PUFAs, have attracted much attention because of their various bioactivities. The purpose of this study was to identify lactic acid bacteria with the ability to convert linoleic acid (LA) to hydroxy FAs. A screening process revealed that a gut bacterium, Lactobacillus acidophilus NTV001, converts LA mainly into 13-hydroxy-cis -9-octadecenoic acid and resulted in the identification of the hydratase responsible, fatty acid hydratase 1 (FA-HY1). Recombinant FA-HY1 was purified, and its enzymatic characteristics were investigated. FA-HY1 could convert not only C18 PUFAs but also C20 and C22 PUFAs. C18 PUFAs with a cis carbon-carbon double bond at the Delta 12 position were converted into the corresponding 13-hydroxy FAs. Arachidonic acid and DHA were converted into the corresponding 15-hydroxy FA and 14-hydroxy FA, respectively. To the best of our knowledge, this is the first report of a bacterial FA hydratase that can convert C20 and C22 PUFAs into the corresponding hydroxy FAs. These novel hydroxy FAs produced by using FA-HY1 should contribute to elucidating the bioactivities of hydroxy FAs.	[Hirata, Akiko; Kishino, Shigenobu; Takeuchi, Michiki; Kitamura, Nahoko; Ogawa, Jun] Kyoto Univ, Div Appl Life Sci, Grad Sch Agr, Kyoto 6068502, Japan; [Park, Si-Bum] Kyoto Univ, Lab Ind Microbiol, Grad Sch Agr, Kyoto 6068502, Japan	Ogawa, J (reprint author), Kyoto Univ, Div Appl Life Sci, Grad Sch Agr, Kyoto 6068502, Japan.	ogawa@kais.kyoto-u.ac.jp			Bio-Oriented Technology Research Advancement Institution of Japan; Advanced Low Carbon Technology Research and Development Program of Japan; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan; NEDO Innovation Commercialization Venture Support Project; NITTO PHARMA	This work was supported by the Bio-Oriented Technology Research Advancement Institution of Japan (J.O.); the Advanced Low Carbon Technology Research and Development Program of Japan (S.K.); the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan (J.O.); and the NEDO Innovation Commercialization Venture Support Project (collaboration of NITTO PHARMA and J.O.).	RAYCHOWDHURY MK, 1985, J APPL BACTERIOL, V59, P183, DOI 10.1111/j.1365-2672.1985.tb03319.x; Zheng CJ, 2005, FEBS LETT, V579, P5157, DOI 10.1016/j.febslet.2005.08.028; Joo YC, 2012, BIOCHIMIE, V94, P907, DOI 10.1016/j.biochi.2011.12.011; Yamada Y, 1996, BIOCHEM BIOPH RES CO, V226, P391, DOI 10.1006/bbrc.1996.1366; Miyamoto J, 2015, J BIOL CHEM, V290, P2902, DOI 10.1074/jbc.M114.610733; Kishino S, 2002, J AM OIL CHEM SOC, V79, P159, DOI 10.1007/s11746-002-0451-4; Bevers LE, 2009, J BACTERIOL, V191, P5010, DOI 10.1128/JB.00306-09; Yang B, 2013, BIOTECHNOL LETT, V35, P75, DOI 10.1007/s10529-012-1044-y; Metzger JO, 2006, APPL MICROBIOL BIOT, V71, P13, DOI 10.1007/s00253-006-0335-4; Volkov A, 2010, J BIOL CHEM, V285, P10353, DOI 10.1074/jbc.M109.081851; Takeuchi M, 2013, EUR J LIPID SCI TECH, V115, P386, DOI 10.1002/ejlt.201200414; Kishino S, 2013, P NATL ACAD SCI USA, V110, P17808, DOI 10.1073/pnas.1312937110; Kishimoto N, 2003, LIPIDS, V38, P1269, DOI 10.1007/s11745-003-1188-4; Ogawa J, 2001, APPL ENVIRON MICROB, V67, P1246, DOI 10.1128/AEM.67.3.1246-1252.2001; Volkov A, 2013, ACTA CRYSTALLOGR D, V69, P648, DOI 10.1107/S0907444913000991; Kim KR, 2013, BIOTECHNOL ADV, V31, P1473, DOI 10.1016/j.biotechadv.2013.07.004; Yu IS, 2008, APPL MICROBIOL BIOT, V78, P157, DOI 10.1007/s00253-007-1280-6; GREENWAY DLA, 1979, J GEN MICROBIOL, V115, P233; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Bergamo P, 2014, J FUNCT FOODS, V11, P192, DOI 10.1016/j.jff.2014.10.007; BOWDEN K, 1946, J CHEM SOC, P39, DOI 10.1039/jr9460000039; Dalla V, 1999, TETRAHEDRON LETT, V40, P5193, DOI 10.1016/S0040-4039(99)01006-0; Goto T, 2015, BIOCHEM BIOPH RES CO, V459, P597, DOI 10.1016/j.bbrc.2015.02.154; Hudson JA, 1998, FEMS MICROBIOL LETT, V169, P277, DOI 10.1111/j.1574-6968.1998.tb13329.x; Kishino S, 2010, J APPL MICROBIOL, V108, P2012, DOI 10.1111/j.1365-2672.2009.04609.x; O'Connell KJ, 2013, BIOENGINEERED, V4, P313, DOI 10.4161/bioe.24159; Okuda T., J BIOSCI BI IN PRESS; Takeuchi M, 2015, J BIOSCI BIOENG, V119, P636, DOI 10.1016/j.jbiosc.2014.10.022; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	JUL	2015	56	7					1340	1350		10.1194/jlr.M059444		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CL3FB	WOS:000356834700011		
J	Harayama, T; Shindou, H; Kita, Y; Otsubo, E; Ikeda, K; Chida, S; Weaver, TE; Shimizu, T				Harayama, Takeshi; Shindou, Hideo; Kita, Yoshihiro; Otsubo, Eiji; Ikeda, Kazushige; Chida, Shoichi; Weaver, Timothy E.; Shimizu, Takao			Establishment of LC-MS methods for the analysis of palmitoylated surfactant proteins	JOURNAL OF LIPID RESEARCH			English	Article						pulmonary surfactant; mass spectrometry; palmitoylation; proteomics; lung; drug therapy; surfactant drug; liquid chromatography	B SP-B; PULMONARY SURFACTANT; MASS-SPECTROMETRY; QUANTITATIVE-ANALYSIS; IN-VIVO; PURIFICATION; DISEASE; LUNG	The surfactant proteins (SPs), SP-B and SP-C, are important components of pulmonary surfactant involved in the reduction of alveolar surface tension. Quantification of SP-B and SP-C in surfactant drugs is informative for their quality control and the evaluation of their biological activity. Western blot analysis enabled the quantification of SP-B, but not SP-C, in surfactant drugs. Here, we report a new procedure involving chemical treatments and LC-MS to analyze SP-C peptides. The procedure enabled qualitative analysis of SP-C from different species with discrimination of the palmitoylation status and the artificial modifications that occur during handling and/or storage. In addition, the method can be used to estimate the total amount of SP-C in pulmonary surfactant drugs. The strategy described here might serve as a prototype to establish analytical methods for peptides that are extremely hydrophobic and behave like lipids. The new method provides an easy measurement of SP-C from various biological samples, which will help the characterization of various experimental animal models and the quality control of surfactant drugs, as well as diagnostics of human samples.	[Harayama, Takeshi; Shindou, Hideo; Otsubo, Eiji; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Res Inst, Shinjuku Ku, Tokyo 1628655, Japan; [Shindou, Hideo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Kita, Yoshihiro] Univ Tokyo, Grad Sch Med, Dept Lipid, Bunkyo Ku, Tokyo 1130033, Japan; [Otsubo, Eiji] Pharma Corp, Div Res, Mitsubishi Tanabe Pharma Corp, Adv Med Res Dept, Yokohama, Kanagawa 2270033, Japan; [Ikeda, Kazushige] Keio Univ, Sch Med, Dept Pediat, Div Neonantol, Tokyo 1608582, Japan; [Chida, Shoichi] Iwate Med Univ, Sch Med, Dept Pediat, Morioka, Iwate 0208505, Japan; [Weaver, Timothy E.] Cincinnati Childrens Hosp, Div Pulm Biol, Med Ctr, Cincinnati, OH 45229 USA	Harayama, T (reprint author), Univ Geneva, Dept Biochem, Sci 2, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	harayama-t@umin.net			JSPS KAKENHI [24229003, 25116707, 23790324, 24790805]; National Center for Global Health and Medicine [24-001, 25-201]; Mitsubishi Tanabe Pharma Corporation; Shimadzu Corporation; Ono Pharmaceutical Company, LTD.	This work was supported by JSPS KAKENHI Grants 24229003 (T.S.), 25116707 (Y.K.), 23790324 (H.S.), 24790805 (T.H.), and the grants for National Center for Global Health and Medicine 24-001 and 25-201 (T.S.). Materials and fees for this research were provided, in part, by Mitsubishi Tanabe Pharma Corporation. The Department of Lipidomics, Graduate School of Medicine, University of Tokyo is financially supported by Shimadzu Corporation and Ono Pharmaceutical Company, LTD.	Amin RS, 2001, J PEDIATR-US, V139, P85, DOI 10.1067/mpd.2001.114545; Jung SY, 2008, ANAL CHEM, V80, P1721, DOI 10.1021/ac7021025; Johansson J, 1998, BBA-MOL BASIS DIS, V1408, P161, DOI 10.1016/S0925-4439(98)00065-9; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; VELDHUIZEN RAW, 1993, BIOCHEM J, V295, P141; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Agassandian M, 2013, BBA-MOL CELL BIOL L, V1831, P612, DOI 10.1016/j.bbalip.2012.09.010; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Yousefi-Salakdeh E, 1999, BIOCHEM J, V343, P557, DOI 10.1042/0264-6021:3430557; Conkright JJ, 2010, AM J RESP CELL MOL, V42, P181, DOI 10.1165/rcmb.2009-0058OC; Bernhard W, 2000, AM J RESP CRIT CARE, V162, P1524; Bunger H, 2000, J CHROMATOGR A, V870, P363, DOI 10.1016/S0021-9673(99)01073-0; Gustafsson M, 1997, BIOCHEM J, V326, P799; Jobe AH, 2001, CLIN PERINATOL, V28, P655, DOI 10.1016/S0095-5108(05)70111-1; Lin S, 1996, BBA-MOL CELL RES, V1312, P177, DOI 10.1016/0167-4889(95)00201-4; Liu SY, 2008, RAPID COMMUN MASS SP, V22, P197, DOI 10.1002/rcm.3345; Ramanathan R., 2013, J PULM RESP MED S, V13, DOI [10.4172/2161-105X.S13-006, DOI 10.4172/2161-105X.S13-006]; Rodriguez-Capote K, 2006, BIOPHYS J, V90, P2808, DOI 10.1529/biophysj.105.073106; Ross GF, 1999, AM J PHYSIOL-LUNG C, V277, pL1104; Speer Christian P, 2013, Early Hum Dev, V89 Suppl 1, pS22, DOI 10.1016/S0378-3782(13)70008-2; Stark M, 1998, ANAL BIOCHEM, V265, P97, DOI 10.1006/abio.1998.2856; SUZUKI Y, 1989, AM REV RESPIR DIS, V140, P75; vanEijk M, 1995, ANAL BIOCHEM, V232, P231, DOI 10.1006/abio.1995.0012; VOSS T, 1992, BIOCHIM BIOPHYS ACTA, V1138, P261, DOI 10.1016/0925-4439(92)90002-5	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	JUL	2015	56	7					1370	1379		10.1194/jlr.D060236		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CL3FB	WOS:000356834700014		
J	Matsunaga, T; Mizuno, T; Takegoshi, K				Matsunaga, Tatsuya; Mizuno, Takashi; Takegoshi, K.			An X-0 shim coil for precise magic-angle adjustment	JOURNAL OF MAGNETIC RESONANCE			English	Article						X-0 shim coil; MAS; High resolution solid state NMR	MAGNETIC-RESONANCE SPECTRA; SOLID-STATE NMR; SPECTROSCOPY	A new method for precise setting of the spinning angle to the magic angle by using a saddle coil is described. The coil, which is referred to as an X-0 shim coil, is wound to produce a uniform static magnetic field B-x perpendicular to the main magnetic field B-0. The magnetic field felt by a sample is a vector sum of the main field B-0 and the transverse field B-x produced by the X-0 shim coil. Hence the angle between the spinner axis and the effective magnetic field can be controlled by current I supplied to the X-0 shim coil, leading to precise angle adjustment without backlash accompanied with a mechanical system conventionally used. It is shown that the angle range achieved is +/- 0.05 degrees for I = +/- 5 A at B-0 = 7 T. (C) 2015 Elsevier Inc. All rights reserved.	[Matsunaga, Tatsuya; Takegoshi, K.] Kyoto Univ, Div Chem, Grad Sch Sci, Kyoto 6068502, Japan; [Mizuno, Takashi] JEOL RESONANCE Inc, Tokyo, Japan	Takegoshi, K (reprint author), Kyoto Univ, Div Chem, Grad Sch Sci, Kyoto 6068502, Japan.	takeyan@kuchem.kyoto-u.ac.jp			Japan Science and Technology Agency (JST)	This work was financially supported by Japan Science and Technology Agency (JST). We thank Uratani Engineering, Inc., for winding the X<INF>0</INF> shim coil.	Huguenard C, 2002, J MAGN RESON, V156, P131, DOI 10.1006/jmre.2002.2548; Shekar SC, 2002, J MAGN RESON, V157, P223, DOI 10.1006/jmre.2002.2587; FRYE JS, 1982, J MAGN RESON, V48, P125, DOI 10.1016/0022-2364(82)90243-8; Mizuno T, 2006, J AM CHEM SOC, V128, P9683, DOI 10.1021/ja062280+; ANDREW ER, 1958, NATURE, V182, P1659, DOI 10.1038/1821659a0; ANDREW ER, 1959, NATURE, V183, P1802, DOI 10.1038/1831802a0; LOWE IJ, 1959, PHYS REV LETT, V2, P285, DOI 10.1103/PhysRevLett.2.285; Mihaliuk E, 2012, J MAGN RESON, V223, P46, DOI 10.1016/j.jmr.2012.08.007; Takeda K, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2712940; Mamone S, 2008, J MAGN RESON, V190, P135, DOI 10.1016/j.jmr.2007.07.012; Mizuno T., 2010, US Pat., Patent No. 8547099; Mizuno T., 2009, JP Pat, Patent No. [5445754 (B2), 5445754]; Mizuno T., 2010, EP Pat., Patent No. [2306215 (Al), 2306215]; SPARKS SW, 1986, J AM CHEM SOC, V108, P3215, DOI 10.1021/ja00272a009; Takeda K., ANN REPORTS NMR SPEC, V74	15	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	JUL	2015	256						1	8		10.1016/j.jmr.2015.04.007		8	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Biochemistry & Molecular Biology; Physics; Spectroscopy	CL3HC	WOS:000356840000001		
J	Hashi, K; Ohki, S; Matsumoto, S; Nishijima, G; Goto, A; Deguchi, K; Yamada, K; Noguchi, T; Sakai, S; Takahashi, M; Yanagisawa, Y; Iguchi, S; Yamazaki, T; Maeda, H; Tanaka, R; Nemoto, T; Suematsu, H; Miki, T; Saito, K; Shimizu, T				Hashi, Kenjiro; Ohki, Shinobu; Matsumoto, Shinji; Nishijima, Gen; Goto, Atsushi; Deguchi, Kenzo; Yamada, Kazuhiko; Noguchi, Takashi; Sakai, Shuji; Takahashi, Masato; Yanagisawa, Yoshinori; Iguchi, Seiya; Yamazaki, Toshio; Maeda, Hideaki; Tanaka, Ryoji; Nemoto, Takahiro; Suematsu, Hiroto; Miki, Takashi; Saito, Kazuyoshi; Shimizu, Tadashi			Achievement of 1020 MHz NMR	JOURNAL OF MAGNETIC RESONANCE			English	Article						Magnet development; 1020 MHz; High-T-c superconducting magnet; Bi-2223; Driven mode magnet	HIGH-RESOLUTION NMR; FIELD NMR; 1 GHZ; MAGNET; OPERATION	We have successfully developed a 1020 MHz (24.0 T) NMR magnet, establishing the world's highest magnetic field in high resolution NMR superconducting magnets. The magnet is a series connection of LTS (low-T-c superconductors NbTi and Nb3Sn) outer coils and an HTS (high-T-c superconductor, Bi-2223) innermost coil, being operated at superfluid liquid helium temperature such as around 1.8 K and in a driven-mode by an external DC power supply. The drift of the magnetic field was initially +/- 0.8 ppm/10 h without the H-2 lock operation; it was then stabilized to be less than 1 ppb/10 h by using an NMR internal lock operation. The full-width at half maximum of a H-1 spectrum taken for 1% CHCl3 in acetone-d(6) was as low as 0.7 Hz (0.7 ppb), which was sufficient for solution NMR. On the contrary, the temporal field stability under the external lock operation for solid-state NMR was 170 ppb/10 h, sufficient for NMR measurements for quadrupolar nuclei such as O-17; a O-17 NMR measurement for labeled tri-peptide clearly demonstrated the effect of high magnetic field on solid-state NMR spectra. (C) 2015 Elsevier Inc. All rights reserved.	[Hashi, Kenjiro; Ohki, Shinobu; Matsumoto, Shinji; Nishijima, Gen; Goto, Atsushi; Deguchi, Kenzo; Yamada, Kazuhiko; Noguchi, Takashi; Sakai, Shuji; Shimizu, Tadashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050003, Japan; [Takahashi, Masato; Yanagisawa, Yoshinori; Iguchi, Seiya; Yamazaki, Toshio; Maeda, Hideaki] RIKEN, Ctr Life Sci Technol, Yokohama, Kanagawa 2300045, Japan; [Iguchi, Seiya] Sophia Univ, Fac Sci & Technol, Yotsuya 1028554, Japan; [Tanaka, Ryoji; Nemoto, Takahiro; Suematsu, Hiroto] JEOL RESONANCE Inc, Akishima, Tokyo 1968558, Japan; [Miki, Takashi; Saito, Kazuyoshi] Kobe Steel Ltd, Nishi Ku, Kobe, Hyogo 6512271, Japan	Hashi, K (reprint author), Natl Inst Mat Sci, 3-13 Sakura, Tsukuba, Ibaraki 3050003, Japan.	HASHI.Kenjiro@nims.go.jp			SENTAN, JST in Japan	This work is supported by SENTAN, JST in Japan. We would like to dedicate this paper to the late Dr. Tsukasa Kiyoshi who started this project.	Fu R, 2005, J MAGN RESON, V177, P1, DOI 10.1016/j.jmr.2005.07.013; Hashi K, 2002, J MAGN RESON, V156, P318, DOI 10.1006/jmre.2002.2559; Yanagisawa Y, 2010, J MAGN RESON, V203, P274, DOI 10.1016/j.jmr.2010.01.007; Maeda H, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2287707; Gan ZH, 2002, J AM CHEM SOC, V124, P5634, DOI 10.1021/ja025849p; Hashi K, 2005, JPN J APPL PHYS 1, V44, P4194, DOI 10.1143/JJAP.44.4194; Kiyoshi T, 2010, IEEE T APPL SUPERCON, V20, P714, DOI 10.1109/TASC.2010.2040148; Kiyoshi T, 2002, IEEE T APPL SUPERCON, V12, P711, DOI 10.1109/TASC.2002.1018500; Kiyoshi T, 2008, IEEE T APPL SUPERCON, V18, P860, DOI 10.1109/TASC.2008.921216; Nishijima G., UNPUB; Nishiyama Y., UNPUB; Pugnat P, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2283225; Shimizu T, 2004, CHEM LETT, V33, P1502, DOI 10.1246/cl.2004.1502; Takahashi M, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4757576; Takahashi M., UNPUB; Yamada K, 2007, Z NATURFORSCH B, V62, P1422; Yanagisawa Y, 2014, J MAGN RESON, V249, P38, DOI 10.1016/j.jmr.2014.10.006; Yanagisawa Y., UNPUB	18	5	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	JUL	2015	256						30	33		10.1016/j.jmr.2015.04.009		4	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Biochemistry & Molecular Biology; Physics; Spectroscopy	CL3HC	WOS:000356840000005		
J	Flottmann, R; Wagner, J; Kobus, K; Curry, CJ; Savarirayan, R; Nishimura, G; Yasui, N; Spranger, J; Van Esch, H; Lyons, MJ; DuPont, BR; Dwivedi, A; Klopocki, E; Horn, D; Mundlos, S; Spielmann, M				Floettmann, Ricarda; Wagner, Johannes; Kobus, Karolina; Curry, Cynthia J.; Savarirayan, Ravi; Nishimura, Gen; Yasui, Natsuo; Spranger, Juergen; Van Esch, Hilde; Lyons, Michael J.; DuPont, Barbara R.; Dwivedi, Alka; Klopocki, Eva; Horn, Denise; Mundlos, Stefan; Spielmann, Malte			Microdeletions on 6p22.3 are associated with mesomelic dysplasia Savarirayan type	JOURNAL OF MEDICAL GENETICS			English	Article							ENHANCER-ADOPTION; DELETION; GENE; DISEASE; GENOME; LIMB; PHENOTYPE; SEQUENCE; DATABASE; DEFECTS	Introduction Mesomelic dysplasias are a group of skeletal disorders characterised by shortness of the middle limb segments (mesomelia). They are divided into 11 different categories. Among those without known molecular basis is mesomelic dysplasia Savarirayan type, characterised by severe shortness of the middle segment of the lower limb. Objective To identify the molecular cause of mesomelic dysplasia Savarirayan type. Methods and results We performed array comparative genomic hybridisation in three unrelated patients with mesomelic dysplasia Savarirayan type and identified 2 Mb overlapping de novo microdeletions on chromosome 6p22.3. The deletions encompass four known genes: MBOAT1, E2F3, CDKAL1 and SOX4. All patients showed mesomelia of the lower limbs with hypoplastic tibiae and fibulae. We identified a fourth patient with intellectual disability and an overlapping slightly larger do novo deletion also encompassing the flanking gene ID4. Given the fact that the fourth patient had no skeletal abnormalities and none of the genes in the deleted interval are known to be associated with abnormalities in skeletal development, other mutational mechanisms than loss of function of the deleted genes have to be considered. Analysis of the genomic region showed that the deletion removes two regulatory boundaries and brings several potential limb enhancers into close proximity of ID4. Thus, the deletion could result in the aberrant activation and misexpression of ID4 in the limb bud, thereby causing the mesomelic dysplasia. Conclusions Our data indicate that the distinct deletion 6p22.3 is associated with mesomelic dysplasia Savarirayan type featuring hypoplastic, triangular-shaped tibiae and abnormally shaped or hypoplastic fibulae.	[Floettmann, Ricarda; Wagner, Johannes; Horn, Denise; Mundlos, Stefan; Spielmann, Malte] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Kobus, Karolina; Mundlos, Stefan; Spielmann, Malte] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Curry, Cynthia J.] UCFS Fresno, Inst Clin Genet, Fresno, CA USA; [Savarirayan, Ravi] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Imaging, Tokyo, Japan; [Yasui, Natsuo] Tokushima Univ Hosp, Tokushima, Japan; [Spranger, Juergen] Johannes Gutenberg Univ Mainz, Childrens Hosp, Mainz, Germany; [Van Esch, Hilde] Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium; [Lyons, Michael J.; DuPont, Barbara R.; Dwivedi, Alka] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Klopocki, Eva] Univ Wurzburg, Inst Human Genet, Wurzburg, Germany; [Mundlos, Stefan; Spielmann, Malte] Berlin Brandenburg Sch Regenerat Therapies BSRT, Berlin, Germany	Spielmann, M (reprint author), Charite, Inst Med Genet & Human Genet, Augustenburger Pl 1, D-13353 Berlin, Germany.	malte.spielmann@charite.de			Deutsche Forschungsgemeinschaft (DFG) [KL 2158/2-2]; Berlin-Brandenburg School for Regenerative Therapies (BSRT), Berlin, Germany	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) grant number KL 2158/2-2 to SM. MS was supported by a fellowship of the Berlin-Brandenburg School for Regenerative Therapies (BSRT), Berlin, Germany.	Giorgio E, 2015, HUM MOL GENET, V24, P3143, DOI 10.1093/hmg/ddv065; Klopocki E, 2008, J MED GENET, V45, P370, DOI 10.1136/jmg.2007.055699; Cotney J, 2013, CELL, V154, P185, DOI 10.1016/j.cell.2013.05.056; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Lettice LA, 2011, HUM MUTAT, V32, P1492, DOI 10.1002/humu.21615; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Spielmann M, 2013, BIOESSAYS, V35, P533, DOI 10.1002/bies.201200178; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Bremer A, 2009, EUR J MED GENET, V52, P358, DOI 10.1016/j.ejmg.2009.06.002; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Humbert PO, 2000, GENE DEV, V14, P690; Chen W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-85; Cloud JE, 2002, MOL CELL BIOL, V22, P2663, DOI 10.1128/MCB.22.8.2663-2672.2002; Dauwerse JG, 2007, EUR J HUM GENET, V15, P743, DOI 10.1038/sj.ejhg.5201833; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Gyurjan I, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-47; HESS OM, 1978, SCHWEIZ MED WSCHR, V108, P1202; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Klopocki E, 2006, EUR J HUM GENET, V14, P1274, DOI 10.1038/sj.ejhg.5201696; Kraft K, 2015, CELL REP; Ladinsky HT, 2014, PEDIAT ALLERG IMM-UK, V25, P500, DOI 10.1111/pai.12213; Lupianez DG, CELL IN PRESS; Nakamura M, 2007, AM J MED GENET A, V143A, P2079, DOI 10.1002/ajmg.a.31888; Okamura T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049055; Savarirayan R, 2000, AM J MED GENET, V94, P59, DOI 10.1002/1096-8628(20000904)94:1<59::AID-AJMG12>3.0.CO;2-2; Spielmann M, 2012, AM J HUM GENET, V91, P629, DOI 10.1016/j.ajhg.2012.08.014; Steichen-Gersdorf E, 2008, CLIN GENET, V74, P560, DOI 10.1111/j.1399-0004.2008.01050.x; Tokuzawa Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001019; Yasui N, 2000, SKELETAL RADIOL, V29, P243	35	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-2593	1468-6244		J MED GENET	J. Med. Genet.	JUL	2015	52	7					476	483		10.1136/jmedgenet-2015-103108		8	Genetics & Heredity	Genetics & Heredity	CL3PH	WOS:000356861900006		
J	Chang, KC; Lee, AS; Chen, WY; Lin, YN; Hsu, JF; Chan, HC; Chang, CM; Chang, SS; Pan, CC; Sawamura, T; Chang, CT; Su, MJ; Chen, CH				Chang, Kuan-Cheng; Lee, An-Sheng; Chen, Wei-Yu; Lin, Yen-Nien; Hsu, Jing-Fang; Chan, Hua-Chen; Chang, Chia-Ming; Chang, Shih-Sheng; Pan, Chia-Chi; Sawamura, Tatsuya; Chang, Chi-Tzong; Su, Ming-Jai; Chen, Chu-Huang			Increased LDL electronegativity in chronic kidney disease disrupts calcium homeostasis resulting in cardiac dysfunction	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Cardiorenal syndrome; Unilateral nephrectomy; Lipoproteins; SERCA2a	LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR OUTCOMES; MYOCARDIAL-INFARCTION; CARDIORENAL SYNDROME; MECHANISMS; APOPTOSIS; FAILURE	Chronic kidney disease (CKD), an independent risk factor for cardiovascular disease, is associated with abnormal lipoprotein metabolism. We examined whether electronegative low-density lipoprotein (LDL) is mechanistically linked to cardiac dysfunction in patients with early CKD. We compared echocardiographic parameters between patients with stage 2 CKD (n = 88) and normal controls (n = 89) and found that impaired relaxation was more common in CKD patients. Reduction in estimated glomerular filtration rate was an independent predictor of left ventricular relaxation dysfunction. We then examined cardiac function in a rat model of early CKD induced by unilateral nephrectomy (UNx) by analyzing pressure-volume loop data. The time constant of isovolumic pressure decay was longer and the maximal velocity of pressure fall was slower in UNx rats than in controls. When we investigated the mechanisms underlying relaxation dysfunction, we found that LDL from CKD patients and UNx rats was more electronegative than LDL from their respective controls and that LDL from UNx rats induced intracellular calcium overload in H9c2 cardiomyocytes in vitro. Furthermore, chronic administration of electronegative LDL, which signals through lectin-like oxidized LDL receptor-1 (LOX-1), induced relaxation dysfunction in wild-type but not LOX-1(-/-) mice. In in vitro and in vivo experiments, impaired cardiac relaxation was associated with increased calcium transient resulting from nitric oxide (NO)-dependent nitrosylation of SERCA2a due to increases in inducible NO synthase expression and endothelial NO synthase uncoupling. In conclusion, LDL becomes more electronegative in early CKD. This change disrupts SERCA2a-regulated calcium homeostasis, which may be the mechanism underlying cardiorenal syndrome. (C) 2015 Elsevier Ltd. All rights reserved.	[Chang, Kuan-Cheng; Lin, Yen-Nien; Chang, Shih-Sheng] China Med Univ CMU Hosp, Div Cardiol, Taichung, Taiwan; [Chang, Kuan-Cheng] CMU, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lee, An-Sheng] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Lee, An-Sheng; Chen, Wei-Yu; Hsu, Jing-Fang; Chan, Hua-Chen; Chang, Chia-Ming; Pan, Chia-Chi; Chen, Chu-Huang] CMU, CMU Hosp, Res Ctr L5, Taichung, Taiwan; [Chan, Hua-Chen] KMU, Kaohsiung Med Univ KMU Hosp, Ctr Lipid Biosci, Kaohsiung, Taiwan; [Sawamura, Tatsuya] Shinshu Univ, Sch Med, Dept Physiol, Matsumoto, Nagano 390, Japan; [Chang, Chi-Tzong] CMU Hosp, Div Nephrol, Taichung, Taiwan; [Su, Ming-Jai] Natl Taiwan Univ, Grad Inst Pharmacol, Taipei 100, Taiwan; [Chen, Chu-Huang] Texas Heart Inst, Vasc & Med Res, Houston, TX 77025 USA; [Chen, Chu-Huang] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Chen, Chu-Huang] KMU, KMU Hosp, Ctr Lipid & Glycomed Res, Kaohsiung, Taiwan	Su, MJ (reprint author), Natl Taiwan Univ, Grad Inst Pharmacol, 1150R,1,Sec 1,Ren Ai Rd, Taipei 100, Taiwan.	mingja@ntu.edu.tw; cchen@texasheart.org			American Diabetes Association [1-04-RA-13]; NIH [HL-63364]; Ministry of Science and Technology [NSC 100-2314-B-039-040-MY3, NSC 102-2314-B-039-019, MOST 103-2314-B-039-029, MOST 103-2314-B-715-008]; National Health Research Institutes of Taiwan [NHRI-EX103-10305SI, NHRI-EX104-10305SI]; Stroke Biosignature Program Grant of Academia Sinica in Taiwan [BM104010092]; China Medical University under the "Aim for the Top University Plan" of the Ministry of Education, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; Mackay Medical College [RD-1020082, RD-1030085]; Mao-Kuei Lin Research Fund of Chicony Electronics; Kaohsiung Medical University [KMU-TP103D09, KMU-TP103D00]	This work was supported by grants from the American Diabetes Association [1-04-RA-13]; the NIH [HL-63364]; the Ministry of Science and Technology [NSC 100-2314-B-039-040-MY3, NSC 102-2314-B-039-019, MOST 103-2314-B-039-029, and MOST 103-2314-B-715-008]; the National Health Research Institutes of Taiwan [NHRI-EX103-10305SI and NHRI-EX104-10305SI]; the Stroke Biosignature Program Grant [BM104010092] of Academia Sinica in Taiwan; the China Medical University under the "Aim for the Top University Plan" of the Ministry of Education, Taiwan; the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; Mackay Medical College [RD-1020082 and RD-1030085]; Mao-Kuei Lin Research Fund of Chicony Electronics; and Kaohsiung Medical University (KMU-TP103D09 and KMU-TP103D00).	Zhang XL, 2012, ENDOCRINE, V41, P398, DOI 10.1007/s12020-012-9623-1; Lokuta AJ, 2005, CIRCULATION, V111, P988, DOI 10.1161/01.CIR.0000156461.81529.D7; Chang PY, 2013, CARDIOVASC RES, V99, P137, DOI 10.1093/cvr/cvt062; Fried LF, 2003, J AM COLL CARDIOL, V41, P1364, DOI 10.1016/S0735-1097(03)00163-3; Chen CH, 2003, CIRCULATION, V107, P2102, DOI 10.1161/01.CIR.0000065220.70220.F7; Bock JS, 2010, CIRCULATION, V121, P2592, DOI 10.1161/CIRCULATIONAHA.109.886473; Patel PC, 2009, CIRC-HEART FAIL, V2, P98, DOI 10.1161/CIRCHEARTFAILURE.108.807271; Batista MC, 2004, METABOLISM, V53, P1255, DOI 10.1016/j.metabol.2004.05.001; Chan DT, 2008, ATHEROSCLEROSIS, V196, P823, DOI 10.1016/j.atherosclerosis.2007.01.023; Karbach S, 2014, CURR PHARM DESIGN, V20, P3579; ATTMAN PO, 1991, NEPHRON, V57, P401; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; Chan HC, 2013, BLOOD, V122, P3632, DOI 10.1182/blood-2013-05-504639; Chen HH, 2007, J LIPID RES, V48, P177, DOI 10.1194/jlr.M500481-JLR200; GONEN B, 1985, METABOLISM, V34, P10, DOI 10.1016/0026-0495(85)90052-6; Ke LY, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0428-y; Ke LY, 2011, PURE APPL CHEM, V83, P1731, DOI 10.1351/PAC-CON-10-12-07; Lee AS, 2012, APOPTOSIS, V17, P1009, DOI 10.1007/s10495-012-0726-1; Lee AS, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-64; Liang HY, 2010, ACTA CARDIOL SIN, V26, P157; Lu J, 2008, DIABETES, V57, P158, DOI 10.2337/db07-1287; Martin FL, 2012, AM J PHYSIOL-REG I, V302, P8292; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577; Yang CY, 2003, ARTERIOSCL THROM VAS, V23, P1083, DOI 10.1161/01.ATV.0000071350.78872.C4	25	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	JUL	2015	84						36	44		10.1016/j.yjmcc.2015.03.016		9	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CL3GU	WOS:000356839200005		
J	Aoyama, Y; Kobayashi, K; Morishita, Y; Maeda, K; Murohara, T				Aoyama, Yutaka; Kobayashi, Koichi; Morishita, Yoshihiro; Maeda, Kengo; Murohara, Toyoaki			Wnt11 gene therapy with adeno-associated virus 9 improves the survival of mice with myocarditis induced by coxsackievirus B3 through the suppression of the inflammatory reaction	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Viral myocarditis; Wnt11; Adeno-associated virus 9; Inflammation	FULMINANT MYOCARDITIS; VIRAL MYOCARDITIS; WINGLESS HOMOLOG; CELLS; CARDIOMYOPATHY; EXPRESSION; VECTORS; MECHANISMS; PATHWAY; TARGET	The wnt signaling pathway plays important roles in development and in many diseases. Recently several reports suggest that non-canonical Wnt proteins contribute to the inflammatory response in adult animals. However, the effects of Wnt proteins on virus-induced myocarditis have not been explored. Here, we investigated the effect of Wnt1 1 protein in a model of myocarditis induced by coxsackievirus B3 (CVB3) using recombinant adeno-associated virus 9 (rAAV9). The effect of Wnt1 1 gene therapy on a CVB3-induced myocarditis model was examined using male BALB/c mice. Mice received a single intravenous injection of either rAAV9-Wnt1 1 or rAAV9-LacZ 2 weeks before intraperitoneal administration of CVB3. Intravenous injection of the rAAV9 vector resulted in efficient, durable, and relatively cardiac-specific transgene expression. Survival was significantly greater among rAAV9-Wnt11 treated mice than among mice treated with rAAV9-LacZ (87.5% vs. 54.1%, P < 0.05). Wnt11 expression also reduced the infiltration of inflammatory cells, necrosis of the myocardium, and suppressed the mRNA expression of inflammatory cytokines. This is the first report to show that Wntl I expression improves the survival of mice with CVB3-induced myocarditis. AAV9-mediated Wnt11 gene therapy produces beneficial effects on cardiac function and increases the survival of mice with CVB3-induced myocarditis through the suppression of both infiltration of inflammatory cells and gene expression of inflammatory cytokines. (C) 2015 The Authors. Published by Elsevier Ltd.	[Aoyama, Yutaka; Kobayashi, Koichi; Morishita, Yoshihiro; Maeda, Kengo; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 466, Japan	Kobayashi, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	k-koba@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014		Ministry of Education, Culture, Sports, Science and Technology of Japan [25461104, 23390208, 20249045]; Suzuken Memorial Foundation, Japan	This study was supported by grants (23390208 and 20249045 to Toyoaki Murohara, and Grant-in-Aid for Young Scientists B and 25461104 to Koichi Kobayashi) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and grant from Suzuken Memorial Foundation, Japan (to Koichi Kobayashi).	Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.0.CO;2-D; Yajima T, 2006, CIRCULATION, V114, P2364, DOI 10.1161/CIRCULATIONAHA.106.642454; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Liu PP, 2001, CIRCULATION, V104, P1076, DOI 10.1161/hc3401.095198; Kawai C, 1999, CIRCULATION, V99, P1091; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Blauwet LA, 2010, PROG CARDIOVASC DIS, V52, P274, DOI 10.1016/j.pcad.2009.11.006; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Esfandiarei M, 2008, ANNU REV PATHOL-MECH, V3, P127, DOI 10.1146/annurev.pathol.3.121806.151534; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; Goser S, 2006, CIRCULATION, V114, P1693, DOI 10.1161/CIRCULATIONAHA.106.635664; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Rose NR, 2009, J CLIN IMMUNOL, V29, P730, DOI 10.1007/s10875-009-9339-z; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Gupta S, 2008, NAT CLIN PRACT CARD, V5, P693, DOI 10.1038/ncpcardio1331; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Xiao X, 1998, J VIROL, V72, P2224; McCarthy RE, 2000, NEW ENGL J MED, V342, P690, DOI 10.1056/NEJM200003093421003; Chandrakesan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079432; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Huber SA, 2006, CIRC RES, V99, P1109, DOI 10.1161/01.RES.0000249405.13536.49; Jiang Z, 2008, J GENE MED, V10, P918, DOI 10.1002/jgm.1215; Liu XY, 2011, AM J PHYSIOL-GASTR L, V301, pG992, DOI 10.1152/ajpgi.00080.2011; Maier Reinhard, 2004, Clin Dev Immunol, V11, P1, DOI 10.1080/10446670410001670427; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Seko Y, 1998, CIRC RES, V82, P613; Shen Yan, 2003, Zhonghua Yi Xue Za Zhi, V83, P981; SMITH WG, 1970, AM HEART J, V80, P34, DOI 10.1016/0002-8703(70)90035-9; Weinzierl AO, 2008, J VIROL, V82, P8149, DOI 10.1128/JVI.00047-08; Yasukawa H, 2003, J CLIN INVEST, V111, P469, DOI 10.1172/JC1200316491; Yuan J, 2009, CIRC RES, V104, P628, DOI 10.1161/CIRCRESAHA.108.192179; Yue Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018186; Zhang HFM, 2005, MOL CELL BIOL, V25, P6247, DOI 10.1128/MCB.25.14.6247-6258.2005	42	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	JUL	2015	84						45	51		10.1016/j.yjmcc.2015.04.009		7	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CL3GU	WOS:000356839200006		
J	Kobayashi, S; Nakamura, TY; Wakabayashi, S				Kobayashi, Soushi; Nakamura, Tomoe Y.; Wakabayashi, Shigeo			Calcineurin B homologous protein 3 negatively regulates cardiomyocyte hypertrophy via inhibition of glycogen synthase kinase 3 phosphorylation	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Cardiac hypertrophy; Calcineurin B homologous protein; Cardiomyocytes	CARDIAC-HYPERTROPHY; NA+/H+ EXCHANGER-1; HEART-FAILURE; CA2+-BINDING PROTEIN; SIGNALING PATHWAYS; ESSENTIAL COFACTOR; PRESSURE-OVERLOAD; CA2+ SIGNALS; TESCALCIN; MYOCYTES	Cardiac hypertrophy is a leading cause of serious heart diseases. Although many signaling molecules are involved in hypertrophy, the functions of some proteins in this process are still unknown. Calcineurin B homologous protein 3 (CHP3)/tescalcin is an EF-hand Ca2+-binding protein that is abundantly expressed in the heart; however, the function of CHP3 is unclear. Here, we aimed to identify the cardiac functions of CHP3. CHP3 was expressed in hearts at a wide range of developmental stages and was specifically detected in neonatal rat ventricular myocytes (NRVMs) but not in cardiac fibroblasts in culture. Moreover, knockdown of CHP3 expression using adenoviral-based RNA interference in NRVMs resulted in enlargement of cardiomyocyte size, concomitant with increased expression of a pathological hypertrophy marker ANP. This same treatment elevated glycogen synthase kinase (GSK3 alpha/beta) phosphorylation, which is known to inhibit GSK3 function. In contrast, CHP3 overexpression blocked the insulin-induced phosphorylation of GSK3 alpha/beta without affecting the phosphorylation of Akt, which is an upstream kinase of GSK3 alpha/beta, in HEK293 cells, and it inhibited both IGF-1-induced phosphorylation of GSK3 beta and cardiomyocyte hypertrophy in NRVMs. Co-immunoprecipitation experiments revealed that GSK3 beta interacted with CHP3. However, a Ca2+-binding-defective mutation of CHP3 (CHP3-D123A) also interacted with GSK3 beta and had the same inhibitory effect on GSK3 alpha/beta phosphorylation, suggesting that the action of CHP3 was independent of Ca2+. These findings suggest that CHP3 functions as a novel negative regulator of cardiomyocyte hypertrophy via inhibition of GSK3 alpha/beta phosphorylation and subsequent enzymatic activation of GSK3 alpha/beta. (C) 2015 Elsevier Ltd. All rights reserved.	[Kobayashi, Soushi; Nakamura, Tomoe Y.; Wakabayashi, Shigeo] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Mol Physiol, Suita, Osaka 5658565, Japan	Wakabayashi, S (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cardiac Physiol, Dept Mol Physiol, Fujishirodai 5-7-1, Suita, Osaka 5658565, Japan.	wak@ri.ncvc.go.jp			JSPS KAKENHI from Ministry of Education, Science, Sports, Technology, and Culture of Japan [24790231, 26860155, 23290046, 26460312, 24590293, 22659046]; Intramural Research Fund for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center [22-2-1]	This work was supported by JSPS KAKENHI Grant-in-Aid for Young Scientists (B) (no. 24790231 and no. 26860155) and by Grants-in-Aid for Scientific Research (B) (no. 23290046) and (C) (no. 26460312 and no. 24590293) and Exploratory Research (no. 22659046) from the Ministry of Education, Science, Sports, Technology, and Culture of Japan and the Intramural Research Fund for Cardiovascular Diseases (22-2-1) of the National Cerebral and Cardiovascular Center.	Ammar Youssef Ben, 2006, EMBO J, V25, P2315, DOI 10.1038/sj.emboj.7601145; Nakamura TY, 2008, CIRC RES, V103, P891, DOI 10.1161/CIRCRESAHA.108.175141; Zarain-Herzberg A, 2011, IUBMB LIFE, V63, P847, DOI 10.1002/iub.545; Swaminathan PD, 2012, CIRC RES, V110, P1661, DOI 10.1161/CIRCRESAHA.111.243956; Pang TX, 2002, J BIOL CHEM, V277, P43771, DOI 10.1074/jbc.M208313200; Palaniyandi SS, 2009, CARDIOVASC RES, V82, P229, DOI 10.1093/cvr/cvp001; Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Woulfe KC, 2010, CIRC RES, V106, P1635, DOI 10.1161/CIRCRESAHA.109.211482; Force T, 2009, J BIOL CHEM, V284, P9643, DOI 10.1074/jbc.R800077200; Perera EM, 2001, ENDOCRINOLOGY, V142, P455, DOI 10.1210/en.142.1.455; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Zhai PY, 2007, J BIOL CHEM, V282, P33181, DOI 10.1074/jbc.M705133200; Fiedler B, 2004, CARDIOVASC RES, V63, P450, DOI 10.1016/j.cardiores.2004.04.002; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Liang QR, 2003, J MOL CELL CARDIOL, V35, P1385, DOI 10.1016/j.yjmcc.2003.10.001; Singh M, 2010, CARDIOVASC RES, V86, P20, DOI 10.1093/cvr/cvp402; Bao Y, 2009, GENE EXPR PATTERNS, V9, P273, DOI 10.1016/j.gep.2009.03.004; Cheng H, 2011, J MOL CELL CARDIOL, V51, P607, DOI 10.1016/j.yjmcc.2010.11.020; Di Sole F, 2012, AM J PHYSIOL-RENAL, V303, pF165, DOI 10.1152/ajprenal.00628.2011; Gutierrez-Ford C, 2003, BIOCHEMISTRY-US, V42, P14553, DOI 10.1021/bi034870f; Heineke Joerg, 2013, Methods Mol Biol, V963, P279, DOI 10.1007/978-1-62703-230-8_17; Inoue H, 2003, BIOL PHARM BULL, V26, P148, DOI 10.1248/bpb.26.148; Levay K, 2007, J CLIN INVEST, V117, P2672, DOI 10.1172/JCI27465; Mailander J, 2001, FEBS LETT, V507, P331, DOI 10.1016/S0014-5793(01)02986-6; Matsuda T, 2008, P NATL ACAD SCI USA, V105, P20900, DOI 10.1073/pnas.0808315106; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; Nakamura TY, 2011, CIRC RES, V109, P512, DOI 10.1161/CIRCRESAHA.111.248864; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Pang TX, 2004, BIOCHEMISTRY-US, V43, P3628, DOI 10.1021/bi0360004; Schaub MC, 2008, BIOCHEM BIOPH RES CO, V369, P247, DOI 10.1016/j.bbrc.2007.10.082; Zaun HC, 2008, J BIOL CHEM, V283, P12456, DOI 10.1074/jbc.M800267200; Zhou JB, 2010, J CLIN INVEST, V120, P2280, DOI 10.1172/JCI41407	35	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	JUL	2015	84						133	142		10.1016/j.yjmcc.2015.04.018		10	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CL3GU	WOS:000356839200017		
J	Miura, M; Taguchi, Y; Nagano, T; Sasaki, M; Handoh, T; Shindoh, C				Miura, Masahito; Taguchi, Yuhto; Nagano, Tsuyoshi; Sasaki, Mai; Handoh, Tetsuya; Shindoh, Chiyohiko			Effect of myofilament Ca2+ sensitivity on Ca2+ wave propagation in rat ventricular muscle	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Ca2+ waves; Myofilament Ca2+ sensitivity; ROS; Muscle stretch	CARDIAC SARCOPLASMIC-RETICULUM; HUMAN HEART-FAILURE; MYOCARDIAL-INFARCTION; SARCOMERE-LENGTH; REDOX REGULATION; CALCIUM; TRABECULAE; ARRHYTHMIA; RELEASE; SENSITIZATION	Background: The propagation velocity of Ca2+ waves determines delayed afterdepolarization and affects the occurrence of triggered arrhythmias in cardiac muscle. We focused on myofilament Ca2+ sensitivity, investigating how the velocity of Ca2+ waves responds to its increased sensitivity resulting from muscle stretch or the addition of a myofilament Ca2+ sensitizer, SCH00013. We further investigated whether production of reactive oxygen species (ROS) may be involved in the change in velocity. Methods: Trabeculae were obtained from rat hearts. Force, sarcomere length, and [Ca2+](1) were measured. ROS production was estimated from 2',7'-dichlorofluorescein (DCF) fluorescence. Trabeculae were exposed to a 10 mM Ca2+ jet for the induction of Ca2+ leak from the sarcoplasmic reticulum in its exposed region. Ca2+ waves were induced by 2.5-Hz stimulus trains for 7.5 s (24 degrees C, 2.0 mM [Ca2+](0)). Muscle stretch of 5, 10, and 15% was applied 300 ms after the last stimulus of the train. Results: Muscle stretch increased the DCF fluorescence, the amplitude of aftercontractions, and the velocity of Ca2+ waves depending on the degree of stretch. After preincubation with 3 mu M diphenyleneiodonium (DPI), muscle stretch increased only the amplitude of aftercontractions but not the DCF fluorescence nor the velocity of Ca2+ waves. SCH00013 (30 mu M) increased the DCF fluorescence, the amplitude of aftercontractions, and the velocity of Ca2+ waves. DPI suppressed these increases. Conclusions: Muscle stretch increases the velocity of Ca2+ waves by increasing ROS production, not by increasing myofilament Ca2+ sensitivity. In the case of SCH00013, ROS production increases myofilament Ca2+ sensitivity and the velocity of Ca2+ waves. These results suggest that ROS rather than myofilament Ca2+ sensitivity plays an important role in the determination of the velocity of Ca2+ waves, that is, arrhythmogenesis. (C) 2015 Elsevier Ltd. All rights reserved.	[Miura, Masahito; Taguchi, Yuhto; Nagano, Tsuyoshi; Sasaki, Mai; Handoh, Tetsuya; Shindoh, Chiyohiko] Tohoku Univ, Grad Sch Med, Dept Clin Physiol, Hlth Sci, Sendai, Miyagi 9808574, Japan	Miura, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Clin Physiol,Hlth Sci, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	mmiura@med.tohoku.ac.jp			Japan Society for the Promotion of Science [23590253]	This work was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (M. Miura, No. 23590253).	Aldieri E, 2008, CURR DRUG METAB, V9, P686, DOI 10.2174/138920008786049285; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Knollmann BC, 2001, TRENDS CARDIOVAS MED, V11, P206, DOI 10.1016/S1050-1738(01)00115-3; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Janssen PML, 1997, AM J PHYSIOL-HEART C, V272, pH1892; Wakayama Y, 2005, CIRC RES, V96, P1266, DOI 10.1161/01.RES.0000172544.56818.54; Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642; Cheng H, 1996, AM J PHYSIOL-CELL PH, V270, pC148; KENTISH JC, 1986, CIRC RES, V58, P755; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; TERKEURS HEDJ, 1980, CIRC RES, V46, P703; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Schober T, 2012, CIRC RES, V111, P170, DOI 10.1161/CIRCRESAHA.112.270041; Jeong EM, 2012, J MOL CELL CARDIOL, V52, P454, DOI 10.1016/j.yjmcc.2011.09.018; Van Eyk JE, 1998, CIRC RES, V82, P261; Wagner S, 2011, CIRC RES, V108, P555, DOI 10.1161/CIRCRESAHA.110.221911; Liu YP, 2003, CIRC RES, V93, P573, DOI 10.1161/01.RES.0000091261.19387.AE; Endoh M, 2008, CIRC J, V72, P1915, DOI 10.1253/circj.CJ-08-0838; van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5; Lukyanenko V, 1999, J PHYSIOL-LONDON, V521, P575, DOI 10.1111/j.1469-7793.1999.00575.x; Iribe G, 2009, CIRC RES, V104, P787, DOI 10.1161/CIRCRESAHA.108.193334; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Prosser BL, 2013, CARDIOVASC RES, V98, P307, DOI 10.1093/cvr/cvt066; BILLMAN GE, 1993, AM J PHYSIOL, V265, pH1529; Diaz ME, 2001, BIOPHYS J, V80, P1915; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; Huke S, 2010, J MOL CELL CARDIOL, V48, P824, DOI 10.1016/j.yjmcc.2010.01.011; Kawakami M, 1998, MOL PHARMACOL, V53, P497; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Miura M, 2013, J MOL CELL CARDIOL, V56, P97, DOI 10.1016/j.yjmcc.2012.12.011; Miura M, 2010, CIRCULATION, V121, P2711, DOI 10.1161/CIRCULATIONAHA.109.907717; Miura M, 1998, AM J PHYSIOL-HEART C, V274, pH266; Myerburg RJ, 1997, AM J CARDIOL, V80, pF10, DOI 10.1016/S0002-9149(97)00477-3; PACKER M, 1985, CIRCULATION, V72, P681; Sugai Y, 2009, J CARDIOVASC PHARM, V53, P517, DOI 10.1097/FJC.0b013e3181a913f4; Sugawara H, 1998, J PHARMACOL EXP THER, V287, P214; Tadano N, 2005, J PHARMACOL SCI, V97, P53, DOI 10.1254/jphs.FP0040654; Tanaki K, 2001, J AM COLL CARDIOL, V37, P676, DOI 10.1016/S0735-1097(00)01123-2; Tang L, 2012, J CARDIOVASC ELECTR, V23, P1364, DOI 10.1111/j.1540-8167.2012.02400.x; Tveito A, 2012, PROG BIOPHYS MOL BIO, V110, P295, DOI 10.1016/j.pbiomolbio.2012.07.005; van der Velden J, 2004, CIRC RES, V95, pE85, DOI 10.1161/01.RES.0000149531.02904.09; Venkataraman R, 2013, J MOL CELL CARDIOL, V60, P8, DOI 10.1016/j.yjmcc.2013.03.022; Wakayama Y, 2001, AM J PHYSIOL-HEART C, V281, pH2133; Wolff MR, 1996, J CLIN INVEST, V98, P167, DOI 10.1172/JCI118762	45	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	JUL	2015	84						162	169		10.1016/j.yjmcc.2015.04.027		8	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CL3GU	WOS:000356839200020		
J	Nishida, K; Yamaguchi, O; Otsu, K				Nishida, Kazuhiko; Yamaguchi, Osamu; Otsu, Kinya			Degradation systems in heart failure	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Review						Heart failure; Calpain; Autophagy; Ubiquitin proteasome system; Inflammation	NF-KAPPA-B; MESSENGER-RNA DECAY; UBIQUITIN-PROTEASOME SYSTEM; NECROSIS-FACTOR-ALPHA; SIGNAL-REGULATING KINASE-1; MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; INDUCED CARDIOMYOCYTE HYPERTROPHY; ENDOPLASMIC-RETICULUM STRESS; ISCHEMIA-REPERFUSION INJURY; CARDIAC MYOCYTE HYPERTROPHY	Heart failure is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or the ejection of blood, and is a leading cause of morbidity and mortality in industrialized countries. The mechanisms underlying the development of heart failure are multiple, complex and not well understood. Cardiac mass and its homeostasis are maintained by the balance between protein synthesis and degradation, and an imbalance is likely to result in cellular dysfunction and disease. The protein degradation systems are the principle mechanisms for maintaining cellular homeostasis via protein quality control. Three major protein degradation systems have been identified, namely the calpain system, autophagy, and the ubiquitin proteasome system. Proinflammatory mediators involve the development and progression of heart failure. DNA and RNA degradation systems play a critical role in regulating inflammation and maintaining cellular homeostasis mediated by damaged DNA clearance and posttranscriptional regulation, respectively. This review discusses some recent advances in understanding the role of these degradation systems in heart failure. (C) 2015 Elsevier Ltd. All rights reserved.	[Nishida, Kazuhiko; Otsu, Kinya] Kings Coll London, British Heart Fdn Ctr Excellence, Div Cardiovasc, London SE5 9NU, England; [Yamaguchi, Osamu] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan	Otsu, K (reprint author), Kings Coll London, British Heart Fdn Ctr Excellence, Div Cardiovasc, 125 Coldharbour Lane, London SE5 9NU, England.	kinya.otsu@kcl.ac.uk			British Heart Foundation [CH/11/3/29051, RG/11/12/29052]; King's BHF Centre of Excellence [2E/08/003]	We are thankful to all members we have worked with for their cooperation, effort and enthusiasm. This work was supported by the British Heart Foundation (CH/11/3/29051, RG/11/12/29052) and the King's BHF Centre of Excellence (2E/08/003).	Kumarswamy R, 2013, CIRC RES, V113, P676, DOI 10.1161/CIRCRESAHA.113.300226; Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162; CLUBB FJ, 1984, LAB INVEST, V50, P571; Ma J, 2012, J BIOL CHEM, V287, P27480, DOI 10.1074/jbc.M112.358929; Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; Briata P, 2013, BBA-GENE REGUL MECH, V1829, P689, DOI 10.1016/j.bbagrm.2012.11.003; Griseri P, 2014, J INTERF CYTOK RES, V34, P242, DOI 10.1089/jir.2013.0140; Li GH, 2009, CIRC RES, V104, P896, DOI 10.1161/CIRCRESAHA.108.172882; Lek A, 2013, J NEUROSCI, V33, P5085, DOI 10.1523/JNEUROSCI.3560-12.2013; Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947; Takano J, 2011, MOL CELL BIOL, V31, P4097, DOI 10.1128/MCB.05189-11; Xiao L, 2002, AM J PHYSIOL-CELL PH, V282, pC926, DOI 10.1152/ajpcell.00254.2001; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Sanduja S, 2011, WIRES RNA, V2, P42, DOI 10.1002/wrna.28; Xiao L, 2014, CURR OPIN PHARMACOL, V19, P46, DOI 10.1016/j.coph.2014.07.006; Rothermel BA, 2008, CIRC RES, V103, P1363, DOI 10.1161/CIRCRESAHA.108.186551; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; Meiners S, 2006, FREE RADICAL BIO MED, V40, P2232, DOI 10.1016/j.freeradbiomed.2006.03.003; Savchenko AS, 2014, BLOOD, V123, P141, DOI 10.1182/blood-2013-07-514992; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Xia HG, 2010, AUTOPHAGY, V6, P61; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/mcb.247.15.6719-6727.2004; Zhang J, 1998, MOL CELL BIOL, V18, P5272; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Bhuiyan MS, 2013, J CLIN INVEST, V123, P5284, DOI 10.1172/JCI70877; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; POLLACK Y, 1984, NUCLEIC ACIDS RES, V12, P4811, DOI 10.1093/nar/12.12.4811; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Inserte J, 2012, CARDIOVASC RES, V96, P23, DOI 10.1093/cvr/cvs232; DANON MJ, 1981, NEUROLOGY, V31, P51; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; Hamid T, 2011, CARDIOVASC RES, V89, P129, DOI 10.1093/cvr/cvq274; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Powell SR, 2005, ANTIOXID REDOX SIGN, V7, P538, DOI 10.1089/ars.2005.7.538; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI 10.1089/ARS.2008.2333; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Aikawa R, 2001, BIOCHEM BIOPH RES CO, V289, P901, DOI 10.1006/bbrc.2001.6068; Stangl K, 2002, BIOCHEM BIOPH RES CO, V291, P542, DOI 10.1006/bbrc.2002.6476; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Deswal A, 2001, CIRCULATION, V103, P2055; Solomon V, 1996, J BIOL CHEM, V271, P26690; Napirei M, 2004, BIOCHEM J, V380, P929, DOI 10.1042/BJ20040046; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; Tanaka Y, 2000, NATURE, V406, P902; Napirei M, 2000, NAT GENET, V25, P177; Kandilis AN, 2014, EXPERT OPIN INV DRUG, V23, P67, DOI 10.1517/13543784.2013.840287; Li XP, 2009, CARDIOVASC RES, V83, P72, DOI 10.1093/cvr/cvp100; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Day SM, 2013, AM J PHYSIOL-HEART C, V304, pH1283, DOI 10.1152/ajpheart.00249.2012; Higuchi Y, 2002, J MOL CELL CARDIOL, V34, P233, DOI 10.1006/jmcc.2001.1505; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Li J, 2011, FASEB J, V25, P883, DOI 10.1096/fj.10-160895; Predmore JM, 2010, CIRCULATION, V121, P997, DOI 10.1161/CIRCULATIONAHA.109.904557; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Amin JK, 2001, J MOL CELL CARDIOL, V33, P131, DOI 10.1006/jmcc.2000.1285; Cheng ZW, 2012, J HUM GENET, V57, P407, DOI 10.1038/jhg.2012.72; Steinberg SF, 2013, CIRC RES, V112, P393, DOI 10.1161/CIRCRESAHA.111.300496; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Maekawa N, 2002, J AM COLL CARDIOL, V39, P1229, DOI 10.1016/S0735-1097(02)01738-2; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Nakamura K, 1998, CIRCULATION, V98, P794; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Tian ZW, 2012, CIRC RES, V111, P532, DOI 10.1161/CIRCRESAHA.112.270983; Sag CM, 2014, J MOL CELL CARDIOL, V73, P103, DOI 10.1016/j.yjmcc.2014.02.002; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Timmers L, 2009, CIRC RES, V104, P699, DOI 10.1161/CIRCRESAHA.108.189746; Kashiwase K, 2005, BIOCHEM BIOPH RES CO, V327, P136, DOI 10.1016/j.bbrc.2004.12.002; HO CY, 1994, BIOCHIMIE, V76, P369, DOI 10.1016/0300-9084(94)90110-4; Osterholt M, 2013, HEART FAIL REV, V18, P645, DOI 10.1007/s10741-012-9346-7; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Misra A, 2003, CIRCULATION, V108, P3075, DOI 10.1161/01.CIR.0000108929.93074.0B; Elliott PJ, 2003, J MOL MED-JMM, V81, P235, DOI 10.1007/s00109-003-0422-2; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Galvez AS, 2007, CIRC RES, V100, P1071, DOI 10.1161/01.RES.0000261938.28365.11; Birks EJ, 2008, CARDIOVASC RES, V79, P472, DOI 10.1093/cvr/cvn083; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Geiger SK, 2008, J MOL MED-JMM, V86, P281, DOI 10.1007/s00109-007-0275-1; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Bliksoen M, 2012, INT J CARDIOL, V158, P132, DOI 10.1016/j.ijcard.2012.04.047; Wang XJ, 2013, CIRC RES, V112, P367, DOI 10.1161/CIRCRESAHA.112.268706; CONG JY, 1989, J BIOL CHEM, V264, P10096; Kawamura N, 2005, CARDIOVASC RES, V66, P520, DOI 10.1016/j.cardiores.2005.02.007; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Atianand MK, 2013, J IMMUNOL, V190, P1911, DOI 10.4049/jimmunol.1203162; Taneike M, 2011, J BIOL CHEM, V286, P32170, DOI 10.1074/jbc.M111.248088; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Li J, 2011, J CLIN INVEST, V121, P3689, DOI 10.1172/JCI45709; Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Condorelli G, 2014, J AM COLL CARDIOL, V63, P2177, DOI 10.1016/j.jacc.2014.01.050; Schmieder RE, 1996, JAMA-J AM MED ASSOC, V275, P1507, DOI 10.1001/jama.275.19.1507; McNeil P, 2009, NAT CELL BIOL, V11, P7, DOI 10.1038/ncb0109-7; Morikawa N, 2007, EUR HEART J, V28, P2992, DOI 10.1093/eurheartj/ehm483; Freund C, 2005, CIRCULATION, V111, P2319, DOI 10.1161/01.CIR.0000164237.58200.5A; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Barta J, 2005, MOL CELL BIOCHEM, V278, P1, DOI 10.1007/s11010-005-1370-7; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Calise J, 2013, AM J PHYSIOL-HEART C, V304, pH337, DOI 10.1152/ajpheart.00604.2012; Cao DJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000016; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; CROALL DE, 1991, PHYSIOL REV, V71, P813; Divald A, 2010, CIRC RES, V106, P1829, DOI 10.1161/CIRCRESAHA.110.219485; Divald A, 2006, FREE RADICAL BIO MED, V40, P156, DOI 10.1016/j.freeradbiomed.2005.09.022; Gherzi R, 2014, SEMIN CELL DEV BIOL, V34, P2, DOI 10.1016/j.semcdb.2014.05.004; Hariharan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051632; Higuchi Y, 2003, J BIOL CHEM, V278, P20770, DOI 10.1074/jbc.M213203200; Hikoso S, 2004, CIRCULATION, V110, P2631, DOI 10.1161/01.CIR.0000146798.70980.9A; Hikoso S, 2007, J AM COLL CARDIOL, V50, P453, DOI 10.1016/j.jacc.2007.03.053; Hirotani S, 2004, J MOL CELL CARDIOL, V36, P799, DOI 10.1016/j.yjmcc.2004.03.002; Honda S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5004; Iwai K, 2014, BBA-MOL CELL RES, V1843, P129, DOI 10.1016/j.bbamcr.2013.03.011; Kassiotis C, 2009, CIRCULATION, V120, pS191, DOI 10.1161/CIRCULATIONAHA.108.842252; Kawano S, 2006, AM J PHYSIOL-HEART C, V291, pH1337, DOI 10.1152/ajpheart.01175.2005; Kobayashi S., 2015, J MOL CELL CARDIOL, V1852, P252; Kotta-Loizou I, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0161-y; Kratsios P, 2010, CIRC RES, V106, P133, DOI 10.1161/CIRCRESAHA.109.202200; Kuribara J, 2009, J CARDIOL, V53, P196, DOI 10.1016/j.jjcc.2008.10.013; Larsen AK, 2008, BIOCHEM J, V411, P657, DOI 10.1042/BJ20070522; Maejima Y, 2015, AM J PHYSIOL-HEART C, V308, pH259, DOI 10.1152/ajpheart.00711.2014; Mason PA, 2012, AGE, V34, P1317, DOI 10.1007/s11357-011-9306-5; Matsumura Y, 2001, MOL CELL, V33, P1133; Meiners S, 2008, MED RES REV, V28, P309; Mino T, 2013, BIOTECHNOL GENET ENG, V29, P49, DOI 10.1080/02648725.2013.801236; Moyzis AG, 2015, AM J PHYSIOL-HEART C, V308, pH183, DOI 10.1152/ajpheart.00708.2014; Nakayama H, 2013, TRENDS ENDOCRIN MET, V24, P546, DOI 10.1016/j.tem.2013.06.004; Oyabu J, 2013, BIOCHEM BIOPH RES CO, V441, P787, DOI 10.1016/j.bbrc.2013.10.135; Pagan J, 2013, CIRC RES, V112, P1046, DOI 10.1161/CIRCRESAHA.112.300521; Portbury AL, 2011, J BIOL CHEM, V286, P9929, DOI 10.1074/jbc.R110.170571; Pye J, 2003, AM J PHYSIOL-HEART C, V284, pH919, DOI 10.1152/ajpheart.00851.2002; Seta Y, 1996, J Card Fail, V2, P243, DOI 10.1016/S1071-9164(96)80047-9; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003; Stotland A, 2015, BIOCH BIOPH IN PRESS; Takahashi M, 2005, CARDIOVASC RES, V65, P356, DOI 10.1016/j.cardiores.2004.09.022; Tanaki K, 2001, J AM COLL CARDIOL, V37, P676, DOI 10.1016/S0735-1097(00)01123-2; TARAZI RC, 1985, ANNU REV MED, V36, P407; Uehata T, 2013, BBA-GENE REGUL MECH, V1829, P708, DOI 10.1016/j.bbagrm.2013.03.001; Walsh S, 2009, SCIENCE, V324, P98; WHIPPLE G, 1991, J ANIM SCI, V69, P4449; Wohlschlaeger J, 2010, J HEART LUNG TRANSPL, V29, P125, DOI 10.1016/j.healun.2009.07.022; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yamaguchi O, 2012, CARDIOVASC RES, V96, P46, DOI 10.1093/cvr/cvs236; Yasuda Toshihiro, 2009, Leg Med (Tokyo), V11 Suppl 1, pS213, DOI 10.1016/j.legalmed.2009.01.092; YOSHIDA K, 1993, BIOCHIM BIOPHYS ACTA, V1182, P215, DOI 10.1016/0925-4439(93)90143-O	176	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	JUL	2015	84						212	222		10.1016/j.yjmcc.2015.05.004		11	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CL3GU	WOS:000356839200026		
J	Dohzono, S; Toyoda, H; Matsumoto, T; Suzuki, A; Terai, H; Nakamura, H				Dohzono, Sho; Toyoda, Hiromitsu; Matsumoto, Tomiya; Suzuki, Akinobu; Terai, Hidetomi; Nakamura, Hiroaki			The influence of preoperative spinal sagittal balance on clinical outcomes after microendoscopic laminotomy in patients with lumbar spinal canal stenosis	JOURNAL OF NEUROSURGERY-SPINE			English	Article						microendoscopic lumbar decompression; sagittal vertical axis; C-7 plumb line; low-back pain	LOW-BACK-PAIN; DEGENERATIVE KYPHOSIS; VOLUNTEERS; ALIGNMENT; PARAMETERS	OBJECT More information about the association between preoperative anterior translation of the C-7 plumb line and clinical outcomes after decompression surgery in patients with lumbar spinal canal stenosis (LSS) would help resolve problems for patients with sagittal imbalance. The authors evaluated whether preoperative sagittal alignment of the spine affects low-back pain and clinical outcomes after microendoscopic laminotomy. METHODS This study was a retrospective review of prospectively collected surgical data. The study comprised 88 patients with LSS (47 men and 41 women) who ranged in age from 39 to 86 years (mean age 68.7 years). All patients had undergone microendoscopic laminotomy at Osaka City University Graduate School of Medicine from May 2008 through October 2012. The minimum duration of clinical and radiological follow-up was 6 months. All patients were evaluated by Japanese Orthopaedic Association (JOA) and visual analog scale (VAS) scores for low-back pain, leg pain, and leg numbness before and after surgery. The distance between the C-7 plumb line and the posterior corner of the sacrum (sagittal vertical axis [SVAD was measured on lateral standing radiographs of the entire spine obtained before surgery. Radiological factors and clinical outcomes were compared between patients with a preoperative SVA >= 50 mm (forward-bending trunk [F] group) and patients with a preoperative SVA < 50 mm (control [C] group). A total of 35 patients were allocated to the F group (19 male and 16 female) and 53 to the C group (28 male and 25 female). RESULTS The mean SVA was 81.0 mm for patients in the F group and 22.0 mm for those in the C group. At final follow-up evaluation, no significant differences between the groups were found for the JOA score improvement ratio (73.3% vs 77.1%) or the VAS score for leg numbness (23.6 vs 24.0 mm); the VAS score for low-back pain was significantly higher for those in the F group (21.1 mm) than for those in the C group (11.0 mm); and the VAS score for leg pain tended to be higher for those in the F group (18.9 +/- 29.1 mm) than for those in the C group (9.4 +/- 16.0 mm). CONCLUSIONS Preoperative alignment of the spine in the sagittal plane did not affect Jak scores after microendoscopic laminotomy in patients with LSS. However, low-back pain was worse for patients with preoperative anterior translation of the C-7 plumb line than for those without.	[Dohzono, Sho; Toyoda, Hiromitsu; Suzuki, Akinobu; Terai, Hidetomi; Nakamura, Hiroaki] Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka 5458585, Japan; [Matsumoto, Tomiya] Osaka Rosai Hosp, Dept Orthopaed Surg, Osaka, Japan	Toyoda, H (reprint author), Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	h-toyoda@msic.med.osaka-cu.ac.jp					Glassman SD, 2005, SPINE, V30, P2024, DOI 10.1097/01.brs.0000179086.30449.96; MAYER TG, 1989, SPINE, V14, P33, DOI 10.1097/00007632-198901000-00006; Jang JS, 2009, NEUROSURGERY, V64, P115, DOI 10.1227/01.NEU.0000335642.14527.26; Shiri R, 2008, AM J EPIDEMIOL, V167, P1110, DOI 10.1093/aje/kwn007; Endo K, 2010, EUR SPINE J, V19, P435, DOI 10.1007/s00586-009-1240-1; TAKEMITSU Y, 1988, SPINE, V13, P1317, DOI 10.1097/00007632-198811000-00019; JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010; Khoo LT, 2002, NEUROSURGERY, V51, pS146, DOI 10.1227/01.NEU.0000031220.75770.29; Suzuki H, 2010, SPINE, V35, pE344, DOI 10.1097/BRS.0b013e3181c91121; Pao JL, 2009, EUR SPINE J, V18, P672, DOI 10.1007/s00586-009-0903-2; Ikuta K, 2005, J NEUROSURG-SPINE, V2, P624, DOI 10.3171/spi.2005.2.5.0624; Barrey C, 2007, EUR SPINE J, V16, P1459, DOI 10.1007/s00586-006-0294-6; GELB DE, 1995, SPINE, V20, P1351, DOI 10.1097/00007632-199506000-00005; TAKAHASHI K, 1995, SPINE, V20, P650, DOI 10.1097/00007632-199503150-00003; Schwab F, 2010, SPINE, V35, P2224, DOI 10.1097/BRS.0b013e3181ee6bd4; vanTulder MW, 1997, SPINE, V22, P2128, DOI 10.1097/00007632-199709150-00012; Enomoto M, 2012, J SPINAL DISORD TECH, V25, pE167, DOI 10.1097/BSD.0b013e31825d63c4; Toyoda H, 2011, SPINE, V36, P410, DOI 10.1097/BRS.0b013e3181d25829	18	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	JUL	2015	23	1					49	54		10.3171/2014.11.SPINE14452		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CL5DU	WOS:000356980800007		
J	Ninomiya, K; Iwatsuki, K; Ohnishi, Y; Ohkawa, T; Yoshimine, T				Ninomiya, Koshi; Iwatsuki, Koichi; Ohnishi, Yu-ichiro; Ohkawa, Toshika; Yoshimine, Toshiki			Intranasal delivery of bone marrow stromal cells to spinal cord lesions	JOURNAL OF NEUROSURGERY-SPINE			English	Article						intranasal delivery; bone marrow stromal cells; spinal cord injury	MESENCHYMAL STEM-CELLS; BRAIN-INJURY; FUNCTIONAL RECOVERY; TRANSPLANTATION; PROMOTE; STROKE; MECHANISMS; REPAIR; MODEL	OBJECT The intranasal delivery of bone marrow stromal cells (BMSCs) or mesenchymal stem cells to the injured brains of rodents has been previously reported. In this study, the authors investigated whether BMSCs migrate to spinal cord lesions through an intranasal route and whether the administration affected functional recovery. METHODS Forty Sprague-Dawley rats that were subjected to spinal cord injuries at the 17-8 level were divided into 5 groups (injured + intranasal BMSC treated group, injured + intrathecal BMSC treated group, injured-only group, injured + intranasal vehicle treated group, and injured + intrathecal vehicle treated group). The Basso-Beattie-Bresnahan (BBB) scale was used to assess hind-limb motor functional recovery for 2 or 4 weeks. Intralesionally migrated BMSCs were examined histologically and counted at 2 and 4 weeks. To evaluate the neuroprotective and trophic effects of BMSCs, the relative volume of the lesion cavity was measured at 4 weeks. In addition, nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) levels in the CSF were evaluated at 2 weeks. RESULTS Intranasally administered BMSCs were confirmed within spinal cord sections at both 2 and 4 weeks. The highest number, which was detected in the intrathecal BMSC treated group at 2 weeks, was significantly higher than that in all the other groups. The BBB score of the intranasal BMSC treated group showed statistically significant improvements by 1 week compared with the control group. However, in the final BBB scores, there was a statistically significant difference only between the intrathecal BMSC treated group and the control group. The cavity ratios in the BMSC-treated groups were smaller than those of the control groups, but the authors did not find any significant differences in the NGF and BDNF levels in the CSF among the treatment and control groups. CONCLUSIONS BMSCs reached the injured spinal cord through the intranasal route and contributed to the recovery of hind limb motor function and lesion cavity reduction. However, the effects were not as significant as those seen in the intrathecal BMSC treated group.	[Ninomiya, Koshi; Iwatsuki, Koichi; Ohnishi, Yu-ichiro; Ohkawa, Toshika; Yoshimine, Toshiki] Osaka Univ, Grad Sch Med, Dept Neurosurg, Suita, Osaka 5650871, Japan	Iwatsuki, K (reprint author), Osaka Univ, Grad Sch Med, Dept Neurosurg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kiwatsuki@nsurg.med.osaka-u.ac.jp			Osaka University Medical Center for Translational and Clinical Research [10]	This study was supported in part by a grant-in-aid for exploratory research (No. 10) from the Osaka University Medical Center for Translational and Clinical Research.	Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Fransson M, 2014, IMMUNOLOGY, V142, P431, DOI 10.1111/imm.12275; Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2; Wei N, 2013, CELL TRANSPLANT, V22, P977, DOI 10.3727/096368912X657251; Danielyan L, 2011, REJUV RES, V14, P3, DOI 10.1089/rej.2010.1130; Xu HY, 2010, J NEUROSCI RES, V88, P3598, DOI 10.1002/jnr.22501; Chapman CD, 2013, PHARM RES-DORDR, V30, P2475, DOI 10.1007/s11095-012-0915-1; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Joyce N, 2010, REGEN MED, V5, P933, DOI [10.2217/rme.10.72, 10.2217/RME.10.72]; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Donega V, 2014, EXP NEUROL, V261, P53, DOI 10.1016/j.expneurol.2014.06.009; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Cizkova D, 2011, J NEUROTRAUM, V28, P1951, DOI 10.1089/neu.2010.1413; Wang ZT, 2013, J MOL NEUROSCI, V49, P409, DOI 10.1007/s12031-012-9908-0; van Velthoven CTJ, 2013, STROKE, V44, P1426, DOI 10.1161/STROKEAHA.111.000326; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Aizman I, 2009, J NEUROSCI RES, V87, P3198, DOI 10.1002/jnr.22146; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Danielyan L, 2009, EUR J CELL BIOL, V88, P315, DOI 10.1016/j.ejcb.2009.02.001; Bakashi A, 2004, J NEUROSURG-SPINE, V1, P330; Boido M, 2014, WORLD NEUROSURG, V81, P183, DOI 10.1016/j.wneu.2012.08.014; Donega V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051253; Nakano N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073494; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570	27	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	JUL	2015	23	1					111	119		10.3171/2014.10.SPINE14690		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CL5DU	WOS:000356980800016		
J	Ohira, T; Kawano, F; Ohira, T; Goto, K; Ohira, Y				Ohira, Takashi; Kawano, Fuminori; Ohira, Tomotaka; Goto, Katsumasa; Ohira, Yoshinobu			Responses of skeletal muscles to gravitational unloading and/or reloading	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Review						Gravitational unloading; Responses of skeletal muscles; Morphological, metabolic, and contractile properties; Neural, mechanical, and metabolic factors	RAT SOLEUS MUSCLE; BETA-ADRENERGIC RECEPTORS; PROLONGED SPACE-FLIGHT; FAST-TWITCH MUSCLES; HINDLIMB SUSPENSION; HEAT-STRESS; BED REST; MECHANICAL-PROPERTIES; METABOLIC PROPERTIES; NUTRITION COUNTERMEASURES	Adaptation of morphological, metabolic, and contractile properties of skeletal muscles to inhibition of antigravity activities by exposure to a microgravity environment or by simulation models, such as chronic bedrest in humans or hindlimb suspension in rodents, has been well reported. Such physiological adaptations are generally detrimental in daily life on earth. Since the development of suitable countermeasure(s) is essential to prevent or inhibit these adaptations, effects of neural, mechanical, and metabolic factors on these properties in both humans and animals were reviewed. Special attention was paid to the roles of the motoneurons (both efferent and afferent neurograms) and electromyogram activities as the neural factors, force development, and/or length of sarcomeres as the mechanical factors and mitochondrial bioenergetics as the metabolic factors.	[Ohira, Takashi] Japan Aerosp Explorat Agcy, Space Biomed Res Off, Tsukuba, Ibaraki 3058505, Japan; [Kawano, Fuminori] Osaka Univ, Grad Sch Med, Toyonaka, Osaka 5600043, Japan; [Ohira, Tomotaka; Goto, Katsumasa] Toyohashi SOZO Univ, Grad Sch Hlth Sci, Toyohashi, Aichi 4408511, Japan; [Ohira, Yoshinobu] Doshisha Univ, Grad Sch Hlth & Sports Sci, Kyoto 6100394, Japan	Ohira, Y (reprint author), Doshisha Univ, Grad Sch Hlth & Sports Sci, Miyakodani 1-3, Kyoto 6100394, Japan.	oyoshinobu@gmail.com					Allen L, 1996, J APPL PHYSIOL, V81, P145; Lambertz D, 2001, J APPL PHYSIOL, V90, P179; Ohira Y, 1999, J APPL PHYSIOL, V87, P1776; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; TSIKA RW, 1987, J APPL PHYSIOL, V63, P2122; CAIOZZO VJ, 1994, J APPL PHYSIOL, V76, P1764; Kobayashi T, 2005, BIOCHEM BIOPH RES CO, V331, P1301, DOI 10.1016/j.bbrc.2005.04.096; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; Trappe S, 2008, AM J PHYSIOL-REG I, V294, pR939, DOI 10.1152/ajpregu.00761.2007; Goto K, 2011, EUR J APPL PHYSIOL, V111, P17, DOI 10.1007/s00421-010-1617-1; Naito H, 2000, J APPL PHYSIOL, V88, P359; Uehara K, 2004, JPN J PHYSIOL, V54, P263, DOI 10.2170/jjphysiol.54.263; WILLIAMS RS, 1984, AM J PHYSIOL, V246, pE160; BERG HE, 1993, CLIN PHYSIOL, V13, P337, DOI 10.1111/j.1475-097X.1993.tb00334.x; Goto K, 2003, PFLUG ARCH EUR J PHY, V447, P247, DOI 10.1007/s00424-003-1177-x; Liu Y, 2000, INT J SPORTS MED, V21, P351, DOI 10.1055/s-2000-3784; Zange J, 1997, INT J SPORTS MED, V18, pS308, DOI 10.1055/s-2007-972738; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013; BALDWIN KM, 1990, FASEB J, V4, P79; JIANG B, 1992, J APPL PHYSIOL, V73, pS58; Prakash YS, 1999, MUSCLE NERVE, V22, P307, DOI 10.1002/(SICI)1097-4598(199903)22:3<307::AID-MUS3>3.0.CO;2-M; Kawano F, 2010, J APPL PHYSIOL, V108, P676, DOI 10.1152/japplphysiol.00478.2009; ALFORD EK, 1987, EXP NEUROL, V96, P635, DOI 10.1016/0014-4886(87)90225-1; De-Doncker L, 2005, J EXP BIOL, V208, P4585, DOI 10.1242/jeb.01931; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387; Kawano F, 2004, AM J PHYSIOL-REG I, V287, pR76, DOI 10.1152/ajpregu.00694.2003; Wang XD, 2006, AM J PHYSIOL-CELL PH, V290, pC981, DOI 10.1152/ajpcell.00298.2005; Widrick JJ, 1999, J PHYSIOL-LONDON, V516, P915, DOI 10.1111/j.1469-7793.1999.0915u.x; Kawano F, 2002, NEUROSCIENCE, V114, P1133, DOI 10.1016/S0306-4522(02)00304-4; Szczesna D, 1996, J BIOL CHEM, V271, P8381; Fitts RH, 2001, J EXP BIOL, V204, P3201; LOCKE M, 1990, AM J PHYSIOL, V258, pC723; Kawano F, 2007, AM J PHYSIOL-CELL PH, V293, pC35, DOI 10.1152/ajpcell.00297.2006; Kojima A, 2007, J ORTHOP SCI, V12, P74, DOI 10.1007/s00776-006-1083-0; Riley DA, 2000, J APPL PHYSIOL, V88, P567; Ohira Y, 2001, AM J PHYSIOL-CELL PH, V280, pC1008; BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; Ohira Y, 2000, JPN J PHYSIOL, V50, P41, DOI 10.2170/jjphysiol.50.41; Kawano F, 2008, AM J PHYSIOL-CELL PH, V295, pC458, DOI 10.1152/ajpcell.00497.2007; Ohira Y, 2000, JPN J PHYSIOL, V50, P303, DOI 10.2170/jjphysiol.50.303; Wakatsuki T, 1996, JPN J PHYSIOL, V46, P171, DOI 10.2170/jjphysiol.46.171; BELL GJ, 1992, J APPL PHYSIOL, V73, P493; BODINEFOWLER SC, 1992, J APPL PHYSIOL, V73, pS82; BOOTH FW, 1982, J APPL PHYSIOL, V52, P1113; BOOTH FW, 1977, J APPL PHYSIOL, V43, P656; Brocca L, 2011, EXP PHYSIOL, V95, P331; Camerino GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072028; Chui L A, 1980, Physiologist, V23, pS76; DESPLANCHES D, 1987, J APPL PHYSIOL, V63, P558; DIFFEE GM, 1991, AM J PHYSIOL, V260, pC528; Edgerton VR, 1996, HDB PHYSL 4, P721; EDGERTON VR, 1995, J APPL PHYSIOL, V78, P1733; FELL RD, 1985, J APPL PHYSIOL, V58, P65; Fernandes GW, 2014, J ENDOCRINOL, V221, P381, DOI 10.1530/JOE-13-0526; FITCH CD, 1975, AM J PHYSIOL, V228, P1123; FITCH CD, 1974, J BIOL CHEM, V249, P1060; FITTS RH, 1986, J APPL PHYSIOL, V60, P1946; FLYNN DE, 1985, AVIAT SPACE ENVIR MD, V56, P1065; GARDETTO PR, 1989, J APPL PHYSIOL, V66, P2739; GOLLVIK L, 1988, ACTA PHYSIOL SCAND, V132, P353, DOI 10.1111/j.1748-1716.1988.tb08339.x; Goto K, 2007, JPN J AEROSPACE ENV, V44, P13; Goto K, 2004, JPN J PHYSIOL, V54, P285, DOI 10.2170/jjphysiol.54.285; GRAHAM SC, 1989, J APPL PHYSIOL, V67, P945; GRAHAM SC, 1989, AVIAT SPACE ENVIR MD, V60, P226; Greenisen MC, 1993, SPACE PHYSL MED, P194; HAUSCHKA EO, 1987, J APPL PHYSIOL, V62, P2338; HERBISON GJ, 1978, ARCH PHYS MED REHAB, V59, P301; Hunter B, 2004, J CLIN INVEST, V114, P1504; Ingalls CP, 1999, J APPL PHYSIOL, V87, P386; KANDARIAN SC, 1991, J APPL PHYSIOL, V71, P910; KRAUS WE, 1989, AM J PHYSIOL, V256, pC506; LEONARD JI, 1983, AM J CLIN NUTR, V38, P667; MAINWOOD GW, 1982, CAN J PHYSIOL PHARM, V60, P120; MARTIN TP, 1988, CELL TISSUE RES, V254, P251; MARTIN TP, 1988, J APPL PHYSIOL, V65, P2318; MARTIN WH, 1989, AM J PHYSIOL, V257, pE736; MCDONALD KS, 1992, J APPL PHYSIOL, V73, P1135; METZGER JM, 1995, BIOPHYS J, V68, P1430; MIU B, 1990, FASEB J, V4, P64; MOERLAND TS, 1989, AM J PHYSIOL, V257, pC810; OHIRA M, 1988, J PHYSIOL-LONDON, V395, P589; Ohira M, 2002, JPN J PHYSIOL, V52, P235, DOI 10.2170/jjphysiol.52.235; Ohira T., 2014, PHYSL REP, V2; Ohira T, 2009, JPN J AEROSP ENV MED, V46, P21; Ohira T., 2012, THESIS NATL I FITNES; Ohira T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021044; Ohira Y, 1992, P SPAC UT S 9 TOK 19, P159; Ohira Yoshinobu, 2002, J Gravit Physiol, V9, P49; OHIRA Y, 1989, JPN J PHYSIOL, V39, P21, DOI 10.2170/jjphysiol.39.21; Ohira Y, 1997, ACTA ANAT, V159, P90; Ohira Y, 2003, JPN J PHYSIOL, V53, P389, DOI 10.2170/jjphysiol.53.389; OHIRA Y, 1994, ACTA ASTRONAUT, V33, P113, DOI 10.1016/0094-5765(94)90115-5; OHIRA Y, 1992, MED SPORT SCI, V37, P318; OHIRA Y, 1994, AM J PHYSIOL, V266, pC1257; OHIRA Y, 1992, J APPL PHYSIOL, V73, pS51; Ohira Y, 1989, P 6 SPAC UT S, P126; Ohira Y, 1996, J APPL PHYSIOL, V81, P152; Ohira Y, 1994, ADV EXERCISE SPORTS, V1, P1; PALMER S, 1994, J PHYSIOL-LONDON, V480, P45; PIEROTTI DJ, 1990, AVIAT SPACE ENVIR MD, V61, P205; REISER PJ, 1987, J APPL PHYSIOL, V63, P2293; Riley D A, 1983, Adv Space Res, V3, P191, DOI 10.1016/0273-1177(83)90056-X; Riley DA, 1996, J APPL PHYSIOL, V81, P133; RILEY DA, 1992, J APPL PHYSIOL, V73, pS33; RILEY DA, 1990, FASEB J, V4, P84; ROMANUL FCA, 1967, ARCH NEUROL-CHICAGO, V17, P387; ROY RR, 1987, J APPL PHYSIOL, V62, P2348; Roy R R, 1991, Exerc Sport Sci Rev, V19, P269; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; SHOUBRIDGE EA, 1985, BIOCHEM J, V232, P125; STUMP CS, 1990, J APPL PHYSIOL, V68, P627; Tanaka T, 1997, J APPL PHYSIOL, V82, P1911; THOMAS DP, 1986, J APPL PHYSIOL, V60, P1722; THOMASON DB, 1990, J APPL PHYSIOL, V68, P1; THOMASON DB, 1987, J APPL PHYSIOL, V63, P138; THOMASON DB, 1987, J APPL PHYSIOL, V63, P130; Trappe S, 2007, J APPL PHYSIOL, V103, P1242, DOI 10.1152/japplphysiol.00560.2007; WALTON KD, 1992, NEUROSCIENCE, V51, P763, DOI 10.1016/0306-4522(92)90517-6; Widrick JJ, 1996, J APPL PHYSIOL, V80, P981; Widrick JJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1690; Widrick JJ, 1998, J APPL PHYSIOL, V85, P1949; WINIARSKI AM, 1987, EXP NEUROL, V96, P650, DOI 10.1016/0014-4886(87)90226-3; Yamashita-Goto K, 2001, J APPL PHYSIOL, V91, P417; Yoshioka T, 1996, ACTA ASTRONAUT, V38, P209, DOI 10.1016/0094-5765(96)00010-0	125	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	JUL	2015	65	4					293	310		10.1007/s12576-015-0375-6		18	Physiology	Physiology	CL1UJ	WOS:000356730100001		
J	Kosaki, K; Sugawara, J; Akazawa, N; Tanahashi, K; Kumagai, H; Ajisaka, R; Maeda, S				Kosaki, Keisei; Sugawara, Jun; Akazawa, Nobuhiko; Tanahashi, Koichiro; Kumagai, Hiroshi; Ajisaka, Ryuichi; Maeda, Seiji			No influence of lower leg heating on central arterial pulse pressure in young men	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Central arterial pulse pressure; Reflected wave; Pulse wave velocity; Lower leg heating	CENTRAL BLOOD-PRESSURE; WAVE REFLECTION; NITRIC-OXIDE; HUMANS; HYPERTENSION; STIFFNESS; EXERCISE; VASODILATION; VELOCITY; MANAGEMENT	Central arterial pulse pressure (PP), a strong predictor of cardiovascular disease, mainly consists of an incident wave generated by left ventricular ejection and a late-arriving reflected wave emanating from the lower body. We have tested the hypothesis that a reduction in leg vascular tone by heat treatment of the lower leg attenuates the central arterial PP. Pressure and wave properties of the peripheral and central arteries were measured in eight young men before and after heat treatment of the lower leg (temperature approx. 43 A degrees C) for 30 and 60 min, respectively. Following the lower leg heat trial, leg (femoral-ankle) pulse wave velocity (PWV) was significantly decreased, but aortic (carotid-femoral) PWV and parameters of wave reflection and carotid arterial PP did not change significantly. No significant changes were observed in these parameters in the control trial. These results suggest that the reduction in leg vascular tone induced by heat treatment of the lower leg may not affect wave reflection and central arterial PP in young men.	[Kosaki, Keisei; Tanahashi, Koichiro; Kumagai, Hiroshi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058574, Japan; [Sugawara, Jun] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Akazawa, Nobuhiko; Ajisaka, Ryuichi; Maeda, Seiji] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki 3058574, Japan; [Ajisaka, Ryuichi] Minist Hlth Labour & Welf, Tokyo, Japan	Maeda, S (reprint author), Univ Tsukuba, Fac Hlth & Sport Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058574, Japan.	maeda@taiiku.tsukuba.ac.jp					Sugawara J, 2010, HYPERTENSION, V56, P920, DOI 10.1161/HYPERTENSIONAHA.110.160549; Kingwell BA, 1997, AM J PHYSIOL-HEART C, V273, pH2186; Tanaka H, 1998, ARTERIOSCL THROM VAS, V18, P127; Sugawara J, 2005, J HUM HYPERTENS, V19, P401, DOI 10.1038/sj.jhh.1001838; Minson CT, 2001, J APPL PHYSIOL, V91, P1619; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Roman MJ, 2010, J HYPERTENS, V28, P384, DOI 10.1097/HJH.0b013e328333d228; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Qasem A, 2008, HYPERTENSION, V51, P188, DOI 10.1161/HYPERTENSIONAHA.107.092676; KELLY R, 1989, HYPERTENSION, V14, P14; ARMENTANO R, 1995, HYPERTENSION, V26, P48; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Sugawara J, 2013, J PHYSIOL SCI, V63, P389, DOI 10.1007/s12576-013-0272-9; McCord GR, 2006, AM J PHYSIOL-REG I, V291, pR596, DOI 10.1152/ajpregu.00710.2005; Westerhof BE, 2006, HYPERTENSION, V48, P595, DOI 10.1161/01.HYP.0000238330.08894.17; Hayashi K, 2005, JPN J PHYSIOL, V55, P235, DOI 10.2170/jjphysiol.S2116; Roman MJ, 2009, J AM COLL CARDIOL, V54, P1730, DOI 10.1016/j.jacc.2009.05.070; Bennett LAT, 2003, J PHYSIOL-LONDON, V552, P223, DOI 10.1113/jphysiol.2003.042135; Taddei S, 2001, HYPERTENSION, V38, P274; DeSouza CA, 2000, CIRCULATION, V102, P1351; Safar ME, 2002, HYPERTENSION, V39, P735, DOI 10.1161/hy0202.098325; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Lefferts WK, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00101; Nichols W, 2005, MCDONALDS BLOOD FLOW; Sharman JE, 2013, J HUM HYPERTENS, V27, P405, DOI 10.1038/jhh.2013.23; TAYLOR WF, 1993, AM J PHYSIOL, V264, pH1355; Wilkinson IB, 2002, BRIT J CLIN PHARMACO, V53, P189, DOI 10.1046/j.1365-2125.2002.1528adoc.x; Wong BJ, 2006, J APPL PHYSIOL, V100, P535, DOI 10.1152/japplphysiol.00902.2005	28	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	JUL	2015	65	4					311	316		10.1007/s12576-015-0368-5		6	Physiology	Physiology	CL1UJ	WOS:000356730100002		
J	Matsuda-Nakamura, M; Yasuhara, S; Nagashima, K				Matsuda-Nakamura, Mayumi; Yasuhara, Saki; Nagashima, Kei			Effect of menstrual cycle on thermal perception and autonomic thermoregulatory responses during mild cold exposure	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Thermal sensation; Thermal pleasantness; Thermoregulation; Cold exposure; Estradiol; Progesterone	THERMOSENSITIVE NEURONS; LUTEAL-PHASE; EXERCISE; WOMEN; PROGESTERONE; TEMPERATURE; BRAIN; ACTIVATION; COMFORT; HUMANS	We investigated the effects of menstrual cycle phase on thermal sensation, thermal pleasantness, and autonomic thermoregulatory responses during mild cold exposure. Eight healthy young women participated. Experiments were conducted in the follicular and luteal phases: 120 min exposure at 23.5 A degrees C after 40-min at a baseline temperature of 29 A degrees C. Body core temperature was higher (P = 0.01) in the luteal phase than in the follicular phase. Thermal sensation of the whole body (P = 0.59), hands (P = 0.46), and toes (P = 0.94), and thermal pleasantness of the whole body (P = 0.79) were no different between phases. In both phases, mean skin temperature decreased (P = 0.00) in the same manner without any change in metabolic rate (P = 0.90). These results suggest the change of body core temperature in the menstrual cycle phases has no effect on thermal perception of cold or on autonomic cold-defense response.	[Matsuda-Nakamura, Mayumi; Yasuhara, Saki; Nagashima, Kei] Waseda Univ, Fac Human Sci, Body Temp & Fluid Lab, Tokorozawa, Saitama 3591192, Japan; [Nagashima, Kei] Waseda Univ, Inst Appl Brain Sci, Tokorozawa, Saitama 3591192, Japan	Matsuda-Nakamura, M (reprint author), Waseda Univ, Fac Human Sci, Body Temp & Fluid Lab, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan.	m.nakamura@suou.waseda.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [20390066]	This study was supported by a Grant-in-Aid for Scientific Research (B), no. 20390066, from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Rolls ET, 2008, NEUROIMAGE, V41, P1504, DOI 10.1016/j.neuroimage.2008.03.005; Hardy JD, 1938, J NUTR, V15, P461; HIRATA K, 1986, EUR J APPL PHYSIOL O, V54, P559, DOI 10.1007/BF00943341; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Romanovsky AA, 2004, AM J PHYSIOL-REG I, V287, pR992, DOI 10.1152/ajpregu.00068.2004; Romanovsky AA, 2014, ACTA PHYSIOL, V210, P498, DOI 10.1111/apha.12231; Frank SM, 1999, J APPL PHYSIOL, V86, P1588; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; CUNNINGH.DJ, 1971, J PHYSIOL-PARIS, V63, P236; Farrell MJ, 2011, J THERM BIOL, V36, P57, DOI 10.1016/j.jtherbio.2010.11.003; FRASCAROLO P, 1990, J APPL PHYSIOL, V69, P2029; Hayashi K, 2012, J APPL PHYSIOL, V113, P237, DOI 10.1152/japplphysiol.01199.2011; Hensel H., 1981, THERMORECEPTION TEMP; HESSEMER V, 1985, J APPL PHYSIOL, V59, P1902; HESSEMER V, 1985, J APPL PHYSIOL, V59, P1911; Hua L. H., 2005, AM J PHYSIOL, V289, P319, DOI DOI 10.1152/AJPREGU.00123.2005; Kanosue K, 2002, NEUROSCI LETT, V329, P157, DOI 10.1016/S0304-3940(02)00621-3; KIM HE, 1995, PHYSIOL BEHAV, V58, P699, DOI 10.1016/0031-9384(95)00118-3; Kingma B. R., 2014, TEMPERATURE, V1, P142, DOI [10.4161/temp.29702, DOI 10.4161/TEMP.29702]; KOLKA MA, 1989, EUR J APPL PHYSIOL O, V58, P890, DOI 10.1007/BF02332224; MARKS LE, 1988, CHEM SENSES, V13, P63, DOI 10.1093/chemse/13.1.63; Nagashima K, 2002, J APPL PHYSIOL, V92, P1029, DOI 10.1152/japplphysiol.00399.2001; Nagashima K, 2006, IND HEALTH, V44, P359, DOI 10.2486/indhealth.44.359; NAKAYAMA T, 1975, NATURE, V258, P80, DOI 10.1038/258080a0; Rossi M, 2009, CLIN HEMORHEOL MICRO, V42, P107, DOI 10.3233/CH-2009-1189; STEPHENSON LA, 1988, EUR J APPL PHYSIOL O, V57, P373, DOI 10.1007/BF00417979; STEPHENSON LA, 1982, MED SCI SPORT EXER, V14, P270, DOI 10.1249/00005768-198204000-00003; TSAI CL, 1988, NEUROSCI LETT, V86, P56, DOI 10.1016/0304-3940(88)90182-6; WEBB P, 1986, AM J CLIN NUTR, V44, P614	29	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	JUL	2015	65	4					339	347		10.1007/s12576-015-0371-x		9	Physiology	Physiology	CL1UJ	WOS:000356730100005		
J	Hamada, T; Miyakawa, K; Kushige, H; Shibata, S; Kurachi, S				Hamada, Toshiyuki; Miyakawa, Kazuko; Kushige, Hiroko; Shibata, Shigenobu; Kurachi, Sumiko			Age-related expression analysis of mouse liver nuclear protein binding to 3'-untranslated region of Period2 gene	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Period 2; hnRNP; Circadian rhythm; Aging; Homeostasis	MESSENGER-RNA DEGRADATION; CIRCADIAN OSCILLATION; ARGININE METHYLATION; PROTEOMIC ANALYSIS; BLOOD-COAGULATION; FACTOR-IX; HNRNP A1; PHOSPHORYLATION; TRANSLATION; MAINTENANCE	In mammals, both circadian rhythm and aging play important roles in regulating time-dependent homeostasis. We previously discovered an age-related increase element binding protein, hnRNP A3, which binds to the 3'-untranslated region (UTR) of blood coagulation factor IX (FIX). Here, we describe other members of this protein family, hnRNP C and hnRNP H, which bind to the 3'-UTR of the mouse circadian clock gene Period 2 (mPer2). RNA electrophoretic mobility shift assays using a P-32-labeled Per2 RNA probe coupled with two-dimensional gel electrophoresis followed by MALDI-TOF/MS peptide mass fingerprint analysis was used to analyze these proteins. Western blotting suggested that the total expression of these proteins in mouse liver cell nuclei does not increase with age. Two-dimensional gel electrophoresis analysis of age-related protein expression showed that many isoforms of these proteins exist in the liver and that each protein exhibits a complex age-related expression pattern. These results suggest that many isoforms of proteins are regulated by different aging systems and that many age regulation systems function in the liver.	[Hamada, Toshiyuki] Hokkaido Univ, Appl Mol Imaging Phys, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Hamada, Toshiyuki] Hakujikai Inst Gerontol, Adachi Ward, Tokyo 1230864, Japan; [Miyakawa, Kazuko; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Shinjuku Ward, Tokyo 1628480, Japan; [Kushige, Hiroko] Natl Inst Adv Ind Sci & Technol, AIST Tsukuba Ctr 6 13, Age Dimens Res Ctr, Tsukuba, Ibaraki 3058566, Japan; [Kurachi, Sumiko] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA	Hamada, T (reprint author), Hokkaido Univ, Appl Mol Imaging Phys, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan.	toshi-ha@med.hokudai.ac.jp; hiroko.kushige@aist.go.jp			internal research fund from AIST; JSPS KAKENHI [24621001]; Suhara Memorial Foundation	This research was supported in part by an internal research fund from AIST, JSPS KAKENHI (Grant Number 24621001), and by a research fund from The Suhara Memorial Foundation. We thank Dr. Kenneth Sutherland for comments on drafts of this manuscript.	Kim TD, 2005, MOL CELL BIOL, V25, P3232, DOI 10.1128/MCB.25.8.3232-3246.2005; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; HONORE B, 1995, J BIOL CHEM, V270, P28780; MITTAG M, 1994, P NATL ACAD SCI USA, V91, P5257, DOI 10.1073/pnas.91.12.5257; Kim TD, 2007, GENE DEV, V21, P797, DOI 10.1101/gad.1519507; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Woo KC, 2009, NUCLEIC ACIDS RES, V37, P26, DOI 10.1093/nar/gkn893; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Kurachi S, 2009, P NATL ACAD SCI USA, V106, P7921, DOI 10.1073/pnas.0902191106; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Hamada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012971; Heintzen C, 1997, P NATL ACAD SCI USA, V94, P8515, DOI 10.1073/pnas.94.16.8515; Kojima S, 2007, P NATL ACAD SCI USA, V104, P1859, DOI 10.1073/pnas.0607567104; Kurachi Kotoku, 2008, Nihon Ronen Igakkai Zasshi, V45, P126; Kurachi Kotoku, 2008, P427, DOI 10.1007/978-4-431-78847-8_30; Kurachi S, 1999, SCIENCE, V285, P739, DOI 10.1126/science.285.5428.739; Mittag M, 1996, P NATL ACAD SCI USA, V93, P14401, DOI 10.1073/pnas.93.25.14401; Shetty S, 2005, MOL CELL BIOCHEM, V272, P107, DOI 10.1007/s11010-005-7644-2; Tamaru T, 2003, NEUROSCI LETT, V341, P111, DOI 10.1016/S0304-3940(03)00181-2; WEIGHARDT F, 1995, J CELL SCI, V108, P545; Woo KC, 2010, MOL CELL BIOL, V30, P197, DOI 10.1128/MCB.01154-09; Yamaoka K, 2006, BIOCHEM BIOPH RES CO, V345, P1240, DOI 10.1016/j.bbrc.2006.04.183; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049; Zhang KZ, 2002, J BIOL CHEM, V277, P4532, DOI 10.1074/jbc.M109524200; Ziemienowicz A, 2003, PLANT MOL BIOL, V53, P201, DOI 10.1023/B:PLAN.0000009288.46713.1f	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	JUL	2015	65	4					349	357		10.1007/s12576-015-0373-8		9	Physiology	Physiology	CL1UJ	WOS:000356730100006		
J	Goto, K; Kawahara, I; Kuniyasu, H; Takaki, M				Goto, Kei; Kawahara, Isao; Kuniyasu, Hiroki; Takaki, Miyako			A protein tyrosine kinase receptor, c-RET signaling pathway contributes to the enteric neurogenesis induced by a 5-HT4 receptor agonist at an anastomosis after transection of the gut in rodents	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						5-HT4-receptor; Granulation tissue; Enteric neuron; RET; PKA	IN-VIVO; NERVOUS-SYSTEM; STEM-CELLS; INHIBITOR; GFR-ALPHA-1; EXPRESSION; MIGRATION; DISEASE; COLON; MICE	We previously reported that a serotonin 4 (5-HT4) receptor agonist, mosapride citrate (MOS), increased the number of c-RET-positive cells and levels of c-RET mRNA in gel sponge implanted in the necks of rats. The 5-HT4 receptor is a G protein coupled receptor (GPCR) coupled to G protein G(s)-cAMP cascades. We investigated the possibility that 5-HT4 receptor activation induced c-RET activation and/or PKA activation by elevating cAMP levels. Rodents were orally administered MOS by adding it to drinking water for 2 weeks after enteric nerve circuit insult via gut transection and anastomosis, together with the RET inhibitors withaferin A (WA) and RPI-1 or the PKA inhibitor H89. We then examined PGP9.5-positive cells in the newly formed granulation tissue at the anastomotic site. MOS significantly increased the number of new neurons, but not when co-administered with WA or RPI-1. Co-administration of H89 failed to alter MOS-induced increases in neurogenesis. In conclusion, the c-RET signaling pathway contributes to enteric neurogenesis facilitated by MOS, though the contribution of PKA activation seems unlikely.	[Goto, Kei; Kawahara, Isao; Kuniyasu, Hiroki; Takaki, Miyako] Nara Med Univ, Dept Mol Pathol, Kashihara, Nara 6348521, Japan	Takaki, M (reprint author), Nara Med Univ, Dept Mol Pathol, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	mtakaki@naramed-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [20659210, 23390330, 24650325, 26560280]	This work was supported by Grants-in-aid for Scientific Research (20659210, 23390330, 24650325, 26560280 for M.T.) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Takaki M, 2011, BIOCHEM BIOPH RES CO, V406, P529, DOI 10.1016/j.bbrc.2011.02.072; Shah BH, 2004, TRENDS NEUROSCI, V27, P48, DOI 10.1016/j.tins.2003.11.003; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Takaki M, 2006, STEM CELLS, V24, P1414, DOI 10.1634/stemcells.2005-0394; Gershon MD, 2010, TRENDS NEUROSCI, V33, P446, DOI 10.1016/j.tins.2010.06.002; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Uesaka T, 2007, DEVELOPMENT, V134, P2171, DOI 10.1242/dev.001388; Obermayr F, 2013, NAT REV GASTRO HEPAT, V10, P43, DOI 10.1038/nrgastro.2012.234; Uesaka T, 2008, J CLIN INVEST, V118, P1890, DOI 10.1172/JCI34425; Enomoto H, 2004, NEURON, V44, P623, DOI 10.1016/j.neuron.2004.10.032; Kobayashi K, 2008, J NEUROSCI, V28, P6272, DOI 10.1523/JNEUROSCI.1656-08.2008; Asai N, 2006, DEVELOPMENT, V133, P4507, DOI 10.1242/dev.02616; Cuccuru G, 2004, J NATL CANCER I, V96, P1006, DOI 10.1093/jnci/djh184; Goto K, 2013, PLOS ONE, V8; Hotta R, 2009, STEM CELLS, V27, P2896, DOI 10.1002/stem.208; Kawahara I, 2012, AM J PHYSIOL-GASTR L, V302, pG588, DOI 10.1152/ajpgi.00284.2011; Lake JI, 2013, AM J PHYSIOL-GASTR L, V305, pG1, DOI 10.1152/ajpgi.00452.2012; Matsuyoshi H, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01474.x; Samadi AK, 2010, SURGERY, V148, P1228, DOI 10.1016/j.surg.2010.09.026; Takaki M, 2014, J NEUROGASTROENTEROL, V20, P17, DOI 10.5056/jnm.2014.20.1.17	20	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	JUL	2015	65	4					377	383		10.1007/s12576-015-0377-4		7	Physiology	Physiology	CL1UJ	WOS:000356730100009		
J	Tono, A; Iwasaki, T; Seo, A; Murakami, N				Tono, Akitaka; Iwasaki, Takaya; Seo, Akihiro; Murakami, Noriaki			Environmental factors contribute to the formation and maintenance of the contact zone observed in deciduous broad-leaved tree species in Japan	JOURNAL OF PLANT RESEARCH			English	Article						Chloroplast DNA; Contact zone; Deciduous broad-leaved forest; Ecological niche model; Geographical information system (GIS); Phylogeography	CHLOROPLAST DNA VARIATION; HYBRID ZONES; CLIMATIC OSCILLATIONS; GENETIC CONSEQUENCES; SUTURE ZONE; ICE AGES; PHYLOGEOGRAPHY; QUATERNARY; BARRIERS; DISTRIBUTIONS	Contact zones are defined as areas where populations from different refugia meet during a postglacial expansion and distinct DNA lineages are mixedly distributed. In Japan, contact zones of various plants and animals were reported from the Kinki-Chugoku region. These contact zones appear to be maintained without any drastic topographic barriers such as those observed in the Alps and Pyrenees Mountains. In this study, the mechanisms underlying the formation and/or maintenance of these contact zones were investigated using six deciduous broad-leaved tree species (Carpinus laxiflora, C. tschonoskii, C. japonica, Magnolia obovata, Padus grayana, and Euonymus oxyphyllus). First, the precise location of the contact zones was examined by intensive genetic analysis of the six species. Second, the relationships between the geographic location of the contact zone and various environmental factors, including climate and topography, were investigated by generalized additive models to reveal the mechanisms of the formation and maintenance of the contact zones. As a result, four of the six examined plant species clearly showed a geographically common contact zone in Hyogo Prefecture and its adjacent areas. The results of the generalized additive models indicate that the pattern of low habitat suitability estimated by ecological niche modeling was the most important factor for determining the location of the common contact zone. These results suggest that areas with low habitat suitability in Hyogo Prefecture restrict the migration and gene flow of the four species in this region, and thus, they maintain the pattern of the contact zones. This study suggests that there are major effects of habitat suitability on the formation and maintenance of the contact zones.	[Tono, Akitaka; Murakami, Noriaki] Tokyo Metropolitan Univ, Makino Herbarium, Hachioji, Tokyo 148 R K SA, Japan; [Iwasaki, Takaya] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Seo, Akihiro] Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan	Tono, A (reprint author), Tokyo Metropolitan Univ, Makino Herbarium, 1-1 Minamiosawa, Hachioji, Tokyo 148 R K SA, Japan.	a.t.19880104@gmail.com			Research Institute for Humanity and Nature	We thank Dr. F. Koike (Department of Risk Management and Environmental Sciences, Yokohama National Univ.), Dr. M. Saito (The Department of General Systems Studies, The Univ. of Tokyo), Mr. H. Mitsuhashi (The Museum of Human Activities Hyogo), Dr. H. Sato (Center for Ecological Research, Kyoto Univ.), Dr. I. Saeki (The Department of World Heritage Studies, Univ. of Tsukuba), Dr. J. Suzuki, Dr. T. Kusano, Dr. M. Kohri (Department of Biological Science, Tokyo Metropolitan Univ.), Dr. T. Sugawara, Dr. H. Kato, Dr. Y. Kakugawa, Mr. M. Nakaji, Mr. S. Shimokawa (Makino Herbarium, Tokyo Metropolitan Univ.), and two anonymous reviewers for their valuable advice. We also thank Dr. A. Ebihara (Department of Botany, National Museum of Nature and Science), Dr. M. Ito, and Mr. O. Kurashima (Department of General Systems Studies, The Univ. of Tokyo) for providing the occurrence data from the locality information of herbarium specimens deposited in the herbarium of National Science Museum, Tsukuba (TNS), and the results of the National Survey on the Natural Environment by the Ministry of the Environment, Japan (NSNE). This study was partly supported by the research project "A new cultural and historical exploration into human-nature relationships in the Japanese archipelago" of the Research Institute for Humanity and Nature (to N.M and A.S).	Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1006/bijl.1999.0332; Higgins SI, 2003, J ECOL, V91, P341, DOI 10.1046/j.1365-2745.2003.00781.x; Thiel-Egenter C, 2009, MOL ECOL, V18, P4495, DOI 10.1111/j.1365-294X.2009.04360.x; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Eidesen PB, 2013, NEW PHYTOL, V200, P898, DOI 10.1111/nph.12412; Moritz C, 2009, P ROY SOC B-BIOL SCI, V276, P1235, DOI 10.1098/rspb.2008.1622; Nagata J, 1999, MOL PHYLOGENET EVOL, V13, P511, DOI 10.1006/mpev.1999.0668; Yasukochi Y, 2009, J HERED, V100, P297, DOI 10.1093/jhered/esn097; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; Cicero C, 2004, EVOLUTION, V58, P1573; Hartmann SA, 2013, CONSERV GENET, V14, P413, DOI 10.1007/s10592-013-0468-9; Aoki K, 2004, J PLANT RES, V117, P77, DOI 10.1007/s10265-003-0132-4; Ohnishi N, 2009, HEREDITY, V102, P579, DOI 10.1038/hdy.2009.28; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Jaramillo-Correa JP, 2010, MOL ECOL, V19, P5452, DOI 10.1111/j.1365-294X.2010.04912.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Hewitt GM, 2004, PHILOS T ROY SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Swenson NG, 2006, J EVOLUTION BIOL, V19, P717, DOI 10.1111/j.1420-9101.2005.01066.x; Waters JM, 2013, TRENDS ECOL EVOL, V28, P78, DOI 10.1016/j.tree.2012.08.024; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Clark JS, 2003, ECOLOGY, V84, P1979, DOI 10.1890/01-0618; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Fujii N, 2002, PLANT SYST EVOL, V232, P21, DOI 10.1007/s006060200024; Iwasaki T, 2012, J PLANT RES, V125, P207, DOI 10.1007/s10265-011-0428-8; Swenson NG, 2004, EVOLUTION, V58, P2391; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; Aoki Kyoko, 2005, APG Acta Phytotaxonomica et Geobotanica, V56, P55; Aoki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087429; Aoki K, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-103; Aoki K, 2008, MOL ECOL, V17, P3276, DOI [10.1111/j.1365-294X.2008.03830.x, 10.1111/j.1365-294X.2007.03830.x]; Aoki Kyoko, 2011, Insects, V2, P128, DOI 10.3390/insects2020128; Barton K., 2012, PACKAGE MUMIN MODEL; Cosic N, 2013, CONSERV GENET, V14, P345, DOI 10.1007/s10592-013-0466-y; Doyle J. L. ., 1987, PHYTOCHEMISTRY B, V19, P11; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; HARRISON RG, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P3; Hewitt Godfrey M., 2004, Frontiers in Zoology, V1, P1, DOI 10.1186/1742-9994-1-4; Ingvarsson PK, 2003, MOL BIOL EVOL, V20, P1737, DOI 10.1093/molbev/msg163; Iwasaki Takaya, 2010, APG Acta Phytotaxonomica et Geobotanica, V61, P1; Kawamoto Y, 2007, PRIMATES, V48, P27, DOI 10.1007/s10329-006-0013-2; Okamoto T, 2009, J ZOOL SYST EVOL RES, V47, P181, DOI 10.1111/j.1439-0469.2008.00513.x; R Development Core Team, 2013, R LANG ENV STAT COMP; REMINGTON C L, 1968, Evolutionary Biology (New York), P321; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Sekiguti T, 1952, P 8 GEN ASS 18 C IGU, P285; Sota T, 2007, J BIOGEOGR, V34, P977, DOI 10.1111/j.1365-2699.2006.01672.x; Sugahara K, 2011, J PLANT RES, V124, P75, DOI 10.1007/s10265-010-0356-z; Yoshino MM, 1980, ERDKUNDE, V34, P81	51	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	JUL	2015	128	4					535	551		10.1007/s10265-015-0722-y		17	Plant Sciences	Plant Sciences	CL1VF	WOS:000356732300002		
J	Takahashi, K; Aoki, K				Takahashi, Koichi; Aoki, Keigo			Effects of climatic conditions on annual shoot length and tree-ring width of alpine dwarf pine Pinus pumila in central Japan	JOURNAL OF PLANT RESEARCH			English	Article						Climatic change; Dendrochronology; Global warming; Radial growth; Shoot elongation; Standardization	SPRUCE PICEA-ABIES; NORWAY SPRUCE; DENDROCLIMATOLOGICAL ANALYSIS; ALTITUDINAL GRADIENTS; PLANT-POPULATIONS; SIZE DISTRIBUTION; GROWTH VARIATION; BETULA-ERMANII; RADIAL GROWTH; TIME-SERIES	This study compared the effects of climatic conditions on annual shoot length (ASL) and tree-ring width (TRW) of alpine dwarf pine Pinus pumila in central Japan, by using dendrochronological techniques. Chronologies of ASL (1951-2009) and TRW (1972-2009) were standardized to remove non-climatic signals, and correlation tests were done for non-standardized observed values and standardized indices with monthly temperatures and precipitation. Monthly mean temperatures from March to October, except for July, increased during 1951aEuro'2009; observed values and a standardized index of ASL increased during this period. For the rate of increase in ASL, the standardized index was lower than the observed values. However, these values of TRW showed no trends. The observed values and standardized index of TRW positively correlated with temperatures of the beginning of the growing season of the current year. The observed values of ASL positively correlated with temperatures during the growing season of the previous and current years. However, the standardized index of ASL positively correlated with only June temperatures of the previous and current years. The different results of ASL between observed values and standardized indices indicate that many significant correlations of observed values were attributable to increasing trends of temperature and ASL. This study suggests that standardized ASL of P. pumila tended to increase greater than TRW, that high temperatures at the beginning of the growing season increases ASL and TRW, and that analyzing observed values of ASL may overestimate the effects of temperature on ASL of P. pumila.	[Takahashi, Koichi; Aoki, Keigo] Shinshu Univ, Fac Sci, Dept Biol, Matsumoto, Nagano 3908621, Japan; [Takahashi, Koichi] Shinshu Univ, Inst Mt Sci, Matsumoto, Nagano 3908621, Japan	Takahashi, K (reprint author), Shinshu Univ, Fac Sci, Dept Biol, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	koichit@shinshu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank Mr. Yoshimi Miyake for making strips, Dr. Takeshi Fujiwara for giving facilities for X-ray, and Dr. Koh Yasue for useful discussion. This study was partially supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Au R, 2007, CAN J BOT, V85, P585, DOI 10.1139/B07-055; Makinen H, 2002, FOREST ECOL MANAG, V171, P243, DOI 10.1016/S0378-1127(01)00786-1; Takahashi K, 2014, LANDSC ECOL ENG, V10, P349, DOI 10.1007/s11355-014-0250-2; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Bar A, 2008, J BIOGEOGR, V35, P625, DOI 10.1111/j.1365-2699.2007.01804.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; Doi H, 2008, AGR FOREST METEOROL, V148, P512, DOI 10.1016/j.agrformet.2007.10.002; Nakamoto A, 2012, CAN J FOREST RES, V42, P167, DOI [10.1139/X11-153, 10.1139/x11-153]; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; HARA T, 1991, J ECOL, V79, P1085, DOI 10.2307/2261100; HADLEY JL, 1986, ECOLOGY, V67, P12, DOI 10.2307/1938498; Rubino DL, 2000, J TORREY BOT SOC, V127, P240, DOI 10.2307/3088761; Savva Y, 2006, TREES-STRUCT FUNCT, V20, P735, DOI 10.1007/s00468-006-0088-9; Weijers S, 2010, QUATERNARY SCI REV, V29, P3831, DOI 10.1016/j.quascirev.2010.09.003; Massaccesi G, 2008, TREES-STRUCT FUNCT, V22, P245, DOI 10.1007/s00468-007-0181-8; Takahashi K, 2013, CLIMATIC CHANGE, V117, P273, DOI 10.1007/s10584-012-0547-9; Wada N, 2005, PHYTON-ANN REI BOT A, V45, P253; Ishida A, 2001, ECOL RES, V16, P107, DOI 10.1046/j.1440-1703.2001.00376.x; SANO Y, 1977, NATURE, V266, P159, DOI 10.1038/266159a0; Makinen H, 2000, CAN J FOREST RES, V30, P769, DOI 10.1139/cjfr-30-5-769; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; Takahashi K, 2003, ARCT ANTARCT ALP RES, V35, P1, DOI 10.1657/1523-0430(2003)035[0001:EOCCOS]2.0.CO;2; Linares JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P485, DOI 10.1111/j.1466-8238.2009.00465.x; Liang E, 2012, ANN BOT-LONDON, V109, P721, DOI 10.1093/aob/mcr315; Takahashi K, 2009, ECOL RES, V24, P847, DOI 10.1007/s11284-008-0558-1; Linares JC, 2010, J ECOL, V98, P592, DOI 10.1111/j.1365-2745.2010.01645.x; Takahashi K, 2005, ECOL RES, V20, P445, DOI 10.1007/s11284-005-0060-y; Nojd P, 2001, FOREST ECOL MANAG, V142, P65, DOI 10.1016/S0378-1127(00)00340-6; Pan C, 1997, FOREST ECOL MANAG, V98, P77, DOI 10.1016/S0378-1127(97)00087-X; Kullman L, 2007, J ECOL, V95, P41, DOI 10.1111/j.1365-2745.2006.01190.x; Brookhouse MT, 2009, TREES-STRUCT FUNCT, V23, P1309, DOI 10.1007/s00468-009-0372-6; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Fritts H.C., 1976, TREE RINGS CLIMATE; HARA T, 1992, ANN BOT-LONDON, V69, P509; Holmes R., 1994, DENDROCHRONOLOGY PRO; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; KAJIMOTO T, 1990, Ecological Research, V5, P333, DOI 10.1007/BF02347008; KAJIMOTO T, 1989, Ecological Research, V4, P55, DOI 10.1007/BF02346943; KAJIMOTO T, 1994, ECOL RES, V9, P193, DOI 10.1007/BF02347495; Kibe T., 1992, P NIPR S POLAR BIOL, V5, P118; Kikuzawa K, 1999, ANN BOT-LONDON, V83, P11, DOI 10.1006/anbo.1998.0782; Kira T., 1948, KANTI NOGAKU, V2, P143; Koizumi T, 1993, NIHON NO YAMA HA NAZ; LeBlanc D., 2001, TREE-RING RES, V57, P55; LescopSinclair K, 1995, J ECOL, V83, P929, DOI 10.2307/2261175; MONSERUD RA, 1986, FOREST SCI, V32, P349; NATORI YO, 1966, JAP J ECOL, V16, P247; OKITSU S, 1988, Japanese Journal of Ecology (Tokyo), V38, P177; Ozeki M, 2011, B NAGANO ENV CONSERV, V7, P39; Saito M., 2002, Report of the National Astronomical Observatory of Japan, V6; SANO Y., 1971, Journal of the Faculty of Agriculture Shinshu University, V7, P57; Sparks JP, 2000, INT J BIOMETEOROL, V44, P82; Takahashi K, 2005, ARCT ANTARCT ALP RES, V37, P620, DOI 10.1657/1523-0430(2005)037[0620:EOAWOS]2.0.CO;2; Takahashi K, 2011, TREES-STRUCT FUNCT, V25, P745, DOI 10.1007/s00468-011-0552-z; Takahashi K, 2006, POLAR BIOSCI, V19, P123; Takahashi K, 2005, POLAR BIOSCIENCE, V18, P82; Takahashi K, 2014, ECOL RES, V29, P121, DOI 10.1007/s11284-014-1129-2; Takahashi K., 2003, J PHYTOGEOGR TAXONOM, V51, P159; Yasuda M, 2007, JPN J FOR ENV, V49, P9	59	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	JUL	2015	128	4					553	562		10.1007/s10265-015-0723-x		10	Plant Sciences	Plant Sciences	CL1VF	WOS:000356732300003		
J	Suetsugu, K; Naito, RS; Fukushima, S; Kawakita, A; Kato, M				Suetsugu, Kenji; Naito, Risa S.; Fukushima, Shigeki; Kawakita, Atsushi; Kato, Makoto			Pollination system and the effect of inflorescence size on fruit set in the deceptive orchid Cephalanthera falcata	JOURNAL OF PLANT RESEARCH			English	Article						Display size; Pollinator limitation; Orchidaceae; Reproductive success	FLORAL DISPLAY SIZE; REPRODUCTIVE SUCCESS; SELF-POLLINATION; SPUR LENGTH; EVOLUTIONARY CONSEQUENCES; INBREEDING DEPRESSION; MEDIATED SELECTION; POLLEN LIMITATION; BEE POLLINATION; SEED PREDATION	Larger inflorescences in reward-producing plants can benefit plants by increasing both pollinator attraction and the duration of visits by individual pollinators. However, ultimately, inflorescence size is determined by the balance between the benefits of large inflorescences and the increased cost of geitonogamy. At present, little is known about the relationship between inflorescence size and fecundity in deceptive plants. Given that pollinators are likely to leave inflorescences lacking rewards quickly, it seems unlikely that longer pollinator visits and the risk of geitonogamy would be strong selective pressures in these species, which indicates that pollinator attraction might be the most important factor influencing their inflorescence size. Here we examined the pollination ecology of the deceptive orchid Cephalanthera falcata in order to clarify the effects of inflorescence size on the fruit set of this non-rewarding species. Field observations of the floral visitors showed that C. falcata is pollinated by the andrenid bee Andrena aburana, whilst pollination experiments demonstrated that this orchid species is neither autogamous nor apogamous, but is strongly pollinator dependent. Three consecutive years of field observations revealed that fruit set was positively correlated with the number of flowers per inflorescence. These results provide strong evidence that the nectarless orchid C. falcata benefits from producing larger inflorescences that attract a greater number of innate pollinators. Large inflorescences may have a greater positive effect on fruit set in deceptive plants because a growing number of studies suggest that fruit set in reward-producing plants is usually unaffected by display size.	[Suetsugu, Kenji; Kato, Makoto] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Naito, Risa S.] Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan; [Fukushima, Shigeki] Chiba Prefectural Agr & Forestry Res Ctr, Sanbu, Chiba 2891223, Japan; [Kawakita, Atsushi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Suetsugu, K (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto 6068501, Japan.	kenji.suetsugu@gmail.com			Japan Society for the Promotion of Science [22247003]; JSPS Research Fellowship for Young Scientists [12J00602]	This work was funded by a Japan Society for the Promotion of Science grant (22247003) to MK, and a JSPS Research Fellowship for Young Scientists (12J00602) to KS.	Agren J, 2008, J ECOL, V96, P334, DOI 10.1111/j.1365-2745.2007.01334.x; Ishii HS, 2008, OECOLOGIA, V156, P341, DOI 10.1007/s00442-008-0991-4; Sletvold N, 2011, ECOLOGY, V92, P2167, DOI 10.1890/11-0791.1; Brody AK, 1997, OECOLOGIA, V110, P86, DOI 10.1007/s004420050136; HARDER LD, 1995, NATURE, V373, P512, DOI 10.1038/373512a0; Biernaskie JM, 2009, AM NAT, V174, P413, DOI 10.1086/603629; Mitchell RJ, 2004, FUNCT ECOL, V18, P116, DOI 10.1111/j.1365-2435.2004.00812.x; Sugiura N, 2013, BOT J LINN SOC, V171, P730, DOI 10.1111/j.1095-8339.2012.01324.x; Adler LS, 2004, ECOLOGY, V85, P1519, DOI 10.1890/03-0409; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Yamazaki J, 2006, ANN BOT-LONDON, V98, P1197, DOI 10.1093/aob/mcl223; Tremblay RL, 2005, BIOL J LINN SOC, V84, P1, DOI 10.1111/j.1095-8312.2004.00400.x; Kearns CA, 1997, BIOSCIENCE, V47, P297, DOI 10.2307/1313191; Smithson A, 2006, NEW PHYTOL, V169, P419, DOI 10.1111/j.1469-8137.2005.01592.x; Johnson SD, 2004, P ROY SOC B-BIOL SCI, V271, P803, DOI 10.1098/rspb.2003.2659; DEJONG TJ, 1993, TRENDS ECOL EVOL, V8, P321, DOI 10.1016/0169-5347(93)90239-L; Jersakova J, 2006, OECOLOGIA, V147, P60, DOI 10.1007/s00442-005-0254-6; Sletvold N, 2010, NEW PHYTOL, V188, P385, DOI 10.1111/j.1469-8137.2010.03296.x; Bidartondo MI, 2004, P ROY SOC B-BIOL SCI, V271, P1799, DOI 10.1098/rspb.2004.2807; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Iwata T, 2012, NEW PHYTOL, V193, P196, DOI 10.1111/j.1469-8137.2011.03892.x; Makino TT, 2007, FUNCT ECOL, V21, P854, DOI 10.1111/j.1365-2435.2007.01293.x; DAFNI A, 1984, ANNU REV ECOL SYST, V15, P259, DOI 10.1146/annurev.es.15.110184.001355; Neiland MRM, 1998, AM J BOT, V85, P1657, DOI 10.2307/2446499; Sletvold N, 2010, INT J PLANT SCI, V171, P999, DOI 10.1086/656597; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; Jersakova J, 2006, BIOL REV, V81, P219, DOI 10.1017/S1464793105006986; Harder LD, 2005, P ROY SOC B-BIOL SCI, V272, P2651, DOI 10.1098/rspb.2005.3268; Arditti J., 1992, FUNDAMENTALS ORCHID; DAFNI A, 1981, PLANT SYST EVOL, V137, P229, DOI 10.1007/BF00982788; Environment Agency of Japan, 2000, THREAT WILDL JAP RED, V2nd; Galizia CG, 2005, BEHAV ECOL, V16, P159, DOI 10.1093/beheco/arh147; Goulson D, 1998, OECOLOGIA, V113, P502, DOI 10.1007/s004420050402; Harder LD, 2004, PLANT SPEC BIOL, V19, P137, DOI 10.1111/j.1442-1984.2004.00110.x; Harder LD, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P297, DOI 10.1017/CBO9780511542268.016; Harder LD, 1996, FLORAL BIOL STUDIES, P140; Harrap A., 2005, ORCHIDS BRITAIN IREL; Internicola AI, 2012, P ROY SOC B-BIOL SCI, V279, P1538, DOI 10.1098/rspb.2011.1849; Ishii HS, 2006, FUNCT ECOL, V20, P1115, DOI 10.1111/j.1365-2435.2006.01181.x; JANZEN DH, 1980, BIOTROPICA, V12, P72, DOI 10.2307/2387776; Johnson SD, 2003, ECOLOGY, V84, P2919, DOI 10.1890/02-0471; Johnson SD, 1997, OECOLOGIA, V109, P530, DOI 10.1007/s004420050113; Kindlmann P, 2006, FOLIA GEOBOT, V41, P47, DOI 10.1007/BF02805261; Kitamura S, 1964, COLORED ILLUSTRATION, VIII; Kropf M, 2008, OECOLOGIA, V155, P497, DOI 10.1007/s00442-007-0919-4; LLOYD DG, 1992, INT J PLANT SCI, V153, P370, DOI 10.1086/297041; NILSSON LA, 1979, BOT NOTISER, V132, P329; NILSSON LA, 1983, NATURE, V305, P799, DOI 10.1038/305799a0; OHARA M, 1994, OECOLOGIA, V98, P25, DOI 10.1007/BF00326086; Ohashi K, 1999, OIKOS, V86, P386, DOI 10.2307/3546457; Ohashi K, 1998, AM J BOT, V85, P219, DOI 10.2307/2446309; Ohashi K, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P274, DOI 10.1017/CBO9780511542268.015; Ohashi K, 2002, FUNCT ECOL, V16, P492, DOI 10.1046/j.1365-2435.2002.00644.x; Pellegrino G, 2010, BOT STUD, V51, P351; R Development Core Team, 2011, R LANG ENV STAT COMP; Renner SS, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P123; Roberts DL, 2003, ORCHID CONSERVATION, P113; Sefferson RP, 2011, OIKOS, V120, P1291; Sletvold N, 2008, ACTA OECOL, V34, P21, DOI 10.1016/j.actao.2008.03.002; Suetsugu K, 2015, J PLANT RES, V128, P115, DOI 10.1007/s10265-014-0669-4; Suetsugu K, 2014, PLANT SYST EVOL, V300, P453, DOI 10.1007/s00606-013-0894-7; Suetsugu K, 2014, PLANT SPEC BIOL, V29, P294, DOI 10.1111/1442-1984.12016; Suetsugu K, 2013, PLANT SYST EVOL, V299, P481, DOI 10.1007/s00606-012-0736-z; Tanaka H, 1965, J JAP BOT, V40, P187; Tomimatsu H, 2002, CONSERV BIOL, V16, P1277, DOI 10.1046/j.1523-1739.2002.00412.x; Walsh RP, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu031; Yagame T, 2013, J PLANT RES, V126, P215, DOI 10.1007/s10265-012-0521-7	67	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	JUL	2015	128	4					585	594		10.1007/s10265-015-0716-9		10	Plant Sciences	Plant Sciences	CL1VF	WOS:000356732300006		
J	Zhang, Y; Sun, TX; Xie, L; Hayashi, T; Kawabata, S; Li, YL				Zhang, Yang; Sun, Tianxun; Xie, Linan; Hayashi, Takahiro; Kawabata, Saneyuki; Li, Yuhua			Relationship between the velvet-like texture of flower petals and light reflection from epidermal cell surfaces	JOURNAL OF PLANT RESEARCH			English	Article						Cell shape; Epidermal cell; Exterior reflected light (ERL); Interior reflected light (IRL); Pigment concentration; Velvet lustre texture	OPTICAL-PROPERTIES; ANTIRRHINUM-MAJUS; SHAPE; PIGMENTATION; POLLINATION; MECHANISM; LEAVES	Texture such as velvet lustre contributes to the ornamental character of a flower, along with shape and colour. This study aims to clarify the relationship between the formation of the velvet lustre texture and the optical characteristics of light reflection from irradiated surfaces of velvety and non-velvety petals from 30 cultivars or varieties of ornamental plants representing 19 species from various families. The angle of incident light from the petal surface was set at 90A degrees, 60A degrees or 30A degrees, then light reflection from the petal surfaces was observed using a digital microscope. The observed reflected light was composed of "exterior" reflected light (ERL), which is observed as sparkling white spots on the surface of the epidermal cells, and "interior" reflected light (IRL), which is reflected from inside the petal and determines the base colour of the petals. Velvety petals had two common characteristics: conical-papillate or domed epidermal cells and a dark colour. As the angle between the petal and the incident light decreased, the ERL spots took on a belt-like shape, and total ERL intensity became stronger. We concluded that the velvety texture is derived from characteristic ERL rays coupled with dark IRL. The long sloping surface of the epidermal cells contributes to the higher ERL intensity as petals are observed from more horizontal angles, causing characteristic reverse shading effects on velvety petals.	[Zhang, Yang; Sun, Tianxun; Xie, Linan; Li, Yuhua] Northeast Forestry Univ, Coll Life Sci, Harbin 150040, Peoples R China; [Hayashi, Takahiro] Kinki Univ, Fac Agr, Dept Agr Sci, Plant Sci Lab Human Hlth & Welf, Nara 6318505, Japan; [Kawabata, Saneyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1880002, Japan	Li, YL (reprint author), Northeast Forestry Univ, Coll Life Sci, Harbin 150040, Peoples R China.	lyhshen@126.com			Fundamental Research Funds for the Central Universities [DL13CA01]; National Natural Science Foundation of China [31000318]; China Postdoctoral Science Foundation [20090450945, 201104405]	We are grateful to Dr. Beth Eva Hazen for improving the English of this manuscript. This study was funded by the Fundamental Research Funds for the Central Universities (DL13CA01), the National Natural Science Foundation of China (31000318) and the China Postdoctoral Science Foundation (20090450945, 201104405).	Gould KS, 2000, J EXP BOT, V51, P1107, DOI 10.1093/jexbot/51.347.1107; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; Martin C, 2002, PHILOS T ROY SOC B, V357, P809, DOI 10.1098/rstb.2002.1089; Gorton HL, 1996, PLANT PHYSIOL, V112, P879; Comba L, 2000, PLANT CELL ENVIRON, V23, P639, DOI 10.1046/j.1365-3040.2000.00580.x; Glover BJ, 1998, HEREDITY, V80, P778, DOI 10.1038/sj.hdy.6883450; Kay QON, 1988, PLANTS TODAY     JUL, P109; Lu R, 1998, APPL OPTICS, V37, P5974, DOI 10.1364/AO.37.005974; Neill S, 1999, CAN J BOT, V77, P1777, DOI 10.1139/cjb-77-12-1777; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Okamura M, 2013, EUPHYTICA, V191, P45, DOI 10.1007/s10681-012-0859-x; Yabuya T., 1993, Cytologia (Tokyo), V58, P47; Yasuda H, 1964, J FAC LIBERAL ARTS S, V14, P31; Zhang Y, 2009, SCI HORTIC-AMSTERDAM, V121, P213, DOI 10.1016/j.scienta.2009.01.030; Zhang Y, 2008, ACTA HORTIC, P469	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	JUL	2015	128	4					623	632		10.1007/s10265-015-0725-8		10	Plant Sciences	Plant Sciences	CL1VF	WOS:000356732300009		
J	Tobe, H				Tobe, Hiroshi			Embryology of Phyllonoma (Phyllonomaceae, Aquifoliales): characteristics and character evolution	JOURNAL OF PLANT RESEARCH			English	Article						Aquifoliales; Embryology; Phyllonoma; Phyllonomaceae	PHYLOGENY GROUP CLASSIFICATION; FLORAL MORPHOLOGY; FLOWERING PLANTS; FAMILIES; CARDIOPTERIS; ANGIOSPERMS; UPDATE; ORDERS; GENES; TAXA	Phyllonoma, the sole genus of Phyllonomaceae (Aquifoliales) consisting of four Central American species, has not been well-characterized morphologically. Following a previous study of flower and inflorescence morphology, I here report the embryology of the genus based on P. tenuidens and compare its characteristics with those of other aquifolialean families, namely, Aquifoliaceae, Cardiopteridaceae, Helwingiaceae, and Stemonuraceae. Comparisons indicate that although Phyllonoma resembles all the other families embryologically, it more closely resembles Aquifoliaceae and Helwingiaceae in lacking a vascular bundle in its integument and bearing ab initio Cellular endosperm. The genus especially resembles Helwingiaceae by possessing a tenuinucellate ovule. This result corroborates molecular and floral morphological evidence, supporting the distinctness of Phyllonoma as a family and its sister-group relationship to EastaEuro'Asian Helwingiaceae. However, Phyllonoma is clearly distinguished from Helwingiaceae by seed coat structure. In Phyllonoma, the seeds (dispersed in berries) have a thick seed coat composed of irregularly enlarged, thick-walled exotestal cells, whereas the seeds (dispersed in drupes) have a thin membranous seed coat in Helwingiaceae. Taken together with earlier information on pollination (entomophily in Phyllonoma versus ambophily in Helwingiaceae), embryological evidence shows that distinct evolution has occurred in reproductive characters relating to pollination and seed dispersal in Phyllonoma.	Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan	Tobe, H (reprint author), Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan.	tobe@sys.bot.kyoto-u.ac.jp			Japan Society for the Promotion of Science [25440208]	The study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 25440208). I am grateful to Peter H. Raven and William A. Haber for their assistance in obtaining the materials used in this study.	Karehed J, 2001, AM J BOT, V88, P2259, DOI 10.2307/3558388; Olmstead RG, 2000, MOL PHYLOGENET EVOL, V16, P96, DOI 10.1006/mpev.1999.0769; Bremer B, 2002, MOL PHYLOGENET EVOL, V24, P274, DOI 10.1016/S1055-7903(02)00240-3; Tank DC, 2010, SYST BOT, V35, P425; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Ao CQ, 2015, J PLANT RES, V128, P161, DOI 10.1007/s10265-014-0672-9; Bremer B, 2003, BOT J LINN SOC, V141, P399; Bremer B, 2009, BOT J LINN SOC, V161, P105; Bentham G., 1865, GENERA PLANTARUM, V1; Bouman F., 1984, EMBRYOLOGY ANGIOSPER, P123; BREWBAKE.JL, 1967, AM J BOT, V54, P1069, DOI 10.2307/2440530; Candolle A de, 1873, PRODROMUS SYSTEMATIS, V17; Copeland H. F., 1963, Phytomorphology, V13, P455; Corner EJH, 1976, SEEDS DICOTYLEDONS, V2; Corner EJH, 1976, SEEDS DICOTYLEDONS; Cronquist S, 1968, EVOLUTION CLASSIFICA; Cronquist S, 1981, INTEGRATED SYSTEM CL; Davis GL, 1966, SYSTEMATIC EMBRYOLOG; Engler A, 1930, NATURLICHEN PFLANZ A, P74; Engler A, 1891, NATURL PFLANZ, P41; Fagerlind F, 1945, SVENSK BOT TIDSKR, V1945, P346; HERR J. M., 1961, JOUR ELISHA MITCHELL SCI SOC, V77, P26; HERR J. M., 1959, JOUR ELISHA MITCHELL SCI SOC, V75, P107; Hutchinson J., 1973, FAMILIES FLOWERING P; Hutchinson J., 1967, GENERA FLOWERING PLA, VII; Kong DR, 2014, J SYST EVOL, V52, P629, DOI 10.1111/jse.12081; Kong DR, 2002, ACTA BOT SIN, V44, P496; KRACH J E, 1976, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V97, P1; Mauritzon J, 1936, SVENSK BOT TIDSKRIFT, V30, P541; Mauritzon J, 1933, STUDIEN EMBRYOLOGIE; MORI SA, 1977, BRITTONIA, V29, P69, DOI 10.2307/2805743; PADMANABHAN D., 1961, PROC NATL INST SCI INDIA PART B BIOL SCI, V27, P389; Reveal J.L., 2012, PHYTONEURON, V37, P1; Rusby HH, 1905, N AM FLORA 2, V22, P191; Schultze-Menz GK, 1964, ENGELERS SYLLABUS PF, P193; Schurhoff PN, 1921, BER DEUT BOT GES, V39, P377; Stevens P.F., 2001, ANGIOSPERM PHYLOGENY; Takhtajan A., 2009, FLOWERING PLANTS; Takhtajan A, 1969, FLOWERING PLANTS; Takhtajan A, 2000, ANATOMIA SEMINUM COM, V6, P270; TOBE H, 1989, BOT MAG TOKYO, V102, P351, DOI 10.1007/BF02488572; Tobe H, 2013, J PLANT RES, V126, P709, DOI 10.1007/s10265-013-0556-4; TOBE H, 1987, BOT GAZ, V148, P235, DOI 10.1086/337652; Tobe Hiroshi, 2014, APG Acta Phytotaxonomica et Geobotanica, V65, P117; van Tieghem P, 1898, J BOT, V12, P197; Yamamoto T, 2014, J PLANT RES, V127, P599, DOI 10.1007/s10265-014-0645-z	46	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	JUL	2015	128	4					633	642		10.1007/s10265-015-0730-y		10	Plant Sciences	Plant Sciences	CL1VF	WOS:000356732300010		
J	Konishi, M; Yanagisawa, S				Konishi, Mineko; Yanagisawa, Shuichi			Transcriptional repression caused by Dof5.8 is involved in proper vein network formation in Arabidopsis thaliana leaves	JOURNAL OF PLANT RESEARCH			English	Article						Arabidopsis thaliana; Auxin; Dof transcription factor; Dof5.8; MONOPTEROS; Vascular patterning	CIS-REGULATORY ELEMENTS; VASCULAR DEVELOPMENT; AUXIN BIOSYNTHESIS; FACTOR GENE; FAMILY GENES; EXPRESSION; PROTEIN; MONOPTEROS; PLANTS; GERMINATION	Vascular plants have a network of vasculature in their leaves, which supplies water and nutrients and exports photoassimilates to other tissues. The vascular network is patterned during the development of leaf primordia through the induction of provascular differentiation by auxin. Arabidopsis thaliana Dof5.8, encoding a Dof-type transcription factor, is expressed early in provascular cells under the control of the MONOPTEROS transcription factor, also known as auxin response factor 5 (ARF5). Here, we report the effect of overexpressing Dof5.8 in provascular cells on the formation of the vascular network. Overexpression of Dof5.8 inhibited the formation of higher-order veins in cotyledons and leaves, probably through transcriptional repression by Dof5.8. The expression of auxin-associated transcription factor genes, DORNRoSCHEN and SHI-RELATED SEQUENCE 5, was downregulated in the Dof5.8 overexpressors, and overexpression of these genes partially rescued the impaired formation of higher-order veins in Dof5.8-overexpressing lines, suggesting that the overexpression of Dof5.8 modulates the auxin response and leads to impaired vein formation in A. thaliana.	[Konishi, Mineko; Yanagisawa, Shuichi] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan	Yanagisawa, S (reprint author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	asyanagi@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science [22380043, 25252014, 25840099]	We thank Dr. Tom J. Guilfoyle (University of Missouri) for generously providing DR5-GUS seeds. This research was supported in part by the Japan Society for the Promotion of Science (no. 22380043 and 25252014 for S.Y., and no. 25840099 for M.K.).	Ulmasov T, 1997, PLANT CELL, V9, P1963; Gabriele S, 2010, PLANT J, V61, P312, DOI 10.1111/j.1365-313X.2009.04055.x; Skirycz A, 2006, PLANT J, V47, P10, DOI 10.1111/j.1365-313X.2006.02767.x; Konishi M, 2010, PLANT J, V63, P269, DOI 10.1111/j.1365-313X.2010.04239.x; Hiratsu K, 2002, FEBS LETT, V514, P351, DOI 10.1016/S0014-5793(02)02435-3; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Chandler JW, 2007, DEVELOPMENT, V134, P1653, DOI 10.1242/dev.001016; Skirycz A, 2007, NEW PHYTOL, V175, P425, DOI 10.1111/i.1469-8137.2007.02129.x; Scarpella E, 2004, DEVELOPMENT, V131, P3445, DOI 10.1242/dev.01182; Schneidereit A, 2008, PLANTA, V228, P651, DOI 10.1007/s00425-008-0767-4; Donner TJ, 2009, DEVELOPMENT, V136, P3235, DOI 10.1242/dev.037028; Staldal V, 2008, NEW PHYTOL, V180, P798, DOI 10.1111/j.1469-8137.2008.02625.x; Kim HS, 2010, PLANT J, V64, P524, DOI 10.1111/j.1365-313X.2010.04346.x; Gualberti G, 2002, PLANT CELL, V14, P1253, DOI 10.1105/tpc.010491; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75; Kato Y, 2010, BIOCHEM BIOPH RES CO, V397, P673, DOI 10.1016/j.bbrc.2010.06.001; Eklund DM, 2010, PLANT CELL, V22, P349, DOI 10.1105/tpc.108.064816; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Skirycz A, 2008, PLANT J, V56, P779, DOI 10.1111/j.1365-313X.2008.03641.x; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Sohlberg JJ, 2006, PLANT J, V47, P112, DOI 10.1111/j.1365-313X.2006.02775.x; Furuta KM, 2014, SCIENCE, V345, P933, DOI 10.1126/science.1253736; Yanagisawa S, 2004, P NATL ACAD SCI USA, V101, P7833, DOI 10.1073/pnas.0402267101; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Wenzel CL, 2007, PLANT J, V49, P387, DOI 10.1111/j.1365-313X.2006.02977.x; Baylis T, 2013, NEW PHYTOL, V197, P737, DOI 10.1111/nph.12084; Kuusk S, 2006, PLANT J, V47, P99, DOI 10.1111/j.1365-313X.2006.02774.x; Mena M, 2002, PLANT PHYSIOL, V130, P111, DOI 10.1104/pp.005561; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Konishi M, 2008, PLANT J, V55, P821, DOI 10.1111/j.1365-313X.2008.03551.x; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gaf.1402406; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Cole M, 2009, DEVELOPMENT, V136, P1643, DOI 10.1242/dev.032177; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; Yanagisawa S, 2000, PLANT J, V21, P281, DOI 10.1046/j.1365-313x.2000.00685.x; Konishi M, 2015, J EXP BOT, V66, P283, DOI 10.1093/jxb/eru418; Ayre BG, 2003, PLANT PHYSIOL, V133, P1229, DOI 10.1104/pp.103.027714; Chisholm ST, 2001, PLANT PHYSIOL, V127, P1667, DOI 10.1104/pp.127.4.1667; Ckurshumova W, 2011, PLANT SCI, V181, P96, DOI 10.1016/j.plantsci.2011.04.008; Eklund DM, 2011, PLANT PHYSIOL, V157, P2069, DOI 10.1104/pp.111.182253; Fridborg I, 2001, PLANT PHYSIOL, V127, P937, DOI 10.1104/pp.127.3.937; Gardiner J, 2010, INT J DEV BIOL, V54, P1389, DOI 10.1387/ijdb.093006jg; Guo Y, 2009, PLANT CELL, V21, P3518, DOI 10.1105/tpc.108.064139; Konishi M, 2007, PLANT PHYSIOL BIOCH, V45, P623, DOI 10.1016/j.plaphy.2007.05.001; Le Hir R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00164; LUEHRSEN KR, 1992, METHOD ENZYMOL, V216, P397; Rueda-Romero P, 2012, J EXP BOT, V63, P1937, DOI 10.1093/jxb/err388; Sugiyama T, 2012, J EXP BOT, V63, P3185, DOI 10.1093/jxb/ers042	53	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	JUL	2015	128	4					643	652		10.1007/s10265-015-0712-0		10	Plant Sciences	Plant Sciences	CL1VF	WOS:000356732300011		
J	Wang, LX; Kikuchi, S; Muto, C; Naito, K; Isemura, T; Ishimoto, M; Cheng, XZ; Kaga, A; Tomooka, N				Wang, Lixia; Kikuchi, Shinji; Muto, Chiaki; Naito, Ken; Isemura, Takehisa; Ishimoto, Masao; Cheng, Xuzhen; Kaga, Akito; Tomooka, Norihiko			Reciprocal translocation identified in Vigna angularis dominates the wild population in East Japan	JOURNAL OF PLANT RESEARCH			English	Article						Azuki bean; Linkage analysis; Cytogenetics; Reciprocal translocation; Wild population	WILLD. OHWI; LINKAGE MAP; GENETIC DIVERSITY; SSR MARKERS; ICE AGES; OHASHI; DOMESTICATION; UMBELLATA; PLANTS; FLOW	Using an F-2 population derived from cultivated and wild azuki bean, we previously detected a reciprocal translocation and a seed size QTL near the translocation site. To test the hypothesis that the translocation in the cultivated variety contributed to the larger seed size, we performed further linkage analyses with several cross combinations between cultivated and wild azuki beans. In addition, we visually confirmed the translocation by cytogenetic approach using 25 wild and cultivated accessions. As a result, we found the translocation-type chromosomes in none of the cultivated accessions, but in a number of the wild accessions. Interestingly, all the wild accessions with the translocation were originally collected from East Japan, while all the accessions with normal chromosomes were from West Japan or the Sea of Japan-side region. Such biased geographical distribution could be explained by the glacial refugium hypothesis, and supported narrowing down the domestication origin of cultivated azuki bean.	[Wang, Lixia; Cheng, Xuzhen] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Kikuchi, Shinji] Chiba Univ, Grad Sch Hort, Matsudo, Chiba 2718510, Japan; [Muto, Chiaki; Naito, Ken; Isemura, Takehisa; Kaga, Akito; Tomooka, Norihiko] Natl Inst Agrobiol Resources, Genet Resource Ctr, Tsukuba, Ibaraki 2718510, Japan; [Ishimoto, Masao] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki 3058602, Japan	Naito, K (reprint author), Natl Inst Agrobiol Resources, Genet Resource Ctr, 2-1-2 Kannondai, Tsukuba, Ibaraki 2718510, Japan.	knaito@affrc.go.jp					Somta P, 2006, PLANT BREEDING, V125, P77, DOI 10.1111/j.1439-0523.2006.01123.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; YAMAGUCHI H, 1992, ECON BOT, V46, P384, DOI 10.1007/BF02866509; Iwata H, 2006, BREEDING SCI, V56, P371, DOI 10.1270/jsbbs.56.371; Wang XW, 2004, THEOR APPL GENET, V109, P352, DOI 10.1007/s00122-004-1634-8; Qi XS, 2012, NEW PHYTOL, V196, P617, DOI 10.1111/j.1469-8137.2012.04242.x; Scriven PN, 1998, PRENATAL DIAG, V18, P1437, DOI 10.1002/(SICI)1097-0223(199812)18:13<1437::AID-PD497>3.3.CO;2-G; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Livingstone KD, 2000, J HERED, V91, P423, DOI 10.1093/jhered/91.6.423; Kaga A, 2008, GENETICS, V178, P1013, DOI 10.1534/genetics.107.078451; Han OK, 2005, THEOR APPL GENET, V111, P1278, DOI 10.1007/s00122-005-0046-8; Iwasaki T, 2012, J PLANT RES, V125, P207, DOI 10.1007/s10265-011-0428-8; Honjo M, 2004, BIOL CONSERV, V120, P211, DOI 10.1016/j.biocon.2004.02.016; Chaitieng B, 2006, THEOR APPL GENET, V113, P1261, DOI 10.1007/s00122-006-0380-5; Isemura T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041304; Isemura T, 2010, ANN BOT-LONDON, V106, P927, DOI 10.1093/aob/mcq188; Kim CG, 2003, GENOMICS, V82, P571, DOI 10.1016/S0888-7543(03)00174-5; LIU CJ, 1994, THEOR APPL GENET, V89, P481, DOI 10.1007/BF00225384; Takeya M, 2011, NUCLEIC ACIDS RES, V39, P1108; Tateishi Y., 2002, Kew Bulletin, V57, P625, DOI 10.2307/4110990; Tomooka N, 2005, PLANT GENOME BIODI C, V1c, P87; Tomooka N, 2007, ARCHAEOLOGICAL REMAI; Vaughan DA, 2005, GENETIC RESOURCES CH, V1, P341; Wang SH, 2012, J EXP BOT, V63, P4983, DOI 10.1093/jxb/ers176; WIMAN KG, 1984, P NATL ACAD SCI-BIOL, V81, P6798, DOI 10.1073/pnas.81.21.6798; Xu HX, 2008, GENOME, V51, P728, DOI 10.1139/G08-058; Yamamoto Y, 2006, PLANT BREEDING, V125, P156, DOI 10.1111/j.1439-0523.2006.01202.x	27	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	JUL	2015	128	4					653	663		10.1007/s10265-015-0720-0		11	Plant Sciences	Plant Sciences	CL1VF	WOS:000356732300012		
J	Chiba, Y; Shimizu, T; Miyakawa, S; Kanno, Y; Koshiba, T; Kamiya, Y; Seo, M				Chiba, Yasutaka; Shimizu, Takafumi; Miyakawa, Shinya; Kanno, Yuri; Koshiba, Tomokazu; Kamiya, Yuji; Seo, Mitsunori			Identification of Arabidopsis thaliana NRT1/PTR FAMILY (NPF) proteins capable of transporting plant hormones	JOURNAL OF PLANT RESEARCH			English	Article						Abscisic acid (ABA); Arabidopsis (Arabidopsis thaliana); Gibberellin (GA); Jasmonoyl-isoleucine (JA-Ile); NRT1/PTR FAMILY (NPF); Transport	ABSCISIC-ACID; AUXIN TRANSPORT; NITRATE TRANSPORTERS; TRANSLOCATION; PHLOEM; NRT1.1; ABA; GIBBERELLIN; RECEPTORS; TOLERANCE	NRT1/PTR FAMILY (NPF) proteins were originally identified as nitrate or di/tri-peptide transporters. Recent studies revealed that this transporter family also transports the plant hormones auxin (indole-3-acetic acid), abscisic acid (ABA), and gibberellin (GA), as well as secondary metabolites (glucosinolates). We developed modified yeast two-hybrid systems with receptor complexes for GA and jasmonoyl-isoleucine (JA-Ile), to detect GA and JA-Ile transport activities of proteins expressed in the yeast cells. Using these GA and JA-Ile systems as well as the ABA system that we had introduced previously, we determined the capacities of Arabidopsis NPFs to transport these hormones. Several NPFs induced the formation of receptor complexes under relatively low hormone concentrations. Hormone transport activities were confirmed for some NPFs by direct analysis of hormone uptake of yeast cells by liquid chromatography-tandem mass spectrometry. Our results suggest that at least some NPFs could function as hormone transporters.	[Chiba, Yasutaka; Miyakawa, Shinya; Koshiba, Tomokazu; Seo, Mitsunori] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920387, Japan; [Chiba, Yasutaka; Shimizu, Takafumi; Kanno, Yuri; Kamiya, Yuji; Seo, Mitsunori] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan	Seo, M (reprint author), RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan.	mitsunori.seo@riken.jp	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010	Kamiya, Yuji/0000-0003-4415-520X	Japan Society of Promotion of Science (JSPS) KAKENHI [Challenging Exploratory Research] [24657040]	This work was supported in part by the Japan Society of Promotion of Science (JSPS) KAKENHI [Challenging Exploratory Research (24657040) to M.S.].	Endo A, 2008, PLANT PHYSIOL, V147, P1984, DOI 10.1104/pp.108.116632; Kanno Y, 2012, P NATL ACAD SCI USA, V109, P9653, DOI 10.1073/pnas.1203567109; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kende H, 1997, PLANT CELL, V9, P1197, DOI 10.1105/tpc.9.7.1197; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Lumba S, 2010, ANNU REV CELL DEV BI, V26, P445, DOI 10.1146/annurev-cellbio-100109-103956; Yang HB, 2009, PLANT J, V59, P179, DOI 10.1111/j.1365-313X.2009.03856.x; Seo M, 2011, J PLANT RES, V124, P501, DOI 10.1007/s10265-011-0411-4; Fan SC, 2009, PLANT CELL, V21, P2750, DOI 10.1105/tpc.109.067603; Almagro A, 2008, PLANT CELL, V20, P3289, DOI 10.1105/tpc.107.056788; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Koiwai H, 2004, PLANT PHYSIOL, V134, P1697, DOI 10.1104/pp.103.036970; Kretzschmar T, 2012, NATURE, V483, P341, DOI 10.1038/nature10873; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Lin SH, 2008, PLANT CELL, V20, P2514, DOI 10.1105/tpc.108.060244; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Sun J, 2014, NATURE, V507, P73, DOI 10.1038/nature13074; Boursiac Y, 2013, TRENDS PLANT SCI, V18, P325, DOI 10.1016/j.tplants.2013.01.007; Habets MEJ, 2014, NEW PHYTOL, V203, P362, DOI 10.1111/nph.12831; Hsu PK, 2013, PLANT PHYSIOL, V163, P844, DOI 10.1104/pp.113.226563; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Li JY, 2010, PLANT CELL, V22, P1633, DOI 10.1105/tpc.110.075242; Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Takeuchi J, 2014, NAT CHEM BIOL, V10, P477, DOI [10.1038/nchembio.1524, 10.1038/NCHEMBIO.1524]; Huang NC, 1999, PLANT CELL, V11, P1381, DOI 10.1105/tpc.11.8.1381; Parker JL, 2014, NATURE, V507, P68, DOI 10.1038/nature13116; Jiang F, 2008, J EXP BOT, V59, P37, DOI 10.1093/jxb/erm127; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Matsuura H, 2012, PHYTOCHEMISTRY, V83, P25, DOI 10.1016/j.phytochem.2012.06.009; Wang YY, 2011, PLANT CELL, V23, P1945, DOI 10.1105/tpc.111.083618; Lange MJP, 2012, J EXP BOT, V63, P2681, DOI 10.1093/jxb/err448; Guo FO, 2003, PLANT CELL, V15, P107, DOI 10.1105/tpc.006312; Komarova NY, 2008, PLANT PHYSIOL, V148, P856, DOI 10.1104/pp.108.123844; Ko D, 2014, P NATL ACAD SCI USA, V111, P7150, DOI 10.1073/pnas.1321519111; Jikumaru Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1461, DOI 10.1271/bbb.68.1461; Karim S, 2007, PLANTA, V225, P1431, DOI 10.1007/s00425-006-0451-5; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Swarup R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00225; Zhang HW, 2014, MOL PLANT, V7, P1522, DOI 10.1093/mp/ssu063; Zhang KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4274	42	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	JUL	2015	128	4					679	686		10.1007/s10265-015-0710-2		8	Plant Sciences	Plant Sciences	CL1VF	WOS:000356732300014		
J	Kuroda, A; Tanaka, T; Hirano, H; Ohara, Y; Kikutani, T; Furuya, H; Obuchi, SP; Kawai, H; Ishii, S; Akishita, M; Tsuji, T; Iijima, K				Kuroda, Aki; Tanaka, Tomoki; Hirano, Hirohiko; Ohara, Yuki; Kikutani, Takeshi; Furuya, Hiroyasu; Obuchi, Shuichi P.; Kawai, Hisashi; Ishii, Shinya; Akishita, Masahiro; Tsuji, Tetsuo; Iijima, Katsuya			Eating Alone as Social Disengagement is Strongly Associated With Depressive Symptoms in Japanese Community-Dwelling Older Adults	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Eating alone; depressive symptoms; social engagement	LATER LIFE; HEALTH LITERACY; RISK-FACTORS; ORAL-HEALTH; LONELINESS; PREVALENCE; MOBILITY; POPULATIONS; ENGAGEMENT; DEMENTIA	Objectives: Depression in later life poses a grave challenge for the aging countries. The reported key risk factors include social disengagement, but the lack of social companionship during mealtimes, namely eating alone, has not been examined extensively, especially in relation to living arrangement. Past studies on changes along geriatric trajectories in the association between social engagement and depression also remain inadequate. This study aims to examine the association between social engagement and depressive symptoms with a particular focus on eating alone and how the association changes along the aging and mental frailty trajectories. Design: A cross-sectional study. Setting: Kashiwa-city, Chiba-prefecture in Japan. Participants: A total of 1856 community-dwelling older adults. Measurements: The 15-item Geriatric Depression Scale was used to measure depressive symptoms. The indicators used to assess social engagement included eating alone, living arrangement, reciprocity of social support, social participation, social stressors and social ties. Results: Social engagement was significantly associated with depressive symptoms. Those who live with their families yet eat alone were found to be at particular risk (odds ratio = 5.02, 95% confidence interval 2.5-9.9 for young-old; odds ratio = 2.41, 95% confidence interval 1.2-4.8 for old-old). Younger and less mentally frail populations showed stronger associations. Conclusions: Eating alone was a key risk factor for depressive symptoms in community-dwelling older adults. The living arrangement in which they eat alone is important in identifying those with the greatest risk. Mental health management for older adults requires comprehensive assessment of their social relations that takes into account their companionship during mealtimes. Social preventive measures need to involve early interventions in order to augment their effectiveness against mental frailty. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Kuroda, Aki; Tsuji, Tetsuo; Iijima, Katsuya] Univ Tokyo, Inst Gerontol, Tokyo 1138656, Japan; [Tanaka, Tomoki; Furuya, Hiroyasu; Obuchi, Shuichi P.] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [Ohara, Yuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Care Educ, Tokyo, Japan; [Kikutani, Takeshi; Furuya, Hiroyasu] Nippon Dent Univ Tokyo, Grad Sch Life Dent Tokyo, Div Clin Oral Rehabil, Tokyo, Japan; [Ishii, Shinya; Akishita, Masahiro] Univ Tokyo, Dept Geriatr Med, Tokyo, Japan	Iijima, K (reprint author), Univ Tokyo, Inst Gerontol, Dept Engn, Bunkyo Ku, 8th Bldg 706,7-3-1 Hongo, Tokyo 1138656, Japan.	iijima@iog.u-tokyo.ac.jp			Ministry of Health, Labor and Welfare, Japan [H24-Choju-Ippan-002]	This work was supported by a Health and Labor Sciences Research Grant (H24-Choju-Ippan-002) from the Ministry of Health, Labor and Welfare, Japan.	Lubben J, 2006, GERONTOLOGIST, V46, P503; Blazer DG, 2005, PSYCHOL MED, V35, P1241, DOI 10.1017/S0033291705004411; Kimura Y, 2012, J NUTR HEALTH AGING, V16, P728, DOI 10.1007/s12603-012-0067-3; Ishii S, 2014, GERIATR GERONTOL INT, V14, P93, DOI 10.1111/ggi.12197; Schreiner AS, 2003, INT J GERIATR PSYCH, V18, P498, DOI 10.1002/gps.880; Tilvis RS, 2012, EUR GERIATR MED, V3, P18, DOI 10.1016/j.eurger.2011.08.004; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Beekman ATF, 1995, J AFFECT DISORDERS, V36, P65, DOI 10.1016/0165-0327(95)00061-5; Fukunaga R, 2012, PSYCHOGERIATRICS, V12, P179, DOI 10.1111/j.1479-8301.2012.00402.x; Tomaka J, 2006, J AGING HEALTH, V18, P359, DOI 10.1177/0898264305280993; Wada T, 2004, ARCH GERONTOL GERIAT, V39, P15, DOI 10.1016/j.archger.2003.12.003; Hassel AJ, 2011, CLIN ORAL INVEST, V15, P691, DOI 10.1007/s00784-010-0437-3; Avlund K, 2004, ARCH GERONTOL GERIAT, V38, P85, DOI 10.1016/j.archger.2003.08.003; Naito M, 2006, J PUBLIC HEALTH DENT, V66, P273; Vesnaver Elisabeth, 2011, Journal of Nutrition in Gerontology and Geriatrics, V30, P2, DOI 10.1080/01639366.2011.545038; Bassuk SS, 1999, ANN INTERN MED, V131, P165; Schwarzbach M, 2014, INT J GERIATR PSYCH, V29, P1, DOI 10.1002/gps.3971; Shimada H, 2010, ARCH GERONTOL GERIAT, V50, P140, DOI 10.1016/j.archger.2009.02.015; Muramatsu N, 2011, GERONTOLOGIST, V51, P425, DOI 10.1093/geront/gnr067; Shimada H, 2010, ARCH PHYS MED REHAB, V91, P241, DOI 10.1016/j.apmr.2009.10.027; Baker PS, 2003, J AM GERIATR SOC, V51, P1610, DOI 10.1046/j.1532-5415.2003.51512.x; Peel C, 2005, PHYS THER, V85, P1008; Markle-Reid M, 2003, J ADV NURS, V44, P58, DOI 10.1046/j.1365-2648.2003.02767.x; Djernes JK, 2006, ACTA PSYCHIAT SCAND, V113, P372, DOI 10.1111/j.1600-0447.2006.00770.x; Crooks VC, 2008, AM J PUBLIC HEALTH, V98, P1221, DOI 10.2105/AJPH.2007.115923; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Atchison K A, 1990, J Dent Educ, V54, P680; Bath PA, 2005, EUR J AGEING, V2, P24, DOI DOI 10.1007/S10433-005-0019-4; de Andrade FB, 2012, J AM GERIATR SOC, V60, P1755, DOI 10.1111/j.1532-5415.2012.04104.x; Gazmararian J, 2000, ARCH INTERN MED, V160, P3307, DOI 10.1001/archinte.160.21.3307; Heun R, 2005, EUR PSYCHIAT, V20, P199, DOI 10.1016/j.eurpsy.2004.09.036; Ishikawa H, 2008, HEALTH PROMOT INT, V23, P269, DOI 10.1093/heapro/dan017; Kumagai Shu, 2003, Nihon Koshu Eisei Zasshi, V50, P1117; Liu Chi-pun Ben, 2011, Aging Ment Health, V15, P732, DOI 10.1080/13607863.2011.562174; Mendes de Leon C.F., 2005, EUR J AGEING, V2, P64; Park NS, 2009, J APPL GERONTOL, V28, P461, DOI 10.1177/0733464808328606; Park NS, 2013, J GERONTOL B-PSYCHOL, V68, P193, DOI 10.1093/geronb/gbs062; Rubenstein LZ, 2001, J GERONTOL A-BIOL, V56, pM366	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	JUL 1	2015	16	7					578	585		10.1016/j.jamda.2015.01.078		8	Geriatrics & Gerontology	Geriatrics & Gerontology	CL0FR	WOS:000356616200008		
J	Koguchi-Yoshioka, H; Wataya-Kaneda, M; Yutani, M; Nakano, H; Sawamura, D; Katayama, I				Koguchi-Yoshioka, H.; Wataya-Kaneda, M.; Yutani, M.; Nakano, H.; Sawamura, D.; Katayama, I.			Partial anhidrosis demonstrated by Q-SART in a patient with a novel mutation in the EDARADD gene	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Letter							TOURNIQUET		[Koguchi-Yoshioka, H.; Wataya-Kaneda, M.; Yutani, M.; Katayama, I.] Osaka Univ, Grad Sch Med, Dept Dermatol, Course Integrated Med, Osaka, Japan; [Nakano, H.; Sawamura, D.] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori, Japan	Wataya-Kaneda, M (reprint author), Osaka Univ, Grad Sch Med, Dept Dermatol, Course Integrated Med, Osaka, Japan.	mkaneda@derma.med.osaka-u.ac.jp					Hollander JE, 1999, ANN EMERG MED, V34, P356, DOI 10.1016/S0196-0644(99)70131-9; Clarke MT, 2001, J BONE JOINT SURG BR, V83B, P40, DOI 10.1302/0301-620X.83B1.10795; GRAHAM B, 1992, J HAND SURG-BRIT EUR, V17B, P262, DOI 10.1016/0266-7681(92)90111-E; Lahham Shadi, 2011, West J Emerg Med, V12, P242; WILGIS EFS, 1971, J BONE JOINT SURG AM, VA 53, P1343	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	JUL	2015	29	7					1443	1444		10.1111/jdv.12493		2	Dermatology	Dermatology	CL2YD	WOS:000356813100032		
J	Ohshima, Y; Yanagishita, T; Ito, K; Tamada, Y; Nishimura, N; Inukai, Y; Iwase, S; Watanabe, D				Ohshima, Y.; Yanagishita, T.; Ito, K.; Tamada, Y.; Nishimura, N.; Inukai, Y.; Iwase, S.; Watanabe, D.			A case of acquired idiopathic generalized anhidrosis in a 2-year-old infant	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Letter							CUTANEOUS COLLAGENOUS VASCULOPATHY; TELANGIECTASIA		[Ohshima, Y.; Yanagishita, T.; Ito, K.; Tamada, Y.; Watanabe, D.] Aichi Med Univ, Sch Med, Dept Dermatol, Nagakute, Aichi 48011, Japan; [Nishimura, N.; Inukai, Y.; Iwase, S.] Aichi Med Univ, Sch Med, Dept Physiol, Nagakute, Aichi 48011, Japan	Ohshima, Y (reprint author), Aichi Med Univ, Sch Med, Dept Dermatol, Nagakute, Aichi 48011, Japan.	y45123@aichi-med-u.ac.jp					Bardazzi F, 2014, CLIN EXP DERMATOL, V39, P228, DOI 10.1111/ced.12258; Becker SW, 1926, ARCH DERMATOL SYPH, V14, P387; Davis TL, 2008, J CUTAN PATHOL, V35, P967, DOI 10.1111/j.1600-0560.2007.00930.x; Gutiérrez-Paredes E, 2012, Actas Dermosifiliogr, V103, P443, DOI 10.1016/j.ad.2011.10.009; Kanitakis J, 2010, AM J CLIN DERMATOL, V11, P63, DOI 10.2165/11311030-000000000-00000; Moulonguet I, 2013, AM J DERMATOPATH, V35, P688, DOI 10.1097/DAD.0b013e3182873e94; Perez A, 2010, J AM ACAD DERMATOL, V63, P882, DOI 10.1016/j.jaad.2009.06.045; Salama S, 2000, J CUTAN PATHOL, V27, P40, DOI 10.1034/j.1600-0560.2000.027001040.x; SCHWARTZ RA, 1995, J AM ACAD DERMATOL, V33, P161, DOI 10.1016/0190-9622(95)90231-7	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	JUL	2015	29	7					1446	1448		10.1111/jdv.12499		3	Dermatology	Dermatology	CL2YD	WOS:000356813100034		
J	Tanahashi, K; Sugiura, K; Muro, Y; Akiyama, M				Tanahashi, K.; Sugiura, K.; Muro, Y.; Akiyama, M.			Disappearance of circulating autoantibodies to RNA polymerase III in a patient with systemic sclerosis successfully treated with corticosteroid and methotrexate	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Letter							LINKED-IMMUNOSORBENT-ASSAY; ANTIBODY		[Tanahashi, K.; Sugiura, K.; Muro, Y.; Akiyama, M.] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan	Sugiura, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan.	kazusugi@med.nagoya-u.ac.jp	Sugiura, Kazumitsu /M-8913-2014; MURO, Yoshinao/M-8883-2014; 	Sugiura, Kazumitsu /0000-0002-5207-4592; Muro, Yoshinao/0000-0003-2329-8375			Kuwana M, 2005, ARTHRITIS RHEUM, V52, P2425, DOI 10.1002/art.21232; Nihtyanova SI, 2009, RHEUMATOLOGY, V48, P1218, DOI 10.1093/rheumatology/kep215; Muro Y, 2012, RHEUMATOLOGY, V51, P800, DOI 10.1093/rheumatology/ker408; Satoh T, 2009, RHEUMATOLOGY, V48, P1570, DOI 10.1093/rheumatology/kep290	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	JUL	2015	29	7					1453	1454		10.1111/jdv.12512		2	Dermatology	Dermatology	CL2YD	WOS:000356813100039		
J	Hata, A; Katakami, N				Hata, Akito; Katakami, Nobuyuki			Afatinib for Erlotinib Refractory Brain Metastases in a Patient with EGFR-Mutant Non-Small-Cell Lung Cancer Can High-Affinity TKI Substitute for High-Dose TKI?	JOURNAL OF THORACIC ONCOLOGY			English	Letter							GEFITINIB		[Hata, Akito; Katakami, Nobuyuki] Inst Biomed Res & Innovat, Div Integrated Oncol, Kobe, Hyogo 6500047, Japan	Hata, A (reprint author), Inst Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, 2-2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	a-hata@fbri.org					Hata A, 2011, J THORAC ONCOL, V6, P653, DOI 10.1097/JTO.0b013e3181d899bb; Jackman DM, 2006, J CLIN ONCOL, V24, P4517, DOI 10.1200/JCO.2006.06.6126; Hata A, 2013, J THORAC ONCOL, V8, pE27, DOI 10.1097/JTO.0b013e318282e047; Hoffknecht P, 2014, J THORAC ONCOL; Jackman DM, 2013, ASCO M, V31, P8116	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	JUL	2015	10	7					E65	E66		10.1097/JTO.0000000000000479		2	Oncology; Respiratory System	Oncology; Respiratory System	CL4SM	WOS:000356944400007		
J	Toyokawa, G; Inamasu, E; Shimamatsu, S; Yoshida, T; Nosaki, K; Hirai, F; Yamaguchi, M; Seto, T; Takenoyama, M; Ichinose, Y				Toyokawa, Gouji; Inamasu, Eiko; Shimamatsu, Shinichiro; Yoshida, Tsukihisa; Nosaki, Kaname; Hirai, Fumihiko; Yamaguchi, Masafumi; Seto, Takashi; Takenoyama, Mitsuhiro; Ichinose, Yukito			Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non-small-cell Lung Cancer Exhibiting Resistance to Ceritinib	JOURNAL OF THORACIC ONCOLOGY			English	Article							NSCLC PATIENTS; ALECTINIB; CRIZOTINIB		[Toyokawa, Gouji; Inamasu, Eiko; Shimamatsu, Shinichiro; Yoshida, Tsukihisa; Nosaki, Kaname; Hirai, Fumihiko; Yamaguchi, Masafumi; Seto, Takashi; Takenoyama, Mitsuhiro; Ichinose, Yukito] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, Fukuoka 8111395, Japan	Seto, T (reprint author), Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, 3-1-1 Notame, Fukuoka 8111395, Japan.	tseto@nk-cc.go.jp					Ou SHI, 2014, J THORAC ONCOL, V9, P549, DOI 10.1097/JTO.0000000000000094; Heuckmann JM, 2011, CLIN CANCER RES, V17, P7394, DOI 10.1158/1078-0432.CCR-11-1648; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Katayama R, 2014, CLIN CANCER RES, V20, P5686, DOI 10.1158/1078-0432.CCR-14-1511; Ou SHI, 2014, J THORAC ONCOL, V9, P1821, DOI 10.1097/JTO.0000000000000368; Toyokawa G, 2014, J THORAC ONCOL, V9, pE86, DOI 10.1097/JTO.0000000000000358	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	JUL	2015	10	7					E55	E57		10.1097/JTO.0000000000000509		3	Oncology; Respiratory System	Oncology; Respiratory System	CL4SM	WOS:000356944400001		
J	Nishiyama, A; Koyama, H; Miyata, T; Watanabe, T				Nishiyama, Ayako; Koyama, Hiroyuki; Miyata, Tetsuro; Watanabe, Toshiaki			Therapeutic site selection is important for the successful development of collateral vessels	JOURNAL OF VASCULAR SURGERY			English	Article							FIBROBLAST-GROWTH-FACTOR; PERIPHERAL ARTERIAL-DISEASE; CHRONIC MYOCARDIAL-ISCHEMIA; VIVO GENE-TRANSFER; INTERMITTENT CLAUDICATION; RABBIT HINDLIMB; LIMB ISCHEMIA; DOUBLE-BLIND; ANGIOGENESIS; ARTERIOGENESIS	Background: Induction of collateral development to improve tissue perfusion is a promising approach for the treatment of arterial occlusive diseases. Several growth factors and cells have been reported to increase collateral circulation; however, the appropriate site for the delivery of these factors and cells is unclear. In this study, we identified the delivery site for growth factor in a rabbit model of limb ischemia and evaluated whether specific delivery of basic fibroblast growth factor (bFGF) to this site enhanced collateral augmentation. Methods: The left femoral artery of Japanese white rabbits was excised to induce limb ischemia. Twenty-eight days thereafter, angiograms were obtained to identify the typical pattern of collateral development in this model. Subsequently, bFGF (100 mu g) was selectively injected into the left coccygeofemoral muscle (coccygeo group) or adductor muscle (adductor group), major thigh muscles in proximity. Collateral development was evaluated at 28 days after injection, and its mechanism was assessed by immunologic and morphometric analyses of muscle samples. Results: Angiographic evaluation of this model revealed that after femoral artery excision, collateral vessels generally developed in the left coccygeofemoral muscle, whereas few collateral vessels were detected in the left adductor muscle. At 28 days after injection, calf blood pressure ratio, defined as left pressure to right pressure, was significantly higher in the coccygeo group than in the adductor group (0.85 +/- 0.05 vs 0.69 +/- 0.05, respectively; P < .01). Similar results were observed in blood flow through the internal iliac artery (resting: 24.6 +/- 6.1 vs 17.4 +/- 8.0 mL/min, P < .01; maximum: 47.4 +/- 12.3 vs 33.2 +/- 10.7 mL/min, P < .01) and in the angiographic score (0.67 +/- 0.13 vs 0.39 +/- 0.11; P < .01). Immunologic analyses of the coccygeofemoral muscle at day 3 showed marked expressions of Ki-67, monocyte chemotactic protein 1, and FGF receptor 1 in the coccygeo group compared with the adductor group. Morphometric analyses of the same muscle at day 14 also revealed that collateral vessel density and wall thickness were significantly increased in the coccygeal group compared with the adductor group. Conclusions: These findings demonstrated that selective bFGF delivery to the coccygeofemoral muscle markedly improved collateral development and limb perfusion compared with delivery to the adductor muscle, suggesting that site selection is important in increasing therapeutic efficacy.	[Nishiyama, Ayako; Koyama, Hiroyuki; Miyata, Tetsuro] Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg, Tokyo 1138655, Japan; [Koyama, Hiroyuki] Tokyo Univ Hosp, Div Translat Res Ctr, Tokyo 113, Japan; [Watanabe, Toshiaki] Univ Tokyo, Grad Sch Med, Dept Surg, Tokyo 1138655, Japan	Koyama, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hkoyama-tky@umin.ac.jp					Ali M, 2010, ADV ENV BIOL, V5, P3159; Rajagopalan S, 2003, CIRCULATION, V108, P1933, DOI 10.1161/01.CIR.0000093398.16124.29; Fujii T, 2006, ARTERIOSCL THROM VAS, V26, P2483, DOI 10.1161/01.ATV.0000244684.23499.bf; He Y, 2006, J CLIN INVEST, V116, P2344, DOI 10.1172/JCI28123; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Scholz D, 2000, VIRCHOWS ARCH, V436, P257, DOI 10.1007/s004280050039; Grossman PM, 2007, AM HEART J, V153, P874, DOI 10.1016/j.ahj.2007.01.038; Ohara N, 2001, GENE THER, V8, P837, DOI 10.1038/sj.gt.3301475; Hershey JC, 2001, CARDIOVASC RES, V49, P618, DOI 10.1016/S0008-6363(00)00232-7; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Demicheva E, 2008, CIRC RES, V103, P477, DOI 10.1161/CIRCRESAHA.108.177782; Schwarz ER, 2000, J AM COLL CARDIOL, V35, P1323, DOI 10.1016/S0735-1097(00)00522-2; Kondoh K, 2004, CARDIOVASC RES, V61, P132, DOI 10.1016/j.cardiores.2003.10.003; Scholz D, 2002, J MOL CELL CARDIOL, V34, P775, DOI 10.1006/jmcc.2002.2013; Isner JM, 1998, J VASC SURG, V28, P964, DOI 10.1016/S0741-5214(98)70022-9; Shintani S, 2001, CIRCULATION, V103, P897; Cai WJ, 2008, ACTA BIOCH BIOPH SIN, V40, P681, DOI 10.1111/j.1745-7270.2008.00436.x; Banquet S, 2011, CIRCULATION, V124, P1059, DOI 10.1161/CIRCULATIONAHA.110.010264; van Royen N, 2001, CARDIOVASC RES, V49, P543, DOI 10.1016/S0008-6363(00)00206-6; LONGLAND CJ, 1953, ANN ROY COLL SURG, V13, P161; Ito WD, 1997, CIRC RES, V80, P829; TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018; Lederman RJ, 2002, LANCET, V359, P2053, DOI 10.1016/S0140-6736(02)08937-7; Schierling W, 2011, EUR J VASC ENDOVASC, V41, P589, DOI 10.1016/j.ejvs.2010.11.034; BERNOTATDANIELOWSKI S, 1993, CARDIOVASC RES, V27, P1220, DOI 10.1093/cvr/27.7.1220; Fuchs S, 2001, J AM COLL CARDIOL, V37, P1726, DOI 10.1016/S0735-1097(01)01200-1; Guiuriat L, 1993, ANAT REC, V235, P95; Haro JD, 2009, HEART VESSELS, V24, P321; Heil M, 2006, J CELL MOL MED, V10, P45, DOI 10.1111/j.1582-4934.2006.tb00290.x; Hosaka A, 2004, CIRCULATION, V110, P3322, DOI 10.1161/01.CIR.0000147779.17602.18; Klein S, 1997, EXS, V79, P159; Ninomiya M, 2003, GENE THER, V10, P1152, DOI 10.1038/sj.gt.3301984; Oostrom M, 2008, J LEUKOCYTE BIOL, V84, P1379; Patel TH, 2005, CARDIOVASC RES, V68, P144, DOI 10.1016/j.cardiores.2005.05.002; Poling Szibor J, 2011, ARTERIOSCLER THROMB, V31, P2297; Popesko P, 1992, COLOR ATLAS ANATOMY, V1, P126; Pu L Q, 1994, J Invest Surg, V7, P49, DOI 10.3109/08941939409018282; Schaper W, 1996, CIRCULATION, V94, P600; Sellke FW, 1996, SURGERY, V120, P182, DOI 10.1016/S0039-6060(96)80286-8; Troidl C, 2010, J MOL CELL CARDIOL, V49, P142, DOI 10.1016/j.yjmcc.2010.03.021; UNGER EF, 1994, AM J PHYSIOL, V266, pH1588	42	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	JUL	2015	62	1					190	199		10.1016/j.jvs.2014.02.004		10	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CL3FR	WOS:000356836300026		
J	Suder, G; Liesch, PW; Inomata, S; Mihailova, I; Meng, B				Suder, Gabriele; Liesch, Peter W.; Inomata, Satoshi; Mihailova, Irina; Meng, Bo			The evolving geography of production hubs and regional value chains across East Asia: Trade in value-added	JOURNAL OF WORLD BUSINESS			English	Article						Regional integration; Production networks; Input-output data; Trade in value-added; East Asia	FOREIGN DIRECT-INVESTMENT; GLOBAL VALUE CHAINS; DIVISION-OF-LABOR; MULTINATIONAL-ENTERPRISES; INTERNATIONALIZATION PROCESS; DEVELOPING-COUNTRIES; INDUSTRIAL CLUSTERS; INTRAINDUSTRY TRADE; KNOWLEDGE; PERSPECTIVE	The interdependence of regional trade and production networks has important implications for national prosperity, regional stability and the internationalization of production. We ask: What are the locational patterns of trade in value-added in East Asia and how are these patterns changing over time? The disintermediation of value chains and the externalization of business activity create hubs of capability and extend value chains between countries. We adopt input-output techniques to analyze the evolution of production networks in East Asia over the period 1990-2005 from a value chain perspective. A high density of cross-border interaction is reported alongside changing geographic dynamics, and an informal integration derived from intermediates trade in value-addition. The locational interdependence of developed and less-developed countries across the region leverages on the heterogeneity of location-specific advantages within the region. (C) 2014 Elsevier Inc. All rights reserved.	[Suder, Gabriele] Univ Melbourne, Int Relat, Melbourne Business Sch, Parkville, Vic 3010, Australia; [Liesch, Peter W.] Univ Queensland, UQ Business Sch, Brisbane, Qld 4072, Australia; [Inomata, Satoshi] JETRO IDE JETRO, Inst Developing Econ, Chiba, Chiba 2618545, Japan; [Mihailova, Irina] Aalto Univ, Sch Business, Dept Management & Int Business, Aalto 00076, Finland; [Meng, Bo] Japan External Trade Org IDE JETRO, Inst Developing Econ, Ctr Dev Studies, Int Input Output Anal Studies Grp, Chiba, Chiba 2618545, Japan	Suder, G (reprint author), Univ Melbourne, Int Relat, Parkville, Vic 3010, Australia.	gabriele.suder@unimelb.edu.au; p.liesch@uq.edu.au; satoshi_inomata@ide.go.jp; irina.mihailova@aalto.fi; mengbo@ide.go.jp		Suder, Gabriele/0000-0002-6008-7879	SKEMA Business School from the European Union/EACEA; Melbourne Business School	This is to acknowledge the co-support/-funding received by the Jean Monnet Chair, held by Prof. G. Suder, at SKEMA Business School, 2011-2014, from the European Union/EACEA. We also acknowledge the institutional support received from all universities concerned. Prof. Suder would also like to express her gratitude to the University of Melbourne and specifically, Melbourne Business School, for support in the final phase of this publication. Finally, we are grateful for the valuable contribution of the anonymous reviewers and the great support by the Editorial Board and team of JWB.	Amin A, 1999, INT J URBAN REGIONAL, V23, P365, DOI 10.1111/1468-2427.00201; Ando M., 2006, N AM J ECON FINANC, V17, P257, DOI 10.1016/j.najef.2006.06.005; Ghemawat P, 2003, J INT BUS STUD, V34, P138, DOI 10.1057/palgrave.jibs.8400013; Banalieva ER, 2009, EUR MANAG J, V27, P344, DOI 10.1016/j.emj.2009.04.001; Mudambi R, 2008, J ECON GEOGR, V8, P699, DOI 10.1093/jeg/lbn024; Musteen M, 2010, J WORLD BUS, V45, P197, DOI 10.1016/j.jwb.2009.12.003; Beugelsdijk S, 2007, ECON GEOGR, V83, P181; Humphrey J, 2002, REG STUD, V36, P1017, DOI 10.1080/0034340022000022198; Sethi D, 2009, INT BUS REV, V18, P404, DOI 10.1016/j.ibusrev.2009.02.006; Johanson J, 2009, J INT BUS STUD, V40, P1411, DOI 10.1057/jibs.2009.24; Rugman AM, 2004, J INT BUS STUD, V35, P3, DOI 10.1057/palgrave.jibs.8400073; Kali R, 2007, J INT BUS STUD, V38, P595, DOI 10.1057/palgrave.jibs.8400286; Ernst D, 2002, RES POLICY, V31, P1417, DOI 10.1016/S0048-7333(02)00072-0; Bell M, 1999, WORLD DEV, V27, P1715, DOI 10.1016/S0305-750X(99)00073-X; Doh JP, 2009, J INT BUS STUD, V40, P926, DOI 10.1057/jibs.2008.89; Gereffi G, 1999, J INT ECON, V48, P37, DOI 10.1016/S0022-1996(98)00075-0; Kedia BL, 2009, J WORLD BUS, V44, P250, DOI 10.1016/j.jwb.2008.08.005; Kaplinsky R, 2000, J DEV STUD, V37, P117, DOI 10.1080/713600071; Ford JB, 1998, J WORLD BUS, V33, P69, DOI 10.1016/S1090-9516(98)80005-9; Morck R, 2008, J INT BUS STUD, V39, P337, DOI 10.1057/palgrave.jibs.8400366; Bello DC, 2012, J INT BUS STUD, V43, P537, DOI 10.1057/jibs.2012.14; Fan CC, 2003, ECON GEOGR, V79, P295; Johnson RC, 2012, J INT ECON, V86, P224, DOI 10.1016/j.jinteco.2011.10.003; Mudambi R, 2010, J MANAGE STUD, V47, P1510, DOI 10.1111/j.1467-6486.2010.00947.x; Fratianni M, 2009, J INT BUS STUD, V40, P1206, DOI 10.1057/jibs.2009.8; Jacobides MG, 2005, STRATEGIC MANAGE J, V26, P1209, DOI 10.1002/smj.501; Dunning JH, 1998, J INT BUS STUD, V29, P45, DOI 10.1057/palgrave.jibs.8490024; Rugman AM, 2010, INT BUS REV, V19, P479, DOI 10.1016/j.ibusrev.2009.02.012; Liesch PW, 2012, MANAGE INT REV, V52, P3, DOI 10.1007/s11575-011-0096-x; Buckley PJ, 2004, J INT BUS STUD, V35, P81, DOI 10.1057/palgrave.jibs.8400076; Dedrick J, 2010, IND CORP CHANGE, V19, P81, DOI 10.1093/icc/dtp032; Fukao K, 2003, J JPN INT ECON, V17, P468, DOI 10.1016/j.jjie.2003.09.004; Cantwell J, 2005, STRATEGIC MANAGE J, V26, P1109, DOI 10.1002/smj.497; Grossman GA, 2008, AM ECON REV, V98, P1978, DOI 10.1257/aer.98.5.1978; BEECHLER S, 1994, J INT BUS STUD, V25, P467, DOI 10.1057/palgrave.jibs.8490208; Manning S, 2008, ACAD MANAGE PERSPECT, V22, P35, DOI 10.5465/AMP.2008.34587994; KOGUT B, 1993, J INT BUS STUD, V24, P625, DOI 10.1057/palgrave.jibs.8490248; Stiglitz JE, 1996, WORLD BANK RES OBSER, V11, P151; Aoyama Y., 2011, ECON GEOGR, V87, P111, DOI DOI 10.1111/J.1944-8287.2011.01114.X; Bchir M. H., 2006, 200615 CEPII; Bebbington A, 2003, TIJDSCHR ECON SOC GE, V94, P297, DOI 10.1111/1467-9663.00258; Buckley P. J., 2011, GLOBALIZATION GLOBAL; Buckley P.J., 1976, FUTURE MULTINATIONAL; Cantwell JA, 2011, GLOB STRATEG J, V1, P206, DOI 10.1111/j.2042-5805.2011.00024.x; Chen WH, 1999, J SMALL BUS MANAGE, V37, P46; Chen YM, 1996, J REGIONAL SCI, V36, P417; Cherry J., 2011, EUROPEAN J E ASIAN S, V10, P59; Detert N., 2010, 257 ADBI; Dunning J. H., 1977, INT ALLOCATION EC AC, P395; Dunning JH, 2007, J INT BUS STUD, V38, P177, DOI 10.1057/palgrave.jibs.8400241; Eden L., 2001, AC MAN P, pC1; Ernst D., 1998, OXFORD DEV STUDIES, V26, P191, DOI 10.1080/13600819808424153; Greenaway D., 1987, B ECON RES, V39, P95, DOI 10.1111/j.1467-8586.1987.tb00235.x; GREENAWAY D, 1987, J COMMON MARK STUD, V26, P153, DOI 10.1111/j.1468-5965.1987.tb00310.x; Henderson J., 1998, EC DYNAMISM ASIA PAC, P356; Hennart JF, 2012, GLOB STRATEG J, V2, P168, DOI 10.1111/j.2042-5805.2012.01038.x; IDE-JETRO, 2001, AS INT INP OUTP TABL, V82; IDE-JETRO, 2006, AS INT INP OUTP TABL, V89, P90; IDE-JETRO, 1998, AS INT INP OUTP TABL, V81; Isogai T., 2002, BANK JAPAN INT DEP W, V02-E-1; James WE, 2003, DEV ECON, V41, P287, DOI 10.1111/j.1746-1049.2003.tb00573.x; JOHANSON J, 1977, J INT BUS STUD, V8, P23, DOI 10.1057/palgrave.jibs.8490676; Kaminski B., 2001, 18139450 WORLD BANK; Kawai M., 2005, Journal of Asian Economics, V16, DOI 10.1016/j.asieco.2005.01.001; Kimura F, 2003, N AM J ECON FINANC, V14, P287, DOI 10.1016/S1062-9408(03)00022-6; Koopman R., 2014, AM ECON REV, V104, P1; Koveshnikov A., 2010, 36 EUR INT BUS AC C; Krueger AO, 1999, J ECON PERSPECT, V13, P105, DOI 10.1257/jep.13.4.105; Lawton T., 2009, BUSINESS POLITICS, V11; Leontief W. W., 1966, INPUT OUTPUT EC; Linden G., 2009, WORKING PAPER; Luo Y, 2011, 5 CHIN GOES GLOB C; Marshall A., 1919, IND TRADE; Mathews John, 2002, ASIA PACIFIC J MANAG, V19, P467, DOI [10.1023/A:1020586223665, DOI 10.1023/A:1020586223665]; Maurer A., 2010, ERSD201012 WTO; McGuire S, 2012, EUR J INT MANAG, V6, P342, DOI 10.1504/EJIM.2012.047028; Meng B., 2011, J APPL INPUT OUTPUT, P16; Meng B., 2012, 362 IDE; Miller R. E., 1985, INPUT OUTPUT ANAL FD; Miller R E, 2009, INPUT OUTPUT ANAL FD; Morlino L, 2009, ROUTL UACES CONTEMP, V8, P26; Murray P, 2010, INT POLITICS, V47, P308, DOI 10.1057/ip.2010.13; Narula R, 2012, GLOB STRATEG J, V2, P188, DOI 10.1111/j.2042-5805.2012.01035.x; Neffke M. H., 2011, ECON GEOGR, V87, P237; NONAKA I, 1985, ACAD MANAGE REV, V10, P181, DOI 10.2307/257961; OECD & WTO, 2013, MEAS TRAD VAL ADD OE; Ohmae K., 1985, TRIAD POWER COMING S; PARK SO, 1993, ENVIRON PLANN A, V25, P81, DOI 10.1068/a250081; Petri P. A., 2006, Journal of Asian Economics, V17, DOI 10.1016/j.asieco.2006.04.001; PETRI PA, 1993, NBER CONF R, P21; Pfeffer J., 1978, EXTERNAL CONTROL ORG; Piekkari R, 2010, MANAGE INT REV, V50, P513, DOI 10.1007/s11575-010-0044-1; Pula G, 2009, WORKING PAPER SERIES, V993; Raines P., 2003, NEW COMPETITION INWA, P119; Riviera M, 2013, EURAM C P EURAM 2013; Rugman Alan M., 2007, European Management Journal, V25, DOI 10.1016/j.emj.2007.07.005; Rugman A. M., 2005, MANAGE INT REV, V45, P5; Rugman A. M., 2007, ASIA PACIFIC J MANAG, V24, P429, DOI 10.1007/s10490-006-9035-y; Rugman A. M, 2005, KELLEY SCH BUSINESS, V2005-12; Rugman A. M., 2005, REGIONAL MULTINATION; Scott A J, 1988, METROPOLIS DIVISION; Sierra OBP, 2011, EUROPE-ASIA STUD, V63, P1377, DOI 10.1080/09668136.2011.601108; Stehrer R., 2012, 81 WIIW; Suder G., 2011, GLOBALISATION REALLY; Tang HK, 1996, INT J TECHNOL MANAGE, V12, P231; TSAY CL, 1993, ENVIRON PLANN A, V25, P111, DOI 10.1068/a250111; UNCTAD, 2009, TRANSN CORP AGR PROD; UNCTAD, 2007, TRAD DEV REP UNCTAD; Verbeke A., 2012, MULTINATIONAL BUSINE, V20, P135; VERNON R, 1966, Q J ECON, V80, P190, DOI 10.2307/1880689; Vernon Raymond, 1974, EC ANAL MULTINATIONA, P89; Wakasugi R., 2007, ASIAN ECON PAP, V6, P26, DOI 10.1162/asep.2007.6.1.26; Wells Louis T., 1972, PRODUCT LIFE CYCLE I; Widodo T., 2009, ASIA PACIFIC J EC BU, V13, P31; World Bank, 2012, CHIN 2030 REP; WTO-IDE, 2011, TRAD PATT GLOB VAL C; ZAHEER S, 1995, ACAD MANAGE J, V38, P341, DOI 10.2307/256683	117	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1090-9516	1878-5573		J WORLD BUS	J. World Bus.	JUL	2015	50	3					404	416		10.1016/j.jwb.2014.05.003		13	Business	Business & Economics	CL2EL	WOS:000356756300002		
J	Suzuki, K; Kitajima, K; Sawaki, Y; Hattori, K; Hirata, T; Maruyama, S				Suzuki, Kazue; Kitajima, Kouki; Sawaki, Yusuke; Hattori, Kentaro; Hirata, Takafumi; Maruyama, Shigenori			Ancient oceanic crust in island arc lower crust: Evidence from oxygen isotopes in zircons from the Tanzawa Tonalitic Pluton	LITHOS			English	Article						Arc lower-crust; Oceanic crust; Zircon oxygen isotope; Tanzawa Tonalitic Pluton; IBM arc	BONIN-MARIANA ARC; ICP-MASS SPECTROMETRY; CONTINENTAL-CRUST; LESSER ANTILLES; VOLCANIC-ROCKS; TRACE-ELEMENT; CENTRAL JAPAN; MANTLE; GEOCHEMISTRY; PETROGENESIS	Knowledge of the lithological variability and genesis of island arc crust is important for understanding continental growth. Although the volcanic architecture of island arcs is comparatively well known, the nature of island arc middle- and lower-crust remains uncertain owing to limited exposure. One of the best targets for deciphering the evolution of an island arc system is the Tanzawa Tonalites (4-9 Ma), in the intra-oceanic lzu-Bonin-Mariana arc. These tonalities which occupied a mid-crustal position were generated by partial melting of lower crust To constrain protoliths of the plutonic rocks in the island arc lower crust, in-situ O-isotopic analysis using an IMS-1280 Secondary Ion Mass Spectrometer was carried out on 202 zircon grains separated from 4 plutons in the Tanzawa Tonalite. delta O-18 value of the zircons ranges from 4.1 parts per thousand to 5.5 parts per thousand and some zircons have delta O-18 slightly lower than the mantle range. The low zircon delta O-18 values from the Tanzawa Tonalite suggest that their protoliths involved materials with lower delta O-18 values than those of the mantle. Hydrothermally altered gabbros in the lower oceanic crust often have lower delta O-18 values than mantle and can be primary components of arc lower crust The Tanzawa Tonalite is interpreted to have been formed by partial melting of island arc lower crust Thus the low delta O-18 values in zircons from the Tanzawa Tonalites may originate by melting of the hydrothermally altered gabbro. Ancient oceanic crustal material was likely present in the lzu-Bonin-Mariana arc lower crust, at the time of formation of the Tanzawa Tonalites. (C) 2015 Elsevier B.V. All rights reserved.	[Suzuki, Kazue; Sawaki, Yusuke] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 152, Japan; [Kitajima, Kouki] Univ Wisconsin, WiscSIMS, Dept Geosci, Madison, WI 53706 USA; [Hattori, Kentaro; Hirata, Takafumi] Kyoto Univ, Div Earth & Planetary Sci, Sakyo Ku, Kyoto, Japan; [Maruyama, Shigenori] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 152, Japan	Suzuki, K (reprint author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, 2-12-1 O Okayama, Tokyo 152, Japan.	suzuku.k.ae@m.titech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; JSPS KAKENHI [14J12001]	We are grateful to Prof. J. W. Valley, N. Kita, and J. Kern for helpful discussions and kind support in oxygen isotope analysis at the University of Wisconsin-Madison. We are also grateful to Prof. K. D. Collerson for correcting our English grammar. KS appreciates Prof. K. Hirose for the support to realize the analysis at the University of Wisconsin-Madison. Prof. C. Grimes and anonymous reviewer gave many constructive and helpful comments, which improved quality of this manuscript. Prof. S.-L. Chung, the editor of this journal, handled this manuscript. This work was supported by grants for the Global COE Program, "From the Earth to "Earths"", from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and JSPS KAKENHI grant number 14J12001.	Cherniak DJ, 2003, REV MINERAL GEOCHEM, V53, P113, DOI 10.2113/0530113; KEMPTON PD, 1988, EARTH PLANET SC LETT, V89, P273, DOI 10.1016/0012-821X(88)90116-1; Tani K, 2010, GEOLOGY, V38, P215, DOI 10.1130/G30526.1; Garrido CJ, 2006, J PETROL, V47, P1873, DOI 10.1093/petrology/egl030; Lackey JS, 2008, J PETROL, V49, P1397, DOI 10.1093/petrology/egn030; ITO E, 1987, CHEM GEOL, V62, P157, DOI 10.1016/0009-2541(87)90083-0; Grimes CB, 2013, LITHOS, V179, P48, DOI 10.1016/j.lithos.2013.07.026; Hoskin PWO, 2003, REV MINERAL GEOCHEM, V53, P27, DOI 10.2113/0530027; Reagan MK, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002871; Holbrook WS, 1999, GEOLOGY, V27, P31; Takahashi N, 2007, GEOLOGY, V35, P203, DOI 10.1130/G23212A.1; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Grimes CB, 2011, CONTRIB MINERAL PETR, V161, P13, DOI 10.1007/s00410-010-0519-x; STRECKEISEN A, 1976, EARTH-SCI REV, V12, P1, DOI 10.1016/0012-8252(76)90052-0; Machida S, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001641; Watson EB, 2006, CONTRIB MINERAL PETR, V151, P413, DOI 10.1007/s00410-006-0068-5; FOUNTAIN DM, 1981, EARTH PLANET SC LETT, V56, P263, DOI 10.1016/0012-821X(81)90133-3; Kita NT, 2009, CHEM GEOL, V264, P43, DOI 10.1016/j.chemgeo.2009.02.012; MATSUHISA Y, 1979, J VOLCANOL GEOTH RES, V5, P271, DOI 10.1016/0377-0273(79)90020-9; Wiedenbeck M, 2004, GEOSTAND GEOANAL RES, V28, P9, DOI 10.1111/j.1751-908X.2004.tb01041.x; Hirata T, 2005, J ANAL ATOM SPECTROM, V20, P696, DOI 10.1039/b504153h; Ferry JM, 2007, CONTRIB MINERAL PETR, V154, P429, DOI 10.1007/s00410-007-0201-0; Smith TE, 1996, J PETROL, V37, P117, DOI 10.1093/petrology/37.1.117; VALLEY JW, 1994, EARTH PLANET SC LETT, V126, P187, DOI 10.1016/0012-821X(94)90106-6; Cosca MA, 1998, ISL ARC, V7, P579, DOI 10.1111/j.1440-1738.1998.00211.x; Eggins SM, 1998, APPL SURF SCI, V127, P278, DOI 10.1016/S0169-4332(97)00643-0; Kawate S, 1998, ISL ARC, V7, P342, DOI 10.1046/j.1440-1738.1998.00194.x; KAY RW, 1986, NATURE, V322, P605, DOI 10.1038/322605a0; Eiler JM, 2000, J PETROL, V41, P229, DOI 10.1093/petrology/41.2.229; Page FZ, 2007, GEOCHIM COSMOCHIM AC, V71, P3887, DOI 10.1016/j.gca.2007.04.031; Hoskin PWO, 2000, GEOLOGY, V28, P627, DOI 10.1130/0091-7613(2000)28<627:REECOZ>2.0.CO;2; Corfu F, 2003, REV MINERAL GEOCHEM, V53, P469, DOI 10.2113/0530469; Ishizuka O, 2006, EARTH PLANET SC LETT, V250, P385, DOI 10.1016/j.epsl.2006.08.007; Valley JW, 1998, CONTRIB MINERAL PETR, V133, P1, DOI 10.1007/s004100050432; Valley JW, 2003, REV MINERAL GEOCHEM, V53, P343, DOI 10.2113/0530343; Kitamura K, 2003, TECTONOPHYSICS, V371, P213, DOI 10.1016/S0040-1951(03)00229-4; Shillington DJ, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000715; Eiler JM, 2001, REV MINERAL GEOCHEM, V43, P319, DOI 10.2138/gsrmg.43.1.319; Thirlwall MF, 1996, GEOCHIM COSMOCHIM AC, V60, P4785, DOI 10.1016/S0016-7037(96)00272-4; Aoike K., 1995, PETR EC GEOL PROGR 1, P14; Aoike K., 1997, GEOLOGY TANZAWA MOUN, P24; Aoike K., 1999, NAT HIST, V9, P111; FOWLER MB, 1990, NATO ADV SCI I C-MAT, V311, P493; GARLICK GD, 1971, SCIENCE, V172, P1025, DOI 10.1126/science.172.3987.1025; GREGORY RT, 1981, J GEOPHYS RES, V86, P2737, DOI 10.1029/JB086iB04p02737; HARMON RS, 1987, CONTRIB MINERAL PETR, V95, P350, DOI 10.1007/BF00371849; IONOV DA, 1994, GEOCHIM COSMOCHIM AC, V58, P1463, DOI 10.1016/0016-7037(94)90549-5; Ishibashi J. -I., 1995, BACKARC BASINS TECTO, P451; Ishihara S., 2005, B GEOL SURV JPN, V56, P315; Ishihara S, 1976, MARINE SCI MONTHLY, V8, P523; ISHIZAKA K, 1977, EARTH PLANET SC LETT, V33, P345, DOI 10.1016/0012-821X(77)90086-3; Ito E, 2003, ISL ARC, V12, P383, DOI 10.1046/j.1440-1738.2003.00408.x; Javoy M., 1980, J MINERALOGY PETROLO, V272, P279; Kawano Y., 1966, J JAPAN ASS MIN PETR, V56, P41; Kawate S, 1996, JAP EARTH PLAN SCI J, P703; KEMPTON PD, 1991, P OCEAN DRILLING PRO, V0118; Kuno H., 1968, B VOLCANOL, V32, P141, DOI 10.1007/BF02596589; Lecuyer C., 1996, P OCEAN DRILL PROGRA, V147, P227; Macpherson C.G., 1998, J VOLCANOLOGY GEOTHE, V30, P1; Macpherson CG, 1998, CHEM GEOL, V144, P177, DOI 10.1016/S0009-2541(97)00130-7; Matsuda T, 1978, J PHYS EARTH S, V26, pS409; Mezger K, 1992, CONTINENTAL LOWER CR, P447; MUEHLENBACHS K, 1976, J GEOPHYS RES, V81, P4365, DOI 10.1029/JB081i023p04365; Muehlenbachs K., 1986, STABLE ISOTOPES HIGH, V16, P425; Muller RD, 1997, J GEOPHYS RES-SOL EA, V102, P3211, DOI 10.1029/96JB01781; Nakajima K, 1998, ISL ARC, V7, P359, DOI 10.1111/j.1440-1738.1998.00195.x; NEAL CR, 1990, EARTH PLANET SC LETT, V99, P362, DOI 10.1016/0012-821X(90)90140-S; ONGLEY JS, 1987, EARTH PLANET SC LETT, V83, P80, DOI 10.1016/0012-821X(87)90052-5; Pearce J.G., 1997, J GEOSTANDARDS GEOAN, V21, P115; PEARSON DG, 1991, EARTH PLANET SC LETT, V102, P289, DOI 10.1016/0012-821X(91)90024-C; Rudnick, 1995, J GEOMAGN GEOELECTR, V378, P571; SAITO K, 1993, J GEOMAGN GEOELECTR, V45, P261; Sato K., 1986, J GEOLOGICAL SOC JAP, V6, P439; Scholl D.W., 1987, GEOLOGY RESOURCE POT, P123; Shimazu M., 1989, Modern Geology, V14; Sugiyama A., 1976, J GEOL SOC JAPAN, V82, P699; Suyehiro K, 1996, SCIENCE, V272, P390, DOI 10.1126/science.272.5260.390; Suzuki K, 2014, LITHOS, V196, P301, DOI 10.1016/j.lithos.2014.02.010; Takahashi M., 1985, MEM GEOL SOC JAPAN, V25, P225; Takahashi M, 1989, MOD GEOL, V14, P127; Takahashi M, 2004, P I NATURAL SCI NIHO, P259; Takita R, 1974, J GEOL SOC JAPAN, V80, P505; Tatsumi Y, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005121; TAYLOR HP, 1986, REV MINERAL, V16, P227; TAYLOR SR, 1965, NATURE, V208, P271, DOI 10.1038/208271a0; Toriumi M., 1986, CHIKYU MONTHLY, V8, P612; Tunheng A, 2004, J ANAL ATOM SPECTROM, V19, P932, DOI 10.1039/b402493a; Wang Z., 2008, EARTH PLANET SC LETT, V269, P377, DOI DOI 10.1016/J.EPSL.2008.02.018; Yamada K, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005368; Yamamoto Y, 2005, ISL ARC, V14, P178, DOI 10.1111/j.1440-1738.2005.00463.x	90	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0024-4937	1872-6143		LITHOS	Lithos	JUL	2015	228						43	54		10.1016/j.lithos.2015.04.005		12	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CL2CK	WOS:000356751000004		
J	Sugiyama, Y				Sugiyama, Yoshie			Partial regularity and blow-up asymptotics of weak solutions to degenerate parabolic systems of porous medium type	MANUSCRIPTA MATHEMATICA			English	Article							KELLER-SEGEL SYSTEMS; GLOBAL EXISTENCE; HIGHER DIMENSIONS; HARMONIC MAPS; MODEL; CHEMOTAXIS; DIFFUSION; THEOREM; MASS	In the present paper, we deal with the degenerate parabolic system of porous medium type with non-linear diffusion m and interaction q in in the critical case of . We establish the -regularity theorem for weak solutions. As an application, the structure of asymptotics of blow-up solution is clarified. In particular, we show that the solution behaves like the delta-function at the blow-up points. Moreover, we prove that the number of blow-up points is finite, which can be controlled in terms of the mass of initial data. We also give a sharp constant for the -regularity theorem.	Kyushu Univ, Fac Math, Nishi Ku, Fukuoka 8190395, Japan	Sugiyama, Y (reprint author), Kyushu Univ, Fac Math, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	sugiyama@math.kyushu-u.ac.jp					CHILDRESS S, 1981, MATH BIOSCI, V56, P217, DOI 10.1016/0025-5564(81)90055-9; Herrero MA, 1996, MATH ANN, V306, P583, DOI 10.1007/BF01445268; KELLER EF, 1970, J THEOR BIOL, V26, P399, DOI 10.1016/0022-5193(70)90092-5; Bian S, 2013, COMMUN MATH PHYS, V323, P1017, DOI 10.1007/s00220-013-1777-z; Sugiyama Y, 2009, SIAM J MATH ANAL, V41, P1664, DOI 10.1137/080721078; Blanchet A, 2009, CALC VAR PARTIAL DIF, V35, P133, DOI 10.1007/s00526-008-0200-7; Kozono H, 2008, J EVOL EQU, V8, P353, DOI 10.1007/s00028-008-0375-6; [Anonymous], 1999, REND MAT APPL, V7, P317; CHEN YM, 1989, MATH Z, V201, P83, DOI 10.1007/BF01161997; STRUWE M, 1988, ACTA MATH-DJURSHOLM, V160, P19, DOI 10.1007/BF02392272; Aronszajn N., 1961, ANN I FOURIER GRENOB, V11, P385; Biler P., 2004, BANACH CTR PUBL, V66, P61; Blanchet A., 2006, ELECT J DIFFERENTIAL, V44, P1; CAFFARELLI L, 1982, COMMUN PUR APPL MATH, V35, P771, DOI 10.1002/cpa.3160350604; Dibenedetto E., 1993, DEGENERATE PARABOLIC; Herrero M. A., 1997, ANN SCUOLA NORMALE S, V24, P633; Horstman D., 2003, JAHRESBER DTSCH MATH, V105, P103; Kim I, 2012, SIAM J MATH ANAL, V44, P568, DOI 10.1137/110823584; Kuroda S. T., 1983, IWANAMI SHOTEN KISO, V17; Lions J. L., 1972, REND MAT APPL, VI; Lions J. L., 1972, REND MAT APPL, VII; Nagai T., 2000, HIROSHIMA MATH J, V30, P463; Nanjundiah V., 1973, THEOR BIOL, V42, P63; SCHOEN R, 1984, INVENT MATH, V78, P89, DOI 10.1007/BF01388715; Stein Elias M., 1970, PRINCETON MATH SERIE, V30; Sugiyama Y, 2010, DIFFER INTEGRAL EQU, V23, P619; Sugiyama Y, 2011, ADV DIFFERENTIAL EQU, V16, P85; Sugiyama Y, 2006, J DIFFER EQUATIONS, V227, P333, DOI 10.1016/j.jde.2006.03.003; Sugiyama Y, 2007, DIFFER INTEGRAL EQU, V20, P133; Sugiyama Y, 2010, DIFFER INTEGRAL EQU, V23, P601; Sugiyama Y, 2006, DIFFER INTEGRAL EQU, V19, P841; Sugiyama Y, 2010, J MATH ANAL APPL, V364, P51, DOI 10.1016/j.jmaa.2009.11.019; Sugiyama Y., 2007, ADV DIFFERENTIAL EQU, V12, P124; Talenti G., 1976, ANN MAT PUR APPL, V110, P353, DOI 10.1007/BF02418013; Yao Y., 2013, PHYSCA D	35	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-2611	1432-1785		MANUSCRIPTA MATH	Manuscr. Math.	JUL	2015	147	3-4					311	363		10.1007/s00229-015-0756-4		53	Mathematics	Mathematics	CL3UL	WOS:000356876000002		
J	Wandel, M				Wandel, Malte			Moduli spaces of semistable pairs in Donaldson-Thomas theory	MANUSCRIPTA MATHEMATICA			English	Article							SHEAVES	Let be a polarized smooth projective variety over the complex numbers. Fix and a nonnegative rational polynomial . Using GIT we contruct a coarse moduli space for -semistable pairs consisting of a coherent sheaf and a homomorphism . We prove a chamber structure result and establish a connection to the moduli space of coherent systems constructed by Le Potier in (Faisceaux semi-stable et systSmes coh,rents. Cambridge University Press, Cambridge, 1995; SystSmes coh,rents et structures de niveau. Ast,risque 214, 1993).	[Wandel, Malte] Leibniz Univ Hannover, Free Univ Berlin, Graduiertenkolleg 1463, D-30167 Hannover, Germany	Wandel, M (reprint author), Kyoto Univ, Math Sci Res Inst, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	wandel@math.uni-hannover.de					[Anonymous], 1994, PUBL MATH IHES, DOI 10.1007/BF02698887; Li J, 1998, J AM MATH SOC, V11, P119, DOI 10.1090/S0894-0347-98-00250-1; Gomez T. L., ARXIVMATH0103150; Grothendieck A., 1960, SEMINAIRE BOURBAKI, V61; Hartshorne R., 1977, ALGEBRAIC GEOMETRY G; HUYBRECHTS D, 1995, INT J MATH, V6, P297, DOI 10.1142/S0129167X9500050X; Huybrechts D., 1997, GEOMETRY MODULI SPAC, V31; Le Potier J., 1993, ASTERISQUE, V214, P604; LEPOTIER J, 1995, LOND MATH S, V208, P179; Mumford D., 1994, ERGEBNISSE DER MATHE, V34; Pandharipande R., ARXIV07072348V3; Schmitt AHW, 2008, ZUR LECT ADV MATH, P1; Schmitt AHW, 2003, ALGEBR REPRESENT TH, V6, P1, DOI 10.1023/A:1022322529046	13	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-2611	1432-1785		MANUSCRIPTA MATH	Manuscr. Math.	JUL	2015	147	3-4					477	500		10.1007/s00229-015-0729-7		24	Mathematics	Mathematics	CL3UL	WOS:000356876000008		
J	Ozawa, R; Shioya, T				Ozawa, Ryunosuke; Shioya, Takashi			Estimate of observable diameter of l (p) -product spaces	MANUSCRIPTA MATHEMATICA			English	Article								We estimate the observable diameter of the l (p) -product space X (n) of an mm-space X by using the limit formula in our previous paper (Ozawa and Shioya, Math. Zeit. (to appear)). The idea of our proof is based on Gromov's book (In: Metric structures for Riemannian and non-Riemannian spaces, 2007). As a corollary we obtain the phase transition property of under a uniform discreteness condition.	[Ozawa, Ryunosuke; Shioya, Takashi] Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan	Shioya, T (reprint author), Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan.	shioya@math.tohoku.ac.jp			Japan Society for the Promotion of Science; Japan Society for the Promotion of Science for Young Scientists	The authors are partially supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. The first author is supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists.	AMIR D, 1980, ISRAEL J MATH, V37, P3, DOI 10.1007/BF02762864; GROMOV M, 1983, AM J MATH, V105, P843, DOI 10.2307/2374298; [Anonymous], 1995, PUBLICATIONS IHES, DOI 10.1007/BF02699376; Berger M., 1971, LECT NOTES MATH, V194; Gromov M., 2007, METRIC STRUCTURES RI; Kechris A. S., 1995, GRADUATE TEXTS MATH, V156; Ledoux M., 2001, MATH SURVEYS MONOGRA, V89; Milman V.D., 1986, LECT NOTES MATH, V1200; Ozawa R., MATH Z IN PRESS; Shioya T., IRMA SERIES IN PRESS	10	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-2611	1432-1785		MANUSCRIPTA MATH	Manuscr. Math.	JUL	2015	147	3-4					501	509		10.1007/s00229-015-0730-1		9	Mathematics	Mathematics	CL3UL	WOS:000356876000009		
J	Blasiak, R				Blasiak, Robert			Balloon effects reshaping global fisheries	MARINE POLICY			English	Article						Balloon effects; Marine capture fisheries; Governance; ABNJ	FISH	The pressures of globalization have seldom proven conducive to sustainable resource management; marine capture fisheries are no exception. It has been convincingly argued that an uneven global governance landscape and the existence of untapped new frontiers for fisheries resources have historically caused a paradigm of serial depletion by so-called "roving bandits". Here, it is suggested that marine resource exploitation has reached such a saturated state that few new frontiers exist, and that the paradigm of serial depletion will increasingly be replaced by balloon effects squeezing both licit and illicit fishing activities into areas of least statehood. Such trends will be most pronounced in highly migratory and straddling fisheries due to weak governance over areas beyond national jurisdiction (ABNJ), but is also likely to occur within the exclusive economic zone (EEZ) of weak states or small island states with vast marine territories. For decades, balloon effects have been the object of study in other disciplines, most notably international drug control and, more recently, carbon leakage. This body of knowledge represents a crucial resource for developing multi-level, holistic management interventions to prevent fisheries management challenges from simply being displaced from one area to another. (C) 2015 Elsevier Ltd. All rights reserved.	Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Blasiak, R (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	a-rb@mail.ecc.u-tokyo.ac.jp			JSPS KAKENHI [4403]	This work was supported by the JSPS KAKENHI (Grant number 4403) "New Ocean Paradigm on its Biogeochemistry, Ecosystem, and Sustainable Use". Sincere appreciation is due to a variety of colleagues for fruitful discussions on these topics, as well as particularly constructive reviewer comments.	Agnew DJ, 2009, PLOS ONE, V10, P1371; Martin R, 2014, ECOL ECON, V105, P78, DOI 10.1016/j.ecolecon.2014.05.010; [Anonymous], 2014, CCAMLR 33 M COMM; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Steneck RS, 2012, P NATL ACAD SCI USA, V109, P7953, DOI 10.1073/pnas.1205591109; Muhamad D, 2014, ECOSYST SERV, V8, P197, DOI 10.1016/j.ecoser.2014.04.003; Pramod G, 2014, MAR POLICY, V48, P102, DOI 10.1016/j.marpol.2014.03.019; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; HARDIN G, 1968, SCIENCE, V162, P1243; Blasiak R, 2015, MAR POLICY, V52, P52, DOI 10.1016/j.marpol.2014.11.001; Brombacher D, 2009, RP10 GERM I INT SEC; F.A.O, 2014, STAT WORLD FISH AQ; Food and Agriculture Organization, 2014, GLOB DAT, P1950; Gray J., 1998, FALSE DAWN DELUSIONS; Guiterrez N. L., 2011, NATURE, V470, P386, DOI DOI 10.1038/NATURE09689; Ianelli JN, 2006, AGE STRUCTURED ASSES, P201; Kaufmann D., 2014, WORLDWIDE GOVERNANCE; McCauley DJ, 2015, SCIENCE, V347, P6291; Mora C, 2009, PLOS ONE, V10, P1371; Osterblom H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012832; UN Office on Drugs and Crime, 2013, TRANSN ORG CRIM E AS	21	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0308-597X	1872-9460		MAR POLICY	Mar. Pol.	JUL	2015	57						18	20		10.1016/j.marpol.2015.03.013		3	Environmental Studies; International Relations	Environmental Sciences & Ecology; International Relations	CL1YF	WOS:000356740100003		
J	Hoshikawa, M; Uchida, S; Osawa, T; Eguchi, K; Arimitsu, T; Suzuki, Y; Kawahara, T				Hoshikawa, Masako; Uchida, Sunao; Osawa, Takuya; Eguchi, Kazumi; Arimitsu, Takuma; Suzuki, Yasuhiro; Kawahara, Takashi			Effects of Five Nights under Normobaric Hypoxia on Sleep Quality	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						HYPOXIA; QUALITY OF SLEEP; ADAPTATION; RESPIRATORY DISTURBANCES	ARTERIAL OXYHEMOGLOBIN SATURATION; HIGH-ALTITUDE; VENTILATORY RESPONSE; HEART-RATE; ACCLIMATIZATION; PERFORMANCE; EXPOSURES; HUMANS; GENDER; APNEA	Purpose The purpose of this study was to evaluate the effects of five nights' sleep under normobaric hypoxia on ventilatory acclimatization and sleep quality. Methods Seven men initially slept for six nights under normoxia and then for five nights under normobaric hypoxia equivalent to a 2000-m altitude. Nocturnal polysomnograms (PSGs), arterial blood oxygen saturation (SpO(2)), and respiratory events were recorded on the first and fifth nights under both conditions. Results The hypoxic ventilatory response (HVR), hypercapnic ventilatory response (HCVR), and resting end-tidal CO2 (resting PETCO2) were measured three times during the experimental period. The duration of slow-wave sleep (SWS: stage N3) and the whole-night delta (1-3 Hz) power of nonrapid eye movement (NREM) sleep EEG decreased on the first night under hypoxia. This hypoxia-induced sleep quality deterioration on the first night was accompanied by a lower mean and minimum SpO(2), a longer time spent with SpO(2) below 90% (<90% SpO(2) time), and more episodes of respiratory disturbance. On the fifth night, the SWS duration and whole-night delta power did not differ between the conditions. Although the mean SpO(2) under hypoxia was still lower than under normoxia, the minimum SpO(2) increased, and the <90% SpO(2) time and number of episodes of respiratory disturbance decreased during the five nights under hypoxia. The HVR increased and resting PETCO2 decreased after five nights under hypoxia. Conclusions The results suggest that five nights under hypoxia improves the sleep quality. This may be derived from improvements of respiratory disturbances, the minimum SpO(2), and <90% SpO(2) time.	[Hoshikawa, Masako; Osawa, Takuya; Eguchi, Kazumi; Arimitsu, Takuma; Suzuki, Yasuhiro] Japan Inst Sports Sci, Dept Sports Sci, Kita Ku, Tokyo 1150056, Japan; [Uchida, Sunao] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Kawahara, Takashi] Japan Inst Sports Sci, Kita Ku, Tokyo 1150056, Japan	Hoshikawa, M (reprint author), Japan Inst Sports Sci, Educ, Kita Ku, 3-15-1 Nishigaoka, Tokyo 1150056, Japan.	masako.hoshikawa@jpnsport.go.jp			JSPS KAKENHI [26350827]	This study was partially supported by JSPS KAKENHI Grant Number 26350827.	Aguillard RN, 1998, APPL PSYCHOPHYS BIOF, V23, P207, DOI 10.1023/A:1022257514209; Eckert DJ, 2007, CHEST, V131, P595, DOI 10.1378/chest.06.2287; Carrier J, 2001, PSYCHOPHYSIOLOGY, V38, P232, DOI 10.1017/S0048577201991838; Salvaggio A, 1998, EUR RESPIR J, V12, P408, DOI 10.1183/09031936.98.12020408; Levine BD, 1997, J APPL PHYSIOL, V83, P102; Sargent C, 2013, BRIT J SPORT MED, V47, P86; Muza SR, 2010, HIGH ALT MED BIOL, V11, P87, DOI 10.1089/ham.2010.1006; Insalaco G, 2012, HIGH ALT MED BIOL, V13, P258, DOI 10.1089/ham.2012.1035; WHITE DP, 1987, J APPL PHYSIOL, V63, P401; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; WEIL JV, 1970, J CLIN INVEST, V49, P1061, DOI 10.1172/JCI106322; Ako M, 2003, PSYCHIAT CLIN NEUROS, V57, P59, DOI 10.1046/j.1440-1819.2003.01080.x; BERSSENBRUGGE AD, 1984, J APPL PHYSIOL, V57, P1089; Byre-Quinn E, 1971, J APPL PHYSIOL, V30, P91; Fulco CS, 2011, AM J PHYSIOL-REG I, V300, pR428, DOI 10.1152/ajpregu.00633.2010; Fulco CS, 2000, AVIAT SPACE ENVIR MD, V71, P162; Gawthorn K, 1998, P AUSTR C SCI MED SP, P127; Hoshikawa M, 2014, EUR J SPORT SCI, V14, pS205, DOI 10.1080/17461391.2012.681805; Hoshikawa M, 2007, J APPL PHYSIOL, V103, P2005, DOI 10.1152/japplphysiol.00315.2007; HUGELIN A, 1959, ELECTROEN CLIN NEURO, V11, P325, DOI 10.1016/0013-4694(59)90086-0; Iber C, 2007, AASM MANUAL SCORING, V1st, P24; Jeukendrup A, 1998, J SPORT SCI, V16, pS91, DOI 10.1080/026404198366722; Kinsman TA, 2005, J SCI MED SPORT, V8, P222, DOI 10.1016/S1440-2440(05)80013-1; Kolb JC, 2004, J APPL PHYSIOL, V96, P1745, DOI 10.1152/japplphysiol.00977.2003; MASUYAMA S, 1989, JPN J PHYSIOL, V39, P523, DOI 10.2170/jjphysiol.39.523; Muza SR, 2001, J APPL PHYSIOL, V91, P1791; Nussbaumer-Ochsner Y, 2012, SLEEP, V35, P419, DOI 10.5665/sleep.1708; Pedlar C, 2005, MED SCI SPORT EXER, V37, P1075, DOI 10.1249/01.mss.0000171623.52757.0f; READ DJC, 1967, AUSTRALAS ANN MED, V16, P20; REITE M, 1975, ELECTROEN CLIN NEURO, V38, P463, DOI 10.1016/0013-4694(75)90188-1; SATO M, 1994, J APPL PHYSIOL, V77, P313; Shirahata K, 2004, P 8 INT S ALT TRAIN, P18; Sunderram J, 2009, AM J PHYSIOL-REG I, V297, pR300, DOI 10.1152/ajpregu.90737.2008; The Atlas Task Force of the American Sleep Disorders Association, 1992, SLEEP, V15, P173; Townsend NE, 2002, J APPL PHYSIOL, V93, P1498, DOI 10.1152/japplphysiol.00381.2002; Weil JV, 2000, PRINCIPLES PRACTICE, P242; Wilber RL, 2004, ALTITUDE TRAINING AT, P65; Zhou XS, 2000, J APPL PHYSIOL, V89, P192; Zieliński J, 2000, High Alt Med Biol, V1, P331, DOI 10.1089/15270290050502408; Zwetsloot KA, 2003, MED SCI SPORT EXER, V35, pS165	40	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUL	2015	47	7					1512	1518		10.1249/MSS.0000000000000569		7	Sport Sciences	Sport Sciences	CK8MW	WOS:000356493300022		
J	Hoshikawa, M; Uchida, S				Hoshikawa, Masako; Uchida, Sunao			Assessing Objective Measures of Sleep Quality in Hypoxia Research Response	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Letter							HIGH-ALTITUDE		[Hoshikawa, Masako] Japan Inst Sports Sci, Dept Sports Sci, Tokyo, Japan; [Uchida, Sunao] Waseda Univ, Fac Sport Sci, Saitama, Japan	Hoshikawa, M (reprint author), Japan Inst Sports Sci, Dept Sports Sci, Tokyo, Japan.						Krystal AD, 2008, SLEEP MED, V9, pS10, DOI 10.1016/S1389-9457(08)70011-X; BLOCK AJ, 1979, NEW ENGL J MED, V300, P513, DOI 10.1056/NEJM197903083001001; Hoshikawa M, 2015, MED SCI SPORT EXER, V47, P1512, DOI 10.1249/MSS.0000000000000569; Iber C, 2007, AASM MANUAL SCORING; MASUYAMA S, 1989, JPN J PHYSIOL, V39, P523, DOI 10.2170/jjphysiol.39.523; Nussbaumer-Ochsner Y, 2012, SLEEP, V35, P419, DOI 10.5665/sleep.1708; Rojc B, 2014, EUR J APPL PHYSIOL, V114, P1973, DOI 10.1007/s00421-014-2909-7; Zieliński J, 2000, High Alt Med Biol, V1, P331, DOI 10.1089/15270290050502408	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUL	2015	47	7					1546	1546		10.1249/MSS.0000000000000668		1	Sport Sciences	Sport Sciences	CK8MW	WOS:000356493300030		
J	Ibrahim, D; Taniguchi, K; Yamamoto, Y; Taniguchi, K; Nakamuta, N				Ibrahim, Dalia; Taniguchi, Kazumi; Yamamoto, Yoshio; Taniguchi, Kazuyuki; Nakamuta, Nobuaki			Immunohistochemical and lectin histochemical studies on the developing olfactory organs of fetal camel	MICROSCOPY RESEARCH AND TECHNIQUE			English	Article						fetus; olfactory epithelium; OMP; PGP 9; 5; vomeronasal organ	VOMERONASAL ORGAN; PRENATAL DEVELOPMENT; EPITHELIUM; SYSTEM; DIFFERENTIATION; DROMEDARIUS; DIMENSIONS; ONTOGENY; PROTEIN; HAMSTER	Little is known about the development of the olfactory organs of camel. In this study, prenatal development and neuronal differentiation of the vomeronasal organ (VNO) and the olfactory epithelium (OE) of the one-humped camel were studied by immunohistochemistry and lectin histochemistry. A neuronal marker, protein gene product (PGP) 9.5, but not a marker of fully differentiated olfactory receptor cells, olfactory marker protein, intensely labeled the olfactory receptor cells of the VNO and OE at 395 mm, 510 mm, and 530 mm fetal ages, indicating that the olfactory receptor cells are differentiated, but not fully matured both in the VNO and the OE. In 187 mm and 190 mm fetuses, PGP 9.5 yielded faint immunoreactive signals in the VNO, but not in the OE, although the presence of olfactory receptor cells were demonstrated in both tissues by intense WGA and LEL stainings. We conclude that the camel VNO and OE bear differentiated, but still immature receptor cells; in addition, the onset of neuronal differentiation seems to be somewhat earlier in the VNO than in the OE till half of the prenatal life. Microsc. Res. Tech. 78:613-619, 2015. (c) 2015 Wiley Periodicals, Inc.	[Ibrahim, Dalia; Yamamoto, Yoshio; Nakamuta, Nobuaki] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan; [Ibrahim, Dalia] South Valley Univ, Dept Histol, Fac Vet Med, Qena 83523, Egypt; [Taniguchi, Kazumi] Kitasato Univ, Sch Vet Med, Lab Vet Anat, Towada, Aomori 0348628, Japan; [Yamamoto, Yoshio; Nakamuta, Nobuaki] Iwate Univ, Lab Vet Anat, Fac Agr, Morioka, Iwate 0208550, Japan; [Taniguchi, Kazuyuki] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan	Nakamuta, N (reprint author), Iwate Univ, Lab Vet Anat, Fac Agr, 3-18-8 Ueda, Morioka, Iwate 0208550, Japan.	nakamuta@iwate-u.ac.jp					Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; ALLISON AC, 1953, BIOL REV, V28, P195, DOI 10.1111/j.1469-185X.1953.tb01376.x; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325; TANIGUCHI K, 1993, NEUROSCI LETT, V156, P24, DOI 10.1016/0304-3940(93)90430-S; Badawi H., 1974, Assiut Veterinary Medical Journal, V1, P1; CUSCHIERI A, 1975, J ANAT, V119, P277; El-Nahla SM, 2011, ANAT HISTOL EMBRYOL, V40, P169, DOI 10.1111/j.1439-0264.2010.01056.x; ELWISHY AB, 1983, VET RES COMMUN, V6, P289, DOI 10.1007/BF02214924; Garrosa M, 1998, MICROSC RES TECHNIQ, V41, P456; Holubcova S, 1997, ACTA VET BRNO, V66, P135, DOI 10.2754/avb199766030135; HUSSEIN FM, 1991, ANIM REPROD SCI, V26, P129, DOI 10.1016/0378-4320(91)90071-7; Ibrahim D, 2015, J VET MED SCI, V77, P291; JOHNSON EW, 1995, ANAT EMBRYOL, V191, P311, DOI 10.1007/BF00534683; MENCO BPM, 1985, J CELL SCI, V78, P283; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; Naghani ES, 2010, J ANIM VET ADV, V9, P1108; Oikawa T, 2001, J VET MED SCI, V63, P759, DOI 10.1292/jvms.63.759; Plendl J, 1998, ACTA ANAT, V161, P234; Salazar I, 2003, MICROSC RES TECHNIQ, V61, P438, DOI 10.1002/jemt.10362; Sherwood RJ, 1999, J ANAT, V195, P413, DOI 10.1046/j.1469-7580.1999.19530413.x; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.neuro.12.1.127; SLABY O, 1987, Folia Morphologica (Prague), V35, P400; Takigami S, 2004, DEV BRAIN RES, V149, P113, DOI 10.1016/j.devbrainres.2004.01.003; Taniguchi K, 2008, J VET MED SCI, V70, P57, DOI 10.1292/jvms.70.57; TANIGUCHI K, 1982, JPN J VET SCI, V44, P709; Tarozzo G, 1998, EUR J NEUROSCI, V10, P392; VERHAAGEN J, 1989, J NEUROSCI, V9, P683	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-910X	1097-0029		MICROSC RES TECHNIQ	Microsc. Res. Tech.	JUL	2015	78	7					613	619		10.1002/jemt.22517		7	Anatomy & Morphology; Biology; Microscopy	Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics; Microscopy	CL2XT	WOS:000356811900010		
J	Rowan, AB; Travis, WJ; Shwalb, DA; Isler, WC; Park, J; Kimura, J				Rowan, Anderson B.; Travis, Wendy J.; Shwalb, David A.; Isler, William C.; Park, Jisuk; Kimura, Jennifer			Postdeployment Psychological Health and Interpersonal Problems Among Air Force Mental Health Personnel	MILITARY PSYCHOLOGY			English	Article						mental health personnel; military; postdeployment; posttraumatic stress; psychological health	POSTTRAUMATIC-STRESS-DISORDER; MILITARY MEDICAL PERSONNEL; DEPLOYMENT; IRAQ; AFGHANISTAN; DEPRESSION; CARE; PROFESSIONALS; VETERANS; ALCOHOL	This study is one of the first to use validated screening measures to examine the rates of self-reported mental health and interpersonal problems following deployment of military mental health personnel (MMHP). Research has examined the impact of deployment on military personnel finding 10.2% to 29.0% screen positive for at least one mental health problem. However, little is known about impacts of deployment among MMHP. Utilizing health data collected three to twelve months post-deployment from a sample of 759 Air Force MMHP, this study examined rates of positive screens for psychological health or interpersonal problems, subsequent confirmation of positive screens by a medical provider upon examination, and the demographic characteristics associated with psychological health or interpersonal problems. The study found 13.9% screened positive for "possible or probable PTSD," 4.6% for depressive symptoms, 3.9% for alcohol problems, and 12.6% for interpersonal problems. In total, nearly 26% screened positive for one or more psychological or interpersonal problem. Of those who screened positive, 48.5% of depressive problems, 36.0% of PTSD, 20.0% of alcohol problems and 29.7% of interpersonal problems were confirmed upon subsequent examination by a medical provider. Those who screened positive were more likely to be (a) female, (b) separated, widowed, or divorced, (c) a mental health nurse or psychiatric nurse practitioner, and (d) deployed to Iraq or Afghanistan. The significance, limitations, and implications of the results, along with recommendations for future research are discussed.	[Rowan, Anderson B.] Royal Air Force Lakenheath, US Air Force, Dept Def, Brandon, Suffolk, England; [Travis, Wendy J.] US Air Force Acad, US Air Force, Dept Def, Colorado Springs, CO 80840 USA; [Shwalb, David A.] US Air Force, Dept Def, Andersen AFB, GU USA; [Isler, William C.] US Air Force, Dept Def, San Antonio, TX USA; [Park, Jisuk] Knowesis Inc, Analyt & Reporting, San Antonio, TX USA; [Kimura, Jennifer] US Air Force, Dept Def, Yokota AFB, Fussa, Japan	Rowan, AB (reprint author), 48 MDOS CC,Unit 5115, APO, AE 09461 USA.	anderson.rowan@us.af.mil					Akbayrak N, 2005, MIL MED, V170, P125; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Dickstein BD, 2010, MIL MED, V175, P482; Vogt D, 2011, J ABNORM PSYCHOL, V120, P797, DOI 10.1037/a0023452; Gates MA, 2012, PSYCHOL SERV, V9, P361, DOI 10.1037/a0027649; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Maguen S, 2008, MIL MED, V173, P1; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Bliese PD, 2007, PSYCHOL SERV, V4, P141, DOI DOI 10.1037/1541-1559.4.3.141; Eisen SV, 2012, AM J PUBLIC HEALTH, V102, pS66, DOI 10.2105/AJPH.2011.300609; Hourani LL, 2003, MIL MED, V168, P736; IBM SPSS, 2010, IBM SPSS STAT WIND V; Jacobson IG, 2012, J TRAUMA STRESS, V25, P616, DOI 10.1002/jts.21753; Johnson WB, 2010, PROF PSYCHOL-RES PR, V41, P298, DOI 10.1037/a0019899; Johnson WB, 2011, PROF PSYCHOL-RES PR, V42, P94, DOI 10.1037/a0022365; Jones DE, 2008, MIL MED, V173, P241; McCarthy MD, 2012, AM J PUBLIC HEALTH, V102, pS60, DOI 10.2105/AJPH.2011.300580; McCauley M, 2012, COMMUNITY MENT HLT J, V48, P238, DOI 10.1007/s10597-011-9407-8; McCauley M, 2010, MENT HLTH PRACT, V14, P14, DOI DOI 10.7748/MHP2010.12.14.4.14.C8106; McLean CP, 2013, PSYCHOL TRAUMA-US, V5, P62, DOI 10.1037/a0022949; Prins A, 2004, PRIMARY CARE PSYCHIA, V9, P151; RUSHING WA, 1979, SOC FORCES, V58, P540, DOI 10.2307/2577605; Schmitz KJ, 2012, MIL MED, V177, P380; Skopp NA, 2012, J CLIN PSYCHOL, V68, P1253, DOI 10.1002/jclp.21887; United States Department of Defense Deployment Health Clinical Center, 2008, POSTD HLTH REASS DD; United States Department of Defense Deployment Health Clinical Center, 2005, POSTD HLTH REASS DD; Visco R, 2009, PERSPECT PSYCHIATR C, V45, P240, DOI 10.1111/j.1744-6163.2009.00227.x; Batzer WB, 2007, MIL MED, V172, P266; Zamorski MA, 2014, CAN J PSYCHIAT, V59, P319	31	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.	JUL	2015	27	4					242	251		10.1037/mil0000076		10	Psychology, Multidisciplinary	Psychology	CL5BS	WOS:000356975400005		
J	Yamashita, K; Ide, M; Furukawa, KT; Suzuki, A; Hirano, H; Ohno, S				Yamashita, Kazunari; Ide, Mariko; Furukawa, Kana T.; Suzuki, Atsushi; Hirano, Hisashi; Ohno, Shigeo			Tumor suppressor protein Lgl mediates G1 cell cycle arrest at high cell density by forming an Lgl-VprBP-DDB1 complex	MOLECULAR BIOLOGY OF THE CELL			English	Article							E3 UBIQUITIN LIGASE; S-PHASE ENTRY; CONTACT INHIBITION; CDK INHIBITORS; DROSOPHILA; POLARITY; P27(KIP1); PROLIFERATION; DEGRADATION; EXPRESSION	Lethal giant larvae (Lgl) is an evolutionarily conserved tumor suppressor whose loss of function causes disrupted epithelial architecture with enhanced cell proliferation and defects in cell polarity. A role for Lgl in the establishment and maintenance of cell polarity via suppression of the PAR-aPKC polarity complex is established; however, the mechanism by which Lgl regulates cell proliferation is not fully understood. Here we show that depletion of Lgl1 and Lgl2 in MDCK epithelial cells results in overproliferation and overproduction of Lgl2 causes G1 arrest. We also show that Lgl associates with the VprBP-DDB1 complex independently of the PAR-aPKC complex and prevents the VprBP-DDB1 subunits from binding to Cul4A, a central component of the CRL4 [VprBP] ubiquitin E3 ligase complex implicated in G1- to S-phase progression. Consistently, depletion of VprBP or Cul4 rescues the overproliferation of Lgl-depleted cells. In addition, the affinity between Lgl2 and the VprBP-DDB1 complex increases at high cell density. Further, aPKC-mediated phosphorylation of Lgl2 negatively regulates the interaction between Lgl2 and VprBP-DDB1 complex. These results suggest a mechanism protecting overproliferation of epithelial cells in which Lgl plays a critical role by inhibiting formation of the CRL4 [VprBP] complex, resulting in G1 arrest.	[Yamashita, Kazunari; Ide, Mariko; Furukawa, Kana T.; Suzuki, Atsushi; Ohno, Shigeo] Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Yokohama, Kanagawa 2360004, Japan; [Suzuki, Atsushi] Yokohama City Univ, Grad Sch Med Life Sci, Mol Cellular Biol Lab, Yokohama, Kanagawa 2300045, Japan; [Hirano, Hisashi] Yokohama City Univ, Int Grad Sch Arts & Sci, Supramol Biol, Yokohama, Kanagawa 2300045, Japan	Ohno, S (reprint author), Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Yokohama, Kanagawa 2360004, Japan.	ohnos@med.yokohama-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Yokohama Foundation for Advancement of Medical Science	We thank A. Yamashita for technical advice concerning protein purification and H. Nakamura for mass spectrometry services. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.O. and H.H.), the Japan Society for the Promotion of Science (A.S. and S.O.), and the Yokohama Foundation for Advancement of Medical Science (K.Y.).	Okada T, 2007, TRENDS CELL BIOL, V17, P222, DOI 10.1016/j.tcb.2007.03.006; Besson A, 2008, DEV CELL, V14, P159, DOI [10.1016/j.devcel.2008.01.013, 10.1016/j.devce1.2008.01.013]; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; McCall CM, 2008, MOL CELL BIOL, V28, P5621, DOI 10.1128/MCB.00232-08; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Zhang SG, 2001, GENE, V263, P131, DOI 10.1016/S0378-1119(00)00583-7; Peng CY, 2000, NATURE, V408, P596; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Li BH, 2006, BLOOD, V107, P4291, DOI 10.1182/blood-2005-08-3349; Tsuruga T, 2007, ONCOL RES, V16, P431; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Schimanski CC, 2005, ONCOGENE, V24, P3100, DOI 10.1038/sj.onc.1208520; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Clark BS, 2012, DEVELOPMENT, V139, P1599, DOI 10.1242/dev.078097; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; Kuphal S, 2006, ONCOGENE, V25, P103, DOI 10.1038/sj.onc.1209008; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Grifoni D, 2004, ONCOGENE, V23, P8688, DOI 10.1038/sj.onc.1208023; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Ohshiro T, 2000, NATURE, V408, P593; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Brumby A, 2004, GENETICS, V168, P227, DOI 10.1534/genetics.104.026617; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Grzeschik NA, 2007, DEV BIOL, V311, P106, DOI 10.1016/j.ydbio.2007.08.025; Kalmes A, 1996, J CELL SCI, V109, P1359; Levenberg S, 1999, ONCOGENE, V18, P869, DOI 10.1038/sj.onc.1202396; Nagase T, 2008, DNA RES, V15, P137, DOI 10.1093/dnares/dsn004; Reischauer S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000720; Sonawane M, 2005, DEVELOPMENT, V132, P3255, DOI 10.1242/dev.01904; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tamori Y, 2011, PLOS BIOL, V8; Tanaka J, 1999, BIOCHEM BIOPH RES CO, V264, P938, DOI 10.1006/bbrc.1999.1617; Yamanaka T, 2006, J CELL SCI, V119, P2107, DOI 10.1242/jcs.02938	55	0	0	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	JUL 1	2015	26	13					2426	2438		10.1091/mbc.E14-10-1462		13	Cell Biology	Cell Biology	CL6BZ	WOS:000357053400004		
J	Iwasaki, M; Koyanagi, S; Suzuki, N; Katamune, C; Matsunaga, N; Watanabe, N; Takahashi, M; Izumi, T; Ohdo, S				Iwasaki, Masaru; Koyanagi, Satoru; Suzuki, Norio; Katamune, Chiharu; Matsunaga, Naoya; Watanabe, Nobuaki; Takahashi, Masayuki; Izumi, Takashi; Ohdo, Shigehiro			Circadian Modulation in the Intestinal Absorption of P-Glycoprotein Substrates in Monkeys	MOLECULAR PHARMACOLOGY			English	Article							SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; CLOCK GENE; DIURNAL RODENT; TRANSCRIPTION; MECHANISM; PROTEIN; CELLS; RHYTHMICITY; PATHWAY	Recent studies in laboratory rodents have revealed that circadian oscillation in the physiologic functions affecting drug disposition underlies the dosing time-dependent change in pharmacokinetics. However, it is difficult to predict the circadian change in the drug pharmacokinetics in a diurnal human by using the data collected from nocturnal rodents. In this study, we used cynomolgus monkeys, diurnal active animals, to evaluate the relevance of intestinal expression of P-glycoprotein (P-gp) to the dosing time dependency of the pharmacokinetics of its substrates. The rhythmic phases of circadian gene expression in the suprachiasmatic nuclei (the mammalian circadian pacemaker) of cynomolgus monkeys were similar to those reported in nocturnal rodents. On the other hand, the expression of circadian clock genes in the intestinal epithelial cells of monkeys oscillated at opposite phases in rodents. The intestinal expression of P-gp in the small intestine of monkeys was also oscillated in a circadian time-dependent manner. Furthermore, the intestinal absorption of P-gp substrates (quinidine and etoposide) was substantially suppressed by administering the drugs at the times of day when P-gp levels were abundant. By contrast, there was no significant dosing time-dependent difference in the absorption of the non-P-gp substrate (acetaminophen). The oscillation in the intestinal expression of P-gp appears to affect the pharmacokinetics of its substrates. Identification of circadian factors affecting the drug disposition in laboratory monkeys may improve the predictive accuracy of pharmacokinetics in humans.	[Iwasaki, Masaru; Takahashi, Masayuki] Daiichi Sankyo RD Novare Co Ltd, Ctr Pharmaceut & Biomed Anal, Tokyo 1348630, Japan; [Koyanagi, Satoru; Katamune, Chiharu; Matsunaga, Naoya; Ohdo, Shigehiro] Kyushu Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Fukuoka 812, Japan; [Suzuki, Norio] Daiichi Sankyo Co Ltd, Translat Med & Clin Pharmacol Dept, Tokyo, Japan; [Watanabe, Nobuaki; Izumi, Takashi] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Tokyo, Japan	Iwasaki, M (reprint author), Daiichi Sankyo RD Novare Co Ltd, Ctr Pharmaceut & Biomed Anal, Edogawa Ku, 1-16-13 Kita-Kasai, Tokyo 1348630, Japan.	iwasaki.masaru.a6@rdn.daiichisankyo.co.jp					Hamdan AM, 2012, J BIOL CHEM, V287, P17224, DOI 10.1074/jbc.M111.333377; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912; Hoogerwerf WA, 2007, GASTROENTEROLOGY, V133, P1250, DOI 10.1053/j.gastro.2007.07.009; Sladek M, 2007, GASTROENTEROLOGY, V133, P1240, DOI 10.1053/j.gastro.2007.05.053; Min DI, 1997, PHARMACOTHERAPY, V17, P457; Caldelas I, 2003, NEUROSCIENCE, V116, P583, DOI 10.1016/S0306-4522(02)00654-1; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Horiguchi M, 2013, CANCER RES, V73, P2639, DOI 10.1158/0008-5472.CAN-12-2492; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Mrosovsky N, 2001, J BIOL RHYTHM, V16, P471, DOI 10.1177/074873001129002141; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Sakamoto K, 1998, J BIOL CHEM, V273, P27039, DOI 10.1074/jbc.273.42.27039; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Erol K, 2001, CHRONOBIOL INT, V18, P841, DOI 10.1081/CBI-100107519; Hashizume T, 2001, DRUG METAB DISPOS, V29, P798; Lambert CM, 2006, J BIOL RHYTHM, V21, P77, DOI 10.1177/0748730405281843; Lambert CM, 2005, J BIOL RHYTHM, V20, P206, DOI 10.1177/0748730405275135; Lemmer Björn, 2005, Expert Opin Drug Deliv, V2, P667, DOI 10.1517/17425247.2.4.667; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Matsunaga T, 2002, BIOL PHARM BULL, V25, P42, DOI 10.1248/bpb.25.42; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Smale L, 2003, J BIOL RHYTHM, V18, P356, DOI 10.1177/0748730403256651; SMITH RB, 1986, J CLIN PHARMACOL, V26, P120; Takiguchi T, 2007, PHARMACOGENET GENOM, V17, P1047, DOI 10.1097/FPC.0b013e3282f12a61	35	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0026-895X	1521-0111		MOL PHARMACOL	Mol. Pharmacol.	JUL	2015	88	1					29	37		10.1124/mol.114.096735		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CL6QK	WOS:000357091800004		
J	Kurita, T; Yamamura, H; Suzuki, Y; Giles, WR; Imaizumi, Y				Kurita, Takashi; Yamamura, Hisao; Suzuki, Yoshiaki; Giles, Wayne R.; Imaizumi, Yuji			The ClC-7 Chloride Channel Is Downregulated by Hypoosmotic Stress in Human Chondrocytes	MOLECULAR PHARMACOLOGY			English	Article							RABBIT ARTICULAR CHONDROCYTES; IN-SITU; EXPRESSION; CARTILAGE; CURRENTS; CALCIUM; CELLS; PH; DIFFERENTIATION; OSTEOARTHRITIS	Articular chondrocytes in osteoarthritis (OA) patients are exposed to hypoosmotic stress because the osmolality of this synovial fluid is significantly decreased. Hypoosmotic stress can cause an efflux of Cl- and an associated decrease of cell volume. We have previously reported that a Cl- conductance contributes to the regulation of resting membrane potential and thus can alter intracellular Ca2+ concentration ([Ca2+](i)) in human chondrocytes. The molecular identity and pathologic function of these Cl- channels, however, remained to be determined. Here, we show that the ClC-7 Cl- channel is strongly expressed in a human chondrocyte cell line (OUMS-27) and that it is responsible for Cl- currents that are activated by extracellular acidification (pH 5.0). These acid-sensitive currents are inhibited by 4,4' diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS; IC50 - 13 mu M) and are markedly reduced by small-interfering RNA-induced knockdown of ClC-7. DIDS hyperpolarized these chondrocytes, and this was followed by an increase in [Ca2+](i). ClC-7 knockdown caused a similar hyperpolarization of the membrane potential. Short-term culture (48 hours) in hypoosmotic medium (270 mOsm) reduced the expression of ClC-7 and decreased the acid-sensitive currents. Interestingly, these hypoosmotic culture conditions, or ClC-7 knockdown, resulted in enhanced cell death. Taken together, our results show that the significant hyperpolarization due to ClC-7 impairment in chondrocytes can significantly increase [Ca2+](i) and cell death. Thus, downregulation of ClC-7 channels during the hypoosmotic stress that accompanies OA progression is one important concept of the complex etiology of OA. These findings suggest novel targets for therapeutic intervention(s) and drug development for OA.	[Kurita, Takashi; Yamamura, Hisao; Suzuki, Yoshiaki; Imaizumi, Yuji] Nagoya City Univ, Dept Mol & Cellular Pharmacol, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan; [Giles, Wayne R.] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada	Imaizumi, Y (reprint author), Nagoya City Univ, Dept Mol & Cellular Pharmacol, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabedori, Nagoya, Aichi 4678603, Japan.	yimaizum@phar.nagoya-cu.ac.jp		Suzuki, Yoshiaki/0000-0002-7879-6059	Japan Society for the Promotion of Science [26293021, 25460104]; Japan Research Foundation for Clinical Pharmacology	This work was supported by Grant-in-Aids for Scientific Research (B) [26293021] and Scientific Research (C) [25460104] from the Japan Society for the Promotion of Science and by a Grant-in-Aid from the Japan Research Foundation for Clinical Pharmacology.	Alford AI, 2003, J CELL BIOCHEM, V90, P938, DOI 10.1002/jcb.10715; Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847; Clark RB, 2011, J PHYSIOL-LONDON, V589, P5071, DOI 10.1113/jphysiol.2011.210757; Kerrigan MJP, 2006, J CELL PHYSIOL, V209, P481, DOI 10.1002/jcp.20758; Kunisada T, 1998, INT J CANCER, V77, P854, DOI 10.1002/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO;2-1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Sugimoto T, 1996, COMP BIOCHEM PHYS C, V115, P223, DOI 10.1016/S0742-8413(96)00091-6; Martel-Pelletier J, 2008, BEST PRACT RES CL RH, V22, P351, DOI 10.1016/j.berh.2008.02.001; Gavenis K, 2009, MOL CELL BIOCHEM, V321, P135, DOI 10.1007/s11010-008-9927-x; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Matsuda JJ, 2010, J BIOL CHEM, V285, P2569, DOI 10.1074/jbc.M109.018002; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Bush PG, 2001, J ORTHOPAED RES, V19, P768, DOI 10.1016/S0736-0266(01)00013-4; Demircan K, 2005, ARTHRITIS RHEUM, V52, P1451, DOI 10.1002/art.21010; Hashimoto S, 1998, ARTHRITIS RHEUM, V41, P1632, DOI 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A; Hdud IM, 2012, INT J MOL SCI, V13, P4433, DOI 10.3390/ijms13044433; Barrett-Jolley R, 2010, FRONT PHYSIOL, V1, P1; Bertram KL, 2012, BIOCHEM BIOPH RES CO, V422, P455, DOI 10.1016/j.bbrc.2012.05.015; BONEN DK, 1991, J CELL BIOL, V115, P1171, DOI 10.1083/jcb.115.4.1171; Diewald L, 2002, BIOCHEM BIOPH RES CO, V291, P421, DOI 10.1006/bbrc.2002.6462; Funabashi K, 2010, AM J PHYSIOL-CELL PH, V298, pC786, DOI 10.1152/ajpcell.00469.2009; Funabashi K, 2010, J PHARMACOL SCI, V113, P94, DOI 10.1254/jphs.10026SC; Goldring MB, 2006, BEST PRACT RES CL RH, V20, P1003, DOI 10.1016/j.berh.2006.06.003; Hdud IM, 2014, AM J PHYSIOL-CELL PH, V306, pC1050, DOI 10.1152/ajpcell.00287.2013; Kajiya H, 2009, PFLUG ARCH EUR J PHY, V458, P1049, DOI 10.1007/s00424-009-0689-4; Kawasaki M, 1999, AM J PHYSIOL-CELL PH, V277, pC948; Lewis R, 2013, CHANNELS, V7, P459, DOI 10.4161/chan.26071; Li XH, 2002, ANNU REV PHYSIOL, V64, P609, DOI 10.1146/annurev.physiol.64.090501.145429; Mobasheri A, 2012, CHANNELS, V6, P416, DOI 10.4161/chan.22340; Ohgi K, 2011, N-S ARCH PHARMACOL, V383, P79, DOI 10.1007/s00210-010-0576-8; Parkerson KA, 2004, GLIA, V46, P419, DOI 10.1002/glia.10361; Ponce A, 2012, CELL PHYSIOL BIOCHEM, V30, P1254, DOI 10.1159/000343316; Schulz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012585; Tsuga K, 2002, J MEMBRANE BIOL, V185, P75, DOI 10.1007/s00232-001-0112-3; Wilson JR, 2004, J PHYSIOL-LONDON, V557, P93, DOI 10.1113/jphysiol.2003.058883; Wohlrab D, 2001, J Orthop Sci, V6, P155, DOI 10.1007/s007760100064	38	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0026-895X	1521-0111		MOL PHARMACOL	Mol. Pharmacol.	JUL	2015	88	1					113	120		10.1124/mol.115.098160		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CL6QK	WOS:000357091800013		
J	Jee, J; Bonnegarde-Bernard, A; Duverger, A; Iwakura, Y; Cormet-Boyaka, E; Martin, TL; Steiner, HE; Bachman, RC; Boyaka, PN				Jee, J.; Bonnegarde-Bernard, A.; Duverger, A.; Iwakura, Y.; Cormet-Boyaka, E.; Martin, T. L.; Steiner, H. E.; Bachman, R. C.; Boyaka, P. N.			Neutrophils negatively regulate induction of mucosal IgA responses after sublingual immunization	MUCOSAL IMMUNOLOGY			English	Article							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; ANTHRACIS EDEMA-TOXIN; GROWTH-FACTOR-BETA; CHOLERA-TOXIN; IMMUNE-RESPONSES; IKK-BETA; ALUMINUM ADJUVANTS; TH17 CELLS; INFECTION	Induction of mucosal immunoglobulin-A (IgA) capable of providing a first line of defense against bacterial and viral pathogens remains a major goal of needle-free vaccines given via mucosal routes. Innate immune cells are known to play a central role in induction of IgA responses by mucosal vaccines, but the relative contribution of myeloid cell subsets to these responses has not firmly been established. Using an in vivo model of sublingual vaccination with Bacillus anthracis edema toxin (EdTx) as adjuvant, we examined the role of myeloid cell subsets for mucosal secretory IgA responses. Sublingual immunization of wild-type mice resulted in a transient increase of neutrophils in sublingual tissues and cervical lymph nodes. These mice later developed Ag-specific serum IgG responses, but not serum or mucosal IgA. Interestingly, EdTx failed to increase neutrophils in sublingual tissues and cervical lymph nodes of IKK beta(Delta Mye) mice, and these mice developed IgA responses. Partial depletion of neutrophils before immunization of wild-type mice allowed the development of both mucosal and serum IgA responses. Finally, co-culture of B cells with neutrophils from either wildtype or IKKbDMye mice suppressed secretion of IgA, but not IgM or IgG. These results identify a new role for neutrophils as negative regulators of IgA responses.	[Jee, J.; Bonnegarde-Bernard, A.; Duverger, A.; Cormet-Boyaka, E.; Martin, T. L.; Steiner, H. E.; Bachman, R. C.; Boyaka, P. N.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Iwakura, Y.] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo, Japan; [Boyaka, P. N.] Ohio State Univ, Internal Med, Columbus, OH 43210 USA; [Boyaka, P. N.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	Boyaka, PN (reprint author), Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA.	boyaka.1@osu.edu			National Institutes of Health [R01 AI043197, R01 AT006552]; Fondation Lelous, France	Supported by grants from the National Institutes of Health (R01 AI043197 and R01 AT006552 to PNB), and a fellowship from Fondation Lelous, France (to AB-B). We thank Dr Michael Karin for providing IKK beta-deficient mice and Dr Kate Hayes-Ozello for editorial assistance.	Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Munks MW, 2010, BLOOD, V116, P5191, DOI 10.1182/blood-2010-03-275529; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Song JH, 2009, J IMMUNOL, V182, P6851, DOI 10.4049/jimmunol.0803568; Brereton CF, 2011, J IMMUNOL, V186, P5896, DOI 10.4049/jimmunol.1003789; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Branzk N, 2013, SEMIN IMMUNOPATHOL, V35, P513, DOI 10.1007/s00281-013-0384-6; May MJ, 2011, NAT IMMUNOL, V12, P813, DOI 10.1038/ni.2093; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Jin J, 2012, NAT IMMUNOL, V13, P1101, DOI 10.1038/ni.2423; Yang CW, 2010, J IMMUNOL, V185, P2927, DOI 10.4049/jimmunol.1001289; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132532; Lapponi MJ, 2013, J PHARMACOL EXP THER, V345, P430, DOI 10.1124/jpet.112.202879; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; Grespan R, 2008, ARTHRITIS RHEUM, V58, P2030, DOI 10.1002/art.23597; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Tang WJ, 2009, MOL ASPECTS MED, V30, P423, DOI 10.1016/j.mam.2009.06.001; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; Duverger A, 2006, J IMMUNOL, V176, P1776; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Yang CW, 2013, J EXP MED, V210, P375, DOI 10.1084/jem.20122183; Maitra A, 2007, P NATL ACAD SCI USA, V104, P7506, DOI 10.1073/pnas.0611589104; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Bonnegarde-Bernard A, 2014, MUCOSAL IMMUNOL, V7, P257, DOI 10.1038/mi.2013.43; Boyaka PN, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P855, DOI 10.1016/B978-012491543-5/50051-6; Boyaka PN, 2003, J IMMUNOL, V170, P454; BROMANDER AK, 1993, SCAND J IMMUNOL, V37, P452, DOI 10.1111/j.1365-3083.1993.tb03318.x; Cong Yingzi, 2001, European Journal of Immunology, V31, P64, DOI 10.1002/1521-4141(200101)31:1<64::AID-IMMU64>3.0.CO;2-P; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Duverger A, 2010, J IMMUNOL, V185, P5943, DOI 10.4049/jimmunol.0902795; Jackson EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041529; Kim PH, 1998, J IMMUNOL, V160, P1198; Klezovich-Benard M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002481; Kraal G, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P415, DOI 10.1016/B978-012491543-5/50027-9; Lillard JW, 1999, P NATL ACAD SCI USA, V96, P651, DOI 10.1073/pnas.96.2.651; Lo DD, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-7; LYCKE N, 1989, J IMMUNOL, V142, P3781; MCGEE DW, 1993, J IMMUNOL, V151, P970; Raghavan S, 2010, INFECT IMMUN, V78, P4251, DOI 10.1128/IAI.00536-10	50	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1933-0219	1935-3456		MUCOSAL IMMUNOL	Mucosal Immunol.	JUL	2015	8	4					735	745		10.1038/mi.2014.105		11	Immunology	Immunology	CL3QP	WOS:000356865700005		
J	Jung, Y; Wen, T; Mingler, MK; Caldwell, JM; Wang, YH; Chaplin, DD; Lee, EH; Jang, MH; Woo, SY; Seoh, JY; Miyasaka, M; Rothenberg, ME				Jung, Y.; Wen, T.; Mingler, M. K.; Caldwell, J. M.; Wang, Y. H.; Chaplin, D. D.; Lee, E. H.; Jang, M. H.; Woo, S. Y.; Seoh, J. Y.; Miyasaka, M.; Rothenberg, M. E.			IL-1 beta in eosinophil-mediated small intestinal homeostasis and IgA production	MUCOSAL IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; ORAL TOLERANCE; IN-VIVO; TGF-BETA; DENDRITIC CELLS; LAMINA PROPRIA; GASTROINTESTINAL EOSINOPHILS; SECRETORY IGA; IMMUNE-SYSTEM; GUT	Eosinophils are multifunctional leukocytes that reside in the gastrointestinal (GI) lamina propria, where their basal function remains largely unexplored. In this study, by examining mice with a selective deficiency of systemic eosinophils (by lineage ablation) or GI eosinophils (eotaxin-1/2 double deficient orCC chemokine receptor 3 deficient), we show that eosinophils support immunoglobulin A (IgA) class switching, maintain intestinal mucus secretions, affect intestinal microbial composition, and promote the development of Peyer's patches. Eosinophil-deficient mice showed reduced expression of mediators of secretory IgA production, including intestinal interleukin 1 beta (IL-1 beta), inducible nitric oxide synthase, lymphotoxin (LT) alpha, and LT-beta, and reduced levels of retinoic acid-related orphan receptor gamma t-positive (ROR-gamma t(+)) innate lymphoid cells (ILCs), while maintaining normal levels of APRIL (a proliferation-inducing ligand), BAFF (B cell-activating factor of the tumor necrosis factor family), and TGF-beta (transforming growth factor beta). GI eosinophils expressed a relatively high level of IL-1 beta, and IL-1 beta-deficient mice manifested the altered gene expression profiles observed in eosinophil-deficient mice and decreased levels of IgA(+) cells and ROR-gamma t(+) ILCs. On the basis of these collective data, we propose that eosinophils are required for homeostatic intestinal immune responses including IgA production and that their affect is mediated via IL-1 beta in the small intestine.	[Jung, Y.; Wen, T.; Mingler, M. K.; Caldwell, J. M.; Wang, Y. H.; Rothenberg, M. E.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Div Allergy & Immunol, Cincinnati, OH 45220 USA; [Jung, Y.; Lee, E. H.] Gachon Univ, Grad Sch Med, Dept Microbiol, Inchon, South Korea; [Chaplin, D. D.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Jang, M. H.] Acad Immunol & Microbiol, Inst Basic Sci, Pohang, South Korea; [Jang, M. H.] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Woo, S. Y.; Seoh, J. Y.] Ewha Womans Univ, Dept Microbiol, Grad Sch Med, Seoul, South Korea; [Miyasaka, M.] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan	Rothenberg, ME (reprint author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Div Allergy & Immunol, Cincinnati, OH 45220 USA.	Rothenberg@cchmc.org			NIH [R37 AI045898, R01 AI083450]; CURED (Campaign Urging Research for Eosinophilic Disease) Foundation; Food Allergy Research & Education (FARE); Buckeye Foundation; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2013R1A1A2004820]; Institute for Basic Science (IBS), Republic of Korea	We thank the Cincinnati Digestive Health Center (P30 DK078392) Integrative Morphology Core for tissue processing, sectioning, histology, and immunohistochemical staining. We also thank Shawna Hottinger for editorial assistance. This work was supported by the NIH grants R37 AI045898 and R01 AI083450, the CURED (Campaign Urging Research for Eosinophilic Disease) Foundation, the Food Allergy Research & Education (FARE), and Buckeye Foundation. Y.J. was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2013R1A1A2004820). M.H.J. was supported by the Institute for Basic Science (IBS), Republic of Korea.	Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Yu Q, 2000, GENE DEV, V14, P163; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Bergqvist P, 2006, J IMMUNOL, V177, P7772; Jung Y, 2014, J IMMUNOL, V193, P999, DOI 10.4049/jimmunol.1400413; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Tunis MC, 2012, J ALLERGY CLIN IMMUN, V130, P705, DOI 10.1016/j.jaci.2012.04.011; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Sutherland DB, 2012, CURR OPIN IMMUNOL, V24, P261, DOI 10.1016/j.coi.2012.03.005; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1039/ni829; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Pope SM, 2005, J IMMUNOL, V175, P5341; Adams V, 2002, CARDIOVASC RES, V54, P95, DOI 10.1016/S0008-6363(02)00228-6; Suzuki K, 2008, TRENDS IMMUNOL, V29, P523, DOI 10.1016/j.it.2008.08.001; Jacobsen EA, 2012, BLOOD, V120, P3882, DOI 10.1182/blood-2012-06-330845; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Eberl G, 2009, MUCOSAL IMMUNOL, V2, P478, DOI 10.1038/mi.2009.114; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Wen T, 2014, J IMMUNOL, V192, P5481, DOI 10.4049/jimmunol.1302846; Chu VT, 2014, IMMUNITY, V40, P582, DOI 10.1016/j.immuni.2014.02.014; Barternes KR, 2005, J ALLERGY CLIN IMMUN, V116, P827, DOI 10.1016/j.jaci.2005.07.014; Carlens J, 2009, J IMMUNOL, V183, P5600, DOI 10.4049/jimmunol.0801581; Carpenter L, 2001, J BIOL CHEM, V276, P5368, DOI 10.1074/jbc.M010036200; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chu DK, 2014, J EXP MED, V211, P1657, DOI 10.1084/jem.20131800; Chu Van Trung, 2011, Nat Immunol, V12, P151, DOI 10.1038/ni.1981; Corazziari ES, 2009, J PEDIATR GASTR NUTR, V48, pS54, DOI 10.1097/MPG.0b013e3181a117ea; Geuking MB, 2012, SEMIN IMMUNOL, V24, P36, DOI 10.1016/j.smim.2011.11.005; Lamm ME, 2002, J EXP MED, V195, pF5, DOI 10.1084/jem.20011910; Lee MR, 2011, BIOCHEM BIOPH RES CO, V410, P602, DOI 10.1016/j.bbrc.2011.06.035; Mishra A, 2000, BLOOD, V96, P1538; Rothenberg M.E., J ALLERGY CLIN IMMUN, V113, P11; Rothenberg ME, 2004, J ALLERGY CLIN IMMUN, V113, P9; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Tunis M.C., 2012, J ALLERGY CLIN IMMUN, V130, pe1; Verjan GN, 2011, J IMMUNOL, V187, P2268; Wen T, 2012, J IMMUNOL, V188, P1075, DOI 10.4049/jimmunol.1102222; Westlund J, 2012, IMMUNOLOGY, V135, P236, DOI 10.1111/j.1365-2567.2011.03536.x	60	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1933-0219	1935-3456		MUCOSAL IMMUNOL	Mucosal Immunol.	JUL	2015	8	4					930	942		10.1038/mi.2014.123		13	Immunology	Immunology	CL3QP	WOS:000356865700021		
J	Ishihara, A; Nagatomo, F; Terada, M; Fujino, H; Kondo, H; Ishioka, N				Ishihara, Akihiko; Nagatomo, Fumiko; Terada, Masahiro; Fujino, Hidemi; Kondo, Hiroyo; Ishioka, Noriaki			EFFECTS OF MICROGRAVITY ON THE MOUSE TRICEPS BRACHII MUSCLE	MUSCLE & NERVE			English	Article						fiber cross-sectional area; fiber oxidative staining intensity; forelimb muscle; muscle oxidative enzyme activity; spaceflight	OXIDATIVE ENZYME-ACTIVITY; SUCCINATE-DEHYDROGENASE ACTIVITY; MESSENGER-RNA LEVELS; EXTENSOR DIGITORUM LONGUS; HIGH OXYGEN CONCENTRATION; SOLEUS MUSCLE; METABOLIC SYNDROME; HYPOBARIC HYPOXIA; CELL-SIZE; HYPERBARIC EXPOSURE	Introduction: In this study we investigated the effects of microgravity on the fiber properties of the mouse triceps brachii, a forelimb muscle that has no antigravity function. Methods: Mice (n=7) were exposed to microgravity for 13 days on the space shuttle Atlantis (Space Transportation System-135). The fiber cross-sectional area (CSA) and succinate dehydrogenase (SDH) staining intensity of the triceps brachii muscle were compared with those of controls (n=7). SDH activity in this muscle was also estimated. Results: Microgravity did not affect the body weight, muscle weight, or fiber CSA, but there was reduced SDH staining intensity of all types of fibers, irrespective of the muscle region (P< 0.05). Microgravity also reduced muscle SDH activity (P< 0.05). Conclusions: Shortterm exposure to microgravity induced a decrease in oxidative capacity, but not atrophy, in the triceps brachii muscle of mice.	[Ishihara, Akihiko; Nagatomo, Fumiko] Kyoto Univ, Grad Sch Human & Environm Studies, Lab Cell Biol & Life Sci, Kyoto 6068501, Japan; [Terada, Masahiro] Jikei Univ, Sch Med, Dept Cell Biol, Tokyo, Japan; [Fujino, Hidemi] Kobe Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Kobe, Hyogo 657, Japan; [Kondo, Hiroyo] Nagoya Womens Univ, Dept Food Sci & Nutr, Nagoya, Aichi, Japan; [Ishioka, Noriaki] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Dept Interdisciplinary Sci, Sagamihara, Kanagawa 2298510, Japan	Ishihara, A (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Lab Cell Biol & Life Sci, Kyoto 6068501, Japan.	ishihara.akihiko.8s@kyoto-u.ac.jp					Behnke BJ, 2013, FASEB J, V27, P399, DOI 10.1096/fj.12-218503; Nagatomo F, 2012, J PHYSIOL SCI, V62, P105, DOI 10.1007/s12576-011-0188-1; Taylor CR, 2013, FASEB J, V27, P2282, DOI 10.1096/fj.12-222687; Blomquist CG, 1983, HDB PHYSL 2, P1025; DESPLANCHES D, 1990, J APPL PHYSIOL, V68, P48; Edgerton V.R., 1996, HDB PHYSIOL SECT 4, V1, P721; Fujino H, 2012, MUSCLE NERVE, V45, P242, DOI 10.1002/mus.22267; Gridley DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075097; ISHIHARA A, 1990, BRAIN RES BULL, V24, P143, DOI 10.1016/0361-9230(90)90298-E; Ishihara A, 2006, NEUROCHEM RES, V31, P411, DOI 10.1007/s11064-005-9027-1; Ishihara A, 2000, MUSCLE NERVE, V23, P753, DOI 10.1002/(SICI)1097-4598(200005)23:5<753::AID-MUS13>3.0.CO;2-J; Ishihara A, 2005, NEUROSCI RES, V52, P146, DOI 10.1016/j.neures.2005.03.001; ISHIHARA A, 1995, NEUROSCIENCE, V68, P813, DOI 10.1016/0306-4522(95)00165-F; Ishihara A, 1996, ACTA ANAT, V157, P303; Ishihara A, 2013, NEUROCHEM RES, V38, P2160, DOI 10.1007/s11064-013-1124-y; Ishihara A, 2004, NEUROSCI RES, V48, P119, DOI 10.1016/j.neures.2003.10.013; Ishihara A, 2000, JPN J PHYSIOL, V50, P561, DOI 10.2170/jjphysiol.50.561; Ishihara A, 1997, AVIAT SPACE ENVIR MD, V68, P421; Ishihara A, 2008, J PHYSIOL SCI, V58, P413, DOI 10.2170/physiolsci.RP000808; Kim W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062437; LATHERS CM, 1989, J CLIN PHARMACOL, V29, P615; Mao XW, 2014, FREE RADICAL RES, V28, P1; Mao XW, 2013, RADIAT RES, V180, P340, DOI 10.1667/RR3309.1; Matsumoto A, 2007, DEV NEUROSCI-BASEL, V29, P452, DOI 10.1159/000097319; Matsumoto A, 2007, J PHYSIOL SCI, V57, P311, DOI 10.2170/physiolsci.RP008907; Nagatomo F, 2012, NUTR RES, V32, P144, DOI 10.1016/j.nutres.2011.12.015; Nagatomo F, 2011, HISTOL HISTOPATHOL, V26, P1545; Nagatomo F, 2014, AEROSP SCI TECHNOL, V34, P20, DOI 10.1016/j.ast.2014.01.009; Nagatomo F, 2011, ACTA HISTOCHEM CYTOC, V44, P73, DOI 10.1267/ahc.10041; Nakatani T, 2003, ACTA HISTOCHEM CYTOC, V36, P105; Nakatani T, 1999, ARCH HISTOL CYTOL, V62, P393, DOI 10.1679/aohc.62.393; Nakatani T, 2000, JPN J PHYSIOL, V50, P413, DOI 10.2170/jjphysiol.50.413; Roy R R, 1996, Exerc Sport Sci Rev, V24, P399; Sung M, 2013, J MUSCULOSKEL NEURON, V13, P405; TAGUCHI S, 1990, NEUROCHEM RES, V15, P923, DOI 10.1007/BF00965913; Watenpaugh DE, 2001, J APPL PHYSIOL, V90, P1552; Zanello SB, 2013, AVIAT SPACE ENVIR MD, V84, P1277, DOI 10.3357/ASEM.3762.2013	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	JUL	2015	52	1					63	68		10.1002/mus.24491		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CK8OQ	WOS:000356498000010		
J	Furukawa, Y; Ogawa, G; Hokkoku, K; Hatanaka, Y; Aoki, R; Saito, K; Sonoo, M				Furukawa, Yuichi; Ogawa, Go; Hokkoku, Keiichi; Hatanaka, Yuki; Aoki, Ryoko; Saito, Kayoko; Sonoo, Masahiro			DIAGNOSTIC USE OF SURFACE EMG IN A PATIENT WITH SPINAL MUSCULAR ATROPHY	MUSCLE & NERVE			English	Letter							CLUSTERING INDEX METHOD		[Furukawa, Yuichi; Ogawa, Go; Hokkoku, Keiichi; Hatanaka, Yuki; Sonoo, Masahiro] Teikyo Univ, Sch Med, Dept Neurol, Itabashi Ku, Tokyo 173, Japan; [Aoki, Ryoko; Saito, Kayoko] Tokyo Womens Med Univ, Inst Med Genet, Tokyo, Japan	Furukawa, Y (reprint author), Teikyo Univ, Sch Med, Dept Neurol, Itabashi Ku, Tokyo 173, Japan.						LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Higashihara M, 2011, MUSCLE NERVE, V44, P539, DOI 10.1002/mus.22119; Uesugi H, 2011, CLIN NEUROPHYSIOL, V122, P1032, DOI 10.1016/j.clinph.2010.08.012	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	JUL	2015	52	1					153	154		10.1002/mus.24643		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CK8OQ	WOS:000356498000028		
J	Aoto, J; Foldy, C; Ilcus, SMC; Tabuchi, K; Sudhof, TC				Aoto, Jason; Foeldy, Csaba; Ilcus, Silviana Maria Ciurea; Tabuchi, Katsuhiko; Suedhof, Thomas C.			Distinct circuit-dependent functions of presynaptic neurexin-3 at GABAergic and glutamatergic synapses	NATURE NEUROSCIENCE			English	Article							CELL-SURFACE PROTEINS; SYNAPTIC-TRANSMISSION; SPECTRUM DISORDER; CA2+ CHANNELS; NEUROLIGIN; RELEASE; SCHIZOPHRENIA; PROBABILITY; RECEPTOR; POLYMORPHISMS	alpha- and beta-neurexins are presynaptic cell-adhesion molecules whose general importance for synaptic transmission is well documented. The specific functions of neurexins, however, remain largely unknown because no conditional neurexin knockouts are available and targeting all alpha- and beta-neurexins produced by a particular gene is challenging. Using newly generated constitutive and conditional knockout mice that target all neurexin-3 alpha and neurexin-3 beta isoforms, we found that neurexin-3 was differentially required for distinct synaptic functions in different brain regions. Specifically, we found that, in cultured neurons and acute slices of the hippocampus, extracellular sequences of presynaptic neurexin-3 mediated trans-synaptic regulation of postsynaptic AMPA receptors. In cultured neurons and acute slices of the olfactory bulb, however, intracellular sequences of presynaptic neurexin-3 were selectively required for GABA release. Thus, our data indicate that neurexin-3 performs distinct essential pre- or postsynaptic functions in different brain regions by distinct mechanisms.	[Aoto, Jason; Foeldy, Csaba; Ilcus, Silviana Maria Ciurea; Tabuchi, Katsuhiko; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Tabuchi, Katsuhiko] Natl Inst Physiol Sci, Div Cerebral Struct, Dept Cerebral Res, Okazaki, Aichi 444, Japan	Aoto, J (reprint author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	jaoto@stanford.edu			National Institute of Mental Health [R37MH52804, 1K99MH103531]; National Institute on Drug Abuse [K99DA034029]; American Heart Association, Western States [11POST7360078]	We thank D. Martinelli, P. Rothwell, L. Chen and R.C. Malenka for advice and technical help. This study was supported by grants from the National Institute of Mental Health (R37MH52804 to T.C.S. and 1K99MH103531to J.A.), the National Institute on Drug Abuse (K99DA034029 to C.F.) and the American Heart Association, Western States (11POST7360078 to J.A.).	Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Hu ZT, 2012, SCIENCE, V337, P980, DOI 10.1126/science.1224896; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Pang ZPP, 2011, NEURON, V70, P244, DOI 10.1016/j.neuron.2011.03.011; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Chen YC, 2012, J NEUROSCI, V32, P16018, DOI 10.1523/JNEUROSCI.1685-12.2012; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Cao P, 2011, CELL, V145, P300, DOI 10.1016/j.cell.2011.03.034; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Reichelt AC, 2012, NEUROPHARMACOLOGY, V62, P1519, DOI 10.1016/j.neuropharm.2011.01.024; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Bang ML, 2013, NEUROCHEM RES, V38, P1174, DOI 10.1007/s11064-013-1029-9; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Knight D, 2011, MOL NEUROBIOL, V44, P426, DOI 10.1007/s12035-011-8213-1; Docampo E, 2012, GENES BRAIN BEHAV, V11, P704, DOI 10.1111/j.1601-183X.2012.00815.x; Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Kelai S, 2008, NEUROREPORT, V19, P751, DOI 10.1097/WNR.0b013e3282fda231; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Lachman HM, 2007, HUM MOL GENET, V16, P1327, DOI 10.1093/hmg/ddm081; Novak G, 2009, WORLD J BIOL PSYCHIA, V10, P929, DOI [10.1080/15622970903079499, 10.3109/15622970903079499]; Prats-Puig A, 2013, INT J OBESITY, V37, P182, DOI 10.1038/ijo.2012.27; Sato N, 2010, PSYCHIAT GENET, V20, P135, DOI 10.1097/YPG.0b013e32833a21f9; Treutlein B, 2014, P NATL ACAD SCI USA, V111, pE1291, DOI 10.1073/pnas.1403244111; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987	36	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2015	18	7					997	+		10.1038/nn.4037		13	Neurosciences	Neurosciences & Neurology	CL3QU	WOS:000356866200015		
J	Ejaz, N; Hamada, M; Diedrichsen, J				Ejaz, Naveed; Hamada, Masashi; Diedrichsen, Joern			Hand use predicts the structure of representations in sensorimotor cortex	NATURE NEUROSCIENCE			English	Article							PRIMARY MOTOR CORTEX; FINGER MOVEMENTS; CORTICAL SURFACE; FORCE PRODUCTION; AREA; MUSCLE; ORGANIZATION; REDUCTION; SYNERGIES; PATTERNS	Fine finger movements are controlled by the population activity of neurons in the hand area of primary motor cortex. Experiments using microstimulation and single-neuron electrophysiology suggest that this area represents coordinated multi-joint, rather than single-finger movements. However, the principle by which these representations are organized remains unclear. We analyzed activity patterns during individuated finger movements using functional magnetic resonance imaging (fMRI). Although the spatial layout of finger-specific activity patterns was variable across participants, the relative similarity between any pair of activity patterns was well preserved. This invariant organization was better explained by the correlation structure of everyday hand movements than by correlated muscle activity. This also generalized to an experiment using complex multi-finger movements. Finally, the organizational structure correlated with patterns of involuntary co-contracted finger movements for high-force presses. Together, our results suggest that hand use shapes the relative arrangement of finger-specific activity patterns in sensory-motor cortex.	[Ejaz, Naveed; Diedrichsen, Joern] UCL, Inst Cognit Neurosci, London, England; [Hamada, Masashi] Univ Tokyo, Dept Neurol, Tokyo, Japan	Diedrichsen, J (reprint author), UCL, Inst Cognit Neurosci, London, England.	j.diedrichsen@ucl.ac.uk			Wellcome trust [094874/Z/10/Z, 091593/Z/10/Z]; James McDonnell foundation	We thank J. Ingram and D. Wolpert, as well as A. Faisal and A. Thomik, for sharing their natural statistics data sets, G. Prichard, S. Clare, J. O'Reilly for help with the acquisition of the 7T data set, and J. Xu, B. Hertler, M. Brentscheidt, M. Wilmer, A. Luft, P. Celnik and J. Krakauer for sharing the data regarding stability of finger representations. Finally we thank J. Krakauer, J. Xu, K. Longden and A. Saleem for helpful comments on the manuscript. The research was supported by grants by the Wellcome trust (094874/Z/10/Z) and James McDonnell foundation to J.D. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust (091593/Z/10/Z).	Santello M, 1998, J NEUROSCI, V18, P10105; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; Kraskov A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0174; SANGER TD, 1994, IEEE T NEURAL NETWOR, V5, P965, DOI 10.1109/72.329694; Ingram JN, 2008, EXP BRAIN RES, V188, P223, DOI 10.1007/s00221-008-1355-3; Yu WS, 2010, J NEUROPHYSIOL, V103, P278, DOI 10.1152/jn.00797.2009; Diedrichsen J, 2012, NEURON, V76, P1043, DOI 10.1016/j.neuron.2012.12.001; Wiestler T, 2011, J NEUROPHYSIOL, V105, P3042, DOI 10.1152/jn.00106.2011; Mollazadeh M, 2014, J NEUROPHYSIOL, V112, P1857, DOI 10.1152/jn.00481.2013; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Zatsiorsky VM, 1998, BIOL CYBERN, V79, P139, DOI 10.1007/s004220050466; Zatsiorsky VM, 2000, EXP BRAIN RES, V131, P187, DOI 10.1007/s002219900261; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Haxby JV, 2014, ANNU REV NEUROSCI, V37, P435, DOI 10.1146/annurev-neuro-062012-170325; Gentner R, 2006, NEURON, V52, P731, DOI 10.1016/j.neuron.2006.09.038; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Overduin SA, 2012, NEURON, V76, P1071, DOI 10.1016/j.neuron.2012.10.018; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Graziano MSA, 2007, NEURON, V56, P239, DOI 10.1016/j.neuron.2007.09.013; LEMON RN, 1981, J PHYSIOL-LONDON, V311, P521; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Gentner R, 2010, CURR BIOL, V20, P1869, DOI 10.1016/j.cub.2010.09.045; Santello M, 2002, J NEUROSCI, V22, P1426; Indovina I, 2001, NEUROIMAGE, V13, P1027, DOI 10.1006/nimg.2001.0776; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; ROSEN I, 1972, EXP BRAIN RES, V14, P257, DOI 10.1007/BF00816162; Borg I, 2005, MODERN MULTIDIMENSIO; Diedrichsen J, 2013, CEREB CORTEX, V23, P1362, DOI 10.1093/cercor/bhs120; Diedrichsen J, 2011, NEUROIMAGE, V55, P1665, DOI 10.1016/j.neuroimage.2011.01.044; Donoghue MJ, 1999, CEREB CORTEX, V9, P586, DOI 10.1093/cercor/9.6.586; Gitton Y, 1999, J NEUROSCI, V19, P4889; Kriegeskorte Nikolaus, 2008, Front Syst Neurosci, V2, P4, DOI 10.3389/neuro.06.004.2008; Lang CE, 2004, J NEUROPHYSIOL, V92, P2802, DOI 10.1152/jn.00480.2004; Ledoit 0., 2003, J EMPIR FINANC, V10, P603, DOI DOI 10.1016/S0927-5398(03)00007-0; Nili H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003553; Schieber MH, 2002, ADV EXP MED BIOL, V508, P411; Thomik A.A.C., 2015, 7 INT IEEE EMBS C NE, P938; Waters-Metenier S, 2014, J NEUROSCI, V34, P1037, DOI 10.1523/JNEUROSCI.2282-13.2014	43	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2015	18	7					1034	+		10.1038/nn.4038		10	Neurosciences	Neurosciences & Neurology	CL3QU	WOS:000356866200019		
J	Sugimoto, K; Ohmomo, H; Shutoh, F; Nogami, H; Hisano, S				Sugimoto, Koji; Ohmomo, Hideki; Shutoh, Fumihiro; Nogami, Haruo; Hisano, Setsuji			Presentation of noise during acute restraint stress attenuates expression of immediate early genes and arginine vasopressin in the hypothalamic paraventricular nucleus but not corticosterone secretion in rats	NEUROSCIENCE RESEARCH			English	Article						Acoustic stimulus; White noise; c-Fos; JunB; Corticotropin-releasing hormone	PITUITARY-ADRENAL AXIS; CORTICOTROPIN-RELEASING HORMONE; PARVOCELLULAR NEUROSECRETORY NEURONS; C-FOS; MESSENGER-RNA; HPA AXIS; TRANSCRIPTIONAL ACTIVATION; ADRENOCORTICAL AXIS; AUDIOGENIC STRESS; EMOTIONAL-STRESS	The present study investigated the effect of acoustic stimulation on the activation of the hypothalamic-pituitary-adrenal (HPA) axis in rats submitted to acute restraint stress, through semi-quantitative histochemical analysis of expression of immediate early gene products (c-Fos, JunB and phosphorylated c-Jun) and arginine vasopressin (AVP) hnRNA in the paraventricular nucleus (PVN). Simultaneous presentation of white or pink noise with restraint resulted in a significant attenuation of stress-induced c-Fos and JunB expression in the dorsal body of dorsal medial parvicellular subdivision (mpdd) of the PVN, as compared with restraint without noise. However, this presentation did not change phosphorylation of c-Jun and the plasma corticosterone level. Moreover, white noise presentation during restraint led to a reduction in the number of c-Fos- or JunB-expressing corticotropin-releasing hormone (CRH) neurons and the number of neurons expressing AVP hnRNA in the mpdd. Dual-histochemical labeling revealed co-expression of c-Fos and JunB, as well as JunB and AVP hnRNA in mpdd neurons. These data suggest that acoustic stimuli have an attenuation effect on the restraint-induced activation of neuroendocrine CRH neurons, resulting in the reduction in AVP production as an adaptation of HPA axis to repeated stress. (C) 2014 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Sugimoto, Koji; Shutoh, Fumihiro; Nogami, Haruo; Hisano, Setsuji] Univ Tsukuba, Neuroendocrinol Lab, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Ohmomo, Hideki] Iwate Med Univ, Iwate Tohoku Med Megabank Org, Div Biomed Informat Anal, Morioka, Iwate, Japan; [Shutoh, Fumihiro; Nogami, Haruo; Hisano, Setsuji] Univ Tsukuba, Fac Med, Div Biomed, Neuroendocrinol Lab, Tsukuba, Ibaraki, Japan	Hisano, S (reprint author), Univ Tsukuba, Neuroendocrinol Lab, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan.	shisano@md.tsukuba.ac.jp			Ministry of Education, Culture Sports, Science, and Technology of Japan [21240020]	This study was supported in part by a Grant-in-Aid (no. 21240020) for Scientific Research (A), from the Ministry of Education, Culture Sports, Science, and Technology of Japan (S.H.).	AGUILERA G, 1994, FRONT NEUROENDOCRIN, V15, P321, DOI 10.1006/frne.1994.1013; Dunn C, 2002, CELL SIGNAL, V14, P585, DOI 10.1016/S0898-6568(01)00275-3; Norgren R, 2006, PHYSIOL BEHAV, V89, P531, DOI 10.1016/j.physbeh.2006.05.024; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Stamp JA, 1999, NEUROSCIENCE, V94, P1313, DOI 10.1016/S0306-4522(99)00368-1; Dumont EC, 2000, J NEUROCHEM, V75, P2200, DOI 10.1046/j.1471-4159.2000.0752200.x; Takahashi C, 2011, PEPTIDES, V32, P2384, DOI 10.1016/j.peptides.2011.09.016; Campeau S, 1997, J NEUROENDOCRINOL, V9, P577; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Aguilera G, 2000, REGUL PEPTIDES, V96, P23, DOI 10.1016/S0167-0115(00)00196-8; Datta S, 2007, NEUROSCI BIOBEHAV R, V31, P775, DOI 10.1016/j.neubiorev.2007.02.004; Jaszberenyi M, 2000, J NEUROENDOCRINOL, V12, P1174, DOI 10.1046/j.1365-2826.2000.00572.x; HERDEGEN T, 1995, J COMP NEUROL, V354, P39, DOI 10.1002/cne.903540105; Evanson NK, 2010, ENDOCRINOLOGY, V151, P4811, DOI 10.1210/en.2010-0285; Kuru M, 2000, NEUROREPORT, V11, P1977, DOI 10.1097/00001756-200006260-00034; Girotti M, 2006, NEUROSCIENCE, V138, P1067, DOI 10.1016/j.neuroscience.2005.12.002; Watts AG, 2005, FRONT NEUROENDOCRIN, V26, P109, DOI 10.1016/j.yfrne.2005.09.001; Ma XM, 1997, J ENDOCRINOL, V152, P81, DOI 10.1677/joe.0.1520081; WHITNALL MH, 1993, PROG NEUROBIOL, V40, P573, DOI 10.1016/0301-0082(93)90035-Q; BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; Liu Y, 2011, J NEUROENDOCRINOL, V23, P216, DOI 10.1111/j.1365-2826.2010.02101.x; KISS JZ, 1991, J COMP NEUROL, V313, P563, DOI 10.1002/cne.903130403; Sterrenburg L, 2012, J NEUROSCI RES, V90, P179, DOI 10.1002/jnr.22737; Dayas CV, 1999, EUR J NEUROSCI, V11, P2312, DOI 10.1046/j.1460-9568.1999.00645.x; Viau V, 2002, J COMP NEUROL, V445, P293, DOI 10.1002/cne.10178; Tanoue A, 2004, J CLIN INVEST, V113, P302, DOI 10.1172/JCI200419656; SWANSON LW, 1989, J COMP NEUROL, V285, P413, DOI 10.1002/cne.902850402; Wotjak CT, 1996, J NEUROSCI, V16, P7725; Masini CV, 2012, PHYSIOL BEHAV, V105, P568, DOI 10.1016/j.physbeh.2011.06.011; Spiga F, 2009, J ENDOCRINOL, V200, P273, DOI 10.1677/JOE-08-0421; Yoshida M, 2006, ENDOCRINOLOGY, V147, P2850, DOI 10.1210/en.2005-1222; Berridge CW, 2010, BRAIN RES, V1314, P91, DOI 10.1016/j.brainres.2009.09.019; Simmons DM, 2009, J COMP NEUROL, V516, P423, DOI 10.1002/cne.22126; Engelmann M, 2004, FRONT NEUROENDOCRIN, V25, P132, DOI 10.1016/j.yfrne.2004.09.001; Day HEW, 2005, EUR J NEUROSCI, V21, P441, DOI 10.1111/j.1460-9568.2005.03865.x; Bali B, 2003, EUR J NEUROSCI, V18, P1518, DOI 10.1046/j.1460-9568.2003.02877.x; Burow A, 2005, BRAIN RES, V1062, P63, DOI 10.1016/j.brainres.2005.09.031; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; Ito A, 2009, NEUROSCI RES, V65, P166, DOI 10.1016/j.neures.2009.06.012; Campeau S, 2002, STRESS, V5, P121, DOI 10.1080/10253890290027895; Chowdhury GMI, 2000, BRAIN RES BULL, V52, P171; ARANKOWSKYSANDOVAL G, 1992, BRAIN RES, V589, P353, DOI 10.1016/0006-8993(92)91299-T; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; GILLIES GE, 1982, NATURE, V299, P355, DOI 10.1038/299355a0; HERMAN JP, 1995, J COMP NEUROL, V363, P15, DOI 10.1002/cne.903630103; Imaki T, 1996, ENDOCR J, V43, P629, DOI 10.1507/endocrj.43.629; Inutsuka A., 2013, FRONT ENDOCRINOL, V4, P1; Kovacs KJ, 1998, MOL BRAIN RES, V54, P85, DOI 10.1016/S0169-328X(97)00324-0; Kovacs KJ, 1996, J NEUROSCI, V16, P262; Kraus K.S., 2012, HEARING RES, V288, P24; LAI H, 1987, PHARMACOL BIOCHEM BE, V28, P147, DOI 10.1016/0091-3057(87)90205-X; Piet R, 2010, NAT NEUROSCI, V13, P1156, DOI 10.1038/nn1010-1156; Martin J., 2010, AM J PHYSIOL-REG I, V298, P1383; PRIOU A, 1993, ACTA ENDOCRINOL-COP, V128, P466; RabadanDiehl C, 1995, J NEUROENDOCRINOL, V7, P903, DOI 10.1111/j.1365-2826.1995.tb00734.x; Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010; Swanson L.W., 1998, BRAIN MAPS STRUCTURE; TIZABI Y, 1992, NEUROENDOCRINOLOGY, V56, P611, DOI 10.1159/000126283; Weiser MJ, 2011, J NEUROENDOCRINOL, V23, P1231, DOI 10.1111/j.1365-2826.2011.02217.x; Zelikowsky M, 2010, BEHAV NEUROSCI, V124, P510, DOI 10.1037/a0020083	61	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JUL	2015	96						20	29		10.1016/j.neures.2014.11.010		10	Neurosciences	Neurosciences & Neurology	CL1ZC	WOS:000356742400003		
J	Ishii, K; Nagai, T; Hirota, Y; Noda, M; Nabeshima, T; Yamada, K; Kubo, K; Nakajima, K				Ishii, Kazuhiro; Nagai, Taku; Hirota, Yuki; Noda, Mariko; Nabeshima, Toshitaka; Yamada, Kiyofumi; Kubo, Ken-ichiro; Nakajima, Kazunori			Reelin has a preventive effect on phencyclidine-induced cognitive and sensory-motor gating deficits	NEUROSCIENCE RESEARCH			English	Article						Reelin; Phencyclidine; GABAergic interneuron; Cognitive deficits; Sonsory-motor gating deficits; Schizophrenia	PREFRONTAL CORTEX; SYNAPTIC PLASTICITY; BIPOLAR DISORDER; LIPOPROTEIN RECEPTOR; VULNERABILITY FACTOR; ALZHEIMERS-DISEASE; GABAERGIC NEURONS; CORTICAL-NEURONS; COMMON VARIANT; SCHIZOPHRENIA	Reelin has recently attracted attention because of its connection to several neuropsychiatric diseases. We previously reported the finding that prior transplantation of GABAergic neuron precursor cells into the medial prefrontal cortex (mPFC) of mice significantly prevented the induction of cognitive and sensory-motor gating deficits induced by phencyclidine (PCP). The majority of the precursor cells transplanted into the mPFC of the recipient mice differentiated into members of a somatostatin/Reelin-expressing class of GABAergic interneurons. These findings raised the possibility that Reelin secreted by the transplanted cells plays an important role in preventing the deficits induced by PCP. In this study, we investigated whether Reelin itself has a preventive effect on PCP-induced behavioral phenotypes by injecting conditioned medium containing Reelin into the lateral ventricle of the brains of 6- to 7-week-old male mice before administrating PCP. Behavioral analyses showed that the prior Reelin injection had a preventive effect against induction of the cognitive and sensory-motor gating deficits associated with PCP. Moreover, one of the types of Reelin receptor was found to be expressed by neurons in the mPFC. The results of this study point to the Reelin signaling pathway as a candidate target for the pharmacologic treatment of neuropsychiatric diseases. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Ishii, Kazuhiro; Hirota, Yuki; Noda, Mariko; Kubo, Ken-ichiro; Nakajima, Kazunori] Keio Univ, Sch Med, Dept Anat, Tokyo 1608582, Japan; [Nagai, Taku; Yamada, Kiyofumi] Nagoya Univ, Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi 466, Japan; [Nabeshima, Toshitaka] Meijo Univ, Dept Reg Pharmaceut Care & Sci, Nagoya, Aichi, Japan; [Nabeshima, Toshitaka] NPO Japanese Drug Org Appropriate Use & Res, Nagoya, Aichi, Japan	Kubo, K (reprint author), Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kkubo@a6.keio.jp; kazunori@keio.jp	Kubo, Ken-ichiro/B-2520-2015; Nakajima, Kazunori/L-3396-2013; 清文, 山田/I-7487-2014; Nagai, Taku/I-7507-2014	Kubo, Ken-ichiro/0000-0003-4023-5069; 清文, 山田/0000-0002-5280-5180; 	Strategic Research Program for Brain Sciences ("Understanding of molecular and environmental bases for brain health", "Integrated Research on Neuropsychiatric Disorders); Ministry of Education, Culture, Sports, Science, and Technology of Japan [22111004, 25640039, 25116522, 26430075]; Keio Gijuku Academic Development Funds; SENSHIN Medical Research Foundation; Terumo Life Science Foundation; Life Science Foundation of Japan; Program for the Advancement of Keio Gijuku Next Generation Research Projects	We thank members of Nakajima and Yamada laboratories for valuable discussions. We thank Dr. Tom Curran (a full-length mouse reelin expression vector), Dr. Jun-ichi Miyazaki (pCAGGS vector) for providing the plasmids, and Dr. Andre Goffinet for providing the G10 antibody. This project was supported by grants from the Strategic Research Program for Brain Sciences ("Understanding of molecular and environmental bases for brain health", "Integrated Research on Neuropsychiatric Disorders), the Grants-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (22111004, 25640039, 25116522, 26430075), Keio Gijuku Academic Development Funds, SENSHIN Medical Research Foundation, Terumo Life Science Foundation, Life Science Foundation of Japan, and Program for the Advancement of Keio Gijuku Next Generation Research Projects.	Breier A, 1997, AM J PSYCHIAT, V154, P805; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Kargieman L, 2007, P NATL ACAD SCI USA, V104, P14843, DOI 10.1073/pnas.0704848104; NIWA H, 1991, GENE, V108, P193; Pujadas L, 2010, J NEUROSCI, V30, P4636, DOI 10.1523/JNEUROSCI.5284-09.2010; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Takahashi K, 2007, BIOL PSYCHIAT, V62, P148, DOI 10.1016/j.biopsych.2006.06.035; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; DArcangelo G, 1997, J NEUROSCI, V17, P23; Nagai T, 2007, PSYCHOPHARMACOLOGY, V194, P21, DOI 10.1007/s00213-007-0820-1; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Mouri A, 2007, NEUROCHEM INT, V51, P173, DOI 10.1016/j.neuint.2007.06.019; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6; Tabata H, 2003, J NEUROSCI, V23, P9996; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Kramer PL, 2011, NEUROBIOL AGING, V32, P2113, DOI 10.1016/j.neurobiolaging.2010.01.010; Liu YP, 2010, PSYCHIAT GENET, V20, P184, DOI 10.1097/YPG.0b013e32833a220b; Teixeira CM, 2011, NEUROPSYCHOPHARMACOL, V36, P2395, DOI 10.1038/npp.2011.153; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; Goes FS, 2010, AM J MED GENET B, V153B, P549, DOI 10.1002/ajmg.b.31018; Gonzalez-Burgos G, 2012, SCHIZOPHRENIA BULL, V38, P950, DOI 10.1093/schbul/sbs010; Kubo K, 2010, J NEUROSCI, V30, P10953, DOI 10.1523/JNEUROSCI.0486-10.2010; Bothwell M, 2000, CELL, V102, P271, DOI 10.1016/S0092-8674(00)00032-5; Qiu SF, 2007, J NEUROPHYSIOL, V97, P2312, DOI 10.1152/jn.00869.2006; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Jodo E, 2005, CEREB CORTEX, V15, P663, DOI 10.1093/cercor/bhh168; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P139, DOI 10.1023/A:1019857620251; Sinagra M, 2005, J NEUROSCI, V25, P6127, DOI 10.1523/JNEUROSCI.1757-05.2005; Koie M, 2014, J BIOL CHEM, V289, P12922, DOI 10.1074/jbc.M113.536326; LAHTI AC, 1995, NEUROREPORT, V6, P869, DOI 10.1097/00001756-199504190-00011; Nakazawa K, 2012, NEUROPHARMACOLOGY, V62, P1574, DOI 10.1016/j.neuropharm.2011.01.022; BAR I, 1995, GENOMICS, V26, P543, DOI 10.1016/0888-7543(95)80173-J; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; Hajszan T, 2006, BIOL PSYCHIAT, V60, P639, DOI 10.1016/j.biopsych.2006.03.015; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; Knuesel I, 2010, PROG NEUROBIOL, V91, P257, DOI 10.1016/j.pneurobio.2010.04.002; Barr AM, 2007, NEUROPHARMACOLOGY, V52, P1114, DOI 10.1016/j.neuropharm.2006.11.011; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Campo CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005505; Hirota Y., 2014, J COMP NEUROL, V523, P463; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Kiss Tamás, 2011, Front Psychiatry, V2, P14, DOI 10.3389/fpsyt.2011.00014; Kubo K, 2002, NEUROSCI RES, V43, P381, DOI 10.1016/S0168-0102(02)00068-8; MaNN O., 2012, NAT REV NEUROSCI, V13, P107; Qiu SF, 2006, J NEUROSCI, V26, P12943, DOI 10.1523/JNEUROSCI.2561-06.2006; Rogers JT, 2011, LEARN MEMORY, V18, P558, DOI 10.1101/lm.2153511; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Skaar DA, 2005, MOL PSYCHIATR, V10, P563, DOI 10.1038/sj.mp.4001614; Snyder MA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00031; Tanaka DH, 2011, J NEUROSCI, V31, P14116, DOI 10.1523/JNEUROSCI.2786-11.2011; Utsunomiya-Tate N, 2000, P NATL ACAD SCI USA, V97, P9729, DOI 10.1073/pnas.160272497	60	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JUL	2015	96						30	36		10.1016/j.neures.2014.12.013		7	Neurosciences	Neurosciences & Neurology	CL1ZC	WOS:000356742400004		
J	Sugimura, T; Yoshimura, Y; Komatsu, Y				Sugimura, Taketoshi; Yoshimura, Yumiko; Komatsu, Yukio			TNF alpha is required for the production of T-type Ca2+ channel-dependent long-term potentiation in visual cortex	NEUROSCIENCE RESEARCH			English	Article						Long-term potentiation; T-type Ca2+ channel; TNF alpha; Experience-dependent development; Ocular dominance plasticity; Visual cortex	NECROSIS-FACTOR-ALPHA; OCULAR DOMINANCE PLASTICITY; MONOCULAR DEPRIVATION; SYNAPTIC-TRANSMISSION; POSTNATAL-DEVELOPMENT; CRITICAL PERIOD; EXPERIENCE; DISINTEGRIN; MECHANISMS; NEURONS	Monocular deprivation produces depression and potentiation of visual responses evoked in visual cortical neurons by stimulation of deprived and nondeprived eyes, respectively, during the critical period of ocular dominance plasticity. Our previous studies suggested that T-type Ca2+ channel-dependent long-term potentiation (LTP), induced by 2 Hz stimulation, mediates the potentiation of visual responses. However, it was proposed that the experience-dependent response potentiation is mediated by tumor necrosis factor-alpha (TNF alpha)-dependent homeostatic synaptic scaling but not by Hebbian synaptic plasticity, because the potentiation was absent in TNFa knockout (TNF alpha-KO) mice. In this study, we investigated whether TNFa is required for LTP induced by 2 Hz stimulation using visual cortical slices prepared from critical period mice and rats. The production of LTP was prevented by pharmacological blockade of TNFa in rats and mice. LTP production was also prevented by an inhibitor of TNF alpha-converting enzyme that converts membrane-bound TNF alpha to soluble TNFa. In TNF alpha-KO mice, LTP did not occur and was rescued by exogenous soluble TNFa. Soluble TNFa was required for LTP production only during a restricted time window soon after 2 Hz stimulation. These results strengthen the view that T-type Ca2+ channel-dependent LTP contributes to the potentiation of nondeprived eye responses following monocular deprivation. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Sugimura, Taketoshi; Komatsu, Yukio] Nagoya Univ, Environm Med Res Inst, Dept Neurosci, Nagoya, Aichi 4648601, Japan; [Yoshimura, Yumiko] Natl Inst Nat Sci, Natl Inst Physiol Sci, Div Visual Informat Proc, Okazaki, Aichi 4448585, Japan; [Yoshimura, Yumiko] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan	Komatsu, Y (reprint author), Nagoya Univ, Environm Med Res Inst, Dept Neurosci, Nagoya, Aichi 4648601, Japan.	komatsu@riem.nagoya-u.ac.jp			Funding Program for Next Generation World-Leading Researchers [LS137]; MEXT, Japan [22115007, 23110004]	This work was supported by the Funding Program for Next Generation World-Leading Researchers (LS137 to Y.Y.) and Grant-in-Aids for Scientific Research on Innovative Areas (#22115007 to Y.Y. and #23110004 to Y.K.), MEXT, Japan.	Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; KOMATSU Y, 1994, J NEUROSCI, V14, P6488; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Xiang ZX, 2011, ACS CHEM NEUROSCI, V2, P730, DOI 10.1021/cn200090z; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Yoon BJ, 2009, P NATL ACAD SCI USA, V106, P9860, DOI 10.1073/pnas.0901305106; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Yoshimura Y, 2008, EUR J NEUROSCI, V28, P730, DOI 10.1111/j.1460-9568.2008.06384.x; MOWER GD, 1981, BRAIN RES, V220, P255, DOI 10.1016/0006-8993(81)91216-6; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Santello M, 2012, TRENDS NEUROSCI, V35, P638, DOI 10.1016/j.tins.2012.06.001; HUBEL DH, 1982, NATURE, V299, P515, DOI 10.1038/299515a0; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419; Pribiag H, 2013, J NEUROSCI, V33, P15879, DOI 10.1523/JNEUROSCI.0530-13.2013; Gordon JA, 1996, J NEUROSCI, V16, P3274; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Liu CH, 2008, NEURON, V58, P340, DOI 10.1016/j.neuron.2008.02.020; Ranson A, 2012, P NATL ACAD SCI USA, V109, P1311, DOI 10.1073/pnas.1112204109; Funahashi R, 2013, J NEUROPHYSIOL, V109, P2064, DOI 10.1152/jn.00912.2012; Horibe S, 2014, NEUROSCI RES, V87, P33, DOI 10.1016/j.neures.2014.07.001; KOMATSU Y, 1988, J NEUROPHYSIOL, V59, P124; KOMATSU Y, 1992, J NEUROPHYSIOL, V67, P401; Lambo ME, 2013, J NEUROSCI, V33, P8810, DOI 10.1523/JNEUROSCI.4502-12.2013; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Ohmura T, 2003, NEUROSCI LETT, V341, P95, DOI 10.1016/S0304-3940(03)00170-8; Poon V.Y., 2013, FRONT SYNAPTIC NEURO, V5	41	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JUL	2015	96						37	44		10.1016/j.neures.2015.02.005		8	Neurosciences	Neurosciences & Neurology	CL1ZC	WOS:000356742400005		
J	Igarashi, M; Habata, T; Akita, H; Noda, K; Ogata, M; Saji, M				Igarashi, Masakazu; Habata, Toshiya; Akita, Hisanao; Noda, Kazuko; Ogata, Masanori; Saji, Makoto			The NR2B antagonist, ifenprodil, corrects the L-DOPA-induced deficit of bilateral movement and reduces c-Fos expression in the subthalamic nucleus of hemiparkinsonian rats	NEUROSCIENCE RESEARCH			English	Article						Parkinson's disease; Cylinder test; L-DOPA; Striatum; Subthalamic nucleus; Bilateral movement	NMDA RECEPTOR ANTAGONIST; LESIONED MARMOSET MODEL; LONG-TERM POTENTIATION; PARKINSONS-DISEASE; BASAL GANGLIA; INDUCED DYSKINESIA; GENE-EXPRESSION; GLUTAMATERGIC MECHANISMS; ANTIPARKINSONIAN ACTIONS; SYNAPTIC PLASTICITY	The use of NR2B antagonists in Parkinsonism is still controversial. To examine their anti-parkinsonian effects, the NR2B antagonist, ifenprodil, and L-DOPA were administered together and separately in hemi-parkinsonian rats (hemi-PD) that were subjected to a cylinder test. Recovery from hypoactivity was achieved by single administration of 3-7 mg/kg of L-DOPA; however, improvement in the deficit of bilateral forelimb use was not observed. When administered alone, ifenprodil had no anti-parkinsonian effects; however, combined administration of ifenprodil and 7 mg/kg of L-DOPA significantly reversed the deficit of bilateral forelimb use without adversely affecting the L-DOPA-induced improvement in motor activity. Next, in order to identify the brain area influenced by L-DOPA and ifenprodil, quantitative analysis of L-DOPA-induced c-Fos immunoreactivity was performed in various brain areas of hemi-PD following administration of L-DOPA with and without ifenprodil. Among brain areas with robust c-Fos expression within the motor loop circuit in dopamine-depleted hemispheres, co-administered ifenprodil markedly attenuated L-DOPA-induced c-Fos expression in only the subthalamic nucleus (STN), suggesting that the STN is the primary target for the anti-parkinsonian action of NR2B antagonists. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Igarashi, Masakazu; Habata, Toshiya; Akita, Hisanao; Saji, Makoto] Kitasato Univ, Div Brain Sci, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan; [Habata, Toshiya] Kitasato Univ, Sch Allied Hlth Sci, Dept Occupat Therapy, Sagamihara, Kanagawa 228, Japan; [Akita, Hisanao; Noda, Kazuko; Ogata, Masanori; Saji, Makoto] Kitasato Univ, Sch Allied Hlth Sci, Dept Physiol, Sagamihara, Kanagawa 228, Japan	Igarashi, M (reprint author), Kitasato Univ, Div Brain Sci, Grad Sch Med Sci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 228, Japan.	mi07511r@gmail.com; habata@kitasato-u.ac.jp; akita310@ahs.kitasato-u.ac.jp; noda1219@ahs.kitasato-u.ac.jp; masa422@ahs.kitasato-u.ac.jp; sajim@ahs.kitasato-u.ac.jp			JSPS KAKENHI [22659264]	We thank Dr. Steven Douglas Aird for English proofreading and editing, and also thank for Mr. Yousuke Kitahara for assistance. This work was supported by JSPS KAKENHI Grant Number 22659264.	Addy C, 2009, J CLIN PHARMACOL, V49, P856, DOI 10.1177/0091270009336735; Akita H, 2010, BRAIN RES, V1306, P159, DOI 10.1016/j.brainres.2009.09.040; Loschmann PA, 2004, EXP NEUROL, V187, P86, DOI 10.1016/j.expneurol.2004.01.018; Boraud T, 1998, BRAIN RES, V787, P157, DOI 10.1016/S0006-8993(97)01563-1; Standaert DG, 1999, MOL BRAIN RES, V64, P11, DOI 10.1016/S0169-328X(98)00293-9; Rylander D, 2009, J PHARMACOL EXP THER, V330, P227, DOI 10.1124/jpet.108.150425; STANDAERT DG, 1994, J COMP NEUROL, V343, P1, DOI 10.1002/cne.903430102; Chase TN, 2000, J NEUROL, V247, P36; Steece-Collier K, 2000, EXP NEUROL, V163, P239, DOI 10.1006/exnr.2000.7374; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Smith Y, 1998, NEUROSCIENCE, V86, P353; Paille V, 2010, J NEUROSCI, V30, P14182, DOI 10.1523/JNEUROSCI.2149-10.2010; Merello M, 1999, CLIN NEUROPHARMACOL, V22, P273; Gardoni F, 2006, J NEUROSCI, V26, P2914, DOI 10.1523/JNEUROSCI.5326-05.2006; Gardoni F, 2009, J NEUROSCI, V29, P669, DOI 10.1523/JNEUROSCI.3921-08.2009; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Bertran-Gonzalez J, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00136; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Andersson M, 1999, NEUROBIOL DIS, V6, P461, DOI 10.1006/nbdi.1999.0259; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Shi LH, 2004, BRAIN RES, V1013, P98, DOI 10.1016/j.brainres.2004.03.053; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Sgambato-Faure V, 2012, PROG NEUROBIOL, V96, P69, DOI 10.1016/j.pneurobio.2011.10.005; Leblois A, 2006, J NEUROSCI, V26, P3567, DOI 10.1523/JNEUROSCI.5050-05.2006; Nash JE, 2004, EXP NEUROL, V188, P471, DOI 10.1016/j.expneurol.2004.05.004; Darmopil S, 2009, BIOL PSYCHIAT, V66, P603, DOI 10.1016/j.biopsych.2009.04.025; Ogura T, 2005, NEUROSCI RES, V51, P299, DOI 10.1016/j.neures.2004.12.006; Chen G, 2013, NEUROSCIENCE, V231, P136, DOI 10.1016/j.neuroscience.2012.11.024; Chen Q, 1996, BRAIN RES, V743, P346, DOI 10.1016/S0006-8993(96)01098-0; Corvol JC, 2004, J NEUROSCI, V24, P7007, DOI 10.1523/JNEUROSCI.0676-04.2004; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; DICHIARA G, 1992, DEV PHARMACOL THERAP, V18, P223; Dybdal D, 2000, J NEUROSCI, V20, P6728; Ebihara K, 2011, NEUROSCI LETT, V496, P90, DOI 10.1016/j.neulet.2011.03.087; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117; Khan AM, 2000, J COMP NEUROL, V428, P428; Li L, 2013, NEUROSCIENCE, V236, P66, DOI 10.1016/j.neuroscience.2012.12.065; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Nadjar A, 2009, PROG NEUROBIOL, V87, P1, DOI 10.1016/j.pneurobio.2008.09.013; Nash JE, 2002, MOVEMENT DISORD, V17, P455, DOI 10.1002/mds.10107; Nash JE, 2000, EXP NEUROL, V165, P136, DOI 10.1006/exnr.2000.7444; Putzki N, 2002, J NEUROL, V249, P824, DOI 10.1007/s00415-002-0727-z; Saji M, 1995, BRAIN RES, V703, P165, DOI 10.1016/0006-8993(95)01090-4; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Svenningsson P, 2002, EUR J NEUROSCI, V15, P133, DOI 10.1046/j.0953-816x.2001.01840.x; Thiele SL, 2014, NEUROBIOL DIS, V71, P334, DOI 10.1016/j.nbd.2014.08.006; Zheng Mei, 2011, Beijing Da Xue Xue Bao, V43, P228	52	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JUL	2015	96						45	53		10.1016/j.neures.2015.02.003		9	Neurosciences	Neurosciences & Neurology	CL1ZC	WOS:000356742400006		
J	Nakano, T				Nakano, Tamami			Blink-related dynamic switching between internal and external orienting networks while viewing videos	NEUROSCIENCE RESEARCH			English	Article						Spontaneous eyeblink; Hippocampus; Orientation; Ventral attention network	DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; SUPPRESSION; BRAIN; ORGANIZATION; EYEBLINKS; ATTENTION; DISEASE; SYSTEMS; RATES	Humans spontaneously generate eyeblinks every few seconds. However, because this blink rate is several times more common than is required for ocular lubrication, the function of most spontaneous eyeblinks remains unknown. Because spontaneous eyeblinks tend to occur at implicit breakpoints in video stories, I hypothesized that spontaneous eyeblinks play an active role in attentional disengagement from external stimuli. Consistent with this, we previously found that spontaneous eyeblinks involve the concurrent deactivation of the dorsal attention network and activation of the default mode network when individuals are viewing videos. However, this previous study examined only the upper brain regions to increase the temporal resolution of the data. Therefore, the present study examined whether the temporal and subcortical regions exhibited blink-related activations or deactivations using the same visual stimuli as in the previous study. Data revealed that the bilateral hippocampus and cerebellum showed a prominent but momentary activation after the blink onset. In contrast, a blink-related deactivation was observed in both the right ventral and dorsal attention networks. These results suggest that spontaneous eyeblinks are involved in the attentional disengagement from external visual information via the massive and dynamic alteration of brain activity between the external and internal orienting networks. (C) 2015 The Author. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Nakano, Tamami] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Nakano, Tamami] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Nakano, Tamami] Ctr Informat & Neural Networks CiNet, Suita, Osaka, Japan	Nakano, T (reprint author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	tamami_nakano@fbs.osaka-u.ac.jp			Osaka University; Ministry of Education, Culture, Sports, Science and Technology, Japan [25700014]	This work was supported in part by the Osaka University Program for the Support of Networking among Present and Future Researchers and a Grant-in-Aid for Young Scientists (A) 25700014 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	STERN JA, 1984, PSYCHOPHYSIOLOGY, V21, P22, DOI 10.1111/j.1469-8986.1984.tb02312.x; KARSON CN, 1983, BRAIN, V106, P643, DOI 10.1093/brain/106.3.643; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; WADIA NH, 1971, BRAIN, V94, P359, DOI 10.1093/brain/94.2.359; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Phongphanphanee P, 2011, J NEUROSCI, V31, P1949, DOI 10.1523/JNEUROSCI.2305-10.2011; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; DOANE MG, 1980, AM J OPHTHALMOL, V89, P507; Nakano T, 2009, P R SOC B, V276, P3635, DOI 10.1098/rspb.2009.0828; Halko MA, 2014, J NEUROSCI, V34, P12049, DOI 10.1523/JNEUROSCI.1776-14.2014; VOLKMANN FC, 1980, SCIENCE, V207, P900, DOI 10.1126/science.7355270; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Taylor JR, 1999, EXP NEUROL, V158, P214, DOI 10.1006/exnr.1999.7093; Nakano T, 2010, EXP BRAIN RES, V205, P577, DOI 10.1007/s00221-010-2387-z; Nakano T, 2013, P NATL ACAD SCI USA, V110, P702, DOI 10.1073/pnas.1214804110; Ridder WH, 1997, VISION RES, V37, P3171; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Holmes G., 1936, IRISH J MED SCI, V129, P565; PONDER ERIC, 1927, QUART JOUR EXP PHYSIOL, V18, P89; Shulman GL, 1997, HUM BRAIN MAPP, V5, P317, DOI 10.1002/(SICI)1097-0193(1997)5:4&lt;317::AID-HBM19&gt;3.0.CO;2-A	27	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JUL	2015	96						54	58		10.1016/j.neures.2015.02.010		5	Neurosciences	Neurosciences & Neurology	CL1ZC	WOS:000356742400007		
J	Maegawa, H; Morimoto, Y; Kudo, C; Hanamoto, H; Boku, A; Sugimura, M; Kato, T; Yoshida, A; Niwa, H				Maegawa, Hiroharu; Morimoto, Yoshinari; Kudo, Chiho; Hanamoto, Hiroshi; Boku, Aiji; Sugimura, Mitsutaka; Kato, Takafumi; Yoshida, Atsushi; Niwa, Hitoshi			Neural mechanism underlying hyperalgesic response to orofacial pain in Parkinson's disease model rats	NEUROSCIENCE RESEARCH			English	Article						6-Hydroxydopamine; Parkinson's disease; Medial forebrain bundle; Tyrosine hydroxylase; c-Fos; Trigeminal spinal subnucleus caudalis; Formalin; Periaqueductal gray matter	SUBSTANTIA-NIGRA NEURONS; PERIAQUEDUCTAL GRAY-MATTER; SIGNAL-REGULATED KINASE; SPINAL-CORD; DORSAL-HORN; FOS EXPRESSION; 6-OHDA LESIONS; FORMALIN TEST; HEMIPARKINSONIAN RATS; NIGROSTRIATAL PATHWAY	To investigate the neural mechanism of pain originating from the orofacidl region in PD patients, we used PD model rats produced by unilateral injection of 6-hydroxydopamine (6-OHDA) into the medial fore-brain bundle. We investigated effects of nigrostriatal lesions on the behavioral response (face rubbing) to formalin injection into the upper lip. We also examined expression of c-Fos and phosphorylated extracellular signal-regulated kinase (pERK) in the trigeminal spinal subnucleus caudalis (Vc) and expression of c-Fos in the periaqueductal gray matter (PAG). Face rubbings following formalin injection showed a biphasic profile, with the first phase for the first 5 min and the second phase from 10 to 90 min. Rats with 6-OHDA lesions showed increased face rubbings in the second phase when formalin was injected ipsilaterally to the lesion, and c-Fos expression in the Vc increased. When formalin was injected contralaterally, face rubbings were reduced in the first phase, however, expression levels of c-Fos and pERK in the Vc were unchanged. No significant difference was found in c-Fos expression in the PAG between 6-OHDA- and saline-injected rats. These results suggest that unilateral dopamine depletion in the nigrostriatal pathway may be involved in hypersensitivity to noxious stimulation delivered to the orofacial region. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Maegawa, Hiroharu; Kudo, Chiho; Hanamoto, Hiroshi; Boku, Aiji; Sugimura, Mitsutaka; Niwa, Hitoshi] Osaka Univ, Dept Dent Anesthesiol, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Kato, Takafumi; Yoshida, Atsushi] Osaka Univ, Dept Oral Anat & Neurobiol, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Morimoto, Yoshinari] Kyushu Univ Hosp, Special Patient Oral Care Unit, Fukuoka 8128582, Japan	Maegawa, H (reprint author), Osaka Univ, Dept Dent Anesthesiol, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	maegawa@dent.osaka-u.ac.jp			JSPS [20592371]	We thank Dr. Yasushi Ishida, Dr. Ryuichiro Takeda and Dr. Yuto Ueda for technical assistance. This work was supported by JSPS Grant-in-Aid for Scientific Research (KAKENHI) Grant Number 20592371.	Abbadie C, 1997, PAIN, V69, P101, DOI 10.1016/S0304-3959(96)03285-X; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Hagelberg N, 2004, EUR J PHARMACOL, V500, P187, DOI 10.1016/j.ejphar.2004.07.024; Bitner RS, 2006, NEUROPHARMACOLOGY, V50, P521, DOI 10.1016/j.neuropharm.2005.10.009; Raboisson P, 2004, NEUROSCI BIOBEHAV R, V28, P219, DOI 10.1016/j.neubiorev.2003.12.003; Magnusson JE, 2000, BRAIN RES, V855, P260, DOI 10.1016/S0006-8993(99)02396-3; Saade NE, 1997, BRAIN RES, V751, P1, DOI 10.1016/S0006-8993(96)01164-X; PERESE DA, 1989, BRAIN RES, V494, P285, DOI 10.1016/0006-8993(89)90597-0; Nolano M, 2008, BRAIN, V131, P1903, DOI 10.1093/brain/awn102; Broen MPG, 2012, MOVEMENT DISORD, V27, P480, DOI 10.1002/mds.24054; Jansen ASP, 1998, BRAIN RES, V784, P329, DOI 10.1016/S0006-8993(97)01293-6; CHUDLER EH, 1995, PAIN, V60, P3, DOI 10.1016/0304-3959(94)00172-B; Sewards TV, 2002, BRAIN RES BULL, V59, P163, DOI 10.1016/S0361-9230(02)00864-X; Coggeshall RE, 2005, PROG NEUROBIOL, V77, P299, DOI 10.1016/j.pneurobio.2005.11.002; PRESLEY RW, 1990, J NEUROSCI, V10, P323; Perez-Lloret S, 2012, EXPERT OPIN EMERG DR, V17, P157, DOI 10.1517/14728214.2012.677949; Dai Y, 2002, J NEUROSCI, V22, P7737; BARASI S, 1979, BRAIN RES, V171, P121, DOI 10.1016/0006-8993(79)90737-6; BARBARESI P, 1994, NEUROSCIENCE, V60, P781, DOI 10.1016/0306-4522(94)90504-5; BARNES CD, 1979, PAIN, V6, P207, DOI 10.1016/0304-3959(79)90128-3; Blandini Fabio, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS124, DOI 10.1016/j.parkreldis.2008.04.015; Chudler EH, 2008, BRAIN RES, V1213, P41, DOI 10.1016/j.brainres.2008.03.053; Clifford T J, 1998, Gerodontology, V15, P73, DOI 10.1111/j.1741-2358.1998.00073.x; Czyrak A, 2000, MOL BRAIN RES, V85, P209, DOI 10.1016/S0169-328X(00)00240-0; DUNNETT SB, 1981, BRAIN RES, V229, P209, DOI 10.1016/0006-8993(81)90759-9; Eaton MJ, 1996, BRAIN RES, V738, P60, DOI 10.1016/0006-8993(96)00765-2; FIELDS HL, 1985, PHILOS T ROY SOC B, V308, P361, DOI 10.1098/rstb.1985.0037; Fields HL, 2006, WALL MELZACKS TXB PA, P125; FLEETWOODWALKER SM, 1988, J PHYSIOL-LONDON, V399, P335; Ford B, 1996, MOVEMENT DISORD, V11, P421, DOI 10.1002/mds.870110411; Heikkila R.E., 1989, NEUROMETHODS DRUGS T, P351; Hu JY, 1999, ACTA PHARMACOL SIN, V20, P193; Inden M, 2004, J PHARMACOL SCI, V96, P53, DOI 10.1254/jphs.FPJ04010X; Ishida Y, 1998, BRAIN RES, V788, P207, DOI 10.1016/S0006-8993(97)01541-2; IWATA K, 1995, BRAIN RES, V678, P127, DOI 10.1016/0006-8993(95)00176-Q; Jolly D E, 1989, Spec Care Dentist, V9, P74, DOI 10.1111/j.1754-4505.1989.tb01032.x; JURNA I, 1978, EUR J PHARMACOL, V51, P239, DOI 10.1016/0014-2999(78)90409-0; Klein A, 2007, NEUROBIOL DIS, V27, P24, DOI 10.1016/j.nbd.2007.03.010; Konig J.F.R., 1963, RAT BRAIN STEREOTAXI; Liu Y, 2004, PAIN, V109, P64, DOI 10.1016/j.pain.2004.01.010; MAYER DJ, 1971, SCIENCE, V174, P1351, DOI 10.1126/science.174.4016.1351; NISHINO H, 1990, BRAIN RES, V534, P83, DOI 10.1016/0006-8993(90)90115-R; PARKER SL, 1992, NEUROENDOCRINOLOGY, V56, P385, DOI 10.1159/000126253; Paxinos G., 2005, RAT BRAIN STEREOTAXI; PAY S, 1982, PAIN, V12, P75, DOI 10.1016/0304-3959(82)90171-3; Reyes S, 2008, INT J NEUROSCI, V118, P1053, DOI 10.1080/00207450701239210; Scherder E, 2005, NEUROSCI BIOBEHAV R, V29, P1047, DOI 10.1016/j.neubiorev.2005.03.001; Shimizu K, 2006, BRAIN RES, V1072, P99, DOI 10.1016/j.brainres.2005.12.040; Shoda E, 2009, J PAIN, V10, P573, DOI 10.1016/j.jpain.2008.11.013; TAKADA M, 1990, NEUROSCI LETT, V115, P33, DOI 10.1016/0304-3940(90)90513-9; Takeda R, 2005, NEUROSCI RES, V52, P31, DOI 10.1016/j.neures.2005.01.005; Tassorelli C, 2007, BRAIN RES, V1176, P53, DOI 10.1016/j.brainres.2007.08.012; TSAI CT, 1989, BRAIN RES BULL, V23, P121; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Ungerstedt U, 1971, Acta Physiol Scand Suppl, V367, P49; WILLIAMS S, 1990, NEUROSCIENCE, V36, P73, DOI 10.1016/0306-4522(90)90352-5	62	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JUL	2015	96						59	68		10.1016/j.neures.2015.01.006		10	Neurosciences	Neurosciences & Neurology	CL1ZC	WOS:000356742400008		
J	Kanemura, S; Kikuchi, M; Yagyu, K				Kanemura, Shinya; Kikuchi, Mariko; Yagyu, Kei			Fingerprinting the extended Higgs sector using one-loop corrected Higgs boson couplings and future precision measurements	NUCLEAR PHYSICS B			English	Article							MAJORANA NEUTRINO MASSES; PROTON-PROTON COLLISIONS; 2-HIGGS DOUBLET MODEL; TREE-LEVEL UNITARITY; GLUON FINAL-STATES; DARK-MATTER; STANDARD MODEL; 2-HIGGS-DOUBLET MODEL; ATLAS DETECTOR; ROOT-S=7 TEV	We calculate radiative corrections to a full set of coupling constants for the 125 GeV Higgs boson at the one-loop level in two Higgs doublet models with four types of Yulcawa interaction under the softly-broken discrete Z(2) symmetry. The renormalization calculations are performed in the on-shell scheme, in which the gauge dependence in the mixing parameter which appears in the previous calculation is consistently avoided. We first show the details of our renormalization scheme, and present the complete set of the analytic formulae of the renormalized couplings. We then numerically demonstrate how the inner parameters of the model can be extracted by the future precision measurements of these couplings at the high luminosity LHC and the International Linear Collider. (C) 2015 The Authors. Published by Elsevier B.V.	[Kanemura, Shinya; Kikuchi, Mariko] Toyama Univ, Dept Phys, Toyama 9308555, Japan; [Yagyu, Kei] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England	Yagyu, K (reprint author), Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England.	kanemu@sci.u-toyama.ac.jp; kikuchi@jodo.sci.u-toyama.ac.jp; K.Yagyu@soton.ac.uk			Japan Society for the Promotion of Science (JSPS) [22244031, 24340046]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [23104006]; JSPS [25.10031]; JSPS postdoctoral fellowships for research abroad	S.K. was supported in part by Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science (JSPS), Nos. 22244031 and 24340046, and Ministry of Education, Culture, Sports, Science, and Technology (MEXT), No. 23104006. M.K. was supported in part by JSPS, No. 25.10031. K.Y. is supported by JSPS postdoctoral fellowships for research abroad.	Aad G, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.012006; Aad G., 2014, PHYS LETT B, V734; Aad G, 2012, EUR PHYS J C, V72, DOI 10.1140/epjc/s10052-012-2244-2; Aad G, 2013, EUR PHYS J C, V73, DOI 10.1140/epjc/s10052-013-2465-z; Aad G, 2013, JHEP, V1302, P095; Aad G., 2012, J HIGH ENERGY PHYS, V1206, P039; Aad G, 2013, PHYS LETT B, V726, P120, DOI 10.1016/j.physletb.2013.08.026; Aaltonen T, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.032005; Abazov VM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.151801; Abbott B, 1999, PHYS REV LETT, V82, P4975, DOI 10.1103/PhysRevLett.82.4975; Abulencia A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.042003; Ahriche A., 2014, J HIGH ENERGY PHYS, V1410, P167; Akeroyd AG, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.035015; Ma E, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.077301; BOCHKAREV AI, 1991, PHYS REV D, V43, P369, DOI 10.1103/PhysRevD.43.369; Akeroyd AG, 1996, PHYS LETT B, V377, P95, DOI 10.1016/0370-2693(96)00330-9; Kanemura S, 2014, PHYS LETT B, V731, P27, DOI 10.1016/j.physletb.2014.02.022; Farzan Y, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.033007; Chen MC, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.093001; GROSSMAN Y, 1994, NUCL PHYS B, V426, P355, DOI 10.1016/0550-3213(94)90316-6; NELSON AE, 1992, NUCL PHYS B, V373, P453, DOI 10.1016/0550-3213(92)90440-M; DESHPANDE NG, 1978, PHYS REV D, V18, P2574, DOI 10.1103/PhysRevD.18.2574; GEORGI HM, 1978, PHYS REV LETT, V40, P692, DOI 10.1103/PhysRevLett.40.692; KANEMURA S, 1993, PHYS LETT B, V313, P155, DOI 10.1016/0370-2693(93)91205-2; PASSARINO G, 1979, NUCL PHYS B, V160, P151, DOI 10.1016/0550-3213(79)90234-7; Kanemura S, 2013, PHYS LETT B, V727, P151, DOI 10.1016/j.physletb.2013.09.061; Aoki M, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.075016; LAZARIDES G, 1981, NUCL PHYS B, V181, P287, DOI 10.1016/0550-3213(81)90354-0; ZEE A, 1980, PHYS LETT B, V95, P461; ZEE A, 1985, PHYS LETT B, V161, P141, DOI 10.1016/0370-2693(85)90625-2; MAGG M, 1980, PHYS LETT B, V94, P61, DOI 10.1016/0370-2693(80)90825-4; Aad G, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.201802; Schael S, 2006, PHYS REP, V427, P257, DOI 10.1016/j.physrep.2005.12.006; Kanemura S, 2011, PHYS LETT B, V704, P303, DOI 10.1016/j.physletb.2011.09.035; Freitas A, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.095014; HABER HE, 1979, NUCL PHYS B, V161, P493, DOI 10.1016/0550-3213(79)90225-6; Nie SQ, 1999, PHYS LETT B, V449, P89, DOI 10.1016/S0370-2693(99)00019-2; Abazov VM, 2009, PHYS LETT B, V682, P278, DOI 10.1016/j.physletb.2009.11.016; BARGER V, 1990, PHYS REV D, V41, P3421, DOI 10.1103/PhysRevD.41.3421; Baek S, 2014, PHYS LETT B, V732, P85, DOI 10.1016/j.physletb.2014.03.021; MAALAMPI J, 1991, PHYS LETT B, V265, P371, DOI 10.1016/0370-2693(91)90068-2; Krawczyk M, 2005, EUR PHYS J C, V44, P435, DOI 10.1140/epjc/s2005-02370-2; Okada H, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.033011; CHENG TP, 1980, PHYS REV D, V22, P2860, DOI 10.1103/PhysRevD.22.2860; Chen CS, 2014, PHYS LETT B, V734, P388, DOI 10.1016/j.physletb.2014.05.082; Posch P, 2011, PHYS LETT B, V696, P447, DOI 10.1016/j.physletb.2011.01.003; HOLLIK W, 1992, PHYS LETT B, V284, P427, DOI 10.1016/0370-2693(92)90456-E; ELLIS J, 1976, NUCL PHYS B, V106, P292, DOI 10.1016/0550-3213(76)90382-5; Branco GC, 2012, PHYS REP, V516, P1, DOI 10.1016/j.physrep.2012.02.002; Gambino P, 2001, NUCL PHYS B, V611, P338, DOI 10.1016/S0550-3213(01)00347-9; Ma E, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.091801; Akeroyd AG, 2003, J PHYS G NUCL PARTIC, V29, P2311, DOI 10.1088/0954-3899/29/10/301; Krauss LM, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.085002; Kanemura S, 2014, PHYS LETT B, V738, P178, DOI 10.1016/j.physletb.2014.09.013; CIUCHINI M, 1994, PHYS LETT B, V334, P137, DOI 10.1016/0370-2693(94)90602-5; Gil G, 2012, PHYS LETT B, V717, P396, DOI 10.1016/j.physletb.2012.09.052; Abazov VM, 2011, PHYS LETT B, V698, P97, DOI 10.1016/j.physletb.2011.02.062; Kanemura S, 2003, PHYS LETT B, V558, P157, DOI 10.1016/S0370-2693(03)00268-5; Gu PH, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.105031; BERGSTROM L, 1985, NUCL PHYS B, V259, P137, DOI 10.1016/0550-3213(85)90302-5; Barbieri R, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.015007; MOHAPATRA RN, 1981, PHYS REV D, V23, P165, DOI 10.1103/PhysRevD.23.165; Arhrib A, 2004, PHYS LETT B, V579, P361, DOI 10.1016/j.physletb.2003.10.006; Hollik W, 2002, EUR PHYS J C, V23, P163, DOI 10.1007/s100520100862; ZEE A, 1986, NUCL PHYS B, V264, P99, DOI 10.1016/0550-3213(86)90475-X; Khalil S, 2008, J PHYS G NUCL PARTIC, V35, DOI 10.1088/0954-3899/35/5/055001; Dobado A, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.095016; Iso S, 2009, PHYS LETT B, V676, P81, DOI 10.1016/j.physletb.2009.04.046; TUROK N, 1990, PHYS REV LETT, V65, P2331, DOI 10.1103/PhysRevLett.65.2331; BERTOLINI S, 1986, NUCL PHYS B, V272, P77, DOI 10.1016/0550-3213(86)90341-X; WILCZEK F, 1977, PHYS REV LETT, V39, P1304, DOI 10.1103/PhysRevLett.39.1304; Peskin ME, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.093003; Chatrchyan S, 2013, PHYS LETT B, V722, P207, DOI 10.1016/j.physletb.2013.04.017; TOUSSAINT D, 1978, PHYS REV D, V18, P1626, DOI 10.1103/PhysRevD.18.1626; LEE TD, 1973, PHYS REV D, V8, P1226, DOI 10.1103/PhysRevD.8.1226; BABU KS, 1988, PHYS LETT B, V203, P132, DOI 10.1016/0370-2693(88)91584-5; PESKIN ME, 1992, PHYS REV D, V46, P381, DOI 10.1103/PhysRevD.46.381; Gu PH, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.073012; Ferreira PM, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.077703; ZEE A, 1980, PHYS LETT B, V93, P389, DOI 10.1016/0370-2693(80)90349-4; APPELQUIST T, 1975, PHYS REV D, V11, P2856, DOI 10.1103/PhysRevD.11.2856; Grimus W, 2008, NUCL PHYS B, V801, P81, DOI 10.1016/j.nuclphysb.2008.04.019; RIZZO TG, 1980, PHYS REV D, V22, P178, DOI 10.1103/PhysRevD.22.178; Kajiyama Y, 2013, NUCL PHYS B, V874, P198, DOI 10.1016/j.nuclphysb.2013.05.020; WEINBERG S, 1976, PHYS REV LETT, V37, P657, DOI 10.1103/PhysRevLett.37.657; Kanemura S, 1999, PHYS LETT B, V471, P182, DOI 10.1016/S0370-2693(99)01351-9; Okada H, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.095005; Schael S, 2006, EUR PHYS J C, V47, P547, DOI 10.1140/epjc/s2006-02569-7; Hahn T, 2003, NUCL PHYS B, V652, P229, DOI 10.1016/S0550-3213(03)00002-6; Ahriche A, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.015024; Hambye T, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.095003; Aoki M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.015017; Guasch J, 2001, PHYS LETT B, V515, P367, DOI 10.1016/S0370-2693(01)00866-8; Aoki M, 2012, PHYS LETT B, V714, P279, DOI 10.1016/j.physletb.2012.07.016; Ginzburg IF, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.115010; SCHECHTER J, 1980, PHYS REV D, V22, P2227, DOI 10.1103/PhysRevD.22.2227; HABER HE, 1985, PHYS REP, V117, P75, DOI 10.1016/0370-1573(85)90051-1; Bernal N, 2009, PHYS LETT B, V677, P39, DOI 10.1016/j.physletb.2009.05.013; ELLIS J, 1979, PHYS LETT B, V83, P339, DOI 10.1016/0370-2693(79)91122-5; Akeroyd AG, 2000, PHYS LETT B, V490, P119, DOI 10.1016/S0370-2693(00)00962-X; Kanemura S, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.073006; Kanemura S, 2011, PHYS LETT B, V703, P66, DOI 10.1016/j.physletb.2011.07.047; Gunion JF, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.075019; HOU WS, 1993, PHYS REV D, V48, P2342, DOI 10.1103/PhysRevD.48.2342; GLASHOW SL, 1977, PHYS REV D, V15, P1958, DOI 10.1103/PhysRevD.15.1958; HOLLIK WFL, 1990, FORTSCHR PHYS, V38, P165, DOI 10.1002/prop.2190380302; Lindner M, 2011, PHYS LETT B, V705, P324, DOI 10.1016/j.physletb.2011.10.022; SHER M, 1989, PHYS REP, V179, P273, DOI 10.1016/0370-1573(89)90061-6; PESKIN ME, 1990, PHYS REV LETT, V65, P964, DOI 10.1103/PhysRevLett.65.964; Aoki M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.051805; Wang L, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.015015; HUFFEL H, 1981, Z PHYS C PART FIELDS, V8, P13, DOI 10.1007/BF01429824; Gustafsson M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.211802; Ciuchini M, 1998, NUCL PHYS B, V527, P21, DOI 10.1016/S0550-3213(98)00244-2; Aoki M., 2010, JHEP, V1007, P084; Aoki M, 2011, PHYS LETT B, V702, P355, DOI 10.1016/j.physletb.2011.07.017; Aoki M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.033007; Aoki M., 2010, JHEP, V1011, P049; Aoki Ni., 2012, JHEP, V706, P495; Arhrib A., 2012, JHEP, V1204, P136; Asner D. M., ARXIV13100763HEPPH; ATLAS Collaboration, ATLASCONF2013090; ATLAS Collaboration, ATLASCONF2013027; ATLAS Collaboration, ARXIV13077292HEPEX A; ATLAS Collaboration, ATLPHYSPUB2013014; ATLAS Collaboration, ATLASCONF2014009; Baek S., 2014, J COSMOL ASTROPART P, V1406, P027; Baer H., ARXIV13066352HEPPH; Basak T, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.063527; BERGSTROM L, 1986, NUCL PHYS B, V276, P744; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Bhattacharyya G., 2013, JHEP, V1310, P081; Bhupal Dev P.S., 2013, JHEP, V1303, P150; Bhupal Dev P.S., 2013, J HIGH ENERGY PHYS, V1305, P049; Blank T, 1998, NUCL PHYS B, V514, P113, DOI 10.1016/S0550-3213(97)00785-2; Borzumati FM, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.074004; CAHN RN, 1979, PHYS LETT B, V82, P113, DOI 10.1016/0370-2693(79)90438-6; Chankowski PH, 2007, EUR PHYS J C, V50, P919, DOI 10.1140/epjc/s10052-007-0259-x; Chatrchyan S, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-2980-6; CHATRCHYAN S., 2014, J HIGH ENERGY PHYS, V1401, P096, DOI DOI 10.1007/JHEP01(2014)096; Chatrchyan S, 2012, EUR PHYS J C, V72, DOI 10.1140/epjc/s10052-012-2189-5; Chen CS, 2013, PHYS LETT B, V723, P156, DOI 10.1016/j.physletb.2013.05.007; Cheung KM, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.113009; Chiang CW, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.033003; Chun E.J., 2012, J HIGH ENERGY PHYS, V1211, P106; CMS Collab, 2010, J HIGH ENERGY PHYS; CMS Collaboration, CMSPASHIG13025; CMS collaboration, ARXIV13077135 CMS CO; DABELSTEIN A, 1995, Z PHYS C PART FIELDS, V67, P495, DOI 10.1007/BF01624592; Dawson S., ARXIV13108361HEPEX; Ferreira PM, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.035020; Funakubo K, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.115024; Ginzburg IF, 2001, NUCL INSTRUM METH A, V472, P149, DOI 10.1016/S0168-9002(01)01174-3; GROSSMAN Y, 1995, PHYS LETT B, V357, P630, DOI 10.1016/0370-2693(95)00946-I; GROSSMAN Y, 1994, PHYS LETT B, V332, P373, DOI 10.1016/0370-2693(94)91267-X; Guidon J.F., 2000, FRONT PHYS, V80, P1; Haber H.E., 2006, NUCL PHYS B, V157, P162; HAGIWARA K, 1994, Z PHYS C PART FIELDS, V64, P559, DOI 10.1007/BF01957770; Heinemeyer S., ARXIV13071347HEPPH L; Helm D., 2013, PHYS LETT B, V718, P988; Iso S, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.115007; Kajiyama Y, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP10(2013)196; Kanemura S, 2010, PHYS LETT B, V694, P233, DOI 10.1016/j.physletb.2010.09.064; Kanemura S, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.033004; Kanemura S, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.013001; Kanemura S, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.115002; Kanemura S., 2014, Nuovo Cimento C, V37, DOI 10.1393/ncc/i2014-11743-1; Kanemura S, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.115009; Kanemura S, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.075001; Kanemura S, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.016004; Khachatryan V., ARXIV14128662HEPEX C; Khachatryan V, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP10(2014)160; Khachatryan V, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.112013; Ko P., 2014, J HIGH ENERGY PHYS, V1411, P054; Krawczyk M., 2007, ECONF C, V0705302, pHIG09; Krawczyk M, 1997, PHYS REV D, V55, P6968, DOI 10.1103/PhysRevD.55.6968; Lepage G. P., ARXIV14040319HEPPH; Lopez-Val D, 2011, PHYS LETT B, V702, P246, DOI 10.1016/j.physletb.2011.07.010; Mahmoudi F, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.035016; March-Russell J., 2010, J HIGH ENERGY PHYS, V1003, P108; McDonald K.L., 2013, J HIGH ENERGY PHYS, V1311, P131; McNeile C, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.034512; Okada N, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.023507; Perez P. Fileviez, 2009, PHYS REV D, V79; Profumo S, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.035018; RIZZO TG, 1980, PHYS REV D, V22, P1824, DOI 10.1103/PhysRevD.22.1824; Tanaka M., 2012, JHEP, V67, P321; Aad G, 2012, PHYS LETT B, V716, P1, DOI 10.1016/j.physletb.2012.08.020; Chatrchyan S, 2012, PHYS LETT B, V716, P30, DOI 10.1016/j.physletb.2012.08.021; Tian J., COMMUNICATION	190	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	JUL	2015	896						80	137		10.1016/j.nuclphysb.2015.04.015		58	Physics, Particles & Fields	Physics	CL0LP	WOS:000356634500004		
J	Gehrlein, J; Petcov, ST; Spinrath, M; Zhang, XY				Gehrlein, Julia; Petcov, Serguey T.; Spinrath, Martin; Zhang, Xinyi			Leptogenesis in an SU(5) x A(5) golden ratio flavour model	NUCLEAR PHYSICS B			English	Article							LEPTONIC CP VIOLATION; MAJORANA NEUTRINOS; MIXING ANGLES; BARYOGENESIS; PHASES	In this paper we discuss a minor modification of a previous SU(5) x A(5) flavour model which exhibits at leading order golden ratio mixing and sum rules for the heavy and the light neutrino masses. Although this model could predict all mixing angles well it fails in generating a sufficient large baryon asymmetry via the leptogenesis mechanism. We repair this deficit here, discuss model building aspects and give analytical estimates for the generated baryon asymmetry before we perform a numerical parameter scan. Our setup has only a few parameters in the lepton sector. This leads to specific constraints and correlations between the neutrino observables. For instance, we find that in the model considered only the neutrino mass spectrum with normal mass ordering and values of the lightest neutrino mass in the interval 10-18 meV are compatible with the current data on the neutrino oscillation parameters. With the introduction of only one NLO operator, the model can accommodate successfully simultaneously even at 1 sigma level the current data on neutrino masses, on neutrino mixing and the observed value of the baryon asymmetry. (C) 2015 The Authors. Published by Elsevier B.V.	[Gehrlein, Julia; Spinrath, Martin] Karlsruhe Inst Technol, Inst Theoret Teilchenphys, D-76131 Karlsruhe, Germany; [Petcov, Serguey T.] Ist Nazl Fis Nucl, SISSA, I-34136 Trieste, Italy; [Petcov, Serguey T.] Univ Tokyo, Kavli IPMU WPI, Tokyo, Japan; [Zhang, Xinyi] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Zhang, Xinyi] Peking Univ, State Key Lab Nucl Phys & Technol, Beijing 100871, Peoples R China; [Petcov, Serguey T.] Bulgarian Acad Sci, Inst Nucl Res & Nucl Energy, BU-1784 Sofia, Bulgaria	Gehrlein, J (reprint author), Karlsruhe Inst Technol, Inst Theoret Teilchenphys, Engesserstr 7, D-76131 Karlsruhe, Germany.	julia.gehrlein@student.kit.edu; martin.spinrath@kit.edu; xzhang_phy@pku.edu.cn	Spinrath, Martin/D-3431-2011	Spinrath, Martin/0000-0003-3595-7980	graduate school of Peking University [zzsq2014000091]; European Union FP7 ITN INVISIBLES (Marie Curie Actions) [PITN-GA-2011-289442-INVISIBLES]; INFN program on Theoretical Astroparticle Physics (TASP); program PRIN - Italian MIUR [2012CPPYP7]; World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan	The work of X. Zhang was done during her visit to SISSA, and it was supported by the graduate school of Peking University (grant number zzsq2014000091). X. Zhang would like to thank Prof. Petcov for hospitality at SISSA, I. Girardi, A. Titov and A.J. Stuart for discussions, and A.J. Stuart for sharing his code on A<INF>5</INF> contractions. S.T.P. acknowledges very useful discussions with E. Molinaro. This work was supported in part by the European Union FP7 ITN INVISIBLES (Marie Curie Actions, PITN-GA-2011-289442-INVISIBLES), by the INFN program on Theoretical Astroparticle Physics (TASP), by the research grant 2012CPPYP7 (Theoretical Astroparticle Physics) under the program PRIN 2012 funded by the Italian MIUR and by the World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan (STP).	Abada A., 2006, JHEP, V0609, P010; Abada A., 2006, JCAP, V0604, P004; Ade P. A. R., ARXIV13035076ASTROPH; Angrik J., FZKA7090 KATR COLL; FUKUGITA M, 1986, PHYS LETT B, V174, P45, DOI 10.1016/0370-2693(86)91126-3; Kajiyama Y, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.117301; Antusch S, 2005, PHYS LETT B, V631, P42, DOI 10.1016/j/physletb.2005.09.075; Datta A, 2003, NUCL PHYS B, V671, P383, DOI 10.1016/jnuclphysb.2003.08.026; Branco GC, 2007, PHYS LETT B, V645, P432, DOI 10.1016/j.physletb.2006.12.060; Pascoli S, 2007, NUCL PHYS B, V774, P1, DOI 10.1016/j.nuclphysb.2007.02.019; Pilaftsis A, 1997, PHYS REV D, V56, P5431, DOI 10.1103/PhysRevD.56.5431; Davidson S, 2008, PHYS REP, V466, P105, DOI 10.1016/j.physrep.2008.06.002; Albert JB, 2014, NATURE, V510, P229, DOI 10.1038/nature13432; Petcov ST, 2015, NUCL PHYS B, V892, P400, DOI 10.1016/j.nuclphysb.2015.01.011; Albright CH, 2010, EUR PHYS J C, V70, P1099, DOI 10.1140/epjc/s10052-010-1492-2; Gehrlein J, 2015, NUCL PHYS B, V890, P539, DOI 10.1016/j.nuclphysb.2014.11.023; Antusch S, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.095004; Cooper IK, 2013, NUCL PHYS B, V875, P650, DOI 10.1016/j.nuclphysb.2013.07.027; Antusch S, 2013, NUCL PHYS B, V866, P255, DOI 10.1016/j.nuclphysb.2012.09.002; Antusch S, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.117301; Antusch S, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.055027; Bennett CL, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/20; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Branco GC, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.515; Everett LL, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.085005; Feruglio F., 2011, JHEP, V1103, P101; Gonzalez-Garcia M. C., 2014, J HIGH ENERGY PHYS, V1411, P052; Hagedorn C., 2009, JHEP, V0909, P115; Marzocca D., 2011, JHEP, V1111; Nardi E., 2006, JHEP, V0601, P164; Pascoli S, 2007, PHYS REV D, V75, DOI [10.1103/PhysRevD.75.083511, 10.1103/PhysRevA.75.083511]; Smolnikov A. A., ARXIV08124194NUCLEX	32	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	JUL	2015	896						311	329		10.1016/j.nuclphysb.2015.04.019		19	Physics, Particles & Fields	Physics	CL0LP	WOS:000356634500011		
J	Maharana, J				Maharana, Jnanadeva			Scattering of stringy states in compactified closed bosonic string	NUCLEAR PHYSICS B			English	Article							SCALE FACTOR DUALITY; SPACE; SYMMETRIES; DIMENSIONS; AMPLITUDES; COSMOLOGY; MODELS; VACUA; O(D	We present scattering of stringy states of closed bosonic string compactified on torus T-d. We focus our attention on scattering of moduli and gauge bosons. These states appear when massless excitations such as graviton and antisymmetric tensor field of the uncompactified theory are dimensionally reduced to lower dimension. The toroidally compactified theory is endowed with the T-duality symmetry, O(d, d). Therefore, it is expected that the amplitude for scattering of such states will be T-duality invariant. The formalism of Kawai-Lewellen-Tye is adopted and appropriately tailored to construct the vertex operators of moduli and gauge bosons. It is shown, in our approach, that N-point amplitude is T-duality invariant. We present illustrative examples for the four point amplitude to explicitly demonstrate the economy of our formalism when three spatial dimensions are compactified on T-3. It is also shown that if we construct an amplitude with a set of 'initial' backgrounds, the T-duality operation transforms it to an amplitude associated with another set backgrounds. We propose a modified version of KLT approach to construct vertex operators for nonabelian massless gauge bosons which appear in certain compactification schemes. (C) 2015 Published by Elsevier B.V.	[Maharana, Jnanadeva] Inst Phys, Bhubaneswar 751005, Orissa, India; [Maharana, Jnanadeva] KEK, Inst Particle & Nucl Studies, KEK Theory Ctr, Tsukuba, Ibaraki 3050801, Japan	Maharana, J (reprint author), Inst Phys, Bhubaneswar 751005, Orissa, India.	maharana@iopb.res.in					HASSAN SF, 1993, NUCL PHYS B, V405, P143, DOI 10.1016/0550-3213(93)90429-S; MEISSNER KA, 1991, PHYS LETT B, V267, P33, DOI 10.1016/0370-2693(91)90520-Z; Maharana J, 2013, INT J MOD PHYS A, V28, DOI 10.1142/S0217751X13300111; Maharana J, 2014, INT J MOD PHYS A, V29, DOI 10.1142/S0217751X14500389; MAHARANA J, 1993, NUCL PHYS B, V390, P3, DOI 10.1016/0550-3213(93)90387-5; VENEZIANO G, 1991, PHYS LETT B, V265, P287, DOI 10.1016/0370-2693(91)90055-U; SHAPERE A, 1989, NUCL PHYS B, V320, P669, DOI 10.1016/0550-3213(89)90016-3; Stieberger S, 2014, NUCL PHYS B, V881, P269, DOI 10.1016/j.nuclphysb.2014.02.005; SEN A, 1991, PHYS LETT B, V271, P295, DOI 10.1016/0370-2693(91)90090-D; LEE JC, 1990, NUCL PHYS B, V336, P222, DOI 10.1016/0550-3213(90)90109-Q; Gasperini M, 2003, PHYS REP, V373, P1, DOI 10.1016/S0370-1573(02)00389-7; FRIEDAN D, 1986, NUCL PHYS B, V271, P93; GROSS DJ, 1986, NUCL PHYS B, V267, P75, DOI 10.1016/0550-3213(86)90146-X; Maharana J, 2011, NUCL PHYS B, V843, P753, DOI 10.1016/j.nuclphysb.2010.10.011; GROSS DJ, 1985, NUCL PHYS B, V256, P253, DOI 10.1016/0550-3213(85)90394-3; KOH IG, 1987, NUCL PHYS B, V292, P201, DOI 10.1016/0550-3213(87)90642-0; KAWAI H, 1986, NUCL PHYS B, V269, P1, DOI 10.1016/0550-3213(86)90362-7; Maharana J, 2011, PHYS LETT B, V695, P370, DOI 10.1016/j.physletb.2010.11.034; SCHERK J, 1979, NUCL PHYS B, V153, P61, DOI 10.1016/0550-3213(79)90462-0; MEISSNER KA, 1991, MOD PHYS LETT A, V6, P3397, DOI 10.1142/S0217732391003924; Stieberger S, 2014, J PHYS A-MATH THEOR, V47, DOI 10.1088/1751-8113/47/15/155401; SEN A, 1995, NUCL PHYS B, V440, P421, DOI 10.1016/0550-3213(95)00063-X; GIVEON A, 1994, PHYS REP, V244, P77, DOI 10.1016/0370-1573(94)90070-1; Narain K. S., 1987, Nuclear Physics B, Particle Physics, VB279, DOI 10.1016/0550-3213(87)90001-0; GIVEON A, 1989, NUCL PHYS B, V322, P167, DOI 10.1016/0550-3213(89)90489-6; HASSAN SF, 1992, NUCL PHYS B, V375, P103, DOI 10.1016/0550-3213(92)90336-A; GROSS DJ, 1985, PHYS REV LETT, V54, P502, DOI 10.1103/PhysRevLett.54.502; Lidsey JE, 2000, PHYS REP, V337, P343, DOI 10.1016/S0370-1573(00)00064-8; Becker Katrin, 2007, STRING THEORY M THEO; Broedel J, 2013, FORTSCHR PHYS, V61, P812, DOI 10.1002/prop.201300019; Dijkgraaf R., 1987, PERSPECTIVES STRING, V1987, P117; Evlvang H., ARXIV13081697; Gasperini M., 1991, PHYS LETT B, V272, P227; Green MB, 1987, SUPERSTRING THEORY, VII; Green M.B., 1984, PHYS LETT B, V149, P117; Green MB, 1987, SUPERSTRING THEORY, Vl; Green M.B., 1985, PHYS LETT B, V151, P21; Hohm O., ARXIV14115696; Maharana J., ARXIVHEPTH9911200; NARAIN KS, 1986, PHYS LETT B, V169, P41, DOI 10.1016/0370-2693(86)90682-9; Polchinski J., 1998, STRING THEORY, VI; Polchinski J., 1998, STRING THEORY, VII; Schwarz JH, 1997, NUCL PHYS B, P1, DOI 10.1016/S0920-5632(97)00070-4; Sen A., ARXIVHEPTH9802051; Townsend P. K., ARXIVHEPTH9607201; Youm D., 1996, PHYS REP, V360, P1	46	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	JUL	2015	896						657	681		10.1016/j.nuclphysb.2015.05.008		25	Physics, Particles & Fields	Physics	CL0LP	WOS:000356634500022		
J	Kohyama, H; Kimura, D; Inagaki, T				Kohyama, H.; Kimura, D.; Inagaki, T.			Regularization dependence on phase diagram in Nambu-Jona-Lasinio model	NUCLEAR PHYSICS B			English	Article							CONSTANT MAGNETIC-FIELD; PI-PI SCATTERING; NJL-MODEL; FINITE-TEMPERATURE; ELECTROMAGNETIC-FIELD; SYMMETRY-BREAKING; DYNAMICAL MODEL; CRITICAL-POINT; QCD; SUPERCONDUCTIVITY	We study the regularization dependence on meson properties and the phase diagram of quark matter by using the two flavor Nambu-Iona-Lasinio model. The model also has the parameter dependence in each regularization, so we explicitly give the model parameters for some sets of the input observables, then investigate its effect on the phase diagram. We find that the location or the existence of the critical end point highly depends on the regularization methods and the model parameters. Then we think that regularization and parameters are carefully considered when one investigates the QCD critical end point in the effective model studies. (C) 2015 The Authors. Published by Elsevier B.V.	[Kohyama, H.] Natl Taiwan Univ, Dept Phys, Taipei 10617, Taiwan; [Kimura, D.] Ube Natl Coll Technol, Gen Educ, Ube, Yamaguchi 7558555, Japan; [Inagaki, T.] Hiroshima Univ, Informat Media Ctr, Hiroshima 7398521, Japan	Kimura, D (reprint author), Ube Natl Coll Technol, Gen Educ, Ube, Yamaguchi 7558555, Japan.	kimura_daiji@yahoo.co.jp			JSPS KAKENHI [26400250]; MOST [103-2811-M-002-087]	TI is supported by JSPS KAKENHI Grant Number 26400250. HK is supported by MOST 103-2811-M-002-087.	Harada M, 1996, PHYS REV D, V54, P1991, DOI 10.1103/PhysRevD.54.1991; SANNINO F, 1995, PHYS REV D, V52, P96, DOI 10.1103/PhysRevD.52.96; PAULI W, 1949, REV MOD PHYS, V21, P434, DOI 10.1103/RevModPhys.21.434; ASAKAWA M, 1989, NUCL PHYS A, V504, P668; WILSON KG, 1974, PHYS REV D, V10, P2445, DOI 10.1103/PhysRevD.10.2445; GELLMANN M, 1968, PHYS REV, V175, P2195, DOI 10.1103/PhysRev.175.2195; GUSYNIN VP, 1994, PHYS REV LETT, V73, P3499, DOI 10.1103/PhysRevLett.73.3499; NAMBU Y, 1961, PHYS REV, V124, P246, DOI 10.1103/PhysRev.124.246; Fukushima K, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/1/014001; KLEVANSKY SP, 1992, REV MOD PHYS, V64, P649, DOI 10.1103/RevModPhys.64.649; HATSUDA T, 1994, PHYS REP, V247, P221, DOI 10.1016/0370-1573(94)90022-1; Inagaki T, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.116004; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; Stephanov M, 2004, PROG THEOR PHYS SUPP, P139; GROSS DJ, 1973, PHYS REV LETT, V30, P1343, DOI 10.1103/PhysRevLett.30.1343; VOGL U, 1991, PROG PART NUCL PHYS, V27, P195, DOI 10.1016/0146-6410(91)90005-9; Fujihara T, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.096008; Buballa M, 2005, PHYS REP, V407, P205, DOI 10.1016/j.physrep.2004.11.004; Stephanov MA, 2005, INT J MOD PHYS A, V20, P4387, DOI 10.1142/S0217751X05027965; Benic S, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.054025; Chen JW, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.094014; Cheng T., 1984, GAUGE THEORY ELEMENT; Cui Z F, 2014, INT J MOD PHYS C SER, V29; Endrodi G., 2011, J HIGH ENERGY PHYS, V1104, P001; Gusynin VP, 1996, PHYS REV LETT, V76, P1005, DOI 10.1103/PhysRevLett.76.1005; THOOFT G, 1972, NUCL PHYS B, VB-44, P189, DOI 10.1016/0550-3213(72)90279-9; Huang M, 2005, INT J MOD PHYS E, V14, P675, DOI 10.1142/S0218301305003491; Inagaki T, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.076002; Inagaki T, 2004, PROG THEOR PHYS SUPP, P321; Inagaki T, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.116013; Inagaki T., 2013, INT J MOD PHYS A, V28; INAGAKI T, 1995, INT J MOD PHYS A, V10, P2241, DOI 10.1142/S0217751X95001091; Inagaki T, 2005, INT J MOD PHYS A, V20, P4995, DOI 10.1142/S0217751X05025073; Inagaki T, 1999, INT J MOD PHYS A, V14, P481, DOI 10.1142/S0217751X99000245; Inagaki T., 2014, INT J MOD PHYS A, V29; Inagaki T, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.034005; Inagaki T, 2004, PROG THEOR PHYS, V111, P371, DOI 10.1143/PTP.111.371; Itzykson C, 1980, QUANTUM FIELD THEORY; Jafarov R. G., 2006, Russian Physics Journal, V49, DOI 10.1007/s11182-006-0114-9; Jafarov R. G., 2006, IZV VUZ FIZ, V49, p[20, 364]; Jafarov RG, 2004, CENT EUR J PHYS, V2, P367, DOI 10.2478/BF02475637; KAHANA D, 1993, PHYS LETT B, V298, P397, DOI 10.1016/0370-2693(93)91839-F; Klimenko K. G., 1991, TEOR MAT FIZ, V89, P211; KLIMENKO KG, 1992, Z PHYS C PART FIELDS, V54, P323, DOI 10.1007/BF01566663; KLIMENKO KG, 1992, THEOR MATH PHYS, V89, P1161; KREWALD S, 1992, ANN PHYS-NEW YORK, V216, P201, DOI 10.1016/0003-4916(92)90175-L; Moreira J, 2012, INT J MOD PHYS A, V27, DOI 10.1142/S0217751X12500601; NAMBU Y, 1961, PHYS REV, V122, P345, DOI 10.1103/PhysRev.122.345; Osipov AA, 2004, NUCL PHYS A, V745, P81, DOI 10.1016/j.nuclphysa.2004.08.022; Philipsen O., 2008, PROG THEOR PHYS SUPP, V174, P206; Schwinger J. S., 1951, PHYS REV, V82, P664; Stephanov M., 2006, POS LAT, V2006; SUGANUMA H, 1991, ANN PHYS-NEW YORK, V208, P470, DOI 10.1016/0003-4916(91)90304-Q; Weise W, 2010, PROG THEOR PHYS SUPP, P390	54	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	JUL	2015	896						682	715		10.1016/j.nuclphysb.2015.05.015		34	Physics, Particles & Fields	Physics	CL0LP	WOS:000356634500023		
J	Hashimoto, K; Kinoshita, S; Murata, K; Oka, T				Hashimoto, Koji; Kinoshita, Shunichiro; Murata, Keiju; Oka, Takashi			Meson turbulence at quark deconfinement from AdS/CFT	NUCLEAR PHYSICS B			English	Article							FINITE TEMPERATURE; STRING THEORY; GLUON PLASMA; TRANSITION; QCD	Based on the QCD string picture at confining phase, we conjecture that the deconfinement transition always accompanies a condensation of higher meson resonances with a power-law behavior, "meson turbulence". We employ the AdS/CFT correspondence to calculate the meson turbulence for N = 2 supersymmetric QCD at large N-c and at strong coupling limit, and find that the energy distribution to each meson level n scales as n(alpha) with the universal scaling alpha = -5. The universality is checked for various ways to attain the quark deconfinement: a static electric field below/around the critical value, a time-dependent electric field quench, and a time-dependent quark mass quench, all result in the turbulent meson condensation with the universal power alpha = -5 around the deconfinement. (C) 2015 The Authors. Published by Elsevier B.V.	[Hashimoto, Koji] Osaka Univ, Dept Phys, Toyonaka, Osaka 5600043, Japan; [Hashimoto, Koji] RIKEN Nishina Ctr, Phys Math Lab, Wako, Saitama 3510198, Japan; [Kinoshita, Shunichiro] Osaka City Univ, Adv Math Inst, Osaka 5588585, Japan; [Murata, Keiju] Keio Univ, Yokohama, Kanagawa 2238521, Japan; [Oka, Takashi] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan	Hashimoto, K (reprint author), Osaka Univ, Dept Phys, Toyonaka, Osaka 5600043, Japan.	koji@phys.sci.osaka-u.ac.jp			RIKEN iTHES project	K.H. would like to thank A. Buchel, H. Fukaya, D.-K. Hong, N. Iqbal, K.-Y. Kim, J. Maldacena, S. Sugimoto, S. Terashima, S. Yamaguchi and P. Yi for valuable discussions, and APCTP focus week program for its hospitality. This research was partially supported by the RIKEN iTHES project.	Albash T, 2008, J HIGH ENERGY PHYS; Arnold P, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.025013; Micha R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.121301; Gubser SS, 1998, PHYS LETT B, V428, P105, DOI 10.1016/S0370-2693(98)00377-3; Bizon P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.031102; Berges J, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.114007; Blaizot JP, 2012, NUCL PHYS A, V873, P68, DOI 10.1016/j.nuclphysa.2011.10.005; POLYAKOV AM, 1978, PHYS LETT B, V72, P477, DOI 10.1016/0370-2693(78)90737-2; Dusling K, 2011, NUCL PHYS A, V850, P69, DOI 10.1016/j.nuclphysa.2010.11.009; Rebhan A, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.045023; Berges J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.074006; Berges J, 2009, PHYS LETT B, V681, P362, DOI 10.1016/j.physletb.2009.10.032; de Oliveira HP, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.051101; Berges J, 2009, PHYS LETT B, V677, P210, DOI 10.1016/j.physletb.2009.05.008; Berges J, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.085004; Schlichting S, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.065008; Arnold P, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.045009; COPPI B, 1969, ANN PHYS-NEW YORK, V55, P207, DOI 10.1016/0003-4916(69)90178-X; Mateos D, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.011602; ATICK JJ, 1988, NUCL PHYS B, V310, P291, DOI 10.1016/0550-3213(88)90151-4; Berges J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.161601; Berges J, 2009, NUCL PHYS B, V813, P383, DOI 10.1016/j.nuclphysb.2008.12.017; Berges J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.041603; Micha R, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.043538; Arnold P, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.025006; Bergman O, 2000, NUCL PHYS B, V580, P289, DOI 10.1016/S0550-3213(00)00230-3; Carrington ME, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1787-y; Emparan R., ARXIVHEPTH9412003; Erdmenger J, 2007, J HIGH ENERGY PHYS; Floerchinger S, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2011)100; Fukushima K, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.024907; Fukushima K, 2011, ACTA PHYS POL B, V42, P2697, DOI 10.5506/APhysPolB.42.2697; Gibbons G, 2002, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2002/09/061; Gibbons G, 2001, NUCL PHYS B, V596, P136, DOI 10.1016/S0550-3213(00)00716-1; HAGEDORN R, 1965, NUOVO CIMENTO, V3, P147; Hanada M., ARXIV14051732HEPTH; Hashimoto K., ARXIV14086293HEPTH; Hashimoto K., ARXIV14110618HEPTH; Hashimoto K., 2015, J HIGH ENER IN PRESS; Hashimoto K., 2014, J HIGH ENERGY PHYS, V1409, P126; Ishii T., 2014, J HIGH ENERGY PHYS, V1404; Karch A., 2007, JHEP, V0709, P024; Karch A, 2002, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2002/06/043; Kruczenski M, 2003, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2003/07/049; Lucini B, 2005, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2005/02/033; Maldacena J M, 1998, ADV THEOR MATH PHYS, V2, P231, DOI DOI 10.1023/A:1026654312961; Mueller AH, 2007, NUCL PHYS B, V760, P145, DOI 10.1016/j.nuclphysb.2006.10.023; PATEL A, 1984, NUCL PHYS B, V243, P411, DOI 10.1016/0550-3213(84)90484-X; PISARSKI RD, 1982, PHYS REV D, V26, P3735, DOI 10.1103/PhysRevD.26.3735; Sagdeev R.Z., 1969, NONLINEAR PLASMA THE; Sato Y, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2013)111; Sato Y, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2013)051; Witten E., 1998, ADV THEOR MATH PHYS, V2, P253, DOI DOI 10.1016/S0370-1573(99)00083-6	53	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	JUL	2015	896						738	762		10.1016/j.nuclphysb.2015.05.004		25	Physics, Particles & Fields	Physics	CL0LP	WOS:000356634500025		
J	Ito, K; Locke, C				Ito, Katsushi; Locke, Christopher			ODE/IM correspondence and Bethe ansatz for affine Toda field equations	NUCLEAR PHYSICS B			English	Article							FUNCTIONAL RELATIONS; ALGEBRAS	We study the linear problem associated with modified affine Toda field equation for the Langlands dual (g) over cap (boolean OR), where (g) over cap is an untwisted affine Lie algebra. The connection coefficients for the asymptotic solutions of the linear problem are found to correspond to the Q-functions for 9-type quantum integrable models. The psi-system for the solutions associated with the fundamental representations of g leads to Bethe ansatz equations associated with the affine Lie algebra (g) over cap. We also study the A(2r)((2)) affine Toda field equation in massless limit in detail and find its Bethe ansatz equations as well as T-Q relations. (C) 2015 Published by Elsevier B.V.	[Ito, Katsushi; Locke, Christopher] Tokyo Inst Technol, Dept Phys, Tokyo 1528551, Japan	Locke, C (reprint author), Tokyo Inst Technol, Dept Phys, Tokyo 1528551, Japan.	clocke@th.phys.titech.ac.jp			Japan Society for Promotion of Science (JSPS) [15K05043]; Japan-Hungary Research Cooperative Program	We would like to thank J. Suzuki for useful discussions. The work of K.I. is supported in part by the Japan Society for Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) No. 15K05043 and Japan-Hungary Research Cooperative Program.	Adamopoulou P, 2014, J PHYS A-MATH THEOR, V47, DOI 10.1088/1751-8113/47/20/205205; Bazhanov VV, 1997, COMMUN MATH PHYS, V190, P247, DOI 10.1007/s002200050240; Bazhanov V.V., 2014, J HIGH ENERGY PHYS, V1409, P147; Bazhanov VV, 2001, J STAT PHYS, V102, P567, DOI 10.1023/A:1004838616921; Dorey P, 2000, J PHYS A-MATH GEN, V33, P8427, DOI 10.1088/0305-4470/33/47/308; Dorey P, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0052; Dorey P, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/44/444013; Dorey P, 2001, NUCL PHYS B, V603, P582, DOI 10.1016/S0550-3213(01)00164-X; Dorey P, 2007, NUCL PHYS B, V772, P249, DOI 10.1016/j.nuclphysb.2007.02.029; Feigin B., 2011, ADV STUD PURE MATH, V61; Francesco P, 1997, CONFORMAL FIELD THEO; Fulton W., 1991, REPRESENTATION THEOR; Ito K, 2014, NUCL PHYS B, V885, P600, DOI 10.1016/j.nuclphysb.2014.06.007; Kac V. G., 1994, INFINITE DIMENSIONAL; KUNIBA A, 1995, J PHYS A-MATH GEN, V28, P711, DOI 10.1088/0305-4470/28/3/024; Lulcyanov S. L., 2010, JHEP, V1007, P008; Masoero D., ARXIV150107421MATHPH; RESHETIKHIN NY, 1987, PHYS LETT B, V189, P125, DOI 10.1016/0370-2693(87)91282-2; Sun JJ, 2012, SYMMETRY INTEGR GEOM, V8, DOI 10.3842/SIGMA.2012.028; Suzuki J, 2000, J PHYS A-MATH GEN, V33, P3507, DOI 10.1088/0305-4470/33/17/308; Zeitlin A.M., 2014, LETT MATH PHYS, V105, P2	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	JUL	2015	896						763	778		10.1016/j.nuclphysb.2015.05.016		16	Physics, Particles & Fields	Physics	CL0LP	WOS:000356634500026		
J	Sano, T; Iwashita, M; Nagayasu, S; Yamashita, A; Shinjo, T; Hashikata, A; Asano, T; Kushiyama, A; Ishimaru, N; Takahama, Y; Nishimura, F				Sano, Tomomi; Iwashita, Misaki; Nagayasu, Shintaro; Yamashita, Akiko; Shinjo, Takanori; Hashikata, Atsushi; Asano, Tomoichiro; Kushiyama, Akifumi; Ishimaru, Naozumi; Takahama, Yousuke; Nishimura, Fusanori			Protection from diet-induced obesity and insulin resistance in mice lacking CCL19-CCR7 signaling	OBESITY			English	Article							ADIPOSE-TISSUE; MACROPHAGE INFILTRATION; DENDRITIC CELLS; INFLAMMATION; CHEMOKINE; IMMUNITY; ATHEROSCLEROSIS; ACCUMULATION; SENSITIVITY; ADIPOCYTES	ObjectiveSeveral chemokines play important roles in recruiting the monocyte/macrophage lineage into adipose tissues. We previously found CCL19 was highly expressed in adipocytes cocultured with macrophages stimulated by endotoxin. This study aimed to evaluate the role of CCL19-CCR7 axis on obesity and insulin resistance. MethodsSerum CCL19 concentration was examined in obese model mice challenged by endotoxin. CCL19 receptor-null, Ccr7(-/-), mice and wild-type mice fed a high-fat diet or normal diet were used to investigate the role of CCL19 signals on obesity-associated inflammation. ResultsCCL19 protein was elevated in the sera of obese model mice challenged by endotoxin. Ccr7(-/-) mice were protected from diet-induced obesity and insulin resistance. The adipose tissue and liver expression of inflammatory genes of Ccr7(-/-) mice was much lower than in diet-induced obese mice. Ccr7(-/-) mice were protected from fatty liver and dyslipidemia and exhibited increased thermogenesis on high-fat feeding. CCL19 attracts activated dendritic cells (DC). The expression of the DC markers, CD11b and 11c, was not observed in the adipose tissues of Ccr7(-/-) mice fed a high-fat diet, which might be closely associated with the protection of these mice from obesity. ConclusionsThe CCL19-CCR7 pathway associates with the development of high-fat-induced obesity and insulin resistance.	[Sano, Tomomi; Nagayasu, Shintaro; Hashikata, Atsushi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dent Sci Hlth Promot, Hiroshima, Japan; [Iwashita, Misaki; Yamashita, Akiko; Shinjo, Takanori; Nishimura, Fusanori] Kyushu Univ, Fac Dent Sci, Sect Periodontol, Fukuoka 812, Japan; [Asano, Tomoichiro] Hiroshima Univ, Dept Biol Chem, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Div Metab Dis, Tokyo, Japan; [Ishimaru, Naozumi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan; [Takahama, Yousuke] Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 770, Japan	Nishimura, F (reprint author), Kyushu Univ, Fac Dent Sci, Sect Periodontol, Fukuoka 812, Japan.	Fusanori@dent.kyushu-u.ac.jp			Japan Society for the Promotion of Science [25293425, 26861816]	This research was supported by a grant-in-aid from the Japan Society for the Promotion of Science (No. 25293425, 26861816).	Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; McKenna HJ, 2000, BLOOD, V95, P3489; Heller EA, 2006, CIRCULATION, V113, P2301, DOI 10.1161/CIRCULATIONAHA.105.605121; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Kushiyama A, 2012, ARTERIOSCL THROM VAS, V32, P291, DOI 10.1161/ATVBAHA.111.234559; Bertola A, 2012, DIABETES, V61, P2238, DOI 10.2337/db11-1274; Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652; Koncarevic A, 2012, ENDOCRINOLOGY, V153, P3133, DOI 10.1210/en.2012-1016; Stefanovic-Racic M, 2012, DIABETES, V61, P2330, DOI 10.2337/db11-1523; Kirk EA, 2008, DIABETES, V57, P1254, DOI 10.2337/db07-1061; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI2000319246; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Jialal I, 2014, J CLIN ENDOCR METAB, V99, P39, DOI 10.1210/jc.2013-3092; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Potteaux S, 2006, ARTERIOSCL THROM VAS, V26, P1858, DOI 10.1161/01.ATV.0000231527.22762.71; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Kitade H, 2012, DIABETES, V61, P1680, DOI 10.2337/db11-1506; Gutierrez DA, 2011, DIABETES, V60, P2820, DOI 10.2337/db11-0314; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Nakarai H, 2012, INNATE IMMUN-LONDON, V18, P164, DOI 10.1177/1753425910393370; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JC126498; Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Forster R, 1999, CELL, V99, P22; Kennedy A, 2013, AM J PHYSIOL-ENDOC M, V305, pE897, DOI 10.1152/ajpendo.00177.2013; Kitahara CM, 2014, CANCER EPIDEM BIOMAR, V23, P2840, DOI 10.1158/1055-9965.EPI-14-0699-T; Lee HS, 2009, CYTOKINE, V46, P160, DOI 10.1016/j.cyto.2008.12.025; Ringholm S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064123; Tourniaire F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066515; Yamashita A, 2008, INT J OBESITY, V32, P1725, DOI 10.1038/ijo.2008.153	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1930-7381	1930-739X		OBESITY	Obesity	JUL	2015	23	7					1460	1471		10.1002/oby.21127		12	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CL4AD	WOS:000356893400019		
J	Mure, K; Yoshimura, N; Hashimoto, M; Muraki, S; Oka, H; Tanaka, S; Kawaguchi, H; Nakamura, K; Akune, T; Takeshita, T				Mure, Kanae; Yoshimura, Noriko; Hashimoto, Marowa; Muraki, Shigeyuki; Oka, Hiroyuki; Tanaka, Sakae; Kawaguchi, Hiroshi; Nakamura, Kozo; Akune, Toru; Takeshita, Tatsuya			Urinary 8-iso-prostaglandin F2 as a marker of metabolic risks in the general Japanese population: The ROAD study	OBESITY			English	Article							SYSTEMIC OXIDATIVE STRESS; LOW-DENSITY-LIPOPROTEIN; LIPID-PEROXIDATION; IN-VIVO; BIOMARKERS; F-2-ISOPROSTANES; ISOPROSTANES; ACCUMULATION; HYPERTENSION; INDIVIDUALS	ObjectiveTo determine whether 8-iso-prostaglandin F2 (8-iso-PGF2) is a reliable biomarker of the accumulation of metabolic risks [e.g., overweight, hypertension, impaired glucose tolerance (IGT), and dyslipidemia]. MethodsThis was a cross-sectional study of the baseline characteristics of a Japanese general population cohort study: Research on Osteoarthritis/Osteoporosis Against Disability (ROAD). Of 1,690 participants, 1,527 fulfilled all questionnaires and examinations. Free and conjugated urinary 8-iso-PGF2 levels and metabolic syndrome (MetS) components including blood pressure, HbA1c, total cholesterol, high-density lipoprotein cholesterol (HDL-C), and non-HDL-C were analyzed. The data were analyzed by ANCOVA, multiple regression analysis, and multinomial logistic analysis. Results8-iso-PGF2 was significantly associated with HbA1c and significantly inversely associated with total cholesterol and non-HDL-C. Notably, IGT with an HbA1c cut-off of 5.5% was significantly associated with 8-iso-PGF2 level in participants aged 50 years. Multinomial logistic regression analysis revealed 8-iso-PGF2 level was significantly associated with a greater number of MetS risks present; this association was stronger in younger participants. In participants aged 71 years, 8-iso-PGF2 was significantly associated with a greater number of MetS risks with higher IGT cut-offs. ConclusionsUrinary 8-iso-PGF2 can be a reliable marker of IGT and the accumulation of MetS risks, especially in younger people.	[Mure, Kanae; Hashimoto, Marowa; Takeshita, Tatsuya] Wakayama Med Univ, Sch Med, Dept Publ Hlth, Wakayama, Japan; [Yoshimura, Noriko; Oka, Hiroyuki] Univ Tokyo, Grad Sch Med, 22nd Century Med & Res Ctr, Dept Joint Dis Res, Tokyo, Japan; [Muraki, Shigeyuki] Univ Tokyo, Grad Sch Med, Dept Clin Motor Syst Med, 22nd Century Med & Res Ctr, Tokyo, Japan; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Kawaguchi, Hiroshi] JCHO Tokyo Shinjuku Med Ctr, Tokyo, Japan; [Nakamura, Kozo; Akune, Toru] Natl Rehabil Ctr Persons Disabil, Saitama, Japan	Mure, K (reprint author), Wakayama Med Univ, Sch Med, Dept Publ Hlth, Wakayama, Japan.	kana@wakayama-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [B26293139, B23390172, B20390182, 24659317, C20591737, B23390357, C20591774, B23390356, 23659580, A18689031, 24659666]; Ministry of Health, Labour, and Welfare of Japan [H17-Men-eki-009, H18-Cho-ju-037, H20-Cho-ju-009, H23-Cho-ju-002, H25-Nanchi-to (Men)-005, H25-Cho-ju-007]; Japan Osteoporosis Society; Japanese Orthopaedic Association (JOA) [2006-1, 2010-2]; National Science Foundation from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [08033011-00262]	This work was supported by Grants-in-Aid for Scientific Research to NY (B26293139, B23390172, B20390182, and Challenging Exploratory Research 24659317), TA (C20591737, B23390357), and SM (C20591774, B23390356, and Challenging Exploratory Research 23659580); for Young Scientists to HO (A18689031 and Challenging Exploratory Research 24659666); and for Collaborating Research with the National Science Foundation to NY (Director; 08033011-00262) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan as well as H17-Men-eki-009 (Director, KN), H18-Cho-ju-037 (Director, TN), H20-Cho-ju-009 (Director, NY), H23-Cho-ju-002 (Director, TA), H25-Nanchi-to (Men)-005 (Director, ST), and H25-Cho-ju-007 (Director, NY) from the Ministry of Health, Labour, and Welfare of Japan. This study was also supported by grants from the Japan Osteoporosis Society (NY, SM, HO, and TA) and by research aid from the Japanese Orthopaedic Association (JOA-Subsidized Science Project Research 2006-1 and 2010-2; Director, HK).	Sjogren P, 2005, ARTERIOSCL THROM VAS, V25, P2580, DOI 10.1161/01.ATV.0000190675.08857.3d; Proudfoot J, 1999, ANAL BIOCHEM, V272, P209, DOI 10.1006/abio.1999.4187; Halliwell B, 2010, ANTIOXID REDOX SIGN, V13, P145, DOI 10.1089/ars.2009.2934; Proudfoot JM, 2009, J LIPID RES, V50, P716, DOI 10.1194/jlr.M800607-JLR200; Jadhav A, 2013, J PHARMACOL EXP THER, V345, P239, DOI 10.1124/jpet.112.200808; Morrow JD, 1997, PROG LIPID RES, V36, P1, DOI 10.1016/S0163-7827(97)00001-5; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; Cohen RM, 2010, J CLIN ENDOCR METAB, V95, P5203, DOI 10.1210/jc.2010-2352; Rodrigo R, 2007, HYPERTENS RES, V30, P1159, DOI 10.1291/hypres.30.1159; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Urata J, 2012, HEART VESSELS, V27, P235, DOI 10.1007/s00380-011-0139-z; Matsuda M, 2013, OBES RES CLIN PRACT, V7, pE330, DOI 10.1016/j.orcp.2013.05.004; Fujita K, 2006, CIRC J, V70, P1437, DOI 10.1253/circj.70.1437; Basu S, 2008, ANTIOXID REDOX SIGN, V10, P1405, DOI [10.1089/ars.2007.1956, 10.1086/ars.2007.1956]; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Kim M, 2013, METABOLISM, V62, P554, DOI 10.1016/j.metabol.2012.10.006; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017; Monnier L, 2010, DIABETOLOGIA, V53, P562, DOI 10.1007/s00125-009-1574-6; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Yan Z, 2010, ANAL BIOCHEM, V403, P126, DOI 10.1016/j.ab.2010.04.016; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Yoshimura N, 2012, OSTEOARTHR CARTILAGE, V20, P1217, DOI 10.1016/j.joca.2012.06.006; Meigs JB, 2007, DIABETES CARE, V30, P2529, DOI 10.2337/dc07-0817; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Barba C, 2004, LANCET, V363, P157; Das SK, 2011, J CLIN ENDOCR METAB, V96, pE1308, DOI 10.1210/jc.2011-0101; Gottlieb MGV, 2010, J CLIN ENDOCR METAB, V95, P586, DOI 10.1210/jc.2009-1592; Helmersson J, 1999, PROSTAG LEUKOTR ESS, V61, P203; Holewijn S, 2009, J CLIN ENDOCR METAB, V94, P2893, DOI 10.1210/jc.2009-0084; Hulsmans M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030414; Janghorbani Mohsen, 2012, Diabetes Metab Syndr, V6, P136, DOI 10.1016/j.dsx.2012.09.011; Kanaya AM, 2011, OBESITY, V19, P861, DOI 10.1038/oby.2010.243; Landmesser R, 2007, CURR OPIN CARDIOL, V22, P316; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Ong KL, 2010, DIABETES CARE, V33, P1856, DOI 10.2337/dc10-0190; Santillan LD, 2013, METAB SYNDR RELAT D, V11, P359, DOI 10.1089/met.2012.0155; Wang X, 2012, MOL CELL ENDOCRINOL, V349, P111, DOI 10.1016/j.mce.2011.08.019; Wu TW, 2014, DIABETES RES CLIN PR, V105, P239, DOI 10.1016/j.diabres.2014.04.027; Yubero-Serrano EM, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.53	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1930-7381	1930-739X		OBESITY	Obesity	JUL	2015	23	7					1517	1524		10.1002/oby.21130		8	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CL4AD	WOS:000356893400026		
J	Yuan, B; Okusumi, S; Yoshino, Y; Moriyama, C; Tanaka, S; Hirano, T; Takagi, N; Toyoda, H				Yuan, Bo; Okusumi, Saki; Yoshino, Yuta; Moriyama, Chihiro; Tanaka, Sachiko; Hirano, Toshihiko; Takagi, Norio; Toyoda, Hiroo			Delphinidin induces cytotoxicity and potentiates cytocidal effect in combination with arsenite in an acute promyelocytic leukemia NB4 cell line	ONCOLOGY REPORTS			English	Article						delphinidin; acute promyelocytic leukemia; NB4; apoptosis; cell-cycle arrest; arsenite	PIGMENTED FRUITS; RECEPTOR-ALPHA; P-GLYCOPROTEIN; CANCER-CELLS; AQUAPORIN 9; APOPTOSIS; TRIOXIDE; INDUCTION; ANTHOCYANIDINS; ACTIVATION	The effects of delphinidin were investigated by focusing on growth inhibition, cell cycle arrest and apoptosis induction in the human acute promyelocytic leukemia (APL) NB4 cell line. Delphinidin exhibited a dose- and time-dependent cytotoxic effect against NB4 cells. Almost no cell cycle arrest, but an apparent increase in the percentage of sub-G1 cells was observed in delphinidin-treated cells. The activation of caspase-8 and -9 was observed as early as 1-h post-exposure to delphinidin, followed by the activation of caspase-3 from 3-h post-exposure. A substantial decrease in the expression level of Bid was also observed as early as 1-h post-exposure. A modest decrease in the mitochondrial membrane potential (Delta psi m) was observed at 3-h post-exposure, followed by a substantial time-dependent decrease in Delta psi m in treated cells. Delphinidin exerted more potent cytotoxicity against NB4 cells than normal peripheral blood mononuclear cells (PBMNCs). In addition, delphinidin in combination with an arsenic derivative arsenite (AS(III)) which has demonstrated marked efficacy in patients with APL, achieved an enhanced cytocidal effect against NB4 cells, but lesser on PBMNCs. Treatment of NB4 cells with AS(III) plus delphinidin did not increase, but decreased slightly, intracellular arsenic accumulation (As[i]) as compared to that treated with As-III alone. These results suggested that delphinidin selectively sensitized NB4 cells to As-III resulting in the enhancement of As-III cytotoxicity by strengthening intrinsic/extrinsic pathway-mediated apoptosis induction, rather than affecting the As[i] levels. These observations may offer a rationale for the use of delphinidin to improve the clinical efficacy of As-III.	[Yuan, Bo; Okusumi, Saki; Yoshino, Yuta; Moriyama, Chihiro; Toyoda, Hiroo] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Clin Mol Genet, Hachioji, Tokyo 1920392, Japan; [Tanaka, Sachiko; Hirano, Toshihiko] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Clin Pharmacol, Hachioji, Tokyo 1920392, Japan; [Yuan, Bo; Takagi, Norio] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Appl Biochem, Hachioji, Tokyo 1920392, Japan	Yuan, B (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Appl Biochem, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yuanbo@toyaku.ac.jp			Japan China Medical Association	We thank Professor Steven R. Kayser of UCSF School of Pharmacy for the critical reading of this manuscript. The present study was supported in part by grants from the Japan China Medical Association to Bo Yuan.	Afaq F, 2008, INT J CANCER, V123, P1508, DOI 10.1002/ijc.23675; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Kitagawa S, 2006, BIOL PHARM BULL, V29, P1, DOI 10.1248/bpb.29.1; Hou DX, 2003, INT J ONCOL, V23, P705; Kiguchi T, 2010, LEUKEMIA RES, V34, P403, DOI 10.1016/j.leukres.2009.08.001; Kon A, 2013, ONCOL REP, V30, P1965, DOI 10.3892/or.2013.2657; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Bremer E, 2006, TRENDS MOL MED, V12, P382, DOI 10.1016/j.molmed.2006.06.002; Yuan B, 2006, BIOCHEM BIOPH RES CO, V341, P822, DOI 10.1016/j.bbrc.2006.01.042; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Lazze MC, 2004, CARCINOGENESIS, V25, P1427, DOI 10.1093/carcin/bgh138; Hou DX, 2004, J BIOMED BIOTECHNOL, P321; Fujisawa S, 2007, CANCER CHEMOTH PHARM, V59, P485, DOI 10.1007/s00280-006-0288-4; Castro AF, 1997, BIOCHEM PHARMACOL, V53, P89, DOI 10.1016/S0006-2952(96)00657-0; Yun JM, 2009, MOL CARCINOGEN, V48, P260, DOI 10.1002/mc.20477; Shen ZX, 1997, BLOOD, V89, P3354; Kausar H, 2012, CANCER LETT, V325, P54, DOI 10.1016/j.canlet.2012.05.029; Iriyama N, 2013, ONCOL REP, V29, P2362, DOI 10.3892/or.2013.2388; Hou DX, 2005, ARCH BIOCHEM BIOPHYS, V440, P101, DOI 10.1016/j.abb.2005.06.002; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Yoshino Y, 2009, ANAL BIOANAL CHEM, V393, P689, DOI 10.1007/s00216-008-2487-9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Aiyer HS, 2012, J AGR FOOD CHEM, V60, P5693, DOI 10.1021/jf204084f; Yoshino Y, 2011, TOXICOL APPL PHARM, V257, P198, DOI 10.1016/j.taap.2011.09.006; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Cvorovic J, 2010, ARCH BIOCHEM BIOPHYS, V501, P151, DOI 10.1016/j.abb.2010.05.019; Hafeez Bilal Bin, 2008, Cancer Res, V68, P8564, DOI 10.1158/0008-5472.CAN-08-2232; Imai M, 2012, ADV BIOL CHEM, V2, P20; Iriyama N, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-1; Katsube N, 2003, J AGR FOOD CHEM, V51, P68, DOI 10.1021/jf025781x; Ramos AM, 2008, BIOCHEM PHARMACOL, V75, P1912, DOI 10.1016/j.bcp.2008.02.007; Sanchez Y, 2008, INT J CANCER, V123, P1205, DOI 10.1002/ijc.23639; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Suzuki R, 2011, NUTR METAB, V8, P8; TONG JH, 1992, ONCOGENE, V7, P311; Yuan B, 2011, BIOL CHEM AS SB BI, P263	38	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JUL	2015	34	1					431	438		10.3892/or.2015.3963		8	Oncology	Oncology	CL0PR	WOS:000356645100052		
J	Kan, S; Koido, S; Okamoto, M; Hayashi, K; Ito, M; Kamata, Y; Komita, H; Ishidao, T; Nagasaki, E; Homma, S				Kan, Shin; Koido, Shigeo; Okamoto, Masato; Hayashi, Kazumi; Ito, Masaki; Kamata, Yuko; Komita, Hideo; Ishidao, Takefumi; Nagasaki, Eijiro; Homma, Sadamu			Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine	ONCOLOGY REPORTS			English	Article						human epidermal growth factor receptor 2; gemcitabine; paclitaxel; trastuzumab emtansine; combination therapy	EPIDERMAL-GROWTH-FACTOR; GENE AMPLIFICATION; CLINICAL-PRACTICE; RESISTANCE; MECHANISMS; THERAPY; PACLITAXEL; ANTIBODY; NETWORK; PLUS	Trastuzumab emtansine (T-DM1), trastuzumab-conjugated with a cytotoxic agent, has shown promising antitumor effects in breast cancer. Since a good therapeutic response using T-DM1 treatment requires high human epidermal growth factor receptor 2 (HER2) expression, breast cancers with low or no HER2 expression have not been used for T-DM1 treatment. The aim of the present study was to show that treatment of low HER2-expressing breast cancer cells with gemcitabine (GEM) enhanced HER2 expression using RT-qPCR, immunoblot and flow cytometric analysis. The results showed that GEM treatment significantly enhanced HER2 expression in MDA-MB-231, MCF7 and BT-20 breast cancer cells, while paclitaxel (PTX) treatment induced lower or no enhancement in HER2 expression. The expression of HER2 mRNA was also enhanced in GEM-treated MCF7 cells. Treatment with an inhibitor for nuclear factor-(NF)-kappa B suppressed GEM-induced HER2 upregulation, indicating that NF-kappa B activation by GEM may be associated with HER2 upregulation. T-DM1 binding to HERZ on MCF-7 cells was enhanced by GEM pretreatment and the combined treatment of GEM and T-DM1 synergistically inhibited the proliferation of MCF7 cells. Thus, the combined treatment with GEM and T-DM1 may be a promising therapeutic modality for low HER2-expressing breast cancers, which was facilitated by the unique HER2-upregulating effect of GEM.	[Kan, Shin; Koido, Shigeo; Hayashi, Kazumi; Ito, Masaki; Kamata, Yuko; Nagasaki, Eijiro; Homma, Sadamu] Jikei Univ, Sch Med, Div Oncol, Res Ctr Med Sci, Tokyo 1058461, Japan; [Koido, Shigeo] Jikei Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med, Tokyo 1058461, Japan; [Hayashi, Kazumi; Nagasaki, Eijiro] Jikei Univ, Sch Med, Dept Internal Med, Div Oncol & Hematol, Tokyo 1058461, Japan; [Okamoto, Masato] Kitasato Univ, Sch Pharm, Dept Adv Immunotherapeut, Tokyo, Japan; [Komita, Hideo] Jikei Univ Hosp, Shimbashi Med Checkup Off, Tokyo, Japan; [Ishidao, Takefumi] Tella Inc, Tokyo, Japan	Homma, S (reprint author), Jikei Univ, Sch Med, Div Oncol, Res Ctr Med Sci,Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	sahya@jikei.ac.jp					Takahara A, 2011, CANCER IMMUNOL IMMUN, V60, P1289, DOI 10.1007/s00262-011-1033-3; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; Hernandez-Vargas H, 2007, BREAST CANCER RES TR, V102, P157, DOI 10.1007/s10549-006-9322-9; Yoshida R, 2012, CANCER IMMUNOL IMMUN, V61, P1905, DOI 10.1007/s00262-012-1249-x; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; [Anonymous], CANC STAT; Spector NL, 2009, J CLIN ONCOL, V27, P5838, DOI 10.1200/JCO.2009.22.1507; LoRusso PM, 2011, CLIN CANCER RES, V17, P6437, DOI 10.1158/1078-0432.CCR-11-0762; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Albain KS, 2008, J CLIN ONCOL, V26, P3950, DOI 10.1200/JCO.2007.11.9362; Seidman AD, 2001, J CLIN ONCOL, V19, P2587; LEWIS GD, 1993, CANCER IMMUNOL IMMUN, V37, P255, DOI 10.1007/BF01518520; Burris HA, 2011, CLIN BREAST CANCER, V11, P275, DOI 10.1016/j.clbc.2011.03.018; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; Barok M, 2011, CANCER LETT, V306, P171, DOI 10.1016/j.canlet.2011.03.002; Cox G, 2001, INT J CANCER, V92, P480, DOI 10.1002/ijc.1214; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Cao N, 2009, RADIAT RES, V171, P9, DOI 10.1667/RR1472.1; Aogi K, 2011, CANCER CHEMOTH PHARM, V67, P1007, DOI 10.1007/s00280-010-1390-1; Barok M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2868; Barok M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3621; Center for Cancer Control and Information Services. National Cancer Center Japan, 2013, VIT STAT JAP; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412	31	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JUL	2015	34	1					504	510		10.3892/or.2015.3974		7	Oncology	Oncology	CL0PR	WOS:000356645100061		
J	Ishibashi, T; Li, XX; Koh, A; Lai, TYY; Lee, FL; Lee, WK; Ma, ZZ; Ohji, M; Tan, N; Cha, SB; Shamsazar, J; Yau, CL				Ishibashi, Tatsuro; Li, Xiaoxin; Koh, Adrian; Lai, Timothy Y. Y.; Lee, Fenq-Lih; Lee, Won-Ki; Ma, Zhizhong; Ohji, Masahito; Tan, Nikolle; Cha, Sung Bok; Shamsazar, Jila; Yau, C. Lillian		REVEAL Study Grp	The REVEAL Study Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema	OPHTHALMOLOGY			English	Article							DIABETIC MACULAR EDEMA; PLUS PROMPT LASER; DEFERRED LASER; INTRAVITREAL RANIBIZUMAB; RISK-FACTORS; RETINOPATHY; PHOTOCOAGULATION; PREVALENCE; MELLITUS; RESTORE	Objective: The primary study hypothesis was that ranibizumab 0.5 mg monotherapy or combined with laser is superior to laser monotherapy based on mean average change in best-corrected visual acuity (BCVA) over 12 months in Asian patients with visual impairment resulting from diabetic macular edema (DME). Design: A 12-month, randomized, double-masked, multicenter, laser-controlled, phase III study. Participants: Three hundred ninety-six patients aged >= 18 years, with type 1 or 2 diabetes mellitus, BCVA of 78-39 Early Treatment Diabetic Retinopathy Study (ETDRS) letters, and visual impairment resulting from DME. Methods: Patients were randomized to ranibizumab vertical bar sham laser (n = 133), ranibizumab vertical bar active laser (n = 132), or sham injection + active laser (n = 131). Ranibizumab/sham injections were administered on day 1 and continued monthly. As of month 3, monthly injections were continued if stable vision was not reached. Treatment was reinitiated if BCVA decreased because of DME progression. Active/sham laser was administered on day 1 and thereafter according to ETDRS guidelines. Main Outcome Measures: Average change in BCVA from baseline to months 1 through 12, central retinal subfield thickness (CRST), and safety over 12 months. Results: Ranibizumab monotherapy or combined with laser was superior to laser in improving mean average change in BCVA from baseline to months 1 through 12 (+5.9 and +5.7 vs +1.4 letters). At month 12, greater proportion of patients gained >= 15 letters with ranibizumab and ranibizumab + laser compared with laser (18.8% and 17.8% vs 7.8%). Mean CRST reduced significantly from baseline to month 12 with ranibizumab (-134.6 mm) and ranibizumab + laser (-171.8 mm) versus laser (-57.2 mm). Patients received a mean of 7.8 and 7.0 ranibizumab injections in the ranibizumab and ranibizumab + laser arms, respectively, and 1.5=1.9 active laser across treatment arms over 12 months. Conjunctival hemorrhage was the most common ocular, whereas nasopharyngitis and hypertension were the most common nonocular adverse events. Ranibizumab was not associated with any cases of cerebrovascular hemorrhage and cerebrovascular ischemia. No death related to study treatment was reported. Conclusions: Ranibizumab monotherapy or combined with laser showed superior BCVA improvements over laser treatment alone in Asian patients with visual impairment resulting from DME. No new ocular or nonocular safety findings were observed and treatment was well tolerated over 12 months. (C) 2015 by the American Academy of Ophthalmology.	[Ishibashi, Tatsuro] Kyushu Univ Hosp, Dept Ophthalmol, Fukuoka 812, Japan; [Li, Xiaoxin] Peking Univ Peoples Hosp, Beijing 100044, Peoples R China; [Koh, Adrian; Tan, Nikolle] Tan Tock Seng Hosp, Dept Ophthalmol, Singapore, Singapore; [Lai, Timothy Y. Y.] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Lee, Fenq-Lih] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Lee, Won-Ki] Catholic Univ Korea, Seoul St Marys Hosp, Dept Ophthalmol, Seoul, South Korea; [Ma, Zhizhong] Peking Univ, Hosp 3, Beijing 100871, Peoples R China; [Ohji, Masahito] Shiga Univ, Med Sci Hosp, Otsu, Shiga, Japan; [Tan, Nikolle] Natl Healthcare Grp Eye Inst, Singapore, Singapore; [Cha, Sung Bok; Shamsazar, Jila; Yau, C. Lillian] Novartis Pharma AG, Basel, Switzerland	Li, XX (reprint author), Peking Univ Peoples Hosp, Beijing 100044, Peoples R China.	dr_lixiaoxin@163.com			Novartis Pharma AG, Basel, Switzerland	Sponsored by Novartis Pharma AG, Basel, Switzerland.	Aiello LM, 2003, AM J OPHTHALMOL, V136, P122, DOI 10.1016/S0002-9394(03)00219-8; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; FERRIS FL, 1984, SURV OPHTHALMOL, V28, P452, DOI 10.1016/0039-6257(84)90227-3; Hariprasad SM, 2008, BRIT J OPHTHALMOL, V92, P89, DOI 10.1136/bjo.2007.122416; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; Hatzitolios AI, 2009, J DIABETES COMPLICAT, V23, P283, DOI 10.1016/j.jdiacomp.2008.01.004; [Anonymous], 2010, CURR MED RES OPIN, V26, P1587; Moss SE, 1998, OPHTHALMOLOGY, V105, P998, DOI 10.1016/S0161-6420(98)96025-0; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Wang N, 2008, OPHTHALMOLOGICA, V222, P32, DOI 10.1159/000109276; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Schmidt-Erfurth U, 2014, OPHTHALMOLOGY, V121, P1045, DOI 10.1016/j.ophtha.2013.11.041; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; [Anonymous], 1995, ARCH OPHTHALMOL-CHIC, V113, P1144, DOI 10.1001/archopht.1995.01100090070025; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Bhagat N, 2009, SURV OPHTHALMOL, V54, P1, DOI 10.1016/j.survophthal.2008.10.001; Baliga Bantwal Suresh, 2006, Curr Cardiol Rep, V8, P23, DOI 10.1007/s11886-006-0006-1; Ip MS, 2008, OPHTHALMOLOGY, V115, P1447, DOI 10.1016/j.ophtha.2008.06.015; Elman MJ, 2015, OPHTHALMOLOGY, V122, P375, DOI 10.1016/j.ophtha.2014.08.047; Lovestam-Adrian M, 2000, ACTA OPHTHALMOL SCAN, V78, P667, DOI 10.1034/j.1600-0420.2000.078006667.x; Mercer BN, 2012, INT J CLIN PRACT, V66, P640, DOI 10.1111/j.1742-1241.2012.02924.x; Nguyen GD, 2009, OPHTHALMOLOGY, V116, P2175; Nguyen Quan Dong, 2010, Ophthalmology, V117, P2146, DOI 10.1016/j.ophtha.2010.08.016; Stanga P E, 1999, Curr Opin Ophthalmol, V10, P483, DOI 10.1097/00055735-199912000-00018; Xie XW, 2009, EUR J OPHTHALMOL, V19, P91	31	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	JUL	2015	122	7					1402	1415		10.1016/j.ophtha.2015.02.006		14	Ophthalmology	Ophthalmology	CL0HI	WOS:000356621700022		
J	Baba, T; Hagino, H; Nonomiya, H; Ikuta, T; Shoda, E; Mogami, A; Sawaguchi, T; Kaneko, K				Baba, T.; Hagino, H.; Nonomiya, H.; Ikuta, T.; Shoda, E.; Mogami, A.; Sawaguchi, T.; Kaneko, K.			Inadequate management for secondary fracture prevention in patients with distal radius fracture by trauma surgeons	OSTEOPOROSIS INTERNATIONAL			English	Article						Distal radius fracture; Osteoporosis; Secondary fracture prevention; Trauma surgeons	BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; FOREARM FRACTURE; CONTROLLED-TRIAL; SUBSEQUENT HIP; OSTEOPOROSIS; PLATE; RISK; REVISION; WRIST	We evaluated the secondary fracture prevention in 1445 patients with distal radius fracture by trauma surgeons. The rate of patients with distal radius fracture who underwent bone mineral density (BMD) examination was low, suggesting that appropriate treatment for osteoporosis by trauma surgeons is not performed at present. Introduction To clarify the status of osteoporosis interventions after distal radial fractures by trauma surgeons who play the main role in treatment for these fractures, we performed a survey involving multiple institutions in Japan. Methods We asked 155 board members of the Japanese Society for Fracture Repair for their cooperation and performed a survey in 48 institutions with which members who gave cooperation were affiliated. The subjects consisted of consecutive patients with distal radial fractures occurring between January and December 2012. The presence or absence of a diagnosis of osteoporosis and bone mineral density examination after fracture was investigated. Results A total of 1445 patients with distal radial fractures were evaluated in this study. BMD examination for diagnosis and treatment for osteoporosis after fracture was performed respectively in 126 (8.7 %) and 193 (13.4 %) of 1445 patients. Treatment for osteoporosis was performed in 93 (73.8 %) of 126 patients who underwent BMD examination after fracture and 100 (8.2 %) of 1219 who did not undergo BMD examination. Of the 126 patients who underwent BMD examination after fracture, 89 showed a BMD < 80 % of the young adult mean as a criterion for the initiation of drug treatment for osteoporosis in Japan and 77 (86.5 %) of the 89 patients were treated with drugs. Conclusions The rate of patients with distal radial fractures who underwent BMD examination was low, suggesting that appropriate treatment for osteoporosis by trauma surgeons is not performed at present.	[Baba, T.; Kaneko, K.] Juntendo Univ, Sch Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 113, Japan; [Hagino, H.] Tottori Univ, Sch Hlth Sci, Tottori 680, Japan; [Nonomiya, H.] Shizuoka Red Cross Hosp, Dept Orthopaed Surg, Shizuoka, Japan; [Ikuta, T.] Kumamoto Orthoped Hosp, Dept Orthopaed Surg, Kumamoto, Japan; [Shoda, E.] Hyogo Prefectural Nishinomiya Hosp, Dept Orthopaed Surg, Nishinomiya, Hyogo, Japan; [Mogami, A.] Juntendo Univ, Shizuoka Hosp, Dept Orthopaed Surg, Shizuoka, Japan; [Sawaguchi, T.] Toyama City Hosp, Dept Orthoped Surg, Toyama, Japan	Baba, T (reprint author), Juntendo Univ, Sch Med, Dept Orthopaed Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 113, Japan.	tobaba@juntendo.ac.jp					Majumdar SR, 2004, ANN INTERN MED, V141, P366; Talbot JC, 2007, INJURY, V38, P1236, DOI 10.1016/j.injury.2007.03.004; Feldstein A, 2003, ARCH INTERN MED, V163, P2165, DOI 10.1001/archinte.163.18.2165; Karantana A, 2013, J BONE JOINT SURG AM, V95A, P1737, DOI 10.2106/JBJS.L.00232; Andrade SE, 2003, ARCH INTERN MED, V163, P2052, DOI 10.1001/archinte.163.17.2052; Drobetz H, 2003, INT ORTHOP, V27, P1, DOI 10.1007/s00264-002-0393-x; MALLMIN H, 1993, CALCIFIED TISSUE INT, V52, P269, DOI 10.1007/BF00296650; [Anonymous], 1991, OSTEOPOROS INT, V1, P114; LAURITZEN JB, 1993, OSTEOPOROSIS INT, V3, P133, DOI 10.1007/BF01623274; Rozental TD, 2008, J BONE JOINT SURG AM, V90A, P953, DOI 10.2106/JBJS.G.01121; Branco JC, 2009, ACTA REUMATOL PORT, V34, P475; Aoyagi Y, 2011, SPORTS MED, V41, P695, DOI 10.2165/11590530-000000000-00000; Soen S, 2013, J BONE MINER METAB, V31, P247, DOI 10.1007/s00774-013-0447-8; Sommer C, 2003, INJURY, V34, P43, DOI 10.1016/j.injury.2003.09.024; Robinson CM, 2002, J BONE JOINT SURG AM, V84A, P1528; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Freedman KB, 2000, J BONE JOINT SURG AM, V82A, P1063; Xie XT, 2013, ACTA ORTHOP, V84, P286, DOI 10.3109/17453674.2013.792029; Cuddihy MT, 2004, OSTEOPOROSIS INT, V15, P695, DOI 10.1007/s00198-004-1597-2; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Earnshaw SA, 1998, OSTEOPOROSIS INT, V8, P53, DOI 10.1007/s001980050048; Hagino H, 2012, CALCIFIED TISSUE INT, V90, P14, DOI 10.1007/s00223-011-9545-6; Iba K, 2006, J ORTHOP SCI, V11, P446, DOI 10.1007/s00776-006-1050-9; Japanese Orthopaedic Association, 2012, CLIN PRACT GUID DIAG; KRAILO MD, 1983, J AM J EPIDEMIOL, V117, P356; Kuzuya M, 2012, NAGOYA J MED SCI, V74, P31; Lentle B, 2011, CAN ASSOC RADIOL J, V62, P243, DOI 10.1016/j.carj.2011.05.001; LUOTO R, 1994, AM J EPIDEMIOL, V139, P64; PEEL NFA, 1994, BRIT MED J, V308, P1543; Sakuma M, 2008, J BONE MINER METAB, V26, P373, DOI 10.1007/s00774-007-0841-1; Sontag A, 2010, J BONE MINER METAB, V28, P485, DOI 10.1007/s00774-009-0144-9; Svedbom A, 2014, Arch Osteoporos, V9, P187, DOI 10.1007/s11657-014-0187-y; Huntjens Kirsten M B, 2014, J Bone Joint Surg Am, V96, pe29, DOI 10.2106/JBJS.L.00223; Yi Hwabok, 2013, J Bone Metab, V20, P17, DOI 10.11005/jbm.2013.20.1.17	34	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	JUL	2015	26	7					1959	1963		10.1007/s00198-015-3103-4		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CL4VR	WOS:000356954500010		
J	Yoshiga, D; Sasaguri, M; Matsuo, K; Kokuryou, S; Habu, M; Oda, M; Kodama, M; Tsurushima, H; Sakaguchi, O; Sakurai, T; Tanaka, J; Morimoto, Y; Yoshioka, I; Tominaga, K				Yoshiga, D.; Sasaguri, M.; Matsuo, K.; Kokuryou, S.; Habu, M.; Oda, M.; Kodama, M.; Tsurushima, H.; Sakaguchi, O.; Sakurai, T.; Tanaka, J.; Morimoto, Y.; Yoshioka, I.; Tominaga, K.			Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation	OSTEOPOROSIS INTERNATIONAL			English	Article						Bisphosphonate-associated osteonecrosis of the jaws; BRONJ; Fluorescence-guided bone resection; VELscope (R)	RISK-FACTORS; CHRONIC OSTEOMYELITIS; SURGICAL-MANAGEMENT; RESECTION; FEATURES; THERAPY; IMPACT; TERIPARATIDE; DEBRIDEMENT; EXPRESSION	There is no standard surgical protocol of bisphosphonate-related osteonecrosis of the jaws (BRONJ), because of the impossibility to visualize this feature intraoperatively. The aim of this study was to introduce how to provide preoperative labeling of the viable bone with minocycline bone fluorescence technique (MBFT) by using VELscope (R) and investigate histopathologically. Introduction The American Association of Oral and Maxillofacial Surgeons (AAOMS) and the Japanese Society of Oral and Maxillofacial Surgeons (JSOMS) now recommend a more conservative treatment strategy. There is no standard surgical protocol of bisphosphonate-related osteonecrosis of the jaws (BRONJ) because of the impossibility to visualize this feature intraoperatively. The aim of this study was to introduce a mechanism providing preoperative labeling of a viable bone using minocycline bone fluorescence technique (MBFT) with VELscope (R) and to histopathologically investigate. Methods This report describes a surgical technique used in six patients with BRONJ who underwent jawbone resection under minocycline bone fluorescence imaging using VELscope (R). Subsequently, we investigated and compared the clinical findings using VELscope (R) and histopathological findings. Results Histopathological examinations showed that the non-fluorescent moiety was consistent with the BRONJ lesions. Conclusions The surgical treatments that were exactly performed using MBFT with VELscope (R) offered successful management of BRONJ. This bone fluorescence helped to define the margins of resection, thus improving surgical therapy for extended osteonecrosis.	[Yoshiga, D.; Sasaguri, M.; Habu, M.; Kodama, M.; Sakurai, T.; Tanaka, J.; Tominaga, K.] Kyushu Dent Univ, Dept Sci Phys Funct, Div Maxillofacial Surg, Fukuoka, Japan; [Matsuo, K.] Kyushu Dent Univ, Div Oral Pathol, Dept Hlth Promot, Fukuoka, Japan; [Kokuryou, S.; Tsurushima, H.; Sakaguchi, O.; Yoshioka, I.] Kyushu Dent Univ, Div Oral Med, Dept Sci Phys Funct, Fukuoka, Japan; [Oda, M.; Morimoto, Y.] Kyushu Dent Univ, Div Oral & Maxillofacial Radiol, Dept Sci Phys Funct, Fukuoka, Japan	Yoshiga, D (reprint author), Kyushu Dent Univ, Dept Sci Phys Funct, Div Maxillofacial Surg, Fukuoka, Japan.	r11yoshiga@fa.kyu-dent.ac.jp					Anavi-Lev K, 2013, OR SURG OR MED OR PA, V115, P660, DOI 10.1016/j.oooo.2013.03.001; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Dimopoulos MA, 2009, ANN ONCOL, V20, P117, DOI 10.1093/annonc/mdn554; Patschan D, 2001, BONE, V29, P498, DOI 10.1016/S8756-3282(01)00610-X; Badros A, 2006, J CLIN ONCOL, V24, P945, DOI 10.1200/JCO.2005.04.2465; [Anonymous], 2007, J ORAL MAXILLOFAC SU, V65, P369; Allen MR, 2009, J ORAL MAXIL SURG, V67, P61, DOI 10.1016/j.joms.2009.01.007; Harper RP, 2007, J ORAL MAXIL SURG, V65, P573, DOI 10.1016/j.joms.2006.10.076; Wilde F, 2009, ORAL SURG ORAL MED O, V107, P412, DOI 10.1016/j.tripleo.2008.09.019; Graziani F, 2012, J ORAL MAXIL SURG, V70, P2501, DOI 10.1016/j.joms.2012.05.019; Agrillo A, 2007, J CRANIOFAC SURG, V18, P1071; Pazianas M, 2011, J NATL CANCER I, V103, P232, DOI 10.1093/jnci/djq516; Farah CS, 2012, HEAD NECK-J SCI SPEC, V34, P856, DOI 10.1002/hed.21834; Cho YA, 2012, OR SURG OR MED OR PA, V114, P785, DOI 10.1016/j.oooo.2012.08.457; Ruggiero SL, 2009, J ORAL MAXIL SURG, V67, P2, DOI 10.1016/j.joms.2009.01.009; Yoshiga D, 2013, OSTEOPOROSIS INT, V24, P2365, DOI 10.1007/s00198-013-2277-x; Bedogni A, 2011, ORAL ONCOL, V47, P420, DOI 10.1016/j.oraloncology.2011.02.024; Pautke C, 2009, J ORAL MAXIL SURG, V67, P471, DOI 10.1016/j.joms.2008.09.037; Lindsay R, 2006, J BONE MINER RES, V21, P366, DOI 10.1359/JBMR.051109; Fleisher KE, 2008, J ORAL MAXIL SURG, V66, P2646, DOI 10.1016/j.joms.2008.07.021; Pautke C, 2011, J ORAL MAXIL SURG, V69, P84, DOI 10.1016/j.joms.2010.07.014; Otto S, 2012, J CRANIO MAXILL SURG, V40, P303, DOI 10.1016/j.jcms.2011.05.003; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Pautke C, 2010, J ORAL MAXIL SURG, V68, P125, DOI 10.1016/j.joms.2009.05.442; Dahners LE, 2002, J ORTHOP TRAUMA, V16, P345, DOI 10.1097/00005131-200205000-00009; Vahtsevanos K, 2009, J CLIN ONCOL, V27, P5356, DOI 10.1200/JCO.2009.21.9584; Lam DK, 2007, J CAN DENT ASSOC, V73, P417; Greenberger S, 2010, NEW ENGL J MED, V362, P1005, DOI 10.1056/NEJMoa0903036; Carlson ER, 2009, J ORAL MAXIL SURG, V67, P85, DOI 10.1016/j.joms.2009.01.006; Adornato MC, 2007, J AM DENT ASSOC, V138, P971; Favia G, 2009, BONE, V45, P406, DOI 10.1016/j.bone.2009.05.008; Farina C, 2004, INT IMMUNOL, V16, P799, DOI 10.1093/intimm/dxh083; Fukuzaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070737; Harvey BR, 2004, J ORAL MAXIL SURG, V62, P752, DOI 10.1016/j.joms.2003.08.036; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Koch FP, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-12; Lee Cameron Y S, 2007, J Oral Implantol, V33, P371, DOI 10.1563/1548-1336(2007)33[371:UOPPIT]2.0.CO;2; Lindsay R, 2013, J BONE MINER RES, V28, P222, DOI 10.1002/jbmr.1818; Lorenzo Sara Di, 2013, J Clin Med Res, V5, P22, DOI 10.4021/jocmr1253e; Markose G, 2009, BRIT J ORAL MAX SURG, V47, P294, DOI 10.1016/j.bjoms.2009.01.007; MARX RE, 1983, J ORAL MAXIL SURG, V41, P283, DOI 10.1016/0278-2391(83)90294-X; Muratsu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067906; Pietschmann P, 1998, CALCIFIED TISSUE INT, V63, P325, DOI 10.1007/s002239900535; Rauch F, 2006, J BONE MINER RES, V21, P513, DOI 10.1359/JBMR.060108; Sakaguchi O, 2014, INT J ORAL IN PRESS; Scoletta M, 2010, PHOTOMED LASER SURG, V28, P179, DOI 10.1089/pho.2009.2501; Tirelli G, 2009, HEAD NECK-J SCI SPEC, V31, P1249, DOI 10.1002/hed.21019; Vescovi P, 2006, J ORAL MAXIL SURG, V64, P1460, DOI 10.1016/j.joms.2006.05.012; Yoshiga Daigo, 2014, J Clin Exp Dent, V6, pe22, DOI 10.4317/jced.51213	50	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	JUL	2015	26	7					1997	2006		10.1007/s00198-015-3096-z		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CL4VR	WOS:000356954500015		
J	Yoshiga, D; Sasaguri, M; Matsuo, K; Kokuryou, S; Habu, M; Oda, M; Kodama, M; Tsurushima, H; Sakaguchi, O; Sakurai, T; Tanaka, J; Morimoto, Y; Yoshioka, I; Tominaga, K				Yoshiga, D.; Sasaguri, M.; Matsuo, K.; Kokuryou, S.; Habu, M.; Oda, M.; Kodama, M.; Tsurushima, H.; Sakaguchi, O.; Sakurai, T.; Tanaka, J.; Morimoto, Y.; Yoshioka, I.; Tominaga, K.			Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation (vol 26, pg 1997, 2015)	OSTEOPOROSIS INTERNATIONAL			English	Correction									[Yoshiga, D.; Sasaguri, M.; Habu, M.; Kodama, M.; Sakurai, T.; Tanaka, J.; Tominaga, K.] Kyushu Dent Univ, Dept Sci Phys Funct, Div Maxillofacial Surg, Fukuoka, Japan; [Matsuo, K.] Kyushu Dent Univ, Dept Hlth Promot, Div Oral Pathol, Fukuoka, Japan; [Kokuryou, S.; Tsurushima, H.; Sakaguchi, O.; Yoshioka, I.] Kyushu Dent Univ, Dept Sci Phys Funct, Div Oral Med, Fukuoka, Japan; [Oda, M.; Morimoto, Y.] Kyushu Dent Univ, Dept Sci Phys Funct, Div Oral & Maxillofacial Radiol, Fukuoka, Japan	Yoshiga, D (reprint author), Kyushu Dent Univ, Dept Sci Phys Funct, Div Maxillofacial Surg, Fukuoka, Japan.	r11yoshiga@fa.kyu-dent.ac.jp					Yoshiga D, 2015, OSTEOPOROSIS INT, V26, P1997, DOI 10.1007/s00198-015-3096-z	1	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	JUL	2015	26	7					2007	2012		10.1007/s00198-015-3208-9		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CL4VR	WOS:000356954500016		
J	Otagaki, S; Ogawa, Y; Oyant, LHS; Foucher, F; Kawamura, K; Horibe, T; Matsumoto, S				Otagaki, S.; Ogawa, Y.; Oyant, L. Hibrand-Saint; Foucher, F.; Kawamura, K.; Horibe, T.; Matsumoto, S.			Genotype of FLOWERING LOCUS T homologue contributes to flowering time differences in wild and cultivated roses	PLANT BIOLOGY			English	Article						CAPS marker; flowering; FT; Rosa	FLORAL INDUCTION; TFL1 HOMOLOG; ARABIDOPSIS; FT; REGULATOR; SIGNALS; TOMATO; INTEGRATION; TRANSITION; EXPRESSION	Rose flowers have long delighted humans as ornamental plants. To improve the ornamental value of roses it is necessary to understand the regulatory mechanisms of flowering. We previously found that flowering time is controlled by three minor quantitative trait loci (QTLs) and a major QTL co-localised with RoFT. In this study, we isolated three RoFT alleles encoding completely identical amino acid sequences from the parents of a mapping population. Correlation analysis of the RoFT genotypes and flowering time phenotypes in the mapping population showed that the RoFT_f and RoFT_g alleles contribute to the early-flowering phenotype, while the RoFT_e allele contributes to the late-flowering phenotype. We developed two novel cleaved amplified polymorphic sequence (CAPS) markers based on the genomic sequences of the RoFT alleles and clearly showed that the relationship between RoFT genotype and flowering time was applicable to 12 of 13 cultivated roses grown at the Higashiyama Botanical Gardens, Japan. Allele-specific expression analysis using a reverse transcription CAPS assay suggested that these RoFT alleles are regulated differentially at the transcription level. Furthermore, transgenic Arabidopsis thaliana plants ectopically expressing the RoFT gene showed an early-flowering phenotype. Conversely, in roses, RoFT was continuously expressed after floral bud formation, and RoFT transcript accumulation reached its peak after that of the floral meristem identity gene RoAP1b. These data suggest that RoFT may be essential not only for floral transition but also for normal floral development and flowering in roses.	[Otagaki, S.; Ogawa, Y.; Matsumoto, S.] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Oyant, L. Hibrand-Saint; Foucher, F.] Univ Angers, INRA, Inst Rech Hort & Semences, AGROCAMPUS OUEST, Beaucouze, France; [Kawamura, K.] Osaka Inst Technol, Dept Environm Engn, Osaka 535, Japan; [Horibe, T.] Chubu Univ, Dept Environm Biol, Kasugai, Aichi 487, Japan	Otagaki, S (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	sotagaki@agr.nagoya-u.ac.jp			 [23658026];  [24688004]	We are indebted to Dr. K. Shiratake and Dr. K. Yamada for their useful suggestions, Mr. S. Ito and Mr. S. Ando for supplying rose cultivar samples from Higashiyama Botanical Gardens, and Mr. R. Nakajima for technical assistance. We thank Tatiana Thouroude for help in plant scoring; David Lalanne for help in SSCP genotyping and the experimental unit (Hortis, INRA, Angers) for taking care of the plants in the field. We are also grateful to Dr. S. Segami for kindly providing CaMV 35S:: GFP transgenic seeds. This research was supported by a Grant-in-Aid for KAKENHI (No. 23658026, 24688004).	Oyant LHS, 2008, TREE GENET GENOMES, V4, P11, DOI 10.1007/s11295-007-0084-2; Zhang HL, 2010, J EXP BOT, V61, P2549, DOI 10.1093/jxb/erq092; Bendahmane M, 2013, J EXP BOT, V64, P847, DOI 10.1093/jxb/ers387; Narusaka M, 2010, PLANT BIOTECHNOL-NAR, V27, P349, DOI 10.5511/plantbiotechnology.27.349; Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Hiraoka K, 2013, PLANT CELL PHYSIOL, V54, P352, DOI 10.1093/pcp/pcs168; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Hanano S, 2011, PLANT CELL, V23, P3172, DOI 10.1105/tpc.111.088641; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Pnueli L, 2001, PLANT CELL, V13, P2687, DOI 10.1105/tpc.13.12.2687; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Niwa M, 2013, PLANT CELL, V25, P1228, DOI 10.1105/tpc.112.109090; Kawamura K, 2011, THEOR APPL GENET, V122, P661, DOI 10.1007/s00122-010-1476-5; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Michaels SD, 2005, PLANT PHYSIOL, V137, P149, DOI 10.1104/pp.104.052811; Umemura H, 2013, PLANTA, V238, P65, DOI 10.1007/s00425-013-1875-3; Matsumoto S, 1998, SCI HORTIC-AMSTERDAM, V77, P73, DOI 10.1016/S0304-4238(98)00169-1; Yoo SC, 2013, PLANT J, V75, P456, DOI 10.1111/tpj.12213; THOMAS MR, 1993, THEOR APPL GENET, V86, P173, DOI 10.1007/BF00222076; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Remay A, 2009, THEOR APPL GENET, V119, P767, DOI 10.1007/s00122-009-1087-1; Casas AM, 2011, THEOR APPL GENET, V122, P1293, DOI 10.1007/s00122-011-1531-x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Danilevskaya Olga N, 2011, Plant Signal Behav, V6, P1267; Debener T, 2009, CRIT REV PLANT SCI, V28, P267, DOI 10.1080/07352680903035481; Dugo ML, 2005, THEOR APPL GENET, V111, P511, DOI 10.1007/s00122-005-2042-4; Grossi C, 2002, ACTA BOT GALLICA, V149, P405; Gudin S, 2001, ACTA HORTIC, P23; Gudin S., 2000, Plant Breeding Reviews, V17, P159; Horibe T., 2015, ACTA HORTIC IN PRESS; Iwata H, 2012, PLANT J, V69, P116, DOI 10.1111/j.1365-313X.2011.04776.x; Molinero-Rosales N, 2004, PLANTA, V218, P427, DOI 10.1007/s00425-003-1109-1; Randoux M, 2012, J EXP BOT, V63, P6543, DOI 10.1093/jxb/ers310; Randoux M, 2014, NEW PHYTOL, V202, P161, DOI 10.1111/nph.12625	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1435-8603	1438-8677		PLANT BIOLOGY	Plant Biol.	JUL	2015	17	4					808	815		10.1111/plb.12299		8	Plant Sciences	Plant Sciences	CL3WD	WOS:000356881400004		
J	Takamatsu, K; Iehisa, JCM; Nishijima, R; Takumi, S				Takamatsu, Kiyofumi; Iehisa, Julio C. M.; Nishijima, Ryo; Takumi, Shigeo			Comparison of gene expression profiles and responses to zinc chloride among inter- and intraspecific hybrids with growth abnormalities in wheat and its relatives	PLANT MOLECULAR BIOLOGY			English	Article						Calcium influx; Microarray; Postzygotic barrier; Programmed cell death; Reactive oxygen species; Wheat	MITOTIC CELL-DIVISION; TRITICUM-AESTIVUM L.; COMMON WHEAT; AEGILOPS-TAUSCHII; TETRAPLOID WHEATS; OXIDATIVE BURST; NECROSIS GENES; URARTU; LINES; SPECIATION	Hybrid necrosis is a well-known reproductive isolation mechanism in plant species, and an autoimmune response is generally considered to trigger hybrid necrosis through epistatic interaction between disease resistance-related genes in hybrids. In common wheat, the complementary Ne1 and Ne2 genes control hybrid necrosis, defined as type I necrosis. Two other types of hybrid necrosis (type II and type III) have been observed in interspecific hybrids between tetraploid wheat and Aegilops tauschii. Another type of hybrid necrosis, defined here as type IV necrosis, has been reported in F-1 hybrids between Triticum urartu and some accessions of Triticum monococcum ssp. aegilopoides. In types I, III and IV, cell death occurs gradually starting in older tissues, whereas type II necrosis symptoms occur only under low temperature. To compare comprehensive gene expression patterns of hybrids showing growth abnormalities, transcriptome analysis of type I and type IV necrosis was performed using a wheat 38k oligo-DNA microarray. Defense-related genes including many WRKY transcription factor genes were dramatically up-regulated in plants showing type I and type IV necrosis, similarly to other known hybrid abnormalities, suggesting an association with an autoimmune response. Reactive oxygen species generation and necrotic cell death were effectively inhibited by ZnCl2 treatment in types I, III and IV necrosis, suggesting a significant association of Ca2+ influx in upstream signaling of necrotic cell death in wheat hybrid necrosis.	[Takamatsu, Kiyofumi; Iehisa, Julio C. M.; Nishijima, Ryo; Takumi, Shigeo] Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Nada Ku, Kobe, Hyogo 6578501, Japan	Takumi, S (reprint author), Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Nada Ku, Rokkodai 1-1, Kobe, Hyogo 6578501, Japan.	takumi@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21380005, 25292008]	We thank emeritus professor Dr. Koichiro Tsunewaki for supplying seeds of NILs, Ne1-S615 and Ne2-S615. We are grateful to Professor Dr. Hitoshi Nakayashiki for his useful suggestions. The diploid wheat seeds used in this study were supplied by the National BioResource Project-Wheat, Japan (www.nbrp.jp). This work was supported by Grants-in-Aid for Scientific Research (B) Nos. 21380005 and 25292008 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334; Alcazar R, 2010, NAT GENET, V42, P1135; Song CJ, 2006, PLANT PHYSIOL, V140, P1222, DOI 10.1104/pp.105.073072; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Hatano H, 2012, NEW PHYTOL, V194, P1143, DOI 10.1111/j.1469-8137.2012.04125.x; Mizuno N, 2011, PLANT J, V68, P114, DOI 10.1111/j.1365-313X.2011.04667.x; Matsuoka Y, 2007, THEOR APPL GENET, V115, P509, DOI 10.1007/s00122-007-0584-3; JOHNSON BL, 1976, AM J BOT, V63, P1088, DOI 10.2307/2441653; Kawaura K, 2008, FUNCT INTEGR GENOMIC, V8, P277, DOI 10.1007/s10142-008-0076-9; Chu CG, 2006, THEOR APPL GENET, V112, P1374, DOI 10.1007/s00122-006-0239-9; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Yamamoto E, 2010, MOL GENET GENOMICS, V283, P305, DOI 10.1007/s00438-010-0514-y; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; TSUNEWAKI K, 1979, EUPHYTICA, V28, P579, DOI 10.1007/BF00038924; NISHIKAWA K, 1962, JPN J GENET, V37, P227, DOI 10.1266/jjg.37.227; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Takumi S, 2013, GENETICA, V141, P463, DOI 10.1007/s10709-013-9745-2; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Ma W, 2007, CELL MICROBIOL, V9, P2571, DOI 10.1111/j.1462-5822.2007.01031.x; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Bindschedler LV, 2001, NEW PHYTOL, V151, P185, DOI 10.1046/j.1469-8137.2001.00170.x; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Brandolini A, 2006, GENOME, V49, P297, DOI 10.1139/G05-110; CASTAGNA R, 1994, THEOR APPL GENET, V88, P818, DOI 10.1007/BF01253991; Castagna R, 1997, THEOR APPL GENET, V94, P424, DOI 10.1007/s001220050432; Chae E, 2014, CELL, V159, P1341, DOI 10.1016/j.cell.2014.10.049; Dalal M, 2001, PHYSIOL PLANTARUM, V111, P297, DOI 10.1034/j.1399-3054.2001.1110306.x; Davies DR, 2006, J EXP BOT, V57, P1817, DOI 10.1093/jxb/erj216; DHALIWAL HS, 1977, THEOR APPL GENET, V49, P283, DOI 10.1007/BF00275134; Fricano A, 2014, G3-GENES GENOM GENET, V4, P1931, DOI 10.1534/g3.114.013623; GILL BS, 1978, THEOR APPL GENET, V51, P265, DOI 10.1007/BF00274813; HERMSEN JGT, 1963, GENETICA, V33, P245, DOI 10.1007/BF01725765; Hoat TX, 2006, PLANT J, V46, P922, DOI 10.1111/j.1365-313X.2006.02752.x; Jeuken MJW, 2009, PLANT CELL, V21, P3368, DOI 10.1105/tpc.109.070334; Khanna-Chopra R, 1998, BIOCHEM BIOPH RES CO, V248, P712, DOI 10.1006/bbrc.1998.9043; Lucas A, 2011, R PACKAGE VERSION 0; Masuda Y, 2007, PLANT CELL REP, V26, P1595, DOI 10.1007/s00299-007-0352-5; Mizumoto K, 2002, HEREDITAS, V137, P208, DOI 10.1034/j.1601-5223.2002.01654.x; Mizuno N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011326; Nakano H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121583; NISHIKAWA KOZO, 1960, SEIKEN ZIHO, V11, P21; NISHIKAWA K., 1962, SEIKEN ZIHO, V14, P45; Pukhalskiy VA, 2000, EUPHYTICA, V114, P233, DOI 10.1023/A:1003915708448; R Core Team, 2012, R LANG ENV STAT COMP; Roy RP, 1955, INDIAN J GENET PLANT, V14, P88; Sears ER, 1944, GENETICS, V29, P113; Sugie A, 2007, GENES GENET SYST, V82, P231, DOI 10.1266/ggs.82.231; Takumi Shigeo, 2011, Plant Signal Behav, V6, P1431, DOI 10.4161/psb.6.10.17065; Tsunewaki K, 1970, SEIKEN ZIHO, V22, P67; TSUNEWAKI KOICHIRO, 1960, JAPANESE JOUR GENETICS, V35, P71, DOI 10.1266/jjg.35.71; TSUNEWAKI K, 1992, GENOME, V35, P594; Warnes GR, 2012, R PACKAGE VERSION 2; Wojtaszek P, 1997, BIOCHEM J, V322, P681; Yamagishi Y, 1987, PHYLOGENETIC DIFFERE	59	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4412	1573-5028		PLANT MOL BIOL	Plant Mol.Biol.	JUL	2015	88	4-5					487	502		10.1007/s11103-015-0338-6		16	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CL6BP	WOS:000357052100013		
J	Yotsuyanagi, T; Yamauchi, M; Yamashita, K; Sugai, A; Gonda, A; Kitada, A; Saito, T; Urushidate, S				Yotsuyanagi, Takatoshi; Yamauchi, Makoto; Yamashita, Ken; Sugai, Asuka; Gonda, Ayako; Kitada, Ayaka; Saito, Tamotsu; Urushidate, Satoshi			Abnormality of Auricular Muscles in Congenital Auricular Deformities	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							NONSURGICAL CORRECTION; CRYPTOTIA	Background: It has been suggested that there is a close association of abnormality in auricular muscles with various congenital auricular deformities. However, there has been no investigation to determine what muscles are involved and how they affect the deformity. The authors examined abnormalities of auricular muscles for patients with various auricular deformities. Methods: The authors examined 77 auricles of 62 patients with congenital auricular deformities, including cryptotia, Stahl's ear, prominent ear, lop ear, and others. The superior and posterior auricular muscles from the extrinsic auricular muscle group and the auricular oblique and transverse muscles from the auricular intrinsic muscle group were investigated. Results: The authors found characteristic features of the abnormality of the muscle for each auricular deformity. In nearly all cases of cryptotia, abnormality was found in the superior auricular, auricular oblique, and auricular transverse muscles. Abnormal insertion was found mainly in the superior auricular muscle and was the main cause of cryptotia. In Stahl's ear, the major abnormality was abnormal insertion of the auricular transverse muscle, which creates an abnormal cartilaginous prominence in the scapha. The abnormality in cases of prominent ear was clearly limited mostly to the auricular transverse muscle and, in some cases, to the posterior auricular muscle. In lop ear, abnormality was mostly found in the auricular transverse muscle, with elongation, and in the superior auricular or auricular oblique muscle in some cases. Conclusions: There is a tendency for a specific muscle abnormality to be found in each deformity. It is important to identify the abnormal muscle and correct the abnormality during the operation.	Sapporo Med Univ, Dept Plast & Reconstruct Surg, Sch Med, Sapporo, Hokkaido 0608543, Japan; Hirosaki Univ, Dept Plast & Reconstruct Surg, Sch Med, Hirosaki, Aomori, Japan	Yotsuyanagi, T (reprint author), Sapporo Med Univ, Dept Plast & Reconstruct Surg, Sch Med, Chuo Ku, S1W16, Sapporo, Hokkaido 0608543, Japan.	yotsuyanagi@sapmed.ac.jp					Allison G R, 1978, Clin Plast Surg, V5, P419; HIROSE T, 1985, BRIT J PLAST SURG, V38, P352, DOI 10.1016/0007-1226(85)90241-3; Yotsuyanagi T, 2002, PLAST RECONSTR SURG, V109, P1366, DOI 10.1097/00006534-200204010-00025; Guyuron B, 1997, PLAST RECONSTR SURG, V100, P457, DOI 10.1097/00006534-199708000-00030; MATSUO K, 1984, PLAST RECONSTR SURG, V73, P38, DOI 10.1097/00006534-198401000-00009; Yotsuyanagi T, 1999, PLAST RECONSTR SURG, V103, P171, DOI 10.1097/00006534-199901000-00027; Davis J, 1987, AESTHETIC RECONSTRUC, P80; ELSAHY NI, 1989, ANN PLAS SURG, V23, P66, DOI 10.1097/00000637-198907000-00011; GOSSEREZ M, 1959, Ann Chir Plast, V4, P143; Marx H, 1926, HDB SPEZ PATHOL ANAT, V12, P609; Moss ML, 1975, MORPHOGENESIS MALFOR, P283; Oda K, 1935, ACTA ANAT NIPPON, V8, P329; Sercer A, 1934, ACTA OTO-LARYNGOL, V20, P59, DOI 10.3109/00016483409118038; Smith D W, 1980, Birth Defects Orig Artic Ser, V16, P299; TORIKAI K, 1982, Japanese Journal of Plastic and Reconstructive Surgery, V25, P46; Wreden A, 1870, MONATSSCHR OHRENH, V4, P21; Yotsuyanagi T, 1998, PLAST RECONSTR SURG, V101, P907, DOI 10.1097/00006534-199804040-00004; Yotsuyanagi T, 2001, BRIT J PLAST SURG, V54, P20, DOI 10.1054/bjps.2000.3463; Yotsuyanagi T, 2007, PLAST RECONSTR SURG, V114, P190; Yotsuyanagi T, 2002, CLIN PLAST SURG, V29, P327, DOI 10.1016/S0094-1298(01)00011-6; ZERIN M, 1982, PEDIATRICS, V69, P91	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	JUL	2015	136	1					78E	88E		10.1097/PRS.0000000000001383		11	Surgery	Surgery	CL6XP	WOS:000357112500001		
J	Kobayashi, S				Kobayashi, Shiro			Enzymatic ring-opening polymerization and polycondensation for the green synthesis of polyesters	POLYMERS FOR ADVANCED TECHNOLOGIES			English	Review						enzymatic ring-opening polymerization; enzymatic polycondensation; green polyester synthesis; lactone monomer; lipase catalyst	LIPASE-CATALYZED POLYMERIZATION; ACID-DIVINYL ESTERS; CROSS-LINKABLE POLYESTERS; IN-VITRO BIOSYNTHESIS; DICARBOXYLIC-ACID; EPSILON-CAPROLACTONE; IMMOBILIZED LIPASE; ORGANIC-SOLVENTS; SUBSTITUTED LACTONES; RENEWABLE RESOURCES	Enzyme-catalyzed polyester synthesis has been briefly reviewed with focusing on the studies achieved mainly by our group. This article describes the polyester synthesis based on the reaction mode catalyzed by enzyme with using lipase in major and protease in minor. First, ring-opening polymerization of cyclic esters (lactones), where the macrolide monomers showed a higher polymerizability by lipase catalyst than smaller ring-sized lactones. This tendency is the reverse with the anionic and metal (Zn) catalyzed polymerizations, which was explained from the specific mechanism of the enzymatic reaction. Chemoselective and enantioselective as well as end-functionalizing polymerizations were mentioned. Second, condensation polymerization (polycondensation), where two modes of reactions using oxyacid or its ester as monomer and carboxylic acid or its ester and diol as monomers were shown. Third, ring-opening addition-condensation polymerization, where carboxylic anhydride and diol monomers were reacted involving dehydration. Finally, advantageous aspects of enzymatic polyester synthesis are described in terms of conducting green polymer chemistry. Copyright (c) 2015 John Wiley & Sons, Ltd.	Kyoto Inst Technol, Ctr Fiber & Text Sci, Sakyo Ku, Kyoto 6068585, Japan	Kobayashi, S (reprint author), Kyoto Inst Technol, Ctr Fiber & Text Sci, Sakyo Ku, Kyoto 6068585, Japan.	kobayash@kit.ac.jp					AJIMA A, 1985, BIOTECHNOL LETT, V7, P303, DOI 10.1007/BF01030275; Duda A, 2002, MACROMOLECULES, V35, P4266, DOI 10.1021/ma012207y; Gross RA, 2001, CHEM REV, V101, P2097, DOI 10.1021/cr0002590; Kobayashi S, 1998, MACROMOL CHEM PHYSIC, V199, P1729, DOI 10.1002/(SICI)1521-3935(19980801)199:8<1729::AID-MACP1729>3.0.CO;2-V; Kobayashi S, 2009, CHEM REV, V109, P5288, DOI 10.1021/cr900165z; Kawai F, 2011, POLYM DEGRAD STABIL, V96, P1342, DOI 10.1016/j.polymdegradstab.2011.03.022; UYAMA H, 1995, B CHEM SOC JPN, V68, P56, DOI 10.1246/bcsj.68.56; Puskas JE, 2009, J POLYM SCI POL CHEM, V47, P2959, DOI 10.1002/pola.23351; MACDONALD RT, 1995, MACROMOLECULES, V28, P73, DOI 10.1021/ma00105a008; Kobayashi S, 2001, CHEM REV, V101, P3793, DOI 10.1021/cr990121l; Namekawa S, 1999, INT J BIOL MACROMOL, V25, P145, DOI 10.1016/S0141-8130(99)00028-8; Kikuchi H, 2000, MACROMOLECULES, V33, P8971, DOI 10.1021/ma0010534; Kobayashi S, 2009, MACROMOL RAPID COMM, V30, P237, DOI 10.1002/marc.200800690; van der Mee L, 2006, MACROMOLECULES, V39, P5021, DOI 10.1021/ma060668j; Kikuchi H, 2002, POLYM J, V34, P835, DOI 10.1295/polymj.34.835; Bisht KS, 1997, MACROMOLECULES, V30, P2705, DOI 10.1021/ma961869y; Uyama H, 1996, ACTA POLYM, V47, P357, DOI 10.1002/actp.1996.010470807; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; JONES JB, 1986, TETRAHEDRON, V42, P3351, DOI 10.1016/S0040-4020(01)87306-3; Anderson EM, 1998, BIOCATAL BIOTRANSFOR, V16, P181, DOI 10.3109/10242429809003198; KNANI D, 1993, J POLYM SCI POL CHEM, V31, P1221, DOI 10.1002/pola.1993.080310518; Habaue S, 2003, POLYMER, V44, P5195, DOI 10.1016/S0032-3861(03)00491-9; HUISGEN R, 1959, TETRAHEDRON, V6, P253, DOI 10.1016/0040-4020(59)80006-5; Hut YM, 2003, BIOTECHNOL PROGR, V19, P303, DOI 10.1021/bp0201197; Kiran KR, 2003, WORLD J MICROB BIOT, V19, P859, DOI 10.1023/A:1026004229239; KLIBANOV AM, 1990, ACCOUNTS CHEM RES, V23, P114, DOI 10.1021/ar00172a004; Kobayashi S., 2014, ENCY POLYM SCI TECHN, V4th, P221; Kobayashi S, 2013, ADV POLYM SCI, V262, P141, DOI 10.1007/12_2013_236; Kobayashi S, 1999, HIGH POLYM JPN, V48, P124; Kobayashi S., 2007, MACROMOLECULAR ENG, P401; Kobayashi S, 1998, POLYM DEGRAD STABIL, V59, P195, DOI 10.1016/S0141-3910(97)00178-X; KOBAYASHI S, 1995, ADV POLYM SCI, V121, P1; Kobayashi S, 2010, P JPN ACAD B-PHYS, V86, P338, DOI 10.2183/pjab.86.338; Kobayashi S., 2002, ACS SYM SER, V840, P128; Kobayashi S., 1997, CATALYSIS PRECISION, P417; Kobayashi S, 2006, MACROMOL SYMP, V240, P178, DOI 10.1002/masy.200650822; Kobayashi S, 2006, ADV POLYM SCI, V194, P1, DOI 10.1007/11549307; Kobayashi S, 2001, B CHEM SOC JPN, V74, P613, DOI 10.1246/bcsj.74.613; KOBAYASHI S, 1993, MAKROMOL CHEM-RAPID, V14, P841; Kobayashi S, 1999, J POLYM SCI POL CHEM, V37, P3041, DOI 10.1002/(SICI)1099-0518(19990815)37:16<3041::AID-POLA1>3.3.CO;2-M; Kobayashi S., 2003, ENCY POLYM SCI TECHN, V3rd, P328; Kobayashi S, 2001, ADV BIOCHEM ENG BIOT, V71, P241; Kobayashi S, 1998, MACROMOLECULES, V31, P5655, DOI 10.1021/ma980396n; Kobayashi S., 2002, HDB BIOPOLYMERS A, V3a, P373; Kobayashi S, 1999, MACROMOL SYMP, V144, P237, DOI 10.1002/masy.19991440121; Kobayashi S, 1997, CHEM LETT, P105, DOI 10.1246/cl.1997.105; Kobayashi S, 2002, CURR ORG CHEM, V6, P209, DOI 10.2174/1385272023374544; Kobayashi S, 2000, BIOMACROMOLECULES, V1, P3, DOI 10.1021/bm990007c; Kubisa P, 2005, J POLYM SCI POL CHEM, V43, P4675, DOI 10.1002/pola.20971; Kullmer K, 1998, MACROMOL RAPID COMM, V19, P127; Matsumura S, 2000, MACROMOL RAPID COMM, V21, P860, DOI 10.1002/1521-3927(20000801)21:12<860::AID-MARC860>3.3.CO;2-L; Matyjaszewski K, 2012, POLYM SCI COMPREHENS, V5, P217; Mueller S., 1999, CHEM LETT, P1317; Namekawa S, 1996, POLYM J, V28, P730, DOI 10.1295/polymj.28.730; Namekawa S, 2000, BIOMACROMOLECULES, V1, P335, DOI 10.1021/bm000030u; Namekawa S, 1998, P JPN ACAD B-PHYS, V74, P65, DOI 10.2183/pjab.74.65; NOMURA R, 1994, MACROMOLECULES, V27, P620, DOI 10.1021/ma00080a046; Ohara H, 2011, J BIOSCI BIOENG, V111, P19, DOI 10.1016/j.jbiosc.2010.08.015; Ohara H, 2010, BIOMACROMOLECULES, V11, P2008, DOI 10.1021/bm1003674; Ohara H, 2011, BIOMACROMOLECULES, V12, P3833, DOI 10.1021/bm201004g; OKUMURA S, 1984, AGR BIOL CHEM TOKYO, V48, P2805; Soeda Y, 2005, MACROMOL BIOSCI, V5, P277, DOI 10.1002/mabi.200400176; Suda S, 1999, P JPN ACAD B-PHYS, V75, P201, DOI 10.2183/pjab.75.201; Sym E. A., 1936, ENZYMOLOGIA, V1, P156; Sym EA, 1933, BIOCHEM Z, V258, P304; Takamoto T, 2001, E-POLYMERS, V4, P1; Tsujimoto T, 2001, BIOMACROMOLECULES, V2, P29, DOI 10.1021/bm000097h; Tsujimoto T, 2002, MACROMOL BIOSCI, V2, P329, DOI 10.1002/1616-5195(200209)2:7<329::AID-MABI329>3.0.CO;2-H; Uyama H, 1998, ACTA POLYM, V49, P700, DOI 10.1002/(SICI)1521-4044(199812)49:12<700::AID-APOL700>3.3.CO;2-3; Uyama H, 2002, POLYM J, V34, P94, DOI 10.1295/polymj.34.94; UYAMA H, 1995, CHEM LETT, P1047, DOI 10.1246/cl.1995.1047; UYAMA H, 1993, CHEM LETT, P1149, DOI 10.1246/cl.1993.1149; Uyama H, 2001, MACROMOL BIOSCI, V1, P40, DOI 10.1002/1616-5195(200101)1:1<40::AID-MABI40>3.3.CO;2-K; Uyama H, 2001, MACROMOLECULES, V34, P6554, DOI 10.1021/ma010893v; Uyama H, 2003, BIOCHEM ENG J, V16, P145, DOI 10.1016/S1369-703X(03)00028-7; Uyama H, 1999, J POLYM SCI POL CHEM, V37, P2737, DOI 10.1002/(SICI)1099-0518(19990801)37:15<2737::AID-POLA7>3.0.CO;2-M; UYAMA H, 1993, P JPN ACAD B-PHYS, V69, P203, DOI 10.2183/pjab.69.203; Uyama H, 1997, CHEM LETT, P1109, DOI 10.1246/cl.1997.1109; Uyama H, 1998, CHEM LETT, P1285, DOI 10.1246/cl.1998.1285; UYAMA H, 1994, CHEM LETT, P1687, DOI 10.1246/cl.1994.1687; Uyama H, 1996, CHEM LETT, P107, DOI 10.1246/cl.1996.107; UYAMA H, 1995, MACROMOLECULES, V28, P7046, DOI 10.1021/ma00125a002; Uyama H, 2000, CHEM LETT, P800, DOI 10.1246/cl.2000.800; Uyama H, 1999, POLYM J, V31, P380, DOI 10.1295/polymj.31.380; Uyama H, 1997, POLYM J, V29, P299, DOI 10.1295/polymj.29.299; Uyama H, 2003, BIOMACROMOLECULES, V4, P211, DOI 10.1021/bm0256092; Uyama H, 1997, B CHEM SOC JPN, V70, P1691, DOI 10.1246/bcsj.70.1691; WONG CH, 1994, ENZYMES SYNTHETIC OR; Yamaguchi S, 2014, POLYM J, V46, P2, DOI 10.1038/pj.2013.62	89	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7147	1099-1581		POLYM ADVAN TECHNOL	Polym. Adv. Technol.	JUL	2015	26	7			SI		677	686		10.1002/pat.3564		10	Polymer Science	Polymer Science	CL3UN	WOS:000356876300002		
J	Brown, JDJ				Brown, James D. J.			"A Nightmare Painted by Goya": Russian Media Coverage of the Syrian Chemical Weapons Attacks in Comparative Perspective	PROBLEMS OF POST-COMMUNISM			English	Article								The Western powers and Russia came head-to-head over the August 2013 chemical weapons attacks in Syria. Not only did Moscow stridently oppose Western plans to intervene militarily, it also steadfastly refused to accept that the Syrian regime had been responsible, a position that the U.S. president described as an insult to reason. This article examines how it can be that the Russian government was able to maintain such a seemingly absurd stance. It does so by analyzing how the Ghouta attacks were presented in the Russian media, and comparing this with coverage in the United States, United Kingdom, and France.	[Brown, James D. J.] Temple Univ, Tokyo 1060047, Japan	Brown, JDJ (reprint author), Temple Univ, Minato Ku, Japan Campus,2-8-12 Minami Azabu, Tokyo 1060047, Japan.	jamesdjbrown@tuj.temple.edu					Alexander Harriet, 2013, DAILY TELEGRAPH; [Anonymous], 2013, NEZAVISIMAIA GA 0821; [Anonymous], 2013, WASHINGTON POST; [Anonymous], 2013, ROSSIISKAIA GAZ 0825; [Anonymous], 2013, DAILY TELEGRAPH; [Anonymous], 2013, ROSSIISKAIA GAZ 0830; [Anonymous], 2013, NEZAVISIMAIA GA 0828; [Anonymous], 2013, ROSSIISKAIA GAZ 0821; [Anonymous], 2013, NEZAVISIMAIA GA 0825; Allison R, 2013, INT AFF, V89, P795, DOI 10.1111/1468-2346.12046; [Anonymous], 2013, GOV ASS SYR GOV US C; [Anonymous], 2013, KOMMERSANT      0826; [Anonymous], 2013, ROSSIISKAYA GAZ 0823; [Anonymous], 2013, KOMMERSANT      0824; [Anonymous], 2013, KOMMERSANT FM   0826; [Anonymous], 2013, NEZAVISIMAIA GA 0826; [Anonymous], 2013, NEZAVISIMAIA GA 0824; [Anonymous], 2013, KOMMERSANT FM   1082; [Anonymous], 2013, KOMMERSANT      0822; [Anonymous], 2013, KOMMERSANT      0828; [Anonymous], 2013, KOMMERSANT      0829; [Anonymous], 2013, KOMMERSANT      0821; [Anonymous], 2013, KOMMERSANT VLAS 0826; Barluet Alain, 2013, FIGARO; Blair David, 2013, DAILY TELEGRAPH; Brown JDJ, 2014, INT POLITICS, V51, P45, DOI 10.1057/ip.2013.45; D'Ancona Matthew, 2013, DAILY TELEGRAPH; DeYoung Karen, 2013, WASHINGTON POST; Dolgov Konstantin, 2013, KOMMERSANT FM   0827; Dominiczak Peter, 2013, DAILY TELEGRAPH; Dyer Geoff, 2013, FINANCIAL TIMES; Efimova Mariia, 2013, KOMMERSANT      0821; Foster Peter, 2013, DAILY TELEGRAPH; Foster Peter, 2013, SUNDAY TELEGRAP 0825; Gerson Michael, 2013, WASHINGTON POST; Gorkovskaia Mariia, 2013, IZVESTIIA       0827; Gorkovskaia Mariia, 2013, IZVESTIIA       0828; Gorkovskaia Mariia, 2013, IZVESTIIA       0830; Ignatius David, 2013, WASHINGTON POST; Interfax, 2013, RUSS DIPL ACT PREV F; Isaev Gumer, 2013, KOMMERSANT FM   0827; Iusin Maksim, 2013, KOMMERSANT FM   1129; Joshi Shashank, 2013, DAILY TELEGRAPH; Khatuntsev Stanislav, 2013, IZVESTIIA       0823; Lasserre Isabelle, 2013, LE FIGARO       0821; Lasserre Isabelle, 2013, FRAPPANT DAMAS PARIS; Lasserre Isabelle, 2013, FIGARO; Leroyer Madeleine, 2013, FIGARO; Levental Vadim, 2013, IZVESTIIA       0826; Lipman Maria, RETURN PUTINS RUSSIA; Litovkin Viktor, 2013, NEZAVISIMAIA GA 0828; Luk'ianov Fedor, 2013, ROSSIISKAIA GAZ 0828; Mankoff Jeffrey, RUSSIAN FOREIGN POLI, P1; Mezhuev Boris, 2013, IZVESTIIA       0827; Morris Loveday, 2013, WASHINGTON POST; Picard Maurin, 2013, FIGARO; Pincus W., 2013, WASHINGTON POST; Putin V. V., 2013, NY TIMES; Robinson Eugene, 2013, WASHINGTON POST; Rogozin Dmitrii, 2013, KOMMERSANT      0827; Ross Tim, 2013, DAILY TELEGRAPH; Samozhnev Aleksandr, 2013, ROSSIISKAIA GAZ 0824; Shachtman Noah, 2013, FOREIGN POLICY; Shargunov Sergei, 2013, KOMMERSANT FM   0827; Shestakov Evgenii, 2013, ROSSIISKAIA GAZ 0829; Shestakov Evgenii, 2013, ROSSIISKAIA GAZ 0830; Sobczyk Marcin, 2013, WALL STREET J; Sobolev Sergei, 2013, KOMMERSANT FM   0830; Spencer Richard, 2013, DAILY TELEGRAPH; Strokan Sergei, 2013, KOMMERSANT      0830; Strokan Sergei, 2013, KOMMERSANT      0827; Tarasenko Pavel, 2013, KOMMERSANT      0823; Tsiliurik Dar'ia, 2013, NEZAVISIMAIA GA 0826; Tsiliurik Dar'ia, 2013, NEZAVISIMAIA GA 0822; Vorob'ev Vladislav, 2013, ROSSIISKAIA GAZ 0826; Vorob'ev Vladislav, 2013, ROSSIISKAIA GAZ 0825; Vorob'ev Vladislav, 2013, ROSSIISKAIA GAZ 0823	77	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1075-8216	1557-783X		PROBL POST-COMMUNISM	Probl. Post-Communism	JUL-AUG	2015	62	4					236	246		10.1080/10758216.2015.1026212		11	Political Science	Government & Law	CK6YV	WOS:000356376300004		
J	Takeda, O				Takeda, Okiyoshi			A Forgotten Minority? A Content Analysis of Asian Pacific Americans in Introductory American Government Textbooks	PS-POLITICAL SCIENCE & POLITICS			English	Article							PORTRAYAL; POLITICS; US	Textbooks are the most important pedagogical tools in higher education and they should convey sufficient and accurate information on minority groups and women in the United States. Yet textbooks tend to marginalize these groups in their depictions. This article examines the coverage of Asian Pacific Americans in twenty-eight American Government or Politics textbooks. Asian Pacific Americans have faced a unique history of exclusion, discrimination, and stereotyping. The content analysis of the textbooks reveals that textbooks do not fully cover their history and contributions to US politics, either measured by page numbers or by historical events and figures important to Asian Pacific Americans. To rectify this lack of coverage, this article concludes with five constructive recommendations, including an option to invite scholars on Asian Pacific American politics to serve as textbook reviewers and textbook coauthors.	Aoyama Gakuin Univ, Sch Int Polit Econ & Commun, Tokyo, Japan	Takeda, O (reprint author), Aoyama Gakuin Univ, Sch Int Polit Econ & Commun, Tokyo, Japan.	otakeda@sipeb.aoyama.ac.jp					Allen M. D., 2010, J POLITICAL SCI ED, V6, P1, DOI [10.1080/15512160903467554, DOI 10.1080/15512160903467554]; Aoki Andrew, 2008, ASIAN AM POLITICS; APSA Task Force on Political Science in the 21 st Century, 2011, POL SCI 21 CENT; Ashley Jeffery S., 1999, AM INDIAN Q, V23, P49, DOI 10.2307/1185828; Babbie E., 1995, PRACTICE SOCIAL RES; BONEPARTH E, 1980, TEACH POLIT SCI, V7, P371; Cassese EC, 2013, POLIT GENDER, V9, P214, DOI 10.1017/S1743923X13000068; Clawson RA, 2002, J BLACK STUD, V32, P352; Clawson Rosalee A., 2000, HOWARD J COMMUNICATI, V11, P179; Eisenstein Marie A., 2013, J POLITICAL SCI ED, V9, P89; Eksterowicz AJ, 2000, PS, V33, P589, DOI 10.2307/420863; Evans Jocelyn Jones, 2013, J POLITICAL SCI ED, V9, P108; Lasswell H. D., 1936, POLITICS WHO GETS WH; LIMERICK PN, 1992, J AM HIST, V78, P1380, DOI 10.2307/2079348; McClain Paula D., 2010, AM GOVT BLACK WHITE; Monforti JL, 2010, PS-POLIT SCI POLIT, V43, P309, DOI 10.1017/S1049096510000181; Nakanishi Don T., 2014, NATL ASIAN PACIFIC A; National Asian American Survey, 2013, NUMB POSTEL SURV AS; Novkov J, 2007, PS-POLIT SCI POLIT, V40, P393, DOI 10.1017/S1049096507070667; Okihiro Gary Y., 1997, TEACHING ASIAN AM HI; Olivo Christiane, 2012, NEW POLITICS TXB PRO, P149; Olivo Christiane, 2012, J POLITICAL SCI ED, V8, P131; Rodriguez Clara E., 2000, CHANGING RACE LATINO; Schneider Monica C., 2014, J POLITICAL SCI ED, V10, P253; Takeda Okiyoshi, 1999, ANN M MIDW POL SCI A; Tong Lorraine H., 2013, AS PAC AM US C JUN 1; United States Census Bureau, 2012, AS POP 2010 2010 CEN; University of California, 2014, TABL 3 1 U CAL CAL R; US Census Bureau, 2014, AS PAC AM HER MONTH; Wallace Sherri L., 2009, NATL POLITICAL SCI R, V12, P247; Wallace SL, 2008, PS-POLIT SCI POLIT, V41, P153, DOI 10.1017/S1049096508080244; Willson Ernest J., 1985, PS POLITICAL SCI POL, V18, P600	32	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1049-0965	1537-5935		PS-POLIT SCI POLIT	PS-Polit. Sci. Polit.	JUL	2015	48	3					430	439		10.1017/S1049096515000190		10	Political Science	Government & Law	CL5TQ	WOS:000357024500004		
J	Ishihara, S				Ishihara, Shunso			Comparative Studies of the Petrochemistry of Sn-W-Mineralized Granitoids: Continent vs. Island Arc	RESOURCE GEOLOGY			English	Article						granitoids; Mo; petrochemistry; Sn; trace elements; W; W-Sn-mineralized	ACCESSORY MINERALS; SOUTHEASTERN CHINA; SOUTHERN CHINA; NANLING RANGE; ERZGEBIRGE; DEPOSITS; ROCKS; DISCRIMINATION; CLASSIFICATION; FRACTIONATION	Granitic rocks obtained during field excursions of the famed mineralized regions of the Erzgebirge, Germany (mainly tin-bearing), and South China (mainly tungsten-bearing) have been geochemically analyzed and their results are compared with similar (mainly tungsten-bearing) granites in the island-arc setting of Southwest Japan. The studied granitoids all belong to the ilmenite-series. The collision-related Erzgebirge granitoids are rich in K2O and P2O5, have high A/CNK ratios (1.11-1.24, i.e. S type), but are also high in Ga/Al ratio (i.e., having some A-type characteristics). In South China, the Xihuashan granites, in contrast, are very low in P2O5, and have A/CNK slightly above 1.0 (1.01-1.05), indicative of I type granites. The (Sn-) W-related granites of southwest Japan have similarly low P2O5 and A/CNK ratios, indicative also of I-type. Both in the Xihuashan and southwest Japan, the tungsten-related granites have high whole-rock O-18 values implying involvement of W-rich crustal rocks. Sn and W contents of the unaltered granites are lowest in the island-arc setting where the related Sn-W deposits are smallest in size relative to the collision and continental margin settings of the Erzgebirge and South China.	Geol Survey Japan, AIST, Tsukuba, Ibaraki 3058567, Japan	Ishihara, S (reprint author), Geol Survey Japan, AIST, Cent 7, Tsukuba, Ibaraki 3058567, Japan.	s-ishihara@aist.go.jp					BEA F, 1992, LITHOS, V29, P43, DOI 10.1016/0024-4937(92)90033-U; PEARCE JA, 1984, J PETROL, V25, P956; Li XH, 2007, CHINESE SCI BULL, V52, P1873, DOI 10.1007/s11434-007-0259-0; Ishihara S, 2008, RESOUR GEOL, V58, P355, DOI 10.1111/j.1751-3928.2008.00070.x; Chappell BW, 2006, RESOUR GEOL, V56, P203, DOI 10.1111/j.1751-3928.2006.tb00281.x; Wang RC, 2003, CAN MINERAL, V41, P727, DOI 10.2113/gscanmin.41.3.727; Forster HJ, 1998, AM MINERAL, V83, P259; Ishihara S, 2006, RESOUR GEOL, V56, P245, DOI 10.1111/j.1751-3928.2006.tb00282.x; Zhang H, 2013, J GEOL, V121, P289, DOI 10.1086/669975; Wang FY, 2011, RESOUR GEOL, V61, P414, DOI 10.1111/j.1751-3928.2011.00176.x; CHAPPELL BW, 1992, T ROY SOC EDIN-EARTH, V83, P1; WHALEN JB, 1987, CONTRIB MINERAL PETR, V95, P407, DOI 10.1007/BF00402202; Baumann L., 1974, GEOL SURV CZECH, V66; Chappell B.W., 1974, PAC GEOL, V8, P173; Forster HJ, 1999, J PETROL, V40, P1613, DOI 10.1093/petrology/40.11.1613; Forster HJ, 1999, COMPUT GEOSCI, V25, P533, DOI 10.1016/S0098-3004(98)00171-X; FRYDA J, 1995, TERRA NOVA, V7, P315, DOI 10.1111/j.1365-3121.1995.tb00800.x; Hong DW, 1998, RESOUR GEOL, V48, P251, DOI 10.1111/j.1751-3928.1998.tb00022.x; Imai H., 1972, MINING GEOLOGY, V22, P371; Ishihara S, 1977, MIN GEOL, V27, P191; Ishihara S., 1986, B GEOL SURV JPN, V37, P207; Ishihara S, 1999, B GEOL SURV JAPAN, V50, P651; Ishihara S., 2002, B GEOLOGICAL SURVEY, V53, P421; Ishihara S., 1971, J GEOL SOC JAPAN, V77, P441; Ishihara S., 2008, B EARTH SCI, P31; Ishihara S., 2002, B GEOL SURV JAPAN, V53, P657; Ishihara S., 2010, B GEOL SURV JAPAN, V61, P383; Ishihara S., 1975, CHISHITSU GEOLOGY NE, V249, P18; Ishihara S, 2004, RESOUR GEOL, V54, P281, DOI 10.1111/j.1751-3928.2004.tb00207.x; Ishihara S, 2010, Z GEOL WISS BERLIN, V38, P243; Ishihara S, 1977, MINING GEOL TOKYO, V27, P293; Ishihara S., 1982, P S TUNGST GEOL JIAN, P115; Lu HZ, 2003, ECON GEOL BULL SOC, V98, P955, DOI 10.2113/98.5.955; MARUEJOL P, 1990, CONTRIB MINERAL PETR, V104, P668, DOI 10.1007/BF01167286; Matsuhisa Y., 1973, GEOCHEM J, V7, P201; Mu Z., 1982, P TUNGST GEOL S JIAN, P385; Pitcher S., 1983, MOUNTAIN BUILDING PR, P19; Rye R. O., 1986, B US GEOL SURV, V1622, P158; Sinclair W. D., 2014, 7688 GEOL SURV CAN; Stemprok M., 1993, RES GEOL SPEC ISS, V15, P373; TISCHENDORF G, 1990, GEOL J, V25, P443, DOI 10.1002/gj.3350250326; Tischendorf G, 1986, CHEM ERDE-GEOCHEM, V45, P75; Wan B, 1982, TUNGST GEOL S JIANGX, P403; Wu C., 1993, RESOUR GEOL, V16, P9; Yang M, 2000, CONCISE REGIONAL GEO, P172	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-1698	1751-3928		RESOUR GEOL	Resour. Geol	JUL	2015	65	3					285	295		10.1111/rge.12071		11	Geology; Mineralogy	Geology; Mineralogy	CL5VX	WOS:000357031600006		
J	Ohno, H; Matsubae, K; Nakajima, K; Kondo, Y; Nakamura, S; Nagasaka, T				Ohno, Hajime; Matsubae, Kazuyo; Nakajima, Kenichi; Kondo, Yasushi; Nakamura, Shinichiro; Nagasaka, Tetsuya			Toward the efficient recycling of alloying elements from end of life vehicle steel scrap	RESOURCES CONSERVATION AND RECYCLING			English	Article						End-of-life vehicle; Alloying element; Scrap steel; Metals recycling; Electric arc furnace; Waste input-output material flow analysis	INPUT-OUTPUT-ANALYSIS; MATERIAL FLOW-ANALYSIS; FERROUS MATERIALS; SUBSTANCE FLOW; CYCLIC USE; IRON; METALS; JAPAN; STOCK; METHODOLOGY	There has been a sharp increase in the production of automobiles over the past decade. In 2010, one billion automobiles were in circulation worldwide. The automobile industry is one of the largest metals consumers and plays an important role in their sustainable use. Steel materials, including alloy steels that contain alloying elements (AEs) such as manganese, chromium, nickel, and molybdenum, are the main component of automobiles. The recycling of end-of-life vehicles (ELVs) significantly affects the cycling of iron, steel, and AEs. Currently, ELV recycling is performed using the electric arc furnace (EAF). In this method, losses of AEs are likely to occur because their presence is rarely considered. This study evaluated the environmental and economic benefits of alternative ELV recycling schemes, which allow more efficient utilization of AEs found in ELV-derived steel scrap (ELV-dSS). The AE contents in ELV-dSS (as car-parts) were estimated by means of a waste input-output material flow analysis (WIO-MFA) model extended for the detailed analysis of automobile composition. Using Japanese data, it was found that sorting ELV-dSS by parts can result in a significant recovery of AEs; more specifically, a 10-fold saving in AEs was achieved by sorting exhaust parts. The recoverable mass of AEs from sorted ELV-dSS was found to correspond to 8.2% of the annual consumption of AEs in Japan, as virgin resources in EAF steelmaking. ELV-dSS sorting was found to be significantly effective in the conservation of AE resources. (C) 2015 Elsevier B.V. All rights reserved.	[Ohno, Hajime] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808579, Japan; [Matsubae, Kazuyo; Nagasaka, Tetsuya] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Nakajima, Kenichi] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management, Tsukuba, Ibaraki 3058506, Japan; [Kondo, Yasushi; Nakamura, Shinichiro] Waseda Univ, Fac Polit Sci & Econ, Tokyo 1698050, Japan	Ohno, H (reprint author), Yale Univ, Sch Forestry & Environm Studies, Ctr Ind Ecol, 195 Prospect St, New Haven, CT 06511 USA.	hajime.ono@yale.edu; matsubae@m.tohoku.ac.jp; nakajima.kenichi@nies.go.jp; ykondo@waseda.jp; nakashin@waseda.jp; t-nagasaka@m.tohoku.ac.jp			Japanese Society for the Promotion of Science (KAKENHI) [23686131, 258801]; Iron and Steel Institute of Japan (a research group focusing on the recycling of automobiles from the perspective of the material industry); Research Institute of Science and Technology for Society of the Japanese Science and Technology Agency (JST-RISTEX)	This research was supported by the Japanese Society for the Promotion of Science (KAKENHI 23686131, 258801), the Iron and Steel Institute of Japan (a research group focusing on the recycling of automobiles from the perspective of the material industry), and the Research Institute of Science and Technology for Society of the Japanese Science and Technology Agency (JST-RISTEX).	Agency for Natural Resource and Energy Energy, 2005, BAL TABL; Nakamura S, 2005, MATER TRANS, V46, P2550, DOI 10.2320/matertrans.46.2550; Nuss P, 2014, ENVIRON SCI TECHNOL, V48, P4171, DOI 10.1021/es405044w; Reck BK, 2010, ENVIRON SCI TECHNOL, V44, P3940, DOI 10.1021/es903584q; Reck BK, 2012, SCIENCE, V337, P690, DOI 10.1126/science.1217501; [Anonymous], 2013, ORD BOOK STEEL PROD; Millet D, 2012, RESOUR CONSERV RECY, V68, P1, DOI 10.1016/j.resconrec.2012.07.002; Hatayama H, 2010, ENVIRON SCI TECHNOL, V44, P6457, DOI 10.1021/es100044n; Graedel TE, 2012, ENVIRON SCI TECHNOL, V46, P1063, DOI 10.1021/es203534z; Daigo I, 2007, ISIJ INT, V47, P1065, DOI 10.2355/isijinternational.47.1065; [Anonymous], 2013, SCRAP SPEC CIRC 2013; Hatayama H, 2014, RESOUR CONSERV RECY, V87, P65, DOI 10.1016/j.resconrec.2014.03.006; Wang T, 2007, ENVIRON SCI TECHNOL, V41, P5120, DOI 10.1021/es062761t; Pauliuk S, 2012, ENVIRON SCI TECHNOL, V46, P148, DOI 10.1021/es201904c; Nakamura S, 2007, J IND ECOL, V11, P50, DOI 10.1162/jiec.2007.1290; Nakamura S, 2011, ENVIRON SCI TECHNOL, V45, P1114, DOI 10.1021/es1024299; Simic V, 2013, RESOUR CONSERV RECY, V73, P197, DOI 10.1016/j.resconrec.2013.02.012; Daigo I, 2005, TETSU TO HAGANE, V91, P171; Ohno H, 2014, J IND ECOL, V18, P242, DOI 10.1111/jiec.12095; Nakamura S, 2014, ENVIRON SCI TECHNOL, V48, P7207, DOI 10.1021/es500820h; Castro MBG, 2004, RESOUR CONSERV RECY, V43, P1, DOI 10.1016/j.resconrec.2004.04.011; Ducker Worldwide, 2012, EAA AL PEN CARS; European Aluminium Associatuion, 2008, AL CARS; European Ferrous Recovery Recycling Federation, 2007, EU 27 STEEL SCARP SP; Froelich D, 2007, MINER ENG, V20, P891, DOI 10.1016/j.mineng.2007.04.019; Gaustad G, 2011, ENVIRON SCI TECHNOL, V45, P4110, DOI 10.1021/es103508u; Geneva International Oraganization for Standardization (ISO), 1981, 5448 ISO; Geneva International Organization for Standardization (ISO), 1980, 5452 ISO; Geneva International Organization for Standardization (ISO), 1988, 6501 ISO; Haque N, 2013, J CLEAN PROD, V39, P220, DOI 10.1016/j.jclepro.2012.08.010; Houpert C, 1997, REV METALL-PARIS, V94, P1369; Internation Organization for Standardization (ISO), 2004, 68314 ISO; International Organization for Standardization (ISO), 1987, 6831 ISO; International Organization for Standardization (ISO), 1980, 5446 ISO; International Organization of Motor Vehicle Manufactures (OICA), 2012, WORLD MOT VEH PROD; Japan Auto Parts Industries Association, 2007, SURV SHIPM AUT PARTS; Japan Automobile Dealers Association, 2005, RANK UN SAL PURCH NE; Japan Environmental Sanitation Center, 2009, REP IMPL EFF RAT TRE; Japan Oil Gas and Metals National Corporation (JOGMEC). JOGMEC, 2007, KOB SHIG MAT FLOW 20; Kondo Y, 2005, ECON SYST RES, V17, P393, DOI 10.1080/09535310500283526; Matsubae K, 2011, ISIJ INT, V51, P151, DOI 10.2355/isijinternational.51.151; Matsubae K, 2014, TETSU TO HAGANE, V100, P794, DOI 10.2355/tetsutohagane.100.794; Matsubae K, 2014, TETSU TO HAGANE, V100, P788, DOI 10.2355/tetsutohagane.100.788; Michaelis P, 2000, RESOUR CONSERV RECY, V29, P131, DOI 10.1016/S0921-3449(00)00048-3; Ministry of Economy Trade and Industry (Japan), 2006, YB IR STEEL NONF MET; Ministry of Environment (Japan), 2012, ADV UT END LIF VEH O; Ministry of Industrial Affairs and Communications (Japan), 2009, 2005 INP OUTP TABL J; Mueller D. B., 2006, P NATL ACAD SCI USA, V103, P16111, DOI DOI 10.1073/PNAS.0603375103; Nakajima K, 2008, ISIJ INT, V48, P549, DOI 10.2355/isijinternational.48.549; Nakajima K, 2011, ENVIRON SCI TECHNOL, V45, P4929, DOI 10.1021/es104231n; Nakajima K, 2013, ENVIRON SCI TECHNOL, V47, P4653, DOI 10.1021/es3043559; Nakamura S, 2012, ENVIRON SCI TECHNOL, V46, P9266, DOI 10.1021/es3013529; Oda T, 2009, TETSU TO HAGANE, V95, pA720; Special Steel Association ofJAPAN, 2002, REP TREND SPEC STEEL; Tasaki T, 2004, CONACCOUNT M 2004; The Japan Ferrous Raw Materials Association, 2008, UN STAND FERR SCRAPS; The Japan Ferrous Raw Materials Association, 2006, TETS NENP 2006	57	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-3449	1879-0658		RESOUR CONSERV RECY	Resour. Conserv. Recycl.	JUL	2015	100						11	20		10.1016/j.resconrec.2015.04.001		10	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CL2CD	WOS:000356750300002		
J	Tanaka, Y; Mizuguchi, M; Takahashi, Y; Fujii, H; Tanaka, R; Fukushima, T; Tomoyose, T; Ansari, AA; Nakamura, M				Tanaka, Yuetsu; Mizuguchi, Mariko; Takahashi, Yoshiaki; Fujii, Hideki; Tanaka, Reiko; Fukushima, Takuya; Tomoyose, Takeaki; Ansari, Aftab A.; Nakamura, Masataka			Human T-cell leukemia virus type-I Tax induces the expression of CD83 on T cells	RETROVIROLOGY			English	Article						CD83; HTLV; Tax; ATL; PGE2	NF-KAPPA-B; ACTIVATED DENDRITIC CELLS; SOLUBLE CD83; TRANSCRIPTIONAL ACTIVATOR; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; HUMAN RETROVIRUS; HUMAN-SERA; LYMPHOCYTES; ANTIBODIES	Background: CD83, a cell surface glycoprotein that is stably expressed on mature dendritic cells, can be transiently induced on other hematopoietic cell lineages upon cell activation. In contrast to the membrane form of CD83, soluble CD83 appears to be immunosuppressive. In an analysis of the phenotype of leukemic CD4(+) T cells from patients with adult T-cell leukemia (ATL), we found that a number of primary CD4(+) T cells became positive for cell surface CD83 after short-term culture, and that most of these CD83(+) CD4(+) T cells were positive for human T-cell leukemia virus type-I (HTLV-I) Tax (Tax1). We hypothesized that Tax1 is involved in the induction of CD83. Result: We found that CD83 was expressed selectively on Tax1-expressing human CD4(+) T cells in short-term cultured peripheral blood mononuclear cells (PBMCs) isolated from HTLV-I+ donors, including ATL patients and HTLV-I carriers. HTLV-I-infected T cell lines expressing Tax1 also expressed cell surface CD83 and released soluble CD83. CD83 can be expressed in the JPX-9 cell line by cadmium-mediated Tax1 induction and in Jurkat cells or PBMCs by Tax1 introduction via infection with a recombinant adenovirus carrying the Tax1 gene. The CD83 promoter was activated by Tax1 in an NF-kappa B-dependent manner. Based on a previous report showing soluble CD83-mediated prostaglandin E2 (PGE2) production from human monocytes in vitro, we tested if PGE2 affected HTLV-I propagation, and found that PGE2 strongly stimulated expression of Tax1 and viral structural molecules. Conclusions: Our results suggest that HTLV-I induces CD83 expression on T cells via Tax1 -mediated NF-kappa B activation, which may promote HTLV-I infection in vivo.	[Tanaka, Yuetsu; Takahashi, Yoshiaki; Fujii, Hideki; Tanaka, Reiko] Univ Ryukyus, Grad Sch Med, Dept Immunol, Nishihara, Okinawa 9030215, Japan; [Mizuguchi, Mariko; Nakamura, Masataka] Tokyo Med & Dent Univ, Human Gene Sci Ctr, Bunkyo Ku, Tokyo, Japan; [Fukushima, Takuya] Univ Ryukyus, Fac Med, Sch Hlth Sci, Lab Hematoimmunol, Nishihara, Okinawa 9030215, Japan; [Tomoyose, Takeaki] Univ Ryukyus, Grad Sch Med, Dept Internal Med 2, Div Endocrinol Diabet & Metab Haematol Rheumatol, Nishihara, Okinawa 9030215, Japan; [Ansari, Aftab A.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA	Tanaka, Y (reprint author), Univ Ryukyus, Grad Sch Med, Dept Immunol, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	yuetsu@s4.dion.ne.jp			Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare of Japan; Okinawa prefecture	We thank Prof. M. Fujii at Niigata University for providing Ton1 cells. This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology and the Ministry of Health, Labor, and Welfare of Japan, and Okinawa prefecture.	Akagi T, 1997, ONCOGENE, V14, P2071, DOI 10.1038/sj.onc.1201045; ZHOU LJ, 1992, J IMMUNOL, V149, P735; Yasunaga J, 2001, BLOOD, V97, P3177, DOI 10.1182/blood.V97.10.3177; Reinwald S, 2008, J IMMUNOL, V180, P5890; Hock BD, 2004, LEUKEMIA RES, V28, P237, DOI 10.1016/S0145-2126(03)00255-8; Hock BD, 2001, INT IMMUNOL, V13, P959, DOI 10.1093/intimm/13.7.959; Bangham CRM, 2009, EUR J IMMUNOL, V39, P1700, DOI 10.1002/eji.200939451; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Chen LW, 2011, P NATL ACAD SCI USA, V108, P18778, DOI 10.1073/pnas.1018994108; Kress AK, 2011, VIRUSES-BASEL, V3, P1439, DOI 10.3390/v3081439; Aerts-Toegaert C, 2007, EUR J IMMUNOL, V37, P686, DOI 10.1002/eji.200636535; Mori N, 1999, BLOOD, V93, P2360; Yamashiro S, 2000, BLOOD, V96, P3958; Mailliard RB, 2005, J EXP MED, V202, P941, DOI 10.1084/hem.20050128; Cao WP, 2005, BIOCHEM J, V385, P85, DOI 10.1042/BJ20040741; Fujimoto Y, 2002, CELL, V108, P755, DOI 10.1016/S0092-8674(02)00673-6; Lechmann M, 2001, J EXP MED, V194, P1813, DOI 10.1084/jem.194.12.1813; Matsuoka M, 2013, CURR OPIN VIROL, V3, P684, DOI 10.1016/j.coviro.2013.08.010; GESSAIN A, 1985, LANCET, V2, P407; Kummer M, 2007, J VIROL, V81, P6326, DOI 10.1128/JVI.02327-06; MIURA S, 1991, MOL CELL BIOL, V11, P1313; [Anonymous], LANCET, V2, P407; Prazma CM, 2007, J IMMUNOL, V179, P4550; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Senechal B, 2004, BLOOD, V103, P4207, DOI 10.1182/blood-2003-10-4350; Nascimento CR, 2011, BLOOD, V117, P489, DOI 10.1182/blood-2010-03-272690; Bates JM, 2015, MUCOSAL IMMUNOL, V8, P414, DOI 10.1038/mi.2014.79; Dudziak D, 2003, J VIROL, V77, P8290, DOI 10.1128/JVI.77.15.8290-8298.2003; Dumais N, 2003, J VIROL, V77, P11170, DOI 10.1128/JVI.77.20.11170-11179.2003; FUJISAWA J, 1989, J VIROL, V63, P3234; Funai N, 1996, CLIN IMMUNOL IMMUNOP, V80, P325, DOI 10.1006/clin.1996.0131; GOTOH YI, 1982, P NATL ACAD SCI-BIOL, V79, P4780, DOI 10.1073/pnas.79.15.4780; Higashimura N, 1996, JPN J CANCER RES, V87, P227; HINUMA Y, 1982, GANN, V73, P341; HIRAI H, 1992, ONCOGENE, V7, P1737; HIRAI H, 1994, P NATL ACAD SCI USA, V91, P3584, DOI 10.1073/pnas.91.9.3584; Hock BD, 2009, LEUKEMIA RES, V33, P1089, DOI 10.1016/j.leukres.2009.01.001; Ishitsuka K, 2014, LANCET ONCOL, V15, pE517, DOI 10.1016/S1470-2045(14)70202-5; KOZLOW EJ, 1993, BLOOD, V81, P454; Kreiser S, 2015, IMMUNOBIOLOGY, V220, P270, DOI 10.1016/j.imbio.2014.08.005; Lin HY, 2014, CELL IMMUNOL, V292, P25, DOI 10.1016/j.cellimm.2014.08.003; Matsumoto K, 1997, J VIROL, V71, P4445; Melamed A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003271; Mizuguchi M, 2009, J BIOL CHEM, V284, P25501, DOI 10.1074/jbc.M109.010959; Moriuchi M, 2001, J VIROL, V75, P192, DOI 10.1128/JVI.75.1.192-198.2001; Murphy EL, 1999, ARCH INTERN MED, V159, P1485, DOI 10.1001/archinte.159.13.1485; Ohtani K, 1998, J BIOL CHEM, V273, P14119, DOI 10.1074/jbc.273.23.14119; OHTANI K, 1987, EMBO J, V6, P389; Ohtani K, 2000, J BIOL CHEM, V275, P11154, DOI 10.1074/jbc.275.15.11154; OOTSUYAMA Y, 1985, JPN J CANCER RES, V76, P1132; OSAME M, 1987, ANN NEUROL, V21, P117, DOI 10.1002/ana.410210203; Romanelli MG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00271; Santos SB, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-7; Tanaka R, 2001, J VIROL, V75, P11534, DOI 10.1128/JVI.75.23.11534-11543.2001; TANAKA Y, 1990, J IMMUNOL, V144, P4202; Tanaka Y, 2014, AIDS RES HUM RETROV, V30, P542, DOI [10.1089/AID.2013.0214, 10.1089/aid.2013.0214]; Wolenski M, 2003, MED MICROBIOL IMMUN, V192, P189, DOI 10.1007/s00430-003-0179-9; Yamazato Y, 2003, CHEST, V124, P2283, DOI 10.1378/chest.124.6.2283; Yoshida M, 2010, P JPN ACAD B-PHYS, V86, P117, DOI 10.2183/pjab.86.117	59	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-4690			RETROVIROLOGY	Retrovirology	JUL 1	2015	12								56	10.1186/s12977-015-0185-1		13	Virology	Virology	CL8XX	WOS:000357258800001		
J	Inomata, A; Murakoshi, F; Ishiwa, A; Takano, R; Takemae, H; Sugi, T; Recuenco, FC; Horimoto, T; Kato, K				Inomata, Atsuko; Murakoshi, Fumi; Ishiwa, Akiko; Takano, Ryo; Takemae, Hitoshi; Sugi, Tatsuki; Recuenco, Frances Cagayat; Horimoto, Taisuke; Kato, Kentaro			Heparin interacts with elongation factor 1 alpha of Cryptosporidium parvum and inhibits invasion	SCIENTIFIC REPORTS			English	Article							INTESTINAL EPITHELIAL-CELLS; SULFATE PROTEOGLYCANS; ENTERIC PATHOGENS; TOXOPLASMA-GONDII; NEWBORN CALVES; LASALOCID-NA; INFECTION; BINDING; SURFACE; POLYSACCHARIDES	Cryptosporidium parvum is an apicomplexan parasite that can cause serious watery diarrhea, cryptosporidiosis, in human and other mammals. C. parvum invades gastrointestinal epithelial cells, which have abundant glycosaminoglycans on their cell surface. However, little is known about the interaction between C. parvum and glycosaminoglycans. In this study, we assessed the inhibitory effect of sulfated polysaccharides on C. parvum invasion of host cells and identified the parasite ligands that interact with sulfated polysaccharides. Among five sulfated polysaccharides tested, heparin had the highest, dose-dependent inhibitory effect on parasite invasion. Heparan sulfate-deficient cells were less susceptible to C. parvum infection. We further identified 31 parasite proteins that potentially interact with heparin. Of these, we confirmed that C. parvum elongation factor 1 alpha (CpEF1 alpha), which plays a role in C. parvum invasion, binds to heparin and to the surface of HCT-8 cells. Our results further our understanding of the molecular basis of C. parvum infection and will facilitate the development of anti-cryptosporidial agents.	[Inomata, Atsuko; Murakoshi, Fumi; Ishiwa, Akiko; Recuenco, Frances Cagayat; Horimoto, Taisuke; Kato, Kentaro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, Tokyo 1138657, Japan; [Murakoshi, Fumi; Ishiwa, Akiko; Takano, Ryo; Takemae, Hitoshi; Sugi, Tatsuki; Recuenco, Frances Cagayat; Kato, Kentaro] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan	Kato, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	kkato@obihiro.ac.jp			Ministry of Education, Culture, Science, Sports, and Technology (MEXT) [3308]; Ministry of Health, Labour and Welfare of Japan; Bio-oriented Technology Research Advancement Institution (BRAIN); Akiyama Life Science Foundation; Japan Science and Technology Agency (JST)	We thank Susan Watson for editing the manuscript. We also thank Dr. Kenji Yagita (Protozoa Laboratory, Department of Parasitology, National Institute of Infectious Diseases) for providing us with C. parvum oocysts. This study was supported by Grants-in-Aids for Young Scientists, Exploratory Scientific Research on Innovative Areas (3308) from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT) and for Research on global health issues from the Ministry of Health, Labour and Welfare of Japan, the Bio-oriented Technology Research Advancement Institution (BRAIN), The Akiyama Life Science Foundation, and the Program to Disseminate Tenure Tracking System from the Japan Science and Technology Agency (JST).	AlvarezDominguez C, 1997, INFECT IMMUN, V65, P78; Andrews KT, 2005, INFECT IMMUN, V73, P4288, DOI 10.1128/IAI.73.7.4288-4294.2005; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI13530; CURRENT WL, 1991, CLIN LAB MED, V11, P873; Merga Y, 2014, DIGEST DIS, V32, P475, DOI 10.1159/000358156; Rossignol JF, 2010, EXP PARASITOL, V124, P45, DOI 10.1016/j.exppara.2009.07.005; Rusnati M, 2009, PHARMACOL THERAPEUT, V123, P310, DOI 10.1016/j.pharmthera.2009.05.001; de Graaf DC, 1999, INT J PARASITOL, V29, P1269, DOI 10.1016/S0020-7519(99)00076-4; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Li PL, 2013, MED RES REV, V33, P665, DOI 10.1002/med.21263; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Thompson RCA, 2005, ADV PARASIT, V59, P77, DOI 10.1016/S0065-308X(05)59002-X; Wilhelm CL, 2014, PARASITE IMMUNOL, V36, P409, DOI 10.1111/pim.12115; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Lendner M, 2014, PARASITOLOGY, V141, P1511, DOI 10.1017/S0031182014000237; Chen Y, 2008, MOL CELLS, V26, P415; Bhat N, 2007, J BIOL CHEM, V282, P34877, DOI 10.1074/jbc.M706950200; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Bouzid M, 2013, CLIN MICROBIOL REV, V26, P115, DOI 10.1128/CMR.00076-12; Weitz JI, 1997, NEW ENGL J MED, V337, P688; Matsubayashi M, 2013, J BIOL CHEM, V288, P34111, DOI 10.1074/jbc.M113.515544; Valigurova A, 2008, INT J PARASITOL, V38, P913, DOI 10.1016/j.ijpara.2007.11.003; Rostand KS, 1997, INFECT IMMUN, V65, P1; Copeland R, 2008, BIOCHEMISTRY-US, V47, P5774, DOI 10.1021/bi800205t; Yates EA, 2004, J MED CHEM, V47, P277, DOI 10.1021/jm0309755; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.biochem.60.1.443; Kobayashi K, 2010, J BIOL CHEM, V285, P1716, DOI 10.1074/jbc.M109.021576; Arrowood MJ, 1996, J EUKARYOT MICROBIOL, V43, pS89, DOI 10.1111/j.1550-7408.1996.tb05015.x; Azzouz N, 2013, GLYCOBIOLOGY, V23, P106, DOI 10.1093/glycob/cws134; CARVALHO MDD, 1984, ARCH BIOCHEM BIOPHYS, V234, P603, DOI 10.1016/0003-9861(84)90310-2; Chen XM, 2000, GASTROENTEROLOGY, V118, P368, DOI 10.1016/S0016-5085(00)70219-8; Cortes LMD, 2012, PARASITOLOGY, V139, P200, DOI 10.1017/S0031182011001910; Davies A. P., 2009, BMJ-BRIT MED J, V339, P10; Ghosh T, 2009, GLYCOBIOLOGY, V19, P2, DOI 10.1093/glycob/cwn092; Henry-Stanley MJ, 2005, SHOCK, V24, P571, DOI 10.1097/01.shk.0000184286.95493.78; Ishiwa A, 2013, PARASITOL RES, V112, P4169, DOI 10.1007/s00436-013-3608-8; Kato Kentaro, 2015, Tropical Medicine and Health, V43, P41, DOI 10.2149/tmh.2014-25; Kobayashi K., 2013, SCI REP, V3, P10; Langer RC, 2001, INFECT IMMUN, V69, P1661, DOI 10.1128/IAI.69.3.1661-1670.2001; LIANG OD, 1992, INFECT IMMUN, V60, P899; LOVE DC, 1993, J CELL BIOL, V123, P759, DOI 10.1083/jcb.123.3.759; Maruyama H, 2007, LIFE SCI, V80, P775, DOI 10.1016/j.lfs.2006.11.020; Moore RC, 1998, CELL MOTIL CYTOSKEL, V41, P168, DOI 10.1002/(SICI)1097-0169(1998)41:2<168::AID-CM7>3.0.CO;2-A; Murakoshi F, 2014, VET REC, V175, DOI 10.1136/vr.102508; ODONOGHUE PJ, 1995, INT J PARASITOL, V25, P139, DOI 10.1016/0020-7519(94)E0059-V; Ortega-Barria E, 1999, J BIOL CHEM, V274, P1267, DOI 10.1074/jbc.274.3.1267; Recuenco F. C., 2014, SCI REP, V4, P7; Sahal M, 2005, DEUT TIERARZTL WOCH, V112, P203; Slapeta J, 2013, INT J PARASITOL, V43, P957, DOI 10.1016/j.ijpara.2013.07.005; Stapulionis R, 1997, J BIOL CHEM, V272, P24980, DOI 10.1074/jbc.272.40.24980; WHITE AC, 1994, J INFECT DIS, V170, P419; Wuppermann FN, 2001, J INFECT DIS, V184, P181, DOI 10.1086/322009	53	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 1	2015	5								11599	10.1038/srep11599		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CL7PV	WOS:000357165100001		
J	Nakagawa, H; Ninomiya, T; Yamashita, T; Takada, M				Nakagawa, Hiroshi; Ninomiya, Taihei; Yamashita, Toshihide; Takada, Masahiko			Reorganization of corticospinal tract fibers after spinal cord injury in adult macaques	SCIENTIFIC REPORTS			English	Article							PRIMARY MOTOR CORTEX; FUNCTIONAL RECOVERY; CERVICAL LESION; PRECISION GRIP; MONKEYS; PROJECTIONS; INTERNEURONS; PRIMATES; MECHANISMS; PLASTICITY	Previous studies have shown that sprouting of corticospinal tract (CST) fibers after spinal cord injury (SCI) contributes to recovery of motor functions. However, the neuroanatomical mechanism underlying the functional recovery through sprouting CST fibers remains unclear. Here we investigated the pattern of reorganization of CST fibers below the lesion site after SCI in adult macaques. Unilateral lesions were made at the level between the C7 and the C8 segment. The extent of spontaneous recovery of manual dexterity was assessed with a reaching/grasping task. The impaired dexterous manual movements were gradually recovered after SCI. When anterograde tract tracing with biotinylated dextran amine was performed to identify the intraspinal reinnervation of sprouting CST fibers, it was found that the laminar distribution of CST fibers was changed. The sprouting CST fibers extended preferentially into lamia IX where the spinal motor neuron pool was located, to innervate the motor neurons directly. Instead, few, if any, CST fibers were distributed in the dorsal laminae. The present results indicate that CST fibers below the lesion site after SCI in macaques are reorganized in conjunction with the recovery of dexterous manual movements.	[Nakagawa, Hiroshi; Ninomiya, Taihei; Takada, Masahiko] Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi 4848506, Japan; [Nakagawa, Hiroshi; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka 5650871, Japan	Nakagawa, H (reprint author), Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi 4848506, Japan.	nakagawa.hiroshi.7u@kyoto-u.ac.jp			Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST);  [15H01434]	We thank Mr. K. Koide and Mr. R. Yasukochi for technical assistance in surgery. This work was supported by Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST) and Grant-in-Aid for Scientific Research on Innovative Areas (15H01434).	Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1033/jcb.200508143; Raineteau O, 2002, EUR J NEUROSCI, V16, P1761, DOI 10.1046/j.1460-9568.2002.02243.x; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Rosenzweig ES, 2009, J COMP NEUROL, V513, P151, DOI 10.1002/cne.21940; Takei T, 2013, J NEUROSCI, V33, P8850, DOI 10.1523/JNEUROSCI.4032-12.2013; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Takei T, 2010, J NEUROSCI, V30, P17041, DOI 10.1523/JNEUROSCI.4297-10.2010; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Martin JH, 2012, CLIN NEUROL NEUROSUR, V114, P515, DOI 10.1016/j.clineuro.2012.01.011; Calancie B, 2004, CLIN NEUROPHYSIOL, V115, P1748, DOI 10.1016/j.clinph.2004.03.002; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; APKARIAN AV, 1989, J COMP NEUROL, V288, P447, DOI 10.1002/cne.902880307; AXEN K, 1985, ARCH PHYS MED REHAB, V66, P219, DOI 10.1016/0003-9993(85)90146-7; Backus D, 2014, ARCH PHYS MED REHAB, V95, P1447, DOI 10.1016/j.apmr.2014.03.011; Freund P, 2009, EUR J NEUROSCI, V29, P983, DOI 10.1111/j.1460-9568.2009.06642.x; Hoogewoud Florence, 2013, Front Neurol, V4, P101, DOI 10.3389/fneur.2013.00101; Inoue K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039149; Lacroix S, 2004, J COMP NEUROL, V473, P147, DOI 10.1002/cne.20051; REXED B, 1952, J Comp Neurol, V96, P414; Schmidlin E, 2004, BRAIN RES, V1017, P172, DOI 10.1016/j.brainres.2004.05.036; Takeoka A, 2014, CELL, V159, P1626, DOI 10.1016/j.cell.2014.11.019; Yoshino-Saito K, 2010, NEUROSCIENCE, V171, P1164, DOI 10.1016/j.neuroscience.2010.10.007	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 1	2015	5								11986	10.1038/srep11986		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CL9DW	WOS:000357276800001		
J	Suehiro, K; Nakamura, Y; Xu, S; Uda, Y; Matsumura, T; Yamaguchi, Y; Okamura, H; Yamashita, T; Takei, Y				Suehiro, Kenji; Nakamura, Yuka; Xu, Shuai; Uda, Youichi; Matsumura, Takafumi; Yamaguchi, Yoshiaki; Okamura, Hitoshi; Yamashita, Toshihide; Takei, Yoshinori			Ecto-domain phosphorylation promotes functional recovery from spinal cord injury (vol 4, 4972, 2014)	SCIENTIFIC REPORTS			English	Correction									[Suehiro, Kenji; Xu, Shuai; Uda, Youichi; Matsumura, Takafumi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Kyoto, Japan; [Nakamura, Yuka; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan; [Yamaguchi, Yoshiaki; Okamura, Hitoshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biol, Kyoto, Japan; [Takei, Yoshinori] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery Sci, Kyoto, Japan	Suehiro, K (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Kyoto, Japan.						Suehiro K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04972	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 1	2015	5								11780	10.1038/srep11780		1	Multidisciplinary Sciences	Science & Technology - Other Topics	CL9DN	WOS:000357275800001		
J	Wang, QP; Jiang, Y; Zhang, JQ; Kawaharada, K; Li, LA; Wang, DJ; Ao, JP				Wang, Qingpeng; Jiang, Ying; Zhang, Jiaqi; Kawaharada, Kazuya; Li, Liuan; Wang, Dejun; Ao, Jin-Ping			A self-aligned gate GaN MOSFET using an ICP-assisted low-temperature Ohmic process	SEMICONDUCTOR SCIENCE AND TECHNOLOGY			English	Article						self-aligned gate; GaN MOSFET; inductively coupled plasma; low-temperature Ohmic		We report a new approach in fabricating a self-aligned gate GaN MOSFET. The fabrication technique is based on a double-layer photoresist (PR) and low-temperature-Ohmic formation process assisted by an inductively coupled plasma (ICP) dry etching process. In this process, the active region was automatically defined by the combination of a subsequently developed positive PR and the existing negative PR pattern. The Al Ohmic electrodes on the ICP-treated active region were formed by a lift-off process followed by 500 degrees C N-2 1 min annealing. The specific contact resistance of 4.8 x 10(-6) Omega cm(2) was obtained in this process. Operation up to a gate bias of 30 V was confirmed. The maximum output current of 98 mA mm(-1) and field-effect mobility of 110 cm(2) V-1 s(-1) were observed in the device with a gate length of 4 mu m. Some non-ideal effects in this device, including the negative threshold voltage, larger off-state leakage and unsaturated on-state drain current, were also observed and analyzed. Some possible ways to improve the performance of the device were proposed.	[Wang, Qingpeng; Jiang, Ying; Zhang, Jiaqi; Kawaharada, Kazuya; Li, Liuan; Ao, Jin-Ping] Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan; [Wang, Qingpeng; Jiang, Ying; Zhang, Jiaqi; Wang, Dejun] Dalian Univ Technol, Sch Elect Sci & Technol, Dalian 116023, Peoples R China	Wang, QP (reprint author), Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan.	jpao@ee.tokushima-u.ac.jp			State Scholarship Fund of China Scholarship Council	The authors Q Wang and Y Jiang are supported by a scholarship under the State Scholarship Fund of China Scholarship Council.	Christou A, 2008, IEEE T DEVICE MAT RE, V8, P239, DOI 10.1109/TDMR.2008.925989; Jeon CM, 2002, SOLID STATE ELECTRON, V46, P695, DOI 10.1016/S0038-1101(01)00325-2; Matocha K, 2005, IEEE T ELECTRON DEV, V52, P6, DOI 10.1109/TED.2004.841355; Matocha K, 2004, MATER SCI FORUM, V457-460, P1633; Ping AT, 1998, J ELECTRON MATER, V27, P261, DOI 10.1007/s11664-998-0397-4; Qingpeng Wang, 2014, Solid-State Electronics, V99, DOI 10.1016/j.sse.2014.05.004; Singisetti U, 2011, IEEE ELECTR DEVICE L, V32, P137, DOI 10.1109/LED.2010.2090125; Taguchi S, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201001018	8	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0268-1242	1361-6641		SEMICOND SCI TECH	Semicond. Sci. Technol.	JUL	2015	30	7							075003	10.1088/0268-1242/30/7/075003		5	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Condensed Matter	Engineering; Materials Science; Physics	CL3PG	WOS:000356861800007		
J	Jin, X; Zeng, ZY; Goto, S; Dai, QH				Jin, Xin; Zeng, Zhuoying; Goto, Satoshi; Dai, Qionghai			A fast encoder of frame-compatible format based on content similarity for 3D distribution	SIGNAL PROCESSING-IMAGE COMMUNICATION			English	Article						Frame-compatible format (FCF) coding; Fast video encoding; Content similarity; Fast average shift estimation; 3D video coding	MODE DECISION ALGORITHM; H.264/AVC INTRA-PREDICTION; VIDEO; CLASSIFICATION; OPTIMIZATION; SELECTION; DESIGN	Frame compatible format (FCF), which multiplexes the left and right eye views into one frame spatially, has been considered as one of the most promising solutions for 3D video broadcasting. In this paper, a fast algorithm exploiting the content similarity is proposed to reduce the computational complexity for coding FCF. A low complexity average shift estimation method is proposed to find the matching blocks in the two interleaved views, based on which mode candidate sets are designed for accelerating intra and inter coding of the second interleaved view (the interleaved view at the bottom/right in FCF) by exploiting inter-view correlations. The proposed algorithm achieves an average of 72.45% reduction in Intra coding complexity and an average of 81.08% reduction in Inter coding complexity for the second interleaved view, respectively, with negligible loss in compression efficiency. By combining with conventional fast algorithms, that is applying an conventional fast algorithm to code the view on the top/left and the proposed one to code the view on the bottom/right, the whole encoder provides up to 5.44 times higher encoding speed relative to applying the conventional algorithm solely to the whole frame with negligible performance degradation. (C) 2015 Elsevier B.V. All rights reserved.	[Jin, Xin; Dai, Qionghai] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Key Lab Broadband Network & Multimedia, Shenzhen, Peoples R China; [Zeng, Zhuoying] China Acad Elect & Informat Technol, Beijing, Peoples R China; [Goto, Satoshi] Waseda Univ, Grad Sch Informat Prod & Syst, Fukuoka, Japan	Jin, X (reprint author), Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Key Lab Broadband Network & Multimedia, Shenzhen, Peoples R China.	jin.xin@sz.tsinghua.edu.cn; stacey.zeng@gmail.com; goto@waseda.jp; qhdai@tsinghua.edu.cn			NSFC-Guangdong [U1201255]; NSFC, China [61371138]; Core Research for Evolution Science and Technology (CREST); Japan Science and Technology Agency (JST), Japan	This work was supported in part by the NSFC-Guangdong Joint Foundation Key Project (U1201255), project of NSFC 61371138, China and a grant from the Core Research for Evolution Science and Technology (CREST), Japan Science and Technology Agency (JST), Japan.	Yeh CH, 2014, IEEE T IND INFORM, V10, P594, DOI 10.1109/TII.2013.2273308; Tseng CH, 2006, IEEE T CIRC SYST VID, V16, P1027, DOI 10.1109/TCSVT.2006.878149; Chen ZB, 2006, J VIS COMMUN IMAGE R, V17, P264, DOI 10.1016/j.jvcir.2004.12.002; Wang JC, 2007, IEEE T CIRC SYST VID, V17, P1414, DOI 10.1109/TCSVT.2007.903786; Kwon DK, 2007, IEEE T CIRC SYST VID, V17, P517, DOI 10.1109/TCSVT.2007.894053; Liu KH, 2010, IEEE INT CON MULTI, P1214, DOI 10.1109/ICME.2010.5583884; Zeng HQ, 2010, IEEE T CIRC SYST VID, V20, P907, DOI 10.1109/TCSVT.2010.2045802; Wu D, 2005, IEEE T CIRC SYST VID, V15, P953, DOI 10.1109/TCSVT.2005.848304; Choi I, 2006, IEEE T CIRC SYST VID, V16, P1557, DOI 10.1109/TCSVT.2006.883506; Kim BG, 2008, IEEE T CIRC SYST VID, V18, P127, DOI 10.1109/TCSVT.2007.913748; Kim C, 2007, IEEE T CIRC SYST VID, V17, P441, DOI 10.1109/TCSVT.2006.888829; Tsai AC, 2008, IEEE T CIRC SYST VID, V18, P694, DOI 10.1109/TCSVT.2008.919113; [Anonymous], 2010, JTC1SC29WG11 ISOIEC; Huang YW, 2005, IEEE T CIRC SYST VID, V15, P378, DOI 10.1109/TCSVT.2004.842620; Bharanitharan K, 2008, IEEE T MULTIMEDIA, V10, P1250, DOI 10.1109/TMM.2008.2004904; Bjontegaard Gisle, 2008, 35 VCEG M BERL GERM; Domanski M., 2009, JTC1SC29WG11 ISOIEC; Feldmann I., 2008, ITC1SC29WG11 ISOIEC; HDMI Licensing, 2009, LLC ANN FEAT UPC HDM; Ho Y.S., 2008, JTC1SC29WG11 ISOIEC; Hsia C.H., 2007, P IEEE INT C INT INF, P535; Joint Video Team, 2003, ITU T REC F IN PRESS; Kuo TY, 2009, ISCAS: 2009 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-5, P864; Li HL, 2008, IEEE T CIRC SYST VID, V18, P756, DOI 10.1109/TCSVT.2008.918778; Li X., 2002, 6 M AW ISL JP DEC; Lin YY, 2010, IEEE T CIRC SYST VID, V20, P1367, DOI 10.1109/TCSVT.2010.2077482; Ma Siwei, 2005, IEEE T CIRCUITS SYST, V15; Pan F., 2004, IEEE INT C MULT EXP, V2, P1147; Pan F., 2003, 7 M PATT 2 THAIL MAR; Su Y., JTC1SC29WG11 ISOIEC; Sullivan G.J., 2009, JVTAE204; Sung YH, 2012, IEEE T MULTIMEDIA, V14, P693, DOI 10.1109/TMM.2012.2186793; Tian D., 2009, P SOC PHOTO-OPT INS, V7443; Tsai AC, 2008, IEEE T CIRC SYST VID, V18, P975; Turaga DS, 2001, IEEE T MULTIMEDIA, V3, P41, DOI 10.1109/6046.909593; Um G.M., 2008, JTC1SC29WG11 ISOIEC; Vetro A, 2010, IEEE IMAGE PROC, P2405, DOI 10.1109/ICIP.2010.5651071; Vetro A., 2005, JT1SC29WG11 ISOIEC; Vetro A., 2008, 27 M GEN CH 23 29 AP; Wang JC, 2013, IEICE T FUND ELECTR, VE96A, P2154, DOI 10.1587/transfun.E96.A.2154; Yin P., 2003, P IEEE INT C IM PROC, V2, pIII; Yin P., 2013, 6 M GEN NOV; You J, 2006, IEEE T CONSUM ELECTR, V52, P1377, DOI 10.1109/TCE.2006.273159; Yu A.C., 2004, P IEEE INT C AC SPEE, V3, pIII; Zeng Z., 2011, P ISQED, P1; Zeng Z., 2011, P 19 EUR SIGN PROC C, P1362; Zhang L., 2012, 100 MPEG M GEN SWITZ	47	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0923-5965	1879-2677		SIGNAL PROCESS-IMAGE	Signal Process.-Image Commun.	JUL	2015	35						20	34		10.1016/j.image.2015.03.007		15	Engineering, Electrical & Electronic	Engineering	CL1XK	WOS:000356738000003		
J	Scholkopf, B; Muandet, K; Fukumizu, K; Harmeling, S; Peters, J				Schoelkopf, Bernhard; Muandet, Krikamol; Fukumizu, Kenji; Harmeling, Stefan; Peters, Jonas			Computing functions of random variables via reproducing kernel Hilbert space representations	STATISTICS AND COMPUTING			English	Article						Kernel methods; Probabilistic programming; Causal inference	INDEPENDENT RANDOM-VARIABLES; SUPPORT	We describe a method to perform functional operations on probability distributions of random variables. The method uses reproducing kernel Hilbert space representations of probability distributions, and it is applicable to all operations which can be applied to points drawn from the respective distributions. We refer to our approach as kernel probabilistic programming. We illustrate it on synthetic data and show how it can be used for nonparametric structural equation models, with an application to causal inference.	[Schoelkopf, Bernhard; Muandet, Krikamol] Max Planck Inst Intelligent Syst, D-72076 Tubingen, Germany; [Fukumizu, Kenji] Inst Stat Math, Tachikawa, Tokyo, Japan; [Harmeling, Stefan] Univ Dusseldorf, Inst Informat, D-40225 Dusseldorf, Germany; [Peters, Jonas] Swiss Fed Inst Technol, Seminar Stat, CH-8092 Zurich, Switzerland	Scholkopf, B (reprint author), Max Planck Inst Intelligent Syst, D-72076 Tubingen, Germany.	bs@tuebingen.mpg.de; krikamol@tuebingen.mpg.de; fukumizu@ism.ac.jp; stefan.harmeling@uni-duesseldorf.de; peters@stat.math.ethz.ch					Gretton A, 2005, LECT NOTES ARTIF INT, V3734, P63; Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677; Fukumizu K, 2013, J MACH LEARN RES, V14, P3753; Steinwart I, 2002, J MACH LEARN RES, V2, P67; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Gretton A, 2012, J MACH LEARN RES, V13, P723; Sriperumbudur BK, 2010, J MACH LEARN RES, V11, P1517; EPSTEIN B, 1948, ANN MATH STAT, V19, P370, DOI 10.1214/aoms/1177730201; Fukumizu K, 2009, ANN STAT, V37, P1871, DOI 10.1214/08-AOS637; Gretton A, 2009, NEURAL INF PROCESS S, P131; SPRINGER MD, 1966, SIAM J APPL MATH, V14, P511, DOI 10.1137/0114046; Bach F.R., 2002, J MACHINE LEARNING R, V3, P1; Boser B, 1992, P 5 ANN WORKSH COMP, V5, P144, DOI DOI 10.1145/130385.130401; Cassel J., 2014, MATH J, V16, DOI [10.3888/tmj.16-1, DOI 10.3888/TMJ.16-1]; Ferson S, 1996, HUM ECOL RISK ASSESS, V2, P990; Fukumizu K, 2008, ADV NEURAL INFORM PR, V20, P489; Gordon A. D., 2014, INT C SOFTW ENG ICSE; Harmeling S, 2013, PROC CVPR IEEE, P1083, DOI 10.1109/CVPR.2013.144; Huang J., 2007, ADV NEURAL INFORM PR, V19, P601; James W., 1961, P 4 BERK S MATH STAT, V1, P361; Kanagawa M., 2014, JMLR W CP, V33, P457; Jaroszewicz S, 2012, SIAM J SCI COMPUT, V34, pA1241, DOI 10.1137/110839680; Kpotufe S., 2014, ICML; Lopez-Paz D., 2015, P 32 INT C IN PRESS; Milios D., 2009, THESIS U EDINBURGH; Mooij J. M., 2014, ARXIV14123773; Muandet K., 2014, JMLR W CP, V32; Muandet K., 2014, ADV NEURAL INFORM PR, V27; Muandet K., 2012, ADV NEURAL INFORM PR, V25, P10; Muandet K., 2013, ICML, P10; Paige B., 2014, J MACHINE LEARNING R, P1935; Pearl J., 2009, CAUSALITY MODELS REA; Peters J, 2014, J MACH LEARN RES, V15, P2009; PRASAD RD, 1970, SIAM J APPL MATH, V18, P614, DOI 10.1137/0118054; Rahimi A., 2007, ADV NEURAL INFORM PR, V20, P1177; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Smola A., 2007, P 18 INT C ALG LEARN, P13; Smola A., 2002, LEARNING KERNELS; Song L., 2008, THESIS U SYDNEY; Song L., 2011, P 14 INT C ART INT S; Song L., 2008, P 25 INT C MACH LEAR, P992, DOI 10.1145/1390156.1390281; Song L., 2010, P 27 INT C MACH LEAR; Song L., 2009, ICML; Springer Melvin Dale, 1979, WILEY SERIES PROBABI; Sriperumbudur B. K., 2008, 21 ANN C LEARN THEOR; Steinwart I, 2008, INFORM SCI STAT, P1; Szabo Z., 2014, ARXIV14021754; Thomas-Agnan C., 2004, REPRODUCING KERNEL H; Williamson R., 1989, THESIS U QUEENSLAND; Wood F., 2014, JMLR W CP, V33; Zhang K., 2011, 27 C UNC ART INT UAI, P804	51	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0960-3174	1573-1375		STAT COMPUT	Stat. Comput.	JUL	2015	25	4			SI		755	766		10.1007/s11222-015-9558-5		12	Computer Science, Theory & Methods; Statistics & Probability	Computer Science; Mathematics	CL3CZ	WOS:000356828600006		
J	Vo, DKH; Urano, Y; Takabe, W; Saito, Y; Noguchi, N				Vo, Diep-Khanh Ho; Urano, Yasuomi; Takabe, Wakako; Saito, Yoshiro; Noguchi, Noriko			24(S)-Hydroxycholesterol induces RIPK1-dependent but MLKL-independent cell death in the absence of caspase-8	STEROIDS			English	Article						24S-Hydroxycholesterol; Cell death; Necroptosis; Receptor-interacting protein kinase 1; Mixed lineage kinase domain-like	MIXED LINEAGE KINASE; PROGRAMMED NECROSIS; DOMAIN-LIKE; MOLECULAR-MECHANISMS; TNF-ALPHA; 24S-HYDROXYCHOLESTEROL; NECROPTOSIS; CHOLESTEROL; PLASMA; RIP3	24(S)-Hydroxycholesterol (24S-OHC), which is enzymatically produced in the brain, is known to play an important role in maintaining brain cholesterol homeostasis. We have previously reported that 24S-OHC induces a type of non-apoptotic programmed necrosis in neuronal cells expressing little caspase-8. Necroptosis has been characterized as a type of programmed necrosis in which activation of receptor-interacting protein kinase 1 (RIPK1), RIPK3, and mixed lineage kinase domain-like (MLKL) is involved in the signaling pathway. In the present study, we investigated the involvement of these three proteins in 24S-OHC-induced cell death. We found that RIPK1 but neither RIPK3 nor MLKL was expressed in human neuroblastoma SH-SY5Y cells, while all three proteins were expressed in human T lymphoma caspase-8-deficient Jurkat (Jurkat(Cas8-/-)) cells. In Jurkat(Cas8-/-) cells, tumor necrosis factor alpha (TNF alpha)-induced cell death was significantly suppressed by treatment with respective inhibitors of RIPK1, RIPK3, and MLKL. In contrast, only RIPK1 inhibitor showed significant suppression of 24S-OHC-induced cell death, and even this was less prominent than was observed in TNF alpha-induced cell death. In Jurkat(Cas8-/-) cells, knockdown of either RIPK1 or RIPK3 caused moderate but significant suppression of 24S-OHC-induced cell death, but no such effect was observed as a result of knockdown of MLKL. Collectively, these results suggest that, for both SH-SY5Y cells and Jurkat(Cas8-/-) cells, 24S-OHC-induced cell death is dependent on RIPK1 but not on MLKL. We therefore conclude that, in the absence of caspase-8 activity, 24S-OHC induces a necroptosis-like cell death which is RIPK1-dependent but MLKL-independent. (C) 2015 Elsevier Inc. All rights reserved.	[Vo, Diep-Khanh Ho; Urano, Yasuomi; Takabe, Wakako; Saito, Yoshiro; Noguchi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Med Life Syst, Syst Life Sci Lab, Kyotanabe, Kyoto 6100394, Japan	Vo, DKH (reprint author), Doshisha Univ, Fac Life & Med Sci, Dept Med Life Syst, Syst Life Sci Lab, 1-3 Miyakodani, Kyotanabe, Kyoto 6100394, Japan.	yurano@mail.doshisha.ac.jp; nnoguchi@mail.doshisha.ac.jp			KAKENHI [25830041]; Adaptable and Seamless Technology Transfer Program through target-driven RD, JST; Foundation of Cosmetology Research; MEXT-Supported Program for the Strategic Research Foundation at Private Universities in Japan	We thank Kowa Co. Ltd (Aichi, Japan) for providing valuable reagents. We also thank Dr. Gerry Peters for his careful editing of the manuscript. This work was supported in part by KAKENHI Grant-in-Aid for Young Scientists (B), 25830041 to Y.U., Adaptable and Seamless Technology Transfer Program through target-driven R&D, JST to Y.U., the Foundation of Cosmetology Research to N.N., and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities in Japan for years 2012-2016.	Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Galluzzi L, 2014, CELL RES, V24, P139, DOI 10.1038/cr.2014.8; Cheung HH, 2009, CANCER RES, V69, P7729, DOI 10.1158/0008-5472.CAN-09-1794; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Noguchi N, 2014, BIOCHEM BIOPH RES CO, V446, P692, DOI 10.1016/j.bbrc.2014.02.010; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Luedde M, 2014, CARDIOVASC RES, V103, P206, DOI 10.1093/cvr/cvu146; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Bjorkhem I, 2013, NEUROSCI LETT, V555, P102, DOI 10.1016/j.neulet.2013.09.003; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Lee CYJ, 2009, ANTIOXID REDOX SIGN, V11, P407, DOI 10.1089/ARS.2008.2179; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Brown J, 2004, J BIOL CHEM, V279, P34674, DOI 10.1074/jbc.M402324200; Yamanaka K, 2011, J BIOL CHEM, V286, P24666, DOI 10.1074/jbc.M111.236273; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bretillon L, 2000, NEUROSCI LETT, V293, P87, DOI 10.1016/S0304-3940(00)01466-X; Wilson CA, 2002, CELL DEATH DIFFER, V9, P1321, DOI 10.1038/sj.cdd.4401107; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Lehmann JM, 1997, J BIOL CHEM, V272, P3137; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Lutjohann D, 2000, J LIPID RES, V41, P195; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Cook WD, 2014, CELL DEATH DIFFER, V21, P1600, DOI 10.1038/cdd.2014.70; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Okabe A, 2014, REDOX BIOL, V2, P28, DOI 10.1016/j.redox.2013.11.007; Saito Y, 2007, FREE RADICAL BIO MED, V42, P675, DOI 10.1016/j.freeradbiomed.2006.12.004; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Urano Y, 2013, FASEB J, V27, P4305, DOI 10.1096/fj.13-231456; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Wu XN, 2014, CELL DEATH DIFFER, V21, P1709, DOI 10.1038/cdd.2014.77; Yamanaka K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.524	40	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0039-128X	1878-5867		STEROIDS	Steroids	JUL	2015	99		B		SI		230	237		10.1016/j.steroids.2015.02.007		8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CL5FK	WOS:000356985000017		
J	Osako, T; Uozumi, Y				Osako, Takao; Uozumi, Yasuhiro			Mechanistic Insights into Copper-Catalyzed Azide-Alkyne Cycloaddition (CuAAC): Observation of Asymmetric Amplification	SYNLETT			English	Article						asymmetric catalysis; azide-alkyne cycloaddition; Huisgen reaction; nonlinear effect	CLICK CHEMISTRY; ORGANIC AZIDES; REACTIVITY; ACETYLIDES; COMPLEX	A mechanistic study of copper-catalyzed azide-alkyne cycloaddition (CuAAC) was examined using an enantioposition-selective asymmetric CuAAC as a probe reaction system. Based on the observed asymmetric amplification (a positive nonlinear effect), we proposed that a dimeric chiral copper complex is involved as a reactive intermediate in the copper-catalyzed azide-alkyne cycloaddition.	[Osako, Takao; Uozumi, Yasuhiro] IMS, Okazaki, Aichi 4448787, Japan; [Uozumi, Yasuhiro] RIKEN Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan	Uozumi, Y (reprint author), IMS, Okazaki, Aichi 4448787, Japan.	uo@ims.ac.jp	Osako, Takao/A-4402-2009		JST-ACCEL program; JST-CREST program; JSPS [2105, 22750141, 26810099]; Shionogi Co., Ltd.	This work was supported by the JST-ACCEL and the JST-CREST programs. We appreciate the partial funding from the JSPS (Grant-in-Aid for Scientific Research on Innovative Area no. 2105; Grant-in-Aid for young scientists (B) no. 22750141, 26810099) and from Shionogi & Co., Ltd. (Shionogi Award in Synthetic Organic Chemistry).	Agalave SG, 2011, CHEM-ASIAN J, V6, P2696, DOI 10.1002/asia.201100432; Yamada YMA, 2012, J AM CHEM SOC, V134, P9285, DOI 10.1021/ja3036543; Lallana E, 2011, ANGEW CHEM INT EDIT, V50, P8794, DOI 10.1002/anie.201101019; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Moses JE, 2007, CHEM SOC REV, V36, P1249, DOI 10.1039/b613014n; Hein JE, 2010, CHEM SOC REV, V39, P1302, DOI 10.1039/b904091a; Wu P, 2007, ALDRICHIM ACTA, V40, P7; Zhou F, 2013, J AM CHEM SOC, V135, P10994, DOI 10.1021/ja4066656; Meng JC, 2005, TETRAHEDRON LETT, V46, P4543, DOI 10.1016/j.tetlet.2005.05.019; Ahlquist M, 2007, ORGANOMETALLICS, V26, P4389, DOI 10.1021/om700669v; Rodionov VO, 2005, ANGEW CHEM INT EDIT, V44, P2210, DOI 10.1002/anie.200461496; Himo F, 2005, J AM CHEM SOC, V127, P210, DOI 10.1021/ja0471525; GUILLANEUX D, 1994, J AM CHEM SOC, V116, P9430, DOI 10.1021/ja00100a004; Partyka DV, 2009, ORGANOMETALLICS, V28, P6171, DOI 10.1021/om9005774; Presolski SI, 2010, J AM CHEM SOC, V132, P14570, DOI 10.1021/ja105743g; Kuang GC, 2011, J AM CHEM SOC, V133, P13984, DOI 10.1021/ja203733q; Hein JE, 2009, ANGEW CHEM INT EDIT, V48, P8018, DOI 10.1002/anie.200903558; Osako T, 2012, ORG LETT, V14, P194, DOI 10.1021/ol202977j; Worrell BT, 2013, SCIENCE, V340, P457, DOI 10.1126/science.1229506; Bock VD, 2006, EUR J ORG CHEM, P51, DOI 10.1002/ejoc.200500483; Brase S., 2010, ORGANIC AZIDES SYNTH; HAYASHI T, 1995, J AM CHEM SOC, V117, P9101, DOI 10.1021/ja00140a041; Johnson DW, 1999, J AM CHEM SOC, V121, P9307, DOI 10.1021/ja991921g; Kagan HB, 2001, SYNLETT, P888; Kagan H. B., 1988, TOP STEREOCHEM, V18, P249, DOI 10.1002/9780470147276.ch4; Kamikawa T, 1996, TETRAHEDRON LETT, V37, P3161, DOI 10.1016/0040-4039(96)00517-5; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5; Osako T, 2014, ORG LETT, V16, P5866, DOI 10.1021/ol502778j; Rodionov L. O., 2007, J AM CHEM SOC, V129, P12705; Saaby S, 2003, CHEM-EUR J, V9, P6145, DOI 10.1002/chem.200305302; Straub BF, 2007, CHEM COMMUN, P3868, DOI 10.1039/b706926j; Zhou HF, 2013, SYNLETT, V24, P2550, DOI 10.1055/s-0033-1339873; Zhou YH, 2010, ANGEW CHEM INT EDIT, V49, P2607, DOI 10.1002/anie.200907016	33	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUL	2015	26	11					1475	1479		10.1055/s-0034-1380534		5	Chemistry, Organic	Chemistry	CL3OJ	WOS:000356859200009		
J	Tanaka, S; Ashida, K; Tatsuta, G; Mori, A				Tanaka, Shota; Ashida, Kana; Tatsuta, Go; Mori, Atsunori			Preparation of Fluorescent Materials from Biomass-Derived Furfural and Natural Amino Acid Cysteine through Cross-Coupling Reactions for Extended pi-Conjugation	SYNLETT			English	Article						furfural; l-cysteine; cross-coupling; pi-conjugation; photoluminescence	CATALYZED DIRECT ARYLATION; TAIL-TYPE OLIGOTHIOPHENES; C-H; HETEROAROMATIC-COMPOUNDS; SOLAR-CELLS; 3-SUBSTITUTED THIOPHENES; ORGANIC SEMICONDUCTORS; ARYL HALIDES; EFFICIENT; DESIGN	Preparation of 2-furylthiazole-4-carboxylic acid methyl ester is achieved in four steps from biomass-derived heteroaromatic compound furfural and a natural amino acid l-cysteine. One-pot bromination and following palladium-catalyzed arylation with arylboronates of the thus obtained furylthiazole at the furan ring gives arylated furylthiazole in excellent yields. Further arylation at the C-H bond of the thiazole ring (5-position) in the presence of AgF as an additive leads to diarylated furylthiazoles, which show strong photoluminescence. Homocoupling at the C-H bond of thiazole is also carried out with AgF to afford the corresponding further conjugated product composed of eight (hetero)aromatic rings.	[Tanaka, Shota; Ashida, Kana; Tatsuta, Go; Mori, Atsunori] Kobe Univ, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Mori, A (reprint author), Kobe Univ, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	amori@kobe-u.ac.jp	Mori, Atsunori/C-2476-2011	Mori, Atsunori/0000-0002-1163-264X	Special Coordination Funds for Promoting Science and Technology; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe); MEXT, Japan [26620146]; JSPS	This work was supported financially by Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe) and Kakenhi (Challenging Exploratory Research # 26620146, 2014-2016) by MEXT, Japan. ST thanks JSPS for the Research Fellowship for Young Scientists.	Mo FY, 2010, ANGEW CHEM INT EDIT, V49, P2028, DOI 10.1002/anie.200906699; Masuda N, 2009, ORG LETT, V11, P2297, DOI 10.1021/ol900622h; SHEPPARD WA, 1962, J AM CHEM SOC, V84, P3072, DOI 10.1021/ja00875a007; Karinen R, 2011, CHEMSUSCHEM, V4, P1002, DOI 10.1002/cssc.201000375; Mori A, 2003, J AM CHEM SOC, V125, P1700, DOI 10.1021/ja0269189; Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; Daugulis O, 2009, ACCOUNTS CHEM RES, V42, P1074, DOI 10.1021/ar9000058; Murphy AR, 2007, CHEM REV, V107, P1066, DOI 10.1021/cr0501386; Satoh T, 2007, CHEM LETT, V36, P200, DOI 10.1246/cl.2007.200; Ackermann L, 2011, CHEM REV, V111, P1315, DOI 10.1021/cr100412j; Cho SH, 2011, CHEM SOC REV, V40, P5068, DOI 10.1039/c1cs15082k; Chheda JN, 2007, ANGEW CHEM INT EDIT, V46, P7164, DOI 10.1002/anie.200604274; Tanaka S, 2013, CHEM-EUR J, V19, P1658, DOI 10.1002/chem.201203331; Warnan J, 2014, CHEM MATER, V26, P2299, DOI 10.1021/cm500172w; Maltsev OV, 2013, SYNTHESIS-STUTTGART, V45, P2763, DOI 10.1055/s-0033-1339492; Mori A, 2008, B CHEM SOC JPN, V81, P548, DOI 10.1246/bcsj.81.548; Allard S, 2008, ANGEW CHEM INT EDIT, V47, P4070, DOI 10.1002/anie.200701920; Tachibana Y, 2010, BIOMACROMOLECULES, V11, P2760, DOI 10.1021/bm100820y; Tanaka S, 2011, J AM CHEM SOC, V133, P16734, DOI 10.1021/ja205953g; Li C, 2010, CHEM REV, V110, P6817, DOI 10.1021/cr100052z; Hayashi M, 2008, CHEM REC, V8, P252, DOI 10.1002/tcr.20152; Masui K, 2004, ORG LETT, V6, P2011, DOI 10.1021/ol049386z; Ackermann L, 2009, ANGEW CHEM INT EDIT, V48, P9792, DOI 10.1002/anie.200902996; Roger J, 2010, CHEMCATCHEM, V2, P20, DOI 10.1002/cctc.200900074; Nielsen CB, 2013, PROG POLYM SCI, V38, P2053, DOI 10.1016/j.progpolymsci.2013.05.003; Kobayashi K, 2005, ORG LETT, V7, P5083, DOI 10.1021/ol052063y; Monguchi D, 2009, ORG LETT, V11, P1607, DOI 10.1021/ol900298e; Gurbuz EI, 2013, ANGEW CHEM INT EDIT, V52, P1270, DOI 10.1002/anie.201207334; Sutton AD, 2013, NAT CHEM, V5, P428, DOI 10.1038/nchem.1609; Binder JB, 2009, J AM CHEM SOC, V131, P1979, DOI 10.1021/ja808537j; Seregin IV, 2007, CHEM SOC REV, V36, P1173, DOI 10.1039/b606984n; Yiu AT, 2012, J AM CHEM SOC, V134, P2180, DOI 10.1021/ja2089662; Chang F, 2014, J AGR FOOD CHEM, V62, P476, DOI 10.1021/jf4045843; Masui K, 2004, J AM CHEM SOC, V126, P5074, DOI 10.1021/ja031855p; Roman-Leshkov Y, 2006, SCIENCE, V312, P1933, DOI 10.1126/science.1126337; Wegenhart BL, 2012, ACS CATAL, V2, P2524, DOI 10.1021/cs300562e; Mishra A, 2009, CHEM REV, V109, P1141, DOI 10.1021/cr8004229; Tamba S, 2010, J ORG CHEM, V75, P6998, DOI [10.1021/jo101433g, 10.1021/jo.101433g]; Campeau LC, 2006, CHEM COMMUN, P1253, DOI 10.1039/B515481M; Dhayalan V, 2012, SYNTHESIS-STUTTGART, V44, P2209, DOI 10.1055/s-0031-1289772; Diederich F., 1998, METAL CATALYZED CROS; He JX, 2012, CHEM-EUR J, V18, P7903, DOI 10.1002/chem.201103702; Lichtenthaler FW, 2002, ACCOUNTS CHEM RES, V35, P728, DOI 10.1021/ar010071i; McGlacken GP, 2009, CHEM SOC REV, V38, P2447, DOI 10.1039/b805701j; Takimiya K, 2014, ACCOUNTS CHEM RES, V47, P1493, DOI 10.1021/ar400282g; Tanaka S, 2012, TETRAHEDRON LETT, V53, P1173, DOI 10.1016/j.tetlet.2011.12.108; Tsuji H, 2014, SYNLETT, V25, P2099, DOI 10.1055/s-0034-1378232; Yamaguchi J, 2013, EUR J ORG CHEM, P19, DOI 10.1002/ejoc.201200914	48	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUL	2015	26	11					1496	1500		10.1055/s-0034-1380460		5	Chemistry, Organic	Chemistry	CL3OJ	WOS:000356859200013		
J	Maji, B; Yamamoto, H				Maji, Biplab; Yamamoto, Hisashi			Asymmetric Synthesis of Tertiary alpha-Hydroxy Phosphonic Acid Derivatives under Aerobic Oxidation Conditions	SYNLETT			English	Article						nitrosocarbonyl compounds; copper; bisoxazoline; alpha-hydroxy phosphonic acid; aerobic oxidation	GENERATED NITROSOCARBONYL COMPOUNDS; BETA-KETO PHOSPHONATES; HIGHLY ENANTIOSELECTIVE HYDROPHOSPHONYLATION; DIELS-ALDER REACTIONS; NITROSO-ENE REACTION; NATURAL-PRODUCTS; THIOUREA ORGANOCATALYSTS; ALDOL REACTION; ALDEHYDES; CATALYSIS	The copper-catalyzed asymmetric -hydroxylation of -ketophosphonates, using in situ generated nitrosocarbonyl compounds as electrophilic source of oxygen, is reported. The reaction merges aerobic oxidation and Lewis acid catalysis. -Aminoxy--ketophosphonates were synthesized in high yields (up to 97% yield) and high enantioselectivities (up to >99% ee).	[Maji, Biplab; Yamamoto, Hisashi] Chubu Univ, Mol Catalyst Res Ctr, Kasugai, Aichi 4878501, Japan	Maji, B (reprint author), Chubu Univ, Mol Catalyst Res Ctr, 1200 Matsumoto Cho, Kasugai, Aichi 4878501, Japan.	biplabmaji@isc.chubu.ac.jp; hyamamoto@isc.chubu.ac.jp	Yamamoto, Hisashi/G-6344-2011		Advance Catalytic Transformation program for Carbon utilization; Uehara Memorial Foundation; Nippon Pharmaceutical Chemicals Co., Ltd, Ltd; Advance Electric Co., Inc.;  [23225002]	This work is supported by a Grant-in-Aid for Scientific Research (No. 23225002), Advance Catalytic Transformation program for Carbon utilization, The Uehara Memorial Foundation, Nippon Pharmaceutical Chemicals Co., Ltd, Ltd, and Advance Electric Co., Inc.	Adam W, 2003, CHEM REV, V103, P4131, DOI 10.1021/cr030004x; Frazier CP, 2013, CHEM SCI, V4, P3857, DOI 10.1039/c3sc51658j; Maji B, 2014, CHEM SCI, V5, P3941, DOI 10.1039/c4sc01272k; Vogt PF, 1998, TETRAHEDRON, V54, P1317, DOI 10.1016/S0040-4020(97)10072-2; Sandoval D, 2012, J AM CHEM SOC, V134, P18948, DOI 10.1021/ja310784f; Uraguchi D, 2009, J AM CHEM SOC, V131, P3836, DOI 10.1021/ja810043d; Uraguchi D, 2010, CHEM SCI, V1, P488, DOI 10.1039/c0sc00268b; Chen XH, 2008, CHEM-EUR J, V14, P10896, DOI 10.1002/chem.200801958; Baidya M, 2012, J AM CHEM SOC, V134, P18566, DOI 10.1021/ja309311z; Kong SS, 2012, ANGEW CHEM INT EDIT, V51, P8864, DOI 10.1002/anie.201204287; Kim SM, 2005, ORG LETT, V7, P2309, DOI 10.1021/ol050413a; Frazier CP, 2011, J AM CHEM SOC, V133, P10430, DOI 10.1021/ja204603u; Xu CM, 2014, ANGEW CHEM INT EDIT, V53, P4149, DOI 10.1002/anie.201400776; Baidya M, 2013, SYNTHESIS-STUTTGART, V45, P1931, DOI 10.1055/s-0033-1339175; KIRBY GW, 1977, CHEM SOC REV, V6, P1, DOI 10.1039/cs9770600001; Fields SC, 1999, TETRAHEDRON, V55, P12237, DOI 10.1016/S0040-4020(99)00701-2; Kano T, 2014, ORG LETT, V16, P1530, DOI 10.1021/ol5000742; STOWASSER B, 1992, TETRAHEDRON LETT, V33, P6625, DOI 10.1016/S0040-4039(00)61002-X; Tao M, 1998, J MED CHEM, V41, P3912, DOI 10.1021/jm980325e; Albrecht L, 2010, CHEM-EUR J, V16, P28, DOI 10.1002/chem.200902634; Chaiyaveij D, 2011, ORG LETT, V13, P3442, DOI 10.1021/ol201188d; Maly A, 2003, TETRAHEDRON-ASYMMETR, V14, P1019, DOI 10.1016/S0957-4166(03)00177-0; Metcalf WW, 2009, ANNU REV BIOCHEM, V78, P65, DOI 10.1146/annurev.biochem.78.091707.100215; Iwasa S, 2005, MINI-REV ORG CHEM, V2, P157, DOI 10.2174/1570193053544445; DELLARIA JF, 1990, J MED CHEM, V33, P534, DOI 10.1021/jm00164a011; Wiemer DF, 1997, TETRAHEDRON, V53, P16609, DOI 10.1016/S0040-4020(97)10305-2; Maji B, 2014, ANGEW CHEM INT EDIT, V53, P8714, DOI 10.1002/anie.201311069; Bernardi L, 2005, J AM CHEM SOC, V127, P5772, DOI 10.1021/ja050989v; Szymanska A, 2006, BIOORGAN MED CHEM, V14, P1924, DOI 10.1016/j.bmc.2005.10.048; Hargaden GC, 2009, CHEM REV, V109, P2505, DOI 10.1021/cr800400z; Johnson JS, 2000, ACCOUNTS CHEM RES, V33, P325, DOI 10.1021/ar960062n; ENGEL R, 1977, CHEM REV, V77, P349, DOI 10.1021/cr60307a003; Frings M, 2014, CHEM-EUR J, V20, P1691, DOI 10.1002/chem.201304331; Frazier CP, 2012, ORG LETT, V14, P3620, DOI 10.1021/ol301414k; Hatano M, 2013, ANGEW CHEM INT EDIT, V52, P4549, DOI 10.1002/anie.201300938; Lin AJ, 2011, ADV SYNTH CATAL, V353, P545, DOI 10.1002/adsc.201000679; Abell JP, 2008, J AM CHEM SOC, V130, P10521, DOI 10.1021/ja803859p; Kano T, 2013, J AM CHEM SOC, V135, P18036, DOI 10.1021/ja4099627; Arai T, 1996, J ORG CHEM, V61, P2926, DOI 10.1021/jo960180o; Azema L, 2006, CURR ENZYME INHIB, V2, P61, DOI 10.2174/157340806775473526; BLAZEWSKA KM, 2011, J MED CHEM, V46, P4820; Bodnar BS, 2011, ANGEW CHEM INT EDIT, V50, P5629, DOI 10.1002/anie.201005764; BRILL E, 1974, EXPERIENTIA, V30, P835, DOI 10.1007/BF01924218; Desimoni G, 2011, CHEM REV, V111, pPR284, DOI 10.1021/cr100339a; Failla S, 2000, HETEROATOM CHEM, V11, P493, DOI 10.1002/1098-1071(2000)11:7<493::AID-HC7>3.0.CO;2-A; Gondi VB, 2009, ANGEW CHEM INT EDIT, V48, P776, DOI 10.1002/anie.200804244; Goulioukina NS, 2009, EUR J ORG CHEM, P510, DOI 10.1002/ejoc.200800943; Groger H., 2000, CHEM-EUR J, V6, P943; Horiguchi M., 1984, BIOCH NATURAL C P CO, P24; Huang JL, 2008, ADV SYNTH CATAL, V350, P287, DOI 10.1002/adsc.200700392; Kafarski P, 2004, J MOL CATAL B-ENZYM, V29, P99, DOI 10.1016/j.molcatb.2003.12.013; KIBAYASHI C, 1995, SYNLETT, P873; KIRBY GW, 1973, J CHEM SOC CHEM COMM, P704, DOI 10.1039/c39730000704; KORN ED, 1973, J BIOL CHEM, V248, P2257; Maji B, 2014, ANGEW CHEM INT EDIT, V53, P14472, DOI 10.1002/anie.201408893; McKenna CE, 2010, J MED CHEM, V53, P3454, DOI 10.1021/jm900232u; Moore Michael L., 1993, Perspectives in Drug Discovery and Design, V1, P85, DOI 10.1007/BF02171657; OGITA T, 1983, TETRAHEDRON LETT, V24, P2283, DOI 10.1016/S0040-4039(00)81904-8; Oleg I. K., 2011, RUSS CHEM REV, V80, P883; Palmer LI, 2014, SYNTHESIS-STUTTGART, V46, P269, DOI 10.1055/s-0033-1338569; Samanta S, 2006, J AM CHEM SOC, V128, P7442, DOI 10.1021/ja062091r; Shibata M, 2012, CHEM COMMUN, V48, P9528, DOI 10.1039/c2cc35262a; Sobhani S, 2010, TETRAHEDRON, V66, P1429, DOI 10.1016/j.tet.2009.11.081; Suyama K, 2010, ANGEW CHEM INT EDIT, V49, P797, DOI 10.1002/anie.200905158; Wang CB, 2012, ORG BIOMOL CHEM, V10, P1680, DOI 10.1039/c1ob06669b; Wang F, 2009, CHEM-EUR J, V15, P589, DOI 10.1002/chem.200802237; Watanabe Y, 2001, LIPIDS, V36, P513, DOI 10.1007/s11745-001-0751-3; Wuggenig F, 1998, MONATSH CHEM, V129, P423, DOI 10.1007/PL00000099; Yamamoto Y, 2006, EUR J ORG CHEM, P2031, DOI 10.1002/ejoc.200500847; Zhou X, 2008, ANGEW CHEM INT EDIT, V47, P392, DOI 10.1002/anie.200704116	70	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUL	2015	26	11					1528	1532		10.1055/s-0034-1380290		5	Chemistry, Organic	Chemistry	CL3OJ	WOS:000356859200020		
J	Komori, T; Yokoshima, S; Fukuyama, T				Komori, Takashi; Yokoshima, Satoshi; Fukuyama, Tohru			Synthetic Studies on Plakinidines	SYNLETT			English	Article						acridine; alkaloids; aromatization; Dieckmann condensation; Friedlander quinoline synthesis	NATURAL-PRODUCTS; ARYL HALIDES; EFFICIENT; DIDEMNUM; AMINES; SPONGE; ETHERS	A synthetic route to the pentacyclic core of the plakinidines was developed. Our synthesis features the construction of the fused heterocycles (the A and the E rings) by the formation of carbon-nitrogen bonds using carbonyl functions prior to the late-stage aromatization of the B ring.	[Komori, Takashi] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yokoshima, Satoshi; Fukuyama, Tohru] Nagoya Univ, Grad Sch Pharmaceut Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Fukuyama, T (reprint author), Nagoya Univ, Grad Sch Pharmaceut Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	fukuyama@ps.nagoya-u.ac.jp			JSPS KAKENHI [20002004, 25221301, 26713001]; Platform for Drug Discovery, Informatics, and Structural Life Science (MEXT)	This work was financially supported by JSPS KAKENHI (Grant Numbers 20002004, 25221301, 26713001) and the Platform for Drug Discovery, Informatics, and Structural Life Science (MEXT).	BOEKELHEIDE V, 1954, J AM CHEM SOC, V76, P1286, DOI 10.1021/ja01634a026; Lu ZY, 2013, NAT CHEM, V5, P679, DOI [10.1038/nchem.1694, 10.1038/NCHEM.1694]; Ma DW, 2008, ACCOUNTS CHEM RES, V41, P1450, DOI 10.1021/ar8000298; Evano G, 2008, CHEM REV, V108, P3054, DOI 10.1021/cr8002505; Kitahara Y, 2004, TETRAHEDRON, V60, P4283, DOI 10.1016/j.tet.2004.03.057; Smith CJ, 1997, J NAT PROD, V60, P1048, DOI 10.1021/np970311w; Okano K, 2014, CHEM COMMUN, V50, P13650, DOI 10.1039/c4cc03895a; Navarro I, 2008, J AM CHEM SOC, V130, P10293, DOI 10.1021/ja803445u; WEST RR, 1990, TETRAHEDRON LETT, V31, P3271, DOI 10.1016/S0040-4039(00)89041-3; INMAN WD, 1990, J AM CHEM SOC, V112, P1, DOI 10.1021/ja00157a001; Buchwald SL, 2006, ADV SYNTH CATAL, V348, P23, DOI 10.1002/adsc.200505158; Ford PW, 1997, J NAT PROD, V60, P1051, DOI 10.1021/np970312o; Hartwig JF, 1998, ACCOUNTS CHEM RES, V31, P852, DOI 10.1021/ar970282g; Hartwig JF, 2006, SYNLETT, P1283, DOI 10.1055/s-2006-939728; Hartwig JF, 2008, ACCOUNTS CHEM RES, V41, P1534, DOI 10.1021/ar800098p; Hartwig JF, 1998, ANGEW CHEM INT EDIT, V37, P2046, DOI 10.1002/(SICI)1521-3773(19980817)37:15<2046::AID-ANIE2046>3.0.CO;2-L; Hatano M, 2006, J AM CHEM SOC, V128, P9998, DOI 10.1021/ja0628405; Li J, 2014, J AM CHEM SOC, V136, P16477, DOI 10.1021/ja5092563; Newton CG, 2015, NAT CHEM, V7, P82, DOI [10.1038/nchem.2112, 10.1038/NCHEM.2112]; SAKAMOTO T, 1981, CHEM PHARM BULL, V29, P2485; Varala R, 2006, SYNTHESIS-STUTTGART, P3825, DOI 10.1055/s-2006-950296; Wolfe JP, 1998, ACCOUNTS CHEM RES, V31, P805, DOI 10.1021/ar9600650	22	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUL	2015	26	11					1537	1540		10.1055/s-0034-1380689		4	Chemistry, Organic	Chemistry	CL3OJ	WOS:000356859200022		
J	Nishimura, H; Eliseeva, MN; Wakamiya, A; Scott, LT				Nishimura, Hidetaka; Eliseeva, Maria N.; Wakamiya, Atsushi; Scott, Lawrence T.			1,3,5,7-Tetra(Bpin)azulene by Exhaustive Direct Borylation of Azulene and 5,7-Di(Bpin)azulene by Selective Subsequent Deborylation	SYNLETT			English	Article						iridium; palladium; catalysis; C-H activation; Suzuki coupling; synthesis; methodology; functionalization	POLYBORYLATION	Exhaustive borylation of azulene with excess bis(pinacolato)-diboron (B(2)pin(2)) under conditions that promote equilibration of the borylated azulenes provides a convenient one-step synthesis of 1,3,5,7-tetra(Bpin)azulene as the major product. The Bpin substituents at positions 1 and 3 can be conveniently removed from 1,3,5,7-tetra-(Bpin)azulene by treatment with trifluoroacetic acid at room temperature to give 5,7-di(Bpin)azulene. The utility of 5,7-di(Bpin)azulene as a synthetic precursor to 5,7-disubstituted azulenes that are otherwise difficult to access is demonstrated by Suzuki coupling to give the previously unknown 5,7-diphenylazulene.	[Nishimura, Hidetaka; Wakamiya, Atsushi] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Eliseeva, Maria N.; Scott, Lawrence T.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA	Scott, LT (reprint author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	lawrence.scott@bc.edu			National Science Foundation; Department of Energy; PRESTO, Japan Science and Technology Agency; Mazume Research Encouragement Prize in Kyoto University	This work was supported financially by the National Science Foundation, the Department of Energy, and PRESTO, Japan Science and Technology Agency. We are grateful to Prof. Yasujiro Murata at Kyoto University for his generous support of this work. H.N. thanks the Mazume Research Encouragement Prize in Kyoto University for a fellowship.	ANDERSON AG, 1950, J AM CHEM SOC, V72, P3824, DOI 10.1021/ja01164a528; ANDERSON AG, 1953, J AM CHEM SOC, V75, P4980, DOI 10.1021/ja01116a030; Xia JL, 2014, NANO LETT, V14, P2941, DOI 10.1021/nl5010702; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Eliseeva MN, 2012, J AM CHEM SOC, V134, P15169, DOI 10.1021/ja307547j; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Fujinaga M, 2009, TETRAHEDRON, V65, P7115, DOI 10.1016/j.tet.2009.06.053; Coulson C. A., 1961, VALENCE; Dubovik J, 2015, SYNTHESIS-STUTTGART, V47, P538, DOI 10.1055/s-0034-1379486; Fleming I., 2010, MOL ORBITALS ORGANIC; FUKAZAWA Y, 1989, J ORG CHEM, V54, P2982, DOI 10.1021/jo00273a043; Garratt P. J., 1971, AROMATICITY; HAFELINGER G, 1984, LIEBIGS ANN CHEM, P1605; Heilbronner E., 1959, NONBENZENOID AROMATI, P171; Heilbronner E., 1966, HMO HUCKEL MOL ORBIT; HUNIG S, 1986, LIEBIGS ANN CHEM, P1222; Ito S, 2011, SYNLETT, P2279, DOI 10.1055/s-0030-1260316; Ji L, 2015, J ORG CHEM, V80, P661, DOI 10.1021/jo5024014; Keller-Schierlein W., 1959, NONBENZENOID AROMATI, P277; Kurotobi K, 2003, EUR J ORG CHEM, P3663, DOI 10.1002/ejoc.200300001; Plattner PA, 1937, HELV CHIM ACTA, V20, P224, DOI 10.1002/hlca.19370200133	21	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUL	2015	26	11					1578	1580		10.1055/s-0034-1380686		3	Chemistry, Organic	Chemistry	CL3OJ	WOS:000356859200031		
J	Hisaki, I; Kometani, E; Shigemitsu, H; Tohnai, N; Miyata, M				Hisaki, Ichiro; Kometani, Eriko; Shigemitsu, Hajime; Tohnai, Norimitsu; Miyata, Mikiji			Synthesis of Chiral Assembly from Achiral Octadehydrotribenzo[14]annulene Derivative by Using a Twofold Helical Hydrogen-Bonding Template	SYNLETT			English	Article						annulenes; macrocycles; carboxylic acid; chirality; supramolecular chemistry	SUPRAMOLECULAR-TILT-CHIRALITY; AMMONIUM CARBOXYLATES; CRYSTAL-STRUCTURE; NETWORKS; POLYMERS; MOLECULES; HYBRIDS; POLYMERIZATION; DIATROPICITY; POLYMORPHISM	Chiral supramolecular architecture was synthesized from the achiral noncentrosymmetric title compound by using a twofold helical hydrogen-bonding network as a template.	[Hisaki, Ichiro; Kometani, Eriko; Shigemitsu, Hajime; Tohnai, Norimitsu; Miyata, Mikiji] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Hisaki, I (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hisaki@mls.eng.osaka-u.ac.jp			MEXT [24685026]; JSPS; NSF	This work was supported by Grant-in-Aid for Young Scientists (A) (24685026) from MEXT. This work is partly supported by JSPS and NSF under the JSPS-NSF International Collaborations in Chemistry (ICC). Crystallographic data was partly collected using a synchrotron radiation at the BL38B1 in the SPring-8 with approval of JASRI (proposal Nos. 2009B1969 and 2014A1252).	Marsden JA, 2005, J AM CHEM SOC, V127, P2464, DOI 10.1021/ja044175a; Hisaki I, 2012, CHEM-EUR J, V18, P10066, DOI 10.1002/chem.201200688; Verbiest T, 1998, SCIENCE, V282, P913, DOI 10.1126/science.282.5390.913; Kobayashi Y, 2009, J AM CHEM SOC, V131, P9995, DOI 10.1021/ja809425b; Hirschberg JHKK, 2000, NATURE, V407, P167; Moulton B, 2001, CHEM REV, V101, P1629, DOI 10.1021/cr9900432; Jin W, 2005, P NATL ACAD SCI USA, V102, P10801, DOI 10.1073/pnas.0500852102; Spitler EL, 2006, CHEM REV, V106, P5344, DOI 10.1021/cr050541c; Miyata M, 2007, ACCOUNTS CHEM RES, V40, P694, DOI 10.1021/ar700017a; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q; Kinbara K, 1996, J AM CHEM SOC, V118, P3441, DOI 10.1021/ja9539960; Yuge T, 2008, CHEM-EUR J, V14, P2984, DOI 10.1002/chem.200701709; Bunz UHF, 1999, CHEM-EUR J, V5, P263, DOI 10.1002/(SICI)1521-3765(19990104)5:1<263::AID-CHEM263>3.0.CO;2-X; Iyoda M, 2011, ANGEW CHEM INT EDIT, V50, P10522, DOI 10.1002/anie.201006198; Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t; Matsumoto A, 2002, ANGEW CHEM INT EDIT, V41, P2502, DOI 10.1002/1521-3773(20020715)41:14<2502::AID-ANIE2502>3.0.CO;2-9; Tahara K, 2011, NAT CHEM, V3, P714, DOI [10.1038/nchem.1111, 10.1038/NCHEM.1111]; Tanaka A, 2007, CHEM-ASIAN J, V2, P230, DOI 10.1002/asia.200600332; Hisaki I, 2011, CRYST GROWTH DES, V11, P5488, DOI 10.1021/cg201075z; Yashima E, 2008, ACCOUNTS CHEM RES, V41, P1166, DOI 10.1021/ar800091w; Tagami K, 2003, J CHEM PHYS, V119, P7491, DOI 10.1063/1.1606436; Hinrichs H, 2006, CHEM-EUR J, V12, P7103, DOI 10.1002/chem.200600498; Sada K, 2004, J AM CHEM SOC, V126, P1764, DOI 10.1021/ja038379n; RIEHL JP, 1986, CHEM REV, V86, P1, DOI 10.1021/cr00071a001; Akagi K, 1998, SCIENCE, V282, P1683, DOI 10.1126/science.282.5394.1683; BALDWIN KP, 1995, SYNLETT, P1215; Boydston AJ, 2002, J ORG CHEM, V67, P8812, DOI 10.1021/jo020463i; Boydston AJ, 2001, ORG LETT, V3, P3599, DOI 10.1021/ol016764g; Hinrichs H., 2005, ORG LETT, V7, P3783; Hisaki I, 2006, EUR J ORG CHEM, P833, DOI 10.1002/ejoc.200500705; Hisaki I, 2009, CRYST GROWTH DES, V9, P1280, DOI 10.1021/cg801336t; KAURANEN M, 1995, SCIENCE, V270, P966, DOI 10.1126/science.270.5238.966; Kimball DB, 2001, ORG LETT, V3, P1709, DOI 10.1021/ol015898r; Kimball DB, 2002, J ORG CHEM, V67, P8798, DOI 10.1021/jo020462q; Lemmerer A, 2008, CRYST GROWTH DES, V8, P1106, DOI 10.1021/cg701020s; Matsumoto A, 1999, J AM CHEM SOC, V121, P11122, DOI 10.1021/ja992558g; Nobusue S, 2013, ANGEW CHEM INT EDIT, V52, P4184, DOI 10.1002/anie.201210233; Sada K, 2006, SYNLETT, P2364, DOI 10.1055/s-2006-951469; Sasaki T, 2012, CRYSTENGCOMM, V14, P5749, DOI 10.1039/c2ce26081f; Sasaki T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2756; Shigemitsu H, 2012, CHEM LETT, V41, P1535, DOI 10.1246/cl.2012.1535	41	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUL	2015	26	11					1601	1605		10.1055/s-0034-1380688		5	Chemistry, Organic	Chemistry	CL3OJ	WOS:000356859200036		
J	Kayahara, E; Patel, VK; Xia, JL; Jasti, R; Yamago, S				Kayahara, Eiichi; Patel, Vijay Kumar; Xia, Jianlong; Jasti, Ramesh; Yamago, Shigeru			Selective and Gram-Scale Synthesis of [6]Cycloparaphenylene	SYNLETT			English	Article						cyclophanes; cyclizations; organometallic reagents; platinum; tin	BOTTOM-UP SYNTHESIS; CYCLOPARAPHENYLENE RADICAL-CATION; WALL CARBON NANOTUBES; CRYSTAL-STRUCTURE; RAMAN-SPECTROSCOPY; ELECTRONIC-PROPERTIES; COUPLING REACTIONS; CONCISE SYNTHESIS; SIZE DEPENDENCE; MOLECULES	A selective, practical, and large-scale synthesis of [6]cycloparaphenylene, the second smallest cycloparaphenylene to be synthesized, was achieved in nine steps starting from commercially available 1,4-dibromobenzene and 4-bromobiphenyl-4-ol. The key intermediate, cis-1,4-(4-bromophenyl)-1,4-bis(triethylsiloxy)cyclohexa-2,5-diene, was prepared on a large scale (>20 g) and was selectively dimerized to form a cyclic precursor of [6]cycloparaphenylene by platinum-mediated assembly and subsequent reductive elimination. Deprotection of the triethylsilyl group and subsequent tetrachlorostannic acid (H2SnCl4)-mediated reductive aromatization gave [6]cycloparaphenylene in 23% overall yield from the commercially available substrates on gram scale.	[Kayahara, Eiichi; Patel, Vijay Kumar; Yamago, Shigeru] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Kayahara, Eiichi; Patel, Vijay Kumar; Yamago, Shigeru] Japan Sci & Technol Agcy JST, CREST, Tokyo 1023531, Japan; [Xia, Jianlong] Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Wuhan 430070, Peoples R China; [Jasti, Ramesh] Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA; [Jasti, Ramesh] Univ Oregon, Mat Sci Inst 1253, Eugene, OR 97403 USA	Yamago, S (reprint author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	yamago@scl.kyoto-u.ac.jp	Xia, Jianlong/I-9076-2012		CREST Program of the Japan Science and Technology Agency;  [26410043]	This work was partly supported by the CREST Program of the Japan Science and Technology Agency (SY) and by a Grant-in-Aid for Scientific Research (C) (Grant Number 26410043 to E.K.). Single-crystal X-ray analysis was performed at BL02B1 of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI; 2014B1203). We thank Dr. Kunihisa Sugimoto (JASRI) and Dr. Nobuhiro Yasuda (JASRI) for their valuable discussions and suggestions regarding X-ray crystallographic analysis.	Abla M, 1999, B CHEM SOC JPN, V72, P1255, DOI 10.1246/bcsj.72.1255; Toriumi N, 2015, J AM CHEM SOC, V137, P82, DOI 10.1021/ja511320f; Sisto TJ, 2012, J ORG CHEM, V77, P5857, DOI 10.1021/jo301024g; Yagi A, 2012, J AM CHEM SOC, V134, P2962, DOI 10.1021/ja300001g; Nishihara T, 2012, J PHYS CHEM LETT, V3, P3125, DOI 10.1021/jz3014826; Iwamoto T, 2013, CHEM-EUR J, V19, P14061, DOI 10.1002/chem.201302694; Evans PJ, 2014, NAT CHEM, V6, P404, DOI [10.1038/nchem.1888, 10.1038/NCHEM.1888]; Batson JM, 2013, SYNLETT, V24, P2545, DOI 10.1055/s-0033-1339882; Segawa Y, 2011, ANGEW CHEM INT EDIT, V50, P3244, DOI 10.1002/anie.201007232; Osakada K, 2000, COORDIN CHEM REV, V198, P379, DOI 10.1016/S0010-8545(99)00210-6; Kayahara E, 2012, ORG LETT, V14, P3284, DOI 10.1021/ol301242t; YAMAMOTO T, 1992, J ORGANOMET CHEM, V428, P223, DOI 10.1016/0022-328X(92)83232-7; Takaba H, 2009, ANGEW CHEM INT EDIT, V48, P6112, DOI 10.1002/anie.200902617; Omachi H, 2010, ANGEW CHEM INT EDIT, V49, P10202, DOI 10.1002/anie.201005734; Matsui K, 2014, J AM CHEM SOC, V136, P16452, DOI 10.1021/ja509880v; Tahara K, 2006, CHEM REV, V106, P5274, DOI 10.1021/cr050556a; Darzi ER, 2012, J ORG CHEM, V77, P6624, DOI 10.1021/jo3011667; Iwamoto T, 2014, CHEM-EUR J, V20, P14403, DOI 10.1002/chem.201403879; Segawa Y, 2012, ORG BIOMOL CHEM, V10, P5979, DOI 10.1039/c2ob25199j; Xia JL, 2012, CHEM SCI, V3, P3018, DOI 10.1039/c2sc20719b; Fujitsuka M, 2012, PHYS CHEM CHEM PHYS, V14, P14585, DOI 10.1039/c2cp42712e; Fujitsuka M, 2014, J PHYS CHEM LETT, V5, P2302, DOI 10.1021/jz5009054; Kayahara E, 2013, CHEM LETT, V42, P621, DOI 10.1246/cl.130188; Segawa Y, 2011, CHEM LETT, V40, P423, DOI 10.1246/cl.2011.423; Iyoda M, 2011, ANGEW CHEM INT EDIT, V50, P10522, DOI 10.1002/anie.201006198; Omachi H, 2011, ORG LETT, V13, P2480, DOI 10.1021/ol200730m; Fujitsuka M, 2013, CHEMPHYSCHEM, V14, P1570, DOI 10.1002/cphc.201300144; Ishii Y, 2014, ORG LETT, V16, P2174, DOI 10.1021/ol500643c; Yagi A, 2014, CHEM COMMUN, V50, P957, DOI 10.1039/c3cc48198k; Steinberg BD, 2009, ANGEW CHEM INT EDIT, V48, P5400, DOI 10.1002/anie.200901025; Golling FE, 2014, ANGEW CHEM INT EDIT, V53, P1525, DOI 10.1002/anie.201309104; Hitosugi S, 2012, J AM CHEM SOC, V134, P12442, DOI 10.1021/ja305723j; Xia JL, 2012, ANGEW CHEM INT EDIT, V51, P2474, DOI 10.1002/anie.201108167; Kayahara E, 2013, ANGEW CHEM INT EDIT, V52, P13722, DOI 10.1002/anie.201306881; Nakanishi Y, 2014, ANGEW CHEM INT EDIT, V53, P3102, DOI 10.1002/anie.201311268; Fujitsuka M, 2014, J PHYS CHEM A, V118, P4527, DOI 10.1021/jp504689q; Yamago S, 2010, ANGEW CHEM INT EDIT, V49, P757, DOI 10.1002/anie.200905659; Jasti R, 2008, J AM CHEM SOC, V130, P17646, DOI 10.1021/ja807126u; Alvarez MP, 2014, ANGEW CHEM INT EDIT, V53, P7033, DOI 10.1002/anie.201400719; Iwamoto T, 2011, J AM CHEM SOC, V133, P8354, DOI 10.1021/ja2020668; Tran-Van AF, 2014, ORG LETT, V16, P1594, DOI 10.1021/ol500194s; Ishii Y, 2012, CHEM SCI, V3, P2340, DOI 10.1039/c2sc20343j; Kayahara E, 2014, J AM CHEM SOC, V136, P2284, DOI 10.1021/ja413214q; Jiang HW, 2015, J AM CHEM SOC, V137, P2219, DOI 10.1021/ja513102m; Xia JL, 2012, J AM CHEM SOC, V134, P19709, DOI 10.1021/ja307373r; Golder MR, 2013, CHEM SCI, V4, P4285, DOI 10.1039/c3sc51861b; Iwamoto T, 2014, ANGEW CHEM INT EDIT, V53, P6430, DOI 10.1002/anie.201403624; Sisto TJ, 2011, J AM CHEM SOC, V133, P15800, DOI 10.1021/ja205606p; Kawase T, 2006, CHEM REV, V106, P5250, DOI 10.1021/cr0509657; Matsui K, 2012, ORG LETT, V14, P1888, DOI 10.1021/ol3005112; Huang CF, 2014, ORG LETT, V16, P2672, DOI 10.1021/ol500904x; MATSUMOTO H, 1983, J ORG CHEM, V48, P840, DOI 10.1021/jo00154a018; Patel VK, 2015, CHEM-EUR J, V21, P5742, DOI 10.1002/chem.201406650; Chen H, 2014, CARBON, V67, P203, DOI 10.1016/j.carbon.2013.09.082; Nishiuchi T, 2012, CHEM-EUR J, V18, P16621, DOI 10.1002/chem.201203227; Iwamoto T, 2011, ANGEW CHEM INT EDIT, V50, P8342, DOI 10.1002/anie.201102302; Sibbel F, 2014, CHEM COMMUN, V50, P954, DOI 10.1039/c3cc48683d; Eisenberg D, 2010, CHEM SOC REV, V39, P2879, DOI 10.1039/b904087k; Evans PJ, 2014, TOP CURR CHEM, V349, P249, DOI 10.1007/128_2012_415; Hitosugi S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1505; Kayahara E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3694; Nakao Y, 2005, J AM CHEM SOC, V127, P6952, DOI 10.1021/ja051281j; OSAKADA K, 1994, ORGANOMETALLICS, V13, P4645, DOI 10.1021/om00023a078; SCHRODER A, 1994, TOP CURR CHEM, V172, P179; Scott LT, 2003, ANGEW CHEM INT EDIT, V42, P4133, DOI 10.1002/anie.200301671; Zabula AV, 2013, ANGEW CHEM INT EDIT, V52, P5033, DOI 10.1002/anie.201301226	66	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUL	2015	26	11					1615	1619		10.1055/s-0034-1380714		5	Chemistry, Organic	Chemistry	CL3OJ	WOS:000356859200038		
J	Shibasaki, K; Watanabe, M; Kijima, M				Shibasaki, Kosuke; Watanabe, Mari; Kijima, Masashi			Synthesis and characterization of soluble poly(3,4-phenylenedioxythiophene)	SYNTHETIC METALS			English	Article						Conjugated polymers; 3,4-Phenylenedioxythiophene; Low band gap polymer	25TH ANNIVERSARY ARTICLE; LIGHT-EMITTING-DIODES; CONJUGATED POLYMERS; 3,4-PHENYLENEDIOXYTHIOPHENE PHEDOT; ORGANIC TRANSISTORS; ELECTRON-RICH; SOLAR-CELLS; CHAIN; POLY(3-ALKYLTHIOPHENES); REGIOREGULARITY	Asymmetric 2,5-dibromo-3,4-phenylenedioxythiophenes having a branched alkyl side chain at the phenylene part are polymerized by Yamamoto (Y) and Grignard metathesis (GRIM) methods to give several soluble poly(3,4-phenylenedioxythiophene)s. Poly{1,4[4-(2-hexylundecyl) phenylene]dioxythiophene-2,5-diyl) synthesized by GRIM (PPTa-G) exhibits a narrower band gap about 1.85 eV, higher absorption coefficient, and shorter pi-stacking distance about 3.9 A than those of the polymer synthesized by Y method (PPTa-Y). Introducing a fluorine substituent at the phenylene part of PPTa-Y deepens the energy level of a highest occupied molecular orbital of the polymer 0.17 eV. Thin film of PPTa-G shows hole mobility of 2.52 x 10(-3) cm(2) V-1 s(-1) determined by performance of the organic field-effect transistor in a preliminary experiment. (C) 2015 Elsevier B.V. All rights reserved.	[Shibasaki, Kosuke; Watanabe, Mari] Univ Tsukuba, Grad Sch Pure & Appl Sci, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan; [Shibasaki, Kosuke; Watanabe, Mari; Kijima, Masashi] Univ Tsukuba, Tsukuba Res Ctr Interdisciplinary Mat Sci, Tsukuba, Ibaraki 3058573, Japan; [Kijima, Masashi] Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan	Kijima, M (reprint author), Univ Tsukuba, Tsukuba Res Ctr Interdisciplinary Mat Sci, 1-1-1 Tenrtodai, Tsukuba, Ibaraki 3058573, Japan.	kijima@ims.tsukuba.ac.jp					Roncali J, 1997, CHEM REV, V97, P173, DOI 10.1021/cr950257t; Kulkarni AP, 2004, CHEM MATER, V16, P4556, DOI 10.1021/cm0494731; Yasuda T, 2013, J POLYM SCI POL CHEM, V51, P2536, DOI 10.1002/pola.26667; Bian LY, 2012, PROG POLYM SCI, V37, P1292, DOI 10.1016/j.progpolymsci.2012.03.001; Liu Y, 2011, MACROMOL CHEM PHYS, V212, P428, DOI 10.1002/macp.201000677; Kim Y, 2006, NAT MATER, V5, P197, DOI 10.1038/nmat1574; BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0; Kang B, 2013, ACS APPL MATER INTER, V5, P2302, DOI 10.1021/am302796z; Dou LT, 2013, MACROMOLECULES, V46, P3384, DOI 10.1021/ma400452j; DIETRICH M, 1994, J ELECTROANAL CHEM, V369, P87, DOI 10.1016/0022-0728(94)87085-3; Scharber MC, 2013, PROG POLYM SCI, V38, P1929, DOI 10.1016/j.progpolymsci.2013.05.001; Dou LT, 2013, ADV MATER, V25, P6642, DOI 10.1002/adma.201302563; Rost C, 2004, APPL PHYS LETT, V85, P1613, DOI 10.1063/1.1785290; Kraft A, 1998, ANGEW CHEM INT EDIT, V37, P402, DOI 10.1002/(SICI)1521-3773(19980302)37:4<402::AID-ANIE402>3.0.CO;2-9; HEYWANG G, 1992, ADV MATER, V4, P116, DOI 10.1002/adma.19920040213; Miyakoshi R, 2005, J AM CHEM SOC, V127, P17542, DOI 10.1021/ja0556880; Chochos CL, 2011, PROG POLYM SCI, V36, P1326, DOI 10.1016/j.progpolymsci.2011.04.003; Gershenson ME, 2006, REV MOD PHYS, V78, P973, DOI 10.1103/RevModPhys.78.973; Iovu MC, 2005, MACROMOLECULES, V38, P8649, DOI 10.1021/ma051122k; YAMAMOTO T, 1992, MACROMOLECULES, V25, P1214, DOI 10.1021/ma00030a003; CHEN TA, 1995, J AM CHEM SOC, V117, P233, DOI 10.1021/ja00106a027; Sirringhaus H, 2014, ADV MATER, V26, P1319, DOI 10.1002/adma.201304346; Facchetti A, 2007, MATER TODAY, V10, P28, DOI 10.1016/S1369-7021(07)70017-2; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; Barta P, 1999, SYNTHETIC MET, V101, P296, DOI 10.1016/S0379-6779(98)00770-X; Charles T.W., 1973, J ORG CHEM, V38, P2675; Grenier CRG, 2007, ANGEW CHEM INT EDIT, V46, P714, DOI 10.1002/anie.200602894; JONAS F, 1991, SYNTHETIC MET, V41, P831, DOI 10.1016/0379-6779(91)91506-6; Lin JY, 2014, MACROMOLECULES, V47, P1001, DOI 10.1021/ma402585n; Nambiar RR, 2007, ADV MATER, V19, P1234, DOI 10.1002/adma.200602902; Perepichka IF, 2006, CHEM-EUR J, V12, P2960, DOI 10.1002/chem.200501284; Roquet S, 2004, J MATER CHEM, V14, P1396, DOI 10.1039/b400491d; Watanabe M, 2012, MACROMOLECULES, V45, P1825, DOI 10.1021/ma202469g; Watanabe M, 2014, IOP CONF SER-MAT SCI, V54, DOI 10.1088/1757-899X/54/1/012023	34	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0379-6779			SYNTHETIC MET	Synth. Met.	JUL	2015	205						18	22		10.1016/j.synthmet.2015.03.027		5	Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer Science	Materials Science; Physics; Polymer Science	CL1XD	WOS:000356737300004		
J	Zheng, YQ; Potscavage, WJ; Zhang, J; Yasuda, T; Wei, B; Adachi, C				Zheng, Yan-qiong; Potscavage, William J., Jr.; Zhang, Jing; Yasuda, Takuma; Wei, Bin; Adachi, Chihaya			Tetraphenyldibenzoperiflanthene as sensitizer for enhancing the performance in dinaphthothienothiophene-based photovoltaics with and without fullerene	SYNTHETIC METALS			English	Article						Dinaphthothienothiophene; Sensitize; Alternative acceptor; DBP-doped-SubPc; Contact modification	ORGANIC SOLAR-CELLS; ELECTRIC-FIELD; HETEROJUNCTION	In this work, various interlayers were inserted between the donor and acceptor in a dinaphthothienothiophene (DN'FF)/C-60 planar heterojunction (PHJ) to sensitize the performance. The power conversion efficiency is enhanced from 1.16% for the DNTT/C-60 PHJ cell to 2.23% by inserting a 5-nm-thick tetraphenyldibenzoperifianthene (DBP) interlayer because of the greatly improved photocurrent and open-circuit voltage (Voc). To achieve high Voc, fullerene-free PHJs of DNTT/boron subphthalocyanine chloride (SubPc) (donor/acceptor) were fabricated, and Voc is further improved by doping various fractions of DBP into the SubPc layer. The Voc clearly increases from 0.82V to 1.24V by 70 wt%-DBP doping and is accompanied by a slight increase in photocurrent. The bipolar transfer characteristics of SubPc and DBP are investigated by field-effect transistors and show that both can transport electrons, indicating their potential as acceptors in photovoltaic devices. When another 5-nm-thick SubPc layer was included in the fullerene-free DNTF/SubPc:DBP PHJ cell, the power conversion efficiency further increases to 1.32%. These results indicate that DBP is a promising sensitizer for enhancing the performance of DNIT-based photovoltaics. (C) 2015 Elsevier B.V. All rights reserved.	[Zheng, Yan-qiong; Wei, Bin] Shanghai Univ, Minist Educ, Key Lab Adv Display & Syst Applicat, Shanghai 200072, Peoples R China; [Zheng, Yan-qiong; Potscavage, William J., Jr.; Yasuda, Takuma; Adachi, Chihaya] Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, Fukuoka 8190395, Japan; [Yasuda, Takuma] Japan Sci & Technol Agcy JST, PRESTO, Chiyoda Ku, Tokyo 1020076, Japan; [Adachi, Chihaya] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan	Adachi, C (reprint author), Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	zhengyangiong@shu.edu.cn; adachi@cstf.kyushu-u.ac.jp			Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST); International Institute for Carbon Neutral Energy Research (WPI-I2CNER) - MEXT of Japan; Precursory Research for Embryonic Science and Technology (PRESTO) from JST of Japan [10111]; Science and Technology Commission of Shanghai Municipality, Science and Technology Commission of Shanghai Municipality, China [15ZR1416600]	This work was supported financially by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) and by the International Institute for Carbon Neutral Energy Research (WPI-I2CNER), sponsored by the MEXT of Japan. It was also supported by Precursory Research for Embryonic Science and Technology (PRESTO) (no. 10111) from JST of Japan, and supported by Science and Technology Commission of Shanghai Municipality (Grant no. 15ZR1416600), China.	Yi Y, 2011, J MATER CHEM, V21, P1479, DOI 10.1039/c0jm02467h; Hirade M, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3650472; Beaumont N, 2012, ADV FUNCT MATER, V22, P561, DOI 10.1002/adfm.201101782; Groves C, 2013, ENERG ENVIRON SCI, V6, P1546, DOI 10.1039/c3ee24455e; Wang ZQ, 2013, ENERG ENVIRON SCI, V6, P249, DOI 10.1039/c2ee22952h; Veldman D, 2008, J AM CHEM SOC, V130, P7721, DOI 10.1021/ja8012598; Tress W, 2013, SOL ENERG MAT SOL C, V117, P599, DOI 10.1016/j.solmat.2013.07.014; Zhou Y, 2013, ADV MATER, V25, P6069, DOI 10.1002/adma.201302167; Zhuang T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4830037; Cha H, 2013, ADV FUNCT MATER, V23, P1556, DOI 10.1002/adfm.201201913; Griffith OL, 2014, NANO LETT, V14, P2353, DOI 10.1021/nl501112z; Petersen A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245208; Guo T.F., 2005, APPL PHYS LETT, V87, P504; Han W.N., 2013, APPL PHYS LETT, V103, P301; Hepp A., 2003, PHYS REV LETT, V91, P406; Cnops K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4406; Hiromitsu I, 2003, J APPL PHYS, V94, P2434, DOI 10.1063/1.1592870; Hormann U., 2011, PHYS STATUS SOLIDI-R, V5, P241; Mori H, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.061602; Tress W, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3553764; Xiao X., 2013, APPL PHYS LETT, V102, P302; Zhang G, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3114379; Zhang Y., 2012, PHYS REV LETT, V108, P404; Zheng YQ, 2014, ORG ELECTRON, V15, P878, DOI 10.1016/j.orgel.2014.01.012	24	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0379-6779			SYNTHETIC MET	Synth. Met.	JUL	2015	205						121	126		10.1016/j.synthmet.2015.04.002		6	Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer Science	Materials Science; Physics; Polymer Science	CL1XD	WOS:000356737300018		
J	Okamoto, M				Okamoto, Mayumi			Is corpus word frequency a good yardstick for selecting words to teach? Threshold levels for vocabulary selection	SYSTEM			English	Article						Vocabulary selection; Word frequency; Word dispersion; Self-reported frequency of word use; Vocabulary teaching goals	ENGLISH	This paper examines the suitability of word frequency as a criterion for vocabulary selection in general courses of English as a Foreign Language. Specifically, it addresses two issues: the relation between word frequency in corpora and native speakers' self-reported frequency of word use, and the relation between word frequency and word dispersion in corpora. Seventeen native speakers of English were asked how frequently they think they use 240 target words. The dispersion rates of the target words were calculated according to their sub-frequencies observed in the British National Corpus and the Corpus of Contemporary American English. The results indicate that corpus word frequency is closely related to native speakers' self-reported frequency of word use up to the 7000-word level, and that word frequency is related to word dispersion, with high dispersion rates observed up to the 6000-word level. These results have important implications for vocabulary selection for EFL textbooks and goal setting for vocabulary teaching. They suggest that native speakers make reasonable judgments on word usefulness up to the 7000-word level in terms of frequency. Furthermore, it would seem sensible to set the upper limit of vocabulary teaching at the 6000-word level in terms of frequency and dispersion. (C) 2015 Elsevier Ltd. All rights reserved.	Kansai Univ, Suita, Osaka 5648680, Japan	Okamoto, M (reprint author), Kansai Univ, 3-3-5 Yamate Cho, Suita, Osaka 5648680, Japan.	mayumi@kansai-u.ac.jp			Kansai University	This research was financially supported by the Kansai University Domestic Researcher, 2014. The author would like to thank Professor Masanori Suiko, who helped me deepen the discussion of this paper.	Alderson JC, 2007, APPL LINGUIST, V28, P383, DOI 10.1093/applin/amm024; RICHARDS JC, 1976, TESOL QUART, V10, P77, DOI 10.2307/3585941; Burton A., 1974, THINKING ITS NATURE; Davies M, 2010, FREQUENCY DICT CONT; Davies Mark, 2004, BYU BNC; Davies Mark, 2008, CORPUS CONT AM ENGLI; Hasegawa S., 2003, JIJI EIGOGAKU KENKYU, V42, P439; Hazenberg S, 1996, APPL LINGUIST, V17, P145, DOI 10.1093/applin/17.2.145; Hunston S., 2002, CORPORA APPL LINGUIS; KENNEDY GD, 1987, TESOL QUART, V21, P69, DOI 10.2307/3586355; Kilgarriff A., 1997, INT J LEXICOGR, V10, P135, DOI [10.1093/ijl/10.2.135, DOI 10.1093/IJ1/10.2.135]; Laufer B., 1992, VOCABULARY APPL LING, P126; Leech G., 2001, ELT CHINA 2001, P1; Lyne A. A., 1985, VOCABULARY FRENCH BU; Masui M., 2008, ENGLISH LANGUAGE LEA, P245; McCrostie J., 2007, RELC J, V38, P53, DOI 10.1177/0033688206076158; Meara P, 1996, PERFORMANCE COMPETEN, P35; Nation P., 1992, READING FOREIGN LANG, V8, P689; Nation P., 1995, SYSTEM, V23, P35, DOI 10.1016/0346-251X(94)00050-G; Nation P., 1990, TEACHING LEARNING VO; Nation Paul, 2006, CANADIAN MODERN LANG, V63, P59; Okamoto M., 2008, ARELE, V19, P141; Palmer H. E., 1936, INTERIM REPORT VOCAB; Richards J., 2001, CURRICULUM DEV LANGU; Rogers M. J., 2010, J INQUIRY RES, V91, P195; Schmitt D., 2012, LANGUAGE TEACHING; SCHMITT N, 1999, SECOND LANG RES, V15, P389, DOI 10.1191/026765899669633186; Schmitt N, 2010, RES PRACT APPL LINGU, P1, DOI 10.1057/9780230293977; Waring R., 1997, VOCABULARY DESCRIPTI, P6; West M., 1953, GEN SERVICE LIST ENG	30	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0346-251X	1879-3282		SYSTEM	System	JUL	2015	51						1	10		10.1016/j.system.2015.03.004		10	Education & Educational Research; Linguistics	Education & Educational Research; Linguistics	CL5GM	WOS:000356987800001		
J	Strong, G				Strong, Gregory			English for Academic Purposes in Neoliberal Universities: A Critical Grounded Theory	SYSTEM			English	Book Review									[Strong, Gregory] Aoyama Gakuin Univ, Dept English, Shibuya Ku, Tokyo 1508366, Japan	Strong, G (reprint author), Aoyama Gakuin Univ, Dept English, Shibuya Ku, 4-4-25 Shibuya, Tokyo 1508366, Japan.	gregstrongtokyo@gmail.com					Glaser B., 1967, DISCOVERY GROUNDED T; Goffman E, 1959, PRESENTATION SELF EV; HADLEY G, 2015, ENGLISH ACAD PURPOSE; Howatt A. P. R., 2004, HIST ENGLISH LANGUAG; Maher J, 1997, SHAUGHNESSY HER LIFE; Matsutani M., 2013, JAPAN TIMES     0506; Whitchurch C., AUSTR US HIGHER ED, V58, P407; Whitchurch C., 2008, HIGHER ED Q, V62, P377, DOI DOI 10.1111/J.1468-2273.2008.00387.X	8	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0346-251X	1879-3282		SYSTEM	System	JUL	2015	51						91	93		10.1016/j.system.2015.04.010		3	Education & Educational Research; Linguistics	Education & Educational Research; Linguistics	CL5GM	WOS:000356987800010		
J	Zeng, WL; Miwa, T; Wakita, Y; Morikawa, T				Zeng, Weiliang; Miwa, Tomio; Wakita, Yukiko; Morikawa, Takayuki			Application of Lagrangian relaxation approach to alpha-reliable path finding in stochastic networks with correlated link travel times	TRANSPORTATION RESEARCH PART C-EMERGING TECHNOLOGIES			English	Article						Reliable path; Lagrangian relaxation; Cholesky decomposition; Stochastic network; Correlated link travel time; Navigation system	VARYING TRANSPORTATION; VEHICLE NAVIGATION; TRANSIT NETWORKS; SHORTEST PATHS; ROUTE GUIDANCE; ROAD NETWORK; RELIABILITY; ALGORITHM; MODEL; SIMULATION	This study investigates the important problem of determining a reliable path in a stochastic network with correlated link travel times. First, the distribution of path travel time is quantified by using trip records from GPS probe vehicles. Second, the spatial correlation of link travel time is explicitly considered by using a correlation coefficient matrix, which is incorporated into the alpha-reliable path problem by Cholesky decomposition. Third, the Lagrangian relaxation based framework is used to handle the alpha-reliable path problem, by which the intractable problem with a non-linear and non-additive structure can be decomposed into several easy-to-solve problems. Finally, the path-finding performance of this approach is tested on a real-world network. The results show that 15 iterations of calculation can yield a small relative gap between upper and lower bounds of the optimal solution and the average running time is about 5 s for most OD settings. The applicability of alpha-reliable path finding is validated by a case study. (C) 2015 Elsevier Ltd. All rights reserved.	[Zeng, Weiliang] Nagoya Univ, Dept Civil Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Miwa, Tomio] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Wakita, Yukiko; Morikawa, Takayuki] Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Zeng, WL (reprint author), Nagoya Univ, Dept Civil Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	zeng.weiliang@g.mbox.nagoya-u.ac.jp; miwa@nagoya-u.jp; wackie@trans.civil.nagoya-u.ac.jp; morikawa@nagoya-u.jp	Miwa, Tomio/I-6084-2014		Center of Innovation Program of Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science [26630240]	This research was financially supported by the Center of Innovation Program of Ministry of Education, Culture, Sports, Science and Technology, Japan, and Japan Society for the Promotion of Science through Grant-in-Aid for Scientific Research, No. 26630240. The authors gratefully acknowledge their support.	Ahuja R.K., 1993, NETWORK FLOWS THEORY, P598; Bates J, 2001, TRANSPORT RES E-LOG, V37, P191, DOI 10.1016/S1366-5545(00)00011-9; Chen BY, 2012, INT J GEOGR INF SCI, V26, P365, DOI 10.1080/13658816.2011.598133; Miller-Hooks E, 2001, NETWORKS, V37, P35, DOI 10.1002/1097-0037(200101)37:1<35::AID-NET4>3.0.CO;2-G; Chen BY, 2013, NETW SPAT ECON, V13, P123, DOI 10.1007/s11067-012-9175-1; Gao S, 2012, TRANSPORT RES C-EMER, V21, P196, DOI 10.1016/j.trc.2011.09.007; FRANK H, 1969, OPER RES, V17, P583, DOI 10.1287/opre.17.4.583; Nie Y, 2012, TRANSPORT RES A-POL, V46, P403, DOI 10.1016/j.tra.2011.10.008; Xing T, 2013, IEEE T INTELL TRANSP, V14, P943, DOI 10.1109/TITS.2013.2250966; MIRCHANDANI PB, 1976, COMPUT OPER RES, V3, P347, DOI 10.1016/0305-0548(76)90017-4; Kaparias I, 2008, J INTELL TRANSPORT S, V12, P202, DOI 10.1080/15472450802448237; Lo HK, 2006, TRANSPORT RES B-METH, V40, P792, DOI 10.1016/j.trb.2005.10.003; Sen S, 2001, TRANSPORT SCI, V35, P37, DOI 10.1287/trsc.35.1.37.10141; Fan YY, 2005, J OPTIMIZ THEORY APP, V127, P497, DOI 10.1007/s10957-005-7498-5; Chang TS, 2005, TRANSPORT SCI, V39, P383, DOI 10.1287/trsc.1040.0094; POLUS A, 1979, TRANSPORTATION, V8, P141, DOI 10.1007/BF00167196; Watling D, 2006, EUR J OPER RES, V175, P1539, DOI 10.1016/j.ejor.2005.02.039; Nie Y, 2006, TRANSPORT RES REC, P193; Xing T, 2011, TRANSPORT RES B-METH, V45, P1660, DOI 10.1016/j.trb.2011.06.004; Hollander Y, 2008, TRANSPORT RES C-EMER, V16, P212, DOI 10.1016/j.trc.2007.07.005; van Lint JWC, 2008, TRANSPORT RES A-POL, V42, P258, DOI 10.1016/j.tra.2007.08.008; Nazemi A, 2013, TRANSPORT RES C-EMER, V26, P1, DOI 10.1016/j.trc.2012.07.005; Schmocker JD, 2013, TRANSPORT RES C-EMER, V36, P406, DOI 10.1016/j.trc.2013.06.014; Jenelius E, 2013, TRANSPORT RES B-METH, V53, P64, DOI 10.1016/j.trb.2013.03.008; Xiao L, 2013, TRANSPORT RES C-EMER, V36, P460, DOI 10.1016/j.trc.2013.06.015; Miller-Hooks ED, 1998, COMPUT OPER RES, V25, P1107, DOI 10.1016/S0305-0548(98)00027-6; Bell MGH, 2009, TRANSPORT RES B-METH, V43, P97, DOI 10.1016/j.trb.2008.05.010; Chen A, 2002, TRANSPORT RES B-METH, V36, P225, DOI 10.1016/S0191-2615(00)00048-5; Miller-Hooks ED, 2000, TRANSPORT SCI, V34, P198, DOI 10.1287/trsc.34.2.198.12304; GUIGNARD M, 1987, MATH PROGRAM, V39, P215, DOI 10.1007/BF02592954; Fu LP, 1998, TRANSPORT RES B-METH, V32, P499, DOI 10.1016/S0191-2615(98)00016-2; SIVAKUMAR RA, 1994, TRANSPORT SCI, V28, P309, DOI 10.1287/trsc.28.4.309; Hart P.E., 1968, IEEE Transactions on Systems Science and Cybernetics, VSSC-4, DOI 10.1109/TSSC.1968.300136; Wang JYT, 2014, TRANSPORT RES B-METH, V66, P4, DOI 10.1016/j.trb.2013.10.007; Nie Y, 2009, TRANSPORT RES B-METH, V43, P597, DOI 10.1016/j.trb.2009.01.008; Chen BY, 2014, J INTELL TRANSPORT S, V18, P177, DOI 10.1080/15472450.2013.806851; Lam TC, 2001, TRANSPORT RES E-LOG, V37, P231, DOI 10.1016/S1366-5545(00)00016-8; Bell MGH, 2000, TRANSPORT RES B-METH, V34, P533, DOI 10.1016/S0191-2615(99)00042-9; Cao P, 2014, PROCD SOC BEHV, V138, P137, DOI 10.1016/j.sbspro.2014.07.189; Chen A, 2005, J ADV TRANSPORT, V39, P19; Chen BY, 2013, IEEE T INTELL TRANSP, V14, P1907, DOI 10.1109/TITS.2013.2270282; Croarkin C., 2006, NIST SEMATECH E HDB; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; FISHER ML, 1981, MANAGE SCI, V27, P1, DOI 10.1287/mnsc.27.1.1; Gajewski B.J., 2004, J TRANSPORTATION STA, V7, P53; Golub G.H., 1989, J HOPKINS SERIES MAT; HALL RW, 1986, TRANSPORT SCI, V20, P182, DOI 10.1287/trsc.20.3.182; HALL RW, 1983, TRANSPORT RES B-METH, V17, P275, DOI 10.1016/0191-2615(83)90046-2; HANDLER GY, 1980, NETWORKS, V10, P293, DOI 10.1002/net.3230100403; Held M., 1974, Mathematical Programming, V6, DOI 10.1007/BF01580223; Ji ZW, 2011, EXPERT SYST APPL, V38, P1515, DOI 10.1016/j.eswa.2010.07.064; Lomax T., 2003, SELECTING TRAVEL REL; Miller-Hooks E, 2003, EUR J OPER RES, V146, P67, DOI 10.1016/S0377-2217(02)00231-X; Miwa T, 2012, TRANSPORT RES C-EMER, V22, P132, DOI 10.1016/j.trc.2012.01.005; JORNSTEN K, 1986, EUR J OPER RES, V27, P313, DOI 10.1016/0377-2217(86)90328-0; Ng M, 2010, TRANSP LETT, V2, P63, DOI 10.3328/TL.2010.02.02.63-74; Ng M, 2010, TRANSPORT RES B-METH, V44, P1202, DOI 10.1016/j.trb.2010.02.008; NGUYEN S, 1988, EUR J OPER RES, V37, P176, DOI 10.1016/0377-2217(88)90327-X; Nie Y, 2009, TRANSPORTATION AND TRAFFIC THEORY 2009: GOLDEN JUBILEE, P169, DOI 10.1007/978-1-4419-0820-9_9; Prakash A.A., 2014, TRANSPORT RES REC, V2467, P110; Rachtan P, 2013, TRANSPORT RES REC, P34, DOI 10.3141/2390-04; Rakha H, 2010, J INTELL TRANSPORT S, V14, P232, DOI 10.1080/15472450.2010.517477; Samaranayake S, 2012, TRANSPORT RES C-EMER, V20, P199, DOI 10.1016/j.trc.2011.05.009; Schmocker JD, 2009, TRANSPORTATION AND TRAFFIC THEORY 2009: GOLDEN JUBILEE, P1, DOI 10.1007/978-1-4419-0820-9_1; Seshadri R, 2010, TRANSP RES RECORD, P83, DOI 10.3141/2196-09; Shao H., 2006, TRANSPORT RES REC, V1985, P220, DOI 10.3141/1985-24; SPIESS H, 1989, TRANSPORT RES B-METH, V23, P83, DOI 10.1016/0191-2615(89)90034-9; Srinivasan K.K., 2013, TRANSPORT RES B-METH, V66, P110; Tas D, 2014, TRANSPORT RES C-EMER, V48, P66, DOI 10.1016/j.trc.2014.08.007; Wang YB, 2012, TRANSPORT RES REC, P66, DOI 10.3141/2315-07; Yang LX, 2014, TRANSPORT RES B-METH, V59, P22, DOI 10.1016/j.trb.2013.10.012; Zockaie A., 2013, TRANSPORT RES REC, V2334, P1	72	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-090X			TRANSPORT RES C-EMER	Transp. Res. Pt. C-Emerg. Technol.	JUL	2015	56						309	334		10.1016/j.trc.2015.04.018		26	Transportation Science & Technology	Transportation	CL1VQ	WOS:000356733400021		
J	Atasoy, B; Ikeda, T; Song, X; Ben-Akiva, ME				Atasoy, Bilge; Ikeda, Takuro; Song, Xiang; Ben-Akiva, Moshe E.			The concept and impact analysis of a flexible mobility on demand system	TRANSPORTATION RESEARCH PART C-EMERGING TECHNOLOGIES			English	Article						Demand responsive transit; Flexible transportation services; Personalized transportation services; Shared-taxi; Shared-ride; Mobility on demand	A-RIDE PROBLEM; PERIOD TRAFFIC CONGESTION; ASSORTMENT OPTIMIZATION; CHOICE MODEL; TRANSIT	This paper introduces an innovative transportation concept called Flexible Mobility on Demand (FMOD), which provides personalized services to passengers. FMOD is a demand responsive system in which a list of travel options is provided in real-time to each passenger request. The system provides passengers with flexibility to choose from a menu that is optimized in an assortment optimization framework. For operators, there is flexibility in terms of vehicle allocation to different service types: taxi, shared-taxi and mini-bus. The allocation of the available fleet to these three services is carried out dynamically so that vehicles can change roles during the day. The FMOD system is built based on a choice model and consumer surplus is taken into account in order to improve passenger satisfaction. Furthermore, profits of the operators are expected to increase since the system adapts to changing demand patterns. In this paper, we introduce the concept of FMOD and present preliminary simulation results. It is shown that the dynamic allocation of the vehicles to different services provides significant benefits over static allocation. Furthermore, it is observed that the trade-off between consumer surplus and operator's profit is critical. The optimization model is adapted in order to take into account this trade-off by controlling the level of passenger satisfaction. It is shown that with such control mechanisms FMOD provides improved results in terms of both profit and consumer surplus. (C) 2015 Elsevier Ltd. All rights reserved.	[Atasoy, Bilge; Song, Xiang; Ben-Akiva, Moshe E.] MIT, Cambridge, MA 02139 USA; [Ikeda, Takuro] Fujitsu Labs Ltd, Kawasaki, Kanagawa, Japan	Atasoy, B (reprint author), MIT, 77 Massachusetts Ave,Room 1-180, Cambridge, MA 02139 USA.	batasoy@mit.edu; ikeda.takuro@jp.fujitsu.com; bensong@mit.edu; mba@mit.edu					Coslovich L, 2006, EUR J OPER RES, V175, P1605, DOI 10.1016/j.ejor.2005.02.038; Talluri K, 2004, MANAGE SCI, V50, P15, DOI 10.1287/mnsc.1030.0147; Fu LP, 2002, TRANSPORT RES B-METH, V36, P485, DOI 10.1016/S0191-2615(01)00014-5; BENAKIVA M, 1986, TRANSPORT SCI, V20, P164, DOI 10.1287/trsc.20.3.164; Bhat CR, 2000, TRANSPORT SCI, V34, P228, DOI 10.1287/trsc.34.2.228.12306; DEPALMA A, 1983, TRANSPORT SCI, V17, P430, DOI 10.1287/trsc.17.4.430; Brake J, 2007, TRANSPORT POLICY, V14, P458, DOI 10.1016/j.tranpol.2007.09.001; Cordeau JF, 2003, TRANSPORT RES B-METH, V37, P579, DOI 10.1016/S0191-2615(02)00045-0; Cordeau JF, 2007, ANN OPER RES, V153, P29, DOI 10.1007/s10479-007-0170-8; Parragh SN, 2010, COMPUT OPER RES, V37, P1129, DOI 10.1016/j.cor.2009.10.003; Khattak AJ, 2004, J URBAN PLAN D-ASCE, V130, P42, DOI 10.1061/(ASCE)0733-9488(2004)130:1(42); Davis J., 2013, TECHNICAL REPORT; Davis J., 2013, WORKING PAPER; Dial RB, 1995, TRANSPORT RES C-EMER, V3, P261, DOI 10.1016/0968-090X(95)00010-G; Gallego G., 2013, TECHNICAL REPORT; Gallego G., 2011, TECHNICAL REPORT; Goodwill J. A., 2008, CREATIVE WAYS MANAGE; Jung J., 2013, TRANSP RES BOARDS 92; Kato H., 2010, 14 WORLD C TRANSP RE; Koppelman F.S., 2006, SELF INSTRUCTING COU; Mulley C., 2009, RES TRANSP ECON, V25, P39; Rusmevichientong P, 2014, PROD OPER MANAG, V23, P2023, DOI 10.1111/poms.12191; Rusmevichientong P, 2010, OPER RES, V58, P1666, DOI 10.1287/opre.1100.0866; Vigo D., 2001, VEHICLE ROUTING PROB; Yang L., 2010, MODELING PREFERENCES	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-090X			TRANSPORT RES C-EMER	Transp. Res. Pt. C-Emerg. Technol.	JUL	2015	56						373	392		10.1016/j.trc.2015.04.009		20	Transportation Science & Technology	Transportation	CL1VQ	WOS:000356733400025		
J	Sugimoto, M; Hirama, H; Yamaguchi, A; Koga, H; Hashine, K; Ninomiya, I; Shinohara, N; Maruyama, S; Egawa, S; Sasaki, H; Kakehi, Y				Sugimoto, Mikio; Hirama, Hiromi; Yamaguchi, Akito; Koga, Hirofumi; Hashine, Katsuyoshi; Ninomiya, Iku; Shinohara, Nobuo; Maruyama, Satoru; Egawa, Shin; Sasaki, Hiroshi; Kakehi, Yoshiyuki		PRIAS-JAPAN Study Grp	Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPAN	WORLD JOURNAL OF UROLOGY			English	Article						Prostate cancer; Active surveillance; PRIAS; Biopsy; Reclassification	RADICAL PROSTATECTOMY; FOLLOW-UP; OUTCOMES; MORTALITY; PROGRAM; MULTICENTER; PROGRESSION; STATISTICS; PREDICTORS; UPDATE	To define clinical and pathological factors predicting reclassification at the time of 1-year repeat biopsy (re-Bx) based on a Japanese cohort forming part of the Prostate Research International: Active Surveillance (PRIAS) study. The inclusion criteria for the PRIAS study are as follows: clinical stage T1c/T2, PSA a parts per thousand currency sign 10 ng/ml, PSA density (PSAD) < 0.2 ng/ml per milliliter, one or two positive biopsy cores, and Gleason score (GS) a parts per thousand currency sign 6 at initial diagnostic biopsy. Baseline clinical characteristics and prostate-specific antigen doubling time (PSADT) at the time of re-Bx were analyzed via multivariate logistic regression with respect to reclassification and 'no cancer' status on the 1-year re-Bx. A total of 386 patients were enrolled in PRIAS-JAPAN by the end of 2013. Of these, 216 underwent re-Bx at 1 year. A total of 73 patients (33.8 %) were reclassified, whereas 74 (34.3 %) had no cancer. Older age, a higher PSAD, a higher positive core rate, and a shorter PSADT were significant predictors of reclassification. The positive core rate was the predictor common to reclassification, no cancer, and high GS, upon re-Bx. An interim analysis of a Japanese AS cohort participating in PRIAS revealed that the positive core rate was strongly associated with reclassification at the 1-year re-Bx. However, although amendment of the PRIAS inclusion criteria to incorporate a positive core might reduce any concern about underestimation, this would also reduce the number of patients undergoing AS.	[Sugimoto, Mikio; Hirama, Hiromi; Kakehi, Yoshiyuki] Kagawa Univ, Dept Urol, Fac Med, Takamatsu, Kagawa 760, Japan; [Yamaguchi, Akito; Koga, Hirofumi] Harasanshin Gen Hosp, Fukuoka, Japan; [Hashine, Katsuyoshi; Ninomiya, Iku] Natl Hosp Org Shikoku Canc Ctr, Dept Urol, Matsuyama, Ehime, Japan; [Shinohara, Nobuo; Maruyama, Satoru] Hokkaido Univ Grad Sch Med, Dept Urol, Sapporo, Hokkaido, Japan; [Egawa, Shin; Sasaki, Hiroshi] Jikei Univ Sch Med, Dept Urol, Minato, Japan	Sugimoto, M (reprint author), Kagawa Univ, Dept Urol, Fac Med, Takamatsu, Kagawa 760, Japan.	micsugi@med.kagawa-u.ac.jp					Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Bul M, 2013, EUR UROL, V63, P597, DOI 10.1016/j.eururo.2012.11.005; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; van den Bergh RCN, 2010, BJU INT, V105, P956, DOI 10.1111/j.1464-410X.2009.08887.x; Tosoian JJ, 2011, J CLIN ONCOL, V29, P2185, DOI 10.1200/JCO.2010.32.8112; Bul M, 2012, EUR UROL, V62, P195, DOI 10.1016/j.eururo.2012.02.002; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Dall'Era MA, 2012, EUR UROL, V62, P976, DOI 10.1016/j.eururo.2012.05.072; van den Bergh RCN, 2007, EUR UROL, V52, P1560, DOI 10.1016/j.eururo.2007.05.011; Lawrentschuk N, 2011, NAT REV UROL, V8, P312, DOI 10.1038/nrurol.2011.50; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Whitson JM, 2011, J UROLOGY, V185, P1656, DOI 10.1016/j.juro.2010.12.042; Fujimoto H, 2011, INT J UROL, V18, P876, DOI 10.1111/j.1442-2042.2011.02895.x; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Ross AE, 2010, J CLIN ONCOL, V28, P2810, DOI 10.1200/JCO.2009.25.7311; Mitsuzuka K, 2013, BJU INT, V111, P914, DOI 10.1111/j.1464-410X.2012.11658.x; Satkunasivam R, 2013, J UROLOGY, V190, P91, DOI 10.1016/j.juro.2013.01.019; Bul M, 2012, EUR UROL, V61, P370, DOI 10.1016/j.eururo.2011.06.027; Briganti Alberto, 2007, Eur J Cancer, V43, P2669, DOI 10.1016/j.ejca.2007.09.022; Crawford ED, 2009, UROLOGY, V73, P4, DOI 10.1016/j.urology.2009.03.001; Hirama H, 2014, J CANCER RES CLIN, V140, P257, DOI 10.1007/s00432-013-1566-2; Ito Y, 2009, CANCER SCI, V100, P2390, DOI 10.1111/j.1349-7006.2009.01311.x; Kakehi Y, 2012, ASIAN J ANDROL, V14, P361, DOI 10.1038/aja.2011.151; Kakehi Y, 2008, JPN J CLIN ONCOL, V38, P122, DOI 10.1093/jjco/hym161; Khatami Ali, 2007, Int J Cancer, V120, P170; San Francisco Ignacio F, 2011, J Urol, V185, P471, DOI 10.1016/j.juro.2010.09.115; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sugimoto M, 2010, JPN J CLIN ONCOL, V40, P973, DOI 10.1093/jjco/hyq082; Venkitaraman R, 2007, J UROLOGY, V178, P833, DOI 10.1016/j.juro.2007.05.038	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-4983	1433-8726		WORLD J UROL	World J. Urol.	JUL	2015	33	7					981	987		10.1007/s00345-014-1453-8		7	Urology & Nephrology	Urology & Nephrology	CL2YQ	WOS:000356814700011		
J	Nuhn, P; Novara, G; Seitz, C; Gupta, A; Matsumoto, K; Kassouf, W; Walton, TJ; Fritsche, HM; Tritschler, S; Martinez-Salamanca, JI; Ficarra, V; Karakiewicz, PI; Mazzoleni, G; Shariat, SF; Bastian, PJ				Nuhn, Philipp; Novara, Giacomo; Seitz, Christian; Gupta, Amit; Matsumoto, Kazumasa; Kassouf, Wassim; Walton, Thomas J.; Fritsche, Hans-Martin; Tritschler, Stefan; Martinez-Salamanca, Juan I.; Ficarra, Vincenzo; Karakiewicz, Pierre I.; Mazzoleni, Guido; Shariat, Shahrokh F.; Bastian, Patrick J.			Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study	WORLD JOURNAL OF UROLOGY			English	Article						Bladder cancer; Prognosis; Urothelial carcinoma; Nephroureterectomy; Recurrence	TRANSITIONAL-CELL-CARCINOMA; 3 EUROPEAN CENTERS; RADICAL CYSTECTOMY; MULTIINSTITUTIONAL DATASET; INDEPENDENT PREDICTORS; TUMOR HISTORY; CANCER; NEPHROURETERECTOMY; RECURRENCE; SURVEILLANCE	Patients with urothelial carcinoma (UC) often develop multifocal metachronous tumors throughout the genitourinary tract. In the present study, we evaluated the prognostic value of prior history of UC of the bladder (UCB) in patients with upper tract urothelial carcinoma (UTUC) in an international multi-institutional cohort. Data from 785 patients who underwent radical nephroureterectomy (RNU) with ipsilateral bladder cuff resection at nine academic institutions in Europe and the USA between 1987 and 2008 were reviewed. Log-rank tests and Cox proportional hazards regression models were used for univariable and multivariable analyses. The median follow-up of the whole cohort was 34 months (interquartile range 15-66 months). Five hundred and fifty-eight (72 %) patients had no UCB before the diagnosis of UTUC; a prior history of non-muscle-invasive and muscle-invasive UCB before the UTUC was found in 179 (23 %) and 36 (5 %), respectively. History of UCB before RNU was an independent predictor of both recurrence-free survival (p = 0.012; no UCB vs. non-muscle-invasive UCB: hazard ratio (HR) 1.4, p = 0.082; no UCB vs. muscle-invasive UCB: HR 2.1, p = 0.007) and cancer-specific survival (p = 0.008; no UCB vs. non-muscle-invasive UCB: HR 1.2, p = 0.279; no UCB vs. muscle-invasive UCB: HR 2.3, p = 0.008) on multivariable Cox regression analyses that included age, gender, surgical type, stage, grade, presence of concomitant carcinoma in situ, presence of lymphovascular invasion, and lymph node status. Prior history of muscle-invasive UCB was significantly associated with an increased risk of disease recurrence and cancer-specific death in patients with UTUC.	[Nuhn, Philipp; Tritschler, Stefan; Bastian, Patrick J.] Univ Munich, Klinikum Grosshadern, Dept Urol, D-81377 Munich, Germany; [Novara, Giacomo] Univ Padua, Dept Urol, Padua, Italy; [Seitz, Christian; Shariat, Shahrokh F.] Med Univ Vienna, Dept Urol, Vienna, Austria; [Gupta, Amit] Univ Iowa, Iowa City, IA USA; [Matsumoto, Kazumasa] Kitasato Univ Sch Med, Dept Urol, Minami Ku, Sagamihara, Kanagawa, Japan; [Kassouf, Wassim] McGill Univ, Dept Urol, Montreal, PQ, Canada; [Walton, Thomas J.] Nottingham Univ Hosp NHS Trust, Dept Urol, Nottingham, England; [Fritsche, Hans-Martin] Univ Regensburg, Caritas St Josef Med Ctr, Dept Urol, D-93053 Regensburg, Germany; [Martinez-Salamanca, Juan I.] Univ Autonoma Madrid, Dept Urol, Hosp Univ Puerta Hierro Majadahonda, Madrid, Spain; [Ficarra, Vincenzo] Univ Udine, Dept Urol, I-33100 Udine, Italy; [Karakiewicz, Pierre I.] Univ Montreal Hlth Ctr, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ, Canada; [Mazzoleni, Guido] Cent Hosp Bolzano, Dept Pathol, Bolzano, Italy; [Bastian, Patrick J.] Paracelsus Med Ctr Golzheim, Dept Urol, Dusseldorf, Germany	Nuhn, P (reprint author), Univ Munich, Klinikum Grosshadern, Dept Urol, Marchioninistr 15, D-81377 Munich, Germany.	nuhn.philipp@gmail.com					AMAR AD, 1985, J UROLOGY, V133, P468; Volkmer BG, 2009, J UROLOGY, V182, P2632, DOI 10.1016/j.juro.2009.08.046; Xylinas E, 2014, EUR UROL, V65, P650, DOI 10.1016/j.eururo.2013.09.003; Sanderson KM, 2007, BJU INT, V100, P11, DOI 10.1111/j.1464-410X.2007.06841.x; Rink M, 2013, EUR UROL, V63, P1082, DOI 10.1016/j.eururo.2012.06.029; Picozzi S, 2012, J UROLOGY, V188, P2046, DOI 10.1016/j.juro.2012.08.017; Rabbani F, 2001, J CLIN ONCOL, V19, P94; Wright JL, 2009, J UROLOGY, V181, P1035, DOI 10.1016/j.juro.2008.10.168; Roupret M, 2011, EUR UROL, V59, P584, DOI 10.1016/j.eururo.2010.12.042; Mullerad M, 2004, J UROLOGY, V172, P2177, DOI 10.1097/01.ju.0000144505.40915.98; Akdogan B, 2006, J UROLOGY, V176, P48, DOI 10.1016/S0022-5347(06)00511-8; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Hall MC, 1998, UROLOGY, V52, P594, DOI 10.1016/S0090-4295(98)00295-7; Rink M, 2013, BJU INT, V112, P623, DOI 10.1111/bju.12014; Novara G, 2007, CANCER, V110, P1715, DOI 10.1002/cncr.22970; Milojevic B, 2013, UROL ONCOL-SEMIN ORI, V31, P1615, DOI 10.1016/j.urolonc.2012.03.004; CHARBIT L, 1991, J UROLOGY, V146, P1243; Greene FL, 2002, AM JOINT COMMITTEE C; Huguet-Perez J, 2001, EUR UROL, V40, P318, DOI 10.1159/000049793; Ishioka J, 2015, BJU INT, V115, P705, DOI 10.1111/bju.12707; Kim KH, 2013, UROL ONCOL-SEMIN ORI, V31, P1643, DOI 10.1016/j.urolonc.2012.04.014; MATEOS JAD, 1987, J UROLOGY, V138, P49; Millan-Rodriguez F, 2000, J UROLOGY, V164, P1183, DOI 10.1016/S0022-5347(05)67137-6; Mostofi F. K., 1973, HISTOLOGICAL TYPING; Novara G, 2009, INT J UROL, V16, P187, DOI 10.1111/j.1442-2042.2008.02201.x; Sanderson KM, 2007, J UROLOGY, V177, P2088, DOI 10.1016/j.juro.2007.01.133	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-4983	1433-8726		WORLD J UROL	World J. Urol.	JUL	2015	33	7					1005	1013		10.1007/s00345-014-1363-9		9	Urology & Nephrology	Urology & Nephrology	CL2YQ	WOS:000356814700015		
J	Lee, R; Wakamiya, S; Sumiya, K				Lee, Ryong; Wakamiya, Shoko; Sumiya, Kazutoshi			Exploring geospatial cognition based on location-based social network sites	WORLD WIDE WEB-INTERNET AND WEB INFORMATION SYSTEMS			English	Article						Urban cognition; Crowd's movements; Location-based social networks		Geospatial cognition to sophisticated urban space is an essential capability to make various location-based decisions for our daily urban lives. To adapt ourselves to an unfamiliar or ever-evolving city, we need to develop urban cognition which usually requires lots of experience taking time and efforts. Moreover, it must be a tiresome work to find and ask knowledgeable people who have enough experience to a local area to learn what we would like to know on the spot. In order to collect and utilize crowd's urban cognition probably obtained from living experience, we attempt to explore geospatial cognition of people through common experience from location-based social networks which can be regarded as a fruitful source of crowd-experienced local information. In particular, we propose a method to extract crowd's movements as a direct and useful hint to know common urban cognition and measure relative socio-cognitive distances between urban clusters. In order to intuitively and simply represent cognitive urban space, we generate a socio-cognitive map by projecting the cognitive relationship into a simplified two-dimensional Euclidean space by way of MDS (Multi-Dimensional Scaling). In the experiment, we show a socio-cognitive map significantly representing cognitive proximity among urban clusters in terms of crowd's movements from massive lifelogs over Twitter. We also provide a practical use case for nearest neighbor areas search on the cognitive map.	[Lee, Ryong] KISTI, Daejeon, South Korea; [Wakamiya, Shoko] Kyoto Sangyo Univ, Fac Comp Sci & Engn, Kyoto 603, Japan; [Sumiya, Kazutoshi] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6712201, Japan	Lee, R (reprint author), KISTI, Daejeon, South Korea.	Lee.Ryong@gmail.com; shoko@cc.kyoto-su.ac.jp; sumiya@shse.u-hyogo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24.9154]	This research was supported in part by the Grant-in-Aid for JSPS Fellows 24.9154 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	ANDREW AM, 1979, INFORM PROCESS LETT, V9, P216, DOI 10.1016/0020-0190(79)90072-3; Lee CH, 2012, EXPERT SYST APPL, V39, P9623, DOI 10.1016/j.eswa.2012.02.136; Byers S, 1998, J AM STAT ASSOC, V93, P577, DOI 10.2307/2670109; Yu ZW, 2013, WORLD WIDE WEB, V16, P749, DOI 10.1007/s11280-012-0189-x; Musial K, 2013, WORLD WIDE WEB, V16, P31, DOI 10.1007/s11280-011-0155-z; Lee R, 2011, WORLD WIDE WEB, V14, P321, DOI 10.1007/s11280-011-0120-x; Yao JJ, 2012, WORLD WIDE WEB, V15, P171, DOI 10.1007/s11280-011-0136-2; Baddeley A., 2008, NOTES, V12, P1; Beaumont C., 2008, MUMBAI ATTACKS; Belouaer L., 2013, P C SPAT INF THEOR, V8116, P338; Carroll J. M., 1972, Information Processing Letters, V1, DOI 10.1016/0020-0190(72)90046-4; De Longueville B., 2009, P 2009 INT WORKSH LO, P73, DOI DOI 10.1145/1629890.1629907; Downs R.M., 1974, IMAGE ENV COGNITIVE; Ester M, 1996, KDD, V96, P226; Kruskal J., 1978, SAGE U PAPER SERIES, P07; Kurashima T, 2005, LECT NOTES COMPUT SC, V3806, P496; Lee R., 2012, PERS UBIQUIT COMPUT, V17, P1; Mislove A., 2011, P 5 INT AAAI C WEBL, P133; Pozdnoukhov A., 2011, P 3 ACM SIGSPATIAL I, P8; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [DOI 10.1145/1772690.1772777, 10.1145/1772690.177277712]; TIME, 2009, IR PROT TWITT MED MO; Wakamiya S., 2012, P 4 INT C EM DAT TEC, P181; Wakamiya S., 2012, P 4 INT WORKSH LOC B, P935; Wakamiya S., 2011, P 3 ACM SIGSPATIAL I, P10; Yuan J., 2012, P 18 ACM SIGKDD C KN, P133; Zheng Y., 2011, P 13 ACM INT C UB CO, P89	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-145X	1573-1413		WORLD WIDE WEB	World Wide Web	JUL	2015	18	4					845	870		10.1007/s11280-014-0284-2		26	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CL4PY	WOS:000356936800004		
J	Ohtori, S; Orita, S; Yamauchi, K; Eguchi, Y; Ochiai, N; Kishida, S; Kuniyoshi, K; Aoki, Y; Nakamura, J; Ishikawa, T; Miyagi, M; Kamoda, H; Suzuki, M; Kubota, G; Sakuma, Y; Oikawa, Y; Inage, K; Sainoh, T; Sato, J; Fujimoto, K; Shiga, Y; Abe, K; Toyone, T; Inoue, G; Takahashi, K				Ohtori, Seiji; Orita, Sumihisa; Yamauchi, Kazuyo; Eguchi, Yawara; Ochiai, Nobuyasu; Kishida, Shunji; Kuniyoshi, Kazuki; Aoki, Yasuchika; Nakamura, Junichi; Ishikawa, Tetsuhiro; Miyagi, Masayuki; Kamoda, Hiroto; Suzuki, Miyako; Kubota, Gou; Sakuma, Yoshihiro; Oikawa, Yasuhiro; Inage, Kazuhide; Sainoh, Takeshi; Sato, Jun; Fujimoto, Kazuki; Shiga, Yasuhiro; Abe, Koki; Toyone, Tomoaki; Inoue, Gen; Takahashi, Kazuhisa			Mini-Open Anterior Retroperitoneal Lumbar Interbody Fusion: Oblique Lateral Interbody Fusion for Lumbar Spinal Degeneration Disease	YONSEI MEDICAL JOURNAL			English	Article						Oblique lateral interbody fusion; lumbar; degeneration disease; decompress; nerve; injury; surgery	TRANSPSOAS APPROACH; SPONDYLOLISTHESIS; SCOLIOSIS; OUTCOMES	Purpose: Surgery for lumbar spinal degeneration disease is widely performed. While posterior decompression and fusion are popular, anterior lumbar interbody fusion (ALIF) is also used for treatment. Extreme lateral interbody fusion (XLIF) is commonly used for noninvasive ALIF; however, several complications, such as spinal nerve and psoas muscle injury, have been reported. In the current study, we examined the clinical efficacy and complications of oblique lateral interbody fusion (OLIF) for lumbar spinal degeneration disease. Materials and Methods: Thirty-five patients with degenerated spondylolisthesis, discogenic pain, and kyphoscoliosis were examined. All patients underwent OLIF surgery (using a cage and bone graft from the iliac crest) with or without posterior decompression, without real-time electromyography monitoring. Posterior screws were used in all patients. Visual analog scale (VAS) score and Oswestry Disability Index (ODI) were evaluated before and 6 months after surgery. Surgical complications were also evaluated. Results: Pain scores significantly improved after surgery, compared to those before surgery (p<0.05). There was no patient who underwent revision surgery. There was no spinal nerve, major vessel, peritoneal, or urinary injury. Few patients showed symptoms from psoas invasion. Conclusion: OLIF surgery produced good surgical results without any major complication.	[Ohtori, Seiji; Orita, Sumihisa; Yamauchi, Kazuyo; Eguchi, Yawara; Ochiai, Nobuyasu; Kishida, Shunji; Kuniyoshi, Kazuki; Aoki, Yasuchika; Nakamura, Junichi; Ishikawa, Tetsuhiro; Miyagi, Masayuki; Kamoda, Hiroto; Suzuki, Miyako; Kubota, Gou; Sakuma, Yoshihiro; Oikawa, Yasuhiro; Inage, Kazuhide; Sainoh, Takeshi; Sato, Jun; Fujimoto, Kazuki; Shiga, Yasuhiro; Abe, Koki; Toyone, Tomoaki; Inoue, Gen; Takahashi, Kazuhisa] Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chiba 2608670, Japan	Ohtori, S (reprint author), Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	sohtori@faculty.chiba-u.jp					Anand N, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.1.FOCUS09278; Oliveira L, 2010, SPINE, V35, pS331, DOI 10.1097/BRS.0b013e3182022db0; Uribe JS, 2010, J NEUROSURG-SPINE, V13, P260, DOI 10.3171/2010.3.SPINE09766; Bergey DL, 2004, SPINE, V29, P1681, DOI 10.1097/01.BRS.0000133643.75795.EF; Marchi L, 2013, J NEUROSURG-SPINE, V19, P110, DOI 10.3171/2013.4.SPINE12319; Youssef JA, 2010, SPINE, V35, pS302, DOI 10.1097/BRS.0b013e3182023438; Videbaek TS, 2006, SPINE, V31, P2875, DOI 10.1097/01.brs.0000247793.99827.b7; Ishihara H, 2001, J SPINAL DISORD, V14, P91, DOI 10.1097/00002517-200104000-00001; TAKAHASHI K, 1990, SPINE, V15, P1211, DOI 10.1097/00007632-199011010-00022; Acosta FL, 2011, J NEUROSURG-SPINE, V15, P92, DOI 10.3171/2011.3.SPINE10425; Cummock MD, 2011, J NEUROSURG-SPINE, V15, P11, DOI 10.3171/2011.2.SPINE10374; Anand N, 2008, J SPINAL DISORD TECH, V21, P459, DOI 10.1097/BSD.0b013e318167b06b; Ohtori S, 2011, J ORTHOP SCI, V16, P352, DOI 10.1007/s00776-011-0088-5; Chastain CA, 2007, ORTHOPEDICS, V30, P389; Davis TT, 2011, J BONE JOINT SURG AM, V93A, P1482, DOI 10.2106/JBJS.J.00962; Okuda S, 2006, J NEUROSURG-SPINE, V4, P304, DOI 10.3171/spi.2006.4.4.304; Gill K, 1993, Acta Orthop Scand Suppl, V251, P108; Kitchel SH, 2002, CURR CONCEPTS REV; Ozgur Burak M, 2006, Spine J, V6, P435, DOI 10.1016/j.spinee.2005.08.012; Pimenta L, 2001, 8 BRAZ SPIN SOC M BE; Schofferman J, 2001, Spine (Phila Pa 1976), V26, pE207, DOI 10.1097/00007632-200105150-00019; Silvestre Clément, 2012, Asian Spine J, V6, P89, DOI 10.4184/asj.2012.6.2.89; Tiusanen H, 1995, Eur Spine J, V4, P339, DOI 10.1007/BF00300293	23	0	0	YONSEI UNIV COLL MEDICINE	SEOUL	50-1 YONSEI-RO, SEODAEMUN-GU, SEOUL 120-752, SOUTH KOREA	0513-5796	1976-2437		YONSEI MED J	Yonsei Med. J.	JUL 1	2015	56	4					1051	1059		10.3349/ymj.2015.56.4.1051		9	Medicine, General & Internal	General & Internal Medicine	CL4DM	WOS:000356902800024		
J	Ryu, B; Kawamata, T; Yamaguchi, K; Kawashima, A; Ono, M; Okada, Y				Ryu, Bikei; Kawamata, Takakazu; Yamaguchi, Koji; Kawashima, Akitsugu; Ono, Masami; Okada, Yoshikazu			Moyamoya disease concurrent with Graves' disease treated by direct bypass: clinical features and treatment strategies	ACTA NEUROCHIRURGICA			English	Article						Direct bypass; Graves' disease; Moyamoya disease; Superficial temporal artery-middle cerebral artery anastomosis Thyroid storm; Thyrotoxic	CEREBRAL HYPERPERFUSION; THYROTOXICOSIS; HEMODYNAMICS; ANASTOMOSIS; VESSELS; PATIENT; RISK	Moyamoya disease (MMD) concurrent with Graves' disease (GD) is rare. There is no guideline about optimizing thyroid hormones and the appropriate timing of surgical treatment for MMD with GD. We encountered eight patients with MMD and GD presenting with cerebral ischemia who were treated by direct bypass. Thyroid hormones [free thyroxin (fT(4)) and free triiodothyronine (fT(3))], thyroid-stimulating hormone (TSH), and TSH receptor antibody (TRAb) were measured sequentially. After thyrotoxic conditions were medically optimized, revascularization surgery was performed by superficial temporal artery-middle cerebral artery (STA-MCA) double bypass in all cases. Clinical outcomes were estimated by modified Rankin scale (mRS) at discharge and 3 months after surgery. In six patients with thyrotoxicosis, the fT(4), fT(3), and TRAb (range) at the onset of cerebral ischemia were 4.81-10.30 pg/ml, 13.08-31.90 pg/ml, and 3.5-83.8 IU/l, respectively. At surgery, mean (range) fT(3) and fT(4) were optimized to 3.02 (1.01-4.87) pg/ml and 1.09 (0.41-1.68) ng/dl, respectively. In the thyrotoxic cases, it took 70-310 days (mean, 142 days) to optimize thyroid hormones before surgery. There was no neurological aggravation after surgery, and outcome was excellent at 3 months with mRS scores a parts per thousand currency sign2 in all cases. For MMD concurrent with GD, optimizing thyroid hormones followed by STA-MCA double bypass was successful to prevent cerebral ischemic events.	[Ryu, Bikei; Kawamata, Takakazu; Yamaguchi, Koji; Ono, Masami; Okada, Yoshikazu] Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, Tokyo 1628666, Japan; [Kawashima, Akitsugu] Tokyo Womens Med Univ, Dept Med 2, Tokyo 1628666, Japan	Kawamata, T (reprint author), Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	tkawamata@twmu.ac.jp					SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; SUZUKI J, 1983, STROKE, V14, P104; Li DS, 2013, CLIN NEUROL NEUROSUR, V115, P1647, DOI 10.1016/j.clineuro.2013.02.018; [Anonymous], 2009, SURG CEREBRAL STROKE, V37, P321; Yamaguchi K, 2010, NEUROSURGERY, V67, P1548, DOI 10.1227/NEU.0b013e3181f8c554; Akamizu T, 2012, THYROID, V22, P661, DOI 10.1089/thy.2011.0334; Suzuki S, 2011, CLIN NEUROL NEUROSUR, V113, P325, DOI 10.1016/j.clineuro.2010.11.022; Im SH, 2005, J NEUROSURG, V102, P1013, DOI 10.3171/jns.2005.102.6.1013; Lee R, 2009, YONSEI MED J, V50, P594, DOI 10.3349/ymj.2009.50.4.594; Kim SJ, 2010, STROKE, V41, P173, DOI 10.1161/STROKEAHA.109.562264; Hintze G, 1999, EUR J ENDOCRINOL, V140, P264, DOI 10.1530/eje.0.1400264; Utku U, 2004, AM J NEURORADIOL, V25, P1541; KUSHIMA K, 1991, CAN J NEUROL SCI, V18, P140; Colleran Kathleen M, 2003, Endocr Pract, V9, P290; Ishigami A, 2014, J STROKE CEREBROVASC, V23, P1256, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.025; Iso H, 2004, CIRCULATION, V109, P2766, DOI 10.1161/01.CIR.0000131942.77635.2D; Japan Thyroid Association, GUID DIAGN GRAV DIS; Kawamata T, 2009, NEUROSURGERY, V64, P447, DOI 10.1227/01.NEU.0000339110.73385.8A; Liu Jia-Shou, 1994, Journal of the Formosan Medical Association, V93, P806; Malik S, 2011, J STROKE CEREBROVASC, V20, P528, DOI 10.1016/j.jstrokecerebrovasdis.2010.03.006; McDermott MT, 2012, ANN INTERN MED, V157, pTIC11; Mikami T, 2012, JPN J STROKE, V34, P82; Morisawa H, 2013, NEUROSURG REV, V36, P411, DOI 10.1007/s10143-012-0441-y; Ohba S, 2011, NEUROSURG REV, V34, P297, DOI 10.1007/s10143-011-0311-z; Okada Y, 1999, NEUROL MED-CHIR, V39, P55, DOI 10.2176/nmc.39.55; Okada Y, 1998, STROKE, V29, P625; PANEGYRES PK, 1993, EUR NEUROL, V33, P260, DOI 10.1159/000116950; SIEGERT CEH, 1995, STROKE, V26, P496; SOLIMAN M, 1995, J CLIN ENDOCR METAB, V80, P905, DOI 10.1210/jc.80.3.905; Tendler BE, 1997, THYROID, V7, P625, DOI 10.1089/thy.1997.7.625	30	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2015	157	7					1095	1102		10.1007/s00701-015-2422-8		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CK6MJ	WOS:000356341900001		
J	Shigematsu, H; Sorimachi, T; Aoki, R; Osada, T; Srivatanakul, K; Matsumae, M				Shigematsu, Hideaki; Sorimachi, Takatoshi; Aoki, Rie; Osada, Takahiro; Srivatanakul, Kittipong; Matsumae, Mitsunori			Acute subdural hematoma caused by a ruptured cavernous internal carotid artery giant aneurysm following abducens nerve palsy: case report and review of the literature	ACTA NEUROCHIRURGICA			English	Review						Acute subdural hematoma; Cavernous sinus syndrome; Magnetic resonance image; Oculomotor nerve palsy	HEMORRHAGE	The authors report a 61-year-old female patient with a giant cavernous aneurysm in the right internal carotid artery (ICA) leading to acute subdural hematoma (ASDH) 7 days after the occurrence of abducens nerve palsy. She underwent ICA occlusion associated with high-flow bypass. In all five reported patients with a cavernous ICA aneurysm causing ASDH, the size of the aneurysm was giant and cranial nerve signs preceded the rupture. When a patient with a symptomatic cavernous ICA giant aneurysm experiences sudden-onset headache and/or consciousness disturbance, rupture of the aneurysm should be differentiated, even though a cavernous ICA aneurysm rarely causes ASDH.	[Shigematsu, Hideaki; Sorimachi, Takatoshi; Aoki, Rie; Osada, Takahiro; Srivatanakul, Kittipong; Matsumae, Mitsunori] Tokai Univ, Dept Neurosurg, Isehara, Kanagawa 2591194, Japan	Sorimachi, T (reprint author), Tokai Univ, Dept Neurosurg, 143 Simokasuya, Isehara, Kanagawa 2591194, Japan.	sorimachi@tokai-u.jp					Andaluz N, 2006, J NEUROSURG, V105, P315, DOI 10.3171/jns.2006.105.2.315; van Rooij WJ, 2006, AM J NEURORADIOL, V27, P185; KUPERSMITH MJ, 1992, J NEUROSURG, V77, P690, DOI 10.3171/jns.1992.77.5.0690; Turowski B, 2011, NEURORADIOLOGY, V53, P37, DOI 10.1007/s00234-010-0676-7; Szikora I, 2010, AM J NEURORADIOL, V31, P1139, DOI 10.3174/ajnr.A2023; BARR HWK, 1971, BRAIN, V94, P607, DOI 10.1093/brain/94.4.607; HODES JE, 1988, J NEUROSURG, V69, P617, DOI 10.3171/jns.1988.69.4.0617; Lee AG, 1996, NEUROSURGERY, V38, P596, DOI 10.1097/00006123-199603000-00038; LINSKEY ME, 1990, NEUROSURGERY, V26, P933; McLaughlin MR, 1996, NEUROSURGERY, V38, P388, DOI 10.1097/00006123-199602000-00032; Schneiders J J, 2013, AJNR Am J Neuroradiol, V34, pE1, DOI 10.3174/ajnr.A2613	11	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2015	157	7					1113	1116		10.1007/s00701-015-2428-2		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CK6MJ	WOS:000356341900003		
J	Kojima, K; Asamoto, S; Kobayashi, Y; Ishikawa, M; Fukui, Y				Kojima, Kota; Asamoto, Shunji; Kobayashi, Yoshiomi; Ishikawa, Masayuki; Fukui, Yasuyuki			Cortical bone trajectory and traditional trajectory-a radiological evaluation of screw-bone contact	ACTA NEUROCHIRURGICA			English	Article						Cortical bone trajectory; Screw-to-bone contact; Radiological study; CT number; Hounsfield unit; Posterior lumbar spine fusion	BIOMECHANICS	Cortical bone trajectory (CBT), a relatively new technique for pedicle screw insertion in the lumbar spine, is believed to have equivalent pullout and toggle characteristics compared with the traditional trajectory (TT). It has been hypothesized that the new trajectory offers higher cortical bone contact with the pedicle screws and therefore has an improved anchoring property over the traditional trajectory where the screws are inserted into the vertebral body trabecular space. The aim of this study is to evaluate the pedicle screw-cortical bone contact between the two trajectories from a radiological standpoint. Two hundred twenty-two patients with degenerative lumbar spine disease underwent computed tomography scanning. For each patient, axial slices of the L4 and L5 vertebra were cut in two planes, one horizontal to the pedicle representing the plane at which pedicle screws are inserted using the TT and another in a more caudo-cranial plane representing the plane at which pedicle screws are inserted using CBT. For each trajectory, a region of interest (ROI) was selected within the area in which the screws are inserted. A CT number (Hounsfield scale) was then calculated within each ROI to compare the bone density. The CT numbers within the ROI for CBT were constantly almost over four times higher than that for the TT, and there was a significant difference between the values (p < 0.0001). This study has demonstrated that, with the cortical bone trajectory, the pedicle screws penetrate a region that is richer in cortical bone compared to when using the traditional trajectory. This is in keeping with previous hypotheses that the new trajectory offers higher cortical bone contact.	[Kojima, Kota; Asamoto, Shunji; Ishikawa, Masayuki; Fukui, Yasuyuki] Int Univ Hlth & Welf, Mita Hosp, Spine & Spinal Cord Ctr, Tokyo 1088329, Japan; [Kojima, Kota; Kobayashi, Yoshiomi] Keio Univ, Dept Orthoped Surg, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Kojima, K (reprint author), Int Univ Hlth & Welf, Mita Hosp, Spine & Spinal Cord Ctr, 1-4-3 Mita, Tokyo 1088329, Japan.	dr.kota.kojima@keio.jp					Cho W, 2010, J BONE JOINT SURG BR, V92B, P1061, DOI 10.1302/0301-620X.92B8.24237; Santoni BG, 2009, SPINE J, V9, P366, DOI 10.1016/j.spinee.2008.07.008; Perez-Orribo L, 2013, SPINE, V38, P635, DOI 10.1097/BRS.0b013e318279a95e; Asamoto S, 2013, ANN M JAP SOC SPIN S; Crookshank M, 2014, ADV BIOMECH APPL, V1, P15; Cyron B M, 1979, Spine (Phila Pa 1976), V4, P163, DOI 10.1097/00007632-197903000-00013; Japiot Gallois M, 1925, REV CHIRURGIE, V63, P687; Krenz J, 1973, J Bone Joint Surg Br, V55, P735	8	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2015	157	7					1173	1178		10.1007/s00701-015-2432-6		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CK6MJ	WOS:000356341900013		
J	Tosaka, M; Tsushima, Y; Watanabe, S; Sakamoto, K; Yodonawa, M; Kunimine, H; Fujita, H; Fujii, T				Tosaka, Masahiko; Tsushima, Yoshito; Watanabe, Saiko; Sakamoto, Kazuya; Yodonawa, Masahiko; Kunimine, Hideo; Fujita, Haruyasu; Fujii, Takashi			Superficial subarachnoid cerebrospinal fluid space expansion after surgical drainage of chronic subdural hematoma	ACTA NEUROCHIRURGICA			English	Article						Chronic subdural hematoma; Computed tomography; Subarachnoid space; Subdural space; Surgical drainage	RECURRENCE RATE; TOMOGRAPHY; EVACUATION; MANAGEMENT	The present study examined the computed tomography (CT) findings after surgery and overnight drainage for chronic subdural hematoma (CSDH) to clear the significance of inner superficial subarachnoid CSF space and outer subdural hematoma cavity between the brain surface and the inner skull. A total of 73 sides in 60 patients were evaluated. Head CT was performed on the day after surgery and overnight drainage (1st CT), within 3 weeks of surgery (2nd CT), and more than 3 weeks after surgery (3rd CT). Subdural and subarachnoid spaces were identified to focus on density of fluid, shape of air collection, and location of silicone drainage tube, etc. Cases with subdural space larger than the subarachnoid CSF space were classified as Group SD between the brain and the skull. Cases with subarachnoid CSF space larger than the subdural space were classified as Group SA. Cases with extremely thin (< 3 mm) spaces between the brain and the skull were classified as Group NS. Group SA, SD, and NS accounted for 31.9, 55.6 and 12.5 % of cases on the 1st CT. No statistical differences were found between Groups SA, SD, and NS in any clinical factors, including recurrence. Group SA were found significantly more on 1st CT than on 2nd and 3rd CT. Subarachnoid CSF space sometimes expands between the brain and skull on CT after surgical overnight drainage. Expansion of the arachnoid space may be a passive phenomenon induced by overnight drainage and delayed re-expansion of the brain parenchyma.	[Tosaka, Masahiko; Watanabe, Saiko; Sakamoto, Kazuya; Yodonawa, Masahiko; Kunimine, Hideo; Fujii, Takashi] Fujii Neurosurg Hosp, Utsunomiya, Tochigi, Japan; [Tosaka, Masahiko] Gunma Univ, Grad Sch Med, Dept Neurosurg, Maebashi, Gunma 3718511, Japan; [Tsushima, Yoshito] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma 3718511, Japan; [Fujita, Haruyasu] Gunma Univ, Grad Sch Med, Dept Publ Hlth, Maebashi, Gunma 3718511, Japan	Tosaka, M (reprint author), Fujii Neurosurg Hosp, Utsunomiya, Tochigi, Japan.	nstosaka@gunma-u.ac.jp					Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; Suzuki Y, 2005, NEUROL MED-CHIR, V45, P333, DOI 10.2176/nmc.45.333; Mokri B, 2001, NEUROLOGY, V56, P1746; Santarius Thomas, 2009, Lancet, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; GRISOLI F, 1988, NEUROSURGERY, V23, P616; ROBINSON RG, 1984, J NEUROSURG, V61, P263, DOI 10.3171/jns.1984.61.2.0263; Ohba S, 2013, NEUROSURG REV, V36, P145, DOI 10.1007/s10143-012-0396-z; Borger V, 2012, ACTA NEUROCHIR, V154, P1549, DOI 10.1007/s00701-012-1434-x; Kuroki T, 2001, ACTA NEUROCHIR, V143, P1041, DOI 10.1007/s007010170010; HASHIMOTO N, 1992, J NEUROSURG, V77, P310, DOI 10.3171/jns.1992.77.2.0310; Janowski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035634; Kung WM, 2012, INJURY, V43, P598, DOI 10.1016/j.injury.2010.07.240; SCOTTI G, 1977, J NEUROSURG, V47, P311, DOI 10.3171/jns.1977.47.3.0311; Sucu HK, 2014, BRIT J NEUROSURG, V28, P93, DOI 10.3109/02688697.2013.804488; Tanikawa M, 2001, ACTA NEUROCHIR, V143, P613, DOI 10.1007/s007010170067; Tosaka M, 2013, NEUROL MED-CHIR, V53, P273; VICTORATOS GC, 1981, SURG NEUROL, V15, P158, DOI 10.1016/0090-3019(81)90041-0; Yu GJ, 2009, BRIT J NEUROSURG, V23, P606, DOI 10.3109/02688690903386983	19	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2015	157	7					1205	1214		10.1007/s00701-015-2435-3		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CK6MJ	WOS:000356341900018		
J	Sakagami, M; Kitahara, T; Ito, T; Ota, I; Nishimura, T; Nishimura, A; Otsuka, S; Yamanaka, T				Sakagami, Masaharu; Kitahara, Tadashi; Ito, Taeko; Ota, Ichiro; Nishimura, Tadashi; Nishimura, Ari; Otsuka, Shintaro; Yamanaka, Toshiaki			Effects of posterior tympanotomy with steroids at round window on hearing recovery after revision surgery for intractable Meniere's disease	ACTA OTO-LARYNGOLOGICA			English	Article						Endolymphatic sac drainage; recurrence; revision surgery; hearing	ENDOLYMPHATIC SAC SURGERY; DEXAMETHASONE; DRAINAGE	Conclusions: At the second postoperative year, there were no significant differences between results for vertigo and hearing after endolymphatic sac drainage with steroid instillation surgery (EDSS) and EDSS with posterior tympanotomy with steroids at the round window (EDRW). In particular, as regards hearing recovery to the preoperative level, the periods after EDRW were shorter than those after the second EDSS. Objectives: Patients sometimes faces recurrent problems years after EDSS due to endolymphatic sac closure and/or disease progression. In the present study, we examined the effects of EDRW on vertigo and hearing after revision surgery for intractable relapsed Meniere's disease. Methods: Sixteen patients with Meniere's disease had revision surgery due to intractable recurrence of disease, and were followed up regularly at least for 2 years. As revision surgery, EDSS was performed repeated in eight cases and EDRW was performed in the other eight. There were no significant differences between the patients' backgrounds in the two groups. Results: Periods of hearing recovery to the preoperative level were 11.5 +/- 4.4 months after the first EDSS, although it took 16.4 +/- 2.6 months longer after revision surgery with the second EDSS (p = 0.038 < 0.05: first EDSS vs second EDSS) and was 10.0 +/- 3.3 months shorter after revision surgery with EDRW (p = 0.010 < 0.05: second EDSS vs EDRW).	[Sakagami, Masaharu; Kitahara, Tadashi; Ito, Taeko; Ota, Ichiro; Nishimura, Tadashi; Nishimura, Ari; Otsuka, Shintaro; Yamanaka, Toshiaki] Nara Med Univ, Dept Otolaryngol Head & Neck Surg, Kashihara, Nara 6348522, Japan	Kitahara, T (reprint author), Nara Med Univ, Dept Otolaryngol Head & Neck Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	tkitahara@naramed-u.ac.jp			Health Science Research Grant for Specific Disease from the Ministry of Health, Labour and Welfare, Japan	The authors wish to thank Dr Michiko Shuto, a registered statistician (certificate no. 62720218), for helpful advice on statistical analysis. This study was supported in part by a Health Science Research Grant for Specific Disease from the Ministry of Health, Labour and Welfare, Japan (2014-2016).	[Anonymous], 1995, OTOLARYNGOL HEAD NEC, V113, P181; Claes J, 2000, Acta Otolaryngol Suppl, V544, P34; Sajjadi H, 2008, LANCET, V372, P406, DOI 10.1016/S0140-6736(08)61161-7; Kitahara T, 2008, LARYNGOSCOPE, V118, P854, DOI 10.1097/MLG.0b013e3181651c4a; Kitahara T, 2013, AURIS NASUS LARYNX, V40, P425, DOI 10.1016/j.anl.2012.11.008; Kitahara T, 2001, ANN OTO RHINOL LARYN, V110, P109; Kitahara T, 2004, ANN OTO RHINOL LARYN, V113, P399; Kitahara T, 2011, AURIS NASUS LARYNX, V38, P178, DOI 10.1016/j.anl.2010.08.002; MORI N, 1985, SCAND AUDIOL, V14, P209, DOI 10.3109/01050398509045943; Paparella MM, 2006, OTOLARYNG CLIN N AM, V39, P713, DOI 10.1016/j.otc.2006.03.001; Sennaroglu L, 2001, OTOLARYNG HEAD NECK, V125, P537, DOI 10.1067/mhn2001.119485; Shea JJ, 1997, OTOLARYNG CLIN N AM, V30, P1051; Wetmore SJ, 2008, ARCH OTOLARYNGOL, V134, P1144, DOI 10.1001/archotol.134.11.1144	13	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	JUL	2015	135	7					667	672		10.3109/00016489.2015.1009161		6	Otorhinolaryngology	Otorhinolaryngology	CL0ZW	WOS:000356672600006		
J	Sei, H; Taguchi, A; Nishida, N; Hato, N; Gyo, K				Sei, Hirofumi; Taguchi, Aki; Nishida, Naoya; Hato, Naohito; Gyo, Kiyofumi			Preventive effects of bortezomib on denervation-induced atrophy of the intrinsic laryngeal muscles: an experimental study in the rat	ACTA OTO-LARYNGOLOGICA			English	Article						Recurrent laryngeal nerve palsy; intrinsic laryngeal muscle atrophy; prevention of proteolysis; ubiquitin-proteasome pathway; muscle fiber composition	SKELETAL-MUSCLE; PROTEASOME INHIBITOR; EXPRESSION; CANCER	Conclusion: Bortezomib was effective in attenuating atrophy of the posterior cricoarytenoid (PCA) muscle, but not the thyroarytenoid (TA) muscle. This was probably due to differences in the fiber composition of the two muscles. The PCA muscle is composed of a combination of fast- and slow-twitch fibers, and therefore is more resistant to atrophy than the TA muscle, which is composed solely of fast-twitch fibers. Objectives: To investigate the preventive effects of bortezomib on denervation-induced atrophy of the TA and PCA muscles in the rat. Methods: Following transection of the left recurrent laryngeal nerve, bortezomib (100 mu g/kg) was administered subcutaneously on post-denervation days 1 and 4, followed by a 10-day rest period every 14 days; each 2-week period constituted a single treatment cycle. In controls, saline was administered instead. Animals were killed for histological examination at 4 (n = 6), 8 (n = 7), and 12 (n = 7) weeks post-denervation. Muscle atrophy was assessed using three indices: wet muscle weight, muscle fiber cross-sectional area, and the number of muscle fibers/mm2. The effects of bortezomib were evaluated by comparing the left (L) and right (R) muscles, with sequential changes in the L/R ratio assessed. Results: In saline-administered animals, atrophy of the left-sided TA and PCA muscles progressed rapidly during the first 4 weeks post-denervation, following which progression slowed. Atrophy was greater in the TA compared with the PCA muscle, although this difference was not statistically significant. In bortezomib-administered animals, atrophy of the PCA muscle was attenuated significantly at post-denervation weeks 8 and 12; no such reduction in atrophy was observed for the TA muscle.	[Sei, Hirofumi; Nishida, Naoya; Hato, Naohito] Ehime Univ, Sch Med, Dept Otolaryngol, Toon City Shitsukawa, Ehime 910295, Japan; [Taguchi, Aki] Matsuyama Red Cross Hosp, Dept Otolaryngol, Matsuyama, Ehime, Japan; [Gyo, Kiyofumi] Takanoko Hosp, Dept Otolaryngol, Matsuyama, Ehime, Japan	Sei, H (reprint author), Ehime Univ, Sch Med, Dept Otolaryngol, Toon City Shitsukawa, Ehime 910295, Japan.	hirofumisei@gmail.com					Combaret L, 2002, BIOCHEM J, V361, P185, DOI 10.1042/0264-6021:3610185; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Beehler BC, 2006, EXP BIOL MED, V231, P335; Isshiki N, 2000, ACTA OTO-LARYNGOL, V120, P120, DOI 10.1080/000164800750000748; Fang CH, 1998, CLIN SCI, V95, P225, DOI 10.1042/CS19980092; Adams J, 2002, ONCOLOGIST, V7, P9, DOI 10.1634/theoncologist.7-1-9; Ikemoto M, 2001, FASEB J, V15, P1279; Jamart C, 2011, MUSCLE NERVE, V43, P708, DOI 10.1002/mus.21949; Kumai Y, 2006, LARYNGOSCOPE, V116, P1027, DOI 10.1097/01.MLG.0000217588.46645.FA; Lecker SH, 1999, J NUTR, V129, p227S; Okamoto T, 2011, J PHYSIOL SCI, V61, P537, DOI 10.1007/s12576-011-0175-6; Orlowski Robert Z., 2005, V301, P339; Remacle Marc, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P148, DOI 10.1097/MOO.0b013e3281084e74; Sei H, 2015, EUR ARCH OTO-RHINO-L, V272, P137, DOI 10.1007/s00405-014-3226-9; Tisdale Michael J, 2005, J Support Oncol, V3, P209	15	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	JUL	2015	135	7					713	717		10.3109/00016489.2015.1006793		5	Otorhinolaryngology	Otorhinolaryngology	CL0ZW	WOS:000356672600013		
J	Ebisumoto, K; Okami, K; Sakai, A; Ogura, G; Sugimoto, R; Saito, K; Komita, K; Nakamura, N; Iida, M				Ebisumoto, Koji; Okami, Kenji; Sakai, Akihiro; Ogura, Go; Sugimoto, Ryousuke; Saito, Kosuke; Komita, Kaoru; Nakamura, Naoya; Iida, Masahiro			The potential risk of vessel infiltration and cervical lymph node metastasis in hypopharyngeal superficial squamous cell carcinoma: a retrospective observational study	ACTA OTO-LARYNGOLOGICA			English	Article						Superficial cancer; hypopharynx; predictor; vessel infiltration; lymph node metastasis; histopathological parameters	ENDOSCOPIC MUCOSAL RESECTION; EN-BLOC RESECTION; PHARYNGEAL CARCINOMA; ESOPHAGEAL CANCER; IN-SITU; INVOLVEMENT; PROGNOSIS; INVASION; HEAD	Conclusion: The depth of hypopharyngeal superficial cancer may predict vessel infiltration and potential risk of cervical lymph node metastasis. Objectives: To elucidate the histopathological predictors of vessel infiltration and the risk of regional lymph node metastasis in hypopharyngeal superficial cancer. Methods: This study included 31 lesions from 30 patients who had undergone transoral en bloc resection in the hospital. Patients with intraepithelial neoplasia or muscular invasion were excluded. Patient characteristics, nodal status, state of vessel infiltration, state of perineural invasion, histopathological parameters, and post-operative cervical lymph node recurrence were retrospectively examined. The histopathological parameters measured were tumor diameter and the following three parameters: tumor thickness, depth from the mucosal surface, and depth from the basement membrane. Correlations between histopathological parameters and state of vessel infiltration were statistically analyzed. Results: Of the 31 lesions examined, four had vessel infiltration. Three of the four lesions with vessel infiltration had regional lymph node metastasis as well as subsequent lymph node metastasis. Lesions with vessel infiltration were significantly deeper than those without. In contrast, there was no significant difference in lesion diameters. In addition, there was no correlation between the depth and the diameter of the lesion.	[Ebisumoto, Koji; Okami, Kenji; Sakai, Akihiro; Sugimoto, Ryousuke; Saito, Kosuke; Komita, Kaoru; Iida, Masahiro] Tokai Univ, Dept Otolaryngol Head & Neck Surg, Isehara, Kanagawa 2591193, Japan; [Ogura, Go; Nakamura, Naoya] Tokai Univ, Dept Pathol, Isehara, Kanagawa 2591193, Japan	Ebisumoto, K (reprint author), Tokai Univ, Dept Otolaryngol Head & Neck Surg, Isehara, Kanagawa 2591193, Japan.	evis@hi.enjoy.ne.jp					Okada K, 2012, ENDOSCOPY, V44, P556, DOI 10.1055/s-0032-1309720; Watanabe A, 2008, OTOLARYNG HEAD NECK, V138, P446, DOI 10.1016/j.otohns.2007.12.034; Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Muto M, 2011, GASTROINTEST ENDOSC, V74, P477, DOI 10.1016/j.gie.2011.04.027; Gockel I, 2011, EXPERT REV GASTROENT, V5, P371, DOI [10.1586/egh.11.33, 10.1586/EGH.11.33]; Pentenero M, 2005, HEAD NECK-J SCI SPEC, V27, P1080, DOI 10.1002/hed.20275; Eguchi T, 2006, MODERN PATHOL, V19, P475, DOI 10.1038/modpathol.3800557; Fujii S, 2010, HISTOPATHOLOGY, V56, P510, DOI 10.1111/j.1365-2559.2010.03512.x; Fujita Y, 2008, Endoscopy, V40 Suppl 2, pE189, DOI 10.1055/s-2007-995570; Greene FL, 2002, AJCC CANC STAGING MA; Inoue H, 1997, DIGEST ENDOSC, V9/1, P16, DOI 10.1111/j.1443-1661.1997.tb00453.x; Muto M, 2004, CANCER, V101, P1375, DOI 10.1002/cncr.20482; Okami K, 2013, HEAD NECK-J SCI SPEC, V35, P1162, DOI 10.1002/hed.23094; Sobin LH, 2009, TNM CLASSIFICATION M; Tajima Y, 2000, CANCER, V88, P1285; Taniguchi M, 2011, AURIS NASUS LARYNX, V38, P710, DOI 10.1016/j.anl.2011.01.001; Tomifuji M, 2011, ANN SURG ONCOL, V18, P490, DOI 10.1245/s10434-010-1219-5; Ugumori T, 2009, HEAD NECK-J SCI SPEC, V31, P189, DOI 10.1002/hed.20943; Watanabe A, 2006, LARYNGOSCOPE, V116, P650, DOI 10.1097/01.mlg.0000204304.38797.34	19	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	JUL	2015	135	7					729	735		10.3109/00016489.2015.1016186		7	Otorhinolaryngology	Otorhinolaryngology	CL0ZW	WOS:000356672600016		
J	Sakai, M; Yokoyama, J; Tashiro, M; Ishikawa, T				Sakai, Mizuno; Yokoyama, Junkichi; Tashiro, Masatugu; Ishikawa, Tooru			A novel procedure combining transoral resection and set-back tongue flap for oropharyngeal cancer	ACTA OTO-LARYNGOLOGICA			English	Article						Minimally invasive surgery; oropharyngeal carcinoma; polyglycolic acid sheet	SQUAMOUS-CELL CARCINOMA; LASER MICROSURGERY; PROGNOSTIC-FACTORS; OUTCOMES	Seven patients with advanced lateral oropharyngeal cancer (T3N2bM0, or T4N2bM0) underwent transoral lateral oropharyngectomy (TLO) with reconstruction performed through set-back tongue flap and polyglycolic acid (PGA) sheet. TLO was performed following en bloc resection of tumors using endoscopy. To cover the resulting defect in the lateral oropharyngeal wall, the set-back tongue flap was moved posteriorly and laterally to the area of the tongue base and lateral pharyngeal wall. The tip of the set-back tongue flap was sutured to the lateral pharynx to reconstruct the elevated tongue base and altered anterior pillar. The defect on the floor of the mouth was reconstructed using a PGA sheet. Following surgery, the mean observation period was 24 months. The mean operating time was 4 h and 2 min, with an average blood loss of 68.1 ml. All oral intake resumed on the first postoperative day via gastric tube. The mean gastric tube removal time was 1.6 postoperative days as a result of sufficient oral intake. None of the patients received postoperative radiotherapy or displayed evidence of tumor recurrence. We conclude that this novel procedure is highly effective for treating advanced oropharyngeal cancer as it demonstrates good prognostic and functional outcomes.	[Sakai, Mizuno; Tashiro, Masatugu; Ishikawa, Tooru] Natl Hosp Org Tochigi, Med Ctr, Dept Otolaryngol Head & Neck Surg, Utsunomiya, Tochigi, Japan; [Yokoyama, Junkichi] Juntendo Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Tokyo 1138431, Japan; [Yokoyama, Junkichi] Kyorin Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Tokyo, Japan	Yokoyama, J (reprint author), Juntendo Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Bunkyo Ku, Tokyo 1138431, Japan.	jyokoya@juntendo.ac.jp			Ministry of Education, Culture, Sports, and Technology of Japan [22591920]	This study was supported in part by Grants-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, and Technology (22591920) of Japan.	Moore EJ, 2009, LARYNGOSCOPE, V119, P2156, DOI 10.1002/lary.20647; Sinha P, 2014, HEAD NECK-J SCI SPEC, V36, P340, DOI 10.1002/hed.23293; Rich JT, 2009, LARYNGOSCOPE, V119, P1709, DOI 10.1002/lary.20552; Moore EJ, 2009, LARYNGOSCOPE, V119, P508, DOI 10.1002/lary.20124; Holsinger FC, 2005, ARCH OTOLARYNGOL, V131, P583, DOI 10.1001/archotol.131.7.583; Ohba S, 2013, HEAD NECK ONCOL, V5, P3; SCHECHTER GL, 1980, ARCH OTOLARYNGOL, V106, P668; STRONG MS, 1979, LARYNGOSCOPE, V89, P897; Yamashita T, 2011, HEAD NECK-J SCI SPEC, V33, P1315, DOI 10.1002/hed.21604; Yonezawa H, 2012, BRIT J ORAL MAX SURG, V50, P459, DOI 10.1016/j.bjoms.2011.07.012	10	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	JUL	2015	135	7					736	740		10.3109/00016489.2015.1011790		5	Otorhinolaryngology	Otorhinolaryngology	CL0ZW	WOS:000356672600017		
J	Yasuda, M; Inokuchi, R; Ohshima, K; Yamamoto, M; Tokunaga, K; Fukuda, T; Nakamura, K				Yasuda, Maki; Inokuchi, Ryota; Ohshima, Kazuma; Yamamoto, Miyuki; Tokunaga, Kurato; Fukuda, Tatsuma; Nakamura, Kensuke			Linezolid is a novel and effective treatment for septic pulmonary embolism	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article								Septic pulmonary embolism (SPE) is an uncommon and severe infectious disease that requires early diagnosis and proper antibiotic therapy. We present the case of a healthy 14-year-old girl with a history of atopic dermatitis, who developed SPE caused by Staphylococcus aureus bacteremia. We initially administered intravenous doripenem and vancomycin. Four days after her admission, blood and urine cultures yielded penicillinase nonproducing, methicillin-sensitive S aureus, with a minimum inhibitory concentration less than 0.06 mu g/mL. However, the administration of penicillin G aggravated her condition; therefore, treatment was switched to linezolid on day 8. Her condition subsequently resolved, and she was discharged 40 days after admission without any complications. To our knowledge, this is the first report regarding the efficacy of linezolid for SPE that is related to community-acquired methicillin-sensitive S aureus bacteremia. The favorable lung tissue transfer of linezolid may have contributed to its efficacy against the SPE.	[Yasuda, Maki; Inokuchi, Ryota; Ohshima, Kazuma; Yamamoto, Miyuki; Tokunaga, Kurato; Fukuda, Tatsuma; Nakamura, Kensuke] Hitachi Gen Hosp, Dept Emergency & Crit Care Med, Hitachi, Ibaraki 3170077, Japan; [Inokuchi, Ryota; Fukuda, Tatsuma; Nakamura, Kensuke] Tokyo Univ Hosp, Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo 1138655, Japan; [Inokuchi, Ryota] JR Gen Hosp, Dept Emergency Med, Shibuya Ku, Tokyo 1518528, Japan	Yasuda, M (reprint author), Hitachi Gen Hosp, Dept Emergency & Crit Care Med, 2-1-1 Jonan, Hitachi, Ibaraki 3170077, Japan.	kakemaki729@yahoo.co.jp					Ye R, 2014, RESP MED, V108, P1, DOI 10.1016/j.rmed.2013.10.012; Surov A, 2009, JPEN-PARENTER ENTER, V33, P677, DOI 10.1177/0148607109335121; Conte JE, 2002, ANTIMICROB AGENTS CH, V46, P1475, DOI 10.1128/AAC.46.5.1475-1480.2002; Cook RJ, 2005, CHEST, V128, P162, DOI 10.1378/chest.128.1.162; Garcia-Roca P, 2006, ARCH MED RES, V37, P31, DOI 10.1016/j.arcmed.2005.05.022; George PA, 2002, ANTIMICROB AGENTS CH, V46, P2606; Lambers C, 2010, INT J CLIN PHARM TH, V48, P419; Ryan Dunn, 2011, ANN CLIN MICROB ANTI, V10, P31; Tatsuro S, 1951, J ANTIBIOT B, V4, P537; Thabet FC, 2013, SAUDI MED J, V34, P1080; Tsuyoshi Sano, 2013, KOKYU, V2, P58; Umesh Goswami, 2014, OPEN RESP MED J, V8, P28	12	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUL	2015	33	7							988.e3	10.1016/j.ajem.2014.12.035		2	Emergency Medicine	Emergency Medicine	CL0BG	WOS:000356602900047		
J	Grabowski, GA; Zimran, A; Ida, H				Grabowski, Gregory A.; Zimran, Ari; Ida, Hiroyuki			Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry	AMERICAN JOURNAL OF HEMATOLOGY			English	Review							ENZYME REPLACEMENT THERAPY; GLUCOCEREBROSIDASE GENE; PARKINSONS-DISEASE; PULMONARY-HYPERTENSION; CORNEAL OPACITIES; D409H MUTATION; ASHKENAZI-JEWS; RECOMMENDATIONS; CHILDREN; PATIENT	Study of the natural history of Gaucher disease has revealed marked phenotypic variation. Correlations to genotypes could provide insight into individual susceptibility to varying disease severity, which may impact whole-life medical care, reproductive decisions, and therapeutic choices for affected families. Importantly, pre-symptomatic or prospective interventions or the use of therapies with significant risk require accurate risk-benefit analyses based on the prognosis for individual patients. The body of international data held within the International Collaborative Gaucher Group (ICGG) Gaucher Registry provides an unprecedented opportunity to characterize the phenotypes of Gaucher disease types 1 and 3 and to appreciate demographic and ethnic factors that may influence phenotypes. The diversity of GBA gene mutations from patients with Gaucher disease represented in the ICGG Gaucher Registry database and in the literature provides the basis for initial genotype/phenotype correlations, the outcomes of which are summarized here.Am. J. Hematol. 90:S12-S18, 2015. (c) 2015 Wiley Periodicals, Inc.	[Grabowski, Gregory A.] Childrens Hosp, Med Ctr, Div Human Genet, Dept Pediat, Cincinnati, OH 45229 USA; [Zimran, Ari] Shaare Zedek Med Ctr, Dept Internal Med, Jerusalem, Israel; [Zimran, Ari] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel; [Ida, Hiroyuki] Jikei Univ, Sch Med, Dept Pediat, Tokyo, Japan	Grabowski, GA (reprint author), Childrens Hosp, Med Ctr, Div Human Genet, 3333 Burnet Ave,MLC 4006, Cincinnati, OH 45229 USA.	greg.grabowski@cchmc.org			Genzyme, a Sanofi company	Contract grant sponsors: Genzyme, a Sanofi company.	Adelino TER, 2013, JIMD REP, V9, P85, DOI 10.1007/8904_2012_184; Andersson HC, 2005, GENET MED, V7, P105, DOI 10.1097/01.GIM.0000153660.88672.3C; Tylki-Szymanska A, 2010, J INHERIT METAB DIS, V33, P339, DOI 10.1007/s10545-009-9009-6; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; Machaczka M, 1999, AM J HEMATOL, V61, P216, DOI 10.1002/(SICI)1096-8652(199907)61:3<216::AID-AJH12>3.0.CO;2-B; Weinreb NJ, 2013, J INHERIT METAB DIS, V36, P543, DOI 10.1007/s10545-012-9528-4; Weinreb NJ, 2004, SEMIN HEMATOL, V41, P15, DOI 10.1073/j.seminhematol.2004.07.010; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Bembi B, 2003, NEUROLOGY, V61, P99; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Tylki-Szymanska A, 2006, GENET MED, V8, P8, DOI 10.1097/01.gim.0000196443.42899.25; Mistry PK, 2002, MOL GENET METAB, V77, P91, DOI 10.1016/S1096-7192(02)00122-1; Sidransky E, 2004, MOL GENET METAB, V83, P6, DOI 10.1016/j.ymgme.2004.08.015; Charrow J, 1998, ARCH INTERN MED, V158, P1754, DOI 10.1001/archinte.158.16.1754; Pastores GM, 2004, SEMIN HEMATOL, V41, P4, DOI 10.1016/j.seminhematol.2004.07.009; ZIMRAN A, 1992, MEDICINE, V71, P337, DOI 10.1097/00005792-199211000-00002; Charrow J, 2000, ARCH INTERN MED, V160, P2835, DOI 10.1001/archinte.160.18.2835; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Balwani M, 2010, ARCH INTERN MED, V170, P1463, DOI 10.1001/archinternmed.2010.302; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Andersson H, 2008, PEDIATRICS, V122, P1182, DOI 10.1542/peds.2007-2144; Khan A, 2012, J BONE MINER RES, V27, P1839, DOI 10.1002/jbmr.1680; Kaplan P, 2006, ARCH PEDIAT ADOL MED, V160, P603, DOI 10.1001/archpedi.160.6.603; Sobreira E, 2007, MOL GENET METAB, V90, P81, DOI 10.1016/j.ymgme.2006.08.009; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Hoeper MM, 1999, ANN INTERN MED, V130, P506; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Grabowski GA, 2003, ANNU REV GENOM HUM G, V4, P403, DOI 10.1146/annurev.genom.4.070802.110415; Baldellou A, 2004, EUR J PEDIATR, V163, P67, DOI 10.1007/s00431-003-1363-z; Chabas A, 1998, J MED GENET, V35, P775, DOI 10.1136/jmg.35.9.775; Charrow J, 2004, J PEDIATR-US, V144, P112, DOI 10.1016/j.jpeds.2003.10.067; Doneda D, 2011, BLOOD CELL MOL DIS, V46, P42, DOI 10.1016/j.bcmd.2010.10.008; DREBORG S, 1980, EUR J PEDIATR, V133, P107, DOI 10.1007/BF00441578; Eblan MJ, 2005, NEW ENGL J MED, V352, P728; ERDURAN E, 1995, GENET COUNSEL, V6, P211; Fairley C, 2008, J INHERIT METAB DIS, V31, P738, DOI 10.1007/s10545-008-0868-z; George R, 2001, CLIN GENET, V59, P360, DOI 10.1034/j.1399-0004.2001.590511.x; Grabowski G, 2010, METABOLIC MOL BASES; Grabowski G, 2006, METABOLIC MOL BASES; Grabowski GA, 1997, GENET TEST, V1, P5; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Liou B., 1996, THESIS U CINCINNATI; Mao R, 2001, MOL GENET METAB, V72, P248, DOI 10.1006/mgme.2000.3141; Mistry PK, 2011, BLOOD CELL MOL DIS, V46, P66, DOI 10.1016/j.bcmd.2010.10.011; Moscicki R., 1995, ICGG REGIS UPDATE, V1995, P1; Oliveira FL, 2013, JIMD REP, V7, P31, DOI 10.1007/8904_2012_136; SIBILLE A, 1993, AM J HUM GENET, V52, P1094; Sidransky E, 2005, MOL GENET METAB, V84, P302, DOI 10.1016/j.ymgme.2004.11.007; TylkiSzymanska A, 1996, EUR J HUM GENET, V4, P334; UYAMA E, 1992, ACTA NEUROL SCAND, V86, P407; WALLEY AJ, 1993, HUM MOL GENET, V2, P1737, DOI 10.1093/hmg/2.10.1737; ZIMRAN A, 1989, LANCET, V2, P349; ZIMRAN A, 1991, AM J HUM GENET, V49, P855	53	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0361-8609	1096-8652		AM J HEMATOL	Am. J. Hematol.	JUL	2015	90			1			S12	S18		10.1002/ajh.24063		7	Hematology	Hematology	CL0JB	WOS:000356627200004		
J	Hiramatsu, R; Ubara, Y; Sawa, N; Hoshino, J; Hasegawa, E; Kawada, M; Imafuku, A; Sumida, K; Mise, K; Hayami, N; Suwabe, T; Takaichi, K				Hiramatsu, Rikako; Ubara, Yoshifumi; Sawa, Naoki; Hoshino, Junichi; Hasegawa, Eiko; Kawada, Masahiro; Imafuku, Aya; Sumida, Keiichi; Mise, Koki; Hayami, Noriko; Suwabe, Tatsuya; Takaichi, Kenmei			Denosumab for Low Bone Mass in Hemodialysis Patients: A Noncontrolled Trial	AMERICAN JOURNAL OF KIDNEY DISEASES			English	Letter							POSTMENOPAUSAL WOMEN; OSTEOPOROSIS; FRACTURE		[Hiramatsu, Rikako; Ubara, Yoshifumi; Sawa, Naoki; Hoshino, Junichi; Hasegawa, Eiko; Kawada, Masahiro; Imafuku, Aya; Sumida, Keiichi; Mise, Koki; Hayami, Noriko; Suwabe, Tatsuya; Takaichi, Kenmei] Toranomon Gen Hosp, Tokyo, Japan; [Hiramatsu, Rikako; Ubara, Yoshifumi; Takaichi, Kenmei] Okinaka Mem Inst, Tokyo, Japan	Hiramatsu, R (reprint author), Toranomon Gen Hosp, Tokyo, Japan.	rikako64@toranomon.gr.jp					Block GA, 2012, J BONE MINER RES, V27, P1471, DOI 10.1002/jbmr.1613; Keaveny TM, 2008, J BONE MINER RES, V23, P1541, DOI [10.1359/jbmr.080406, 10.1359/JBMR.080406]; Jamal SA, 2010, AM J KIDNEY DIS, V55, P291, DOI 10.1053/j.ajkd.2009.10.049; Tentori F, 2014, KIDNEY INT, V85, P166, DOI 10.1038/ki.2013.279; McCormick BB, 2012, AM J KIDNEY DIS, V60, P626, DOI 10.1053/j.ajkd.2012.06.019; Sutjandra L, 2011, CLIN PHARMACOKINET, V50, P793, DOI 10.2165/11594240-000000000-00000; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Jamal SA, 2011, J BONE MINER RES, V26, P1829, DOI 10.1002/jbmr.403; Chen CL, 2014, J CLIN ENDOCR METAB, V99, P2426, DOI 10.1210/jc.2014-1154; Cunningham J, 2004, AM J KIDNEY DIS, V43, P566, DOI 10.1053/j.ajkd.2003.12.004	10	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0272-6386	1523-6838		AM J KIDNEY DIS	Am. J. Kidney Dis.	JUL	2015	66	1					175	177		10.1053/j.ajkd.2015.03.012		4	Urology & Nephrology	Urology & Nephrology	CL1UO	WOS:000356730600034		
J	Iida, R; Furuya, T; Suzuki, T				Iida, Ryoji; Furuya, Tomonori; Suzuki, Takahiro			Giant Caseous Calcification of the Mitral Annulus Identified by Three- Dimensional Transesophageal Echocardiography	ANESTHESIA AND ANALGESIA			English	Article									[Iida, Ryoji; Furuya, Tomonori; Suzuki, Takahiro] Nihon Univ, Sch Med, Dept Anesthesiol, Tokyo 1730032, Japan	Iida, R (reprint author), Nihon Univ, Sch Med, Dept Anesthesiol, Itabashi Ku, 30-1 Oyaguchi Kamicho, Tokyo 1730032, Japan.	ryoiida03@gmail.com					Akram Mohammad, 2012, J Saudi Heart Assoc, V24, P205, DOI 10.1016/j.jsha.2012.02.003; Alkadhi H, 2005, J THORAC CARDIOV SUR, V129, P1438, DOI 10.1016/j.jtcvs.2004.11.051; Deluca G, 2008, J AM SOC ECHOCARDIOG, V21, P828, DOI 10.1016/j.echo.2007.12.004; Assudani J, 2010, ECHOCARDIOGR-J CARD, V27, P1147, DOI 10.1111/j.1540-8175.2010.01315.x; Harpaz D, 2001, J AM SOC ECHOCARDIOG, V14, P825, DOI 10.1067/mje.2001.111877; Marcì Marcello, 2009, Cases J, V2, P95, DOI 10.1186/1757-1626-2-95	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	JUL	2015	121	1					62	64		10.1213/ANE.0000000000000674		3	Anesthesiology	Anesthesiology	CL0YR	WOS:000356669500004		
J	Igarashi, T; Suzuki, T; Mori, K; Inoue, K; Seki, H; Yamada, T; Kosugi, S; Minamishima, S; Katori, N; Sano, F; Abe, T; Morisaki, H				Igarashi, Toru; Suzuki, Takeshi; Mori, Katsuya; Inoue, Kei; Seki, Hiroyuki; Yamada, Takashige; Kosugi, Shizuko; Minamishima, Shizuka; Katori, Nobuyuki; Sano, Fumiya; Abe, Takayuki; Morisaki, Hiroshi			The Effects of Epidural Anesthesia on Growth of Escherichia coli at Pseudosurgical Site: The Roles of the Lipocalin-2 Pathway	ANESTHESIA AND ANALGESIA			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; COLORECTAL SURGERY; INFECTION; EXPRESSION; LIDOCAINE; ANALGESIA; RABBITS; IRON	BACKGROUND: Neutrophil-derived lipocalin-2 exerts bacteriostatic effects through retardation of iron uptake by the Gram-negative organisms like Escherichia coli. We tested the hypothesis that the expression of lipocalin-2, a bacteriostatic protein, was upregulated by induction of surgical site infection (SSI) with E coli in healthy and diseased rats and that epidural anesthesia modulated its expression. METHODS: Male Wistar rats were randomized into a healthy or disease group, the latter of which was administered lipopolysaccharide. Both groups were further divided into 3 subgroups, the control, saline, and lidocaine groups: group healthy control (n = 10), healthy saline (n = 10), and healthy lidocaine (n = 10) versus group disease control (n = 15), disease saline (n = 18), and disease lidocaine (n = 19), respectively. While saline was epidurally administered to the control and saline groups, lidocaine was administered to the lidocaine groups. Except for the control groups, E coli was injected to the pseudosurgical site to mimic SSI after abdominal surgery. Plasma concentrations of inflammatory cytokine and lipocalin-2 were measured. At 72 hours, the surgical site tissues were obtained to evaluate mRNA expression of lipocalin-2 and E coli DNA expression. RESULTS: All disease subgroups showed markedly increased plasma inflammatory cytokines versus the healthy subgroups. Among the disease subgroups, plasma concentrations of lipocalin-2 and tissue mRNA expression of lipocalin-2 were significantly increased in group disease lidocaine versus the others. Concurrently, E coli DNA expression in the tissue specimens was also significantly lower in group disease lidocaine as compared with group disease saline. CONCLUSIONS: Epidural anesthesia was associated with an increase in the expression lipocalin-2 and a decrease in the expression of E coli DNA at pseudosurgical sites in sick but not healthy rats. These observations suggest a potential mechanism by which epidural anesthesia could reduce the risk of SSI.	[Igarashi, Toru; Suzuki, Takeshi; Mori, Katsuya; Inoue, Kei; Seki, Hiroyuki; Yamada, Takashige; Kosugi, Shizuko; Minamishima, Shizuka; Katori, Nobuyuki; Morisaki, Hiroshi] Keio Univ, Sch Med, Dept Anesthesiol, Tokyo 1608582, Japan; [Sano, Fumiya] Keio Univ, Sch Med, Ctr Clin Res, Tokyo 1608582, Japan; [Abe, Takayuki] Keio Univ, Sch Med, Clin Res Ctr, Dept Prevent Med & Publ Hlth, Tokyo 1608582, Japan	Morisaki, H (reprint author), Keio Univ, Sch Med, Dept Anesthesiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	morisaki@z8.keio.jp					Kabon B, 2003, ANESTH ANALG, V97, P1812, DOI 10.1213/01.ANE.0000087040.48267.54; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; BURKE JF, 1961, SURGERY, V50, P161; Akca O, 1999, LANCET, V354, P41, DOI 10.1016/S0140-6736(99)00874-0; Altenburg SP, 1997, J LEUKOCYTE BIOL, V61, P689; McOrist AL, 2002, J MICROBIOL METH, V50, P131, DOI 10.1016/S0167-7012(02)00018-0; Ho VP, 2011, SURG INFECT, V12, P255, DOI 10.1089/sur.2010.073; SCHMIDT RM, 1970, J INFECT DIS, V121, P597; Chang CC, 2010, ANESTHESIOLOGY, V113, P279, DOI 10.1097/ALN.0b013e3181e2c1c3; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Gulluoglu BM, 2013, ANN SURG, V257, P37, DOI 10.1097/SLA.0b013e31826d832d; Seo SJ, 2006, J INVEST DERMATOL, V126, P510, DOI 10.1038/sj.jid.5700035; Chloropoulou P, 2013, MED SCI MONITOR, V19, P73; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Freise H, 2005, ANESTH ANALG, V100, P255, DOI 10.1213/01.ANE.0000140253.65577.1C; Gunsalus IC, 1941, J BIOL CHEM, V141, P853; Keenan JE, 2014, JAMA SURG, V149, P1045, DOI 10.1001/jamasurg.2014.346; Kosugi S, 2005, ANESTH ANALG, V101, P265, DOI 10.1213/01.ANE.0000153863.95598.08; Taniguchi T, 2000, CRIT CARE MED, V28, P755, DOI 10.1097/00003246-200003000-00025; Tsai PS, 2011, BRIT J ANAESTH, V107, P757, DOI 10.1093/bja/aer262; Wu H, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-96	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	JUL	2015	121	1					81	89		10.1213/ANE.0000000000000694		9	Anesthesiology	Anesthesiology	CL0YZ	WOS:000356670300002		
J	Komai, H; Shindo, S; Sato, M; Ogino, H				Komai, Hiroyoshi; Shindo, Shunya; Sato, Masahiro; Ogino, Hitoshi			Reduced Protein C Activity Might be Associated With Progression of Peripheral Arterial Disease	ANGIOLOGY			English	Article						peripheral arterial disease; abdominal aortic aneurysm; critical limb ischemia; protein C; protein S; hypercoagulability	THROMBOPHILIA; PREVALENCE; JAPANESE; EVENTS; POPULATION; DEFICIENCY; ACTIVATION; FREQUENCY; COMPLEX	We evaluated the effect of reduced activities of protein C (PC) and protein S (PS) on the progression of peripheral arterial disease (PAD). We measured PC and PS activities in 106 patients with PAD and 44 patients with abdominal aortic aneurysm (AAA) in the same period. The incidences of PC deficiency in PAD and AAA were 4.7% and 4.5%, respectively, and those of PS were 14.1% and 11.4%, respectively; these incidences were much higher than those in the normal population. The PC and PS activities were significantly lower in patients having critical limb ischemia (CLI) than in patients with intermittent claudication. In particular, lower PC activity and female gender were determinant factors of CLI in multivariate logistic regression analysis. We suggest that PC deficiency is an independent predictor for the progression of CLI.	[Komai, Hiroyoshi; Shindo, Shunya; Sato, Masahiro] Tokyo Med Univ, Hachioji Med Ctr, Dept Cardiovasc Surg, Moriguchi, Osaka, Japan; [Ogino, Hitoshi] Tokyo Med Univ, Dept Cardiovasc Surg, Hachioji, Tokyo, Japan	Komai, H (reprint author), Kansai Med Univ, Dept Surg, Takii Hosp, Unit Peripheral Vasc Surg, 10-15 Fumizonocho, Moriguchi, Osaka 570, Japan.	komaihir@takii.kmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of the Japanese government	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was conducted as part of the Biobank Japan Project that was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government.	Mota APL, 2009, ANGIOLOGY, V60, P529, DOI 10.1177/0003319708325444; de Moerloose P, 2007, SEMIN HEMATOL, V44, P106, DOI 10.1053/j.seminhematol.2007.01.008; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Kolbel T, 2006, J VASC SURG, V43, P935, DOI 10.1016/j.jvs.2006.01.019; Gabazza EC, 1996, DIABETOLOGIA, V39, P1455, DOI 10.1007/s001250050598; Gremmel T, 2014, EUR J CLIN INVEST, V44, P319, DOI 10.1111/eci.12236; Kolbel T, 2010, THROMB RES, V125, P171, DOI 10.1016/j.thromres.2009.07.018; Komai H, 2009, INT ANGIOL, V28, P138; Nomura T, 2000, THROMB RES, V100, P367, DOI 10.1016/S0049-3848(00)00337-6; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Sakata T, 2000, SEMIN THROMB HEMOST, V26, P11, DOI 10.1055/s-2000-9796; Suehisa E, 2001, BLOOD COAGUL FIBRIN, V12, P95, DOI 10.1097/00001721-200103000-00002; Vig S, 2004, EUR J VASC ENDOVASC, V28, P124, DOI 10.1016/j.ejvs.2004.03.027; Vig S, 2006, BRIT J SURG, V93, P577, DOI 10.1002/bjs.5300; Zarrouk M, 2013, J THROMB THROMBOLYS, V36, P495, DOI 10.1007/s11239-013-0871-6	15	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-3197	1940-1574		ANGIOLOGY	Angiology	JUL	2015	66	6					584	587		10.1177/0003319714544946		4	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CK7NH	WOS:000356418700015		
J	Suzuki, TN; Sakurai, R				Suzuki, Toshitaka N.; Sakurai, Reika			Bent posture improves the protective value of bird dropping masquerading by caterpillars	ANIMAL BEHAVIOUR			English	Article						bird dropping masquerade; caterpillar; defensive coloration; posture; predation	DISRUPTIVE COLORATION; POLLINATOR DECEPTION; ORCHID MANTIS; CAMOUFLAGE; CRYPSIS; PREY; PREDATORS; EYESPOTS; PATTERN; VISION	Masquerade describes a defence by animals that have evolved to closely resemble inedible objects such as twigs, stones or bird droppings. Animals that masquerade often match their models in size or shape, and may even adopt specific postures in order to enhance their resemblance, causing predators to misclassify them as their model objects. The caterpillars of some moth species resemble bird droppings, and bend their bodies while resting on branches or leaves. We hypothesized that such bending might enhance the caterpillars' resemblance to real bird droppings. In this study, we tested this hypothesis by pinning artificial caterpillars with green or bird dropping coloration onto tree branches in both straight and bent postures, after which we exposed them to bird predation in the wild. We found that the adoption of a bent posture resulted in a lower attack rate by birds on the artificial caterpillars with the bird dropping coloration, while green caterpillars experienced no benefit from the same treatment. This study is the first experimental demonstration of the protective value of a specific posture in masquerading prey, and highlights the importance of considering an organism's shape and posture in the study of masquerade. (C) 2015 The Association for the Study of Animal Behaviour. Published by Elsevier Ltd. All rights reserved.	[Suzuki, Toshitaka N.] Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa 2400193, Japan; [Sakurai, Reika] Rikkyo Univ, Dept Life Sci, Tokyo 171, Japan	Suzuki, TN (reprint author), Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa 2400193, Japan.	toshi.n.suzuki@gmail.com					ALLEN JA, 1985, J BIOL EDUC, V19, P268, DOI 10.1080/00219266.1985.9654747; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351; Skelhorn J, 2010, SCIENCE, V327, P51, DOI 10.1126/science.1181931; Skelhorn J, 2010, BIOL J LINN SOC, V99, P1; O''Hanlon JC, 2014, AM NAT, V183, P126, DOI 10.1086/673858; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; Stuart-Fox DM, 2003, ANIM BEHAV, V66, P541, DOI 10.1006/anbe.2003.2235; Tullberg BS, 2005, P ROY SOC B-BIOL SCI, V272, P1315, DOI 10.1098/rspb.2005.3079; Rowland HM, 2008, P ROY SOC B-BIOL SCI, V275, P2539, DOI 10.1098/rspb.2008.0812; Fraser S, 2007, P R SOC B, V274, P1325, DOI 10.1098/rspb.2007.0153; Stevens M, 2006, P R SOC B, V273, P2433, DOI 10.1098/rspb.2006.3614; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Osorio D, 2005, P ROY SOC B-BIOL SCI, V272, P1745, DOI 10.1098/rspb.2005.3156; Schaefer HM, 2006, P R SOC B, V273, P2427, DOI 10.1098/rspb.2006.3615; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Hossie TJ, 2013, ANIM BEHAV, V86, P383, DOI 10.1016/j.anbehav.2013.05.029; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; ASAB/ABS, 2014, ANIM BEHAV, V99, pI; Caro T., 2005, ANTIPREDATOR DEFENSE; Cooper WE, 2012, CURR ZOOL, V58, P541; Dockery Michael, 2009, British Journal of Entomology and Natural History, V22, P247; Edmunds M., 1990, P3; ENDLER JA, 1981, BIOL J LINN SOC, V16, P25, DOI 10.1111/j.1095-8312.1981.tb01840.x; Gomez D., 2006, AVICOL PROGRAMME ANA; Hossie TJ, 2012, ANIM BEHAV, V84, P167, DOI 10.1016/j.anbehav.2012.04.027; Liu MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05058; O'Hanlon JC, 2014, ETHOLOGY, V120, P652, DOI 10.1111/eth.12238; R Core Team, 2014, R LANG ENV STAT COMP; Ruxton G. D., 2004, AVOIDING ATTACK EVOL; Skelhorn J, 2014, BEHAV ECOL, V25, P1417, DOI 10.1093/beheco/aru154; Skelhorn J, 2010, BEHAV ECOL, V21, P1344, DOI 10.1093/beheco/arq159; Skelhorn J, 2013, BEHAV ECOL, V24, P89, DOI 10.1093/beheco/ars139; Skelhorn J, 2010, BIOL LETTERS, V6, P597, DOI 10.1098/rsbl.2010.0226; Valkonen JK, 2014, CURR ZOOL, V60, P114; Wagner DL, 2005, CATERPILLARS E N AM; Yasuda M., 2012, HDB JAPANESE CATERPI, VII; Yasuda M., 2010, HDB JAPANESE CATERPI; Yasuda M., 2014, HDB JAPANESE CATERPI, VIII	38	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0003-3472	1095-8282		ANIM BEHAV	Anim. Behav.	JUL	2015	105						79	84		10.1016/j.anbehav.2015.04.009		6	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CL0ED	WOS:000356611200010		
J	Sugino, M; Okada, H; Kusaka, T; Itoh, S				Sugino, Masahiro; Okada, Hitoshi; Kusaka, Takashi; Itoh, Susumu			Evaluation of bilirubin displacement effect by acetaminophen invitro	ANNALS OF CLINICAL BIOCHEMISTRY			English	Article						Erythrocyte-bound bilirubin; unbound bilirubin; glucose oxidase peroxidase method; accelerator; sulfisoxazole	HUMAN ERYTHROCYTES; UNBOUND BILIRUBIN; BINDING; KERNICTERUS; SERUM; PEROXIDASE; OXIDATION; NEWBORNS; INFANTS	Background The use of acetaminophen as a drug for pain control is expected to increase in the neonatal field. The displacement factor of acetaminophen in the reaction in the glucose oxidase peroxidase method is very high, but is also considered to be inaccurate based on physicochemical properties. Method Unbound bilirubin was measured using the erythrocyte-bound bilirubin measurement method and glucose oxidase peroxidase method by the addition of acetaminophen or sulfisoxazole. The displacement factor was measured using glucose oxidase peroxidase method with the addition of tert-butyl-p-hydroxyanisole. Results Acetaminophen did not increase erythrocyte-bound bilirubin, and the addition of tert-butyl-p-hydroxyanisole lowered its displacement factor. On the other hand, sulfisoxazole increased erythrocyte-bound bilirubin, while tert-butyl-p-hydroxyanisole did not change its displacement factor. Conclusion Acetaminophen is an accelerator of the reaction in the glucose oxidase peroxidase method and does not displace bilirubin from human serum albumin.	[Sugino, Masahiro; Okada, Hitoshi; Kusaka, Takashi; Itoh, Susumu] Kagawa Univ, Fac Med, Dept Pediat, Miki, Kagawa 7610793, Japan	Okada, H (reprint author), Kagawa Univ, Fac Med, Dept Pediat, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	hiokada@kms.ac.jp					BRATLID D, 1972, SCAND J CLIN LAB INV, V30, P331, DOI 10.3109/00365517209084298; SILVERMAN WA, 1956, PEDIATRICS, V18, P614; Palmer GM, 2008, BRIT J ANAESTH, V101, P523, DOI 10.1093/bja/aen208; BRODERSEN R, 1979, SCAND J CLIN LAB INV, V39, P143, DOI 10.3109/00365517909106086; BRODERSE.R, 1974, J CLIN INVEST, V54, P1353, DOI 10.1172/JCI107882; GAZZARD BG, 1973, J PHARM PHARMACOL, V25, P964; GULIAN JM, 1987, J ANTIMICROB CHEMOTH, V19, P823, DOI 10.1093/jac/19.6.823; HAYER M, 1990, CLIN CHIM ACTA, V186, P345, DOI 10.1016/0009-8981(90)90320-R; Itoh S, 2001, ANN CLIN BIOCHEM, V38, P323, DOI 10.1258/0004563011900821; Itoh S, 1990, PHARMACOL THERAPEUT, V14, P75; Itoh S, 1987, SOUNIKA RINSHYO, V40, P1923; JACOBSEN J, 1974, CLIN CHEM, V20, P783; NAKAMURA H, 1977, CLIN CHIM ACTA, V79, P411; ODELL GB, 1959, J CLIN INVEST, V38, P823, DOI 10.1172/JCI103864; Onishi S, 1983, RES REPORT, P376; SHIMABUKU R, 1982, Kobe Journal of Medical Sciences, V28, P91; Sugino M, 2013, 40 JAP SOC DEV PHARM, P84; WATSON D, 1962, CLIN CHIM ACTA, V7, P733, DOI 10.1016/0009-8981(62)90160-2; Wennberg RP, 2006, PEDIATRICS, V117, P474, DOI 10.1542/peds.2005-0395	19	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0004-5632	1758-1001		ANN CLIN BIOCHEM	Ann. Clin. Biochem.	JUL	2015	52	4					476	480		10.1177/0004563214567477		5	Medical Laboratory Technology	Medical Laboratory Technology	CK7PF	WOS:000356423900009		
J	Fukami, K; Shibata, R; Nakayama, H; Yamada, K; Okuda, S; Koga, M				Fukami, Kei; Shibata, Ryo; Nakayama, Hitomi; Yamada, Kentaro; Okuda, Seiya; Koga, Masafumi			Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis	ANNALS OF CLINICAL BIOCHEMISTRY			English	Article						Diabetic nephropathy; glycated albumin; HbA1c; end-stage renal disease; serum albumin	CHRONIC KIDNEY-DISEASE; PLASMA-GLUCOSE; HEMOGLOBIN; COMPLICATIONS; NEPHROPATHY; DIAGNOSIS; MELLITUS; VALUES; DEATH	Backgrounds Diabetic patients with end-stage renal disease who are not on haemodialysis show low concentrations of HbA1c and glycated albumin due to renal anaemia and proteinuria, respectively. In the present study, we examined whether serum albumin-adjusted glycated albumin could accurately reflect glycaemic control in these patients. Methods To examine the correlation between glycated albumin and serum albumin (Study 1), 49 diabetic patients with end-stage renal disease not on haemodialysis were used. To evaluate the association between the glycaemic control indicators and the glycaemic control state (Study 2), 30 diabetic patients with end-stage renal disease were enrolled. The estimated HbA1c and the estimated glycated albumin concentrations were calculated based on the mean blood glucose concentrations obtained from the diurnal variation. The adjusted glycated albumin concentrations were calculated from the regression formula between the serum albumin and glycated albumin obtained from Study 1. Results No significant correlation was found between the measured HbA1c and estimated HbA1c concentrations. The estimated HbA1c (inversely) and measured HbA1c/estimated HbA1c ratio (positively), but not measured HbA1c, showed a significant correlation with Hb concentrations. The estimated glycated albumin was positively associated with the measured glycated albumin and adjusted glycated albumin concentrations. Although measured glycated albumin/estimated glycated albumin ratio was positively correlated with serum albumin, there was no significant association between the adjusted glycated albumin/estimated glycated albumin ratio and serum albumin, Hb and estimated glomerular filtration rate. Conclusions We found for the first time that the adjustment of glycated albumin by serum albumin could be useful to determine glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis. These findings suggest that adjusted glycated albumin might be a better indicator of glycaemic control than measured HbA1c and measured glycated albumin in these patients.	[Fukami, Kei; Shibata, Ryo; Okuda, Seiya] Kurume Univ, Sch Med, Dept Med, Div Nephrol, Kurume, Fukuoka 830, Japan; [Nakayama, Hitomi; Yamada, Kentaro] Kurume Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Kurume, Fukuoka 830, Japan; [Koga, Masafumi] Kawanishi City Hosp, Dept Internal Med, Kawanishi, Hyogo 6660195, Japan	Koga, M (reprint author), Kawanishi City Hosp, Dept Internal Med, 5-21-1 Higashi Uneno, Kawanishi, Hyogo 6660195, Japan.	m-koga@kawanishi-city-hospital.com					Genuth S, 2003, DIABETES CARE, V26, P3160; Koga M, 2014, CLIN CHIM ACTA, V433, P96, DOI 10.1016/j.cca.2014.03.001; Peacock TP, 2008, KIDNEY INT, V73, P1062, DOI 10.1038/ki.2008.25; Okada T, 2011, INTERNAL MED, V50, P23, DOI 10.2169/internalmedicine.50.4129; Kitamura T, 2013, CLIN CHIM ACTA, V424, P164, DOI 10.1016/j.cca.2013.06.011; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Jeffcoate SL, 2004, DIABETIC MED, V21, P657, DOI 10.1046/j.1464-5491.2003.01065.x; Freedman BI, 2011, CLIN J AM SOC NEPHRO, V6, P1635, DOI 10.2215/CJN.11491210; Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Ly J, 2004, AM J KIDNEY DIS, V44, P715, DOI 10.1053/j.ajkd.2004.06.018; Muramoto Y, 1999, CLIN CHIM ACTA, V289, P69, DOI 10.1016/S0009-8981(99)00158-8; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; Sacks DB, 2002, CLIN CHEM, V48, P436; Shima K, 2012, ANN CLIN BIOCHEM, V49, P68, DOI 10.1258/acb.2011.011161; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Koga M, 2008, DIABETES RES CLIN PR, V81, P258, DOI 10.1016/j.diabres.2008.04.012; Ng JM, 2010, DIABETES CARE, V33, P2310, DOI 10.2337/dc10-0917; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Kouzuma T, 2002, CLIN CHIM ACTA, V324, P61, DOI 10.1016/S0009-8981(02)00207-3; Chujo Keiko, 2006, J Med Invest, V53, P223, DOI 10.2152/jmi.53.223; Hirata T, 2015, CLIN CHIM ACTA, V438, P248, DOI 10.1016/j.cca.2014.08.038; Imai Enyu, 2007, Clin Exp Nephrol, V11, P156, DOI 10.1007/s10157-007-0463-x; Inaba M, 2012, CLIN NEPHROL, V78, P273, DOI 10.5414/CN106940; Koga M, 2011, DIABETOL INT, V2, P141, DOI DOI 10.1007/S13340-011-0033-Z; Sung Joyce F, 2012, J Diabetes Sci Technol, V6, P1478; The Committee on the standardization of diabetes mellitus-related laboratory tesiting of the Japan Diabetes Society, 2012, DIABETOL INT, V3, P8; The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]	28	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0004-5632	1758-1001		ANN CLIN BIOCHEM	Ann. Clin. Biochem.	JUL	2015	52	4					488	496		10.1177/0004563214568162		9	Medical Laboratory Technology	Medical Laboratory Technology	CK7PF	WOS:000356423900011		
J	Choi, DH; Kwon, YM; Chiura, HX; Yang, EC; Bae, SS; Kang, SG; Lee, JH; Yoon, HS; Kim, SJ				Choi, Dong Hee; Kwon, Yong Min; Chiura, Hiroshi Xavier; Yang, Eun Chan; Bae, Seung Seob; Kang, Sung Gyun; Lee, Jung-Hyun; Yoon, Hwan Su; Kim, Sang-Jin			Extracellular Vesicles of the Hyperthermophilic Archaeon "Thermococcus onnurineus" NA1(T)	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							OUTER-MEMBRANE VESICLES; PROTEOME ANALYSIS; H-2 PRODUCTION; DNA; TRANSFORMATION; REVEALS; VIRUSES; ENUMERATION; SULFOLOBUS; MICROSCOPY	Extracellular vesicles (EVs) produced by a sulfur-reducing, hyperthermophilic archaeon, "Thermococcus onnurineus" NA1(T), were purified and characterized. A maximum of four EV bands, showing buoyant densities between 1.1899 and 1.2828 g cm(-3), were observed after CsCl ultracentrifugation. The two major EV bands, B (buoyant density at 25 degrees C [rho(25)] = 1.2434 g cm(-3)) and C (rho(25) = 1.2648 g cm(-3)), were separately purified and counted using a qNano particle analyzer. These EVs, showing different buoyant densities, were identically spherical in shape, and their sizes varied from 80 to 210 nm in diameter, with 120- and 190-nm sizes predominant. The average size of DNA packaged into EVs was about 14 kb. The DNA of the EVs in band C was sequenced and assembled. Mapping of the T. onnurineus NA1(T) EV (ToEV) DNA sequences onto the reference genome of the parent archaeon revealed that most genes of T. onnurineus NA1(T) were packaged into EVs, except for an similar to 9.4-kb region from TON_0536 to TON_0544. The absence of this specific region of the genome in the EVs was confirmed from band B of the same culture and from bands B and C purified from a different batch culture. The presence of the 3'-terminal sequence and the absence of the 5'-terminal sequence of TON_0536 were repeatedly confirmed. On the basis of these results, we hypothesize that the unpackaged part of the T. onnurineus NA1(T) genome might be related to the process that delivers DNA into ToEVs and/or the mechanism generating the ToEVs themselves.	[Choi, Dong Hee; Kwon, Yong Min; Bae, Seung Seob; Kang, Sung Gyun; Lee, Jung-Hyun; Kim, Sang-Jin] Korea Inst Ocean Sci & Technol, Marine Biotechnol Res Div, Ansan, South Korea; [Chiura, Hiroshi Xavier] Univ Tokyo, Marine Microbiol Lab, Dept Marine Ecosyst Dynam, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Yang, Eun Chan] Korea Inst Ocean Sci & Technol, Marine Ecosyst Res Div, Ansan, South Korea; [Bae, Seung Seob; Kang, Sung Gyun; Lee, Jung-Hyun; Kim, Sang-Jin] Korea Univ Sci & Technol, Dept Marine Biotechnol, Taejon, South Korea; [Yoon, Hwan Su] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea	Kim, SJ (reprint author), Korea Inst Ocean Sci & Technol, Marine Biotechnol Res Div, Ansan, South Korea.	s-jkim@kiost.ac			KIOST in-house programs [PE99314, PE99252, PE99263]; Marine and Extreme Genome Research Center Program; Development of Biohydrogen Production Technology Program of the Ministry of Ocean and Fisheries, Republic of Korea	This study was supported by the KIOST in-house programs (PE99314, PE99252, and PE99263), as well as the Marine and Extreme Genome Research Center Program and the Development of Biohydrogen Production Technology Program of the Ministry of Ocean and Fisheries, Republic of Korea.	Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Gaudin M, 2013, ENV MICROBIOL REP, V5, P109, DOI 10.1111/j.1758-2229.2012.00348.x; Lee HS, 2008, J BACTERIOL, V190, P7491, DOI 10.1128/JB.00746-08; Soler N, 2008, RES MICROBIOL, V159, P390, DOI 10.1016/j.resmic.2008.04.015; Manning AJ, 2013, J MOL MICROB BIOTECH, V23, P131, DOI 10.1159/000346548; Kim YJ, 2010, NATURE, V467, P352, DOI 10.1038/nature09375; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Perez-Cruz C, 2013, APPL ENVIRON MICROB, V79, P1874, DOI 10.1128/AEM.03657-12; Bae SS, 2006, J MICROBIOL BIOTECHN, V16, P1826; Soler N, 2011, BIOCHEM SOC T, V39, P36, DOI 10.1042/BST0390036; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; Kim MS, 2013, APPL ENVIRON MICROB, V79, P2048, DOI 10.1128/AEM.03298-12; Prangishvili D, 2000, J BACTERIOL, V182, P2985, DOI 10.1128/JB.182.10.2985-2988.2000; Patel A, 2007, NAT PROTOC, V2, P269, DOI 10.1038/nprot.2007.6; Biller SJ, 2014, SCIENCE, V343, P183, DOI 10.1126/science.1243457; Prangishvili D, 2006, NAT REV MICROBIOL, V4, P837, DOI 10.1038/nrmicro1527; Reysenbach AL, 2006, NATURE, V442, P444, DOI 10.1038/nature04921; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; BORSHEIM KY, 1990, APPL ENVIRON MICROB, V56, P352; Ellen AF, 2009, EXTREMOPHILES, V13, P67, DOI 10.1007/s00792-008-0199-x; Momen-Heravi F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00354; Chatterjee S, 2012, OUTER MEMBRANE VESIC; Chiura HX, 2004, MICROBES ENVIRON, V19, P249, DOI 10.1264/jsme2.19.249; Cortez D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001166; Hagemann S, 2013, J BASIC MICROB, V53, P1; Levine SM, 2007, FASEB J, V21, P3458, DOI 10.1096/fj.07-8501com; MORRISON DA, 1972, J BACTERIOL, V112, P220; Rachel Reinhard, 2002, Archaea, V1, P9, DOI 10.1155/2002/307480; Sugitate T, 2005, P INT S EXTR THEIR A, P141; Yun SH, 2011, J PROTEOMICS, V74, P1926, DOI 10.1016/j.jprot.2011.05.010	30	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JUL	2015	81	14					4591	4599		10.1128/AEM.00428-15		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CK8ZE	WOS:000356528200004		
J	Hirano, K; Nihei, S; Hasegawa, H; Haruki, M; Hirano, N				Hirano, Katsuaki; Nihei, Satoshi; Hasegawa, Hiroki; Haruki, Mitsuru; Hirano, Nobutaka			Stoichiometric Assembly of the Cellulosome Generates Maximum Synergy for the Degradation of Crystalline Cellulose, as Revealed by In Vitro Reconstitution of the Clostridium thermocellum Cellulosome	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							QUANTITATIVE PROTEOMIC ANALYSIS; FREE PROTEIN-SYNTHESIS; SUBSTRATE-SPECIFICITY; DOCKERIN DOMAIN; SCAFFOLDIN; GENE; CIPA; COMPLEXES; COMPONENT; SUBUNIT	The cellulosome is a supramolecular multienzyme complex formed by species-specific interactions between the cohesin modules of scaffoldin proteins and the dockerin modules of a wide variety of polysaccharide-degrading enzymes. Cellulosomal enzymes bound to the scaffoldin protein act synergistically to degrade crystalline cellulose. However, there have been few attempts to reconstitute intact cellulosomes due to the difficulty of heterologously expressing full-length scaffoldin proteins. We describe the synthesis of a full-length scaffoldin protein containing nine cohesin modules, CipA; its deletion derivative containing two cohesin modules, Delta CipA; and three major cellulosomal cellulases, Cel48S, Cel8A, and Cel9K, of the Clostridium thermocellum cellulosome. The proteins were synthesized using a wheat germ cell-free protein synthesis system, and the purified proteins were used to reconstitute cellulosomes. Analysis of the cellulosome assembly using size exclusion chromatography suggested that the dockerin module of the enzymes stoichiometrically bound to the cohesin modules of the scaffoldin protein. The activity profile of the reconstituted cellulosomes indicated that cellulosomes assembled at a CipA/enzyme molar ratio of 1/9 (cohesin/dockerin = 1/1) and showed maximum synergy (4-fold synergy) for the degradation of crystalline substrate and similar to 2.4-fold-higher synergy for its degradation than minicellulosomes assembled at a Delta CipA/enzyme molar ratio of 1/2 (cohesin/dockerin = 1/1). These results suggest that the binding of more enzyme molecules on a single scaffoldin protein results in higher synergy for the degradation of crystalline cellulose and that the stoichiometric assembly of the cellulosome, without excess or insufficient enzyme, is crucial for generating maximum synergy for the degradation of crystalline cellulose.	[Hirano, Katsuaki; Nihei, Satoshi; Hasegawa, Hiroki; Haruki, Mitsuru; Hirano, Nobutaka] Nihon Univ, Coll Engn, Dept Chem Biol & Appl Chem, Koriyama, Fukushima 963, Japan; [Hirano, Nobutaka] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Hirano, N (reprint author), Nihon Univ, Coll Engn, Dept Chem Biol & Appl Chem, Koriyama, Fukushima 963, Japan.	nhirano@chem.ce.nihon-u.ac.jp			Japan Science and Technology Agency; Japan Association for Chemical Innovation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26550103]; MEXT of Japan [22760612]; Strategic Research Foundations at Private Universities from the MEXT of Japan	This work was supported by PRESTO from the Japan Science and Technology Agency; the Japan Association for Chemical Innovation; Challenging Exploratory Research grant 26550103 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grant-in-Aid for Young Scientists (B) 22760612 from the MEXT of Japan; and the Strategic Research Foundations at Private Universities 2013-2017 and 2014-2018 from the MEXT of Japan.	Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Olson DG, 2013, J BACTERIOL, V195, P733, DOI 10.1128/JB.02014-12; Fierobe HP, 2001, J BIOL CHEM, V276, P21257, DOI 10.1074/jbc.M102082200; Berger E, 2007, FEMS MICROBIOL LETT, V268, P194, DOI 10.1111/j.1574-6968.2006.00583.x; MORAG E, 1995, APPL ENVIRON MICROB, V61, P1980; Zverlov VV, 2008, J BACTERIOL, V190, P4321, DOI 10.1128/JB.00097-08; Kataeva I, 1999, J BACTERIOL, V181, P5288; Bomble YJ, 2011, J BIOL CHEM, V286, P5614, DOI 10.1074/jbc.M110.186031; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; YARON S, 1995, FEBS LETT, V360, P121, DOI 10.1016/0014-5793(95)00074-J; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; Mechaly A, 2001, J BIOL CHEM, V276, P9883, DOI 10.1074/jbc.M009237200; Hirano N, 2006, NUCLEIC ACIDS RES, V34, P4743, DOI 10.1093/nar/gkl553; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Lytle B, 1996, J BACTERIOL, V178, P1200; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; GERNGROSS UT, 1993, MOL MICROBIOL, V8, P325, DOI 10.1111/j.1365-2958.1993.tb01576.x; KRUUS K, 1995, J BACTERIOL, V177, P1641; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Jindou S, 2004, BIOSCI BIOTECH BIOCH, V68, P924, DOI 10.1271/bbb.68.924; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; [Anonymous], 1988, METHOD ENZYMOL, DOI DOI 10.1016/0076-6879(88)60103-0; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Deng K, 2014, ACS CHEM BIOL, V9, P1470, DOI 10.1021/cb5000289; Hirano N, 2006, PROTEINS, V64, P343, DOI 10.1002/prot.21008; Krauss J, 2012, APPL ENVIRON MICROB, V78, P4301, DOI 10.1128/AEM.07959-11; Gold ND, 2007, J BACTERIOL, V189, P6787, DOI 10.1128/JB.00882-07; Borne R, 2013, FEBS J, V280, P5764, DOI 10.1111/febs.12497; Currie DH, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-32; Currie MA, 2012, J BIOL CHEM, V287, P26953, DOI 10.1074/jbc.M112.343897; Currie MA, 2013, J BIOL CHEM, V288, P7978, DOI 10.1074/jbc.M112.408757; Fendri I, 2009, FEBS J, V276, P3076, DOI 10.1111/j.1742-4658.2009.07025.x; Hirano N, 2013, FEMS MICROBIOL LETT, V344, P25, DOI 10.1111/1574-6968.12149; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; SCHWARZ WH, 1986, APPL ENVIRON MICROB, V51, P1293; Waller BH, 2013, FEMS MICROBIOL LETT, V338, P46, DOI 10.1111/1574-6968.12029	37	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JUL	2015	81	14					4756	4766		10.1128/AEM.00772-15		11	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CK8ZE	WOS:000356528200021		
J	Maky, MA; Ishibashi, N; Zendo, T; Perez, RH; Doud, JR; Karmi, M; Sonomoto, K				Maky, Mohamed Abdelfattah; Ishibashi, Naoki; Zendo, Takeshi; Perez, Rodney Honrada; Doud, Jehan Ragab; Karmi, Mohamed; Sonomoto, Kenji			Enterocin F4-9, a Novel O-Linked Glycosylated Bacteriocin	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							LACTIC-ACID BACTERIA; ANTIMICROBIAL PROPERTIES; GENETIC-CHARACTERIZATION; MULTIPLE BACTERIOCINS; PURIFICATION; IDENTIFICATION; FAECIUM; FOOD; GLYCOPEPTIDE; SUBLANCIN	Enterococcus faecalis F4-9 isolated from Egyptian salted-fermented fish produces a novel bacteriocin, termed enterocin F4-9. Enterocin F4-9 was purified from the culture supernatant by three steps, and its molecular mass was determined to be 5,516.6 Da by mass spectrometry. Amino acid and DNA sequencing showed that the propeptide consists of 67 amino acid residues, with a leader peptide containing a double glycine cleavage site to produce a 47-amino-acid mature peptide. Enterocin F4-9 is modified by two molecules of N-acetylglucosamine beta-O-linked to Ser37 and Thr46. The O-linked N-acetylglucosamine moieties are essential for the antimicrobial activity of enterocin F4-9. Further analysis of the enterocin F4-9 gene cluster identified enfC, which has high sequence similarity to a glycosyltransferase. The antimicrobial activity of enterocin F4-9 covered a limited range of bacteria, including, interestingly, a Gram-negative strain, Escherichia coli JM109. Enterocin F4-9 is sensitive to protease, active at a wide pH range, and moderately resistant to heat.	[Maky, Mohamed Abdelfattah; Ishibashi, Naoki; Zendo, Takeshi; Perez, Rodney Honrada; Sonomoto, Kenji] Kyushu Univ, Grad Sch, Dept Biosci & Biotechnol,Fac Agr, Lab Microbial Technol,Div Syst Bioengn,Higashi Ku, Fukuoka 812, Japan; [Doud, Jehan Ragab] South Valley Univ, Fac Vet Med, Dept Food Hyg & Control, Qena, Egypt; [Karmi, Mohamed] Aswan Univ, Fac Vet Med, Dept Food Hyg & Control, Aswan, Egypt; [Sonomoto, Kenji] Kyushu Univ, Dept Funct Metab Design, Bioarchitecture Ctr, Fukuoka 812, Japan	Sonomoto, K (reprint author), Kyushu Univ, Grad Sch, Dept Biosci & Biotechnol,Fac Agr, Lab Microbial Technol,Div Syst Bioengn,Higashi Ku, Fukuoka 812, Japan.	sonomoto@agr.kyushu-u.ac.jp			Egyptian Channel System Program (CSP); JSPS KAKENHI [24380051]	This work was supported in part by the Egyptian Channel System Program (CSP) to Mohamed Abdelfattah Maky and JSPS KAKENHI grant 24380051. We are grateful to T. Nakashima of Kyushu University for kindly giving us access to the protein sequencer.	Ishibashi N, 2012, BIOSCI BIOTECH BIOCH, V76, P947, DOI 10.1271/bbb.110972; Sawa N, 2012, APPL ENVIRON MICROB, V78, P900, DOI 10.1128/AEM.06497-11; Kelly WJ, 1996, J APPL BACTERIOL, V81, P657; Fujita K, 2007, APPL ENVIRON MICROB, V73, P2871, DOI 10.1128/AEM.02286-06; Casaus P, 1997, MICROBIOL-UK, V143, P2287; Klein G, 2003, INT J FOOD MICROBIOL, V88, P123, DOI 10.1016/S0168-1605(03)00175-2; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Paik SH, 1998, J BIOL CHEM, V273, P23134, DOI 10.1074/jbc.273.36.23134; Jack RW, 1996, APPL ENVIRON MICROB, V62, P2897; Venugopal H, 2011, BIOCHEMISTRY-US, V50, P2748, DOI 10.1021/bi200217u; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1240; Castro MP, 2011, MEAT SCI, V87, P321, DOI 10.1016/j.meatsci.2010.11.006; Zendo T, 2013, BIOSCI BIOTECH BIOCH, V77, P893, DOI 10.1271/bbb.130014; Franz CMAP, 2002, APPL ENVIRON MICROB, V68, P2550, DOI 10.1128/AEM.68.5.2550-2554.2002; Stepper J, 2011, FEBS LETT, V585, P645, DOI 10.1016/j.febslet.2011.01.023; Galvez A, 2007, INT J FOOD MICROBIOL, V120, P51, DOI 10.1016/j.ijfoodmicro.2007.06.001; Aymerich T, 1996, APPL ENVIRON MICROB, V62, P1676; Oman TJ, 2011, NAT CHEM BIOL, V7, P78, DOI [10.1038/nchembio.509, 10.1038/NCHEMBIO.509]; GALVEZ A, 1989, ANTIMICROB AGENTS CH, V33, P437; WONGMADDEN ST, 1995, GLYCOBIOLOGY, V5, P19, DOI 10.1093/glycob/5.1.19; Voisin S, 2007, J BACTERIOL, V189, P151, DOI 10.1128/JB.01224-06; KLAENHAMMER TR, 1993, FEMS MICROBIOL REV, V12, P39, DOI 10.1111/j.1574-6976.1993.tb00012.x; Zendo T, 2005, J APPL MICROBIOL, V99, P1181, DOI 10.1111/j.1365-2672.2005.02704.x; Bhugaloo-Vial P, 1999, APPL ENVIRON MICROB, V65, P2895; Hu CB, 2008, J APPL MICROBIOL, V105, P681, DOI 10.1111/j.1365-2672.2008.03798.x; Izquierdo E, 2009, APPL ENVIRON MICROB, V75, P4273, DOI 10.1128/AEM.02772-08; Perez RH, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S3; RAY B., 2004, FUNDAMENTAL FOOD MIC; Sambrook J, 2001, MOL CLONING LAB MANU; Sawa N, 2013, J APPL MICROBIOL, V115, P61, DOI 10.1111/jam.12226; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R	31	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JUL	2015	81	14					4819	4826		10.1128/AEM.00940-15		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CK8ZE	WOS:000356528200028		
J	Mizumo, T; Muragishi, H; Yamamoto, K; Ohshita, J; Kanezashi, M; Tsuru, T				Mizumo, Tomonobu; Muragishi, Haruna; Yamamoto, Kazuki; Ohshita, Joji; Kanezashi, Masakoto; Tsuru, Toshinori			Preparation and separation properties of oxalylurea-bridged silica membranes	APPLIED ORGANOMETALLIC CHEMISTRY			English	Article						bridged silica; gas separation; water separation; sol-gel process; porous membrane	HYBRID ORGANOSILICA MEMBRANES; HYDROTHERMAL STABILITY; REVERSE-OSMOSIS; POLYSILSESQUIOXANES; PERFORMANCE; PERMEATION; ETHYLENE; ETHANE	Two new bridged alkoxysilanes, bis(triethoxysilylalkyl)-N,N-oxalylureas (alkyl = methyl or n-propyl), bearing a highly rigid and polar oxalylurea unit in the bridges, were employed as precursors of bridged silica membranes. The gas and water separation performance of the membranes prepared from the precursors using the sol-gel process was investigated. Interestingly, the membrane properties depended on the alkyl chain length. The membrane containing methylene units (alkyl = methyl) was porous and rather hydrophilic but the other with longer propylene units (alkyl = n-propyl) was non-porous and more hydrophobic. High H-2/SF6 gas permeance ratios of 3100 and 1700, and NaCl rejections of 89 and 85% for 2000 ppm aqueous NaCl were obtained using the membranes containing methyl and n-propyl, respectively. The membrane with alkyl = methyl also showed a high CO2/N-2 permeance ratio of 20.6 at 50 degrees C. These results indicate the potential applications of the membranes as gas and water separation materials. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Mizumo, Tomonobu; Muragishi, Haruna; Yamamoto, Kazuki; Ohshita, Joji; Kanezashi, Masakoto; Tsuru, Toshinori] Hiroshima Univ, Grad Sch Engn, Higashihiroshima 7398527, Japan	Ohshita, J (reprint author), Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan.	jo@hiroshima-u.ac.jp; tsuru@hiroshima-u.ac.jp	Ohshita, Joji/C-7576-2011; Kanezashi, Masakoto/G-3938-2010		Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency (JST)	This research was supported by the project 'Development of Robust RO/NF Membranes for Various Water Resources' of the Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency (JST).	Yamamoto K, 2015, J NON-CRYST SOLIDS, V408, P137, DOI 10.1016/j.jnoncrysol.2014.10.024; Kanezashi M, 2009, J AM CHEM SOC, V131, P414, DOI 10.1021/ja806762q; Xu R, 2013, ACS APPL MATER INTER, V5, P6147, DOI 10.1021/am401056a; Xu R, 2013, AICHE J, V59, P1298, DOI 10.1002/aic.13885; Xu R, 2014, ACS APPL MATER INTER, V6, P9357, DOI 10.1021/am501731d; Tsuru T, 2011, J MEMBRANE SCI, V384, P149, DOI 10.1016/j.memsci.2011.09.018; Luo Y, 2008, MICROPOR MESOPOR MAT, V111, P194, DOI 10.1016/j.micromeso.2007.07.029; LOY DA, 1995, CHEM REV, V95, P1431, DOI 10.1021/cr00037a013; [Anonymous], 2011, D336305 ASTM, DOI [10.1520/D3363-05R11E02, DOI 10.1520/D3363-05R11E02]; Castricum HL, 2008, J MATER CHEM, V18, P2150, DOI 10.1039/b801972j; Qi H, 2010, CHEMSUSCHEM, V3, P1375, DOI 10.1002/cssc.201000242; Castricum HL, 2008, CHEM COMMUN, P1103, DOI 10.1039/b718082a; Castricum HL, 2011, ADV FUNCT MATER, V21, P2319, DOI 10.1002/adfm.201002361; Xu R, 2011, LANGMUIR, V27, P13996, DOI 10.1021/la203711u; Castricum H. L., 2014, MICROPOR MESOPOR MAT, V183, P224; Ibrahim SM, 2014, RSC ADV, V4, P12404, DOI 10.1039/c3ra47736c; Ren XX, 2014, IND ENG CHEM RES, V53, P6113, DOI 10.1021/ie404386r	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0268-2605	1099-0739		APPL ORGANOMET CHEM	Appl. Organomet. Chem.	JUL	2015	29	7					433	438		10.1002/aoc.3311		6	Chemistry, Applied; Chemistry, Inorganic & Nuclear	Chemistry	CL1MQ	WOS:000356708100002		
J	Minamoto, T; Shipstead, Z; Osaka, N; Engle, RW				Minamoto, Takehiro; Shipstead, Zach; Osaka, Naoyuki; Engle, Randall W.			Low cognitive load strengthens distractor interference while high load attenuates when cognitive load and distractor possess similar visual characteristics	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Selective attention; Attentional capture; Attention and executive control; Visual workingmemory	WORKING-MEMORY CAPACITY; INDIVIDUAL-DIFFERENCES; SELECTIVE ATTENTION; AUTOMATIC GUIDANCE; PREFRONTAL CORTEX; TASK; FACES; SEARCH; RECOGNITION; INFORMATION	Studies on visual cognitive load have reported inconsistent effects of distractor interference when distractors have visual characteristic that are similar to the cognitive load. Some studies have shown that the cognitive load enhances distractor interference, while others reported an attenuating effect. We attribute these inconsistencies to the amount of cognitive load that a person is required to maintain. Lower amounts of cognitive load increase distractor interference by orienting attention toward visually similar distractors. Higher amounts of cognitive load attenuate distractor interference by depleting attentional resources needed to process distractors. In the present study, cognitive load consisted of faces (Experiments 1-3) or scenes (Experiment 2). Participants performed a selective attention task in which they ignored face distractors while judging a color of a target dot presented nearby, under differing amounts of load. Across these experiments distractor interference was greater in the low-load condition and smaller in the high-load condition when the content of the cognitive load had similar visual characteristic to the distractors. We also found that when a series of judgments needed to be made, the effect was apparent for the first trial but not for the second. We further tested an involvement of working memory capacity (WMC) in the load effect (Experiment 3). Interestingly, both high and low WMC groups received an equivalent effect of the cognitive load in the first distractor, suggesting these effects are fairly automatic.	[Minamoto, Takehiro] Osaka Univ, Grad Sch Human Sci, Dept Psychol, Suita, Osaka 5650871, Japan; [Shipstead, Zach] Arizona State Univ, Dept Social & Behav Sci, Phoenix, AZ 85069 USA; [Osaka, Naoyuki] Kyoto Univ, Fac Letters, Dept Psychol, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan; [Engle, Randall W.] Georgia Inst Technol, Sch Psychol, Atlanta, GA 30332 USA	Minamoto, T (reprint author), Osaka Univ, Grad Sch Human Sci, Dept Psychol, 1-2 Yamadaoka, Suita, Osaka 5650871, Japan.	txminamoto@hus.osaka-u.ac.jp			Japan Society for the Promotion of Science [20-5480, 23800034, 22220003]	This study was supported by the Japan Society for the Promotion of Science, grant numbers 20-5480 and 23800034 to TM, and 22220003 to NO.	TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Dolcos F, 2007, BRAIN RES, V1152, P171, DOI 10.1016/j.brainres.2007.03.059; Cheung OS, 2010, J EXP PSYCHOL HUMAN, V36, P448, DOI 10.1037/a0016471; Minamoto T, 2010, BRAIN RES, V1335, P63, DOI 10.1016/j.brainres.2010.03.088; Sobel KV, 2007, PSYCHON B REV, V14, P840, DOI 10.3758/BF03194109; Unsworth N, 2004, J EXP PSYCHOL LEARN, V30, P1302, DOI 10.1037/0278-7393.30.6.1302; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Gao W, 2008, IEEE T SYST MAN CY A, V38, P149, DOI 10.1109/TSMCA.2007.909557; Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; Unsworth N, 2009, MEMORY, V17, P635, DOI 10.1080/09658210902998047; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Theeuwes J, 2006, VIS COGN, V13, P657, DOI 10.1080/13506280500410949; Soto D, 2008, TRENDS COGN SCI, V12, P342, DOI 10.1016/j.tics.2008.05.007; Conway ARA, 2001, PSYCHON B REV, V8, P331, DOI 10.3758/BF03196169; Soto D, 2007, J EXP PSYCHOL HUMAN, V33, P730, DOI 10.1037/0096-1523.33.3.730; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Horry R, 2010, MEM COGNITION, V38, P134, DOI 10.3758/MC.38.2.134; Jha Amishi P., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P517, DOI 10.3758/CABN.4.4.517; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Lang P. J., 2008, A8 U FLOR; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Minamoto T, 2012, BRAIN RES, V1429, P82, DOI 10.1016/j.brainres.2011.10.034; Park S, 2007, J EXP PSYCHOL HUMAN, V33, P1062, DOI 10.1037/0096-1523.33.5.1062; Robinson A, 2008, J VISION, V8, DOI 10.1167/8.16.7; Soto David, 2008, Percept Psychophys, V70, P924, DOI 10.3758/PP.70.5.924; Theeuwes J, 1998, J EXP PSYCHOL HUMAN, V24, P1342, DOI 10.1037//0096-1523.24.5.1342	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	JUL	2015	77	5					1659	1673		10.3758/s13414-015-0866-9		15	Psychology; Psychology, Experimental	Psychology	CK5FL	WOS:000356248000015		
J	Osugi, T; Kawahara, JI				Osugi, Takayuki; Kawahara, Jun I.			Effects of bowing on perception of attractiveness	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Facial attractiveness; Bowing motion; Greeting behavior; Pareidolia	GAZE DIRECTION; FACES; EMOTION; GENDER; METAANALYSIS; EXPRESSIONS; PREFERENCES; EVOLUTION; DOMINANCE; BEAUTIFUL	Bowing is a greeting behavior. The present study examined the modulation effect of bowing on perception of attractiveness. In each trial, a portrait digitized from university yearbooks was presented on a computer screen. The portrait was mildly tilted toward participants to simulate a greeting bow (25-degree angle). Participants evaluated the subjective attractiveness of the face using a visual analog scale (0-100). The mean attractiveness judgment of the bowing portrait was significantly higher relative to that of the bending-backward or standing-still control conditions (Experiment 1). Additional control experiments revealed that alternative accounts relying on apparent spatial proximity and physical characteristics could not solely explain the effect of bowing (Experiment 2) and indicated that the effect was specific to objects perceived as faces (Experiment 3). Furthermore, observers' in-return bowing behavior did not reduce the bowing effect (Experiment 4), and bowing motion increased the ratings of subjective politeness and submissiveness (Experiment 5). Finally, tilting the 3D faces elicited the same effect from observers as did tilting the still photos (Experiment 6). These results suggest that a tilting motion of portraits (or images of face-like objects) mimicking bowing enhances perceived attractiveness, at least as measured in a culture familiar with greeting by bowing.	[Osugi, Takayuki] Univ Tokyo, Dept Psychol, Tokyo, Japan; [Kawahara, Jun I.] Chukyo Univ, Dept Psychol, Showa Ku, Nagoya, Aichi 4668666, Japan	Kawahara, JI (reprint author), Chukyo Univ, Dept Psychol, Showa Ku, 101-2 Yagoto, Nagoya, Aichi 4668666, Japan.	jkawa@lets.chukyo-u.ac.jp		Kawahara, Jun/0000-0002-4096-3923	MEXT KAKENHI [23119731, 26590183]	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas, "Face perception and recognition" from MEXT KAKENHI 23119731 and 26590183 to JK. We thank Shuto Chi-na for collecting data.	Akechi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059312; Andersson M., 1994, SEXUAL SELECTION; Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; REIS HT, 1990, EUR J SOC PSYCHOL, V20, P259; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Conway CA, 2008, P R SOC B, V275, P63, DOI 10.1098/rspb.2007.1073; Willis ML, 2011, EMOTION, V11, P514, DOI 10.1037/a0022571; Markman AB, 2005, PSYCHOL SCI, V16, P6, DOI 10.1111/j.0956-7976.2005.00772.x; Realo A, 1997, J RES PERS, V31, P93, DOI 10.1006/jrpe.1997.2170; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rule NO, 2012, PERCEPTION, V41, P687, DOI 10.1068/p7023; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; CASH TF, 1985, J APPL SOC PSYCHOL, V15, P591, DOI 10.1111/j.1559-1816.1985.tb00903.x; Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Mason MF, 2005, PSYCHOL SCI, V16, P236, DOI 10.1111/j.0956-7976.2005.00809.x; Mignault A, 2003, J NONVERBAL BEHAV, V27, P111, DOI 10.1023/A:1023914509763; Jones BC, 2006, PSYCHOL SCI, V17, P588, DOI 10.1111/j.1467-9280.2006.01749.x; Freeman JB, 2009, NEUROIMAGE, V47, P353, DOI 10.1016/j.neuroimage.2009.04.038; Takahashi K, 2013, I-PERCEPTION, V4, P490, DOI 10.1068/i0617sas; Kampe KKW, 2001, NATURE, V413, P589, DOI 10.1038/35098149; Hadjikhani N, 2009, NEUROREPORT, V20, P403, DOI 10.1097/WNR.0b013e328325a8e1; Stewart GL, 2008, J APPL PSYCHOL, V93, P1139, DOI 10.1037/0021-9010.93.5.1139; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; SIGALL H, 1975, J PERS SOC PSYCHOL, V31, P410, DOI 10.1037/h0076472; CACIOPPO JT, 1993, J PERS SOC PSYCHOL, V65, P5, DOI 10.1037//0022-3514.65.1.5; MOSKOWITZ DS, 1994, J PERS SOC PSYCHOL, V66, P753, DOI 10.1037//0022-3514.66.4.753; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Argyle Michael, 1976, GAZE MUTUAL GAZE; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Burke D, 2010, EVOL PSYCHOL-US, V8, P573; BUSS DM, 1986, J PERS SOC PSYCHOL, V50, P559, DOI 10.1037//0022-3514.50.3.559; Chaplin WF, 2000, J PERS SOC PSYCHOL, V79, P110, DOI 10.1037/0022-3514.79.1.110; Endo N., 2003, JAPANESE J PSYCHOL, V74, P346; Ewing L, 2010, VIS COGN, V18, P321, DOI 10.1080/13506280902965599; KAPPAS A, 1994, J NONVERBAL BEHAV, V18, P263, DOI 10.1007/BF02172289; Moller AP, 1998, AM NAT, V151, P174, DOI 10.1086/286110; Nakane Chie, 1970, JAPANESE SOC; Ohashi J, 2010, J POLITENESS RES-LAN, V6, P183, DOI 10.1515/JPLR.2010.010; Peterson M.A., 2003, PERCEPTION FACES OBJ; Rosenberger N. R., 1995, JAPANESE SENSE SELF; Sato S, 2015, PSYCHOL RES-PSYCH FO, V79, P523, DOI 10.1007/s00426-014-0599-8; Valentine T., 1988, BRIT J PSYCHOL, V79; van Peer JM, 2010, COGNITION EMOTION, V24, P863, DOI 10.1080/02699930902935485; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	45	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	JUL	2015	77	5					1697	1714		10.3758/s13414-015-0879-4		18	Psychology; Psychology, Experimental	Psychology	CK5FL	WOS:000356248000018		
J	Choi, YJ; Chen, J; Sawada, Y				Choi, Yun Jeong; Chen, Joe; Sawada, Yasuyuki			Life Insurance and Suicide: Asymmetric Information Revisited	B E JOURNAL OF ECONOMIC ANALYSIS & POLICY			English	Article						life insurance; suicide; asymmetric information	ADVERSE SELECTION; SEMIPARAMETRIC ESTIMATION; MARKET; REGRESSION; COUNTRIES; DEMAND	This paper investigates the nexus between life insurance and suicide behavior by applying semiparametric instrumental variable regressions to OECD cross-country data from 1980 to 2002. The novelty of our analysis lies in the use of cross-country variations in the lengths of the suicide exemption period in policies and foreign market shares in life insurance industries as identifying instruments for life insurance demand. We find that, for the majority of observations, there exists a positive causality from life insurance demand to suicide. This result suggests the existence of adverse selection and moral hazards in life insurance markets in OECD countries.	[Choi, Yun Jeong] Yonsei Univ, Sch Econ, Seoul 120749, South Korea; [Chen, Joe] Natl Chengchi Univ, Dept Publ Finance, Taipei 11623, Taiwan; [Sawada, Yasuyuki] Univ Tokyo, Fac Econ, Tokyo, Japan	Choi, YJ (reprint author), Yonsei Univ, Sch Econ, 50 Yonsei Ro, Seoul 120749, South Korea.	yun.choi@yonsei.ac.kr; joe@nccu.edu.tw; sawada@e.u-tokyo.ac.jp			National Research Foundation of Korea [NRF-2013S1A3A2053586]	The National Research Foundation of Korea (Grant/Award Number: "NRF-2013S1A3A2053586").	Amamiya S., 2002, COSTS OF SUICIDE; Lokshin M, 2006, STATA J, V6, P377; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Beck T, 2003, WORLD BANK ECON REV, V17, P51, DOI 10.1093/wber/lhg011; Blundell R, 1998, J APPL ECONOMET, V13, P435; FAN JQ, 1992, J AM STAT ASSOC, V87, P998, DOI 10.2307/2290637; Finkelstein A, 2004, J POLIT ECON, V112, P183, DOI 10.1086/379936; He DF, 2009, J PUBLIC ECON, V93, P1090, DOI 10.1016/j.jpubeco.2009.07.001; Gong XD, 2005, J APPL ECONOM, V20, P509, DOI 10.1002/jae.780; Cawley J, 1999, AM ECON REV, V89, P827, DOI 10.1257/aer.89.4.827; Chiappori PA, 2000, J POLIT ECON, V108, P56, DOI 10.1086/262111; Polborn MK, 2006, ECON J, V116, P327, DOI 10.1111/j.1468-0297.2006.01059.x; Yatchew A, 1997, ECON LETT, V57, P135, DOI 10.1016/S0165-1765(97)00218-8; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Banerjee A., 2011, POOR EC RADICAL RETH; BELIVEAU BC, 1984, J RISK INSUR, V51, P286, DOI 10.2307/252558; Chen J, 2010, ECON LETT, V109, P69, DOI 10.1016/j.econlet.2010.08.007; Chiappori P., 2000, HDB INSURANCE, P365, DOI DOI 10.1007/978-94-010-0642-2; Doherty N., 1992, HUEBNER INT SERIES R, V13, P97; Durkheim E., 1857, SUICIDE ETUDE SOCIOL; Enz R., 2000, GENEVA PAP RISK INS, V25, P396, DOI 10.1111/1468-0440.00072; Financial Services Agency, 2006, SURV CONS CRED GROUP; Gans J., 2006, TOPICS EC ANAL POLIC, V6; Gatzert N, 2009, J RISK INSUR, V76, P887, DOI 10.1111/j.1539-6975.2009.01320.x; HAMERMES.DS, 1974, J POLIT ECON, V82, P83, DOI 10.1086/260171; Kopczuk W, 2003, REV ECON STAT, V85, P256, DOI 10.1162/003465303765299783; Li DH, 2007, J RISK INSUR, V74, P637, DOI 10.1111/j.1539-6975.2007.00228.x; Mader P., 2013, GOVERNANCE BORDERS F; McCarthy D, 2010, INT STUD POPUL, V8, P119, DOI 10.1007/978-90-481-3553-0_6; Morduch J., 2010, EC MICROFINANCE; Neumayer E, 2003, URBAN STUD, V40, P2769, DOI 10.1080/0042098032000146803; OECD, 2008, INS STAT YB; Pope N., 2008, RISK MANAGEMENT INSU, V11, P327, DOI 10.1111/j.1540-6296.2008.00143.x; Salanie B., 2013, HDB INSURANCE, P397; Sargan D. J., 1982, CAHIERS RECHERCHES E, V8204; Spindler M., 2013, ASYMMETRIC INFORM PR; Stock J. H., 2002, NBER WORKING PAPER S, V284; Su LJ, 2013, J BUS ECON STAT, V31, P208, DOI 10.1080/07350015.2012.755127; Toyokawa Y., 1998, J ASS LIFE INSURANCE, V96, P143; Tseng S. H., 2006, THESIS U CHICAGO; Tsukitari K., 2001, CRIMES LIFE INSURANC; Villeneuve B., 2000, HDB INSURANCE, P901; World Health Organization, 2014, PREV SUIC GLOB IMP	43	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1935-1682			BE J ECON ANAL POLI	B E J. Econ. Anal. Policy	JUL	2015	15	3					1127	1149		10.1515/bejeap-2014-0081		23	Economics	Business & Economics	CK1XG	WOS:000356001900006		
J	Nakasaki, K; Kwon, SH; Takemoto, Y				Nakasaki, Kiyohiko; Kwon, Sang Hagk; Takemoto, Yuji			An interesting correlation between methane production rates and archaea cell density during anaerobic digestion with increasing organic loading	BIOMASS & BIOENERGY			English	Article						Methane production; Anaerobic digestion; Bacteria; Archaea; Real-time PCR	MICROBIAL COMMUNITY; BIOGAS PRODUCTION; WASTE-WATER; START-UP; FERMENTATION; REACTOR; BATCH	Changes in the cell density of bacteria and archaea during anaerobic digestion producing methane gas with increasing the organic loading were determined using real-time polymerase chain reaction (PCR). It was confirmed that the methane production rate (MPR) was proportional to the cell density of archaea, whereas no clear relationship was observed between the cell density of bacteria and MPR. When the organic loading rate (OLR) increased, the bacteria activated quickly to produce volatile fatty acids (VFAs). However, the enhancement of archaeal activity to consume VFAs and produce methane gas was relatively small. This was because the high oxidation-reduction potential (ORP) and VFA concentration associated with the high OLR were harmful to the archaea. Consequently, when the OLR was very high, VFAs accumulated at high concentrations, the cell density of archaea was reduced, and finally the fermentative methane production deteriorated. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakasaki, Kiyohiko; Kwon, Sang Hagk] Tokyo Inst Technol, Dept Int Dev Engn, Meguro Ku, Tokyo 1528550, Japan; [Takemoto, Yuji] Shizuoka Univ, Grad Sch Engn, Dept Appl Chem & Biochem Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan	Nakasaki, K (reprint author), Tokyo Inst Technol, Dept Int Dev Engn, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	nakasaki@ide.titech.ac.jp					Liu WT, 2002, WATER RES, V36, P3203; Nakamura Y, 2003, BIOTECHNOL BIOPROC E, V8, P179, DOI 10.1007/BF02935893; Rincon B, 2008, BIOCHEM ENG J, V40, P253, DOI 10.1016/j.bej.2007.12.019; Lastella G, 2002, ENERG CONVERS MANAGE, V43, P63, DOI 10.1016/S0196-8904(01)00011-5; Dearman B, 2006, APPL MICROBIOL BIOT, V69, P589, DOI 10.1007/s00253-005-0076-9; Ueno Y, 2001, APPL MICROBIOL BIOT, V57, P65; Wagner AO, 2013, SCI TOTAL ENVIRON, V458, P256, DOI 10.1016/j.scitotenv.2013.04.034; Palatsi J, 2011, BIORESOURCE TECHNOL, V102, P2219, DOI 10.1016/j.biortech.2010.09.121; Dinh NT, 2014, BIOMASS BIOENERG, V68, P240, DOI 10.1016/j.biombioe.2014.06.022; Gallert C, 2003, WATER RES, V37, P1433, DOI 10.1016/S0043-1354(02)00537-7; Kwon SH, 2015, J IND ENG CHEM, V21, P443, DOI 10.1016/j.jiec.2014.03.003; Kwon SH, 2013, PROCEDIA ENVIRON SCI, V18, P427, DOI 10.1016/j.proenv.2013.04.057; Moset V, 2014, ENERGY, V74, P389, DOI 10.1016/j.energy.2014.07.003; Nakasaki K, 2013, PROCESS BIOCHEM, V48, P912, DOI 10.1016/j.procbio.2013.03.011; Shigematsu T, 2006, APPL MICROBIOL BIOT, V72, P401, DOI 10.1007/s00253-005-0275-4; Uemura S, 2000, BIORESOURCE TECHNOL, V72, P275, DOI 10.1016/S0960-8524(99)00118-2	16	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0961-9534	1873-2909		BIOMASS BIOENERG	Biomass Bioenerg.	JUL	2015	78						17	24		10.1016/j.biombioe.2015.04.004		8	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	CL2CY	WOS:000356752400003		
J	Oda, K; Mera, K; Nagasaka, Y; Tokoro, K				Oda, Kazuo; Mera, Katsumi; Nagasaka, Yasuhisa; Tokoro, Kazumi			Simultaneous determination of a novel oral Janus kinase inhibitor ASP015K and its sulfated metabolite in rat plasma using LC-MS/MS	BIOMEDICAL CHROMATOGRAPHY			English	Article						ASP015K; sulfate; rat plasma; LC-MS; MS; pharmacokinetics		A sensitive and selective liquid chromatography with tandem mass spectrometry (LC-MS/MS) was developed for determining the concentrations of novel Janus kinase inhibitor ASP015K and its sulfated metabolite M2 in rat plasma. This method involves solid-phase extraction (SPE) from 25 L of rat plasma. LC separation was performed on an Inertsil PH-3 column (100 mm L x4.6 mm I.D., 5 mu m) with a mobile phase consisting of 10 mM ammonium acetate and methanol under linear gradient conditions. Analytes were introduced to the LC-MS/MS through an electrospray ionization source and detected in positive-ion mode using selected reaction monitoring. Standard curves were linear from 0.25 to 500 ng/mL (r 0.9964). This assay enabled quantification of ASP015K and M2 at a concentration as low as 0.25 ng/mL in rat plasma. Validation data demonstrated that the method is selective, sensitive and accurate. Further, we also successfully applied this method to a preclinical pharmacokinetic study in rats. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Oda, Kazuo; Mera, Katsumi; Nagasaka, Yasuhisa] Astellas Pharma Inc, Anal & Pharmacokinet Res Labs, Yodogawa Ku, Osaka 5328514, Japan; [Tokoro, Kazumi] Astellas Pharma Inc, Safety Res Labs, Yodogawa Ku, Osaka 5328514, Japan	Oda, K (reprint author), Astellas Pharma Inc, Anal & Pharmacokinet Res Labs, Yodogawa Ku, 1-6 Kashima,2 Chome, Osaka 5328514, Japan.	kazuo.oda@astellas.com					Muzzio M, 2012, J PHARMACEUT BIOMED, V59, P201, DOI 10.1016/j.jpba.2011.10.023; Nguyen HP, 2008, J SEP SCI, V31, P1465, DOI 10.1002/jssc.200700630; Mochizuki N, 2011, YAKUGAKU ZASSHI, V131, P1019, DOI 10.1248/yakushi.131.1019; Higashis Y, 2012, 3 WORLD PSOR PSOR AR; Takeuchis T, 2014, EULAR; U.S. Food and Drug Administration (FDA), 2001, GUID IND BIOAN METH	6	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-3879	1099-0801		BIOMED CHROMATOGR	Biomed. Chromatogr.	JUL	2015	29	7					967	969		10.1002/bmc.3380		3	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	CL1HS	WOS:000356694000001		
J	Furugen, A; Yamaguchi, H; Mano, N				Furugen, Ayako; Yamaguchi, Hiroaki; Mano, Nariyasu			Simultaneous quantification of leukotrienes and hydroxyeicosatetraenoic acids in cell culture medium using liquid chromatography/tandem mass spectrometry	BIOMEDICAL CHROMATOGRAPHY			English	Article						leukotriene; hydroxyeicosatetraenoic acid; lipoxygenase; liquid chromatography; tandem mass spectrometry; cell culture medium	BIOACTIVE LIPIDS; EICOSANOIDS; IONIZATION; LIPOXYGENASE; METABOLITES; THROMBOXANE; PATHWAY; DISEASE	Leukotrienes (LTs) and hydroxyeicosatetraenoic acids (HETEs) are important bioactive lipid mediators that participate in various pathophysiological processes. To advance understanding of the mechanisms that regulate these mediators in physiological and pathological processes, an analytical method using liquid chromatography/tandem mass spectrometry for the simultaneous quantification of LTB4, LTC4, LTD4, LTE4, 5-HETE, 8-HETE, 12-HETE and 15-HETE in cell culture media was developed. A Supel-Select HLB solid-phase extraction cartridge was used for sample preparation. The compounds were separated on a C-18 column using gradient elution with acetonitrile-water-formic acid (20:80:0.1, v/v/v) and acetonitrile-formic acid (100:0.1, v/v). The calibration curves of LTB4, LTD4, LTE4 and HETEs were linear in the range of 0.025-10 ng/mL, and the calibration curve of LTC4 was linear in the range of 0.25-10 ng/mL. Validation assessment showed that the method was highly reliable with good accuracy and precision. The stability of LTs and HETEs was also investigated. Using the developed method, we measured LTs and HETEs in the culture supernatant of the human mast cell line HMC-1. The present method could facilitate investigations of the mechanisms that regulate the production, release and signaling of LTs and HETEs. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Furugen, Ayako] Hokkaido Univ, Fac Pharmaceut Sci, Div Pharmasci, Lab Clin Pharmaceut & Therapeut, Sapporo, Hokkaido 0600812, Japan; [Yamaguchi, Hiroaki; Mano, Nariyasu] Tohoku Univ Hosp, Dept Pharmaceut Sci, Sendai, Miyagi 9808574, Japan	Yamaguchi, H (reprint author), Tohoku Univ Hosp, Dept Pharmaceut Sci, Sendai, Miyagi 9808574, Japan.	yamaguchi@hosp.tohoku.ac.jp			Hokkaido University Clark Memorial Foundation; Towa Foundation for Food Research; Japan Society for the Promotion of Science (JSPS) KAKENHI [25460184]	We thank Dr Joseph H. Butterfield (Mayo Clinic) for providing the HMC-1 cell line. This work was supported in part by a grant from the Hokkaido University Clark Memorial Foundation, the Towa Foundation for Food Research, and Japan Society for the Promotion of Science (JSPS) KAKENHI grant number 25460184.	Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Miller TM, 2009, J CHROMATOGR B, V877, P3991, DOI 10.1016/j.jchromb.2009.10.012; Masoodi M, 2010, ANAL CHEM, V82, P8176, DOI 10.1021/ac1015563; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Rius M, 2008, J PHARMACOL EXP THER, V324, P86, DOI 10.1124/jpet.107.131342; Yang PY, 2006, PROSTAG LEUKOTR ESS, V75, P385, DOI 10.1016/j.plefa.2006.07.015; Zhang JH, 2007, ANAL BIOCHEM, V365, P40, DOI 10.1016/j.ab.2007.03.001; Le Faouder P, 2013, J CHROMATOGR B, V932, P123, DOI 10.1016/j.jchromb.2013.06.014; Sterz K, 2012, J LIPID RES, V53, P1026, DOI 10.1194/jlr.D023739; Golovko MY, 2008, J LIPID RES, V49, P893, DOI 10.1194/jlr.D700030-JLR200; LEIER I, 1994, J BIOL CHEM, V269, P27807; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Murphy RC, 2005, ANAL BIOCHEM, V346, P1, DOI 10.1016/j.ab.2005.04.042; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; Martin-Venegas R, 2014, J CHROMATOGR B, V964, P41, DOI 10.1016/j.jchromb.2014.05.024; Martin-Venegas R, 2011, J PHARMACEUT BIOMED, V56, P976, DOI 10.1016/j.jpba.2011.06.018; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Caos H, 2008, ANAL BIOCHEM, V372, P41; Chappell GP, 2011, J CHROMATOGR B, V879, P277, DOI 10.1016/j.jchromb.2010.12.014; Furugen A, 2011, J CHROMATOGR B, V879, P3378, DOI 10.1016/j.jchromb.2011.09.003; MACCHIA L, 1995, BBA-LIPID LIPID MET, V1257, P58, DOI 10.1016/0005-2760(95)00048-H; Mals M, 2011, RAPID COMMUNICATIONS, V25, P755; Montuschi P, 2007, DRUG DISCOV TODAY, V12, P404, DOI 10.1016/j.drudis.2007.03.004; Tsukamoto H, 2002, J CHROMATOGR B, V774, P205, DOI 10.1016/S1570-0232(02)00220-9; Willey MB, 2008, J PHARMACEUT BIOMED, V48, P1397, DOI 10.1016/j.jpba.2008.09.034; Yues H, 2007, J PHARMACEUT BIOMED, V43, P1122; Yues H, 2004, J CHROMATOGR B, V803, P267	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-3879	1099-0801		BIOMED CHROMATOGR	Biomed. Chromatogr.	JUL	2015	29	7					1084	1093		10.1002/bmc.3395		10	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	CL1HS	WOS:000356694000016		
J	Yoshida, K; Yamazaki, H; Kotsuma, T; Takenaka, T; Masui, K; Yoshioka, Y; Uesugi, Y; Shimbo, T; Yoshikawa, N; Yoshioka, H; Narumi, Y; Tatsumi, K; Tanaka, E				Yoshida, Ken; Yamazaki, Hideya; Kotsuma, Tadayuki; Takenaka, Tadashi; Masui, Koji; Yoshioka, Yasuo; Uesugi, Yasuo; Shimbo, Taiju; Yoshikawa, Nobuhiko; Yoshioka, Hiroto; Narumi, Yoshifumi; Tatsumi, Keiji; Tanaka, Eiichi			Treatment results of image-guided high-dose-rate interstitial brachytherapy for pelvic recurrence of uterine cancer	BRACHYTHERAPY			English	Article						Pelvic recurrence; Uterine cancer; Image guided; High-dose-rate interstitial brachytherapy; Magnetic resonance imaging	VAGINAL RECURRENCES; MAGNETIC-RESONANCE; GYNECOLOGIC MALIGNANCIES; ENDOMETRIAL CARCINOMA; CERVICAL-CARCINOMA; LOCALLY RECURRENT; SALVAGE TREATMENT; IMPLANTS; REIRRADIATION; RADIOTHERAPY	PURPOSE: We analyzed clinical data to evaluate the effectiveness of image-guided high-dose-rate interstitial brachytherapy (HDR-ISBT) for pelvic recurrence of uterine cancer. METHODS AND MATERIALS: Between 2003 and 2011,56 patients were treated with HDR-ISBT with or without external beam radiotherapy (EBRT). The median followup time was 33 months (range, 1-109 months). Pre-ISBT treatments included radical hysterectomy for 35 patients (Group A), radical hysterectomy with postoperative radiotherapy for 8 patients (Group B), and radical radiotherapy for 13 patients (Group C). We initiated MRI-assisted CT-based planning for the last 49 patients. The median ISBT single fraction dose was 6 Gy. The median total doses were 30 and 54 Gy with and without EBRT (range, 30-50 Gy) for Group A, respectively and 48 Gy without EBRT for Groups B and C. RESULTS: The 3-year local control (LC) rates were 85%, 75%, and 46% for Groups A, B, and C, respectively (p = 0.017). The 3-year LC rates were 84%, 73%, and 33% for clinical target volume at the time of HDR-ISBT of <10, 10-29, and >= 30 cc, respectively (p = 0.005). The 3-year LC results tended to be higher for patients whose D-100 (clinical target volume) was equal or higher than 67.1 Gy (p = 0.098). A total of 13 late complications of Grades 3-5 occurred in 11 patients (20%). CONCLUSIONS: Our image-guided HDR-ISBT for pelvic recurrence of uterine cancer provided good treatment outcomes. The treatment results for patients who underwent radical surgery with or without postoperative radiotherapy are better than those for patients who underwent radical radiotherapy. (C) 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.	[Yoshida, Ken; Uesugi, Yasuo; Shimbo, Taiju; Yoshikawa, Nobuhiko; Yoshioka, Hiroto] Osaka Med Coll, Dept Radiat Oncol, Takatsuki, Osaka 5698686, Japan; [Yamazaki, Hideya; Masui, Koji] Kyoto Prefectural Univ Med, Dept Radiol, Kyoto, Japan; [Kotsuma, Tadayuki; Tanaka, Eiichi] Natl Hosp Org, Osaka Natl Hosp, Dept Radiat Oncol, Osaka, Japan; [Takenaka, Tadashi] Natl Hosp Org, Himeji Med Ctr, Dept Radiol, Himeji, Hyogo, Japan; [Yoshioka, Yasuo] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Osaka, Japan; [Narumi, Yoshifumi] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka 5698686, Japan; [Tatsumi, Keiji] Natl Hosp Org, Osaka Natl Hosp, Dept Obstet & Gynecol, Osaka, Japan	Yoshida, K (reprint author), Osaka Med Coll, Dept Radiat Oncol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	rad113@poh.osaka-med.ac.jp			JSPS [25461931]; Ministry of Health, Labor and Welfare [26270801]; Japan mHDR Research Fund	This work was supported by JSPS Grant-in-Aid for Scientific Research (KAKENHI) (C) Grant Number 25461931, Ministry of Health, Labor and Welfare Grant-in-Aid for Scientific Research (KAKENHI) Grant Number 26270801, and Japan mHDR Research Fund.	Kotsuma T, 2011, J RADIAT RES, V52, P329, DOI 10.1269/jrr.10172; Viswanathan AN, 2006, INT J RADIAT ONCOL, V66, P91, DOI 10.1016/j.ijrobp.2006.04.037; Haie-Meder C, 2005, RADIOTHER ONCOL, V74, P235, DOI 10.1016/j.radonc.2004.12.015; Erickson B, 1996, INT J RADIAT ONCOL, V36, P699, DOI 10.1016/S0360-3016(96)00373-2; Charra C, 1998, INT J RADIAT ONCOL, V40, P421, DOI 10.1016/S0360-3016(97)00576-2; Tewari K, 1999, GYNECOL ONCOL, V74, P416, DOI 10.1006/gyno.1999.5487; Beriwal S, 2012, BRACHYTHERAPY, V11, P176, DOI 10.1016/j.brachy.2011.05.005; Jensen PT, 1998, INT J RADIAT ONCOL, V42, P1041, DOI 10.1016/S0360-3016(98)00290-9; Nag S, 2002, INT J RADIAT ONCOL, V54, P1153, DOI 10.1016/S0360-3016(02)03019-5; CORN BW, 1995, GYNECOL ONCOL, V56, P255, DOI 10.1006/gyno.1995.1042; Beriwal S, 2012, BRACHYTHERAPY, V11, P68, DOI 10.1016/j.brachy.2011.06.008; Yoshida K, 2010, INT J RADIAT ONCOL, V77, P765, DOI 10.1016/j.ijrobp.2009.05.027; Badakh DK, 2009, J CANC RES THER, V5, P24, DOI 10.4103/0973-1482.48766; Demato AL, 2014, BRACHYTHERAPY, V13, P100; Eisbruch A, 1998, INT J RADIAT ONCOL, V40, P1087, DOI 10.1016/S0360-3016(98)00010-8; Gynecologic Oncology Group (GOG), 2011, GOG 238 RAND TRIAL P; Mabuchi S, 2014, INT J GYNECOL CANCER, V24, P141, DOI 10.1097/IGC.0000000000000028; Maneo A, 1999, ANN ONCOL, V10, P803, DOI 10.1023/A:1008356010556; Mikami M, 2011, BRACHYTHERAPY, V10, P318, DOI 10.1016/j.brachy.2010.11.006; MILLER B, 1993, GYNECOL ONCOL, V50, P94, DOI 10.1006/gyno.1993.1170; Nose T, 2008, INT J RADIAT ONCOL, V70, P626, DOI 10.1016/j.ijrobp.2007.09.053; Ogawa Y, 2011, INT J ONCOL, V39, P553, DOI 10.3892/ijo.2011.1069; Onoe T, 2013, J RADIAT RES, V54, P663, DOI 10.1093/jrr/rrs130; Pinnaduwage DS, 2013, BRACHYTHERAPY, V12, P487, DOI 10.1016/j.brachy.2013.02.003; Popowski Y, 2000, INT J RADIAT ONCOL, V47, P759, DOI 10.1016/S0360-3016(00)00488-0; Rey F, 2013, RADIOTHER ONCOL, V107, P112, DOI 10.1016/j.radonc.2012.12.013; Shulda P, 2012, INT J RADIAT ONCOL, V82, P617; Stock RG, 1997, INT J RADIAT ONCOL, V37, P819, DOI 10.1016/S0360-3016(96)00558-5; Thibault I, 2012, BRACHYTHERAPY, V11, P181, DOI 10.1016/j.brachy.2011.06.005; Vees H, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-176; Weitmann HD, 2006, STRAHLENTHER ONKOL, V182, P86, DOI 10.1007/s00066-006-1420-4; Yamazaki H, 2013, ANTICANCER RES, V33, P643; Yoshida Ken, 2006, Radiat Med, V24, P595, DOI 10.1007/s11604-007-0058-1; Yoshida K, 2012, J RADIAT RES, V53, P295, DOI 10.1269/jrr.11165; Yoshida K, 2002, J JPN SOC THER RADIO, V13, P253	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1538-4721	1873-1449		BRACHYTHERAPY	Brachytherapy	JUL-AUG	2015	14	4					440	448		10.1016/j.brachy.2015.02.195		9	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CK9JH	WOS:000356555900003		
J	Ikudome, S; Nakamoto, H; Yotani, K; Unenaka, S; Mori, S				Ikudome, Sachi; Nakamoto, Hiroki; Yotani, Kengo; Unenaka, Satoshi; Mori, Shiro			Potential of rapid adjustment of brief interceptive action using predicted information	BRAIN AND COGNITION			English	Article						Predicted sensory consequence of movement (pSCM); Transcranial magnetic stimulation (TMS); Supplementary motor area (SMA); Interceptive action; Motor preparation	TRANSCRANIAL MAGNETIC STIMULATION; SUPPLEMENTARY MOTOR AREA; REACHING MOVEMENTS; TIME-COURSE; TARGET; SPECIFICATION; ANTICIPATION; INHIBITION; PERCEPTION; READINESS	Interceptive actions, such as hitting a ball in baseball or tennis, feature a moving target whose parameters (i.e., velocity or trajectory) differ across trials. This means that players are required to make rapid trial-by-trial adjustments. The purpose of this study was to determine whether a brief interceptive action could be adjusted using predicted sensory consequence of movement (pSCM) information, even under severe time constraints where the participants could not adjust their movement using only visual feedback. Participants performed an interceptive action for targets with two different velocities with different occurrence probabilities (20%, 50%, and 80%). Prior to movement onset, we applied transcranial magnetic stimulation (TMS) to the supplementary motor area (SMA), as TMS of the SMA is known to disrupt pSCM activity. We hypothesized that if pSCM information were used to adjust the motor parameters of a brief interception, then TMS would significantly increase the constant temporal error (i.e., the difference between the sum of reaction time and movement time and the total target visible time) for a target velocity with a low probability (20%). This hypothesis is based on the previous findings that the pSCM plays an important role in the adjustment of relatively brief interception. We found that while interceptions that lasted about 250 ms after movement onset were unaffected, interceptions that lasted about 350 ms after movement onset could be influenced by TMS. However, TMS interfered with performance provided that the delivery of the pulse occurred 100 ms before movement onset. This finding suggests that pSCM information that is used for a rapid adjustment is generated only in that specific time interval. (C) 2015 Elsevier Inc. All rights reserved.	[Ikudome, Sachi; Nakamoto, Hiroki; Yotani, Kengo; Mori, Shiro] Natl Inst Fitness & Sports Kanoya, Fac Phys Educ, Kanoya, Kagoshima 8912393, Japan; [Unenaka, Satoshi] Kyorin Univ, Sch Med, Dept Integrat Physiol, Tokyo, Japan	Ikudome, S (reprint author), Natl Inst Fitness & Sports Kanoya, Fac Phys Educ, 1 Shiromizu, Kanoya, Kagoshima 8912393, Japan.	ra_sa1101@yahoo.co.jp			JSPS KAKENHI [26750269]	This work was supported by JSPS KAKENHI Grant Number 26750269.	ABERNETHY B, 1987, HUM MOVEMENT SCI, V6, P283, DOI 10.1016/0167-9457(87)90001-7; Abernethy B, 1990, J SPORT SCI, V8, P17, DOI 10.1080/02640419008732128; Cunnington R, 1996, BRAIN, V119, P815, DOI 10.1093/brain/119.3.815; Mirabella G, 2008, COGN NEUROPSYCHOL, V25, P996, DOI 10.1080/02643290802003216; Makoshi Z, 2011, J MOTOR BEHAV, V43, P303, DOI 10.1080/00222895.2011.584085; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Zago M, 2009, EXP BRAIN RES, V192, P571, DOI 10.1007/s00221-008-1691-3; Federico P, 2014, EXP BRAIN RES, V232, P1293, DOI 10.1007/s00221-014-3846-8; Tresilian JR, 2005, PERCEPT PSYCHOPHYS, V67, P129, DOI 10.3758/BF03195017; Sabes PN, 2000, CURR OPIN NEUROBIOL, V10, P740, DOI 10.1016/S0959-4388(00)00149-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Gray R, 2002, J EXP PSYCHOL HUMAN, V28, P1131, DOI 10.1037//0096-1523.28.5.1131; Toma K, 2002, NEUROIMAGE, V17, P161, DOI 10.1006/nimg.2002.1165; Brouwer AM, 2002, PERCEPT PSYCHOPHYS, V64, P1160, DOI 10.3758/BF03194764; Harmer CJ, 2001, NAT NEUROSCI, V4, P17, DOI 10.1038/82854; Kwan VSY, 2007, EXP BRAIN RES, V182, P379, DOI 10.1007/s00221-007-0992-2; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Bardy B. G., 2005, HUMAN MOVEMENT SCI, V24, P429; Chunnington R., 1996, HUM MOVEMENT SCI, V15, P627; Chunnington R., 2005, HUMAN MOVEMENT SCI, V24, P644; de Lussanet M. H. E., 2001, EXPT BRAIN RES, V133, P242; Marinovic W, 2014, J PHYSIOL-LONDON, V592, P153, DOI 10.1113/jphysiol.2013.254581; DEECKE L, 1982, EXP BRAIN RES, V48, P144; Gray R., 2002, PSYCHOL SCI, V13, P543; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Haggard P, 1999, EXP BRAIN RES, V127, P102, DOI 10.1007/s002210050778; Ikudome S, 2013, NEUROREPORT, V24, P879, DOI 10.1097/WNR.0000000000000010; Kudo K, 1998, EXP BRAIN RES, V122, P23, DOI 10.1007/s002210050487; Marinovic W, 2008, EXP BRAIN RES, V188, P275, DOI 10.1007/s00221-008-1360-6; Marinovic W, 2010, EXP PSYCHOL, V57, P292, DOI 10.1027/1618-3169/a000034; Marinovic W, 2013, J NEUROPHYSIOL, V109, P996, DOI 10.1152/jn.01119.2011; Marinovic W., 2010, J NEUROPHYSIOL, V105, P1122; Marinovic W, 2010, ACTA PSYCHOL, V135, P30, DOI 10.1016/j.actpsy.2010.04.009; Mirabella G, 2009, EXP BRAIN RES, V192, P199, DOI 10.1007/s00221-008-1570-y; Mulliken G. H., 2009, COGNITIVE NEUROSCIEN, V4th, P599; Neto RMD, 2009, EXP BRAIN RES, V199, P135, DOI 10.1007/s00221-009-1987-y; Ohta Y, 2014, PERCEPT MOTOR SKILL, V118, P96, DOI 10.2466/23.25.PMS.118k15w8; Orbi S. S., 2002, MOTOR CONTROL, V6, P319; Ridderinkhof K. R., 2014, NEUROSCIENCE BIOBEHA, DOI 10.10161j.neubiorev.2014.05.008; SCHMIDT R. A., 2011, MOTOR CONTROL LEARNI; Teixeira LA, 2006, J MOTOR BEHAV, V38, P467, DOI 10.3200/JMBR.38.6.467-477; Tresilian J. R., 2012, SENSORIMOTOR CONTROL; Tresilian JR, 2006, NEUROSCIENCE, V142, P579, DOI 10.1016/j.neuroscience.2006.06.029; Verwey WB, 2002, NEUROPSYCHOLOGIA, V40, P1268, DOI 10.1016/S0028-3932(01)00221-4	45	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626	1090-2147		BRAIN COGNITION	Brain Cogn.	JUL	2015	97						51	58		10.1016/j.bandc.2015.04.007		8	Neurosciences; Psychology, Experimental	Neurosciences & Neurology; Psychology	CK6DV	WOS:000356319600006		
J	Yoshida, S; Kubo, Y; Kobayashi, Y; Zhou, Y; Nakama, T; Yamaguchi, M; Tachibana, T; Ishikawa, K; Arita, R; Nakao, S; Sassa, Y; Oshima, Y; Kono, T; Ishibashi, T				Yoshida, Shigeo; Kubo, Yuki; Kobayashi, Yoshiyuki; Zhou, Yedi; Nakama, Takahito; Yamaguchi, Muneo; Tachibana, Takashi; Ishikawa, Keijiro; Arita, Ryoichi; Nakao, Shintaro; Sassa, Yukio; Oshima, Yuji; Kono, Toshihiro; Ishibashi, Tatsuro			Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular oedema	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							INTRAVITREAL BEVACIZUMAB; CYTOKINE LEVELS; AQUEOUS-HUMOR; NEOVASCULARIZATION; TRIAMCINOLONE; EXPRESSION; MEDIATORS; THERAPY; EYES	Purpose To determine whether vitreal concentrations of MCP-1, IL-6 and IL-8 are altered after vitrectomy in patients with proliferative diabetic retinopathy (PDR) and to investigate whether the altered levels of these cytokines are associated with postoperative macular oedema. Methods Vitreous samples were collected from 36 eyes of 33 patients with PDR before pars plana vitrectomy without intraocular lens (IOL) implantation, and also from the same 36 eyes during IOL implantation surgery approximately 7 months after the initial vitrectomy. Levels of MCP-1, IL-6, IL-8 and vascular endothelial growth factor were measured by flow cytometry using cytometric bead array (CBA) technology. Results The mean vitreous levels of MCP-1, IL-6 and IL-8 in the samples collected before vitrectomy were significantly higher in patients with PDR than in control patients (p<0.0001). The levels of MCP-1 and IL-6 in the samples collected at the time of IOL implantation were significantly higher than those collected before vitrectomy (p<0.05). In contrast, the level of IL-8 was significantly lower after vitrectomy (p<0.05). The levels of IL-6 and IL-8, but not MCP-1, in the vitreous from eyes with PDR were inversely correlated with the interval between the initial vitrectomy and the time of implantation surgery. Among the vitrectomised patients, the mean vitreous level of MCP-1 in eyes with diabetic macular oedema (DME) was significantly higher than in those without DME (p=0.028). Conclusions The elevated levels of MCP-1 and IL-6 may indicate prolonged inflammation even after successful vitrectomy, which can cause postoperative DME.	[Yoshida, Shigeo; Kubo, Yuki; Kobayashi, Yoshiyuki; Zhou, Yedi; Nakama, Takahito; Yamaguchi, Muneo; Tachibana, Takashi; Ishikawa, Keijiro; Arita, Ryoichi; Nakao, Shintaro; Sassa, Yukio; Oshima, Yuji; Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 8128582, Japan; [Sassa, Yukio; Kono, Toshihiro] Fukuoka Univ, Chikushi Hosp, Dept Ophthalmol, Chikushino, Japan	Yoshida, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 8128582, Japan.	yosida@eye.med.kyushu-u.ac.jp			JSPS KAKENHI [24249083, 26293374, 26670757]; Takeda Science Foundation	This work was supported in part by JSPS KAKENHI grant numbers 24249083, 26293374 and 26670757 and Takeda Science Foundation.	Hiscott P, 2000, EYE, V14, P549; Stefansson E, 2009, GRAEF ARCH CLIN EXP, V247, P147, DOI 10.1007/s00417-008-0980-7; Sohn HJ, 2011, AM J OPHTHALMOL, V152, P686, DOI 10.1016/j.ajo.2011.03.033; Boyer DS, 2011, RETINA-J RET VIT DIS, V31, P915, DOI 10.1097/IAE.0b013e318206d18c; Tesch GH, 2007, CLIN EXP PHARMACOL P, V34, P1016, DOI 10.1111/j.1440-1681.2007.04729.x; ELNER SG, 1995, CURR EYE RES, V14, P1045, DOI 10.3109/02713689508998529; Yoshida A, 1998, INVEST OPHTH VIS SCI, V39, P1097; Shimura M, 2008, AM J OPHTHALMOL, V145, P854, DOI 10.1016/j.ajo.2007.12.031; BLANKENSHIP GW, 1985, OPHTHALMOLOGY, V92, P503; Funatsu H, 2009, OPHTHALMOLOGY, V116, P73, DOI 10.1016/j.ophtha.2008.09.037; Owen LA, 2013, CURR DIABETES REP, V13, P476, DOI 10.1007/s11892-013-0382-z; Sivaprasad S, 2012, SURV OPHTHALMOL, V57, P347, DOI 10.1016/j.survophthal.2012.01.004; Funatsu H, 2003, OPHTHALMOLOGY, V110, P1690, DOI 10.1016/S0161-6420(03)00568-2; Kawai M, 2012, INVEST OPHTH VIS SCI, V53, P7951, DOI 10.1167/iovs.12-10231; Yoshida S, 2003, J LEUKOCYTE BIOL, V73, P137, DOI 10.1189/jlb.0302117; Yanyali A, 2007, AM J OPHTHALMOL, V144, P124, DOI 10.1016/j.ajo.2007.02.048; ETDRS Research Group, 1991, OPHTHALMOLOGY, V98, P786; Funk M, 2010, RETINA-J RET VIT DIS, V30, P1412, DOI 10.1097/IAE.0b013e3181e095c0; Kastelan S, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/213130; Morescalchi F, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/269787; Roh MI, 2009, OPHTHALMOLOGY, V116, P80, DOI 10.1016/j.ophtha.2008.09.036; Yoshida S, 2011, INVEST OPHTH VIS SCI, V52, P5670, DOI 10.1167/iovs.10-6625; Yoshida S, 2012, INVEST OPHTH VIS SCI, V53, P6997, DOI 10.1167/iovs.12-9671; Yoshida S, 2010, GRAEF ARCH CLIN EXP, V248, P799, DOI 10.1007/s00417-010-1301-5; Yoshimura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008158	25	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	JUL	2015	99	7					960	966		10.1136/bjophthalmol-2014-306366		7	Ophthalmology	Ophthalmology	CL0BH	WOS:000356603000016		
J	Ninomiya, M; Shirabe, K; Kayashima, H; Ikegami, T; Nishie, A; Harimoto, N; Yamashita, Y; Yoshizumi, T; Uchiyama, H; Maehara, Y				Ninomiya, M.; Shirabe, K.; Kayashima, H.; Ikegami, T.; Nishie, A.; Harimoto, N.; Yamashita, Y.; Yoshizumi, T.; Uchiyama, H.; Maehara, Y.			Functional assessment of the liver with gadolinium-ethoxybenzyl-diethylenetriamine penta-acetate-enhanced MRI in living-donor liver transplantation	BRITISH JOURNAL OF SURGERY			English	Article							GD-EOB-DTPA; 3-DIMENSIONAL COMPUTED-TOMOGRAPHY; RIGHT LOBE LIVER; ISCHEMIA-REPERFUSION; CONTRAST AGENT; RECONSTRUCTION; REGENERATION; HEPATECTOMY; MCI-186; GRAFTS	Background: A precise estimation of the capacity of the remnant liver following partial liver resection is important. In this study, the regional function of the liver in patients undergoing living-donor liver transplantation was evaluated by gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid (EOB)-enhanced MRI, with special reference to the congested region. Methods: EOB-MRI analysis was performed before hepatectomy in donors, and 7days after surgery in the donor and recipient. In the hepatocyte phase, from images obtained 15min after Primovist (R) injection, the signal intensity in each liver segment was measured and divided by the signal intensity of the erector spinae muscle (liver to muscle ratio, LMR) for standardization. Inter-regional differences in LMRs were analysed in donors and recipients. Results: Thirty-two living donors and 31 recipients undergoing living-donor liver transplantation were enrolled. In donors, the LMRs of the remnant left lobe were almost equivalent among the liver segments. In the remnant right lobe without the middle hepatic vein, the mean(s.d.) LMR for congested segments (S5 and S8) was significantly lower than that for non-congested segments (S6 and S7): 260(052) versus 364(056) respectively (P<0001). After surgery, values in the non-congested region were almost identical to those in the preoperative donor liver. LMR values in the left and right lobe graft were significantly lower than those in the corresponding segment before donor surgery (P<0001). Conclusion: The function of the congested region secondary to outflow obstruction in the remnant donor liver was approximately 70 per cent of that in the non-congested region. EOB-MRI is a promising tool to assess regional liver function, with good spatial resolution.	[Ninomiya, M.; Shirabe, K.; Kayashima, H.; Ikegami, T.; Harimoto, N.; Yamashita, Y.; Yoshizumi, T.; Uchiyama, H.; Maehara, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Nishie, A.] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka 8128582, Japan	Ninomiya, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan.	nino-m@surg2.med.kyushu-u.ac.jp					Leonhardt M, 2010, DRUG METAB DISPOS, V38, P1024, DOI 10.1124/dmd.110.032862; Nishie A, 2012, EUR J RADIOL, V81, P1100, DOI 10.1016/j.ejrad.2011.02.053; Ninomiya M, 2010, AM J TRANSPLANT, V10, P1580, DOI 10.1111/j.1600-6143.2010.03150.x; Van Beers BE, 2012, J HEPATOL, V57, P421, DOI 10.1016/j.jhep.2012.01.031; Hoekstra LT, 2013, ANN SURG, V257, P27, DOI 10.1097/SLA.0b013e31825d5d47; Soejima Y, 2012, AM J TRANSPLANT, V12, P1877, DOI 10.1111/j.1600-6143.2012.04022.x; Kawaguchi Y, 2013, J HEPATOL, V58, P247, DOI 10.1016/j.jhep.2012.09.028; Utsunomiya T, 2012, J GASTROENTEROL, V47, P470, DOI 10.1007/s00535-011-0513-8; Yonemura Y, 2005, LIVER TRANSPLANT, V11, P1556, DOI 10.1002/lt.20537; Iimuro Y, 2010, J HEPATO-BIL-PAN SCI, V17, P673, DOI 10.1007/s00534-010-0264-6; Ikegami T, 2013, SURG TODAY, V43, P769, DOI 10.1007/s00595-012-0449-5; Kayashima H, 2011, SURG TODAY, V41, P1266, DOI 10.1007/s00595-010-4464-0; Ninomiya Mizuki, 2010, J Med Case Rep, V4, P163, DOI 10.1186/1752-1947-4-163; Ninomiya M, 2004, BRIT J SURG, V91, P184, DOI 10.1002/bjs.4401; Ninomiya M, 2002, TRANSPLANTATION, V74, P1470, DOI 10.1097/01.TP.000038708.71408.1F; Ninomiya M, 2003, TRANSPLANT INT, V16, P814, DOI 10.1007/s00147-003-0628-9; SCHUHMANNGIAMPIERI G, 1992, RADIOLOGY, V183, P59; Shimada M, 2002, ARCH SURG-CHICAGO, V137, P1174, DOI 10.1001/archsurg.137.10.1174; Soejima Y, 2010, LIVER TRANSPLANT, V16, P909, DOI 10.1002/lt.22071; Sugimachi K, 2009, TRANSPLANTATION, V88, P598, DOI 10.1097/TP.0b013e3181b1600f; Taketomi A, 2010, J AM COLL SURGEONS, V211, P456, DOI 10.1016/j.jamcollsurg.2010.04.018; Yoshida M, 2014, ANN NUCL MED, V28, P780, DOI 10.1007/s12149-014-0872-3	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	JUL	2015	102	8					944	951		10.1002/bjs.9820		8	Surgery	Surgery	CK8VD	WOS:000356516400011		
J	Kumano-go, N; Murthy, ASV				Kumano-go, Naoto; Murthy, A. S. Vasudeva			Phase space Feynman path integrals of higher order parabolic type with general functional as integrand	BULLETIN DES SCIENCES MATHEMATIQUES			English	Article						Path integrals; Pseudodifferential operators; Initial value problems for higher-order parabolic equations	TIME SLICING APPROXIMATION; FUNDAMENTAL SOLUTION; DERIVATIVES; OPERATORS	We give a general class of functionals for which the phase space Feynman path integrals of higher order parabolic type have a mathematically rigorous meaning. More precisely, for any functional belonging to our class, the time slicing approximation of the phase space path integral converges uniformly on compact subsets with respect to the endpoint of position paths and to the starting point of momentum: paths. Our class of functionals is rich because it is closed under addition and multiplication. The interchange of the order with the integration with respect to time, the interchange of the order with a limit and the perturbation expansion formula hold in the path integrals. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Kumano-go, Naoto] Kogakuin Univ, Div Liberal Arts, Hachioji, Tokyo 1920015, Japan; [Murthy, A. S. Vasudeva] TIFR CAM, Bangalore 560065, Karnataka, India	Kumano-go, N (reprint author), Kogakuin Univ, Div Liberal Arts, 2665-1 Nakanomachi, Hachioji, Tokyo 1920015, Japan.	ft24343@ns.kogakuin.ac.jp; vasu@math.tifrbng.res.in			JSPS KAKENHI (C) [24540193]	This work was supported by JSPS KAKENHI (C) 24540193.	Albeverio S., 2008, LECT NOTES MATH, V523; Albeverio S, 2002, J MATH PHYS, V43, P2847, DOI 10.1063/1.1470705; FEYNMAN RP, 1951, PHYS REV, V84, P108, DOI 10.1103/PhysRev.84.108; Smolyanov OG, 2002, J MATH PHYS, V43, P5161, DOI 10.1063/1.1500422; Ichinose W, 2006, COMMUN MATH PHYS, V265, P739, DOI 10.1007/s00220-006-0005-5; Bock W., 2011, TEOR IMOVIR TA MATEM, V85x, P7; Chung K.L., 2003, INTRO RANDOM TIME QU; DAUBECHIES I, 1985, J MATH PHYS, V26, P2239, DOI 10.1063/1.526803; Fujiwara D, 2005, B SCI MATH, V129, P57, DOI 10.1016/j.bulsci.2004.09.003; Fujiwara D., 1997, FUNKCIAL EKVAC, V40, P459; FUJIWARA D, 1991, NAGOYA MATH J, V124, P61; KITADA H, 1981, OSAKA J MATH, V18, P291; Kumano-go H., 1981, PSEUDODIFFERENTIAL O; Kumano-Go N., 1995, Journal of Mathematical Sciences, University of Tokyo, V2; Kumano-go N, 2011, B SCI MATH, V135, P936, DOI 10.1016/j.bulsci.2011.09.003; Kumano-go N., 1996, J MATH SCI-U TOKYO, V3, P57; Kumano-Go N, 2008, B SCI MATH, V132, P313, DOI 10.1016/j.bulsci.2007.06.003; Kumano-Go N, 1998, OSAKA J MATH, V35, P357; Mazzucchi S., 2009, MATH FEYNMAN PATH IN; Potrykus A., ARXIV12045624; Schulman L.S., 2005, MONOGR TEXTS PHYS AS; Tsutsumi C., 1977, OSAKA J MATH, V14, P453; TSUTSUMI C, 1974, P JPN ACAD, V50, P11	23	0	0	GAUTHIER-VILLARS/EDITIONS ELSEVIER	PARIS	23 RUE LINOIS, 75015 PARIS, FRANCE	0007-4497	1952-4773		B SCI MATH	Bull. Sci. Math.	JUL	2015	139	5					495	537		10.1016/j.bulsci.2014.11.001		43	Mathematics, Applied	Mathematics	CL1XJ	WOS:000356737900002		
J	Kinugasa, H; Nouso, K; Miyahara, K; Morimoto, Y; Dohi, C; Tsutsumi, K; Kato, H; Matsubara, T; Okada, H; Yamamoto, K				Kinugasa, Hideaki; Nouso, Kazuhiro; Miyahara, Koji; Morimoto, Yuki; Dohi, Chihiro; Tsutsumi, Koichiro; Kato, Hironari; Matsubara, Takehiro; Okada, Hiroyuki; Yamamoto, Kazuhide			Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer	CANCER			English	Article						digital polymerase chain reaction; liquid biopsy; circulating tumor DNA (ctDNA); pancreatic cancer; K-ras; circulating DNA	EUS-GUIDED FNA; COLORECTAL-CANCER; DIGITAL PCR; DNA; DIAGNOSIS; PLASMA; CARCINOGENESIS; METAANALYSIS; PROGRESSION; CARCINOMAS	BACKGROUNDCell-free circulating tumor DNA (ctDNA) in serum has been considered to be a useful candidate for noninvasive cancer diagnosis. The current study was designed to estimate the clinical usefulness of genetic analysis for ctDNA by digital polymerase chain reaction in patients with pancreatic cancer. METHODSThe authors compared K-ras mutations detected in endoscopic ultrasound-guided fine-needle aspiration biopsy tissue DNA and in ctDNA from 75 patients with pancreatic cancer. K-ras mutations in the serum of 66 independent, consecutive patients with pancreatic cancer were also analyzed and the authors compared the results with survival rates. RESULTSThe frequencies of the mutations in tissue samples at G12V, G12D, and G12R in codon 12 were 28 of 75 samples (37.3%), 22 of 75 samples (29.3%), and 6 of 75 samples (8.0%), respectively. Conversely, the rates of the mutations in ctDNA were 26 of 75 samples (34.6%), 29 of 75 samples (38.6%), and 4 of 75 samples (5.3%), respectively. Overall, the K-ras mutation rates in tissue and ctDNA were 74.7% and 62.6%, respectively, and the concordance rate between them was 58 of 75 samples (77.3%). Survival did not appear to differ by the presence of K-ras mutations in tissue DNA, but the survival of patients with K-ras mutations in ctDNA was significantly shorter than that of patients without mutations in both a development set (P=.006) and an independent validation set (P=.002). The difference was especially evident in cases with a G12V mutation. CONCLUSIONSAnalysis of ctDNA is a new useful procedure for detecting mutations in patients with pancreatic cancer. This noninvasive method may have great potential as a new strategy for the diagnosis of pancreatic cancer as well as for predicting survival. Cancer 2015;121:2271-2280. (c) 2015 American Cancer Society.	[Kinugasa, Hideaki; Nouso, Kazuhiro; Miyahara, Koji; Morimoto, Yuki; Dohi, Chihiro; Tsutsumi, Koichiro; Kato, Hironari; Okada, Hiroyuki; Yamamoto, Kazuhide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008558, Japan; [Matsubara, Takehiro] Okayama Univ Hosp, Innovat Clin Med, BioRepository BioMarker Anal Ctr, Okayama, Japan	Kinugasa, H (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	gyacy14@gmail.com			Japan Society for the Promotion of Science [25220206]	Supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI 25220206).	Keohavong P, 1996, CLIN CANCER RES, V2, P411; BOS JL, 1989, CANCER RES, V49, P4682; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Harewood GC, 2002, AM J GASTROENTEROL, V97, P1386, DOI 10.1016/S0002-9270(02)04133-3; JOHN J, 1988, J BIOL CHEM, V263, P11792; Al-Mulla F, 2001, J PATHOL, V195, P549, DOI 10.1002/path.995; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Hewitt MJ, 2012, GASTROINTEST ENDOSC, V75, P319, DOI 10.1016/j.gie.2011.08.049; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Ogura T, 2013, J GASTROENTEROL, V48, P640, DOI 10.1007/s00535-012-0664-2; Gevensleben H, 2013, CLIN CANCER RES, V19, P3276, DOI 10.1158/1078-0432.CCR-12-3768; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Fuccio L, 2013, GASTROINTEST ENDOSC, V78, P596, DOI 10.1016/j.gie.2013.04.162; Andreyev HJN, 2001, BRIT J CANCER, V85, P692, DOI 10.1054/bjoc.2001.1964; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.biochem.56.1.779; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; GRUNEWALD K, 1989, INT J CANCER, V43, P1037, DOI 10.1002/ijc.2910430614; KAPLAN PL, 1983, CELL, V33, P931, DOI 10.1016/0092-8674(83)90036-3; Nelson MR, 2004, GENOME RES, V14, P1664, DOI 10.1101/gr.2421604; OKA T, 1994, NUCLEIC ACIDS RES, V22, P1541, DOI 10.1093/nar/22.9.1541; Otsuki M, 2003, J GASTROENTEROL, V38, P315, DOI 10.1007/s005350300058; Rhim AD, 2014, GASTROENTEROLOGY, V146, P647, DOI 10.1053/j.gastro.2013.12.007; Span M, 1996, INT J CANCER, V69, P241, DOI 10.1002/(SICI)1097-0215(19960621)69:3<241::AID-IJC15>3.0.CO;2-A; TADA M, 1991, GASTROENTEROLOGY, V100, P233	33	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0008-543X	1097-0142		CANCER-AM CANCER SOC	Cancer	JUL 1	2015	121	13					2271	2280		10.1002/cncr.29364		10	Oncology	Oncology	CK7SU	WOS:000356433600026		
J	Miura, T; Taketomi, A; Nakabayashi, T; Nishinaka, T; Terada, T				Miura, Takeshi; Taketomi, Ayako; Nakabayashi, Toshikatsu; Nishinaka, Toru; Terada, Tomoyuki			Identification of a functional antioxidant responsive element in the promoter of the Chinese hamster carbonyl reductase 3 (Chcr3) gene	CELL BIOLOGY INTERNATIONAL			English	Article						carbonyl reductase; Chinese hamster; genome walk; SDR21C2; short-chain dehydrogenase; reductase	TRANSCRIPTION FACTOR NRF2; DOXORUBICIN DISPOSITION; CANCER-CELLS; CBR3; EXPRESSION; PROTEIN; CARBONYL-REDUCTASE-1; HYPOXIA; SDR21C2; BINDING	CHCR3, a member of the short-chain dehydrogenase/reductase superfamily, is a carbonyl reductase 3 enzyme in Chinese hamsters. Carbonyl reductase 3 in humans has been believed to involve the metabolism and/or pharmacokinetics of anthracycline drugs, and the mechanism underlying the gene regulation has been investigated. In this study, the nucleotide sequence of the Chcr3 promoter was originally determined, and its promoter activity was characterised. The proximal promoter region is TATA-less and GC-rich, similar to the promoter region of human carbonyl reductase 3. Cobalt stimulated the transcriptional activity of the Chcr3 gene. The results of a luciferase gene reporter assay demonstrated that cobalt-induced stimulation required an antioxidant responsive element. Forced expression of Nrf2, the transcription factor that binds to antioxidant responsive elements, enhanced the transcriptional activity of the Chcr3 gene. These results suggest that cobalt induces the expression of the Chcr3 gene via the Nrf2-antioxidant responsive element pathway.	[Miura, Takeshi; Taketomi, Ayako; Nishinaka, Toru; Terada, Tomoyuki] Osaka Ohtani Univ, Biochem Lab, Fac Pharm, Tondabaya, Osaka 5848540, Japan; [Miura, Takeshi; Nakabayashi, Toshikatsu] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Pharmaceut Educ Support Ctr, Nishinomiya, Hyogo 6638179, Japan; [Nakabayashi, Toshikatsu] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Dept Biochem 1, Nishinomiya, Hyogo 6638179, Japan	Miura, T (reprint author), Osaka Ohtani Univ, Biochem Lab, Fac Pharm, 3-11-1 Nishikiori Kita, Tondabaya, Osaka 5848540, Japan.	tmiura@mukogawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	The authors thank Ms. Y. Sugihara and Ms. K. Nakamura for their participation in the initial stage of the study. This work was supported in part by a grant-in-aid for young scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (TM).	Blanco JG, 2012, J CLIN ONCOL, V30, P1415, DOI 10.1200/JCO.2011.34.8987; Fan L, 2008, PHARMACOGENET GENOM, V18, P621, DOI 10.1097/FPC.0b013e328301a869; Malatkova P, 2010, CURR DRUG METAB, V11, P639, DOI 10.2174/138920010794233530; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lal S, 2008, CANCER SCI, V99, P2045, DOI 10.1111/j.1349-7006.2008.00903.x; Miura T, 2008, MOL CELL BIOCHEM, V315, P113, DOI 10.1007/s11010-008-9794-5; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Nishinaka T, 2007, TOXICOL LETT, V170, P238, DOI 10.1016/j.toxlet.2007.03.011; Matsunaga T, 2006, DRUG METAB PHARMACOK, V21, P1, DOI 10.2133/dmpk.21.1; Gong PF, 2001, J BIOL CHEM, V276, P27018, DOI 10.1074/jbc.M103658200; Yoshioka H, 2012, TOXICOL LETT, V211, P257, DOI 10.1016/j.toxlet.2012.04.005; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Choi BH, 2014, MOLECULES, V19, P12727, DOI 10.3390/molecules190812727; WERMUTH B, 1988, J BIOL CHEM, V263, P16185; Miura T, 2013, CHEM-BIOL INTERACT, V202, P126, DOI 10.1016/j.cbi.2012.11.023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; El-Hawari Y, 2009, CHEM-BIOL INTERACT, V178, P234, DOI 10.1016/j.cbi.2008.11.004; Chang YC, 2012, J MOL MED, V90, P847, DOI 10.1007/s00109-012-0898-8; Cheng QY, 2012, BIOCHEM PHARMACOL, V83, P139, DOI 10.1016/j.bcp.2011.09.027; Ebert B, 2010, BIOCHEMISTRY-US, V49, P8499, DOI 10.1021/bi100814d; Gonzalez-Covarrubias V, 2008, PHARM RES-DORDR, V25, P1730, DOI 10.1007/s11095-008-9592-5; Han YH, 2012, BIOL TRACE ELEM RES, V148, P61, DOI 10.1007/s12011-012-9346-4; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Malatkova P, 2012, BIOCHEM BIOPH RES CO, V420, P368, DOI 10.1016/j.bbrc.2012.03.002; Miura T, 2009, CHEM-BIOL INTERACT, V178, P110, DOI 10.1016/j.cbi.2008.10.006; Miura T, 2009, LIFE SCI, V85, P303, DOI 10.1016/j.lfs.2009.06.005; Nishinaka T, 2011, CHEM-BIOL INTERACT, V191, P185, DOI 10.1016/j.cbi.2011.01.026; Nishinaka T, 2005, J PHARMACOL SCI, V97, P43, DOI 10.1254/jphs.FP0040404; Ohkura-Hada Shuri, 2008, Open Dent J, V2, P78, DOI 10.2174/1874210600802010078; Pilka ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007113; Terada T, 2001, CHEM-BIOL INTERACT, V130, P847, DOI 10.1016/S0009-2797(00)00240-4; Terada T, 2003, CHEM-BIOL INTERACT, V143, P373, DOI 10.1016/S0009-2797(02)00208-9; Triantafyllou S, 2006, FREE RADICAL RES, V40, P847; Volkan-Salanci B, 2012, J CHEMOTHERAPY, V24, P285, DOI 10.1179/1973947812Y.0000000037; Watanabe K, 1998, GENOMICS, V52, P95, DOI 10.1006/geno.1998.5380; Zhang JP, 2009, PHARM RES-DORD, V26, P2209, DOI 10.1007/s11095-009-9936-9	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-6995	1095-8355		CELL BIOL INT	Cell Biol. Int.	JUL	2015	39	7					808	815		10.1002/cbin.10450		8	Cell Biology	Cell Biology	CK7YN	WOS:000356453400005		
J	Mahmoud, ME; Ui, F; Salman, D; Nishimura, M; Nishikawa, Y				Mahmoud, Motamed Elsayed; Ui, Fumiki; Salman, Doaa; Nishimura, Maki; Nishikawa, Yoshifumi			Mechanisms of interferon-beta-induced inhibition of Toxoplasma gondii growth in murine macrophages and embryonic fibroblasts: role of immunity-related GTPase M1	CELLULAR MICROBIOLOGY			English	Article							INDOLEAMINE 2,3-DIOXYGENASE ACTIVITY; IFN-GAMMA; HOST-RESISTANCE; INTRACELLULAR PATHOGENS; ACTIVATED MACROPHAGES; ACUTE INFECTION; MICE DEFICIENT; P47 GTPASES; LRG-47; REPLICATION	The apical complex of Toxoplasma gondii enables it to invade virtually all nucleated cells in warm-blooded animals, including humans, making it a parasite of global importance. Anti-T.gondii cellular defence mechanisms depend largely on interferon (IFN)- production by immune cells. However, the molecular mechanism of IFN--mediated defence remains largely unclear. Here, mouse peritoneal macrophages and murine embryonic fibroblasts (MEFs) primed with recombinant IFN- and IFN- showed different pathways of activation. Treatment of these cells with IFN- or IFN- inhibited T.gondii (type II PLK strain) growth. Priming macrophages with IFN- had no effect on inflammatory cytokine expression, inducible nitric oxide synthase or indoleamine 2,3-dioxygenase, nor did it have an effect on their metabolites, nitric oxide and kynurenine respectively. In contrast, IFN- stimulation was characterized by classical macrophage activation and T.gondii elimination. IFN- activation recruited the immunity-related GTPase M1 (IRGM1) to the parasitophorous vacuole in the macrophages and MEFs. Anti-toxoplasma activities induced by IFN- were significantly reduced after IRGM1 knockdown in murine macrophages and in IRGM1-deficient MEFs. Thus, this study unravels an alternative pathway of macrophage activation by IFN- and provides a mechanistic explanation for the contribution of IRGM1 induced by IFN- to the elimination of T.gondii.	[Mahmoud, Motamed Elsayed; Ui, Fumiki; Salman, Doaa; Nishimura, Maki; Nishikawa, Yoshifumi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Mahmoud, Motamed Elsayed] Sohag Univ, Fac Vet Med, Dept Anim Behav Management Genet & Breeding, Sohag City 82524, Sohag, Egypt; [Salman, Doaa] Sohag Univ, Fac Vet Med, Dept Anim Med, Sohag City 82524, Sohag, Egypt	Nishikawa, Y (reprint author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Inada Cho, Obihiro, Hokkaido 0808555, Japan.	nisikawa@obihiro.ac.jp			Egyptian Ministry of Higher Education and Scientific Research; Japanese Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation of World-Leading Researchers (NEXT Program); Council of Science and Technology Policy [2011/LS003]	We thank Dr. G. Taylor (Duke University) and M. Yamamoto (Osaka University) for kindly providing the IRGM1-deficient MEFs and wild-type MEFs. Motamed E. Mahmoud was supported by a postdoctoral fellowship from the Egyptian Ministry of Higher Education and Scientific Research. This research was supported by the Japanese Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation of World-Leading Researchers (NEXT Program), initiated by the Council of Science and Technology Policy (2011/LS003).	Andrade RM, 2005, INFECT IMMUN, V73, P3115, DOI 10.1128/IAI.73.5.3115-3123.2005; Degrandi D, 2007, J IMMUNOL, V179, P7729; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Tanaka S, 2013, INFECT IMMUN, V81, P3609, DOI 10.1128/IAI.00439-13; SIBLEY LD, 1991, J IMMUNOL, V147, P2340; CARLIN JM, 1989, J LEUKOCYTE BIOL, V45, P29; Adams O, 2004, J VIROL, V78, P2632, DOI 10.1128/JVI.78.5.2632-2636.2004; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; PFEFFERKORN ER, 1986, J INTERFERON RES, V6, P267, DOI 10.1089/jir.1986.6.267; Fox BA, 2004, INT J PARASITOL, V34, P323, DOI 10.1016/j.ijpara.2003.12.001; CARLIN JM, 1989, J INTERFERON RES, V9, P329, DOI 10.1089/jir.1989.9.329; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Nagineni CN, 1996, INFECT IMMUN, V64, P4188; ORELLANA MA, 1991, INFECT IMMUN, V59, P3287; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; Sturge CR, 2013, P NATL ACAD SCI USA, V110, P10711, DOI 10.1073/pnas.1307868110; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; ADAMS LB, 1990, J IMMUNOL, V144, P2725; Henry SC, 2007, J IMMUNOL, V179, P6963; SCHMITZ JL, 1989, INFECT IMMUN, V57, P3254; Terkawi MA, 2013, CLIN VACCINE IMMUNOL, V20, P596, DOI 10.1128/CVI.00747-12; Feng CG, 2004, J IMMUNOL, V172, P1163; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Boehm U, 1998, J IMMUNOL, V161, P6715; Traver MK, 2011, J BIOL CHEM, V286, P30471, DOI 10.1074/jbc.M111.251967; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Scharton-Kersten T, 1998, J IMMUNOL, V160, P2565; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Coers J, 2008, J IMMUNOL, V180, P6237; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Potula R, 2005, BLOOD, V106, P2382, DOI 10.1182/blood-2005-04-1403; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Martens S, 2004, J IMMUNOL, V173, P2594; Beiting DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088398; Collazo CM, 2002, INFECT IMMUN, V70, P6933, DOI 10.1128/IAI.70.12.6933-6939.2002; Contini C, 2005, INT J PARASITOL, V35, P275, DOI 10.1016/j.ijpara.2004.11.016; DAUBENER W, 1994, J IMMUNOL METHODS, V168, P39, DOI 10.1016/0022-1759(94)90207-0; Fischer HG, 1998, MOL BIOCHEM PARASIT, V91, P251, DOI 10.1016/S0166-6851(97)00227-2; Hunn JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001008; Kay Maryam, 2013, Iran J Neurol, V12, P149; Lieberman LA, 2004, J IMMUNOL, V172, P457; Liesenfeld O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020568; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Melo MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003779; NATHAN CF, 1984, J EXP MED, V160, P600, DOI 10.1084/jem.160.2.600; Ortaldo J. R., 1986, IMMUNOBIOLOGY NATURA, P145; OZAKI Y, 1987, BIOCHEM BIOPH RES CO, V144, P1147, DOI 10.1016/0006-291X(87)91431-8; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Santiago HC, 2005, J IMMUNOL, V175, P8165; Schneider AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060215; SHIRAHATA T, 1986, MICROBIOL IMMUNOL, V30, P1307; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Verma S, 2011, J INTERF CYTOK RES, V31, P211, DOI 10.1089/jir.2010.0118; WILSON CB, 1985, INFECT IMMUN, V49, P351; Yarovinsky F, 2006, INT J PARASITOL, V36, P255, DOI 10.1016/j.ijpara.2005.12.003	62	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-5814	1462-5822		CELL MICROBIOL	Cell Microbiol.	JUL	2015	17	7					1069	1083		10.1111/cmi.12423		15	Cell Biology; Microbiology	Cell Biology; Microbiology	CL0CI	WOS:000356605900011		
J	Manoj, K; Takahashi, H; Morita, Y; Gonnade, RG; Iwama, S; Tsue, H; Tamura, R				Manoj, Kochunnoonny; Takahashi, Hiroki; Morita, Yoko; Gonnade, Rajesh G.; Iwama, Sekai; Tsue, Hirohito; Tamura, Rui			Preferential Enrichment of DL-Leucine Using Cocrystal Formation With Oxalic Acid Under Nonequilibrium Crystallization Conditions	CHIRALITY			English	Article						preferential enrichment; leucine; chiral resolution; cocrystal formation; phase transition	ENANTIOMERIC RESOLUTION PHENOMENON; CRYSTAL-STRUCTURE; POLYMORPHIC TRANSITION; MECHANISM; RECRYSTALLIZATION	By utilizing the preferential enrichment (PE) technique, we achieved an improved enantiomeric resolution of DL-leucine (Leu) using a 1:1 cocrystal (DL-1) of DL-Leu and oxalic acid. The crystal structure analysis of DL-1 indicated the occurrence of a novel type of phase transition and subsequent preferential redissolution of one enantiomer from the resulting crystals into solution. Chirality 27:405-410 2015. (c) 2015 Wiley Periodicals, Inc.	[Manoj, Kochunnoonny; Takahashi, Hiroki; Morita, Yoko; Tsue, Hirohito; Tamura, Rui] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan; [Gonnade, Rajesh G.] CSIR NCL Pune, Natl Chem Lab, Ctr Mat Characterizat, Pune, Maharashtra, India; [Iwama, Sekai] Meijigakuin Univ, Fac Law, Grp Chem, Yokohama, Kanagawa, Japan	Tamura, R (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto 6068501, Japan.	tamura.rui.8c@kyoto-u.ac.jp	Manoj, K/F-4645-2011	Manoj, K/0000-0002-1511-1091	JSPS KAKENHI [23245008, 26248024]	Contract grant sponsor: JSPS KAKENHI; Contract grant numbers: 23245008 and 26248024.	Iwama S, 2014, CHEM-EUR J, V20, P10343, DOI 10.1002/chem.201402446; Tamura R, 2002, J AM CHEM SOC, V124, P13139, DOI 10.1021/ja020454r; [Anonymous], 1996, ANGEW CHEM, V108, P2544; Altomare A, 1999, J APPL CRYSTALLOGR, V32, P115, DOI 10.1107/S0021889898007717; Desiraju G. R., 1989, CRYSTAL ENG DESIGN O; ETTER MC, 1990, ACCOUNTS CHEM RES, V23, P120, DOI 10.1021/ar00172a005; Fujimoto D, 2003, CRYST GROWTH DES, V3, P973, DOI 10.1021/cg034162t; Gonnade RG, 2011, CRYST GROWTH DES, V11, P607, DOI 10.1021/cg1015274; Iwama S, 2010, CRYST GROWTH DES, V10, P2668, DOI 10.1021/cg100152c; Kabuto C., 2009, J CRYST SOC JPN, V51, P218; Rajagopal K, 2003, ACTA CRYSTALLOGR E, V59, pO878, DOI 10.1107/S1600536803011267; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Tamura R, 1998, ANGEW CHEM INT EDIT, V37, P2876, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2876::AID-ANIE2876>3.3.CO;2-9; Tamura R, 2010, SYMMETRY-BASEL, V2, P112, DOI 10.3390/sym2010112; Tamura R, 2007, TOP CURR CHEM, V269, P53, DOI 10.1007/128_069; Tamura R, 2011, CRYSTENGCOMM, V13, P5269, DOI 10.1039/c1ce05294b; Tamura R, 2004, FUNDAMENTALS PRACTIC, P135; Tamura R, 1998, ANGEW CHEM, V110, P3002, DOI 10.1002/(SICI)1521-3757(19981016)110:20<3002::AID-ANGE3002>3.0.CO;2-G; Ushio T, 1996, ANGEW CHEM INT EDIT, V35, P2372, DOI 10.1002/anie.199623721	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	JUL	2015	27	7					405	410		10.1002/chir.22431		6	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CK6WX	WOS:000356370500002		
J	Shou, MR; Terashima, H; Aizawa, SI; Taga, A; Yamamoto, A; Kodama, S				Shou, Mirei; Terashima, Hiroyuki; Aizawa, Sen-Ichi; Taga, Atsushi; Yamamoto, Atsushi; Kodama, Shuji			Simultaneous Enantioseparation of Aldohexoses and Aldopentoses Derivatized With L-Tryptophanamide by Reversed Phase HPLC Using Butylboronic Acid as a Complexation Reagent of Monosaccharides	CHIRALITY			English	Article						enantioseparation; monosaccharide; HPLC; butylboronic acid; tryptophanamide	PERFORMANCE LIQUID-CHROMATOGRAPHY; CAPILLARY-ZONE-ELECTROPHORESIS; ENANTIOMERS	Three aldohexoses, glucose, galactose, and mannose, and three aldopentoses, arabinose, xylose, and ribose, were derivatized with L-tryptophanamide (L-TrpNH(2)) under alkaline conditions. Using a basic mobile phase (pH9.2), the three aldohexoses or the three aldopentoses were simultaneously enantioseparated, respectively, but all the six monosaccharides could not be simultaneously enantioseparated. A large amount of nonreacted L-TrpNH(2) was detected after the derivatized monosaccharides. In order to widen the separation window, a large portion of nonreacted L-TrpNH(2) could be eliminated by liquid-liquid extraction with ethylacetate, and elution order of the derivatized monosaccharides and nonreacted L-TrpNH(2) was found to be reversed using a neutral mobile phase. All of the six monosaccharides were simultaneously enantioseparated by reversed phase high-performance liquid chromatography (HPLC) using InertSustainSwift C18 column (4.6mm i.d. x 150mm) and a mobile phase containing 180mM phosphate buffer (pH7.6), 1.5mM butylboronic acid, and 5% acetonitrile at 40 degrees C. Nomenclature of D and L for monosaccharides is based on the configurations of the asymmetric C4 center for aldopentoses and C5 center for aldohexoses. It was found that the enantiomer elution order of these six monosaccharides and fucose in the proposed method conformed to be the absolute configuration of the C2 center. Chirality 27:417-421, 2015. (c) 2015 Wiley Periodicals, Inc.	[Shou, Mirei; Kodama, Shuji] Tokai Univ, Sch Sci, Hiratsuka, Kanagawa 2591292, Japan; [Terashima, Hiroyuki] GL Sci Inc, Tokyo, Japan; [Aizawa, Sen-Ichi] Toyama Univ, Grad Sch Sci & Engn, Toyama 930, Japan; [Taga, Atsushi] Kinki Univ, Fac Pharm, Higashiosaka, Osaka 577, Japan; [Yamamoto, Atsushi] Chubu Univ, Coll Biosci & Biotechnol, Dept Biol Chem, Kasugai, Aichi 487, Japan	Kodama, S (reprint author), Tokai Univ, Sch Sci, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	kodama@tokai-u.jp					Akabane M, 2014, ANAL SCI, V30, P739; Chavez-Servin JL, 2004, J CHROMATOGR A, V1043, P211, DOI 10.1016/j.chroma.2004.06.002; Honda S, 2003, J PHARMACEUT BIOMED, V30, P1689, DOI 10.1016/S0731-7085(02)00512-5; Castro-Puyana M, 2012, ELECTROPHORESIS, V33, P147, DOI 10.1002/elps.201100385; Lamari FN, 2003, J CHROMATOGR B, V793, P15, DOI 10.1016/S1570-0232(03)00362-3; Muir JG, 2009, J AGR FOOD CHEM, V57, P554, DOI 10.1021/jf802700e; Tanaka T, 2007, CHEM PHARM BULL, V55, P899, DOI 10.1248/cpb.55.899; Lopes JF, 2008, J CHROMATOGR A, V1188, P34, DOI 10.1016/j.chroma.2007.12.016; Wang YH, 2012, PLANTA MED, V78, P834, DOI 10.1055/s-0031-1298432; Bai C, 1997, ANAL BIOCHEM, V246, P246, DOI 10.1006/abio.1997.2016; Hiltunen S, 2013, ANAL BIOANAL CHEM, V405, P5773, DOI 10.1007/s00216-013-7031-x; HONDA S, 1989, ANAL BIOCHEM, V176, P72, DOI 10.1016/0003-2697(89)90274-1; Wang XY, 2003, J CHROMATOGR A, V992, P181, DOI 10.1016/S0021-9673(03)00273-5	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	JUL	2015	27	7					417	421		10.1002/chir.22456		5	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CK6WX	WOS:000356370500004		
J	Fong, K; Takeichi, T; Liu, L; Pramanik, R; Lee, J; Akiyama, M; McGrath, JA				Fong, K.; Takeichi, T.; Liu, L.; Pramanik, R.; Lee, J.; Akiyama, M.; McGrath, J. A.			Ichthyosis follicularis, atrichia, and photophobia syndrome associated with a new mutation in MBTPS2	CLINICAL AND EXPERIMENTAL DERMATOLOGY			English	Article							IFAP SYNDROME; SPINULOSA DECALVANS	Ichthyosis follicularis, atrichia and photophobia (IFAP) syndrome (OMIM 308205) is a rare X-linked genetic disorder. Mutations in MBTPS2 underlie IFAP syndrome, with 19 different mutations reported to date. Keratosis follicularis spinulosa decalvans (KFSD) is an allelic disorder that results from a single recurrent mutation, p.Asn508Ser. We report a case from the UK of IFAP syndrome resulting from a new mutation, p.Asn508Thr, emphasizing the significant overlap between IFAP and KFSD at both the molecular and clinical levels. An area of alopecia on the scalp of the proband's mother was also noted, suggesting lyonization.	[Fong, K.; Takeichi, T.; Pramanik, R.; Lee, J.; McGrath, J. A.] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; [Takeichi, T.; Akiyama, M.] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan; [Liu, L.] St Thomas Hosp, Viapath, London, England	McGrath, JA (reprint author), Guys Hosp, Dermatol Res Labs, 9th Floor,Tower Wing, London SE1 9RT, England.	john.mcgrath@kcl.ac.uk	McGrath, John/D-6824-2012	McGrath, John/0000-0002-3708-9964	Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust	This study was supported by the Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.	Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Zelenski NG, 1999, J BIOL CHEM, V274, P21973, DOI 10.1074/jbc.274.31.21973; Aten E, 2010, HUM MUTAT, V31, P1125, DOI 10.1002/humu.21335; Bornholdt D, 2013, HUM MUTAT, V34, P587, DOI 10.1002/humu.22275; Ding YG, 2010, BRIT J DERMATOL, V163, P886, DOI 10.1111/j.1365-2133.2010.09890.x; Fong K, 2012, CLIN EXP DERMATOL, V37, P631, DOI 10.1111/j.1365-2230.2011.04288.x; Haghighi A, 2013, J INVEST DERMATOL, V133, P571, DOI 10.1038/jid.2012.289; Konig A, 1999, AM J MED GENET, V85, P365, DOI 10.1002/(SICI)1096-8628(19990806)85:4<365::AID-AJMG12>3.0.CO;2-#; Oeffner F, 2009, AM J HUM GENET, V84, P459, DOI 10.1016/j.ajhg.2009.03.014; Wang HJ, 2014, CLIN EXP DERMATOL, V39, P158, DOI 10.1111/ced.12248	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6938	1365-2230		CLIN EXP DERMATOL	Clin. Exp. Dermatol.	JUL	2015	40	5					529	532		10.1111/ced.12587		4	Dermatology	Dermatology	CL0JL	WOS:000356628600012		
J	Miura, H; Shirai, H				Miura, H.; Shirai, H.			Low-dose administration of oral pazopanib for the treatment of recurrent angiosarcoma	CLINICAL AND EXPERIMENTAL DERMATOLOGY			English	Letter									[Miura, H.; Shirai, H.] Sakai City Hosp, Dept Dermatol, Sakai, Osaka 5900064, Japan	Miura, H (reprint author), Sakai City Hosp, Dept Dermatol, 1-1-1 Minamiyasui Cho, Sakai, Osaka 5900064, Japan.	tori2@mac.com					van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Young RJ, 2010, LANCET ONCOL, V11, P983, DOI 10.1016/S1470-2045(10)70023-1; Tomita H, 2014, J AM ACAD DERMATOL, V70, pE19, DOI 10.1016/j.jaad.2013.08.055; Fujita M, 2014, EUR J DERMATOL, V24, P267, DOI 10.1684/ejd.2014.2298; Miura H, 2006, J AM ACAD DERMATOL, V54, P907, DOI 10.1016/j.jaad.2005.11.1047	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6938	1365-2230		CLIN EXP DERMATOL	Clin. Exp. Dermatol.	JUL	2015	40	5					575	577		10.1111/ced.12575		3	Dermatology	Dermatology	CL0JL	WOS:000356628600024		
J	Takeshita, M; Suzuki, K; Kassai, Y; Takiguchi, M; Nakayama, Y; Otomo, Y; Morita, R; Miyazaki, T; Yoshimura, A; Takeuchi, T				Takeshita, Masaru; Suzuki, Katsuya; Kassai, Yoshiaki; Takiguchi, Maiko; Nakayama, Yusuke; Otomo, Yuki; Morita, Rimpei; Miyazaki, Takahiro; Yoshimura, Akihiko; Takeuchi, Tsutonnu			Polarization diversity of human CD4(+) stem cell memory T cells	CLINICAL IMMUNOLOGY			English	Article						Helper T cell; Stem cell memory T; Th17 precursor	TGF-BETA; HELPER-CELLS; T(H)17 CELLS; EFFECTOR; DIFFERENTIATION; LINEAGE; CYTOKINE; SPECIFICITY; GENERATION; PHENOTYPE	T cells are considered to develop through three stages, from naive T (Tn) into central memory T (Tcm) and finally into effector memory T (Tem). Among the subsets of Tn, stem cell memory T (Tscm) were recently found to be the least developed memory subset. While this subset was revealed to possess self-reproducibility and multipotentiality, little is known about the relationship between development and polarity. We conducted transcriptome analysis of human CD4(+) T subsets and found that Tscm was a clearly distinct subset, located between Tn and Tcm. Surface antigen analysis and differentiation assay showed that the flexibility of polarity and the cytokine production progressively changed as the differentiation of CD4(+) T cells advanced. Interestingly, we found that most cells of the CD45RO(-)CCR7(+)CCR6(+) subset, hitherto considered the naive precursor of Th17, were in fact Tscm. These findings may advance our understanding of the highly heterogeneous human helper T cells. (C) 2015 Elsevier Inc. All rights reserved.	[Takeshita, Masaru; Suzuki, Katsuya; Otomo, Yuki; Takeuchi, Tsutonnu] Keio Univ, Sch Med, Div Rheumatol,Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan; [Kassai, Yoshiaki; Takiguchi, Maiko; Miyazaki, Takahiro] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Inflammat Drug Discovery Unit, Fujisawa, Kanagawa 2518555, Japan; [Nakayama, Yusuke] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Integrated Technol Res Labs, Fujisawa, Kanagawa 2518555, Japan; [Morita, Rimpei; Miyazaki, Takahiro; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan	Takeuchi, T (reprint author), Keio Univ, Sch Med, Div Rheumatol,Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	takeshita@a5.keio.jp; katsuyas@z5.keio.jp; yoshiaki.kassai@takeda.com; maiko.takiguchi@takeda.com; yuusuke.nakayama@takeda.com; yukiootomo@a7.keio.jp; rimpeim@a7.keio.jp; takahiro.miyazaki@takeda.com; yoshimura@a6.keio.jp; tsutake@z5.keio.jp	Yoshimura, Akihiko/K-5515-2013; Takeuchi, Tsutomu/L-2327-2013	Takeuchi, Tsutomu/0000-0003-1111-8218	Takeda Pharmaceutical Company Limited, Kanagawa, Japan [04-078-0067]	This work was partly supported by Takeda Pharmaceutical Company Limited, Kanagawa, Japan (grant number 04-078-0067).	Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Mercer F, 2014, J IMMUNOL, V193, P1047, DOI 10.4049/jimmunol.1302936; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Strutt TM, 2013, IMMUNOL REV, V255, P149, DOI 10.1111/imr.12088; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2013, BLOOD, V121, P567, DOI 10.1182/blood-2012-11-468660; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Cohen CJ, 2011, J IMMUNOL, V187, P5615, DOI 10.4049/jimmunol.1101058; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI [10.1016/j.autrev.2013.12.004, 10.1016/jautrev2013.12.004]; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Cottrez F, 2001, J IMMUNOL, V167, P773; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Cieri N, 2015, BLOOD, V125, P2865, DOI 10.1182/blood-2014-11-608539; Geginat J, 2013, SEMIN IMMUNOL, V25, P252, DOI 10.1016/j.smim.2013.10.012; Valmori D, 2010, P NATL ACAD SCI USA, V107, P19402, DOI 10.1073/pnas.1008247107; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326; Schmitt N, 2014, TRENDS IMMUNOL, V35, P436, DOI 10.1016/j.it.2014.06.002; Zhang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077322	35	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1521-6616	1521-7035		CLIN IMMUNOL	Clin. Immunol.	JUL	2015	159	1					107	117		10.1016/j.clim.2015.04.010		11	Immunology	Immunology	CK9MQ	WOS:000356564600012		
J	Fukae, J; Higuchi, M; Yanamoto, S; Fukuhara, K; Tsugawa, J; Ouma, S; Hatano, T; Yoritaka, A; Okuma, Y; Kashihara, K; Hattori, N; Tsuboi, Y				Fukae, Jiro; Higuchi, Masa-aki; Yanamoto, Shosaburo; Fukuhara, Kosuke; Tsugawa, Jun; Ouma, Shinji; Hatano, Taku; Yoritaka, Asako; Okuma, Yasuyuki; Kashihara, Kenichi; Hattori, Nobutaka; Tsuboi, Yoshio			Utility of the Japanese version of the 9-item Wearing-off Questionnaire	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Parkinson's disease; Wearing-off; Questionnaire; Motor symptom; Non-motor symptom	PARKINSONS-DISEASE; MOTOR FLUCTUATIONS; NONMOTOR FLUCTUATIONS; PATIENT QUESTIONNAIRE; LEVODOPA; VALIDATION; DYSKINESIAS; DIAGNOSIS; THERAPY	Background and purpose: The 9-item Wearing-off Questionnaire (WOQ-9) is a useful tool for screening of wearing-off. We performed a validation study of the Japanese version of the WOQ-9 (JWOQ-9) using a cross-sectional design in Japanese Parkinson's disease (PD) patients diagnosed with sporadic PD and treated with levodopa. Methods: Subjects with severe dementia, uncontrolled psychiatric comorbidities, and previous PD neurosurgery were excluded. The wearing-off phenomenon was detected according to the JWOQ-9, and the results were compared with independent evaluations of wearing-off conducted by PD specialists blinded to the JWOQ-9 results. To validate the JWOQ-9, a sample size of at least 70 patients with wearing-off and 70 patients without wearing-off was required. Therefore, a total of 180 patients (101 patients with wearing-off and 79 patients without wearing-off) were enrolled. Results: The sensitivity, specificity, positive predictive value, and negative predictive value of the JWOQ-9 were 94.1%, 39.2%, 66.4%, and 83.8%, respectively. Motor symptom questions demonstrated both moderate sensitivity (58.1-87.3%) and specificity (60.4-87.5%). In contrast, non-motor symptom questions demonstrated fair to moderate sensitivity (51.5-64.6%), with high specificity (80.0-94.1%). Like the original WOQ-9, the JWOQ-9 exhibits significant value for detecting possible wearing-off. Conclusions: The JWOQ-9 is a useful screening tool for detecting wearing-off of both motor and non-motor symptoms. (C) 2015 Elsevier B.V. All rights reserved.	[Fukae, Jiro; Higuchi, Masa-aki; Yanamoto, Shosaburo; Fukuhara, Kosuke; Tsugawa, Jun; Ouma, Shinji; Tsuboi, Yoshio] Fukuoka Univ, Dept Neurol, Sch Med, Jonan Ku, Fukuoka 8140180, Japan; [Hatano, Taku; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan; [Yoritaka, Asako] Juntendo Koshigaya Hosp, Dept Neurol, Koshigaya, Japan; [Okuma, Yasuyuki] Juntendo Shizuoka Hosp, Dept Neurol, Izunokuni, Japan; [Kashihara, Kenichi] Okayama Kyokuto Hosp, Dept Neurol, Okayama, Japan	Tsuboi, Y (reprint author), Fukuoka Univ, Dept Neurol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	tsuboi@cis.fukuoka-u.ac.jp					Fahn S, 2004, NEW ENGL J MED, V351, P2498; Bares M, 2012, J NEURAL TRANSM, V119, P373, DOI 10.1007/s00702-011-0683-9; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Stacy M, 2007, J NEURAL TRANSM, V114, P211, DOI 10.1007/s00702-006-0554-y; Chan A, 2011, CLIN NEUROL NEUROSUR, V113, P538, DOI 10.1016/j.clineuro.2011.03.007; Martinez-Martin P, 2012, PARKINSONISM RELAT D, V18, P382, DOI 10.1016/j.parkreldis.2011.12.011; Witjas T, 2002, NEUROLOGY, V59, P408; Sato K, 2006, MOVEMENT DISORD, V21, P1384, DOI 10.1002/mds.20993; Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Stacy MA, 2008, PARKINSONISM RELAT D, V14, P205, DOI 10.1016/j.parkreldis.2007.07.013; Stacy M, 2005, MOVEMENT DISORD, V20, P726, DOI 10.1002/mds.20383; Martinez-Martin P, 2008, MOVEMENT DISORD, V23, P830, DOI 10.1002/mds.21944; Seki M, 2013, PARKINSONISM RELAT D, V19, P104, DOI 10.1016/j.parkreldis.2012.08.004; Schrag A, 2000, BRAIN, V123, P2297, DOI 10.1093/brain/123.11.2297; Olanow CW, 2013, MOVEMENT DISORD, V28, P1064, DOI 10.1002/mds.25364; Hattori Nobutaka, 2012, Patient Relat Outcome Meas, V3, P31, DOI 10.2147/PROM.S29443; Konde Tomoyoshi, 2011, Brain and Nerve (Tokyo), V63, P1285; MARSDEN CD, 1977, LANCET, V1, P345; Stacy MA, 2010, PROG NEURO-PSYCHOPH, V34, P57, DOI 10.1016/j.pnpbp.2009.09.023; Stocchi F, 2014, PARKINSONISM RELAT D, V20, P204, DOI 10.1016/j.parkreldis.2013.10.027	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUL	2015	134						110	115		10.1016/j.clineuro.2015.04.021		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CK9HD	WOS:000356550300020		
J	Yamao, Y; Matsumoto, R; Kunieda, T; Arakawa, Y; Kikuchi, T; Shibata, S; Shimotake, A; Fukuyama, H; Ikeda, A; Miyamoto, S				Yamao, Yukihiro; Matsumoto, Riki; Kunieda, Takeharu; Arakawa, Yoshiki; Kikuchi, Takayuki; Shibata, Sumiya; Shimotake, Akihiro; Fukuyama, Hidenao; Ikeda, Akio; Miyamoto, Susumu			A possible variant of negative motor seizure arising from the supplementary negative motor area	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Negative motor area; Motor evoked potential; Ictal onset zone	CORTICAL STIMULATION; SYSTEM; HUMANS		[Yamao, Yukihiro; Kunieda, Takeharu; Arakawa, Yoshiki; Kikuchi, Takayuki; Shibata, Sumiya; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan; [Matsumoto, Riki; Ikeda, Akio] Kyoto Univ, Grad Sch Med, Dept Epilepsy Movement Disorders & Physiol, Kyoto 6068507, Japan; [Shimotake, Akihiro] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto 6068507, Japan; [Fukuyama, Hidenao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto 6068507, Japan	Matsumoto, R (reprint author), Kyoto Univ, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	matsumot@kuhp.kyoto-u.ac.jp; kuny@kuhp.kyoto-u.ac.jp		Matsumoto, Riki/0000-0003-3985-9210; Ikeda, Akio/0000-0002-0790-2598	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan [26282218, 24592159, 25861273, 26560465]; GlaxoSmithKline K.K.; NIHON KOHDEN CORPORATION; Otsuka Pharmaceutical Co.; UCB Japan Co., Ltd.	This work was partly supported by Grants-in-Aid for Scientific Research (KAKENHI) (B) 26282218 (RM), (C) 24592159 (TX), Grants-in-Aid for Young Scientists (B) 25861273 (TX), and Exploratory Research 26560465 (RM) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine is an endowment department, supported with grants by GlaxoSmithKline K.K., NIHON KOHDEN CORPORATION, Otsuka Pharmaceutical Co., and UCB Japan Co., Ltd.	Ikeda A, 2009, EPILEPSIA, V50, P2072, DOI 10.1111/j.1528-1167.2009.02097.x; Matsumoto R, 2007, BRAIN, V130, P181, DOI 10.1093/brain/awl257; Krolak-Salmon P, 2006, ANN NEUROL, V59, P196, DOI 10.1002/ana.20706; LUDERS HO, 1995, ADV NEUROL, V67, P115; Kikuchi T, 2012, CLIN NEUROPHYSIOL, V123, P324, DOI 10.1016/j.clinph.2011.06.011; Filevich E, 2012, CORTEX, V48, P1251, DOI 10.1016/j.cortex.2012.04.014; BERGER MS, 1993, J NEUROSURG, V79, P62, DOI 10.3171/jns.1993.79.1.0062; Usui N, 2008, J NEUROSURG, V109, P605, DOI 10.3171/JNS/2008/109/10/0605	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUL	2015	134						126	129		10.1016/j.clineuro.2015.04.024		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CK9HD	WOS:000356550300023		
J	Wu, C; Koishi, M; Hu, W				Wu, C. T.; Koishi, M.; Hu, W.			A displacement smoothing induced strain gradient stabilization for the meshfree Galerkin nodal integration method	COMPUTATIONAL MECHANICS			English	Article						Meshfree; Nodal integration; Stabilization	FINITE-ELEMENT FORMULATION; KERNEL PARTICLE METHODS; MESHLESS METHODS; ELASTICITY; HYDRODYNAMICS; EQUATIONS; SCHEMES	In this paper, we present a gradient-type stabilization formulation for the meshfree Galerkin nodal integration method in liner elastic analysis. The stabilization is introduced to the standard variational formulation through an enhanced strain induced by a decomposed smoothed displacement field using the first-order meshfree convex approximations. It leads to a penalization formulation containing a symmetric strain gradient stabilization term for the enhancement of coercivity in the direct nodal integration method. As a result, the stabilization parameter comes naturally from the enhanced strain field and provides the simplest means for effecting stabilization. This strain gradient stabilization formulation is also shown to pass the constant stress patch test if the SCNI scheme is applied to the non-stabilized terms. Several numerical benchmarks are examined to demonstrate the effectiveness and accuracy of the proposed stabilization method in linear elastic analysis.	[Wu, C. T.; Hu, W.] Livermore Software Technol Corp, Livermore, CA 94550 USA; [Koishi, M.] Yokohama Rubber Co Ltd, Koishi Lab, Tokyo, Japan	Wu, C (reprint author), Livermore Software Technol Corp, Livermore, CA 94550 USA.	ctwu@lstc.com			Yokohama Rubber Co, Ltd, Japan	The authors would like to thank Dr. John O. Hallquist of LSTC for his support to this research. The support of this work by Yokohama Rubber Co, Ltd, Japan under the Yosemite Project is gratefully acknowledged.	Duan QL, 2012, INT J NUMER METH ENG, V92, P399, DOI 10.1002/nme.4359; Wang DD, 2004, COMPUT METHOD APPL M, V193, P1065, DOI 10.1016/j.cma.2003.12.006; BELYTSCHKO T, 1994, INT J NUMER METH ENG, V37, P229, DOI 10.1002/nme.1620370205; Hao S, 2006, COMPUT METHOD APPL M, V195, P6059, DOI 10.1016/j.cma.2005.10.030; FRANCA LP, 1993, COMPUT METHOD APPL M, V105, P285, DOI 10.1016/0045-7825(93)90126-I; Bochev PB, 1998, SIAM REV, V40, P789, DOI 10.1137/S0036144597321156; Chen JS, 2000, INT J NUMER METH ENG, V47, P1303, DOI 10.1002/(SICI)1097-0207(20000310)47:7<1303::AID-NME826>3.3.CO;2-X; THOMPSON LL, 1995, INT J NUMER METH ENG, V38, P371, DOI 10.1002/nme.1620380303; Sukumar N, 2004, INT J NUMER METH ENG, V61, P2159, DOI 10.1002/nme.1193; Arroyo M, 2006, INT J NUMER METH ENG, V65, P2167, DOI 10.1002/nme.1534; Puso MA, 2008, INT J NUMER METH ENG, V74, P416, DOI 10.1002/nme.2181; Wang HP, 2009, INT J IMPACT ENG, V36, P1210, DOI 10.1016/j.ijimpeng.2009.03.004; LIU WK, 1985, COMPUT METHOD APPL M, V53, P13; LIU WK, 1995, INT J NUMER METH FL, V20, P1081, DOI 10.1002/fld.1650200824; LIBERSKY LD, 1993, J COMPUT PHYS, V109, P67, DOI 10.1006/jcph.1993.1199; Wu CT, 2013, COMPOS PART B-ENG, V45, P1397, DOI 10.1016/j.compositesb.2012.09.061; Wu CT, 2012, INT J NUMER METH ENG, V90, P882, DOI 10.1002/nme.3349; Chen JS, 2001, INT J NUMER METH ENG, V50, P435, DOI 10.1002/1097-0207(20010120)50:2<435::AID-NME32>3.0.CO;2-A; Chen JS, 2002, INT J NUMER METH ENG, V53, P2587, DOI 10.1002/nme.338; Chen JS, 2013, INT J NUMER METH ENG, V95, P387, DOI 10.1002/nme.4512; Rabczuk T, 2010, INT J NUMER METH ENG, V81, P48, DOI 10.1002/nme.2670; Guan PC, 2011, INT J IMPACT ENG, V38, P1033, DOI 10.1016/j.ijimpeng.2011.08.001; Wu CT, 2011, INT J NUMER METH ENG, V85, P693, DOI 10.1002/nme.2991; Beissel S, 1996, COMPUT METHOD APPL M, V139, P49, DOI 10.1016/S0045-7825(96)01079-1; Brenner SC, 2008, MATH THEORY FINITE E; Chen JS, 1996, COMPUT METHOD APPL M, V139, P195, DOI 10.1016/S0045-7825(96)01083-3; Chen JS, 2000, COMPUT METHOD APPL M, V181, P117, DOI 10.1016/S0045-7825(99)00067-5; Donning BM, 1998, COMPUT METHOD APPL M, V152, P47, DOI 10.1016/S0045-7825(97)00181-3; Gunther FC, 1998, COMPUT METHOD APPL M, V163, P205, DOI 10.1016/S0045-7825(98)00014-0; Hillman M, 2014, COMPUT PART MECH, V1, P245; HUGHES TJR, 1989, COMPUT METHOD APPL M, V73, P173, DOI 10.1016/0045-7825(89)90111-4; Hughes TJR, 1982, FINITE ELEMENTS FLUI, V4; Li S, 2004, MESHFREE PARTICLE ME; Liu GR, 2007, INT J SOLIDS STRUCT, V44, P3840, DOI 10.1016/j.ijsolstr.2006.10.025; Liu G.R., 2010, MESHFREE METHODS MOV; Park CK, 2011, FINITE ELEM ANAL DES, V47, P683, DOI 10.1016/j.finel.2011.02.001; Simkins DC, 2006, COMPUT MECH, V38, P235, DOI 10.1007/s00466-005-0744-8; Timoshenko S., 1970, THEORY ELASTICITY; Vignjevic R, 2000, COMPUT METHOD APPL M, V184, P67, DOI 10.1016/S0045-7825(99)00441-7; Wu CT, 2014, INT J NUMER METH ENG, V100, P374, DOI 10.1002/nme.4751; Wu CT, 2012, INT J NUMER METH ENG, V91, P1137, DOI 10.1002/nme.4306; Wu CT, 2014, 13 INT LS DYNA US C, P1; Wu YC, 2014, THEOR APPL FRACT MEC, V27, P89	43	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-7675	1432-0924		COMPUT MECH	Comput. Mech.	JUL	2015	56	1					19	37		10.1007/s00466-015-1153-2		19	Mathematics, Interdisciplinary Applications; Mechanics	Mathematics; Mechanics	CL1UZ	WOS:000356731700002		
J	Kittaka, M; Kajiya, M; Shiba, H; Takewaki, M; Takeshita, K; Khung, R; Fujita, T; Iwata, T; Nguyen, TQ; Ouhara, K; Takeda, K; Fujita, T; Kurihara, H				Kittaka, Mizuho; Kajiya, Mikihito; Shiba, Hideki; Takewaki, Manabu; Takeshita, Kei; Khung, Rathvisal; Fujita, Takako; Iwata, Tomoyuki; Truong Quoc Nguyen; Ouhara, Kazuhisa; Takeda, Katsuhiro; Fujita, Tsuyoshi; Kurihara, Hidemi			Clumps of a mesenchymal stromal cell/extracellular matrix complex can be a novel tissue engineering therapy for bone regeneration	CYTOTHERAPY			English	Article						bone regeneration; complex mesenchymal stromal cells; extracellular matrix; mesenchymal stromal cells	STEM-CELLS; IN-VITRO; DIFFERENTIATION; BIOMATERIALS; SCAFFOLDS; MARROW; PERIOSTEUM; CARTILAGE; INSIGHTS; REPAIR	Background aims. The transplantation of mesenchymal stromal cells (MSCs) to damaged tissue has attracted attention in scientific and medical fields as an effective regenerative therapy. Nevertheless, additional studies are required to develop an MSC transplant method for bone regeneration because the use of an artificial scaffold restricts the number of transplanted cells and their function. Furthermore, regulating the degree of cell differentiation in vitro is desirable for a more effective regenerative therapy. To address these unresolved issues, with the use of a self-produced extracellular matrix (ECM), we developed clumps of an MSC/ECM complex (C-MSCs). Methods. MSCs isolated from rat femur were cultured in growth medium supplemented with 50 mu g/mL of ascorbic acid for 7 days. To obtain C-MSCs, confluent cells were scratched with the use of a micropipette tip to roll up the cellular sheet, which consisted of ECM produced by the MSCs. The biological properties of C-MSCs were assessed in vitro and their bone regenerative activity was tested by use of a rat calvarial defect model. Results. Immunofluorescent confocal microscopic analysis revealed that type I collagen formed C-MSCs. Osteopontin messenger RNA expression and amount of calcium content were higher in C-MSCs cultured in osteo-inductive medium than those of untreated C-MSCs. The transplantation of osteogenic-differentiated C-MSCs led to rapid bone regeneration in the rat calvarial defect model. Conclusions. These results suggest that the use of C-MSCs refined by self-produced ECM, which contain no artificial scaffold and can be processed in vitro, may represent a novel tissue engineering therapy.	[Kittaka, Mizuho; Kajiya, Mikihito; Shiba, Hideki; Takewaki, Manabu; Takeshita, Kei; Khung, Rathvisal; Fujita, Takako; Iwata, Tomoyuki; Truong Quoc Nguyen; Ouhara, Kazuhisa; Takeda, Katsuhiro; Fujita, Tsuyoshi; Kurihara, Hidemi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Inst Biomed & Hlth Sci, Dept Periodontal Med,Appl Life Sci, Hiroshima 7348553, Japan	Shiba, H (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Inst Biomed & Hlth Sci, Dept Periodontal Med,Appl Life Sci,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	bashihi@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [26861814, 24593122]; Japanese Society of Periodontology	This work was supported by the Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientist [B], No. 26861814, and Grant-in-Aid for Scientific Research [C], No. 24593122) and the Japanese Society of Periodontology (Encouragement Research Grant-in-Aid for Seeds Foster Young Researcher, 2012). We thank Daniel Mrozek, who provided English language editing services on behalf of the Medical English Service (Kyoto, Japan).	Nooeaid P, 2012, J CELL MOL MED, V16, P2247, DOI 10.1111/j.1582-4934.2012.01571.x; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005; Seebach C, 2012, CELL TRANSPLANT, V21, P1667, DOI 10.3727/096368912X638937; Kawaguchi H, 2004, J PERIODONTOL, V75, P1281, DOI 10.1902/jop.2004.75.9.1281; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Colnot C, 2011, TISSUE ENG PART B-RE, V17, P449, DOI [10.1089/ten.TEB.2011.0243, 10.1089/ten.teb.2011.0243]; Kuroda R, 2014, TISSUE ENG PART B-RE, V20, P190, DOI [10.1089/ten.TEB.2013.0511, 10.1089/ten.teb.2013.0511]; Bianco P, 2011, J CELL BIOCHEM, V112, P1713, DOI 10.1002/jcb.23103; Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586; Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052; Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015; Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI [10.1359/jbmr.081003, 10.1359/JBMR.081003]; Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038; Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Colnot C, 2012, J ORTHOP RES, V30, P1869, DOI 10.1002/jor.22181; Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202; Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X; Fu RH, 2011, CELL TRANSPLANT, V20, P37, DOI 10.3727/096368910X532756; Kang AhRan, 2014, Biomaterials, V35, P2651, DOI 10.1016/j.biomaterials.2013.12.073; Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002; Leeming DJ, 2009, OSTEOPOROSIS INT, V20, P1461, DOI 10.1007/s00198-009-0904-3; O'Grady JE, 2003, ADV DRUG DELIVER REV, V55, P1699, DOI 10.1016/j.addr.2003.08.006; Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	JUL	2015	17	7					860	873		10.1016/j.jcyt.2015.01.007		14	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	CL0KS	WOS:000356632200004		
J	Nishiwaki, S				Nishiwaki, Satoshi			Rules of providing cord blood for induced pluripotent stem cells for research	CYTOTHERAPY			English	Letter									[Nishiwaki, Satoshi] Minist Hlth Labour & Welf, Hlth Serv Bur, Off Transplantat Med, Tokyo 1008916, Japan	Nishiwaki, S (reprint author), Minist Hlth Labour & Welf, Hlth Serv Bur, Off Transplantat Med, Chiyoda Ku, 1-2-2 Kasumigaseki, Tokyo 1008916, Japan.	n-3104@tf7.so-net.ne.jp					[Anonymous], 2013, NATURE, V494, P5; Fox IJ, 2014, SCIENCE, V345, P889, DOI 10.1126/science.1247391; Hasse A, 2009, CELL STEM CELL, V5, P434; 2013, LANCET, V382, P1609	4	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	JUL	2015	17	7					1008	1008		10.1016/j.jcyt.2015.03.606		1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	CL0KS	WOS:000356632200017		
J	Araki, E; Tanizawa, Y; Tanaka, Y; Taniguchi, A; Koiwai, K; Kim, G; Salsali, A; Woerle, HJ; Broedl, UC				Araki, E.; Tanizawa, Y.; Tanaka, Y.; Taniguchi, A.; Koiwai, K.; Kim, G.; Salsali, A.; Woerle, H. J.; Broedl, U. C.			Long-term treatment with empagliflozin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus	DIABETES OBESITY & METABOLISM			English	Article						empagliflozin; SGLT2 inhibitor; type 2 diabetes	PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; GLYCEMIC CONTROL; METFORMIN; 24-WEEK; SULFONYLUREA; MONOTHERAPY; INHIBITORS; EFFICACY; SAFETY	Aims: To evaluate the safety and efficacy of empagliflozin for 52 weeks as add-on to one other oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus (T2DM). Methods: Patients on biguanide (n=133), thiazolidinedione (n=273), alpha-glucosidase inhibitor (n=139), dipeptidyl-peptidase-4 inhibitor (n=139) or glinide (n=140) were randomized 1:1 to receive empagliflozin 10 or 25 mg double-blind as add-on therapy for 52 weeks. Patients on sulphonylurea (SU; n=336) were randomized 2:2:1 to receive empagliflozin 10 or 25 mg double-blind or open-label metformin as add-on therapy for 52 weeks. The primary objective was to evaluate safety. Change from baseline in glycated haemoglobin (HbA1c) at week 52 was a secondary endpoint. Results: Adverse events (AEs) were reported in 67.6-84.6% of patients receiving empagliflozin. Confirmed hypoglycaemic AEs (plasma glucose <= 70 mg/dl and/or requiring assistance) were reported in 4.4 and 6.6%, respectively, of patients receiving empagliflozin 10 and 25 mg as add-on to SU and in 0.0 to 2.9%, respectively, of patients receiving empagliflozin 10 and 25 mg as add-on to other therapies. Baseline mean +/- standard deviation HbA1c ranged from -7.51 +/- 0.73 to 8.06 +/- 0.76% across background therapy groups. At week 52, adjusted mean +/- standard error changes from baseline in HbA1c ranged from -0.77 +/- 0.06 to -1.00 +/- 0.06% in patients receiving empagliflozin. Conclusions: In Japanese patients with T2DM, empagliflozin 10 and 25 mg as add-on to one other oral antidiabetes therapy for 52 weeks were well tolerated and were associated with clinically meaningful reductions in HbA1c.	[Araki, E.] Kumamoto Univ, Dept Metab Med, Kumamoto, Japan; [Tanizawa, Y.] Yamaguchi Univ, Grad Sch Med, Div Endocrinol, Ube, Yamaguchi 755, Japan; [Tanaka, Y.; Taniguchi, A.; Koiwai, K.] Nippon Boehringer Ingelheim Co Ltd, Tokyo 1416017, Japan; [Kim, G.; Woerle, H. J.; Broedl, U. C.] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Salsali, A.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA	Tanaka, Y (reprint author), Nippon Boehringer Ingelheim Co Ltd, Clin Trial Management Dept, Med Dev Div, Shinagawa Ku, 2-1-1 Osaki, Tokyo 1416017, Japan.	yuko.tanaka@boehringer-ingelheim.com			Boehringer Ingelheim; Eli Lilly and Company	This study was funded by Boehringer Ingelheim and Eli Lilly and Company. Medical writing assistance, supported financially by Boehringer Ingelheim, was provided by Jill Powell and Elizabeth Ng of Fleishman-Hillard Group, Ltd, London, UK, during the preparation of this manuscript. The authors were fully responsible for all content and editorial decisions were involved at all stages of manuscript development and have approved the final version.	ADA (American Diabetes Association), 2013, DIABETES CARE S1, V36, pS11; Oishi M, 2014, J DIABETES INVEST, V5, P581, DOI 10.1111/jdi.12183; Feldstein AC, 2008, DIABETES CARE, V31, P1960, DOI 10.2337/dc08-0426; Neville SE, 2009, DIABETES-METAB RES, V25, P705, DOI 10.1002/dmrr.1012; DeFronzo RA, 2012, DIABETES OBES METAB, V14, P5, DOI 10.1111/j.1463-1326.2011.01511.x; Roden M, 2013, LANCET DIABETES ENDO, V1, P208, DOI 10.1016/S2213-8587(13)70084-6; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Kadowaki T, 2015, ADV THER, V32, P306, DOI 10.1007/s12325-015-0198-0; Barnett AH, 2014, LANCET DIABETES ENDO, V2, P369, DOI 10.1016/S2213-8587(13)70208-0; Grempler R, 2012, DIABETES OBES METAB, V14, P83, DOI 10.1111/j.1463-1326.2011.01517.x; Kovacs CS, 2014, DIABETES OBES METAB, V16, P147, DOI 10.1111/dom.12188; Haring HU, 2014, DIABETES CARE, V37, P1650, DOI 10.2337/dc13-2105; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Haring HU, 2013, DIABETES CARE, V36, P3396, DOI 10.2337/dc12-2673; Nakagami T, 2003, DIABETOLOGIA, V46, P1063, DOI 10.1007/s00125-003-1158-9; Hach T., 2013, DIABETES S1, V62, pLB19; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI [10.2337/dc12-0413, 10.2337/dc12-041.3]; Japan Diabetes Society, TREATM GUID DIAB 201; Japanese Pharmaceutical and Medical Device Agency (PMDA), 2010, GUID CLIN EV OR HYP; List JF, 2011, KIDNEY INT, V79, pS20, DOI 10.1038/ki.2010.512; Yatsuya Hiroshi, 2011, EPMA J, V2, P65, DOI 10.1007/s13167-011-0071-4	21	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8902	1463-1326		DIABETES OBES METAB	Diabetes Obes. Metab.	JUL	2015	17	7					665	674		10.1111/dom.12464		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CK9XG	WOS:000356592200008		
J	Kaku, K; Enya, K; Nakaya, R; Ohira, T; Matsuno, R				Kaku, K.; Enya, K.; Nakaya, R.; Ohira, T.; Matsuno, R.			Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial	DIABETES OBESITY & METABOLISM			English	Article						fasiglifam; GPR40; Japanese patients; TAK-875; type 2 diabetes	INSULIN-SECRETION; GPR40 AGONIST; HYPOGLYCEMIA; MANAGEMENT; MELLITUS; OBESITY; FEAR	Aim: To assess the efficacy and safety of fasiglifam 25 and 50 mg in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise. Methods: This phase III, double-blind, placebo-controlled, multicentre study included 192 patients randomized to once-daily treatment with fasiglifam 25 mg (n=63) or 50 mg (n=62) or placebo (n=67) for 24 weeks. The primary efficacy endpoint was the change from baseline in glycated haemoglobin (HbA1c) at week 24. Results: At week 24, both fasiglifam groups had significantly reduced HbA1c levels compared with the placebo group (p<0.0001). The least squares mean change from baseline in HbA1c was 0.16% with placebo, -0.57% with fasiglifam 25 mg and -0.83% with fasiglifam 50 mg. The percentage of patients who achieved an HbA1c target of <6.9% at week 24 was also significantly higher (p<0.05) for fasiglifam 25 mg (30.2%) and 50 mg (54.8%) compared with placebo (13.8%). Fasiglifam significantly reduced fasting plasma glucose levels at all assessment points, starting from week 2. The incidence and types of treatment-emergent adverse events in each fasiglifam group were similar to those in the placebo group, and hypoglycaemia was reported in 1 patient receiving fasiglifam 50 mg. There were no clinically meaningful changes in body weight in any treatment group. Conclusions: Fasiglifam significantly improved glycaemic control and was well tolerated, with a low risk of hypoglycaemia in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise; however, in a recent review of data from overall fasiglifam global clinical trials, concerns about liver safety arose and the clinical development of fasiglifam was terminated after this trial was completed.	[Kaku, K.] Kawasaki Med Univ, Dept Med, Okayama, Japan; [Enya, K.; Nakaya, R.; Ohira, T.; Matsuno, R.] Takeda Pharmaceut Co Ltd, Pharmaceut Dev Div, Osaka, Japan	Kaku, K (reprint author), 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	kka@med.kawasaki-m.ac.jp			Content Ed Net	K.K. is the guarantor of this work and, as such, had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The authors thank all investigators (Appendix S1) for their assistance with this study. The authors also thank the sponsor for assistance with data monitoring and gathering, and for funding editorial writing that was provided by Steve Clissold, Content Ed Net.	Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Araki T, 2012, DIABETES OBES METAB, V14, P271, DOI 10.1111/j.1463-1326.2011.01525.x; Cahn A, 2013, EXPERT OPIN EMERG DR, V18, P245, DOI 10.1517/14728214.2013.807796; Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003; Sturm R, 2008, PUBLIC HEALTH, V122, P739, DOI 10.1016/j.puhe.2008.01.004; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Arai K, 2010, ENDOCR J, V57, P499; Cryer PE, 1999, DIABETES-METAB RES, V15, P42, DOI 10.1002/(SICI)1520-7560(199901/02)15:1<42::AID-DMRR1>3.0.CO;2-B; Matthews DR, 1998, DIABETIC MED, V15, P297, DOI 10.1002/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.3.CO;2-N; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Leifke E, 2012, CLIN PHARMACOL THER, V92, P29, DOI 10.1038/clpt.2012.43; Leese GP, 2003, DIABETES CARE, V26, P1176, DOI 10.2337/diacare.26.4.1176; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Pratley RE, 2009, EXPERT OPIN PHARMACO, V10, P503, DOI [10.1517/14656560802694713 , 10.1517/14656560802694713]; COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617; Bailey CJ, 2012, LANCET, V379, P1370, DOI 10.1016/S0140-6736(12)60165-2; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; International Diabetes Federation, GLOB GUID TYP 2 DIAB; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI [10.2337/dc12-0413, 10.2337/dc12-041.3]; Kaku K, 2013, DIABETES CARE, V36, P245, DOI 10.2337/dc12-0872; The Japan Diabetes Society, 2014, TREATM GUID DIAB 201	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8902	1463-1326		DIABETES OBES METAB	Diabetes Obes. Metab.	JUL	2015	17	7					675	681		10.1111/dom.12467		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CK9XG	WOS:000356592200009		
J	Yamauchi, K; Sato, Y; Nakasone, Y; Aizawa, T				Yamauchi, Keishi; Sato, Yuka; Nakasone, Yasuto; Aizawa, Toru			Comparison of HOMA-IR, HOMA-beta% and disposition index between US white men and Japanese men in Japan in the ERA JUMP study: was the calculation of disposition index legitimate?	DIABETOLOGIA			English	Letter						Disposition index; HOMA-beta%; HOMA-IR	INSULIN-RESISTANCE; GLUCOSE		[Yamauchi, Keishi; Sato, Yuka; Nakasone, Yasuto; Aizawa, Toru] Aizawa Hosp, Ctr Diabet, Matsumoto, Nagano 3908510, Japan	Aizawa, T (reprint author), Aizawa Hosp, Ctr Diabet, 2-5-1 Honjo, Matsumoto, Nagano 3908510, Japan.	taizawax@ai-hosp.or.jp					Ahuja Y, 2015, DIABETOLOGIA, V58, P265; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Retnakaran R, 2008, OBESITY, V16, P1901, DOI 10.1038/oby.2008.307; Sato Y, 2015, ENDOCR J IN PRESS; Simonson DC, 2015, DIABETOLOGIA, V58, P207, DOI 10.1007/s00125-014-3454-y	6	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	JUL	2015	58	7					1679	1680		10.1007/s00125-015-3612-x		2	Endocrinology & Metabolism	Endocrinology & Metabolism	CK8ZL	WOS:000356528900033		
J	Uchida, Y; Morimoto, Y; Uchiike, T; Kamamoto, T; Hayashi, T; Arai, I; Nishikubo, T; Takahashi, Y				Uchida, Yumiko; Morimoto, Yukihiro; Uchiike, Takao; Kamamoto, Tomoyuki; Hayashi, Tamaki; Arai, Ikuyo; Nishikubo, Toshiya; Takahashi, Yukihiro			Phototherapy with blue and green mixed-light is as effective against unconjugated jaundice as blue light and reduces oxidative stress in the Gunn rat model	EARLY HUMAN DEVELOPMENT			English	Article						Side effects; Hyperbilirubinemia; Neonate; Light emitting diode; Unbound bilirubin	URINARY 8-HYDROXY-2'-DEOXYGUANOSINE 8-OHDG; BILIRUBIN; HYPERBILIRUBINEMIA; INFANTS; SPE	Objective: Phototherapy using blue light-emitting diodes (LED) is effective against neonatal jaundice. However, green light phototherapy also reduces unconjugated jaundice. We aimed to determine whether mixed blue and green light can relieve jaundice with minimal oxidative stress as effectively as either blue or green light alone in a rat model. Methods: Gunn rats were exposed to phototherapy with blue (420-520 nm), filtered blue (FB; 440-520 nm without < 440-nm wavelengths, FB50 (half the irradiance of filtered blue), mixed (filtered 50% blue and 50% green), and green (490-590 nm) LED irradiation for 24 h. The effects of phototherapy are expressed as ratios of serum total (TB) and unbound (UB) bilirubin before and after exposure to each LED. Urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) was measured by HPLC before and after exposure to each LED to determine photooxidative stress. Results: Values <1.00 indicate effective phototherapy. The ratios of TB and UB were decreased to 0.85, 0.89, 1.07, 0.90, and 1.04, and 0.85, 0.94, 0.93, 0.89, and 1.09 after exposure to blue, filtered blue, FB50, and filtered blue mixed with green LED, respectively. In contrast, urinary 8-OHdG increased to 2.03, 1.25, 0.96, 1.36, 1.31, and 1.23 after exposure to blue, filtered blue, FB50, mixed, green LED, and control, indicating side-effects (>1.00), respectively. Conclusions: Blue plus green phototherapy is as effective as blue phototherapy and it attenuates irradiation-induced oxidative stress. Practice implications: Combined blue and green spectra might be effective against neonatal hyperbilirubinemia. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Uchida, Yumiko; Kamamoto, Tomoyuki; Hayashi, Tamaki; Arai, Ikuyo; Nishikubo, Toshiya; Takahashi, Yukihiro] Nara Med Univ Hosp, Ctr Perinatal Med, Div Neonatal Intens Care, Kashihara, Nara 6348522, Japan; [Morimoto, Yukihiro] Ushio Inc, Project Promot Dept, Technol & Engn Div, Himeji, Hyogo 6710224, Japan; [Uchiike, Takao] Nara Med Univ Hosp, Cent Clin Lab, Kashihara, Nara 6348522, Japan	Uchida, Y (reprint author), Nara Med Univ Hosp, Ctr Perinatal Med, Div Neonatal Intens Care, 840 Shijyo Cho, Kashihara, Nara 6348522, Japan.	rmbsh274@yahoo.co.jp					CREMER RJ, 1958, LANCET, V1, P1094; AYYASH H, 1987, ARCH DIS CHILD, V62, P843; Seidman DS, 2000, J PEDIATR-US, V136, P771, DOI 10.1067/mpd.2000.105651; Tyson JE, 2012, J PERINATOL, V32, P677, DOI 10.1038/jp.2012.64; BRADLEY MO, 1977, NATURE, V266, P724, DOI 10.1038/266724a0; Chang YS, 2005, J KOREAN MED SCI, V20, P61; DOBBS RH, 1975, ARCH DIS CHILD, V50, P833; Ebbsen F, 1976, Arch Dis Child, V51, P476; Inaba Y, 2011, J CHROMATOGR SCI, V49, P303; ITOH S, 1987, BIOL NEONATE, V51, P10; Koide S, 2010, J CHROMATOGR B, V878, P2163, DOI 10.1016/j.jchromb.2010.06.015; Matsumoto Y, 2008, J OCCUP HEALTH, V50, P366, DOI 10.1539/joh.L7144; Mohammadizadeh Majid, 2012, Adv Biomed Res, V1, P51, DOI 10.4103/2277-9175.100158; NAKAMURA H, 1977, CLIN CHIM ACTA, V79, P411; Nixon ET, 1977, PHOTOCHEM PHOTOBIOL, V26, P589; ONISHI S, 1984, BIOCHEM J, V221, P717; SPECK WT, 1979, ENVIRON MUTAGEN, V1, P321, DOI 10.1002/em.2860010404; SPECK WT, 1975, PEDIATR RES, V9, P703, DOI 10.1203/00006450-197509000-00003; Uchida Y, 2011, J JPN SOC PREMATURE, V23, P263; VECCHI C, 1983, PEDIATR RES, V17, P461, DOI 10.1203/00006450-198306000-00006	20	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-3782	1872-6232		EARLY HUM DEV	Early Hum. Dev.	JUL	2015	91	7					381	385		10.1016/j.earlhumdev.2015.04.010		5	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CK9GX	WOS:000356549700001		
J	Duffy, JE; Reynolds, PL; Bostrom, C; Coyer, JA; Cusson, M; Donadi, S; Douglass, JG; Eklof, JS; Engelen, AH; Eriksson, BK; Fredriksen, S; Gamfeldt, L; Gustafsson, C; Hoarau, G; Hori, M; Hovel, K; Iken, K; Lefcheck, JS; Moksnes, PO; Nakaoka, M; O'Connor, MI; Olsen, JL; Richardson, JP; Ruesink, JL; Sotka, EE; Thormar, J; Whalen, MA; Stachowicz, JJ				Duffy, J. Emmett; Reynolds, Pamela L.; Bostroem, Christoffer; Coyer, James A.; Cusson, Mathieu; Donadi, Serena; Douglass, James G.; Ekloef, Johan S.; Engelen, Aschwin H.; Eriksson, Britas Klemens; Fredriksen, Stein; Gamfeldt, Lars; Gustafsson, Camilla; Hoarau, Galice; Hori, Masakazu; Hovel, Kevin; Iken, Katrin; Lefcheck, Jonathan S.; Moksnes, Per-Olav; Nakaoka, Masahiro; O'Connor, Mary I.; Olsen, Jeanine L.; Richardson, J. Paul; Ruesink, Jennifer L.; Sotka, Erik E.; Thormar, Jonas; Whalen, Matthew A.; Stachowicz, John J.			Biodiversity mediates top-down control in eelgrass ecosystems: a global comparative-experimental approach	ECOLOGY LETTERS			English	Article						Biodiversity-ecosystem functioning; bottom-up control; coordinated experiments; food webs; metabolic ecology; structural equation modelling; top-down control	ZOSTERA-MARINA; TROPHIC INTERACTIONS; NUTRIENT ENRICHMENT; MICROSATELLITE LOCI; SEAGRASS ECOSYSTEM; FUNCTIONAL-ROLE; DIVERSITY; COMMUNITY; EUTROPHICATION; POPULATIONS	Nutrient pollution and reduced grazing each can stimulate algal blooms as shown by numerous experiments. But because experiments rarely incorporate natural variation in environmental factors and biodiversity, conditions determining the relative strength of bottom-up and top-down forcing remain unresolved. We factorially added nutrients and reduced grazing at 15 sites across the range of the marine foundation species eelgrass (Zostera marina) to quantify how top-down and bottom-up control interact with natural gradients in biodiversity and environmental forcing. Experiments confirmed modest top-down control of algae, whereas fertilisation had no general effect. Unexpectedly, grazer and algal biomass were better predicted by cross-site variation in grazer and eelgrass diversity than by global environmental gradients. Moreover, these large-scale patterns corresponded strikingly with prior small-scale experiments. Our results link global and local evidence that biodiversity and top-down control strongly influence functioning of threatened seagrass ecosystems, and suggest that biodiversity is comparably important to global change stressors.	[Duffy, J. Emmett; Reynolds, Pamela L.; Lefcheck, Jonathan S.; Richardson, J. Paul] Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; [Duffy, J. Emmett] Smithsonian Inst, Tennenbaum Marine Observ Network, Washington, DC 20013 USA; [Bostroem, Christoffer] Abo Akad Univ, Dept Biosci Environm & Marine Biol, FIN-20520 Turku, Finland; [Coyer, James A.] Cornell Univ, Shoals Marine Lab, Portsmouth, NH 03801 USA; [Cusson, Mathieu] Univ Quebec Chicoutimi, Dept Sci Fondamentales & Quebec Ocean, Chicoutimi, PQ G7H 2B1, Canada; [Donadi, Serena; Eriksson, Britas Klemens; Olsen, Jeanine L.] Univ Groningen, Ctr Ecol & Evolutionary Studies, NL-9747 AG Groningen, Netherlands; [Douglass, James G.] Florida Gulf Coast Univ, Ft Myers, FL 33965 USA; [Ekloef, Johan S.] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Engelen, Aschwin H.] Univ Algarve, CCMAR, P-8005139 Faro, Portugal; [Fredriksen, Stein; Thormar, Jonas] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Gamfeldt, Lars; Moksnes, Per-Olav] Univ Gothenburg, Dept Biol & Environm Sci, SE-40530 Gothenburg, Sweden; [Gustafsson, Camilla] Univ Helsinki, Tvarminne Zool Stn, Hango 10900, Finland; [Hoarau, Galice] Univ Nordland, Fac Biosci & Aquaculture, N-8049 Bodo, Norway; [Hori, Masakazu] Fisheries Res Agcy, Hiroshima 7390452, Japan; [Hovel, Kevin] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Iken, Katrin] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK 99775 USA; [Nakaoka, Masahiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Akkeshi Marine Stn, Akkeshi, Hokkaido 0881113, Japan; [O'Connor, Mary I.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [O'Connor, Mary I.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Ruesink, Jennifer L.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Sotka, Erik E.] Coll Charleston, Grice Marine Lab, Charleston, SC 29412 USA; [Whalen, Matthew A.; Stachowicz, John J.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	Duffy, JE (reprint author), Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA.	duffye@si.edu	O'Connor, Mary/F-2275-2010; Eriksson, Britas Klemens/D-8601-2015; Engelen, Aschwin/M-3432-2013; 	Engelen, Aschwin/0000-0002-9579-9606; Lefcheck, Jonathan/0000-0002-8787-1786	National Science Foundation [OCE-1031061]	We thank the many staff, students, and volunteers who assisted with field and laboratory research; Jim Grace and Jarrett Byrnes for advice on structural equation modelling; Brad Cardinale and Jonathan Losos for comments that improved the MS; and the home institutions of all project partners, who provided invaluable in-kind support. Primary funding was provided by the National Science Foundation (OCE-1031061 to J.E.D.).	Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Whalen MA, 2013, ECOLOGY, V94, P510; Moksnes PO, 2008, OIKOS, V117, P763, DOI 10.1111/j.2008.0030-1299.16521.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Duffy JE, 2003, ECOL LETT, V6, P637; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; O'Connor MI, 2009, ECOLOGY, V90, P388, DOI 10.1890/08-0034.1; Hughes BB, 2013, P NATL ACAD SCI USA, V110, P15313, DOI 10.1073/pnas.1302805110; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Chao A, 2012, ECOLOGY, V93, P2533; Hughes AR, 2004, MAR ECOL PROG SER, V282, P87, DOI 10.3354/meps282087; Best RJ, 2013, ECOL LETT, V16, P72, DOI 10.1111/ele.12016; Reynolds PL, 2014, LIMNOL OCEANOGR, V59, P1053, DOI 10.4319/lo.2014.59.3.1053; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Burkholder JM, 2007, J EXP MAR BIOL ECOL, V350, P46, DOI 10.1016/j.jembe.2007.06.024; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Eriksson BK, 2009, ECOL APPL, V19, P1975, DOI 10.1890/08-0964.1; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Heck KL, 2007, ESTUAR COAST, V30, P371; Borer ET, 2014, NATURE, V508, P517, DOI 10.1038/nature13144; Shipley B, 2013, ECOLOGY, V94, P560; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Tomas F, 2011, ECOLOGY, V92, P1807, DOI 10.1890/10-2095.1; Frank KT, 2007, TRENDS ECOL EVOL, V22, P236, DOI 10.1016/j.tree.2007.03.002; Oksanen L, 2000, AM NAT, V155, P703, DOI 10.1086/303354; Baden S, 2010, LIMNOL OCEANOGR, V55, P1435, DOI 10.4319/lo.2010.55.3.1435; Duffy J. E., 2013, MARINE COMMUNITY ECO, P271; Valentine JF, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P463; EDGAR GJ, 1990, J EXP MAR BIOL ECOL, V137, P195, DOI 10.1016/0022-0981(90)90185-F; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Grace J. B., 2006, STRUCTURAL EQUATION, P1; Holt RD, 2002, MG POP BIOL, V33, P246; MATSON PA, 1992, ECOLOGY, V73, P723, DOI 10.2307/1940151; Lefcheck J. S., 2015, PEERJ PREPRINTS, V3, pe1137; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Moore KA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P361; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Olsen JL, 2013, MAR ECOL PROG SER, V486, P121, DOI 10.3354/meps10373; Paquette A., 2010, GLOBAL ECOL BIOGEOGR, V20, P170; Poore AGB, 2009, J ECOL, V97, P164, DOI 10.1111/j.1365-2745.2008.01457.x; R Core Team, 2014, R LANG ENV STAT COMP; Reusch TBH, 1999, MOL ECOL, V8, P317, DOI 10.1046/j.1365-294X.1999.00531.x; Reusch TBH, 2000, MOL ECOL, V9, P371, DOI 10.1046/j.1365-294x.2000.00874-4.x; Spivak AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007473	51	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1461-023X	1461-0248		ECOL LETT	Ecol. Lett.	JUL	2015	18	7					696	705		10.1111/ele.12448		10	Ecology	Environmental Sciences & Ecology	CL0CJ	WOS:000356606100011		
J	Sakuta, R; Takeda, K; Ishida, T; Igarashi, K; Samejima, M; Nakamura, N; Ohno, H				Sakuta, Riku; Takeda, Kouta; Ishida, Takuya; Igarashi, Kiyohiko; Samejima, Masahiro; Nakamura, Nobuhumi; Ohno, Hiroyuki			Multi-enzyme anode composed of FAD-dependent and NAD-dependent enzymes with a single ruthenium polymer mediator for biofuel cells	ELECTROCHEMISTRY COMMUNICATIONS			English	Article						Redox polymer mediator; 1,10-Phenanthroline-5,6-dione; Flavin adenine dinucleotide dependent-glucose dehydrogenase; Nicotinamide adenine dinucleotide-dependent alcohol dehydrogenase; Multi-enzyme electrode; Entrapping immobilization method	GLUCOSE-DEHYDROGENASE; ADENINE-DINUCLEOTIDE; ALCOHOL-DEHYDROGENASE; ELECTRON-TRANSFER; OXIDATION; BIOANODE; OXIDASE	A multi-enzyme electrode composed of FAD-dependent and NAD-dependent enzymes was fabricated using a poly-ruthenium complex (PAHA-Ru), which has two 1,10-phenanthroline-5,6-dione molecules as ligands. PAHA-Ru was used to immobilize FAD-dependent glucose dehydrogenase (FAD-GDH) onto an electrode and to examine PAIA-Ru containing the quinone moieties as an electron mediator. In cyclic voltammetry measurements of the FAD-GDH modified electrode in the presence of D-glucose, a catalytic current was obtained, which indicated electron transfer from FAD-GDH to PAHA-Ru. Our previous study has reported that PAHA-Ru with the quinone ligands also works as a mediator for NADH oxidation on an NAD-dependent alcohol dehydrogenase (NAD-ADH) modified electrode. Hence, FAD-GDH and NAD-ADH were co-immobilized with PAHA-Ru to make a multi-enzyme electrode. Using this multi-enzyme electrode as an anode, catalytic currents were observed in D-glucose solution, ethanol solution, and a mixed D-glucose and ethanol solution. The catalytic current in the mixed solution was greater than the currents obtained in the single substrate solutions, indicating bioelectrocatalysis reactions by the two enzymes and the single mediator in the mixed solution. Thus, we demonstrated that PAHA-Ru modified electrode enables selection of enzymes and their substrates from a wider range for enzymatic biofuel cells. (C) 2015 Elsevier B.V. All rights reserved.	[Sakuta, Riku; Takeda, Kouta; Nakamura, Nobuhumi; Ohno, Hiroyuki] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Ishida, Takuya; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Ishida, Takuya; Igarashi, Kiyohiko; Nakamura, Nobuhumi] JST ALCA, Chiyoda Ku, Tokyo 1020025, Japan	Nakamura, N (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Nakacho, Koganei, Tokyo 1848588, Japan.	nobu1@cc.tuat.ac.jp	Ohno, Hiroyuki/F-6459-2012; Nakamura, Nobuhumi/C-1972-2013	Ohno, Hiroyuki/0000-0001-9716-3495; Nakamura, Nobuhumi/0000-0002-5373-2972	Advanced Low Carbon Technology Research and Development Program; Japan Science and Technology Agency;  [268641]	This work was supported financially by the Advanced Low Carbon Technology Research and Development Program, a program from the Japan Science and Technology Agency and by a Grant-in-Aid for JSPS Fellows (Grant No. 268641 to K.T.). We would like to dedicate this article to celebrate the 20th anniversary of the Department of Biotechnology and Life Science at Tokyo University of Agriculture and Technology.	Yehezkeli O, 2011, ACS NANO, V5, P2385, DOI 10.1021/nn200313t; Xu S, 2012, ACS CATAL, V2, P91, DOI 10.1021/cs200523s; Bullen RA, 2006, BIOSENS BIOELECTRON, V21, P2015, DOI 10.1016/j.bios.2006.01.030; Tsujimura S, 2014, J AM CHEM SOC, V136, P14432, DOI 10.1021/ja5053736; Palmore GTR, 1998, J ELECTROANAL CHEM, V443, P155, DOI 10.1016/S0022-0728(97)00393-8; Tsujimura S, 2006, BIOSCI BIOTECH BIOCH, V70, P654, DOI 10.1271/bbb.70.654; Kakehi N, 2007, BIOSENS BIOELECTRON, V22, P2250, DOI 10.1016/j.bios.2006.11.004; WILLIAMS DL, 1970, ANAL CHEM, V42, P118, DOI 10.1021/ac60283a032; Cracknell JA, 2008, CHEM REV, V108, P2439, DOI 10.1021/cr0680639; Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611; Arechederra RL, 2009, FUEL CELLS, V9, P63, DOI 10.1002/fuce.200800029; Shao ML, 2013, BIOSENS BIOELECTRON, V40, P308, DOI 10.1016/j.bios.2012.07.069; Bartlett P. N., 2008, BIOELECTROCHEMISTRY; Hui TW, 1996, ELECTROANAL, V8, P597, DOI 10.1002/elan.1140080618; Lazic D.S., 2008, BIOSENS BIOELECTRON, V24, P939; Liu ZF, 2010, REACT FUNCT POLYM, V70, P715, DOI 10.1016/j.reactfunctpolym.2010.07.002; Motoyama Y, 2008, ELECTROANAL, V20, P923, DOI 10.1002/elan.200704103; Takeda K, 2013, BIOELECTROCHEMISTRY, V94, P75, DOI 10.1016/j.bioelechem.2013.08.001; Tsujimura S, 2012, BIOSENS BIOELECTRON, V34, P244, DOI 10.1016/j.bios.2012.02.013; Zafar MN, 2012, ANAL CHEM, V84, P334, DOI 10.1021/ac202647z	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1388-2481	1873-1902		ELECTROCHEM COMMUN	Electrochem. Commun.	JUL	2015	56						75	78		10.1016/j.elecom.2015.04.013		4	Electrochemistry	Electrochemistry	CL2BN	WOS:000356748700017		
J	Murakami, K; Aboshi, M; Kinoshita, K; Isshiki, M				Murakami, Kenji; Aboshi, Makoto; Kinoshita, Koji; Isshiki, Masaharu			Fast Line Detection by Hough Transform Using Inter-Image Operations	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						image analysis; line detection; Hough transform; processing in image space; voting in parameter space	VOTING SCHEME; EFFICIENT	In image analysis, it is important to detect lines (straight lines) that represent the edges of an object in the image. The most popular technique for line detection is the Hough transform. In this transform, peaks resulting in the accumulator array that are obtained through a voting procedure in the parameter space represent strong evidence that a corresponding line exists in the image. In the voting procedure, large numbers of votes that are far from the peaks are unnecessary and reduce the speed of the transform. In this paper, we propose a method to speed up this process by introducing a procedure in image space that removes lines except for limited directions. This procedure makes it possible to reduce the voting range and to remove unnecessary votes. Experimental results confirm that the proposed method performs effectively.	[Murakami, Kenji; Aboshi, Makoto; Kinoshita, Koji; Isshiki, Masaharu] Ehime Univ, Matsuyama, Ehime 790, Japan	Murakami, K (reprint author), Ehime Univ, Matsuyama, Ehime 790, Japan.				 [22500156]	This research was supported in part by 2010, 2011, and 2012 Scientific Research Grants-in-Aid (topic number 22500156).	Agui J, 1992, IMAGE PROCESSING REC; Agui T., 1987, Transactions of the Institute of Electronics, Information and Communication Engineers D, VJ70D; Gotz WA, 1995, PATTERN RECOGN, V28, P1985; Fernandes LAF, 2008, PATTERN RECOGN, V41, P299, DOI 10.1016/j.patcog.2007.04.003; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; Kiryati N, 2000, PATTERN RECOGN LETT, V21, P1157, DOI 10.1016/S0167-8655(00)00077-5; KIRYATI N, 1991, PATTERN RECOGN, V24, P303, DOI 10.1016/0031-3203(91)90073-E; BALLARD DH, 1981, PATTERN RECOGN, V13, P111, DOI 10.1016/0031-3203(81)90009-1; Bandera A, 2006, PATTERN RECOGN LETT, V27, P578, DOI 10.1016/j.patrec.2005.09.023; Chung KL, 2004, PATTERN RECOGN, V37, P953, DOI 10.1016/j.patcog.2003.09.008; Goto H., 1998, Transactions of the Institute of Electronics, Information and Communication Engineers D-II, VJ81D-II; Guo SY, 2009, PATTERN RECOGN LETT, V30, P1241, DOI 10.1016/j.patrec.2009.05.003; Hilditch C. J., 1969, LINEAR SKELETONS SQU, V4, P403; Ichikawa K, 1996, T IEICE JPN, P322; Kim E., 2001, Transactions of the Institute of Electronics, Information and Communication Engineers D-II, VJ84-II; Kimura S., 1989, Transactions of the Institute of Electronics, Information and Communication Engineers D-II, VJ72D-II; Koshimizu H., 1985, Transactions of the Institute of Electronics and Communication Engineers of Japan, Part D, VJ68D; Koshimizu H., 1989, Transactions of the Institute of Electronics, Information and Communication Engineers D-II, VJ72D-II; Minami T, 1989, IMAGE SCI TECHNOLOGY; Murakami K, 2007, T IEICE JPN D, V90, P1781; Murakami K, 2011, IC2010167 IEICE, P123; Murakami K., 2004, Transactions of the Institute of Electronics, Information and Communication Engineers D-II, VJ87D-II; Murakami K., 2000, Transactions of the Institute of Electronics, Information and Communication Engineers D-II, VJ83D-II; Murakami K, 2010, TECHN C I IM EL ENG, P29; OGORMAN F, 1976, IEEE T COMPUT, V25, P449; Onda K., 1987, Transactions of the Institute of Electronics, Information and Communication Engineers D, VJ70D; Rosenfeld A., 1969, PICTURE PROCESSING C; Suematsu R, 2000, IMAGE PROCESSING ENG; Yamato J., 1989, Transactions of the Institute of Electronics, Information and Communication Engineers D-II, VJ72D-II; Yan Jiafeng, 1992, Transactions of the Institute of Electronics, Information and Communication Engineers D-II, VJ75D-II	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	JUL	2015	98	7					1	12		10.1002/ecj.11677		12	Engineering, Electrical & Electronic	Engineering	CL1GA	WOS:000356689500001		
J	Mizuta, T; Izumi, K; Yagi, I; Yoshimura, S				Mizuta, Takanobu; Izumi, Kiyoshi; Yagi, Isao; Yoshimura, Shinobu			Investigation of Price Variation Limits, Short Selling Regulation, and Uptick Rules and Their Optimal Design by Artificial Market Simulations	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						artificial market; multi-agent simulation; price limit; short sell regulation; uptick rule		We built an artificial market model and compared the effects of price variation limits, short sell regulations, and uptick rules. When there were no regulations, the price fell below the fundamental value when economic bubble collapses occurred. When there were regulations, this overshoot did not occur and the market was more effective. However, the short sell regulations and uptick rules caused the trading prices to be higher than the base value. To summarize these points, the price variation limits have the potential to make the market more effective. We also surveyed an adequate limitation price range and an adequate limitation time span for the price variation limit and found conditions for the parameters for the price variation limit that prevent such overshoots.	[Mizuta, Takanobu] SPARX Asset Management Co Ltd, Tokyo, Japan; [Mizuta, Takanobu] Univ Tokyo, Grad Sch Engn, Doctoral Program Syst Innovat, Tokyo 1138654, Japan; [Izumi, Kiyoshi] Univ Tokyo, Grad Sch Engn, Tokyo 1138654, Japan; [Izumi, Kiyoshi] Univ Tokyo, CREST, Tokyo 1138654, Japan; [Izumi, Kiyoshi] CREST, Tokyo, Japan; [Yagi, Isao] Kanagawa Inst Technol, Fac Informat Technol, Atsugi, Kanagawa, Japan; [Yoshimura, Shinobu] Univ Tokyo, Grad Sch Engn, Quantum Syst Engn, Tokyo 1138654, Japan	Mizuta, T (reprint author), SPARX Asset Management Co Ltd, Tokyo, Japan.				Japan Science and Technology Agency CREST	This research was supported in part under the research topic "A Framework to Manage and Implement Simulations of Social Phenomena Using Massively Parallel Computers" in the Japan Science and Technology Agency CREST Research Field of "Creation of System Software Technology to Contribute to Post-Peta-Scale High-Performance Computing." The authors express their gratitude for this support. This paper does not represent the official view of SPARX Asset Management. The ideas expressed herein are those of the individual authors.	Lebaron B, 2006, HANDB ECON, V13, P1187; Cont R, 2001, QUANT FINANC, V1, P223, DOI 10.1088/1469-7688/1/2/304; Chiarella C, 2009, J ECON DYN CONTROL, V33, P525, DOI 10.1016/j.jedc.2008.08.001; Chan K., 1998, PACIFIC BASIN FINANC, V6, P125, DOI 10.1016/S0927-538X(97)00027-9; Chen SH, 2009, AGENT BASED EC MODEL; Friedman D., 1993, DOUBLE AUCTION MARKE, V14, P3; McQueen G, 1994, J FINANC QUANTIT ANA, V29; Mizuta T, 2012, J JSAI, V27, P320; Mizuta Y, 2012, P 26 C JSAI; Otsuka K., 2012, 1 TOK STOCK EXCH; Tokyo Stock Exchange, 2010, EC MIN IT JAP AW 201; Tokyo Stock Exchange, 2012, GUID TSE TRAD METH; Yagi I, 2010, EVOLUTIONARY I EC RE, V7, P113; Yagi I, 2012, J IPSJ, V53; Yagi I, 2011, J JSAI, V26, P208	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	JUL	2015	98	7					13	21		10.1002/ecj.11684		9	Engineering, Electrical & Electronic	Engineering	CL1GA	WOS:000356689500002		
J	Hashimoto, G; Fujiwara, T; Suzuki, M; Okuda, H; Ise, J; Shioya, M				Hashimoto, Gaku; Fujiwara, Takanori; Suzuki, Masaaki; Okuda, Hiroshi; Ise, Junji; Shioya, Masanori			Multi-Agent-Based Simulation of Knowledge Propagation in Organizations	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						knowledge management; multi-agent modeling; SECI model; knowledge spiral; scenario analysis		In this paper, we propose an agent model based on Nonaka's SECI model for encouraging the propagation of knowledge in organizations. In this model, the complexity of knowledge is expressed as a bit tag, and worker agents and knowledge manager agents are introduced. Parametric studies are performed on the bit tag length and on the internalization rates and communication patterns of the worker agents. We evaluate the acquisition of knowledge in order to verify the present simulation model. Furthermore, a scenario simulation is implemented with respect to employment periods for worker agents and the effectiveness of the multi-agent model is shown by means of a qualitative evaluation of knowledge variations corresponding to joining and leaving an organization.	[Hashimoto, Gaku; Fujiwara, Takanori; Suzuki, Masaaki; Okuda, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Tokyo 1138654, Japan; [Fujiwara, Takanori; Suzuki, Masaaki; Okuda, Hiroshi] Univ Tokyo, Tokyo 1138654, Japan; [Ise, Junji; Shioya, Masanori] Nippon Steel & Sumitomo Met Corp, Control Res & Dev Dept, Technol Dev Div, Tokai, Aichi, Japan	Hashimoto, G (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Tokyo 1138654, Japan.						Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Fujita S, 2007, T IEICEJ D, P52; Georgescu S, 2008, J POWER ENERGY SYSTE, V2, P1320, DOI 10.1299/jpes.2.1320; Hatakemura Y., 2006, TECHNOLOGY TRANSMISS; Hirai C, 2007, J IPSJ, V48, P16; Nonaka I., 1995, KNOWLEDGE CREATING C; Nonaka T, 1999, PROGR INTELLIGENT MA; NTT Eastern Japan Corporate Headquarters CRM/CTI implementation office, 2000, CREAT US CRM; Ono T, 2013, J IPSJ, V54, P284; Otsuka C, 2003, T IEICEJ, P17; Saito N, 2013, J IPSJ, V54, P295; Uamame S, 1998, MULTIPLE AGENTS COMP; Weiss G., 2000, MULTIAGENT SYSTEMS M	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	JUL	2015	98	7					22	33		10.1002/ecj.11685		12	Engineering, Electrical & Electronic	Engineering	CL1GA	WOS:000356689500003		
J	Ohno, Y; Shimamoto, K; Mizoguchi, T; Ohnishi, K				Ohno, Yoshiki; Shimamoto, Keita; Mizoguchi, Takahiro; Ohnishi, Kouhei			Method of Time-Delay Compensation in Multi-Degree-of-Freedom Bilateral Control Systems with Different Configurations	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						haptics; bilateral control; time delay; communication disturbance observer; work space	TELEOPERATION	In this paper, a time-delay compensation method based on a work space communication disturbance observer (WCDOB) is proposed. Time delay degrades the stability of a control system. A communication disturbance observer (CDOB) has been proposed to solve this problem. However, CDOB cannot compensate for time delay in multi-degree-of-freedom bilateral control systems with different configurations, because the inertia of the robots is not fixed. In contrast, WCDOB can estimate the time delay based on work space information and compensate for them. The experimental results confirm the validity of the proposed method.	[Ohno, Yoshiki; Shimamoto, Keita; Mizoguchi, Takahiro; Ohnishi, Kouhei] Keio Univ, Tokyo 108, Japan	Ohno, Y (reprint author), Keio Univ, Tokyo 108, Japan.				JSPS [S-25220903]	This study was supported in part by a JSPS Grant-in-Aid for Scientific Research (S-25220903 "Innovation of Unified Medicine and Engineering Platforms by Haptic Technology"), and we express our gratitude to all concerned.	Aziminejad A, 2008, IEEE T CONTR SYST T, V16, P548, DOI 10.1109/TCST.2007.908222; Chopra N, 2006, IEEE T ROBOT, V22, P861, DOI 10.1109/TRO.2006.878942; Ohnishi K, 1996, IEEE-ASME T MECH, V1, P56, DOI 10.1109/3516.491410; Imaida T, 2004, IEEE T ROBOTIC AUTOM, V20, P499, DOI 10.1109/TRA.2004.825271; ANDERSON RJ, 1989, IEEE T AUTOMAT CONTR, V34, P494, DOI 10.1109/9.24201; Lee DJ, 2006, IEEE T ROBOT, V22, P269, DOI 10.1109/TRO.2005.862637; Iida W, 2004, 8TH IEEE INTERNATIONAL WORKSHOP ON ADVANCED MOTION CONTROL, PROCEEDINGS, P217, DOI 10.1109/AMC.2004.1297669; Murakami T, 1993, IEEJ T IND APPL D, V113, P639; MURAKAMI T, 1993, IEEE T IND ELECTRON, V40, P259, DOI 10.1109/41.222648; Natori K, 2008, IEEE T IND ELECTRON, V57, P1050; Natori K, 2006, P 9 IEEE INT WORKSH, V3, P218; Natori K, 2008, IEEE T IND ELECT, V55; NIEMEYER G, 1991, IEEE J OCEANIC ENG, V16, P152, DOI 10.1109/48.64895; Smith O.J.M., 1959, ISA Journal, V6; Tian D, 2010, IECON 2010 36 ANN C, P1246, DOI 10.1109/IECON.2010.5675548; Yamashita T, 2010, IEEJ T IND APPL, V131, P777	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	JUL	2015	98	7					34	43		10.1002/ecj.11740		10	Engineering, Electrical & Electronic	Engineering	CL1GA	WOS:000356689500004		
J	Murakami, I; Mori, Y; Aikawa, N				Murakami, Ikuya; Mori, Yukio; Aikawa, Naoyuki			An L-1-Approximation for the Design of FIR Digital Filters with Complex Coefficients	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						FIR digital filter; L-1 norm; complex coefficients; differentiability; Newton's method	LINEAR-PHASE; CHEBYSHEV-APPROXIMATION; GIBBS PHENOMENON	In this paper, we propose an L-1-approximation for the design of FIR digital filters with complex coefficients. The L-1-approximation has the advantage of having a flatter passband and a small overshoot around the discontinuity point as compared with the L-2-approximation and L-approximation. As the obtained filter has complex coefficients, it is possible to reduce group delay and to design a digital filter with a asymmetric amplitude characteristic with respect to the origin. The algorithm proposed in this paper is based on Newton's method, which is an efficient iterative approximation algorithm. We show the effectiveness of the proposed method through a design example.	[Murakami, Ikuya; Aikawa, Naoyuki] Tokyo Univ Sci, Tokyo 162, Japan; [Mori, Yukio] Salesian Polytech, Tokyo, Japan	Murakami, I (reprint author), Tokyo Univ Sci, Tokyo 162, Japan.						Adams J. W., 1991, IEEE T CIRCUITS SYST, V39, P376; Aikawa N., 2000, Transactions of the Institute of Electronics, Information and Communication Engineers A, VJ83-A; PARKS TW, 1972, IEEE T CIRCUITS SYST, VCT19, P189, DOI 10.1109/TCT.1972.1083419; Antoniou A., 2007, PRACTICAL OPTIMIZATI; Bastys A, 2003, IEEE IMAGE PROC, P1017; BURRUS CS, 1994, IEEE T SIGNAL PROCES, V42, P2926, DOI 10.1109/78.330353; Fukae S., 1997, Transactions of the Institute of Electronics, Information and Communication Engineers A, VJ80-A; Grossmann LD, 2007, IEEE T SIGNAL PROCES, V55, P5253, DOI 10.1109/TSP.2007.896088; KARAM LJ, 1995, IEEE T CIRCUITS-II, V42, P207, DOI 10.1109/82.372870; Kidambi SS, 1996, IEEE T SIGNAL PROCES, V44, P710, DOI 10.1109/78.489045; LIM YC, 1983, IEEE T CIRCUITS SYST, V30, P723; MOSKONA E, 1995, CONSTR APPROX, V11, P391, DOI 10.1007/BF01208562; Okuda M, 1998, IEEE T SIGNAL PROCES, V46, P1485, DOI 10.1109/78.678462; PEI SC, 1993, IEEE T CIRCUITS-II, V40, P32, DOI 10.1109/82.215358; Rice JR, 1964, APPROXIMATION FUNCTI; STEIGLITZ K, 1981, IEEE T ACOUST SPEECH, V29, P171, DOI 10.1109/TASSP.1981.1163537	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	JUL	2015	98	7					44	52		10.1002/ecj.11747		9	Engineering, Electrical & Electronic	Engineering	CL1GA	WOS:000356689500005		
J	Kato, T; Saitoh, F				Kato, Tetsuya; Saitoh, Fumihiko			Upgradation of Ultralow-Gradation Images by Using Spatial Features	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						spatial features; low-gradation image; upgradation; tone restoration		This paper proposes a method that obtains high-tone images from ultra-low-tone image by using spatial features. Areas are smoothed when the adjacent tone value of the area of interest is continuous, but areas are saved as edges when the adjacent tone value of the area of interest is discontinuous. Thus the area of interest can be classified into six patterns by area. Low-gradation images are changed into high-gradation images by processing with each pattern. Comparative experiments indicated that the proposed method was quantitatively and visually better than existing methods. The proposed method can change ultra-low-tone images into naturally high-gradation images.	[Kato, Tetsuya; Saitoh, Fumihiko] Gifu Univ, Gifu, Japan	Kato, T (reprint author), Gifu Univ, Gifu, Japan.						Fujiwara T, 2010, IEEJ T, V130, P1597; Hashii H, 2010, IEICE SIS, V109, P33; Ishii A, 2008, MACHINE VISION, P88; Kawai N, 2007, FIT, V6, P245; Koshimizu H, 2003, IEICE PRMU, V103, P31; Kubo T, 2009, ITE, V33, P23; Nishihara S, 1984, IPS, V25, P321; Reinhard E., 2005, HIGH DYNAMIC RANGE I; Suzuki R, 2007, IEICE CAS, V107, P31; Tanaka M, 2011, JSPE, V77, P1099	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	JUL	2015	98	7					53	62		10.1002/ecj.11748		10	Engineering, Electrical & Electronic	Engineering	CL1GA	WOS:000356689500006		
J	Hayashi, S; Komoda, N				Hayashi, Shinichi; Komoda, Norihisa			Evaluation of Volume Tiering Method and SSD Cache Method in Tiered Storage System	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						tiered storage; volume tiering method; SSD cache method; I/O response time; SSD		We evaluated the storage I/O response time with the volume tiering method and the SSD cache method on tiered storage having SSD and HDD. The simulation results show that the volume tiering method improves the storage performance with low I/O locality workload and small SSD capacity. The SSD cache method is effective with read-intensive and high I/O locality workloads. Utilizing both methods simultaneously reduces the storage I/O response time by up to 20% with write-intensive workloads and large SSD capacity compared to using the volume tiering method or the SSD cache method separately.	[Hayashi, Shinichi] Hitachi Ltd, Tokyo, Japan; [Komoda, Norihisa] Osaka Univ, Fac Engn, Suita, Osaka 565, Japan	Hayashi, S (reprint author), Hitachi Ltd, Tokyo, Japan.						Chen Feng, 2011, P INT C SUP, P22, DOI DOI 10.1145/1995896.1995902; Cooper Brian F., 2008, P VLDB ENDOW, V1, P1277; Dawkins Scott, 2012, Operating Systems Review, V46; DeCandia G, 2007, P 21 ACM SIGOPS S OP, V41, P205; EMC Corporation, 2012, FULL AUT STOR TIER V; Faibish S, 2010, P 3 ANN HAIF EXP SYS, V3; Hewlett-Packard Development Company, 2012, HP 3PAR AD OPT SOFTW; Horiuchi Y., 2012, IDEMA JAPAN NEWS 201, V106, P1; Oe K, 2012, 1 IPSJ SIG, P1; Schmidt G, 2012, IBM SYSTEM STORAGE D; Strunk John D., 2012, Operating Systems Review, V46; Sukigara T, 2011, HITACHI HYORON, V93, P44; Takahashi N, 2003, PERFORMANCE INPR D 1, VJ86-D-I, P375	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	JUL	2015	98	7					63	70		10.1002/ecj.11749		8	Engineering, Electrical & Electronic	Engineering	CL1GA	WOS:000356689500007		
J	Itakura, H; Kaino, T; Miyake, Y; Kitagawa, T; Kimura, S				Itakura, Hikaru; Kaino, Tsubasa; Miyake, Yoichi; Kitagawa, Takashi; Kimura, Shingo			Feeding, condition, and abundance of Japanese eels from natural and revetment habitats in the Tone River, Japan	ENVIRONMENTAL BIOLOGY OF FISHES			English	Article						Anguilla japonica; Shoreline revetment; Habitat degradation; Diet; Biodiversity; Eel conservation	FRESH-WATER EELS; PHASE AMERICAN EELS; NORTH EQUATORIAL CURRENT; ANGUILLA-JAPONICA; EUROPEAN EEL; LARVAL TRANSPORT; NEW-ZEALAND; SMALL STREAM; NEW-YORK; EL-NINO	The rivers and lakes of Japan have had a wide range of shoreline modifications for flood control and stabilization, but the effects of this on the ecology of Japanese eels, Anguilla japonica, is not known. To clarify possible effects of riverbank modifications on yellow-phase Japanese eels in the lower Tone River, Japan, the abundance, condition factor and stomach contents were investigated using 586 eels collected in both revetment and natural shore areas at four sites. Eel abundances and their condition factors were higher in the natural shore areas than those of revetment areas at the three freshwater sites, and the smallest sizes of eels appeared to prefer the natural areas at all sites. The number of feeding eels, their food consumption, and the diversity of consumed prey were also generally greater in the natural shore areas than in the revetment areas. Other differences in diet were observed, such as terrestrial oligochaetes only being eaten by eels at the freshwater river natural shore areas and bivalves being eaten more in the revetment areas of those sites. In contrast, in the brackish habitat eels appeared to be less affected by concrete revetment with wave-dissipating tetrapod blocks. The range of differences found between the freshwater sampling areas suggest that revetment shorelines are used less by eels, particularly smaller eels, when natural shore areas are available, and eels that live near revetment have a lower abundance and diversity of prey to feed on.	[Itakura, Hikaru; Kaino, Tsubasa; Miyake, Yoichi; Kitagawa, Takashi; Kimura, Shingo] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Itakura, H (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778564, Japan.	itakura09a@nenv.k.u-tokyo.ac.jp			River Fund in charge of the Foundation of River and Watershed Environment Management (FOREM) in Japan; Futaba Electronics Memorial Foundation	This study was supported in part by the River Fund in charge of the Foundation of River and Watershed Environment Management (FOREM) in Japan, and was also supported in part by the Futaba Electronics Memorial Foundation. M.J. Miller helped to improve the manuscript. This study followed the animal experimental use guidelines of The University of Tokyo.	Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; KIMURA S, 1994, MAR BIOL, V119, P185, DOI 10.1007/BF00349555; Oliveira K, 1997, T AM FISH SOC, V126, P638, DOI 10.1577/1548-8659(1997)126<0638:MAGROY>2.3.CO;2; Krueger WH, 1999, ENVIRON BIOL FISH, V55, P381, DOI 10.1023/A:1007575600789; Yokouchi K, 2012, ESTUAR COAST SHELF S, V107, P132, DOI 10.1016/j.ecss.2012.05.009; Roncarati A, 1997, J APPL ICHTHYOL, V13, P131, DOI 10.1111/j.1439-0426.1997.tb00112.x; Miller MJ, 2009, AM FISH S S, V69, P231; HELFMAN GS, 1983, T AM FISH SOC, V112, P105, DOI 10.1577/1548-8659(1983)112<105:UTOAEM>2.0.CO;2; Haro A, 2000, FISHERIES, V25, P7, DOI 10.1577/1548-8446(2000)025<0007:PDOTAE>2.0.CO;2; Davidson D, 2010, J FISH BIOL, V76, P913, DOI 10.1111/j.1095-8649.2010.02546.x; Ward JV, 1999, REGUL RIVER, V15, P125, DOI 10.1002/(SICI)1099-1646(199901/06)15:1/3<125::AID-RRR523>3.0.CO;2-E; Nakamura K, 2006, BIOSCIENCE, V56, P419, DOI 10.1641/0006-3568(2006)056[0419:RAWRLF]2.0.CO;2; Machut LS, 2007, T AM FISH SOC, V136, P1699, DOI 10.1577/T06-140.1; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Han YS, 2009, ZOOL STUD, V48, P632; FORD TE, 1986, ENVIRON BIOL FISH, V17, P309, DOI 10.1007/BF00001497; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; FAUSCH KD, 1992, CAN J FISH AQUAT SCI, V49, P682, DOI 10.1139/f92-077; Kaifu K, 2013, ENVIRON BIOL FISH, V96, P439, DOI 10.1007/s10641-012-0027-0; Okamura A, 2007, ENVIRON BIOL FISH, V80, P77, DOI 10.1007/s10641-006-9121-5; Wolter C, 2001, LANDSCAPE URBAN PLAN, V53, P135, DOI 10.1016/S0169-2046(00)00147-X; LABAR GW, 1987, ENVIRON BIOL FISH, V19, P111, DOI 10.1007/BF00001881; Hedger RD, 2010, J FISH BIOL, V76, P1294, DOI 10.1111/j.1095-8649.2010.02561.x; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; Feunteun E, 2002, ECOL ENG, V18, P575, DOI 10.1016/S0925-8574(02)00021-6; LAMMENS EHRR, 1985, CAN J FISH AQUAT SCI, V42, P1342, DOI 10.1139/f85-169; Kimura S, 2001, FISH OCEANOGR, V10, P51, DOI 10.1046/j.1365-2419.2001.00159.x; Usuda H, 2012, LANDSC ECOL ENG, V8, P9, DOI 10.1007/s11355-010-0136-x; TZENG WN, 1995, J FISH BIOL, V46, P183, DOI 10.1111/j.1095-8649.1995.tb05961.x; Yokouchi K, 2008, ECOL FRESHW FISH, V17, P639, DOI 10.1111/j.1600-0633.2008.00315.x; Tsukamoto K, 2001, MAR ECOL PROG SER, V220, P265, DOI 10.3354/meps220265; Zenimoto K, 2009, J FISH BIOL, V74, P1878, DOI 10.1111/j.1095-8649.2009.02295.x; LECREN ED, 1951, J ANIM ECOL, V20, P201; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Tsukamoto K, 2009, J FISH BIOL, V74, P1833, DOI 10.1111/j.1095-8649.2009.02242.x; Yoshimura C, 2005, RIVER RES APPL, V21, P93, DOI 10.1002/rra.835; Tsukamoto Katsumi, 2009, P21; MOORE KMS, 1988, T AM FISH SOC, V117, P162, DOI 10.1577/1548-8659(1988)117<0162:ROYOTY>2.3.CO;2; Tsukamoto K, 1998, NATURE, V396, P635, DOI 10.1038/25264; Cooke Steven J., 2012, Endangered Species Research, V17, P179, DOI 10.3354/esr00426; Kim H, 2007, ICES J MAR SCI, V64, P1387, DOI 10.1093/icesjms/fsm091; Bouchereau JL, 2009, CAH BIOL MAR, V50, P319; Morrison WE, 2003, CAN J FISH AQUAT SCI, V60, P1487, DOI 10.1139/F03-129; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; Aoyama J, 2005, J FISH BIOL, V67, P1534, DOI 10.1111/j.1095-8649.2005.00860.x; Aoyama J, 2002, HYDROBIOLOGIA, V470, P31, DOI 10.1023/A:1015604906154; Baras E, 1998, HYDROBIOLOGIA, V372, P187, DOI 10.1023/A:1017072213791; BEUMER JP, 1979, J FISH BIOL, V14, P573; Buchanan BP, 2014, RIVER RES APPL, V30, P245, DOI 10.1002/rra.2639; Casselman MJ, 2003, EEL BIOL, P255; CHISNALL BL, 1993, NEW ZEAL J MAR FRESH, V27, P333; Dekker W, 2003, FISHERIES, V28, P28, DOI DOI 10.1577/1548-8446-28-12; DeLeo GA, 1996, ECOL APPL, V6, P1281; DENONCOURT CE, 1993, AM MIDL NAT, V129, P301, DOI 10.2307/2426511; Dorner H, 2009, J FISH BIOL, V74, P2115, DOI 10.1111/j.1095-8649.2009.02289.x; Fukuda N, 2013, FISHERIES SCI, V79, P425, DOI 10.1007/s12562-013-0621-x; Han YS, 2003, AQUACULTURE, V219, P783, DOI 10.1016/S0044-8486(02)00578-1; Han YS, 2007, MAR ECOL PROG SER, V338, P193, DOI 10.3354/meps338193; Holmgren K, 1996, J FISH BIOL, V49, P910, DOI 10.1111/j.1095-8649.1996.tb00089.x; Itakura H, 2015, LANDSC ECOL ENG, V11, P147, DOI 10.1007/s11355-014-0252-0; JELLYMAN DJ, 1989, NEW ZEAL J MAR FRESH, V23, P1; Jellyman DJ, 2003, ENVIRON BIOL FISH, V66, P143, DOI 10.1023/A:1023691604088; Kaifu K, 2013, ECOL FRESHW FISH, V22, P127, DOI 10.1111/eff.12010; Kaifu K, 2010, ENVIRON BIOL FISH, V88, P273, DOI 10.1007/s10641-010-9640-y; Kanazawa Koji, 2006, Ecology and Civil Engineering, V9, P141, DOI 10.3825/ece.9.141; Kawakami Y, 1999, B MAR SCI, V64, P315; Kimura S, 1999, MAR ECOL PROG SER, V186, P303, DOI 10.3354/meps186303; Krebs CJ, 1998, ECOLOGICAL METHODOLO; Kusakabe T, 2005, NIPPON SUISAN GAKK, V71, P594, DOI 10.2331/suisan.71.594; LaBar GW, 1983, T AM FISH SOC, V112, P114; Michel Pascal, 1995, Cybium, V19, P5; Mikami S, 2011, FISHERIES SCI, V78, P113; Ministry of Agriculture Forestry and Fisheries, 1954, ANN REP CATCH STAT F; Morrison WE, 2004, T AM FISH SOC, V133, P896, DOI 10.1577/T02-100.1; Nakano D, 2008, LANDSC ECOL ENG, V4, P63, DOI 10.1007/s11355-008-0038-3; Nihira A, 2006, J IBARAGI INL WAT FI, V40, P55; Onikura N, 2007, J JPN SOC WATER ENV, V30, P277, DOI DOI 10.2965/JSWE.30.277; Osugi Tomonori, 2007, Landscape and Ecological Engineering, V3, P159, DOI 10.1007/s11355-007-0023-2; PIANKA E. R., 1973, ANNU REV ECOL SYST, V4, P53, DOI DOI 10.1146/ANNUREV.ES.04.110173.000413; Shimatani Y, 1994, SUIKOUGAKU RONBUNSHU, V38, P337; SLOANE RD, 1984, AUST J MAR FRESH RES, V35, P325; Strayer DL, 2012, AQUAT SCI, V74, P597, DOI 10.1007/s00027-012-0252-9; TAKAHASHI G, 1984, Japanese Journal of Limnology, V45, P178; Takahasi Y, 2004, GLOBAL ENVIRON CHANG, V14, P63, DOI 10.1016/j.gloenvcha.2003.11.005; Taniguchi Yoshinori, 2001, Aquatic Ecosystem Health & Management, V4, P357, DOI 10.1080/146349801317276035; Tatsukawa K, 2003, EEL BIOLOGY, P293; Tesch F. -W, 2003, EEL BIOL MANAGEMENT; Tesch FW, 1968, METHODS ASSESSMENT F, P93; Tomie JPN, 2013, AQUAT BIOL, V19, P287, DOI 10.3354/ab00538; TSUKAMOTO K, 1990, J FISH BIOL, V36, P659; Tzeng WN, 2002, MAR ECOL PROG SER, V245, P213, DOI 10.3354/meps245213; Van Liefferinge C, 2012, J APPL ICHTHYOL, V28, P572, DOI 10.1111/j.1439-0426.2012.01963.x; Verreault G, 2004, HABITAT LOSSES ANTHR; Wasserman RJ, 2012, AFR J AQUAT SCI, V37, P347, DOI 10.2989/16085914.2012.692320	95	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0378-1909	1573-5133		ENVIRON BIOL FISH	Environ. Biol. Fishes	JUL	2015	98	8					1871	1888		10.1007/s10641-015-0404-6		18	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	CK7VH	WOS:000356442100002		
J	Yamanaka, T; Cullinane, A; Gildea, S; Bannai, H; Nemoto, M; Tsujimura, K; Kondo, T; Matsumura, T				Yamanaka, T.; Cullinane, A.; Gildea, S.; Bannai, H.; Nemoto, M.; Tsujimura, K.; Kondo, T.; Matsumura, T.			The potential impact of a single amino-acid substitution on the efficacy of equine influenza vaccines	EQUINE VETERINARY JOURNAL			English	Article						horse; equine influenza; cross-neutralisation; equine antisera; vaccine update	VIRUS HEMAGGLUTININ; GENETIC EVOLUTION; H3N8; OUTBREAK; HORSES; SURVEILLANCE; VACCINATION; EPIDEMIC; IRELAND; NUMBER	Reasons for performing studyThe protection induced by an equine influenza (EI) vaccine strain depends on its antigenic relatedness to the challenge virus. Although the World Organisation for Animal Health (OIE) recommend that both Florida sublineage clade 1 (Fc1) and clade 2 (Fc2) viruses should be included in EI vaccines, Japanese EI vaccines have not, thus far, been updated to include a Fc2 virus. ObjectivesTo evaluate the efficacy of antibodies raised against Japanese EI vaccine strains in the neutralisation of recent Fc2 viruses. Study designAntigenic analysis. MethodsVirus neutralisation tests were performed using antisera from experimentally infected horses and from horses that had received a primary course of the currently available vaccines. ResultsAntiserum raised against the Japanese EI vaccine strain, A/equine/La Plata/1993, exhibited poor cross-neutralising activity against the Fc2 viruses isolated recently in Ireland and the UK, which have the substitution of alanine to valine at position 144 in antigenic site A of the haemagglutinin gene. In contrast, the antiserum exhibited good cross-neutralising activity against the Fc2 viruses without the substitution. This finding was supported in experiments with antisera collected from vaccinated horses. ConclusionsThis suggests that the efficacy of the Japanese EI vaccine for some of the recent Fc2 viruses is suboptimal and that vaccines should be updated in accordance with the OIE recommendations.	[Yamanaka, T.; Bannai, H.; Nemoto, M.; Tsujimura, K.; Kondo, T.; Matsumura, T.] Japan Racing Assoc, Equine Res Inst, Epizoot Res Ctr, Shimotsuke, Japan; [Cullinane, A.; Gildea, S.] Irish Equine Ctr, Virol Unit, Kildare, Johnstown Naas, Ireland	Yamanaka, T (reprint author), Japan Racing Assoc, Equine Res Inst, Epizoot Res Ctr, Shimotsuke, Japan.	yamanaka@epizoo.equinst.go.jp			Japan Racing Association; Department of Agriculture, Food and the Marine, Ireland	This study was funded by the Japan Racing Association. Irish viruses were collected and characterised as part of the EI surveillance programme funded by the Department of Agriculture, Food and the Marine, Ireland.	Motoshima M, 2011, ARCH VIROL, V156, P1379, DOI 10.1007/s00705-011-1000-5; Gildea S, 2012, EQUINE VET J, V44, P387, DOI 10.1111/j.2042-3306.2011.00472.x; ADA GL, 1986, CURR TOP MICROBIOL, V128, P1; Bryant NA, 2009, VET MICROBIOL, V138, P41, DOI 10.1016/j.vetmic.2009.03.004; Cullinane A, 2010, INFLUENZA OTHER RESP, V4, P339, DOI 10.1111/j.1750-2659.2010.00176.x; WEBSTER RG, 1992, MICROBIOL REV, V56, P152; Bryant NA, 2011, VET MICROBIOL, V147, P19, DOI 10.1016/j.vetmic.2010.05.040; Gildea S, 2013, INFLUENZA OTHER RESP, V7, P61, DOI 10.1111/irv.12192; Newton JR, 2006, VET REC, V158, P185; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Lewis NS, 2011, J VIROL, V85, P12742, DOI 10.1128/JVI.05319-11; Yamanaka T, 2008, J VET MED SCI, V70, P623, DOI 10.1292/jvms.70.623; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Paillot R, 2006, VACCINE, V24, P4047, DOI 10.1016/j.vaccine.2006.02.030; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.immunol.8.1.737; Lai ACK, 2001, ARCH VIROL, V146, P1063, DOI 10.1007/s007050170106; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Cooke G, 2013, EQUINE VET J, V45, P770, DOI 10.1111/evj.12151; Daly JM, 2010, VET J, V189, P7; Guthrie AJ, 1999, REV SCI TECH OIE, V18, P179; Imagawa Hiroshi, 1997, Journal of Equine Science, V8, P1, DOI 10.1294/jes.8.1; Lai ACK, 2004, VIRUS RES, V100, P159, DOI 10.1016/j.virusres.2003.11.019; Martella V, 2007, VET MICROBIOL, V121, P56, DOI 10.1016/j.vetmic.2006.11.017; OIE, 2011, B OIE; OIE, 2010, B OIE; OIE, 2012, B OIE; OIE, 2013, B OIE; Qi T, 2010, ARCH VIROL, V155, P1425, DOI 10.1007/s00705-010-0724-y; Satou K, 2006, J EQUINE VET SCI, V26, P310, DOI 10.1016/j.jevs.2006.05.003; Watson J, 2011, REV SCI TECH OIE, V30, P87; WEBSTER RG, 1980, VIROLOGY, V104, P139, DOI 10.1016/0042-6822(80)90372-4; Woodward AL, 2014, VET MICROBIOL, V169, P113, DOI 10.1016/j.vetmic.2013.11.039; Yamanaka T, 2008, J VET MED SCI, V70, P189, DOI 10.1292/jvms.70.189; Yamanaka T, 2006, J VET MED SCI, V68, P923, DOI 10.1292/jvms.68.923; Yamanaka T, 2011, J VET MED SCI, V73, P483, DOI 10.1292/jvms.10-0408; Yamanaka T, 2012, VET J, V193, P358, DOI 10.1016/j.tvjl.2012.01.005	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0425-1644	2042-3306		EQUINE VET J	Equine Vet. J.	JUL	2015	47	4					456	462		10.1111/evj.12290		7	Veterinary Sciences	Veterinary Sciences	CK7TR	WOS:000356436700015		
J	Chung, S; Suzaki, H; Kasai, A; Nakata, H				Chung, Sangdeok; Suzaki, Hirokazu; Kasai, Akihide; Nakata, Hideaki			The Response of Fish Communities to Climate and Human-Induced Changes Inferred from Fishery Landings in an Enclosed Bay	ESTUARIES AND COASTS			English	Article						Fish community; Enclosed bay; Climate variability; Human impacts; Hypoxia; Habitat degradation	SARDINE SARDINOPS-MELANOSTICTUS; TSUSHIMA WARM CURRENT; LONG-TERM TRENDS; JAPANESE SARDINE; JAPAN/EAST SEA; REGIME SHIFT; SEMIENCLOSED SEAS; MARINE ECOSYSTEMS; RIVER ESTUARY; TOKYO BAY	Variations in the fish community structure in Omura Bay, an enclosed bay in the East China Sea, were investigated using long-term fishery landing data over the past five decades (1965-2006). We confirmed that the fish community structure in Omura Bay showed three conspicuous regimes during the study period. Anchovies dominated in the pelagic domain with abundant and various demersal fish species in the first phase (1965-1978). Demersal fish declined remarkably with the dominance of sardines in the pelagic domain during the second phase (1979-1987), and the fish community was simplified with the return of anchovies and no recovery of demersal fish in the third phase (1988-2006). These changes were significantly related with periodic large-scale climate changes and cumulative regional-scale human impacts. The replacement of sardine/anchovy caused by a climate regime shift in the North Pacific contributed to the fish community regime shifts in Omura Bay. Moreover, habitat degradation such as depletion of dissolved oxygen combined with climate-induced changes in food web systems resulted in a rapid reduction in demersal fish. Contraction of the habitat volume due to an increase in oxygen-restricted water simplified the fish community structure and eventually reduced fishery landings in Omura Bay. These findings demonstrate that long-term fish community responses to large-scale climate changes and regional-scale human impacts can be observed in a coastal enclosed bay, providing useful information for fisheries management in areas with climate and human-induced changes.	[Chung, Sangdeok; Suzaki, Hirokazu; Nakata, Hideaki] Nagasaki Univ, Grad Sch Sci & Technol, Nagasaki 8528521, Japan; [Kasai, Akihide] Kyoto Univ, Field Sci Educ & Res Ctr, Sakyo Ku, Kyoto 6068502, Japan	Chung, S (reprint author), Nagasaki Univ, Grad Sch Sci & Technol, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	codchung@gmail.com			Japan Society for the Promotion of Science [22248022]	This study was supported in part by a grant-in-aid for scientific research (No. 22248022) from the Japan Society for the Promotion of Science. We thank Dr. K. Abo at the National Research Institute of Aquaculture, Fisheries Research Agency, for providing the Omura Bay temperature data.	An Young Su, 2012, Korean Journal of Fisheries and Aquatic Sciences, V45, P76; Breitburg DL, 2009, ANNU REV MAR SCI, V1, P329, DOI 10.1146/annurev.marine.010908.163754; Olsson J, 2012, ICES J MAR SCI, V69, P961, DOI 10.1093/icesjms/fss072; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Pauly D, 2001, CAN J FISH AQUAT SCI, V58, P51, DOI 10.1139/cjfas-58-1-51; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Collie JS, 2008, CAN J FISH AQUAT SCI, V65, P1352, DOI 10.1139/F08-048; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Moreno JID, 2000, ICES J MAR SCI, V57, P1091, DOI 10.1006/jmsc.2000.0705; Hollowed AB, 2001, PROG OCEANOGR, V49, P257, DOI 10.1016/S0079-6611(01)00026-X; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Pauly D, 2005, B MAR SCI, V76, P197; Lehodey P, 2006, J CLIMATE, V19, P5009, DOI 10.1175/JCLI3898.1; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Eby LA, 2005, MAR ECOL PROG SER, V291, P249, DOI 10.3354/meps291249; Takeshige A, 2013, FISHERIES SCI, V79, P989, DOI 10.1007/s12562-013-0672-z; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Yatsu A, 2005, FISH OCEANOGR, V14, P263, DOI 10.1111/j.1365-2419.2005.00335.x; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Rodionov S, 2005, ICES J MAR SCI, V62, P328, DOI 10.1016/j.icesjms.2005.01.013; Caddy JF, 2000, ICES J MAR SCI, V57, P628, DOI 10.1006/jmsc.2000.0739; Izsak J, 2000, ECOL MODEL, V130, P151, DOI 10.1016/S0304-3800(00)00203-9; Genner MJ, 2004, P ROY SOC B-BIOL SCI, V271, P655, DOI 10.1098/rspb.2003.2651; Ohshimo S, 2009, FISH OCEANOGR, V18, P346, DOI 10.1111/j.1365-2419.2009.00516.x; Akamatsu T, 2010, MAR BIOL, V157, P1879, DOI 10.1007/s00227-010-1459-8; Eby LA, 2002, CAN J FISH AQUAT SCI, V59, P952, DOI 10.1139/F02-067; Takeshige A, 2013, CONT SHELF RES, V66, P73, DOI 10.1016/j.csr.2013.07.010; Cowan JH, 2012, MAR COAST FISH, V4, P496, DOI 10.1080/19425120.2012.690825; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Mueter FJ, 2009, PROG OCEANOGR, V81, P93, DOI 10.1016/j.pocean.2009.04.018; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Ishii Mitsuhiro, 2008, Bulletin of the Japanese Society of Fisheries Oceanography, V72, P189; Seitz RD, 2009, J EXP MAR BIOL ECOL, V381, pS4, DOI 10.1016/j.jembe.2009.07.004; Azeta M, 1981, GYOGYOU SHIGEN KENKY, V22, P7; Chiba S, 2005, FISH OCEANOGR, V14, P401, DOI 10.1111/j.1365-2419.2005.00355.x; Cloern J. E., 2012, REV GEOPHYS, V50, P1; Hinrichsen HH, 2011, ICES J MAR SCI, V68, P2019, DOI 10.1093/icesjms/fsr145; Hiyama Y, 1995, RES POPUL ECOL, V37, P177, DOI 10.1007/BF02515818; Huh S, 1999, KOR J ICHTHYOL, V11, P191; Iizuka S., 1989, ENGAN KAIYO KENKYU, V26, P75; Inda-Diaz EA, 2010, J PLANKTON RES, V32, P1241, DOI 10.1093/plankt/fbq051; Kindt R., 2014, PACKAGE BIODIVERSITY; Kodama K, 2011, MAR POLLUT BULL, V63, P215, DOI 10.1016/j.marpolbul.2011.04.022; Kurota H., 2011, MARINE FISHERIES STO, P785; O'Connor MP, 2012, MAR COAST FISH, V4, P327, DOI 10.1080/19425120.2012.675970; Oksanen J., 2009, THE VEGAN PACKAGE; Oksanen J., 2013, MULTIVARIATE ANAL EC; Oksanen J, 2013, VEGAN ECOLOGICAL DIV; Renyi A., 1961, P 4 BERK S MATH STAT, V1, P547; Rodionov SN, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019448; Sakuramoto Kazumi, 2010, Bulletin of the Japanese Society of Fisheries Oceanography, V74, P88; Schwartzlose R.A., 1999, S AFRICAN J MARINE S, V21, P1999; Tanaka H., 2010, MARINE FISHERIES STO, P61; Tatara K, 1964, B NAIKAI REGIONAL FI, V22, P1; Tian YJ, 2008, PROG OCEANOGR, V77, P127, DOI 10.1016/j.pocean.2008.03.007; Tian YJ, 2006, PROG OCEANOGR, V68, P217, DOI 10.1016/j.pocean.2006.02.009; TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223; Tsujita T, 1953, J OCEANOGR SOC JAPAN, V9, P23; Zhang CI, 2004, PROG OCEANOGR, V61, P245, DOI 10.1016/j.pocean.2004.06.009	61	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1559-2723	1559-2731		ESTUAR COAST	Estuaries Coasts	JUL	2015	38	4					1365	1375		10.1007/s12237-014-9884-4		11	Environmental Sciences; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	CL0AP	WOS:000356601100022		
J	Lin, TH; Akamatsu, T; Chou, LS				Lin, Tzu-Hao; Akamatsu, Tomonari; Chou, Lien-Siang			Seasonal Distribution of Indo-Pacific Humpback Dolphins at an Estuarine Habitat: Influences of Upstream Rainfall	ESTUARIES AND COASTS			English	Article						Sousa chinensis; Seasonal distribution; River discharge; Echolocation; Ambient noise; Eastern Taiwan Strait	BOTTLE-NOSED DOLPHINS; PEARL RIVER ESTUARY; SOUSA-CHINENSIS; WATER-QUALITY; FLORIDA BAY; PORPOISES; ABUNDANCE; PATTERNS; PHYTOPLANKTON; SALINITY	River estuaries are dynamic regions that are influenced by the interactions between freshwater and seawater as well as seasonal variations in river runoffs. Studies focusing on the distribution of Indo-Pacific humpback dolphins (Sousa chinensis) have indicated their general tendency toward estuarine habitats. The seasonal activities of humpback dolphins are likely to synchronize with environmental fluctuations. This study investigated the effects of seasonal changes in river runoffs on the distribution gradient of humpback dolphins by deploying acoustic data loggers along the Xin Huwei River estuary, Western Taiwan, between July 2009 and September 2012. Seasonal shifts were observed in the areas with high detected duration of humpback dolphins, which mainly stayed near the river mouth during the dry seasons but moved seaward during rainy seasons and following heavy rainfall. In addition, the gradient of ambient ultrasonic pulses, dominated by snapping shrimp sounds, exhibited regional differences following heavy rainfall. The outward movements of the humpback dolphins and the snapping shrimp sounds in the estuary indicated a temporary trophic-system shift in response to local environmental changes resulting from high volumes of river runoffs. In the future, the seasonal variation in the distribution of humpback dolphins must be considered during the conservation management of this critically endangered population.	[Lin, Tzu-Hao; Chou, Lien-Siang] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10617, Taiwan; [Akamatsu, Tomonari] Fisheries Res Agcy, Natl Res Inst Fisheries Engn, Kamisu, Ibaraki 3140408, Japan; [Akamatsu, Tomonari] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Chou, LS (reprint author), Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	chouls@ntu.edu.tw			Formosa Plastics Group; Forestry Bureau; Council of Agriculture Executive Yuan of Taiwan [100-FD-07.1-C-37]; Ministry of Science and Technology of Taiwan [MOST 103-3113-E-002-013-]; Research and Development Program for New Bio-industry Initiatives of Japan	This study was supported by the Formosa Plastics Group, Forestry Bureau, Council of Agriculture Executive Yuan of Taiwan (100-FD-07.1-C-37), Ministry of Science and Technology of Taiwan (MOST 103-3113-E-002-013-), and Research and Development Program for New Bio-industry Initiatives of Japan. We thank the Tainan Hydraulics Laboratory at National Cheng Kung University and the Industrial Development Bureau of the Ministry of Economic Affairs, Taiwan for allowing us to access the fixed pile at the Xin Huwei River estuary. We appreciate Li-Cing Mei, Long-Jhen Lin, Siou-Syong Wu, and the members of the Cetacean Laboratory, National Taiwan University for their dedicated support in conducting the field surveys of the Indo-Pacific humpback dolphins off the west coast of Taiwan. We also thank Shiang-Lin Huang for improving the quality of this manuscript.	Parra GJ, 2006, J ANIM ECOL, V75, P862, DOI 10.1111/j.1365-2656.2006.01104.x; Dong LX, 2004, CONT SHELF RES, V24, P1761, DOI 10.1016/j.csr.2004.06.006; Verfuss UK, 2007, J MAR BIOL ASSOC UK, V87, P165, DOI 10.1017/S0025315407054938; Kimura S, 2012, MAR MAMMAL SCI, V28, P308, DOI 10.1111/j.1748-7692.2011.00490.x; JOHNSON MW, 1947, BIOL BULL, V93, P122, DOI 10.2307/1538284; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Chen T, 2010, MAMMALIA, V74, P117, DOI 10.1515/MAMM.2010.024; Moller OO, 2009, ESTUAR COAST, V32, P787, DOI 10.1007/s12237-009-9168-6; Laran S, 2007, J MAR BIOL ASSOC UK, V87, P345, DOI 10.1017/S0025315407054719; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254; Boyer JN, 1999, ESTUARIES, V22, P417, DOI 10.2307/1353208; Lane RR, 2002, ESTUARIES, V25, P30, DOI 10.1007/BF02696047; Zimmer WMX, 2008, J ACOUST SOC AM, V124, P2823, DOI 10.1121/1.2988277; Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3; Lin TH, 2013, MAR BIOL, V160, P1353, DOI 10.1007/s00227-013-2187-7; Rayment W, 2010, AQUAT CONSERV, V20, P106, DOI 10.1002/aqc.1049; WENZ GM, 1962, J ACOUST SOC AM, V34, P1936, DOI 10.1121/1.1909155; Hastie GD, 2004, MAR BIOL, V144, P397, DOI 10.1007/s00227-003-1195-4; Chen BY, 2008, MAMM BIOL, V73, P156, DOI 10.1016/j.mambio.2006.12.002; MALLIN MA, 1994, ECOLOGY, V75, P2168, DOI 10.2307/1940875; Martin AR, 2004, J ZOOL, V263, P295, DOI 10.1017/S095283690400528X; Jefferson TA, 2000, WILDLIFE MONOGR, P1; MALLIN MA, 1991, ESTUAR COAST SHELF S, V32, P609, DOI 10.1016/0272-7714(91)90078-P; Akamatsu T, 2010, MAR BIOL, V157, P1879, DOI 10.1007/s00227-010-1459-8; Browder JA, 2002, ESTUARIES, V25, P1355, DOI 10.1007/BF02692230; Fury CA, 2011, ESTUAR COAST SHELF S, V93, P389, DOI 10.1016/j.ecss.2011.05.003; Huang LM, 2004, MAR POLLUT BULL, V49, P588, DOI 10.1016/j.marpolbul.2004.03.015; Au W. W. L., 1993, SONAR DOLPHINS; Au WWL, 1998, J ACOUST SOC AM, V103, P41, DOI 10.1121/1.423234; Barros Nelio B., 2004, Aquatic Mammals, V30, P179, DOI 10.1578/AM.30.1.2004.179; Cato D, 1992, ACOUST AUST, V20, P76; Cato D. H., 1992, ULTRASONIC AMBIENT N; Chou L.S., 2011, POPULATION ECOLOGY C; Fury C.A., 2011, MARINE MAMMAL SCI, V27, P185; Fury CA, 2012, SCI TOTAL ENVIRON, V416, P536, DOI 10.1016/j.scitotenv.2011.11.056; Goold John C., 2004, Aquatic Mammals, V30, P175, DOI 10.1578/AM.30.1.2004.175; HUGHES DA, 1969, BIOL BULL, V136, P43, DOI 10.2307/1539667; Jefferson Thomas A., 2001, Mammalian Species, V655, P1, DOI 10.1644/1545-1410(2001)655<0001:SC>2.0.CO;2; Kimura S, 2010, J ACOUST SOC AM, V128, P1435, DOI 10.1121/1.3442574; Lin T.-H., 2013, THESIS NATL TAIWAN U; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65	41	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1559-2723	1559-2731		ESTUAR COAST	Estuaries Coasts	JUL	2015	38	4					1376	1384		10.1007/s12237-014-9886-2		9	Environmental Sciences; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	CL0AP	WOS:000356601100023		
J	Chang, CT; Sun, DL; Kakihara, F; Hondo, K				Chang, Caitao; Sun, Deling; Kakihara, Fumika; Hondo, Kana			Cytoplasmic effects of Brassica napus and B-juncea on extreme temperature stresses of B-carinata	EUPHYTICA			English	Article						Cold resistance; Heat tolerance; Lethal temperature; Alloplasmic effect; Chlorophyll fluorescence; Wilt index	CHLOROPHYLL FLUORESCENCE; FERTILITY RESTORATION; MALE-STERILITY; SYSTEM; LEAVES; RESISTANCE; PLANTS; DONOR	Alloplasmic lines of Brassica carinata were developed from the interspecific crosses B. napus x B. carinata and B. juncea x B. carinata followed by repeated backcrossing to B. carinata as the recurrent male parent up to the BC7 generation. The BC7 generations with cytoplasm of B. napus and B. juncea were designated NC-7 and JC-7, respectively, and the corresponding euplasmic lines were designated CN-7 and CJ-7, respectively. Four lines (NC-7 vs. CN-7 and JC-7 vs. CJ-7) were grown in a closed vinyl greenhouse at 55 A degrees C and outdoors during winter in two cold regions of China (-3 to -10 A degrees C) to investigate the heat and cold tolerance of the alloplasmic and euplasmic lines. Plants with the cytoplasm of B. napus showed lower leaf chlorophyll content and little difference in heat tolerance, whereas plants with the cytoplasm of B. juncea showed higher severity of heat injury compared with that of the euplasmic lines with cytoplasm of B. carinata. Alloplasmic plants with cytoplasm of B. napus and B. juncea showed decreased cold tolerance compared with that of euplasmic lines with cytoplasm of B. carinata. The difference in cold tolerance also was observed in the lethal temperature of the alloplasmic and euplasmic plants. The results suggest that tolerance of extreme temperature stress was controlled mainly by the nucleus but also was affected by the cytoplasm. Interaction between the maternal genome and nucleus was also observed.	[Chang, Caitao; Sun, Deling] Vegetable Res Inst Tianjin Kernel Agr Sci & Techn, Tianjin Vegetable Res Ctr, Tianjin 300384, Peoples R China; [Kakihara, Fumika; Hondo, Kana] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan	Sun, DL (reprint author), Vegetable Res Inst Tianjin Kernel Agr Sci & Techn, Tianjin Vegetable Res Ctr, Jinjing Rd, Tianjin 300384, Peoples R China.	sundeling1961@163.com; kakihara@agr.ehime-u.ac.jp			Tianjin Kernel Agricultural Science & Technology Co., Ltd	We express our sincere gratitude to Prof. Dr. Masahiro Kato, Laboratory of Plant Breeding, Faculty of Agriculture, Ehime University, Japan, for providing pertinent criticism from the beginning of this research to submission of the manuscript. We also thank the Tianjin Kernel Agricultural Science & Technology Co., Ltd for support.	BEVERSDORF WD, 1980, CAN J GENET CYTOL, V22, P167; Kitao M, 2000, PHYSIOL PLANTARUM, V109, P284, DOI 10.1034/j.1399-3054.2000.100309.x; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; BILGER HW, 1984, OECOLOGIA, V63, P256, DOI 10.1007/BF00379886; Weng JH, 1997, PHOTOSYNTHETICA, V34, P307, DOI 10.1023/A:1006809111468; Chang C, 2007, EUPHYTICA, V158, P261, DOI 10.1007/s10681-007-9424-4; SCHREIBER U, 1977, PLANTA, V136, P233, DOI 10.1007/BF00385990; SMILLIE RM, 1979, AUST J PLANT PHYSIOL, V6, P135; Knight CA, 2002, OECOLOGIA, V130, P505, DOI 10.1007/s00442-001-0841-0; Arumugam N, 2002, PLANT BREEDING, V121, P168, DOI 10.1046/j.1439-0523.2002.00681.x; BANGA SS, 1984, THEOR APPL GENET, V67, P195, DOI 10.1007/BF00317032; Banga SS, 2003, THEOR APPL GENET, V106, P1390, DOI 10.1007/s00122-002-1180-1; Chang CT, 2009, EUPHYTICA, V170, P317, DOI 10.1007/s10681-009-9989-1; DELRIO M, 2003, BRAUN THEOR APPL GEN, V107, P643; Deol JS, 2003, PLANT BREEDING, V122, P438, DOI 10.1046/j.1439-0523.2003.00836.x; Hinata K., 1979, Japanese Journal of Breeding (Ikushugaku Zasshi), V29, P305; Kempken F, 1999, PROG BOT, V60, P139; Liu JH, 1996, PHYSIOL PLANTARUM, V96, P123; PRADHAN AK, 1991, PLANT BREEDING, V106, P204, DOI 10.1111/j.1439-0523.1991.tb00502.x; Prakash S, 2001, PLANT BREEDING, V120, P479, DOI 10.1046/j.1439-0523.2001.00627_x; SCHWARZ AG, 1989, PHOTOSYNTHETICA, V23, P449; Wu YW, 1998, SCI CHINA SER C, V41, P449, DOI 10.1007/BF02882881; Yamada M, 1996, SCI HORTIC-AMSTERDAM, V67, P39, DOI 10.1016/S0304-4238(96)00931-4	23	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0014-2336	1573-5060		EUPHYTICA	Euphytica	JUL	2015	204	2					335	342		10.1007/s10681-014-1337-4		8	Agronomy; Plant Sciences; Horticulture	Agriculture; Plant Sciences	CK7VN	WOS:000356442800007		
J	Suwabe, T; Araoka, H; Ubara, Y; Kikuchi, K; Hazue, R; Mise, K; Hamanoue, S; Ueno, T; Sumida, K; Hayami, N; Hoshino, J; Imafuku, A; Kawada, M; Hiramatsu, R; Hasegawa, E; Sawa, N; Takaichi, K				Suwabe, T.; Araoka, H.; Ubara, Y.; Kikuchi, K.; Hazue, R.; Mise, K.; Hamanoue, S.; Ueno, T.; Sumida, K.; Hayami, N.; Hoshino, J.; Imafuku, A.; Kawada, M.; Hiramatsu, R.; Hasegawa, E.; Sawa, N.; Takaichi, K.			Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics	EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES			English	Article							RENAL CYST; FLUID; PATIENT; SULFAMETHOXAZOLE; CIPROFLOXACIN; TRIMETHOPRIM; PENETRATION; DIAGNOSIS; ACCESS	Cyst infection is a frequent and serious complication of autosomal dominant polycystic kidney disease (ADPKD). Lipid-soluble antibiotics like fluoroquinolones show good penetration into cysts and are recommended for cyst infection, but causative microorganisms are often resistant to these agents. This study investigated the profile of the microorganisms causing cyst infection in ADPKD, their susceptibility to lipid-soluble antibiotics, and clinical outcomes. This retrospective study reviewed all ADPKD patients admitted to Toranomon Hospital with a diagnosis of cyst infection from January 2004 to March 2014. All patients who underwent cyst drainage and had positive cyst fluid cultures were enrolled. Patients with positive blood cultures who satisfied our criteria for cyst infection or probable infection were also enrolled. There were 99 episodes with positive cyst fluid cultures and 93 episodes with positive blood cultures. The majority of patients were on dialysis. The death rate was high when infection was caused by multiple microorganisms or when there were multiple infected cysts. Gram-negative bacteria accounted for 74-79 % of the isolates in all groups, except for patients with positive hepatic cyst fluid cultures. The susceptibility of Escherichia coli to fluoroquinolones was very low in patients with hepatic cyst infection, especially those with frequent episodes and those with hepatomegaly. Fungi were detected in two episodes. Fluoroquinolone-resistant microorganisms showed a high prevalence in cyst infection. It is important to identify causative microorganisms to avoid the overuse of fluoroquinolones and to improve the outcome of cyst infection in ADPKD.	[Suwabe, T.; Ubara, Y.; Kikuchi, K.; Hazue, R.; Mise, K.; Hamanoue, S.; Ueno, T.; Sumida, K.; Hayami, N.; Hoshino, J.; Takaichi, K.] Toranomon Hosp Kajigaya, Dept Nephrol, Takatsu Ku, Kawasaki, Kanagawa 2138587, Japan; [Araoka, H.] Toranomon Gen Hosp, Dept Infect Dis, Tokyo, Japan; [Ubara, Y.; Takaichi, K.] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo, Japan; [Imafuku, A.; Kawada, M.; Hiramatsu, R.; Hasegawa, E.; Sawa, N.; Takaichi, K.] Toranomon Gen Hosp, Dept Nephrol, Tokyo, Japan	Suwabe, T (reprint author), Toranomon Hosp Kajigaya, Dept Nephrol, Takatsu Ku, 1-3-1 Kajigaya, Kawasaki, Kanagawa 2138587, Japan.	suwabe@toranomon.gr.jp			Ministry of Health, Labour and Welfare of Japan; Okinaka Memorial Institute for Medical Research, Toranomon Hospital	This study was supported in part by a Grant-in-Aid for Progressive Renal Disease Research from the Ministry of Health, Labour and Welfare of Japan and by the Okinaka Memorial Institute for Medical Research, Toranomon Hospital. The language content of this manuscript was checked by a native English-speaking medical editor from Yamada Translation Bureau, Inc. (Tokyo, Japan).	Ravani P, 2013, J AM SOC NEPHROL, V24, P1668, DOI 10.1681/ASN.2012121234; Sallee M, 2009, CLIN J AM SOC NEPHRO, V4, P1183, DOI 10.2215/CJN.01870309; Lu PL, 2012, INT J ANTIMICROB AG, V40, pS37, DOI 10.1016/S0924-8579(12)70008-0; Suwabe T, 2009, NEPHRON CLIN PRACT, V112, pC157, DOI 10.1159/000214211; Jouret F, 2011, CLIN J AM SOC NEPHRO, V6, P1644, DOI 10.2215/CJN.06900810; ELZINGA LW, 1987, KIDNEY INT, V32, P884, DOI 10.1038/ki.1987.290; Jouret F, 2012, NEPHROL DIAL TRANSPL, V27, P3746, DOI 10.1093/ndt/gfs352; BENNETT WM, 1985, AM J KIDNEY DIS, V6, P400; CHAPMAN AB, 1990, AM J KIDNEY DIS, V16, P252; Chapman AB, 2014, URINARY TRACT INFECT; ELZINGA LW, 1988, ANTIMICROB AGENTS CH, V32, P844; Fissell RB, 2013, J VASC ACCESS, V14, P264, DOI 10.5301/jva.5000140; GARDNER KD, 1984, AM J KIDNEY DIS, V3, P403; Harris PC, 2011, GENEREVIEWS; Hiyama L, 2006, AM J KIDNEY DIS, V47, DOI 10.1053/j.ajkd.2005.09.021; Matsumoto T, 2011, INT J ANTIMICROB AG, V37, P210, DOI 10.1016/j.ijantimicag.2010.10.032; MUTHER RS, 1981, KIDNEY INT, V20, P519, DOI 10.1038/ki.1981.170; ROSSI SJ, 1993, ANN PHARMACOTHER, V27, P38; SCHWAB S, 1983, AM J KIDNEY DIS, V3, P63; SCHWAB SJ, 1987, AM J MED, V82, P714, DOI 10.1016/0002-9343(87)90005-2; SCHWAB SJ, 1986, AM J KIDNEY DIS, V7, P434; Suwabe T, 2012, CLIN EXP NEPHROL, V16, P892, DOI 10.1007/s10157-012-0650-2; Torres VE, 2001, TXB NEPHROLOGY, V4th, P896; Truven Health Analytics Inc., 2014, DOS INF DOS REN FAIL	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0934-9723	1435-4373		EUR J CLIN MICROBIOL	Eur. J. Clin. Microbiol. Infect. Dis.	JUL	2015	34	7					1369	1379		10.1007/s10096-015-2361-6		11	Infectious Diseases; Microbiology	Infectious Diseases; Microbiology	CK8YU	WOS:000356527200012		
J	Uusi-Heikkila, S; Whiteley, AR; Kuparinen, A; Matsumura, S; Venturelli, PA; Wolter, C; Slate, J; Primmer, CR; Meinelt, T; Killen, SS; Bierbach, D; Polverino, G; Ludwig, A; Arlinghaus, R				Uusi-Heikkilae, Silva; Whiteley, Andrew R.; Kuparinen, Anna; Matsumura, Shuichi; Venturelli, Paul A.; Wolter, Christian; Slate, Jon; Primmer, Craig R.; Meinelt, Thomas; Killen, Shaun S.; Bierbach, David; Polverino, Giovanni; Ludwig, Arne; Arlinghaus, Robert			The evolutionary legacy of size-selective harvesting extends from genes to populations	EVOLUTIONARY APPLICATIONS			English	Article						conservation; fisheries-induced evolution; life-history evolution; personality; population dynamics	FISHERIES-INDUCED EVOLUTION; ZEBRAFISH DANIO-RERIO; LIFE-HISTORY EVOLUTION; EXPLOITED FISH STOCKS; COD GADUS-MORHUA; PIKE ESOX-LUCIUS; PERSONALITY-TRAITS; REPRODUCTIVE SUCCESS; REACTION NORMS; RECREATIONAL ANGLERS	Size-selective harvesting is assumed to alter life histories of exploited fish populations, thereby negatively affecting population productivity, recovery, and yield. However, demonstrating that fisheries-induced phenotypic changes in the wild are at least partly genetically determined has proved notoriously difficult. Moreover, the population-level consequences of fisheries-induced evolution are still being controversially discussed. Using an experimental approach, we found that five generations of size-selective harvesting altered the life histories and behavior, but not the metabolic rate, of wild-origin zebrafish (Danio rerio). Fish adapted to high positively size selective fishing pressure invested more in reproduction, reached a smaller adult body size, and were less explorative and bold. Phenotypic changes seemed subtle but were accompanied by genetic changes in functional loci. Thus, our results provided unambiguous evidence for rapid, harvest-induced phenotypic and evolutionary change when harvesting is intensive and size selective. According to a life-history model, the observed life-history changes elevated population growth rate in harvested conditions, but slowed population recovery under a simulated moratorium. Hence, the evolutionary legacy of size-selective harvesting includes populations that are productive under exploited conditions, but selectively disadvantaged to cope with natural selection pressures that often favor large body size.	[Uusi-Heikkilae, Silva; Wolter, Christian; Bierbach, David; Polverino, Giovanni; Arlinghaus, Robert] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; [Uusi-Heikkilae, Silva; Primmer, Craig R.] Univ Turku, Dept Biol, Div Genet & Physiol, SF-20500 Turku, Finland; [Whiteley, Andrew R.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Kuparinen, Anna] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Matsumura, Shuichi] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan; [Venturelli, Paul A.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Slate, Jon] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Meinelt, Thomas] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecophysiol & Aquaculture, Berlin, Germany; [Killen, Shaun S.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Ludwig, Arne] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Genet, Berlin, Germany; [Arlinghaus, Robert] Humboldt Univ, Albrecht Daniel Thaer Inst Agr & Hort Sci, Fac Life Sci, Chair Integrat Fisheries Management, D-10099 Berlin, Germany	Uusi-Heikkila, S (reprint author), Univ Turku, Dept Biol, Div Genet & Physiol, Turku 20014, Finland.	silva.uusi-heikkila@utu.fi	Venturelli, Paul/A-2337-2008; Wolter, Christian/F-6210-2014; 	Venturelli, Paul/0000-0002-7329-7517; Killen, Shaun/0000-0003-4949-3988	Gottfried-Wilhelm-Leibniz-Community in the Leibniz-Competition; German Federal Ministry for Education and Research [01UU0907]; Japanese Ministry of Education, Culture, Sports, Science and Technology [25440190]; Kone Foundation	We thank Karena Kuntze, Asja Vogt, Marcus Ebert, Yvonne Klaar, Sylvia Werner, Theresa Arlt, Sarah Becker, and Julie Menard for fish husbandry, care taking, and data collection; Rachel Tucker for helping in genotyping the samples; and Henrik Zwadlo for technical assistance. Funding for this study was received through the Adaptfish grant to RA and CW, through the BTypes grant to RA, both funded by the Gottfried-Wilhelm-Leibniz-Community in the Leibniz-Competition, through the Besatzlisch grant to RA funded by the German Federal Ministry for Education and Research (Grant # 01UU0907), through grant-in-aid for Scientific Research (C) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (Grant # 25440190) to SM and through the Kone Foundation to SUII. We express our gratitude to two anonymous reviewers and thank them for their unusually rich and constructive comments that helped to improve the manuscript.	Alos J, 2014, MAR ECOL PROG SER, V503, P219, DOI 10.3354/meps10745; Alos J, 2015, CAN J FISH AQUAT SCI, V72, P217, DOI 10.1139/cjfas-2014-0183; Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; Neubauer P, 2013, SCIENCE, V340, P347, DOI 10.1126/science.1230441; Hilborn R, 2008, B MAR SCI, V83, P95; Andersen KH, 2009, P NATL ACAD SCI USA, V106, P11657, DOI 10.1073/pnas.0901690106; Hendry AP, 2001, AM NAT, V157, P387, DOI 10.1086/319316; Philipp DP, 2009, T AM FISH SOC, V138, P189, DOI 10.1577/T06-243.1; Hutchings JA, 2009, EVOL APPL, V2, P324, DOI 10.1111/j.1752-4571.2009.00085.x; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Naish KA, 2008, FISH FISH, V9, P396, DOI 10.1111/j.1467-2979.2008.00302.x; Klefoth T, 2012, BEHAV ECOL SOCIOBIOL, V66, P547, DOI 10.1007/s00265-011-1303-2; Lester NP, 2004, P ROY SOC B-BIOL SCI, V271, P1625, DOI 10.1098/rspb.2004.2778; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Jorgensen C, 2009, EVOL APPL, V2, P356, DOI 10.1111/j.1752-4571.2009.00075.x; RIJNSDORP AD, 1993, OECOLOGIA, V96, P391, DOI 10.1007/BF00317510; Kuparinen A, 2012, P ROY SOC B-BIOL SCI, V279, P2571, DOI 10.1098/rspb.2012.0120; Hixon MA, 2014, ICES J MAR SCI, V71, P2171, DOI 10.1093/icesjms/fst200; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Conover DO, 2009, P R SOC B, V276, P2015, DOI 10.1098/rspb.2009.0003; Cote J, 2010, P ROY SOC B-BIOL SCI, V277, P1571, DOI 10.1098/rspb.2009.2128; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; Palkovacs EP, 2012, EVOL APPL, V5, P183, DOI 10.1111/j.1752-4571.2011.00212.x; Enberg K, 2012, MAR ECOL-EVOL PERSP, V33, P1, DOI 10.1111/j.1439-0485.2011.00460.x; Engen S, 2014, AM NAT, V184, P714, DOI 10.1086/678407; Paull GC, 2010, ZEBRAFISH, V7, P109, DOI 10.1089/zeb.2009.0618; Barot S, 2004, EVOL ECOL RES, V6, P659; Enberg K, 2009, EVOL APPL, V2, P394, DOI 10.1111/j.1752-4571.2009.00077.x; Varshney GK, 2013, GENOME RES, V23, P727, DOI 10.1101/gr.151464.112; Dupont-Prinet A, 2010, J EXP BIOL, V213, P1143, DOI 10.1242/jeb.037812; Borrell B, 2013, NATURE, V493, P597, DOI 10.1038/493597a; Laugen AT, 2014, FISH FISH, V15, P65, DOI 10.1111/faf.12007; Arlinghaus R, 2010, BIOL CONSERV, V143, P1444, DOI 10.1016/j.biocon.2010.03.020; Hutchings JA, 2014, ICES J MAR SCI, V71, P1467, DOI 10.1093/icesjms/fsu041; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Pauli BD, 2015, J FISH BIOL, V86, P1030, DOI 10.1111/jfb.12620; Uusi-Heikkila S, 2010, J FISH BIOL, V77, P552, DOI 10.1111/j.1095-8649.2010.02698.x; BULL JJ, 1979, AM NAT, V114, P296, DOI 10.1086/283476; Theriault V, 2008, EVOL APPL, V1, P409, DOI 10.1111/j.1752-4571.2008.00022.x; Sharpe DMT, 2009, EVOL APPL, V2, P260, DOI 10.1111/j.1752-4571.2009.00080.x; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Heino M, 2002, EVOLUTION, V56, P669, DOI 10.1111/j.0014-3820.2002.tb01378.x; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Whiteley AR, 2011, MOL ECOL, V20, P4259, DOI 10.1111/j.1365-294X.2011.05272.x; Dieckmann U, 2007, MAR ECOL PROG SER, V335, P253, DOI 10.3354/meps335253; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; Jorgensen C, 2008, SCIENCE, V320, P48; HALDANE JBS, 1949, EVOLUTION, V3, P51, DOI 10.2307/2405451; Uusi-Heikkila S, 2012, ENVIRON BIOL FISH, V93, P461, DOI 10.1007/s10641-011-9937-5; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Uusi-Heikkila S, 2008, TRENDS ECOL EVOL, V23, P419, DOI 10.1016/j.tree.2008.04.006; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Eikeset AM, 2013, P NATL ACAD SCI USA, V110, P12259, DOI 10.1073/pnas.1212593110; Conover DO, 2009, EVOL APPL, V2, P276, DOI 10.1111/j.1752-4571.2009.00079.x; Sutter DAH, 2012, P NATL ACAD SCI USA, V109, P20960, DOI 10.1073/pnas.1212536109; Vital C, 2011, J COMP PSYCHOL, V125, P278, DOI 10.1037/a0023906; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Heino M, 2013, ICES J MAR SCI, V70, P707, DOI 10.1093/icesjms/fst077; Falcon J, 2010, GEN COMP ENDOCR, V165, P469, DOI 10.1016/j.ygcen.2009.04.026; Poos JJ, 2011, J THEOR BIOL, V279, P102, DOI 10.1016/j.jtbi.2011.03.001; Jorgensen C, 2013, J SEA RES, V75, P8, DOI 10.1016/j.seares.2012.04.003; Tingaud-Sequeira A, 2007, GENE, V386, P98, DOI 10.1016/j.gene.2006.08.018; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; Munch SB, 2005, CAN J FISH AQUAT SCI, V62, P802, DOI 10.1139/F05-078; Dunlop ES, 2009, ECOL APPL, V19, P1815, DOI 10.1890/08-1404.1; Matsumura S, 2012, BIOSCIENCE, V62, P1039, DOI 10.1525/bio.2012.62.12.6; Swain DP, 2007, P ROY SOC B-BIOL SCI, V274, P1015, DOI 10.1098/rapb.2006.0275; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Hare JA, 1997, ECOLOGY, V78, P2415; Matsumura S, 2011, EVOL ECOL, V25, P711, DOI 10.1007/s10682-010-9444-8; Bunnefeld N, 2014, P NATL ACAD SCI USA, V111, P12964, DOI 10.1073/pnas.1413571111; Heino M, 2002, B MAR SCI, V70, P639; Law R, 2007, MAR ECOL PROG SER, V335, P271, DOI 10.3354/meps335271; Hutchings JA, 2008, MOL ECOL, V17, P294, DOI 10.1111/j.1365-294X.2007.03485.x; Alderman SL, 2007, J COMP NEUROL, V502, P783, DOI 10.1002/cne.21332; Johnson DW, 2011, EVOL APPL, V4, P621, DOI 10.1111/j.1752-4571.2011.00185.x; Ariyomo TO, 2012, ANIM BEHAV, V83, P41, DOI 10.1016/j.anbehav.2011.10.004; Audzijonyte A, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1103; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Arlinghaus R, 2009, EVOL APPL, V2, P335, DOI 10.1111/j.1752-4571.2009.00081.x; MCALLISTER MK, 1992, CAN J FISH AQUAT SCI, V49, P1305, DOI 10.1139/f92-146; LAW R, 1989, EVOL ECOL, V3, P343, DOI 10.1007/BF02285264; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Hutter S, 2010, BEHAVIOUR, V147, P641, DOI 10.1163/000579510X12632972473944; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Arlinghaus R, 2014, J FISH BIOL, V85, P1843, DOI 10.1111/jfb.12546; Audzijonyte A, 2013, EVOL APPL, V6, P585, DOI 10.1111/eva.12044; Boukal D. S., 2008, 2008F07 ICES CM; Browman R., 2008, SCIENCE, V320, P47; Cuveliers EL, 2011, MOL ECOL, V20, P3555, DOI 10.1111/j.1365-294X.2011.05196.x; DesRoos A. M., 2002, P NATL ACAD SCI USA, V99, P12907; Devine JA, 2012, CAN J FISH AQUAT SCI, V69, P1105, DOI 10.1139/F2012-047; Diaz Pauli B, 2013, J EVOLUTION BIOL, V26, P2184, DOI 10.1111/jeb.12215; Diaz Pauli B, 2014, BIOL J LINN SOC, V111, P485, DOI 10.1111/bij.12241; Harkonen L, 2014, CAN J FISH AQUAT SCI, V71, P1900, DOI 10.1139/cjfas-2014-0221; Haugen TO, 2007, ECOL MONOGR, V77, P483, DOI 10.1890/06-0163.1; Hilborn R, 2010, FISHERIES, V35, P113, DOI 10.1577/1548-8446-35.3.113; Houde E.D., 1987, AM FISH SOC S, V2, P17; JOrgensen C., 2015, CANADIAN J FISHERIES, V72, P612; Jorgensen C, 2010, CAN J FISH AQUAT SCI, V67, P1086, DOI 10.1139/F10-049; KIMMEL CB, 1995, DEV DYNAM, V203, P253; Kuparinen A, 2014, EVOL APPL, V7, P1218, DOI 10.1111/eva.12217; Lorenzen K, 2002, P ROY SOC B-BIOL SCI, V269, P49, DOI 10.1098/rspb.2001.1853; Marty L, 2015, EVOL APPL, V8, P47, DOI 10.1111/eva.12220; Nussle S, 2009, EVOL APPL, V2, P200, DOI 10.1111/j.1752-4571.2008.00054.x; Perez-Rodriguez A, 2013, FISH RES, V138, P62, DOI 10.1016/j.fishres.2012.09.004; Peters R. H., 1983, AM J PHYS ANTHR, V66; Policansky David, 1993, Lecture Notes in Biomathematics, V99, P2; Roff D. A., 2010, MODELLING EVOLUTION; Salinas S, 2012, EVOL APPL, V5, P657, DOI 10.1111/j.1752-4571.2012.00243.x; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; Stearns S. C., 1992, EVOLUTION LIFE HIST; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Therkildsen NO, 2010, CAN J FISH AQUAT SCI, V67, P1585, DOI 10.1139/F10-084; Uusi-Heikkila S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048317; Uusi-Heikkila S, 2011, P ROY SOC B-BIOL SCI, V278, P709, DOI 10.1098/rspb.2010.1507; vansWalraven L., 2010, J SEA RES, V64, P84; vansWijk S. J., 2013, FRONTIERS ECOLOGY EN, V11, P181; Walters C. J., 2004, FISHERIES ECOLOGY MA; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080	125	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1752-4571			EVOL APPL	Evol. Appl.	JUL	2015	8	6					597	620		10.1111/eva.12268		24	Evolutionary Biology	Evolutionary Biology	CL1DH	WOS:000356682200008		
J	Takeuchi, M; Yamamoto, T				Takeuchi, Mikio; Yamamoto, Tomoko			Apoptosis induced by NAD depletion is inhibited by KN-93 in a CaMKII-independent manner	EXPERIMENTAL CELL RESEARCH			English	Article						Nicotinamide phosphoribosyltransferase; KN-93; KN-92; NAD; FK866; Apoptosis; AS1604498	NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE NAMPT; CELL-DEATH; T-LYMPHOCYTES; FK866; KINASE; ACTIVATION; DISCOVERY; AUTOPHAGY; CHANNELS; CALPAIN	Nicotinamide phosphoribosyltransferase (NAMPT) is a key enzyme that catalyzes the synthesis of nicotinamide mononucleotide from nicotinamide (Nam) in the salvage pathway of mammalian NAD biosynthesis. Several potent NAMPT inhibitors have been identified and used to investigate the role of intracellular NAD and to develop therapeutics. NAD depletion induced by NAMPT inhibitors depolarizes mitochondrial membrane potential and causes apoptosis in a range of cell types. However, the mechanisms behind this depolarization have not been precisely elucidated. We observed that apoptosis of THP-1 cells in response to NAMPT inhibitors was reduced by the Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor KN-93 via an unknown mechanism. The inactive analog of KN-93, KN-92, exhibited the same activity, but the CaMKII-inhibiting cell-permeable autocamtide-2-related inhibitory peptide II did not, indicating that the inhibition of THP-1 cell apoptosis was not dependent on CaMKII. In evaluating the mechanism of action, we confirmed that KN-93 did not inhibit decreases in NAD levels but did inhibit decreases in mitochondrial membrane potential, indicating that KN-93 exerts inhibition upstream of the mitochondrial pathway of apoptosis. Further, qPCR analysis of the Bc1-2 family of proteins showed that Bim is efficiently expressed following NAMPT inhibition and that KN-92 did not inhibit this expression. The L-type Ca2+ channel blockers verapamil and nimodipine partially inhibited apoptosis, indicating that part of this effect is dependent on Ca2+ channel inhibition, as both KN-93 and KN-92 are reported to inhibit L-type Ca2+ channels. On the other hand, KN-93 and KN-92 did not markedly inhibit apoptosis induced by anti-cancer agents such as etoposide, actinomycin D, ABT-737, or TW-37, indicating that the mechanism of inhibition is specific to apoptosis induced by NAD depletion. These results demonstrate that NAD depletion induces a specific type of apoptosis that is effectively inhibited by the KN-93 series of compounds. (C) 2015 Elsevier Inc. All rights reserved.	[Takeuchi, Mikio] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan; [Takeuchi, Mikio; Yamamoto, Tomoko] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Microbiol & Mol Genet, Chiba 2608675, Japan	Takeuchi, M (reprint author), Astellas Pharma Inc, Drug Discovery Res, Miyukigaoka 21, Tsukuba, Ibaraki 3058585, Japan.	mikio.takeuchi@astellas.com			Astellas Pharma Inc.	We thank Astellas Pharma Inc. for supporting this research.	Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Shamas-Din A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008714; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Ravaud A, 2005, EUR J CANCER, V41, P702, DOI 10.1016/j.ejca.2004.12.023; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Magnone M, 2012, J BIOL CHEM, V287, P21067, DOI 10.1074/jbc.M111.324269; Lopatniuk P, 2011, ACTA BIOCHIM POL, V58, P287; Billington RA, 2008, AUTOPHAGY, V4, P385; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Xu WF, 2001, J NEUROSCI, V21, P5944; Cea M, 2012, BLOOD, V120, P3519, DOI 10.1182/blood-2012-03-416776; Wosikowski K, 2002, CANCER RES, V62, P1057; Hasmann M, 2003, CANCER RES, V63, P7436; Thakur BK, 2013, INT J CANCER, V132, P766, DOI 10.1002/ijc.27726; Del Nagro C, 2014, J BIOL CHEM, V289, P35182, DOI 10.1074/jbc.M114.580159; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Choi WS, 2001, J NEUROCHEM, V77, P1531, DOI 10.1046/j.1471-4159.2001.00368.x; Ferreira E, 2012, MOL BIOTECHNOL, V50, P121, DOI 10.1007/s12033-011-9425-3; Martinsson P, 2001, EUR J PHARMACOL, V417, P181, DOI 10.1016/S0014-2999(01)00925-6; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; Takeuchi M, 2014, BIOL PHARM BULL, V37, P31; Thakur BK, 2012, BIOCHEM BIOPH RES CO, V424, P371, DOI 10.1016/j.bbrc.2012.06.075; TOMBES RM, 1995, CELL GROWTH DIFFER, V6, P1063; Vandesompele J., 2002, GENOME BIOL, V18, P3, DOI DOI 10.1186/GB-2002-3-7-RESEARCH0034; Zheng XZ, 2014, BIOORG MED CHEM LETT, V24, P337, DOI 10.1016/j.bmcl.2013.11.006	27	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	JUL 1	2015	335	1					62	67		10.1016/j.yexcr.2015.05.019		6	Oncology; Cell Biology	Oncology; Cell Biology	CK9MG	WOS:000356563600006		
J	Atoji, Y				Atoji, Yasuro			Expression of ionotropic glutamate receptors, AMPA, kainite and NMDA, in the pigeon retina	EXPERIMENTAL EYE RESEARCH			English	Article						Bipolar cell; Horizontal cell; Ganglion cell; Bird; In situ hybridization	SUBUNIT MESSENGER-RNAS; CENTRAL-NERVOUS-SYSTEM; VESICULAR GLUTAMATE; RAT RETINA; COLUMBA-LIVIA; DIFFERENTIAL EXPRESSION; MAMMALIAN RETINA; IMMUNOCYTOCHEMICAL LOCALIZATION; KAINATE RECEPTORS; VERTEBRATE RETINA	Glutamate is an excitatory neurotransmitter in the vertebrate retina. A previous study found vesicular glutamate transporter 2 (vGluT2) mRNA in the pigeon retina, suggesting that bipolar and ganglion cells are glutamatergic. The present study examined the localization of ionotropic glutamate receptors to identify receptor cells in the pigeon retina using in situ hybridization histochemistry. Nine subunits of AMPA receptor (GluAl, GluA2, GluA3, and GluA4), kainate receptor (GluK1, GluK2, and GluK4), and NMDA receptor (GluN1 and GluN2A) were found to be expressed in the inner nuclear layer (INL) and ganglion cell layers. GluA1, GluA2, GluA3, and GluA4 were primarily expressed in the inner half of INL, and the signal intensity was strong for GluA2, GluA3, and GluA4. GluK1 was intensely expressed in the outer half of INL, whereas GluK2 and GluK4 were mainly localized in the inner half of INL. GluN1 and GluN2A were moderately expressed in the inner half of INL. Horizontal cells expressed GluA3 and GluA4, and ganglion cells expressed all subunits examined. These results suggest that the glutamatergic neurotransmission in the pigeon retina is similar to that in mammals. (C) 2015 Elsevier Ltd. All rights reserved.	Gifu Univ, Fac Appl Biol Sci, Lab Vet Anat, Yanagi, Gifu 5011193, Japan	Atoji, Y (reprint author), Gifu Univ, Fac Appl Biol Sci, Lab Vet Anat, Yanagi, Gifu 5011193, Japan.	atozi@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of japan [18590165]	This study was supported by a Grant-in Aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of japan (18590165). The author thanks S. Saito for DIG-labeled probes synthesis and M.T. Hussan for technical assistance.	Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; BRANDSTATTER JH, 1994, EUR J NEUROSCI, V6, P1100, DOI 10.1111/j.1460-9568.1994.tb00607.x; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; Kalloniatis M, 2004, VISUAL NEUROSCI, V21, P587, DOI 10.1017/S0952523804214080; Islam MR, 2008, J COMP NEUROL, V511, P658, DOI 10.1002/cne.21871; KALLONIATIS M, 1993, J COMP NEUROL, V336, P174, DOI 10.1002/cne.903360203; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Mpodozis J, 1995, Int J Neurosci, V81, P123, DOI 10.3109/00207459509015304; Haverkamp S, 2001, J COMP NEUROL, V436, P471, DOI 10.1002/cne.1081; Brandstatter JH, 1997, J NEUROSCI, V17, P9298; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; MASSEY S C, 1987, Progress in Neurobiology (Oxford), V28, P55, DOI 10.1016/0301-0082(87)90005-0; Haverkamp S, 2000, NEURON, V27, P85, DOI 10.1016/S0896-6273(00)00011-8; Gras C, 2002, J NEUROSCI, V22, P5442; Fischer AJ, 1998, J COMP NEUROL, V393, P1; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; Fletcher EL, 2000, J COMP NEUROL, V420, P98; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Atoji Y, 2011, J COMP NEUROL, V519, P2887, DOI 10.1002/cne.22663; Brandstatter JH, 2001, CELL TISSUE RES, V303, P1, DOI 10.1007/s004410000304; Bredariol ASD, 2001, J COMP NEUROL, V441, P58; Collingridge G.L., 1989, PHARMACOL REV, V40, P143; Dye JC, 1996, VISUAL NEUROSCI, V13, P747; Fyk-Kolodziej B, 2004, J COMP NEUROL, V475, P518, DOI 10.1002/cne.20199; HAMASSAKIBRITTO DE, 1993, J NEUROSCI, V13, P1888; HARDY O, 1984, BRAIN RES, V311, P65, DOI 10.1016/0006-8993(84)91399-4; HUGHES TE, 1992, VISUAL NEUROSCI, V8, P49; Islam MR, 2009, EXP EYE RES, V89, P439, DOI 10.1016/j.exer.2009.03.024; Johnson J, 2003, J NEUROSCI, V23, P518; Kalloniatis M, 2013, CLIN EXP OPTOM, V96, P310, DOI 10.1111/cxo.12015; Kamphuis W, 2003, J COMP NEUROL, V455, P172, DOI 10.1002/cne.10469; Karim MR, 2014, J COMP NEUROL, V522, P2129, DOI 10.1002/cne.23522; Kertesz S, 2004, BRAIN RES, V1025, P123, DOI 10.1016/j.brainres.2004.08.010; Lerma J, 2006, CURR OPIN PHARMACOL, V6, P89, DOI 10.1016/j.coph.2005.08.004; Letelier JC, 2000, EUR J NEUROSCI, V12, P47, DOI 10.1046/j.1460-9568.2000.00872.x; Lindstrom SH, 2010, VISUAL NEUROSCI, V27, P103, DOI 10.1017/S0952523810000155; Mimura Y, 2002, NEUROREPORT, V13, P1925, DOI 10.1097/00001756-200210280-00019; MULLER F, 1992, NEUROSCI LETT, V138, P179, DOI 10.1016/0304-3940(92)90500-7; OTTIGER HP, 1995, J NEUROCHEM, V64, P2413; Perrais D, 2010, TRENDS PHARMACOL SCI, V31, P516, DOI 10.1016/j.tips.2010.08.004; Sun H, 2000, ANAT REC, V260, P158, DOI 10.1002/1097-0185(20001001)260:2<158::AID-AR60>3.0.CO;2-V; Theiss C, 1998, BRAIN RES, V785, P114, DOI 10.1016/S0006-8993(97)01395-4; Thoreson WB, 1999, PROG RETIN EYE RES, V18, P765, DOI 10.1016/S1350-9462(98)00031-7; WATANABE M, 1994, BRAIN RES, V634, P328, DOI 10.1016/0006-8993(94)91938-0	48	0	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	JUL	2015	136						72	77		10.1016/j.exer.2015.05.005		6	Ophthalmology	Ophthalmology	CK9LR	WOS:000356562100009		
J	Yamada, M; Sakamoto, T; Otake, Y; Nakajima, T; Kuchiba, A; Taniguchi, H; Sekine, S; Kushima, R; Ramberan, H; Parra-Blanco, A; Fujii, T; Matsuda, T; Saito, Y				Yamada, Masayoshi; Sakamoto, Taku; Otake, Yosuke; Nakajima, Takeshi; Kuchiba, Aya; Taniguchi, Hirokazu; Sekine, Shigeki; Kushima, Ryoji; Ramberan, Hemchand; Parra-Blanco, Adolfo; Fujii, Takahiro; Matsuda, Takahisa; Saito, Yutaka			Investigating endoscopic features of sessile serrated adenomas/polyps by using narrow-band imaging with optical magnification	GASTROINTESTINAL ENDOSCOPY			English	Article							SMALL COLORECTAL POLYPS; DIFFERENTIAL-DIAGNOSIS; PIT PATTERN; LESIONS; ADENOMA; VALIDATION; CARCINOMA; PATHWAY; SYSTEM	Background: A sessile serrated adenoma/ polyp (SSA/P) is a common type of colorectal polyp that possesses malignant potential. Although narrow-band imaging (NBI) can easily differentiate neoplastic lesions from hyperplastic polyps (HPs), SSA/Ps can be a challenge to distinguish from HPs. Objective: To investigate specific endoscopic features of SSA/Ps by using NBI with optical magnification. Design: Retrospective study. Setting: Single high-volume referral center. Patients: A total of 289 patients with histopathologically proven SSA/Ps or HPs obtained from colonoscopic polypectomy. Intervention: Endoscopic images obtained by using NBI with optical magnification of 242 lesions (124 HPs, 118 SSA/Ps) removed between January 2010 and December 2012 were independently evaluated by 2 experienced endoscopists. Three external experienced endoscopists systematically validated the diagnostic accuracies by using 40 lesions (21 HPs and 19 SSA/Ps) removed between January and March 2013. Main Outcome Measurements: Specific endoscopic features of SSA/Ps by using 5 potential characteristics: dilated and branching vessels (DBVs), irregular dark spots, a regular network pattern, a disorganized network pattern, and a dense pattern. Results: Multivariate analysis demonstrated that DBV had a 2.3-fold odds ratio (95% confidence interval, 0.96-5.69) among SSA/Ps compared with HPs (sensitivity, 56%; specificity, 75%; accuracy, 65%). Interobserver and intraobserver agreement indicated almost perfect agreement for DBVs in both the evaluation and validation studies. When DBVs, proximal location, and tumor size (>= 10 mm) were combined, the positive predictive value was 92% and the area under the curve was 0.783 in the receiver-operating characteristics by using the validation group. Limitations: Retrospective study. Conclusions: The current study suggests that a DBV is a potentially unique endoscopic feature of a colorectal SSA/P.	[Yamada, Masayoshi; Sakamoto, Taku; Otake, Yosuke; Nakajima, Takeshi; Matsuda, Takahisa; Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Tokyo 1040045, Japan; [Kuchiba, Aya] Natl Canc Ctr, Dept Biostat, Tokyo 104, Japan; [Taniguchi, Hirokazu; Kushima, Ryoji] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo 1040045, Japan; [Sekine, Shigeki] Natl Canc Ctr Res, Mol Pathol Div, Tokyo, Japan; [Ramberan, Hemchand] Univ Tennessee, Erlanger Hosp, Coll Med, Dept Gastroenterol, Chattanooga, TN USA; [Parra-Blanco, Adolfo] Pontificia Univ Catolica Chile, Escuela Med, Dept Gastroenterol, Santiago, Chile; [Fujii, Takahiro] TF Clin, Tokyo, Japan	Saito, Y (reprint author), Natl Canc Ctr, Endoscopy Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.						Lash RH, 2010, J CLIN PATHOL, V63, P681, DOI 10.1136/jcp.2010.075507; Iacucci M, 2014, GASTROINTEST ENDOSC, V79, P182, DOI 10.1016/j.gie.2013.08.016; KUDO S, 1994, J CLIN PATHOL, V47, P880, DOI 10.1136/jcp.47.10.880; Hewett DG, 2012, GASTROENTEROLOGY, V143, P599, DOI 10.1053/j.gastro.2012.05.006; Machida H, 2004, ENDOSCOPY, V36, P1094, DOI 10.1055/s-2004-826040; Matsuda T, 2008, AM J GASTROENTEROL, V103, P1926, DOI 10.1111/j.1572-0241.2008.01931.x; Tadepalli US, 2011, GASTROINTEST ENDOSC, V74, P1360, DOI 10.1016/j.gie.2011.08.008; Kumar S, 2013, GASTROINTEST ENDOSC, V78, P902, DOI 10.1016/j.gie.2013.06.004; Hazewinkel Y, 2013, GASTROINTEST ENDOSC, V77, P916, DOI 10.1016/j.gie.2012.12.018; Rex DK, 2011, GASTROINTEST ENDOSC, V73, P419, DOI 10.1016/j.gie.2011.01.023; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Tajiri H, 2008, ENDOSCOPY, V40, P775, DOI 10.1055/s-2008-1077507; Kudo SE, 1996, GASTROINTEST ENDOSC, V44, P8, DOI 10.1016/S0016-5107(96)70222-5; Farris AB, 2008, AM J SURG PATHOL, V32, P30; Burt RW, 2010, J NATL COMPR CANC NE, V8, P8; Sano Y, 2009, GASTROINTEST ENDOSC, V69, P278, DOI 10.1016/j.gie.2008.04.066; Jaramillo E, 2005, ENDOSCOPY, V37, P254, DOI 10.1055/s-2005-861007; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Kimura T, 2012, AM J GASTROENTEROL, V107, P460, DOI 10.1038/ajg.2011.457; Fu KI, 2004, ENDOSCOPY, V36, P1089, DOI 10.1055/s-2004-826039; Osawa H, 2014, DIGEST ENDOSC, V26, P105, DOI 10.1111/den.12205; Ikematsu H, 2012, J GASTROENTEROL, V47, P1099, DOI 10.1007/s00535-012-0575-2; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Wada Y, 2009, GASTROINTEST ENDOSC, V70, P522, DOI 10.1016/j.gie.2009.01.040; Bosman FT, 2010, WHO CLASSIFICATION T, V3, P134; Goldstein NS, 2005, AM J CLIN PATHOL, V123, P329, DOI 10.1309/8H7MUH9ET9U21R2E; Ikematsu H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-33; Jass JR, 2005, NAT CLIN PRACT ONCOL, V2, P398, DOI 10.1038/ncponc0248; Kutsukawa M, 2014, GASTROINTEST ENDOSC, V79, P648, DOI 10.1016/j.gie.2013.08.029; Sakamoto T, 2012, J GASTROEN HEPATOL, V27, P351, DOI 10.1111/j.1440-1746.2011.06854.x; Snover DC, 2010, WHO CLASSIFICATION T, P160	31	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JUL	2015	82	1					108	117		10.1016/j.gie.2014.12.037		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK4GR	WOS:000356182600015		
J	Maeda, M; Kanai, N; Kobayashi, S; Hosoi, T; Takagi, R; Ohki, T; Muragaki, Y; Yamato, M; Eguchi, S; Fukai, F; Okano, T				Maeda, Masanori; Kanai, Nobuo; Kobayashi, Shinichiro; Hosoi, Takahiro; Takagi, Ryo; Ohki, Takashi; Muragaki, Yoshihiro; Yamato, Masayuki; Eguchi, Susumu; Fukai, Fumio; Okano, Teruo			Endoscopic cell sheet transplantation device developed by using a 3-dimensional printer and its feasibility evaluation in a porcine model	GASTROINTESTINAL ENDOSCOPY			English	Article							STEROID GEL APPLICATION; SUBMUCOSAL DISSECTION; ESOPHAGEAL STRICTURE; PREVENTION; SURFACES; STENT	Background: To prevent severe esophageal stenosis after aggressive endoscopic submucosal dissection (ESD), our group previously reported an efficient treatment using cell sheets that had been fabricated from patient cells. However, this transplantation procedure had not been easy for every endoscopist and needed to be improved to derive the full effect of epithelial cell sheets. Objective: To develop an endoscopic device that enables easy and effective cell sheet transplantation and to evaluate its performance and clinical feasibility. Design: Animal study. Setting: Animal experimentation laboratory. Intervention: Three pigs underwent circumferential esophageal ESD while under general anesthesia. A total of 12 cell sheets were endoscopically transplanted to the ESD site; 6 cell sheets were transplanted by using an endoscopic device that we developed, and 6 cell sheets were transplanted by using the conventional method. Main Outcome Measurements: Procedure time, transplanted area on the ESD site, transplantation success rate, and monitoring of adverse events or incidents. Results: The device allowed successful transplantation of all cell sheets with a shorter procedure time than with the conventional method (4.8 +/- 0.8 minutes vs 13.3 +/- 5.7 minutes, respectively) (P = .005) and onto a larger area (111.3 +/- 56.3 mm(2) vs 41.8 +/- 4.2 mm(2), respectively) (P = .023) with a higher success rate (100% vs 83%, respectively). No adverse incidents were monitored in each method. Limitations: Animal study, small sample. Conclusion: A newly designed endoscopic cell sheet transplantation device would be useful.	[Maeda, Masanori; Kanai, Nobuo; Kobayashi, Shinichiro; Hosoi, Takahiro; Takagi, Ryo; Ohki, Takashi; Muragaki, Yoshihiro; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan; [Kobayashi, Shinichiro; Eguchi, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 852, Japan; [Hosoi, Takahiro; Fukai, Fumio] Tokyo Univ Sci, Grad Sch Pharmaceut Sci, Dept Pharmaceut Sci, Tokyo 162, Japan; [Ohki, Takashi] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo 1628666, Japan; [Muragaki, Yoshihiro] Tokyo Womens Med Univ, Neurol Inst, Dept Neurosurg, Tokyo 1628666, Japan	Yamato, M (reprint author), Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, TWIns, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.				CellSeed Inc.; Cell Sheet Tissue Engineering Center (CSTEC); Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Health Labor Scientific Research Grants [26220101, 26270801];  [14483609]	Dr Okano is a founder of CellSeed Inc, is a member of the Board of Directors of CellSeed Inc and has licensed technologies and patents from Tokyo Women's Medical University related to this study and is a shareholder in CellSeed Inc. Dr Yamato is a consultant and shareholder in CellSeed Inc. All other authors disclosed no financial relationships relevant to this article. This study was supported by Grant-in-Aid for Scientific Research (14483609 to Dr Kanai), Cell Sheet Tissue Engineering Center (CSTEC), The Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a Health Labor Scientific Research Grants (26220101 to Dr Okano and 26270801 to Dr Yamato).	Ono S, 2014, ENDOSCOPY, V46, pE44, DOI 10.1055/s-0033-1359125; Verschuur EML, 2006, GASTROINTEST ENDOSC, V63, P134, DOI 10.1016/j.gie.2005.07.051; Repici A, 2010, GASTROINTEST ENDOSC, V71, P715, DOI 10.1016/j.gie.2009.11.020; Yamato M, 2000, BIOMATERIALS, V21, P981, DOI 10.1016/S0142-9612(99)00239-2; Mori H, 2013, J GASTROEN HEPATOL, V28, P999, DOI 10.1111/jgh.12154; YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571; Yamaguchi N, 2011, GASTROINTEST ENDOSC, V73, P1115, DOI 10.1016/j.gie.2011.02.005; Ohki T, 2006, GUT, V55, P1704, DOI 10.1136/gut.2005.088518; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Ono S, 2009, GASTROINTEST ENDOSC, V70, P860, DOI 10.1016/j.gie.2009.04.044; Hammad Hazem, 2014, Curr Gastroenterol Rep, V16, P386, DOI 10.1007/s11894-014-0386-0; Kanai N, 2012, GASTROINTEST ENDOSC, V76, P873, DOI 10.1016/j.gie.2012.06.017; LEE M, 1995, GASTROINTEST ENDOSC, V41, P598, DOI 10.1016/S0016-5107(95)70199-0; Lee Wook Jin, 2013, Clin Endosc, V46, P643, DOI 10.5946/ce.2013.46.6.643; Takagi R, 2011, BIOCHEM BIOPH RES CO, V412, P226, DOI 10.1016/j.bbrc.2011.07.069; Takimoto K, 2012, Endoscopy, V44 Suppl 2 UCTN, pE414, DOI 10.1055/s-0032-1325739; Tietjen T G, 1994, Gastrointest Endosc Clin N Am, V4, P851; Wen J, 2014, DIGEST DIS SCI, V59, P658, DOI 10.1007/s10620-013-2958-5; Yang F, 2013, J GASTROEN HEPATOL, V28, P1795, DOI 10.1111/jgh.12370	19	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JUL	2015	82	1					147	152		10.1016/j.gie.2015.01.062		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK4GR	WOS:000356182600021		
J	Hanaoka, N; Ishihara, R; Matsuura, N; Uedo, N; Takeuchi, Y; Higashino, K; Yamashina, T; Aoi, K; Iishi, H				Hanaoka, Noboru; Ishihara, Ryu; Matsuura, Noriko; Uedo, Noriya; Takeuchi, Yoji; Higashino, Koji; Yamashina, Takeshi; Aoi, Kenji; Iishi, Hiroyasu			Esophageal EUS by filling water-soluble lubricating jelly for diagnosis of depth of invasion in superficial esophageal cancer	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Hanaoka, Noboru; Ishihara, Ryu; Matsuura, Noriko; Uedo, Noriya; Takeuchi, Yoji; Higashino, Koji; Yamashina, Takeshi; Aoi, Kenji; Iishi, Hiroyasu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Osaka, Japan	Hanaoka, N (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Osaka, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JUL	2015	82	1					164	165		10.1016/j.gie.2015.01.028		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK4GR	WOS:000356182600024		
J	Ikeuchi, N; Itoi, T; Tsuchiya, T; Nagakawa, Y; Tsuchida, A				Ikeuchi, Nobuhito; Itoi, Takao; Tsuchiya, Takayoshi; Nagakawa, Yuichi; Tsuchida, Akihiko			One-step EUS-guided gastrojejunostomy with use of lumen-apposing metal stent for afferent loop syndrome treatment	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Ikeuchi, Nobuhito; Itoi, Takao; Tsuchiya, Takayoshi] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan; [Nagakawa, Yuichi; Tsuchida, Akihiko] Tokyo Med Univ, Dept Surg, Tokyo 1608402, Japan	Ikeuchi, N (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JUL	2015	82	1					166	166		10.1016/j.gie.2015.01.010		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK4GR	WOS:000356182600026		
J	Yamaguchi, T; Inoue, T; Nishida, T; Kato, M; Hayashi, Y; Tsujii, Y; Maekawa, A; Kawai, S; Fujinaga, T; Araki, M; Nagai, K; Yoshii, S; Hiyama, S; Shinzaki, S; Iijima, H; Tsujii, M; Takehara, T				Yamaguchi, Toshio; Inoue, Takuya; Nishida, Tsutomu; Kato, Motohiko; Hayashi, Yoshito; Tsujii, Yoshiki; Maekawa, Akira; Kawai, Shoichiro; Fujinaga, Tetsuji; Araki, Manabu; Nagai, Kengo; Yoshii, Shunsuke; Hiyama, Satoshi; Shinzaki, Shinichiro; Iijima, Hideki; Tsujii, Masahiko; Takehara, Tetsuo			Localized gastric amyloidosis mimicking a submucosal tumor-like gastric cancer	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Yamaguchi, Toshio; Inoue, Takuya; Nishida, Tsutomu; Kato, Motohiko; Hayashi, Yoshito; Tsujii, Yoshiki; Maekawa, Akira; Kawai, Shoichiro; Fujinaga, Tetsuji; Araki, Manabu; Nagai, Kengo; Yoshii, Shunsuke; Hiyama, Satoshi; Shinzaki, Shinichiro; Iijima, Hideki; Tsujii, Masahiko; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Osaka, Japan; [Nishida, Tsutomu] Toyonaka City Hosp, Osaka, Japan; [Kato, Motohiko] Tokyo Med Ctr, Osaka, Japan	Yamaguchi, T (reprint author), Osaka Univ, Grad Sch Med, Osaka, Japan.			Nishida, Tsutomu/0000-0003-4037-9003				0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JUL	2015	82	1					175	177		10.1016/j.gie.2015.01.043		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK4GR	WOS:000356182600036		
J	Nakai, Y; Isayama, H; Koike, K				Nakai, Yousuke; Isayama, Hiroyuki; Koike, Kazuhiko			Guidewire cannulation: Are we moving in the opposite direction from evidence-based medicine? Response	GASTROINTESTINAL ENDOSCOPY			English	Letter							POST-ERCP PANCREATITIS; RISK-FACTORS		[Nakai, Yousuke; Isayama, Hiroyuki; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan	Nakai, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.						Freeman ML, 2001, GASTROINTEST ENDOSC, V54, P425, DOI 10.1067/mge.2001.117550; Tse F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009662.pub2; Nakai Y, 2015, GASTROINTEST ENDOSC, V81, P119, DOI 10.1016/j.gie.2014.06.005	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JUL	2015	82	1					183	184		10.1016/j.gie.2015.02.048		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK4GR	WOS:000356182600045		
J	Nakai, Y; Isayama, H; Koike, K				Nakai, Yousuke; Isayama, Hiroyuki; Koike, Kazuhiko			Pancreatic duct manipulation and risk of post-ERCP pancreatitis Response	GASTROINTESTINAL ENDOSCOPY			English	Letter							ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; VOLUME; CANNULATION		[Nakai, Yousuke; Isayama, Hiroyuki; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan	Nakai, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.						Testoni PA, 2010, AM J GASTROENTEROL, V105, P1753, DOI 10.1038/ajg.2010.136; Kapral C, 2008, ENDOSCOPY, V40, P625, DOI 10.1055/s-2008-1077461; Choudhary A, 2011, GASTROINTEST ENDOSC, V73, P275, DOI 10.1016/j.gie.2010.10.039; Cote GA, 2013, MED CARE, V51, P1040, DOI 10.1097/MLR.0b013e3182a502dc; Cote GA, 2011, GASTROINTEST ENDOSC, V74, P65, DOI 10.1016/j.gie.2011.01.072; Nakai Y, 2015, GASTROINTEST ENDOSC, V81, P119, DOI 10.1016/j.gie.2014.06.005; Peng CY, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-147; Varadarajulu S, 2006, GASTROINTEST ENDOSC, V64, P338, DOI 10.1016/j.gie.2005.05.016	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JUL	2015	82	1					184	185		10.1016/j.gie.2015.02.049		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK4GR	WOS:000356182600047		
J	Watanabe, K; Kuwae, T				Watanabe, Kenta; Kuwae, Tomohiro			How organic carbon derived from multiple sources contributes to carbon sequestration processes in a shallow coastal system?	GLOBAL CHANGE BIOLOGY			English	Article						blue carbon; carbon sequestration; estuary; organic carbon dynamics; phytoplankton; seagrass meadow; sediment; stable isotope	SUSPENDED PARTICULATE MATTER; MARINE-PHYTOPLANKTON; ISOTOPIC COMPOSITION; POSIDONIA-OCEANICA; DOMINATED ESTUARY; ATMOSPHERIC CO2; RIVER; SEA; NITROGEN; SINKS	Carbon captured by marine organisms helps sequester atmospheric CO2, especially in shallow coastal ecosystems, where rates of primary production and burial of organic carbon (OC) from multiple sources are high. However, linkages between the dynamics of OC derived from multiple sources and carbon sequestration are poorly understood. We investigated the origin (terrestrial, phytobenthos derived, and phytoplankton derived) of particulate OC (POC) and dissolved OC (DOC) in the water column and sedimentary OC using elemental, isotopic, and optical signatures in Furen Lagoon, Japan. Based on these data analysis, we explored how OC from multiple sources contributes to sequestration via storage in sediments, water column sequestration, and air-sea CO2 exchanges, and analyzed how the contributions vary with salinity in a shallow seagrass meadow as well. The relative contribution of terrestrial POC in the water column decreased with increasing salinity, whereas autochthonous POC increased in the salinity range 10-30. Phytoplankton-derived POC dominated the water column POC (65-95%) within this salinity range; however, it was minor in the sediments (3-29%). In contrast, terrestrial and phytobenthos-derived POC were relatively minor contributors in the water column but were major contributors in the sediments (49-78% and 19-36%, respectively), indicating that terrestrial and phytobenthos-derived POC were selectively stored in the sediments. Autochthonous DOC, part of which can contribute to long-term carbon sequestration in the water column, accounted for >25% of the total water column DOC pool in the salinity range 15-30. Autochthonous OC production decreased the concentration of dissolved inorganic carbon in the water column and thereby contributed to atmospheric CO2 uptake, except in the low-salinity zone. Our results indicate that shallow coastal ecosystems function not only as transition zones between land and ocean but also as carbon sequestration filters. They function at different timescales, depending on the salinity, and OC sources.	[Watanabe, Kenta; Kuwae, Tomohiro] Port & Airport Res Inst, Coastal & Estuarine Environm Res Grp, Yokosuka, Kanagawa 2390826, Japan	Watanabe, K (reprint author), Port & Airport Res Inst, Coastal & Estuarine Environm Res Grp, 3-1-1 Nagase, Yokosuka, Kanagawa 2390826, Japan.	watanabe-ke@ipc.pari.go.jp	Kenta, Watanabe/O-2786-2015	Kenta, Watanabe/0000-0002-0106-3623	Canon Foundation; Japan Society for the Promotion of Science (JSPS) [24656316, 26630251]	We thank S. Montani, T. Inoue, and anonymous reviewers for helpful comments; S. Shibanuma, E. Miyoshi, T. Tokoro, J. Kyoda, K. Tada, and the students of Hokkaido University for help in observations; K. Sakihara for chemical analysis. This study was supported by a lCanon Foundation grant and a Grant-in-Aid for Challenging Exploratory Research (No. 24656316, 26630251) from the Japan Society for the Promotion of Science (JSPS).	Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Savoye N, 2012, ESTUAR COAST SHELF S, V108, P16, DOI 10.1016/j.ecss.2011.12.005; Astoreca R, 2009, ESTUAR COAST SHELF S, V85, P633, DOI 10.1016/j.ecss.2009.10.010; Chen CTA, 2009, DEEP-SEA RES PT II, V56, P578, DOI 10.1016/j.dsr2.2009.01.001; Bergamaschi BA, 2012, ENVIRON SCI TECHNOL, V46, P1371, DOI 10.1021/es2029137; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Saadi I, 2006, CHEMOSPHERE, V63, P530, DOI 10.1016/j.chemosphere.2005.07.075; Harmelin-Vivien M, 2010, BIOGEOCHEMISTRY, V100, P139, DOI 10.1007/s10533-010-9411-z; Romera-Castillo C, 2010, LIMNOL OCEANOGR, V55, P446, DOI 10.4319/lo.2010.55.1.0446; Perdue EM, 2007, ESTUAR COAST SHELF S, V73, P65, DOI 10.1016/j.ecss.2006.12.021; Goni MA, 2003, ESTUAR COAST SHELF S, V57, P1023, DOI 10.1016/S0272-7714(03)00008-8; Borges AV, 2005, ESTUARIES, V28, P3, DOI 10.1007/BF02732750; Maksymowska D, 2000, ESTUAR COAST SHELF S, V51, P585, DOI 10.1006/ecss.2000.0701; Biddanda B, 1997, LIMNOL OCEANOGR, V42, P506; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Dubois S, 2012, J MARINE SYST, V94, P64, DOI 10.1016/j.jmarsys.2011.10.009; Tokoro T, 2014, GLOBAL CHANGE BIOL, V20, P1873, DOI 10.1111/gcb.12543; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Macreadie PI, 2012, GLOBAL CHANGE BIOL, V18, P891, DOI 10.1111/j.1365-2486.2011.02582.x; Zurbrugg R, 2013, BIOGEOSCIENCES, V10, P23, DOI 10.5194/bg-10-23-2013; Yamashita Y, 2008, LIMNOL OCEANOGR, V53, P1900, DOI 10.4319/lo.2008.53.5.1900; Macreadie PI, 2014, MAR POLLUT BULL, V83, P430, DOI 10.1016/j.marpolbul.2013.07.038; Jiao N, 2014, BIOGEOSCIENCES, V11, P5285, DOI 10.5194/bg-11-5285-2014; Hur J, 2009, ENVIRON SCI TECHNOL, V43, P2315, DOI 10.1021/es802773b; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/ngeo1830, 10.1038/NGEO1830]; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Cai WJ, 2011, ANNU REV MAR SCI, V3, P123, DOI 10.1146/annurev-marine-120709-142723; HEDGES JI, 1994, LIMNOL OCEANOGR, V39, P743; Wada S, 2008, MAR ECOL PROG SER, V370, P33, DOI 10.3354/meps07645; Borges AV, 2005, GEOPHYS RES LETT, V32, DOI [10.1029/2004GL022155, 10.1029/2005GL023794]; Fichot CG, 2012, LIMNOL OCEANOGR, V57, P1453, DOI 10.4319/lo.2012.57.5.1453; Duarte CM, 2013, NAT CLIM CHANGE, V3, P961, DOI [10.1038/nclimate1970, 10.1038/NCLIMATE1970]; Agusti S, 2013, BIOGEOSCIENCES, V10, P1259, DOI 10.5194/bg-10-1259-2013; BRICAUD A, 1981, LIMNOL OCEANOGR, V26, P43; Barron C, 2009, MAR ECOL PROG SER, V374, P75, DOI 10.3354/meps07715; Zonneveld KAF, 2010, BIOGEOSCIENCES, V7, P483; Helms JR, 2008, LIMNOL OCEANOGR, V53, P955, DOI 10.4319/lo.2008.53.3.0955; Bauer JE, 2013, NATURE, V504, P61, DOI 10.1038/nature12857; Chen CTA, 2012, CURR OPIN ENV SUST, V4, P179, DOI 10.1016/j.cosust.2012.02.003; Chen ZQ, 2007, MAR CHEM, V104, P98, DOI 10.1016/j.marchem.2006.12.007; Bianchi T. S., 2007, BIOGEOCHEMISTRY ESTU; Cai WJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026219; Carlson C.A., 2002, BIOGEOCHEMISTRY MARI, P91, DOI DOI 10.1016/B978-012323841-2/50006-3; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Fry B., 2006, STABLE ISOTOPE ECOLO; Guerra R, 2013, ESTUAR COAST SHELF S, V135, P24, DOI 10.1016/j.ecss.2013.06.022; International Panel on Climate Change (IPCC), 2013, CLIMATE CHANGE 2013, P465; Kennedy H., 2009, MANAGEMENT NATURAL C, P23; Lonborg C, 2009, ESTUAR COAST SHELF S, V81, P513, DOI 10.1016/j.ecss.2008.12.009; Maher TD, 2012, GLOBAL BIOGEOCHEMICA, V26; Montani S, 2011, B COASTAL OCEANOGRAP, V49, P59; Nagata T., 2008, MICROBIAL ECOLOGY OC, P207, DOI DOI 10.1002/9780470281840.CH7; Nellemann C., 2009, BLUE CARBON RAPID RE; OPSAHL S, 1993, MAR ECOL PROG SER, V94, P191, DOI 10.3354/meps094191; Para J, 2013, BIOGEOSCIENCES, V10, P2761, DOI 10.5194/bg-10-2761-2013; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Redfield A. C., 1963, SEA, V2, P26; Mateo MA, 1997, ESTUAR COAST SHELF S, V44, P103, DOI 10.1006/ecss.1996.0116; Sato T, 2006, ESTUAR COAST SHELF S, V68, P245, DOI 10.1016/j.ecss.2006.02.007; VansMooy BAS, 2002, GEOCHIMICA COSMOCHIM, V66, P457; ZEITZSCH.B, 1970, MAR BIOL, V7, P305, DOI 10.1007/BF00750823	62	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-1013	1365-2486		GLOBAL CHANGE BIOL	Glob. Change Biol.	JUL	2015	21	7					2612	2623		10.1111/gcb.12924		12	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CK7OS	WOS:000356422500013		
J	Tubiello, FN; Salvatore, M; Ferrara, AF; House, J; Federici, S; Rossi, S; Biancalani, R; Golec, RDC; Jacobs, H; Flammini, A; Prosperi, P; Cardenas-Galindo, P; Schmidhuber, J; Sanchez, MJS; Srivastava, N; Smith, P				Tubiello, Francesco N.; Salvatore, Mirella; Ferrara, Alessandro F.; House, Jo; Federici, Sandro; Rossi, Simone; Biancalani, Riccardo; Golec, Rocio D. Condor; Jacobs, Heather; Flammini, Alessandro; Prosperi, Paolo; Cardenas-Galindo, Paola; Schmidhuber, Josef; Sanchez, Maria J. Sanz; Srivastava, Nalin; Smith, Pete			The Contribution of Agriculture, Forestry and other Land Use activities to Global Warming, 1990-2012	GLOBAL CHANGE BIOLOGY			English	Article						AFOLU; Agriculture; Climate Change; Emissions; GHG; Mitigation		We refine the information available through the IPCC AR5 with regard to recent trends in global GHG emissions from agriculture, forestry and other land uses (AFOLU), including global emission updates to 2012. Using all three available AFOLU datasets employed for analysis in the IPCC AR5, rather than just one as done in the IPCC AR5 WGIII Summary for Policy Makers, our analyses point to a down-revision of global AFOLU shares of total anthropogenic emissions, while providing important additional information on subsectoral trends. Our findings confirm that the share of AFOLU emissions to the anthropogenic total declined over time. They indicate a decadal average of 28.7 +/- 1.5% in the 1990s and 23.6 +/- 2.1% in the 2000s and an annual value of 21.2 +/- 1.5% in 2010. The IPCC AR5 had indicated a 24% share in 2010. In contrast to previous decades, when emissions from land use (land use, land use change and forestry, including deforestation) were significantly larger than those from agriculture (crop and livestock production), in 2010 agriculture was the larger component, contributing 11.2 +/- 0.4% of total GHG emissions, compared to 10.0 +/- 1.2% of the land use sector. Deforestation was responsible for only 8% of total anthropogenic emissions in 2010, compared to 12% in the 1990s. Since 2010, the last year assessed by the IPCC AR5, new FAO estimates indicate that land use emissions have remained stable, at about 4.8Gt CO2 eqyr(-1) in 2012. Emissions minus removals have also remained stable, at 3.2Gt CO2 eqyr(-1) in 2012. By contrast, agriculture emissions have continued to grow, at roughly 1% annually, and remained larger than the land use sector, reaching 5.4Gt CO2 eqyr(-1) in 2012. These results are useful to further inform the current climate policy debate on land use, suggesting that more efforts and resources should be directed to further explore options for mitigation in agriculture, much in line with the large efforts devoted to REDD+ in the past decade.	[Tubiello, Francesco N.; Salvatore, Mirella; Ferrara, Alessandro F.; Federici, Sandro; Rossi, Simone; Biancalani, Riccardo; Golec, Rocio D. Condor; Jacobs, Heather; Flammini, Alessandro; Prosperi, Paolo; Cardenas-Galindo, Paola] Food & Agr Org United Nations, Climate Energy & Tenure Div, I-00153 Rome, Italy; [House, Jo] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Rossi, Simone] Commiss European Communities, Joint Res Ctr, I-28100 Ispra, VA, Italy; [Schmidhuber, Josef] Food & Agr Org United Nations, Div Stat, I-00153 Rome, Italy; [Sanchez, Maria J. Sanz] Food & Agr Org United Nations, Forest Management Div, I-00153 Rome, Italy; [Srivastava, Nalin] IGES, IPCC Task Force Natl GHG Inventories, Kamiyamaguchi Hayama, Kanagawa 210811, Japan; [Smith, Pete] Univ Aberdeen, Inst Biol & Environm Sci, Sch Biol Sci, Aberdeen AB24 3UU, Scotland	Tubiello, FN (reprint author), Food & Agr Org United Nations, Climate Energy & Tenure Div, Via Terme Caracalla, I-00153 Rome, Italy.	francesco.tubiello@fao.org	Smith, Pete/G-1041-2010	Smith, Pete/0000-0002-3784-1124	Government of Germany [GCP/GLO/286/GER]; Government of Norway [GCP/GLO/325/NOR]; Royal Society; Leverhulme Research Fellowship	This work was carried out with generous funding by the Governments of Germany (GCP/GLO/286/GER) and Norway (GCP/GLO/325/NOR) to the 'Monitoring and Assessment of GHG Emissions and Mitigation Potential from Agriculture' Project of the FAO Climate, Energy and Tenure Division. P. Smith is a Royal Society Wolfson Merit Award holder, and his input contributes to the University of Aberdeen Environment and Food Security Theme and to Scotland's ClimateXChange. J. House was funded by a Leverhulme Research Fellowship. The FAO Statistics Division maintains the FAOSTAT Emissions database with regular program funds allocated through Strategic Objective 6.	Pongratz J, 2014, EARTH SYST DYNAM, V5, P177, DOI 10.5194/esd-5-177-2014; Ciais P, 2013, CLIMATE CHANGE 2013, P465, DOI DOI 10.1017/CBO9781107415324.014; Edenhofer O, 2014, CLIMATE CHANGE 2014, P5; Eggleston HS, 2006, 2006 IPCC GUIDELINES; FAO, 2011, LINK SUST CLIM FIN I; FAO, 2014, AGR FOR OTH LAND US, V14/01; FAO, 2010, GLOB FOR RES ASS; FAOSTAT, 2014, FAOSTAT EM DAT; Friedlingstein P, 2011, NATURE CLIMATE CHANG, V1, P4457; Houghton RA, 2012, BIOGEOSCIENCES DISCU, V9, P835, DOI DOI 10.5194/BGD-9-835-2012; LesQuere C, 2014, EARTH SYSTEM SCI DAT, V6, P1; LesQuere C, 2013, EARTH SYSTEM SCI DAT, V5, P165, DOI DOI 10.5194/ESSD-5-165-2013; Metz B, 2007, CLIMATE CHANGE 2007; Smith P, 2014, CLIMATE CHANGE 2014, P799; Stern N., 2007, EC CLIMATE CHANGE ST; Tubiello FN, 2013, ENVIRON RES LETT, V8, P1; Werf G.R., 2006, ATMOS CHEM PHYS DISC, V6, P3175, DOI DOI 10.5194/ACPD-6-3175-2006	17	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-1013	1365-2486		GLOBAL CHANGE BIOL	Glob. Change Biol.	JUL	2015	21	7					2655	2660		10.1111/gcb.12865		6	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CK7OS	WOS:000356422500017		
J	Hirotsu, Y; Kanda, T; Matsumura, H; Moriyama, M; Yokosuka, O; Omata, M				Hirotsu, Yosuke; Kanda, Tatsuo; Matsumura, Hiroshi; Moriyama, Mitsuhiko; Yokosuka, Osamu; Omata, Masao			HCV NS5A resistance-associated variants in a group of real-world Japanese patients chronically infected with HCV genotype 1b	HEPATOLOGY INTERNATIONAL			English	Article						HCV; Drug resistance; NS5A; RAV; Ultra-deep sequencing	DACLATASVIR PLUS ASUNAPREVIR; C VIRUS VARIANTS; HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; INHIBITOR BMS-790052; SOFOSBUVIR; RIBAVIRIN; ABT-450/R-OMBITASVIR; DASABUVIR; LEDIPASVIR	Recent advances in interferon-free treatment could lead to the eradication of hepatitis C virus (HCV) from patients infected with HCV. One of the direct-acting anti-viral agents, HCV NS5A inhibitor, is available for these combination therapies. However, naturally occurring resistance-associated variants (RAVs) to HCV NS5A inhibitors in treatment-na < ve patients chronically infected with HCV genotype 1b are still unknown. We performed ultra-deep sequencing and analysed previously reported RAVs in a total 132 HCV genotype 1b-infected Japanese patients who had never used HCV NS5A inhibitors. We also performed direct-sequencing by Sanger method in consecutively selected 50 of the total 132 samples, and the differences between the results of the two methods were compared. In the comparison of the variant frequencies of ultra-deep sequencing with RAVs of direct-sequencing by Sanger method in 50 patients, we identified 32 RAVs by direct-sequencing with the Sanger method; minimum variant frequency was shown by ultra-deep sequencing to be 9 %. A total of 110 RAVs were identified only by ultra-deep sequencing. In the samples from all 132 patients, L31W (2.3 %), L31V (49.2 %), L31F (41.7 %), L31M (1.5 %), L31I (5.3 %), L31S (2.0 %), L31P (3.0 %) and L31R (0.8 %), and Y93N (2.3 %), Y93H (25 %), Y93C (0.8 %), Y93P (2.3 %) and Y93D (0.8 %) were identified. We demonstrated naturally-occurring RAVs of HCV NS5A inhibitors by ultra-deep sequencing and that several mutations including Y93H are common in HCV NS5A inhibitor-treatment-na < ve patients with chronic HCV genotype 1b. Careful attention should be paid to these RAVs, and further improvement of treatment options might be needed.	[Hirotsu, Yosuke; Omata, Masao] Yamanashi Prefectural Cent Hosp, Genome Anal Ctr, Kofu, Yamanashi 4008506, Japan; [Kanda, Tatsuo; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, Chiba 2608677, Japan; [Matsumura, Hiroshi; Moriyama, Mitsuhiko] Nihon Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Tokyo 1738610, Japan; [Omata, Masao] Univ Tokyo, Bunkyo Ku, Tokyo 1138655, Japan	Kanda, T (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan.	kandat-cib@umin.ac.jp			Yamanashi Prefecture	We are all thankful to our colleagues at the liver units of each hospital who cared for the patients described herein. This study was supported by a Grant-in-Aid for the Genome Research Project from Yamanashi Prefecture (to Yosuke Hirotsu and Masao Omata).	Shiratori Y, 2005, ANN INTERN MED, V142, P105; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Watashi K, 2007, REV MED VIROL, V17, P245, DOI 10.1002/rmv.534; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Suzuki F, 2012, J CLIN VIROL, V54, P352, DOI 10.1016/j.jcv.2012.04.024; Gane EJ, 2010, LANCET, V376, P1467, DOI 10.1016/S0140-6736(10)61384-0; Bartels DJ, 2013, J VIROL, V87, P1544, DOI 10.1128/JVI.02294-12; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Fridell RA, 2010, ANTIMICROB AGENTS CH, V54, P3641, DOI 10.1128/AAC.00556-10; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Suzuki Y, 2013, J HEPATOL, V58, P655, DOI 10.1016/j.jhep.2012.09.037; Nakamoto S, 2014, WORLD J GASTROENTERO, V20, P2902, DOI 10.3748/wjg.v20.i11.2902; Applegate T.L., 2014, ANTIVIR THER, V20, P199, DOI DOI 10.3851/IMP2821; Deuffic-Burban S, 2008, J HEPATOL, V49, P175, DOI 10.1016/j.jhep.2008.04.012; DiBisceglie AM, 1997, HEPATOLOGY, V26, pS34, DOI 10.1002/hep.510260706; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Miura M, 2014, HEPATOL RES, V44, pE360, DOI 10.1111/hepr.12316; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Quail MA, 2012, BMC GENOMICS, V13, P34; Schregel V, 2009, P NATL ACAD SCI USA, V106, P5342, DOI 10.1073/pnas.0810950106; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073615; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	30	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-0533	1936-0541		HEPATOL INT	Hepatol. Int.	JUL	2015	9	3					424	430		10.1007/s12072-015-9624-2		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK8SB	WOS:000356507300014		
J	Wada, S; Ideno, H; Shimada, A; Kamiunten, T; Nakamura, Y; Nakashima, K; Kimura, H; Shinkai, Y; Tachibana, M; Nifuji, A				Wada, Satoshi; Ideno, Hisashi; Shimada, Akemi; Kamiunten, Taichi; Nakamura, Yoshiki; Nakashima, Kazuhisa; Kimura, Hiroshi; Shinkai, Yoichi; Tachibana, Makoto; Nifuji, Akira			H3K9MTase G9a is essential for the differentiation and growth of tenocytes in vitro	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						Cell differentiation; Tenocytes; Epigenetics; Histone modification	LYSINE 9 METHYLTRANSFERASES; HISTONE METHYLTRANSFERASES; COORDINATED EXPRESSION; TENDON DIFFERENTIATION; METHYLATION; TRANSCRIPTION; GENE; GLP; SCLERAXIS; MORPHOGENESIS	Cell differentiation is controlled by specific transcription factors. The functions and expression levels of these transcription factors are regulated by epigenetic modifications, such as histone modifications and cytosine methylation of the genome. In tendon tissue, tendon-specific transcription factors have been shown to play functional roles in the regulation of tenocyte differentiation. However, the effects of epigenetic modifications on gene expression and differentiation in tenocytes are unclear. In this study, we investigated the epigenetic regulation of tenocyte differentiation, focusing on the enzymes mediating histone 3 lysine 9 (H3K9) methylation. In primary mouse tenocytes, six H3K9 methyltransferase (H3K9MTase) genes, i.e., G9a, G9a-like protein (GLP), PR domain zinc finger protein 2 (PRDM2), SUV39H1, SUV39H2, and SETDB1/ESET were all expressed, with increased mRNA levels observed during tenocyte differentiation. In mouse embryos, G9a and Prdm2 mRNAs were expressed in tenocyte precursor cells, which were overlapped with or were adjacent to cells expressing a tenocyte-specific marker, tenomodulin. Using tenocytes isolated from G9a-flox/flox mice, we deleted G9a by infecting the cells with Cre-expressing adenoviruses. Proliferation of G9a-null tenocytes was significantly decreased compared with that of control cells infected with GFP-expressing adenoviruses. Moreover, the expression levels of tendon transcription factors gene, i.e., Scleraxis (Scx), Mohawk (Mkx), Egr1, Six1, and Six2 were all suppressed in G9a-null tenocytes. The tendon-related genes Col1a1, tenomodulin, and periostin were also downregulated. Consistent with this, Western blot analysis showed that tenomodulin protein expression was significantly suppressed by G9a deletion. These results suggested that expression of the H3K9MTase G9a was essential for the differentiation and growth of tenocytes and that H3K9MTases may play important roles in tendinogenesis.	[Wada, Satoshi; Ideno, Hisashi; Shimada, Akemi; Kamiunten, Taichi; Nakashima, Kazuhisa; Nifuji, Akira] Tsurumi Univ, Dept Pharmacol, Sch Dent Med, Tsurumi Ku, Yokohama, Kanagawa 2308501, Japan; [Wada, Satoshi; Kamiunten, Taichi; Nakamura, Yoshiki] Tsurumi Univ, Dept Orthodont, Sch Dent Med, Yokohama, Kanagawa 2308501, Japan; [Ideno, Hisashi; Nifuji, Akira] Natl Inst Radiol Sci, Transcriptome Res Grp, Chiba 260, Japan; [Kimura, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Shinkai, Yoichi] RIKEN, Cellular Memory Lab, Wako, Saitama, Japan; [Tachibana, Makoto] Univ Tokushima, Inst Enzyme Res, Tokushima 770, Japan	Nifuji, A (reprint author), Tsurumi Univ, Dept Pharmacol, Sch Dent Med, Tsurumi Ku, 2-1-3 Tsurumi, Yokohama, Kanagawa 2308501, Japan.	nifuji-a@tsurumi-u.ac.jp					Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad989402; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Guerquin MJ, 2013, J CLIN INVEST, V123, P3564, DOI 10.1172/JCI67521; Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Lehnertz B, 2010, J EXP MED, V207, P915, DOI 10.1084/jem.20100363; Ling BMT, 2012, P NATL ACAD SCI USA, V109, P841, DOI 10.1073/pnas.1111628109; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Shankar SR, 2013, EPIGENETICS-US, V8, P16, DOI 10.4161/epi.23331; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Balemans MCM, 2014, DEV BIOL, V386, P395, DOI 10.1016/j.ydbio.2013.12.016; Asou Y, 2002, J ORTHOPAED RES, V20, P827, DOI 10.1016/S0736-0266(01)00169-3; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; Soeda T, 2010, GENESIS, V48, P635, DOI 10.1002/dvg.20667; Purcell DJ, 2012, J CELL BIOCHEM, V113, P2406, DOI 10.1002/jcb.24114; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Rao RC, 2010, INVEST OPHTH VIS SCI, V51, P6784, DOI 10.1167/iovs.09-4730; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Blackburn ML, 2003, BBA-GENE STRUCT EXPR, V1629, P8, DOI 10.1016/S0167-4781(03)00155-6; Dodge E, 2004, MOL CELL BIOL, V24, P2478; Ideno H, 2013, GENE EXPR PATTERNS, V13, P84, DOI 10.1016/j.gep.2013.01.002; Inagawa M, 2013, MECH DEVELOP, V130, P519, DOI 10.1016/j.mod.2013.07.002; Kamiunten T, 2015, HISTOCHEM CELL BIOL, V143, P259, DOI 10.1007/s00418-014-1284-0; Nifuji A, 1999, J BONE MINER RES, V14, P2057, DOI 10.1359/jbmr.1999.14.12.2057; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Oshima Y, 2004, J CELL SCI, V117, P2731, DOI 10.1242/jcs.01112; Shimada A, 2014, HISTOCHEM CELL BIOL, V142, P205, DOI 10.1007/s00418-014-1191-4	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	JUL	2015	144	1					13	20		10.1007/s00418-015-1318-2		8	Cell Biology; Microscopy	Cell Biology; Microscopy	CK5MH	WOS:000356268300002		
J	Komine, K; Shimodaira, H; Takao, M; Soeda, H; Zhang, XF; Takahashi, M; Ishioka, C				Komine, Keigo; Shimodaira, Hideki; Takao, Masashi; Soeda, Hiroshi; Zhang, Xiaofei; Takahashi, Masanobu; Ishioka, Chikashi			Functional Complementation Assay for 47 MUTYH Variants in a MutY-Disrupted Escherichia Coli Strain	HUMAN MUTATION			English	Article						MUTYH; MAP; functional assay; polyposis; prediction	ADENINE-DNA GLYCOSYLASE; ADENOMATOUS POLYPOSIS; COLORECTAL-CANCER; HOMOLOG HMYH; REPAIR; MUTATIONS; DAMAGE; GENE; SPECIFICITY; BINDING	MUTYH-associated polyposis (MAP) is an adenomatous polyposis transmitted in an autosomal-recessive pattern, involving biallelic inactivation of the MUTYH gene. Loss of a functional MUTYH protein will result in the accumulation of G:T mismatched DNA caused by oxidative damage. Although p.Y179C and p.G396D are the two most prevalent MUTYH variants, more than 200 missense variants have been detected. It is difficult to determine whether these variants are disease-causing mutations or single-nucleotide polymorphisms. To understand the functional consequences of these variants, we generated 47 MUTYH gene variants via site-directed mutagenesis, expressed the encoded proteins in MutY-disrupted Escherichia coli, and assessed their abilities to complement the functional deficiency in the E. coli by monitoring spontaneous mutation rates. Although the majority of variants exhibited intermediate complementation relative to the wild type, some variants severely interfered with this complementation. However, some variants retained functioning similar to the wild type. In silico predictions of functional effects demonstrated a good correlation. Structural prediction of MUTYH based on the MutY protein structure allowed us to interpret effects on the protein stability or catalytic activity. These data will be useful for evaluating the functional consequences of missense MUTYH variants detected in patients with suspected MAP. Published 2015 Wiley Periodicals, Inc.*	[Komine, Keigo; Shimodaira, Hideki; Soeda, Hiroshi; Zhang, Xiaofei; Takahashi, Masanobu; Ishioka, Chikashi] Tohoku Univ, Dept Clin Oncol, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Komine, Keigo; Shimodaira, Hideki; Soeda, Hiroshi; Takahashi, Masanobu; Ishioka, Chikashi] Tohoku Univ Hosp, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi, Japan; [Takao, Masashi] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Genet, Aoba Ku, Sendai, Miyagi 9808575, Japan	Ishioka, C (reprint author), Tohoku Univ, Dept Clin Oncol, Inst Dev Aging & Canc, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	chikashi@idac.tohoku.ac.jp			JSPS KAKENHI [12217010, 16390122]; Takeda Medical Science Foundation; Chugai Pharmaceutical Company, Ltd.; Novartis Pharmaceutical Corporation	Contract grant sponsors: JSPS KAKENHI (grant number: 12217010 and 16390122); Takeda Medical Science Foundation; Chugai Pharmaceutical Company, Ltd.; Novartis Pharmaceutical Corporation.	Picelli S, 2010, EUR J CANCER, V46, P1041, DOI 10.1016/j.ejca.2010.01.013; Gismondi V, 2004, INT J CANCER, V109, P680, DOI 10.1002/ijc.20054; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Kundu S, 2009, DNA REPAIR, V8, P1400, DOI 10.1016/j.dnarep.2009.09.009; Lukianova OA, 2005, CURR OPIN CHEM BIOL, V9, P145, DOI 10.1016/j.cbpa.2005.02.006; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Turco E, 2013, NUCLEIC ACIDS RES, V41, P4093, DOI 10.1093/nar/gkt130; Takahashi M, 2007, CANCER RES, V67, P4595, DOI 10.1158/0008-5472.CAN-06-3509; Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917; Nielsen M, 2009, GASTROENTEROLOGY, V136, P471, DOI 10.1053/j.gastro.2008.10.056; Boal AK, 2007, J INORG BIOCHEM, V101, P1913, DOI 10.1016/j.jinorgbio.2007.05.001; Tenesa A, 2006, BRIT J CANCER, V95, P239, DOI 10.1038/sj.bjc.6603239; Noll DM, 1999, BIOCHEMISTRY-US, V38, P6374, DOI 10.1021/bi990335x; Takao M, 1999, NUCLEIC ACIDS RES, V27, P3638, DOI 10.1093/nar/27.18.3638; Out AA, 2010, HUM MUTAT, V31, P1205, DOI 10.1002/humu.21343; Nielsen M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033217; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Manuel RC, 2004, J BIOL CHEM, V279, P46930, DOI 10.1074/jbc.M403944200; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Goto M, 2010, HUM MUTAT, V31, pE1861, DOI 10.1002/humu.21363; Ali M, 2008, GASTROENTEROLOGY, V135, P499, DOI 10.1053/j.gastro.2008.04.035; D'Agostino VG, 2010, DNA REPAIR, V9, P700, DOI 10.1016/j.dnarep.2010.03.008; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Bai HB, 2005, NUCLEIC ACIDS RES, V33, P597, DOI 10.1093/nar/gki209; Bai HB, 2007, CANCER LETT, V250, P74, DOI 10.1016/j.canlet.2006.09.016; Molatore S, 2010, HUM MUTAT, V31, P159, DOI 10.1002/humu.21158; Nielsen M, 2010, CRIT REV ONCOL HEMAT, V79, P1; Parker AR, 2005, CARCINOGENESIS, V26, P2010, DOI 10.1093/carcin/bgi166; Shimodaira H, 1998, NAT GENET, V19, P384; Shinmura Kazuya, 2000, Nucleic Acids Research, V28, P4912, DOI 10.1093/nar/28.24.4912; Wooden SH, 2004, CANCER LETT, V205, P89, DOI 10.1016/j.canlet.2003.10.006; Yanaru-Fujisawa R, 2008, CLIN GENET, V73, P545, DOI 10.1111/j.1399-0004.2008.00998.x	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-7794	1098-1004		HUM MUTAT	Hum. Mutat.	JUL	2015	36	7					704	711		10.1002/humu.22794		8	Genetics & Heredity	Genetics & Heredity	CK8NT	WOS:000356495700008		
J	Yu, TY; Xiao, J; Wang, FY; Zhang, R; Gu, ZH; Cichocki, A; Li, YQ				Yu, Tianyou; Xiao, Jun; Wang, Fangyi; Zhang, Rui; Gu, Zhenghui; Cichocki, Andrzej; Li, Yuanqing			Enhanced Motor Imagery Training Using a Hybrid BCI With Feedback	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Brain-computer interface (BCI); hybrid feature; motor imagery training; neuro-feedback; steady-state visually evoked potentials (SSVEPs)	BRAIN-COMPUTER INTERFACE; POTENTIALS; DESYNCHRONIZATION; PERFORMANCE; RHYTHM; STATE	Goal: Motor imagery-related mu/beta rhythms, which can be voluntarily modulated by subjects, have been widely used in EEG-based brain computer interfaces (BCIs). Moreover, it has been suggested that motor imagery-specific EEG differences can be enhanced by feedback training. However, the differences observed in the EEGs of naive subjects are typically not sufficient to provide reliable EEG control and thus result in unintended feedback. Such feedback can frustrate subjects and impede training. In this study, a hybrid BCI paradigm combining motor imagery and steady-state visually evoked potentials (SSVEPs) has been proposed to provide effective continuous feedback for motor imagery training. Methods: During the initial training sessions, subjects must focus on flickering buttons to evoke SSVEPs as they perform motor imagery tasks. The output/feedback of the hybrid BCI is based on hybrid features consisting of motor imagery-and SSVEP-related brain signals. In this context, the SSVEP plays a more important role than motor imagery in generating feedback. As the training progresses, the subjects can gradually decrease their visual attention to the flickering buttons, provided that the feedback is still effective. In this case, the feedback is mainly based on motor imagery. Results: Our experimental results demonstrate that subjects generate distinguishable brain patterns of hand motor imagery after only five training sessions lasting approximately 1.5 h each. Conclusion: The proposed hybrid feedback paradigm can be used to enhance motor imagery training. Significance: This hybrid BCI system with feedback can effectively identify the intentions of the subjects.	[Li, Yuanqing] S China Univ Technol, Sch Automat Sci & Engn, Guangzhou 510640, Guangdong, Peoples R China; [Yu, Tianyou; Xiao, Jun; Wang, Fangyi; Zhang, Rui; Gu, Zhenghui] S China Univ Technol, Guangzhou 510640, Guangdong, Peoples R China; [Cichocki, Andrzej] RIKEN Brain Sci Inst, Wako, Saitama, Japan	Li, YQ (reprint author), S China Univ Technol, Sch Automat Sci & Engn, Guangzhou 510640, Guangdong, Peoples R China.	auyqli@scut.edu.cn			National High-Tech R&D Program of China (863 Program) [2012AA011601]; National Natural Science Foundation of China [91120305, 61401162]; Guangdong Province Science Foundation for Research Team Program	This work was supported by the National High-Tech R&D Program of China (863 Program) under Grant 2012AA011601, the National Natural Science Foundation of China under Grants 91120305 and 61401162, Guangdong Province Science Foundation for Research Team Program. Asterisk indicates corresponding author.	Yuan H, 2014, IEEE T BIO-MED ENG, V61, P1425, DOI 10.1109/TBME.2014.2312397; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Hwang HJ, 2009, J NEUROSCI METH, V179, P150, DOI 10.1016/j.jneumeth.2009.01.015; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI [10.1109/MSP.2008.4408441, 10.1109/MSP.200790.900,9]; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Liavas AP, 1998, IEEE T BIO-MED ENG, V45, P242, DOI 10.1109/10.661272; Blankertz B, 2008, IEEE T BIO-MED ENG, V55, P2452, DOI 10.1109/TBME.2008.923152; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; McFarland DJ, 2005, IEEE T NEUR SYS REH, V13, P372, DOI 10.1109/TNSRE.2005.848627; Lu J, 2014, IEEE T NEUR SYS REH, V22, P847, DOI 10.1109/TNSRE.2014.2315717; Bayliss JD, 2003, IEEE T NEUR SYS REH, V11, P113, DOI 10.1109/TNSRE.2003.814438; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Li YQ, 2010, IEEE T BIO-MED ENG, V57, P2495, DOI 10.1109/TBME.2010.2055564; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Neuper C, 1999, J CLIN NEUROPHYSIOL, V16, P373, DOI 10.1097/00004691-199907000-00010; Pfurtscheller G, 2000, IEEE T REHABIL ENG, V8, P216, DOI 10.1109/86.847821; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; Vidaurre C, 2007, IEEE T BIO-MED ENG, V54, P550, DOI 10.1109/TBME.2006.888836; Ono T, 2013, CLIN NEUROPHYSIOL, V124, P1779, DOI 10.1016/j.clinph.2013.03.006; Bin G., 2009, J NEURAL ENG, V6; Bishop C. M., 2006, PATTERN RECOGNITION; Doud A. J., 2011, PLOS ONE, V6; Gazzaniga M. S., 2008, COGNITIVE NEUROSCIEN; Kaiser V, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00086; LaFleur K, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046003; Li Y, 2008, MACH LEARN, V71, P33, DOI 10.1007/s10994-007-5039-1; Lu J., 2013, J NEURAL ENG, V10; McFarland D. J., 1998, REHABILITATION ENG I, V6, P7; Neuper Christa, 2005, Brain Res Cogn Brain Res, V25, P668; Wang Y., 2006, BRAIN RES COGN BRAIN, V14, P234; Zhang H., 2011, J NEURAL ENG, V8	35	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	JUL	2015	62	7					1706	1717		10.1109/TBME.2015.2402283		12	Engineering, Biomedical	Engineering	CK6AR	WOS:000356310700004		
J	Yin, Y; Wang, T				Yin, You; Wang, Tao			Localization of Joule Heating in Phase-Change Memory With Incorporated Nanostructures and Nanolayer for Reducing Reset Current	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Low reset current; nanostructure; phase-change memory (PCM)	RANDOM-ACCESS MEMORY; TECHNOLOGY; FUTURE; FILMS; CELL	In this paper, we intensively investigated the proposed nanocontact phase-change memory (nano-C PCM) with incorporated nanostructures and high-resistivity nanolayer (nano-L) for reducing reset current. The high resistivity was able to be tuned by doping N into the conventional Ge2Sb2Te5 phase-change material. The analysis based on finite-element method exhibited that the current density in the nano-C PCM could be locally enhanced to about two times that of both conventional and nano-L PCM devices. This resulted in the localization of Joule heating in the nano-C PCM, making it have the highest temperature at the same programming current among the three types of PCM devices. Reset current of nano-C PCM could be greatly reduced to 8.2% of that of the conventional one, owing to its high-efficiency heating for amorphization.	[Yin, You] Gunma Univ, Fac Sci & Technol, Div Elect & Informat, Kiryu, Gumma 3768515, Japan; [Wang, Tao] Zhejiang Univ, Coll Elect Engn, Hangzhou 130025, Zhejiang, Peoples R China	Wang, T (reprint author), Zhejiang Univ, Coll Elect Engn, Hangzhou 130025, Zhejiang, Peoples R China.	yinyou@gunma-u.ac.jp; twang@zju.edu.cn			Ministry of Education, Culture, Sports, Science and Technology of Japan [24686042]	Manuscript received March 12, 2015; revised April 28, 2015; accepted May 3, 2015. Date of publication May 18, 2015; date of current version June 17, 2015. This work was supported by a Grant-in-Aid for Young Scientists through the Ministry of Education, Culture, Sports, Science and Technology of Japan under Grant 24686042. The review of this paper was arranged by Editor G. L. Snider.	Ando K., 2014, J APPL PHYS, V115; Kang DH, 2003, J APPL PHYS, V94, P3536, DOI 10.1063/1.1598272; Lankhorst MHR, 2005, NAT MATER, V4, P347, DOI 10.1038/nmat1350; Kohlstedt H, 2005, MICROELECTRON ENG, V80, P296, DOI 10.1016/j.mee.2005.04.084; Diao ZT, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/16/165209; Hosaka S, 2014, ACS APPL MATER INTER, V6, P6208, DOI 10.1021/am501230d; Raoux S, 2008, IBM J RES DEV, V52, P465; Park WI, 2013, ACS NANO, V7, P2651, DOI 10.1021/nn4000176; Kim K, 2007, MICROELECTRON ENG, V84, P1976, DOI 10.1016/j.mee.2007.04.120; Sun QQ, 2011, IEEE ELECTR DEVICE L, V32, P1167, DOI 10.1109/LED.2011.2159770; Friedrich I, 2000, J APPL PHYS, V87, P4130, DOI 10.1063/1.373041; Hou Y., 2013, APPL PHYS LETT, V102; Hubert Q., 2012, P EUR SOL STAT DEV R, P286; Ishiwara H, 2012, J NANOSCI NANOTECHNO, V12, P7619, DOI 10.1166/jnn.2012.6651; Jung Y., 2011, NANOTECHNOLOGY, V22; Kim YT, 2014, PHYS STATUS SOLIDI B, V251, P435, DOI 10.1002/pssb.201350003; Lu N., 2015, J PHYS D, V48; Meena J. S., 2014, NANOSCALE RES LETT, V9; Portal J. M., 2014, Journal of Electronic Science and Technology, V12, DOI 10.3969/j.issn.1674-862X.2014.02.007; Stainer Q., 2014, APPL PHYS LETT, V105; Xing M.-J., 2013, J APPL PHYS, V114; Yang H., 2014, APPL PHYS LETT, V105; Yin Y., 2013, APPL PHYS LETT, V103; Yin Y., 2008, APPL PHYS LETT, V92; Yin Y, 2006, JPN J APPL PHYS 1, V45, P8600, DOI 10.1143/JJAP.45.8600; Yin Y., 2009, APPL PHYS LETT, V95; Yin Y., 2013, J PHYS D, V46; Yin Y, 2006, JPN J APPL PHYS 1, V45, P6177, DOI 10.1143/JJAP.45.6177; Yin Y, 2005, JPN J APPL PHYS 1, V44, P6208, DOI 10.1143/JJAP.44.6208; Zhang H., 2014, APPL PHYS LETT, V104; Zhou P., 2009, APPL PHYS LETT, V94	31	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	JUL	2015	62	7					2184	2189		10.1109/TED.2015.2429689		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CK7ZY	WOS:000356457900017		
J	Fujisaki, Y; Takahashi, D; Nakajima, Y; Nakata, M; Tsuji, H; Yamamoto, T				Fujisaki, Yoshihide; Takahashi, Daichi; Nakajima, Yoshiki; Nakata, Mitsuru; Tsuji, Hiroshi; Yamamoto, Toshihiro			Alignment Control of Patterned Organic Semiconductor Crystals in Short-Channel Transistor Using Unidirectional Solvent Evaporation Process	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Alignment control; organic transistor; polymer gate dielectric; short channel; solution process	FIELD-EFFECT TRANSISTORS; THIN-FILM TRANSISTORS; TRIETHYLSILYLETHYNYL ANTHRADITHIOPHENE; HIGH-MOBILITY; PERFORMANCE; GROWTH; DOMAINS; ARRAYS; AIR	The patterning deposition of highly crystalline organic semiconductor films is a key issue in achieving high-mobility organic thin-film transistor (OTFT) arrays and circuits with practical device dimensions. However, it is generally difficult to obtain uniform crystalline films only on the desired channel regions over a large-area substrate. The alignment control of crystalline domains decreases size variations in the crystalline film. Herein, we present a patterning scheme that can control the alignment direction of solution-grown organic crystals. We employed a simple coating method combining drop casting and lamination coating. By creating a striped pattern of solvent-wettable/solvent-nonwettable regions on a polymer dielectric, we grew nearly uniaxially aligned ribbon-like crystals with a length of 100 mu m order within a confined channel region. Bottom-contact short-channel TFTs fabricated on such a stripe pattern showed a high mobility of up to 1.5 cm(2)/Vs. The proposed method is compatible with the fabrication of OTFTs over an arbitrary large area.	[Fujisaki, Yoshihide; Nakajima, Yoshiki; Nakata, Mitsuru; Tsuji, Hiroshi; Yamamoto, Toshihiro] NHK Japan Broadcasting Corp, Sci & Technol Res Labs, Tokyo 1578510, Japan; [Takahashi, Daichi] Tokyo Univ Sci, Tokyo 1628601, Japan	Fujisaki, Y (reprint author), NHK Japan Broadcasting Corp, Sci & Technol Res Labs, Tokyo 1578510, Japan.	fujisaki.y-hu@nhk.or.jp; nakajima.y-iq@nhk.or.jp; nakata.m-ji@nhk.or.jp; tsuji.h-hi@nhk.or.jp; yamamoto.t-ha@nhk.or.jp					Akkerman HB, 2012, ORG ELECTRON, V13, P235, DOI 10.1016/j.orgel.2011.11.005; Minemawari H, 2011, NATURE, V475, P364, DOI 10.1038/nature10313; Soeda J, 2011, ADV MATER, V23, P3681, DOI 10.1002/adma.201101467; Sakamoto K, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3695169; Zirkl M, 2011, ADV MATER, V23, P2069, DOI 10.1002/adma.201100054; Baeg KJ, 2013, IEEE ELECTR DEVICE L, V34, P126, DOI 10.1109/LED.2012.2226556; Dickey KC, 2006, ADV MATER, V18, P1721, DOI 10.1002/adma.200600188; Choi MH, 2012, IEEE ELECTR DEVICE L, V33, P1571, DOI 10.1109/LED.2012.2213294; Li HY, 2012, J AM CHEM SOC, V134, P2760, DOI 10.1021/ja210430b; Fujisaki Y, 2012, IEEE T ELECTRON DEV, V59, P3442, DOI 10.1109/TED.2012.2220968; Sekitani T, 2009, NAT MATER, V8, P494, DOI [10.1038/nmat2459, 10.1038/NMAT2459]; Giri G, 2014, ADV MATER, V26, P487, DOI 10.1002/adma.201302439; Diao Y, 2013, NAT MATER, V12, P665, DOI [10.1038/nmat3650, 10.1038/NMAT3650]; Fujisaki Y, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802499; Li LQ, 2010, J AM CHEM SOC, V132, P8807, DOI 10.1021/ja1017267; Minari T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3095665; Fujisaki Y, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3491815; Fujisaki Y., 2013, ADV FUNC MAT, V24, P1657; Fukuda K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5147; Goto O, 2012, ADV MATER, V24, P1117, DOI 10.1002/adma.201104373; Headrick RL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2839394; Keum CM, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807461; Kim S. H., 2009, J APPL PHYS, V105; Kumatani A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00393; Li Y, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/2/024203; Liu ZH, 2009, IEEE T ELECTRON DEV, V56, P176, DOI 10.1109/TED.2008.2010580; Nam S, 2013, ACS APPL MATER INTER, V5, P2146, DOI 10.1021/am303192b; Nausieda I, 2008, IEEE T ELECTRON DEV, V55, P527, DOI 10.1109/TED.2007.913081; Ng T. N., 2008, J APPL PHYS, V103; Sirringhaus H, 2009, P IEEE, V97, P1570, DOI 10.1109/JPROC.2009.2021680; Uemura T., 2006, APPL PHYS EXP, V2; Yu LY, 2012, J MATER CHEM, V22, P9458, DOI 10.1039/c2jm30893b	32	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	JUL	2015	62	7					2306	2312		10.1109/TED.2015.2431372		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CK7ZY	WOS:000356457900035		
J	Fujiwara, I; Koibuchi, M; Matsutani, H; Casanova, H				Fujiwara, Ikki; Koibuchi, Michihiro; Matsutani, Hiroki; Casanova, Henri			Swap-And-Randomize: A Method for Building Low-Latency HPC Interconnects	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Network topologies; cabinet layout; interconnection networks; high-performance computing	NETWORKS; TOPOLOGY; ARCHITECTURE; PERFORMANCE; HYPERCUBES; COMPUTERS	Random network topologies have been proposed to create low-diameter, low-latency interconnection networks in large-scale computing systems. However, these topologies are difficult to deploy in practice, especially when re-designing existing systems, because they lead to increased total cable length and cable packaging complexity. In this work we propose a new method for creating random topologies without increasing cable length: randomly swap link endpoints in a non-random topology that is already deployed across several cabinets in a machine room. We quantitatively evaluate topologies created in this manner using both graph analysis and cycle-accurate network simulation, including comparisons with non-random topologies and previously-proposed random topologies.	[Fujiwara, Ikki; Koibuchi, Michihiro] Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Koibuchi, Michihiro] Grad Univ Adv Studies SOKENDAI, Chiyoda Ku, Tokyo 1018430, Japan; [Matsutani, Hiroki] Keio Univ, Yokohama, Kanagawa 2238522, Japan; [Casanova, Henri] Univ Hawaii Manoa, Honolulu, HI 96822 USA	Fujiwara, I (reprint author), Natl Inst Informat, Chiyoda Ku, 2-1-2 Hitotsuba Shi, Tokyo 1018430, Japan.	ikki@nii.ac.jp; koibuchi@nii.ac.jp; koibuchi@nii.ac.jp; henric@hawaii.edu			JSPS KAKENHI [25280018, 25730068]; JST CREST; NSF [CNS-0855245]	This work was partially supported by JSPS KAKENHI Grant Numbers 25280018 and 25730068, JST CREST, and NSF Award CNS-0855245.	Ahn J. H., 2009, P C HIGH PERF COMP N, P1; Akers S. B., 1987, Proceedings of the 1987 International Conference on Parallel Processing; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; ELAMAWY A, 1991, IEEE T PARALL DISTR, V2, P31, DOI 10.1109/71.80187; Koibuchi M, 2012, CONF PROC INT SYMP C, P177, DOI 10.1109/ISCA.2012.6237016; Coteus P, 2005, IBM J RES DEV, V49, P213; Kim J, 2007, CONF PROC INT SYMP C, P126; TZENG NF, 1991, IEEE T COMPUT, V40, P284, DOI 10.1109/12.76405; [Anonymous], 2002, EARTH SIMULATOR PROJ; [Anonymous], 2008, CONF PROC INT SYMP C; Ajima Y, 2009, COMPUTER, V42, P36, DOI 10.1109/MC.2009.370; Bollobas B., 1988, SIAM J DISCRETE MATH, V1, P328; CONNOLLY DT, 1990, EUR J OPER RES, V46, P93, DOI 10.1016/0377-2217(90)90301-Q; Dally W. J., 1991, COMPUTERS IEEE T, V40, P1016; Dally W. J., 2003, PRINCIPLES PRACTICES; Duato J., 1995, PARALLEL DISTRIBUTED, V6, P1055; EFE K, 1991, IEEE T COMPUT, V40, P1312, DOI 10.1109/12.102840; Fujiwara I, 2012, 2012 13TH INTERNATIONAL CONFERENCE ON PARALLEL AND DISTRIBUTED COMPUTING, APPLICATIONS, AND TECHNOLOGIES (PDCAT 2012), P227, DOI 10.1109/PDCAT.2012.86; GANESAN E, 1993, IEEE T PARALL DISTR, V4, P962, DOI 10.1109/71.243525; Hemmert K. S., 2008, I ADV ARCH ALG INT W; HP, 2007, OPT FAC OP HIGH DENS; HWANG K, 1987, IEEE T COMPUT, V36, P1450; InfiniBand Trade Association, 2007, PLUGG INT PASS COPP; Kleinberg J., 2004, SIAM NEWS, V37, P1; Koibuchi M, 2013, INT S HIGH PERF COMP, P484; MALLUHI QM, 1994, IEEE T PARALL DISTR, V5, P17, DOI 10.1109/71.262585; Miller M., 2005, ELECT J COMBIN DS, V14, P61; SAMATHAM MR, 1989, IEEE T COMPUT, V38, P567, DOI 10.1109/12.21149; Shin J.-Y., 2011, P ACM 2 ACM S CLOUD, P2; Silla F, 2000, IEEE T PARALL DISTR, V11, P699, DOI 10.1109/71.877816; Singla A., 2012, P 9 USENIX C NETW SY, P17; Tomkins J., 2007, SAND NAT LAB ACS WOR	32	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	JUL	2015	26	7					2051	2060		10.1109/TPDS.2014.2340863		10	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CK3TM	WOS:000356138700022		
J	Sasaki, K; Iwai, K				Sasaki, Katsuhiro; Iwai, Kazuhiro			Roles of linear ubiquitinylation, a crucial regulator of NF-kappa B and cell death, in the immune system	IMMUNOLOGICAL REVIEWS			English	Review						LUBAC; ubiquitin; linear ubiquitinylation; NF-kappa B; inflammation; cell death	CHAIN ASSEMBLY COMPLEX; CHRONIC PROLIFERATIVE DERMATITIS; K63-LINKED POLYUBIQUITIN CHAINS; SHARPIN-DEFICIENT MICE; TOLL-LIKE RECEPTOR; IKK-BETA SUBUNIT; ZINC-FINGER 7; DEUBIQUITINATING ENZYME; BINDING DOMAINS; INFLAMMASOME ACTIVATION	Linear ubiquitinylation, a newly identified post-translational modification, is catalyzed by the linear ubiquitin assembly complex (LUBAC), which is composed of three different subunits, HOIL-1L (heme-oxidized IRP2 ligase 1L), HOIP (HOIL-1 interacting protein), and SHARPIN (SHANK-associated RH domain-interacting protein). LUBAC plays a critical role in the activation of nuclear factor-B (NF-B) signaling triggered by a variety of stimuli, including tumor necrosis factor- (TNF-), interleukin-1 (IL-1), and pathogen-derived components, and in the protection from cell death. Loss of function of SHARPIN in mice triggers chronic inflammation in multiple organs including the skin, as well as immunodeficiency. In humans, mutations in the gene encoding HOIL-1L cause chronic hyperinflammation and immunodeficiency, which are both associated with decreased levels of LUBAC. The linear ubiquitinylation activity of LUBAC is indispensable for B-cell function in mice, and hyperactivation of LUBAC is associated with oncogenesis in certain forms of B-cell lymphoma. In this review, the current understanding of the biochemistry of LUBAC-mediated linear ubiquitinylation and its involvement in the immune system are discussed.	[Sasaki, Katsuhiro; Iwai, Kazuhiro] Kyoto Univ, Grad Sch Med, Mol & Cellular Physiol, Kyoto 6068501, Japan	Iwai, K (reprint author), Kyoto Univ, Grad Sch Med, Mol & Cellular Physiol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	kiwai@mcp.med.kyoto-u.ac.jp					Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Davidovich P, 2014, BIOL CHEM, V395, P1163, DOI 10.1515/hsz-2014-0164; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Fiil BK, 2014, FEBS J, V281, P4337, DOI 10.1111/febs.12944; Kimura Y, 2010, J BIOCHEM, V147, P793, DOI 10.1093/jb/mvq044; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Zinngrebe J, 2014, EMBO REP, V15, P28, DOI 10.1002/embr.201338025; HOGENESCH H, 1993, AM J PATHOL, V143, P972; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Chen IY, 2015, TRENDS MICROBIOL, V23, P55, DOI 10.1016/j.tim.2014.09.007; Pouwels J, 2013, CELL REP, V5, P619, DOI 10.1016/j.celrep.2013.10.011; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Iwai K, 2014, NAT REV MOL CELL BIO, V15, P503, DOI 10.1038/nrm3836; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yang YB, 2014, CANCER DISCOV, V4, P480, DOI 10.1158/2159-8290.CD-13-0915; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Dubois SM, 2014, BLOOD, V123, P2199, DOI 10.1182/blood-2013-05-504019; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Bignell GR, 2000, NAT GENET, V25, P160; Spratt DE, 2014, BIOCHEM J, V458, P421, DOI 10.1042/BJ20140006; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Wickliffe K, 2009, CHEM REV, V109, P1537, DOI 10.1021/cr800414e; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.06.041; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Nikolaou K, 2012, CANCER CELL, V21, P738, DOI 10.1016/j.ccr.2012.04.026; Gijbels MJJ, 1996, AM J PATHOL, V148, P941; Stieglitz B, 2013, NATURE, V503, P422, DOI 10.1038/nature12638; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Elliott PR, 2014, MOL CELL, V54, P335, DOI 10.1016/j.molcel.2014.03.018; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Rickard JA, 2014, ELIFE, V3, DOI 10.7554/eLife.03464; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Seymour R, 2006, VET PATHOL, V43, P401, DOI 10.1354/vp.43-4-401; Gantke T, 2012, IMMUNOL REV, V246, P168, DOI 10.1111/j.1600-065X.2012.01104.x; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Schaeffer V, 2014, MOL CELL, V54, P349, DOI 10.1016/j.molcel.2014.03.016; Sasaki Y, 2013, EMBO J, V32, P2463, DOI 10.1038/emboj.2013.184; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Iwai K, 2012, TRENDS CELL BIOL, V22, P355, DOI 10.1016/j.tcb.2012.04.001; HogenEsch H, 1999, J IMMUNOL, V162, P3890; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Belgnaoui SM, 2012, CELL HOST MICROBE, V12, P211, DOI 10.1016/j.chom.2012.06.009; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Rothwarf DM, 1998, NATURE, V395, P297; Inn KS, 2011, MOL CELL, V41, P354, DOI 10.1016/j.molcel.2010.12.029; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Damgaard RB, 2013, EMBO MOL MED, V5, P1278, DOI 10.1002/emmm.201303090; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; OZKAYNAK E, 1984, NATURE, V312, P663, DOI 10.1038/312663a0; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Roget K, 2012, MOL CELL BIOL, V32, P4684, DOI 10.1128/MCB.01065-12; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Shirane M, 1999, J BIOL CHEM, V274, P28169, DOI 10.1074/jbc.274.40.28169; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Catic A, 2005, TRENDS BIOCHEM SCI, V30, P600, DOI 10.1016/j.tibs.2005.09.002; Rivkin E, 2013, NATURE, V498, P318, DOI 10.1038/nature12296; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Tokunaga F, 2013, J BIOCHEM, V154, P313, DOI 10.1093/jb/mvt079; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Hellerbrand C, 2007, CARCINOGENESIS, V28, P21, DOI 10.1093/carcin/bg1081; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Nilsson J, 2013, ANN NEUROL, V74, P914, DOI 10.1002/ana.23963; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Deguine Jacques, 2014, F1000Prime Rep, V6, P97, DOI 10.12703/P6-97; Fiil Berthe Katrine, 2013, Mol Cell, V50, P818, DOI 10.1016/j.molcel.2013.06.004; Fu QS, 2012, CURR PROTEIN PEPT SC, V13, P482; Fujita H, 2014, MOL CELL BIOL, V34, P1322, DOI 10.1128/MCB.01538-13; GIJBELS MJJ, 1995, ULTRASTRUCT PATHOL, V19, P107; Heissmeyer V, 2001, MOL CELL BIOL, V21, P1024, DOI 10.1128/MCB.21.4.1024-1035.2001; Kumari S, 2014, ELIFE, V3, DOI 10.7554/eLife.03422; Lee DA, 2005, J MED GENET, V42, P811, DOI 10.1136/jmg.2004.025577; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; MacDuff DA, 2015, ELIFE, V4, DOI 10.7554/eLife.04494; MacKay C, 2014, CANCER RES, V74, P2246, DOI 10.1158/0008-5472.CAN-13-2131; McGouran JF, 2013, CHEM BIOL, V20, P1447, DOI 10.1016/j.chembiol.2013.10.012; Rodgers MA, 2014, J EXP MED, V211, P1331, DOI 10.1084/jem.20132486; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Paz S, 2011, CELL RES, V21, P895, DOI 10.1038/cr.2011.2; Peltzer N, 2014, CELL REP, V9, P153, DOI 10.1016/j.celrep.2014.08.066; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Potter CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085666; Queisser MA, 2014, AM J RESP CRIT CARE, V190, P688, DOI 10.1164/rccm.201403-0463OC; Rohaim A, 2012, ACTA CRYSTALLOGR D, V68, P102, DOI 10.1107/S0907444911051195; Saggar S, 2008, J MED GENET, V45, P298, DOI 10.1136/jmg.2007.056127; Sakamoto H, 2015, ACS CHEM BIOL, V20, P675, DOI DOI 10.1021/CB500653Y; Sheikh M Saeed, 2003, Cell Cycle, V2, P550; Smit Judith J, 2013, J Biol Chem, V288, P31728, DOI 10.1074/jbc.M113.495846; Takiuchi T, 2014, GENES CELLS, V19, P254, DOI 10.1111/gtc.12128; Tamiya H, 2014, J IMMUNOL, V192, P3793, DOI 10.4049/jimmunol.1302308; Tomonaga M, 2012, INT J ONCOL, V40, P409, DOI 10.3892/ijo.2011.1209; Torres HIG, 1995, PATHOBIOLOGY, V63, P341; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Walczak H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-23; Wang K, 2013, GENOME MED, V5, DOI 10.1186/gm471; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Wu C, 1999, J BIOL CHEM, V274, P29591, DOI 10.1074/jbc.274.42.29591; Wu P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.13; Yagi H, 2012, EMBO REP, V13, P462, DOI 10.1038/embor.2012.24; Zhao SK, 2010, P NATL ACAD SCI USA, V107, P7704, DOI 10.1073/pnas.0908764107	148	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-2896	1600-065X		IMMUNOL REV	Immunol. Rev.	JUL	2015	266	1			SI		175	189		10.1111/imr.12308		15	Immunology	Immunology	CK7ZQ	WOS:000356457000013		
J	Mashima, R				Mashima, Ryuichi			Physiological roles of miR-155	IMMUNOLOGY			English	Review						inflammation; microRNA; SH2-domain containing inositol-5-phosphatase 1; signal transduction; tyrosine kinase	B-CELL LYMPHOMAS; CHRONIC LYMPHOCYTIC-LEUKEMIA; INDUCED CYTIDINE DEAMINASE; REGULATORY T-CELLS; ATOPIC-DERMATITIS; IN-VIVO; PROINFLAMMATORY REGULATOR; INFLAMMATORY RESPONSE; NEGATIVE REGULATOR; GENE-EXPRESSION	miR-155 is involved in non-coding microRNAs found in humans, mice and chickens of which the sequence is conserved. Historically, miR-155 was identified as a B-cell integration cluster (bic), which induces B-cell leucosis in chickens, by its activation through viral promoter insertion. Subsequent studies have shown that transgenic mice expressing miR-155 in B cells generated lymphoma, showing that miR-155 is oncogenic. Biochemical investigation identifies many substrates of miR-155, and one of them in B cells and macrophages is the SH2-domain containing inositol-5-phosphatase 1. A deficiency of miR-155 in the immune system causes attenuated immune functions. Clinically, several types of malignancy including diffuse large B-cell lymphoma have high miR-155 expression levels.	[Mashima, Ryuichi] Keio Univ, Dept Microbiol & Immunol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Mashima, R (reprint author), Keio Univ, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	mashima-r@ncchd.go.jp					Oertli M, 2011, J IMMUNOL, V187, P3578, DOI 10.4049/jimmunol.1101772; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Sandhu SK, 2012, P NATL ACAD SCI USA, V109, P20047, DOI 10.1073/pnas.1213764109; Babar IA, 2012, P NATL ACAD SCI USA, V109, pE1695, DOI 10.1073/pnas.1201516109; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Malmhall C, 2014, J ALLERGY CLIN IMMUN, V133, P1429, DOI 10.1016/j.jaci.2013.11.008; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647; Sin SH, 2013, BLOOD, V121, P2952, DOI 10.1182/blood-2012-03-415620; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Auriemma M, 2013, EUR CYTOKINE NETW, V24, P37, DOI 10.1684/ecn.2013.0333; Okoye IS, 2014, P NATL ACAD SCI USA, V111, pE3081, DOI 10.1073/pnas.1406322111; Huffaker TB, 2012, CELL REP, V2, P1697, DOI 10.1016/j.celrep.2012.10.025; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Escobar TM, 2014, IMMUNITY, V40, P865, DOI 10.1016/j.immuni.2014.03.014; Ferrajoli A, 2013, BLOOD, V122, P1891, DOI 10.1182/blood-2013-01-478222; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Boss IW, 2011, J VIROL, V85, P9877, DOI 10.1128/JVI.05558-11; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Tili E, 2007, J IMMUNOL, V179, P5082; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Trotta R, 2012, BLOOD, V119, P3478, DOI 10.1182/blood-2011-12-398099; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lind EF, 2013, J IMMUNOL, V190, P1210, DOI 10.4049/jimmunol.1202700; Tam W, 1997, MOL CELL BIOL, V17, P1490; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Tsai CY, 2013, J VIROL, V87, P2348, DOI 10.1128/JVI.01742-12; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Bluml S, 2011, ARTHRITIS RHEUM-US, V63, P1281, DOI 10.1002/art.30281; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Hu RZ, 2013, J IMMUNOL, V190, P5972, DOI 10.4049/jimmunol.1300351; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Sin SH, 2013, J VIROL, V87, P11908, DOI 10.1128/JVI.01620-13; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Thai TH, 2013, P NATL ACAD SCI USA, V110, P20194, DOI 10.1073/pnas.1317632110; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Wang L, 2014, CELL STEM CELL, V15, P51, DOI 10.1016/j.stem.2014.04.021; Choi SY, 2005, PEDIATR ALLERGY IMMU, V16, P422, DOI 10.1111/j.1399-3038.2005.00274.x; Cremer TJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00073; Cui B, 2014, BLOOD, V124, P546, DOI 10.1182/blood-2014-03-559690; Garfias Y, 2003, IMMUNOL INVEST, V32, P95, DOI 10.1081/IMM-120019211; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jin HM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4531; Jones G, 2006, BRIT J DERMATOL, V154, P467, DOI 10.1111/j.1365-2133.2005.07080.x; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; Mastroeni Pietro, 2002, Current Molecular Medicine (Hilversum), V2, P393, DOI 10.2174/1566524023362492; Roongapinun S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014174; Sonkoly E, 2010, J ALLERGY CLIN IMMUN, V126; Yao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046082	69	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0019-2805	1365-2567		IMMUNOLOGY	Immunology	JUL	2015	145	3					323	333		10.1111/imm.12468		11	Immunology	Immunology	CL1JR	WOS:000356699200002		
J	Kadokawa, J; Endo, R; Tanaka, K; Ohta, K; Yamamoto, K				Kadokawa, Jun-ichi; Endo, Ryo; Tanaka, Kohei; Ohta, Keisuke; Yamamoto, Kazuya			Fabrication of porous chitin with continuous substructure by regeneration from gel with CaBr2 center dot 2H(2)O/methanol	INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES			English	Article						Chitin; Inter-connected pore; Regeneration	BIOMEDICAL APPLICATIONS; BETA-CHITIN; MEDIA; RESOURCES; SCAFFOLDS; HYDROGEL; SOLVENT; SYSTEM	In this study, we investigated the fabrication of porous chitins with continuous channel substructure by regeneration from gels with CaBr2 center dot 2H(2)O/methanol solution. After rapidly removing methanol from the gels, the products were immersed in methanol, followed by washing out CaBr2 with water and lyophilization to obtain regenerated chitins with inter-connected continuous pore morphology. Scanning electron microscopic results supported that the materials were consisted of continuous substructures of porous channels. The materials were further characterized by SEM-EDX and XRD measurements. The mechanical property and water absorbability were also evaluated. The plausible mechanism for the formation of the inter-connected pore morphology during the regeneration procedure was discussed. (C) 2015 Elsevier B.V. All rights reserved.	[Kadokawa, Jun-ichi; Endo, Ryo; Tanaka, Kohei; Ohta, Keisuke; Yamamoto, Kazuya] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan	Kadokawa, J (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, 1-21-40 Korimoto, Kagoshima 8900065, Japan.	kadokawa@eng.kagoshima-u.ac.jp					Heath L, 2013, CHEMSUSCHEM, V6, P537, DOI 10.1002/cssc.201200717; Rouilly A, 2002, J MACROMOL SCI-POL R, VC42, P441, DOI 10.1081/MC-120015987; Tokura S, 1996, MACROMOL SYMP, V101, P389, DOI 10.1002/masy.19961010144; Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5; Mohanty AK, 2002, J POLYM ENVIRON, V10, P19, DOI 10.1023/A:1021013921916; Muzzarelli RAA, 2014, MAR DRUGS, V12, P5468, DOI 10.3390/md12115468; Tamura H, 2011, CARBOHYD POLYM, V84, P820, DOI 10.1016/j.carbpol.2010.06.001; Tamura H, 2006, CELLULOSE, V13, P357, DOI 10.1007/s10570-006-9058-z; Maeda Y, 2008, INT J BIOL MACROMOL, V42, P463, DOI 10.1016/j.ijbiomac.2008.03.002; Nakanishi K, 1997, J POROUS MAT, V4, P67, DOI 10.1023/A:1009627216939; Shigemasa Y, 1996, INT J BIOL MACROMOL, V18, P237, DOI 10.1016/0141-8130(95)01079-3; Kadokawa J, 2015, RSC ADV, V5, P12736, DOI 10.1039/c4ra15319g; Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001; Berg J. M., 2006, BIOCHEMISTRY-US; Garcia-Gonzalez C.A., 2011, CARBOHYD POLYM, V86, P1426; Kanamori K, 2012, J CERAM SOC JPN, V120, P1, DOI 10.2109/jcersj2.120.1; Muzzarelli R. A. A., 2012, POLYM SCI COMPREHENS, V10, P153; Nagahama H, 2008, INT J BIOL MACROMOL, V42, P309, DOI 10.1016/j.ijbiomac.2007.10.011; Poirier M, 2002, CARBOHYD POLYM, V50, P363, DOI 10.1016/S0144-8617(02)00040-1; Rinaudo M., 2006, SCI, V31, P603; Schuerch C., 1986, ENCY POLYM SCI ENG, V13, P87; Tajiri R, 2014, RSC ADV, V4, P5542, DOI 10.1039/c3ra46285d; TOKURA S, 1995, MACROMOL SYMP, V99, P201, DOI 10.1002/masy.19950990121	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0141-8130	1879-0003		INT J BIOL MACROMOL	Int. J. Biol. Macromol.	JUL	2015	78						313	317		10.1016/j.ijbiomac.2015.04.022		5	Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CK4LN	WOS:000356195400042		
J	Muroya, Y; Kuniya, T				Muroya, Yoshiaki; Kuniya, Toshikazu			Global stability for a delayed multi-group SIRS epidemic model with cure rate and incomplete recovery rate	INTERNATIONAL JOURNAL OF BIOMATHEMATICS			English	Article						Multi-group SIRS epidemic model; delay; permanence; global stability; Lyapunov functional	NONLINEAR INCIDENCE; DISTRIBUTED DELAYS; HEROIN EPIDEMICS; TRANSMISSION; INFECTION; MIGRATION; BEHAVIOR	In this paper, by applying Lyapunov functional approach, we establish a sufficient condition on the global stability of a "delayed" multi-group SIRS epidemic model with cure rate and incomplete recovery rate which does not depend on the delays and is an extension of the "light drug model" studied in the recent paper [Muroya, Li and Kuniya, Complete global analysis of an SIRS epidemic model with graded cure rate and incomplete recovery rate, J. Math. Anal. Appl. 410 (2014) 719-732] to a multi-group model. Applying a Lyapunov functional on total population of each compartment, we offer new techniques for the delayed system, how to prove the permanence, the existence of the endemic equilibrium and the global stability of disease-free equilibrium for the reproduction number (R) over tilde (0) <= 1 and endemic equilibrium for (R) over tilde (0) > 1.	[Muroya, Yoshiaki] Waseda Univ, Dept Math, Shinjuku Ku, Tokyo 1698555, Japan; [Kuniya, Toshikazu] Kobe Univ, Grad Sch Syst Informat, Nada Ku, Kobe, Hyogo 6578501, Japan	Muroya, Y (reprint author), Waseda Univ, Dept Math, Shinjuku Ku, 3-4-1 Ohkubo, Tokyo 1698555, Japan.	ymuroya@waseda.jp; tkuniya@port.kobe-u.ac.jp			Japan Society for the Promotion of Science [24540219, 25887011]	The authors wish to express their gratitude to anonymous referee for his/her valuable suggestions which greatly improved the quality of the paper in the present style. The first author's research was supported by Scientific Research (c), No. 24540219 of Japan Society for the Promotion of Science. The second author's research was supported by Grant-in-Aid for Research Activity Start-Up, No. 25887011 of Japan Society for the Promotion of Science.	Kuniya T, 2014, DISCRETE CONT DYN-B, V19, P1105, DOI 10.3934/dcdsb.2014.19.1105; Li MY, 2010, J MATH ANAL APPL, V361, P38, DOI 10.1016/j.jmaa.2009.09.017; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Guo HB, 2008, P AM MATH SOC, V136, P2793, DOI 10.1090/S0002-9939-08-09341-6; Muroya Y, 2013, ACTA MATH SCI, V33, P341; White E, 2007, MATH BIOSCI, V208, P312, DOI 10.1016/j.mbs.2006.10.008; McCluskey CC, 2010, NONLINEAR ANAL-REAL, V11, P55, DOI 10.1016/j.nonrwa.2008.10.014; Gomes MGM, 2005, J MATH BIOL, V51, P414, DOI 10.1007/s00285-005-0331-9; Huang G, 2013, APPL MATH LETT, V26, P687, DOI 10.1016/j.aml.2013.01.010; Muroya Y, 2014, APPL MATH LETT, V38, P73, DOI 10.1016/j.aml.2014.07.005; Muroya Y, 2013, NONLINEAR ANAL-REAL, V14, P1693, DOI 10.1016/j.nonrwa.2012.11.005; Muroya Y, 2014, ACTA MATH SCI, V34, P1427; Liu JL, 2009, CHAOS SOLITON FRACT, V40, P145, DOI 10.1016/j.chaos.2007.07.047; Yuan ZH, 2010, NONLINEAR ANAL-REAL, V11, P3479, DOI 10.1016/j.nonrwa.2009.12.008; Liu JL, 2011, APPL MATH LETT, V24, P1685, DOI 10.1016/j.aml.2011.04.019; Chen H, 2011, APPL MATH COMPUT, V218, P4391, DOI 10.1016/j.amc.2011.10.015; Sun RY, 2010, COMPUT MATH APPL, V60, P2286, DOI 10.1016/j.camwa.2010.08.020; Li MY, 2010, J DIFFER EQUATIONS, V248, P1, DOI 10.1016/j.jde.2009.09.003; Mulone G, 2009, MATH BIOSCI, V218, P138, DOI 10.1016/j.mbs.2009.01.006; Shu HY, 2012, NONLINEAR ANAL-REAL, V13, P1581, DOI 10.1016/j.nonrwa.2011.11.016; Enatsu Y, 2012, NONLINEAR ANAL-REAL, V13, P2120, DOI 10.1016/j.nonrwa.2012.01.007; Muroya Y, 2014, J MATH ANAL APPL, V410, P719, DOI 10.1016/j.jmaa.2013.08.024; Yuan ZH, 2010, NONLINEAR ANAL-REAL, V11, P995, DOI 10.1016/j.nonrwa.2009.01.040; Arino J, 2009, MODELING DYNAMICS IN, V11, P65; Berman A., 1979, NONNEGATIVE MATRICES; Guo H., 2006, CAN APPL MATH Q, V14, P259; Hale J. K., 1993, APPL MATH SCI, V99; Kuniya T, 2014, MATH BIOSCI ENG, V11, P1375, DOI [10.3934/mbe.2014.11. 1375, 10.3934/mbe.2014.11.1375]; LaSalle J.P., 1976, CBMS NSF REGIONAL C, V25; Muroya Y, 2015, MATH METHOD APPL SCI, V38, P281, DOI 10.1002/mma.3068; Muroya Y., 1968, MEM FS KYUSHU U A, V22, P56, DOI 10.2206/kyushumfs.22.56; Nakata Y., 2011, DISCRETE CONT DYN-A, V2011, P1119; Ortega J., 1967, SIAM J NUM, V4, P171, DOI 10.1137/0704017; Wang JL, 2012, INT J BIOMATH, V5, DOI 10.1142/S1793524512600017; Zhao X. Q., 1996, CANAD APPL MATH Q, V4, P421	35	1	1	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-5245	1793-7159		INT J BIOMATH	Int. J. Biomath.	JUL	2015	8	4							1550048	10.1142/S1793524515500485		30	Mathematical & Computational Biology	Mathematical & Computational Biology	CL2SH	WOS:000356794400007		
J	Watanabe, T; Kume, K; Yoshikawa, I; Harada, M				Watanabe, Tatsuyuki; Kume, Keiichiro; Yoshikawa, Ichiro; Harada, Masaru			Usefulness of a novel calibrated hood to determine indications for colon polypectomy: visual estimation of polyp size is not accurate	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Colon cancer; Colon polyp; Calibrated hood; Polyp size	CAP-ASSISTED COLONOSCOPY; RANDOMIZED CONTROLLED-TRIAL; ADENOMA DETECTION	Accurate measurement of polyp size during colonoscopy is important because the size is a surrogate marker of cancer, but a standardized measurement technique to measure polyp size has yet to be determined. We have developed a new device "a novel calibrated hood." We assessed polyp size by visual estimation and measurement using the calibrated hood. Patients who underwent polypectomy from November 2012 to September 2013 and who had received screening colonoscopy within 6 months prior to the polypectomy were included in this study. Polypectomy was performed attaching the calibrated hood. The endoscopist measured the polyp size using the calibrated hood. Polyp size was compared between visual estimation and measurement using the calibrated hood. Seventy-five patients with 157 polyps were included. Seventy-seven polyps fulfilled the selection criteria. Mean polyp size by visual estimation was 6.57 +/- 2.15, and by using calibrated hood was 5.94 +/- 1.73 (p = 0.005). There was a significant difference between measurements using the calibrated hood vs. visual estimation by inexperienced trainees; however, there was no difference in case of well-experienced endoscopists. By visual estimation, 11 of 19 polyps were decided for a parts per thousand yen5 mm despite being less than 5 mm, and 5 of 58 polyps were decided for < 5 mm despite being 5 mm or larger in diameter. Visual estimation of polyp size is not accurate. It is important to measure the size by an objective way, and the calibrated hood is useful in measuring polyp size, from the standpoint of accurately determining indication for polypectomy.	[Watanabe, Tatsuyuki; Kume, Keiichiro; Yoshikawa, Ichiro; Harada, Masaru] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 3, Yahatanishi Ku, Kitakyushu 8078555, Japan	Watanabe, T (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 3, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu 8078555, Japan.	tattun-w@med.uoeh-u.ac.jp					Schoen RE, 1997, GASTROINTEST ENDOSC, V46, P492, DOI 10.1016/S0016-5107(97)70002-6; Rastogi A, 2012, GUT, V61, P402, DOI 10.1136/gutjnl-2011-300187; Gopalswamy N, 1997, GASTROINTEST ENDOSC, V46, P497, DOI 10.1016/S0016-5107(97)70003-8; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; de Wijkerslooth TR, 2012, GUT, V61, P1426, DOI 10.1136/gutjnl-2011-301327; Tsai FC, 2011, DIGEST DIS SCI, V56, P2384, DOI 10.1007/s10620-011-1598-x; Chang CY, 2010, INT J COLORECTAL DIS, V25, P655, DOI 10.1007/s00384-010-0878-9; Hyun YS, 2011, DIGEST LIVER DIS, V43, P391, DOI 10.1016/j.dld.2010.12.015; Kashida Hiroshi, 2006, Int J Clin Oncol, V11, P1, DOI 10.1007/s10147-005-0550-5; Kim HH, 2012, WORLD J GASTROENTERO, V18, P1953, DOI 10.3748/wjg.v18.i16.1953; Kume K, 2014, GASTROENT RES PRACT, DOI 10.1155/2014/714294; MARGULIES C, 1994, GASTROINTEST ENDOSC, V40, P174; Morales TG, 1996, GASTROINTEST ENDOSC, V43, P25; Moug SJ, 2010, COLORECTAL DIS, V12, P646, DOI 10.1111/j.1463-1318.2009.01870.x; PANISH JF, 1979, AM J GASTROENTEROL, V71, P315; Westwood DA, 2012, DIS COLON RECTUM, V55, P218, DOI 10.1097/DCR.0b013e31823461ef	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	JUL	2015	30	7					933	938		10.1007/s00384-015-2203-0		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CK6PV	WOS:000356350900010		
J	Sekine, K; Nagata, N; Shindo, T; Morino, E; Shimbo, T; Akiyama, J; Mizokami, M; Uemura, N				Sekine, Katsunori; Nagata, Naoyoshi; Shindo, Takuma; Morino, Eriko; Shimbo, Takuro; Akiyama, Junichi; Mizokami, Masashi; Uemura, Naomi			Combined identifying granuloma and biopsy culture is useful for diagnosing intestinal tuberculosis	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Inflammatory bowel disease; Biopsy sample analysis; Abdominal tuberculosis; Mycobacterium tuberculosis	CROHNS-DISEASE; COLONIC TUBERCULOSIS; HISTOLOGICAL DIFFERENTIATIONS; MYCOBACTERIUM-TUBERCULOSIS; ABDOMINAL TUBERCULOSIS; PCR; AMPLIFICATION; COLONOSCOPY; INDIA	Differential diagnosis of intestinal tuberculosis (ITB) and inflammatory bowel disease (IBD) can be difficult, but many gastroenterologists may only perform biopsy for pathology and their own experience. This study aimed to identify optimal sample collection and pathogen detection methods for diagnosing ITB. A cohort of 182 patients (50 had ITB and 132 had IBD or other colonic diseases) who underwent colonoscopy was analyzed. Sensitivity of acid-fast bacilli (AFB), culture, polymerase chain reaction (PCR), and granuloma pathology on hematoxylin and eosin stain for diagnosing ITB were compared in relation to biopsy, endoscopic aspirated intestinal fluid, or standard stool evaluations. We also evaluated which combination offered the highest yield to diagnose intestinal tuberculosis in addition to granuloma pathology. Between ITB and non-ITB, no significant differences were observed in age, sex, and nationality. In biopsy analysis, sensitivity was as follows: culture (50 %), AFB (38 %), PCR (25 %), granuloma pathology (51 %), and caseous granuloma (8.2 %), while specificity of granuloma pathology was low (80 %), compared to other tests. In intestinal fluid analysis, sensitivity was as follows: culture (46 %), AFB (42 %), and PCR (35 %). In standard stool analysis, sensitivity was as follows: culture (47 %), AFB (37 %), and PCR (23 %). Granuloma pathology plus biopsy culture offered the highest combination sensitivity (77 %), significantly (P < 0.01) higher than that for granuloma pathology alone (51 %). When encountering suspected intestinal tuberculosis or IBD on colonoscopy, biopsy culture is recommended in addition to pathological assessment of granuloma. This diagnostic strategy will lead to accurate differential diagnosis of colonic disease, facilitating appropriate treatment.	[Sekine, Katsunori; Nagata, Naoyoshi; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1628655, Japan; [Shindo, Takuma; Morino, Eriko] Natl Ctr Global Hlth & Med NCGM, Resp Med, Tokyo, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Clin Res & Informat, Tokyo 1628655, Japan; [Mizokami, Masashi] Kohnodai Hosp, Res Ctr Hepatitis & Immunol, Natl Ctr Global Hlth & Med, Chiba, Japan; [Uemura, Naomi] Kohnodai Hosp, Dept Gastroenterol & Hepatol, Natl Ctr Global Hlth & Med, Chiba, Japan	Nagata, N (reprint author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nnagata_ncgm@yahoo.co.jp			National Center for Global Health and Medicine [26A-201]	This study was partly supported by a grant from the National Center for Global Health and Medicine (26A-201).	Alvares JF, 2005, ENDOSCOPY, V37, P351, DOI 10.1055/s-2005-861116; Amarapurkar D N, 2004, J Assoc Physicians India, V52, P863; Amarapurkar DN, 2008, WORLD J GASTROENTERO, V14, P741, DOI 10.3748/wjg.14.741; Hallur V, 2013, DIAGN MICR INFEC DIS, V76, P51, DOI 10.1016/j.diagmicrobio.2013.02.022; Epstein D, 2007, ALIMENT PHARM THER, V25, P1373, DOI 10.1111/j.1365-2036.2007.03332.x; Mehta PK, 2012, FEMS IMMUNOL MED MIC, V66, P20, DOI 10.1111/j.1574-695X.2012.00987.x; Makharia GK, 2010, AM J GASTROENTEROL, V105, P642, DOI 10.1038/ajg.2009.585; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Lee YJ, 2006, ENDOSCOPY, V38, P592, DOI 10.1055/s-2006-924996; Yonal O, 2010, TURK J GASTROENTEROL, V21, P91, DOI 10.4318/tjg.2010.0063; Nagata N, 2013, CLIN GASTROENTEROL H, V11, P673, DOI 10.1016/j.cgh.2012.12.034; Balamurugan R, 2006, J CLIN MICROBIOL, V44, P1884, DOI 10.1128/JCM.44.5.1884-1886.2006; BHARGAVA DK, 1985, GASTROINTEST ENDOSC, V31, P68, DOI 10.1016/S0016-5107(85)71995-5; Chang CY, 2013, DRUG DES DEV THER, V7, P53, DOI 10.2147/DDDT.S39247; Chung Kyoung Myeun, 2008, Korean J Gastroenterol, V52, P351; Das H S, 2000, J Assoc Physicians India, V48, P708; Das K, 2009, DIGEST DIS SCI, V54, P1099, DOI 10.1007/s10620-008-0469-6; DeAngelis CD, 2005, JAMA-J AM MED ASSOC, V293, P2793, DOI 10.1001/jama.293.22.2793; DiPlacido R, 1996, AM J GASTROENTEROL, V91, P807; Donoghue HD, 2009, CURR OPIN INFECT DIS, V22, P490, DOI 10.1097/QCO.0b013e3283306712; Kapoor VK, 1998, POSTGRAD MED J, V74, P459; Kirsch R, 2006, J CLIN PATHOL, V59, P840, DOI 10.1136/jcp.2005.032383; Kurasawa Takuya, 2011, Nihon Rinsho, V69, P1351; Leung V. K. S., 2006, Hong Kong Medical Journal, V12, P264; Misra SP, 2004, ENDOSCOPY, V36, P612, DOI 10.1055/s-2004-814518; MORITA N, 1995, J GASTROENTEROL, V30, P1; Rudeeaneksin J, 2012, JPN J INFECT DIS, V65, P306; Sato S, 2004, GASTROINTEST ENDOSC, V59, P362, DOI 10.1016/S0016-5107(03)02716-0; Yu HS, 2012, DIGESTION, V85, P202, DOI 10.1159/000335431	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	JUL	2015	30	7					939	945		10.1007/s00384-015-2208-8		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CK6PV	WOS:000356350900011		
J	Horimatsu, T; Sano, Y; Tanaka, S; Kawamura, T; Saito, S; Iwatate, M; Oka, S; Uno, K; Yoshimura, K; Ishikawa, H; Muto, M; Tajiri, H				Horimatsu, Takahiro; Sano, Yasushi; Tanaka, Shinji; Kawamura, Takuji; Saito, Shoichi; Iwatate, Mineo; Oka, Shiro; Uno, Koji; Yoshimura, Kenichi; Ishikawa, Hideki; Muto, Manabu; Tajiri, Hisao			Next-generation narrow band imaging system for colonic polyp detection: a prospective multicenter randomized trial	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Colonoscopy; Number of polyps detected per patient; Narrow band imaging (NBI); Wide-angle colonoscopy	DEFINITION WHITE-LIGHT; COLORECTAL-CANCER; CONVENTIONAL COLONOSCOPY; ADENOMA DETECTION; MISS RATE; SCREENING COLONOSCOPY; SURVEILLANCE; METAANALYSIS; POLYPECTOMY; ENDOSCOPY	Previous studies have yielded conflicting results on the colonic polyp detection rate with narrow-band imaging (NBI) compared with white-light imaging (WLI). We compared the mean number of colonic polyps detected per patient for NBI versus WLI using a next-generation NBI system (EVIS LUCERA ELITE; Olympus Medical Systems) used with standard-definition (SD) colonoscopy and wide-angle (WA) colonoscopy. Design: this study is a 2 x 2 factorial, prospective, multicenter randomized controlled trial. Setting: this study was conducted at five academic centers in Japan. Interventions: patients were allocated to one of four groups: (1) WLI with SD colonoscopy (H260AZI), (2) NBI with SD colonoscopy (H260AZI), (3) WLI with WA colonoscopy (CF-HQ290), and (4) NBI with WA colonoscopy (CF-HQ290). Main outcome: the mean numbers of polyps detected per patient were compared between the four groups: WLI with/without WA colonoscopy and NBI with/without WA colonoscopy. Of the 454 patients recruited, 431 patients were enrolled. The total numbers of polyps detected by WLI with SD, NBI with SD, WLI with WA, and NBI with WA were 164, 176, 188, and 241, respectively. The mean number of polyps detected per patient was significantly higher in the NBI group than in the WLI group (2.01 vs 1.56; P = 0.032). The rate was not higher in the WA group than in the SD group (1.97 vs 1.61; P = 0.089). Although WA colonoscopy did not improve the polyp detection, next-generation NBI colonoscopy represents a significant improvement in the detection of colonic polyps.	[Horimatsu, Takahiro; Muto, Manabu] Kyoto Univ Hosp, Dept Therapeut Oncol, Kyoto 6068507, Japan; [Horimatsu, Takahiro] Kyoto Univ Hosp, Dept Expt Therapeut, Inst Adv Clin & Translat Sci iACT, Kyoto 606, Japan; [Sano, Yasushi; Iwatate, Mineo] Sano Hosp, Gastrointestinal Ctr, Kobe, Hyogo, Japan; [Sano, Yasushi; Iwatate, Mineo] Sano Hosp, Inst Minimally Invas Endoscop Care iMEC, Kobe, Hyogo, Japan; [Tanaka, Shinji; Oka, Shiro] Hiroshima Univ, Dept Endoscopy, Hiroshima, Japan; [Kawamura, Takuji; Uno, Koji] Kyoto Second Red Cross Hosp, Dept Gastroenterol, Kyoto, Japan; [Saito, Shoichi] Jikei Univ, Sch Med, Dept Endoscopy, Tokyo, Japan; [Yoshimura, Kenichi] Kobe Univ Hosp, Clin Res Ctr, Kobe, Hyogo, Japan; [Muto, Manabu] Kyoto Prefectural Univ Med, Dept Mol Targeting Canc Prevent, Kyoto, Japan; [Tajiri, Hisao] Jikei Univ, Dept Internal Med, Sch Med, Div Gastroenterol & Hepatol, Tokyo, Japan	Horimatsu, T (reprint author), Kyoto Univ Hosp, Dept Therapeut Oncol, 54 Kawahara Cho, Kyoto 6068507, Japan.	thorimat@kuhp.kyoto-u.ac.jp					Rex DK, 2007, GASTROENTEROLOGY, V133, P42, DOI 10.1053/j.gastro.2007.04.029; Hassan C, 2013, ENDOSCOPY, V45, P842, DOI 10.1055/s-0033-1344548; Heresbach D, 2008, ENDOSCOPY, V40, P284, DOI 10.1055/s-2007-995618; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Adler A, 2009, GASTROENTEROLOGY, V136, P410, DOI 10.1053/j.gastro.2008.10.022; Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Rex DK, 2006, AM J GASTROENTEROL, V101, P2866, DOI 10.1111/j.1572-0241.2006.00905.x; Rastogi A, 2011, GASTROINTEST ENDOSC, V74, P593, DOI 10.1016/j.gie.2011.04.050; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1288, DOI 10.1001/jama.289.10.1288; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Sugai T, 2006, J MOL DIAGN, V8, P193, DOI 10.2353/jmoldx.2006.050052; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Pasha SF, 2012, AM J GASTROENTEROL, V107, P363, DOI 10.1038/ajg.2011.436; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Ikematsu H, 2012, J GASTROENTEROL, V47, P1099, DOI 10.1007/s00535-012-0575-2; Gono K, 2004, J BIOMED OPT, V9, P568, DOI 10.1117/1.1695563; Dinesen L, 2012, GASTROINTEST ENDOSC, V75, P604, DOI 10.1016/j.gie.2011.10.017; East JE, 2008, GUT, V57, P65, DOI 10.1136/gut.2007.128926; East JE, 2012, COLORECTAL DIS, V14, pE771, DOI 10.1111/codi.12014; Inoue T, 2008, J GASTROENTEROL, V43, P45, DOI 10.1007/s00535-007-2125-x; Jin XF, 2012, J GASTROEN HEPATOL, V27, P882, DOI 10.1111/j.1440-1746.2011.06987.x; Morini S, 2009, INT J COLORECTAL DIS, V24, P527, DOI 10.1007/s00384-009-0633-2; Nagorni A, 2012, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD008361.PUB2; Sabbagh LC, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-100; Sano Y, 2006, DIGEST ENDOSC, V18, pS44, DOI DOI 10.1111/J.1443-1661.2006.00621.X; Soetikno R, 2006, GASTROENTEROLOGY, V130, P566, DOI 10.1053/j.gastro.2005.12.006; Tsuda S, 2002, GUT, V51, P550, DOI 10.1136/gut.51.4.550	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	JUL	2015	30	7					947	954		10.1007/s00384-015-2230-x		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CK6PV	WOS:000356350900012		
J	Francesco, P; Tohru, O; Salvatore, C				Francesco, Perri; Tohru, Ohta; Salvatore, Critelli			Characterization of submarine canyon bathymetries in northern Ionian Sea, Italy, using sediment geochemical variation induced by transportation distance and basin depth	INTERNATIONAL JOURNAL OF EARTH SCIENCES			English	Review						Marine mud; Ionian Sea; Geochemistry; Transportation distance; Basin bathymetry; Principal component analysis	MEDITERRANEAN ALPINE CHAINS; CONTINENTAL REDBEDS; CALABRIAN ARC; PROVENANCE; EVOLUTION; SIGNATURES; HISTORY; GULF	Geochemical data of marine mud sediments collected from the Esaro, Neto and Corigliano canyons in the northern Ionian Sea (southern Italy) were investigated in order to characterize canyon bathymetry types. Mud sample compositions analyzed by the principal component analysis (PCA) provided useful information for the morphology of the depositional area of the northern Ionian Sea. The use of sediment geochemical data as well as transportation distance and depth as input variables for PCA enabled the extraction of following latent variables: basin depth (PC1), sedimentation rate (PC2) and transportation distance (PC3). Based on these results, we further developed geochemical indices that can estimate basin depth (F1), sedimentation rate (F2) and transportation distance (F3); these functions can be solely calculated from the elemental concentration data of the mud samples. Since these F1, F2 and F3 functions are mathematically independent variables, they facilitate more precise characterization of individual canyon types. That is, the Esaro Canyon is regarded as a sediment-starved deep canyon characterized by a single source area; the Neto Canyon can be seen as a deeply sloped submarine apron system and sediments are mainly supplied by the sediment gravity flows; the Corigliano Canyon is characterized by multiple sources and moderately sloped system, whose sediments disperse mainly by traction currents. These interpretations are concordant with the basin bathymetry of the studied area. Therefore, F1, F2 and F3 functions might be applicable to any oceanic basins.	[Francesco, Perri; Salvatore, Critelli] Univ Calabria, Dipartimento Biol Ecol & Sci Terra, I-87036 Arcavacata Di Rende, CS, Italy; [Tohru, Ohta] Waseda Univ, Fac Educ & Integrated Arts & Sci, Dept Earth Sci, Shinjuku Ku, Tokyo 1698050, Japan	Francesco, P (reprint author), Univ Calabria, Dipartimento Biol Ecol & Sci Terra, Via P Bucci, I-87036 Arcavacata Di Rende, CS, Italy.	francesco.perri@unical.it; tohta@waseda.jp; salvatore.critelli@unical.it		Perri, Francesco/0000-0002-1364-744X	OGS	This research has been carried out within the OGS-funded projects WGDT (Morphology and Architecture of the Western Portions of the Gulf of Taranto: a Study of Submarine Instability in a Tectonically Active Margin; Resp. S. Critelli), and MIUR-UNICAL (Relationships between Tectonic Accretion, Volcanism and Clastic Sedimentation within the Circum-Mediterranean Orogenic Belts, 2006-2011; Resp. S. Critelli). The authors are indebted to Robert Cullers and an anonymous referee, and the Editor Wolf-Christian Dullo for their reviews and suggestions on the final version of the manuscript.	Aitchison J., 1986, STAT ANAL COMPOSITIO, P416; Railsback LB, 2003, GEOLOGY, V31, P737, DOI 10.1130/G19542.1; BOCCALETTI M, 1984, MAR GEOL, V55, P219, DOI 10.1016/0025-3227(84)90070-7; ROSSI S, 1981, MAR GEOPHYS RES, V4, P403, DOI 10.1007/BF00286036; Perri F, 2013, EARTH-SCI REV, V117, P1, DOI 10.1016/j.earscirev.2012.11.002; Rebesco M, 2009, INT J EARTH SCI, V98, P791, DOI 10.1007/s00531-009-0429-1; AITCHISON J, 1980, BIOMETRIKA, V67, P261, DOI 10.2307/2335470; Mongelli G, 2006, GEOCHEM J, V40, P197, DOI 10.2343/geochemj.40.197; Zecchin M, 2011, MAR GEOL, V281, P43, DOI 10.1016/j.margeo.2011.02.003; Perri F, 2008, INT GEOL REV, V50, P1116, DOI 10.2747/0020-6814.50.12.1116; Critelli S, 1998, INT GEOL REV, V40, P609; Critelli S, 2012, REND ONLINE SOC GEOL, V21, P959; CRITELLI S., 2013, RENDICONTI ONLINE SO, V25, P21; Critelli S, 2008, J GEOL, V116, P375, DOI 10.1086/588833; Del Ben A, 1993, B GEOFIS TEOR APPL, V35, P339; Finetti I, 1976, B GEOFIS TEOR APPL, V13, P1; Oebius HU, 2001, DEEP-SEA RES PT II, V48, P3453, DOI 10.1016/S0967-0645(01)00052-2; Perri F, 2011, ITAL J GEOSCI, V130, P318, DOI 10.3301/IJG.2011.04; Perri F, 2012, GEOL MAG, V149, P423, DOI 10.1017/S001675681100094X; Perri F, 2014, PALAEOGEOGR PALAEOCL, V395, P144, DOI 10.1016/j.palaeo.2013.12.029; Perri F, 2012, SEDIMENT GEOL, V280, P244, DOI 10.1016/j.sedgeo.2012.01.007; Perri F, 2014, ITAL J GEOSCI, V133, P101, DOI 10.3301/IJG.2013.17; Pescatore T., 1988, MEM SOC GEOL ITAL, V41, P353; Pescatore T., 1986, INT ASS SEDIMENTOLOG, V8, P169; R Development Core Team, 2009, R LANG ENV STAT COMP; Reyment RA, 1999, GFF, V121, P49; ROMAGNOLI C., 1990, GIORNALE GEOLOGIA, V52, P33; ROSSI S, 1983, MAR GEOL, V51, P327, DOI 10.1016/0025-3227(83)90110-X; Senatore MR, 1987, MEM SOC GEOL ITAL, V38, P177; Senatore MR, 1988, MEM SOC GEOL ITAL, V41, P533; Weltje GJ, 2002, EARTH-SCI REV, V57, P211, DOI 10.1016/S0012-8252(01)00076-9	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1437-3254	1437-3262		INT J EARTH SCI	Int. J. Earth Sci.	JUL	2015	104	5					1353	1364		10.1007/s00531-015-1150-x		12	Geosciences, Multidisciplinary	Geology	CK8BI	WOS:000356462200014		
